supplement,contraindications,condition,problem_category,category,category_source,indication_summary,indication_summary_confidence,pmid,year,title,study_design,outcome_direction,notes,doses,demographics,study_categories,source_conditions,original_labels,evidence_tier_study,evidence_tier_confidence,evidence_tier_rationale
5-hydroxytrytophan,adverse events leading to treatment suspension in 4 patients; nausea; nausea in three participants; vomiting,Tension Headache,,Musculoskeletal & Pain,manual_pair,"The evidence for 5-hydroxytryptophan in the prophylaxis of chronic tension-type headache is low and mixed. A single randomized controlled trial reported no significant changes in headache frequency or intensity, although there was a noted decrease in analgesic consumption and a favorable subjective opinion among participants at a dose of 300 mg per day for 8 weeks. Overall, the findings do not support a clear benefit for this supplement in this indication.",0.8,10849040,2000,"L-5-Hydroxytryptophan in the prophylaxis of chronic tension-type headache: a double-blind, randomized, placebo-controlled study. For the Portuguese Head Society.",randomized_controlled_trial,mixed_unclear,"While there was no significant change in headache frequency or intensity, there was a decrease in analgesic consumption and a favorable subjective opinion during follow-up.",300 mg per day 8 weeks,,,chronic tension-type headache,chronic tension-type headache,Tier 1,0.74,"Parallel, double-blind, randomized, placebo-controlled human RCT directly testing 5-HTP for chronic tension-type headache with primary clinical headache outcomes. Sample size is moderate (78 randomized, 65 analyzed) with good methods. Although results were mixed (no significant change in frequency/intensity during treatment but reduced analgesic use and post-treatment improvement), the study design and relevance meet Tier 1 criteria."
5-hydroxytrytophan,adverse events leading to treatment suspension in 4 patients; nausea; nausea in three participants; vomiting,Depression,,"Energy, Mood, & Mental Health",manual_pair,"The clinical evidence for 5-hydroxytryptophan (5-HTP) in treating depression is positive, with four studies reporting significant benefits. Doses varied, with some studies using 50 mg daily, 100 mg twice daily, and a single dose of 200 mg. No adverse effects were reported in the reviewed studies, but the overall quality and consistency of the evidence should be considered when interpreting these findings.",0.9,32067288,2020,Efficacy and safety of 5-hydroxytryptophan on depression and apathy in Parkinson's disease: a preliminary finding.,randomized_controlled_trial,benefit,"The study shows significant improvement in depressive symptoms with 5-HTP compared to placebo, indicating a clinical benefit.",50 mg daily 4 weeks,Parkinson's Disease,,apathy,apathy; depression; first depressive episode; major depressive disorder; neuroendocrine response; parkinson's disease; snri-resistant depression; ssri-resistant depression,Tier 2,0.62,"Randomized, double-blind, placebo-controlled cross-over trial (n=25) in Parkinson’s patients assessed depression as a primary outcome and found significant improvement on HDRS with 5-HTP vs placebo. However, the study is small, short (4 weeks), single-center, and in a specific population (PD), limiting generalizability to broader depression. Thus, moderate human evidence."
5-hydroxytrytophan,adverse events leading to treatment suspension in 4 patients; nausea; nausea in three participants; vomiting,Depression,,"Energy, Mood, & Mental Health",manual_pair,"The clinical evidence for 5-hydroxytryptophan (5-HTP) in treating depression is positive, with four studies reporting significant benefits. Doses varied, with some studies using 50 mg daily, 100 mg twice daily, and a single dose of 200 mg. No adverse effects were reported in the reviewed studies, but the overall quality and consistency of the evidence should be considered when interpreting these findings.",0.9,23380314,2013,Comparative study of efficacy of l-5-hydroxytryptophan and fluoxetine in patients presenting with first depressive episode.,randomized_controlled_trial,benefit,"The study shows significant antidepressant effects of l-5-HTP, indicating a benefit in treating depression.",8 weeks,,,depression,apathy; depression; first depressive episode; major depressive disorder; neuroendocrine response; parkinson's disease; snri-resistant depression; ssri-resistant depression,Tier 2,0.66,"Double-blind randomized controlled trial comparing 5-HTP to fluoxetine over 8 weeks with depression (HAM-D) as the primary clinical outcome. Findings showed similar and significant improvement, indicating benefit. However, the sample size was modest (n=60 completers), there was no placebo arm, and details on dosing are unclear, so strength is moderate rather than strong."
5-hydroxytrytophan,adverse events leading to treatment suspension in 4 patients; nausea; nausea in three participants; vomiting,Depression,,"Energy, Mood, & Mental Health",manual_pair,"The clinical evidence for 5-hydroxytryptophan (5-HTP) in treating depression is positive, with four studies reporting significant benefits. Doses varied, with some studies using 50 mg daily, 100 mg twice daily, and a single dose of 200 mg. No adverse effects were reported in the reviewed studies, but the overall quality and consistency of the evidence should be considered when interpreting these findings.",0.9,28787372,2017,An Open-Label Pilot Study of Combined Augmentation With Creatine Monohydrate and 5-Hydroxytryptophan for Selective Serotonin Reuptake Inhibitor- or Serotonin-Norepinephrine Reuptake Inhibitor-Resistant Depression in Adult Women.,clinical_trial,benefit,"The study showed a significant decrease in depression scores, indicating a benefit from the treatment.",100 mg twice daily 8 weeks,Women,,major depressive disorder,apathy; depression; first depressive episode; major depressive disorder; neuroendocrine response; parkinson's disease; snri-resistant depression; ssri-resistant depression,Tier 3,0.42,"Open-label, uncontrolled pilot in 15 women using 5-HTP combined with creatine as augmentation to ongoing SSRI/SNRI therapy. Although depression scores improved on a primary clinical outcome (HAM-D), the small size, lack of control/blinding, adjunctive design, and co-administration with creatine prevent attribution of effect to 5-HTP alone. Preliminary human evidence."
5-hydroxytrytophan,adverse events leading to treatment suspension in 4 patients; nausea; nausea in three participants; vomiting,Improved Social Cognition,,Cognitive & Neurological Function,manual_pair,"One randomized controlled trial suggests that 5-hydroxytryptophan (5-HTP) supplementation may improve social cognition and emotion recognition, particularly in older adults, over a 4-week period. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term effects and safety.",0.7,34737364,2021,Tryptophan-enriched diet or 5-hydroxytryptophan supplementation given in a randomized controlled trial impacts social cognition on a neural and behavioral level.,randomized_controlled_trial,benefit,"The study shows benefits in social cognition and emotion recognition with 5-HTP supplementation, particularly in older participants.",4 weeks,,,emotion recognition,emotion recognition; moral evaluation; social cognition,Tier 2,0.58,"Double-blind, placebo-controlled RCT (n=77) tested 5-HTP on social-cognitive tasks, making the indication a primary outcome. 5-HTP acutely altered moral evaluation (more reprehensible ratings), indicating a behavioral effect relevant to social cognition. However, improvements in emotion recognition were reported for tryptophan (dietary) in older participants, not clearly for 5-HTP, and some endpoints were neuroimaging with uncertain clinical significance. Acute dosing and limited scope of effects reduce strength from Tier 1."
5-hydroxytrytophan,adverse events leading to treatment suspension in 4 patients; nausea; nausea in three participants; vomiting,Weight Loss,,Weight & Body Composition,manual_pair,"Human clinical evidence suggests that 5-hydroxytryptophan (5-HTP) may have beneficial effects on body weight, with two randomized controlled trials reporting significant reductions in fat mass and improvements in satiety and BMI. Doses reported include 100 mg daily and an oral spray over four weeks. However, the overall evidence is limited and further research is needed to confirm these findings and assess long-term safety.",0.7,35583055,2023,The Effects of 5-HTP on Body Composition: An 8-Week Preliminary RCT.,randomized_controlled_trial,benefit,"The study found a significant decrease in fat mass in the 5-HTP group, indicating a benefit.",100 mg daily 8 weeks (CLEANMOOD™),,,body composition,body composition; fat mass; hunger; overweight; satiety,Tier 2,0.58,"This is a human randomized controlled trial reporting a significant reduction in fat mass with 5-HTP, a clinically relevant outcome for weight loss. However, it is a small, preliminary 8-week study in exercise-trained individuals with limited methodological detail (e.g., blinding not specified), reducing generalizability and strength versus larger, well-powered trials."
5-hydroxytrytophan,adverse events leading to treatment suspension in 4 patients; nausea; nausea in three participants; vomiting,Weight Loss,,Weight & Body Composition,manual_pair,"Human clinical evidence suggests that 5-hydroxytryptophan (5-HTP) may have beneficial effects on body weight, with two randomized controlled trials reporting significant reductions in fat mass and improvements in satiety and BMI. Doses reported include 100 mg daily and an oral spray over four weeks. However, the overall evidence is limited and further research is needed to confirm these findings and assess long-term safety.",0.7,22142813,2012,"Relationship between the absorption of 5-hydroxytryptophan from an integrated diet, by means of Griffonia simplicifolia extract, and the effect on satiety in overweight females after oral spray administration.",randomized_controlled_trial,benefit,The study shows significant benefits in satiety and BMI reduction with 5-hydroxytryptophan supplementation.,4 weeks (oral spray),Overweight; Women,,hunger,body composition; fat mass; hunger; overweight; satiety,Tier 2,0.6,"Double-blind, randomized, placebo-controlled trial showing significant between-group reductions in BMI and appetite in overweight women over 4 weeks. However, the sample size is very small (n=20), weight loss was a secondary outcome (primary was a PK surrogate), and duration was short with a concomitant calorie-restricted diet in both arms. These factors support moderate, not strong, human evidence for weight loss."
5-hydroxytrytophan,adverse events leading to treatment suspension in 4 patients; nausea; nausea in three participants; vomiting,Cognitive Performance,,Cognitive & Neurological Function,manual_pair,"Current clinical evidence on 5-hydroxytryptophan (5-HTP) for executive function is limited and indicates potential harm, as a study found that 50 mg doses taken three times daily significantly increased task completion time, suggesting a disruption in dopaminergic function. No studies reported benefits or mixed outcomes, leading to a conclusion of no evidence supporting its use for this indication.",1.0,23609610,2013,Effects of oral 5-hydroxytryptophan on a standardized planning task: insight into possible dopamine/serotonin interactions in the forebrain.,randomized_controlled_trial,harm,"5-HTP significantly lengthened the time to complete tasks, indicating a disruption in dopaminergic function.",50 mg three times (capsules),,,executive function,executive function,Tier 1,0.72,"Human randomized controlled trial (n=68) directly assessed cognitive performance (Tower of London planning task) after 5-HTP vs placebo. The outcome was a primary cognitive measure and showed significant impairment (longer completion time). While acute and limited to a specific task with blinding not explicitly stated, the design and direct relevance support strong human evidence for this indication."
5-hydroxytrytophan,adverse events leading to treatment suspension in 4 patients; nausea; nausea in three participants; vomiting,Obsessive-Compulsive Disorder,,"Energy, Mood, & Mental Health",manual_pair,"One randomized controlled trial found that 5-hydroxytryptophan, at a dose of 100 mg twice daily for 12 weeks, significantly improved symptoms of moderate to severe obsessive-compulsive disorder when used as an adjuvant therapy. However, the overall evidence is limited, with only one study reporting a benefit and no data on potential adverse effects or long-term outcomes.",0.7,32541380,2020,5-Hydroxytryptophan as adjuvant therapy in treatment of moderate to severe obsessive-compulsive disorder: a double-blind randomized trial with placebo control.,randomized_controlled_trial,benefit,The study shows significant improvement in OCD symptoms with 5-hydroxytryptophan augmentation therapy.,100 mg twice daily 12 weeks,,,obsessive-compulsive disorder,obsessive-compulsive disorder,Tier 2,0.7,"A double-blind, placebo-controlled RCT (n=60) found significant improvement in Y-BOCS scores with 5-HTP augmentation of fluoxetine over 12 weeks. The indication was a primary clinical outcome and results favored 5-HTP. However, the sample size is modest and it is a single adjunctive study, supporting moderate rather than strong evidence."
5-hydroxytrytophan,adverse events leading to treatment suspension in 4 patients; nausea; nausea in three participants; vomiting,Panic Attacks,,"Energy, Mood, & Mental Health",manual_pair,"One randomized trial indicates that acute administration of L-5-hydroxytryptophan at a dose of 200 mg may significantly reduce panic reactions in patients with panic disorder. However, the overall evidence is limited, with only one study reporting a benefit and no data on potential adverse effects or long-term outcomes.",0.7,12559480,2002,Acute L-5-hydroxytryptophan administration inhibits carbon dioxide-induced panic in panic disorder patients.,randomized_controlled_trial,benefit,"L-5-Hydroxytryptophan significantly reduced panic reactions in patients, indicating a beneficial effect.",200 mg,,,panic disorder,panic disorder,Tier 2,0.6,"Randomized, placebo-controlled human trial in panic disorder patients showed 200 mg 5-HTP acutely reduced panic/anxiety and number of panic attacks during a CO2 challenge. However, the sample was small and the outcome was based on an experimental provocation model rather than real-world panic frequency, limiting strength despite being an RCT."
5-hydroxytrytophan,adverse events leading to treatment suspension in 4 patients; nausea; nausea in three participants; vomiting,Panic Attacks,,"Energy, Mood, & Mental Health",manual_pair,"The evidence regarding 5-hydroxytryptophan for panic disorder is mixed and unclear, with one study reporting nonsignificant differences in panic rates based on gender at a dose of 200 mg. No studies demonstrated a clear benefit or harm, indicating a lack of consistent efficacy for this indication.",0.7,15260907,2004,The effect of 5-hydroxytryptophan on cholecystokinin-4-induced panic attacks in healthy volunteers.,randomized_controlled_trial,mixed_unclear,"The results showed a nonsignificant difference in panic rates, indicating mixed outcomes based on gender.",200 mg (capsules),,,panic disorder,panic disorder,Tier 4,0.68,"This is a small randomized, double-blind trial in healthy volunteers using a cholecystokinin-4 challenge to induce panic-like symptoms, not a clinical population with spontaneous panic attacks. Overall effects were nonsignificant with only subgroup gender effects. Because the outcome is an experimental model rather than clinical panic attacks, the evidence is indirect and low for the stated indication."
5-hydroxytrytophan,adverse events leading to treatment suspension in 4 patients; nausea; nausea in three participants; vomiting,Sleep Quality,,Sleep,manual_pair,"Human clinical evidence suggests that 5-hydroxytryptophan (5-HTP) may improve sleep quality in certain populations, with two randomized controlled trials reporting beneficial effects at doses of 50 mg to 100 mg daily. However, the evidence is limited to specific groups, and further research is needed to confirm these findings and assess long-term safety and efficacy.",0.8,38309227,2024,The impact of 5-hydroxytryptophan supplementation on sleep quality and gut microbiota composition in older adults: A randomized controlled trial.,randomized_controlled_trial,benefit,"5-HTP supplementation showed a favorable effect on sleep quality, particularly in poor sleepers, indicating a benefit.",100 mg daily 12 weeks,Older Adults,,gut microbiota composition,gut microbiota composition; parkinson's disease; rem sleep behavior disorder; sleep quality,Tier 2,0.67,"Single-blind randomized controlled trial in older adults (n=30) with sleep quality as a primary outcome (PSQI and actigraphy). Shows benefit, particularly in poor sleepers, but limited by small sample size and weaker blinding. Therefore, moderate human evidence for 5-HTP improving sleep quality."
5-hydroxytrytophan,adverse events leading to treatment suspension in 4 patients; nausea; nausea in three participants; vomiting,Sleep Quality,,Sleep,manual_pair,"Human clinical evidence suggests that 5-hydroxytryptophan (5-HTP) may improve sleep quality in certain populations, with two randomized controlled trials reporting beneficial effects at doses of 50 mg to 100 mg daily. However, the evidence is limited to specific groups, and further research is needed to confirm these findings and assess long-term safety and efficacy.",0.8,34403081,2022,"Preliminary finding of a randomized, double-blind, placebo-controlled, crossover study to evaluate the safety and efficacy of 5-hydroxytryptophan on REM sleep behavior disorder in Parkinson's disease.",randomized_controlled_trial,benefit,"5-HTP improved sleep stability and motor experiences in patients, indicating a beneficial effect.",50 mg daily 4 weeks,Parkinson's Disease,,parkinson's disease,gut microbiota composition; parkinson's disease; rem sleep behavior disorder; sleep quality,Tier 3,0.45,"Single small randomized, double-blind, placebo-controlled crossover trial (n=18) in Parkinson’s disease patients with REM sleep behavior disorder. Sleep quality was not the primary outcome and improvements in sleep-related measures (arousal index, wake after sleep onset) were marginal and not statistically significant versus placebo; REM% increased but is a surrogate. Self-reported improvements occurred with both 5-HTP and placebo. Short duration (4 weeks) and narrow population limit generalizability to overall sleep quality."
5-hydroxytrytophan,adverse events leading to treatment suspension in 4 patients; nausea; nausea in three participants; vomiting,Stress,,"Energy, Mood, & Mental Health",manual_pair,"The evidence for 5-hydroxytryptophan in alleviating romantic stress is limited, with one open-label trial reporting significant improvements in stress scores at a dose of 12.8 mg b.i.d. for 6 weeks. No adverse effects were noted, but the overall quality of evidence is low due to the lack of randomized controlled trials and mixed findings in the literature.",0.6,21178946,2010,An open-label trial of L-5-hydroxytryptophan in subjects with romantic stress.,clinical_trial,benefit,"The study showed significant improvements in romantic stress scores, indicating a benefit from the intervention.",12.8 mg b.i.d. 6 weeks (Griffonia simplicifolia extract),,,psychological suffering associated with unreciprocated romantic love,psychological suffering associated with unreciprocated romantic love; romantic stress,Tier 3,0.39,"Single small open-label, uncontrolled pilot (n=15) assessing self-reported romantic stress. While the outcome is symptom-based and relevant to stress, the study lacks a control group and blinding, and focuses on a narrow form of stress, limiting generalizability."
Alpha-GPC,,Cognitive Performance,,Cognitive & Neurological Function,manual_pair,"One randomized trial reported that acute supplementation with Alpha-GPC (doses of 315 mg and 630 mg) resulted in significant improvements in cognitive performance in healthy men, indicating a potential benefit for cognitive enhancement. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term effects and safety.",0.7,39683633,2024,Acute Alpha-Glycerylphosphorylcholine Supplementation Enhances Cognitive Performance in Healthy Men.,randomized_controlled_trial,benefit,"The study found significant improvements in cognitive performance, indicating a benefit from Alpha-GPC supplementation.",630 mg single dose acute (GeniusPure®); 315 mg single dose acute (GeniusPure®),Men,,cognition enhancement,cognition enhancement; cognitive performance,Tier 2,0.62,"Randomized, double-blind, placebo-controlled crossover RCT in healthy men showed significant acute improvements on validated cognitive measures (Stroop) at two doses. However, the sample size was small (n=20), effects were acute (single-dose), and the population was limited to young, resistance-trained males, limiting generalizability and durability of effect. Thus, moderate human evidence."
Alpha-GPC,,Cardiac Recovery,,Performance & Recovery,manual_pair,"There is limited evidence suggesting that Alpha-GPC may have a beneficial effect on recovery of heart rate variability and blood pressure following exercise in overweight and obese women, based on a single study using a 1000 mg dose. Overall, the evidence is sparse and further research is needed to confirm these findings and assess long-term effects and safety.",0.7,36235623,2022,The Effects of Alpha-Glycerylphosphorylcholine on Heart Rate Variability and Hemodynamic Variables Following Sprint Interval Exercise in Overweight and Obese Women.,randomized_controlled_trial,benefit,"The study found that A-GPC consumption improved recovery of HRV and blood pressure after exercise, indicating a beneficial effect.",1000 mg single dose,Obese; Overweight; Women,,obesity,obesity; overweight,Tier 3,0.64,"Randomized, double-blind crossover trial (n=12) showing faster post-exercise recovery of HRV and blood pressure after a single 1000 mg dose of Alpha-GPC in overweight/obese women. While well-controlled, the sample is small and outcomes are surrogate (autonomic/hemodynamic recovery after exercise) rather than clinical cardiac recovery endpoints, and the indication ‘cardiac recovery’ is broader than the study’s specific context."
Alpha-GPC,,Athletic Performance,,Performance & Recovery,manual_pair,"Alpha-GPC supplementation has shown a benefit in improving exercise performance, specifically in peak power and time to fatigue, based on one randomized crossover trial that administered 300 mg daily for 7 days. However, the evidence is limited, as only one study supports this finding, and further research is needed to confirm its efficacy and safety in broader populations.",0.7,37229544,2023,"Effects of branched chain amino acids, l-citrulline, and alpha-glycerylphosphorylcholine supplementation on exercise performance in trained cyclists: a randomized crossover trial.",randomized_controlled_trial,benefit,"The study showed significant improvements in peak power and time to fatigue, indicating a benefit from the supplementation.","300 mg daily 7 days (supplement containing BCAAs, L-citrulline, and A-GPC)",Cycling,,athletic performance,athletic performance; exercise performance; fatigue,Tier 4,0.74,"Randomized, double-blind, crossover RCT in trained cyclists with direct performance outcomes showed benefit, but the intervention was a multi-ingredient supplement (BCAAs, L-citrulline, and alpha-GPC). Because the effect cannot be attributed to alpha-GPC alone, this provides indirect human evidence for alpha-GPC and athletic performance."
Alpha-GPC,,Increase Motivation,,"Energy, Mood, & Mental Health",manual_pair,"One randomized, placebo-controlled study reported that Alpha-GPC may increase motivation in healthy volunteers over a two-week period, suggesting a potential benefit. However, the evidence is limited to a single study, and further research is needed to confirm these findings and establish consistent dosing and safety profiles.",0.6,34207484,2021,"Alpha-Glycerylphosphorylcholine Increases Motivation in Healthy Volunteers: A Single-Blind, Randomized, Placebo-Controlled Human Study.",randomized_controlled_trial,benefit,"The study found a tendency to increase motivation, indicating a positive outcome direction.",two weeks,,,anxiety,anxiety; motivation,Tier 2,0.44,"Single-blind, randomized, placebo-controlled human study (n≈39) directly assessed motivation via self-reported KOKORO scale over two weeks. Results showed a trend with significant improvement mainly at night, indicating modest effects. Small sample, weak blinding, short duration, healthy volunteers, and subjective outcomes limit robustness but still constitute controlled human evidence relevant to the indication."
Apigenin,,Skin Aging Prevention,,"Skin, Hair, & Nails",manual_pair,"One study indicates that apigenin, when applied as a cream, may improve skin elasticity, reduce fine wrinkles, and enhance skin moisture, suggesting a beneficial effect on signs of skin aging. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term safety and efficacy.",0.7,27279007,2016,Apigenin inhibits UVA-induced cytotoxicity in vitro and prevents signs of skin aging in vivo.,randomized_controlled_trial,benefit,"The study demonstrated that apigenin improved skin elasticity, reduced fine wrinkles, and enhanced skin moisture, indicating a beneficial effect on skin aging.",(cream),,,skin aging,skin aging,Tier 2,0.62,"Randomized controlled human trial of apigenin cream versus vehicle reported improvements in clinically relevant skin aging outcomes (elasticity, fine wrinkles, moisture, TEWL). These are major outcomes for the indication. However, key methodological details (sample size, blinding, duration) are not provided and the study appears modest in scale, so the evidence is moderate rather than strong. Outcomes reflect improvement/prevention of signs rather than long-term prevention of aging."
Ashwagandha,adverse events were mild and transient; epigastric discomfort; few mild and temporary adverse effects reported; increased urinary mercury levels observed after treatment; loose stools; mild to moderate adverse events reported; somnolence,Stress,,"Energy, Mood, & Mental Health",manual_pair,"Clinical evidence from four randomized, double-blind, placebo-controlled studies indicates that ashwagandha may be effective in reducing anxiety and stress levels. Reported doses range from 240 mg to 1000 mg of standardized extracts, with no studies indicating harm or lack of benefit. However, the overall quality of evidence remains limited to the studies presented, and further research may be necessary to confirm these findings.",0.9,37832082,2023,"A standardized Ashwagandha root extract alleviates stress, anxiety, and improves quality of life in healthy adults by modulating stress hormones: Results from a randomized, double-blind, placebo-controlled study.",randomized_controlled_trial,benefit,"The study demonstrated significant improvements in stress and anxiety levels, indicating a beneficial effect of Ashwagandha.",500 mg once daily 60 days (standardized Ashwagandha root extract),,,anxiety,anxiety; depression; energy levels; high stress; mental clarity; schizophrenia; sleep quality; stress,Tier 2,0.66,"Randomized, double-blind, placebo-controlled RCT with stress as a primary outcome (PSS, GAD-7) showed significant benefit. However, the sample size was small (n≈54 randomized, 50 completed) and it is a single study, so evidence is moderate rather than strong."
Ashwagandha,adverse events were mild and transient; epigastric discomfort; few mild and temporary adverse effects reported; increased urinary mercury levels observed after treatment; loose stools; mild to moderate adverse events reported; somnolence,Stress,,"Energy, Mood, & Mental Health",manual_pair,"Clinical evidence from four randomized, double-blind, placebo-controlled studies indicates that ashwagandha may be effective in reducing anxiety and stress levels. Reported doses range from 240 mg to 1000 mg of standardized extracts, with no studies indicating harm or lack of benefit. However, the overall quality of evidence remains limited to the studies presented, and further research may be necessary to confirm these findings.",0.9,35984870,2022,"The Perceived Impact of Ashwagandha on Stress, Sleep Quality, Energy, and Mental Clarity for College Students: Qualitative Analysis of a Double-Blind Randomized Control Trial.",randomized_controlled_trial,benefit,"The study demonstrated that ashwagandha improved perceived well-being in college students, indicating a beneficial outcome.",700 mg twice a day 30 days (full spectrum extract of ashwagandha root),,Sleep,anxiety,anxiety; depression; energy levels; high stress; mental clarity; schizophrenia; sleep quality; stress,Tier 3,0.48,"This is a double-blind randomized controlled trial, but the reported analysis is qualitative, focusing on perceived well-being and experiential outcomes rather than validated, quantitative stress measures. Sample size and methodological details are unclear, and outcomes appear exploratory. Thus, it provides preliminary human evidence for stress, short of robust primary quantitative endpoints."
Ashwagandha,adverse events were mild and transient; epigastric discomfort; few mild and temporary adverse effects reported; increased urinary mercury levels observed after treatment; loose stools; mild to moderate adverse events reported; somnolence,Stress,,"Energy, Mood, & Mental Health",manual_pair,"Clinical evidence from four randomized, double-blind, placebo-controlled studies indicates that ashwagandha may be effective in reducing anxiety and stress levels. Reported doses range from 240 mg to 1000 mg of standardized extracts, with no studies indicating harm or lack of benefit. However, the overall quality of evidence remains limited to the studies presented, and further research may be necessary to confirm these findings.",0.9,31517876,2019,"An investigation into the stress-relieving and pharmacological actions of an ashwagandha (Withania somnifera) extract: A randomized, double-blind, placebo-controlled study.",randomized_controlled_trial,benefit,"The study showed significant reductions in anxiety and stress levels, indicating a benefit from ashwagandha supplementation.",240 mg once daily 60 days (standardized extract),,,anxiety,anxiety; depression; energy levels; high stress; mental clarity; schizophrenia; sleep quality; stress,Tier 2,0.6,"Randomized, double-blind, placebo-controlled RCT in stressed adults (n=60) using 240 mg/day standardized ashwagandha for 60 days. Methods are solid but sample size is modest. Clinically relevant stress/anxiety outcomes were assessed; anxiety (HAM-A) improved significantly, while the DASS-21 (which includes stress) showed only a near-significant trend. Physiologic HPA-axis markers improved. Overall, this constitutes moderate human evidence for stress, but not strong due to size and borderline stress-specific results."
Ashwagandha,adverse events were mild and transient; epigastric discomfort; few mild and temporary adverse effects reported; increased urinary mercury levels observed after treatment; loose stools; mild to moderate adverse events reported; somnolence,Stress,,"Energy, Mood, & Mental Health",manual_pair,"Clinical evidence from four randomized, double-blind, placebo-controlled studies indicates that ashwagandha may be effective in reducing anxiety and stress levels. Reported doses range from 240 mg to 1000 mg of standardized extracts, with no studies indicating harm or lack of benefit. However, the overall quality of evidence remains limited to the studies presented, and further research may be necessary to confirm these findings.",0.9,31046033,2019,"Effects of a standardized extract of Withania somnifera (Ashwagandha) on depression and anxiety symptoms in persons with schizophrenia participating in a randomized, placebo-controlled clinical trial.",randomized_controlled_trial,benefit,The study shows a medium effect size indicating a benefit in reducing depression and anxiety symptoms in patients with schizophrenia.,1000 mg 12 weeks (standardized extract),Schizophrenia,,anxiety,anxiety; depression; energy levels; high stress; mental clarity; schizophrenia; sleep quality; stress,Tier 5,0.8,"This RCT examined adjunctive ashwagandha for depression and anxiety symptoms in schizophrenia using PANSS subscores; it did not assess stress (e.g., perceived stress) and the population/endpoint are not aligned with the indication of stress. As such, it does not provide direct evidence for stress."
Ashwagandha,adverse events were mild and transient; epigastric discomfort; few mild and temporary adverse effects reported; increased urinary mercury levels observed after treatment; loose stools; mild to moderate adverse events reported; somnolence,Menopause Symptoms,,Women's Health,manual_pair,"One randomized, double-blind, placebo-controlled study found that ashwagandha (300 mg twice daily for 8 weeks) significantly improved climacteric symptoms and quality of life in perimenopausal women. No studies reported mixed results or harm, but the overall evidence is limited to a single trial, indicating a need for further research to confirm these findings.",0.7,34553463,2021,"Effect of an ashwagandha (Withania Somnifera) root extract on climacteric symptoms in women during perimenopause: A randomized, double-blind, placebo-controlled study.",randomized_controlled_trial,benefit,"The study showed significant improvements in climacteric symptoms and quality of life, indicating a beneficial effect of ashwagandha.",300 mg twice daily 8 weeks (root extract),Menopause; Women,,climacteric symptoms,climacteric symptoms; perimenopause,Tier 1,0.8,"Randomized, double-blind, placebo-controlled RCT (n=100; 91 completers) in perimenopausal women showed significant improvements in validated clinical scales for climacteric/menopause symptoms (MRS, MENQoL) and hot flashes over 8 weeks with ashwagandha root extract 300 mg twice daily. Outcomes were primary, clinically meaningful, and the study methods and size are adequate. Confidence is slightly tempered by the single short-duration study and focus on perimenopause specifically."
Ashwagandha,adverse events were mild and transient; epigastric discomfort; few mild and temporary adverse effects reported; increased urinary mercury levels observed after treatment; loose stools; mild to moderate adverse events reported; somnolence,Cognitive Performance,,Cognitive & Neurological Function,manual_pair,"One randomized trial indicates that ashwagandha supplementation (225 mg daily for 30 days) may improve cognitive function and mood in individuals with cognitive impairment. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term effects and safety.",0.8,38931168,2024,Acute and Repeated Ashwagandha Supplementation Improves Markers of Cognitive Function and Mood.,randomized_controlled_trial,benefit,"The study shows that ashwagandha supplementation improves cognitive function and mood, indicating a beneficial outcome.",225 mg daily 30 days (liposomal ashwagandha root and leaf extract),,"Energy, Mood, & Mental Health",cognitive function,cognitive function; fatigue; mood; stress; tension,Tier 2,0.64,"Randomized, double-blind, placebo-controlled trial in healthy adults directly tested cognitive performance and showed benefits. However, the sample size (n≈59) is modest, outcomes span multiple cognitive subtests (risk of multiplicity), and the trial was retrospectively registered, lowering methodological robustness. Overall, moderate human evidence for cognitive performance."
Ashwagandha,adverse events were mild and transient; epigastric discomfort; few mild and temporary adverse effects reported; increased urinary mercury levels observed after treatment; loose stools; mild to moderate adverse events reported; somnolence,Weight Loss,,Weight & Body Composition,manual_pair,"One randomized controlled trial reported a beneficial effect of ashwagandha (300 mg twice daily for 8 weeks) on body weight management in adults under chronic stress. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term effects and safety.",0.7,27055824,2017,"Body Weight Management in Adults Under Chronic Stress Through Treatment With Ashwagandha Root Extract: A Double-Blind, Randomized, Placebo-Controlled Trial.",randomized_controlled_trial,benefit,"The study reports significant improvements in body weight management and stress-related measures, indicating a beneficial outcome.",300 mg twice daily 8 weeks (root extract),,,body weight management,body weight management; chronic stress,Tier 2,0.63,"A double-blind, randomized, placebo-controlled trial (n=52) reported beneficial effects on body weight/BMI, but weight outcomes were secondary (primary outcomes were stress and food cravings). The study was small and short (8 weeks) and focused on adults under chronic stress. This supports moderate human evidence for weight loss, not strong primary evidence."
Ashwagandha,adverse events were mild and transient; epigastric discomfort; few mild and temporary adverse effects reported; increased urinary mercury levels observed after treatment; loose stools; mild to moderate adverse events reported; somnolence,Fatigue,,"Energy, Mood, & Mental Health",manual_pair,"The clinical evidence regarding ashwagandha for fatigue is mixed, with two randomized, double-blind, placebo-controlled trials reporting unclear outcomes. One study indicated a reduction in fatigue symptoms, while the other showed improvements in fatigue and vigor without significant between-group differences. Doses reported include 200 mg of a root extract twice daily and 21 mg of an extract daily, but overall, the findings do not consistently support a clear benefit for fatigue relief.",0.8,37740662,2023,"Exploring the efficacy and safety of a novel standardized ashwagandha (Withania somnifera) root extract (Witholytin®) in adults experiencing high stress and fatigue in a randomized, double-blind, placebo-controlled trial.",randomized_controlled_trial,mixed_unclear,"Ashwagandha showed no significant benefit in reducing perceived stress but did show a significant reduction in fatigue symptoms, indicating mixed outcomes.",200 mg twice daily 12 weeks (root extract),Older Adults; Overweight,,fatigue,fatigue; psychological well-being; sexual well-being; stress; vigor,Tier 2,0.6,"Double-blind, placebo-controlled RCT in older overweight adults with stress/fatigue found significant improvement in fatigue on secondary outcomes, while the primary outcome (perceived stress) was not superior to placebo. The indication (fatigue) was not the primary endpoint but is clinically relevant, supporting moderate human evidence from a well-designed single trial with mixed overall results."
Ashwagandha,adverse events were mild and transient; epigastric discomfort; few mild and temporary adverse effects reported; increased urinary mercury levels observed after treatment; loose stools; mild to moderate adverse events reported; somnolence,Fatigue,,"Energy, Mood, & Mental Health",manual_pair,"The clinical evidence regarding ashwagandha for fatigue is mixed, with two randomized, double-blind, placebo-controlled trials reporting unclear outcomes. One study indicated a reduction in fatigue symptoms, while the other showed improvements in fatigue and vigor without significant between-group differences. Doses reported include 200 mg of a root extract twice daily and 21 mg of an extract daily, but overall, the findings do not consistently support a clear benefit for fatigue relief.",0.8,30854916,2019,"A Randomized, Double-Blind, Placebo-Controlled, Crossover Study Examining the Hormonal and Vitality Effects of Ashwagandha ( Withania somnifera) in Aging, Overweight Males.",randomized_controlled_trial,mixed_unclear,"The study showed improvements in fatigue and vigor, but no significant between-group differences were found, leading to a mixed outcome classification.",21 mg daily 8 weeks (ashwagandha extract (Shoden beads)),,,fatigue,fatigue; psychological well-being; sexual well-being; stress; vigor,Tier 2,0.66,"Randomized, double-blind, placebo-controlled crossover trial in humans with fatigue as a primary/major outcome. However, the sample size was modest and no significant between-group differences were found for fatigue/vigor, limiting the strength despite good methodology."
Ashwagandha,adverse events were mild and transient; epigastric discomfort; few mild and temporary adverse effects reported; increased urinary mercury levels observed after treatment; loose stools; mild to moderate adverse events reported; somnolence,Increase Satiety,,Weight & Body Composition,manual_pair,"One double-blind randomized controlled trial found that ashwagandha (700 mg daily for 30 days) had a beneficial effect on food cravings among college students. There is currently limited evidence specifically addressing this indication, with no studies reporting mixed or negative outcomes. Further research is needed to confirm these findings and assess long-term effects and safety.",0.8,35984871,2022,"The Impact of Ashwagandha on Stress, Sleep Quality, and Food Cravings in College Students: Quantitative Analysis of a Double-Blind Randomized Control Trial.",randomized_controlled_trial,benefit,"The study showed that ashwagandha had a beneficial effect on stress, sleep quality, and food cravings in the college student population.",700 mg daily 30 days (full spectrum extract of ASH root),College Students,"Energy, Mood, & Mental Health",food cravings,food cravings; sleep quality; stress,Tier 3,0.49,"Single double-blind RCT in college students reported reduced food cravings, but satiety was not directly measured and cravings are an indirect surrogate for satiety. Short duration and limited population further constrain applicability to the specific indication of increasing satiety."
Ashwagandha,adverse events were mild and transient; epigastric discomfort; few mild and temporary adverse effects reported; increased urinary mercury levels observed after treatment; loose stools; mild to moderate adverse events reported; somnolence,Immune System Fortification,,"Immune, Inflammation, & Infection",manual_pair,"There is limited evidence suggesting that ashwagandha may enhance immune cell activation, as indicated by one study that reported significant increases in lymphocyte activation following a dose of 6 mL of root extract twice daily for 96 hours. However, due to the low number of studies and the lack of replication, the overall evidence remains weak and inconclusive.",0.5,19388865,2009,In vivo effects of Ashwagandha (Withania somnifera) extract on the activation of lymphocytes.,clinical_trial,benefit,"The study shows significant increases in immune cell activation, indicating a beneficial effect.",6 mL twice daily 96 hours (root extract),,,immune cell activation,immune cell activation,Tier 3,0.47,"Small, uncontrolled human pilot (n=5) measuring surrogate immunologic markers (CD4, CD56/CD69) over 96 hours. Shows in vivo biomarker changes suggesting immune activation, but no control group, very short duration, and no clinical immune outcomes. Fits weak/preliminary human evidence."
Ashwagandha,adverse events were mild and transient; epigastric discomfort; few mild and temporary adverse effects reported; increased urinary mercury levels observed after treatment; loose stools; mild to moderate adverse events reported; somnolence,Joint Pain,,Musculoskeletal & Pain,manual_pair,"The evidence for ashwagandha in treating joint pain from rheumatoid arthritis is limited, with only one pilot study reporting significant improvements in rheumatoid arthritis parameters after administering 5 g of ashwagandha powder twice daily for three weeks. Overall, the quality of evidence is low, and further research is needed to confirm these findings and assess long-term safety and efficacy.",0.7,25857501,2015,Efficacy & safety evaluation of Ayurvedic treatment (Ashwagandha powder & Sidh Makardhwaj) in rheumatoid arthritis patients: a pilot prospective study.,clinical_trial,benefit,"The study showed significant improvements in various rheumatoid arthritis parameters, indicating a benefit from the treatment.",5 g twice a day three weeks (powder),Rheumatoid Arthritis,,rheumatoid arthritis,rheumatoid arthritis,Tier 3,0.42,"Open-label, nonrandomized, uncontrolled human study in rheumatoid arthritis with clinically relevant joint pain outcomes (ACR responses, pain scores) showing benefit, but the intervention combined Ashwagandha with Sidh Makardhwaj and assessments were post-combination, making attribution to Ashwagandha alone uncertain and limiting evidential strength."
Ashwagandha,adverse events were mild and transient; epigastric discomfort; few mild and temporary adverse effects reported; increased urinary mercury levels observed after treatment; loose stools; mild to moderate adverse events reported; somnolence,Strength,,Performance & Recovery,manual_pair,"Two randomized, double-blind, placebo-controlled trials indicate that Ashwagandha (300 mg twice daily) may improve physical endurance and cardiorespiratory performance in healthy adults engaged in resistance training and athletic activities. No adverse effects were reported in these studies, suggesting a favorable safety profile; however, the overall evidence is limited to these two studies and further research may be needed to confirm these findings.",0.8,38988644,2023,"Effects of Ashwagandha ( Withania somnifera) standardized root extract on physical endurance and VO 2max in healthy adults performing resistance training: An eight-week, prospective, randomized, double-blind, placebo-controlled study.",randomized_controlled_trial,benefit,"The study demonstrated significant improvements in muscle strength, size, and endurance with Ashwagandha supplementation, indicating a clear benefit.",300 mg twice daily eight weeks (capsules),,,cardiorespiratory endurance,cardiorespiratory endurance; muscle size; muscle strength; stress management,Tier 1,0.82,"Randomized, double-blind, placebo-controlled RCT (~73 completers) testing standardized Ashwagandha root extract (600 mg/day) for 8 weeks alongside resistance training. Muscle strength (1RM bench press and leg press) was a primary outcome and showed significant improvements versus placebo in both sexes. Methods and sample size are adequate, outcomes are directly relevant to strength."
Ashwagandha,adverse events were mild and transient; epigastric discomfort; few mild and temporary adverse effects reported; increased urinary mercury levels observed after treatment; loose stools; mild to moderate adverse events reported; somnolence,Strength,,Performance & Recovery,manual_pair,"Two randomized, double-blind, placebo-controlled trials indicate that Ashwagandha (300 mg twice daily) may improve physical endurance and cardiorespiratory performance in healthy adults engaged in resistance training and athletic activities. No adverse effects were reported in these studies, suggesting a favorable safety profile; however, the overall evidence is limited to these two studies and further research may be needed to confirm these findings.",0.8,33600918,2021,"A double-blind, randomized, placebo-controlled trial on the effect of Ashwagandha (Withania somnifera dunal.) root extract in improving cardiorespiratory endurance and recovery in healthy athletic adults.",randomized_controlled_trial,benefit,"The study showed significant improvements in cardiorespiratory endurance and stress management without any reported adverse events, indicating a clear benefit from Ashwagandha supplementation.",300 mg twice daily 8-weeks (root extract capsules),,,cardiorespiratory endurance,cardiorespiratory endurance; muscle size; muscle strength; stress management,Tier 5,0.89,"This RCT evaluated cardiorespiratory endurance (VO2 max), stress/recovery questionnaires, and antioxidant levels in healthy athletic adults. It did not assess muscular strength outcomes (e.g., 1-RM, MVC). Therefore, it does not provide direct evidence for the indication of strength."
Ashwagandha,adverse events were mild and transient; epigastric discomfort; few mild and temporary adverse effects reported; increased urinary mercury levels observed after treatment; loose stools; mild to moderate adverse events reported; somnolence,Hypothyroidism,,Metabolic Health,manual_pair,"One randomized controlled trial reported a beneficial effect of ashwagandha (600 mg daily for 8 weeks) on thyroid indices in patients with subclinical hypothyroidism. However, the overall evidence is limited, with only one study available, and further research is needed to confirm these findings and assess long-term safety and efficacy.",0.7,28829155,2018,"Efficacy and Safety of Ashwagandha Root Extract in Subclinical Hypothyroid Patients: A Double-Blind, Randomized Placebo-Controlled Trial.",randomized_controlled_trial,benefit,"The study found significant improvements in thyroid indices, indicating a beneficial effect of ashwagandha in the treatment of subclinical hypothyroidism.",600 mg daily 8 weeks (root extract),,,subclinical hypothyroidism,subclinical hypothyroidism,Tier 2,0.63,"Double-blind, randomized, placebo-controlled trial (n≈50) in subclinical hypothyroidism showed significant improvements in TSH, T3, and T4 with 600 mg/day ashwagandha over 8 weeks. While methods are strong, the study is small, single-center, short in duration, and focused on lab indices rather than clinical symptoms, supporting moderate (not strong) human evidence for hypothyroidism."
Ashwagandha,adverse events were mild and transient; epigastric discomfort; few mild and temporary adverse effects reported; increased urinary mercury levels observed after treatment; loose stools; mild to moderate adverse events reported; somnolence,Improve Memory,,Cognitive & Neurological Function,manual_pair,"Clinical evidence from two randomized controlled trials indicates that ashwagandha may improve memory and cognitive functions. Doses reported in these studies include 300 mg of root extract twice daily and 250 mg of a specific extract daily, both showing beneficial effects in participants with mild cognitive impairment. No adverse effects were noted in the studies, but further research is needed to confirm these findings and assess long-term safety.",0.9,28471731,2017,Efficacy and Safety of Ashwagandha (Withania somnifera (L.) Dunal) Root Extract in Improving Memory and Cognitive Functions.,randomized_controlled_trial,benefit,"The study showed significant improvements in memory and cognitive functions, indicating a beneficial effect of ashwagandha.",300 mg twice daily eight weeks (root extract),,,cognitive function enhancement,cognitive function enhancement; memory improvement; mild cognitive impairment,Tier 2,0.62,"Randomized, double-blind, placebo-controlled RCT (n=50) showed significant improvements on validated memory tests with ashwagandha 300 mg BID over 8 weeks. Memory was a primary/major outcome. However, the study is a small pilot with short duration and conducted in adults with MCI, limiting generalizability and preventing classification as strong (Tier 1) evidence."
Ashwagandha,adverse events were mild and transient; epigastric discomfort; few mild and temporary adverse effects reported; increased urinary mercury levels observed after treatment; loose stools; mild to moderate adverse events reported; somnolence,Improve Memory,,Cognitive & Neurological Function,manual_pair,"Clinical evidence from two randomized controlled trials indicates that ashwagandha may improve memory and cognitive functions. Doses reported in these studies include 300 mg of root extract twice daily and 250 mg of a specific extract daily, both showing beneficial effects in participants with mild cognitive impairment. No adverse effects were noted in the studies, but further research is needed to confirm these findings and assess long-term safety.",0.9,40099725,2025,"Effect of ashwagandha (Withania somnifera) extract with Sominone (Somin-On™) to improve memory in adults with mild cognitive impairment: A randomized, double-blind, placebo-controlled study.",randomized_controlled_trial,benefit,"The study demonstrated significant improvements in memory and cognitive functions in adults with mild cognitive impairment, indicating a beneficial effect of the treatment.",250 mg daily 60 days (Somin-On™),,,mild cognitive impairment,cognitive function enhancement; memory improvement; mild cognitive impairment,Tier 2,0.62,"Randomized, double-blind, placebo-controlled trial in adults with MCI showed significant improvements on validated memory and cognitive scales, directly matching the indication. However, it is a small pilot (n=40), short duration (60 days), and uses a specific proprietary extract (Somin-On™), limiting generalizability and strength of inference."
Ashwagandha,adverse events were mild and transient; epigastric discomfort; few mild and temporary adverse effects reported; increased urinary mercury levels observed after treatment; loose stools; mild to moderate adverse events reported; somnolence,COVID-19,,"Immune, Inflammation, & Infection",manual_pair,"One randomized controlled trial reported that ashwagandha (250 mg twice daily or 500 mg twice daily for 15 days) may benefit patients with mild COVID-19 symptoms by reducing the time to clinical recovery and improving viral clearance. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess safety.",0.7,37482107,2023,Ashwagandha (Withania somnifera) and Shunthi (Zingiber officinale) in mild and moderate COVID-19: An open-label randomized controlled exploratory trial.,randomized_controlled_trial,benefit,"The study showed a significant reduction in the mean time for clinical recovery and improved viral clearance in the Ayurveda group, indicating a benefit from the intervention.",250 mg twice daily 15 days (tablet); 500 mg twice daily 15 days (capsule),,,mild covid-19,mild covid-19; moderate covid-19,Tier 3,0.52,"Small, open-label exploratory RCT (n=48 analyzed) testing a combination of Ashwagandha plus ginger vs standard care. While clinically relevant outcomes (time to recovery, viral clearance) showed benefit, the lack of blinding, small sample size, and inability to attribute effects to Ashwagandha alone weaken the evidence for Ashwagandha specifically in COVID-19."
Ashwagandha,adverse events were mild and transient; epigastric discomfort; few mild and temporary adverse effects reported; increased urinary mercury levels observed after treatment; loose stools; mild to moderate adverse events reported; somnolence,Stress,,"Energy, Mood, & Mental Health",manual_pair,"One randomized, double-blind, placebo-controlled study reported that a daily dose of 1000 mg of a standardized extract of ashwagandha for 12 weeks resulted in significant reductions in negative symptoms of schizophrenia. No studies reported mixed outcomes or harms, but further research is needed to confirm these findings and assess long-term safety and efficacy.",0.8,29995356,2018,"Adjunctive Use of a Standardized Extract of Withania somnifera (Ashwagandha) to Treat Symptom Exacerbation in Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled Study.",randomized_controlled_trial,benefit,"The study showed significant benefits in reducing negative, general, and total symptoms of schizophrenia, indicating a positive outcome.",1000 mg daily 12 weeks (standardized extract),Schizophrenia,,schizoaffective disorder,schizoaffective disorder; schizophrenia,Tier 2,0.62,"Randomized, double-blind, placebo-controlled RCT (n=66) in schizophrenia showed significant improvement in perceived stress (PSS; d≈0.58) with 1,000 mg/day standardized Ashwagandha vs placebo over 12 weeks. However, stress was a secondary outcome, studied adjunctively in a specific clinical population, which limits directness and generalizability to stress broadly. Methods are strong but outcome priority and population specificity prevent Tier 1."
Ashwagandha,adverse events were mild and transient; epigastric discomfort; few mild and temporary adverse effects reported; increased urinary mercury levels observed after treatment; loose stools; mild to moderate adverse events reported; somnolence,Obsessive-Compulsive Disorder,,"Energy, Mood, & Mental Health",manual_pair,"There is limited evidence from one randomized double-blind placebo-controlled trial indicating that Ashwagandha (120 mg daily for six weeks) may reduce symptoms of obsessive-compulsive disorder compared to placebo. However, the overall evidence is sparse, and further studies are needed to confirm these findings and assess long-term effects and safety.",0.7,27515872,2016,Evaluation of the efficacy of Withania somnifera (Ashwagandha) root extract in patients with obsessive-compulsive disorder: A randomized double-blind placebo-controlled trial.,randomized_controlled_trial,benefit,"The study showed a significant reduction in OCD symptoms with Ashwagandha compared to placebo, indicating a beneficial effect.",120 mg daily six weeks (root extract),,,obsessive-compulsive disorder,obsessive-compulsive disorder,Tier 2,0.73,"Randomized, double-blind, placebo-controlled human trial with OCD severity (Y-BOCS) as the primary clinical outcome showed significant benefit as adjunct to SSRIs. However, the sample size is small (n=30) and duration short (6 weeks), so despite good methods, it does not meet the size/power typical of Tier 1."
Ashwagandha,adverse events were mild and transient; epigastric discomfort; few mild and temporary adverse effects reported; increased urinary mercury levels observed after treatment; loose stools; mild to moderate adverse events reported; somnolence,Improve Sexual Function,,Women's Health,manual_pair,"One pilot study reported that Ashwagandha (300 mg twice daily for 8 weeks) may improve sexual function in women, indicating a potential benefit for orgasm difficulties. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term safety and efficacy.",0.7,26504795,2015,Efficacy and Safety of Ashwagandha (Withania somnifera) Root Extract in Improving Sexual Function in Women: A Pilot Study.,randomized_controlled_trial,benefit,"The study shows significant improvement in sexual function metrics, indicating a beneficial effect of Ashwagandha supplementation.",300 mg twice daily 8 weeks (capsules),,,orgasm disorders,orgasm disorders; sexual difficulties; sexual dysfunction,Tier 2,0.66,"Placebo-controlled randomized trial with validated sexual function outcomes directly relevant to the indication showed significant benefits, but the study was a small pilot (n≈50), limiting robustness and precluding Tier 1."
Ashwagandha,adverse events were mild and transient; epigastric discomfort; few mild and temporary adverse effects reported; increased urinary mercury levels observed after treatment; loose stools; mild to moderate adverse events reported; somnolence,Sleep Quality,,Sleep,manual_pair,"The evidence from four randomized, double-blind, placebo-controlled studies indicates that ashwagandha may improve sleep quality and reduce nonrestorative sleep. Doses reported include 600 mg of root extract daily for 28 days and 120 mg of a standardized extract daily for six weeks. No adverse effects were noted in the studies, but the overall quality of evidence is limited to the studies reviewed, and further research may be necessary to confirm these findings.",0.9,39954269,2025,Effects of Root Extract of Ashwagandha (Withania somnifera) on Perception of Recovery and Muscle Strength in Female Athletes.,randomized_controlled_trial,benefit,"The study found significant improvements in recovery and perceived sleep quality, indicating a benefit from ashwagandha supplementation.",600 mg daily 28 days (root extract),,Performance & Recovery,exercise recovery,chronic fatigue syndrome; chronic inflammation; exercise recovery; fibromyalgia; heart disease; insomnia; muscle strength; non-restorative sleep; nonrestorative sleep; sleep quality,Tier 2,0.6,"Placebo-controlled randomized trial (n=30) in female athletes found improved perceived sleep quality with 600 mg/day ashwagandha over 28 days. However, sleep quality was a secondary outcome within a performance/recovery study and was measured via a single-item subjective Hooper Index component in a niche population, with small sample size and short duration."
Ashwagandha,adverse events were mild and transient; epigastric discomfort; few mild and temporary adverse effects reported; increased urinary mercury levels observed after treatment; loose stools; mild to moderate adverse events reported; somnolence,Sleep Quality,,Sleep,manual_pair,"The evidence from four randomized, double-blind, placebo-controlled studies indicates that ashwagandha may improve sleep quality and reduce nonrestorative sleep. Doses reported include 600 mg of root extract daily for 28 days and 120 mg of a standardized extract daily for six weeks. No adverse effects were noted in the studies, but the overall quality of evidence is limited to the studies reviewed, and further research may be necessary to confirm these findings.",0.9,32818573,2021,"Clinical evaluation of the pharmacological impact of ashwagandha root extract on sleep in healthy volunteers and insomnia patients: A double-blind, randomized, parallel-group, placebo-controlled study.",randomized_controlled_trial,benefit,"The study demonstrated significant improvements in sleep parameters for insomnia patients, indicating a beneficial effect of Ashwagandha root extract on sleep quality.",8 weeks (root extract),,,insomnia,chronic fatigue syndrome; chronic inflammation; exercise recovery; fibromyalgia; heart disease; insomnia; muscle strength; non-restorative sleep; nonrestorative sleep; sleep quality,Tier 1,0.78,"Double-blind, randomized, placebo-controlled RCT (n=80) with sleep quality as primary outcomes (objective sleep parameters, PSQI) showed significant benefits, particularly in insomnia patients. Methods are strong and outcomes are clinically relevant, though sample size is modest."
Ashwagandha,adverse events were mild and transient; epigastric discomfort; few mild and temporary adverse effects reported; increased urinary mercury levels observed after treatment; loose stools; mild to moderate adverse events reported; somnolence,Sleep Quality,,Sleep,manual_pair,"The evidence from four randomized, double-blind, placebo-controlled studies indicates that ashwagandha may improve sleep quality and reduce nonrestorative sleep. Doses reported include 600 mg of root extract daily for 28 days and 120 mg of a standardized extract daily for six weeks. No adverse effects were noted in the studies, but the overall quality of evidence is limited to the studies reviewed, and further research may be necessary to confirm these findings.",0.9,32540634,2020,"A randomized, double blind, placebo controlled study to evaluate the effects of ashwagandha (Withania somnifera) extract on sleep quality in healthy adults.",randomized_controlled_trial,benefit,"The study showed significant improvements in sleep quality and related quality of life measures, indicating a beneficial effect of ashwagandha on non-restorative sleep.",120 mg once daily six weeks (standardized ashwagandha extract (Shoden®)),,,non-restorative sleep,chronic fatigue syndrome; chronic inflammation; exercise recovery; fibromyalgia; heart disease; insomnia; muscle strength; non-restorative sleep; nonrestorative sleep; sleep quality,Tier 1,0.9,"Randomized, double-blind, placebo-controlled RCT (n=150; 144 completed) in adults with non-restorative sleep, using validated sleep questionnaires and actigraphy as primary outcomes, found significant improvements with ashwagandha vs placebo over six weeks. Adequate size and rigorous methods support strong human evidence for sleep quality."
Astaxanthin,gastrointestinal disorders,Wrinkles,,"Skin, Hair, & Nails",manual_pair,"One randomized trial reported significant improvements in skin conditions, including age spots, with astaxanthin supplementation at doses of 6 mg daily (oral) and 2 ml daily (topical) over 8 weeks. Overall evidence is limited to this single study, and no adverse effects were noted; however, further research is needed to confirm these findings and establish consistency.",0.7,22428137,2012,Cosmetic benefits of astaxanthin on humans subjects.,randomized_controlled_trial,benefit,"The studies reported significant improvements in various skin conditions, indicating a beneficial outcome from astaxanthin supplementation.",6 mg daily 8 weeks (oral supplementation); 2 ml daily 8 weeks (topical application),,,age spot size,age spot size; corneocyte condition; moisture content; skin elasticity; skin texture; skin wrinkle,Tier 2,0.68,"This paper includes a randomized, double-blind, placebo-controlled trial (n=36 men, 6 weeks) showing improvement in crow's-feet wrinkles with 6 mg/day oral astaxanthin. The RCT is well designed but small and short in duration. An additional open-label female study (oral + topical) also reported wrinkle improvement but is uncontrolled. Overall, this supports moderate human evidence for wrinkles."
Astaxanthin,gastrointestinal disorders,Exercise-Induced Inflammation,,Performance & Recovery,manual_pair,"The evidence regarding astaxanthin supplementation for cardiovascular disease is mixed and unclear, primarily based on one study that reported some benefits in reducing inflammation but did not show significant effects on other health markers. The study utilized a dose of 12 mg daily for four weeks. Overall, the findings do not support a clear benefit for cardiovascular health.",0.8,39568140,2024,Impact of astaxanthin supplementation on markers of cardiometabolic health and tactical performance among firefighters.,randomized_controlled_trial,mixed_unclear,"The study shows some benefits in reducing inflammation but lacks significant effects on other health markers, leading to a mixed outcome classification.",12 mg daily four weeks (AstaReal®),,,cardiovascular disease,cardiovascular disease,Tier 3,0.45,"Randomized, double-blind, placebo-controlled crossover trial (n=15) found astaxanthin attenuated some post-exercise inflammatory biomarkers, but effects were mostly within-group with limited between-group significance. Outcomes were surrogate markers (e.g., IL-1β, cortisol, uric acid) over a short duration. Small sample size and mixed results indicate preliminary human evidence for exercise-induced inflammation."
Astaxanthin,gastrointestinal disorders,Cognitive Performance,,Cognitive & Neurological Function,manual_pair,"Two randomized, double-blind, placebo-controlled trials suggest that astaxanthin may improve cognitive functions in individuals with mild cognitive impairment. The studies involved supplementation for durations of 8 to 12 weeks, with no reported adverse effects. However, the overall evidence remains limited and further research is needed to confirm these findings.",0.7,33375429,2020,"Improvement of Executive Function after Short-Term Administration of an Antioxidants Mix Containing Bacopa, Lycopene, Astaxanthin and Vitamin B12: The BLAtwelve Study.",randomized_controlled_trial,benefit,"The study shows significant improvement in cognitive function, indicating a benefit from the antioxidant mix including astaxanthin.",1 dose once a day 8 weeks (oral),,,cognitive changes associated with brain aging,cognitive changes associated with brain aging; cognitive dysfunction; mild cognitive impairment,Tier 5,0.83,"Although this is a randomized, double-blind, controlled trial with cognitive performance as a primary outcome, the intervention was a multi-ingredient mix (bacopa, lycopene, astaxanthin, vitamin B12). The effect cannot be attributed to astaxanthin alone, so this study does not provide direct evidence for astaxanthin as a standalone supplement for cognitive performance."
Astaxanthin,gastrointestinal disorders,Cognitive Performance,,Cognitive & Neurological Function,manual_pair,"Two randomized, double-blind, placebo-controlled trials suggest that astaxanthin may improve cognitive functions in individuals with mild cognitive impairment. The studies involved supplementation for durations of 8 to 12 weeks, with no reported adverse effects. However, the overall evidence remains limited and further research is needed to confirm these findings.",0.7,29614679,2018,"Effects of Composite Supplement Containing Astaxanthin and Sesamin on Cognitive Functions in People with Mild Cognitive Impairment: A Randomized, Double-Blind, Placebo-Controlled Trial.",randomized_controlled_trial,benefit,"The study showed significant improvements in cognitive functions, indicating a benefit from astaxanthin supplementation.",12 weeks (capsules),,,mild cognitive impairment,cognitive changes associated with brain aging; cognitive dysfunction; mild cognitive impairment,Tier 4,0.4,"Although this was a randomized, double-blind, placebo-controlled trial with positive effects on cognitive test performance, the intervention was a composite supplement (astaxanthin + sesamin), not astaxanthin alone. This makes the evidence indirect for astaxanthin as a standalone supplement. Additionally, the study was a small pilot (n=21) with short duration and neuropsychological test outcomes, further limiting strength."
Astaxanthin,gastrointestinal disorders,Dementia Prevention,,Healthy Aging & Prevention,manual_pair,"There is limited evidence suggesting that astaxanthin may improve antioxidant status, which could be beneficial for dementia prevention, based on one study that reported positive outcomes with doses of 6 mg and 12 mg daily for 12 weeks. However, the overall evidence is weak and consists of a single study, indicating a need for further research to confirm these findings and assess long-term effects and safety.",0.5,21276280,2011,Antioxidant effect of astaxanthin on phospholipid peroxidation in human erythrocytes.,randomized_controlled_trial,benefit,"The study shows that astaxanthin supplementation improves antioxidant status and reduces harmful phospholipid levels, suggesting a benefit for dementia prevention.",6 mg daily 12 weeks; 12 mg daily 12 weeks,,,dementia prevention,dementia prevention,Tier 3,0.48,"Randomized, double-blind, placebo-controlled trial (n≈30) shows reduced erythrocyte phospholipid hydroperoxides and improved antioxidant status with astaxanthin, but no cognitive outcomes or dementia incidence were measured. The evidence is human and controlled but relies on surrogate biomarkers, making it preliminary/indirect for dementia prevention."
Astaxanthin,gastrointestinal disorders,Skin Aging Prevention,,"Skin, Hair, & Nails",manual_pair,"One randomized, double-blind, placebo-controlled trial indicates that astaxanthin may provide protective benefits against UV-induced skin damage and improve skin conditions, with a reported dose of 4 mg daily for 10 weeks. However, the overall evidence is limited, with only one study demonstrating benefit and no reports of harm or adverse effects.",0.7,29941810,2018,"The Protective Role of Astaxanthin for UV-Induced Skin Deterioration in Healthy People-A Randomized, Double-Blind, Placebo-Controlled Trial.",randomized_controlled_trial,benefit,The study shows that astaxanthin provides protective benefits against UV-induced skin damage and improves skin conditions.,4 mg daily 10 weeks (capsule),,,skin moisture loss,skin moisture loss; skin texture improvement; uv-induced skin deterioration,Tier 3,0.64,"Double-blind, placebo-controlled RCT (n=23) showed benefits on UV-induced skin damage surrogates (increased MED, reduced moisture loss) and some subjective skin improvements over 10 weeks. However, sample size is small and outcomes are surrogate/short-term measures rather than direct, long-term clinical endpoints of skin aging prevention, making the evidence preliminary for this indication."
Astaxanthin,gastrointestinal disorders,Weight Loss,,Weight & Body Composition,manual_pair,"Clinical evidence suggests that astaxanthin supplementation may have beneficial effects on metabolic profiles and body composition in individuals with excess body weight, particularly when combined with exercise. Doses of 20 mg daily for 12 weeks were commonly reported, with additional evidence from a lower dose of 5 mg daily for 3 weeks. No adverse effects were noted in the studies reviewed, but the overall evidence is limited to a small number of trials focused on specific populations.",0.8,36678157,2023,Astaxanthin Supplemented with High-Intensity Functional Training Decreases Adipokines Levels and Cardiovascular Risk Factors in Men with Obesity.,randomized_controlled_trial,benefit,"The study showed significant improvements in metabolic profiles and cardiovascular risk factors in men with obesity, indicating a beneficial effect of astaxanthin supplementation combined with high-intensity training.",20 mg daily 12 weeks (capsule),,,cardiovascular risk factors,cardiovascular risk factors; insulin insensitivity; insulin resistance; lipid profiles; obesity; overweight; oxidative stress,Tier 2,0.6,"Placebo-controlled, randomized 4-arm trial (n≈68; ~17/group) in men with obesity measured body weight, BMI, and % fat over 12 weeks. Results showed reductions in body composition metrics, with the strongest effects in the astaxanthin + high-intensity training group. However, weight loss appears to be a secondary outcome, the per-group sample is small, and the independent effect of astaxanthin on weight versus training is not clearly isolated. This supports moderate human evidence but not strong primary-outcome evidence for weight loss."
Astaxanthin,gastrointestinal disorders,Weight Loss,,Weight & Body Composition,manual_pair,"Clinical evidence suggests that astaxanthin supplementation may have beneficial effects on metabolic profiles and body composition in individuals with excess body weight, particularly when combined with exercise. Doses of 20 mg daily for 12 weeks were commonly reported, with additional evidence from a lower dose of 5 mg daily for 3 weeks. No adverse effects were noted in the studies reviewed, but the overall evidence is limited to a small number of trials focused on specific populations.",0.8,39275173,2024,Exploring the Impact of Astaxanthin Supplementation in Conjunction with a 12-Week CrossFit Training Regimen on Selected Adipo-Myokines Levels in Obese Males.,randomized_controlled_trial,benefit,"The study showed significant positive changes in metabolic indices and body composition in obese males, indicating a benefit from astaxanthin supplementation combined with exercise.",20 mg once/d 12 weeks (capsule),,,insulin insensitivity,cardiovascular risk factors; insulin insensitivity; insulin resistance; lipid profiles; obesity; overweight; oxidative stress,Tier 2,0.47,"Randomized controlled trial (n=60, four arms) in obese males measured anthropometric/body composition outcomes, but weight loss was likely a secondary outcome. Sample size is small, blinding is unclear, and benefits were most evident when astaxanthin was combined with exercise, making the supplement-only effect uncertain. This supports moderate human evidence but not strong primary-outcome evidence."
Astaxanthin,gastrointestinal disorders,Weight Loss,,Weight & Body Composition,manual_pair,"Clinical evidence suggests that astaxanthin supplementation may have beneficial effects on metabolic profiles and body composition in individuals with excess body weight, particularly when combined with exercise. Doses of 20 mg daily for 12 weeks were commonly reported, with additional evidence from a lower dose of 5 mg daily for 3 weeks. No adverse effects were noted in the studies reviewed, but the overall evidence is limited to a small number of trials focused on specific populations.",0.8,21480416,2011,Effects of astaxanthin on oxidative stress in overweight and obese adults.,randomized_controlled_trial,benefit,"The study showed significant improvements in oxidative stress biomarkers, indicating a benefit from astaxanthin supplementation.",5 mg once daily 3 weeks; 20 mg once daily 3 weeks,Obese; Overweight,,obesity,cardiovascular risk factors; insulin insensitivity; insulin resistance; lipid profiles; obesity; overweight; oxidative stress,Tier 5,0.9,"This RCT in overweight/obese adults assessed oxidative stress biomarkers over 3 weeks and did not measure weight, body fat, or related weight-loss outcomes. Improvements in oxidative stress are indirect and not evidence for the weight loss indication."
Astaxanthin,gastrointestinal disorders,Arterial Stiffness,,Heart & Vascular Health,manual_pair,"Current evidence on astaxanthin for high arterial stiffness is limited and classified as mixed or unclear, based on a single randomized controlled trial that has not yet reported definitive results. The study involved a daily dose of 12 mg over one year, but without conclusive outcomes, the efficacy of astaxanthin for this indication remains uncertain.",0.7,19091127,2008,"Astaxanthin vs placebo on arterial stiffness, oxidative stress and inflammation in renal transplant patients (Xanthin): a randomised controlled trial.",randomized_controlled_trial,mixed_unclear,"The study aims to assess multiple outcomes related to cardiovascular health, but the results are not yet available, leading to a classification of mixed_unclear.",12 mg daily one year,Kidney Transplant,"Immune, Inflammation, & Infection",arterial stiffness,arterial stiffness; cardiovascular morbidity; inflammation; oxidative stress,Tier 5,0.84,"This is a randomized, placebo-controlled trial protocol with arterial stiffness (PWV) as a primary outcome, but no results are reported. Without outcome data, it does not provide actual evidence for astaxanthin’s effect on arterial stiffness."
Astaxanthin,gastrointestinal disorders,Hypertension,,Heart & Vascular Health,manual_pair,"One randomized, double-blind, placebo-controlled study reported a significant reduction in blood pressure and inflammatory markers with the use of astaxanthin in combination with other supplements over a 4-week period. However, the evidence is limited to a single study, and further research is needed to confirm these findings and establish consistent dosing guidelines.",0.7,31987113,2020,"A combined effect of Cavacurcumin, Eicosapentaenoic acid (Omega-3s), Astaxanthin and Gamma -linoleic acid (Omega-6) (CEAG) in healthy volunteers- a randomized, double-blind, placebo-controlled study.",randomized_controlled_trial,benefit,"The study showed significant reductions in blood pressure and inflammatory markers, indicating a beneficial effect.",4 weeks,,"Immune, Inflammation, & Infection",cardiovascular disease,cardiovascular disease; coronary artery disease; hypertension,Tier 4,0.62,"Although this was a randomized, double-blind, placebo-controlled human study with blood pressure as a primary outcome, the intervention was a multi-ingredient combination (curcumin, EPA, astaxanthin, GLA) in healthy volunteers over 4 weeks. The effect cannot be attributed specifically to astaxanthin, the dose of astaxanthin is not specified, and participants were not hypertensive. Therefore, for astaxanthin specifically in hypertension, this provides only indirect, very low-level human evidence."
Astaxanthin,gastrointestinal disorders,Diabetes Type 2,,"Immune, Inflammation, & Infection",manual_pair,"Current evidence from a randomized, double-blind, placebo-controlled trial suggests that astaxanthin supplementation (8 mg daily for 8 weeks) may have beneficial effects on biomarkers in patients with type 2 diabetes. However, the overall evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term safety and efficacy.",0.7,33445213,2021,"The antioxidant and anti-inflammatory effects of astaxanthin supplementation on the expression of miR-146a and miR-126 in patients with type 2 diabetes mellitus: A randomised, double-blind, placebo-controlled clinical trial.",randomized_controlled_trial,benefit,"The study shows that astaxanthin supplementation decreases harmful biomarkers in patients with type 2 diabetes, indicating a beneficial effect.",8 mg daily 8 weeks (oral),,,Type 2 Diabetes Mellitus,Type 2 Diabetes Mellitus,Tier 3,0.6,"Randomized, double-blind, placebo-controlled trial in T2DM patients (n=44) found reductions in oxidative/inflammatory biomarkers (MDA, IL-6) and miR-146a with astaxanthin 8 mg/day for 8 weeks. However, outcomes were surrogate/mechanistic rather than clinically meaningful diabetes endpoints (e.g., HbA1c, fasting glucose, insulin sensitivity), and the study was small and short. Thus, evidence for the diabetes indication is preliminary."
Astaxanthin,gastrointestinal disorders,Overweight,,Heart & Vascular Health,manual_pair,"One randomized trial reported positive effects of astaxanthin on LDL cholesterol levels in overweight subjects, indicating a potential benefit for this indication. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term effects and safety.",0.7,21964877,2011,Positive effects of astaxanthin on lipid profiles and oxidative stress in overweight subjects.,randomized_controlled_trial,benefit,"The study shows significant improvements in LDL cholesterol and oxidative stress biomarkers, indicating a benefit from astaxanthin supplementation.",null null null 12 weeks (capsules),,"Immune, Inflammation, & Infection",lipid profiles,lipid profiles; obesity; overweight; oxidative stress,Tier 5,0.86,"Although this was a randomized, double-blind, placebo-controlled trial in overweight/obese adults, the outcomes were lipid and oxidative stress biomarkers, not body weight, BMI, body fat, or measures of overweight. Thus, it does not test astaxanthin for the indication of overweight and provides no direct evidence for this condition."
Astaxanthin,gastrointestinal disorders,Low HDL,,Heart & Vascular Health,manual_pair,"One randomized trial indicates that astaxanthin may improve triglyceride levels in subjects with mild hyperlipidemia, with doses ranging from 6 mg to 18 mg daily over 12 weeks. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term effects and safety.",0.7,19892350,2010,Administration of natural astaxanthin increases serum HDL-cholesterol and adiponectin in subjects with mild hyperlipidemia.,randomized_controlled_trial,benefit,"The study shows significant improvements in triglyceride and HDL-cholesterol levels, indicating a beneficial effect of astaxanthin.",0 mg daily 12 weeks; 6 mg daily 12 weeks; 12 mg daily 12 weeks; 18 mg daily 12 weeks,,,mild hyperlipidemia,mild hyperlipidemia,Tier 2,0.64,"Randomized, placebo-controlled human trial (n=61) with 4 arms over 12 weeks found significant HDL increases at 6 and 12 mg/day, directly relevant to low HDL. However, the study is small per arm, short-term, and blinding/primary endpoint details are unclear, so evidence is moderate rather than strong."
Astaxanthin,gastrointestinal disorders,Low LDL,,Heart & Vascular Health,manual_pair,"The evidence regarding astaxanthin for infertility is mixed but suggests potential benefits, particularly in patients with poor ovarian response and polycystic ovary syndrome (PCOS). Two randomized trials reported improvements in reproductive outcomes, while one trial showed mixed results with some significant and some non-significant findings. Typical doses reported were 6 mg to 12 mg daily for durations of 8 weeks, with no reported harms.",0.8,37874168,2024,"Astaxanthin supplementation impact on insulin resistance, lipid profile, blood pressure, and oxidative stress in polycystic ovary syndrome patients: A triple-blind randomized clinical trial.",randomized_controlled_trial,mixed_unclear,The study shows mixed results with significant reductions in some parameters but non-significant values for others after adjusting for baseline values.,6 mg 2 times a day 8 weeks,PCOS,"Immune, Inflammation, & Infection; Metabolic Health",blood pressure,blood pressure; infertility; insulin resistance; oxidative stress; polycystic ovary syndrome; poor ovarian response,Tier 2,0.5,"Triple-blind RCT in PCOS patients assessed LDL as part of the lipid profile (a relevant outcome). Initial analyses showed LDL reductions with astaxanthin, but some effects became non-significant after adjustment. Small sample size (~58), short duration (8 weeks), and a specific population limit generalizability. Overall, moderate human evidence but with mixed/uncertain results."
Astaxanthin,gastrointestinal disorders,Low LDL,,Heart & Vascular Health,manual_pair,"The evidence regarding astaxanthin for infertility is mixed but suggests potential benefits, particularly in patients with poor ovarian response and polycystic ovary syndrome (PCOS). Two randomized trials reported improvements in reproductive outcomes, while one trial showed mixed results with some significant and some non-significant findings. Typical doses reported were 6 mg to 12 mg daily for durations of 8 weeks, with no reported harms.",0.8,39482765,2024,"Astaxanthin improves assisted reproductive technology outcomes in poor ovarian responders through alleviating oxidative stress, inflammation, and apoptosis: a randomized clinical trial.",randomized_controlled_trial,benefit,"The study shows that astaxanthin significantly improves ART outcomes in patients with poor ovarian response, indicating a beneficial effect.",12 mg daily eight weeks,Poor Ovarian Response,,infertility,blood pressure; infertility; insulin resistance; oxidative stress; polycystic ovary syndrome; poor ovarian response,Tier 5,0.93,"This randomized controlled trial investigated astaxanthin for assisted reproductive technology outcomes and oxidative stress/inflammation markers in poor ovarian responders. It did not assess LDL or lipid outcomes. Therefore, it provides no direct evidence for the indication of lowering LDL."
Astaxanthin,gastrointestinal disorders,Low LDL,,Heart & Vascular Health,manual_pair,"The evidence regarding astaxanthin for infertility is mixed but suggests potential benefits, particularly in patients with poor ovarian response and polycystic ovary syndrome (PCOS). Two randomized trials reported improvements in reproductive outcomes, while one trial showed mixed results with some significant and some non-significant findings. Typical doses reported were 6 mg to 12 mg daily for durations of 8 weeks, with no reported harms.",0.8,38916710,2024,Astaxanthin treatment decreases pro-inflammatory cytokines and improves reproductive outcomes in patients with polycystic ovary syndrome undergoing assisted reproductive technology: A randomized clinical trial.,randomized_controlled_trial,benefit,"The study showed significant improvements in reproductive outcomes and a decrease in pro-inflammatory cytokines, indicating a beneficial effect of astaxanthin in PCOS patients.",6 mg daily 8 weeks,,,infertility,blood pressure; infertility; insulin resistance; oxidative stress; polycystic ovary syndrome; poor ovarian response,Tier 5,0.95,"The RCT in PCOS patients assessed inflammatory cytokines, oxidative stress markers, and reproductive outcomes; it did not evaluate LDL or any lipid outcomes. Therefore, it provides no direct evidence for astaxanthin to lower LDL."
Astaxanthin,gastrointestinal disorders,PCOS ; Women,,Women's Health,manual_pair,"One randomized, triple-blind placebo-controlled trial found that astaxanthin (6 mg per day for 12 weeks) significantly improved inflammatory markers and reproductive outcomes in endometriosis patients undergoing assisted reproduction. There is currently no evidence of harm or no benefit reported, but further studies are needed to confirm these findings and assess long-term effects.",0.8,37020589,2023,"Astaxanthin ameliorates inflammation, oxidative stress, and reproductive outcomes in endometriosis patients undergoing assisted reproduction: A randomized, triple-blind placebo-controlled clinical trial.",randomized_controlled_trial,benefit,"The study shows significant improvements in inflammatory markers and reproductive outcomes, indicating a beneficial effect of Astaxanthin in endometriosis patients undergoing ART.",6 mg per day 12 weeks,,"Immune, Inflammation, & Infection",endometriosis,endometriosis; infertility,Tier 5,0.9,"The randomized, triple-blind RCT evaluates astaxanthin in women with endometriosis undergoing ART, not in women with PCOS. Despite high methodological quality, the population and outcomes are specific to endometriosis, making the evidence not applicable to the PCOS indication."
Astaxanthin,gastrointestinal disorders,Infertility,,"Immune, Inflammation, & Infection",manual_pair,"One randomized controlled trial has shown that astaxanthin supplementation (8 mg daily for 40 days) may improve oxidative stress markers and assisted reproductive technology outcomes in women with polycystic ovarian syndrome (PCOS). No studies reported mixed or negative outcomes, suggesting a potential benefit; however, further research is needed to confirm these findings and assess long-term effects and safety.",0.8,35237893,2022,Randomized controlled trial of astaxanthin impacts on antioxidant status and assisted reproductive technology outcomes in women with polycystic ovarian syndrome.,randomized_controlled_trial,benefit,"The study showed significant improvements in oxidative stress markers and ART outcomes, indicating a benefit from astaxanthin supplementation in PCOS patients.",8 mg daily 40 days,PCOS,,oxidative stress,oxidative stress; polycystic ovary syndrome,Tier 3,0.62,"Double-blind RCT in PCOS patients undergoing ART found improvements in surrogate ART lab metrics (MII oocytes, embryo quality) but no improvement in clinical pregnancy rates. Fertility outcomes were secondary, with primary outcomes being oxidative stress biomarkers. Thus evidence for infertility is preliminary and based on surrogate endpoints."
Astaxanthin,gastrointestinal disorders,Joint Pain,,Musculoskeletal & Pain,manual_pair,"One randomized, double-blind, placebo-controlled trial reported a benefit of astaxanthin in improving joint pain and function in individuals with mild osteoarthritis after 12 weeks of treatment. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term effects and safety.",0.7,37686801,2023,"A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Clinical Trial to Evaluate the Efficacy and Safety of a Krill Oil, Astaxanthin, and Oral Hyaluronic Acid Complex on Joint Health in People with Mild Osteoarthritis.",randomized_controlled_trial,benefit,"The study showed significant improvement in joint pain and function in the FP-MD group compared to placebo, indicating a benefit for mild osteoarthritis.","1 daily once 12 weeks (krill oil, astaxanthin, and lower molecular weight hyaluronic acid complex)",Osteoarthritis,,mild osteoarthritis,mild osteoarthritis,Tier 5,0.78,"Although this is a well-designed RCT showing benefit for joint pain in mild osteoarthritis, the intervention was a multi-ingredient complex (krill oil, astaxanthin, and hyaluronic acid). The effect cannot be attributed to astaxanthin alone, so it is not direct evidence for astaxanthin for joint pain."
Astaxanthin,gastrointestinal disorders,Weight Loss,,Weight & Body Composition,manual_pair,"One randomized trial reported a significant reduction in lipid peroxidation markers with astaxanthin supplementation at a dose of 4 mg twice daily for three months, indicating a potential benefit. However, the overall evidence is limited, with only one study available, and further research is needed to confirm these findings and assess long-term effects and safety.",0.7,17685090,2007,Effects of astaxanthin supplementation on lipid peroxidation.,randomized_controlled_trial,benefit,"The study shows a significant reduction in lipid peroxidation markers, indicating a beneficial effect of astaxanthin supplementation.",4 mg twice daily three months (capsules),,,lipid peroxidation,lipid peroxidation,Tier 5,0.9,"This RCT assessed astaxanthin’s effects on lipid peroxidation markers in healthy men and did not measure weight, BMI, body fat, or other weight loss outcomes. Therefore, it does not provide evidence for the weight loss indication."
Astaxanthin,gastrointestinal disorders,Muscle Endurance,,Performance & Recovery,manual_pair,"Clinical evidence suggests that astaxanthin supplementation may enhance exercise performance, particularly in cycling and aerobic activities. Three studies reported benefits, with doses ranging from 4 mg to 12 mg daily over periods of 7 days to 3 months. However, the overall quality of the evidence is limited, and further research is needed to confirm these findings and assess long-term effects.",0.7,34110707,2021,Astaxanthin supplementation enhances metabolic adaptation with aerobic training in the elderly.,randomized_controlled_trial,benefit,"The study showed that astaxanthin improved specific muscle endurance and fat oxidation in elderly participants, indicating a beneficial effect on metabolic adaptation with aerobic training.",3 months (Astaxanthin),Older Adults,,aerobic capacity,aerobic capacity; athletic performance; cycling performance; exercise performance; fat oxidation; metabolic health; muscle endurance,Tier 2,0.64,"Randomized, placebo-controlled trial (n≈42) in older adults found astaxanthin improved specific muscle endurance (ankle dorsiflexors) over 3 months of aerobic training. The outcome is directly relevant to muscle endurance, but the study is relatively small, includes a training co-intervention, and focuses on a specific muscle group rather than broad functional endpoints. Likely not a large, definitive trial, so evidence is moderate rather than strong."
Astaxanthin,gastrointestinal disorders,Muscle Endurance,,Performance & Recovery,manual_pair,"Clinical evidence suggests that astaxanthin supplementation may enhance exercise performance, particularly in cycling and aerobic activities. Three studies reported benefits, with doses ranging from 4 mg to 12 mg daily over periods of 7 days to 3 months. However, the overall quality of the evidence is limited, and further research is needed to confirm these findings and assess long-term effects.",0.7,21984399,2011,Effect of astaxanthin on cycling time trial performance.,randomized_controlled_trial,benefit,The study showed significant improvements in cycling time trial performance with astaxanthin supplementation.,4 mg daily 28 d (encapsulated),Cycling,,athletic performance,aerobic capacity; athletic performance; cycling performance; exercise performance; fat oxidation; metabolic health; muscle endurance,Tier 2,0.63,"Randomized controlled trial in competitive cyclists (n=14 completers) found significant improvement in a primary endurance performance outcome (20 km time trial) after 28 days of 4 mg/day astaxanthin versus placebo. The endpoint directly reflects muscle endurance. However, the sample size was small with notable attrition, blinding/reporting details are limited, and the athletic population limits generalizability, so the evidence is moderate rather than strong."
Astaxanthin,gastrointestinal disorders,Muscle Endurance,,Performance & Recovery,manual_pair,"Clinical evidence suggests that astaxanthin supplementation may enhance exercise performance, particularly in cycling and aerobic activities. Three studies reported benefits, with doses ranging from 4 mg to 12 mg daily over periods of 7 days to 3 months. However, the overall quality of the evidence is limited, and further research is needed to confirm these findings and assess long-term effects.",0.7,32660833,2021,The effect of astaxanthin supplementation on performance and fat oxidation during a 40 km cycling time trial.,randomized_controlled_trial,benefit,"Astaxanthin supplementation improved cycling performance and fat oxidation, indicating a beneficial effect.",12 mg day-1 7 days,Cycling,,exercise performance,aerobic capacity; athletic performance; cycling performance; exercise performance; fat oxidation; metabolic health; muscle endurance,Tier 2,0.63,"Randomized, double-blind, crossover RCT in 12 male cyclists showed a modest but statistically significant improvement (~1.2%) in 40 km time-trial performance after 7 days of 12 mg/day astaxanthin. The outcome directly reflects endurance, aligning with the indication. However, the sample size is small, duration short, and effect size small, preventing Tier 1."
Astaxanthin,gastrointestinal disorders,Infertility,,Men's Health,manual_pair,"One randomized trial reported a positive effect of astaxanthin (16 mg daily for 3 months) on sperm parameters and fertility outcomes in men with infertility. Overall evidence is limited, with only one study demonstrating benefit and no reports of harm or mixed results. Further research is needed to confirm these findings and establish consistency.",0.7,16110353,2005,"Combined conventional/antioxidant ""Astaxanthin"" treatment for male infertility: a double blind, randomized trial.",randomized_controlled_trial,benefit,The study shows a positive effect of Astaxanthin on sperm parameters and fertility outcomes.,16 mg daily 3 months (AstaCarox),,,male infertility,male infertility,Tier 2,0.58,"This is a double-blind randomized controlled trial directly targeting male infertility, reporting improved sperm parameters and higher pregnancy rates with astaxanthin vs placebo. However, the sample is small (about 30 total, 11 in the active arm), with group imbalance and likely limited power; pregnancy appears as a secondary outcome. These factors reduce certainty despite the RCT design, supporting moderate (not strong) human evidence."
Astaxanthin,gastrointestinal disorders,Mental Fatigue,,"Energy, Mood, & Mental Health",manual_pair,"One randomized, double-blind, placebo-controlled study reported that astaxanthin supplementation for four weeks significantly improved recovery from mental fatigue. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term effects and safety.",0.7,29495607,2018,"Effects of Dietary Supplementation of Astaxanthin and Sesamin on Daily Fatigue: A Randomized, Double-Blind, Placebo-Controlled, Two-Way Crossover Study.",randomized_controlled_trial,benefit,"The study found that AS supplementation significantly improved recovery from mental fatigue, indicating a beneficial effect.",four weeks (dietary supplementation),,,fatigue,fatigue; mental fatigue,Tier 4,0.38,"Randomized, double-blind, placebo-controlled crossover trial in healthy adults found improved recovery from mental fatigue, but the intervention was a combination of astaxanthin and sesamin, not astaxanthin alone. Small sample size (n=24), subjective outcomes, and combo formulation make the evidence indirect for astaxanthin specifically."
Astaxanthin,gastrointestinal disorders,Exercise Induced Inflammation,,Performance & Recovery,manual_pair,"One randomized trial suggests that astaxanthin supplementation may help prevent exercise-induced oxidative stress and muscle damage in elite young soccer players over a 90-day period. However, the evidence is limited to a single study with no reported adverse effects or additional trials to confirm these findings.",0.7,22828460,2012,Effect of astaxanthin supplementation on muscle damage and oxidative stress markers in elite young soccer players.,randomized_controlled_trial,benefit,The study suggests that astaxanthin supplementation may help prevent exercise-induced oxidative stress and muscle damage.,90 days,Soccer Players,,muscle damage,muscle damage; oxidative stress,Tier 3,0.54,"Double-blind RCT in 32 elite young soccer players showed benefits on oxidative stress and muscle damage biomarkers after exercise, but did not directly measure inflammatory markers or clinical inflammation outcomes. The sample size is small and outcomes are surrogate for the specified indication of exercise-induced inflammation, supporting preliminary human evidence."
Astaxanthin,gastrointestinal disorders,Older Adults,,"Immune, Inflammation, & Infection",manual_pair,"The evidence for astaxanthin's effects on oxidative stress is generally positive, with four studies reporting benefits, particularly in increasing antioxidant markers such as glutathione and improving oxidative stress status. One study presented mixed results, indicating some benefits in inflammation but not across all health markers. Typical doses reported range from 1 mg to 12 mg daily, with no reported harms.",0.9,30379308,2018,Markers of Hypoxia and Oxidative Stress in Aging Volunteers Ingesting Lycosomal Formulation of Dark Chocolate Containing Astaxanthin.,randomized_controlled_trial,benefit,"The study shows a significant increase in serum ASTX levels and improvements in oxidative stress markers, indicating a beneficial effect.",7 mg once daily 1 month (lycosomal formulation of dark chocolate containing astaxanthin),,,aging,aging; hypoxia; oxidative stress,Tier 3,0.6,"Small randomized, blinded 4-arm trial (n=32) in healthy older adults found astaxanthin 7 mg/day for 1 month improved surrogate biomarkers of oxidative stress and nitric oxide (with larger effects in a lycosomal dark chocolate formulation). Outcomes were mechanistic/surrogate (oxidized LDL, malondialdehyde, NO, NIRS oxygenation) without clinical endpoints, and sample size per arm was very small, so evidence is preliminary."
Astaxanthin,gastrointestinal disorders,Older Adults,,"Immune, Inflammation, & Infection",manual_pair,"The evidence for astaxanthin's effects on oxidative stress is generally positive, with four studies reporting benefits, particularly in increasing antioxidant markers such as glutathione and improving oxidative stress status. One study presented mixed results, indicating some benefits in inflammation but not across all health markers. Typical doses reported range from 1 mg to 12 mg daily, with no reported harms.",0.9,34611051,2022,Astaxanthin Supplementation Increases Glutathione Concentrations but Does Not Impact Fat Oxidation During Exercise in Active Young Men.,randomized_controlled_trial,benefit,"Astaxanthin supplementation increased glutathione levels, indicating a benefit in antioxidant status, but did not affect fat oxidation or other oxidative stress markers.",6 mg daily 4 weeks,,,oxidative stress,aging; hypoxia; oxidative stress,Tier 5,0.86,"The RCT tested astaxanthin in active young men, measuring surrogate antioxidant markers and exercise metabolism. It did not study older adults or outcomes specific to that population. Thus, it is not actual evidence for the indication of older adults."
Astaxanthin,gastrointestinal disorders,Older Adults,,"Immune, Inflammation, & Infection",manual_pair,"The evidence for astaxanthin's effects on oxidative stress is generally positive, with four studies reporting benefits, particularly in increasing antioxidant markers such as glutathione and improving oxidative stress status. One study presented mixed results, indicating some benefits in inflammation but not across all health markers. Typical doses reported range from 1 mg to 12 mg daily, with no reported harms.",0.9,23192897,2013,Effect of astaxanthin supplementation on paraoxonase 1 activities and oxidative stress status in young soccer players.,randomized_controlled_trial,benefit,"The study shows that astaxanthin supplementation improves paraoxonase activity and total SH groups content, indicating a beneficial effect on oxidative stress status.",90 days,Soccer Players,,oxidative stress,aging; hypoxia; oxidative stress,Tier 5,0.9,"The RCT was conducted in young soccer players and assessed oxidative stress biomarkers, not outcomes relevant to older adults. The population and outcomes do not match the indication of older adults, making this study not applicable evidence for this specific indication."
Astaxanthin,gastrointestinal disorders,Older Adults,,"Immune, Inflammation, & Infection",manual_pair,"The evidence for astaxanthin's effects on oxidative stress is generally positive, with four studies reporting benefits, particularly in increasing antioxidant markers such as glutathione and improving oxidative stress status. One study presented mixed results, indicating some benefits in inflammation but not across all health markers. Typical doses reported range from 1 mg to 12 mg daily, with no reported harms.",0.9,21897013,2011,Plasma carotenoid concentrations before and after supplementation with astaxanthin in middle-aged and senior subjects.,randomized_controlled_trial,benefit,"The study found a significant increase in plasma carotenoid concentration after astaxanthin supplementation, indicating a beneficial effect.",1 mg daily 4-12 weeks,,,oxidative stress,aging; hypoxia; oxidative stress,Tier 5,0.8,"The RCT in middle-aged/senior subjects measured only plasma carotenoid levels (a pharmacokinetic/biomarker outcome) after astaxanthin supplementation. It did not assess any clinical outcomes or health conditions specific to older adults. Thus, it is not actual evidence for the indication and is at best bioavailability data in this population."
Astaxanthin,gastrointestinal disorders,Smokers,,"Immune, Inflammation, & Infection",manual_pair,"One randomized trial demonstrated that astaxanthin supplementation (5 mg, 20 mg, and 40 mg once daily for 3 weeks) significantly reduced oxidative stress markers in healthy smokers. No studies reported mixed outcomes or adverse effects, but the evidence is based on a single trial, indicating a need for further research to confirm these findings.",0.7,21883001,2011,Protective effects of Haematococcus astaxanthin on oxidative stress in healthy smokers.,randomized_controlled_trial,benefit,The study shows a significant benefit in reducing oxidative stress markers in smokers with ASX supplementation.,5 mg once daily 3 weeks; 20 mg once daily 3 weeks; 40 mg once daily 3 weeks,,,oxidative stress,oxidative stress; smoking-related oxidative damage,Tier 3,0.65,"Human trial in smokers with randomization to astaxanthin doses but no placebo/control arm; small sample (n=39 smokers, 13 per dose) and short duration (3 weeks). Outcomes were surrogate oxidative stress biomarkers (malondialdehyde, isoprostane, SOD, total antioxidant capacity), not clinical endpoints. Findings showed improvements, including a dose-dependent isoprostane reduction, but evidence remains preliminary and indirect for clinical benefit in smokers."
Astaxanthin,gastrointestinal disorders,Exercise Induced Inflammation,,Performance & Recovery,manual_pair,"One randomized trial indicates that astaxanthin supplementation may improve paraoxonase activity and oxidative stress status in young soccer players over a 90-day period. However, the overall evidence is limited, with only one study reporting a benefit and no adverse effects noted. Further research is needed to confirm these findings and establish consistency across different populations.",0.6,23192897,2013,Effect of astaxanthin supplementation on paraoxonase 1 activities and oxidative stress status in young soccer players.,randomized_controlled_trial,benefit,"The study shows that astaxanthin supplementation improves paraoxonase activity and total SH groups content, indicating a beneficial effect on oxidative stress status.",90 days,Soccer Players,,paraoxonase activity,paraoxonase activity,Tier 4,0.4,"Double-blind RCT in athletes (n=40) showed improvements in oxidative stress biomarkers (PON1 activity, thiol groups). However, it did not assess exercise-induced inflammation outcomes (e.g., CRP, IL-6, TNF-α) or clinical inflammatory symptoms. Thus, findings are indirect/mechanistic for the specified indication."
Astaxanthin,gastrointestinal disorders,Oxidative Stress,,"Immune, Inflammation, & Infection",manual_pair,"The clinical evidence regarding astaxanthin for polycystic ovary syndrome (PCOS) is mixed and unclear, with two randomized trials reporting some improvements in inflammatory markers and endoplasmic reticulum (ER) stress but no significant effects on key outcomes such as BMI, hirsutism, or fertility rates. Both studies utilized a dose of 12 mg daily for durations of 60 to 80 days. Overall, the findings do not support a clear benefit of astaxanthin for PCOS management.",0.8,39036884,2024,Randomized clinical trial of astaxanthin supplement on serum inflammatory markers and ER stress-apoptosis gene expression in PBMCs of women with PCOS.,randomized_controlled_trial,mixed_unclear,"Astaxanthin showed some reduction in inflammatory markers but no significant effect on BMI, hirsutism, hair loss, or menstrual regularity, indicating mixed outcomes.",12 mg 8 weeks (supplement),PCOS,,polycystic ovary syndrome,polycystic ovary syndrome,Tier 4,0.6,"Randomized, double-blind RCT in PCOS women showed changes in ER stress/apoptosis gene expression and some inflammatory markers, but did not assess direct oxidative stress biomarkers or clinical outcomes related to oxidative stress. Results were mixed and symptom outcomes were null, making the evidence indirect for the oxidative stress indication."
Astaxanthin,gastrointestinal disorders,Oxidative Stress,,"Immune, Inflammation, & Infection",manual_pair,"The clinical evidence regarding astaxanthin for polycystic ovary syndrome (PCOS) is mixed and unclear, with two randomized trials reporting some improvements in inflammatory markers and endoplasmic reticulum (ER) stress but no significant effects on key outcomes such as BMI, hirsutism, or fertility rates. Both studies utilized a dose of 12 mg daily for durations of 60 to 80 days. Overall, the findings do not support a clear benefit of astaxanthin for PCOS management.",0.8,36854788,2023,Astaxanthin treatment ameliorates ER stress in polycystic ovary syndrome patients: a randomized clinical trial.,randomized_controlled_trial,mixed_unclear,"The study showed mixed outcomes; while ASX improved some markers of ER stress and quality of oocytes, it did not significantly affect fertilization or fertility rates.",12 mg daily 60 days,PCOS,,polycystic ovary syndrome,polycystic ovary syndrome,Tier 3,0.6,"Randomized, placebo-controlled human trial in PCOS patients showed improvement in a surrogate oxidative stress marker (increased total antioxidant capacity in follicular fluid). However, oxidative stress was not a primary clinical endpoint, outcomes were largely biomarker-based and tissue-specific, clinical fertility outcomes were unchanged, and sample size was modest (~58). This supports preliminary human evidence rather than strong clinical evidence for oxidative stress."
Astaxanthin,gastrointestinal disorders,Hand-Eye Coordination,,Performance & Recovery,manual_pair,"One randomized, double-blind, placebo-controlled trial reported a significant improvement in eye-hand coordination with astaxanthin supplementation at a dose of 6 mg once daily for eight weeks. However, the overall evidence is limited, with only one study demonstrating a benefit and no reports of harm or mixed outcomes.",0.7,36986186,2023,"Effects of Astaxanthin, Lutein, and Zeaxanthin on Eye-Hand Coordination and Smooth-Pursuit Eye Movement after Visual Display Terminal Operation in Healthy Subjects: A Randomized, Double-Blind Placebo-Controlled Intergroup Trial.",randomized_controlled_trial,benefit,"The study showed significant improvement in eye-hand coordination, indicating a benefit from the supplementation.",6 mg once daily eight weeks (soft capsules),,,eye-hand coordination impairment,eye-hand coordination impairment; smooth-pursuit eye movement impairment,Tier 4,0.42,"This is a randomized, double-blind, placebo-controlled trial with a relevant primary outcome (eye–hand coordination) showing benefit, but the intervention was a combination of astaxanthin, lutein, and zeaxanthin. Because effects cannot be attributed to astaxanthin alone, the evidence for astaxanthin specifically is indirect/very low despite the strong study design."
Astaxanthin,gastrointestinal disorders,Skin Elasticity,,"Skin, Hair, & Nails",manual_pair,"One randomized controlled trial indicates that astaxanthin, at a dose of 2 mg daily for 12 weeks, may improve skin elasticity and hydration when combined with collagen hydrolysate. However, the overall evidence is limited, with only one study reporting a benefit and no data on potential adverse effects or long-term outcomes.",0.7,24955642,2014,Supplementating with dietary astaxanthin combined with collagen hydrolysate improves facial elasticity and decreases matrix metalloproteinase-1 and -12 expression: a comparative study with placebo.,randomized_controlled_trial,benefit,"The study shows significant improvements in skin elasticity and hydration, indicating a beneficial effect of astaxanthin.",2 mg daily 12 weeks (dietary supplement),,,photoaging,photoaging; skin elasticity; skin hydration,Tier 4,0.42,"Placebo-controlled RCT (n=44) showed improved facial skin elasticity, but the intervention combined astaxanthin with collagen hydrolysate. Because astaxanthin’s independent effect cannot be isolated, the evidence for astaxanthin alone on skin elasticity is indirect despite clinically relevant outcomes."
Astaxanthin,gastrointestinal disorders,Insomnia,,Sleep,manual_pair,"There is limited evidence suggesting that astaxanthin may improve sleep efficiency and sleep onset, as indicated by one randomized controlled trial involving healthy individuals. The study reported benefits when astaxanthin was combined with zinc over a 12-week period. However, due to the small number of studies and lack of consistency in findings, the overall evidence remains weak.",0.6,28019085,2017,Zinc-rich oysters as well as zinc-yeast- and astaxanthin-enriched food improved sleep efficiency and sleep onset in a randomized controlled trial of healthy individuals.,randomized_controlled_trial,benefit,"The study showed that astaxanthin, along with zinc, improved sleep outcomes, indicating a beneficial effect.",12 weeks (astaxanthin oil),,,sleep efficiency,sleep efficiency; sleep onset,Tier 4,0.3,"Although this was a randomized, double-blind, placebo-controlled trial with objective sleep measures, astaxanthin was only given in combination with zinc and there was no astaxanthin-only arm. Zinc-alone improved sleep outcomes, so any benefit cannot be attributed specifically to astaxanthin. Participants were healthy rather than diagnosed with insomnia, further limiting relevance to the indication."
Astaxanthin,gastrointestinal disorders,Gastric Reflux,,Gut Health,manual_pair,"The evidence for astaxanthin in treating reflux symptoms is limited and mixed. One randomized controlled trial reported no overall curative effect, but noted a significant reduction in reflux symptoms at a higher dose of 40 mg for four weeks. Overall, the findings do not support a clear benefit for this indication.",0.7,18467083,2008,"Efficacy of the natural antioxidant astaxanthin in the treatment of functional dyspepsia in patients with or without Helicobacter pylori infection: A prospective, randomized, double blind, and placebo-controlled study.",randomized_controlled_trial,mixed_unclear,"No overall curative effect was found, but a significant reduction in reflux symptoms was noted at the higher dose.",16 mg 4 weeks; 40 mg 4 weeks,,,functional dyspepsia,functional dyspepsia,Tier 2,0.55,"Randomized, double-blind, placebo-controlled human RCT (~132 participants) with good methods. Reflux symptoms were assessed via a GSRS reflux subscale and showed greater reduction only at the higher dose, while no difference in mean reflux scores at week 4 was found. The study population had functional dyspepsia rather than GERD, and reflux was a secondary/subscale outcome, making applicability to gastric reflux indirect despite the rigorous design."
Astaxanthin,gastrointestinal disorders,Rheumatoid Arthritis,,"Immune, Inflammation, & Infection",manual_pair,"One randomized clinical trial reported that astaxanthin supplementation (20 mg/day for 8 weeks) improved clinical outcomes and quality of life in patients with rheumatoid arthritis, demonstrating significant reductions in disease activity and inflammatory markers. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term effects and safety.",0.7,40569081,2025,"Astaxanthin supplement improves clinical outcomes, quality of life, and inflammatory factors in patients with rheumatoid arthritis: a randomized clinical trial.",randomized_controlled_trial,benefit,"The study showed beneficial effects of astaxanthin on clinical outcomes and quality of life in RA patients, with significant reductions in DAS-28, HAQ, ESR, and CRP levels.",20 mg day-1 8 weeks (supplement),,,rheumatoid arthritis,rheumatoid arthritis,Tier 1,0.78,"Triple-blind, randomized, placebo-controlled trial in RA patients (n≈60) with clinically relevant primary outcomes (DAS-28, HAQ) showing benefit, along with reductions in ESR/CRP. Methods and outcomes align directly with the indication. Confidence tempered slightly by modest sample size and short 8-week duration."
Astaxanthin,gastrointestinal disorders,Oxidative Stress,,"Immune, Inflammation, & Infection",manual_pair,"There is limited evidence suggesting that astaxanthin may have a protective effect against vocal fold injury and inflammation, based on a single clinical trial that reported a benefit with a dose of 24 mg daily for 28 days. However, due to the low quantity of studies and lack of corroborating evidence, the overall confidence in this finding is low.",0.2,27481232,2017,Protective Effect of Astaxanthin on Vocal Fold Injury and Inflammation Due to Vocal Loading: A Clinical Trial.,clinical_trial,benefit,"The study shows that astaxanthin protects against vocal fold injury and inflammation, indicating a beneficial effect.",24 mg daily 28 days,,,inflammation,inflammation; vocal fold injury; voice disorders,Tier 4,0.34,"Small, uncontrolled pre–post human trial (n=10) assessing vocal function parameters after astaxanthin. No randomization/blinding and no direct oxidative stress biomarkers were measured. Clinical outcomes (phonatory parameters, GRBAS) relate to vocal fold injury/inflammation and only indirectly to oxidative stress, making the evidence for the specific indication of oxidative stress very indirect."
Bacopa Monnieri,abdominal cramps; gastrointestinal tract side-effects; increased stool frequency; insomnia; mild side-effects reported by 2.3% of participants; nausea; stomach upset; weight loss,Stresss,,"Energy, Mood, & Mental Health",manual_pair,"Clinical evidence from two randomized, double-blind, placebo-controlled trials suggests that Bacopa monnieri may have beneficial effects on anxiety and cognitive performance. Doses reported include 300 mg daily for 12 weeks and single doses of 320 mg and 640 mg. No adverse effects were noted in the studies, but further research is needed to confirm these findings and assess long-term safety.",0.9,23788517,2014,"An acute, double-blind, placebo-controlled cross-over study of 320 mg and 640 mg doses of Bacopa monnieri (CDRI 08) on multitasking stress reactivity and mood.",randomized_controlled_trial,benefit,"The study showed positive effects on mood and cognitive performance, indicating a benefit from Bacopa monnieri supplementation.",320 mg single dose (Bacopa monnieri extract); 640 mg single dose (Bacopa monnieri extract),,,anxiety,anxiety; cognitive enhancement; cognitive performance; depression; stress,Tier 3,0.64,"Small, acute, double-blind cross-over RCT (n=17) in healthy volunteers measured mood and salivary cortisol during a lab stress task. While results suggested reduced stress reactivity, outcomes were surrogate (cortisol, transient mood) and not clinical stress symptoms over time. Thus, preliminary human evidence for stress."
Bacopa Monnieri,abdominal cramps; gastrointestinal tract side-effects; increased stool frequency; insomnia; mild side-effects reported by 2.3% of participants; nausea; stomach upset; weight loss,Stresss,,"Energy, Mood, & Mental Health",manual_pair,"Clinical evidence from two randomized, double-blind, placebo-controlled trials suggests that Bacopa monnieri may have beneficial effects on anxiety and cognitive performance. Doses reported include 300 mg daily for 12 weeks and single doses of 320 mg and 640 mg. No adverse effects were noted in the studies, but further research is needed to confirm these findings and assess long-term safety.",0.9,18611150,2008,"Effects of a standardized Bacopa monnieri extract on cognitive performance, anxiety, and depression in the elderly: a randomized, double-blind, placebo-controlled trial.",randomized_controlled_trial,benefit,"The study showed enhanced cognitive performance and reduced anxiety and depression scores in the Bacopa group compared to placebo, indicating a benefit.",300 mg daily 12 weeks (standardized extract),Older Adults,,anxiety,anxiety; cognitive enhancement; cognitive performance; depression; stress,Tier 3,0.57,"Randomized, double-blind, placebo-controlled RCT (n=54 randomized; 48 completers) in older adults using 300 mg/day standardized Bacopa for 12 weeks found reductions in anxiety and depression versus placebo. However, stress was not a primary outcome and was not directly measured (e.g., no perceived stress scale); affective measures were secondary to the primary cognitive endpoint. Small sample and older population limit generalizability to stress specifically, making the evidence preliminary/indirect for this indication."
Bacopa Monnieri,abdominal cramps; gastrointestinal tract side-effects; increased stool frequency; insomnia; mild side-effects reported by 2.3% of participants; nausea; stomach upset; weight loss,Cognitive Performance,,Cognitive & Neurological Function,manual_pair,"The evidence for Bacopa monnieri in improving cognitive impairment is mixed. One study reported a benefit with a single dose of 320 mg, while another study found some improvements in cognitive performance parameters but no significant overall effect at a dose of 160 mg over two months. No adverse effects were reported in the studies reviewed.",0.8,23281132,2013,"An acute, double-blind, placebo-controlled crossover study of 320 mg and 640 mg doses of a special extract of Bacopa monnieri (CDRI 08) on sustained cognitive performance.",randomized_controlled_trial,benefit,"The study showed that the 320 mg dose improved cognitive performance, indicating a benefit in cognitive function.",320 mg single dose (extract); 640 mg single dose (extract),,,anxiety,anxiety; cognitive performance; mild cognitive impairment,Tier 2,0.6,"Double-blind, placebo-controlled crossover RCT in healthy adults with cognitive performance as the primary outcome showed benefit at 320 mg. However, the sample size was small (n=24) and effects were assessed after a single acute dose, limiting robustness and generalizability."
Bacopa Monnieri,abdominal cramps; gastrointestinal tract side-effects; increased stool frequency; insomnia; mild side-effects reported by 2.3% of participants; nausea; stomach upset; weight loss,Cognitive Performance,,Cognitive & Neurological Function,manual_pair,"The evidence for Bacopa monnieri in improving cognitive impairment is mixed. One study reported a benefit with a single dose of 320 mg, while another study found some improvements in cognitive performance parameters but no significant overall effect at a dose of 160 mg over two months. No adverse effects were reported in the studies reviewed.",0.8,38538390,2024,"Evaluating the effects of Bacopa monnieri on cognitive performance and sleep quality of patients with mild cognitive impairment: A triple-blinded, randomized, placebo-controlled trial.",randomized_controlled_trial,mixed_unclear,"The study showed some improvement in cognitive performance parameters but no significant effect on overall cognitive performance score or sleep quality, indicating mixed outcomes.",160 mg 1 pill 2 months (Bacopa monnieri extract),,,mild cognitive impairment,anxiety; cognitive performance; mild cognitive impairment,Tier 2,0.67,"Triple-blinded randomized placebo-controlled human trial (n≈62) directly targeting cognitive performance. While methodology and relevance are good, the sample size is small and results are mixed, so it does not meet the threshold for strong, large RCT evidence."
Bacopa Monnieri,abdominal cramps; gastrointestinal tract side-effects; increased stool frequency; insomnia; mild side-effects reported by 2.3% of participants; nausea; stomach upset; weight loss,Improve Emotional Function,,Cognitive & Neurological Function,manual_pair,"There is limited evidence from a pilot study suggesting that Bacopa monnieri may improve emotional function in patients with Parkinson's disease, particularly at a higher dose of 450 mg daily. However, the evidence is based on a single study, and further research is needed to confirm these findings and assess safety and efficacy more comprehensively.",0.6,36800346,2023,Bacopa monnieri in Patients with Parkinson's Disease: A Pilot Study.,randomized_controlled_trial,benefit,The study suggests a benefit in improving emotional function in Parkinson's disease patients with the higher dose of Bacopa monnieri.,225 mg daily (extract); 450 mg daily (extract),Parkinson's Disease,,parkinson's disease,parkinson's disease,Tier 2,0.58,"Pilot randomized controlled trial in Parkinson’s disease patients reported benefit on emotional function at the higher dose. It is an RCT but likely small and possibly with emotional outcomes as secondary measures, so methods and scope are not strong enough for Tier 1. Still, it is controlled human evidence directly addressing the indication."
Bacopa Monnieri,abdominal cramps; gastrointestinal tract side-effects; increased stool frequency; insomnia; mild side-effects reported by 2.3% of participants; nausea; stomach upset; weight loss,Memory,,Cognitive & Neurological Function,manual_pair,"Clinical evidence from two randomized, placebo-controlled trials indicates that Bacopa monnieri may improve memory function, with one study using a dose of 300 mg daily for 12 weeks and another using Brahmi for three months. No studies reported harm or lack of benefit, suggesting a positive effect on memory problems; however, further research may be needed to confirm these findings and assess long-term safety.",0.9,12093601,2002,Chronic effects of Brahmi (Bacopa monnieri) on human memory.,randomized_controlled_trial,benefit,"The study showed a significant effect of Brahmi on memory retention, indicating a benefit in memory function.",three months (Brahmi (Bacopa monnieri)),,,anxiety,anxiety; healthy aging; memory disorders; memory performance improvement,Tier 1,0.78,"Double-blind, randomized, placebo-controlled trial in 76 adults tested memory as a primary domain and found significant improvement in retention of new information after 3 months of Bacopa monnieri. Methods and sample size are adequate for strong human evidence, though benefits were specific to retention and not other cognitive domains."
Bacopa Monnieri,abdominal cramps; gastrointestinal tract side-effects; increased stool frequency; insomnia; mild side-effects reported by 2.3% of participants; nausea; stomach upset; weight loss,Memory,,Cognitive & Neurological Function,manual_pair,"Clinical evidence from two randomized, placebo-controlled trials indicates that Bacopa monnieri may improve memory function, with one study using a dose of 300 mg daily for 12 weeks and another using Brahmi for three months. No studies reported harm or lack of benefit, suggesting a positive effect on memory problems; however, further research may be needed to confirm these findings and assess long-term safety.",0.9,20590480,2010,"Does Bacopa monnieri improve memory performance in older persons? Results of a randomized, placebo-controlled, double-blind trial.",randomized_controlled_trial,benefit,"The study demonstrated significant improvements in memory performance, indicating a benefit from Bacopa monnieri supplementation.",300 mg daily 12 weeks (extract of Bacopa monnieri),Older Adults,,healthy aging,anxiety; healthy aging; memory disorders; memory performance improvement,Tier 1,0.78,"Randomized, double-blind, placebo-controlled RCT in healthy older adults with memory as a primary outcome. Statistically significant improvements on validated memory measures (AVLT) were observed with 300 mg/day Bacopa for 12 weeks. Sample size (n=98 randomized, 81 completers) and methods are adequate, supporting strong human evidence for memory improvement."
Beetroot (Nitrate),Red urine production,Hypertension,,Heart & Vascular Health,manual_pair,"Current evidence regarding beetroot (nitrate) supplementation for blood pressure is mixed and unclear, with a single study reporting uncertain effects on blood pressure following various doses of beetroot juice (572 mg, 280 mg, 43 mg). No studies have demonstrated a clear benefit, and the overall quality of evidence is low, indicating a need for further research to clarify these findings.",0.5,33498220,2021,Pharmacokinetics of Nitrate and Nitrite Following Beetroot Juice Drink Consumption.,randomized_controlled_trial,mixed_unclear,"The study shows mixed results regarding the impact of nitrate and nitrite on blood pressure, indicating some effects but also uncertainty about the role of nitrite.",572 mg single dose 6 hours (beetroot juice); 280 mg single dose 6 hours (beetroot juice); 43 mg single dose 6 hours (beetroot juice); 8 mg single dose 6 hours (placebo),,,blood pressure,blood pressure,Tier 4,0.55,"This is a small PK-focused RCT in healthy adults (n=11) primarily assessing nitrate/nitrite kinetics after beetroot juice. Any blood pressure data appear exploratory, acute, and mixed, and the population is not hypertensive. Thus, evidence for the hypertension indication is indirect and very low-quality for this specific study."
Beetroot (Nitrate),Red urine production,Cognitive Performance,,Cognitive & Neurological Function,manual_pair,"Current evidence on beetroot (nitrate) supplementation for cognitive enhancement in healthy adults is limited and mixed, with one pilot study indicating potential cognitive improvement at a dose of 400 mg of beetroot juice, but lacking significant performance outcomes. Overall, the findings do not support a clear benefit, and further research is needed to clarify its effects.",0.7,34639501,2021,"Effects of Beetroot Juice Supplementation on Cognitive Function, Aerobic and Anaerobic Performances of Trained Male Taekwondo Athletes: A Pilot Study.",randomized_controlled_trial,mixed_unclear,"Cognitive function improved with BJ-400, but no significant differences in performance outcomes were observed.",400 mg single dose acute (juice); 800 mg single dose acute (juice),,Performance & Recovery,cognitive function,cognitive function; taekwondo performance,Tier 2,0.6,"Randomized controlled pilot in trained male athletes with acute beetroot juice doses assessed cognitive performance. Cognitive function improved at the 400 mg dose but findings were not consistent across doses. Small sample and likely secondary cognitive outcomes reduce robustness, yet the RCT design provides moderate human evidence relevant to cognitive performance."
Beetroot (Nitrate),Red urine production,Cognitive Performance,,Cognitive & Neurological Function,manual_pair,"Current evidence suggests that beetroot (nitrate) may have beneficial effects on cognitive performance, with two randomized trials reporting improvements in cognitive functions following supplementation. Doses included 3 g of chewable tablets in one study and beetroot juice over 14 days in another. However, the overall evidence is limited and further research is needed to confirm these findings and establish optimal dosing and long-term effects.",0.7,37875637,2024,Acute effects of a chewable beetroot-based supplement on cognitive performance: a double-blind randomized placebo-controlled crossover clinical trial.,randomized_controlled_trial,benefit,"The study found significant improvements in cognitive functions, indicating a beneficial effect of the beetroot supplement.",3 g single dose (chewable tablets),,,cognitive flexibility,cognitive flexibility; cognitive function; cognitive performance; frontal lobe functions; memory consolidation; overweight; vascular function,Tier 2,0.63,"Double-blind, randomized, placebo-controlled crossover RCT (n=44) tested a single dose of a beetroot-based nitrate supplement with cognitive performance as the primary outcome. It showed significant improvements in certain domains (memory consolidation, frontal functions/cognitive flexibility) but not others, and was an acute, modest-sized study. Methods are strong but sample size and mixed domain effects support moderate (not strong) human evidence."
Beetroot (Nitrate),Red urine production,Cognitive Performance,,Cognitive & Neurological Function,manual_pair,"Current evidence suggests that beetroot (nitrate) may have beneficial effects on cognitive performance, with two randomized trials reporting improvements in cognitive functions following supplementation. Doses included 3 g of chewable tablets in one study and beetroot juice over 14 days in another. However, the overall evidence is limited and further research is needed to confirm these findings and establish optimal dosing and long-term effects.",0.7,36839248,2023,Caloric Restriction (CR) Plus High-Nitrate Beetroot Juice Does Not Amplify CR-Induced Metabolic Adaptation and Improves Vascular and Cognitive Functions in Overweight Adults: A 14-Day Pilot Randomised Trial.,randomized_controlled_trial,benefit,"The study shows that combining caloric restriction with beetroot juice improves vascular and cognitive functions, indicating a benefit.",14 days (beetroot juice),Overweight,,cognitive function,cognitive flexibility; cognitive function; cognitive performance; frontal lobe functions; memory consolidation; overweight; vascular function,Tier 3,0.58,"Small, 14-day pilot randomized trial (n≈29) in overweight adults assessing cognitive function as a secondary outcome while combining caloric restriction with high-nitrate beetroot juice. Although randomized, the short duration, small sample, and combination with caloric restriction make the evidence preliminary for beetroot nitrate’s effect on cognitive performance."
Beetroot (Nitrate),Red urine production,Cold Extremities,,"Skin, Hair, & Nails",manual_pair,"One randomized trial indicated that beetroot juice supplementation may improve fingertip rewarming and blood flow in individuals with cold hands. However, the evidence is limited to a single study, and further research is needed to confirm these findings and establish consistent dosing recommendations. No adverse effects were reported in the study.",0.7,36305974,2023,Influence of acute beetroot juice supplementation on cold-induced vasodilation and fingertip rewarming.,randomized_controlled_trial,benefit,"The study found that beetroot juice supplementation accelerated rewarming of fingertip skin temperature and blood flow, indicating a beneficial effect.",(beetroot juice),,,cold-induced vasodilation,cold-induced vasodilation; fingertip rewarming,Tier 3,0.58,"Single small randomized crossover trial (n=20 healthy males) using acute beetroot juice ingestion showed faster fingertip rewarming and increased blood flow after cold exposure. Outcomes are physiologic surrogates (CIVD parameters, skin temperature) rather than clinical symptom relief in people with cold extremities or Raynaud’s, and the population was healthy. This supports preliminary human evidence relevant to the indication but not strong clinical evidence."
Beetroot (Nitrate),Red urine production,Cardiac Recovery,,Performance & Recovery,manual_pair,"Current evidence on beetroot (nitrate) for coronary artery disease is limited and mixed, with one randomized trial indicating enhanced vagal modulation and heart rate recovery but no significant changes in heart rate variability or cardiovascular parameters. The study utilized a single dose of 500 mg of beetroot extract. Overall, the findings do not support a clear benefit for this indication.",0.7,39853480,2025,"Acute effects of beetroot extract and resveratrol ingestion on cardiovascular and cardiac autonomic modulation recovery after moderate-intensity aerobic exercise in individuals with coronary artery disease: a triple-blinded, randomized, placebo-controlled trial.",randomized_controlled_trial,mixed_unclear,"The study showed enhanced vagal modulation and heart rate recovery but did not significantly alter HRV or cardiovascular parameters, indicating mixed outcomes.",500 mg single dose (extract),,,coronary artery disease,coronary artery disease,Tier 2,0.47,"Triple-blinded randomized placebo-controlled trial in CAD patients directly assessed cardiac recovery (autonomic modulation and HR recovery) after acute beetroot extract. Despite rigorous design, the sample was very small (n=14), outcomes were surrogate (HRV/HR recovery), effects were mixed with no between-protocol HRV or cardiovascular differences, and benefits were modest/unclear. Thus, moderate human evidence but with limited confidence."
Beetroot (Nitrate),Red urine production,Athletic Performance,,Performance & Recovery,manual_pair,"The evidence for beetroot (nitrate) supplementation in reducing fatigue is mixed. One randomized trial reported benefits in strength and recovery metrics with a dose of 450 mg of beetroot juice daily for three days, while another trial found no significant improvement in functional outcomes despite positive effects on gut microbiota and inflammation with a daily intake of 200 mL for 14 days. Overall, the findings are not consistent, and further research is needed to clarify the effects on fatigue.",0.8,40431460,2025,"Short-Term Beetroot Juice Supplementation Enhances Strength, Reduces Fatigue, and Promotes Recovery in Physically Active Individuals: A Randomized, Double-Blind, Crossover Trial.",randomized_controlled_trial,benefit,"The study shows significant improvements in strength performance and recovery metrics, indicating a beneficial effect of beetroot juice supplementation.",450 mg daily 3 days (beetroot juice),,,fatigue,fatigue; gut microbiota composition; inflammation; long covid; recovery; strength performance,Tier 2,0.63,"Randomized, double-blind, crossover human trial directly assessing athletic performance outcomes with positive results. However, likely small sample size and short duration (3 days) temper overall strength, keeping it below Tier 1 despite strong methodology."
Beetroot (Nitrate),Red urine production,Athletic Performance,,Performance & Recovery,manual_pair,"The evidence for beetroot (nitrate) supplementation in reducing fatigue is mixed. One randomized trial reported benefits in strength and recovery metrics with a dose of 450 mg of beetroot juice daily for three days, while another trial found no significant improvement in functional outcomes despite positive effects on gut microbiota and inflammation with a daily intake of 200 mL for 14 days. Overall, the findings are not consistent, and further research is needed to clarify the effects on fatigue.",0.8,39571342,2024,Beetroot juice intake positively influenced gut microbiota and inflammation but failed to improve functional outcomes in adults with long COVID: A pilot randomized controlled trial.,randomized_controlled_trial,mixed_unclear,"While beetroot juice improved gut microbiota and inflammatory markers, it did not significantly improve functional outcomes compared to placebo.",200 mL daily 14 days (juice),,,fatigue,fatigue; gut microbiota composition; inflammation; long covid; recovery; strength performance,Tier 5,0.9,"This RCT tested beetroot juice in adults with long COVID, assessing clinical functional measures (fatigue resistance, 6-minute walk, handgrip, FMD) and biological markers. It did not evaluate athletic performance in healthy or trained individuals, and functional outcomes did not differ from placebo. Therefore, it is not direct evidence for the athletic performance indication."
Beetroot (Nitrate),Red urine production,Cardiac Recovery,,Performance & Recovery,manual_pair,"One randomized double-blind crossover study indicates that beetroot juice supplementation may improve heart rate variability by reducing internal load during resistance training in men. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess consistency across different populations and doses.",0.7,36501148,2022,Beetroot Juice Produces Changes in Heart Rate Variability and Reduces Internal Load during Resistance Training in Men: A Randomized Double-Blind Crossover.,randomized_controlled_trial,benefit,"The study shows that beetroot juice supplementation reduces internal load during resistance training, indicating a beneficial effect.",(juice),,,heart rate variability,heart rate variability,Tier 4,0.38,"Randomized double-blind crossover (n=11) in healthy men assessed HRV and internal load during resistance training after acute beetroot juice. Outcomes are surrogate/autonomic measures and exercise load, not direct measures of cardiac recovery or clinical recovery endpoints. Evidence is human but indirect and small, supporting very low/indirect relevance for the specified indication."
Beetroot (Nitrate),Red urine production,Cardiac Recovery,,Performance & Recovery,manual_pair,"Clinical evidence suggests that beetroot nitrate supplementation may reduce blood pressure, with three randomized controlled trials reporting beneficial effects. Doses reported include 800 mg (acute), 400 mg (daily for 6 days), and 12.8 mmol (juice), with significant reductions observed particularly in specific populations such as postmenopausal women and young males. However, the evidence is limited to a small number of studies, and further research is needed to confirm these findings across diverse populations.",0.8,38092272,2024,Acute and short-term beetroot juice nitrate-rich ingestion enhances cardiovascular responses following aerobic exercise in postmenopausal women with arterial hypertension: A triple-blinded randomized controlled trial.,randomized_controlled_trial,benefit,"The study shows significant improvements in blood pressure and flow-mediated dilation, indicating a beneficial effect of beetroot nitrate on cardiovascular health.",800 mg acute (juice); 400 mg daily 6 days (juice),Hypertension; Menopause; Women,,cardiovascular performance,cardiovascular performance; high blood pressure; hypertension; systemic arterial hypertension,Tier 3,0.54,"Triple-blinded crossover RCT in 14 postmenopausal hypertensive women showed improved post-exercise BP and FMD after acute and short-term beetroot juice nitrate. While randomized and well-controlled, the study is small, short in duration, and uses surrogate vascular outcomes during exercise recovery rather than direct clinical measures of cardiac recovery. Findings are suggestive but preliminary and indirectly related to the stated indication."
Beetroot (Nitrate),Red urine production,Cardiac Recovery,,Performance & Recovery,manual_pair,"Clinical evidence suggests that beetroot nitrate supplementation may reduce blood pressure, with three randomized controlled trials reporting beneficial effects. Doses reported include 800 mg (acute), 400 mg (daily for 6 days), and 12.8 mmol (juice), with significant reductions observed particularly in specific populations such as postmenopausal women and young males. However, the evidence is limited to a small number of studies, and further research is needed to confirm these findings across diverse populations.",0.8,37120928,2023,Acute beetroot juice reduces blood pressure in young Black and White males but not females.,randomized_controlled_trial,benefit,"The study found that beetroot juice supplementation significantly reduced systolic blood pressure in young adults, particularly in males.",12.8 mmol (juice),Men,,high blood pressure,cardiovascular performance; high blood pressure; hypertension; systemic arterial hypertension,Tier 5,0.88,"The randomized, placebo-controlled trial evaluated acute effects of beetroot juice on blood pressure and cardiovascular reactivity in young adults. The outcomes were blood pressure changes, not cardiac recovery (e.g., post-exercise heart rate recovery, post-MI/surgery recovery, or cardiac functional recovery). Therefore, despite being an RCT, it does not provide direct evidence for the specified indication of cardiac recovery."
Beetroot (Nitrate),Red urine production,Cardiac Recovery,,Performance & Recovery,manual_pair,"Clinical evidence suggests that beetroot nitrate supplementation may reduce blood pressure, with three randomized controlled trials reporting beneficial effects. Doses reported include 800 mg (acute), 400 mg (daily for 6 days), and 12.8 mmol (juice), with significant reductions observed particularly in specific populations such as postmenopausal women and young males. However, the evidence is limited to a small number of studies, and further research is needed to confirm these findings across diverse populations.",0.8,32729923,2020,Nitrate-Rich Beetroot Juice Reduces Blood Pressure in Tanzanian Adults with Elevated Blood Pressure: A Double-Blind Randomized Controlled Feasibility Trial.,randomized_controlled_trial,benefit,"The study shows a significant reduction in blood pressure, indicating a beneficial effect of beetroot nitrate supplementation.",400 mg 60 d (high-nitrate beetroot juice),,,hypertension,cardiovascular performance; high blood pressure; hypertension; systemic arterial hypertension,Tier 5,0.86,"This double-blind RCT evaluated beetroot nitrate for blood pressure reduction in hypertensive adults, not for cardiac recovery. No outcomes related to post-cardiac event recovery, cardiac function, or rehabilitation were assessed. Thus, it is not evidence for the specified indication."
Beetroot (Nitrate),Red urine production,Inflammation,,"Immune, Inflammation, & Infection",manual_pair,"One randomized clinical trial suggests that beetroot juice (12 ml twice daily for 12 weeks) may reduce certain inflammatory markers in patients with type 2 diabetes, indicating a potential benefit. However, the evidence is limited, with only one study reporting a positive outcome and no data on adverse effects or consistency across multiple trials.",0.7,36342289,2022,A randomized clinical trial of beetroot juice consumption on inflammatory markers and oxidative stress in patients with type 2 diabetes.,randomized_controlled_trial,benefit,"The study shows that beetroot juice reduces certain inflammatory markers, indicating a beneficial effect in patients with type 2 diabetes.",12 ml twice daily 12 weeks (concentrated beetroot juice),Diabetes Type 2,,Type 2 Diabetes Mellitus,Type 2 Diabetes Mellitus,Tier 3,0.6,"Single small RCT (n=52) in T2DM, randomized but unblinded with no placebo control, evaluated surrogate inflammatory biomarkers (IL-6, TNF-α, NF-κB) rather than clinical inflammatory outcomes. Some markers improved while hs-CRP and MDA did not. This supports preliminary human evidence for inflammation-related effects but not strong clinical evidence."
Beetroot (Nitrate),Red urine production,Long COVID,,"Immune, Inflammation, & Infection",manual_pair,"One randomized controlled trial reported a beneficial effect of beetroot juice supplementation on inflammatory markers in adults with long COVID, suggesting a potential anti-inflammatory effect. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess the consistency and safety of beetroot supplementation in this context.",0.7,39940991,2025,Mitochondria-Derived Vesicles and Inflammatory Profiles of Adults with Long COVID Supplemented with Red Beetroot Juice: Secondary Analysis of a Randomized Controlled Trial.,randomized_controlled_trial,benefit,"The study reports a decrease in inflammatory markers, indicating a beneficial effect of beetroot juice supplementation.",null null null 14 days (beetroot juice),,,long covid,long covid,Tier 3,0.62,"Secondary analysis of a small, placebo-controlled RCT (n=25) in long COVID showed reductions in inflammatory biomarkers after 14 days of beetroot juice. Outcomes were surrogate (cytokines) rather than primary clinical symptoms or functional endpoints, and duration/sample size were limited. Thus, evidence is preliminary human evidence rather than strong/moderate clinical evidence."
Beetroot (Nitrate),Red urine production,High Insulin,,Metabolic Health,manual_pair,"Current evidence regarding beetroot (nitrate) supplementation for insulin levels is limited and of low quality. A preliminary study reported mixed results with no significant changes in biochemical parameters after 12 weeks of daily supplementation with 20 g of beetroot extract. No serious adverse events were noted, but the lack of consistent positive outcomes suggests further research is needed.",0.7,38931296,2024,Evaluation of 12-Week Standardized Beetroot Extract Supplementation in Older Participants: A Preliminary Study of Human Health Safety.,randomized_controlled_trial,mixed_unclear,"The study found no serious adverse events, but the outcomes regarding anthropometric, biochemical, and hemodynamic parameters were not statistically significant, indicating mixed results.",20 g daily 12 weeks (beetroot extract),Older Adults,,insulin levels,insulin levels,Tier 5,0.85,"This randomized trial primarily evaluated safety/tolerability of beetroot extract in older adults. It did not target high insulin as a primary or clinically relevant outcome, and reported no significant changes in measured parameters. Thus, it provides no substantive evidence for beetroot (nitrate) in treating high insulin."
Beetroot (Nitrate),Red urine production,Strength,,Performance & Recovery,manual_pair,"Current evidence regarding beetroot (nitrate) supplementation for isometric muscle strength is limited and mixed. One randomized, double-blind, controlled trial reported a positive effect on endurance but no significant impact on maximum strength, suggesting that the effects may vary by outcome measure. The typical dose reported in this study was 140 mL of concentrated beetroot juice.",0.7,36432445,2022,"Acute Effects of Beetroot Juice Supplementation on Isometric Muscle Strength, Rate of Torque Development and Isometric Endurance in Young Adult Men and Women: A Randomized, Double-Blind, Controlled Cross-Over Pilot Study.",randomized_controlled_trial,mixed_unclear,"The study shows a positive effect on endurance in men but no effect on maximum strength, indicating mixed outcomes.",140 mL (concentrated beetroot juice),,,isometric muscle strength,isometric muscle strength,Tier 2,0.72,"Randomized, double-blind, controlled cross-over trial directly testing beetroot juice on isometric strength in healthy adults. Strength was a primary outcome. The study is small (n=18) and a pilot, with mixed/mostly null effects on maximal strength (some sex-specific effects on explosive strength/endurance), but the design supports moderate-quality human evidence for this indication."
Beetroot (Nitrate),Red urine production,Muscle Endurance,,Performance & Recovery,manual_pair,"The evidence regarding beetroot (nitrate) supplementation for knee extensor muscle endurance is limited and mixed, with one randomized controlled trial reporting a positive effect on endurance in men but no effect on maximum strength. The study utilized a dose of 140 mL of concentrated beetroot juice. Overall, the findings do not support a clear benefit for this indication.",0.8,36432445,2022,"Acute Effects of Beetroot Juice Supplementation on Isometric Muscle Strength, Rate of Torque Development and Isometric Endurance in Young Adult Men and Women: A Randomized, Double-Blind, Controlled Cross-Over Pilot Study.",randomized_controlled_trial,mixed_unclear,"The study shows a positive effect on endurance in men but no effect on maximum strength, indicating mixed outcomes.",140 mL (concentrated beetroot juice),,,knee extensor muscle endurance,knee extensor muscle endurance,Tier 3,0.6,"Randomized, double-blind, cross-over pilot (n=18) assessing a primary endurance outcome. While methodology is strong, the sample is small and effects were sex-specific (benefit in men only), yielding mixed results and preliminary evidence rather than robust, well-powered support."
Beetroot (Nitrate),Red urine production,Athletic Performance,,Performance & Recovery,manual_pair,"The evidence from multiple randomized controlled trials indicates that beetroot juice supplementation consistently improves exercise performance across various metrics, including aerobic capacity, strength, and endurance. Typical doses reported range from 50 mL to 140 mL of beetroot juice or equivalent nitrate content, with no studies reporting adverse effects. However, the variability in dosing and specific performance outcomes suggests that further research may be needed to fully understand the optimal use of beetroot for enhancing exercise performance.",0.9,40145446,2025,"Caffeine and Beetroot Juice Optimize 1,000-m Performance: Shapley Additive Explanations Analysis.",randomized_controlled_trial,benefit,"The study shows that beetroot juice supplementation improves 1,000-m running performance, indicating a beneficial outcome.",70 mL (juice),Running,,"1,000-m running performance","1,000-m running performance; aerobic capacity; aerobic power; anaerobic performance; anaerobic power; athletic performance; crossfit performance; endurance performance; endurance strength; exercise capacity; exercise performance; explosive force; field performance; high-intensity interval exercise responses; hormonal response; intermittent exercise performance; jump performance; maximal oxygen uptake; maximal strength; muscle fatigue; muscle power; muscle speed; muscular endurance; muscular power; muscular strength; neuromuscular performance; oxygen consumption during exercise; physical performance; power output; resistance exercise performance; sprint performance; ventilatory efficiency",Tier 2,0.64,"Randomized crossover human trial directly testing beetroot juice on 1,000-m running performance with a beneficial effect on the primary performance outcome. However, likely small sample size and unclear blinding/methodological details prevent assigning Tier 1."
Beetroot (Nitrate),Red urine production,Athletic Performance,,Performance & Recovery,manual_pair,"The evidence from multiple randomized controlled trials indicates that beetroot juice supplementation consistently improves exercise performance across various metrics, including aerobic capacity, strength, and endurance. Typical doses reported range from 50 mL to 140 mL of beetroot juice or equivalent nitrate content, with no studies reporting adverse effects. However, the variability in dosing and specific performance outcomes suggests that further research may be needed to fully understand the optimal use of beetroot for enhancing exercise performance.",0.9,39796497,2024,Effect of Beetroot Juice Supplementation on Aerobic Capacity in Female Athletes: A Randomized Controlled Study.,randomized_controlled_trial,benefit,"The study found significant improvements in aerobic capacity metrics, indicating a beneficial effect of beetroot juice supplementation.",50 mL (juice concentrate),Athletes; Women,,aerobic capacity,"1,000-m running performance; aerobic capacity; aerobic power; anaerobic performance; anaerobic power; athletic performance; crossfit performance; endurance performance; endurance strength; exercise capacity; exercise performance; explosive force; field performance; high-intensity interval exercise responses; hormonal response; intermittent exercise performance; jump performance; maximal oxygen uptake; maximal strength; muscle fatigue; muscle power; muscle speed; muscular endurance; muscular power; muscular strength; neuromuscular performance; oxygen consumption during exercise; physical performance; power output; resistance exercise performance; sprint performance; ventilatory efficiency",Tier 2,0.62,"Randomized controlled trial in the target population (female athletes) showing benefit on aerobic capacity, which is relevant to athletic performance. However, details on sample size and blinding are not provided, and the outcomes appear to be physiological (aerobic capacity metrics) rather than direct performance measures, so the evidence is moderate rather than strong."
Beetroot (Nitrate),Red urine production,Athletic Performance,,Performance & Recovery,manual_pair,"The evidence from multiple randomized controlled trials indicates that beetroot juice supplementation consistently improves exercise performance across various metrics, including aerobic capacity, strength, and endurance. Typical doses reported range from 50 mL to 140 mL of beetroot juice or equivalent nitrate content, with no studies reporting adverse effects. However, the variability in dosing and specific performance outcomes suggests that further research may be needed to fully understand the optimal use of beetroot for enhancing exercise performance.",0.9,35726852,2024,"The effect of eight weeks beetroot juice supplement on aerobic, anaerobic power, and field performance of soccer players.",randomized_controlled_trial,benefit,"The study shows significant improvements in various performance metrics, indicating a beneficial effect of beetroot juice supplementation.",eight weeks (juice),Soccer Players,,aerobic power,"1,000-m running performance; aerobic capacity; aerobic power; anaerobic performance; anaerobic power; athletic performance; crossfit performance; endurance performance; endurance strength; exercise capacity; exercise performance; explosive force; field performance; high-intensity interval exercise responses; hormonal response; intermittent exercise performance; jump performance; maximal oxygen uptake; maximal strength; muscle fatigue; muscle power; muscle speed; muscular endurance; muscular power; muscular strength; neuromuscular performance; oxygen consumption during exercise; physical performance; power output; resistance exercise performance; sprint performance; ventilatory efficiency",Tier 2,0.64,"Randomized controlled design in 40 male soccer players over 8 weeks with direct performance outcomes (aerobic/anaerobic power, field test) supports relevance to athletic performance. However, small sample size and likely lack of blinding/placebo control reduce methodological strength, placing it below Tier 1."
Beetroot (Nitrate),Red urine production,Athletic Performance,,Performance & Recovery,manual_pair,"The evidence from multiple randomized controlled trials indicates that beetroot juice supplementation consistently improves exercise performance across various metrics, including aerobic capacity, strength, and endurance. Typical doses reported range from 50 mL to 140 mL of beetroot juice or equivalent nitrate content, with no studies reporting adverse effects. However, the variability in dosing and specific performance outcomes suggests that further research may be needed to fully understand the optimal use of beetroot for enhancing exercise performance.",0.9,35010917,2021,"Combined Effects of Citrulline Plus Nitrate-Rich Beetroot Extract Co-Supplementation on Maximal and Endurance-Strength and Aerobic Power in Trained Male Triathletes: A Randomized Double-Blind, Placebo-Controlled Trial.",randomized_controlled_trial,benefit,"The study showed significant improvements in aerobic power and trends in strength tests, indicating a benefit from the supplementation.",3 g daily 9 weeks (nitrate-rich beetroot extract),Men; Triathletes,,aerobic power,"1,000-m running performance; aerobic capacity; aerobic power; anaerobic performance; anaerobic power; athletic performance; crossfit performance; endurance performance; endurance strength; exercise capacity; exercise performance; explosive force; field performance; high-intensity interval exercise responses; hormonal response; intermittent exercise performance; jump performance; maximal oxygen uptake; maximal strength; muscle fatigue; muscle power; muscle speed; muscular endurance; muscular power; muscular strength; neuromuscular performance; oxygen consumption during exercise; physical performance; power output; resistance exercise performance; sprint performance; ventilatory efficiency",Tier 4,0.33,"Although this was a randomized, double-blind, placebo-controlled trial with relevant performance outcomes in trained athletes, the intervention combined citrulline with nitrate-rich beetroot extract. Because the effect cannot be attributed specifically to beetroot (nitrate) alone, the evidence is indirect for this supplement-indication pair."
Beetroot (Nitrate),Red urine production,Athletic Performance,,Performance & Recovery,manual_pair,"The evidence from multiple randomized controlled trials indicates that beetroot juice supplementation consistently improves exercise performance across various metrics, including aerobic capacity, strength, and endurance. Typical doses reported range from 50 mL to 140 mL of beetroot juice or equivalent nitrate content, with no studies reporting adverse effects. However, the variability in dosing and specific performance outcomes suggests that further research may be needed to fully understand the optimal use of beetroot for enhancing exercise performance.",0.9,33430250,2021,Acute Beetroot Juice Supplementation Attenuates Morning-Associated Decrements in Supramaximal Exercise Performance in Trained Sprinters.,randomized_controlled_trial,benefit,"BRJ supplementation prevented morning-associated decrements in performance, indicating a beneficial effect.",(juice),Men; Sprinting,,anaerobic performance,"1,000-m running performance; aerobic capacity; aerobic power; anaerobic performance; anaerobic power; athletic performance; crossfit performance; endurance performance; endurance strength; exercise capacity; exercise performance; explosive force; field performance; high-intensity interval exercise responses; hormonal response; intermittent exercise performance; jump performance; maximal oxygen uptake; maximal strength; muscle fatigue; muscle power; muscle speed; muscular endurance; muscular power; muscular strength; neuromuscular performance; oxygen consumption during exercise; physical performance; power output; resistance exercise performance; sprint performance; ventilatory efficiency",Tier 2,0.62,"Human randomized controlled trial in trained male sprinters assessing acute beetroot juice on exercise performance—a primary, clinically relevant outcome. Positive effect reported (attenuated morning performance decrements). Likely small sample and narrow population with acute, context-specific outcome limit generalizability and study size, placing it below strong/large RCTs."
Beetroot (Nitrate),Red urine production,Athletic Performance,,Performance & Recovery,manual_pair,"The evidence from multiple randomized controlled trials indicates that beetroot juice supplementation consistently improves exercise performance across various metrics, including aerobic capacity, strength, and endurance. Typical doses reported range from 50 mL to 140 mL of beetroot juice or equivalent nitrate content, with no studies reporting adverse effects. However, the variability in dosing and specific performance outcomes suggests that further research may be needed to fully understand the optimal use of beetroot for enhancing exercise performance.",0.9,39579758,2025,"Multiday Beetroot Juice Ingestion Improves Some Aspects of Neuromuscular Performance in Semi-Professional, Male Handball Players: A Randomized, Double-Blind, Placebo-Controlled, Crossover Study.",randomized_controlled_trial,benefit,The study found significant improvements in specific neuromuscular performance metrics with beetroot juice ingestion.,70 ml daily 3 days (juice),Handball Players,,athletic performance,"1,000-m running performance; aerobic capacity; aerobic power; anaerobic performance; anaerobic power; athletic performance; crossfit performance; endurance performance; endurance strength; exercise capacity; exercise performance; explosive force; field performance; high-intensity interval exercise responses; hormonal response; intermittent exercise performance; jump performance; maximal oxygen uptake; maximal strength; muscle fatigue; muscle power; muscle speed; muscular endurance; muscular power; muscular strength; neuromuscular performance; oxygen consumption during exercise; physical performance; power output; resistance exercise performance; sprint performance; ventilatory efficiency",Tier 2,0.62,"Randomized, double-blind, placebo-controlled crossover RCT in athletes directly testing performance outcomes relevant to athletic performance. However, the sample size is small (n=12), duration short (3 days), and benefits were limited to some neuromuscular metrics, reducing strength and generalizability despite good methods."
Beetroot (Nitrate),Red urine production,Athletic Performance,,Performance & Recovery,manual_pair,"The evidence from multiple randomized controlled trials indicates that beetroot juice supplementation consistently improves exercise performance across various metrics, including aerobic capacity, strength, and endurance. Typical doses reported range from 50 mL to 140 mL of beetroot juice or equivalent nitrate content, with no studies reporting adverse effects. However, the variability in dosing and specific performance outcomes suggests that further research may be needed to fully understand the optimal use of beetroot for enhancing exercise performance.",0.9,38953606,2024,"Effects of acute beetroot juice intake on performance, maximal oxygen uptake, and ventilatory efficiency in well-trained master rowers: a randomized, double-blinded crossover study.",randomized_controlled_trial,benefit,"The study shows an improvement in time trial performance and V˙O2max, indicating a benefit from beetroot juice intake.",3 hours before tests 2 weeks (beetroot juice),Men; Rowers,,athletic performance,"1,000-m running performance; aerobic capacity; aerobic power; anaerobic performance; anaerobic power; athletic performance; crossfit performance; endurance performance; endurance strength; exercise capacity; exercise performance; explosive force; field performance; high-intensity interval exercise responses; hormonal response; intermittent exercise performance; jump performance; maximal oxygen uptake; maximal strength; muscle fatigue; muscle power; muscle speed; muscular endurance; muscular power; muscular strength; neuromuscular performance; oxygen consumption during exercise; physical performance; power output; resistance exercise performance; sprint performance; ventilatory efficiency",Tier 2,0.6,"Randomized, double-blind, crossover RCT in well-trained male master rowers showed improved 2000-m time-trial performance (primary, clinically relevant athletic outcome) after acute beetroot juice intake, with indications of VO2max benefit. However, the sample size was very small (n=10), effects were reported with 90% rather than 95% confidence limits, and the population is narrow (trained male rowers), limiting generalizability. Overall, this is moderate-quality human evidence for athletic performance from a small but well-controlled trial."
Beetroot (Nitrate),Red urine production,Athletic Performance,,Performance & Recovery,manual_pair,"The evidence from multiple randomized controlled trials indicates that beetroot juice supplementation consistently improves exercise performance across various metrics, including aerobic capacity, strength, and endurance. Typical doses reported range from 50 mL to 140 mL of beetroot juice or equivalent nitrate content, with no studies reporting adverse effects. However, the variability in dosing and specific performance outcomes suggests that further research may be needed to fully understand the optimal use of beetroot for enhancing exercise performance.",0.9,33187518,2020,"Understanding the effects of beetroot juice intake on CrossFit performance by assessing hormonal, metabolic and mechanical response: a randomized, double-blind, crossover design.",randomized_controlled_trial,benefit,The study found that beetroot juice intake improved anaerobic performance and affected hormonal responses positively.,140 mL single dose (juice),CrossFit Athletes,,crossfit performance,"1,000-m running performance; aerobic capacity; aerobic power; anaerobic performance; anaerobic power; athletic performance; crossfit performance; endurance performance; endurance strength; exercise capacity; exercise performance; explosive force; field performance; high-intensity interval exercise responses; hormonal response; intermittent exercise performance; jump performance; maximal oxygen uptake; maximal strength; muscle fatigue; muscle power; muscle speed; muscular endurance; muscular power; muscular strength; neuromuscular performance; oxygen consumption during exercise; physical performance; power output; resistance exercise performance; sprint performance; ventilatory efficiency",Tier 2,0.61,"Randomized, double-blind, crossover RCT in 12 trained male CrossFit athletes assessed acute beetroot juice on a primary, clinically relevant performance outcome (repetitions). It showed a benefit under specific rest conditions. The high-quality design supports moderate evidence, but the small sample size, acute dosing, male-only cohort, and context-specific effect limit strength and generalizability."
Beetroot (Nitrate),Red urine production,Athletic Performance,,Performance & Recovery,manual_pair,"The evidence from multiple randomized controlled trials indicates that beetroot juice supplementation consistently improves exercise performance across various metrics, including aerobic capacity, strength, and endurance. Typical doses reported range from 50 mL to 140 mL of beetroot juice or equivalent nitrate content, with no studies reporting adverse effects. However, the variability in dosing and specific performance outcomes suggests that further research may be needed to fully understand the optimal use of beetroot for enhancing exercise performance.",0.9,35512758,2023,Influence of Chronic Nitrate-Rich Beetroot Juice Supplementation on the Endurance Performance of Active Winter Triathletes: A Randomized Controlled Trial.,randomized_controlled_trial,benefit,"The study found that BRJ supplementation improved running economy and time to exhaustion, indicating a benefit for endurance performance.",6.5 mmol NO3- 3 times per day 7 days (beetroot juice),Running,,endurance performance,"1,000-m running performance; aerobic capacity; aerobic power; anaerobic performance; anaerobic power; athletic performance; crossfit performance; endurance performance; endurance strength; exercise capacity; exercise performance; explosive force; field performance; high-intensity interval exercise responses; hormonal response; intermittent exercise performance; jump performance; maximal oxygen uptake; maximal strength; muscle fatigue; muscle power; muscle speed; muscular endurance; muscular power; muscular strength; neuromuscular performance; oxygen consumption during exercise; physical performance; power output; resistance exercise performance; sprint performance; ventilatory efficiency",Tier 2,0.66,"Randomized controlled trial with a relatively large athletic cohort (n=80) tested beetroot juice for endurance performance. It improved lab-based performance measures (running economy, time to exhaustion), which are relevant to athletic performance, but did not improve a real-world 10-km time trial. Methods/blinding details aren’t fully clear. Overall, this supports moderate human evidence rather than strong."
Beetroot (Nitrate),Red urine production,Athletic Performance,,Performance & Recovery,manual_pair,"The evidence from multiple randomized controlled trials indicates that beetroot juice supplementation consistently improves exercise performance across various metrics, including aerobic capacity, strength, and endurance. Typical doses reported range from 50 mL to 140 mL of beetroot juice or equivalent nitrate content, with no studies reporting adverse effects. However, the variability in dosing and specific performance outcomes suggests that further research may be needed to fully understand the optimal use of beetroot for enhancing exercise performance.",0.9,39308082,2024,Effects of an Isotonic Beetroot Drink on Power Output During Sprint Exercise and Jump Performance in Physically Active Individuals: A Randomized Crossover Trial.,randomized_controlled_trial,benefit,"The isotonic beetroot drink significantly improved peak power output during sprint cycling, indicating a beneficial effect on exercise performance.",570 mL single dose 3 hours before exercise (isotonic beetroot juice drink),Sprinting,,exercise performance,"1,000-m running performance; aerobic capacity; aerobic power; anaerobic performance; anaerobic power; athletic performance; crossfit performance; endurance performance; endurance strength; exercise capacity; exercise performance; explosive force; field performance; high-intensity interval exercise responses; hormonal response; intermittent exercise performance; jump performance; maximal oxygen uptake; maximal strength; muscle fatigue; muscle power; muscle speed; muscular endurance; muscular power; muscular strength; neuromuscular performance; oxygen consumption during exercise; physical performance; power output; resistance exercise performance; sprint performance; ventilatory efficiency",Tier 2,0.66,"Randomized crossover human trial in physically active adults directly tested beetroot (nitrate) on exercise performance and found improved sprint peak power. While the outcome is a primary performance measure and the design is robust, the sample size is modest (n=23) and blinding/details are unclear, so evidence is moderate rather than strong."
Beetroot (Nitrate),Red urine production,Athletic Performance,,Performance & Recovery,manual_pair,"The evidence from multiple randomized controlled trials indicates that beetroot juice supplementation consistently improves exercise performance across various metrics, including aerobic capacity, strength, and endurance. Typical doses reported range from 50 mL to 140 mL of beetroot juice or equivalent nitrate content, with no studies reporting adverse effects. However, the variability in dosing and specific performance outcomes suggests that further research may be needed to fully understand the optimal use of beetroot for enhancing exercise performance.",0.9,35603411,2022,Acute Effects of Beetroot Juice Supplements on Lower-Body Strength in Female Athletes: Double-Blind Crossover Randomized Trial.,randomized_controlled_trial,benefit,The study shows that beetroot juice significantly improves performance in explosive force and muscular endurance tests.,70 mL single dose (juice),Athletes; Women,,explosive force,"1,000-m running performance; aerobic capacity; aerobic power; anaerobic performance; anaerobic power; athletic performance; crossfit performance; endurance performance; endurance strength; exercise capacity; exercise performance; explosive force; field performance; high-intensity interval exercise responses; hormonal response; intermittent exercise performance; jump performance; maximal oxygen uptake; maximal strength; muscle fatigue; muscle power; muscle speed; muscular endurance; muscular power; muscular strength; neuromuscular performance; oxygen consumption during exercise; physical performance; power output; resistance exercise performance; sprint performance; ventilatory efficiency",Tier 2,0.66,"Double-blind, randomized crossover RCT in female athletes with performance outcomes (explosive force, muscular endurance) as primary endpoints showed benefit after acute beetroot juice ingestion. However, the sample size is small (n=14) and the findings are limited to acute, lower-body strength tasks in women, preventing Tier 1 classification."
Beetroot (Nitrate),Red urine production,Athletic Performance,,Performance & Recovery,manual_pair,"The evidence from multiple randomized controlled trials indicates that beetroot juice supplementation consistently improves exercise performance across various metrics, including aerobic capacity, strength, and endurance. Typical doses reported range from 50 mL to 140 mL of beetroot juice or equivalent nitrate content, with no studies reporting adverse effects. However, the variability in dosing and specific performance outcomes suggests that further research may be needed to fully understand the optimal use of beetroot for enhancing exercise performance.",0.9,38535518,2024,"Acute effects of various doses of nitrate-rich beetroot juice on high-intensity interval exercise responses in women: a randomized, double-blinded, placebo-controlled, crossover trial.",randomized_controlled_trial,benefit,"Nitrate supplementation led to significant decreases in heart rate and rating of perceived exertion during exercise, indicating a beneficial effect.",6.45 mmol single-dose (beetroot juice); 12.9 mmol double-dose (beetroot juice),Women,,high-intensity interval exercise responses,"1,000-m running performance; aerobic capacity; aerobic power; anaerobic performance; anaerobic power; athletic performance; crossfit performance; endurance performance; endurance strength; exercise capacity; exercise performance; explosive force; field performance; high-intensity interval exercise responses; hormonal response; intermittent exercise performance; jump performance; maximal oxygen uptake; maximal strength; muscle fatigue; muscle power; muscle speed; muscular endurance; muscular power; muscular strength; neuromuscular performance; oxygen consumption during exercise; physical performance; power output; resistance exercise performance; sprint performance; ventilatory efficiency",Tier 3,0.6,"Double-blind, randomized, placebo-controlled crossover RCT in 13 women showed reduced heart rate and perceived exertion during high-intensity intervals after acute beetroot nitrate. However, sample size is small and outcomes are surrogate (HR, RPE) rather than direct performance metrics (e.g., time trial, power output, time to exhaustion), making the evidence preliminary for the indication of athletic performance."
Beetroot (Nitrate),Red urine production,Athletic Performance,,Performance & Recovery,manual_pair,"The evidence from multiple randomized controlled trials indicates that beetroot juice supplementation consistently improves exercise performance across various metrics, including aerobic capacity, strength, and endurance. Typical doses reported range from 50 mL to 140 mL of beetroot juice or equivalent nitrate content, with no studies reporting adverse effects. However, the variability in dosing and specific performance outcomes suggests that further research may be needed to fully understand the optimal use of beetroot for enhancing exercise performance.",0.9,35889796,2022,Acute Beetroot Juice Supplementation Enhances Intermittent Running Performance but Does Not Reduce Oxygen Cost of Exercise among Recreational Adults.,randomized_controlled_trial,benefit,"The study found that beetroot nitrate supplementation improved running performance but did not affect oxygen consumption, indicating a performance benefit.",12.8 mmol single dose 3 hours before exercise (concentrated beetroot juice),Running,,intermittent exercise performance,"1,000-m running performance; aerobic capacity; aerobic power; anaerobic performance; anaerobic power; athletic performance; crossfit performance; endurance performance; endurance strength; exercise capacity; exercise performance; explosive force; field performance; high-intensity interval exercise responses; hormonal response; intermittent exercise performance; jump performance; maximal oxygen uptake; maximal strength; muscle fatigue; muscle power; muscle speed; muscular endurance; muscular power; muscular strength; neuromuscular performance; oxygen consumption during exercise; physical performance; power output; resistance exercise performance; sprint performance; ventilatory efficiency",Tier 2,0.65,"Double-blind, randomized, placebo-controlled crossover RCT in recreational runners showed improved intermittent running performance after acute beetroot nitrate (~12.8 mmol) vs placebo. The indication (athletic performance) was a primary outcome. However, the sample size was small (n=12) and single-session design limits generalizability, preventing Tier 1."
Beetroot (Nitrate),Red urine production,Athletic Performance,,Performance & Recovery,manual_pair,"The evidence from multiple randomized controlled trials indicates that beetroot juice supplementation consistently improves exercise performance across various metrics, including aerobic capacity, strength, and endurance. Typical doses reported range from 50 mL to 140 mL of beetroot juice or equivalent nitrate content, with no studies reporting adverse effects. However, the variability in dosing and specific performance outcomes suggests that further research may be needed to fully understand the optimal use of beetroot for enhancing exercise performance.",0.9,37244392,2023,Short-term beetroot juice supplementation improves muscle speed and power but does not reduce blood pressure or oxidative stress in 65-79 y old men and women.,randomized_controlled_trial,benefit,The study shows significant improvements in muscle function without adverse effects on blood pressure or oxidative stress.,18.2 mmol daily 2 weeks (beetroot juice),Older Adults,,muscle power,"1,000-m running performance; aerobic capacity; aerobic power; anaerobic performance; anaerobic power; athletic performance; crossfit performance; endurance performance; endurance strength; exercise capacity; exercise performance; explosive force; field performance; high-intensity interval exercise responses; hormonal response; intermittent exercise performance; jump performance; maximal oxygen uptake; maximal strength; muscle fatigue; muscle power; muscle speed; muscular endurance; muscular power; muscular strength; neuromuscular performance; oxygen consumption during exercise; physical performance; power output; resistance exercise performance; sprint performance; ventilatory efficiency",Tier 2,0.63,"Randomized controlled trial in older adults found improved muscle speed and power after 2 weeks of beetroot juice (nitrate). Outcomes are performance-related and appear to be primary, but the population is not athletes and sample size/power not specified. Short duration and demographic specificity limit generalizability to athletic performance, so evidence is moderate rather than strong."
Beetroot (Nitrate),Red urine production,Athletic Performance,,Performance & Recovery,manual_pair,"The evidence from multiple randomized controlled trials indicates that beetroot juice supplementation consistently improves exercise performance across various metrics, including aerobic capacity, strength, and endurance. Typical doses reported range from 50 mL to 140 mL of beetroot juice or equivalent nitrate content, with no studies reporting adverse effects. However, the variability in dosing and specific performance outcomes suggests that further research may be needed to fully understand the optimal use of beetroot for enhancing exercise performance.",0.9,40369047,2025,"Single and combined effect of beetroot juice and caffeine intake on muscular strength, power and endurance performance in resistance-trained males.",randomized_controlled_trial,benefit,The study found that beetroot juice significantly improved muscular endurance performance.,70 mL single dose acute (juice),Men,,muscular endurance,"1,000-m running performance; aerobic capacity; aerobic power; anaerobic performance; anaerobic power; athletic performance; crossfit performance; endurance performance; endurance strength; exercise capacity; exercise performance; explosive force; field performance; high-intensity interval exercise responses; hormonal response; intermittent exercise performance; jump performance; maximal oxygen uptake; maximal strength; muscle fatigue; muscle power; muscle speed; muscular endurance; muscular power; muscular strength; neuromuscular performance; oxygen consumption during exercise; physical performance; power output; resistance exercise performance; sprint performance; ventilatory efficiency",Tier 2,0.62,"Triple-blind, randomized, crossover RCT in resistance-trained men testing acute beetroot juice (70 mL) with performance outcomes; reported significant improvement in muscular endurance. However, small sample size (n=13), acute single-dose design, and narrow demographic limit generalizability, so evidence is moderate rather than strong."
Beetroot (Nitrate),Red urine production,Athletic Performance,,Performance & Recovery,manual_pair,"The evidence from multiple randomized controlled trials indicates that beetroot juice supplementation consistently improves exercise performance across various metrics, including aerobic capacity, strength, and endurance. Typical doses reported range from 50 mL to 140 mL of beetroot juice or equivalent nitrate content, with no studies reporting adverse effects. However, the variability in dosing and specific performance outcomes suggests that further research may be needed to fully understand the optimal use of beetroot for enhancing exercise performance.",0.9,32605284,2020,Acute Effects of Beetroot Juice Supplements on Resistance Training: A Randomized Double-Blind Crossover.,randomized_controlled_trial,benefit,The study found that acute supplementation of beetroot juice improved muscular endurance performance in resistance training.,(juice),Men,,muscular endurance,"1,000-m running performance; aerobic capacity; aerobic power; anaerobic performance; anaerobic power; athletic performance; crossfit performance; endurance performance; endurance strength; exercise capacity; exercise performance; explosive force; field performance; high-intensity interval exercise responses; hormonal response; intermittent exercise performance; jump performance; maximal oxygen uptake; maximal strength; muscle fatigue; muscle power; muscle speed; muscular endurance; muscular power; muscular strength; neuromuscular performance; oxygen consumption during exercise; physical performance; power output; resistance exercise performance; sprint performance; ventilatory efficiency",Tier 2,0.66,"Randomized double-blind crossover RCT directly testing beetroot juice on athletic performance (muscular endurance and movement velocity) with beneficial results. However, the sample size is small (n=12) and the effect is from an acute, single-session study, limiting overall strength despite good methods."
Beetroot (Nitrate),Red urine production,Athletic Performance,,Performance & Recovery,manual_pair,"The evidence from multiple randomized controlled trials indicates that beetroot juice supplementation consistently improves exercise performance across various metrics, including aerobic capacity, strength, and endurance. Typical doses reported range from 50 mL to 140 mL of beetroot juice or equivalent nitrate content, with no studies reporting adverse effects. However, the variability in dosing and specific performance outcomes suggests that further research may be needed to fully understand the optimal use of beetroot for enhancing exercise performance.",0.9,33801665,2021,The Relationship between Resistance Exercise Performance and Ventilatory Efficiency after Beetroot Juice Intake in Well-Trained Athletes.,randomized_controlled_trial,benefit,"The study found that beetroot juice improved both ventilatory efficiency and resistance exercise performance, indicating a beneficial effect.",140 mL (juice),Athletes,,resistance exercise performance,"1,000-m running performance; aerobic capacity; aerobic power; anaerobic performance; anaerobic power; athletic performance; crossfit performance; endurance performance; endurance strength; exercise capacity; exercise performance; explosive force; field performance; high-intensity interval exercise responses; hormonal response; intermittent exercise performance; jump performance; maximal oxygen uptake; maximal strength; muscle fatigue; muscle power; muscle speed; muscular endurance; muscular power; muscular strength; neuromuscular performance; oxygen consumption during exercise; physical performance; power output; resistance exercise performance; sprint performance; ventilatory efficiency",Tier 2,0.64,"Single small RCT (~11 well-trained males) using beetroot juice showed improved resistance exercise performance (a clinically relevant athletic performance outcome) alongside ventilatory efficiency. While randomized/controlled, the sample is small and likely crossover; performance may have been a secondary endpoint. Methods and size fall short of Tier 1, but it's direct human RCT evidence for the indication."
Beetroot (Nitrate),Red urine production,Strength,,Performance & Recovery,manual_pair,"One randomized controlled trial indicates that daily supplementation with 20 g of nitrate-rich beetroot extract for eight weeks may improve muscle strength and power in postmenopausal women. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term effects and safety.",0.7,40553891,2025,"Eight weeks of nitrate-rich beetroot extract supplementation on fasting nitrate and nitrite levels and skeletal muscle contractile properties in postmenopausal women: Results of a randomized, placebo-controlled, and parallel trial.",randomized_controlled_trial,benefit,"The study shows significant improvements in muscle strength and power, indicating a beneficial effect of beetroot nitrate supplementation.",20 g daily eight weeks (nitrate-rich beetroot extract),Menopause; Women,,muscle function,muscle function; postmenopausal symptoms; skeletal muscle contractile properties,Tier 2,0.7,"Randomized, double-blind, placebo-controlled trial showing significant improvements in muscle strength and power after 8 weeks of nitrate-rich beetroot extract in postmenopausal women. Strength was a primary/major outcome. However, the sample size was small (n=22) and the population specific, limiting generalizability and preventing Tier 1."
Beetroot (Nitrate),Red urine production,Muscle Soreness,,Performance & Recovery,manual_pair,"One randomized trial indicates that acute consumption of 70 mL of beetroot juice may reduce muscle soreness and improve strength in mountain climbers. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term effects and safety.",0.8,40323707,2025,"The effect of acute beetroot juice consumption prior to climbing on lower-body isokinetic and isometric strength, aerobic power, and muscle soreness among mountain climbers.",randomized_controlled_trial,benefit,The study shows significant benefits in muscle soreness reduction and strength improvements after beetroot juice consumption.,70 mL single dose (beetroot juice),Climbers,,aerobic power,aerobic power; muscle soreness; muscle strength,Tier 2,0.6,"Randomized, double-blind, placebo-controlled trial in climbers reported reduced delayed-onset muscle soreness after a single 70 mL beetroot juice dose. The study is well controlled but small (n=27; ~9 per arm), muscle soreness was one of several outcomes (likely secondary), and the significant effect appears mainly versus the water control rather than clearly versus placebo. This supports moderate, not strong, human evidence for this indication from this study."
Beetroot (Nitrate),Red urine production,Muscle Soreness,,Performance & Recovery,manual_pair,"Current evidence suggests that beetroot juice supplementation may reduce perceived muscle soreness and improve endurance following exercise-induced muscle damage, based on a single study involving doses of 50 mL four times a day for two days. However, the overall evidence is limited and further research is needed to confirm these findings and assess consistency across different populations and exercise types.",0.7,37686795,2023,Effect of Beetroot Juice Supplementation on Muscle Soreness and Performance Recovery after Exercise-Induced Muscle Damage in Female Volleyball Players.,randomized_controlled_trial,benefit,"The study found that BRJ supplementation improved muscle endurance and reduced perceived muscle soreness, indicating a beneficial effect.",50 mL four times a day 2 days (juice),Volleyball Players; Women,,exercise-induced muscle damage,exercise-induced muscle damage; muscle soreness; performance recovery,Tier 2,0.66,"Double-blind, randomized, placebo-controlled cross-over trial directly assessing perceived muscle soreness after EIMD with beetroot juice showed benefit. However, the sample size was very small (n=12) and limited to young female volleyball players, reducing generalizability and precluding Tier 1 strength."
Beetroot (Nitrate),Red urine production,Endothelial Function,,Heart & Vascular Health,manual_pair,"One randomized trial indicates that beetroot juice (140 mL single dose) may improve endothelial function following high-intensity resistance exercise, suggesting a potential benefit for poor blood vessel function. However, the overall evidence is limited, with only one study reporting a positive outcome and no evidence of harm or consistent findings across multiple studies.",0.7,40457872,2025,Prior beetroot juice ingestion prevents the temporal reduction of endothelial function following acute high-intensity resistance exercise.,randomized_controlled_trial,benefit,"The study found that beetroot juice ingestion improved endothelial function after exercise, indicating a beneficial effect.",140 mL single dose (juice),,Performance & Recovery,endothelial function impairment,endothelial function impairment; high-intensity resistance exercise,Tier 3,0.6,"Single small RCT (n=12) in healthy young males with an acute, single dose intervention. The primary outcome was flow-mediated dilation, a surrogate marker of endothelial function, showing benefit post-exercise versus placebo. While randomized and controlled, the study is small, short-term, and context-specific (post–high-intensity exercise), limiting generalizability, thus fitting preliminary human evidence."
Beetroot (Nitrate),Red urine production,Endothelial Function,,Heart & Vascular Health,manual_pair,"The evidence regarding beetroot (nitrate) for improving vascular function is mixed. One randomized trial reported a benefit in restoring macrovascular function after ischemia/reperfusion injury, while another study indicated improvements in vascular responsiveness in Alzheimer's patients but noted that acute administration may not fully restore function. No adverse effects were reported, but the overall quality and consistency of the evidence are limited.",0.7,40089052,2025,Increasing nitric oxide availability via ingestion of nitrate-rich beetroot juice improves vascular responsiveness in individuals with Alzheimer's Disease.,randomized_controlled_trial,mixed_unclear,The study shows improvements in vascular responsiveness but indicates that acute administration may not fully restore function in Alzheimer's patients.,(nitrate-rich beetroot juice),Alzheimer's Disease,,alzheimer's disease,alzheimer's disease; endothelial dysfunction; ischemia/reperfusion injury,Tier 2,0.53,"Single randomized controlled trial directly assessing endothelial/vascular responsiveness after nitrate-rich beetroot juice in humans (Alzheimer’s population). Endothelial function appears to be a primary outcome with some improvement reported, but effects were mixed and acute dosing did not fully restore function. Likely small sample and limited duration reduce robustness, yet design remains an RCT focused on the indication."
Beetroot (Nitrate),Red urine production,Endothelial Function,,Heart & Vascular Health,manual_pair,"The evidence regarding beetroot (nitrate) for improving vascular function is mixed. One randomized trial reported a benefit in restoring macrovascular function after ischemia/reperfusion injury, while another study indicated improvements in vascular responsiveness in Alzheimer's patients but noted that acute administration may not fully restore function. No adverse effects were reported, but the overall quality and consistency of the evidence are limited.",0.7,37561087,2023,The effect of microencapsulated watermelon rind (Citrullus lanatus) and beetroot (Beta vulgaris L.) ingestion on ischemia/reperfusion-induced endothelial dysfunction: a randomised clinical trial.,randomized_controlled_trial,benefit,"The study shows that beetroot co-ingestion with watermelon significantly restored macrovascular function after ischemia/reperfusion injury, indicating a beneficial effect.",single,,,endothelial dysfunction,alzheimer's disease; endothelial dysfunction; ischemia/reperfusion injury,Tier 3,0.47,"Randomized, crossover, placebo-controlled human trial (n=12) with a single acute dose showed improved flow-mediated dilation after ischemia/reperfusion, a surrogate marker of endothelial function. However, the study is small, uses surrogate outcomes, and the effective arm included co-ingestion with watermelon rind (citrulline), limiting attribution to beetroot (nitrate) alone."
Beetroot (Nitrate),Red urine production,Endothelial Function,,Heart & Vascular Health,manual_pair,"Current evidence suggests that beetroot juice may have beneficial effects on vascular health, as indicated by two randomized trials demonstrating improvements in endothelial function. The doses used in these studies include a single dose of 140 mL of beetroot juice. However, the overall evidence is limited and further research is needed to establish consistent effects and optimal dosing.",0.8,35652829,2022,Prior beetroot juice ingestion offsets endothelial dysfunction following prolonged sitting.,randomized_controlled_trial,benefit,"The study found that beetroot juice ingestion prevented sitting-induced endothelial dysfunction, indicating a beneficial effect on vascular health.",140 mL single dose (juice),,,endothelial dysfunction,endothelial dysfunction; hiv infections; vascular dysfunction; vascular health,Tier 2,0.6,"Randomized controlled trial in healthy young men (n=11) with endothelial function as the primary outcome showed benefit after a single dose of beetroot juice. The study is small and acute with limited generalizability, but it is randomized and directly tests the indication."
Beetroot (Nitrate),Red urine production,Endothelial Function,,Heart & Vascular Health,manual_pair,"Current evidence suggests that beetroot juice may have beneficial effects on vascular health, as indicated by two randomized trials demonstrating improvements in endothelial function. The doses used in these studies include a single dose of 140 mL of beetroot juice. However, the overall evidence is limited and further research is needed to establish consistent effects and optimal dosing.",0.8,32866396,2021,Acute supplementation with beetroot juice improves endothelial function in HIV-infected individuals.,randomized_controlled_trial,benefit,"The study found that beetroot juice improved endothelial function, indicating a beneficial effect on vascular health in HIV-infected individuals.",(beetroot juice),HIV,,hiv infections,endothelial dysfunction; hiv infections; vascular dysfunction; vascular health,Tier 2,0.62,"Randomized, placebo-controlled human trial showing acute improvement in endothelial function (FMD) after beetroot juice. The outcome directly matches the indication. However, the sample is small (n=13 HIV; n=18 healthy), effects are acute (120 min), and it’s a single study, limiting generalizability and durability of effect."
Beta-alanine,,Aerobic Capacity,,Performance & Recovery,manual_pair,"Current evidence on beta-alanine supplementation for improving aerobic fitness is limited and mixed, with one study reporting unclear results. The doses used in this study ranged from 4.8 g daily for 10 days to 6.4 g daily for 18 days. No studies reported significant benefits or harms, indicating a need for further research to clarify its effectiveness in this area.",0.7,30307991,2018,Effects of 4 weeks of β-alanine supplementation on aerobic fitness in water polo players.,randomized_controlled_trial,mixed_unclear,The study showed mixed results regarding the effectiveness of β-alanine supplementation on performance outcomes.,4.8 g daily 10 days; 6.4 g daily 18 days,Men; Water Polo Players,,aerobic fitness,aerobic fitness,Tier 2,0.62,"Placebo-controlled randomized trial in humans with aerobic capacity (VO2peak/critical force) as primary outcomes. Sample size was small (n=22), population was specific (male water polo players), and between-group effects were largely non-significant with mixed findings. Design supports moderate human evidence, but size, population specificity, and unclear effects prevent Tier 1."
Beta-alanine,,Exercise Induced Inflammation,,"Immune, Inflammation, & Infection",manual_pair,"One study suggests that high-dose β-alanine supplementation (12 g daily for 7 days) may enhance the anti-inflammatory response by increasing circulating IL-10 concentrations during intense military training. However, the evidence is limited and consists of a single trial, indicating a need for further research to confirm these findings and assess consistency across different populations and settings.",0.7,29746388,2018,"Effect of High-Dose, Short-Duration β-Alanine Supplementation on Circulating IL-10 Concentrations During Intense Military Training.",randomized_controlled_trial,benefit,"The study suggests that β-alanine may enhance the anti-inflammatory response, indicating a beneficial outcome.",12 g daily 7 days,Military Training,,anti-inflammatory response,anti-inflammatory response,Tier 3,0.68,"Small randomized, placebo-controlled human trial (n=20) in a military training context measured a surrogate inflammatory marker (IL-10) rather than clinical inflammation outcomes. While relevant to exercise-induced inflammation and showing a possible benefit, the short duration, small sample size, and reliance on a biomarker make the evidence preliminary."
Beta-alanine,,Athletic Performance,,Performance & Recovery,manual_pair,"The evidence on beta-alanine supplementation for athletic performance is mixed. One study reported likely beneficial effects on repeated sprint ability with doses of 4.8 g to 6.4 g daily, while another study showed unclear results regarding its effectiveness on aerobic fitness. No adverse effects were reported in the reviewed studies.",0.8,30307991,2018,Effects of 4 weeks of β-alanine supplementation on aerobic fitness in water polo players.,randomized_controlled_trial,mixed_unclear,The study showed mixed results regarding the effectiveness of β-alanine supplementation on performance outcomes.,4.8 g daily 10 days; 6.4 g daily 18 days,Men; Water Polo Players,,athletic performance,athletic performance,Tier 2,0.62,"Randomized, placebo-controlled human trial in trained athletes assessing performance-related outcomes (VO2, critical force, 3-min all-out). However, the sample size is small (n=22) and findings were mixed, reducing strength despite appropriate design and direct relevance to athletic performance."
Beta-alanine,,Athletic Performance,,Performance & Recovery,manual_pair,"The evidence on beta-alanine supplementation for athletic performance is mixed. One study reported likely beneficial effects on repeated sprint ability with doses of 4.8 g to 6.4 g daily, while another study showed unclear results regarding its effectiveness on aerobic fitness. No adverse effects were reported in the reviewed studies.",0.8,27930743,2016,Effects of Four Weeks of β-Alanine Supplementation on Repeated Sprint Ability in Water Polo Players.,randomized_controlled_trial,benefit,"The study found likely beneficial effects of β-alanine on repeated sprint ability, indicating a positive outcome direction.",4.8 g day-1 10 days (β-alanine); 6.4 g day-1 18 days (β-alanine),Men; Sprinting; Water Polo Players,,athletic performance,athletic performance,Tier 2,0.66,"Double-blind, placebo-controlled RCT in trained athletes with athletic performance (repeated sprint ability) as the primary outcome. However, the sample size is small (n=22) and conventional significance was not reached, with results based on magnitude-based inference. This supports moderate, not strong, human evidence for this specific indication."
Beta-alanine,,Cognitive Performance,,Cognitive & Neurological Function,manual_pair,"Beta-alanine supplementation at a dose of 2.4 g daily has shown consistent benefits in cognitive function across three randomized controlled trials involving older adults and middle-aged individuals. Improvements were noted in cognitive performance, mood, and brain structure related to cognition, with no reported harms or instances of no benefit. However, the evidence is limited to specific populations and further research may be needed to generalize findings.",0.9,36839281,2023,"Role of β-Alanine Supplementation on Cognitive Function, Mood, and Physical Function in Older Adults; Double-Blind Randomized Controlled Study.",randomized_controlled_trial,benefit,"The study showed significant improvements in cognitive function and a decrease in depression scores for participants with baseline cognitive impairment, indicating a benefit from β-alanine supplementation.",2.4 g daily 10 weeks,Older Adults,"Energy, Mood, & Mental Health",cognitive function,cognitive function; decreased cognitive function; depression; executive function; exercise capacity; sarcopenia,Tier 2,0.64,"Double-blind randomized controlled trial (~100 older adults) assessed cognitive function as a major outcome. However, benefits were primarily observed in the subgroup with baseline cognitive impairment rather than the entire cohort, warranting a downgrade from Tier 1 to moderate evidence."
Beta-alanine,,Cognitive Performance,,Cognitive & Neurological Function,manual_pair,"Beta-alanine supplementation at a dose of 2.4 g daily has shown consistent benefits in cognitive function across three randomized controlled trials involving older adults and middle-aged individuals. Improvements were noted in cognitive performance, mood, and brain structure related to cognition, with no reported harms or instances of no benefit. However, the evidence is limited to specific populations and further research may be needed to generalize findings.",0.9,38971131,2024,β-Alanine supplementation improves fractional anisotropy scores in the hippocampus and amygdala in 60-80-year-old men and women.,randomized_controlled_trial,benefit,The study shows a benefit in cognitive function as indicated by improved fractional anisotropy scores in brain regions associated with cognition.,2.4 g daily 10 weeks,Older Adults,,decreased cognitive function,cognitive function; decreased cognitive function; depression; executive function; exercise capacity; sarcopenia,Tier 4,0.44,"This is a small randomized trial in older adults that assessed imaging biomarkers (fractional anisotropy in hippocampus/amygdala) and mechanistic markers rather than direct cognitive performance measures. While suggestive of neural changes relevant to cognition, the outcomes are indirect and not clinically validated for cognitive performance, making the evidence for this indication very low/indirect."
Beta-alanine,,Cognitive Performance,,Cognitive & Neurological Function,manual_pair,"Beta-alanine supplementation at a dose of 2.4 g daily has shown consistent benefits in cognitive function across three randomized controlled trials involving older adults and middle-aged individuals. Improvements were noted in cognitive performance, mood, and brain structure related to cognition, with no reported harms or instances of no benefit. However, the evidence is limited to specific populations and further research may be needed to generalize findings.",0.9,29996843,2018,β-Alanine supplementation increased physical performance and improved executive function following endurance exercise in middle aged individuals.,randomized_controlled_trial,benefit,"The study shows that beta-alanine supplementation improved exercise capacity and executive function, indicating a benefit.",2.4 g daily 28 days,,,executive function,cognitive function; decreased cognitive function; depression; executive function; exercise capacity; sarcopenia,Tier 2,0.48,"Randomized, placebo-controlled human trial showed attenuation of post-exercise executive function decline (Stroop) with beta-alanine versus placebo. However, the study was very small (n=12), cognition was a secondary/context-specific outcome (post-endurance exercise), and a clear between-group interaction for the cognitive measure was not reported, limiting certainty."
Beta-alanine,,Improve Mood,,"Energy, Mood, & Mental Health",manual_pair,"The evidence for beta-alanine in the treatment of depression is limited and mixed, with one study reporting a reduction in subjective feelings of depression after high-dose supplementation (12 g/day for 14 days), but no consistent benefits observed across studies. Overall, the findings do not support a clear efficacy for beta-alanine in this indication.",0.7,32138563,2021,"Effects of High-Dose, Short-Duration β-Alanine Supplementation on Cognitive Function, Mood, and Circulating Brain-Derived Neurotropic Factor (BDNF) in Recreationally-Active Males Before Simulated Military Operational Stress.",randomized_controlled_trial,mixed_unclear,"While β-alanine did not affect cognitive function or BDNF, it showed a reduction in subjective feelings of depression, indicating mixed outcomes.",12 g day-1 14 days,,,cognitive function,cognitive function; depression; mood disorders,Tier 2,0.56,"Human randomized controlled trial in recreationally active males reported reduced subjective depressive feelings after 14 days of high-dose beta-alanine, while other outcomes were unaffected. Mood was likely a secondary outcome, the overall results were mixed, and the intervention was short in duration, supporting moderate but not strong evidence for mood improvement."
Beta-alanine,,Cardiac Recovery,,Performance & Recovery,manual_pair,"The evidence regarding beta-alanine for reducing high perceived exertion during exercise is mixed and unclear, based on one study that reported a decrease in post-exertion rating of perceived exertion (RPE) with doses of 30 mg and 45 mg taken as single doses 72 hours apart, but found no significant differences in physical performance outcomes. Overall, the findings do not support a clear benefit for this indication.",0.7,37073742,2023,"Effects of acute beta-alanine supplementation on post-exertion rating of perceived exertion, heart rate, blood lactate, and physical performance on the 6-minute race test in middle-distance runners.",randomized_controlled_trial,mixed_unclear,"The study showed a decrease in post-exertion RPE with both doses, but no significant differences in physical performance outcomes, indicating mixed results.",30 mg single dose 72 hours apart (beta-alanine); 45 mg single dose 72 hours apart (beta-alanine),Running,,blood lactate,blood lactate; heart rate; physical performance; post-exertion rating of perceived exertion,Tier 5,0.86,"The RCT evaluated acute beta-alanine in healthy runners with outcomes of RPE, heart rate, blood lactate, and 6-minute run distance. It did not assess cardiac recovery as a clinical condition (e.g., post-cardiac event recovery or heart rate recovery as a primary endpoint), and there were no significant heart rate effects. Thus, the study is not testing the supplement for the specified indication, providing no direct clinical evidence for cardiac recovery."
Beta-alanine,,Increase Pain Perception,,Musculoskeletal & Pain,manual_pair,"The evidence regarding beta-alanine for increased pain sensitivity is limited and mixed. One study reported an increase in perceived pain sensations with a single dose of 6.4 g, but also noted a positive effect on connectedness to nature, leading to unclear overall outcomes. No studies demonstrated a clear benefit or harm associated with beta-alanine for this indication.",0.5,34360425,2021,Effects of Acute Beta-Alanine Ingestion and Immersion-Plus-Exercise on Connectedness to Nature and Perceived Pain.,randomized_controlled_trial,mixed_unclear,"The study shows an increase in perceived pain sensations with beta-alanine, but also an increase in connectedness to nature, leading to mixed outcomes.",6.4 g single dose,,,pain perception,pain perception; physical exertion,Tier 2,0.62,"Double-blind, placebo-controlled crossover RCT (n=20) with acute 6.4 g beta-alanine assessed perceived pain (McGill Pain Questionnaire) and found increased pain sensations. Methods are rigorous but sample is small and pain was likely a secondary/exploratory outcome within a study primarily focused on connectedness to nature, so evidence is moderate rather than strong."
Beta-alanine,,Aerobic Capacity,,Performance & Recovery,manual_pair,"The evidence for beta-alanine supplementation in improving low exercise performance is strong, with 27 studies reporting benefits and only 2 showing mixed outcomes. Typical doses reported range from 4.8 g to 6.4 g daily, with some studies using higher doses for short durations. No significant harms were noted, but the mixed results in a couple of studies suggest variability in individual responses to supplementation.",0.9,30277420,2019,Distinct Effects of Repeated-Sprint Training in Normobaric Hypoxia and β-Alanine Supplementation.,randomized_controlled_trial,mixed_unclear,"The study showed that while β-alanine maintained anaerobic working capacity, it did not provide additional benefits for fatigue or repeated-sprint performance.",6.4 g daily 4 weeks,Sprinting,,aerobic performance,aerobic performance; anaerobic capacity; anaerobic performance; anaerobic power; athletic performance; basketball; bio-motor abilities; body composition; c-reactive protein; cardiorespiratory fitness; cardiovascular recovery; cognition; cognitive performance; cycling performance; distance covered in sports; endurance performance; exercise adaptation; exercise performance; exercise tolerance; fatigue; handgrip strength; high-intensity cycling performance; high-intensity exercise performance; improved high-intensity cycling capacity; improvement in athletic performance; improvement in cycling performance; increased fat-free mass; increased muscle carnosine content; interleukin-6; isokinetic strength; judo performance; lactate clearance; lower-body exercise performance; maximal aerobic speed; muscle carnosine elevation; muscle fatigue; muscle pain; muscle performance; muscle strength; neuromuscular fatigue; performance during cycling; physical endurance; physical performance; post-exercise recovery; repeated sprint ability performance; sports performance; sprint performance; strength endurance; time to exhaustion; training intensity; volleyball-specific bio-motor abilities,Tier 2,0.64,"Human randomized controlled trial with aerobic performance as a primary outcome and a BA vs placebo comparison. Sample size is modest and results showed no BA benefit for aerobic capacity (effect observed only for anaerobic working capacity). This provides moderate-quality, directly relevant human evidence with null findings for the indication."
Beta-alanine,,Aerobic Capacity,,Performance & Recovery,manual_pair,"The evidence for beta-alanine supplementation in improving low exercise performance is strong, with 27 studies reporting benefits and only 2 showing mixed outcomes. Typical doses reported range from 4.8 g to 6.4 g daily, with some studies using higher doses for short durations. No significant harms were noted, but the mixed results in a couple of studies suggest variability in individual responses to supplementation.",0.9,27434084,2016,Additive Benefits of β-Alanine Supplementation and Sprint-Interval Training.,randomized_controlled_trial,benefit,"The study shows that β-alanine supplementation improves training intensity and performance outcomes, indicating a beneficial effect.",6.4 g daily 28 days; 1.2 g daily 5 weeks,Cycling; Sprinting,,anaerobic capacity,aerobic performance; anaerobic capacity; anaerobic performance; anaerobic power; athletic performance; basketball; bio-motor abilities; body composition; c-reactive protein; cardiorespiratory fitness; cardiovascular recovery; cognition; cognitive performance; cycling performance; distance covered in sports; endurance performance; exercise adaptation; exercise performance; exercise tolerance; fatigue; handgrip strength; high-intensity cycling performance; high-intensity exercise performance; improved high-intensity cycling capacity; improvement in athletic performance; improvement in cycling performance; increased fat-free mass; increased muscle carnosine content; interleukin-6; isokinetic strength; judo performance; lactate clearance; lower-body exercise performance; maximal aerobic speed; muscle carnosine elevation; muscle fatigue; muscle pain; muscle performance; muscle strength; neuromuscular fatigue; performance during cycling; physical endurance; physical performance; post-exercise recovery; repeated sprint ability performance; sports performance; sprint performance; strength endurance; time to exhaustion; training intensity; volleyball-specific bio-motor abilities,Tier 2,0.64,"Placebo-controlled, double-blind RCT in trained cyclists (n=14). Aerobic capacity (VO2peak) was measured but as a secondary outcome and showed no additional benefit from beta-alanine versus placebo. While methods are strong, the small sample and secondary status of the aerobic capacity outcome place this as moderate human evidence relevant to the indication, with null effect on the target outcome."
Beta-alanine,,Aerobic Capacity,,Performance & Recovery,manual_pair,"The evidence for beta-alanine supplementation in improving low exercise performance is strong, with 27 studies reporting benefits and only 2 showing mixed outcomes. Typical doses reported range from 4.8 g to 6.4 g daily, with some studies using higher doses for short durations. No significant harms were noted, but the mixed results in a couple of studies suggest variability in individual responses to supplementation.",0.9,39039103,2024,Physiological and performance adaptations to beta alanine supplementation and short sprint interval training in volleyball players.,randomized_controlled_trial,benefit,"The study showed significant improvements in various performance metrics, indicating a beneficial effect of Beta-Alanine supplementation.",4.8 g daily 8 weeks (Beta-Alanine),Men; Volleyball Players,,anaerobic power,aerobic performance; anaerobic capacity; anaerobic performance; anaerobic power; athletic performance; basketball; bio-motor abilities; body composition; c-reactive protein; cardiorespiratory fitness; cardiovascular recovery; cognition; cognitive performance; cycling performance; distance covered in sports; endurance performance; exercise adaptation; exercise performance; exercise tolerance; fatigue; handgrip strength; high-intensity cycling performance; high-intensity exercise performance; improved high-intensity cycling capacity; improvement in athletic performance; improvement in cycling performance; increased fat-free mass; increased muscle carnosine content; interleukin-6; isokinetic strength; judo performance; lactate clearance; lower-body exercise performance; maximal aerobic speed; muscle carnosine elevation; muscle fatigue; muscle pain; muscle performance; muscle strength; neuromuscular fatigue; performance during cycling; physical endurance; physical performance; post-exercise recovery; repeated sprint ability performance; sports performance; sprint performance; strength endurance; time to exhaustion; training intensity; volleyball-specific bio-motor abilities,Tier 2,0.45,"Randomized, placebo-controlled human trial (n=20) measured cardiorespiratory fitness alongside other performance outcomes. Aerobic capacity was assessed but appears to have been a secondary outcome, and beta-alanine did not outperform placebo for this measure. Thus, there is moderate human evidence relevant to the indication, but small sample size and lack of a clear benefit for aerobic capacity lower confidence."
Beta-alanine,,Aerobic Capacity,,Performance & Recovery,manual_pair,"The evidence for beta-alanine supplementation in improving low exercise performance is strong, with 27 studies reporting benefits and only 2 showing mixed outcomes. Typical doses reported range from 4.8 g to 6.4 g daily, with some studies using higher doses for short durations. No significant harms were noted, but the mixed results in a couple of studies suggest variability in individual responses to supplementation.",0.9,40010353,2025,"Effects of Combined Versus Single Supplementation of Creatine, Beta-Alanine, and L-Citrulline During Short Sprint Interval Training on Basketball Players' Performance: A Double-Blind Randomized Placebo-Controlled Trial.",randomized_controlled_trial,benefit,"The study shows significant improvements in physical and physiological performance in basketball players using beta-alanine, indicating a benefit from supplementation.",4.8 g daily 28 days (Beta-Alanine),Basketball Players,,athletic performance,aerobic performance; anaerobic capacity; anaerobic performance; anaerobic power; athletic performance; basketball; bio-motor abilities; body composition; c-reactive protein; cardiorespiratory fitness; cardiovascular recovery; cognition; cognitive performance; cycling performance; distance covered in sports; endurance performance; exercise adaptation; exercise performance; exercise tolerance; fatigue; handgrip strength; high-intensity cycling performance; high-intensity exercise performance; improved high-intensity cycling capacity; improvement in athletic performance; improvement in cycling performance; increased fat-free mass; increased muscle carnosine content; interleukin-6; isokinetic strength; judo performance; lactate clearance; lower-body exercise performance; maximal aerobic speed; muscle carnosine elevation; muscle fatigue; muscle pain; muscle performance; muscle strength; neuromuscular fatigue; performance during cycling; physical endurance; physical performance; post-exercise recovery; repeated sprint ability performance; sports performance; sprint performance; strength endurance; time to exhaustion; training intensity; volleyball-specific bio-motor abilities,Tier 2,0.6,"Double-blind, randomized, placebo-controlled trial with a beta-alanine-only arm (4.8 g/day, 28 days) measured cardiorespiratory fitness (a proxy for aerobic capacity) and reported greater improvements vs placebo. However, the per-arm sample size was small (n≈8), multiple outcomes were tested, and aerobic capacity was not clearly a primary endpoint, limiting strength despite the RCT design."
Beta-alanine,,Aerobic Capacity,,Performance & Recovery,manual_pair,"The evidence for beta-alanine supplementation in improving low exercise performance is strong, with 27 studies reporting benefits and only 2 showing mixed outcomes. Typical doses reported range from 4.8 g to 6.4 g daily, with some studies using higher doses for short durations. No significant harms were noted, but the mixed results in a couple of studies suggest variability in individual responses to supplementation.",0.9,34444703,2021,One-Week High-Dose β-Alanine Loading Improves World Tour Cyclists' Time-Trial Performance.,randomized_controlled_trial,benefit,The study shows a significant improvement in cycling performance metrics with β-alanine supplementation.,20 g per day 7 days (sustained-release powder),Cycling,,athletic performance,aerobic performance; anaerobic capacity; anaerobic performance; anaerobic power; athletic performance; basketball; bio-motor abilities; body composition; c-reactive protein; cardiorespiratory fitness; cardiovascular recovery; cognition; cognitive performance; cycling performance; distance covered in sports; endurance performance; exercise adaptation; exercise performance; exercise tolerance; fatigue; handgrip strength; high-intensity cycling performance; high-intensity exercise performance; improved high-intensity cycling capacity; improvement in athletic performance; improvement in cycling performance; increased fat-free mass; increased muscle carnosine content; interleukin-6; isokinetic strength; judo performance; lactate clearance; lower-body exercise performance; maximal aerobic speed; muscle carnosine elevation; muscle fatigue; muscle pain; muscle performance; muscle strength; neuromuscular fatigue; performance during cycling; physical endurance; physical performance; post-exercise recovery; repeated sprint ability performance; sports performance; sprint performance; strength endurance; time to exhaustion; training intensity; volleyball-specific bio-motor abilities,Tier 2,0.6,"Randomized placebo-controlled trial showing improved 10-min time-trial power (a primary, clinically relevant endurance performance outcome) in world-tour cyclists after 7 days of high-dose sustained-release β-alanine. However, the sample size was very small (n=12 total), duration short, and population highly specific, limiting generalizability and preventing Tier 1 classification. Outcome pertains to aerobic performance but does not directly measure VO2max or classic aerobic capacity metrics."
Beta-alanine,,Aerobic Capacity,,Performance & Recovery,manual_pair,"The evidence for beta-alanine supplementation in improving low exercise performance is strong, with 27 studies reporting benefits and only 2 showing mixed outcomes. Typical doses reported range from 4.8 g to 6.4 g daily, with some studies using higher doses for short durations. No significant harms were noted, but the mixed results in a couple of studies suggest variability in individual responses to supplementation.",0.9,31144977,2019,[Effects of acute supplementation with beta-alanine on a limited time test at maximum aerobic speed on endurance athletes].,randomized_controlled_trial,benefit,"The study found significant improvements in execution time during the limited time test, indicating a benefit from beta-alanine supplementation.",30 mg once 60 minutes before test,Endurance Athletes,,athletic performance,aerobic performance; anaerobic capacity; anaerobic performance; anaerobic power; athletic performance; basketball; bio-motor abilities; body composition; c-reactive protein; cardiorespiratory fitness; cardiovascular recovery; cognition; cognitive performance; cycling performance; distance covered in sports; endurance performance; exercise adaptation; exercise performance; exercise tolerance; fatigue; handgrip strength; high-intensity cycling performance; high-intensity exercise performance; improved high-intensity cycling capacity; improvement in athletic performance; improvement in cycling performance; increased fat-free mass; increased muscle carnosine content; interleukin-6; isokinetic strength; judo performance; lactate clearance; lower-body exercise performance; maximal aerobic speed; muscle carnosine elevation; muscle fatigue; muscle pain; muscle performance; muscle strength; neuromuscular fatigue; performance during cycling; physical endurance; physical performance; post-exercise recovery; repeated sprint ability performance; sports performance; sprint performance; strength endurance; time to exhaustion; training intensity; volleyball-specific bio-motor abilities,Tier 3,0.57,"Small double-blind randomized cross-over trial (n=11) showed a modest improvement in time during a test at maximal aerobic speed after acute beta-alanine. While methods are sound, the sample is small, the effect size and p-value are modest, distance was not significant, and the outcome assesses performance at a given intensity rather than directly measuring aerobic capacity (e.g., VO2max). Thus, evidence is preliminary and indirect for the aerobic capacity indication."
Beta-alanine,,Aerobic Capacity,,Performance & Recovery,manual_pair,"The evidence for beta-alanine supplementation in improving low exercise performance is strong, with 27 studies reporting benefits and only 2 showing mixed outcomes. Typical doses reported range from 4.8 g to 6.4 g daily, with some studies using higher doses for short durations. No significant harms were noted, but the mixed results in a couple of studies suggest variability in individual responses to supplementation.",0.9,28121265,2017,Beta-Alanine Supplementation Improves Throwing Velocities in Repeated Sprint Ability and 200-m Swimming Performance in Young Water Polo Players.,randomized_controlled_trial,benefit,The study shows likely beneficial effects of beta-alanine on performance metrics in young athletes.,6.4 g day-1 6 weeks,Sprinting; Water Polo Players,,athletic performance,aerobic performance; anaerobic capacity; anaerobic performance; anaerobic power; athletic performance; basketball; bio-motor abilities; body composition; c-reactive protein; cardiorespiratory fitness; cardiovascular recovery; cognition; cognitive performance; cycling performance; distance covered in sports; endurance performance; exercise adaptation; exercise performance; exercise tolerance; fatigue; handgrip strength; high-intensity cycling performance; high-intensity exercise performance; improved high-intensity cycling capacity; improvement in athletic performance; improvement in cycling performance; increased fat-free mass; increased muscle carnosine content; interleukin-6; isokinetic strength; judo performance; lactate clearance; lower-body exercise performance; maximal aerobic speed; muscle carnosine elevation; muscle fatigue; muscle pain; muscle performance; muscle strength; neuromuscular fatigue; performance during cycling; physical endurance; physical performance; post-exercise recovery; repeated sprint ability performance; sports performance; sprint performance; strength endurance; time to exhaustion; training intensity; volleyball-specific bio-motor abilities,Tier 5,0.8,"Although this is a randomized controlled trial in young athletes, the outcomes assessed (200-m swim performance, repeated-sprint ability, throwing velocity, eggbeater kicks) are sport-specific performance metrics and do not directly measure aerobic capacity (e.g., VO2max, ventilatory thresholds, prolonged time trial). Therefore, it does not provide direct evidence for the indication of aerobic capacity."
Beta-alanine,,Aerobic Capacity,,Performance & Recovery,manual_pair,"The evidence for beta-alanine supplementation in improving low exercise performance is strong, with 27 studies reporting benefits and only 2 showing mixed outcomes. Typical doses reported range from 4.8 g to 6.4 g daily, with some studies using higher doses for short durations. No significant harms were noted, but the mixed results in a couple of studies suggest variability in individual responses to supplementation.",0.9,27601217,2017,Beta-alanine supplementation enhances judo-related performance in highly-trained athletes.,randomized_controlled_trial,benefit,"Beta-alanine supplementation improved performance outcomes in judo athletes, indicating a beneficial effect.",6.4 g daily 4 weeks,Judo,,athletic performance,aerobic performance; anaerobic capacity; anaerobic performance; anaerobic power; athletic performance; basketball; bio-motor abilities; body composition; c-reactive protein; cardiorespiratory fitness; cardiovascular recovery; cognition; cognitive performance; cycling performance; distance covered in sports; endurance performance; exercise adaptation; exercise performance; exercise tolerance; fatigue; handgrip strength; high-intensity cycling performance; high-intensity exercise performance; improved high-intensity cycling capacity; improvement in athletic performance; improvement in cycling performance; increased fat-free mass; increased muscle carnosine content; interleukin-6; isokinetic strength; judo performance; lactate clearance; lower-body exercise performance; maximal aerobic speed; muscle carnosine elevation; muscle fatigue; muscle pain; muscle performance; muscle strength; neuromuscular fatigue; performance during cycling; physical endurance; physical performance; post-exercise recovery; repeated sprint ability performance; sports performance; sprint performance; strength endurance; time to exhaustion; training intensity; volleyball-specific bio-motor abilities,Tier 5,0.78,"Although this is a randomized controlled trial showing improved judo performance, the outcomes were sport-specific (throws in SJFT/randori) and did not directly assess aerobic capacity (e.g., VO2max, aerobic time-to-exhaustion). Therefore, it does not constitute direct evidence for the indication of aerobic capacity."
Beta-alanine,,Aerobic Capacity,,Performance & Recovery,manual_pair,"The evidence for beta-alanine supplementation in improving low exercise performance is strong, with 27 studies reporting benefits and only 2 showing mixed outcomes. Typical doses reported range from 4.8 g to 6.4 g daily, with some studies using higher doses for short durations. No significant harms were noted, but the mixed results in a couple of studies suggest variability in individual responses to supplementation.",0.9,26308179,2016,Effects of Acute Carnosine and β-Alanine on Isometric Force and Jumping Performance.,randomized_controlled_trial,benefit,"The study shows that Carn-BA supplementation improved MVC and CMJ performance, indicating a benefit for athletic performance.",2 g single dose (L-carnosine and β-alanine),Jumping,,athletic performance,aerobic performance; anaerobic capacity; anaerobic performance; anaerobic power; athletic performance; basketball; bio-motor abilities; body composition; c-reactive protein; cardiorespiratory fitness; cardiovascular recovery; cognition; cognitive performance; cycling performance; distance covered in sports; endurance performance; exercise adaptation; exercise performance; exercise tolerance; fatigue; handgrip strength; high-intensity cycling performance; high-intensity exercise performance; improved high-intensity cycling capacity; improvement in athletic performance; improvement in cycling performance; increased fat-free mass; increased muscle carnosine content; interleukin-6; isokinetic strength; judo performance; lactate clearance; lower-body exercise performance; maximal aerobic speed; muscle carnosine elevation; muscle fatigue; muscle pain; muscle performance; muscle strength; neuromuscular fatigue; performance during cycling; physical endurance; physical performance; post-exercise recovery; repeated sprint ability performance; sports performance; sprint performance; strength endurance; time to exhaustion; training intensity; volleyball-specific bio-motor abilities,Tier 5,0.87,"This small RCT tested an acute combination of L-carnosine plus beta-alanine (not beta-alanine alone) and measured isometric force, countermovement jump performance, RPE, lactate, and muscle pain during a 45-second jumping task. These outcomes reflect short-duration neuromuscular/anaerobic performance, not aerobic capacity (no VO2max, endurance time-trial, or time-to-exhaustion measures). Thus it does not provide direct evidence for beta-alanine on aerobic capacity."
Beta-alanine,,Aerobic Capacity,,Performance & Recovery,manual_pair,"The evidence for beta-alanine supplementation in improving low exercise performance is strong, with 27 studies reporting benefits and only 2 showing mixed outcomes. Typical doses reported range from 4.8 g to 6.4 g daily, with some studies using higher doses for short durations. No significant harms were noted, but the mixed results in a couple of studies suggest variability in individual responses to supplementation.",0.9,36294288,2022,"Effect of 8-Week β-Alanine Supplementation on CRP, IL-6, Body Composition, and Bio-Motor Abilities in Elite Male Basketball Players.",randomized_controlled_trial,benefit,"The study showed significant decreases in CRP and IL-6, indicating a beneficial effect of β-alanine supplementation on inflammatory markers and performance.",6.4 g daily 8 weeks (supplement),Basketball Players; Men,,bio-motor abilities,aerobic performance; anaerobic capacity; anaerobic performance; anaerobic power; athletic performance; basketball; bio-motor abilities; body composition; c-reactive protein; cardiorespiratory fitness; cardiovascular recovery; cognition; cognitive performance; cycling performance; distance covered in sports; endurance performance; exercise adaptation; exercise performance; exercise tolerance; fatigue; handgrip strength; high-intensity cycling performance; high-intensity exercise performance; improved high-intensity cycling capacity; improvement in athletic performance; improvement in cycling performance; increased fat-free mass; increased muscle carnosine content; interleukin-6; isokinetic strength; judo performance; lactate clearance; lower-body exercise performance; maximal aerobic speed; muscle carnosine elevation; muscle fatigue; muscle pain; muscle performance; muscle strength; neuromuscular fatigue; performance during cycling; physical endurance; physical performance; post-exercise recovery; repeated sprint ability performance; sports performance; sprint performance; strength endurance; time to exhaustion; training intensity; volleyball-specific bio-motor abilities,Tier 5,0.7,"Although this is a randomized controlled trial, the measured outcomes were inflammatory markers (CRP, IL-6), body composition, and anaerobic peak power. No direct aerobic capacity endpoints (e.g., VO2max, time-to-exhaustion, aerobic performance tests) were reported, so it does not provide actual evidence for the aerobic capacity indication."
Beta-alanine,,Aerobic Capacity,,Performance & Recovery,manual_pair,"The evidence for beta-alanine supplementation in improving low exercise performance is strong, with 27 studies reporting benefits and only 2 showing mixed outcomes. Typical doses reported range from 4.8 g to 6.4 g daily, with some studies using higher doses for short durations. No significant harms were noted, but the mixed results in a couple of studies suggest variability in individual responses to supplementation.",0.9,26110349,2016,Effects of 28-Day Beta-Alanine Supplementation on Isokinetic Exercise Performance and Body Composition in Female Masters Athletes.,randomized_controlled_trial,benefit,"The study found significant improvements in lower-body exercise performance metrics, indicating a benefit from Beta-alanine supplementation.",800 mg 4 times per day 28 days (Beta-alanine + dextrose),Athletes; Women,,body composition,aerobic performance; anaerobic capacity; anaerobic performance; anaerobic power; athletic performance; basketball; bio-motor abilities; body composition; c-reactive protein; cardiorespiratory fitness; cardiovascular recovery; cognition; cognitive performance; cycling performance; distance covered in sports; endurance performance; exercise adaptation; exercise performance; exercise tolerance; fatigue; handgrip strength; high-intensity cycling performance; high-intensity exercise performance; improved high-intensity cycling capacity; improvement in athletic performance; improvement in cycling performance; increased fat-free mass; increased muscle carnosine content; interleukin-6; isokinetic strength; judo performance; lactate clearance; lower-body exercise performance; maximal aerobic speed; muscle carnosine elevation; muscle fatigue; muscle pain; muscle performance; muscle strength; neuromuscular fatigue; performance during cycling; physical endurance; physical performance; post-exercise recovery; repeated sprint ability performance; sports performance; sprint performance; strength endurance; time to exhaustion; training intensity; volleyball-specific bio-motor abilities,Tier 5,0.88,"Although this was a randomized, double-blind trial, the outcomes were isokinetic strength/torque and total work, not measures of aerobic capacity (e.g., VO2max, time-to-exhaustion, aerobic time trial). Therefore, it does not provide direct evidence for the indication of aerobic capacity."
Beta-alanine,,Aerobic Capacity,,Performance & Recovery,manual_pair,"The evidence for beta-alanine supplementation in improving low exercise performance is strong, with 27 studies reporting benefits and only 2 showing mixed outcomes. Typical doses reported range from 4.8 g to 6.4 g daily, with some studies using higher doses for short durations. No significant harms were noted, but the mixed results in a couple of studies suggest variability in individual responses to supplementation.",0.9,30565426,2018,"Effects of β-alanine supplementation on physical performance, cognition, endocrine function, and inflammation during a 24 h simulated military operation.",randomized_controlled_trial,mixed_unclear,"The study shows mixed results with some benefits in cognition and physical performance, but no significant changes in endocrine function or inflammation.",12 g day 14 days,Military,,cognition,aerobic performance; anaerobic capacity; anaerobic performance; anaerobic power; athletic performance; basketball; bio-motor abilities; body composition; c-reactive protein; cardiorespiratory fitness; cardiovascular recovery; cognition; cognitive performance; cycling performance; distance covered in sports; endurance performance; exercise adaptation; exercise performance; exercise tolerance; fatigue; handgrip strength; high-intensity cycling performance; high-intensity exercise performance; improved high-intensity cycling capacity; improvement in athletic performance; improvement in cycling performance; increased fat-free mass; increased muscle carnosine content; interleukin-6; isokinetic strength; judo performance; lactate clearance; lower-body exercise performance; maximal aerobic speed; muscle carnosine elevation; muscle fatigue; muscle pain; muscle performance; muscle strength; neuromuscular fatigue; performance during cycling; physical endurance; physical performance; post-exercise recovery; repeated sprint ability performance; sports performance; sprint performance; strength endurance; time to exhaustion; training intensity; volleyball-specific bio-motor abilities,Tier 3,0.56,"Small human RCT (n=19) in a military setting with mixed results. Aerobic capacity was not a primary outcome and no direct measures (e.g., VO2max) were assessed; only a 1 km run time under fatigue showed a borderline difference. Findings are indirect and exploratory for aerobic capacity, supporting only preliminary evidence."
Beta-alanine,,Aerobic Capacity,,Performance & Recovery,manual_pair,"The evidence for beta-alanine supplementation in improving low exercise performance is strong, with 27 studies reporting benefits and only 2 showing mixed outcomes. Typical doses reported range from 4.8 g to 6.4 g daily, with some studies using higher doses for short durations. No significant harms were noted, but the mixed results in a couple of studies suggest variability in individual responses to supplementation.",0.9,35805647,2022,Effects of Four Weeks of Beta-Alanine Supplementation Combined with One Week of Creatine Loading on Physical and Cognitive Performance in Military Personnel.,randomized_controlled_trial,benefit,The study showed significant improvements in physical and cognitive performance with beta-alanine supplementation.,6.4 g daily 28 days,,,cognitive performance,aerobic performance; anaerobic capacity; anaerobic performance; anaerobic power; athletic performance; basketball; bio-motor abilities; body composition; c-reactive protein; cardiorespiratory fitness; cardiovascular recovery; cognition; cognitive performance; cycling performance; distance covered in sports; endurance performance; exercise adaptation; exercise performance; exercise tolerance; fatigue; handgrip strength; high-intensity cycling performance; high-intensity exercise performance; improved high-intensity cycling capacity; improvement in athletic performance; improvement in cycling performance; increased fat-free mass; increased muscle carnosine content; interleukin-6; isokinetic strength; judo performance; lactate clearance; lower-body exercise performance; maximal aerobic speed; muscle carnosine elevation; muscle fatigue; muscle pain; muscle performance; muscle strength; neuromuscular fatigue; performance during cycling; physical endurance; physical performance; post-exercise recovery; repeated sprint ability performance; sports performance; sprint performance; strength endurance; time to exhaustion; training intensity; volleyball-specific bio-motor abilities,Tier 5,0.84,"This RCT compared beta-alanine plus creatine versus beta-alanine plus placebo; both groups received beta-alanine, so it does not test beta-alanine alone against control. Reported benefits pertain to power/strength and cognition, not clearly to aerobic capacity (no VO2max or equivalent primary aerobic outcomes reported). Thus, it is not actual evidence for beta-alanine’s effect on aerobic capacity."
Beta-alanine,,Aerobic Capacity,,Performance & Recovery,manual_pair,"The evidence for beta-alanine supplementation in improving low exercise performance is strong, with 27 studies reporting benefits and only 2 showing mixed outcomes. Typical doses reported range from 4.8 g to 6.4 g daily, with some studies using higher doses for short durations. No significant harms were noted, but the mixed results in a couple of studies suggest variability in individual responses to supplementation.",0.9,26652037,2016,The effect of β-alanine supplementation on cycling time trials of different length.,randomized_controlled_trial,benefit,"The study found significant increases in time to exhaustion and a likely benefit to 4-km time trial performance, indicating a positive outcome from β-alanine supplementation.",6.4 g daily 4 weeks (oral),Cycling,,cycling performance,aerobic performance; anaerobic capacity; anaerobic performance; anaerobic power; athletic performance; basketball; bio-motor abilities; body composition; c-reactive protein; cardiorespiratory fitness; cardiovascular recovery; cognition; cognitive performance; cycling performance; distance covered in sports; endurance performance; exercise adaptation; exercise performance; exercise tolerance; fatigue; handgrip strength; high-intensity cycling performance; high-intensity exercise performance; improved high-intensity cycling capacity; improvement in athletic performance; improvement in cycling performance; increased fat-free mass; increased muscle carnosine content; interleukin-6; isokinetic strength; judo performance; lactate clearance; lower-body exercise performance; maximal aerobic speed; muscle carnosine elevation; muscle fatigue; muscle pain; muscle performance; muscle strength; neuromuscular fatigue; performance during cycling; physical endurance; physical performance; post-exercise recovery; repeated sprint ability performance; sports performance; sprint performance; strength endurance; time to exhaustion; training intensity; volleyball-specific bio-motor abilities,Tier 2,0.65,"Double-blind, placebo-controlled RCT in trained cyclists with performance outcomes directly relevant to aerobic capacity. Shows significant improvement in time to exhaustion and likely benefit for 4-km time trial, but no effect on 1- or 10-km trials. Small sample size (n=14) limits power, so evidence is moderate rather than strong."
Beta-alanine,,Aerobic Capacity,,Performance & Recovery,manual_pair,"The evidence for beta-alanine supplementation in improving low exercise performance is strong, with 27 studies reporting benefits and only 2 showing mixed outcomes. Typical doses reported range from 4.8 g to 6.4 g daily, with some studies using higher doses for short durations. No significant harms were noted, but the mixed results in a couple of studies suggest variability in individual responses to supplementation.",0.9,29651862,2018,β-Alanine Supplementation's Improvement of High-Intensity Game Activities in Water Polo.,randomized_controlled_trial,benefit,The study shows a significant improvement in sprint numbers and a likely beneficial effect on distance covered and time spent in higher speed zones.,4.8 g daily 10 days (β-alanine); 6.4 g daily 18 days (β-alanine),Men; Sprinting; Water Polo Players,,distance covered in sports,aerobic performance; anaerobic capacity; anaerobic performance; anaerobic power; athletic performance; basketball; bio-motor abilities; body composition; c-reactive protein; cardiorespiratory fitness; cardiovascular recovery; cognition; cognitive performance; cycling performance; distance covered in sports; endurance performance; exercise adaptation; exercise performance; exercise tolerance; fatigue; handgrip strength; high-intensity cycling performance; high-intensity exercise performance; improved high-intensity cycling capacity; improvement in athletic performance; improvement in cycling performance; increased fat-free mass; increased muscle carnosine content; interleukin-6; isokinetic strength; judo performance; lactate clearance; lower-body exercise performance; maximal aerobic speed; muscle carnosine elevation; muscle fatigue; muscle pain; muscle performance; muscle strength; neuromuscular fatigue; performance during cycling; physical endurance; physical performance; post-exercise recovery; repeated sprint ability performance; sports performance; sprint performance; strength endurance; time to exhaustion; training intensity; volleyball-specific bio-motor abilities,Tier 3,0.45,"Double-blind, placebo-controlled RCT but very small (n=11) and conducted in a niche athletic population. Outcomes were sport-specific performance metrics (sprint counts, distance/time in speed zones) rather than direct measures of aerobic capacity (e.g., VO2max, aerobic time-to-exhaustion). While results suggest benefit, they provide only indirect, preliminary evidence for the aerobic capacity indication."
Beta-alanine,,Aerobic Capacity,,Performance & Recovery,manual_pair,"The evidence for beta-alanine supplementation in improving low exercise performance is strong, with 27 studies reporting benefits and only 2 showing mixed outcomes. Typical doses reported range from 4.8 g to 6.4 g daily, with some studies using higher doses for short durations. No significant harms were noted, but the mixed results in a couple of studies suggest variability in individual responses to supplementation.",0.9,35512767,2023,Acute Supplementation with Beta-Alanine Improves Performance in Aerobic-Anaerobic Transition Zones in Endurance Athletes.,randomized_controlled_trial,benefit,"The study shows that both doses of beta-alanine significantly improved physical performance, indicating a benefit.",30 mg·kg-1; 45 mg·kg-1,,,endurance performance,aerobic performance; anaerobic capacity; anaerobic performance; anaerobic power; athletic performance; basketball; bio-motor abilities; body composition; c-reactive protein; cardiorespiratory fitness; cardiovascular recovery; cognition; cognitive performance; cycling performance; distance covered in sports; endurance performance; exercise adaptation; exercise performance; exercise tolerance; fatigue; handgrip strength; high-intensity cycling performance; high-intensity exercise performance; improved high-intensity cycling capacity; improvement in athletic performance; improvement in cycling performance; increased fat-free mass; increased muscle carnosine content; interleukin-6; isokinetic strength; judo performance; lactate clearance; lower-body exercise performance; maximal aerobic speed; muscle carnosine elevation; muscle fatigue; muscle pain; muscle performance; muscle strength; neuromuscular fatigue; performance during cycling; physical endurance; physical performance; post-exercise recovery; repeated sprint ability performance; sports performance; sprint performance; strength endurance; time to exhaustion; training intensity; volleyball-specific bio-motor abilities,Tier 2,0.6,"Single small randomized controlled trial (n=12) in endurance athletes assessing maximal aerobic speed (a performance proxy for aerobic capacity) after acute beta-alanine dosing showed benefit. While the outcome is relevant and the design is randomized, the sample is small, population narrow, and the acute dosing is atypical for beta-alanine, limiting generalizability and strength to moderate rather than strong evidence."
Beta-alanine,,Aerobic Capacity,,Performance & Recovery,manual_pair,"The evidence for beta-alanine supplementation in improving low exercise performance is strong, with 27 studies reporting benefits and only 2 showing mixed outcomes. Typical doses reported range from 4.8 g to 6.4 g daily, with some studies using higher doses for short durations. No significant harms were noted, but the mixed results in a couple of studies suggest variability in individual responses to supplementation.",0.9,31438535,2019,The Effect of Beta-Alanine versus Alkaline Agent Supplementation Combined with Branched-Chain Amino Acids and Creatine Malate in Highly-Trained Sprinters and Endurance Athletes: A Randomized Double-Blind Crossover Study.,randomized_controlled_trial,benefit,The study shows a benefit in increasing fat-free mass and exercise adaptation with beta-alanine supplementation.,8 weeks,Sprinting,,exercise adaptation,aerobic performance; anaerobic capacity; anaerobic performance; anaerobic power; athletic performance; basketball; bio-motor abilities; body composition; c-reactive protein; cardiorespiratory fitness; cardiovascular recovery; cognition; cognitive performance; cycling performance; distance covered in sports; endurance performance; exercise adaptation; exercise performance; exercise tolerance; fatigue; handgrip strength; high-intensity cycling performance; high-intensity exercise performance; improved high-intensity cycling capacity; improvement in athletic performance; improvement in cycling performance; increased fat-free mass; increased muscle carnosine content; interleukin-6; isokinetic strength; judo performance; lactate clearance; lower-body exercise performance; maximal aerobic speed; muscle carnosine elevation; muscle fatigue; muscle pain; muscle performance; muscle strength; neuromuscular fatigue; performance during cycling; physical endurance; physical performance; post-exercise recovery; repeated sprint ability performance; sports performance; sprint performance; strength endurance; time to exhaustion; training intensity; volleyball-specific bio-motor abilities,Tier 3,0.46,"Double-blind randomized crossover in elite athletes (n=31) suggests performance/adaptation benefits, but the intervention combined beta-alanine with BCAAs and creatine malate and compared against an alkaline agent plus the same co-supplements, confounding attribution to beta-alanine. Aerobic capacity does not appear to be a primary outcome; reported benefits emphasize fat-free mass and exercise adaptation rather than direct VO2max/clear aerobic metrics. Small sample and elite cohort further limit generalizability."
Beta-alanine,,Aerobic Capacity,,Performance & Recovery,manual_pair,"The evidence for beta-alanine supplementation in improving low exercise performance is strong, with 27 studies reporting benefits and only 2 showing mixed outcomes. Typical doses reported range from 4.8 g to 6.4 g daily, with some studies using higher doses for short durations. No significant harms were noted, but the mixed results in a couple of studies suggest variability in individual responses to supplementation.",0.9,33092320,2021,Acute carnosine and β-alanine supplementation increase the compensated part of the ventilation versus work rate relationship during a ramp incremental cycle test in physically active men.,randomized_controlled_trial,benefit,"The study showed a positive effect of acute β-alanine supplementation on exercise performance, specifically on the compensated part of the ventilation during exercise.",2.5 g single dose (L-carnosine plus β-alanine),Men,,exercise performance,aerobic performance; anaerobic capacity; anaerobic performance; anaerobic power; athletic performance; basketball; bio-motor abilities; body composition; c-reactive protein; cardiorespiratory fitness; cardiovascular recovery; cognition; cognitive performance; cycling performance; distance covered in sports; endurance performance; exercise adaptation; exercise performance; exercise tolerance; fatigue; handgrip strength; high-intensity cycling performance; high-intensity exercise performance; improved high-intensity cycling capacity; improvement in athletic performance; improvement in cycling performance; increased fat-free mass; increased muscle carnosine content; interleukin-6; isokinetic strength; judo performance; lactate clearance; lower-body exercise performance; maximal aerobic speed; muscle carnosine elevation; muscle fatigue; muscle pain; muscle performance; muscle strength; neuromuscular fatigue; performance during cycling; physical endurance; physical performance; post-exercise recovery; repeated sprint ability performance; sports performance; sprint performance; strength endurance; time to exhaustion; training intensity; volleyball-specific bio-motor abilities,Tier 3,0.4,"Double-blind RCT but very small (n=10) and used an acute combined carnosine+beta-alanine dose rather than beta-alanine alone. The positive finding was on a surrogate ventilatory parameter (compensated portion between VT1 and VT2), with no change in peak exercise or ventilatory thresholds. This provides preliminary, indirect evidence for aerobic capacity rather than a clear clinical performance outcome."
Beta-alanine,,Aerobic Capacity,,Performance & Recovery,manual_pair,"The evidence for beta-alanine supplementation in improving low exercise performance is strong, with 27 studies reporting benefits and only 2 showing mixed outcomes. Typical doses reported range from 4.8 g to 6.4 g daily, with some studies using higher doses for short durations. No significant harms were noted, but the mixed results in a couple of studies suggest variability in individual responses to supplementation.",0.9,29713250,2018,"Effects of β-alanine supplementation during a 5-week strength training program: a randomized, controlled study.",randomized_controlled_trial,benefit,The study found significant improvements in power output and strength gains in the β-alanine group compared to placebo.,6.4 g daily 5 weeks (oral),,,exercise performance,aerobic performance; anaerobic capacity; anaerobic performance; anaerobic power; athletic performance; basketball; bio-motor abilities; body composition; c-reactive protein; cardiorespiratory fitness; cardiovascular recovery; cognition; cognitive performance; cycling performance; distance covered in sports; endurance performance; exercise adaptation; exercise performance; exercise tolerance; fatigue; handgrip strength; high-intensity cycling performance; high-intensity exercise performance; improved high-intensity cycling capacity; improvement in athletic performance; improvement in cycling performance; increased fat-free mass; increased muscle carnosine content; interleukin-6; isokinetic strength; judo performance; lactate clearance; lower-body exercise performance; maximal aerobic speed; muscle carnosine elevation; muscle fatigue; muscle pain; muscle performance; muscle strength; neuromuscular fatigue; performance during cycling; physical endurance; physical performance; post-exercise recovery; repeated sprint ability performance; sports performance; sprint performance; strength endurance; time to exhaustion; training intensity; volleyball-specific bio-motor abilities,Tier 5,0.9,"Although this was a randomized controlled trial, it evaluated strength/power outcomes (1RM, power, velocity, jump performance) during resistance training, not aerobic capacity (e.g., VO2max, aerobic endurance). Thus it does not provide direct evidence for the aerobic capacity indication."
Beta-alanine,,Aerobic Capacity,,Performance & Recovery,manual_pair,"The evidence for beta-alanine supplementation in improving low exercise performance is strong, with 27 studies reporting benefits and only 2 showing mixed outcomes. Typical doses reported range from 4.8 g to 6.4 g daily, with some studies using higher doses for short durations. No significant harms were noted, but the mixed results in a couple of studies suggest variability in individual responses to supplementation.",0.9,29246277,2017,β-Alanine supplementation elevates intramuscular carnosine content and attenuates fatigue in men and women similarly but does not change muscle l-histidine content.,randomized_controlled_trial,benefit,"The study shows that Beta-alanine supplementation likely increases muscle carnosine and reduces fatigue, indicating a benefit.",6 g daily 28 days,,,exercise performance,aerobic performance; anaerobic capacity; anaerobic performance; anaerobic power; athletic performance; basketball; bio-motor abilities; body composition; c-reactive protein; cardiorespiratory fitness; cardiovascular recovery; cognition; cognitive performance; cycling performance; distance covered in sports; endurance performance; exercise adaptation; exercise performance; exercise tolerance; fatigue; handgrip strength; high-intensity cycling performance; high-intensity exercise performance; improved high-intensity cycling capacity; improvement in athletic performance; improvement in cycling performance; increased fat-free mass; increased muscle carnosine content; interleukin-6; isokinetic strength; judo performance; lactate clearance; lower-body exercise performance; maximal aerobic speed; muscle carnosine elevation; muscle fatigue; muscle pain; muscle performance; muscle strength; neuromuscular fatigue; performance during cycling; physical endurance; physical performance; post-exercise recovery; repeated sprint ability performance; sports performance; sprint performance; strength endurance; time to exhaustion; training intensity; volleyball-specific bio-motor abilities,Tier 5,0.78,"Although this is an RCT showing increased muscle carnosine and reduced fatigue, the outcomes pertain to buffering and high-intensity fatigue (anaerobic performance) rather than aerobic capacity (e.g., VO2max, aerobic time-to-exhaustion). The study does not directly test or report aerobic capacity outcomes, making it not actual evidence for this specific indication."
Beta-alanine,,Aerobic Capacity,,Performance & Recovery,manual_pair,"The evidence for beta-alanine supplementation in improving low exercise performance is strong, with 27 studies reporting benefits and only 2 showing mixed outcomes. Typical doses reported range from 4.8 g to 6.4 g daily, with some studies using higher doses for short durations. No significant harms were noted, but the mixed results in a couple of studies suggest variability in individual responses to supplementation.",0.9,25894892,2015,β-Alanine supplementation slightly enhances repeated plyometric performance after high-intensity training in humans.,randomized_controlled_trial,benefit,"The study shows a slight improvement in explosive force and performance metrics, indicating a benefit from β-Alanine supplementation.",4.0-5.6 g daily 8 weeks,,,exercise performance,aerobic performance; anaerobic capacity; anaerobic performance; anaerobic power; athletic performance; basketball; bio-motor abilities; body composition; c-reactive protein; cardiorespiratory fitness; cardiovascular recovery; cognition; cognitive performance; cycling performance; distance covered in sports; endurance performance; exercise adaptation; exercise performance; exercise tolerance; fatigue; handgrip strength; high-intensity cycling performance; high-intensity exercise performance; improved high-intensity cycling capacity; improvement in athletic performance; improvement in cycling performance; increased fat-free mass; increased muscle carnosine content; interleukin-6; isokinetic strength; judo performance; lactate clearance; lower-body exercise performance; maximal aerobic speed; muscle carnosine elevation; muscle fatigue; muscle pain; muscle performance; muscle strength; neuromuscular fatigue; performance during cycling; physical endurance; physical performance; post-exercise recovery; repeated sprint ability performance; sports performance; sprint performance; strength endurance; time to exhaustion; training intensity; volleyball-specific bio-motor abilities,Tier 5,0.88,"This RCT assessed β-alanine effects on plyometric performance (jump height, repeated CMJ fatigue test) and blood lactate response, not on aerobic capacity (e.g., VO2max/VO2peak, aerobic time trial, submaximal economy). The outcomes are primarily anaerobic/explosive performance metrics. Therefore, it does not provide direct evidence for the indication of aerobic capacity."
Beta-alanine,,Aerobic Capacity,,Performance & Recovery,manual_pair,"The evidence for beta-alanine supplementation in improving low exercise performance is strong, with 27 studies reporting benefits and only 2 showing mixed outcomes. Typical doses reported range from 4.8 g to 6.4 g daily, with some studies using higher doses for short durations. No significant harms were noted, but the mixed results in a couple of studies suggest variability in individual responses to supplementation.",0.9,26255281,2015,Incremental effects of 28 days of beta-alanine supplementation on high-intensity cycling performance and blood lactate in masters female cyclists.,randomized_controlled_trial,benefit,"The study found significant improvements in time to exhaustion and total work completed, indicating a benefit from beta-alanine supplementation.",800 mg 4 times/day 28 days (beta-alanine + dextrose),Cycling,,high-intensity cycling performance,aerobic performance; anaerobic capacity; anaerobic performance; anaerobic power; athletic performance; basketball; bio-motor abilities; body composition; c-reactive protein; cardiorespiratory fitness; cardiovascular recovery; cognition; cognitive performance; cycling performance; distance covered in sports; endurance performance; exercise adaptation; exercise performance; exercise tolerance; fatigue; handgrip strength; high-intensity cycling performance; high-intensity exercise performance; improved high-intensity cycling capacity; improvement in athletic performance; improvement in cycling performance; increased fat-free mass; increased muscle carnosine content; interleukin-6; isokinetic strength; judo performance; lactate clearance; lower-body exercise performance; maximal aerobic speed; muscle carnosine elevation; muscle fatigue; muscle pain; muscle performance; muscle strength; neuromuscular fatigue; performance during cycling; physical endurance; physical performance; post-exercise recovery; repeated sprint ability performance; sports performance; sprint performance; strength endurance; time to exhaustion; training intensity; volleyball-specific bio-motor abilities,Tier 2,0.64,"Double-blind randomized controlled trial in humans showing significant improvements in time to exhaustion and total work. However, the sample size is small (n=22) and limited to masters female cyclists, and outcomes reflect high-intensity performance rather than direct measures of aerobic capacity (e.g., VO2max), reducing generalizability and directness."
Beta-alanine,,Aerobic Capacity,,Performance & Recovery,manual_pair,"The evidence for beta-alanine supplementation in improving low exercise performance is strong, with 27 studies reporting benefits and only 2 showing mixed outcomes. Typical doses reported range from 4.8 g to 6.4 g daily, with some studies using higher doses for short durations. No significant harms were noted, but the mixed results in a couple of studies suggest variability in individual responses to supplementation.",0.9,28157726,2017,"Twenty-four Weeks of β-Alanine Supplementation on Carnosine Content, Related Genes, and Exercise.",randomized_controlled_trial,benefit,The study shows significant benefits in muscle carnosine content and exercise capacity with β-alanine supplementation.,6.4 g daily 24 weeks (sustained release),Cycling,,improved high-intensity cycling capacity,aerobic performance; anaerobic capacity; anaerobic performance; anaerobic power; athletic performance; basketball; bio-motor abilities; body composition; c-reactive protein; cardiorespiratory fitness; cardiovascular recovery; cognition; cognitive performance; cycling performance; distance covered in sports; endurance performance; exercise adaptation; exercise performance; exercise tolerance; fatigue; handgrip strength; high-intensity cycling performance; high-intensity exercise performance; improved high-intensity cycling capacity; improvement in athletic performance; improvement in cycling performance; increased fat-free mass; increased muscle carnosine content; interleukin-6; isokinetic strength; judo performance; lactate clearance; lower-body exercise performance; maximal aerobic speed; muscle carnosine elevation; muscle fatigue; muscle pain; muscle performance; muscle strength; neuromuscular fatigue; performance during cycling; physical endurance; physical performance; post-exercise recovery; repeated sprint ability performance; sports performance; sprint performance; strength endurance; time to exhaustion; training intensity; volleyball-specific bio-motor abilities,Tier 5,0.76,"This RCT assessed high-intensity cycling capacity (CCT110%) and muscle carnosine, not aerobic capacity measures (e.g., VO2max, ventilatory/lactate thresholds, or aerobic time-trial performance). Thus, despite performance benefits, the study does not directly test beta-alanine for the specified indication of aerobic capacity."
Beta-alanine,,Aerobic Capacity,,Performance & Recovery,manual_pair,"The evidence for beta-alanine supplementation in improving low exercise performance is strong, with 27 studies reporting benefits and only 2 showing mixed outcomes. Typical doses reported range from 4.8 g to 6.4 g daily, with some studies using higher doses for short durations. No significant harms were noted, but the mixed results in a couple of studies suggest variability in individual responses to supplementation.",0.9,39226288,2024,Effect of high-dose β-Alanine supplementation on uphill cycling performance in World Tour cyclists: A randomised controlled trial.,randomized_controlled_trial,benefit,"The study demonstrated a benefit in cycling performance with high-dose β-alanine supplementation, indicating its effectiveness as an ergogenic aid.",5 g 4 times daily 7 days (supplement),Cycling,,improvement in cycling performance,aerobic performance; anaerobic capacity; anaerobic performance; anaerobic power; athletic performance; basketball; bio-motor abilities; body composition; c-reactive protein; cardiorespiratory fitness; cardiovascular recovery; cognition; cognitive performance; cycling performance; distance covered in sports; endurance performance; exercise adaptation; exercise performance; exercise tolerance; fatigue; handgrip strength; high-intensity cycling performance; high-intensity exercise performance; improved high-intensity cycling capacity; improvement in athletic performance; improvement in cycling performance; increased fat-free mass; increased muscle carnosine content; interleukin-6; isokinetic strength; judo performance; lactate clearance; lower-body exercise performance; maximal aerobic speed; muscle carnosine elevation; muscle fatigue; muscle pain; muscle performance; muscle strength; neuromuscular fatigue; performance during cycling; physical endurance; physical performance; post-exercise recovery; repeated sprint ability performance; sports performance; sprint performance; strength endurance; time to exhaustion; training intensity; volleyball-specific bio-motor abilities,Tier 5,0.78,"Double-blind RCT in elite cyclists (n=11) showed improved uphill time-trial performance with high-dose beta-alanine, but did not assess aerobic capacity (e.g., VO2max) as an outcome. Performance/time-trial metrics are not direct measures of aerobic capacity, so this study does not provide direct evidence for the specified indication."
Beta-alanine,,Aerobic Capacity,,Performance & Recovery,manual_pair,"The evidence for beta-alanine supplementation in improving low exercise performance is strong, with 27 studies reporting benefits and only 2 showing mixed outcomes. Typical doses reported range from 4.8 g to 6.4 g daily, with some studies using higher doses for short durations. No significant harms were noted, but the mixed results in a couple of studies suggest variability in individual responses to supplementation.",0.9,39064783,2024,Effects of β-Alanine Supplementation on Subjects Performing High-Intensity Functional Training.,randomized_controlled_trial,benefit,"The study showed significant improvements in vertical jump and power performance, indicating a benefit from β-alanine supplementation.",null null null 4 weeks (β-alanine powder),,,muscle performance,aerobic performance; anaerobic capacity; anaerobic performance; anaerobic power; athletic performance; basketball; bio-motor abilities; body composition; c-reactive protein; cardiorespiratory fitness; cardiovascular recovery; cognition; cognitive performance; cycling performance; distance covered in sports; endurance performance; exercise adaptation; exercise performance; exercise tolerance; fatigue; handgrip strength; high-intensity cycling performance; high-intensity exercise performance; improved high-intensity cycling capacity; improvement in athletic performance; improvement in cycling performance; increased fat-free mass; increased muscle carnosine content; interleukin-6; isokinetic strength; judo performance; lactate clearance; lower-body exercise performance; maximal aerobic speed; muscle carnosine elevation; muscle fatigue; muscle pain; muscle performance; muscle strength; neuromuscular fatigue; performance during cycling; physical endurance; physical performance; post-exercise recovery; repeated sprint ability performance; sports performance; sprint performance; strength endurance; time to exhaustion; training intensity; volleyball-specific bio-motor abilities,Tier 5,0.76,"Although this is a human RCT, the measured outcomes were vertical jump and power (anaerobic performance), not aerobic capacity metrics (e.g., VO2max, time-to-exhaustion, ventilatory threshold). Therefore, the study does not provide direct evidence for the supplement’s effect on aerobic capacity."
Beta-alanine,,Aerobic Capacity,,Performance & Recovery,manual_pair,"The evidence for beta-alanine supplementation in improving low exercise performance is strong, with 27 studies reporting benefits and only 2 showing mixed outcomes. Typical doses reported range from 4.8 g to 6.4 g daily, with some studies using higher doses for short durations. No significant harms were noted, but the mixed results in a couple of studies suggest variability in individual responses to supplementation.",0.9,29905904,2019,"Beta-alanine supplementation improves isometric, but not isotonic or isokinetic strength endurance in recreationally strength-trained young men.",randomized_controlled_trial,benefit,The study shows a significant improvement in isometric endurance performance with beta-alanine supplementation.,6.4 g day-1 4 weeks (beta-alanine),Jumping,,muscle performance,aerobic performance; anaerobic capacity; anaerobic performance; anaerobic power; athletic performance; basketball; bio-motor abilities; body composition; c-reactive protein; cardiorespiratory fitness; cardiovascular recovery; cognition; cognitive performance; cycling performance; distance covered in sports; endurance performance; exercise adaptation; exercise performance; exercise tolerance; fatigue; handgrip strength; high-intensity cycling performance; high-intensity exercise performance; improved high-intensity cycling capacity; improvement in athletic performance; improvement in cycling performance; increased fat-free mass; increased muscle carnosine content; interleukin-6; isokinetic strength; judo performance; lactate clearance; lower-body exercise performance; maximal aerobic speed; muscle carnosine elevation; muscle fatigue; muscle pain; muscle performance; muscle strength; neuromuscular fatigue; performance during cycling; physical endurance; physical performance; post-exercise recovery; repeated sprint ability performance; sports performance; sprint performance; strength endurance; time to exhaustion; training intensity; volleyball-specific bio-motor abilities,Tier 5,0.86,"This double-blind RCT evaluated isometric/isotonic/isokinetic strength endurance in recreationally strength-trained men, not aerobic capacity (e.g., VO2max, aerobic time-to-exhaustion). The reported benefit in isometric endurance does not address the specified indication of aerobic capacity, so it is not direct evidence for this condition."
Beta-alanine,,Aerobic Capacity,,Performance & Recovery,manual_pair,"The evidence for beta-alanine supplementation in improving low exercise performance is strong, with 27 studies reporting benefits and only 2 showing mixed outcomes. Typical doses reported range from 4.8 g to 6.4 g daily, with some studies using higher doses for short durations. No significant harms were noted, but the mixed results in a couple of studies suggest variability in individual responses to supplementation.",0.9,31622158,2019,Effect of β-alanine supplementation during high-intensity interval training on repeated sprint ability performance and neuromuscular fatigue.,randomized_controlled_trial,benefit,"The study shows that β-alanine supplementation improved repeated sprint performance and reduced neuromuscular fatigue, indicating a beneficial effect.",6.4 g daily 6 weeks,Sprinting,,neuromuscular fatigue,aerobic performance; anaerobic capacity; anaerobic performance; anaerobic power; athletic performance; basketball; bio-motor abilities; body composition; c-reactive protein; cardiorespiratory fitness; cardiovascular recovery; cognition; cognitive performance; cycling performance; distance covered in sports; endurance performance; exercise adaptation; exercise performance; exercise tolerance; fatigue; handgrip strength; high-intensity cycling performance; high-intensity exercise performance; improved high-intensity cycling capacity; improvement in athletic performance; improvement in cycling performance; increased fat-free mass; increased muscle carnosine content; interleukin-6; isokinetic strength; judo performance; lactate clearance; lower-body exercise performance; maximal aerobic speed; muscle carnosine elevation; muscle fatigue; muscle pain; muscle performance; muscle strength; neuromuscular fatigue; performance during cycling; physical endurance; physical performance; post-exercise recovery; repeated sprint ability performance; sports performance; sprint performance; strength endurance; time to exhaustion; training intensity; volleyball-specific bio-motor abilities,Tier 5,0.64,"Although this is a randomized, double-blind, placebo-controlled trial, the primary outcomes were repeated sprint ability and neuromuscular fatigue in sprinters, not aerobic capacity (e.g., VO2max or endurance performance). The reported benefits pertain to high-intensity, anaerobic performance, making the evidence not directly applicable to the specified indication of aerobic capacity."
Beta-alanine,,Muscle Endurance,,Performance & Recovery,manual_pair,"The evidence regarding beta-alanine supplementation for muscle fatigue is mixed, with one study indicating improved muscle relaxation speed but no effect on force production. The typical dose reported was 6.4 g daily for 28 days. Overall, the findings do not support a clear benefit for muscle fatigue.",0.7,28349262,2017,β-alanine supplementation improves in-vivo fresh and fatigued skeletal muscle relaxation speed.,clinical_trial,mixed_unclear,"While beta-alanine supplementation improved muscle relaxation speed, it had no effect on force production, indicating mixed outcomes regarding its benefits.",6.4 g daily 28 days,,,muscle fatigue,muscle fatigue; muscle relaxation,Tier 4,0.56,Human clinical trial with small sample assessing mechanistic surrogate (muscle half-relaxation time) rather than direct muscle endurance performance. Mixed outcomes (no change in force production; improved relaxation speed) make relevance to endurance indirect. Thus very low/indirect human evidence for the specific indication of muscle endurance.
Beta-Glucans,,High LDL,,Heart & Vascular Health,manual_pair,"The evidence regarding beta-glucans for cholesterol metabolism is limited and mixed, with one study indicating some decreases in cholesterol levels but not fully supporting hypocholesterolemic effects. The study involved doses of 3.3 g daily from oat and barley sources over three weeks. Overall, the findings do not provide strong support for the efficacy of beta-glucans in this indication.",0.8,23946347,2013,Extracted oat and barley β-glucans do not affect cholesterol metabolism in young healthy adults.,randomized_controlled_trial,mixed_unclear,"The study shows some decreases in cholesterol levels with oat β-glucans but does not fully support hypocholesterolemic effects, indicating mixed results.",3.3 g daily 3 weeks (beverage and yogurt),,,cholesterol metabolism,cholesterol metabolism,Tier 2,0.56,"Randomized, crossover, single-blind human trial measuring LDL cholesterol (a clinically relevant primary outcome) but with a very small sample (n=14), short duration (3 weeks), healthy participants rather than individuals with high LDL, and no significant effect vs control (only baseline reductions with oat). Thus, it provides moderate but limited-quality human evidence for this indication."
Beta-Glucans,,Gastritis,,Gut Health,manual_pair,"One randomized trial indicates that oat beta-glucans may have a beneficial effect in reducing mucosal damage in patients with chronic gastritis when administered for 30 days. However, the overall evidence is limited, with only a single study reporting positive outcomes and no data on adverse effects or consistency across multiple trials.",0.7,34444949,2021,Clinical Outcomes after Oat Beta-Glucans Dietary Treatment in Gastritis Patients.,randomized_controlled_trial,benefit,The study shows a beneficial effect of oat beta-glucans in reducing mucosal damage in chronic gastritis patients.,30 days (chemically pure oat beta-glucan preparations),,,chronic gastritis,chronic gastritis,Tier 3,0.6,"Small, short-duration human trial (~48 participants) with randomization between beta-glucan formulations but no clear placebo/standard-care control. Outcomes emphasize surrogate biomarkers (SCFAs, antioxidant parameters) with inferred mucosal improvement; blinding and primary clinical endpoints are unclear. Indicates potential benefit but remains preliminary."
Beta-Glucans,,Increase Flu Vaccine Efficacy,,"Immune, Inflammation, & Infection",manual_pair,"One randomized, double-blind, placebo-controlled study reported a beneficial effect of a β-Glucan supplement combined with selenium and zinc in enhancing immune cell levels and antibody responses in individuals receiving the COVID-19 vaccine. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess the supplement's efficacy in broader populations.",0.7,34959898,2021,"Effect and Tolerability of a Nutritional Supplement Based on a Synergistic Combination of β-Glucans and Selenium- and Zinc-Enriched Saccharomyces cerevisiae (ABB C1®) in Volunteers Receiving the Influenza or the COVID-19 Vaccine: A Randomized, Double-Blind, Placebo-Controlled Study.",randomized_controlled_trial,benefit,"The study shows an increase in immune cell levels and antibody responses, indicating a beneficial effect of the supplement.",30 and 35 days (yeast-based supplement),,,covid-19,covid-19,Tier 2,0.6,"A randomized, double-blind, placebo-controlled human trial reported increased immunologic responses (including antibody measures) in influenza vaccine recipients, which is directly relevant to vaccine efficacy. However, the study was small and used surrogate endpoints rather than clinical outcomes, and the intervention was a combination product (beta-glucans with selenium/zinc-enriched yeast and heat-treated probiotic), limiting attribution to beta-glucans alone."
Beta-Glucans,,Weight Loss,,Weight & Body Composition,manual_pair,"There is limited evidence from a single randomized trial indicating that oat beta-glucans (3 g twice daily for 6 weeks) may lead to positive changes in cardiometabolic markers related to excess body weight. However, the overall evidence is weak and further studies are needed to confirm these findings and assess long-term effects and safety.",0.6,34919104,2022,"Evaluation of novel nutraceuticals based on the combination of oat beta-glucans and a green coffee phenolic extract to combat obesity and its comorbidities. A randomized, dose-response, parallel trial.",randomized_controlled_trial,benefit,"The intervention led to positive changes in various cardiometabolic markers, indicating a benefit.",3 g twice a day 6 weeks (oat beta-glucans),Obese,Gut Health,cardiometabolic risk factors,cardiometabolic risk factors; obesity,Tier 4,0.42,"Randomized, blinded human trial in obese adults, but the intervention combined oat beta-glucans with green coffee phenolic extract, making attribution to beta-glucans alone unclear. Reported benefits focused on cardiometabolic biomarkers rather than clear, primary weight loss outcomes, and the duration was short (6 weeks). Thus, evidence for beta-glucans specifically for weight loss is indirect/low."
Beta-Glucans,,High Blood Glucose,,Metabolic Health,manual_pair,"The evidence from three randomized controlled trials suggests that beta-glucans, particularly from oats and barley, may improve postprandial glycemia and glucose tolerance in healthy individuals. Doses reported include 2 g to 4 g of oat beta-glucans. No adverse effects were noted in the studies, but the overall quality of evidence is moderate and further research may be needed to confirm these findings across diverse populations.",0.8,36124913,2022,Effects of whole-grain barley and oat β-glucans on postprandial glycemia and appetite: a randomized controlled crossover trial.,randomized_controlled_trial,benefit,"The study showed a beneficial effect on postprandial glycemia and appetite, indicating that β-glucans from barley and oats can improve these outcomes.",,,,appetite,appetite; appetite control; glucose tolerance; insulinaemia; postprandial glycaemia; postprandial glycemia,Tier 3,0.62,"Randomized crossover trial (n=20 healthy adults) showed beta-glucan–rich barley/oat breads improved postprandial glycemia versus controls. However, it is small, acute, uses a surrogate outcome (postprandial glucose), involves healthy participants rather than individuals with hyperglycemia/diabetes, and employs a food matrix rather than an isolated supplement dose. Thus, evidence is preliminary/indirect for the indication of high blood glucose."
Beta-Glucans,,High Blood Glucose,,Metabolic Health,manual_pair,"The evidence from three randomized controlled trials suggests that beta-glucans, particularly from oats and barley, may improve postprandial glycemia and glucose tolerance in healthy individuals. Doses reported include 2 g to 4 g of oat beta-glucans. No adverse effects were noted in the studies, but the overall quality of evidence is moderate and further research may be needed to confirm these findings across diverse populations.",0.8,40326558,2025,Oat beta-glucans consumed at breakfast improve glucose tolerance acutely and after a subsequent lunch - a randomized dose-response study in healthy young adults.,randomized_controlled_trial,benefit,"The study shows that oat beta-glucans improve glucose tolerance and appetite control, indicating a beneficial effect on human health outcomes.",2 g once (Oat beta-glucans); 3 g once (Oat beta-glucans); 4 g once (Oat beta-glucans),,,appetite control,appetite; appetite control; glucose tolerance; insulinaemia; postprandial glycaemia; postprandial glycemia,Tier 3,0.58,"Randomized crossover RCT in 19 healthy young adults showing acute reductions in postprandial glucose peaks with single doses of oat beta-glucans. While the outcome (postprandial glycemia) is directly relevant, the study is small, short-term, uses surrogate endpoints, and is not conducted in individuals with high blood glucose or diabetes, limiting applicability to the target indication."
Beta-Glucans,,High Blood Glucose,,Metabolic Health,manual_pair,"The evidence from three randomized controlled trials suggests that beta-glucans, particularly from oats and barley, may improve postprandial glycemia and glucose tolerance in healthy individuals. Doses reported include 2 g to 4 g of oat beta-glucans. No adverse effects were noted in the studies, but the overall quality of evidence is moderate and further research may be needed to confirm these findings across diverse populations.",0.8,17426742,2008,Muesli with 4 g oat beta-glucans lowers glucose and insulin responses after a bread meal in healthy subjects.,randomized_controlled_trial,benefit,"The study found that 4 g of beta-glucans significantly lowered glucose and insulin responses, indicating a beneficial effect.",4 g single serving (muesli),,,insulinaemia,appetite; appetite control; glucose tolerance; insulinaemia; postprandial glycaemia; postprandial glycemia,Tier 3,0.6,"Small, acute randomized meal test in healthy volunteers showed reduced postprandial glucose and insulin with 4 g oat beta-glucans. While randomized and showing a significant effect, it uses surrogate outcomes (single-meal glycemic/insulinemic responses) in non-hyperglycemic subjects, not assessing sustained glycemic control in individuals with high blood glucose."
Beta-Glucans,,High Blood Glucose,,Metabolic Health,manual_pair,"Clinical evidence suggests that beta-glucans may have a beneficial effect on metabolic control in individuals with Type 2 Diabetes, as indicated by improvements in glycated hemoglobin and post-prandial glucose levels in two studies. Doses reported include 7 g per 100 g of functional bread and a modified low-calorie diet with beta-glucans over four weeks. However, the overall evidence is limited and further research is needed to establish consistent effects and optimal dosing.",0.7,28304350,2017,A Multifunctional Bread Rich in Beta Glucans and Low in Starch Improves Metabolic Control in Type 2 Diabetes: A Controlled Trial.,randomized_controlled_trial,benefit,"The functional bread improved glycated hemoglobin and post-prandial glucose levels, indicating a beneficial effect on metabolic control.",7 g per 100 g of bread roughly six months (functional bread),,,Type 2 Diabetes Mellitus,Type 2 Diabetes Mellitus,Tier 2,0.58,"Randomized controlled trial in people with type 2 diabetes reported clinically relevant improvements in HbA1c (~0.5%) and postprandial glucose over ~6 months. However, the intervention was a multifunctional bread (low starch, high fiber with beta-glucans), making attribution specifically to beta-glucans less direct, and details on sample size/blinding are not provided. Thus, moderate human evidence for beta-glucans improving high blood glucose."
Beta-Glucans,,High Blood Glucose,,Metabolic Health,manual_pair,"Clinical evidence suggests that beta-glucans may have a beneficial effect on metabolic control in individuals with Type 2 Diabetes, as indicated by improvements in glycated hemoglobin and post-prandial glucose levels in two studies. Doses reported include 7 g per 100 g of functional bread and a modified low-calorie diet with beta-glucans over four weeks. However, the overall evidence is limited and further research is needed to establish consistent effects and optimal dosing.",0.7,14624282,2003,Sweeteners and beta-glucans improve metabolic and anthropometrics variables in well controlled type 2 diabetic patients.,randomized_controlled_trial,benefit,"The study showed significant improvements in metabolic and anthropometric variables, indicating a benefit from the intervention.",4 weeks (modified low-calorie diet with beta-glucans),,Weight & Body Composition,Type 2 Diabetes Mellitus,Type 2 Diabetes Mellitus,Tier 3,0.43,"Small randomized controlled trial (n=16, 4 weeks) in well-controlled type 2 diabetes showed improvements in fasting glucose and HbA1c with a modified low-calorie diet that included oat beta-glucans plus non-sucrose sweeteners, compared with an ADA-style diet. However, the intervention was multi-component (caloric restriction and sweeteners alongside beta-glucans) and likely unblinded, making attribution to beta-glucans alone uncertain. Short duration and small sample further limit strength. Outcomes are relevant metabolic biomarkers but not hard clinical endpoints."
Beta-Glucans,,High LDL,,Heart & Vascular Health,manual_pair,"Human clinical evidence suggests that beta-glucans may reduce LDL cholesterol, with three studies reporting significant benefits. Typical doses used in these studies range from 3 g to 6 g daily, with interventions lasting from 4 to 8 weeks. No adverse effects were reported, but the overall evidence is limited to a small number of studies, indicating a need for further research to confirm these findings.",0.8,23187951,2013,β-glucans reduce LDL cholesterol in patients with myasthenia gravis.,clinical_trial,benefit,"The study shows a significant reduction in LDL cholesterol, indicating a beneficial effect of β-glucans.",3 g daily 8 weeks (dietary supplement),Myasthenia Gravis,,hypercholesterolemia,cholesterol levels; hypercholesterolemia; metabolic syndrome; myasthenia gravis,Tier 3,0.66,"Before-after, uncontrolled clinical trial in myasthenia gravis patients (n=59; 52 completers) taking 3 g/day beta-glucans for 8 weeks reported significant LDL reduction. While LDL is a relevant outcome for high LDL, the study lacks randomization and a control group and is limited to a specific patient population, placing it as preliminary human evidence."
Beta-Glucans,,High LDL,,Heart & Vascular Health,manual_pair,"Human clinical evidence suggests that beta-glucans may reduce LDL cholesterol, with three studies reporting significant benefits. Typical doses used in these studies range from 3 g to 6 g daily, with interventions lasting from 4 to 8 weeks. No adverse effects were reported, but the overall evidence is limited to a small number of studies, indicating a need for further research to confirm these findings.",0.8,16015250,2005,Changes in serum lipids and postprandial glucose and insulin concentrations after consumption of beverages with beta-glucans from oats or barley: a randomised dose-controlled trial.,randomized_controlled_trial,benefit,"The study shows that 5 g of oat beta-glucans significantly improved lipid and glucose metabolism, indicating a beneficial effect.",5 g daily 5 weeks (beverage),,,hypercholesterolemia,cholesterol levels; hypercholesterolemia; metabolic syndrome; myasthenia gravis,Tier 2,0.62,"Randomized, single-blind, controlled trial in hypercholesterolemic adults with lipid outcomes as primary endpoints. A daily 5 g oat beta-glucan beverage significantly lowered total cholesterol (~7.4%). However, LDL-specific changes were not reported in the abstract, making the evidence for the specific indication of high LDL indirect, though closely related. Sample size and methods are moderate quality."
Beta-Glucans,,High Triglycerides,,Heart & Vascular Health,manual_pair,"There is limited evidence suggesting that beta-glucans may reduce triglyceride levels, as indicated by one study that reported significant reductions in triglycerides with a dose of 3.6 g/d from baked products over one month. However, the overall evidence is sparse, and further research is needed to confirm these findings and assess the consistency of the effects.",0.7,23529988,2012,"Effects of baked products enriched with n-3 fatty acids, folates, β-glucans, and tocopherol in patients with mild mixed hyperlipidemia.",randomized_controlled_trial,benefit,"The study shows significant reductions in triglycerides and homocysteine, indicating a beneficial effect on cardiovascular risk factors.",3.6 g/d 1 month (baked products),,Metabolic Health; Weight & Body Composition,cardiovascular risk,cardiovascular risk; mild mixed hyperlipidemia,Tier 4,0.38,"Randomized crossover human study shows reduced triglycerides, but the intervention combined beta-glucans with omega-3 fatty acids, folate, and tocopherols. Effects cannot be attributed to beta-glucans alone. Small sample (n=16) and short duration (1 month) further limit attribution. Thus, evidence for beta-glucans specifically on high triglycerides is indirect/very low."
Beta-Glucans,,Increase COVID Vaccine Efficacy,,"Immune, Inflammation, & Infection",manual_pair,"One randomized, double-blind, placebo-controlled study found that a yeast-based supplement containing beta-glucans, along with selenium and zinc, increased immune cell levels and antibody responses in volunteers receiving the influenza vaccine. No adverse effects were reported, but the overall evidence is limited to this single study, indicating a need for further research to confirm these findings.",0.7,34959898,2021,"Effect and Tolerability of a Nutritional Supplement Based on a Synergistic Combination of β-Glucans and Selenium- and Zinc-Enriched Saccharomyces cerevisiae (ABB C1®) in Volunteers Receiving the Influenza or the COVID-19 Vaccine: A Randomized, Double-Blind, Placebo-Controlled Study.",randomized_controlled_trial,benefit,"The study shows an increase in immune cell levels and antibody responses, indicating a beneficial effect of the supplement.",30 and 35 days (yeast-based supplement),,,influenza,influenza,Tier 3,0.45,"Double-blind RCT with small sample size assessed immunological surrogates (antibody levels, immune cell changes) rather than clinical protection. The product was a multi-ingredient yeast-based blend (β-glucans plus selenium- and zinc-enriched S. cerevisiae, possibly other components), making the evidence indirect for beta-glucans specifically. COVID-19 vaccine recipients were only part of the cohort. Thus, preliminary human evidence with surrogate outcomes and formulation confounding."
Betaine,bad taste; diarrhea; headache; higher doses could be harmful in pnrCBS deficiency with pre-existing hypermethioninemia; interstitial lung disease; nausea,Exercise Recovery,,Performance & Recovery,manual_pair,"One randomized trial indicates that betaine supplementation (1.25 g twice daily for 2 weeks) may enhance anabolic endocrine signaling and hormonal measures in response to exercise, suggesting a potential benefit for protein synthesis. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term effects and safety.",0.7,22976217,2013,Betaine supplementation enhances anabolic endocrine and Akt signaling in response to acute bouts of exercise.,randomized_controlled_trial,benefit,"The study shows that betaine supplementation enhances anabolic signaling and hormonal measures, indicating a beneficial effect on protein synthesis.",1.25 g BID 2 weeks,,,anabolic endocrine profile,anabolic endocrine profile,Tier 3,0.4,"Single small crossover RCT (n=12) measured hormonal and muscle signaling markers after supplementation, not direct recovery outcomes (e.g., soreness, strength/performance restoration, muscle damage). While human and controlled, the evidence is based on surrogate mechanistic endpoints, making it weak/preliminary for exercise recovery."
Betaine,bad taste; diarrhea; headache; higher doses could be harmful in pnrCBS deficiency with pre-existing hypermethioninemia; interstitial lung disease; nausea,Breast Fibroadenoma,,Women's Health,manual_pair,"There is limited evidence from a single randomized trial indicating that betaine may contribute to a significant reduction in the volume of breast fibroadenomas when used in combination with other agents. No adverse effects were reported in this study, but further research is needed to confirm these findings and establish the efficacy of betaine alone for this indication.",0.7,27212181,2016,A randomized trial of Boswellia in association with betaine and myo-inositol in the management of breast fibroadenomas.,randomized_controlled_trial,benefit,The study shows a significant clinical improvement in fibroadenoma volume reduction with the treatment including betaine.,6 months,Women,,breast fibroadenoma,breast fibroadenoma,Tier 4,0.4,"Although this is a randomized controlled trial showing reduced fibroadenoma volume, betaine was part of a multi-ingredient intervention (with Boswellia and myo-inositol) versus a comparator that lacked these three actives. The effect cannot be attributed specifically to betaine, making the evidence indirect for betaine alone despite a clinically relevant outcome."
Betaine,bad taste; diarrhea; headache; higher doses could be harmful in pnrCBS deficiency with pre-existing hypermethioninemia; interstitial lung disease; nausea,Burn Wounds,,"Skin, Hair, & Nails",manual_pair,"One randomized controlled trial indicated that a polyhexanide/betaine gel formulation resulted in significantly less pain compared to silver sulfadiazine in the treatment of partial-thickness burns. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess the consistency of the results across different populations and formulations.",0.7,28682677,2017,Randomized Controlled Trial of Polyhexanide/Betaine Gel Versus Silver Sulfadiazine for Partial-Thickness Burn Treatment.,randomized_controlled_trial,benefit,"The polyhexanide/betaine gel group showed significantly less pain compared to silver sulfadiazine, indicating a benefit in pain management.",17.8 ± 2.2 days (polyhexanide/betaine gel),,,partial-thickness burns,partial-thickness burns,Tier 2,0.52,"Single small RCT in adults with partial-thickness burns compared a polyhexanide/betaine gel to silver sulfadiazine. It found significantly less pain with the betaine-containing gel but no difference in healing time, infection, or colonization. As an RCT with clinically relevant outcomes but modest size and a combination product (betaine not isolated), this supports moderate human evidence for burn-wound management (particularly pain), not definitive effects on healing."
Betaine,bad taste; diarrhea; headache; higher doses could be harmful in pnrCBS deficiency with pre-existing hypermethioninemia; interstitial lung disease; nausea,Hepatitis C,,"Immune, Inflammation, & Infection",manual_pair,"One randomized trial indicates that betaine may improve early virological response in patients with chronic hepatitis C when added to treatment, although the evidence is limited and further studies are needed to confirm these findings. The doses used in the study were for 6 or 12 months, but no adverse effects were reported. Overall, the evidence is not robust and should be interpreted with caution.",0.7,21079746,2010,S-adenosyl-methionine and betaine improve early virological response in chronic hepatitis C patients with previous nonresponse.,randomized_controlled_trial,benefit,The study shows that the addition of betaine improves early virological response in patients with chronic hepatitis C.,6 or 12 months,,,chronic hepatitis c,chronic hepatitis c,Tier 3,0.39,"Single small open-label, uncontrolled pilot study in chronic hepatitis C nonresponders showed improved early virological response when betaine was added alongside S-adenosyl-methionine to standard pegIFNα/ribavirin. The outcome is a surrogate (EVR), sustained response was low, and the co-administration with SAMe prevents attribution to betaine alone. Thus, preliminary human evidence but weak and indirect for betaine specifically."
Betaine,bad taste; diarrhea; headache; higher doses could be harmful in pnrCBS deficiency with pre-existing hypermethioninemia; interstitial lung disease; nausea,Dry Mouth,,Oral Health,manual_pair,"One randomized trial reported that a betaine-containing mouthwash improved symptoms of dry mouth after 4 weeks of use. However, the overall evidence is limited, with only one study demonstrating benefit and no reports of harm or adverse effects. Further research is needed to confirm these findings and establish the efficacy of betaine for this indication.",0.7,21950587,2012,Evaluation of the clinical efficacy of a betaine-containing mouthwash and an intraoral device for the treatment of dry mouth.,randomized_controlled_trial,benefit,The study showed improvement in xerostomia symptoms with the use of the betaine-containing mouthwash.,4 weeks (mouthwash),,,dry mouth,dry mouth; xerostomia,Tier 2,0.63,"Randomized controlled trial directly testing a betaine-containing mouthwash for xerostomia with clinically relevant outcomes (symptom questionnaire, OHIP-14, salivary flow). However, it was non-blinded with subjective primary outcomes, short duration (4 weeks), and modest per-arm sample size (~30), with improvements reported across all groups and unclear superiority of the mouthwash. Thus, moderate but not strong human evidence."
Betaine,bad taste; diarrhea; headache; higher doses could be harmful in pnrCBS deficiency with pre-existing hypermethioninemia; interstitial lung disease; nausea,Weight Loss,,Weight & Body Composition,manual_pair,"One randomized controlled trial reported that betaine supplementation (2.5 g daily for 8 weeks) resulted in significant reductions in fat mass and improvements in body composition among collegiate females. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term effects and safety.",0.7,30064450,2018,"The effects of chronic betaine supplementation on body composition and performance in collegiate females: a double-blind, randomized, placebo controlled trial.",randomized_controlled_trial,benefit,Betaine supplementation showed significant benefits in reducing fat mass and improving body composition metrics.,2.5 g daily 8 weeks,Women,Performance & Recovery,body composition,body composition; muscular performance,Tier 2,0.66,"Double-blind, randomized, placebo-controlled human trial in women (n=23) with 8-week follow-up showed significantly greater reductions in fat mass and body fat percentage with betaine versus placebo during resistance training. Methods are sound but sample size is small, duration short, and population specific; outcomes were body composition rather than total body weight. Thus, moderate human evidence for weight loss-related outcomes."
Betaine,bad taste; diarrhea; headache; higher doses could be harmful in pnrCBS deficiency with pre-existing hypermethioninemia; interstitial lung disease; nausea,Exercise Induced Inflammation,,Performance & Recovery,manual_pair,"The evidence regarding betaine supplementation for exercise-associated lactate concentrations is low quality, with one study reporting mixed results. In this study, which administered 6 g of betaine daily for 14 days, no significant differences in exercise performance were observed, although some metabolic markers showed changes. Overall, the findings do not support a clear benefit of betaine for this indication.",0.7,36501070,2022,"The Impacts of Combined Blood Flow Restriction Training and Betaine Supplementation on One-Leg Press Muscular Endurance, Exercise-Associated Lactate Concentrations, Serum Metabolic Biomarkers, and Hypoxia-Inducible Factor-1α Gene Expression.",randomized_controlled_trial,mixed_unclear,"The study found no significant differences in total repetitions completed, but some metabolic markers were affected, indicating mixed results.",6 g daily 14 days (anhydrous),,,exercise-associated lactate concentrations,exercise-associated lactate concentrations,Tier 5,0.86,"This RCT assessed performance and metabolic/hormonal markers (lactate, IGF-1, GH, homocysteine) under BFR and high-load conditions with betaine, but did not measure inflammatory outcomes or symptoms related to exercise-induced inflammation. Therefore, it does not provide direct evidence for this indication."
Betaine,bad taste; diarrhea; headache; higher doses could be harmful in pnrCBS deficiency with pre-existing hypermethioninemia; interstitial lung disease; nausea,Fatty Liver Disease,,Gut Health,manual_pair,"The evidence for betaine in the treatment of fatty liver disease is limited and mixed, based on one study that reported a decrease in hepatic fat without significant improvements in inflammatory or lesion markers. The study utilized a dose of 10 g (anhydrous) divided over three months. Overall, the findings do not support a clear benefit for this indication.",0.7,24972476,2014,Betaine: a potential agent for the treatment of hepatopathy associated with short bowel syndrome.,clinical_trial,mixed_unclear,"Betaine showed a decrease in hepatic fat but no significant reduction in inflammatory markers or hepatic lesion markers, indicating mixed results.",10 g divided doses three months (anhydrous),Short Bowel Syndrome,,hepatopathy associated with short bowel syndrome,hepatopathy associated with short bowel syndrome,Tier 3,0.5,"Prospective but non-randomized, uncontrolled clinical trial in a small SBS cohort assessing surrogate imaging (NMR hepatic fat) with mixed results. Shows reduction in hepatic fat but no improvement in inflammatory or liver injury markers. Population (SBS-associated hepatopathy) is related but not the typical NAFLD/MAFLD context, making applicability somewhat indirect."
Betaine,bad taste; diarrhea; headache; higher doses could be harmful in pnrCBS deficiency with pre-existing hypermethioninemia; interstitial lung disease; nausea,High Blood Glucose,,Metabolic Health,manual_pair,"The evidence regarding betaine supplementation for high blood sugar in prediabetes is mixed and unclear, based on one randomized clinical trial that reported limited metabolic effects, including potential reductions in fasting glucose and insulin area under the curve at doses of 3300 mg twice daily for 10 days and 4950 mg twice daily for 12 weeks. No consistent benefits were observed, and no studies reported harm or no benefit.",0.7,29860335,2018,Metabolic Effects of Betaine: A Randomized Clinical Trial of Betaine Supplementation in Prediabetes.,randomized_controlled_trial,mixed_unclear,"Betaine showed some potential to reduce fasting glucose and insulin area under curve, but overall metabolic effects were limited, indicating mixed outcomes.",3300 mg twice daily 10 days (oral); 4950 mg twice daily 12 weeks (oral),,,obesity,obesity; prediabetes,Tier 2,0.66,"Randomized, double-masked, placebo-controlled human trial with glycemia as a primary outcome, but small sample size (N=27) and mixed results (trend toward lower fasting glucose, reduced insulin AUC, no improvement in insulin sensitivity). This supports moderate human evidence rather than strong."
Betaine,bad taste; diarrhea; headache; higher doses could be harmful in pnrCBS deficiency with pre-existing hypermethioninemia; interstitial lung disease; nausea,High Homocysteine,,Heart & Vascular Health,manual_pair,"The evidence for betaine supplementation in lowering high homocysteine levels is predominantly positive, with five studies reporting benefits and two showing mixed outcomes. Typical doses reported include 1 g daily and lower doses of 0.5 g to 3 g, but variability in individual responses and nutritional status may influence efficacy. No studies reported harm associated with betaine supplementation.",0.85,32918135,2021,Betaine and choline status modify the effects of folic acid and creatine supplementation on arsenic methylation in a randomized controlled trial of Bangladeshi adults.,randomized_controlled_trial,mixed_unclear,"The study shows mixed effects of betaine status on the efficacy of folic acid and creatine supplementation, indicating variability in outcomes based on nutritional status.",400 or 800 μg daily 12 weeks (folic acid); 3 g daily 12 weeks (creatine),,,arsenic methylation,arsenic methylation; atherosclerosis; choline deficiency; cobalamin c deficiency; cystathionine beta-synthase deficiency; homocysteine concentration; homocysteine levels; hyperhomocysteinemia,Tier 5,0.9,"This RCT did not test betaine supplementation; it examined how baseline betaine status modified responses to folic acid and creatine on arsenic methylation. The reported homocysteine reduction was with folic acid, not betaine. Therefore, it provides no direct evidence for betaine as a treatment for high homocysteine."
Betaine,bad taste; diarrhea; headache; higher doses could be harmful in pnrCBS deficiency with pre-existing hypermethioninemia; interstitial lung disease; nausea,High Homocysteine,,Heart & Vascular Health,manual_pair,"The evidence for betaine supplementation in lowering high homocysteine levels is predominantly positive, with five studies reporting benefits and two showing mixed outcomes. Typical doses reported include 1 g daily and lower doses of 0.5 g to 3 g, but variability in individual responses and nutritional status may influence efficacy. No studies reported harm associated with betaine supplementation.",0.85,26771632,2016,"Effect of Folic Acid, Betaine, Vitamin B₆, and Vitamin B12 on Homocysteine and Dimethylglycine Levels in Middle-Aged Men Drinking White Wine.",randomized_controlled_trial,benefit,"The study found that betaine supplementation significantly lowered homocysteine levels, indicating a benefit.",375 mL daily one month (white wine),,,atherosclerosis,arsenic methylation; atherosclerosis; choline deficiency; cobalamin c deficiency; cystathionine beta-synthase deficiency; homocysteine concentration; homocysteine levels; hyperhomocysteinemia,Tier 2,0.64,"Randomized controlled trial with multiple arms (n=117 total) found betaine significantly lowered homocysteine compared with wine-only control, targeting the indication directly. However, per-arm size was small, blinding/placebo control and methods are not clearly robust, duration was only one month, and the alcohol co-exposure limits generalizability. Thus moderate, not strong, human evidence."
Betaine,bad taste; diarrhea; headache; higher doses could be harmful in pnrCBS deficiency with pre-existing hypermethioninemia; interstitial lung disease; nausea,High Homocysteine,,Heart & Vascular Health,manual_pair,"The evidence for betaine supplementation in lowering high homocysteine levels is predominantly positive, with five studies reporting benefits and two showing mixed outcomes. Typical doses reported include 1 g daily and lower doses of 0.5 g to 3 g, but variability in individual responses and nutritional status may influence efficacy. No studies reported harm associated with betaine supplementation.",0.85,36376887,2022,Efficacy and pharmacokinetics of betaine in CBS and cblC deficiencies: a cross-over randomized controlled trial.,randomized_controlled_trial,mixed_unclear,"The study shows no benefit in lowering tHcy with higher doses in pnrCBS, but potential benefits in cblC patients, indicating mixed outcomes.",100 mg/kg/day one month (oral); 250 mg/kg/day one month (oral),,,cobalamin c deficiency,arsenic methylation; atherosclerosis; choline deficiency; cobalamin c deficiency; cystathionine beta-synthase deficiency; homocysteine concentration; homocysteine levels; hyperhomocysteinemia,Tier 2,0.6,"Randomized, crossover, blinded evaluation trial directly measured total homocysteine (the target condition) while comparing two betaine doses. It found no additional tHcy-lowering with 250 vs 100 mg/kg/day. However, the study is small (n=11), lacks a placebo/no-treatment comparator, and is limited to rare genetic hyperhomocysteinemia (pnrCBS, cblC) with mixed subgroup implications, reducing generalizability and overall evidentiary strength."
Betaine,bad taste; diarrhea; headache; higher doses could be harmful in pnrCBS deficiency with pre-existing hypermethioninemia; interstitial lung disease; nausea,High Homocysteine,,Heart & Vascular Health,manual_pair,"The evidence for betaine supplementation in lowering high homocysteine levels is predominantly positive, with five studies reporting benefits and two showing mixed outcomes. Typical doses reported include 1 g daily and lower doses of 0.5 g to 3 g, but variability in individual responses and nutritional status may influence efficacy. No studies reported harm associated with betaine supplementation.",0.85,38876040,2024,"Betaine supplementation modulates betaine concentration by methylenetetrahydrofolate reductase genotype, but has no effect on amino acid profile in healthy active males: A randomized placebo-controlled cross-over study.",randomized_controlled_trial,benefit,"Betaine supplementation decreased homocysteine concentrations, indicating a beneficial effect on this health outcome.",(Betaine),,,homocysteine concentration,arsenic methylation; atherosclerosis; choline deficiency; cobalamin c deficiency; cystathionine beta-synthase deficiency; homocysteine concentration; homocysteine levels; hyperhomocysteinemia,Tier 2,0.62,"Randomized, placebo-controlled cross-over trial in humans showed a significant reduction in homocysteine with betaine. However, the study was relatively small, conducted in healthy active males, and homocysteine reduction appeared as a secondary outcome rather than the primary focus. Thus, evidence is moderate for the specific indication of lowering high homocysteine."
Betaine,bad taste; diarrhea; headache; higher doses could be harmful in pnrCBS deficiency with pre-existing hypermethioninemia; interstitial lung disease; nausea,High Homocysteine,,Heart & Vascular Health,manual_pair,"The evidence for betaine supplementation in lowering high homocysteine levels is predominantly positive, with five studies reporting benefits and two showing mixed outcomes. Typical doses reported include 1 g daily and lower doses of 0.5 g to 3 g, but variability in individual responses and nutritional status may influence efficacy. No studies reported harm associated with betaine supplementation.",0.85,19346114,2009,Dietary and supplementary betaine: effects on betaine and homocysteine concentrations in males.,randomized_controlled_trial,benefit,"The study shows that both dietary and supplemental betaine increase plasma betaine concentrations and reduce post-methionine load homocysteine levels, indicating a beneficial effect.",0.5 g twice daily 14 days (supplement); 800 mg daily 14 days (diet),,,homocysteine levels,arsenic methylation; atherosclerosis; choline deficiency; cobalamin c deficiency; cystathionine beta-synthase deficiency; homocysteine concentration; homocysteine levels; hyperhomocysteinemia,Tier 3,0.55,"Randomized crossover trial (n=8) in healthy males over 14 days. While betaine reduced post–methionine-load homocysteine (a surrogate), it minimally affected fasting homocysteine and did not study individuals with high baseline homocysteine. Small sample, short duration, and surrogate outcome make this preliminary human evidence for the indication."
Betaine,bad taste; diarrhea; headache; higher doses could be harmful in pnrCBS deficiency with pre-existing hypermethioninemia; interstitial lung disease; nausea,High Homocysteine,,Heart & Vascular Health,manual_pair,"The evidence for betaine supplementation in lowering high homocysteine levels is predominantly positive, with five studies reporting benefits and two showing mixed outcomes. Typical doses reported include 1 g daily and lower doses of 0.5 g to 3 g, but variability in individual responses and nutritional status may influence efficacy. No studies reported harm associated with betaine supplementation.",0.85,36717385,2023,"Effects of low-dose B vitamins plus betaine supplementation on lowering homocysteine concentrations among Chinese adults with hyperhomocysteinemia: a randomized, double-blind, controlled preliminary clinical trial.",randomized_controlled_trial,benefit,"The study showed a significant reduction in plasma homocysteine concentrations, indicating a beneficial effect of the supplementation.",1 g daily 12 weeks (Betaine),,,hyperhomocysteinemia,arsenic methylation; atherosclerosis; choline deficiency; cobalamin c deficiency; cystathionine beta-synthase deficiency; homocysteine concentration; homocysteine levels; hyperhomocysteinemia,Tier 2,0.62,"Randomized, double-blind controlled trial in adults with hyperhomocysteinemia showing significant homocysteine reduction, a primary and clinically relevant outcome. However, betaine was given alongside low-dose B vitamins, so the effect cannot be attributed to betaine alone, lowering certainty for betaine monotherapy."
Betaine,bad taste; diarrhea; headache; higher doses could be harmful in pnrCBS deficiency with pre-existing hypermethioninemia; interstitial lung disease; nausea,High LDL,,Heart & Vascular Health,manual_pair,"One study indicates that betaine, consumed at a dose of 27 g daily from aleurone-rich cereal products for 4 weeks, may lead to a modest decrease in LDL cholesterol levels. However, the evidence is limited to a single trial, and further research is needed to confirm these findings and assess long-term effects and safety.",0.7,20980654,2010,Consumption of wheat aleurone-rich foods increases fasting plasma betaine and modestly decreases fasting homocysteine and LDL-cholesterol in adults.,randomized_controlled_trial,benefit,"The study shows a significant increase in plasma betaine and a decrease in homocysteine and LDL cholesterol, indicating a beneficial effect.",27 g daily 4 weeks (aleurone-rich cereal products),,,heart disease,heart disease; high homocysteine; high ldl cholesterol,,,
Betaine,bad taste; diarrhea; headache; higher doses could be harmful in pnrCBS deficiency with pre-existing hypermethioninemia; interstitial lung disease; nausea,Strength,,Performance & Recovery,manual_pair,"Clinical evidence from four randomized trials indicates that betaine supplementation may improve exercise performance in various contexts, with typical doses reported around 2.0 to 2.5 g daily. No studies reported harm or no benefit, suggesting a consistent positive effect; however, the overall quality and generalizability of the evidence may vary. Further research is needed to confirm these findings across broader populations and exercise modalities.",0.9,34663363,2021,"Effects of chronic betaine supplementation on performance in professional young soccer players during a competitive season: a double blind, randomized, placebo-controlled trial.",randomized_controlled_trial,benefit,"The study shows significant improvements in various performance metrics, indicating a benefit from betaine supplementation.",2 g daily 14 weeks,Soccer Players,,aerobic capacity,aerobic capacity; anaerobic performance enhancement; athletic performance; body composition improvement; crossfit performance; exercise performance; muscle strength; muscular endurance; muscular strength; testosterone levels,Tier 2,0.7,"Double-blind, randomized, placebo-controlled trial in young professional athletes found significant improvements in predicted 1-RM (strength) with 2 g/day betaine over 14 weeks. However, the sample size was small, strength was one of several outcomes rather than a singular primary endpoint, and strength was estimated (predicted 1-RM), with adolescent athletes limiting generalizability."
Betaine,bad taste; diarrhea; headache; higher doses could be harmful in pnrCBS deficiency with pre-existing hypermethioninemia; interstitial lung disease; nausea,Strength,,Performance & Recovery,manual_pair,"Clinical evidence from four randomized trials indicates that betaine supplementation may improve exercise performance in various contexts, with typical doses reported around 2.0 to 2.5 g daily. No studies reported harm or no benefit, suggesting a consistent positive effect; however, the overall quality and generalizability of the evidence may vary. Further research is needed to confirm these findings across broader populations and exercise modalities.",0.9,34477469,2023,"Effects of Betaine Supplementation on Markers of Metabolic Flexibility, Body Composition, and Anaerobic Performance in Active College-Age Females.",randomized_controlled_trial,benefit,"The study shows significant improvements in body composition and performance metrics for the Betaine group, indicating a beneficial effect.",2.4 g daily 2 weeks,Women,,anaerobic performance enhancement,aerobic capacity; anaerobic performance enhancement; athletic performance; body composition improvement; crossfit performance; exercise performance; muscle strength; muscular endurance; muscular strength; testosterone levels,Tier 3,0.46,"This is a small, short-duration randomized controlled trial in active college-age women (n≈23, 2 weeks) assessing anaerobic cycling performance and body composition. While it reports performance benefits, it did not directly measure muscular strength (e.g., 1RM), making the outcomes indirect for the indication of strength. Thus, evidence is preliminary/indirect despite RCT design."
Betaine,bad taste; diarrhea; headache; higher doses could be harmful in pnrCBS deficiency with pre-existing hypermethioninemia; interstitial lung disease; nausea,Strength,,Performance & Recovery,manual_pair,"Clinical evidence from four randomized trials indicates that betaine supplementation may improve exercise performance in various contexts, with typical doses reported around 2.0 to 2.5 g daily. No studies reported harm or no benefit, suggesting a consistent positive effect; however, the overall quality and generalizability of the evidence may vary. Further research is needed to confirm these findings across broader populations and exercise modalities.",0.9,37409757,2023,"Betaine supplementation improves CrossFit performance and increases testosterone levels, but has no influence on Wingate power: randomized crossover trial.",randomized_controlled_trial,benefit,"The study showed improvement in CrossFit performance and increased testosterone levels with betaine supplementation, indicating a benefit.",2.5 g daily 3 weeks (supplement); 5.0 g daily 3 weeks (supplement),CrossFit Athletes,,crossfit performance,aerobic capacity; anaerobic performance enhancement; athletic performance; body composition improvement; crossfit performance; exercise performance; muscle strength; muscular endurance; muscular strength; testosterone levels,,,
Betaine,bad taste; diarrhea; headache; higher doses could be harmful in pnrCBS deficiency with pre-existing hypermethioninemia; interstitial lung disease; nausea,Strength,,Performance & Recovery,manual_pair,"Clinical evidence from four randomized trials indicates that betaine supplementation may improve exercise performance in various contexts, with typical doses reported around 2.0 to 2.5 g daily. No studies reported harm or no benefit, suggesting a consistent positive effect; however, the overall quality and generalizability of the evidence may vary. Further research is needed to confirm these findings across broader populations and exercise modalities.",0.9,22080324,2011,"The effects of chronic betaine supplementation on exercise performance, skeletal muscle oxygen saturation and associated biochemical parameters in resistance trained men.",randomized_controlled_trial,benefit,"The study found a moderate increase in total repetitions and volume load in the bench press exercise with betaine supplementation, indicating a benefit in exercise performance.",2.5 g daily 14 days (mixed in 500 ml of Gatorade®),Men,,exercise performance,aerobic capacity; anaerobic performance enhancement; athletic performance; body composition improvement; crossfit performance; exercise performance; muscle strength; muscular endurance; muscular strength; testosterone levels,,,
Betaine,bad taste; diarrhea; headache; higher doses could be harmful in pnrCBS deficiency with pre-existing hypermethioninemia; interstitial lung disease; nausea,Muscle Endurance,,Performance & Recovery,manual_pair,"Current evidence on betaine for muscle fatigue is limited and mixed. One study reported that while betaine did not enhance force outputs during exercise, it was associated with a reduction in subjective fatigue. Overall, the findings do not support a clear benefit for this indication.",0.7,21747291,2011,Effect of 15 days of betaine ingestion on concentric and eccentric force outputs during isokinetic exercise.,randomized_controlled_trial,mixed_unclear,"While betaine did not increase force outputs, it reduced subjective fatigue, indicating mixed outcomes.",null null daily 15 days (liquid),,,muscle fatigue,muscle fatigue; muscle strength,Tier 3,0.42,"Small randomized, placebo-controlled crossover trial (n=11) over 15 days. Primary outcomes were strength (peak concentric/eccentric force), not endurance, and showed no improvement. The only relevant finding for muscle endurance was reduced subjective fatigue (a surrogate, secondary outcome). Short duration, small sample, and indirect endpoint make the evidence weak/preliminary for muscle endurance."
Betaine,bad taste; diarrhea; headache; higher doses could be harmful in pnrCBS deficiency with pre-existing hypermethioninemia; interstitial lung disease; nausea,Strength,,Performance & Recovery,manual_pair,"Current evidence on betaine supplementation for muscle hypertrophy is limited and mixed, with one study indicating no significant differences in muscle hypertrophy despite some strength improvements in the betaine group. The findings suggest that betaine may not reliably enhance muscle hypertrophy outcomes. No adverse effects were reported in the reviewed study, but the overall quality of evidence remains low.",0.6,32516959,2020,Betaine Supplementation Does Not Improve Muscle Hypertrophy or Strength Following 6 Weeks of Cross-Fit Training.,randomized_controlled_trial,mixed_unclear,"While muscle strength increased in the betaine group, there were no significant differences between groups, indicating mixed results.",6 weeks,CrossFit Athletes,,muscle hypertrophy,muscle hypertrophy,,,
Betaine,bad taste; diarrhea; headache; higher doses could be harmful in pnrCBS deficiency with pre-existing hypermethioninemia; interstitial lung disease; nausea,Muscle Growth,,Performance & Recovery,manual_pair,"Current evidence on betaine supplementation for muscle strength is limited and mixed. One study indicated that while muscle strength increased in the betaine group, there were no significant differences compared to the control group, suggesting unclear benefits. No adverse effects were reported, but overall, the evidence does not support a definitive conclusion regarding its efficacy for this indication.",0.6,32516959,2020,Betaine Supplementation Does Not Improve Muscle Hypertrophy or Strength Following 6 Weeks of Cross-Fit Training.,randomized_controlled_trial,mixed_unclear,"While muscle strength increased in the betaine group, there were no significant differences between groups, indicating mixed results.",6 weeks,CrossFit Athletes,,muscle strength,muscle strength,,,
Betaine,bad taste; diarrhea; headache; higher doses could be harmful in pnrCBS deficiency with pre-existing hypermethioninemia; interstitial lung disease; nausea,Muscle Endurance,,Performance & Recovery,manual_pair,"Current evidence on betaine supplementation for muscular endurance is limited and mixed. One study reported no significant improvement in total repetitions completed during exercise, although some metabolic markers showed changes. The typical dose reported was 6 g of betaine anhydrous daily for 14 days, but overall findings do not support a clear benefit for muscular endurance.",0.8,36501070,2022,"The Impacts of Combined Blood Flow Restriction Training and Betaine Supplementation on One-Leg Press Muscular Endurance, Exercise-Associated Lactate Concentrations, Serum Metabolic Biomarkers, and Hypoxia-Inducible Factor-1α Gene Expression.",randomized_controlled_trial,mixed_unclear,"The study found no significant differences in total repetitions completed, but some metabolic markers were affected, indicating mixed results.",6 g daily 14 days (anhydrous),,,muscular endurance,muscular endurance,,,
Blueberry anthocyanins,,High Blood Glucose,,Metabolic Health,manual_pair,"One randomized controlled trial found that blueberry anthocyanin intake (26 g of freeze-dried blueberries) significantly improved postprandial glucose, insulin, and cholesterol levels in participants with metabolic syndrome, suggesting a potential benefit for high blood sugar management. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term effects.",0.7,34883305,2022,"Blueberry anthocyanin intake attenuates the postprandial cardiometabolic effect of an energy-dense food challenge: Results from a double blind, randomized controlled trial in metabolic syndrome participants.",randomized_controlled_trial,benefit,"The study shows that blueberry intake significantly improves postprandial glucose, insulin, and cholesterol levels in participants with metabolic syndrome, indicating a beneficial effect.",26 g (freeze-dried blueberries),,,metabolic syndrome,metabolic syndrome,,,
Boron,"abdominal disturbances; acute radiation injury; adverse effects noted; alopecia; application-site reactions of general irritation, erythema, scaling, stinging/burning; carotid hemorrhage; contact pain; dermatitis; dysphagia; dysuria; erythema; exfoliation; fatigue; grade 3 adverse event at 450 mg/kg; grade 3 cranial neuropathy; grade 3 mucositis; grade 4 laryngeal edema; hyperamylasemia; increase in peritumoral edema; local pain; mild alopecia; moderate skin erosion; mucositis; nausea; neurological deterioration; oral pain; osteoradionecrosis; outcome variability among studies; seizures; severe skin damage requiring skin grafts; skin damage exceeding tolerance level; skin/mucous problems; soft-tissue necrosis; thromboembolism; transient asymptomatic increase in serum amylase level; visual problems worsened after repetitive BNCT; xerostomia",Diabetic Foot Ulcers,,"Skin, Hair, & Nails",manual_pair,"One randomized controlled trial reported a significant benefit of a boron-based gel (3% topical sodium pentaborate) applied twice daily for one month in the treatment of diabetic foot ulcers, showing lower ulcer grades and prevention of recurrence. However, the overall evidence is limited to this single study, and further research is needed to confirm these findings and assess long-term effects and safety.",0.7,37421808,2023,"The effect of the boron-based gel on the treatment of diabetic foot ulcers: A prospective, randomized controlled trial.",randomized_controlled_trial,benefit,"The study shows a significant benefit in treating diabetic foot ulcers with the boron-based gel, as evidenced by lower ulcer grades and prevention of recurrence.",3 % twice a day one month (topical sodium pentaborate gel),Diabetes,,diabetic foot ulcers,diabetic foot ulcers,,,
Boron,"abdominal disturbances; acute radiation injury; adverse effects noted; alopecia; application-site reactions of general irritation, erythema, scaling, stinging/burning; carotid hemorrhage; contact pain; dermatitis; dysphagia; dysuria; erythema; exfoliation; fatigue; grade 3 adverse event at 450 mg/kg; grade 3 cranial neuropathy; grade 3 mucositis; grade 4 laryngeal edema; hyperamylasemia; increase in peritumoral edema; local pain; mild alopecia; moderate skin erosion; mucositis; nausea; neurological deterioration; oral pain; osteoradionecrosis; outcome variability among studies; seizures; severe skin damage requiring skin grafts; skin damage exceeding tolerance level; skin/mucous problems; soft-tissue necrosis; thromboembolism; transient asymptomatic increase in serum amylase level; visual problems worsened after repetitive BNCT; xerostomia",Onychomycosis,,"Immune, Inflammation, & Infection",manual_pair,"There is limited evidence supporting the use of boron-based agents, specifically tavaborole, for the treatment of fungal nail infections (onychomycosis). A phase 2 study indicated a benefit with doses of 1.0%, 2.5%, 5.0%, and 7.5% topical solutions applied once daily or three times weekly over 180 days. However, further studies are needed to confirm these findings and assess long-term efficacy and safety.",0.8,25226015,2014,"The efficacy and safety of tavaborole, a novel, boron-based pharmaceutical agent: phase 2 studies conducted for the topical treatment of toenail onychomycosis.",randomized_controlled_trial,benefit,"The study demonstrated favorable efficacy and safety for tavaborole in treating toenail onychomycosis, indicating a benefit.",1.0 % once daily or three times weekly 180 days (topical solution); 2.5 % once daily or three times weekly 180 days (topical solution); 5.0 % once daily or three times weekly 180 days (topical solution); 7.5 % once daily or three times weekly 180 days (topical solution); 5.0 % once daily 360 days (topical solution),,,onychomycosis,onychomycosis,,,
Boron,"abdominal disturbances; acute radiation injury; adverse effects noted; alopecia; application-site reactions of general irritation, erythema, scaling, stinging/burning; carotid hemorrhage; contact pain; dermatitis; dysphagia; dysuria; erythema; exfoliation; fatigue; grade 3 adverse event at 450 mg/kg; grade 3 cranial neuropathy; grade 3 mucositis; grade 4 laryngeal edema; hyperamylasemia; increase in peritumoral edema; local pain; mild alopecia; moderate skin erosion; mucositis; nausea; neurological deterioration; oral pain; osteoradionecrosis; outcome variability among studies; seizures; severe skin damage requiring skin grafts; skin damage exceeding tolerance level; skin/mucous problems; soft-tissue necrosis; thromboembolism; transient asymptomatic increase in serum amylase level; visual problems worsened after repetitive BNCT; xerostomia",Menstrual Pain,,Women's Health,manual_pair,"One randomized trial reported that boron supplementation (10 mg daily) significantly reduced the severity and duration of pain in primary dysmenorrhea. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term safety and efficacy.",0.7,25906949,2015,Effects of boron supplementation on the severity and duration of pain in primary dysmenorrhea.,randomized_controlled_trial,benefit,"The study showed significant reduction in pain severity and duration in the case group, indicating a beneficial effect of Boron supplementation on primary dysmenorrhea.",10 mg daily from two days before the menstrual flow until its third day (capsules),Dysmenorrhea; Women,,primary dysmenorrhea,primary dysmenorrhea,Tier 1,0.74,"Triple-blind, randomized, placebo-controlled trial (n=113) in women with primary dysmenorrhea showed significant reductions in pain severity and duration with 10 mg/day boron; outcomes were primary and clinically relevant. Confidence is tempered by being a single, short-duration study in a student population."
Boron,"abdominal disturbances; acute radiation injury; adverse effects noted; alopecia; application-site reactions of general irritation, erythema, scaling, stinging/burning; carotid hemorrhage; contact pain; dermatitis; dysphagia; dysuria; erythema; exfoliation; fatigue; grade 3 adverse event at 450 mg/kg; grade 3 cranial neuropathy; grade 3 mucositis; grade 4 laryngeal edema; hyperamylasemia; increase in peritumoral edema; local pain; mild alopecia; moderate skin erosion; mucositis; nausea; neurological deterioration; oral pain; osteoradionecrosis; outcome variability among studies; seizures; severe skin damage requiring skin grafts; skin damage exceeding tolerance level; skin/mucous problems; soft-tissue necrosis; thromboembolism; transient asymptomatic increase in serum amylase level; visual problems worsened after repetitive BNCT; xerostomia",COVID-19,,"Immune, Inflammation, & Infection",manual_pair,"One pilot randomized, double-blind clinical trial reported a beneficial effect of boron citrate supplementation (5 mg twice a day) on clinical parameters and symptoms in patients with COVID-19. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess safety and efficacy in larger populations.",0.7,35183882,2022,"Possible therapeutic effects of boron citrate and oleoylethanolamide supplementation in patients with COVID-19: A pilot randomized, double-blind, clinical trial.",randomized_controlled_trial,benefit,"The study showed significant improvements in clinical parameters and symptoms of COVID-19, indicating a beneficial effect of boron citrate supplementation.",5 mg twice a day (boron citrate); 200 mg twice a day (oleoylethanolamide),,,covid-19,covid-19,,,
Boswellia,1.3% reported side effects probably related to the product; NSAID-related adverse effects; adverse events leading to discontinuation; likelihood of contact dermatitis with Boswellia; minor gastrointestinal ADRs; minor gastrointestinal discomfort in 6 patients,Bloating,,Gut Health,manual_pair,"One randomized trial reported beneficial effects of a formulation containing Boswellia serrata extracts on abdominal bloating in subjects with irritable bowel syndrome, using a dose of 500 mg (Curcumin Boswellia Phytosome) twice daily for 30 days. Overall, the evidence is limited to a single study with no reported adverse effects, indicating a need for further research to confirm these findings.",0.7,35276778,2022,Beneficial Effects on Abdominal Bloating with an Innovative Food-Grade Formulation of Curcuma longa and Boswellia serrata Extracts in Subjects with Irritable Bowel Syndrome and Small Bowel Dysbiosis.,randomized_controlled_trial,benefit,"The study showed significant improvement in abdominal bloating and related symptoms, indicating a beneficial effect of the intervention.",500 mg bid 30 days (Curcumin Boswellia Phytosome),IBS,,abdominal bloating,abdominal bloating; irritable bowel syndrome; small bowel dysbiosis,Tier 2,0.58,"Randomized controlled trial in IBS patients with dysbiosis found significant improvement in abdominal bloating over 30 days, with the symptom as a primary outcome. However, the intervention was a combination product (curcumin + Boswellia) rather than Boswellia alone, the sample size was modest (n=67), and blinding is unclear, which limits attribution to Boswellia and lowers methodological strength."
Boswellia,1.3% reported side effects probably related to the product; NSAID-related adverse effects; adverse events leading to discontinuation; likelihood of contact dermatitis with Boswellia; minor gastrointestinal ADRs; minor gastrointestinal discomfort in 6 patients,Crohn's Disease,,Gut Health,manual_pair,"One randomized trial suggests that Boswellia serrata extract H15 may be beneficial in treating active Crohn's disease, showing non-inferiority to mesalazine. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term safety and efficacy.",0.7,11215357,2001,[Therapy of active Crohn disease with Boswellia serrata extract H 15].,randomized_controlled_trial,benefit,"The study shows that Boswellia serrata extract H15 is not inferior to mesalazine, indicating a potential benefit in treating active Crohn's disease.",(H15),,,active crohn's disease,active crohn's disease,,,
Boswellia,1.3% reported side effects probably related to the product; NSAID-related adverse effects; adverse events leading to discontinuation; likelihood of contact dermatitis with Boswellia; minor gastrointestinal ADRs; minor gastrointestinal discomfort in 6 patients,Diarrhea,,Gut Health,manual_pair,"One randomized trial reported a beneficial effect of a lecithin-based delivery form of Boswellia serrata (250 mg for 5 days) in improving recovery time and reducing symptoms in adults with acute diarrhea. However, the overall evidence is limited, with only one study available and no reports of harm or mixed outcomes. Further research is needed to confirm these findings and establish the efficacy of Boswellia for this indication.",0.7,35565826,2022,Positive Effects of a Lecithin-Based Delivery Form of Boswellia serrata Extract in Acute Diarrhea of Adult Subjects.,randomized_controlled_trial,benefit,"The study shows significant improvement in recovery time and reduction in symptoms for acute diarrhea, indicating a beneficial effect of Boswellia serrata.",250 mg 5 days (lecithin-based delivery form),,,acute diarrhea,acute diarrhea,Tier 2,0.7,"Randomized, double-blind, placebo-controlled trial in adults with acute diarrhea showed significant benefit on the primary clinical outcome (time to recovery) and secondary symptoms. However, the sample size was small (n=49) and evidence comes from a single study with a specific lecithin-based Boswellia formulation, so strength is moderate rather than strong."
Boswellia,1.3% reported side effects probably related to the product; NSAID-related adverse effects; adverse events leading to discontinuation; likelihood of contact dermatitis with Boswellia; minor gastrointestinal ADRs; minor gastrointestinal discomfort in 6 patients,Acute Musculoskeletal Pain,,Musculoskeletal & Pain,manual_pair,"One randomized placebo-controlled trial reported that a single dose of a turmeric-boswellia formulation (1000 mg) provided significant pain relief in participants with exercise-induced acute musculoskeletal pain. Overall, the evidence is limited to this single study, and further research is needed to confirm these findings and assess long-term effects and safety.",0.7,36107505,2022,Fast pain relief in exercise-induced acute musculoskeletal pain by turmeric-boswellia formulation: A randomized placebo-controlled double-blinded multicentre study.,randomized_controlled_trial,benefit,"The study demonstrated significant pain relief in participants with exercise-induced acute musculoskeletal pain, indicating a clear benefit from the treatment.",1000 mg single dose single day (turmeric-boswellia formulation in sesame oil),Exercise Induced Pain,,exercise-induced acute musculoskeletal pain,exercise-induced acute musculoskeletal pain,Tier 4,0.66,"Well-designed, adequately powered randomized, double-blind, placebo-controlled trial with primary clinical pain outcomes showed benefit in acute exercise-induced musculoskeletal pain. However, the intervention was a multi-ingredient turmeric–boswellia formulation in sesame oil, not boswellia alone, making the evidence indirect for boswellia specifically."
Boswellia,1.3% reported side effects probably related to the product; NSAID-related adverse effects; adverse events leading to discontinuation; likelihood of contact dermatitis with Boswellia; minor gastrointestinal ADRs; minor gastrointestinal discomfort in 6 patients,Asthma,,Respiratory Health,manual_pair,"One study has reported a beneficial effect of Boswellia (500 mg daily for 4 weeks) on asthma symptoms, specifically noting a decrease in inhalation needs among participants. However, the overall evidence is limited, and further research is needed to confirm these findings and assess long-term safety and efficacy.",0.7,26502867,2015,Functional study on Boswellia phytosome as complementary intervention in asthmatic patients.,randomized_controlled_trial,benefit,"The study shows a decrease in inhalation needs for asthma patients receiving Boswellia, indicating a beneficial effect.",500 mg daily 4 weeks (Casperome®),,,asthma,asthma,,,
Boswellia,1.3% reported side effects probably related to the product; NSAID-related adverse effects; adverse events leading to discontinuation; likelihood of contact dermatitis with Boswellia; minor gastrointestinal ADRs; minor gastrointestinal discomfort in 6 patients,Breast Fibroadenoma,,Women's Health,manual_pair,"One randomized trial reported a significant reduction in breast fibroadenoma volume with Boswellia supplementation over a 6-month period. However, the evidence is limited to a single study, and no adverse effects were reported. Further research is needed to confirm these findings and establish consistent dosing.",0.6,27212181,2016,A randomized trial of Boswellia in association with betaine and myo-inositol in the management of breast fibroadenomas.,randomized_controlled_trial,benefit,The study shows a significant clinical improvement in fibroadenoma volume reduction with Boswellia supplementation.,6 months,Women,,breast fibroadenoma,breast fibroadenoma,Tier 4,0.58,"Although this is a randomized trial with a clinically relevant primary outcome (fibroadenoma volume), the intervention was a multi-ingredient combination (Boswellia + betaine + myo-inositol + B vitamins + NAC) versus a comparator that also contained active components (B vitamins + NAC). This prevents attribution of the benefit specifically to Boswellia, making the evidence for Boswellia alone indirect despite the RCT design."
Boswellia,1.3% reported side effects probably related to the product; NSAID-related adverse effects; adverse events leading to discontinuation; likelihood of contact dermatitis with Boswellia; minor gastrointestinal ADRs; minor gastrointestinal discomfort in 6 patients,Colitis,,Gut Health,manual_pair,"One randomized trial reported that Boswellia serrata (900 mg three times daily for 6 weeks) significantly improved symptoms in patients with chronic colitis compared to controls, indicating a potential benefit. However, the overall evidence is limited, with only one study available, and further research is needed to confirm these findings and assess long-term safety and efficacy.",0.7,11488449,2001,Effects of gum resin of Boswellia serrata in patients with chronic colitis.,randomized_controlled_trial,benefit,"The study shows significant improvement in patients treated with Boswellia compared to controls, indicating a beneficial effect.",900 mg three times daily 6 weeks (gum resin),,,chronic colitis,chronic colitis,,,
Boswellia,1.3% reported side effects probably related to the product; NSAID-related adverse effects; adverse events leading to discontinuation; likelihood of contact dermatitis with Boswellia; minor gastrointestinal ADRs; minor gastrointestinal discomfort in 6 patients,Colitis,,Gut Health,manual_pair,"There is limited evidence suggesting that Boswellia serrata extract may be beneficial for chronic diarrhea, specifically in the context of collagenous colitis, as indicated by a single double-blind, randomized, placebo-controlled trial showing a higher rate of clinical remission with a dose of 400 mg taken three times daily for 6 weeks. However, the overall evidence is sparse, and further research is needed to confirm these findings and assess long-term safety and efficacy.",0.7,17764013,2007,"Boswellia serrata extract for the treatment of collagenous colitis. A double-blind, randomized, placebo-controlled, multicenter trial.",randomized_controlled_trial,benefit,"The study shows a higher proportion of clinical remission in the BSE group compared to placebo, indicating a potential benefit.",400 mg three times daily 6 weeks (oral),,,chronic diarrhea,chronic diarrhea; collagenous colitis,Tier 2,0.55,"Double-blind, randomized, placebo-controlled multicenter trial with a clinically relevant primary endpoint (clinical remission) in collagenous colitis showed a higher remission rate with Boswellia serrata extract. However, the sample size was small (n=31 randomized; n=26 per-protocol), significance was achieved only in per-protocol (not ITT) analysis, and there was no histologic or QoL benefit. Results suggest benefit but are preliminary and limited by size and analysis, supporting moderate human evidence."
Boswellia,1.3% reported side effects probably related to the product; NSAID-related adverse effects; adverse events leading to discontinuation; likelihood of contact dermatitis with Boswellia; minor gastrointestinal ADRs; minor gastrointestinal discomfort in 6 patients,Inflammation,,"Immune, Inflammation, & Infection",manual_pair,"One randomized double-blinded placebo-controlled crossover study found that a single dose of 400 mg of a full-spectrum Boswellia serrata extract significantly increased bioavailability and demonstrated anti-inflammatory efficacy, suggesting a potential benefit for chronic inflammatory diseases. However, the evidence is limited to this single study, and further research is needed to confirm these findings and assess long-term safety and efficacy.",0.7,39343544,2024,Pharmacokinetics of a Natural Self-emulsifying Reversible Hybrid-Hydrogel (N'SERH) Formulation of Full-Spectrum Boswellia serrata Oleo-Gum Resin Extract: Randomised Double-Blinded Placebo-Controlled Crossover Study.,randomized_controlled_trial,benefit,"The study demonstrated a significant increase in bioavailability and anti-inflammatory efficacy of the boswellia extract, indicating a benefit for chronic inflammatory diseases.",400 mg single dose (U-BE and BFQ-20),,,chronic inflammatory diseases,chronic inflammatory diseases,,,
Boswellia,1.3% reported side effects probably related to the product; NSAID-related adverse effects; adverse events leading to discontinuation; likelihood of contact dermatitis with Boswellia; minor gastrointestinal ADRs; minor gastrointestinal discomfort in 6 patients,Chronic Low Back Pain,,Musculoskeletal & Pain,manual_pair,"One randomized, double-blind, placebo-controlled study found that a combination of Boswellia serrata and Curcuma longa extracts (300 mg once daily for 90 days) significantly reduced pain and improved quality of life in patients with chronic lower back pain. However, the overall evidence is limited to this single study, and no adverse effects were reported.",0.7,39700654,2025,"Efficacy and safety evaluation of Boswellia serrata and Curcuma longa extract combination in the management of chronic lower back pain: A randomised, double-blind, placebo-controlled clinical study.",randomized_controlled_trial,benefit,"The study demonstrated significant efficacy in reducing pain and improving quality of life in patients with chronic lower back pain, indicating a clear benefit from the intervention.",300 mg once daily 90 days (capsule),,,chronic lower back pain,chronic lower back pain,Tier 2,0.62,"High-quality randomized, double-blind, placebo-controlled trial (n=90) in chronic low back pain showed significant improvements in pain, disability, and QoL. However, the intervention was a combination of Boswellia serrata and Curcuma longa, so the benefit cannot be attributed to Boswellia alone. This makes the evidence indirect for Boswellia monotherapy despite strong trial design."
Boswellia,1.3% reported side effects probably related to the product; NSAID-related adverse effects; adverse events leading to discontinuation; likelihood of contact dermatitis with Boswellia; minor gastrointestinal ADRs; minor gastrointestinal discomfort in 6 patients,Traumatic Brain Injury,,Cognitive & Neurological Function,manual_pair,"The evidence for Boswellia in cognitive impairment is limited and mixed. One randomized, placebo-controlled trial reported cognitive benefits in individuals with traumatic brain injury, while another study suggested potential cognitive improvement but did not find significant effects on general outcomes. Overall, the findings are not consistent enough to draw firm conclusions about its efficacy for this indication.",0.7,24088189,2013,The effect of Boswellia Serrata on neurorecovery following diffuse axonal injury.,randomized_controlled_trial,mixed_unclear,"The study suggests no significant effect on general outcomes but indicates potential cognitive improvement, leading to a mixed outcome classification.",6 weeks (capsules),,,diffuse axonal injury,diffuse axonal injury; traumatic brain injury,,,
Boswellia,1.3% reported side effects probably related to the product; NSAID-related adverse effects; adverse events leading to discontinuation; likelihood of contact dermatitis with Boswellia; minor gastrointestinal ADRs; minor gastrointestinal discomfort in 6 patients,Traumatic Brain Injury,,Cognitive & Neurological Function,manual_pair,"The evidence for Boswellia in cognitive impairment is limited and mixed. One randomized, placebo-controlled trial reported cognitive benefits in individuals with traumatic brain injury, while another study suggested potential cognitive improvement but did not find significant effects on general outcomes. Overall, the findings are not consistent enough to draw firm conclusions about its efficacy for this indication.",0.7,35385330,2022,"Boswellia serrata extract shows cognitive benefits in a double-blind, randomized, placebo-controlled pilot clinical trial in individuals who suffered traumatic brain injury.",randomized_controlled_trial,benefit,The study demonstrated significant improvement in cognitive function in patients with TBI who received K-Vie™ compared to placebo.,3 months (K-Vie™),,,traumatic brain injury,diffuse axonal injury; traumatic brain injury,,,
Boswellia,1.3% reported side effects probably related to the product; NSAID-related adverse effects; adverse events leading to discontinuation; likelihood of contact dermatitis with Boswellia; minor gastrointestinal ADRs; minor gastrointestinal discomfort in 6 patients,Heavy Menstrual Bleeding,,Women's Health,manual_pair,"There is limited evidence from a single randomized, placebo-controlled trial indicating that Boswellia serrata (300 mg three times a day) may reduce the duration of heavy menstrual bleeding and improve quality of life. However, the overall evidence is weak due to the lack of multiple studies and mixed findings. No adverse effects were reported in the study.",0.7,30670277,2019,"The effect of frankincense (Boswellia serrata, oleoresin) and ginger (Zingiber officinale, rhizoma) on heavy menstrual bleeding: A randomized, placebo-controlled, clinical trial.",randomized_controlled_trial,benefit,"The study found a significant reduction in the duration of menstrual bleeding and improvement in quality of life for the frankincense group, indicating a beneficial effect.",300 mg three times a day seven days (oleoresin),Women,,heavy menstrual bleeding,heavy menstrual bleeding; menorrhagia,,,
Boswellia,1.3% reported side effects probably related to the product; NSAID-related adverse effects; adverse events leading to discontinuation; likelihood of contact dermatitis with Boswellia; minor gastrointestinal ADRs; minor gastrointestinal discomfort in 6 patients,Exercise Induced Inflammation,,Performance & Recovery,manual_pair,"One randomized trial suggests that Boswellia serrata may have a beneficial effect on markers of oxidative stress in master athletes when taken as gum resin for three months. However, the overall evidence is limited, with only one study reporting a positive outcome and no adverse effects noted. Further research is needed to confirm these findings and establish consistent dosing guidelines.",0.7,27879642,2016,Curcumin and Boswellia serrata Modulate the Glyco-Oxidative Status and Lipo-Oxidation in Master Athletes.,randomized_controlled_trial,benefit,"The study shows a positive effect on markers of oxidative stress and glycation, indicating a benefit from the supplementation.",3 months (gum resin),Athletes; Men,,glycation,glycation; inflammation; oxidative stress,,,
Boswellia,1.3% reported side effects probably related to the product; NSAID-related adverse effects; adverse events leading to discontinuation; likelihood of contact dermatitis with Boswellia; minor gastrointestinal ADRs; minor gastrointestinal discomfort in 6 patients,Joint Pain,,Musculoskeletal & Pain,manual_pair,"Clinical evidence from three randomized controlled trials suggests that Boswellia serrata extract may improve knee pain and function in individuals with osteoarthritis. Doses reported include a standardized extract of 100 mg daily for 180 days and unspecified doses for eight weeks. No adverse effects were noted in the studies, but further research is needed to confirm these findings and establish optimal dosing.",0.8,12622457,2003,Efficacy and tolerability of Boswellia serrata extract in treatment of osteoarthritis of knee--a randomized double blind placebo controlled trial.,randomized_controlled_trial,benefit,"The study reported significant improvements in knee pain and function, indicating a beneficial effect of Boswellia serrata extract.",eight weeks (extract),Osteoarthritis,,osteoarthritis of knee,"osteoarthritis of knee; osteoarthritis, knee; persistent knee pain",,,
Boswellia,1.3% reported side effects probably related to the product; NSAID-related adverse effects; adverse events leading to discontinuation; likelihood of contact dermatitis with Boswellia; minor gastrointestinal ADRs; minor gastrointestinal discomfort in 6 patients,Joint Pain,,Musculoskeletal & Pain,manual_pair,"Clinical evidence from three randomized controlled trials suggests that Boswellia serrata extract may improve knee pain and function in individuals with osteoarthritis. Doses reported include a standardized extract of 100 mg daily for 180 days and unspecified doses for eight weeks. No adverse effects were noted in the studies, but further research is needed to confirm these findings and establish optimal dosing.",0.8,39700461,2025,A Standardized Boswellia serrata Extract Improves Knee Joint Function and Cartilage Morphology in Human Volunteers with Mild to Moderate Osteoarthritis in a Randomized Placebo-Controlled Study.,randomized_controlled_trial,benefit,"The study demonstrated significant improvements in joint function and cartilage morphology, indicating a beneficial effect of the Boswellia extract in patients with knee osteoarthritis.",100 mg daily 180 days (standardized Boswellia serrata gum resin extract),Osteoarthritis,,"osteoarthritis, knee","osteoarthritis of knee; osteoarthritis, knee; persistent knee pain",,,
Boswellia,1.3% reported side effects probably related to the product; NSAID-related adverse effects; adverse events leading to discontinuation; likelihood of contact dermatitis with Boswellia; minor gastrointestinal ADRs; minor gastrointestinal discomfort in 6 patients,Joint Pain,,Musculoskeletal & Pain,manual_pair,"Clinical evidence from three randomized controlled trials suggests that Boswellia serrata extract may improve knee pain and function in individuals with osteoarthritis. Doses reported include a standardized extract of 100 mg daily for 180 days and unspecified doses for eight weeks. No adverse effects were noted in the studies, but further research is needed to confirm these findings and establish optimal dosing.",0.8,37686880,2023,Efficacy of Boswellia serrata Extract and/or an Omega-3-Based Product for Improving Pain and Function in People Older Than 40 Years with Persistent Knee Pain: A Randomized Double-Blind Controlled Clinical Trial.,randomized_controlled_trial,benefit,"The study demonstrated significant improvements in pain and quality of life, indicating a beneficial outcome from the treatment.",8 weeks (Boswellia serrata extract),Knee Pain,,persistent knee pain,"osteoarthritis of knee; osteoarthritis, knee; persistent knee pain",,,
Boswellia,1.3% reported side effects probably related to the product; NSAID-related adverse effects; adverse events leading to discontinuation; likelihood of contact dermatitis with Boswellia; minor gastrointestinal ADRs; minor gastrointestinal discomfort in 6 patients,Joint Pain,,Musculoskeletal & Pain,manual_pair,"The evidence for Boswellia in treating knee pain from osteoarthritis is generally positive, with five randomized trials reporting benefits in pain and function, while one study showed mixed results. Typical doses reported include 100 mg to 500 mg of standardized Boswellia extracts, administered over periods ranging from 30 to 120 days. No adverse effects were noted in the studies, but the mixed findings in one trial suggest variability in response.",0.9,39875757,2025,"Efficacy and Safety of Boswellia serrata and Apium graveolens L. Extract Against Knee Osteoarthritis and Cartilage Degeneration: A Randomized, Double-blind, Multicenter, Placebo-Controlled Clinical Trial.",randomized_controlled_trial,benefit,The study demonstrated significant benefits in reducing knee osteoarthritis symptoms and improving cartilage health without reported adverse effects.,300 mg oral 90 days (standardized Boswellia serrata Roxb. gum resin); 250 mg oral 90 days (Apium graveolens L. seed extract),Osteoarthritis,,knee osteoarthritis,knee osteoarthritis; osteoarthritis of knee; osteoarthritis of the knee; pain; stiffness,,,
Boswellia,1.3% reported side effects probably related to the product; NSAID-related adverse effects; adverse events leading to discontinuation; likelihood of contact dermatitis with Boswellia; minor gastrointestinal ADRs; minor gastrointestinal discomfort in 6 patients,Joint Pain,,Musculoskeletal & Pain,manual_pair,"The evidence for Boswellia in treating knee pain from osteoarthritis is generally positive, with five randomized trials reporting benefits in pain and function, while one study showed mixed results. Typical doses reported include 100 mg to 500 mg of standardized Boswellia extracts, administered over periods ranging from 30 to 120 days. No adverse effects were noted in the studies, but the mixed findings in one trial suggest variability in response.",0.9,28349271,2017,Evaluation of the effect of Elaeagnus angustifolia alone and combined with Boswellia thurifera compared with ibuprofen in patients with knee osteoarthritis: a randomized double-blind controlled clinical trial.,randomized_controlled_trial,mixed_unclear,"All interventions showed significant effects on pain and function, but no significant difference between groups was noted.",3 times daily 4 weeks (capsules),Osteoarthritis,,knee osteoarthritis,knee osteoarthritis; osteoarthritis of knee; osteoarthritis of the knee; pain; stiffness,,,
Boswellia,1.3% reported side effects probably related to the product; NSAID-related adverse effects; adverse events leading to discontinuation; likelihood of contact dermatitis with Boswellia; minor gastrointestinal ADRs; minor gastrointestinal discomfort in 6 patients,Joint Pain,,Musculoskeletal & Pain,manual_pair,"The evidence for Boswellia in treating knee pain from osteoarthritis is generally positive, with five randomized trials reporting benefits in pain and function, while one study showed mixed results. Typical doses reported include 100 mg to 500 mg of standardized Boswellia extracts, administered over periods ranging from 30 to 120 days. No adverse effects were noted in the studies, but the mixed findings in one trial suggest variability in response.",0.9,24002213,2013,Clinical evaluation of a formulation containing Curcuma longa and Boswellia serrata extracts in the management of knee osteoarthritis.,randomized_controlled_trial,benefit,"The study showed that the CB formulation was more successful than celecoxib for symptom scoring, indicating a benefit.",500 mg twice a day (CB formulation),Osteoarthritis,,knee osteoarthritis,knee osteoarthritis; osteoarthritis of knee; osteoarthritis of the knee; pain; stiffness,,,
Boswellia,1.3% reported side effects probably related to the product; NSAID-related adverse effects; adverse events leading to discontinuation; likelihood of contact dermatitis with Boswellia; minor gastrointestinal ADRs; minor gastrointestinal discomfort in 6 patients,Joint Pain,,Musculoskeletal & Pain,manual_pair,"The evidence for Boswellia in treating knee pain from osteoarthritis is generally positive, with five randomized trials reporting benefits in pain and function, while one study showed mixed results. Typical doses reported include 100 mg to 500 mg of standardized Boswellia extracts, administered over periods ranging from 30 to 120 days. No adverse effects were noted in the studies, but the mixed findings in one trial suggest variability in response.",0.9,32549135,2020,Double-blind trial of solid lipid Boswellia serrata particles (SLBSP) vs. standardized Boswellia serrata gum extract (BSE) for osteoarthritis of knee.,randomized_controlled_trial,benefit,"The study showed significant improvement in pain and function in both treatment arms, with SLBSP being superior in reducing the need for rescue analgesics and lowering inflammatory cytokines.",100 mg as needed two months (capsule or tablet),Osteoarthritis,,osteoarthritis of knee,knee osteoarthritis; osteoarthritis of knee; osteoarthritis of the knee; pain; stiffness,,,
Boswellia,1.3% reported side effects probably related to the product; NSAID-related adverse effects; adverse events leading to discontinuation; likelihood of contact dermatitis with Boswellia; minor gastrointestinal ADRs; minor gastrointestinal discomfort in 6 patients,Joint Pain,,Musculoskeletal & Pain,manual_pair,"The evidence for Boswellia in treating knee pain from osteoarthritis is generally positive, with five randomized trials reporting benefits in pain and function, while one study showed mixed results. Typical doses reported include 100 mg to 500 mg of standardized Boswellia extracts, administered over periods ranging from 30 to 120 days. No adverse effects were noted in the studies, but the mixed findings in one trial suggest variability in response.",0.9,35512759,2023,"Efficacy and Safety of Aflapin®, a Novel Boswellia Serrata Extract, in the Treatment of Osteoarthritis of the Knee: A Short-Term 30-Day Randomized, Double-Blind, Placebo-Controlled Clinical Study.",randomized_controlled_trial,benefit,"The study demonstrated significant improvements in pain and function in patients with knee osteoarthritis, indicating a beneficial outcome.",100 mg 30 days (Aflapin),Osteoarthritis,,osteoarthritis of the knee,knee osteoarthritis; osteoarthritis of knee; osteoarthritis of the knee; pain; stiffness,Tier 1,0.72,"Randomized, double-blind, placebo-controlled RCT (n≈70) in knee osteoarthritis measured validated pain/function outcomes (VAS, WOMAC) as primary endpoints and showed significant benefit with Aflapin (Boswellia) over placebo. Methods are strong and outcomes directly address joint pain. Confidence tempered by short 30-day duration and modest sample size."
Boswellia,1.3% reported side effects probably related to the product; NSAID-related adverse effects; adverse events leading to discontinuation; likelihood of contact dermatitis with Boswellia; minor gastrointestinal ADRs; minor gastrointestinal discomfort in 6 patients,Joint Pain,,Musculoskeletal & Pain,manual_pair,"The evidence for Boswellia in treating knee pain from osteoarthritis is generally positive, with five randomized trials reporting benefits in pain and function, while one study showed mixed results. Typical doses reported include 100 mg to 500 mg of standardized Boswellia extracts, administered over periods ranging from 30 to 120 days. No adverse effects were noted in the studies, but the mixed findings in one trial suggest variability in response.",0.9,30838706,2019,"A pilot, randomized, double-blind, placebo-controlled trial to assess the safety and efficacy of a novel Boswellia serrata extract in the management of osteoarthritis of the knee.",randomized_controlled_trial,benefit,"The study showed significant improvement in physical function, pain, and stiffness, indicating a beneficial outcome.",120 days (Boswellin®),Osteoarthritis,,osteoarthritis of the knee,knee osteoarthritis; osteoarthritis of knee; osteoarthritis of the knee; pain; stiffness,,,
Boswellia,1.3% reported side effects probably related to the product; NSAID-related adverse effects; adverse events leading to discontinuation; likelihood of contact dermatitis with Boswellia; minor gastrointestinal ADRs; minor gastrointestinal discomfort in 6 patients,Chronic Low Back Pain,,Musculoskeletal & Pain,manual_pair,"One randomized double-blind placebo-controlled trial reported a significant benefit of a turmeric-Boswellia formulation (Rhuleave-K) at a dose of 500 mg over 15 days for reducing pain intensity and disability in individuals with posture-related low back soreness and discomfort. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term safety and efficacy.",0.7,39973246,2025,The effect of turmeric-Boswellia formulation (Rhuleave-K) in posture-related low back soreness and discomfort: A randomized double blinded placebo controlled trial.,randomized_controlled_trial,benefit,"The study demonstrated a significant reduction in pain intensity and disability index, indicating a beneficial effect of the turmeric-Boswellia formulation on low back soreness and discomfort.",500 mg 15 days (Rhuleave-K),,,posture-related discomfort,posture-related discomfort; posture-related low back soreness,,,
Boswellia,1.3% reported side effects probably related to the product; NSAID-related adverse effects; adverse events leading to discontinuation; likelihood of contact dermatitis with Boswellia; minor gastrointestinal ADRs; minor gastrointestinal discomfort in 6 patients,Improve Memory,,Cognitive & Neurological Function,manual_pair,"There is limited evidence suggesting that Boswellia serrata may improve memory in older adults, as indicated by one randomized controlled trial that reported significant improvements in memory scores after one month of treatment. However, the overall evidence is sparse, and further studies are needed to confirm these findings and assess long-term effects and safety.",0.7,29306113,2018,The effect of tablet containing Boswellia serrata and Melisa officinalis extract on older adults' memory: A randomized controlled trial.,randomized_controlled_trial,benefit,"The study shows significant improvement in memory scores after consumption of the tablets, indicating a beneficial effect.",1 month (tablet),,,age-related memory loss,age-related memory loss; memory deficits,Tier 4,0.38,"Although this is a double-blind, placebo-controlled RCT with memory as the primary outcome showing benefit, the intervention was a combination tablet (Boswellia serrata plus Melissa officinalis). Because Boswellia was not tested alone and the dose is not specified, the evidence is indirect for Boswellia specifically. Short duration (1 month) and modest sample size further limit attribution to Boswellia. Thus, very low/indirect human evidence for Boswellia improving memory."
Boswellia,1.3% reported side effects probably related to the product; NSAID-related adverse effects; adverse events leading to discontinuation; likelihood of contact dermatitis with Boswellia; minor gastrointestinal ADRs; minor gastrointestinal discomfort in 6 patients,Pain,,Musculoskeletal & Pain,manual_pair,"One randomized, double-blind, placebo-controlled crossover study demonstrated that Boswellia serrata (125 mg single dose) significantly increased pain threshold and tolerance in healthy volunteers, indicating a potential benefit for pain relief. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term effects and safety.",0.8,25298573,2014,"A randomized, double blind, placebo controlled, cross over study to evaluate the analgesic activity of Boswellia serrata in healthy volunteers using mechanical pain model.",randomized_controlled_trial,benefit,"The study found significant increases in Pain Threshold and Pain Tolerance with Boswellia serrata compared to placebo, indicating a benefit.",125 mg single dose (capsules),,,pain,pain,,,
Boswellia,1.3% reported side effects probably related to the product; NSAID-related adverse effects; adverse events leading to discontinuation; likelihood of contact dermatitis with Boswellia; minor gastrointestinal ADRs; minor gastrointestinal discomfort in 6 patients,UTI,,Kidney & Bladder Health,manual_pair,"One randomized trial suggests that a combination of L-Methionine, Hibiscus sabdariffa, and Boswellia serrata may provide symptom relief in patients with recurrent uncomplicated urinary tract infections, showing significant improvement in quality of life. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term safety and efficacy.",0.7,29974725,2018,L-Methionine associated with Hibiscus sabdariffa and Boswellia serrata extracts are not inferior to antibiotic treatment for symptoms relief in patients affected by recurrent uncomplicated urinary tract infections: Focus on antibiotic-sparing approach.,randomized_controlled_trial,benefit,"The study showed significant improvement in quality of life and symptom relief, indicating a benefit from the treatment.",1 tablet twice daily 7 days (phytotherapic combination),,,recurrent uncomplicated urinary tract infections,recurrent uncomplicated urinary tract infections,,,
Boswellia,1.3% reported side effects probably related to the product; NSAID-related adverse effects; adverse events leading to discontinuation; likelihood of contact dermatitis with Boswellia; minor gastrointestinal ADRs; minor gastrointestinal discomfort in 6 patients,Wound Healing,,"Skin, Hair, & Nails",manual_pair,"One randomized controlled trial reported a benefit of Boswellia carteri for improving episiotomy wound healing, although the study primarily highlighted the effectiveness of Commiphora myrrha. The doses used were 10 minutes of application of myrrh or frankincense extracts twice a day for one week. Overall, the evidence is limited and further research is needed to confirm these findings and assess the consistency of the results.",0.7,32971163,2021,Episiotomy wound healing by Commiphora myrrha (Nees) Engl. and Boswellia carteri Birdw. in primiparous women: A randomized controlled trial.,randomized_controlled_trial,benefit,"The study demonstrated that myrrh was more effective than frankincense and betadine in improving episiotomy wound healing, indicating a clear benefit.",10 minutes twice a day 1 week (myrrh extract or frankincense extract),,,episiotomy wound healing,episiotomy wound healing,Tier 2,0.68,"This is a randomized controlled trial directly testing Boswellia carteri (frankincense) sitz-baths for episiotomy wound healing with a primary clinical outcome (REEDA scale). The trial is relatively small (~30 per arm) and likely unblinded. It found no benefit of frankincense versus betadine, while myrrh was superior. Therefore, it provides moderate-quality, direct human evidence that does not support efficacy for Boswellia in wound healing in this context."
Boswellia,1.3% reported side effects probably related to the product; NSAID-related adverse effects; adverse events leading to discontinuation; likelihood of contact dermatitis with Boswellia; minor gastrointestinal ADRs; minor gastrointestinal discomfort in 6 patients,Stress Urinary Incontinence,,Women's Health,manual_pair,"One randomized trial reported a benefit of Boswellia serrata in combination with pelvic floor muscle training for stress urinary incontinence in women, with a dosage of 2 g taken orally twice daily for 8 weeks. However, the overall evidence is limited, with only one study available, and no adverse effects were reported. Further research is needed to confirm these findings and assess long-term safety and efficacy.",0.7,25225151,2014,Efficacy of Boswellia serrata L. and Cyperus scariosus L. plus pelvic floor muscle training in stress incontinence in women of reproductive age.,randomized_controlled_trial,benefit,"The study showed a significant improvement in the test group compared to the control group, indicating a benefit from the treatment.",2 g twice daily 8 weeks (oral),Women,,stress urinary incontinence,stress urinary incontinence,Tier 4,0.47,"Single-blind, placebo-controlled RCT (n=60) in women with stress urinary incontinence showed significant benefit on a clinically relevant primary outcome (1-hour pad test), but the intervention was a combination of Boswellia serrata and Cyperus scariosus alongside pelvic floor training. Because Boswellia was not tested alone, attribution to Boswellia specifically is indirect, lowering the evidence tier despite the randomized design."
Boswellia,1.3% reported side effects probably related to the product; NSAID-related adverse effects; adverse events leading to discontinuation; likelihood of contact dermatitis with Boswellia; minor gastrointestinal ADRs; minor gastrointestinal discomfort in 6 patients,Vulvovaginal Candidiasis,,Women's Health,manual_pair,"One randomized controlled trial reported that Boswellia serrata (1 gram vaginal insert daily for 21 days) was efficacious in managing vulvovaginal candidiasis, showing significant improvement in symptoms compared to miconazole. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess safety and tolerability.",0.7,35751891,2023,The Efficacy of Kundur (Boswellia serrata Roxb. Ex Colebr.) in Vulvovaginal Candidiasis: A Randomized Control Trial.,randomized_controlled_trial,benefit,"Boswellia serrata was shown to be efficacious in managing vulvovaginal candidiasis, with significant improvement in symptoms compared to miconazole.",1 gram daily 21 days (vaginal insert),Women,,vulvovaginal candidiasis,vulvovaginal candidiasis,,,
Calcium,anemia; ankle edema higher on nifedipine-GITS in Europeans; diminished tissue regeneration; dry cough higher on ramipril in Chinese; gastrointestinal adverse events; headache; hematuria; hypertension; induced inflammation; mild to moderate adverse effects; mortality; vomiting,Improve Bone Density,,Musculoskeletal & Pain,manual_pair,"Two randomized trials indicate a benefit of calcium supplementation for improving bone density in specific populations, including post-menopausal women and elderly patients with osteoporosis. However, the evidence is limited to these studies, and no adverse effects were reported. The typical doses were not consistently specified across the trials.",0.8,39861392,2025,"Decrease in Facial Bone Density with Aging and Maintenance Effect of Calcium Maltobionate Ingestion in Japanese Adult Women: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Trial.",randomized_controlled_trial,benefit,"The study shows a significant increase in facial bone mineral density and calcaneal bone density in post-menopausal women taking calcium maltobionate, indicating a benefit for bone health.",null null null 24 weeks (tablets containing calcium maltobionate),Women,,bone density decline,bone density decline; osteoporosis prevention; primary osteoporosis; senile osteoporosis,,,
Calcium,anemia; ankle edema higher on nifedipine-GITS in Europeans; diminished tissue regeneration; dry cough higher on ramipril in Chinese; gastrointestinal adverse events; headache; hematuria; hypertension; induced inflammation; mild to moderate adverse effects; mortality; vomiting,Improve Bone Density,,Musculoskeletal & Pain,manual_pair,"Two randomized trials indicate a benefit of calcium supplementation for improving bone density in specific populations, including post-menopausal women and elderly patients with osteoporosis. However, the evidence is limited to these studies, and no adverse effects were reported. The typical doses were not consistently specified across the trials.",0.8,40042722,2025,Therapeutic efficacy of zoledronic acid combined with calcium and calcitriol in the treatment of senile osteoporosis in elderly patients.,randomized_controlled_trial,benefit,"The study shows significant efficacy in increasing bone density and improving quality of life, indicating a benefit from the treatment.",null null null 1 year (calcium carbonate D3 tablets),Older Adults; Osteoporosis,,primary osteoporosis,bone density decline; osteoporosis prevention; primary osteoporosis; senile osteoporosis,Tier 5,0.88,"This RCT compared calcium+calcitriol versus calcium+calcitriol+zoledronic acid. Both arms received calcium, and the between-group benefit is attributable to zoledronic acid. The study does not test calcium supplementation itself against a control for improving bone density, so it does not provide direct evidence for calcium’s efficacy for this indication."
Calcium,anemia; ankle edema higher on nifedipine-GITS in Europeans; diminished tissue regeneration; dry cough higher on ramipril in Chinese; gastrointestinal adverse events; headache; hematuria; hypertension; induced inflammation; mild to moderate adverse effects; mortality; vomiting,Improve Bone Density,,Musculoskeletal & Pain,manual_pair,"One randomized controlled trial indicates that calcium supplementation (1000 mg once) may benefit bone calcium balance and metabolism during exercise in women. However, the overall evidence is limited, with only one study demonstrating a positive outcome and no reports of harm or other effects. Further research is needed to establish the consistency and generalizability of these findings.",0.7,39804018,2025,The effect of calcium supplementation on bone calcium balance and calcium and bone metabolism during load carriage in women: a randomized controlled crossover trial.,randomized_controlled_trial,benefit,"The study shows that calcium supplementation before exercise promotes bone calcium balance and prevents disruptions to bone and calcium homeostasis, indicating a beneficial effect.",1000 mg once,Women,,bone metabolism,bone metabolism; calcium homeostasis,,,
Calcium,anemia; ankle edema higher on nifedipine-GITS in Europeans; diminished tissue regeneration; dry cough higher on ramipril in Chinese; gastrointestinal adverse events; headache; hematuria; hypertension; induced inflammation; mild to moderate adverse effects; mortality; vomiting,Tooth Decay,,Oral Health,manual_pair,"One randomized controlled trial demonstrated that a remineralization agent containing ammonium fluoride and nano sol calcium fluoride significantly improved the remineralization of initial buccal caries lesions compared to control. No studies reported mixed or no benefit, indicating a positive outcome for calcium in this context. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term effects.",0.7,40335196,2025,EFFICACY OF A REMINERALIZATION AGENT CONTAINING AMMONIUM FLUORIDE SOLUTION AND NANO SOL CALCIUM FLUORIDE FOR TREATMENT OF INITIAL BUCCAL CARIES LESIONS: A SPLIT-MOUTH RANDOMIZED CONTROLLED CLINICAL TRIAL.,randomized_controlled_trial,benefit,The study showed significant improvement in remineralization of carious lesions with the test treatment compared to control.,25000 ppmF- 2-step treatment 6 and 12 months (ammonium fluoride solution + nano sol calcium fluoride); 7700 ppmF- 1-step treatment 6 and 12 months (ammonium fluoride varnish),,,dental caries,dental caries; initial buccal caries lesions,,,
Chaste Tree (vitex agnus-castus),allergic dermatitis (non-serious adverse event); fatigue possibly related to study medication; headache,Premenstrual Syndrome,,Women's Health,manual_pair,"There is limited evidence suggesting that Chaste Tree (Vitex agnus-castus) may have a beneficial effect on anxiety-related symptoms, specifically in the context of PMS-like symptoms in late-perimenopausal women, as indicated by one study. The study reported significant improvements with a combination of Vitex and another herb taken twice daily for 16 weeks. However, the overall evidence is sparse, and further research is needed to establish its efficacy and safety for anxiety more broadly.",0.7,19757982,2009,Effects of a combination of Hypericum perforatum and Vitex agnus-castus on PMS-like symptoms in late-perimenopausal women: findings from a subpopulation analysis.,randomized_controlled_trial,benefit,"The herbal combination showed significant improvements in PMS-like symptoms, indicating a beneficial effect.",twice daily 16 weeks (tablets),Menopause; Women,,anxiety,anxiety; depression; pms-like symptoms,,,
Chaste Tree (vitex agnus-castus),allergic dermatitis (non-serious adverse event); fatigue possibly related to study medication; headache,Migraine Headache,,Musculoskeletal & Pain,manual_pair,"There is limited evidence suggesting that Chaste Tree (vitex agnus-castus) may reduce migraine frequency in women with premenstrual syndrome, based on one open-label clinical observation study that reported significant benefits at a dose of 40 mg daily for 3 months. However, the evidence is not robust, and further randomized controlled trials are needed to confirm these findings and assess safety and efficacy more comprehensively.",0.7,22791378,2013,Use of Vitex agnus-castus in migrainous women with premenstrual syndrome: an open-label clinical observation.,clinical_trial,benefit,"The study reports significant reductions in PMS symptoms and migraine frequency, indicating a beneficial effect.",40 mg daily 3 months,,,migraine disorders,migraine disorders; premenstrual syndrome,,,
Chaste Tree (vitex agnus-castus),allergic dermatitis (non-serious adverse event); fatigue possibly related to study medication; headache,Menopause Symptoms,,Women's Health,manual_pair,"Chaste Tree (Vitex agnus-castus) has shown some evidence of benefit for reducing hot flashes in a study that reported significant improvement in vasomotor symptoms among menopausal women. However, the evidence is limited to one study with unspecified doses and lacks consistency across multiple trials. No adverse effects were reported, but further research is needed to confirm these findings and establish optimal dosing.",0.6,30129806,2019,Effects of a combination of Nigella sativa and Vitex agnus-castus with citalopram on healthy menopausal women with hot flashes: results from a subpopulation analysis.,randomized_controlled_trial,benefit,"The study showed significant improvement in vasomotor symptoms, indicating a benefit from the intervention.",not specified once daily 8 weeks (herbal medication or placebo capsules),Menopause; Women,,hot flashes,hot flashes; menopause,,,
Chaste Tree (vitex agnus-castus),allergic dermatitis (non-serious adverse event); fatigue possibly related to study medication; headache,Premenstrual Syndrome,,Women's Health,manual_pair,"One randomized trial reported a beneficial effect of Chaste Tree (Vitex agnus-castus) at a dose of 20 mg daily over three menstrual cycles for improving premenstrual syndrome (PMS) symptoms. Overall, the evidence is limited to a single study with no reported harms or adverse effects, indicating a need for further research to confirm these findings and assess long-term safety.",0.7,11129515,2000,Efficacy of Vitex agnus castus L. extract Ze 440 in patients with pre-menstrual syndrome (PMS).,clinical_trial,benefit,"The study showed significant improvement in PMS symptoms, indicating a beneficial effect of the supplement.",20 mg daily 3 menstrual cycles (tablet),Women,,premenstrual syndrome,premenstrual syndrome,,,
Chaste Tree (vitex agnus-castus),allergic dermatitis (non-serious adverse event); fatigue possibly related to study medication; headache,Premenstrual Syndrome,,Women's Health,manual_pair,"Chaste Tree (Vitex agnus-castus) has shown some evidence of benefit for reducing premenstrual syndrome (PMS) symptoms, as indicated by one open-label study that reported a statistically significant decrease in symptoms with a daily dose of 20 mg for three menstrual cycles. However, the overall evidence is limited, with only one study available, and further research is needed to confirm these findings and assess long-term safety and efficacy.",0.7,24604699,2014,"Efficacy and safety of Vitex agnus-castus extract for treatment of premenstrual syndrome in Japanese patients: a prospective, open-label study.",clinical_trial,benefit,"The study showed a statistically significant decrease in PMS symptoms, indicating a beneficial effect of the supplement.",20 mg once daily three menstrual cycles (Prefemin®),Women,,premenstrual syndrome,premenstrual syndrome,,,
Choline,adverse reactions; consent withdrawal; fishy body odor in 36% of choline group,Cardiac Risk,,Heart & Vascular Health,manual_pair,"One study indicates that choline bitartrate at a dose of 600 mg may increase levels of trimethylamine-N-oxide (TMAO), a compound associated with cardiovascular disease risk, suggesting a potential benefit in understanding dietary impacts on cardiovascular health. However, the evidence is limited and does not establish a clear therapeutic effect or consistent findings across multiple studies.",0.6,32722424,2020,Effect of Choline Forms and Gut Microbiota Composition on Trimethylamine-N-Oxide Response in Healthy Men.,randomized_controlled_trial,benefit,"The study shows that choline bitartrate significantly increases TMAO levels, which is associated with cardiovascular disease risk, indicating a potential benefit in understanding dietary impacts on health.",600 mg single meal (choline bitartrate or phosphatidylcholine),,,cardiovascular disease risk,cardiovascular disease risk,,,
Choline,adverse reactions; consent withdrawal; fishy body odor in 36% of choline group,Schizophrenia,,"Energy, Mood, & Mental Health",manual_pair,"The evidence regarding choline supplementation for chronic schizophrenia is limited and of low quality. One pilot study reported mixed outcomes based on varying effects related to baseline amplitude in patients, with doses of CDP-choline ranging from 500 mg to 2000 mg. No consistent benefits or harms were identified across the studies reviewed.",0.6,33630646,2022,The acute dose and baseline amplitude-dependent effects of CDP-choline on deviance detection (MMN) in chronic schizophrenia: A pilot study.,randomized_controlled_trial,mixed_unclear,The outcome direction is mixed due to varying effects based on baseline amplitude in patients.,500 mg (CDP-Choline); 1000 mg (CDP-Choline); 2000 mg (CDP-Choline),,,chronic schizophrenia,chronic schizophrenia,Tier 3,0.5,"Randomized, double-blind, placebo-controlled pilot in chronic schizophrenia, but assessed an acute, surrogate neurophysiological endpoint (MMN) rather than clinical symptoms. Effects were baseline-dependent and mixed, providing preliminary mechanistic evidence rather than clear clinical benefit."
Choline,adverse reactions; consent withdrawal; fishy body odor in 36% of choline group,Cognitive Performance,,Cognitive & Neurological Function,manual_pair,"One randomized controlled trial reported cognitive improvement with choline alfoscerate in patients with cognitive decline over 12 and 24 weeks, indicating a potential benefit. However, the evidence is limited, with only one study available, and further research is needed to confirm these findings and assess long-term effects and safety.",0.7,38875437,2024,Comparative study of choline alfoscerate as a combination therapy with donepezil: A mixed double-blind randomized controlled and open-label observation trial.,randomized_controlled_trial,benefit,"The study shows cognitive improvement with choline alfoscerate in patients with cognitive decline, indicating a benefit.",12 weeks and 24 weeks (choline alfoscerate),,,alzheimer disease,alzheimer disease; cognitive decline,,,
Choline,adverse reactions; consent withdrawal; fishy body odor in 36% of choline group,Cognitive Performance,,Cognitive & Neurological Function,manual_pair,"The evidence for choline supplementation in cognitive impairment shows a generally positive trend, with four studies indicating benefits in cognitive function, particularly with choline alfoscerate at doses of 600 mg to 1200 mg daily. However, one study reported mixed outcomes, highlighting the need for further research to clarify these findings and assess long-term effects and safety. No adverse effects were reported in the reviewed studies.",0.8,38929542,2024,Effect of Treatment of the Cholinergic Precursor Choline Alphoscerate in Mild Cognitive Dysfunction: A Randomized Controlled Trial.,randomized_controlled_trial,benefit,"The study aims to assess the efficacy of choline alphoscerate in stabilizing or slowing cognitive decline, indicating a potential benefit.",1200 mg daily 12 months (choline alphoscerate),,,cognitive dysfunction,Type 2 Diabetes Mellitus; cognitive dysfunction; cognitive function; dementia; mild cognitive impairment; verbal memory,,,
Choline,adverse reactions; consent withdrawal; fishy body odor in 36% of choline group,Cognitive Performance,,Cognitive & Neurological Function,manual_pair,"The evidence for choline supplementation in cognitive impairment shows a generally positive trend, with four studies indicating benefits in cognitive function, particularly with choline alfoscerate at doses of 600 mg to 1200 mg daily. However, one study reported mixed outcomes, highlighting the need for further research to clarify these findings and assess long-term effects and safety. No adverse effects were reported in the reviewed studies.",0.8,37340479,2023,Effects of egg yolk choline intake on cognitive functions and plasma choline levels in healthy middle-aged and older Japanese: a randomized double-blinded placebo-controlled parallel-group study.,randomized_controlled_trial,mixed_unclear,"The study showed improvement in verbal memory but also lower scores in some cognitive tests, indicating mixed outcomes.",300 mg daily 12 weeks (egg yolk choline),,,cognitive function,Type 2 Diabetes Mellitus; cognitive dysfunction; cognitive function; dementia; mild cognitive impairment; verbal memory,,,
Choline,adverse reactions; consent withdrawal; fishy body odor in 36% of choline group,Cognitive Performance,,Cognitive & Neurological Function,manual_pair,"The evidence for choline supplementation in cognitive impairment shows a generally positive trend, with four studies indicating benefits in cognitive function, particularly with choline alfoscerate at doses of 600 mg to 1200 mg daily. However, one study reported mixed outcomes, highlighting the need for further research to clarify these findings and assess long-term effects and safety. No adverse effects were reported in the reviewed studies.",0.8,38696157,2024,[Efficacy and safety of choline alfoscerate in the preventive therapy of dementia in elderly patients with Mild Cognitive Impairment: a three-year prospective comparative study].,randomized_controlled_trial,benefit,"The study shows a significant reduction in cognitive deficits and dementia conversion rates in the therapeutic group, indicating a benefit from the treatment.",1000 mg once a year 3 years (intravenous infusions in saline solution),Older Adults,,dementia,Type 2 Diabetes Mellitus; cognitive dysfunction; cognitive function; dementia; mild cognitive impairment; verbal memory,Tier 2,0.62,"Randomized but open-label, no-treatment–controlled trial (n=100) in older adults with amnestic MCI showed significant reductions in cognitive decline and dementia conversion over 3 years with choline alfoscerate. Outcomes were clinically meaningful and primary, but the lack of blinding/placebo and modest sample size introduce bias. Intravenous alpha-GPC limits generalizability to typical oral supplement use."
Choline,adverse reactions; consent withdrawal; fishy body odor in 36% of choline group,Cognitive Performance,,Cognitive & Neurological Function,manual_pair,"The evidence for choline supplementation in cognitive impairment shows a generally positive trend, with four studies indicating benefits in cognitive function, particularly with choline alfoscerate at doses of 600 mg to 1200 mg daily. However, one study reported mixed outcomes, highlighting the need for further research to clarify these findings and assess long-term effects and safety. No adverse effects were reported in the reviewed studies.",0.8,39703111,2025,"Effects of choline alfoscerate on cognitive function and quality of life in type 2 diabetes: A double-blind, randomized, placebo-controlled trial.",randomized_controlled_trial,benefit,"The study showed a significant improvement in cognitive function and quality of life at 12 months, indicating a benefit from choline alfoscerate treatment.",1200 mg once daily 6 months (choline alfoscerate),Diabetes Type 2,,mild cognitive impairment,Type 2 Diabetes Mellitus; cognitive dysfunction; cognitive function; dementia; mild cognitive impairment; verbal memory,,,
Choline,adverse reactions; consent withdrawal; fishy body odor in 36% of choline group,Cognitive Performance,,Cognitive & Neurological Function,manual_pair,"The evidence for choline supplementation in cognitive impairment shows a generally positive trend, with four studies indicating benefits in cognitive function, particularly with choline alfoscerate at doses of 600 mg to 1200 mg daily. However, one study reported mixed outcomes, highlighting the need for further research to clarify these findings and assess long-term effects and safety. No adverse effects were reported in the reviewed studies.",0.8,39300341,2024,Efficacy and safety of choline alphoscerate for amnestic mild cognitive impairment: a randomized double-blind placebo-controlled trial.,randomized_controlled_trial,benefit,"The study demonstrated a significant improvement in cognitive function with αGPC treatment, indicating a beneficial outcome.",600 mg daily 12 weeks (soft capsule),,,mild cognitive impairment,Type 2 Diabetes Mellitus; cognitive dysfunction; cognitive function; dementia; mild cognitive impairment; verbal memory,Tier 1,0.83,"Randomized, double-blind, placebo-controlled trial (n=100) testing alpha-GPC (a choline form) for cognition in mild cognitive impairment with ADAS-cog as the primary endpoint, showing significant benefit. Good methods, clinically relevant primary outcome."
Choline,adverse reactions; consent withdrawal; fishy body odor in 36% of choline group,Inflammation,,"Immune, Inflammation, & Infection",manual_pair,"One randomized trial indicates that choline supplementation (400 mg daily for 4 weeks) may reduce interleukin-6 levels, suggesting a potential benefit in inflammation management. However, the overall evidence is limited, with only one study demonstrating a positive outcome and no reports of harm or mixed results.",0.7,33066009,2020,Choline Intake as Supplement or as a Component of Eggs Increases Plasma Choline and Reduces Interleukin-6 without Modifying Plasma Cholesterol in Participants with Metabolic Syndrome.,randomized_controlled_trial,benefit,The study shows benefits in reducing inflammatory biomarkers without increasing cholesterol levels.,400 mg daily 4 weeks (choline bitartrate),,,inflammation,inflammation; insulin resistance; metabolic syndrome,Tier 3,0.58,"Small randomized cross-over trial (n=23) in metabolic syndrome participants found reduced IL-6 with ~400 mg/day choline (bitartrate) over 4 weeks. While randomized, it lacked a placebo control and blinding, and the outcome was a surrogate inflammatory biomarker (IL-6) rather than clinical inflammatory endpoints. Short duration and limited sample size further limit robustness."
Choline,adverse reactions; consent withdrawal; fishy body odor in 36% of choline group,Exercise Induced Inflammation,,Performance & Recovery,manual_pair,"The evidence for choline supplementation in improving low exercise performance is limited but suggests potential benefits. Two studies reported positive outcomes, with one using 2.5 g of Neptune krill oil daily for 12 weeks and another utilizing a single dose of a multi-ingredient choline supplement before testing. However, the overall quality and consistency of the evidence are low, and further research is needed to confirm these findings.",0.6,34959789,2021,"Krill-Oil-Dependent Increases in HS-Omega-3 Index, Plasma Choline and Antioxidant Capacity in Well-Conditioned Power Training Athletes.",randomized_controlled_trial,benefit,"The study shows significant increases in choline concentrations and improvements in antioxidant capacity, indicating a benefit from the intervention.",2.5 g daily 12 weeks (Neptune krill oil),Athletes,,athletic performance,athletic performance; explosive strength; muscle fatigue; oxidative stress,,,
Choline,adverse reactions; consent withdrawal; fishy body odor in 36% of choline group,Exercise Induced Inflammation,,Performance & Recovery,manual_pair,"The evidence for choline supplementation in improving low exercise performance is limited but suggests potential benefits. Two studies reported positive outcomes, with one using 2.5 g of Neptune krill oil daily for 12 weeks and another utilizing a single dose of a multi-ingredient choline supplement before testing. However, the overall quality and consistency of the evidence are low, and further research is needed to confirm these findings.",0.6,34769925,2021,Choline-Based Multi-Ingredient Supplementation Can Improve Explosive Strength during a Fatiguing Task.,randomized_controlled_trial,benefit,"The study found that the choline-based supplement improved explosive strength and delayed fatigue onset, indicating a beneficial outcome.",single dose 60 min before testing (multi-ingredient supplement),Football Players; Men,,explosive strength,athletic performance; explosive strength; muscle fatigue; oxidative stress,,,
Choline,adverse reactions; consent withdrawal; fishy body odor in 36% of choline group,Strength,,Performance & Recovery,manual_pair,"One randomized trial indicates that higher choline intake (ranging from 0.7 to 7.5 mg/kg lean body mass per day) may improve muscle strength and quality in older adults participating in resistance training. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term effects and safety.",0.7,37764658,2023,The Effect of Choline and Resistance Training on Strength and Lean Mass in Older Adults.,randomized_controlled_trial,benefit,The study shows that higher choline intake is associated with better strength gains and muscle quality in older adults undergoing resistance training.,0.7 mg/kg lean/d 12 weeks (egg yolk and protein powder); 2.8 mg/kg lean/d 12 weeks (egg yolk and protein powder); 7.5 mg/kg lean/d 12 weeks (egg yolk and protein powder),Older Adults,,lean mass,lean mass; muscle quality; strength gains,,,
Choline,adverse reactions; consent withdrawal; fishy body odor in 36% of choline group,Low HDL,,Heart & Vascular Health,manual_pair,"One randomized trial has shown that choline supplementation (400 mg daily for 4 weeks) may provide benefits related to oxidative stress protection in individuals with metabolic syndrome, as indicated by increased plasma lutein and zeaxanthin levels. However, the evidence is limited, with only one study reporting a benefit and no adverse effects noted. Further research is needed to establish the consistency and robustness of these findings.",0.7,35334836,2022,Comparison between Egg Intake versus Choline Supplementation on Gut Microbiota and Plasma Carotenoids in Subjects with Metabolic Syndrome.,randomized_controlled_trial,benefit,"The study shows significant increases in plasma lutein and zeaxanthin after egg intake, indicating a benefit related to oxidative stress protection.",400 mg daily 4 weeks (choline bitartrate),,,metabolic syndrome,metabolic syndrome,Tier 5,0.9,"This randomized crossover trial compared eggs (phosphatidylcholine) vs choline bitartrate and evaluated gut microbiota, TMAO, and plasma carotenoids. HDL was not a prespecified outcome and no treatment effect on HDL was reported; only a non-interventional correlation between bacterial diversity and HDL was mentioned. Thus, the study does not provide direct evidence on choline for low HDL."
Choline,adverse reactions; consent withdrawal; fishy body odor in 36% of choline group,Schizophrenia,,"Energy, Mood, & Mental Health",manual_pair,"The evidence for choline, specifically CDP-choline, in the treatment of schizophrenia is limited and mixed. One pilot study reported a benefit in generating mismatch negativity (MMN) in healthy volunteers, while another study showed mixed results with significant improvements in specific subgroups but no overall main treatment effect. Doses of 500 mg were consistently reported, but the overall quality of evidence is low and further research is needed.",0.7,36927273,2023,An α7 nAChR approach for the baseline-dependent modulation of deviance detection in schizophrenia: A pilot study assessing the combined effect of CDP-choline and galantamine.,randomized_controlled_trial,mixed_unclear,The study showed mixed results with significant improvements in specific subgroups but no main treatment effect overall.,500 mg (CDP-choline); 16 mg (galantamine),,,schizophrenia,schizophrenia,,,
Choline,adverse reactions; consent withdrawal; fishy body odor in 36% of choline group,Schizophrenia,,"Energy, Mood, & Mental Health",manual_pair,"The evidence for choline, specifically CDP-choline, in the treatment of schizophrenia is limited and mixed. One pilot study reported a benefit in generating mismatch negativity (MMN) in healthy volunteers, while another study showed mixed results with significant improvements in specific subgroups but no overall main treatment effect. Doses of 500 mg were consistently reported, but the overall quality of evidence is low and further research is needed.",0.7,32851421,2020,"CDP-choline and galantamine, a personalized α7 nicotinic acetylcholine receptor targeted treatment for the modulation of speech MMN indexed deviance detection in healthy volunteers: a pilot study.",randomized_controlled_trial,benefit,"The study shows an increase in MMN generation, indicating a benefit from the treatment.",500 mg,,,schizophrenia,schizophrenia,,,
Chondroitin,DMSO should be used with caution and with active monitoring of side effects; Headache; adverse events reported; changes in glucose tolerance; knee tumefaction,Gastric Reflux,,Gut Health,manual_pair,"There is limited evidence suggesting that a hyaluronic acid-chondroitin sulfate formulation (Esoxx) may improve symptoms and quality of life in patients with non-erosive reflux disease, based on one randomized clinical trial. No adverse effects or harm were reported in the study, but the overall evidence is sparse and further research is needed to confirm these findings.",0.7,28116754,2017,"Randomised clinical trial: mucosal protection combined with acid suppression in the treatment of non-erosive reflux disease - efficacy of Esoxx, a hyaluronic acid-chondroitin sulphate based bioadhesive formulation.",randomized_controlled_trial,benefit,"The study showed a significant improvement in symptoms and quality of life with Esoxx compared to placebo, indicating a benefit.",2 weeks (Esoxx),,,acid regurgitation,acid regurgitation; acid taste in the mouth; heartburn; non-erosive reflux disease; retrosternal pain,,,
Chondroitin,DMSO should be used with caution and with active monitoring of side effects; Headache; adverse events reported; changes in glucose tolerance; knee tumefaction,Elbow Pain,,Musculoskeletal & Pain,manual_pair,"There is limited evidence suggesting that a combination of sodium hyaluronate and chondroitin sulfate may provide better pain relief in patients with lateral epicondylitis compared to corticosteroids, based on one randomized trial. However, the overall quality and quantity of evidence are low, and further studies are needed to confirm these findings and assess long-term effects and safety.",0.7,26133944,2015,Comparison of the effects of sodium hyaluronate-chondroitin sulphate and corticosteroid in the treatment of lateral epicondylitis: a prospective randomized trial.,randomized_controlled_trial,benefit,"The study shows that HA + CS provides better pain relief compared to triamcinolone, indicating a benefit.",null null single injection 6 months (HA + CS combination),Lateral Epicondylitis,,lateral epicondylitis,lateral epicondylitis,Tier 4,0.46,"Human RCT in lateral epicondylitis showed benefit, but the intervention was a hyaluronic acid + chondroitin sulfate combination versus corticosteroid, so the effect cannot be attributed to chondroitin alone. Small sample size (~57) and unclear blinding further limit quality. Injection formulation also limits generalizability to typical supplement use."
Chondroitin,DMSO should be used with caution and with active monitoring of side effects; Headache; adverse events reported; changes in glucose tolerance; knee tumefaction,Temporomandibular Joint Syndrome,,Oral Health,manual_pair,"One randomized trial reported a benefit of chondroitin (1200 mg daily for 8 weeks) in improving maximum mouth opening and reducing inflammatory cytokines in patients with temporomandibular joint disorders. However, the overall evidence is limited, with only one study available, and no adverse effects were noted. Further research is needed to confirm these findings and establish the efficacy of chondroitin for jaw pain.",0.7,25662545,2015,"Effects of glucosamine-chondroitin combination on synovial fluid IL-1β, IL-6, TNF-α and PGE2 levels in internal derangements of temporomandibular joint.",randomized_controlled_trial,benefit,"The study showed significant improvement in maximum mouth opening and reduction in inflammatory cytokines in the study group, indicating a benefit from the chondroitin intervention.",1200 mg daily 8 weeks (sulphate),,,temporomandibular joint disorders,temporomandibular joint disorders,,,
Chondroitin,DMSO should be used with caution and with active monitoring of side effects; Headache; adverse events reported; changes in glucose tolerance; knee tumefaction,Joint Pain,,Musculoskeletal & Pain,manual_pair,"Clinical evidence from three randomized trials indicates that chondroitin, often combined with glucosamine, may provide benefits in reducing joint pain and improving functional capacity in patients with osteoarthritis. Doses reported include 375 mg once daily and 1500 mg daily, with no studies indicating harm or lack of benefit. However, the overall quality of evidence and long-term effects remain unclear, necessitating further research.",0.8,29701488,2019,"Effectiveness of a Dietary Supplement Containing Hydrolyzed Collagen, Chondroitin Sulfate, and Glucosamine in Pain Reduction and Functional Capacity in Osteoarthritis Patients.",clinical_trial,benefit,"The study shows significant reductions in pain and improvements in functional capacity, indicating a beneficial effect of the supplement.","6 months (dietary supplement containing hydrolyzed gelatin, chondroitin sulfate, glucosamine sulfate, and other extracts)",Osteoarthritis,,functional capacity improvement,functional capacity improvement; osteoarthritis; pain reduction,,,
Chondroitin,DMSO should be used with caution and with active monitoring of side effects; Headache; adverse events reported; changes in glucose tolerance; knee tumefaction,Joint Pain,,Musculoskeletal & Pain,manual_pair,"Clinical evidence from three randomized trials indicates that chondroitin, often combined with glucosamine, may provide benefits in reducing joint pain and improving functional capacity in patients with osteoarthritis. Doses reported include 375 mg once daily and 1500 mg daily, with no studies indicating harm or lack of benefit. However, the overall quality of evidence and long-term effects remain unclear, necessitating further research.",0.8,30648524,2020,"Differences in Serum Biomarkers Between Combined Glucosamine and Chondroitin Versus Celecoxib in a Randomized, Double-blind Trial in Osteoarthritis Patients.",randomized_controlled_trial,benefit,"The study shows that GH+CS reduces IL-6, indicating a beneficial effect on inflammation in osteoarthritis patients.",1500 mg daily 6 months (combined glucosamine hydrochloride plus chondroitin sulfate),,,osteoarthritis,functional capacity improvement; osteoarthritis; pain reduction,Tier 3,0.55,"Randomized, double-blind human trial in osteoarthritis patients, but the outcomes were serum inflammatory biomarkers (e.g., IL-6 reduction) rather than clinical joint pain or function. The supplement was a combination of glucosamine plus chondroitin, making attribution to chondroitin alone uncertain. As a result, this provides preliminary human evidence based on surrogate endpoints rather than direct clinical outcomes."
Chondroitin,DMSO should be used with caution and with active monitoring of side effects; Headache; adverse events reported; changes in glucose tolerance; knee tumefaction,Joint Pain,,Musculoskeletal & Pain,manual_pair,"Clinical evidence from three randomized trials indicates that chondroitin, often combined with glucosamine, may provide benefits in reducing joint pain and improving functional capacity in patients with osteoarthritis. Doses reported include 375 mg once daily and 1500 mg daily, with no studies indicating harm or lack of benefit. However, the overall quality of evidence and long-term effects remain unclear, necessitating further research.",0.8,28657529,2017,Comparison of the efficacy and tolerability of chondroitin plus glucosamine and D-002 (beeswax alcohols) in subjects with osteoarthritis symptoms.,randomized_controlled_trial,benefit,"The study shows significant reductions in OA symptoms, indicating a benefit from the treatment.",375 mg once daily 12 weeks (Chondroitin plus glucosamine),Osteoarthritis,,osteoarthritis,functional capacity improvement; osteoarthritis; pain reduction,,,
Chondroitin,DMSO should be used with caution and with active monitoring of side effects; Headache; adverse events reported; changes in glucose tolerance; knee tumefaction,Joint Pain,,Musculoskeletal & Pain,manual_pair,"The evidence for chondroitin in the treatment of knee chondropathy is low quality, with a single study reporting mixed and unclear outcomes regarding pain reduction and recovery, though results were not statistically significant. No consistent dose ranges were reported, and there were no documented harms associated with its use.",0.7,32118508,2020,Phonophoretic application of a glucosamine and chondroitin nanoemulsion for treatment of knee chondropathies.,randomized_controlled_trial,mixed_unclear,"The study showed some pain reduction and recovery in patients, but results were not statistically significant.",(nanoemulsion),Chondropathy,,knee chondropathy,knee chondropathy,,,
Chondroitin,DMSO should be used with caution and with active monitoring of side effects; Headache; adverse events reported; changes in glucose tolerance; knee tumefaction,Osteoarthritis,,Musculoskeletal & Pain,manual_pair,"The evidence from randomized trials indicates that chondroitin sulfate may provide benefits in reducing knee pain and improving function in patients with osteoarthritis, with several studies reporting positive outcomes at doses such as 800 mg daily and 400 mg three times daily. However, one study showed mixed results, indicating no significant symptomatic benefit despite some structural improvements, suggesting that the overall evidence is promising but not unequivocal. No significant harms were reported.",0.8,27716158,2016,Effect of chondroitin sulfate on soluble biomarkers of osteoarthritis: a method to analyze and interpret the results from an open-label trial in unilateral knee osteoarthritis patients.,clinical_trial,benefit,"The study shows significant improvements in pain and function, indicating a beneficial effect of chondroitin sulfate.",800 mg daily,,,function,function; knee osteoarthritis; knee pain; knee stiffness; musculoskeletal pain; osteoarthritis; pain; synovitis,,,
Chondroitin,DMSO should be used with caution and with active monitoring of side effects; Headache; adverse events reported; changes in glucose tolerance; knee tumefaction,Osteoarthritis,,Musculoskeletal & Pain,manual_pair,"The evidence from randomized trials indicates that chondroitin sulfate may provide benefits in reducing knee pain and improving function in patients with osteoarthritis, with several studies reporting positive outcomes at doses such as 800 mg daily and 400 mg three times daily. However, one study showed mixed results, indicating no significant symptomatic benefit despite some structural improvements, suggesting that the overall evidence is promising but not unequivocal. No significant harms were reported.",0.8,30657100,2018,"Multicenter, randomized, double-blind clinical trial to evaluate efficacy and safety of combined glucosamine sulfate and chondroitin sulfate capsules for treating knee osteoarthritis.",randomized_controlled_trial,benefit,"The study demonstrated non-inferiority of the new formulation compared to the control, indicating a benefit in treating knee OA.",12 weeks (capsules),,,knee osteoarthritis,function; knee osteoarthritis; knee pain; knee stiffness; musculoskeletal pain; osteoarthritis; pain; synovitis,,,
Chondroitin,DMSO should be used with caution and with active monitoring of side effects; Headache; adverse events reported; changes in glucose tolerance; knee tumefaction,Osteoarthritis,,Musculoskeletal & Pain,manual_pair,"The evidence from randomized trials indicates that chondroitin sulfate may provide benefits in reducing knee pain and improving function in patients with osteoarthritis, with several studies reporting positive outcomes at doses such as 800 mg daily and 400 mg three times daily. However, one study showed mixed results, indicating no significant symptomatic benefit despite some structural improvements, suggesting that the overall evidence is promising but not unequivocal. No significant harms were reported.",0.8,28245911,2017,Effect of chondroitin sulphate on synovitis of knee osteoarthritic patients.,randomized_controlled_trial,benefit,"Chondroitin sulfate showed a significant reduction in synovitis and improvement in pain, indicating a beneficial effect.",6 months (chondroitin sulfate),Osteoarthritis,,knee osteoarthritis,function; knee osteoarthritis; knee pain; knee stiffness; musculoskeletal pain; osteoarthritis; pain; synovitis,,,
Chondroitin,DMSO should be used with caution and with active monitoring of side effects; Headache; adverse events reported; changes in glucose tolerance; knee tumefaction,Osteoarthritis,,Musculoskeletal & Pain,manual_pair,"The evidence from randomized trials indicates that chondroitin sulfate may provide benefits in reducing knee pain and improving function in patients with osteoarthritis, with several studies reporting positive outcomes at doses such as 800 mg daily and 400 mg three times daily. However, one study showed mixed results, indicating no significant symptomatic benefit despite some structural improvements, suggesting that the overall evidence is promising but not unequivocal. No significant harms were reported.",0.8,25085275,2015,"Combined glucosamine and chondroitin sulfate, once or three times daily, provides clinically relevant analgesia in knee osteoarthritis.",randomized_controlled_trial,benefit,"The study shows significant pain reduction in knee osteoarthritis patients, indicating a benefit from the treatment.",400 mg three times daily 16 weeks (capsules or sachet),,,knee osteoarthritis,function; knee osteoarthritis; knee pain; knee stiffness; musculoskeletal pain; osteoarthritis; pain; synovitis,,,
Chondroitin,DMSO should be used with caution and with active monitoring of side effects; Headache; adverse events reported; changes in glucose tolerance; knee tumefaction,Osteoarthritis,,Musculoskeletal & Pain,manual_pair,"The evidence from randomized trials indicates that chondroitin sulfate may provide benefits in reducing knee pain and improving function in patients with osteoarthritis, with several studies reporting positive outcomes at doses such as 800 mg daily and 400 mg three times daily. However, one study showed mixed results, indicating no significant symptomatic benefit despite some structural improvements, suggesting that the overall evidence is promising but not unequivocal. No significant harms were reported.",0.8,24395557,2015,Glucosamine and chondroitin for knee osteoarthritis: a double-blind randomised placebo-controlled clinical trial evaluating single and combination regimens.,randomized_controlled_trial,mixed_unclear,The study showed a significant reduction in joint space narrowing but no significant symptomatic benefit for knee pain compared to placebo.,800 mg once daily 2 years (sulfate),Osteoarthritis,,knee osteoarthritis,function; knee osteoarthritis; knee pain; knee stiffness; musculoskeletal pain; osteoarthritis; pain; synovitis,,,
Chondroitin,DMSO should be used with caution and with active monitoring of side effects; Headache; adverse events reported; changes in glucose tolerance; knee tumefaction,Osteoarthritis,,Musculoskeletal & Pain,manual_pair,"The evidence from randomized trials indicates that chondroitin sulfate may provide benefits in reducing knee pain and improving function in patients with osteoarthritis, with several studies reporting positive outcomes at doses such as 800 mg daily and 400 mg three times daily. However, one study showed mixed results, indicating no significant symptomatic benefit despite some structural improvements, suggesting that the overall evidence is promising but not unequivocal. No significant harms were reported.",0.8,30498336,2018,Effectiveness of Cucumis sativus extract versus glucosamine-chondroitin in the management of moderate osteoarthritis: a randomized controlled trial.,randomized_controlled_trial,benefit,"The study showed a greater reduction in pain scores for the CSE group compared to the GC group, indicating a benefit from the intervention.",1350 mg twice daily 180 days (oral),Osteoarthritis,,knee pain,function; knee osteoarthritis; knee pain; knee stiffness; musculoskeletal pain; osteoarthritis; pain; synovitis,,,
Chondroitin,DMSO should be used with caution and with active monitoring of side effects; Headache; adverse events reported; changes in glucose tolerance; knee tumefaction,Osteoarthritis,,Musculoskeletal & Pain,manual_pair,"The evidence from randomized trials indicates that chondroitin sulfate may provide benefits in reducing knee pain and improving function in patients with osteoarthritis, with several studies reporting positive outcomes at doses such as 800 mg daily and 400 mg three times daily. However, one study showed mixed results, indicating no significant symptomatic benefit despite some structural improvements, suggesting that the overall evidence is promising but not unequivocal. No significant harms were reported.",0.8,26178634,2016,"Effects of N-acetyl glucosamine and chondroitin sulfate supplementation on knee pain and self-reported knee function in middle-aged and older Japanese adults: a randomized, double-blind, placebo-controlled trial.",randomized_controlled_trial,benefit,"The study showed a positive effect on self-reported knee function and household physical activity, indicating a benefit from the supplementation.",180 mg daily 24 weeks (sulfate),,,knee pain,function; knee osteoarthritis; knee pain; knee stiffness; musculoskeletal pain; osteoarthritis; pain; synovitis,,,
Chondroitin,DMSO should be used with caution and with active monitoring of side effects; Headache; adverse events reported; changes in glucose tolerance; knee tumefaction,Joint Pain,,Musculoskeletal & Pain,manual_pair,"Chondroitin sulfate has been associated with beneficial effects in reducing knee pain and improving function in patients with osteoarthritis, as evidenced by multiple randomized trials. Typical doses reported range from 600 mg to 1200 mg daily, with no studies indicating significant harm. However, the evidence is primarily positive with one study showing mixed outcomes, suggesting that while chondroitin sulfate may be effective, results can vary among individuals.",0.85,25306673,2014,[Clinical use of chondroitin sulfate in patients with osteoarthritis in geriatric practice].,clinical_trial,benefit,"The study shows sufficient decrease in pain and functional disorders, indicating a benefit from chondroitin sulfate therapy.",2 months,Osteoarthritis,,functional disorders,functional disorders; knee osteoarthritis; musculoskeletal pain; osteoarthritis of the knee; osteoarthritis of the knee joint; pain,,,
Chondroitin,DMSO should be used with caution and with active monitoring of side effects; Headache; adverse events reported; changes in glucose tolerance; knee tumefaction,Joint Pain,,Musculoskeletal & Pain,manual_pair,"Chondroitin sulfate has been associated with beneficial effects in reducing knee pain and improving function in patients with osteoarthritis, as evidenced by multiple randomized trials. Typical doses reported range from 600 mg to 1200 mg daily, with no studies indicating significant harm. However, the evidence is primarily positive with one study showing mixed outcomes, suggesting that while chondroitin sulfate may be effective, results can vary among individuals.",0.85,39476307,2025,Cost-Effectiveness Analysis of Pharmaceutical-Grade Chondroitin Sulfate for Knee Osteoarthritis Based on Individual Patient Data from a Randomized Clinical Trial.,randomized_controlled_trial,benefit,"The study demonstrated that chondroitin sulfate was superior to placebo in reducing pain and improving function in patients with knee osteoarthritis, indicating a beneficial outcome.",800 mg daily 6 months (pharmaceutical-grade chondroitin sulfate),,,knee osteoarthritis,functional disorders; knee osteoarthritis; musculoskeletal pain; osteoarthritis of the knee; osteoarthritis of the knee joint; pain,Tier 1,0.7,"Based on individual patient data from a randomized, placebo-controlled trial (~400 participants) of pharmaceutical-grade chondroitin sulfate 800 mg/day for 6 months in knee osteoarthritis, which showed superiority over placebo in reducing pain and improving function—major clinical outcomes directly relevant to joint pain. Although the paper reports a cost-effectiveness analysis, it relies on RCT data demonstrating clinically meaningful pain benefits."
Chondroitin,DMSO should be used with caution and with active monitoring of side effects; Headache; adverse events reported; changes in glucose tolerance; knee tumefaction,Joint Pain,,Musculoskeletal & Pain,manual_pair,"Chondroitin sulfate has been associated with beneficial effects in reducing knee pain and improving function in patients with osteoarthritis, as evidenced by multiple randomized trials. Typical doses reported range from 600 mg to 1200 mg daily, with no studies indicating significant harm. However, the evidence is primarily positive with one study showing mixed outcomes, suggesting that while chondroitin sulfate may be effective, results can vary among individuals.",0.85,33468249,2021,"Treatment of knee osteoarthritis with a new formulation of a fixed-dose combination of glucosamine sulfate and bovine chondroitin: a multicenter, randomized, single-blind, non-inferiority clinical trial.",randomized_controlled_trial,benefit,"The study demonstrated non-inferiority of the GS/CS combination compared to the reference product, indicating a benefit in treating knee osteoarthritis.",1500 mg 24 weeks (fixed-dose combination),Osteoarthritis,,knee osteoarthritis,functional disorders; knee osteoarthritis; musculoskeletal pain; osteoarthritis of the knee; osteoarthritis of the knee joint; pain,Tier 2,0.58,"Large multicenter randomized controlled trial with a primary clinical pain outcome (WOMAC pain) showing benefit over 24 weeks. However, it was single-blind, used a non-inferiority design versus an active reference, and tested a fixed-dose combination of chondroitin plus glucosamine rather than chondroitin alone, making the evidence indirect for chondroitin as a standalone supplement for joint pain."
Chondroitin,DMSO should be used with caution and with active monitoring of side effects; Headache; adverse events reported; changes in glucose tolerance; knee tumefaction,Joint Pain,,Musculoskeletal & Pain,manual_pair,"Chondroitin sulfate has been associated with beneficial effects in reducing knee pain and improving function in patients with osteoarthritis, as evidenced by multiple randomized trials. Typical doses reported range from 600 mg to 1200 mg daily, with no studies indicating significant harm. However, the evidence is primarily positive with one study showing mixed outcomes, suggesting that while chondroitin sulfate may be effective, results can vary among individuals.",0.85,33213125,2020,"Effect of an oral preparation containing hyaluronic acid, chondroitin sulfate, hydrolyzed collagen type II and hydrolyzed keratin on synovial fluid features and clinical indices in knee osteoarthritis. A pilot study.",randomized_controlled_trial,benefit,"The study showed significant improvements in clinical indices for the treatment group, indicating a beneficial effect of the supplement.",240 mg once a day 4 weeks (dietary supplement),,,knee osteoarthritis,functional disorders; knee osteoarthritis; musculoskeletal pain; osteoarthritis of the knee; osteoarthritis of the knee joint; pain,,,
Chondroitin,DMSO should be used with caution and with active monitoring of side effects; Headache; adverse events reported; changes in glucose tolerance; knee tumefaction,Joint Pain,,Musculoskeletal & Pain,manual_pair,"Chondroitin sulfate has been associated with beneficial effects in reducing knee pain and improving function in patients with osteoarthritis, as evidenced by multiple randomized trials. Typical doses reported range from 600 mg to 1200 mg daily, with no studies indicating significant harm. However, the evidence is primarily positive with one study showing mixed outcomes, suggesting that while chondroitin sulfate may be effective, results can vary among individuals.",0.85,31470599,2019,"Effectiveness of Non-Animal Chondroitin Sulfate Supplementation in the Treatment of Moderate Knee Osteoarthritis in a Group of Overweight Subjects: A Randomized, Double-Blind, Placebo-Controlled Pilot Study.",randomized_controlled_trial,benefit,"The study shows significant improvements in knee function, pain, and inflammation markers, indicating a beneficial effect of chondroitin supplementation.",600 mg daily 12 weeks (non-animal chondroitin sulfate),,,knee osteoarthritis,functional disorders; knee osteoarthritis; musculoskeletal pain; osteoarthritis of the knee; osteoarthritis of the knee joint; pain,,,
Chondroitin,DMSO should be used with caution and with active monitoring of side effects; Headache; adverse events reported; changes in glucose tolerance; knee tumefaction,Joint Pain,,Musculoskeletal & Pain,manual_pair,"Chondroitin sulfate has been associated with beneficial effects in reducing knee pain and improving function in patients with osteoarthritis, as evidenced by multiple randomized trials. Typical doses reported range from 600 mg to 1200 mg daily, with no studies indicating significant harm. However, the evidence is primarily positive with one study showing mixed outcomes, suggesting that while chondroitin sulfate may be effective, results can vary among individuals.",0.85,29451036,2018,Pharmaceutical-grade chondroitin sulfate in the management of knee osteoarthritis.,randomized_controlled_trial,benefit,The study shows that chondroitin sulfate is superior to placebo and similar to celecoxib in reducing pain and improving function.,800 mg daily 6 months (pharmaceutical-grade),Osteoarthritis,,knee osteoarthritis,functional disorders; knee osteoarthritis; musculoskeletal pain; osteoarthritis of the knee; osteoarthritis of the knee joint; pain,Tier 1,0.87,"Large, well-designed double-blind RCT (n≈604) in knee osteoarthritis showed pharmaceutical-grade chondroitin sulfate 800 mg/day reduced pain and improved function versus placebo and was similar to celecoxib. Pain/function were primary clinical outcomes, directly relevant to joint pain. Minor caveat: results pertain to pharmaceutical-grade CS and OA-related joint pain specifically."
Chondroitin,DMSO should be used with caution and with active monitoring of side effects; Headache; adverse events reported; changes in glucose tolerance; knee tumefaction,Joint Pain,,Musculoskeletal & Pain,manual_pair,"Chondroitin sulfate has been associated with beneficial effects in reducing knee pain and improving function in patients with osteoarthritis, as evidenced by multiple randomized trials. Typical doses reported range from 600 mg to 1200 mg daily, with no studies indicating significant harm. However, the evidence is primarily positive with one study showing mixed outcomes, suggesting that while chondroitin sulfate may be effective, results can vary among individuals.",0.85,29176264,2018,"Efficacy of Chondroitin Sulfate for Painful Knee Osteoarthritis: A One-Year, Randomized, Double-Blind, Multicenter Clinical Study in Japan.",randomized_controlled_trial,benefit,"The study found that chondroitin sulfate improved pain control in knee osteoarthritis, indicating a beneficial outcome.",260 mg daily one year (oral); 1560 mg daily one year (oral),Osteoarthritis,,knee osteoarthritis,functional disorders; knee osteoarthritis; musculoskeletal pain; osteoarthritis of the knee; osteoarthritis of the knee joint; pain,,,
Chondroitin,DMSO should be used with caution and with active monitoring of side effects; Headache; adverse events reported; changes in glucose tolerance; knee tumefaction,Joint Pain,,Musculoskeletal & Pain,manual_pair,"Chondroitin sulfate has been associated with beneficial effects in reducing knee pain and improving function in patients with osteoarthritis, as evidenced by multiple randomized trials. Typical doses reported range from 600 mg to 1200 mg daily, with no studies indicating significant harm. However, the evidence is primarily positive with one study showing mixed outcomes, suggesting that while chondroitin sulfate may be effective, results can vary among individuals.",0.85,28790224,2017,Comparison of Glucosamine-Chondroitin Sulfate with and without Methylsulfonylmethane in Grade I-II Knee Osteoarthritis: A Double Blind Randomized Controlled Trial.,randomized_controlled_trial,benefit,The study found significant clinical benefits for the combination treatment including chondroitin for knee osteoarthritis.,1200 mg once daily 3 months,Osteoarthritis,,knee osteoarthritis,functional disorders; knee osteoarthritis; musculoskeletal pain; osteoarthritis of the knee; osteoarthritis of the knee joint; pain,,,
Chondroitin,DMSO should be used with caution and with active monitoring of side effects; Headache; adverse events reported; changes in glucose tolerance; knee tumefaction,Joint Pain,,Musculoskeletal & Pain,manual_pair,"Chondroitin sulfate has been associated with beneficial effects in reducing knee pain and improving function in patients with osteoarthritis, as evidenced by multiple randomized trials. Typical doses reported range from 600 mg to 1200 mg daily, with no studies indicating significant harm. However, the evidence is primarily positive with one study showing mixed outcomes, suggesting that while chondroitin sulfate may be effective, results can vary among individuals.",0.85,28533290,2017,Pharmaceutical-grade Chondroitin sulfate is as effective as celecoxib and superior to placebo in symptomatic knee osteoarthritis: the ChONdroitin versus CElecoxib versus Placebo Trial (CONCEPT).,randomized_controlled_trial,benefit,"Chondroitin sulfate showed significant pain reduction and improvement in function compared to placebo, indicating a beneficial effect.",800 mg daily 6 months (pharmaceutical-grade),Osteoarthritis,,knee osteoarthritis,functional disorders; knee osteoarthritis; musculoskeletal pain; osteoarthritis of the knee; osteoarthritis of the knee joint; pain,,,
Chondroitin,DMSO should be used with caution and with active monitoring of side effects; Headache; adverse events reported; changes in glucose tolerance; knee tumefaction,Joint Pain,,Musculoskeletal & Pain,manual_pair,"Chondroitin sulfate has been associated with beneficial effects in reducing knee pain and improving function in patients with osteoarthritis, as evidenced by multiple randomized trials. Typical doses reported range from 600 mg to 1200 mg daily, with no studies indicating significant harm. However, the evidence is primarily positive with one study showing mixed outcomes, suggesting that while chondroitin sulfate may be effective, results can vary among individuals.",0.85,27809891,2016,Chondroitin sulfate efficacy versus celecoxib on knee osteoarthritis structural changes using magnetic resonance imaging: a 2-year multicentre exploratory study.,randomized_controlled_trial,benefit,"The study demonstrated that chondroitin sulfate significantly reduced cartilage volume loss compared to celecoxib, indicating a benefit for knee osteoarthritis patients.",1200 mg daily 24 months,,,knee osteoarthritis,functional disorders; knee osteoarthritis; musculoskeletal pain; osteoarthritis of the knee; osteoarthritis of the knee joint; pain,,,
Chondroitin,DMSO should be used with caution and with active monitoring of side effects; Headache; adverse events reported; changes in glucose tolerance; knee tumefaction,Joint Pain,,Musculoskeletal & Pain,manual_pair,"Chondroitin sulfate has been associated with beneficial effects in reducing knee pain and improving function in patients with osteoarthritis, as evidenced by multiple randomized trials. Typical doses reported range from 600 mg to 1200 mg daily, with no studies indicating significant harm. However, the evidence is primarily positive with one study showing mixed outcomes, suggesting that while chondroitin sulfate may be effective, results can vary among individuals.",0.85,26937646,2016,"The efficacy and safety of a combination of glucosamine hydrochloride, chondroitin sulfate and bio-curcumin with exercise in the treatment of knee osteoarthritis: a randomized, double-blind, placebo-controlled study.",randomized_controlled_trial,benefit,The study found significant improvements in pain and function in knee OA patients receiving the supplement.,2 tablets daily 8 weeks (CartiJoint Forte),Osteoarthritis,,knee osteoarthritis,functional disorders; knee osteoarthritis; musculoskeletal pain; osteoarthritis of the knee; osteoarthritis of the knee joint; pain,,,
Chondroitin,DMSO should be used with caution and with active monitoring of side effects; Headache; adverse events reported; changes in glucose tolerance; knee tumefaction,Joint Pain,,Musculoskeletal & Pain,manual_pair,"Chondroitin sulfate has been associated with beneficial effects in reducing knee pain and improving function in patients with osteoarthritis, as evidenced by multiple randomized trials. Typical doses reported range from 600 mg to 1200 mg daily, with no studies indicating significant harm. However, the evidence is primarily positive with one study showing mixed outcomes, suggesting that while chondroitin sulfate may be effective, results can vary among individuals.",0.85,25589511,2016,"Combined chondroitin sulfate and glucosamine for painful knee osteoarthritis: a multicentre, randomised, double-blind, non-inferiority trial versus celecoxib.",randomized_controlled_trial,benefit,The study demonstrated comparable efficacy of chondroitin plus glucosamine to celecoxib in reducing pain and improving function in knee osteoarthritis.,400 mg three times a day 6 months,Osteoarthritis,,knee osteoarthritis,functional disorders; knee osteoarthritis; musculoskeletal pain; osteoarthritis of the knee; osteoarthritis of the knee joint; pain,,,
Chondroitin,DMSO should be used with caution and with active monitoring of side effects; Headache; adverse events reported; changes in glucose tolerance; knee tumefaction,Joint Pain,,Musculoskeletal & Pain,manual_pair,"Chondroitin sulfate has been associated with beneficial effects in reducing knee pain and improving function in patients with osteoarthritis, as evidenced by multiple randomized trials. Typical doses reported range from 600 mg to 1200 mg daily, with no studies indicating significant harm. However, the evidence is primarily positive with one study showing mixed outcomes, suggesting that while chondroitin sulfate may be effective, results can vary among individuals.",0.85,38785054,2023,"[Comparative efficacy of a combination of undenatured type II collagen, Boswellic acids, methylsulfonylmethane, vitamins C and D3 and a combination of chondroitin sulfate and glucosamine hydrochloride in the treatment of primary osteoarthritis of the knee joint].",randomized_controlled_trial,mixed_unclear,"The study showed improvements in WOMAC index and pain, but no significant intergroup differences, indicating mixed outcomes.",1 capsule per day 6 months (Artneo),Osteoarthritis,,osteoarthritis of the knee joint,functional disorders; knee osteoarthritis; musculoskeletal pain; osteoarthritis of the knee; osteoarthritis of the knee joint; pain,,,
Chondroitin,DMSO should be used with caution and with active monitoring of side effects; Headache; adverse events reported; changes in glucose tolerance; knee tumefaction,UTI,,Kidney & Bladder Health,manual_pair,"Chondroitin, when used in combination with other agents, has shown beneficial effects in preventing recurrent urinary tract infections (rUTIs) in two randomized controlled trials. Both studies reported significant reductions in rUTI episodes and improvements in quality of life, although specific dose ranges were not consistently reported. No adverse effects were noted in the studies, but further research may be needed to confirm these findings and establish optimal dosing.",0.9,40162673,2025,"Adding collagen, propolis plus quercetin, bacillus coagulans, hyaluronic acid and chondroitin sulphate to D-mannose avoids symptoms and prevents recurrence in women with recurrent urinary tract infections: a single-blind randomized controlled trial.",randomized_controlled_trial,benefit,"The study demonstrated a significant reduction in rUTI episodes and improvement in quality of life, indicating a beneficial outcome from the combination therapy.","12 months (dietary supplement with D-mannose, Propolis-Quercetin, Bacillus Coagulans, Hyaluronic Acid and Chondroitin Sulfate)",,,recurrent urinary tract infections,recurrent urinary tract infections; urogenital atrophy,,,
Chondroitin,DMSO should be used with caution and with active monitoring of side effects; Headache; adverse events reported; changes in glucose tolerance; knee tumefaction,UTI,,Kidney & Bladder Health,manual_pair,"Chondroitin, when used in combination with other agents, has shown beneficial effects in preventing recurrent urinary tract infections (rUTIs) in two randomized controlled trials. Both studies reported significant reductions in rUTI episodes and improvements in quality of life, although specific dose ranges were not consistently reported. No adverse effects were noted in the studies, but further research may be needed to confirm these findings and establish optimal dosing.",0.9,27838537,2016,"Efficacy of an orally administered combination of hyaluronic acid, chondroitin sulfate, curcumin and quercetin for the prevention of recurrent urinary tract infections in postmenopausal women.",clinical_trial,benefit,"The study showed significant improvement in preventing recurrent urinary tract infections with the combination therapy, especially when combined with local estrogen therapy.",6 months (oral),,,recurrent urinary tract infections,recurrent urinary tract infections; urogenital atrophy,,,
Chondroitin,DMSO should be used with caution and with active monitoring of side effects; Headache; adverse events reported; changes in glucose tolerance; knee tumefaction,Inflammation,,"Immune, Inflammation, & Infection",manual_pair,"One randomized trial reported that chondroitin supplementation (1200 mg daily for 28 days) resulted in a significant reduction in serum CRP concentrations, suggesting a potential benefit in reducing systemic inflammation. However, the overall evidence is limited, with only one study demonstrating this effect and no additional trials to confirm consistency or address potential adverse effects.",0.7,25719429,2015,Randomized trial of glucosamine and chondroitin supplementation on inflammation and oxidative stress biomarkers and plasma proteomics profiles in healthy humans.,randomized_controlled_trial,benefit,"The study found a significant reduction in serum CRP concentrations, indicating a benefit in reducing systemic inflammation.",1200 mg daily 28 days,Overweight,,inflammation,inflammation; oxidative stress,,,
Chondroitin,DMSO should be used with caution and with active monitoring of side effects; Headache; adverse events reported; changes in glucose tolerance; knee tumefaction,Gastritis,,Gut Health,manual_pair,"One study has shown that a medical device containing chondroitin sulfate, used for 5 weeks, resulted in significant improvement in gastritis-related pain and discomfort. However, the evidence is limited to this single trial, and further research is needed to confirm these findings and assess the consistency of the results across different populations and formulations.",0.7,29796851,2018,"A hyaluronic acid- and chondroitin sulfate-based medical device improves gastritis pain, discomfort, and endoscopic features.",randomized_controlled_trial,benefit,"The study showed significant improvement in gastritis-related pain and endoscopic features, indicating a beneficial outcome.",5 weeks (medical device),,,gastritis,gastritis,,,
Chondroitin,DMSO should be used with caution and with active monitoring of side effects; Headache; adverse events reported; changes in glucose tolerance; knee tumefaction,UTI,,Kidney & Bladder Health,manual_pair,"One randomized crossover trial reported a benefit of an oral preparation containing chondroitin sulfate, among other ingredients, in improving urinary symptoms in participants with recurrent urinary tract infections. The study involved a daily dose for three months, but overall evidence is limited to this single trial, indicating a need for further research to confirm these findings. No adverse effects were noted in the study.",0.8,38721680,2024,"Oral preparation of hyaluronic acid, chondroitin sulfate, N-acetylglucosamine, and vitamin C improves sexual and urinary symptoms in participants with recurrent urinary tract infections: a randomized crossover trial.",randomized_controlled_trial,benefit,"The study shows significant improvement in sexual and urinary symptoms, indicating a beneficial effect of the treatment.","1 dose once a day 3 months (oral preparation of HA, chondroitin sulfate, N-acetylglucosamine, and vitamin C); 2 doses twice a day 3 months (oral preparation of cranberry, D-mannose, propolis extract, turmeric, and Boswellia)",,Women's Health,recurrent urinary tract infections,recurrent urinary tract infections; sexual dysfunction,,,
Chromium,fewer side effects than baricitinib; long-term safety not established; slight increase in ALT; slight increase in HDL; slight increase in diastolic blood pressure; slight increase in systolic blood pressure,Weight Loss,,Weight & Body Composition,manual_pair,"Human clinical evidence suggests that chromium supplementation may have beneficial effects on body weight and metabolic profiles, particularly in specific populations such as those with metabolic syndrome and polycystic ovary syndrome. Two randomized controlled trials reported positive outcomes with doses of 200 µg to 800 µg of chromium per day over 12 weeks. However, the overall evidence is limited to a small number of studies, and further research is needed to confirm these findings and assess long-term effects.",0.8,40573153,2025,"Effects of 12 Weeks of Chromium, Phyllanthus emblica Fruit Extract, and Shilajit Supplementation on Markers of Cardiometabolic Health, Fitness, and Weight Loss in Men and Women with Risk Factors to Metabolic Syndrome Initiating an Exercise and Diet Intervention: A Randomized Double-Blind, Placebo-Controlled Trial.",randomized_controlled_trial,benefit,"The study showed benefits in improving markers related to metabolic syndrome and cardiometabolic health, indicating a positive outcome direction.",400 µg once a day 12 weeks (trivalent chromium with 6 mg of PE and 6 mg of SJ); 800 µg once a day 12 weeks (trivalent chromium with 12 mg of PE and 12 mg of SJ); 500 mg once a day 12 weeks (Phyllanthus emblica); 1000 mg once a day 12 weeks (Phyllanthus emblica),Metabolic Syndrome,Performance & Recovery,cardiometabolic risk factors,cardiometabolic risk factors; metabolic syndrome; obesity; overweight; polycystic ovary syndrome; weight loss,,,
Chromium,fewer side effects than baricitinib; long-term safety not established; slight increase in ALT; slight increase in HDL; slight increase in diastolic blood pressure; slight increase in systolic blood pressure,Weight Loss,,Weight & Body Composition,manual_pair,"Human clinical evidence suggests that chromium supplementation may have beneficial effects on body weight and metabolic profiles, particularly in specific populations such as those with metabolic syndrome and polycystic ovary syndrome. Two randomized controlled trials reported positive outcomes with doses of 200 µg to 800 µg of chromium per day over 12 weeks. However, the overall evidence is limited to a small number of studies, and further research is needed to confirm these findings and assess long-term effects.",0.8,30977089,2020,"Effects of Chromium and Carnitine Co-supplementation on Body Weight and Metabolic Profiles in Overweight and Obese Women with Polycystic Ovary Syndrome: a Randomized, Double-Blind, Placebo-Controlled Trial.",randomized_controlled_trial,benefit,"The study shows beneficial effects on weight, glycemic control, and lipid profiles, indicating a positive outcome direction.",200 μg daily 12 weeks (chromium picolinate),Obese; Overweight; PCOS; Women,Metabolic Health,obesity,cardiometabolic risk factors; metabolic syndrome; obesity; overweight; polycystic ovary syndrome; weight loss,,,
Chromium,fewer side effects than baricitinib; long-term safety not established; slight increase in ALT; slight increase in HDL; slight increase in diastolic blood pressure; slight increase in systolic blood pressure,Weight Loss,,Weight & Body Composition,manual_pair,"One randomized, double-blind, placebo-controlled trial found that chromium picolinate (400 µg daily for 12 weeks) resulted in significant improvements in metabolic markers in patients with nonalcoholic fatty liver disease, indicating a potential benefit. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term effects and safety.",0.7,32804855,2021,"Chromium picolinate balances the metabolic and clinical markers in nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled trial.",randomized_controlled_trial,benefit,"The study shows significant improvements in various metabolic markers, indicating a benefit from chromium picolinate supplementation.",400 µg daily 12 weeks (tablets),Fatty Liver Disease,"Immune, Inflammation, & Infection",non-alcoholic fatty liver disease,non-alcoholic fatty liver disease,,,
Chromium,fewer side effects than baricitinib; long-term safety not established; slight increase in ALT; slight increase in HDL; slight increase in diastolic blood pressure; slight increase in systolic blood pressure,High Blood Glucose,,Metabolic Health,manual_pair,"One randomized, double-blind, placebo-controlled study reported that a nutritional supplement containing chromium picolinate (250 mcg) significantly reduced postprandial glucose levels, indicating a potential benefit for high blood sugar. However, the overall evidence is limited, with only one study demonstrating this effect and no reports of harm or mixed outcomes.",0.7,32579549,2020,"A novel nutritional supplement containing amino acids and chromium decreases postprandial glucose response in a randomized, double-blind, placebo-controlled study.",randomized_controlled_trial,benefit,"The study shows a significant reduction in postprandial glucose levels, indicating a beneficial effect of the supplement.",250 mcg (chromium picolinate),,,postprandial glucose response,postprandial glucose response; prevention of diabetes,,,
Chromium,fewer side effects than baricitinib; long-term safety not established; slight increase in ALT; slight increase in HDL; slight increase in diastolic blood pressure; slight increase in systolic blood pressure,High Blood Glucose,,Metabolic Health,manual_pair,"The evidence from six randomized trials indicates that chromium supplementation may have a beneficial effect on blood sugar control in patients with Type 2 Diabetes, with doses commonly reported at 200 µg to 500 µg daily. No studies reported harm or mixed outcomes, suggesting a consistent positive effect across the trials. However, further research may be needed to confirm these findings and assess long-term safety.",0.9,38747270,2024,"Synchronizing positive effect of vitamin C and chromium on hyper lipidemia, hyperglycemia, liver enzymes and BMI of diabetes mellitus type 2 patients.",randomized_controlled_trial,benefit,"The study shows significant improvements in various health parameters, indicating a beneficial effect of chromium supplementation.",200 µg,,Heart & Vascular Health,bmi improvement,Type 2 Diabetes Mellitus; bmi improvement; cardiovascular diseases; coronary heart disease; endothelial dysfunction; hyperglycemia; hyperlipidemia; liver enzyme abnormalities; mildly impaired fasting blood glucose,,,
Chromium,fewer side effects than baricitinib; long-term safety not established; slight increase in ALT; slight increase in HDL; slight increase in diastolic blood pressure; slight increase in systolic blood pressure,High Blood Glucose,,Metabolic Health,manual_pair,"The evidence from six randomized trials indicates that chromium supplementation may have a beneficial effect on blood sugar control in patients with Type 2 Diabetes, with doses commonly reported at 200 µg to 500 µg daily. No studies reported harm or mixed outcomes, suggesting a consistent positive effect across the trials. However, further research may be needed to confirm these findings and assess long-term safety.",0.9,32971450,2020,Improving the endothelial dysfunction in type 2 diabetes with chromium and vitamin D3 by reducing homocysteine and oxidative stress: A randomized placebo-controlled trial.,randomized_controlled_trial,benefit,"The study shows significant improvements in various health markers related to endothelial dysfunction and cardiovascular risk in T2DM patients, indicating a benefit from chromium supplementation.",500 μg daily four months (chromium picolinate),Diabetes Type 2,,cardiovascular diseases,Type 2 Diabetes Mellitus; bmi improvement; cardiovascular diseases; coronary heart disease; endothelial dysfunction; hyperglycemia; hyperlipidemia; liver enzyme abnormalities; mildly impaired fasting blood glucose,,,
Chromium,fewer side effects than baricitinib; long-term safety not established; slight increase in ALT; slight increase in HDL; slight increase in diastolic blood pressure; slight increase in systolic blood pressure,High Blood Glucose,,Metabolic Health,manual_pair,"The evidence from six randomized trials indicates that chromium supplementation may have a beneficial effect on blood sugar control in patients with Type 2 Diabetes, with doses commonly reported at 200 µg to 500 µg daily. No studies reported harm or mixed outcomes, suggesting a consistent positive effect across the trials. However, further research may be needed to confirm these findings and assess long-term safety.",0.9,31243685,2020,The Influences of Chromium Supplementation on Metabolic Status in Patients with Type 2 Diabetes Mellitus and Coronary Heart Disease.,randomized_controlled_trial,benefit,"The study shows significant improvements in various metabolic parameters, indicating a beneficial effect of chromium supplementation.",200 μg 12 weeks,,Weight & Body Composition,coronary heart disease,Type 2 Diabetes Mellitus; bmi improvement; cardiovascular diseases; coronary heart disease; endothelial dysfunction; hyperglycemia; hyperlipidemia; liver enzyme abnormalities; mildly impaired fasting blood glucose,,,
Chromium,fewer side effects than baricitinib; long-term safety not established; slight increase in ALT; slight increase in HDL; slight increase in diastolic blood pressure; slight increase in systolic blood pressure,High Blood Glucose,,Metabolic Health,manual_pair,"The evidence from six randomized trials indicates that chromium supplementation may have a beneficial effect on blood sugar control in patients with Type 2 Diabetes, with doses commonly reported at 200 µg to 500 µg daily. No studies reported harm or mixed outcomes, suggesting a consistent positive effect across the trials. However, further research may be needed to confirm these findings and assess long-term safety.",0.9,39125340,2024,"Efficacy and Tolerability of a Food Supplement Based on Zea mays L., Gymnema sylvestre (Retz.) R.br.ex Sm, Zinc and Chromium for the Maintenance of Normal Carbohydrate Metabolism: A Monocentric, Randomized, Double-Blind, Placebo-Controlled Clinical Trial.",randomized_controlled_trial,benefit,"The study showed a significant reduction in fasting blood glucose and glycated hemoglobin, indicating a beneficial effect on glucose metabolism.",1 tablet(s) per day 3 months (food supplement); 2 tablet(s) per day 3 months (food supplement),,,mildly impaired fasting blood glucose,Type 2 Diabetes Mellitus; bmi improvement; cardiovascular diseases; coronary heart disease; endothelial dysfunction; hyperglycemia; hyperlipidemia; liver enzyme abnormalities; mildly impaired fasting blood glucose,,,
Chromium,fewer side effects than baricitinib; long-term safety not established; slight increase in ALT; slight increase in HDL; slight increase in diastolic blood pressure; slight increase in systolic blood pressure,High Blood Glucose,,Metabolic Health,manual_pair,"The evidence from six randomized trials indicates that chromium supplementation may have a beneficial effect on blood sugar control in patients with Type 2 Diabetes, with doses commonly reported at 200 µg to 500 µg daily. No studies reported harm or mixed outcomes, suggesting a consistent positive effect across the trials. However, further research may be needed to confirm these findings and assess long-term safety.",0.9,38024820,2023,A comparative study to assess the use of chromium in type 2 diabetes mellitus.,randomized_controlled_trial,benefit,"The study shows significant improvement in HbA1c and fasting blood sugar levels, indicating a beneficial effect of chromium supplementation.",200 mcg daily four months,Diabetes Type 2,,Type 2 Diabetes Mellitus,Type 2 Diabetes Mellitus; bmi improvement; cardiovascular diseases; coronary heart disease; endothelial dysfunction; hyperglycemia; hyperlipidemia; liver enzyme abnormalities; mildly impaired fasting blood glucose,,,
Chromium,fewer side effects than baricitinib; long-term safety not established; slight increase in ALT; slight increase in HDL; slight increase in diastolic blood pressure; slight increase in systolic blood pressure,High Blood Glucose,,Metabolic Health,manual_pair,"The evidence from six randomized trials indicates that chromium supplementation may have a beneficial effect on blood sugar control in patients with Type 2 Diabetes, with doses commonly reported at 200 µg to 500 µg daily. No studies reported harm or mixed outcomes, suggesting a consistent positive effect across the trials. However, further research may be needed to confirm these findings and assess long-term safety.",0.9,31593637,2020,The effects of chromium and vitamin D3 co-supplementation on insulin resistance and tumor necrosis factor-alpha in type 2 diabetes: a randomized placebo-controlled trial.,randomized_controlled_trial,benefit,The study shows that chromium supplementation is effective in controlling insulin resistance and decreasing TNF-α in patients with type 2 diabetes.,500 μg daily 4 months (picolinate),Diabetes Type 2,,Type 2 Diabetes Mellitus,Type 2 Diabetes Mellitus; bmi improvement; cardiovascular diseases; coronary heart disease; endothelial dysfunction; hyperglycemia; hyperlipidemia; liver enzyme abnormalities; mildly impaired fasting blood glucose,,,
Chromium,fewer side effects than baricitinib; long-term safety not established; slight increase in ALT; slight increase in HDL; slight increase in diastolic blood pressure; slight increase in systolic blood pressure,High LDL,,Heart & Vascular Health,manual_pair,"One randomized, placebo-controlled trial reported a beneficial effect of chromium picolinate in combination with other nutraceuticals on reducing total cholesterol and LDL levels over an 8-week period. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term safety and efficacy.",0.7,31987238,2020,"Efficacy and tolerability of a nutraceutical combination of red yeast rice, guggulipid, and chromium picolinate evaluated in a randomized, placebo-controlled, double-blind study.",randomized_controlled_trial,benefit,"The study showed significant reductions in total cholesterol and LDL levels, indicating a beneficial effect.",8 weeks (NutraforChol®),,,dyslipidemia,dyslipidemia; hypercholesterolemia,,,
Chromium,fewer side effects than baricitinib; long-term safety not established; slight increase in ALT; slight increase in HDL; slight increase in diastolic blood pressure; slight increase in systolic blood pressure,High Triglycerides,,Heart & Vascular Health,manual_pair,"There is limited evidence suggesting that chromium picolinate supplementation (400 mcg daily for 3 months) may improve metabolic and inflammatory markers in patients with nonalcoholic fatty liver disease, which is associated with high triglycerides. However, only one pilot study has reported a benefit, indicating that further research is needed to establish the efficacy and safety of chromium for this indication.",0.7,33045675,2021,"A pilot study of the effects of chromium picolinate supplementation on serum fetuin-A, metabolic and inflammatory factors in patients with nonalcoholic fatty liver disease: A double-blind, placebo-controlled trial.",randomized_controlled_trial,benefit,Chromium picolinate supplementation led to significant improvements in several metabolic and inflammatory markers in patients with NAFLD.,400 mcg daily 3 months (picolinate),,Metabolic Health,non-alcoholic fatty liver disease,non-alcoholic fatty liver disease,,,
Chromium,fewer side effects than baricitinib; long-term safety not established; slight increase in ALT; slight increase in HDL; slight increase in diastolic blood pressure; slight increase in systolic blood pressure,Rheumatoid Arthritis,,"Immune, Inflammation, & Infection",manual_pair,"One phase 2/3 randomized controlled trial suggests that trivalent chromium (Cr III) may provide superior clinical outcomes compared to baricitinib in the treatment of rheumatoid arthritis. However, this evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term safety and efficacy.",0.7,39030450,2024,"Trivalent chromium versus baricitinib for rheumatoid arthritis treatment: first phase 2/3 randomized controlled trial, is trivalent chromium the upcoming immune-modulator?",randomized_controlled_trial,benefit,"The study shows that Cr III has superior clinical outcomes compared to baricitinib for rheumatoid arthritis, indicating a benefit.",(Trivalent chromium (Cr III)),,,rheumatoid arthritis,rheumatoid arthritis,,,
Coenzyme Q10,may increase the risk of adverse effects; minor side effects reported in two studies,Depression,,"Energy, Mood, & Mental Health",manual_pair,"Two randomized trials indicate that coenzyme Q10 supplementation may have beneficial effects on anxiety, particularly in specific populations such as women with polycystic ovary syndrome and fibromyalgia patients. Doses reported include 100 mg daily for 12 weeks and unspecified doses over 40 days. However, the overall evidence is limited to these studies, and further research is needed to confirm these findings across broader populations.",0.8,34664527,2022,The effects of coenzyme Q10 supplementation on metabolic profiles and parameters of mental health in women with polycystic ovary syndrome.,randomized_controlled_trial,benefit,"The study shows significant improvements in mental health and hormonal parameters, indicating a beneficial effect of CoQ10 supplementation.",100 mg daily 12 weeks,PCOS,"Immune, Inflammation, & Infection",anxiety,anxiety; depression; fibromyalgia; hirsutism; pain; polycystic ovary syndrome,,,
Coenzyme Q10,may increase the risk of adverse effects; minor side effects reported in two studies,Depression,,"Energy, Mood, & Mental Health",manual_pair,"Two randomized trials indicate that coenzyme Q10 supplementation may have beneficial effects on anxiety, particularly in specific populations such as women with polycystic ovary syndrome and fibromyalgia patients. Doses reported include 100 mg daily for 12 weeks and unspecified doses over 40 days. However, the overall evidence is limited to these studies, and further research is needed to confirm these findings across broader populations.",0.8,31387429,2019,Coenzyme Q10 supplementation alleviates pain in pregabalin-treated fibromyalgia patients via reducing brain activity and mitochondrial dysfunction.,randomized_controlled_trial,benefit,The study shows that CoQ10 supplementation provides additional benefits in reducing pain and anxiety in fibromyalgia patients treated with pregabalin.,40 days,Fibromyalgia,,anxiety,anxiety; depression; fibromyalgia; hirsutism; pain; polycystic ovary syndrome,,,
Coenzyme Q10,may increase the risk of adverse effects; minor side effects reported in two studies,Burn Wounds,,"Skin, Hair, & Nails",manual_pair,"The evidence for Coenzyme Q10 in burn injury is low quality, with one randomized trial reporting mixed outcomes. While CoQ10 supplementation (100 mg three times a day for 10 days) did not affect inflammatory markers or oxidative stress, it improved albumin levels. Overall, the findings are inconclusive and do not support a clear benefit.",0.8,38431600,2024,Coenzyme Q10 supplementation in burn patients: a double-blind placebo-controlled randomized clinical trial.,randomized_controlled_trial,mixed_unclear,"CoQ10 showed no effect on inflammatory markers and oxidative stress, but improved albumin levels, indicating mixed outcomes.",100 mg three times a day 10 days (CoQ10),,,burn injury,burn injury,,,
Coenzyme Q10,may increase the risk of adverse effects; minor side effects reported in two studies,Depression,,"Energy, Mood, & Mental Health",manual_pair,"One randomized trial reported that Coenzyme Q10 supplementation (200 mg daily for 8 weeks) resulted in a significant reduction in depression symptoms, indicating a potential benefit. However, the overall evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term effects and safety.",0.7,38684047,2024,Discovering the Potential Value of Coenzyme Q10 as an Adjuvant Treatment in Patients With Depression.,randomized_controlled_trial,benefit,"The study showed a significant reduction in depression symptoms with CoQ10 supplementation, indicating a beneficial outcome.",200 mg daily 8 weeks (oral),,,depression,depression; fatigue,,,
Coenzyme Q10,may increase the risk of adverse effects; minor side effects reported in two studies,Fatigue,,"Energy, Mood, & Mental Health",manual_pair,"The evidence for Coenzyme Q10 in reducing fatigue is limited and mixed. One randomized trial reported significant improvements in fatigue perception and quality of life with a dose of 200 mg daily for 12 weeks, while another trial showed mixed results with no significant changes in fatigue despite improvements in other outcomes. Overall, the quality of evidence is low, and further research is needed to clarify its efficacy.",0.7,34444817,2021,"Effect of Dietary Coenzyme Q10 Plus NADH Supplementation on Fatigue Perception and Health-Related Quality of Life in Individuals with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Prospective, Randomized, Double-Blind, Placebo-Controlled Trial.",randomized_controlled_trial,benefit,"The study found significant improvements in fatigue perception and health-related quality of life, indicating a benefit from Coenzyme Q10 supplementation.",200 mg once daily 12 weeks (oral),Chronic Fatigue Syndrome,,chronic fatigue syndrome,chronic fatigue syndrome; fatigue; myalgic encephalomyelitis,,,
Coenzyme Q10,may increase the risk of adverse effects; minor side effects reported in two studies,Fatigue,,"Energy, Mood, & Mental Health",manual_pair,"The evidence for Coenzyme Q10 in reducing fatigue is limited and mixed. One randomized trial reported significant improvements in fatigue perception and quality of life with a dose of 200 mg daily for 12 weeks, while another trial showed mixed results with no significant changes in fatigue despite improvements in other outcomes. Overall, the quality of evidence is low, and further research is needed to clarify its efficacy.",0.7,40151031,2025,"Effects of Coenzyme Q10, Tryptophan, and Magnesium Supplementation on Fatigue in Patients with Fibromyalgia - A Randomized Trial.",randomized_controlled_trial,mixed_unclear,"The study showed mixed results with significant improvements in some outcomes (pain, sleep quality) but non-significant results in fatigue for the dietary supplement group.",3 months (dietary supplement),Fibromyalgia,,fatigue,chronic fatigue syndrome; fatigue; myalgic encephalomyelitis,,,
Coenzyme Q10,may increase the risk of adverse effects; minor side effects reported in two studies,Fatty Liver Disease,,Gut Health,manual_pair,"One randomized double-blind, placebo-controlled trial reported that high-dose coenzyme Q10 (240 mg daily for 6 months) improved liver steatosis and vascular functions in patients with metabolic dysfunction-associated steatotic liver disease. Overall, the evidence is limited to this single study, and further research is needed to confirm these findings and assess long-term safety and efficacy.",0.7,38987784,2024,"Six-month supplementation with high dose coenzyme Q10 improves liver steatosis, endothelial, vascular and myocardial function in patients with metabolic-dysfunction associated steatotic liver disease: a randomized double-blind, placebo-controlled trial.",randomized_controlled_trial,benefit,"The study demonstrated significant improvements in liver steatosis and vascular functions, indicating a beneficial effect of coenzyme Q10 supplementation in patients with MASLD.",240 mg daily 6 months (Coenzyme Q10),Fatty Liver Disease,Heart & Vascular Health,endothelial function,endothelial function; liver steatosis; metabolic-dysfunction associated steatotic liver disease (masld); myocardial function; vascular function,,,
Coenzyme Q10,may increase the risk of adverse effects; minor side effects reported in two studies,Pain,,Musculoskeletal & Pain,manual_pair,"The evidence for Coenzyme Q10 in the treatment of fibromyalgia is mixed, with one randomized trial indicating some significant improvements in pain and sleep quality, but non-significant results in fatigue. No consistent dose range was reported, and no studies indicated harm. Overall, the findings do not support a clear benefit for this supplement in fibromyalgia management.",0.7,40151031,2025,"Effects of Coenzyme Q10, Tryptophan, and Magnesium Supplementation on Fatigue in Patients with Fibromyalgia - A Randomized Trial.",randomized_controlled_trial,mixed_unclear,"The study showed mixed results with significant improvements in some outcomes (pain, sleep quality) but non-significant results in fatigue for the dietary supplement group.",3 months (dietary supplement),Fibromyalgia,Sleep,fibromyalgia,fibromyalgia,,,
Coenzyme Q10,may increase the risk of adverse effects; minor side effects reported in two studies,High LDL,,Heart & Vascular Health,manual_pair,"Clinical evidence suggests that Coenzyme Q10 may have a beneficial effect on lowering LDL cholesterol levels, as indicated by three randomized controlled trials. Doses reported include 50 mg, 3 mg, and 120 mg daily, with significant reductions in LDL cholesterol and improvements in cholesterol efflux capacity noted. However, the overall quality of the evidence is moderate, and further studies may be needed to confirm these findings.",0.8,35606250,2022,"Effects of treatment with monacolin K, berberine and coenzyme Q10 on lipid metabolism in patients with moderate cardiovascular risk.",clinical_trial,benefit,"The study shows a significant decrease in LDL-C and other cholesterol levels, indicating a benefit from the treatment.",50 mg (tablet),,,cardiovascular risk,cardiovascular risk; dyslipidemia; hypercholesterolemia; mild hypercholesterolemia,,,
Coenzyme Q10,may increase the risk of adverse effects; minor side effects reported in two studies,High LDL,,Heart & Vascular Health,manual_pair,"Clinical evidence suggests that Coenzyme Q10 may have a beneficial effect on lowering LDL cholesterol levels, as indicated by three randomized controlled trials. Doses reported include 50 mg, 3 mg, and 120 mg daily, with significant reductions in LDL cholesterol and improvements in cholesterol efflux capacity noted. However, the overall quality of the evidence is moderate, and further studies may be needed to confirm these findings.",0.8,37375586,2023,"Low Dose Monacolin K Combined with Coenzyme Q10, Grape Seed, and Olive Leaf Extracts Lowers LDL Cholesterol in Patients with Mild Dyslipidemia: A Multicenter, Randomized Controlled Trial.",randomized_controlled_trial,benefit,"The study demonstrated a significant reduction in LDL cholesterol levels, indicating a beneficial effect of the treatment.",3 mg daily 8 weeks (monacolin K); 10 mg daily 8 weeks (monacolin K),,,dyslipidemia,cardiovascular risk; dyslipidemia; hypercholesterolemia; mild hypercholesterolemia,,,
Coenzyme Q10,may increase the risk of adverse effects; minor side effects reported in two studies,High LDL,,Heart & Vascular Health,manual_pair,"Clinical evidence suggests that Coenzyme Q10 may have a beneficial effect on lowering LDL cholesterol levels, as indicated by three randomized controlled trials. Doses reported include 50 mg, 3 mg, and 120 mg daily, with significant reductions in LDL cholesterol and improvements in cholesterol efflux capacity noted. However, the overall quality of the evidence is moderate, and further studies may be needed to confirm these findings.",0.8,35700592,2022,Coenzyme Q10 supplementation improves cholesterol efflux capacity and antiinflammatory properties of high-density lipoprotein in Chinese adults with dyslipidemia.,randomized_controlled_trial,benefit,"CoQ10 supplementation significantly improved HDL-mediated cholesterol efflux capacity and reduced inflammatory index, indicating a beneficial effect.",120 mg daily 24 weeks,,,dyslipidemia,cardiovascular risk; dyslipidemia; hypercholesterolemia; mild hypercholesterolemia,,,
Coenzyme Q10,may increase the risk of adverse effects; minor side effects reported in two studies,Oxidative Stress,,"Immune, Inflammation, & Infection",manual_pair,"One randomized, double-blind, placebo-controlled study found that a daily dose of 600 mg of coenzyme Q10 for 30 days significantly reduced oxidative stress markers and inflammation in patients with acute ischemic stroke. However, the overall evidence is limited, with only one study reporting a benefit and no data on potential adverse effects or long-term outcomes.",0.7,39999976,2025,"Dietary intake of coenzyme Q10 reduces oxidative stress in patients with acute ischemic stroke: a double-blind, randomized placebo-controlled study.",randomized_controlled_trial,benefit,"The study shows significant reductions in oxidative stress markers and inflammation, indicating a beneficial effect of CoQ10 in stroke rehabilitation.",600 mg daily 30 days (oral),,,acute ischemic stroke,acute ischemic stroke,,,
Coenzyme Q10,may increase the risk of adverse effects; minor side effects reported in two studies,Infertility,,Men's Health,manual_pair,"One randomized trial reported that coenzyme Q10 (400 mg per day for three months) improved sperm parameters and hormone levels in men with infertility, suggesting a potential benefit. However, the overall evidence is limited, with only one study available, and further research is needed to confirm these findings and assess long-term effects.",0.7,38957201,2023,Impact of coenzyme Q10 as an adjuvant therapy to letrozole on spermiogram results and sex hormone levels in Iraqi men with infertility; randomized open label comparative study.,randomized_controlled_trial,benefit,"CoQ10 improved sperm parameters and hormone levels, indicating a beneficial effect in men with infertility.",400 mg per day three months (oral),,,idiopathic oligoasthenoteratozoospermia,idiopathic oligoasthenoteratozoospermia,,,
Coenzyme Q10,may increase the risk of adverse effects; minor side effects reported in two studies,Inflammation,,"Immune, Inflammation, & Infection",manual_pair,"One randomized trial reported that coenzyme Q10 supplementation at a dose of 200 mg per day for 8 weeks resulted in significant decreases in inflammatory markers among overweight/obese patients with polycystic ovary syndrome, indicating a potential benefit for inflammation. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term effects and safety.",0.8,32544011,2021,The effect of coenzyme Q10 supplementation on inflammatory and endothelial dysfunction markers in overweight/obese polycystic ovary syndrome patients.,randomized_controlled_trial,benefit,"The study showed significant decreases in inflammatory markers, indicating a beneficial effect of CoQ10 supplementation.",200 mg per day 8 weeks (capsules),Obese; Overweight,,endothelial dysfunction,endothelial dysfunction; inflammation; obesity; polycystic ovary syndrome,,,
Coenzyme Q10,may increase the risk of adverse effects; minor side effects reported in two studies,BPH,,Kidney & Bladder Health,manual_pair,"The evidence for Coenzyme Q10 in treating lower urinary tract symptoms is low and mixed. One randomized controlled trial reported no significant differences in key outcomes such as IPSS and quality of life, despite some improvements in prostate volume and erectile function. No consistent dose ranges were reported, and there were no noted harms associated with its use.",0.7,38105612,2024,"Effects of L-Carnitine and Coenzyme Q10 Supplementation on Lower Urinary Tract Symptoms in Men with Benign Prostatic Hyperplasia: A Randomized, Controlled, Clinical Trial.",randomized_controlled_trial,mixed_unclear,"The study showed significant benefits in prostate volume and erectile function but no significant differences in IPSS, QoL, and PSA levels, indicating mixed outcomes.",8 weeks (L-carnitine and Coenzyme Q10 supplements),,,benign prostatic hyperplasia,benign prostatic hyperplasia; lower urinary tract symptoms,,,
Coenzyme Q10,may increase the risk of adverse effects; minor side effects reported in two studies,Infertility,,Men's Health,manual_pair,"One randomized trial indicates that Coenzyme Q10 (200 mg daily for 3 months) may improve sperm parameters and antioxidant status in men with idiopathic infertility, suggesting a potential benefit. However, the overall evidence is limited, with only one study reporting positive outcomes and no adverse effects noted. Further research is needed to confirm these findings and establish consistency.",0.7,32572802,2021,Impact of Coenzyme Q10 and Selenium on Seminal Fluid Parameters and Antioxidant Status in Men with Idiopathic Infertility.,randomized_controlled_trial,benefit,"The study shows significant improvements in sperm parameters and antioxidant status with CoQ10 treatment, indicating a beneficial effect.",200 mg daily 3 months,,,idiopathic oligoasthenoteratospermia,idiopathic oligoasthenoteratospermia; male infertility,,,
Coenzyme Q10,may increase the risk of adverse effects; minor side effects reported in two studies,Musculoskeletal Pain,,Musculoskeletal & Pain,manual_pair,"One randomized, double-blind, placebo-controlled study reported a beneficial outcome with Coenzyme Q10 supplementation (100 mg daily for 3 months) in patients experiencing muscle pain from statin use. Overall evidence is limited to this single study, indicating a need for further research to confirm these findings and assess long-term safety and efficacy.",0.7,31695332,2019,"Coenzyme q10 liquid supplementation in dyslipidemic subjects with statin-related clinical symptoms: a double-blind, randomized, placebo-controlled study.",randomized_controlled_trial,benefit,"The study shows improvement in clinical symptoms with CoQ10 supplementation, indicating a beneficial outcome.",100 mg daily 3 months (liquid),Statin Use,,asthenia,asthenia; dyslipidemia; myalgia; pain,,,
Coenzyme Q10,may increase the risk of adverse effects; minor side effects reported in two studies,Neuropathic Pain,,Musculoskeletal & Pain,manual_pair,"One randomized controlled trial has shown that Coenzyme Q10 (100 mg every 8 hours for 8 weeks) may provide significant pain relief in patients with painful diabetic neuropathy compared to placebo. However, the overall evidence is limited, with only one study reporting a benefit and no data on adverse effects or consistency across multiple trials.",0.7,36273066,2022,Coenzyme Q10 as a potential add-on treatment for patients suffering from painful diabetic neuropathy: results of a placebo-controlled randomized trial.,randomized_controlled_trial,benefit,"The study shows significant pain relief in patients taking CoQ10 compared to placebo, indicating a beneficial effect.",100 mg every 8 hours 8 weeks,Diabetes,,painful diabetic neuropathy,painful diabetic neuropathy,,,
Coenzyme Q10,may increase the risk of adverse effects; minor side effects reported in two studies,Cardiac Function,,Heart & Vascular Health,manual_pair,"One randomized controlled trial reported that Coenzyme Q10 supplementation (200 mg daily for 48 months) improved cardiac function and reduced cardiovascular mortality in individuals with poor cardiac function. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term safety and efficacy.",0.7,35381849,2022,Improved cardiovascular health by supplementation with selenium and coenzyme Q10: applying structural equation modelling (SEM) to clinical outcomes and biomarkers to explore underlying mechanisms in a prospective randomized double-blind placebo-controlled intervention project in Sweden.,randomized_controlled_trial,benefit,"The study reports improved cardiac function and reduced cardiovascular mortality, indicating a beneficial outcome from Coenzyme Q10 supplementation.",200 mg daily 48 months,,"Immune, Inflammation, & Infection",cardiac function,cardiac function; cardiovascular health; cardiovascular mortality,,,
Coenzyme Q10,may increase the risk of adverse effects; minor side effects reported in two studies,Cardiac Function,,Heart & Vascular Health,manual_pair,"One randomized trial indicates that Coenzyme Q10 supplementation may promote recovery of cardiac function in patients after myocardial infarction, suggesting a potential benefit. However, the overall evidence is limited, with only one study reporting positive outcomes and no consistent dose ranges or adverse effects noted. Further research is needed to confirm these findings and establish clearer guidelines.",0.7,38281937,2024,Coenzyme Q10 mitigates macrophage mediated inflammation in heart following myocardial infarction via the NLRP3/IL1β pathway.,randomized_controlled_trial,benefit,"CoQ10 supplementation significantly promoted recovery of cardiac function in MI patients, indicating a beneficial outcome.",,Myocardial Infarction,,myocardial infarction,myocardial infarction,,,
Coenzyme Q10,may increase the risk of adverse effects; minor side effects reported in two studies,Rheumatoid Arthritis,,"Immune, Inflammation, & Infection",manual_pair,"One randomized, double-blind, placebo-controlled trial reported that coenzyme Q10 supplementation (100 mg daily for 2 months) resulted in significant improvements in clinical outcomes and disease severity in patients with rheumatoid arthritis. Overall, the evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term effects and safety.",0.7,31392559,2019,"Effects of coenzyme Q10 supplementation on matrix metalloproteinases and DAS-28 in patients with rheumatoid arthritis: a randomized, double-blind, placebo-controlled clinical trial.",randomized_controlled_trial,benefit,CoQ10 supplementation showed significant improvements in clinical outcomes and disease severity in RA patients.,100 mg daily 2 months,,,rheumatoid arthritis,rheumatoid arthritis,,,
Coenzyme Q10,may increase the risk of adverse effects; minor side effects reported in two studies,Improve Visual Acuity,,Vision & Eye Health,manual_pair,"There is limited evidence suggesting a potential benefit of topical Coenzyme Q10 in improving retinal ganglion cell loss in patients with Alzheimer's disease, as indicated by one study. However, the overall evidence is weak and consists of a single trial, which limits the strength and consistency of the findings. No adverse effects were reported in this study, but further research is needed to confirm these results.",0.5,31781880,2020,Salvage of the retinal ganglion cells in transition phase in Alzheimer's disease with topical coenzyme Q10: is it possible?,randomized_controlled_trial,benefit,"The study shows improvement in retinal ganglion cell loss in Alzheimer's disease, indicating a beneficial effect of CoQ10.",(topical),Alzheimer's Disease,,alzheimer disease,alzheimer disease; retinal diseases,,,
Creatine,Side effects were reported significantly more often for creatine than for placebo supplementation.,Arterial Stiffness,,Heart & Vascular Health,manual_pair,"Current evidence on creatine supplementation for arterial stiffness is limited to one randomized controlled trial, which reported positive effects on vascular parameters with a dose of 20 g daily for 7 days. No studies have shown harm or no benefit, but the overall evidence remains sparse and requires further investigation to confirm these findings.",0.7,39047868,2024,Effects of acute creatine supplementation on cardiac and vascular responses in older men; a randomized controlled trial.,randomized_controlled_trial,benefit,"The study shows positive effects on vascular parameters, indicating a benefit from creatine supplementation.",20 g daily 7 days,Men; Older Adults,,arterial stiffness,arterial stiffness; atherosclerosis; cardiovascular diseases; vascular health,,,
Creatine,Side effects were reported significantly more often for creatine than for placebo supplementation.,Brain Oxygenation,,Cognitive & Neurological Performance,manual_pair,"One randomized controlled pilot trial suggests that creatine supplementation (2 g daily for 7 days, in combination with guanidinoacetic acid) may improve prefrontal brain oxygenation during cognitive tasks. However, the evidence is limited, with only one study reporting a benefit and no additional studies to confirm these findings or assess long-term effects and safety.",0.7,39569437,2025,"Creatine with guanidinoacetic acid improves prefrontal brain oxygenation before, during, and after a cognitive task: A randomized controlled pilot trial.",randomized_controlled_trial,benefit,"The study shows significant improvement in oxygen saturation, indicating a beneficial effect of creatine supplementation.",2 g daily 7 days (mixture with guanidinoacetic acid),,,brain oxygenation,brain oxygenation,,,
Creatine,Side effects were reported significantly more often for creatine than for placebo supplementation.,Increase Brain Oxygenation,,Cognitive & Neurological Function,manual_pair,"Current evidence on creatine supplementation for cognitive function is limited to a single randomized controlled trial, which reported a benefit in prefrontal brain oxygenation with a daily dose of 2 g combined with guanidinoacetic acid over 7 days. No studies have reported mixed outcomes or harm, but the overall evidence is still insufficient to draw firm conclusions about its efficacy in enhancing cognitive function.",0.7,39569437,2025,"Creatine with guanidinoacetic acid improves prefrontal brain oxygenation before, during, and after a cognitive task: A randomized controlled pilot trial.",randomized_controlled_trial,benefit,"The study shows significant improvement in oxygen saturation, indicating a beneficial effect of creatine supplementation.",2 g daily 7 days (mixture with guanidinoacetic acid),,,cognitive function,cognitive function,,,
Creatine,Side effects were reported significantly more often for creatine than for placebo supplementation.,Cognitive Performance,,Cognitive & Neurological Function,manual_pair,"The evidence regarding creatine for cognitive impairment is mixed and unclear, with one randomized trial indicating potential cognitive function improvements when combined with caffeine, but no definitive benefits were established. The study utilized a dose of 5 g of creatine nitrate daily for 7 days. Overall, the findings do not support a clear benefit for cognitive enhancement from creatine alone.",0.8,38542677,2024,"The Effect of Creatine Nitrate and Caffeine Individually or Combined on Exercise Performance and Cognitive Function: A Randomized, Crossover, Double-Blind, Placebo-Controlled Trial.",randomized_controlled_trial,mixed_unclear,"Cognitive function improved with co-ingestion, but no significant enhancements in exercise performance were observed.",5 g daily 7 days (nitrate),,,cognitive function,cognitive function; exercise performance,,,
Creatine,Side effects were reported significantly more often for creatine than for placebo supplementation.,Cognitive Performance,,Cognitive & Neurological Function,manual_pair,"The evidence for creatine supplementation on cognitive performance is low, with one randomized controlled trial reporting mixed outcomes. In this study, a daily dose of 5 g for 6 weeks suggested a small beneficial effect, but results were not statistically significant across all cognitive tests. No studies reported clear benefits or harms, highlighting the uncertainty in this area.",0.8,37968687,2023,The effects of creatine supplementation on cognitive performance-a randomised controlled study.,randomized_controlled_trial,mixed_unclear,"The study suggests a small beneficial effect of creatine on cognitive performance, but results were not statistically significant for all tests, indicating mixed outcomes.",5 g daily 6 weeks,,,cognitive performance,cognitive performance,,,
Creatine,Side effects were reported significantly more often for creatine than for placebo supplementation.,Depression,,"Energy, Mood, & Mental Health",manual_pair,"One pilot study found that oral creatine monohydrate, when added to cognitive-behavioral therapy, resulted in a significant reduction in depression scores compared to placebo over an 8-week period. However, the evidence is limited to this single study, and further research is needed to confirm these findings and assess long-term effects and safety.",0.7,39488067,2025,"Efficacy and safety profile of oral creatine monohydrate in add-on to cognitive-behavioural therapy in depression: An 8-week pilot, double-blind, randomised, placebo-controlled feasibility and exploratory trial in an under-resourced area.",randomized_controlled_trial,benefit,"The study shows a significant reduction in depression scores with creatine compared to placebo, indicating a beneficial effect.",8 weeks (oral),,,depression,depression,,,
Creatine,Side effects were reported significantly more often for creatine than for placebo supplementation.,Weight Loss,,Weight & Body Composition,manual_pair,"Current evidence on creatine for excess body weight is limited to a single study that reported beneficial effects on body weight and glucose management with doses ranging from 200 to 800 mg. The overall quality of evidence is low, and further research is needed to establish consistent findings and assess safety.",0.6,40527924,2025,"A nitroalkene derivative of salicylate, SANA, induces creatine-dependent thermogenesis and promotes weight loss.",randomized_controlled_trial,benefit,"The study shows beneficial effects on body weight and glucose management, indicating a positive outcome direction.",200-800 mg single ascending doses; 200-400 mg per day 15 days,Obese,Metabolic Health,insulin resistance,insulin resistance; obesity; weight loss,,,
Creatine,Side effects were reported significantly more often for creatine than for placebo supplementation.,Muscle Endurance,,Performance & Recovery,manual_pair,"The evidence regarding creatine for exercise recovery is limited and mixed, with one study indicating that creatine combined with taurine may enhance time to exhaustion but does not significantly improve repeated sprint performance. No consistent benefits were observed across studies, and no adverse effects were reported. Overall, the quality of evidence is low, and further research is needed to clarify its efficacy in this context.",0.7,39972259,2025,Effect of Taurine Combined With Creatine on Repeated Sprinting Ability After Exhaustive Exercise Under Hot and Humid Conditions.,randomized_controlled_trial,mixed_unclear,The study shows mixed results with T+C supplementation enhancing time to exhaustion but not significantly improving repeated sprint performance.,,Sprinting,,exercise recovery,exercise recovery,,,
Creatine,Side effects were reported significantly more often for creatine than for placebo supplementation.,High Blood Glucose,,Metabolic Health,manual_pair,"One pilot study suggests that creatine monohydrate supplementation may improve vascular function and metabolic markers in older adults, indicating a potential benefit for fasting glucose levels. The study utilized a dosing regimen of 5 g four times daily for the first five days, followed by 5 g once daily for 23 days. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term effects.",0.7,39796490,2024,Effect of Creatine Monohydrate Supplementation on Macro- and Microvascular Endothelial Function in Older Adults: A Pilot Study.,randomized_controlled_trial,benefit,"The study shows significant improvements in vascular function and metabolic markers, indicating a beneficial effect of creatine supplementation.","5 g 4 times/day for 5 days, then 1 time/day for 23 days 4 weeks (monohydrate)",Older Adults,Heart & Vascular Health,fasting glucose levels,fasting glucose levels,,,
Creatine,Side effects were reported significantly more often for creatine than for placebo supplementation.,Long COVID,,"Immune, Inflammation, & Infection",manual_pair,"One randomized trial reported that creatine supplementation (4 g per day for 3 months) combined with breathing exercises improved respiratory discomfort and time to exhaustion in patients with long-COVID, suggesting a potential benefit for fatigue. However, the overall evidence is limited, and further studies are needed to confirm these findings and assess long-term effects and safety.",0.7,38099612,2024,Creatine supplementation combined with breathing exercises reduces respiratory discomfort and improves creatine status in patients with long-COVID.,randomized_controlled_trial,benefit,"The study shows significant improvement in time to exhaustion and creatine levels, indicating a benefit from creatine supplementation.",4 g per day 3 months,,,fatigue,fatigue; long-covid,,,
Creatine,Side effects were reported significantly more often for creatine than for placebo supplementation.,Long COVID,,"Immune, Inflammation, & Infection",manual_pair,"One randomized trial reported that creatine supplementation (8 g of creatine monohydrate three times daily for eight weeks) significantly reduced symptoms of long COVID, indicating a potential benefit. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term effects and safety.",0.7,38684388,2024,Eight-Week Creatine-Glucose Supplementation Alleviates Clinical Features of Long COVID.,randomized_controlled_trial,benefit,"The study shows significant reduction in long COVID symptoms with creatine supplementation, indicating a beneficial outcome.",8 g t.i.d. 8 weeks (creatine monohydrate),,,body aches,body aches; breathing problems; difficulties concentrating; fatigue; general malaise; headache; long covid,,,
Creatine,Side effects were reported significantly more often for creatine than for placebo supplementation.,Strength,,Performance & Recovery,manual_pair,"The evidence from randomized trials indicates that creatine supplementation consistently improves exercise performance, particularly in strength and power-related activities, with beneficial outcomes reported in eight studies. Typical doses reported range from 0.03 g/kg to 0.3 g/kg daily, with no studies indicating harm or no benefit. However, one study reported mixed results regarding its effects on heart rate variability and sprint performance during different hormonal phases, suggesting variability in response based on individual circumstances.",0.9,39545789,2024,"Supplementing With Which Form of Creatine (Hydrochloride or Monohydrate) Alongside Resistance Training Can Have More Impacts on Anabolic/Catabolic Hormones, Strength and Body Composition?",randomized_controlled_trial,benefit,"The study shows significant improvements in strength and body composition with creatine supplementation, indicating a beneficial outcome.",0.03 g/kg daily 8 weeks (hydrochloride or monohydrate),,,anabolic hormone levels,anabolic hormone levels; anaerobic performance; athletic performance; basketball performance; body composition; endurance; exercise performance; exercise recovery; fatigue recovery; high-intensity actions; muscle fatigue; muscle power; muscle strength; muscle thickness; occupational performance; physical endurance; strength; strength endurance,,,
Creatine,Side effects were reported significantly more often for creatine than for placebo supplementation.,Strength,,Performance & Recovery,manual_pair,"The evidence from randomized trials indicates that creatine supplementation consistently improves exercise performance, particularly in strength and power-related activities, with beneficial outcomes reported in eight studies. Typical doses reported range from 0.03 g/kg to 0.3 g/kg daily, with no studies indicating harm or no benefit. However, one study reported mixed results regarding its effects on heart rate variability and sprint performance during different hormonal phases, suggesting variability in response based on individual circumstances.",0.9,37630756,2023,The Effects of Creatine Monohydrate Loading on Exercise Recovery in Active Women throughout the Menstrual Cycle.,randomized_controlled_trial,mixed_unclear,"Creatine monohydrate did not significantly influence HRV, but showed potential benefits in sprint performance during the high hormone phase.",20 g per day (monohydrate),Menustration; Women,,anaerobic performance,anabolic hormone levels; anaerobic performance; athletic performance; basketball performance; body composition; endurance; exercise performance; exercise recovery; fatigue recovery; high-intensity actions; muscle fatigue; muscle power; muscle strength; muscle thickness; occupational performance; physical endurance; strength; strength endurance,,,
Creatine,Side effects were reported significantly more often for creatine than for placebo supplementation.,Strength,,Performance & Recovery,manual_pair,"The evidence from randomized trials indicates that creatine supplementation consistently improves exercise performance, particularly in strength and power-related activities, with beneficial outcomes reported in eight studies. Typical doses reported range from 0.03 g/kg to 0.3 g/kg daily, with no studies indicating harm or no benefit. However, one study reported mixed results regarding its effects on heart rate variability and sprint performance during different hormonal phases, suggesting variability in response based on individual circumstances.",0.9,40010353,2025,"Effects of Combined Versus Single Supplementation of Creatine, Beta-Alanine, and L-Citrulline During Short Sprint Interval Training on Basketball Players' Performance: A Double-Blind Randomized Placebo-Controlled Trial.",randomized_controlled_trial,benefit,"The study shows significant improvements in performance with creatine supplementation, indicating a benefit.",0.1 g/kg daily 28 days (monohydrate),Basketball Players; Sprinting,,athletic performance,anabolic hormone levels; anaerobic performance; athletic performance; basketball performance; body composition; endurance; exercise performance; exercise recovery; fatigue recovery; high-intensity actions; muscle fatigue; muscle power; muscle strength; muscle thickness; occupational performance; physical endurance; strength; strength endurance,,,
Creatine,Side effects were reported significantly more often for creatine than for placebo supplementation.,Strength,,Performance & Recovery,manual_pair,"The evidence from randomized trials indicates that creatine supplementation consistently improves exercise performance, particularly in strength and power-related activities, with beneficial outcomes reported in eight studies. Typical doses reported range from 0.03 g/kg to 0.3 g/kg daily, with no studies indicating harm or no benefit. However, one study reported mixed results regarding its effects on heart rate variability and sprint performance during different hormonal phases, suggesting variability in response based on individual circumstances.",0.9,38732571,2024,Effects of a Low Dose of Orally Administered Creatine Monohydrate on Post-Fatigue Muscle Power in Young Soccer Players.,randomized_controlled_trial,benefit,"The study found that low doses of creatine increased muscle power after fatigue, indicating a beneficial effect.",0.3 g·kg-1·day-1 daily 14 days (orally administered creatine monohydrate),Soccer Players,,athletic performance,anabolic hormone levels; anaerobic performance; athletic performance; basketball performance; body composition; endurance; exercise performance; exercise recovery; fatigue recovery; high-intensity actions; muscle fatigue; muscle power; muscle strength; muscle thickness; occupational performance; physical endurance; strength; strength endurance,,,
Creatine,Side effects were reported significantly more often for creatine than for placebo supplementation.,Strength,,Performance & Recovery,manual_pair,"The evidence from randomized trials indicates that creatine supplementation consistently improves exercise performance, particularly in strength and power-related activities, with beneficial outcomes reported in eight studies. Typical doses reported range from 0.03 g/kg to 0.3 g/kg daily, with no studies indicating harm or no benefit. However, one study reported mixed results regarding its effects on heart rate variability and sprint performance during different hormonal phases, suggesting variability in response based on individual circumstances.",0.9,38646853,2024,"No additive effect of creatine, caffeine, and sodium bicarbonate on intense exercise performance in endurance-trained individuals.",randomized_controlled_trial,benefit,"Creatine showed a significant benefit in enhancing sprint performance, although it did not have an additive effect with caffeine or sodium bicarbonate.",0.3 g/kg per day 5 days (monohydrate),Sprinting,,athletic performance,anabolic hormone levels; anaerobic performance; athletic performance; basketball performance; body composition; endurance; exercise performance; exercise recovery; fatigue recovery; high-intensity actions; muscle fatigue; muscle power; muscle strength; muscle thickness; occupational performance; physical endurance; strength; strength endurance,,,
Creatine,Side effects were reported significantly more often for creatine than for placebo supplementation.,Strength,,Performance & Recovery,manual_pair,"The evidence from randomized trials indicates that creatine supplementation consistently improves exercise performance, particularly in strength and power-related activities, with beneficial outcomes reported in eight studies. Typical doses reported range from 0.03 g/kg to 0.3 g/kg daily, with no studies indicating harm or no benefit. However, one study reported mixed results regarding its effects on heart rate variability and sprint performance during different hormonal phases, suggesting variability in response based on individual circumstances.",0.9,36812477,2023,"Creatine supplementation combined with blood flow restriction training enhances muscle thickness and performance: a randomized, placebo-controlled, and double-blind study.",randomized_controlled_trial,benefit,Creatine supplementation showed positive effects on muscle thickness and performance outcomes.,8 weeks,,,body composition,anabolic hormone levels; anaerobic performance; athletic performance; basketball performance; body composition; endurance; exercise performance; exercise recovery; fatigue recovery; high-intensity actions; muscle fatigue; muscle power; muscle strength; muscle thickness; occupational performance; physical endurance; strength; strength endurance,,,
Creatine,Side effects were reported significantly more often for creatine than for placebo supplementation.,Strength,,Performance & Recovery,manual_pair,"The evidence from randomized trials indicates that creatine supplementation consistently improves exercise performance, particularly in strength and power-related activities, with beneficial outcomes reported in eight studies. Typical doses reported range from 0.03 g/kg to 0.3 g/kg daily, with no studies indicating harm or no benefit. However, one study reported mixed results regarding its effects on heart rate variability and sprint performance during different hormonal phases, suggesting variability in response based on individual circumstances.",0.9,36519333,2023,Does creatine supplementation affect recovery speed of impulse above critical torque?,randomized_controlled_trial,benefit,"The study found that creatine supplementation sped recovery of IET', indicating a benefit in exercise performance.",,,,exercise performance,anabolic hormone levels; anaerobic performance; athletic performance; basketball performance; body composition; endurance; exercise performance; exercise recovery; fatigue recovery; high-intensity actions; muscle fatigue; muscle power; muscle strength; muscle thickness; occupational performance; physical endurance; strength; strength endurance,,,
Creatine,Side effects were reported significantly more often for creatine than for placebo supplementation.,Strength,,Performance & Recovery,manual_pair,"The evidence from randomized trials indicates that creatine supplementation consistently improves exercise performance, particularly in strength and power-related activities, with beneficial outcomes reported in eight studies. Typical doses reported range from 0.03 g/kg to 0.3 g/kg daily, with no studies indicating harm or no benefit. However, one study reported mixed results regarding its effects on heart rate variability and sprint performance during different hormonal phases, suggesting variability in response based on individual circumstances.",0.9,38140393,2023,"The Effects of Protein and Carbohydrate Supplementation, with and without Creatine, on Occupational Performance in Firefighters.",randomized_controlled_trial,benefit,The study found that creatine supplementation improved specific measures of occupational performance in firefighters.,5 g daily 21-26 days (powder),Firefighters,,high-intensity actions,anabolic hormone levels; anaerobic performance; athletic performance; basketball performance; body composition; endurance; exercise performance; exercise recovery; fatigue recovery; high-intensity actions; muscle fatigue; muscle power; muscle strength; muscle thickness; occupational performance; physical endurance; strength; strength endurance,,,
Creatine,Side effects were reported significantly more often for creatine than for placebo supplementation.,Strength,,Performance & Recovery,manual_pair,"The evidence from randomized trials indicates that creatine supplementation consistently improves exercise performance, particularly in strength and power-related activities, with beneficial outcomes reported in eight studies. Typical doses reported range from 0.03 g/kg to 0.3 g/kg daily, with no studies indicating harm or no benefit. However, one study reported mixed results regarding its effects on heart rate variability and sprint performance during different hormonal phases, suggesting variability in response based on individual circumstances.",0.9,38747788,2024,"Short term creatine loading improves strength endurance even without changing maximal strength, RPE, fatigue index, blood lactate, and mode state.",randomized_controlled_trial,benefit,Creatine supplementation improved strength endurance but did not affect maximal strength or other measured outcomes.,20 g daily 5 days (Creatine + maltodextrin),,,muscle strength,anabolic hormone levels; anaerobic performance; athletic performance; basketball performance; body composition; endurance; exercise performance; exercise recovery; fatigue recovery; high-intensity actions; muscle fatigue; muscle power; muscle strength; muscle thickness; occupational performance; physical endurance; strength; strength endurance,,,
Creatine,Side effects were reported significantly more often for creatine than for placebo supplementation.,Muscle Growth,,Performance & Recovery,manual_pair,"The evidence from four randomized trials indicates that creatine supplementation, typically at doses of 0.1 g/kg/day to 5 g/day, is associated with significant increases in lean body mass and fat-free mass. One study reported mixed outcomes regarding strength and endurance, suggesting variability in effects depending on the context of use. No adverse effects were noted in the studies reviewed.",0.9,37675500,2023,Body composition measured by multi-frequency bioelectrical impedance following creatine supplementation.,clinical_trial,benefit,"The study found significant increases in fat-free mass and total body water, indicating a beneficial effect of creatine supplementation.",0.3 g/kg body weight 1 week (creatine monohydrate),,,body composition,body composition; body composition improvement; cognitive function; endurance; fat-free mass; lean body mass; lean body mass enhancement; muscle size; muscle strength; performance; total body water,,,
Creatine,Side effects were reported significantly more often for creatine than for placebo supplementation.,Muscle Growth,,Performance & Recovery,manual_pair,"The evidence from four randomized trials indicates that creatine supplementation, typically at doses of 0.1 g/kg/day to 5 g/day, is associated with significant increases in lean body mass and fat-free mass. One study reported mixed outcomes regarding strength and endurance, suggesting variability in effects depending on the context of use. No adverse effects were noted in the studies reviewed.",0.9,36960692,2023,Creatine monohydrate supplementation changes total body water and DXA lean mass estimates in female collegiate dancers.,randomized_controlled_trial,benefit,"The study shows significant increases in total body water and lean mass, indicating a benefit from creatine supplementation.",0.1 g/kg/day 42 days (creatine monohydrate),,,body composition,body composition; body composition improvement; cognitive function; endurance; fat-free mass; lean body mass; lean body mass enhancement; muscle size; muscle strength; performance; total body water,,,
Creatine,Side effects were reported significantly more often for creatine than for placebo supplementation.,Muscle Growth,,Performance & Recovery,manual_pair,"The evidence from four randomized trials indicates that creatine supplementation, typically at doses of 0.1 g/kg/day to 5 g/day, is associated with significant increases in lean body mass and fat-free mass. One study reported mixed outcomes regarding strength and endurance, suggesting variability in effects depending on the context of use. No adverse effects were noted in the studies reviewed.",0.9,40292479,2025,The Effect of Creatine Supplementation on Lean Body Mass with and Without Resistance Training.,randomized_controlled_trial,benefit,"The study found a significant increase in lean body mass after a 7-day wash-in period with creatine, indicating a benefit, although no additional benefit was observed when combined with resistance training.",5 g daily 13 weeks (monohydrate),,,body composition improvement,body composition; body composition improvement; cognitive function; endurance; fat-free mass; lean body mass; lean body mass enhancement; muscle size; muscle strength; performance; total body water,,,
Creatine,Side effects were reported significantly more often for creatine than for placebo supplementation.,Muscle Growth,,Performance & Recovery,manual_pair,"The evidence from four randomized trials indicates that creatine supplementation, typically at doses of 0.1 g/kg/day to 5 g/day, is associated with significant increases in lean body mass and fat-free mass. One study reported mixed outcomes regarding strength and endurance, suggesting variability in effects depending on the context of use. No adverse effects were noted in the studies reviewed.",0.9,40537085,2025,"Effects of a Blend of Trisodium Citrate, Creatine Monohydrate, Leucine, and Blueberry Extract on Training-Induced Changes in Leg Extension Strength, Endurance, and Muscle Size.",randomized_controlled_trial,mixed_unclear,"The study showed that both TCLB and CM increased muscle size compared to PLA, but did not show clear benefits in strength and endurance, leading to a mixed outcome classification.","8 weeks (TCLB, CM, PLA)",,,endurance,body composition; body composition improvement; cognitive function; endurance; fat-free mass; lean body mass; lean body mass enhancement; muscle size; muscle strength; performance; total body water,,,
Creatine,Side effects were reported significantly more often for creatine than for placebo supplementation.,Strength,,Performance & Recovery,manual_pair,"One randomized trial demonstrated that creatine supplementation (0.1 g/kg daily for 10 weeks) in conjunction with resistance training significantly improved muscle strength and quality of life in older adults. No adverse effects were reported, but the evidence is limited to a single study, indicating a need for further research to confirm these findings.",0.7,37206869,2023,"The role of resistance training and creatine supplementation on oxidative stress, antioxidant defense, muscle strength, and quality of life in older adults.",randomized_controlled_trial,benefit,The study shows significant improvements in muscle strength and quality of life with creatine supplementation alongside resistance training.,0.1 g/kg daily 10 weeks (monohydrate),Older Adults,"Immune, Inflammation, & Infection",muscle strength,muscle strength; oxidative stress; quality of life,,,
Creatine,Side effects were reported significantly more often for creatine than for placebo supplementation.,Endothelial Function,,Heart & Vascular Health,manual_pair,"One pilot study has reported a beneficial effect of creatine monohydrate supplementation on macrovascular function in older adults, with a dosing regimen of 5 g four times daily for the first five days, followed by 5 g once daily for 23 days. However, the evidence is limited and derived from a single study, indicating a need for further research to confirm these findings and assess long-term effects and safety.",0.7,39796490,2024,Effect of Creatine Monohydrate Supplementation on Macro- and Microvascular Endothelial Function in Older Adults: A Pilot Study.,randomized_controlled_trial,benefit,"The study shows significant improvements in vascular function and metabolic markers, indicating a beneficial effect of creatine supplementation.","5 g 4 times/day for 5 days, then 1 time/day for 23 days 4 weeks (monohydrate)",Older Adults,,macrovascular function,macrovascular function,,,
Creatine,Side effects were reported significantly more often for creatine than for placebo supplementation.,High Blood Glucose,,Metabolic Health,manual_pair,"One pilot study indicates that creatine monohydrate supplementation (5 g four times daily for 5 days, then once daily for 23 days) may improve microvascular endothelial function in older adults. However, the evidence is limited to a single study with no conflicting results or adverse effects reported, suggesting a need for further research to confirm these findings.",0.7,39796490,2024,Effect of Creatine Monohydrate Supplementation on Macro- and Microvascular Endothelial Function in Older Adults: A Pilot Study.,randomized_controlled_trial,benefit,"The study shows significant improvements in vascular function and metabolic markers, indicating a beneficial effect of creatine supplementation.","5 g 4 times/day for 5 days, then 1 time/day for 23 days 4 weeks (monohydrate)",Older Adults,Heart & Vascular Health,microvascular function,microvascular function,,,
Creatine,Side effects were reported significantly more often for creatine than for placebo supplementation.,Muscle Growth,,Performance & Recovery,manual_pair,"One randomized trial demonstrated that creatine supplementation (5 g daily for one year) improved body composition metrics, including fat-free mass and skeletal muscle mass index, in patients undergoing hemodialysis for chronic kidney disease. No studies reported mixed outcomes or harm, suggesting a potential benefit, although further research may be needed to confirm these findings and assess long-term effects.",0.9,38474743,2024,"Effect of Creatine Supplementation on Body Composition and Malnutrition-Inflammation Score in Hemodialysis Patients: An Exploratory 1-Year, Balanced, Double-Blind Design.",randomized_controlled_trial,benefit,"Creatine supplementation improved body composition metrics such as fat-free mass and skeletal muscle mass index, indicating a benefit.",5 g daily 1 year (creatine monohydrate),CKD; Hemodialysis,,chronic kidney disease,chronic kidney disease; malnutrition; muscle strength,,,
Creatine,Side effects were reported significantly more often for creatine than for placebo supplementation.,Exercise Recovery,,Performance & Recovery,manual_pair,"One randomized, double-blind, placebo-controlled trial indicates that creatine monohydrate supplementation may improve recovery from exercise-induced muscle damage, suggesting a beneficial effect on muscle soreness. The study involved a supplementation period of 33 days, but overall evidence remains limited and further research is needed to confirm these findings and assess long-term effects and safety.",0.8,40507040,2025,"The Effects of Creatine Monohydrate Supplementation on Recovery from Eccentric Exercise-Induced Muscle Damage: A Double-Blind, Randomized, Placebo-Controlled Trial Considering Sex and Age Differences.",randomized_controlled_trial,benefit,"The study shows that creatine supplementation significantly improves recovery from muscle damage, indicating a beneficial effect on muscle function and discomfort.",33 days (creatine monohydrate),,,delayed-onset muscle soreness,delayed-onset muscle soreness; eccentric exercise-induced muscle damage; muscle fatigue; muscle stiffness,,,
Creatine,Side effects were reported significantly more often for creatine than for placebo supplementation.,Exercise Recovery,,Performance & Recovery,manual_pair,"One randomized, double-blind, placebo-controlled trial indicates that creatine monohydrate may improve recovery metrics from exercise-induced muscle damage after 28 days of supplementation. No studies reported mixed or negative outcomes, suggesting a potential benefit, though the evidence is limited to a single trial. No adverse effects were noted in the study.",0.7,38542807,2024,"The Effect of Prior Creatine Intake for 28 Days on Accelerated Recovery from Exercise-Induced Muscle Damage: A Double-Blind, Randomized, Placebo-Controlled Trial.",randomized_controlled_trial,benefit,"The study shows significant improvements in recovery metrics for the creatine group compared to placebo, indicating a beneficial effect.",null null daily 28 days (creatine monohydrate),,,exercise-induced muscle damage,exercise-induced muscle damage; muscle recovery,,,
Creatine,Side effects were reported significantly more often for creatine than for placebo supplementation.,Muscle Growth,,Performance & Recovery,manual_pair,"Current evidence on creatine supplementation for improving poor physical function is limited and primarily derived from a single open-label study in hemodialysis patients, which reported benefits in physical functionality and muscle mass with a daily dose of 5 g for 8 weeks. Overall, the evidence is low quality and lacks consistency, with no reported harms or additional studies to corroborate these findings.",0.7,40743209,2025,"Oral creatine in hemodialysis patients increases physical functional capacity and muscle mass, an open label study.",clinical_trial,benefit,"The study demonstrated significant improvements in physical functionality and muscle mass, indicating a beneficial effect of creatine supplementation in hemodialysis patients.",5 g daily 8 weeks (oral),CKD; Hemodialysis,,cardiovascular disease,cardiovascular disease; chronic hemodialysis; chronic inflammation; poor nutritional status,,,
Creatine,Side effects were reported significantly more often for creatine than for placebo supplementation.,Sleep Duration,,Sleep,manual_pair,"One randomized trial suggests that creatine supplementation (5 g daily for 6 weeks) may improve total sleep duration in naturally menstruating females following resistance training days. However, the evidence is limited, with only one study reporting a benefit and no adverse effects noted. Further research is needed to confirm these findings and assess the effects in broader populations.",0.7,39203908,2024,Creatine Improves Total Sleep Duration Following Resistance Training Days versus Non-Resistance Training Days among Naturally Menstruating Females.,randomized_controlled_trial,benefit,Creatine supplementation led to significant increases in total sleep duration on resistance training days.,5 g daily 6 weeks (creatine + maltodextrin),,,poor sleep,poor sleep; sleep disturbances,,,
Creatine,Side effects were reported significantly more often for creatine than for placebo supplementation.,Athletic Performance,,Performance & Recovery,manual_pair,"Current evidence regarding the effect of creatine on repeated sprinting ability is limited and mixed, with one study indicating that while creatine combined with taurine may enhance time to exhaustion, it does not significantly improve repeated sprint performance. Overall, there is no consistent evidence supporting the efficacy of creatine for this specific outcome. No adverse effects were reported in the reviewed study.",0.5,39972259,2025,Effect of Taurine Combined With Creatine on Repeated Sprinting Ability After Exhaustive Exercise Under Hot and Humid Conditions.,randomized_controlled_trial,mixed_unclear,The study shows mixed results with T+C supplementation enhancing time to exhaustion but not significantly improving repeated sprint performance.,,Sprinting,,repeated sprinting ability,repeated sprinting ability,,,
Creatine,Side effects were reported significantly more often for creatine than for placebo supplementation.,High Triglycerides,,Heart & Vascular Health,manual_pair,"Current evidence on creatine supplementation for lowering triglyceride levels is limited, with only one pilot study reporting a beneficial effect on vascular function and metabolic markers. The study utilized a dosing regimen of 5 g of creatine monohydrate four times daily for the first five days, followed by once daily for 23 days. Overall, the evidence is insufficient to draw definitive conclusions, and further research is needed to confirm these findings.",0.7,39796490,2024,Effect of Creatine Monohydrate Supplementation on Macro- and Microvascular Endothelial Function in Older Adults: A Pilot Study.,randomized_controlled_trial,benefit,"The study shows significant improvements in vascular function and metabolic markers, indicating a beneficial effect of creatine supplementation.","5 g 4 times/day for 5 days, then 1 time/day for 23 days 4 weeks (monohydrate)",Older Adults,,triglyceride levels,triglyceride levels,,,
Curcumin,Higher incidence of adverse events in curcumin group compared to control group.; diarrhea; headache; mild adverse drug reaction observed in three cases of the curcumin group and one case of group A; minor gastrointestinal adverse effects reported by 7.1% of patients; nausea; potentially impairing performance recovery; significantly more vomiting in the curcumin group; yellow stool,Ulcerative Colitis,,Gut Health,manual_pair,"Curcumin supplementation at a dose of 1600 mg daily for 8 weeks has shown benefit in reducing disease activity and improving quality of life in patients with active ulcerative colitis, according to a multicenter randomized clinical trial. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term safety and efficacy.",0.7,38794742,2024,"Effects of Mediterranean Diet, Curcumin, and Resveratrol on Mild-to-Moderate Active Ulcerative Colitis: A Multicenter Randomized Clinical Trial.",randomized_controlled_trial,benefit,"The study showed that curcumin supplementation, along with the Mediterranean diet, was effective in reducing disease activity and improving quality of life in patients with ulcerative colitis.",1600 mg daily 8 weeks,,,ulcerative colitis,ulcerative colitis,,,
Curcumin,Higher incidence of adverse events in curcumin group compared to control group.; diarrhea; headache; mild adverse drug reaction observed in three cases of the curcumin group and one case of group A; minor gastrointestinal adverse effects reported by 7.1% of patients; nausea; potentially impairing performance recovery; significantly more vomiting in the curcumin group; yellow stool,Stress,,"Energy, Mood, & Mental Health",manual_pair,"Current evidence on curcumin for anxiety is limited to one randomized controlled trial, which reported a benefit in mental health and health-related quality of life with a daily dose of 1 g of a curcumin-probiotic drink powder over 8 weeks. No studies reported mixed outcomes or harm, but the overall evidence remains sparse and requires further investigation to establish efficacy and safety.",0.7,40375569,2025,"Mental health and health-related quality of life response to curcumin-probiotic drink powder co-supplementation in adults with overweight/obesity and metabolic syndrome: a four-arm randomised, double-blind, placebo-controlled, clinical trial.",randomized_controlled_trial,benefit,"The study showed significant improvements in mental health and HRQOL, indicating a benefit from curcumin-probiotic co-supplementation.",1 g daily 8 weeks (drink powder),Obese; Overweight,,anxiety,anxiety; health-related quality of life; mental health; metabolic syndrome; stress,,,
Curcumin,Higher incidence of adverse events in curcumin group compared to control group.; diarrhea; headache; mild adverse drug reaction observed in three cases of the curcumin group and one case of group A; minor gastrointestinal adverse effects reported by 7.1% of patients; nausea; potentially impairing performance recovery; significantly more vomiting in the curcumin group; yellow stool,Bacterial Vaginosis,,Women's Health,manual_pair,"One randomized clinical trial indicated that curcumin may be more effective than metronidazole in treating bacterial vaginosis, with fewer adverse effects reported. However, the evidence is limited to a single study, and further research is needed to confirm these findings and establish consistent dosing guidelines.",0.7,40032905,2025,A clinical trial of curcumin effect in comparison to metronidazole on the treatment of bacterial vaginosis.,randomized_controlled_trial,benefit,Curcumin showed superior effectiveness and fewer adverse effects compared to metronidazole in treating bacterial vaginosis.,every 12 hours seven days,Women,,bacterial vaginosis,bacterial vaginosis,,,
Curcumin,Higher incidence of adverse events in curcumin group compared to control group.; diarrhea; headache; mild adverse drug reaction observed in three cases of the curcumin group and one case of group A; minor gastrointestinal adverse effects reported by 7.1% of patients; nausea; potentially impairing performance recovery; significantly more vomiting in the curcumin group; yellow stool,Chronic Kidney Disease,,Kidney & Bladder Health,manual_pair,"One randomized, double-blind, placebo-controlled trial reported a benefit of phospholipid curcumin (Meriva) at a dose of 2 g daily over 72 weeks, showing significant improvements in kidney function in patients with chronic kidney disease. No studies reported mixed outcomes or harm, but the overall evidence is limited to a single trial, necessitating caution in generalizing these findings.",0.8,38809154,2025,"Effect of phospholipid curcumin Meriva on liver histology and kidney disease in nonalcoholic steatohepatitis: A randomized, double-blind, placebo-controlled trial.",randomized_controlled_trial,benefit,"The study shows significant improvements in liver histology and kidney function, indicating a beneficial effect of Meriva.",2 g daily 72 weeks (phospholipid curcumin (Meriva)),Fatty Liver Disease,,chronic kidney disease,chronic kidney disease; non-alcoholic steatohepatitis,,,
Curcumin,Higher incidence of adverse events in curcumin group compared to control group.; diarrhea; headache; mild adverse drug reaction observed in three cases of the curcumin group and one case of group A; minor gastrointestinal adverse effects reported by 7.1% of patients; nausea; potentially impairing performance recovery; significantly more vomiting in the curcumin group; yellow stool,Pain,,Musculoskeletal & Pain,manual_pair,"One randomized, double-blind, controlled trial reported a beneficial effect of curcumin (80 mg daily for 8 weeks) as an adjunct therapy in improving pain and quality of life in patients with endometriosis-related chronic pelvic pain. No studies reported mixed outcomes or harm, but the overall evidence is limited to a single trial, indicating a need for further research to confirm these findings.",0.7,40220411,2025,"Add-on effect of curcumin to dienogest in patients with endometriosis: a randomized, double-blind, controlled trial.",randomized_controlled_trial,benefit,"The study demonstrated significant improvements in pain and quality of life, indicating a beneficial effect of curcumin as an adjunct therapy in endometriosis.",80 mg daily 8 weeks (nanocurcumin soft gel capsules),,Women's Health,chronic pelvic pain,chronic pelvic pain; dyschezia; dysmenorrhea; dyspareunia; endometriosis,,,
Curcumin,Higher incidence of adverse events in curcumin group compared to control group.; diarrhea; headache; mild adverse drug reaction observed in three cases of the curcumin group and one case of group A; minor gastrointestinal adverse effects reported by 7.1% of patients; nausea; potentially impairing performance recovery; significantly more vomiting in the curcumin group; yellow stool,Depression,,"Energy, Mood, & Mental Health",manual_pair,"One randomized controlled trial indicates that curcumin may reduce depression severity in obese patients with type 2 diabetes over a 12-month period. No adverse effects were reported in this study, but further research is needed to confirm these findings and assess the effects in broader populations.",0.9,39125295,2024,Curcumin Reduces Depression in Obese Patients with Type 2 Diabetes: A Randomized Controlled Trial.,randomized_controlled_trial,benefit,"The study shows significant improvement in depression severity and related biomarkers, indicating a beneficial effect of curcumin.",12 months (supplement),Diabetes Type 2; Obese,,depression,Type 2 Diabetes Mellitus; depression; obesity,,,
Curcumin,Higher incidence of adverse events in curcumin group compared to control group.; diarrhea; headache; mild adverse drug reaction observed in three cases of the curcumin group and one case of group A; minor gastrointestinal adverse effects reported by 7.1% of patients; nausea; potentially impairing performance recovery; significantly more vomiting in the curcumin group; yellow stool,Dry Eyes,,Vision & Eye Health,manual_pair,"There is limited evidence suggesting that oral bio-enhanced curcumin may improve objective parameters of dry eye disease, as indicated by one study reporting a beneficial outcome. However, the overall quality of evidence is low, and further research is needed to confirm these findings and assess consistency across different populations and formulations. No adverse effects were reported in the study.",0.5,40244565,2025,Role of oral bio-enhanced curcumin in dry eye disease.,randomized_controlled_trial,benefit,"The study shows significant improvement in various objective parameters of dry eye disease with the use of oral bio-enhanced curcumin, indicating a beneficial outcome.",(oral bio-enhanced curcumin),,,dry eye disease,dry eye disease,,,
Curcumin,Higher incidence of adverse events in curcumin group compared to control group.; diarrhea; headache; mild adverse drug reaction observed in three cases of the curcumin group and one case of group A; minor gastrointestinal adverse effects reported by 7.1% of patients; nausea; potentially impairing performance recovery; significantly more vomiting in the curcumin group; yellow stool,Burping,,Gut Health,manual_pair,"Curcumin supplementation at a dose of 1500 mg daily for 13 weeks demonstrated a beneficial effect on gastrointestinal symptoms in a pilot study involving women with severe obesity. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term safety and efficacy.",0.7,40647170,2025,"Curcumin Supplementation Improves Gastrointestinal Symptoms in Women with Severe Obesity: A Double-Blind, Randomized, Placebo-Controlled Trial-A Pilot Study.",randomized_controlled_trial,benefit,"The study showed significant improvements in gastrointestinal symptoms and anthropometric measures, indicating a beneficial effect of curcumin supplementation.",1500 mg daily 13 weeks (curcumin),Obese; Women,Weight & Body Composition,altered bowel patterns,altered bowel patterns; bloating; dyspepsia; gastrointestinal symptoms; obesity; reflux; stomach pain,,,
Curcumin,Higher incidence of adverse events in curcumin group compared to control group.; diarrhea; headache; mild adverse drug reaction observed in three cases of the curcumin group and one case of group A; minor gastrointestinal adverse effects reported by 7.1% of patients; nausea; potentially impairing performance recovery; significantly more vomiting in the curcumin group; yellow stool,Improve Hearing,,Quality of Life & Function,manual_pair,"One randomized controlled trial has reported a significant improvement in hearing thresholds with curcumin in patients with chronic kidney disease, suggesting a potential benefit for hearing impairment. The study utilized a daily dose of curcumin for 12 weeks. However, further research is needed to confirm these findings and assess long-term effects and safety.",0.8,39079962,2024,"The effectiveness of curcumin as a safe agent on hearing threshold improvement in patients with chronic kidney disease: a double-blind, placebo-controlled trial.",randomized_controlled_trial,benefit,"The study shows significant improvement in hearing thresholds with curcumin, indicating a beneficial effect.",daily 12 weeks,CKD,,chronic kidney disease,chronic kidney disease; hearing impairment,,,
Curcumin,Higher incidence of adverse events in curcumin group compared to control group.; diarrhea; headache; mild adverse drug reaction observed in three cases of the curcumin group and one case of group A; minor gastrointestinal adverse effects reported by 7.1% of patients; nausea; potentially impairing performance recovery; significantly more vomiting in the curcumin group; yellow stool,High Blood Glucose,,Metabolic Health,manual_pair,"There is limited evidence suggesting a potential benefit of curcumin supplementation for high blood sugar, with one randomized trial reporting positive outcomes at a dose of 80 mg of nano-curcumin daily for 12 weeks. However, the overall evidence is sparse, and further studies are needed to establish consistency and efficacy. No adverse effects were reported in the available study.",0.7,39085864,2024,"Effect of nano-curcumin supplementation on cardiometabolic risk factors, physical and psychological quality of life, and depression in patients with coronary slow flow phenomenon: a randomized double-blind clinical trial.",randomized_controlled_trial,benefit,"The study showed significant improvements in quality of life and depression, indicating a beneficial effect of curcumin supplementation.",80 mg daily 12 weeks (nano-curcumin),Coronary Slow Flow Phenomenon,"Energy, Mood, & Mental Health",cardiometabolic risk factors,cardiometabolic risk factors; coronary slow flow phenomenon; depression; quality of life,,,
Curcumin,Higher incidence of adverse events in curcumin group compared to control group.; diarrhea; headache; mild adverse drug reaction observed in three cases of the curcumin group and one case of group A; minor gastrointestinal adverse effects reported by 7.1% of patients; nausea; potentially impairing performance recovery; significantly more vomiting in the curcumin group; yellow stool,High Blood Glucose,,Metabolic Health,manual_pair,"Curcumin supplementation at a dose of 80 mg daily for 12 weeks demonstrated a beneficial effect on glucose homeostasis in a pilot study involving prediabetic older adults. However, this evidence is based on a single randomized trial, and further research is needed to confirm these findings and assess long-term effects and safety.",0.8,40647269,2025,"Twelve-Week Curcumin Supplementation Improves Glucose Homeostasis and Gut Health in Prediabetic Older Adults: A Pilot, Double-Blind, Placebo-Controlled Trial.",randomized_controlled_trial,benefit,"Curcumin supplementation showed significant improvement in glucose homeostasis markers, indicating a beneficial effect in prediabetic older adults.",80 mg daily 12 weeks (capsules),Prediabetes,,prediabetes,Type 2 Diabetes Mellitus; prediabetes,,,
Curcumin,Higher incidence of adverse events in curcumin group compared to control group.; diarrhea; headache; mild adverse drug reaction observed in three cases of the curcumin group and one case of group A; minor gastrointestinal adverse effects reported by 7.1% of patients; nausea; potentially impairing performance recovery; significantly more vomiting in the curcumin group; yellow stool,Cardiac Risk,,Heart & Vascular Health,manual_pair,"Curcumin supplementation appears to provide consistent benefits for individuals with type 2 diabetes, as evidenced by five randomized controlled trials demonstrating improvements in glucose levels, β-cell function, inflammation, and cardiovascular risk factors. Reported doses varied, with common ranges including 80 mg to 1500 mg daily. All studies noted mild adverse effects, indicating that curcumin is generally well tolerated.",1.0,40759997,2025,Curcumin supplementation improves the clinical outcomes of patients with diabetes and atherosclerotic cardiovascular risk.,randomized_controlled_trial,benefit,Curcumin supplementation showed significant improvements in various cardiovascular risk factors and was well tolerated with mild adverse effects.,500 mg thrice daily (Turmeric curcumin®),,,atherosclerotic cardiovascular disease,Type 2 Diabetes Mellitus; atherosclerotic cardiovascular disease; insulin resistance; metabolic dysfunction-associated steatotic liver disease; obesity,,,
Curcumin,Higher incidence of adverse events in curcumin group compared to control group.; diarrhea; headache; mild adverse drug reaction observed in three cases of the curcumin group and one case of group A; minor gastrointestinal adverse effects reported by 7.1% of patients; nausea; potentially impairing performance recovery; significantly more vomiting in the curcumin group; yellow stool,Cardiac Risk,,Heart & Vascular Health,manual_pair,"Curcumin supplementation appears to provide consistent benefits for individuals with type 2 diabetes, as evidenced by five randomized controlled trials demonstrating improvements in glucose levels, β-cell function, inflammation, and cardiovascular risk factors. Reported doses varied, with common ranges including 80 mg to 1500 mg daily. All studies noted mild adverse effects, indicating that curcumin is generally well tolerated.",1.0,39354480,2024,Curcumin extract improves beta cell functions in obese patients with type 2 diabetes: a randomized controlled trial.,randomized_controlled_trial,benefit,"The study reports significant improvements in glucose levels and β-cell function, indicating a beneficial effect of curcumin in type 2 diabetes patients.",1500 mg daily 12 months,Diabetes Type 2,,insulin resistance,Type 2 Diabetes Mellitus; atherosclerotic cardiovascular disease; insulin resistance; metabolic dysfunction-associated steatotic liver disease; obesity,,,
Curcumin,Higher incidence of adverse events in curcumin group compared to control group.; diarrhea; headache; mild adverse drug reaction observed in three cases of the curcumin group and one case of group A; minor gastrointestinal adverse effects reported by 7.1% of patients; nausea; potentially impairing performance recovery; significantly more vomiting in the curcumin group; yellow stool,Cardiac Risk,,Heart & Vascular Health,manual_pair,"Curcumin supplementation appears to provide consistent benefits for individuals with type 2 diabetes, as evidenced by five randomized controlled trials demonstrating improvements in glucose levels, β-cell function, inflammation, and cardiovascular risk factors. Reported doses varied, with common ranges including 80 mg to 1500 mg daily. All studies noted mild adverse effects, indicating that curcumin is generally well tolerated.",1.0,40573083,2025,Curcumin for Inflammation Control in Individuals with Type 2 Diabetes Mellitus and Metabolic Dysfunction-Associated Steatotic Liver Disease: A Randomized Controlled Trial.,randomized_controlled_trial,benefit,"Curcumin showed significant improvements in inflammation and liver parameters, indicating a beneficial effect in the studied conditions.",1500 mg daily 12 months,Diabetes Type 2; Fatty Liver Disease,,metabolic dysfunction-associated steatotic liver disease,Type 2 Diabetes Mellitus; atherosclerotic cardiovascular disease; insulin resistance; metabolic dysfunction-associated steatotic liver disease; obesity,,,
Curcumin,Higher incidence of adverse events in curcumin group compared to control group.; diarrhea; headache; mild adverse drug reaction observed in three cases of the curcumin group and one case of group A; minor gastrointestinal adverse effects reported by 7.1% of patients; nausea; potentially impairing performance recovery; significantly more vomiting in the curcumin group; yellow stool,Cardiac Risk,,Heart & Vascular Health,manual_pair,"Curcumin supplementation appears to provide consistent benefits for individuals with type 2 diabetes, as evidenced by five randomized controlled trials demonstrating improvements in glucose levels, β-cell function, inflammation, and cardiovascular risk factors. Reported doses varied, with common ranges including 80 mg to 1500 mg daily. All studies noted mild adverse effects, indicating that curcumin is generally well tolerated.",1.0,40481568,2025,Effect of adding fenofibrate versus curcumin to glimepiride in patients with type 2 diabetes: a randomized controlled trial.,randomized_controlled_trial,benefit,Both fenofibrate and curcumin showed benefits in improving lipid profiles and inflammatory markers in patients with type 2 diabetes.,1100 mg once daily three months (oral); 160 mg once daily three months (oral); 4 mg once daily three months (oral),Diabetes Type 2,,Type 2 Diabetes Mellitus,Type 2 Diabetes Mellitus; atherosclerotic cardiovascular disease; insulin resistance; metabolic dysfunction-associated steatotic liver disease; obesity,,,
Curcumin,Higher incidence of adverse events in curcumin group compared to control group.; diarrhea; headache; mild adverse drug reaction observed in three cases of the curcumin group and one case of group A; minor gastrointestinal adverse effects reported by 7.1% of patients; nausea; potentially impairing performance recovery; significantly more vomiting in the curcumin group; yellow stool,Cardiac Risk,,Heart & Vascular Health,manual_pair,"Curcumin supplementation appears to provide consistent benefits for individuals with type 2 diabetes, as evidenced by five randomized controlled trials demonstrating improvements in glucose levels, β-cell function, inflammation, and cardiovascular risk factors. Reported doses varied, with common ranges including 80 mg to 1500 mg daily. All studies noted mild adverse effects, indicating that curcumin is generally well tolerated.",1.0,38589346,2024,The effect of curcumin and high-content eicosapentaenoic acid supplementations in type 2 diabetes mellitus patients: a double-blinded randomized clinical trial.,randomized_controlled_trial,benefit,"The study shows significant benefits in reducing insulin levels and improving metabolic parameters, indicating a positive effect of curcumin supplementation.",80 mg daily 12 weeks (nano-curcumin),Diabetes Type 2,,Type 2 Diabetes Mellitus,Type 2 Diabetes Mellitus; atherosclerotic cardiovascular disease; insulin resistance; metabolic dysfunction-associated steatotic liver disease; obesity,,,
Curcumin,Higher incidence of adverse events in curcumin group compared to control group.; diarrhea; headache; mild adverse drug reaction observed in three cases of the curcumin group and one case of group A; minor gastrointestinal adverse effects reported by 7.1% of patients; nausea; potentially impairing performance recovery; significantly more vomiting in the curcumin group; yellow stool,Atherosclerosis,,Heart & Vascular Health,manual_pair,"Current evidence from a randomized controlled trial indicates that curcumin may reduce atherogenic risks and improve cardiometabolic biomarkers in obese patients with type 2 diabetes, suggesting a potential benefit for lowering high LDL cholesterol. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term safety and efficacy.",0.7,39125322,2024,The Effect of Curcumin on Reducing Atherogenic Risks in Obese Patients with Type 2 Diabetes: A Randomized Controlled Trial.,randomized_controlled_trial,benefit,"The study found significant reductions in atherogenic risks and cardiometabolic biomarkers, indicating a beneficial effect of curcumin.",12 months,Diabetes Type 2; Obese,,atherosclerosis,Type 2 Diabetes Mellitus; atherosclerosis; obesity,,,
Curcumin,Higher incidence of adverse events in curcumin group compared to control group.; diarrhea; headache; mild adverse drug reaction observed in three cases of the curcumin group and one case of group A; minor gastrointestinal adverse effects reported by 7.1% of patients; nausea; potentially impairing performance recovery; significantly more vomiting in the curcumin group; yellow stool,Fatty Liver Disease,,Gut Health,manual_pair,"Curcumin supplementation at a dose of 500 mg daily for 24 weeks has shown a beneficial effect in reducing hepatic fat content in patients with nonalcoholic simple fatty liver disease, according to a randomized controlled trial. However, the overall evidence is limited, with only one study reporting positive outcomes and no data on potential adverse effects or long-term efficacy.",0.7,38795741,2024,Curcumin supplementation alleviates hepatic fat content associated with modulation of gut microbiota-dependent bile acid metabolism in patients with nonalcoholic simple fatty liver disease: a randomized controlled trial.,randomized_controlled_trial,benefit,"Curcumin significantly reduced hepatic fat content and improved various metabolic parameters, indicating a beneficial effect.",500 mg daily 24 weeks,,,nonalcoholic simple fatty liver disease,nonalcoholic simple fatty liver disease,,,
Curcumin,Higher incidence of adverse events in curcumin group compared to control group.; diarrhea; headache; mild adverse drug reaction observed in three cases of the curcumin group and one case of group A; minor gastrointestinal adverse effects reported by 7.1% of patients; nausea; potentially impairing performance recovery; significantly more vomiting in the curcumin group; yellow stool,High Triglycerides,,Heart & Vascular Health,manual_pair,"One randomized trial reported that curcumin-piperine supplementation (500 mg for 12 weeks) significantly reduced triglyceride levels in patients with type 2 diabetes and hypertriglyceridemia, indicating a potential benefit. However, the overall evidence is limited to this single study, and further research is needed to confirm these findings and assess long-term effects and safety.",0.7,39165011,2024,"The effect of curcumin-piperine supplementation on lipid profile, glycemic index, inflammation, and blood pressure in patients with type 2 diabetes mellitus and hypertriglyceridemia.",randomized_controlled_trial,benefit,"The study showed significant reductions in triglycerides and fasting blood glucose, indicating a benefit from curcumin-piperine supplementation.",500 mg 12 weeks (tablet),Diabetes Type 2,"Immune, Inflammation, & Infection; Metabolic Health",hypertriglyceridemia,Type 2 Diabetes Mellitus; hypertriglyceridemia,,,
Curcumin,Higher incidence of adverse events in curcumin group compared to control group.; diarrhea; headache; mild adverse drug reaction observed in three cases of the curcumin group and one case of group A; minor gastrointestinal adverse effects reported by 7.1% of patients; nausea; potentially impairing performance recovery; significantly more vomiting in the curcumin group; yellow stool,Inflammation,,"Immune, Inflammation, & Infection",manual_pair,"One randomized placebo-controlled trial reported that curcumin supplementation at a dose of 1000 mg daily for 10 weeks significantly reduced inflammatory markers, including anti-ds DNA and IL-6 levels, in patients with systemic lupus erythematosus. However, the overall evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term safety and efficacy.",0.7,39546036,2024,The effects of curcumin supplementation on inflammatory markers in systemic lupus erythematosus patients: a randomized placebo-controlled trial.,randomized_controlled_trial,benefit,"Curcumin supplementation significantly reduced anti-ds DNA and IL-6 levels, indicating a beneficial effect on inflammation in SLE patients.",1000 mg daily 10 weeks,Systemic Lupus Erythematosus,,systemic lupus erythematosus,systemic lupus erythematosus,,,
Curcumin,Higher incidence of adverse events in curcumin group compared to control group.; diarrhea; headache; mild adverse drug reaction observed in three cases of the curcumin group and one case of group A; minor gastrointestinal adverse effects reported by 7.1% of patients; nausea; potentially impairing performance recovery; significantly more vomiting in the curcumin group; yellow stool,Chronic Kidney Disease,,Kidney & Bladder Health,manual_pair,"One randomized trial suggests that phospholipid curcumin (Meriva) may improve GLP-2 response and related outcomes in patients with metabolic dysfunction-associated steatohepatitis (MASH), indicating a potential benefit for kidney injury. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term safety and efficacy.",0.7,39620369,2024,"Impaired postprandial GLP-2 response enhances endotoxemia, systemic inflammation, and kidney injury in metabolic dysfunction-associated steatohepatitis (MASH): effect of phospholipid curcumin meriva.",randomized_controlled_trial,benefit,"The study shows that curcumin may improve GLP-2 response and related outcomes in MASH patients, indicating a potential benefit.",72 weeks (phospholipid curcumin meriva),Fatty Liver Disease,,chronic kidney disease,chronic kidney disease; metabolic dysfunction-associated steatohepatitis,,,
Curcumin,Higher incidence of adverse events in curcumin group compared to control group.; diarrhea; headache; mild adverse drug reaction observed in three cases of the curcumin group and one case of group A; minor gastrointestinal adverse effects reported by 7.1% of patients; nausea; potentially impairing performance recovery; significantly more vomiting in the curcumin group; yellow stool,Osteoarthritis,,Musculoskeletal & Pain,manual_pair,"Current evidence from a randomized trial indicates that curcumin may have a beneficial effect on knee pain in patients with osteoarthritis, as demonstrated by significant changes in gene expression related to Th17 function. However, the evidence is limited to a single study, and no adverse effects were reported. Further research is needed to confirm these findings and establish consistent dosing guidelines.",0.7,39586746,2024,The Immunomodulatory Effects of Curcumin on Forkhead Box O1 and MicroRNA-873 in Patients with Osteoarthritis.,randomized_controlled_trial,benefit,"The study shows a significant increase in gene expression related to Th17 function, indicating a beneficial effect of curcumin in OA patients.",3 months,,,knee osteoarthritis,knee osteoarthritis; osteoarthritis,,,
Curcumin,Higher incidence of adverse events in curcumin group compared to control group.; diarrhea; headache; mild adverse drug reaction observed in three cases of the curcumin group and one case of group A; minor gastrointestinal adverse effects reported by 7.1% of patients; nausea; potentially impairing performance recovery; significantly more vomiting in the curcumin group; yellow stool,COVID-19,,"Immune, Inflammation, & Infection",manual_pair,"One randomized, double-blind, placebo-controlled trial reported a benefit of curcumin in patients with mild COVID-19 symptoms, showing a reduction in disease progression and antipyretic medication use with a dose of 360 mg (curcuRouge®) twice daily for 7 days. However, the overall evidence is limited to this single study, and further research is needed to confirm these findings and assess long-term safety and efficacy.",0.7,38915116,2024,"Efficacy of highly bioavailable oral curcumin in asymptomatic or mild COVID-19 patients: a double-blind, randomized, placebo-controlled trial.",randomized_controlled_trial,benefit,"The study shows a reduction in disease progression and antipyretic medication use, indicating a beneficial effect of curcumin.",360 mg twice daily 7 days (curcuRouge®),,,asymptomatic covid-19,asymptomatic covid-19; covid-19; mild covid-19,,,
Curcumin,Higher incidence of adverse events in curcumin group compared to control group.; diarrhea; headache; mild adverse drug reaction observed in three cases of the curcumin group and one case of group A; minor gastrointestinal adverse effects reported by 7.1% of patients; nausea; potentially impairing performance recovery; significantly more vomiting in the curcumin group; yellow stool,Increase Muscle Mass,,Weight & Body Composition,manual_pair,"One randomized, double-blind, placebo-controlled trial reported that curcumin combined with piperine (1000 mg and 10 mg daily, respectively) improved body composition and muscle mass in patients with inflammatory bowel disease. Overall evidence is limited to this single study, and further research is needed to confirm these findings and assess long-term effects and safety.",0.7,39934549,2025,"Curcumin plus piperine improve body composition in patients with inflammatory bowel disease: a randomized, double-blind, placebo-controlled clinical trial.",randomized_controlled_trial,benefit,"The study shows significant improvements in body composition and muscle mass in patients with IBD, indicating a beneficial effect of curcumin plus piperine.",1000 mg daily 12 weeks (oral supplementation); 10 mg daily 12 weeks (oral supplementation with piperine),IBD,,inflammatory bowel disease,inflammatory bowel disease,,,
Curcumin,Higher incidence of adverse events in curcumin group compared to control group.; diarrhea; headache; mild adverse drug reaction observed in three cases of the curcumin group and one case of group A; minor gastrointestinal adverse effects reported by 7.1% of patients; nausea; potentially impairing performance recovery; significantly more vomiting in the curcumin group; yellow stool,Exercise Induced Inflammation,,Performance & Recovery,manual_pair,"Current evidence on curcumin for muscle soreness after exercise is mixed, with one study indicating that higher doses (750 mg and 1500 mg, taken twice daily for 7 days) may improve biochemical recovery but could impair performance recovery. No consistent benefits have been established, and further research is needed to clarify its effects.",0.7,40781899,2025,"The dose-response effects of hydrolyzed curcumin on recovery, inflammation, and oxidative stress following exercise-induced muscle damage in males.",randomized_controlled_trial,mixed_unclear,The study shows mixed outcomes; higher doses improved biochemical recovery but may have impaired performance recovery.,750 mg 2 times/day 7 days (gel sachets); 1500 mg 2 times/day 7 days (gel sachets),Men,,exercise-induced muscle damage,exercise-induced muscle damage; inflammation; oxidative stress,,,
Curcumin,Higher incidence of adverse events in curcumin group compared to control group.; diarrhea; headache; mild adverse drug reaction observed in three cases of the curcumin group and one case of group A; minor gastrointestinal adverse effects reported by 7.1% of patients; nausea; potentially impairing performance recovery; significantly more vomiting in the curcumin group; yellow stool,Fatty Liver Disease,,Gut Health,manual_pair,"Curcumin supplementation has shown a beneficial effect in preventing tamoxifen-induced nonalcoholic fatty liver disease (NAFLD) in a specific population of ER+ breast cancer patients, based on a triple-blind randomized placebo-controlled trial that used a dose of 500 mg daily for 6 months. However, the evidence is limited to this single study, and further research is needed to establish broader efficacy and safety in other populations.",0.7,39948699,2025,Curcumin Supplementation as a Preventive Strategy Against Tamoxifen-Induced Nonalcoholic Fatty Liver Disease in ER+ Breast Cancer Patients: A Triple-Blind Randomized Placebo-Controlled Trial.,randomized_controlled_trial,benefit,"Curcumin showed a protective effect against tamoxifen-induced NAFLD, indicating a benefit in the studied population.",500 mg daily 6 months,Cancer,,breast cancer,breast cancer; nonalcoholic fatty liver disease,,,
Curcumin,Higher incidence of adverse events in curcumin group compared to control group.; diarrhea; headache; mild adverse drug reaction observed in three cases of the curcumin group and one case of group A; minor gastrointestinal adverse effects reported by 7.1% of patients; nausea; potentially impairing performance recovery; significantly more vomiting in the curcumin group; yellow stool,Peridontitis,,Oral Health,manual_pair,"One randomized trial reported a benefit of liposomal curcumin gel in improving clinical and biochemical parameters in diabetic patients with periodontitis over 6 and 12 weeks. However, the overall evidence is limited, with only one study available, and further research is needed to confirm these findings and assess long-term effects and safety.",0.7,38953482,2024,Sustained Release of Liposomal Curcumin: Enhanced Periodontal Outcomes in Diabetic Patients.,randomized_controlled_trial,benefit,"The study shows significant improvement in clinical and biochemical parameters, indicating a benefit from the treatment with liposomal curcumin.",6 and 12 weeks (liposomal curcumin gel),Diabetes,,diabetes,diabetes; periodontitis,,,
Curcumin,Higher incidence of adverse events in curcumin group compared to control group.; diarrhea; headache; mild adverse drug reaction observed in three cases of the curcumin group and one case of group A; minor gastrointestinal adverse effects reported by 7.1% of patients; nausea; potentially impairing performance recovery; significantly more vomiting in the curcumin group; yellow stool,Weight Loss,,Weight & Body Composition,manual_pair,"One randomized clinical trial reported a beneficial effect of curcumin (80 mg of nanocurcumin soft gel capsule) in improving health parameters in women with polycystic ovary syndrome over 12 weeks. However, the overall evidence is limited, with only one study available, and further research is needed to confirm these findings and assess long-term safety and efficacy.",0.7,39461199,2024,Effects of metformin and curcumin in women with polycystic ovary syndrome: A factorial clinical trial.,randomized_controlled_trial,benefit,"The study shows significant improvements in various health parameters, indicating a beneficial effect of curcumin in the treatment of PCOS.",80 mg 8 h 12 weeks (nanocurcumin soft gel capsule),PCOS; Women,Heart & Vascular Health; Metabolic Health,polycystic ovary syndrome,polycystic ovary syndrome,,,
Curcumin,Higher incidence of adverse events in curcumin group compared to control group.; diarrhea; headache; mild adverse drug reaction observed in three cases of the curcumin group and one case of group A; minor gastrointestinal adverse effects reported by 7.1% of patients; nausea; potentially impairing performance recovery; significantly more vomiting in the curcumin group; yellow stool,Depression,,"Energy, Mood, & Mental Health",manual_pair,"One double-blind randomized placebo-controlled trial has reported a beneficial effect of curcumin (500 mg once daily for eight weeks) on postpartum anxiety and depression scores in primiparous women. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term safety and efficacy.",0.7,40281561,2025,The effect of curcumin on postpartum depression and anxiety in primiparous women: a double-blind randomized placebo-controlled clinical trial.,randomized_controlled_trial,benefit,"The study shows significant improvement in postpartum depression and anxiety scores, indicating a beneficial effect of curcumin.",500 mg once daily eight weeks (capsules),,,postpartum anxiety,postpartum anxiety; postpartum depression,,,
Curcumin,Higher incidence of adverse events in curcumin group compared to control group.; diarrhea; headache; mild adverse drug reaction observed in three cases of the curcumin group and one case of group A; minor gastrointestinal adverse effects reported by 7.1% of patients; nausea; potentially impairing performance recovery; significantly more vomiting in the curcumin group; yellow stool,Rheumatoid Arthritis,,Musculoskeletal & Pain,manual_pair,"Curcumin supplementation at a dose of 500 mg daily for 8 weeks has shown a benefit in improving serum total antioxidant capacity and reducing disease activity scores in women with rheumatoid arthritis, according to a randomized, double-blind, placebo-controlled trial. However, the overall evidence is limited, with only one study reporting positive outcomes and no data on potential adverse effects or long-term efficacy.",0.7,38699839,2024,"The efficacy of curcumin supplementation on serum total antioxidant capacity, malondialdehyde, and disease activity in women with rheumatoid arthritis: A randomized, double-blind, placebo-controlled clinical trial.",randomized_controlled_trial,benefit,Curcumin supplementation significantly improved serum TAC and reduced disease activity scores in women with RA.,500 mg daily 8 weeks (capsule),Women,,rheumatoid arthritis,rheumatoid arthritis,,,
Curcumin,Higher incidence of adverse events in curcumin group compared to control group.; diarrhea; headache; mild adverse drug reaction observed in three cases of the curcumin group and one case of group A; minor gastrointestinal adverse effects reported by 7.1% of patients; nausea; potentially impairing performance recovery; significantly more vomiting in the curcumin group; yellow stool,Peridontitis,,Oral Health,manual_pair,"One randomized clinical trial demonstrated that a 0.2% curcumin mouthwash used twice daily for 20 days significantly reduced Streptococcus mutans levels compared to chlorhexidine, indicating a potential benefit. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term effects and safety.",0.7,40258261,2025,Comparison of the antimicrobial effects of 0.2% curcumin mouthwash and chlorhexidine mouthwash on Streptococcus mutans in orthodontic patients: a randomized clinical trial.,randomized_controlled_trial,benefit,"The study shows that curcumin mouthwash significantly reduced S mutans more than chlorhexidine after 20 days, indicating a benefit.",0.2 % twice daily 20 days (mouthwash),,,streptococcus mutans,streptococcus mutans,,,
Docosahexaenoic acid (DHA),adverse effect on behavioral functioning; gastrointestinal symptoms; higher risk of gestational diabetes associated with DHA supplementation; higher risk of obesity in high-DHA group; less rested compared to placebo; participants reported feeling less energetic; possible adverse effect on language of females at 1.5 years,Depression,,"Energy, Mood, & Mental Health",manual_pair,"The evidence regarding docosahexaenoic acid (DHA) supplementation for anxiety is mixed and unclear, based on a single randomized controlled trial that reported positive effects on anxiety in a specific subgroup (APOE ɛ4 carriers) but no overall effect on cognition. The study utilized a daily dose of 1491 mg of DHA from a fish oil supplement over 12 months. No adverse effects were reported, but the limited and mixed nature of the evidence suggests caution in interpretation.",0.7,35373862,2022,The effects of docosahexaenoic acid supplementation on cognition and well-being in mild cognitive impairment: A 12-month randomised controlled trial.,randomized_controlled_trial,mixed_unclear,"The study found no effect on cognition but positive effects on depression and anxiety in APOE ɛ4 carriers, indicating mixed outcomes.",1491 mg daily 12 months (fish oil supplement),,Heart & Vascular Health,anxiety,anxiety; depression; mild cognitive impairment,,,
Docosahexaenoic acid (DHA),adverse effect on behavioral functioning; gastrointestinal symptoms; higher risk of gestational diabetes associated with DHA supplementation; higher risk of obesity in high-DHA group; less rested compared to placebo; participants reported feeling less energetic; possible adverse effect on language of females at 1.5 years,Systemic Lupus Erythematosus,,"Immune, Inflammation, & Infection",manual_pair,"The evidence for docosahexaenoic acid (DHA) in reducing chronic inflammation is limited and mixed. One randomized trial reported a beneficial effect on pro-inflammatory cytokines with a dose of 3 g daily for 10 weeks, while another study indicated mixed outcomes regarding gene expression related to inflammation. No studies reported harm or no benefit, but the overall quality and consistency of the evidence are low.",0.7,33303222,2021,"EPA and DHA differentially modulate monocyte inflammatory response in subjects with chronic inflammation in part via plasma specialized pro-resolving lipid mediators: A randomized, double-blind, crossover study.",randomized_controlled_trial,benefit,"DHA showed a broader effect in attenuating pro-inflammatory cytokines, indicating a beneficial outcome.",3 g daily 10 weeks,,,chronic inflammation,chronic inflammation; low-grade chronic inflammation,,,
Docosahexaenoic acid (DHA),adverse effect on behavioral functioning; gastrointestinal symptoms; higher risk of gestational diabetes associated with DHA supplementation; higher risk of obesity in high-DHA group; less rested compared to placebo; participants reported feeling less energetic; possible adverse effect on language of females at 1.5 years,Systemic Lupus Erythematosus,,"Immune, Inflammation, & Infection",manual_pair,"The evidence for docosahexaenoic acid (DHA) in reducing chronic inflammation is limited and mixed. One randomized trial reported a beneficial effect on pro-inflammatory cytokines with a dose of 3 g daily for 10 weeks, while another study indicated mixed outcomes regarding gene expression related to inflammation. No studies reported harm or no benefit, but the overall quality and consistency of the evidence are low.",0.7,38091778,2024,Monocyte transcriptomic profile following EPA and DHA supplementation in men and women with low-grade chronic inflammation.,randomized_controlled_trial,mixed_unclear,"The study shows both similar and differential effects of DHA and EPA on gene expression related to inflammation, indicating mixed outcomes.",3 g daily (DHA),,,low-grade chronic inflammation,chronic inflammation; low-grade chronic inflammation,,,
Docosahexaenoic acid (DHA),adverse effect on behavioral functioning; gastrointestinal symptoms; higher risk of gestational diabetes associated with DHA supplementation; higher risk of obesity in high-DHA group; less rested compared to placebo; participants reported feeling less energetic; possible adverse effect on language of females at 1.5 years,Cognitive Performance,,Cognitive & Neurological Function,manual_pair,"Current evidence from a single randomized trial suggests that docosahexaenoic acid (DHA) may prevent age-related cognitive decline when consumed at a dose of 297 mg daily for 12 months. However, the overall evidence is limited, with only one study reporting a benefit and no adverse effects noted. Further research is needed to confirm these findings and assess long-term effects.",0.7,34759112,2021,Intake of Docosahexaenoic Acid-Enriched Milk Beverage Prevents Age-Related Cognitive Decline and Decreases Serum Bone Resorption Marker Levels.,randomized_controlled_trial,benefit,"The study shows that DHA intake prevents cognitive decline and may benefit bone health, indicating a positive outcome.",297 mg daily 12 months (milk beverage),,Healthy Aging & Prevention,bone health,bone health; cognitive decline; dementia,,,
Docosahexaenoic acid (DHA),adverse effect on behavioral functioning; gastrointestinal symptoms; higher risk of gestational diabetes associated with DHA supplementation; higher risk of obesity in high-DHA group; less rested compared to placebo; participants reported feeling less energetic; possible adverse effect on language of females at 1.5 years,Dementia Prevention,,Healthy Aging & Prevention,manual_pair,"The evidence for docosahexaenoic acid (DHA) in improving cognitive function in individuals with mild cognitive impairment is mixed. Three studies reported benefits with doses of 800 mg daily, while one study showed unclear outcomes despite high doses of 2 grams per day. No studies reported harm, but the overall findings suggest that while DHA may have potential benefits, further research is needed to clarify its effectiveness and optimal dosing.",0.8,37874103,2023,Baseline Findings of PreventE4: A Double-Blind Placebo Controlled Clinical Trial Testing High Dose DHA in APOE4 Carriers before the Onset of Dementia.,randomized_controlled_trial,mixed_unclear,"The study aims to assess the effects of DHA on cognitive function and brain imaging biomarkers, but the outcomes are not definitively beneficial or harmful based on the abstract.",2 grams per day 2 years,,,alzheimer disease,alzheimer disease; cognitive function; mild cognitive impairment,,,
Docosahexaenoic acid (DHA),adverse effect on behavioral functioning; gastrointestinal symptoms; higher risk of gestational diabetes associated with DHA supplementation; higher risk of obesity in high-DHA group; less rested compared to placebo; participants reported feeling less energetic; possible adverse effect on language of females at 1.5 years,Dementia Prevention,,Healthy Aging & Prevention,manual_pair,"The evidence for docosahexaenoic acid (DHA) in improving cognitive function in individuals with mild cognitive impairment is mixed. Three studies reported benefits with doses of 800 mg daily, while one study showed unclear outcomes despite high doses of 2 grams per day. No studies reported harm, but the overall findings suggest that while DHA may have potential benefits, further research is needed to clarify its effectiveness and optimal dosing.",0.8,40044083,2025,"Supplementation of medium-chain triglycerides combined with docosahexaenoic acid improves cognitive function in Chinese older adults with mild cognitive impairment: A randomized double-blind, placebo-controlled trial.",randomized_controlled_trial,benefit,"The study shows significant improvements in cognitive function for MCI patients, indicating a benefit from the supplementation.",14 g daily 12 months (octanoic acid and capric acid); 800 mg daily 12 months (DHA),Older Adults,,mild cognitive impairment,alzheimer disease; cognitive function; mild cognitive impairment,,,
Docosahexaenoic acid (DHA),adverse effect on behavioral functioning; gastrointestinal symptoms; higher risk of gestational diabetes associated with DHA supplementation; higher risk of obesity in high-DHA group; less rested compared to placebo; participants reported feeling less energetic; possible adverse effect on language of females at 1.5 years,Dementia Prevention,,Healthy Aging & Prevention,manual_pair,"The evidence for docosahexaenoic acid (DHA) in improving cognitive function in individuals with mild cognitive impairment is mixed. Three studies reported benefits with doses of 800 mg daily, while one study showed unclear outcomes despite high doses of 2 grams per day. No studies reported harm, but the overall findings suggest that while DHA may have potential benefits, further research is needed to clarify its effectiveness and optimal dosing.",0.8,38952108,2024,"Cognitive Benefits of Folic Acid, Docosahexaenoic Acid, and a Combination of Both Nutrients in Mild Cognitive Impairment: Possible Alterations through Mitochondrial Function and DNA Damage.",randomized_controlled_trial,benefit,"The study demonstrated significant cognitive improvements in participants with mild cognitive impairment, indicating a beneficial effect of DHA supplementation.",800 μg daily 12 months (oral); 800 mg daily 12 months (oral),Older Adults,,mild cognitive impairment,alzheimer disease; cognitive function; mild cognitive impairment,,,
Docosahexaenoic acid (DHA),adverse effect on behavioral functioning; gastrointestinal symptoms; higher risk of gestational diabetes associated with DHA supplementation; higher risk of obesity in high-DHA group; less rested compared to placebo; participants reported feeling less energetic; possible adverse effect on language of females at 1.5 years,Atherosclerosis,,Heart & Vascular Health,manual_pair,"The evidence regarding docosahexaenoic acid (DHA) supplementation for coronary artery disease is mixed. One study indicated potential harm, showing increased coronary artery calcium progression with DHA and eicosapentaenoic acid (EPA) supplementation at a dose of 1.86 g daily, while another study suggested a benefit with a higher dose of 3.36 g daily, reporting regression of coronary fatty plaque and reduced cardiac events. Overall, the findings are inconsistent, and caution is warranted due to the potential for adverse effects.",0.7,38885922,2024,The Effect of Eicosapentaenoic and Docosahexaenoic Acid Supplementation on Coronary Artery Calcium Progression in Subjects With Diabetes and Coronary Artery Disease: A Secondary Analysis of a Randomized Trial.,randomized_controlled_trial,harm,"The study found that EPA+DHA supplementation was associated with greater coronary artery calcium progression in subjects with diabetes, indicating potential harm.",1.86 g daily 30 months (EPA and DHA),Diabetes Type 2,,coronary artery disease,coronary artery disease; diabetes mellitus,,,
Docosahexaenoic acid (DHA),adverse effect on behavioral functioning; gastrointestinal symptoms; higher risk of gestational diabetes associated with DHA supplementation; higher risk of obesity in high-DHA group; less rested compared to placebo; participants reported feeling less energetic; possible adverse effect on language of females at 1.5 years,Atherosclerosis,,Heart & Vascular Health,manual_pair,"The evidence regarding docosahexaenoic acid (DHA) supplementation for coronary artery disease is mixed. One study indicated potential harm, showing increased coronary artery calcium progression with DHA and eicosapentaenoic acid (EPA) supplementation at a dose of 1.86 g daily, while another study suggested a benefit with a higher dose of 3.36 g daily, reporting regression of coronary fatty plaque and reduced cardiac events. Overall, the findings are inconsistent, and caution is warranted due to the potential for adverse effects.",0.7,37681568,2023,Regression of Coronary Fatty Plaque and Risk of Cardiac Events According to Blood Pressure Status: Data From a Randomized Trial of Eicosapentaenoic Acid and Docosahexaenoic Acid in Patients With Coronary Artery Disease.,randomized_controlled_trial,benefit,"The study shows that DHA, along with eicosapentaenoic acid, leads to regression of coronary fatty plaque and reduced cardiac events, indicating a beneficial outcome.",3.36 g daily 30 months,,,coronary artery disease,coronary artery disease; diabetes mellitus,,,
Docosahexaenoic acid (DHA),adverse effect on behavioral functioning; gastrointestinal symptoms; higher risk of gestational diabetes associated with DHA supplementation; higher risk of obesity in high-DHA group; less rested compared to placebo; participants reported feeling less energetic; possible adverse effect on language of females at 1.5 years,Cardiac Risk,,Heart & Vascular Health,manual_pair,"Clinical evidence suggests that docosahexaenoic acid (DHA) supplementation may have beneficial effects on metabolic health and body weight in individuals with excess body weight, as indicated by two studies showing improvements in cardiometabolic markers and adiponectin levels. Doses reported include 4 g of fish oil daily for 4 weeks and DHA-rich n-3 PUFA for 16 weeks. However, the overall evidence is limited to a small number of studies, and further research is needed to confirm these findings and assess long-term effects.",0.8,40806137,2025,Myokine Circulating Levels in Postmenopausal Women with Overweight or Obesity: Effects of Resistance Training and/or DHA-Rich n-3 PUFA Supplementation.,randomized_controlled_trial,benefit,"The study indicates improvements in cardiometabolic health markers and muscle function, suggesting a benefit from DHA supplementation and resistance training.",16 weeks (DHA-rich n-3 PUFA),,,cardiovascular diseases,cardiovascular diseases; muscle function; obesity; overweight,,,
Docosahexaenoic acid (DHA),adverse effect on behavioral functioning; gastrointestinal symptoms; higher risk of gestational diabetes associated with DHA supplementation; higher risk of obesity in high-DHA group; less rested compared to placebo; participants reported feeling less energetic; possible adverse effect on language of females at 1.5 years,Cardiac Risk,,Heart & Vascular Health,manual_pair,"Clinical evidence suggests that docosahexaenoic acid (DHA) supplementation may have beneficial effects on metabolic health and body weight in individuals with excess body weight, as indicated by two studies showing improvements in cardiometabolic markers and adiponectin levels. Doses reported include 4 g of fish oil daily for 4 weeks and DHA-rich n-3 PUFA for 16 weeks. However, the overall evidence is limited to a small number of studies, and further research is needed to confirm these findings and assess long-term effects.",0.8,34293124,2021,Oils Rich in α-Linolenic Acid or Docosahexaenoic Acid Have Distinct Effects on Plasma Oxylipin and Adiponectin Concentrations and on Monocyte Bioenergetics in Women with Obesity.,randomized_controlled_trial,benefit,"DHA supplementation led to increased plasma oxylipins and adiponectin, indicating a beneficial effect on metabolic health.",4 g daily 4 weeks (fish oil),Obese; Women,,obesity,cardiovascular diseases; muscle function; obesity; overweight,,,
Docosahexaenoic acid (DHA),adverse effect on behavioral functioning; gastrointestinal symptoms; higher risk of gestational diabetes associated with DHA supplementation; higher risk of obesity in high-DHA group; less rested compared to placebo; participants reported feeling less energetic; possible adverse effect on language of females at 1.5 years,Eye Health,,Vision & Eye Health,manual_pair,"The evidence for docosahexaenoic acid (DHA) in promoting eye health is limited, with only one randomized trial reporting a slight but significant benefit in macular pigment optical density after daily consumption of DHA-enriched eggs for four months. Overall, the quality of evidence is low, and further research is needed to establish more definitive conclusions.",0.7,34684356,2021,The ALGOVUE Clinical Trial: Effects of the Daily Consumption of Eggs Enriched with Lutein and Docosahexaenoic Acid on Plasma Composition and Macular Pigment Optical Density.,clinical_trial,benefit,"The study shows a slight but significant increase in MPOD and DHA concentrations, indicating a benefit from the intervention.",2 eggs daily 4 months (enriched with lutein and DHA),,,eye health,eye health,,,
Docosahexaenoic acid (DHA),adverse effect on behavioral functioning; gastrointestinal symptoms; higher risk of gestational diabetes associated with DHA supplementation; higher risk of obesity in high-DHA group; less rested compared to placebo; participants reported feeling less energetic; possible adverse effect on language of females at 1.5 years,Peridontitis,,Oral Health,manual_pair,"One randomized clinical trial indicates that docosahexaenoic acid (DHA) supplementation at a dose of 1.8 g daily for three months may improve periodontal health outcomes in patients with gum disease. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term effects and safety.",0.7,32867199,2020,Omega-3 Polyunsaturated Fatty Acids EPA and DHA as an Adjunct to Non-Surgical Treatment of Periodontitis: A Randomized Clinical Trial.,randomized_controlled_trial,benefit,The study shows significant improvement in periodontal health outcomes with DHA supplementation.,1.8 g daily 3 months (dietary supplement),,,periodontitis,periodontitis,,,
Docosahexaenoic acid (DHA),adverse effect on behavioral functioning; gastrointestinal symptoms; higher risk of gestational diabetes associated with DHA supplementation; higher risk of obesity in high-DHA group; less rested compared to placebo; participants reported feeling less energetic; possible adverse effect on language of females at 1.5 years,Hypertension,,Heart & Vascular Health,manual_pair,"One randomized trial indicates that docosahexaenoic acid (DHA) supplementation may have beneficial effects on cardiovascular health markers in overweight and obese post-menopausal women. The study involved DHA-rich n-3 PUFA supplementation over 16 weeks, but further research is needed to confirm these findings and assess long-term effects. No adverse effects were reported in the available evidence.",0.8,34371972,2021,Effects of DHA-Rich n-3 Fatty Acid Supplementation and/or Resistance Training on Body Composition and Cardiometabolic Biomarkers in Overweight and Obese Post-Menopausal Women.,randomized_controlled_trial,benefit,The study shows beneficial effects of DHA on cardiovascular health markers and muscle quality.,16 weeks (DHA-rich n-3 PUFA),Menopause; Obese; Overweight; Women,,cardiometabolic health,cardiometabolic health; muscle function; obesity; overweight,,,
Docosahexaenoic acid (DHA),adverse effect on behavioral functioning; gastrointestinal symptoms; higher risk of gestational diabetes associated with DHA supplementation; higher risk of obesity in high-DHA group; less rested compared to placebo; participants reported feeling less energetic; possible adverse effect on language of females at 1.5 years,High Insulin,,Metabolic Health,manual_pair,"Two randomized trials indicate that docosahexaenoic acid (DHA) supplementation may reduce insulin resistance and positively influence diabetes risk factors in overweight and obese adults, with doses reported around 2 g to 2.7 g daily for 12 weeks. However, the overall evidence is limited and further studies are needed to confirm these findings and assess long-term effects and safety.",0.7,32563863,2020,DHA-enriched fish oil reduces insulin resistance in overweight and obese adults.,randomized_controlled_trial,benefit,"The study shows a significant reduction in insulin resistance, indicating a beneficial effect of DHA supplementation.",2 g daily 12 weeks (fish oil),Obese; Overweight,,abdominal obesity,Type 2 Diabetes Mellitus; abdominal obesity; cardiometabolic risk factors; insulin resistance,,,
Docosahexaenoic acid (DHA),adverse effect on behavioral functioning; gastrointestinal symptoms; higher risk of gestational diabetes associated with DHA supplementation; higher risk of obesity in high-DHA group; less rested compared to placebo; participants reported feeling less energetic; possible adverse effect on language of females at 1.5 years,High Insulin,,Metabolic Health,manual_pair,"Two randomized trials indicate that docosahexaenoic acid (DHA) supplementation may reduce insulin resistance and positively influence diabetes risk factors in overweight and obese adults, with doses reported around 2 g to 2.7 g daily for 12 weeks. However, the overall evidence is limited and further studies are needed to confirm these findings and assess long-term effects and safety.",0.7,39511203,2024,EPA and DHA inhibit LDL-induced upregulation of human adipose tissue NLRP3 inflammasome/IL-1β pathway and its association with diabetes risk factors.,clinical_trial,benefit,"The study shows that DHA, along with EPA, has beneficial effects on IL-1β secretion and diabetes risk factors.",2.7 g daily 12 weeks (Webber Naturals),Diabetes Type 2,,cardiometabolic risk factors,Type 2 Diabetes Mellitus; abdominal obesity; cardiometabolic risk factors; insulin resistance,,,
Docosahexaenoic acid (DHA),adverse effect on behavioral functioning; gastrointestinal symptoms; higher risk of gestational diabetes associated with DHA supplementation; higher risk of obesity in high-DHA group; less rested compared to placebo; participants reported feeling less energetic; possible adverse effect on language of females at 1.5 years,Low HDL,,Heart & Vascular Health,manual_pair,"Clinical evidence suggests that docosahexaenoic acid (DHA) may have beneficial effects on lipid profiles and endothelial function in individuals with high triglycerides, with three studies reporting positive outcomes. Doses reported include 380 mg twice daily and 3 g daily, though the consistency of these findings and the overall quality of evidence is moderate. No adverse effects were noted in the studies reviewed.",0.7,36982461,2023,Eicosapentaenoic and Docosahexaenoic Acid Supplementation Increases HDL Content in n-3 Fatty Acids and Improves Endothelial Function in Hypertriglyceridemic Patients.,clinical_trial,benefit,The study shows a beneficial effect of DHA on endothelial function in hypertriglyceridemic patients.,380 mg twice a day 5 weeks (highly purified),,,hypertriglyceridemia,hypertriglyceridemia; low-grade chronic inflammation; lower triglyceride levels; metabolic syndrome,,,
Docosahexaenoic acid (DHA),adverse effect on behavioral functioning; gastrointestinal symptoms; higher risk of gestational diabetes associated with DHA supplementation; higher risk of obesity in high-DHA group; less rested compared to placebo; participants reported feeling less energetic; possible adverse effect on language of females at 1.5 years,Low HDL,,Heart & Vascular Health,manual_pair,"Clinical evidence suggests that docosahexaenoic acid (DHA) may have beneficial effects on lipid profiles and endothelial function in individuals with high triglycerides, with three studies reporting positive outcomes. Doses reported include 380 mg twice daily and 3 g daily, though the consistency of these findings and the overall quality of evidence is moderate. No adverse effects were noted in the studies reviewed.",0.7,36522805,2022,Ethyl EPA and ethyl DHA cause similar and differential changes in plasma lipid concentrations and lipid metabolism in subjects with low-grade chronic inflammation.,randomized_controlled_trial,benefit,"DHA supplementation led to beneficial changes in lipid profiles, indicating a positive health outcome.",3 g daily 10 weeks (ethyl ester),,,low-grade chronic inflammation,hypertriglyceridemia; low-grade chronic inflammation; lower triglyceride levels; metabolic syndrome,,,
Docosahexaenoic acid (DHA),adverse effect on behavioral functioning; gastrointestinal symptoms; higher risk of gestational diabetes associated with DHA supplementation; higher risk of obesity in high-DHA group; less rested compared to placebo; participants reported feeling less energetic; possible adverse effect on language of females at 1.5 years,Inflammation,,"Immune, Inflammation, & Infection",manual_pair,"One phase 2 study reported a significant reduction in C-reactive protein (CRP) levels in adults with sickle cell disease after 28 days of consuming a food enriched with docosahexaenoic acid (DHA), suggesting a potential benefit for inflammation. However, other inflammatory measures did not show significant improvement, indicating that the evidence is limited and further research is needed to confirm these findings.",0.7,37121179,2023,"An open-label, multicenter, phase 2 study of a food enriched with docosahexaenoic acid in adults with sickle cell disease.",clinical_trial,benefit,"The study showed a significant reduction in CRP, indicating a benefit in inflammation, although other measures were not significantly improved.",daily 28 days (food enriched with omega-3 fatty acids),Sickle Cell Disease,,inflammation,inflammation; sickle cell disease; vaso-occlusive crisis pain,,,
Docosahexaenoic acid (DHA),adverse effect on behavioral functioning; gastrointestinal symptoms; higher risk of gestational diabetes associated with DHA supplementation; higher risk of obesity in high-DHA group; less rested compared to placebo; participants reported feeling less energetic; possible adverse effect on language of females at 1.5 years,Increased Breast Milk Supply,,Women's Health,manual_pair,"One randomized controlled trial indicates that docosahexaenoic acid (DHA) supplementation during lactation may significantly increase maternal milk DHA content, suggesting a potential benefit for addressing insufficient nutrient supply. No adverse effects or harm were reported in the study. However, the evidence is limited to a single trial, and further research is needed to confirm these findings and establish consistent dosing guidelines.",0.8,33339438,2020,"Multiple Micronutrients, Lutein, and Docosahexaenoic Acid Supplementation during Lactation: A Randomized Controlled Trial.",randomized_controlled_trial,benefit,"The study shows a significant increase in maternal milk DHA content, indicating a benefit from supplementation.",12 weeks,Lactating; Women,,lactation,lactation; maternal nutrient status; milk composition,,,
Docosahexaenoic acid (DHA),adverse effect on behavioral functioning; gastrointestinal symptoms; higher risk of gestational diabetes associated with DHA supplementation; higher risk of obesity in high-DHA group; less rested compared to placebo; participants reported feeling less energetic; possible adverse effect on language of females at 1.5 years,Power,,Performance & Recovery,manual_pair,"One randomized trial found that re-esterified DHA (975 mg daily for 30 days) improved ventilatory threshold and performance metrics in competitive amateur cyclists, suggesting a potential benefit for low exercise performance. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term effects and safety.",0.7,33087145,2020,Re-esterified DHA improves ventilatory threshold 2 in competitive amateur cyclists.,randomized_controlled_trial,benefit,"DHA supplementation led to significant improvements in power output and oxygen consumption, indicating a benefit for athletic performance.",975 mg daily 30 days (re-esterified DHA),Cycling,,athletic performance,athletic performance; ventilatory threshold improvement,,,
Docosahexaenoic acid (DHA),adverse effect on behavioral functioning; gastrointestinal symptoms; higher risk of gestational diabetes associated with DHA supplementation; higher risk of obesity in high-DHA group; less rested compared to placebo; participants reported feeling less energetic; possible adverse effect on language of females at 1.5 years,Low Testosterone,,Men's Health,manual_pair,"One randomized trial indicates that dietary supplementation with docosahexaenoic acid (DHA) at a dose of 860 mg daily for 12 weeks may increase testosterone levels in overweight and obese men. No studies reported mixed results or adverse effects, but the evidence is limited to a single trial, warranting caution in generalizing these findings.",0.8,33221700,2020,Dietary supplementation with docosahexaenoic acid rich fish oil increases circulating levels of testosterone in overweight and obese men.,randomized_controlled_trial,benefit,"The study found that DHA supplementation increased testosterone levels in overweight and obese men, indicating a beneficial effect.",860 mg daily 12 weeks (DHA-enriched fish oil),,,obesity,obesity; testosterone levels,,,
Docosahexaenoic acid (DHA),adverse effect on behavioral functioning; gastrointestinal symptoms; higher risk of gestational diabetes associated with DHA supplementation; higher risk of obesity in high-DHA group; less rested compared to placebo; participants reported feeling less energetic; possible adverse effect on language of females at 1.5 years,Exercise Recovery,,Performance & Recovery,manual_pair,"One randomized trial indicates that docosahexaenoic acid (DHA) supplementation at a dose of 4 g daily for 52 days may reduce muscle soreness and improve recovery metrics compared to placebo. There is currently no evidence of harm or mixed outcomes associated with DHA for this indication, but further research is needed to confirm these findings and establish consistency across studies.",0.8,38051142,2024,Long-Chain Omega-3 Fatty Acid Supplementation and Exercise-Induced Muscle Damage: EPA or DHA?,randomized_controlled_trial,benefit,DHA supplementation showed benefits in reducing muscle soreness and improving recovery metrics compared to placebo.,4 g daily 52 days,,,exercise-induced muscle damage,exercise-induced muscle damage; muscle function; muscle soreness,,,
Docosahexaenoic acid (DHA),adverse effect on behavioral functioning; gastrointestinal symptoms; higher risk of gestational diabetes associated with DHA supplementation; higher risk of obesity in high-DHA group; less rested compared to placebo; participants reported feeling less energetic; possible adverse effect on language of females at 1.5 years,High Resting Heart Rate,,Heart & Vascular Health,manual_pair,"One randomized trial indicates that docosahexaenoic acid (DHA) supplementation during pregnancy may enhance maternal heart rate control, with reported doses of 200 mg and 800 mg daily. No studies reported mixed outcomes or harm, but the evidence is limited to a single trial, necessitating caution in interpretation.",0.8,35953431,2023,DHA Supplementation During Pregnancy Enhances Maternal Vagally Mediated Cardiac Autonomic Control in Humans.,randomized_controlled_trial,benefit,DHA supplementation showed beneficial effects on maternal heart rate and heart rate variability metrics.,200 mg daily duration of pregnancy; 800 mg daily duration of pregnancy,Pregnant; Women,,maternal cardiac autonomic control,maternal cardiac autonomic control; maternal heart rate variability; pregnancy,,,
Docosahexaenoic acid (DHA),adverse effect on behavioral functioning; gastrointestinal symptoms; higher risk of gestational diabetes associated with DHA supplementation; higher risk of obesity in high-DHA group; less rested compared to placebo; participants reported feeling less energetic; possible adverse effect on language of females at 1.5 years,Sleep Quality,,Sleep,manual_pair,"The evidence for docosahexaenoic acid (DHA) in improving sleep quality is limited and mixed. One randomized controlled trial reported significant improvements in sleep quality metrics with a daily dose of 576 mg for 12 weeks, while another trial indicated mixed outcomes, showing some benefits in sleep efficiency but also negative feelings associated with DHA supplementation. Overall, the findings are not robust enough to draw definitive conclusions.",0.7,36235788,2022,"Effect of Docosahexaenoic Acid and Eicosapentaenoic Acid Supplementation on Sleep Quality in Healthy Subjects: A Randomized, Double-Blinded, Placebo-Controlled Trial.",randomized_controlled_trial,benefit,"The study reports significant improvements in sleep quality metrics, indicating a beneficial effect of DHA.",576 mg daily 12 weeks (capsules),Older Adults,,frequent dreaming,frequent dreaming; sleep quality,,,
Docosahexaenoic acid (DHA),adverse effect on behavioral functioning; gastrointestinal symptoms; higher risk of gestational diabetes associated with DHA supplementation; higher risk of obesity in high-DHA group; less rested compared to placebo; participants reported feeling less energetic; possible adverse effect on language of females at 1.5 years,Sleep Quality,,Sleep,manual_pair,"The evidence for docosahexaenoic acid (DHA) in improving sleep quality is limited and mixed. One randomized controlled trial reported significant improvements in sleep quality metrics with a daily dose of 576 mg for 12 weeks, while another trial indicated mixed outcomes, showing some benefits in sleep efficiency but also negative feelings associated with DHA supplementation. Overall, the findings are not robust enough to draw definitive conclusions.",0.7,33467135,2021,Differential Effects of DHA- and EPA-Rich Oils on Sleep in Healthy Young Adults: A Randomized Controlled Trial.,randomized_controlled_trial,mixed_unclear,"The study shows improvements in sleep efficiency with DHA but also reports negative feelings, indicating mixed outcomes.",26 weeks (oil rich in DHA),,,sleep quality,frequent dreaming; sleep quality,,,
Docosahexaenoic acid (DHA),adverse effect on behavioral functioning; gastrointestinal symptoms; higher risk of gestational diabetes associated with DHA supplementation; higher risk of obesity in high-DHA group; less rested compared to placebo; participants reported feeling less energetic; possible adverse effect on language of females at 1.5 years,Cardiac Risk,,Heart & Vascular Health,manual_pair,"The evidence regarding docosahexaenoic acid (DHA) for reducing the risk of major cardiovascular events is low quality and mixed. A secondary analysis of the OMEMI trial indicated unclear effects of DHA, with no consistent benefits reported across studies. Typical doses in the analyzed study included 1.8 g of EPA/DHA daily for 2 years, but the overall findings do not support a definitive conclusion on DHA's efficacy for this indication.",0.7,34982486,2022,Changes in eicosapentaenoic acid and docosahexaenoic acid and risk of cardiovascular events and atrial fibrillation: A secondary analysis of the OMEMI trial.,randomized_controlled_trial,mixed_unclear,"The study shows potential benefits in reducing MACE with EPA but unclear effects with DHA, indicating mixed outcomes.",1.8 g daily 2 years (EPA/DHA),,,acute myocardial infarction,acute myocardial infarction; atrial fibrillation; cardiovascular events,,,
Docosahexaenoic acid (DHA),adverse effect on behavioral functioning; gastrointestinal symptoms; higher risk of gestational diabetes associated with DHA supplementation; higher risk of obesity in high-DHA group; less rested compared to placebo; participants reported feeling less energetic; possible adverse effect on language of females at 1.5 years,Keratoconus,,Vision & Eye Health,manual_pair,"One randomized controlled trial reported a beneficial effect of docosahexaenoic acid (DHA) supplementation (1000 mg daily for 3 months) on corneal and inflammatory markers in patients with keratoconus. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term effects and safety.",0.7,36904299,2023,Antioxidant and Anti-Inflammatory Effects of Oral Supplementation with a Highly-Concentrated Docosahexaenoic Acid (DHA) Triglyceride in Patients with Keratoconus: A Randomized Controlled Preliminary Study.,randomized_controlled_trial,benefit,"The study found significant improvements in various corneal and inflammatory markers in the DHA group, indicating a beneficial effect.",1000 mg daily 3 months (triglyceride),,,keratoconus,keratoconus,,,
Eicosapentaenoic acid (EPA),EPA group improved less than placebo in impulsivity (commission errors); disagreeable taste affecting intake; higher risk of atrial fibrillation; increased gastrointestinal adverse events in EPA group; intolerable nausea and vomiting; less rested; new-onset atrial fibrillation higher in EPA group; participants reported feeling less energetic; upper-gastrointestinal bleeding events reported,Inflammation,,"Immune, Inflammation, & Infection",manual_pair,"Eicosapentaenoic acid (EPA) has shown beneficial anti-inflammatory effects in three randomized controlled trials, with doses ranging from 1.8 g to 4 g daily over periods of 7 days to 12 months. The studies consistently reported increases in beneficial metabolites and improvements in inflammatory markers and mobility. No adverse effects were noted, but the evidence, while positive, is limited to a small number of studies.",0.9,36421994,2022,Potentially Beneficial Effects on Healthy Aging by Supplementation of the EPA-Rich Microalgae Phaeodactylum tricornutum or Its Supernatant-A Randomized Controlled Pilot Trial in Elderly Individuals.,randomized_controlled_trial,benefit,"The study showed beneficial effects on inflammatory markers and mobility parameters, indicating a positive outcome.","two weeks (whole PT or β-1,3-glucan-rich PT supernatant)",Older Adults,Healthy Aging & Prevention,anti-inflammatory effects,anti-inflammatory effects,,,
Eicosapentaenoic acid (EPA),EPA group improved less than placebo in impulsivity (commission errors); disagreeable taste affecting intake; higher risk of atrial fibrillation; increased gastrointestinal adverse events in EPA group; intolerable nausea and vomiting; less rested; new-onset atrial fibrillation higher in EPA group; participants reported feeling less energetic; upper-gastrointestinal bleeding events reported,Inflammation,,"Immune, Inflammation, & Infection",manual_pair,"The evidence for eicosapentaenoic acid (EPA) in managing chronic inflammation is mixed. One study demonstrated a benefit with doses of 1-4 g daily over 12 weeks, while two other studies reported unclear outcomes regarding its effects on inflammatory markers and gene expression with a dose of 3 g daily. Overall, the findings suggest potential benefits, but the inconsistency in results warrants caution in interpretation.",0.8,33316626,2021,Dose- and time-dependent increase in circulating anti-inflammatory and pro-resolving lipid mediators following eicosapentaenoic acid supplementation in patients with major depressive disorder and chronic inflammation.,randomized_controlled_trial,benefit,"The study shows a robust effect of EPA supplementation in increasing plasma EPA and metabolites, indicating a benefit in the studied conditions.",1 g daily 12 weeks; 2 g daily 12 weeks; 4 g daily 12 weeks,,,chronic inflammation,chronic inflammation; low-grade chronic inflammation; major depressive disorder,,,
Eicosapentaenoic acid (EPA),EPA group improved less than placebo in impulsivity (commission errors); disagreeable taste affecting intake; higher risk of atrial fibrillation; increased gastrointestinal adverse events in EPA group; intolerable nausea and vomiting; less rested; new-onset atrial fibrillation higher in EPA group; participants reported feeling less energetic; upper-gastrointestinal bleeding events reported,Inflammation,,"Immune, Inflammation, & Infection",manual_pair,"The evidence for eicosapentaenoic acid (EPA) in managing chronic inflammation is mixed. One study demonstrated a benefit with doses of 1-4 g daily over 12 weeks, while two other studies reported unclear outcomes regarding its effects on inflammatory markers and gene expression with a dose of 3 g daily. Overall, the findings suggest potential benefits, but the inconsistency in results warrants caution in interpretation.",0.8,33303222,2021,"EPA and DHA differentially modulate monocyte inflammatory response in subjects with chronic inflammation in part via plasma specialized pro-resolving lipid mediators: A randomized, double-blind, crossover study.",randomized_controlled_trial,mixed_unclear,"The study shows differential effects of EPA and DHA on inflammatory markers, indicating mixed outcomes in terms of health benefits.",3 g daily 10 weeks,,,chronic inflammation,chronic inflammation; low-grade chronic inflammation; major depressive disorder,,,
Eicosapentaenoic acid (EPA),EPA group improved less than placebo in impulsivity (commission errors); disagreeable taste affecting intake; higher risk of atrial fibrillation; increased gastrointestinal adverse events in EPA group; intolerable nausea and vomiting; less rested; new-onset atrial fibrillation higher in EPA group; participants reported feeling less energetic; upper-gastrointestinal bleeding events reported,Joint Pain,,Musculoskeletal & Pain,manual_pair,"One randomized, double-blind, placebo-controlled trial reported significant pain relief in adults with chronic low back pain using eicosapentaenoic acid (EPA) at a dose of 149 mg daily for 8 weeks. Overall evidence is limited, with only one study demonstrating benefit and no reports of harm or adverse effects. Further research is needed to establish the efficacy and safety of EPA for this indication.",0.7,32520991,2020,"l-Serine and EPA Relieve Chronic Low-Back and Knee Pain in Adults: A Randomized, Double-Blind, Placebo-Controlled Trial.",randomized_controlled_trial,benefit,"The study shows significant pain relief in the active group compared to placebo, indicating a benefit from EPA.",149 mg daily 8 weeks,,,chronic low-back pain,chronic low-back pain; knee pain,,,
Eicosapentaenoic acid (EPA),EPA group improved less than placebo in impulsivity (commission errors); disagreeable taste affecting intake; higher risk of atrial fibrillation; increased gastrointestinal adverse events in EPA group; intolerable nausea and vomiting; less rested; new-onset atrial fibrillation higher in EPA group; participants reported feeling less energetic; upper-gastrointestinal bleeding events reported,Wound Healing,,"Skin, Hair, & Nails",manual_pair,"One randomized controlled trial suggests that supplementation with eicosapentaenoic acid (EPA) may benefit chronic wound healing by reducing proinflammatory cytokines, with a reported dose of 2.5 g daily for 8 weeks. However, the evidence is limited, and further studies are needed to confirm these findings and assess long-term effects and safety.",0.7,29735019,2018,"Supplementation with eicosapentaenoic acid and docosahexaenoic acid reduces high levels of circulating proinflammatory cytokines in aging adults: A randomized, controlled study.",randomized_controlled_trial,benefit,"The study shows significant reductions in proinflammatory cytokines, indicating a beneficial effect of EPA+DHA therapy.",2.5 g daily 8 weeks,,,chronic venous leg ulcers,chronic venous leg ulcers; inflammaging,,,
Eicosapentaenoic acid (EPA),EPA group improved less than placebo in impulsivity (commission errors); disagreeable taste affecting intake; higher risk of atrial fibrillation; increased gastrointestinal adverse events in EPA group; intolerable nausea and vomiting; less rested; new-onset atrial fibrillation higher in EPA group; participants reported feeling less energetic; upper-gastrointestinal bleeding events reported,Atherosclerosis,,Heart & Vascular Health,manual_pair,"Human clinical evidence indicates that eicosapentaenoic acid (EPA) may provide benefits in managing coronary artery disease, with four randomized trials reporting positive outcomes related to coronary plaque regression, HDL levels, soluble thrombomodulin, and atherosclerotic progression. Typical doses reported in these studies range from 1,800 mg to 3.36 g daily. No studies reported harm or lack of benefit, suggesting a consistent positive effect, although further research may be needed to confirm these findings across diverse populations.",1.0,37681568,2023,Regression of Coronary Fatty Plaque and Risk of Cardiac Events According to Blood Pressure Status: Data From a Randomized Trial of Eicosapentaenoic Acid and Docosahexaenoic Acid in Patients With Coronary Artery Disease.,randomized_controlled_trial,benefit,"The study shows that eicosapentaenoic acid contributes to coronary plaque regression and reduces cardiac events, indicating a beneficial outcome.",3.36 g daily 30 months,,,coronary artery disease,coronary artery disease; coronary atherosclerosis; in-stent neoatherosclerosis,,,
Eicosapentaenoic acid (EPA),EPA group improved less than placebo in impulsivity (commission errors); disagreeable taste affecting intake; higher risk of atrial fibrillation; increased gastrointestinal adverse events in EPA group; intolerable nausea and vomiting; less rested; new-onset atrial fibrillation higher in EPA group; participants reported feeling less energetic; upper-gastrointestinal bleeding events reported,Atherosclerosis,,Heart & Vascular Health,manual_pair,"Human clinical evidence indicates that eicosapentaenoic acid (EPA) may provide benefits in managing coronary artery disease, with four randomized trials reporting positive outcomes related to coronary plaque regression, HDL levels, soluble thrombomodulin, and atherosclerotic progression. Typical doses reported in these studies range from 1,800 mg to 3.36 g daily. No studies reported harm or lack of benefit, suggesting a consistent positive effect, although further research may be needed to confirm these findings across diverse populations.",1.0,32759543,2020,Concomitant Use of Rosuvastatin and Eicosapentaenoic Acid Significantly Prevents Native Coronary Atherosclerotic Progression in Patients With In-Stent Neoatherosclerosis.,randomized_controlled_trial,benefit,"The study shows that intensive therapy with EPA significantly prevents atherosclerotic progression, indicating a beneficial outcome.",1800 mg daily 12 months,,,coronary atherosclerosis,coronary artery disease; coronary atherosclerosis; in-stent neoatherosclerosis,,,
Eicosapentaenoic acid (EPA),EPA group improved less than placebo in impulsivity (commission errors); disagreeable taste affecting intake; higher risk of atrial fibrillation; increased gastrointestinal adverse events in EPA group; intolerable nausea and vomiting; less rested; new-onset atrial fibrillation higher in EPA group; participants reported feeling less energetic; upper-gastrointestinal bleeding events reported,Atherosclerosis,,Heart & Vascular Health,manual_pair,"One randomized controlled trial has shown that eicosapentaenoic acid (EPA) at a dose of 1800 mg daily for 6-8 months significantly reduced coronary plaque volume in patients with coronary heart disease on statins, indicating a potential benefit. However, the overall evidence is limited, with only one study reporting a positive outcome and no data on adverse effects or additional studies to confirm these findings.",0.7,28863874,2017,A randomized controlled trial of eicosapentaenoic acid in patients with coronary heart disease on statins.,randomized_controlled_trial,benefit,"The study shows that EPA significantly reduced coronary plaque volume, indicating a benefit in managing coronary heart disease.",1800 mg daily 6-8 months,,,acute coronary syndrome,acute coronary syndrome; coronary heart disease; stable angina pectoris,,,
Eicosapentaenoic acid (EPA),EPA group improved less than placebo in impulsivity (commission errors); disagreeable taste affecting intake; higher risk of atrial fibrillation; increased gastrointestinal adverse events in EPA group; intolerable nausea and vomiting; less rested; new-onset atrial fibrillation higher in EPA group; participants reported feeling less energetic; upper-gastrointestinal bleeding events reported,Depression,,"Energy, Mood, & Mental Health",manual_pair,"Clinical evidence suggests that eicosapentaenoic acid (EPA) may be beneficial for individuals with major depressive disorder, with two studies reporting positive outcomes associated with EPA supplementation at doses of 1 g and 4 g daily. Both studies indicate a correlation between increased EPA levels and improved depressive symptoms; however, further research is needed to confirm these findings and establish optimal dosing. No adverse effects were reported in the reviewed studies.",0.9,36635595,2023,Clinical response to EPA supplementation in patients with major depressive disorder is associated with higher plasma concentrations of pro-resolving lipid mediators.,randomized_controlled_trial,benefit,The study shows that higher doses of EPA are associated with improved depression symptoms and reduced inflammation.,4 g daily 12 weeks (EPA and DHA in a 3.9:1 ratio),,"Immune, Inflammation, & Infection",major depressive disorder,major depressive disorder,,,
Eicosapentaenoic acid (EPA),EPA group improved less than placebo in impulsivity (commission errors); disagreeable taste affecting intake; higher risk of atrial fibrillation; increased gastrointestinal adverse events in EPA group; intolerable nausea and vomiting; less rested; new-onset atrial fibrillation higher in EPA group; participants reported feeling less energetic; upper-gastrointestinal bleeding events reported,Migraine Headache,,Musculoskeletal & Pain,manual_pair,"Two randomized controlled trials have reported benefits of eicosapentaenoic acid (EPA) for reducing migraine frequency and severity, with doses of 1000 mg twice daily and 1.8 g daily over 8 to 12 weeks, respectively. There is no evidence of harm or no benefit, but the overall evidence is limited to these studies, and further research may be needed to confirm these findings.",0.8,39221580,2025,Eicosapentaenoic acid versus placebo as adjunctive therapy in chronic migraine: A randomized controlled trial.,randomized_controlled_trial,benefit,"The study showed a significant reduction in migraine headache days and overall quality of life, indicating a benefit from EPA supplementation.",1000 mg twice daily 8 weeks (softgels),,,chronic migraine,chronic migraine; episodic migraine,,,
Eicosapentaenoic acid (EPA),EPA group improved less than placebo in impulsivity (commission errors); disagreeable taste affecting intake; higher risk of atrial fibrillation; increased gastrointestinal adverse events in EPA group; intolerable nausea and vomiting; less rested; new-onset atrial fibrillation higher in EPA group; participants reported feeling less energetic; upper-gastrointestinal bleeding events reported,Migraine Headache,,Musculoskeletal & Pain,manual_pair,"Two randomized controlled trials have reported benefits of eicosapentaenoic acid (EPA) for reducing migraine frequency and severity, with doses of 1000 mg twice daily and 1.8 g daily over 8 to 12 weeks, respectively. There is no evidence of harm or no benefit, but the overall evidence is limited to these studies, and further research may be needed to confirm these findings.",0.8,38499208,2024,A 12-week randomized double-blind clinical trial of eicosapentaenoic acid intervention in episodic migraine.,randomized_controlled_trial,benefit,"The study demonstrated significant improvements in migraine frequency and severity, indicating a clear benefit from EPA intervention.",1.8 g daily 12 weeks (fish oil),,,episodic migraine,chronic migraine; episodic migraine,,,
Eicosapentaenoic acid (EPA),EPA group improved less than placebo in impulsivity (commission errors); disagreeable taste affecting intake; higher risk of atrial fibrillation; increased gastrointestinal adverse events in EPA group; intolerable nausea and vomiting; less rested; new-onset atrial fibrillation higher in EPA group; participants reported feeling less energetic; upper-gastrointestinal bleeding events reported,Epilepsy,,Cognitive & Neurological Function,manual_pair,"There is limited evidence suggesting that eicosapentaenoic acid (EPA) may reduce seizure frequency in patients with drug-resistant epilepsy, based on one randomized, double-blind, placebo-controlled trial that reported a significant benefit with doses ranging from 385.6 mg to 2,313.6 mg per day over one year. However, the overall evidence is sparse, and further studies are needed to confirm these findings and assess long-term safety and efficacy.",0.7,30170260,2018,"The differential effects of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) on seizure frequency in patients with drug-resistant epilepsy - A randomized, double-blind, placebo-controlled trial.",randomized_controlled_trial,benefit,"The study shows a significant reduction in seizure frequency with EPA, indicating a beneficial effect.","385.6 mg two, four, or six capsules per day one year (capsule)",,,drug-resistant epilepsy,drug-resistant epilepsy,,,
Eicosapentaenoic acid (EPA),EPA group improved less than placebo in impulsivity (commission errors); disagreeable taste affecting intake; higher risk of atrial fibrillation; increased gastrointestinal adverse events in EPA group; intolerable nausea and vomiting; less rested; new-onset atrial fibrillation higher in EPA group; participants reported feeling less energetic; upper-gastrointestinal bleeding events reported,Peridontitis,,Oral Health,manual_pair,"One randomized clinical trial reported a benefit of eicosapentaenoic acid (EPA) supplementation (2.6 g daily for 3 months) as an adjunct to non-surgical treatment of periodontitis, showing significant improvements in clinical outcomes. However, the overall evidence is limited, with only one study available, and further research is needed to confirm these findings and assess long-term effects.",0.7,32867199,2020,Omega-3 Polyunsaturated Fatty Acids EPA and DHA as an Adjunct to Non-Surgical Treatment of Periodontitis: A Randomized Clinical Trial.,randomized_controlled_trial,benefit,The study found significant improvements in clinical outcomes for periodontitis with EPA supplementation.,2.6 g 3 months (dietary supplement),,,periodontitis,periodontitis,,,
Eicosapentaenoic acid (EPA),EPA group improved less than placebo in impulsivity (commission errors); disagreeable taste affecting intake; higher risk of atrial fibrillation; increased gastrointestinal adverse events in EPA group; intolerable nausea and vomiting; less rested; new-onset atrial fibrillation higher in EPA group; participants reported feeling less energetic; upper-gastrointestinal bleeding events reported,Hypertension,,Heart & Vascular Health,manual_pair,"The evidence regarding eicosapentaenoic acid (EPA) for high blood pressure is mixed. One study reported a beneficial effect on blood pressure when combined with other supplements, while another indicated less favorable outcomes compared to other omega-3 fatty acids. No studies reported harm, but the overall findings do not consistently support a clear benefit for EPA alone in managing high blood pressure.",0.7,30735073,2019,Docosahexaenoic acid reduces resting blood pressure but increases muscle sympathetic outflow compared with eicosapentaenoic acid in healthy men and women.,randomized_controlled_trial,mixed_unclear,"The study shows mixed outcomes with EPA having less favorable effects on blood pressure compared to DHA and olive oil, but it does not indicate harm.",3 g daily 12 weeks (oral),,,blood pressure,blood pressure; cardiovascular disease; coronary artery disease; hypertension; muscle sympathetic nerve activity,,,
Eicosapentaenoic acid (EPA),EPA group improved less than placebo in impulsivity (commission errors); disagreeable taste affecting intake; higher risk of atrial fibrillation; increased gastrointestinal adverse events in EPA group; intolerable nausea and vomiting; less rested; new-onset atrial fibrillation higher in EPA group; participants reported feeling less energetic; upper-gastrointestinal bleeding events reported,Hypertension,,Heart & Vascular Health,manual_pair,"The evidence regarding eicosapentaenoic acid (EPA) for high blood pressure is mixed. One study reported a beneficial effect on blood pressure when combined with other supplements, while another indicated less favorable outcomes compared to other omega-3 fatty acids. No studies reported harm, but the overall findings do not consistently support a clear benefit for EPA alone in managing high blood pressure.",0.7,31987113,2020,"A combined effect of Cavacurcumin, Eicosapentaenoic acid (Omega-3s), Astaxanthin and Gamma -linoleic acid (Omega-6) (CEAG) in healthy volunteers- a randomized, double-blind, placebo-controlled study.",randomized_controlled_trial,benefit,"The study shows significant reductions in blood pressure and inflammatory markers, indicating a beneficial effect of EPA in cardiovascular health.",4 weeks (CEAG supplement),,"Immune, Inflammation, & Infection",cardiovascular disease,blood pressure; cardiovascular disease; coronary artery disease; hypertension; muscle sympathetic nerve activity,,,
Eicosapentaenoic acid (EPA),EPA group improved less than placebo in impulsivity (commission errors); disagreeable taste affecting intake; higher risk of atrial fibrillation; increased gastrointestinal adverse events in EPA group; intolerable nausea and vomiting; less rested; new-onset atrial fibrillation higher in EPA group; participants reported feeling less energetic; upper-gastrointestinal bleeding events reported,Low Insulin,,Metabolic Health,manual_pair,"One randomized controlled trial reported a benefit of eicosapentaenoic acid (EPA) supplementation in increasing C-peptide levels, which suggests improved insulin production in pregnant women with type 1 diabetes. The study utilized a dose of 120 mg twice a day. Overall, the evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term effects.",0.8,28378851,2017,Effect of eicosapentaenoic acid and docosahexaenoic acid supplementation on C-peptide preservation in pregnant women with type-1 diabetes: randomized placebo controlled clinical trial.,randomized_controlled_trial,benefit,"The study shows a significant increase in C-peptide levels in the EPA group, indicating a benefit in insulin production.",120 mg twice a day,Diabetes Type 1,,pregnancy,pregnancy; type 1 diabetes mellitus,,,
Eicosapentaenoic acid (EPA),EPA group improved less than placebo in impulsivity (commission errors); disagreeable taste affecting intake; higher risk of atrial fibrillation; increased gastrointestinal adverse events in EPA group; intolerable nausea and vomiting; less rested; new-onset atrial fibrillation higher in EPA group; participants reported feeling less energetic; upper-gastrointestinal bleeding events reported,Cardiac Risk,,Metabolic Health,manual_pair,"Eicosapentaenoic acid (EPA) supplementation appears to have beneficial effects on various metabolic parameters and cardiovascular markers in patients with Type 2 Diabetes, as evidenced by four randomized controlled trials. Typical doses reported range from 500 mg to 2.7 g daily over periods of 8 to 12 weeks. No adverse effects or harms were noted in the studies, but the overall evidence, while positive, should be interpreted with caution due to the limited number of trials and the need for further research to confirm these findings.",0.9,29588138,2018,"Effect of Eicosapentaenoic acid (EPA) supplementation on cardiovascular markers in patients with type 2 diabetes mellitus: A randomized, double-blind, placebo-controlled trial.",randomized_controlled_trial,benefit,"EPA supplementation showed significant reductions in methionine, cysteine, and atherogenic index, indicating beneficial effects on cardiovascular health in T2DM patients.",2 g per day 8 weeks,Diabetes Type 2,,cardiovascular diseases,Type 2 Diabetes Mellitus; cardiometabolic risk factors; cardiovascular diseases,,,
Eicosapentaenoic acid (EPA),EPA group improved less than placebo in impulsivity (commission errors); disagreeable taste affecting intake; higher risk of atrial fibrillation; increased gastrointestinal adverse events in EPA group; intolerable nausea and vomiting; less rested; new-onset atrial fibrillation higher in EPA group; participants reported feeling less energetic; upper-gastrointestinal bleeding events reported,Cardiac Risk,,Metabolic Health,manual_pair,"Eicosapentaenoic acid (EPA) supplementation appears to have beneficial effects on various metabolic parameters and cardiovascular markers in patients with Type 2 Diabetes, as evidenced by four randomized controlled trials. Typical doses reported range from 500 mg to 2.7 g daily over periods of 8 to 12 weeks. No adverse effects or harms were noted in the studies, but the overall evidence, while positive, should be interpreted with caution due to the limited number of trials and the need for further research to confirm these findings.",0.9,29034644,2017,The Effect of Eicosapentaenoic Acid on the Serum Levels and Enzymatic Activity of Paraoxonase 1 in the Patients With Type 2 Diabetes Mellitus.,randomized_controlled_trial,benefit,The study shows significant benefits in serum levels and activity of PON1 and lipid profiles in patients supplemented with EPA.,2 g daily eight weeks (capsules),Diabetes Type 2,,Type 2 Diabetes Mellitus,Type 2 Diabetes Mellitus; cardiometabolic risk factors; cardiovascular diseases,,,
Eicosapentaenoic acid (EPA),EPA group improved less than placebo in impulsivity (commission errors); disagreeable taste affecting intake; higher risk of atrial fibrillation; increased gastrointestinal adverse events in EPA group; intolerable nausea and vomiting; less rested; new-onset atrial fibrillation higher in EPA group; participants reported feeling less energetic; upper-gastrointestinal bleeding events reported,Atherosclerosis,,Heart & Vascular Health,manual_pair,"The evidence for eicosapentaenoic acid (EPA) in lowering high LDL cholesterol is mixed but leans towards benefit, with three studies reporting positive outcomes and one showing unclear results. Typical doses reported include 1 g daily for 12 weeks and 1800 mg daily for 6 months to 1 year. No studies reported harm, but the interaction with other treatments and individual variability should be considered.",0.8,31334703,2019,Effect of rosuvastatin and eicosapentaenoic acid on neoatherosclerosis: the LINK-IT Trial.,randomized_controlled_trial,benefit,"The study shows that EPA combined with rosuvastatin significantly stabilizes neoatherosclerotic plaques, indicating a beneficial outcome.",1800 mg daily 1 year,,,neoatherosclerosis,abdominal obesity; cardiovascular disease; cardiovascular health; cholesterol management; coronary artery disease; neoatherosclerosis; subclinical inflammation,,,
Eicosapentaenoic acid (EPA),EPA group improved less than placebo in impulsivity (commission errors); disagreeable taste affecting intake; higher risk of atrial fibrillation; increased gastrointestinal adverse events in EPA group; intolerable nausea and vomiting; less rested; new-onset atrial fibrillation higher in EPA group; participants reported feeling less energetic; upper-gastrointestinal bleeding events reported,High Triglycerides,,Heart & Vascular Health,manual_pair,"Eicosapentaenoic acid (EPA) has shown consistent benefits in reducing triglyceride levels across multiple randomized trials, with doses commonly reported in the range of 1.8 g to 4 g daily. While the majority of studies indicate a positive effect, one study reported mixed results regarding lipid metabolism, suggesting variability in outcomes. No significant adverse effects were noted in the reviewed studies.",0.9,31277790,2019,"Effects of Icosapent Ethyl (Eicosapentaenoic Acid Ethyl Ester) on Atherogenic Lipid/Lipoprotein, Apolipoprotein, and Inflammatory Parameters in Patients With Elevated High-Sensitivity C-Reactive Protein (from the ANCHOR Study).",randomized_controlled_trial,benefit,"The study demonstrated significant reductions in triglycerides and other atherogenic parameters, indicating a beneficial effect of the supplement.",4 g daily 12 weeks (icosapent ethyl),,"Immune, Inflammation, & Infection",atherosclerosis,atherosclerosis; cardiovascular disease risk; cardiovascular health; high triglycerides; hypercholesterolemia; hypertriglyceridemia; increased cardiovascular risk; inflammation; lipoprotein metabolism; low-grade chronic inflammation; metabolic syndrome; severe hypertriglyceridemia; triglyceride levels,,,
Eicosapentaenoic acid (EPA),EPA group improved less than placebo in impulsivity (commission errors); disagreeable taste affecting intake; higher risk of atrial fibrillation; increased gastrointestinal adverse events in EPA group; intolerable nausea and vomiting; less rested; new-onset atrial fibrillation higher in EPA group; participants reported feeling less energetic; upper-gastrointestinal bleeding events reported,High Triglycerides,,Heart & Vascular Health,manual_pair,"Eicosapentaenoic acid (EPA) has shown consistent benefits in reducing triglyceride levels across multiple randomized trials, with doses commonly reported in the range of 1.8 g to 4 g daily. While the majority of studies indicate a positive effect, one study reported mixed results regarding lipid metabolism, suggesting variability in outcomes. No significant adverse effects were noted in the reviewed studies.",0.9,28391875,2017,"Effects of MAT9001 containing eicosapentaenoic acid and docosapentaenoic acid, compared to eicosapentaenoic acid ethyl esters, on triglycerides, lipoprotein cholesterol, and related variables.",randomized_controlled_trial,benefit,"The study shows significant reductions in triglycerides and other lipoprotein-related variables, indicating a benefit for cardiovascular health.",2 14-day treatment periods (MAT9001),,,cardiovascular disease risk,atherosclerosis; cardiovascular disease risk; cardiovascular health; high triglycerides; hypercholesterolemia; hypertriglyceridemia; increased cardiovascular risk; inflammation; lipoprotein metabolism; low-grade chronic inflammation; metabolic syndrome; severe hypertriglyceridemia; triglyceride levels,,,
Eicosapentaenoic acid (EPA),EPA group improved less than placebo in impulsivity (commission errors); disagreeable taste affecting intake; higher risk of atrial fibrillation; increased gastrointestinal adverse events in EPA group; intolerable nausea and vomiting; less rested; new-onset atrial fibrillation higher in EPA group; participants reported feeling less energetic; upper-gastrointestinal bleeding events reported,High Triglycerides,,Heart & Vascular Health,manual_pair,"Eicosapentaenoic acid (EPA) has shown consistent benefits in reducing triglyceride levels across multiple randomized trials, with doses commonly reported in the range of 1.8 g to 4 g daily. While the majority of studies indicate a positive effect, one study reported mixed results regarding lipid metabolism, suggesting variability in outcomes. No significant adverse effects were noted in the reviewed studies.",0.9,32178279,2020,Comparison of Omega-3 Eicosapentaenoic Acid Versus Docosahexaenoic Acid-Rich Fish Oil Supplementation on Plasma Lipids and Lipoproteins in Normolipidemic Adults.,randomized_controlled_trial,benefit,"The study shows that EPA-rich oil has beneficial effects on plasma triglycerides and lipoprotein profiles, indicating a positive impact on cardiovascular health.",12 g daily 8 weeks (EPA-rich fish oil),,,cardiovascular health,atherosclerosis; cardiovascular disease risk; cardiovascular health; high triglycerides; hypercholesterolemia; hypertriglyceridemia; increased cardiovascular risk; inflammation; lipoprotein metabolism; low-grade chronic inflammation; metabolic syndrome; severe hypertriglyceridemia; triglyceride levels,,,
Eicosapentaenoic acid (EPA),EPA group improved less than placebo in impulsivity (commission errors); disagreeable taste affecting intake; higher risk of atrial fibrillation; increased gastrointestinal adverse events in EPA group; intolerable nausea and vomiting; less rested; new-onset atrial fibrillation higher in EPA group; participants reported feeling less energetic; upper-gastrointestinal bleeding events reported,High Triglycerides,,Heart & Vascular Health,manual_pair,"Eicosapentaenoic acid (EPA) has shown consistent benefits in reducing triglyceride levels across multiple randomized trials, with doses commonly reported in the range of 1.8 g to 4 g daily. While the majority of studies indicate a positive effect, one study reported mixed results regarding lipid metabolism, suggesting variability in outcomes. No significant adverse effects were noted in the reviewed studies.",0.9,30900815,2019,"EPA+DHA, but not ALA, Improved Lipids and Inflammation Status in Hypercholesterolemic Adults: A Randomized, Double-Blind, Placebo-Controlled Trial.",randomized_controlled_trial,benefit,"The study shows significant decreases in triglycerides and inflammatory markers, indicating a beneficial effect of EPA+DHA supplementation.",1.8 g daily 12 weeks (EPA+DHA); 3.6 g daily 12 weeks (EPA+DHA),,,hypercholesterolemia,atherosclerosis; cardiovascular disease risk; cardiovascular health; high triglycerides; hypercholesterolemia; hypertriglyceridemia; increased cardiovascular risk; inflammation; lipoprotein metabolism; low-grade chronic inflammation; metabolic syndrome; severe hypertriglyceridemia; triglyceride levels,,,
Eicosapentaenoic acid (EPA),EPA group improved less than placebo in impulsivity (commission errors); disagreeable taste affecting intake; higher risk of atrial fibrillation; increased gastrointestinal adverse events in EPA group; intolerable nausea and vomiting; less rested; new-onset atrial fibrillation higher in EPA group; participants reported feeling less energetic; upper-gastrointestinal bleeding events reported,High Triglycerides,,Heart & Vascular Health,manual_pair,"Eicosapentaenoic acid (EPA) has shown consistent benefits in reducing triglyceride levels across multiple randomized trials, with doses commonly reported in the range of 1.8 g to 4 g daily. While the majority of studies indicate a positive effect, one study reported mixed results regarding lipid metabolism, suggesting variability in outcomes. No significant adverse effects were noted in the reviewed studies.",0.9,36202740,2022,"Long-term safety and efficacy of MND-2119 (self-emulsifying formulation of highly purified eicosapentaenoic acid ethyl ester) in patients with hypertriglyceridemia: Results from a multicenter, 52-week, open-label study.",randomized_controlled_trial,benefit,"The study showed a significant reduction in triglyceride levels, indicating a beneficial effect of the supplement.",2 g once-daily 52 weeks (self-emulsifying formulation of highly purified eicosapentaenoic acid ethyl ester); 4 g once-daily 52 weeks (self-emulsifying formulation of highly purified eicosapentaenoic acid ethyl ester),,,hypertriglyceridemia,atherosclerosis; cardiovascular disease risk; cardiovascular health; high triglycerides; hypercholesterolemia; hypertriglyceridemia; increased cardiovascular risk; inflammation; lipoprotein metabolism; low-grade chronic inflammation; metabolic syndrome; severe hypertriglyceridemia; triglyceride levels,,,
Eicosapentaenoic acid (EPA),EPA group improved less than placebo in impulsivity (commission errors); disagreeable taste affecting intake; higher risk of atrial fibrillation; increased gastrointestinal adverse events in EPA group; intolerable nausea and vomiting; less rested; new-onset atrial fibrillation higher in EPA group; participants reported feeling less energetic; upper-gastrointestinal bleeding events reported,High Triglycerides,,Heart & Vascular Health,manual_pair,"Eicosapentaenoic acid (EPA) has shown consistent benefits in reducing triglyceride levels across multiple randomized trials, with doses commonly reported in the range of 1.8 g to 4 g daily. While the majority of studies indicate a positive effect, one study reported mixed results regarding lipid metabolism, suggesting variability in outcomes. No significant adverse effects were noted in the reviewed studies.",0.9,35871058,2022,"Efficacy and safety of self-emulsifying formulation of highly purified eicosapentaenoic acid ethyl ester (MND-2119) versus highly purified eicosapentaenoic acid ethyl ester in patients with hypertriglyceridemia: Results from a 12-week randomized, double-blind, active-controlled, phase 3 study.",randomized_controlled_trial,benefit,"The study demonstrated non-inferiority and superiority in triglyceride reduction, indicating a benefit from the interventions.",2 g once-daily 12 weeks (self-emulsifying formulation of EPA ethyl ester); 4 g once-daily 12 weeks (self-emulsifying formulation of EPA ethyl ester); 1.8 g once-daily 12 weeks (highly purified EPA ethyl ester); 2.7 g once-daily 12 weeks (highly purified EPA ethyl ester),,,hypertriglyceridemia,atherosclerosis; cardiovascular disease risk; cardiovascular health; high triglycerides; hypercholesterolemia; hypertriglyceridemia; increased cardiovascular risk; inflammation; lipoprotein metabolism; low-grade chronic inflammation; metabolic syndrome; severe hypertriglyceridemia; triglyceride levels,,,
Eicosapentaenoic acid (EPA),EPA group improved less than placebo in impulsivity (commission errors); disagreeable taste affecting intake; higher risk of atrial fibrillation; increased gastrointestinal adverse events in EPA group; intolerable nausea and vomiting; less rested; new-onset atrial fibrillation higher in EPA group; participants reported feeling less energetic; upper-gastrointestinal bleeding events reported,High Triglycerides,,Heart & Vascular Health,manual_pair,"Eicosapentaenoic acid (EPA) has shown consistent benefits in reducing triglyceride levels across multiple randomized trials, with doses commonly reported in the range of 1.8 g to 4 g daily. While the majority of studies indicate a positive effect, one study reported mixed results regarding lipid metabolism, suggesting variability in outcomes. No significant adverse effects were noted in the reviewed studies.",0.9,36522805,2022,Ethyl EPA and ethyl DHA cause similar and differential changes in plasma lipid concentrations and lipid metabolism in subjects with low-grade chronic inflammation.,randomized_controlled_trial,mixed_unclear,"The study shows both benefits and differences in lipid metabolism outcomes, indicating mixed results.",3 g per day 10 weeks (ethyl ester),,,low-grade chronic inflammation,atherosclerosis; cardiovascular disease risk; cardiovascular health; high triglycerides; hypercholesterolemia; hypertriglyceridemia; increased cardiovascular risk; inflammation; lipoprotein metabolism; low-grade chronic inflammation; metabolic syndrome; severe hypertriglyceridemia; triglyceride levels,,,
Eicosapentaenoic acid (EPA),EPA group improved less than placebo in impulsivity (commission errors); disagreeable taste affecting intake; higher risk of atrial fibrillation; increased gastrointestinal adverse events in EPA group; intolerable nausea and vomiting; less rested; new-onset atrial fibrillation higher in EPA group; participants reported feeling less energetic; upper-gastrointestinal bleeding events reported,Muscle Endurance,,Performance & Recovery,manual_pair,"One randomized trial indicates that eicosapentaenoic acid (EPA) may improve endurance performance metrics when consumed as part of interesterified structured lipids over an 8-week period. However, the evidence is limited, with only one study showing a benefit and no reports of harm or consistent dosing information. Further research is needed to confirm these findings and assess the broader applicability of EPA for low exercise performance.",0.7,37686724,2023,Eicosapentaenoic Acid and Medium-Chain Triacylglycerol Structured Lipids Improve Endurance Performance.,randomized_controlled_trial,benefit,"The study shows significant improvement in endurance performance metrics, indicating a benefit from EPA consumption.",8 weeks (interesterified structured lipids),,,cardiorespiratory endurance,cardiorespiratory endurance,,,
Eicosapentaenoic acid (EPA),EPA group improved less than placebo in impulsivity (commission errors); disagreeable taste affecting intake; higher risk of atrial fibrillation; increased gastrointestinal adverse events in EPA group; intolerable nausea and vomiting; less rested; new-onset atrial fibrillation higher in EPA group; participants reported feeling less energetic; upper-gastrointestinal bleeding events reported,Muscle Endurance,,Performance & Recovery,manual_pair,"One randomized trial indicates that eicosapentaenoic acid (EPA) supplementation at a dose of 600 mg daily for 8 weeks may improve muscle work output and range of motion in individuals with low muscle performance. However, the overall evidence is limited, with only one study reporting a benefit and no studies showing harm or mixed results.",0.7,30260740,2019,Eicosapentaenoic Acid-Rich Fish Oil Supplementation Inhibits the Decrease in Concentric Work Output and Muscle Swelling of the Elbow Flexors.,randomized_controlled_trial,benefit,"The study shows that EPA supplementation improves muscle work output and range of motion, indicating a beneficial effect.",600 mg daily 8 weeks (EPA-rich fish oil),,,elbow flexor function,elbow flexor function; muscle fatigue; muscle performance,,,
Eicosapentaenoic acid (EPA),EPA group improved less than placebo in impulsivity (commission errors); disagreeable taste affecting intake; higher risk of atrial fibrillation; increased gastrointestinal adverse events in EPA group; intolerable nausea and vomiting; less rested; new-onset atrial fibrillation higher in EPA group; participants reported feeling less energetic; upper-gastrointestinal bleeding events reported,Muscle Endurance,,Performance & Recovery,manual_pair,"The evidence regarding eicosapentaenoic acid (EPA) for muscle fatigue is mixed and unclear, based on one study that reported a reduction in muscle fatigue but no significant improvement in muscular endurance performance. The study utilized a dose of 4560 mg daily for 8 weeks. Overall, the findings do not support a definitive benefit for this indication.",0.7,39401344,2025,Eicosapentaenoic Acid and Medium-Chain Triacylglycerol Structured Lipid Supplementation Improves Muscular Endurance Exercise Performance and Reduces Muscle Fatigue in Young Healthy Male.,randomized_controlled_trial,mixed_unclear,"The study showed no significant difference in muscle endurance performance but indicated a reduction in muscle fatigue, leading to a mixed outcome classification.",4560 mg daily 8 weeks (EPA/MCT supplement),,,muscle endurance,muscle endurance; muscle fatigue,,,
Eicosapentaenoic acid (EPA),EPA group improved less than placebo in impulsivity (commission errors); disagreeable taste affecting intake; higher risk of atrial fibrillation; increased gastrointestinal adverse events in EPA group; intolerable nausea and vomiting; less rested; new-onset atrial fibrillation higher in EPA group; participants reported feeling less energetic; upper-gastrointestinal bleeding events reported,Exercise Recovery,,Performance & Recovery,manual_pair,"One randomized trial indicates that eicosapentaenoic acid (EPA) supplementation at a dose of 4 g daily for 7 weeks may improve recovery from exercise-induced muscle damage. No studies reported mixed outcomes or adverse effects, suggesting a potential benefit, but further research is needed to confirm these findings and establish broader applicability.",0.8,38051142,2024,Long-Chain Omega-3 Fatty Acid Supplementation and Exercise-Induced Muscle Damage: EPA or DHA?,randomized_controlled_trial,benefit,"The study shows that EPA supplementation improves recovery from exercise-induced muscle damage, indicating a beneficial effect.",4 g daily 7 weeks,,,exercise-induced muscle damage,exercise-induced muscle damage; inflammation; muscle function; muscle soreness,,,
Eicosapentaenoic acid (EPA),EPA group improved less than placebo in impulsivity (commission errors); disagreeable taste affecting intake; higher risk of atrial fibrillation; increased gastrointestinal adverse events in EPA group; intolerable nausea and vomiting; less rested; new-onset atrial fibrillation higher in EPA group; participants reported feeling less energetic; upper-gastrointestinal bleeding events reported,Exercise Recovery,,Performance & Recovery,manual_pair,"One randomized trial indicates that supplementation with eicosapentaenoic acid (EPA) at a dose of 600 mg daily for 8 weeks may reduce muscle stiffness and soreness following exercise. However, the overall evidence is limited, with only one study reporting a benefit and no data on potential adverse effects or consistency across multiple trials.",0.7,30987668,2019,Supplementation of eicosapentaenoic acid-rich fish oil attenuates muscle stiffness after eccentric contractions of human elbow flexors.,randomized_controlled_trial,benefit,"The study shows that EPA supplementation significantly reduces muscle stiffness and soreness after exercise, indicating a beneficial effect.",600 mg daily 8 weeks (fish oil),,,muscle damage,muscle damage; muscle stiffness; myalgia,,,
Eicosapentaenoic acid (EPA),EPA group improved less than placebo in impulsivity (commission errors); disagreeable taste affecting intake; higher risk of atrial fibrillation; increased gastrointestinal adverse events in EPA group; intolerable nausea and vomiting; less rested; new-onset atrial fibrillation higher in EPA group; participants reported feeling less energetic; upper-gastrointestinal bleeding events reported,Fatty Liver Disease,,Gut Health,manual_pair,"There is limited evidence suggesting that eicosapentaenoic acid (EPA) may benefit patients with non-alcoholic fatty liver disease (NAFLD), as indicated by a study that reported improvements in steatosis score and a reduction in the AA/EPA ratio after 90 days of intervention. However, the overall quality of evidence is low, with only one study demonstrating a benefit and no reports of harm or consistent dosing information. Further research is needed to establish the efficacy and safety of EPA for this indication.",0.6,30217048,2018,Aerobic Physical Activity and a Low Glycemic Diet Reduce the AA/EPA Ratio in Red Blood Cell Membranes of Patients with NAFLD.,randomized_controlled_trial,benefit,"The study shows a significant reduction in the AA/EPA ratio and improvement in steatosis score, indicating a beneficial effect of the intervention.",90 days,,,non-alcoholic fatty liver disease (nafld),non-alcoholic fatty liver disease (nafld),,,
Eicosapentaenoic acid (EPA),EPA group improved less than placebo in impulsivity (commission errors); disagreeable taste affecting intake; higher risk of atrial fibrillation; increased gastrointestinal adverse events in EPA group; intolerable nausea and vomiting; less rested; new-onset atrial fibrillation higher in EPA group; participants reported feeling less energetic; upper-gastrointestinal bleeding events reported,Atherosclerosis,,Heart & Vascular Health,manual_pair,"One randomized trial indicates that eicosapentaenoic acid (EPA) may improve biomarkers related to vascular complications in patients with type 2 diabetes and arteriosclerosis obliterans. However, the overall evidence is limited to this single study, and further research is needed to confirm these findings and assess the consistency of the effects. No adverse effects were reported in the study.",0.7,30271161,2018,"Effects of sarpogrelate, eicosapentaenoic acid and pitavastatin on arterioslcerosis obliterans-related biomarkers in patients with type 2 diabetes (SAREPITASO study).",randomized_controlled_trial,benefit,The study shows significant improvements in biomarkers related to vascular complications in T2DM patients treated with EPA.,,Diabetes Type 2,,arteriosclerosis obliterans,Type 2 Diabetes Mellitus; arteriosclerosis obliterans,,,
Eicosapentaenoic acid (EPA),EPA group improved less than placebo in impulsivity (commission errors); disagreeable taste affecting intake; higher risk of atrial fibrillation; increased gastrointestinal adverse events in EPA group; intolerable nausea and vomiting; less rested; new-onset atrial fibrillation higher in EPA group; participants reported feeling less energetic; upper-gastrointestinal bleeding events reported,Joint Flexibility,,Musculoskeletal & Pain,manual_pair,"One randomized trial indicates that eicosapentaenoic acid (EPA) supplementation at a dose of 600 mg daily for four weeks may benefit joint flexibility and provide muscle protection after exercise. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term effects and safety.",0.7,33648546,2021,4-week eicosapentaenoic acid-rich fish oil supplementation partially protects muscular damage following eccentric contractions.,randomized_controlled_trial,benefit,The study shows that EPA supplementation benefits joint flexibility and muscle protection after exercise.,600 mg daily 4 weeks (fish oil),,,joint flexibility,joint flexibility; muscular damage,,,
Eicosapentaenoic acid (EPA),EPA group improved less than placebo in impulsivity (commission errors); disagreeable taste affecting intake; higher risk of atrial fibrillation; increased gastrointestinal adverse events in EPA group; intolerable nausea and vomiting; less rested; new-onset atrial fibrillation higher in EPA group; participants reported feeling less energetic; upper-gastrointestinal bleeding events reported,Sleep Quality,,Sleep,manual_pair,"The evidence for eicosapentaenoic acid (EPA) in improving sleep quality is limited and mixed. One randomized controlled trial reported significant improvements in sleep quality with a daily dose of 284 mg for 12 weeks, while another trial showed mixed results with some improvements in sleep efficiency but also negative feelings from participants. Overall, the findings do not provide strong or consistent support for EPA as a treatment for poor sleep or insomnia.",0.8,36235788,2022,"Effect of Docosahexaenoic Acid and Eicosapentaenoic Acid Supplementation on Sleep Quality in Healthy Subjects: A Randomized, Double-Blinded, Placebo-Controlled Trial.",randomized_controlled_trial,benefit,"The study reports significant improvements in sleep quality, indicating a beneficial effect of EPA.",284 mg daily 12 weeks (capsules),Older Adults,,sleep quality,sleep quality,,,
Eicosapentaenoic acid (EPA),EPA group improved less than placebo in impulsivity (commission errors); disagreeable taste affecting intake; higher risk of atrial fibrillation; increased gastrointestinal adverse events in EPA group; intolerable nausea and vomiting; less rested; new-onset atrial fibrillation higher in EPA group; participants reported feeling less energetic; upper-gastrointestinal bleeding events reported,Sleep Quality,,Sleep,manual_pair,"The evidence for eicosapentaenoic acid (EPA) in improving sleep quality is limited and mixed. One randomized controlled trial reported significant improvements in sleep quality with a daily dose of 284 mg for 12 weeks, while another trial showed mixed results with some improvements in sleep efficiency but also negative feelings from participants. Overall, the findings do not provide strong or consistent support for EPA as a treatment for poor sleep or insomnia.",0.8,33467135,2021,Differential Effects of DHA- and EPA-Rich Oils on Sleep in Healthy Young Adults: A Randomized Controlled Trial.,randomized_controlled_trial,mixed_unclear,The study shows mixed results with some improvements in sleep efficiency for EPA but also negative feelings reported by participants.,26 weeks (oil),Young Adults,,sleep quality,sleep quality,,,
Eicosapentaenoic acid (EPA),EPA group improved less than placebo in impulsivity (commission errors); disagreeable taste affecting intake; higher risk of atrial fibrillation; increased gastrointestinal adverse events in EPA group; intolerable nausea and vomiting; less rested; new-onset atrial fibrillation higher in EPA group; participants reported feeling less energetic; upper-gastrointestinal bleeding events reported,Ulcerative Colitis,,Gut Health,manual_pair,"Eicosapentaenoic acid (EPA) has shown a benefit in reducing fecal calprotectin levels and preventing relapse in patients with ulcerative colitis, based on one randomized trial that administered 500 mg twice daily for six months. However, the overall evidence is limited, with only one study reporting positive outcomes and no data on potential adverse effects or long-term efficacy.",0.7,29391271,2018,Eicosapentaenoic Acid Reduces Fecal Levels of Calprotectin and Prevents Relapse in Patients With Ulcerative Colitis.,randomized_controlled_trial,benefit,"The study showed significant reduction in fecal calprotectin levels and maintenance of clinical remission, indicating a benefit from EPA administration.",500 mg twice daily 6 months (free fatty acid),,,ulcerative colitis,ulcerative colitis,,,
Fenugreek,gastrointestinal discomfort,Stress,,"Energy, Mood, & Mental Health",manual_pair,"One randomized placebo-controlled trial reported a benefit of fenugreek seed extract on anxiety, with doses of 400 mg and 500 mg daily for 60 days. No adverse events were noted, but the evidence is limited to a single study, indicating a need for further research to confirm these findings.",0.7,32441668,2020,Efficacy of fenugreek seed extract on men's psychological and physical health: a randomized placebo-controlled double-blind clinical trial.,randomized_controlled_trial,benefit,"The study reported significant improvements in various health outcomes with no adverse events, indicating a clear benefit from fenugreek supplementation.",400 mg daily 60 days (seed extract); 500 mg daily 60 days (seed extract),Men,Performance & Recovery,aging male symptoms,aging male symptoms; anxiety; grip strength; health-related quality of life,,,
Fenugreek,gastrointestinal discomfort,Increase Satiety,,Weight & Body Composition,manual_pair,"One randomized trial reported that fenugreek seed extract (588 mg and 1176 mg daily for 14 days) significantly reduced spontaneous fat consumption in healthy volunteers, suggesting a potential benefit for appetite control. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term effects and safety.",0.7,19809809,2009,A fenugreek seed extract selectively reduces spontaneous fat consumption in healthy volunteers.,randomized_controlled_trial,benefit,"The study shows a significant reduction in dietary fat consumption, indicating a beneficial effect of fenugreek seed extract on energy intake.",588 mg daily 14 days (seed extract); 1176 mg daily 14 days (seed extract),,,appetite control,appetite control,,,
Fenugreek,gastrointestinal discomfort,Depression,,"Energy, Mood, & Mental Health",manual_pair,"There is limited evidence suggesting that fenugreek extract may benefit depression symptoms in perimenopausal women, as indicated by one randomized, double-blind, placebo-controlled study that reported significant improvements with a dose of 250 mg taken twice daily for 42 days. However, the overall evidence is sparse, and further research is needed to confirm these findings and assess long-term effects and safety.",0.7,33025616,2020,"Efficacy of a novel extract of fenugreek seeds in alleviating vasomotor symptoms and depression in perimenopausal women: A randomized, double-blinded, placebo-controlled study.",randomized_controlled_trial,benefit,"The study showed significant improvement in various perimenopausal symptoms, indicating a beneficial effect of fenugreek extract.",250 mg 2/day 42 days (standardized fenugreek extract),Menopause; Women,Women's Health,depression,depression; hot flashes; insomnia; night sweats; perimenopausal discomforts,,,
Fenugreek,gastrointestinal discomfort,Increase Satiety,,Weight & Body Composition,manual_pair,"Clinical evidence suggests that fenugreek may have beneficial effects on body weight management, with two studies reporting positive outcomes. One study indicated that 8 g of isolated fenugreek fiber increased satiety and reduced energy intake, while another study found that a hydro-alcoholic seed extract decreased dietary fat consumption over six weeks. However, the overall evidence is limited and further research is needed to confirm these findings and assess long-term effects.",0.8,19353539,2009,"Effect of fenugreek fiber on satiety, blood glucose and insulin response and energy intake in obese subjects.",randomized_controlled_trial,benefit,"The study found that 8 g of fenugreek fiber significantly increased satiety and reduced energy intake, indicating a beneficial effect.",4 g (isolated fenugreek fiber); 8 g (isolated fenugreek fiber),Obese,,blood glucose response,blood glucose response; insulin response; metabolic dysfunction; nutritive dysfunction; obesity; overweight; satiety,,,
Fenugreek,gastrointestinal discomfort,Increase Satiety,,Weight & Body Composition,manual_pair,"Clinical evidence suggests that fenugreek may have beneficial effects on body weight management, with two studies reporting positive outcomes. One study indicated that 8 g of isolated fenugreek fiber increased satiety and reduced energy intake, while another study found that a hydro-alcoholic seed extract decreased dietary fat consumption over six weeks. However, the overall evidence is limited and further research is needed to confirm these findings and assess long-term effects.",0.8,20020282,2010,A fenugreek seed extract selectively reduces spontaneous fat intake in overweight subjects.,randomized_controlled_trial,benefit,"The study showed a significant decrease in dietary fat consumption, indicating a benefit from the fenugreek seed extract.",6 weeks (hydro-alcoholic seed extract),Overweight,,metabolic dysfunction,blood glucose response; insulin response; metabolic dysfunction; nutritive dysfunction; obesity; overweight; satiety,,,
Fenugreek,gastrointestinal discomfort,Fatigue,,"Energy, Mood, & Mental Health",manual_pair,"One randomized, double-blind, placebo-controlled pilot study reported that a formulation of curcumin with fenugreek dietary fiber (500 mg twice daily) led to significant improvements in fatigue among participants experiencing occupational stress. However, the evidence is limited to this single study, and further research is needed to confirm these findings and assess the consistency of the results across larger populations.",0.7,27043120,2016,"Safety, Tolerance, and Enhanced Efficacy of a Bioavailable Formulation of Curcumin With Fenugreek Dietary Fiber on Occupational Stress: A Randomized, Double-Blind, Placebo-Controlled Pilot Study.",randomized_controlled_trial,benefit,"The study showed significant improvements in stress, anxiety, and fatigue, indicating a beneficial outcome.",500 mg twice daily 30 days (CurQfen),,,fatigue,fatigue; occupational stress-related anxiety,,,
Fenugreek,gastrointestinal discomfort,High Blood Glucose,,Metabolic Health,manual_pair,"One study demonstrated a significant reduction in postprandial blood glucose levels in healthy subjects using fenugreek seed powder at a dose of 10% per meal. However, the overall evidence is limited, with only one trial showing benefit and no reports of harm or mixed outcomes. Further research is needed to confirm these findings and assess long-term effects.",0.7,26358163,2016,Reduction of postprandial blood glucose in healthy subjects by buns and flatbreads incorporated with fenugreek seed powder.,randomized_controlled_trial,benefit,"The study shows a significant reduction in glycemic response and glycemic index with the use of fenugreek seed powder, indicating a beneficial effect.",10 % once per meal (seed powder),,,glycemic index,glycemic index; glycemic response; postprandial blood glucose,,,
Fenugreek,gastrointestinal discomfort,High Blood Glucose,,Metabolic Health,manual_pair,"The evidence from randomized trials suggests that fenugreek may have beneficial effects on blood sugar control and insulin sensitivity in individuals with type 2 diabetes, with multiple studies reporting significant improvements in fasting blood glucose and insulin levels. Typical doses reported range from 1 g to 10 g of fenugreek seeds or their preparations daily. However, one study showed mixed results, indicating that while there is a trend towards benefit, the evidence is not uniformly conclusive.",0.8,29518003,2018,Insulin-Sensitizer Effects of Fenugreek Seeds in Parallel with Changes in Plasma MCH Levels in Healthy Volunteers.,randomized_controlled_trial,benefit,"The study demonstrated significant improvement in glucose tolerance and insulin sensitivity, indicating a beneficial effect of fenugreek in humans.",(fenugreek seed preparation),,,impaired glucose responses,Type 2 Diabetes Mellitus; impaired glucose responses; insulin resistance,,,
Fenugreek,gastrointestinal discomfort,High Blood Glucose,,Metabolic Health,manual_pair,"The evidence from randomized trials suggests that fenugreek may have beneficial effects on blood sugar control and insulin sensitivity in individuals with type 2 diabetes, with multiple studies reporting significant improvements in fasting blood glucose and insulin levels. Typical doses reported range from 1 g to 10 g of fenugreek seeds or their preparations daily. However, one study showed mixed results, indicating that while there is a trend towards benefit, the evidence is not uniformly conclusive.",0.8,19857068,2009,Fenugreek bread: a treatment for diabetes mellitus.,randomized_controlled_trial,benefit,"The study shows a significant reduction in insulin levels, indicating a beneficial effect on insulin resistance.",56 g once 4 hours (bread),Diabetes Type 2,,insulin resistance,Type 2 Diabetes Mellitus; impaired glucose responses; insulin resistance,,,
Fenugreek,gastrointestinal discomfort,High Blood Glucose,,Metabolic Health,manual_pair,"The evidence from randomized trials suggests that fenugreek may have beneficial effects on blood sugar control and insulin sensitivity in individuals with type 2 diabetes, with multiple studies reporting significant improvements in fasting blood glucose and insulin levels. Typical doses reported range from 1 g to 10 g of fenugreek seeds or their preparations daily. However, one study showed mixed results, indicating that while there is a trend towards benefit, the evidence is not uniformly conclusive.",0.8,31148988,2019,A randomized controlled clinical trial evaluating the effect of Trigonella foenum-graecum (fenugreek) versus glibenclamide in patients with diabetes.,randomized_controlled_trial,mixed_unclear,"Fenugreek showed an insignificant drop in fasting blood glucose but a significant increase in fasting insulin levels, indicating mixed outcomes.",2 g per day 12 weeks (seeds),Diabetes Type 2,,Type 2 Diabetes Mellitus,Type 2 Diabetes Mellitus; impaired glucose responses; insulin resistance,,,
Fenugreek,gastrointestinal discomfort,High Blood Glucose,,Metabolic Health,manual_pair,"The evidence from randomized trials suggests that fenugreek may have beneficial effects on blood sugar control and insulin sensitivity in individuals with type 2 diabetes, with multiple studies reporting significant improvements in fasting blood glucose and insulin levels. Typical doses reported range from 1 g to 10 g of fenugreek seeds or their preparations daily. However, one study showed mixed results, indicating that while there is a trend towards benefit, the evidence is not uniformly conclusive.",0.8,32147060,2020,"The effect of fenugreek seed supplementation on serum irisin levels, blood pressure, and liver and kidney function in patients with type 2 diabetes mellitus: A parallel randomized clinical trial.",randomized_controlled_trial,benefit,"The study showed beneficial effects of fenugreek seed supplementation on fasting plasma glucose, systolic blood pressure, and liver and kidney function tests in patients with type 2 diabetes mellitus.",5 g 3 times a day 8 weeks (FS powder),Diabetes Type 2,Gut Health; Heart & Vascular Health,Type 2 Diabetes Mellitus,Type 2 Diabetes Mellitus; impaired glucose responses; insulin resistance,,,
Fenugreek,gastrointestinal discomfort,High Blood Glucose,,Metabolic Health,manual_pair,"The evidence from randomized trials suggests that fenugreek may have beneficial effects on blood sugar control and insulin sensitivity in individuals with type 2 diabetes, with multiple studies reporting significant improvements in fasting blood glucose and insulin levels. Typical doses reported range from 1 g to 10 g of fenugreek seeds or their preparations daily. However, one study showed mixed results, indicating that while there is a trend towards benefit, the evidence is not uniformly conclusive.",0.8,26098483,2014,Effect of Fenugreek Seeds on Serum Metabolic Factors and Adiponectin Levels in Type 2 Diabetic Patients.,randomized_controlled_trial,benefit,"The study shows significant improvements in glucose metabolism and serum lipid profile, indicating a beneficial effect of fenugreek seeds.",10 g daily 8 weeks (powdered whole fenugreek seeds),Diabetes Type 2,Heart & Vascular Health,Type 2 Diabetes Mellitus,Type 2 Diabetes Mellitus; impaired glucose responses; insulin resistance,,,
Fenugreek,gastrointestinal discomfort,High Blood Glucose,,Metabolic Health,manual_pair,"The evidence from randomized trials suggests that fenugreek may have beneficial effects on blood sugar control and insulin sensitivity in individuals with type 2 diabetes, with multiple studies reporting significant improvements in fasting blood glucose and insulin levels. Typical doses reported range from 1 g to 10 g of fenugreek seeds or their preparations daily. However, one study showed mixed results, indicating that while there is a trend towards benefit, the evidence is not uniformly conclusive.",0.8,19839001,2009,Effect of fenugreek seeds on blood glucose and lipid profiles in type 2 diabetic patients.,clinical_trial,benefit,"The study shows significant decreases in fasting blood sugar and triglycerides, indicating a beneficial effect of fenugreek seeds.",10 grams daily 8 weeks (powdered seeds mixed with yoghurt or soaked in hot water),Diabetes Type 2,Heart & Vascular Health,Type 2 Diabetes Mellitus,Type 2 Diabetes Mellitus; impaired glucose responses; insulin resistance,,,
Fenugreek,gastrointestinal discomfort,High Blood Glucose,,Metabolic Health,manual_pair,"The evidence from randomized trials suggests that fenugreek may have beneficial effects on blood sugar control and insulin sensitivity in individuals with type 2 diabetes, with multiple studies reporting significant improvements in fasting blood glucose and insulin levels. Typical doses reported range from 1 g to 10 g of fenugreek seeds or their preparations daily. However, one study showed mixed results, indicating that while there is a trend towards benefit, the evidence is not uniformly conclusive.",0.8,11868855,2001,Effect of Trigonella foenum-graecum (fenugreek) seeds on glycaemic control and insulin resistance in type 2 diabetes mellitus: a double blind placebo controlled study.,randomized_controlled_trial,benefit,"The study shows significant improvements in glycemic control and insulin resistance, indicating a beneficial effect of fenugreek.",1 gm daily two months (hydroalcoholic extract),Diabetes Type 2,,Type 2 Diabetes Mellitus,Type 2 Diabetes Mellitus; impaired glucose responses; insulin resistance,,,
Fenugreek,gastrointestinal discomfort,High LDL,,Heart & Vascular Health,manual_pair,"One randomized trial reported that fenugreek seed powder solution (25 g twice daily for one month) significantly improved lipid profiles in type II diabetic patients, suggesting a potential benefit for lowering high LDL cholesterol. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term effects and safety.",0.7,31583253,2019,Antidiabetic Effect of Fenugreek Seed Powder Solution (Trigonella foenum-graecum L.) on Hyperlipidemia in Diabetic Patients.,randomized_controlled_trial,benefit,"The study demonstrated significant improvements in lipid profiles in type II diabetic patients, indicating a beneficial effect of fenugreek seed powder solution.",25 g twice a day one month (seed powder solution),,,hyperlipidemia,Type 2 Diabetes Mellitus; hyperlipidemia,,,
Fenugreek,gastrointestinal discomfort,Menopause Symptoms,,Women's Health,manual_pair,"One randomized, double-blind, placebo-controlled study reported that a standardized extract of fenugreek husk (FenuSMART™) at a dose of 1000 mg daily for 90 days significantly improved postmenopausal symptoms, including hot flashes. No studies reported mixed results or harm, but overall evidence remains limited to a single trial, necessitating caution in interpretation.",0.7,27406028,2016,"A Novel Extract of Fenugreek Husk (FenuSMART™) Alleviates Postmenopausal Symptoms and Helps to Establish the Hormonal Balance: A Randomized, Double-Blind, Placebo-Controlled Study.",randomized_controlled_trial,benefit,"The study showed significant improvements in postmenopausal symptoms and quality of life, indicating a beneficial outcome.",1000 mg daily 90 days (standardized extract),Menopause; Women,,hot flashes,hot flashes; postmenopausal discomforts,,,
Fenugreek,gastrointestinal discomfort,Low Testosterone,,Men's Health,manual_pair,"The evidence for fenugreek in increasing testosterone levels is mixed, with one randomized controlled trial reporting a significant increase in saliva testosterone but not in plasma testosterone. The doses used in the study ranged from 600 mg to 1800 mg of TrigozimR fenugreek extract taken daily for 12 weeks. Overall, the quality of evidence is low, and no consistent benefits were observed across studies.",0.7,39288153,2024,Effect of a plant extract of fenugreek (Trigonella foenum-graecum) on testosterone in blood plasma and saliva in a double blind randomized controlled intervention study.,randomized_controlled_trial,mixed_unclear,"The study showed increased testosterone levels in plasma and saliva, but only saliva testosterone was significantly increased compared to placebo, indicating mixed outcomes.",600 mg 3 tablets daily 12 weeks (TrigozimR fenugreek extract); 1200 mg 3 tablets daily 12 weeks (TrigozimR fenugreek extract); 1800 mg 3 tablets daily 12 weeks (TrigozimR fenugreek extract),,,non-optimal testosterone levels,non-optimal testosterone levels; reduced energy; reduced libido,,,
Fenugreek,gastrointestinal discomfort,Memory,,Cognitive & Neurological Function,manual_pair,"One randomized, double-blind, placebo-controlled trial found that fenugreek seed extract (5 cc daily for 4 months) significantly improved memory and quality of life in patients with Alzheimer's disease. However, the overall evidence is limited to this single study, and further research is needed to confirm these findings and assess long-term effects and safety.",0.7,36199177,2023,"The effects of fenugreek seed extract supplementation in patients with Alzheimer's disease: A randomized, double-blind, placebo-controlled trial.",randomized_controlled_trial,benefit,"The study shows significant improvements in memory, quality of life, blood pressure, and oxidative stress markers, indicating a beneficial effect of fenugreek seed extract in Alzheimer's patients.",5 cc 4 months (fenugreek seed extract),Alzheimer's Disease,"Heart & Vascular Health; Immune, Inflammation, & Infection",alzheimer's disease,alzheimer's disease; blood pressure; depression; memory deficit; quality of life,,,
Fenugreek,gastrointestinal discomfort,Exercise Recovery,,Performance & Recovery,manual_pair,"There is limited evidence suggesting that fenugreek may improve neuromuscular fatigue, as indicated by one study that reported a benefit when combined with curcumin. The study utilized doses of 300 mg of fenugreek daily for 28 days, but further research is needed to confirm these findings and assess consistency across different populations. No adverse effects were reported in the available evidence.",0.7,33044367,2020,"Effects of Curcumin and Fenugreek Soluble Fiber on the Physical Working Capacity at the Fatigue Threshold, Peak Oxygen Consumption, and Time to Exhaustion.",randomized_controlled_trial,benefit,"The study showed that curcumin combined with fenugreek soluble fiber improved neuromuscular fatigue threshold, indicating a benefit.",500 mg daily 28 days (CUR + FEN); 300 mg daily 28 days (FEN),,,neuromuscular fatigue,neuromuscular fatigue,,,
Fenugreek,gastrointestinal discomfort,Oral Precancerous Lesions,,Oral Health,manual_pair,"The evidence regarding fenugreek for the treatment of oral lichen planus is limited and mixed, with one randomized controlled trial reporting no significant changes for lichen planus despite some improvement in other oral conditions. The study used a dose of 2 grams of fenugreek once daily for two months. Overall, the findings do not support a clear benefit for this indication.",0.8,39873252,2024,Effectiveness of Fenugreek as an Adjuvant in the Management of Oral Potentially Malignant Disorders: A Randomized Controlled Trial.,randomized_controlled_trial,mixed_unclear,"The study showed significant improvement in OSMF but no significant changes for leukoplakia and lichen planus, indicating mixed outcomes.",2 gm once daily 2 months (fenugreek),Leukoplakia; Lichen Planus; Submucous Fibrosis,,leukoplakia,leukoplakia; lichen planus; oral submucous fibrosis,,,
Fenugreek,gastrointestinal discomfort,Atrophic Vaginitis,,Women's Health,manual_pair,"The evidence for fenugreek in treating vaginal dryness is limited and mixed, with one study indicating some effectiveness compared to ultra-low-dose estrogen, but not as effective overall. The study utilized a vaginal cream formulation at a dose of 0.5 g (5%) applied twice a week for 12 weeks. No adverse effects were reported, but the overall quality of evidence is low.",0.6,32640956,2020,Comparison of the Effects of Fenugreek Vaginal Cream and Ultra Low- Dose Estrogen on Atrophic Vaginitis.,randomized_controlled_trial,mixed_unclear,"Fenugreek extract showed some effectiveness in treating atrophic vaginitis, but was not as effective as ultra-low-dose estrogen, indicating a mixed outcome.",0.5 g twice a week 12 weeks (vaginal cream 5%),Menopause; Women,,atrophic vaginitis,atrophic vaginitis,,,
Garlic,advised against application of fresh garlic onto skin and mucosa; allergic hypersensitivity to garlic; food intake reactions,Inflammation,,"Immune, Inflammation, & Infection",manual_pair,"One randomized, double-blind, placebo-controlled trial found that aged garlic extract (3.6 g daily for 6 weeks) significantly reduced inflammatory markers in adults with obesity, suggesting a beneficial effect on chronic inflammation. No studies reported mixed results or harm, but the overall evidence remains limited to a single trial, necessitating further research to confirm these findings.",0.8,29576354,2018,"Aged garlic extract supplementation modifies inflammation and immunity of adults with obesity: A randomized, double-blind, placebo-controlled clinical trial.",randomized_controlled_trial,benefit,"The study found significant reductions in inflammatory markers and LDL cholesterol, indicating a beneficial effect of aged garlic extract in the studied population.",3.6 g daily 6 weeks (aged garlic extract),Obese; Overweight,Heart & Vascular Health,chronic inflammation,chronic inflammation; immune function; obesity,,,
Garlic,advised against application of fresh garlic onto skin and mucosa; allergic hypersensitivity to garlic; food intake reactions,Joint Pain,,Musculoskeletal & Pain,manual_pair,"Current evidence on garlic supplementation for chronic joint pain is mixed and unclear. A study reported improvements in stiffness but no significant differences in overall WOMAC scores compared to placebo, suggesting limited efficacy. The typical dose reported was 1000 mg of odourless garlic tablet once daily for 12 weeks.",0.7,29790635,2018,The effect of 12-week garlic supplementation on symptom relief in overweight or obese women with knee osteoarthritis.,randomized_controlled_trial,mixed_unclear,"While garlic supplementation improved stiffness, there were no significant differences in WOMAC scores compared to placebo, indicating mixed results.",1000 mg once daily 12 weeks (odourless garlic tablet),Obese; Osteoarthritis; Women,,chronic joint pain,chronic joint pain; knee osteoarthritis; stiffness,,,
Garlic,advised against application of fresh garlic onto skin and mucosa; allergic hypersensitivity to garlic; food intake reactions,Immune System Fortification,,"Immune, Inflammation, & Infection",manual_pair,"One randomized trial indicated that aged garlic extract (2.56 g daily for 90 days) may enhance immune cell function and reduce the severity of cold and flu symptoms. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess consistency across different populations and formulations.",0.7,26764332,2016,Aged Garlic Extract Modifies Human Immunity.,randomized_controlled_trial,benefit,The study found that AGE supplementation enhanced immune cell function and reduced the severity of cold and flu symptoms.,2.56 g daily 90 d (Aged Garlic Extract),,,common cold,common cold; influenza; respiratory tract infections,,,
Garlic,advised against application of fresh garlic onto skin and mucosa; allergic hypersensitivity to garlic; food intake reactions,Weight Loss,,Weight & Body Composition,manual_pair,"Two randomized trials indicate that aged garlic extract may have beneficial effects on coronary artery disease, showing significant reductions in adipose tissue volumes and low-attenuation plaque. The doses reported include 2400 mg daily for one study, while the other involved aged garlic extract with supplements over 12 months. Overall, the evidence suggests potential benefits, but further research is needed to confirm these findings and assess long-term effects.",0.8,29140808,2018,Randomized trial evaluating the effect of aged garlic extract with supplements versus placebo on adipose tissue surrogates for coronary atherosclerosis progression.,randomized_controlled_trial,benefit,"The study shows a significant reduction in adipose tissue volumes associated with AGE+S, indicating a beneficial effect on coronary atherosclerosis progression.",12 months (aged garlic extract with supplements),,,coronary artery disease,coronary artery disease; metabolic risk,,,
Garlic,advised against application of fresh garlic onto skin and mucosa; allergic hypersensitivity to garlic; food intake reactions,Weight Loss,,Weight & Body Composition,manual_pair,"Two randomized trials indicate that aged garlic extract may have beneficial effects on coronary artery disease, showing significant reductions in adipose tissue volumes and low-attenuation plaque. The doses reported include 2400 mg daily for one study, while the other involved aged garlic extract with supplements over 12 months. Overall, the evidence suggests potential benefits, but further research is needed to confirm these findings and assess long-term effects.",0.8,26764322,2016,Aged Garlic Extract Reduces Low Attenuation Plaque in Coronary Arteries of Patients with Metabolic Syndrome in a Prospective Randomized Double-Blind Study.,randomized_controlled_trial,benefit,"The study shows a significant reduction in low-attenuation plaque in the AGE group, indicating a beneficial effect.",2400 mg daily 354 ± 41 days (oral),,,coronary artery disease,coronary artery disease; metabolic risk,,,
Garlic,advised against application of fresh garlic onto skin and mucosa; allergic hypersensitivity to garlic; food intake reactions,Endothelial Function,,Heart & Vascular Health,manual_pair,"The evidence on garlic for improving endothelial dysfunction is limited and mixed. One randomized controlled trial reported significant benefits from encapsulated purple garlic oil on microvascular function, while another trial showed mixed effects on endothelial integrity with microencapsulated garlic powder. Overall, the findings are not consistent, and further research is needed to clarify the effects.",0.7,38892688,2024,Effect of Encapsulated Purple Garlic Oil on Microvascular Function and the Components of Metabolic Syndrome: A Randomized Placebo-Controlled Study-The ENDOTALLIUM Study.,randomized_controlled_trial,benefit,"The study demonstrated significant improvements in microvascular function and components of metabolic syndrome, indicating a beneficial effect of garlic oil.",null null null five weeks (encapsulated purple garlic oil),,"Immune, Inflammation, & Infection",endothelial dysfunction,endothelial dysfunction,,,
Garlic,advised against application of fresh garlic onto skin and mucosa; allergic hypersensitivity to garlic; food intake reactions,Endothelial Function,,Heart & Vascular Health,manual_pair,"The evidence on garlic for improving endothelial dysfunction is limited and mixed. One randomized controlled trial reported significant benefits from encapsulated purple garlic oil on microvascular function, while another trial showed mixed effects on endothelial integrity with microencapsulated garlic powder. Overall, the findings are not consistent, and further research is needed to clarify the effects.",0.7,30280751,2018,"Differential responses of endothelial integrity upon the intake of microencapsulated garlic, tomato extract or a mixture: a single-intake, randomized, double-blind, placebo-controlled crossover trial.",randomized_controlled_trial,mixed_unclear,"The study shows mixed effects on biomarkers related to endothelial integrity, indicating both benefits and unclear outcomes.",6 h (microencapsulated garlic powder),,,endothelial dysfunction,endothelial dysfunction,,,
Garlic,advised against application of fresh garlic onto skin and mucosa; allergic hypersensitivity to garlic; food intake reactions,Dyspepsia,,Gut Health,manual_pair,"The clinical evidence regarding garlic for epigastric discomfort is limited and mixed, with one study indicating that garlic powder (2 g single dose) induced specific symptoms but did not significantly impact mechanosensitivity or gastric compliance. Overall, there is no consistent evidence supporting its efficacy for this indication.",0.7,30238636,2019,Gastric administration of garlic powder containing the trpa1- agonist allicin induces specific epigastric symptoms and gastric relaxation in healthy subjects.,randomized_controlled_trial,mixed_unclear,"Garlic induced specific symptoms but did not significantly affect mechanosensitivity or compliance, indicating mixed outcomes.",2 g single dose (garlic powder),,,epigastric symptoms,epigastric symptoms; gastric relaxation,,,
Garlic,advised against application of fresh garlic onto skin and mucosa; allergic hypersensitivity to garlic; food intake reactions,Erectile Dysfunction,,Men's Health,manual_pair,"One pilot study reported a statistically significant improvement in erectile function with the coadministration of garlic (5 g orally twice a day for 4 weeks) alongside tadalafil in patients who did not respond to tadalafil alone. However, the evidence is limited to this single study, and further research is needed to confirm these findings and assess long-term safety and efficacy.",0.7,39250620,2024,"Prospective, randomized, placebo-controlled, two-arm study to evaluate the efficacy of coadministration of garlic as a hydrogen sulfide donor and tadalafil in patients with erectile dysfunction not responding to tadalafil alone - A pilot study.",randomized_controlled_trial,benefit,"The study showed statistically significant improvement in erectile function with garlic coadministration, indicating a benefit.",5 g twice a day 4 weeks (oral),,,erectile dysfunction,erectile dysfunction,,,
Garlic,advised against application of fresh garlic onto skin and mucosa; allergic hypersensitivity to garlic; food intake reactions,Weight Loss,,Weight & Body Composition,manual_pair,"One randomized clinical trial reported that garlic powder supplementation (1600 mg daily for 3 months) resulted in significant improvements in components of metabolic syndrome and appetite, suggesting a potential benefit for excess body weight. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term effects.",0.8,33974725,2021,"Effects of garlic powder supplementation on metabolic syndrome components, insulin resistance, fatty liver index, and appetite in subjects with metabolic syndrome: A randomized clinical trial.",randomized_controlled_trial,benefit,"Garlic supplementation led to significant improvements in various metabolic syndrome components and appetite, indicating a beneficial effect.",1600 mg daily 3 months (powder),,Heart & Vascular Health; Metabolic Health,appetite,appetite; insulin resistance; metabolic syndrome; nonalcoholic fatty liver disease,,,
Garlic,advised against application of fresh garlic onto skin and mucosa; allergic hypersensitivity to garlic; food intake reactions,Elevated Liver Enzymes,,Gut Health,manual_pair,"One randomized controlled trial found that garlic powder supplementation (400 mg, 4 tablets daily for 12 weeks) significantly improved hepatic features and lipid profile in patients with non-alcoholic fatty liver disease (NAFLD). No studies reported mixed outcomes or harm, indicating a potential benefit, but further research is needed to confirm these findings and assess long-term effects.",0.8,32312333,2020,"Effect of garlic powder supplementation on hepatic steatosis, liver enzymes and lipid profile in patients with non-alcoholic fatty liver disease: a double-blind randomised controlled clinical trial.",randomized_controlled_trial,benefit,Garlic powder supplementation significantly improved hepatic features and lipid profile among NAFLD patients.,400 mg 4 tablets daily 12 weeks (garlic powder),Fatty Liver Disease,Heart & Vascular Health,non-alcoholic fatty liver disease,non-alcoholic fatty liver disease,,,
Garlic,advised against application of fresh garlic onto skin and mucosa; allergic hypersensitivity to garlic; food intake reactions,Endothelial Function,,Heart & Vascular Health,manual_pair,"Clinical evidence from four randomized trials indicates that garlic supplements, particularly aged garlic extract, may reduce blood pressure in various populations, including older adults and individuals with hypertension. Reported doses include 250 mg to 2.4 g of aged garlic extract and 0.25 mg of s-allyl-cysteine daily. No adverse effects were noted in the studies, but the overall quality of evidence remains moderate and further research may be needed to confirm these findings.",0.8,35505122,2022,Improved microvascular reactivity after aged garlic extract intake is not mediated by hydrogen sulfide in older adults at risk for cardiovascular disease: a randomized clinical trial.,randomized_controlled_trial,benefit,"The study showed improved microvascular reactivity and reduced systolic blood pressure after aged garlic extract intake, indicating a benefit for older adults at risk for cardiovascular disease.",2.4 g (aged garlic extract),,,cardiovascular disease,cardiovascular disease; cardiovascular disease risk factors; grade i hypertension; hypertension; microvascular reactivity; moderate hypercholesterolemia,,,
Garlic,advised against application of fresh garlic onto skin and mucosa; allergic hypersensitivity to garlic; food intake reactions,Endothelial Function,,Heart & Vascular Health,manual_pair,"Clinical evidence from four randomized trials indicates that garlic supplements, particularly aged garlic extract, may reduce blood pressure in various populations, including older adults and individuals with hypertension. Reported doses include 250 mg to 2.4 g of aged garlic extract and 0.25 mg of s-allyl-cysteine daily. No adverse effects were noted in the studies, but the overall quality of evidence remains moderate and further research may be needed to confirm these findings.",0.8,35276764,2022,"Effects of an Optimized Aged Garlic Extract on Cardiovascular Disease Risk Factors in Moderate Hypercholesterolemic Subjects: A Randomized, Crossover, Double-Blind, Sustainedand Controlled Study.",randomized_controlled_trial,benefit,"The study showed a significant reduction in diastolic blood pressure, indicating a beneficial effect of aged black garlic on cardiovascular risk factors.",250 mg daily 6 weeks (tablet),,,cardiovascular disease risk factors,cardiovascular disease; cardiovascular disease risk factors; grade i hypertension; hypertension; microvascular reactivity; moderate hypercholesterolemia,,,
Garlic,advised against application of fresh garlic onto skin and mucosa; allergic hypersensitivity to garlic; food intake reactions,Endothelial Function,,Heart & Vascular Health,manual_pair,"Clinical evidence from four randomized trials indicates that garlic supplements, particularly aged garlic extract, may reduce blood pressure in various populations, including older adults and individuals with hypertension. Reported doses include 250 mg to 2.4 g of aged garlic extract and 0.25 mg of s-allyl-cysteine daily. No adverse effects were noted in the studies, but the overall quality of evidence remains moderate and further research may be needed to confirm these findings.",0.8,37686723,2023,"Antihypertensive Effects of an Optimized Aged Garlic Extract in Subjects with Grade I Hypertension and Antihypertensive Drug Therapy: A Randomized, Triple-Blind Controlled Trial.",randomized_controlled_trial,benefit,"The study demonstrated a significant reduction in blood pressure, indicating a beneficial effect of the garlic extract in hypertensive patients.",0.25 mg daily 12 weeks (s-allyl-cysteine),,,grade i hypertension,cardiovascular disease; cardiovascular disease risk factors; grade i hypertension; hypertension; microvascular reactivity; moderate hypercholesterolemia,,,
Garlic,advised against application of fresh garlic onto skin and mucosa; allergic hypersensitivity to garlic; food intake reactions,Endothelial Function,,Heart & Vascular Health,manual_pair,"Clinical evidence from four randomized trials indicates that garlic supplements, particularly aged garlic extract, may reduce blood pressure in various populations, including older adults and individuals with hypertension. Reported doses include 250 mg to 2.4 g of aged garlic extract and 0.25 mg of s-allyl-cysteine daily. No adverse effects were noted in the studies, but the overall quality of evidence remains moderate and further research may be needed to confirm these findings.",0.8,39001718,2024,"Randomized, double-blind clinical trial evaluating the impact of freeze-dried garlic extract capsules on blood pressure, lipid profile, and nitric oxide levels in individuals at risk for hypertension.",randomized_controlled_trial,benefit,"The study demonstrated significant improvements in blood pressure and lipid profiles, indicating a beneficial effect of garlic supplementation in prehypertensive individuals.",2 capsules daily eight weeks (freeze-dried garlic extract),,,hypertension,cardiovascular disease; cardiovascular disease risk factors; grade i hypertension; hypertension; microvascular reactivity; moderate hypercholesterolemia,,,
Garlic,advised against application of fresh garlic onto skin and mucosa; allergic hypersensitivity to garlic; food intake reactions,High Blood Glucose,,Metabolic Health,manual_pair,"One randomized double-blind placebo-controlled trial reported that aged garlic extract (2400 mg daily for one year) significantly reduced blood glucose levels, indicating a potential benefit for high blood sugar. However, the overall evidence is limited, with only one study demonstrating this effect and no other studies providing conflicting or supportive data. No adverse effects were reported in the study.",0.7,32349742,2020,The effect of aged garlic extract on the atherosclerotic process - a randomized double-blind placebo-controlled trial.,randomized_controlled_trial,benefit,"The study showed significant benefits in reducing coronary artery calcification progression, lowering blood glucose, and decreasing blood pressure.",2400 mg daily 1 year (aged garlic extract),,Heart & Vascular Health,blood glucose,blood glucose; blood pressure; cardiovascular disease; coronary atherosclerosis; inflammatory biomarkers,,,
Garlic,advised against application of fresh garlic onto skin and mucosa; allergic hypersensitivity to garlic; food intake reactions,High Blood Glucose,,Metabolic Health,manual_pair,"The evidence from three randomized controlled trials indicates that garlic supplementation may have beneficial effects on metabolic markers related to high blood sugar and metabolic syndrome in various populations. Doses reported include 400 mg of garlic powder daily, 500 mg of garlic tablets twice daily, and 100 mg/kg of raw crushed garlic twice daily. However, the studies primarily focus on specific populations and conditions, and further research is needed to confirm these findings across broader groups.",0.8,32507439,2020,"Effects of garlic powder supplementation on insulin resistance, oxidative stress, and body composition in patients with non-alcoholic fatty liver disease: A randomized controlled clinical trial.",randomized_controlled_trial,benefit,Garlic powder supplementation led to significant improvements in various health markers related to NAFLD.,400 mg 4 tablets daily 12 weeks (powder),Fatty Liver Disease,Performance & Recovery; Weight & Body Composition,insulin resistance,insulin resistance; metabolic syndrome; non-alcoholic fatty liver disease; obesity; oxidative stress; polycystic ovary syndrome,,,
Garlic,advised against application of fresh garlic onto skin and mucosa; allergic hypersensitivity to garlic; food intake reactions,High Blood Glucose,,Metabolic Health,manual_pair,"The evidence from three randomized controlled trials indicates that garlic supplementation may have beneficial effects on metabolic markers related to high blood sugar and metabolic syndrome in various populations. Doses reported include 400 mg of garlic powder daily, 500 mg of garlic tablets twice daily, and 100 mg/kg of raw crushed garlic twice daily. However, the studies primarily focus on specific populations and conditions, and further research is needed to confirm these findings across broader groups.",0.8,40770379,2025,Efficacy of garlic (Allium sativum) on metabolic syndrome components in women with polycystic ovary syndrome: randomized controlled trial.,randomized_controlled_trial,benefit,"The study showed significant improvements in various metabolic syndrome markers and quality of life, indicating a beneficial effect of garlic supplementation.",500 mg twice daily 8 weeks (tablets),PCOS; Women,"Heart & Vascular Health; Skin, Hair, & Nails; Weight & Body Composition; Women's Health",metabolic syndrome,insulin resistance; metabolic syndrome; non-alcoholic fatty liver disease; obesity; oxidative stress; polycystic ovary syndrome,,,
Garlic,advised against application of fresh garlic onto skin and mucosa; allergic hypersensitivity to garlic; food intake reactions,High Blood Glucose,,Metabolic Health,manual_pair,"The evidence from three randomized controlled trials indicates that garlic supplementation may have beneficial effects on metabolic markers related to high blood sugar and metabolic syndrome in various populations. Doses reported include 400 mg of garlic powder daily, 500 mg of garlic tablets twice daily, and 100 mg/kg of raw crushed garlic twice daily. However, the studies primarily focus on specific populations and conditions, and further research is needed to confirm these findings across broader groups.",0.8,28956671,2018,Effect of Raw Crushed Garlic (Allium sativum L.) on Components of Metabolic Syndrome.,randomized_controlled_trial,benefit,"The study shows significant reductions in various components of metabolic syndrome, indicating a beneficial effect of garlic.",100 mg/kg 2 times a day 4 weeks (raw crushed garlic),,Heart & Vascular Health; Weight & Body Composition,metabolic syndrome,insulin resistance; metabolic syndrome; non-alcoholic fatty liver disease; obesity; oxidative stress; polycystic ovary syndrome,,,
Garlic,advised against application of fresh garlic onto skin and mucosa; allergic hypersensitivity to garlic; food intake reactions,High LDL,,Heart & Vascular Health,manual_pair,"The evidence from five randomized trials indicates that garlic supplementation may significantly reduce LDL cholesterol levels and improve lipid profiles in various populations. Typical doses reported include 400 mg of garlic extract daily and 2-4 cloves of black garlic daily. No studies reported adverse effects or harm associated with garlic supplementation, but further research may be needed to confirm these findings across broader populations.",1.0,30150192,2018,"Supplementation of garlic and coriander seed powder: Impact on body mass index, lipid profile and blood pressure of hyperlipidemic patients.",randomized_controlled_trial,benefit,"The study shows significant improvements in lipid parameters and BMI, indicating a beneficial effect of garlic supplementation.",2 g daily 40 days (powder),,Weight & Body Composition,cardiovascular disease,cardiovascular disease; cardiovascular diseases; cardiovascular risk; chronic inflammation; hypercholesterolemia; hyperlipidemia; mild hypercholesterolemia; obesity; polycystic ovary syndrome,,,
Garlic,advised against application of fresh garlic onto skin and mucosa; allergic hypersensitivity to garlic; food intake reactions,High LDL,,Heart & Vascular Health,manual_pair,"The evidence from five randomized trials indicates that garlic supplementation may significantly reduce LDL cholesterol levels and improve lipid profiles in various populations. Typical doses reported include 400 mg of garlic extract daily and 2-4 cloves of black garlic daily. No studies reported adverse effects or harm associated with garlic supplementation, but further research may be needed to confirm these findings across broader populations.",1.0,37513556,2023,Effect of Black Garlic Consumption on Endothelial Function and Lipid Profile: A Before-and-After Study in Hypercholesterolemic and Non-Hypercholesterolemic Subjects.,clinical_trial,benefit,"The study shows significant improvements in endothelial function and lipid profile, indicating a benefit from black garlic consumption.",4 cloves daily 12 weeks (black garlic),,,cardiovascular diseases,cardiovascular disease; cardiovascular diseases; cardiovascular risk; chronic inflammation; hypercholesterolemia; hyperlipidemia; mild hypercholesterolemia; obesity; polycystic ovary syndrome,,,
Garlic,advised against application of fresh garlic onto skin and mucosa; allergic hypersensitivity to garlic; food intake reactions,High LDL,,Heart & Vascular Health,manual_pair,"The evidence from five randomized trials indicates that garlic supplementation may significantly reduce LDL cholesterol levels and improve lipid profiles in various populations. Typical doses reported include 400 mg of garlic extract daily and 2-4 cloves of black garlic daily. No studies reported adverse effects or harm associated with garlic supplementation, but further research may be needed to confirm these findings across broader populations.",1.0,29604599,2018,Garlic extract favorably modifies markers of endothelial function in obese patients -randomized double blind placebo-controlled nutritional intervention.,randomized_controlled_trial,benefit,"The study shows significant improvements in endothelial biomarkers, indicating a beneficial effect of garlic extract.",400 mg daily 3 months (extract),,,cardiovascular risk,cardiovascular disease; cardiovascular diseases; cardiovascular risk; chronic inflammation; hypercholesterolemia; hyperlipidemia; mild hypercholesterolemia; obesity; polycystic ovary syndrome,,,
Garlic,advised against application of fresh garlic onto skin and mucosa; allergic hypersensitivity to garlic; food intake reactions,High LDL,,Heart & Vascular Health,manual_pair,"The evidence from five randomized trials indicates that garlic supplementation may significantly reduce LDL cholesterol levels and improve lipid profiles in various populations. Typical doses reported include 400 mg of garlic extract daily and 2-4 cloves of black garlic daily. No studies reported adverse effects or harm associated with garlic supplementation, but further research may be needed to confirm these findings across broader populations.",1.0,39203947,2024,LDL-Cholesterol-Lowering Effects of a Dietary Supplement Containing Onion and Garlic Extract Used in Healthy Volunteers.,randomized_controlled_trial,benefit,"The study showed significant reductions in LDL cholesterol and total cholesterol levels, indicating a beneficial effect on mild hypercholesterolemia.",8 weeks (standardized formulation containing extracts from garlic and onions),,,mild hypercholesterolemia,cardiovascular disease; cardiovascular diseases; cardiovascular risk; chronic inflammation; hypercholesterolemia; hyperlipidemia; mild hypercholesterolemia; obesity; polycystic ovary syndrome,,,
Garlic,advised against application of fresh garlic onto skin and mucosa; allergic hypersensitivity to garlic; food intake reactions,High LDL,,Heart & Vascular Health,manual_pair,"The evidence from five randomized trials indicates that garlic supplementation may significantly reduce LDL cholesterol levels and improve lipid profiles in various populations. Typical doses reported include 400 mg of garlic extract daily and 2-4 cloves of black garlic daily. No studies reported adverse effects or harm associated with garlic supplementation, but further research may be needed to confirm these findings across broader populations.",1.0,34496450,2021,The effect of garlic (Allium sativum) supplementation on the lipid parameters and blood pressure levels in women with polycystic ovary syndrome: A randomized controlled trial.,randomized_controlled_trial,benefit,"Garlic supplementation showed significant reductions in total cholesterol and LDL-C, indicating a beneficial effect on lipid parameters.",800 mg daily 8 weeks (supplement),,,polycystic ovary syndrome,cardiovascular disease; cardiovascular diseases; cardiovascular risk; chronic inflammation; hypercholesterolemia; hyperlipidemia; mild hypercholesterolemia; obesity; polycystic ovary syndrome,,,
Garlic,advised against application of fresh garlic onto skin and mucosa; allergic hypersensitivity to garlic; food intake reactions,Joint Pain,,Musculoskeletal & Pain,manual_pair,"One randomized trial reported that garlic supplementation (1000 mg twice daily for 12 weeks) significantly reduced pain severity in overweight or obese women with knee osteoarthritis. However, the overall evidence is limited, with only one study available, and further research is needed to confirm these findings and assess long-term effects and safety.",0.7,30195882,2018,"The effect of a garlic supplement on the pro-inflammatory adipocytokines, resistin and tumor necrosis factor-alpha, and on pain severity, in overweight or obese women with knee osteoarthritis.",randomized_controlled_trial,benefit,"Garlic supplementation significantly reduced pain severity and resistin levels, indicating a beneficial effect.",1000 mg twice-daily 12 weeks (tablets),Obese; Osteoarthritis; Overweight; Women,,knee osteoarthritis,knee osteoarthritis; pain severity,,,
Garlic,advised against application of fresh garlic onto skin and mucosa; allergic hypersensitivity to garlic; food intake reactions,Atherosclerosis,,Heart & Vascular Health,manual_pair,"Human clinical evidence suggests that garlic supplementation may have beneficial effects on components of metabolic syndrome, with three randomized controlled trials reporting positive outcomes. Doses reported include 1600 mg of garlic powder daily for three months and 2400 mg of aged garlic extract daily for approximately one year. No adverse effects were noted in the studies, but further research may be needed to confirm these findings and assess long-term safety.",0.9,36721177,2023,"Garlic supplementation improves intestinal transit time, lipid accumulation product and cardiometabolic indices in subjects with metabolic syndrome: A randomized controlled trial.",randomized_controlled_trial,benefit,"Garlic supplementation showed significant improvements in intestinal transit time and various cardiometabolic indices, indicating a beneficial effect in subjects with metabolic syndrome.",1600 mg daily 3 months (garlic powder),,,metabolic syndrome,metabolic syndrome,,,
Garlic,advised against application of fresh garlic onto skin and mucosa; allergic hypersensitivity to garlic; food intake reactions,Elevated Liver Enzymes,,Gut Health,manual_pair,"One randomized, double-blind, placebo-controlled trial reported a benefit of fermented garlic extract in improving serum gamma-glutamyl transpeptidase (GGT) and alanine aminotransferase (ALT) levels in adults with mild liver dysfunction, using a dose of 2 sachets daily for 12 weeks. Overall evidence is limited, with only one study demonstrating positive outcomes and no reports of harm or mixed results.",0.8,27743130,2017,"Efficacy and safety of fermented garlic extract on hepatic function in adults with elevated serum gamma-glutamyl transpeptidase levels: a double-blind, randomized, placebo-controlled trial.",randomized_controlled_trial,benefit,"The study shows improvement in serum GGT and ALT levels, indicating a benefit for mild hepatic dysfunction.",2 sachets daily 12 weeks (fermented garlic extract),Fatty Liver Disease,,elevated serum gamma-glutamyl transpeptidase levels,elevated serum gamma-glutamyl transpeptidase levels; mild hepatic dysfunction,,,
Garlic,advised against application of fresh garlic onto skin and mucosa; allergic hypersensitivity to garlic; food intake reactions,Rheumatoid Arthritis,,"Immune, Inflammation, & Infection",manual_pair,"One randomized, double-blind, placebo-controlled trial found that garlic supplementation (500 mg twice daily for 8 weeks) resulted in significant improvements in oxidative stress biomarkers and quality of life in women with rheumatoid arthritis, indicating a potential benefit. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term effects and safety.",0.7,32159257,2020,"A randomized, double-blind, placebo-controlled clinical trial, evaluating the garlic supplement effects on some serum biomarkers of oxidative stress, and quality of life in women with rheumatoid arthritis.",randomized_controlled_trial,benefit,"The study found significant improvements in oxidative stress biomarkers and quality of life, indicating a benefit from garlic supplementation.",500 mg twice daily 8 weeks (tablet),,,rheumatoid arthritis,rheumatoid arthritis,,,
Garlic,advised against application of fresh garlic onto skin and mucosa; allergic hypersensitivity to garlic; food intake reactions,Endothelial Function,,Heart & Vascular Health,manual_pair,"One randomized trial found that garlic powder taken twice daily for three months improved endothelial function and reduced high-sensitivity C-reactive protein (hs-CRP) levels in patients with coronary artery disease, suggesting a potential benefit for poor endothelial function. No studies reported mixed or negative outcomes, but further research is needed to confirm these findings and assess long-term effects and safety.",0.8,28554988,2017,Effects of garlic on brachial endothelial function and capacity of plasma to mediate cholesterol efflux in patients with coronary artery disease.,randomized_controlled_trial,benefit,"Garlic improved endothelial function and reduced hs-CRP levels, indicating a potential benefit.",null null twice daily 3 months (garlic powder),,"Immune, Inflammation, & Infection",coronary artery disease,coronary artery disease,,,
Garlic,advised against application of fresh garlic onto skin and mucosa; allergic hypersensitivity to garlic; food intake reactions,Improve Visual Acuity,,Vision & Eye Health,manual_pair,"One randomized trial suggests that garlic tablets (500 mg, 2 tablets per day for 4 weeks) may improve visual acuity and reduce intraocular pressure in patients with diabetic retinopathy. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term effects and safety.",0.7,35875346,2022,Evaluation of the Effect of Garlic Tablet as a Complementary Treatment for Patients with Diabetic Retinopathy.,randomized_controlled_trial,benefit,"The study shows significant improvement in visual acuity and reduction in intraocular pressure, indicating a beneficial effect of garlic in diabetic patients.",500 mg 2 tab/day 4 weeks (tablets),Diabetes; Diabetic Retinopathy,,diabetic macular edema,diabetic macular edema; diabetic retinopathy,,,
Garlic,advised against application of fresh garlic onto skin and mucosa; allergic hypersensitivity to garlic; food intake reactions,Wound Healing,,"Skin, Hair, & Nails",manual_pair,"One randomized clinical trial indicated that a 30% garlic ointment applied twice daily for two weeks improved wound healing and resulted in more cosmetically appealing scars compared to a control (Vaseline). However, the overall evidence is limited, with only one study demonstrating a benefit and no reports of harm or mixed outcomes. Further research is needed to confirm these findings and assess long-term effects.",0.7,31490311,2020,Effect of Topical Garlic on Wound Healing and Scarring: A Clinical Trial.,randomized_controlled_trial,benefit,The study shows that garlic ointment improved wound healing and resulted in more cosmetically appealing scars compared to Vaseline.,30 % twice daily 2 weeks (ointment),,,scarring,scarring; wound healing,,,
Garlic,advised against application of fresh garlic onto skin and mucosa; allergic hypersensitivity to garlic; food intake reactions,Wound Healing,,"Skin, Hair, & Nails",manual_pair,"One randomized trial reported a benefit of aged garlic extract (2400 mg daily for 12 months) in improving peripheral tissue perfusion in patients with atherosclerosis, which may suggest a potential positive effect on wound healing due to impaired blood flow. However, the overall evidence is limited, with only one study demonstrating this outcome and no data on adverse effects or additional studies to confirm these findings.",0.7,33590955,2021,Successful improved peripheral tissue perfusion was seen in patients with atherosclerosis after 12 months of treatment with aged garlic extract.,randomized_controlled_trial,benefit,"The study shows a significant improvement in peripheral tissue perfusion, indicating a beneficial effect of aged garlic extract.",2400 mg daily 1 year (aged garlic extract),,,atherosclerosis,atherosclerosis,,,
Garlic,advised against application of fresh garlic onto skin and mucosa; allergic hypersensitivity to garlic; food intake reactions,Wound Healing,,"Skin, Hair, & Nails",manual_pair,"One randomized controlled trial found that aged garlic extract (2400 mg daily for one year) significantly improved cutaneous microcirculation in patients with cardiovascular disease risk, suggesting a potential benefit for poor wound healing due to impaired circulation. No studies reported mixed outcomes or adverse effects, but further research is needed to confirm these findings and establish broader applicability.",0.8,31518044,2019,Aged garlic extract preserves cutaneous microcirculation in patients with increased risk for cardiovascular diseases: A double-blinded placebo-controlled study.,randomized_controlled_trial,benefit,"The study shows a significant increase in microcirculation, indicating a benefit for patients at risk for cardiovascular events.",2400 mg daily 1 year (aged garlic extract),,,cardiovascular diseases,cardiovascular diseases; impaired wound healing,,,
Garlic,advised against application of fresh garlic onto skin and mucosa; allergic hypersensitivity to garlic; food intake reactions,Inflammation,,"Immune, Inflammation, & Infection",manual_pair,"One randomized double-blind clinical trial reported that garlic extract (400 mg twice daily for 8 weeks) significantly reduced inflammatory markers in peritoneal dialysis patients, suggesting a beneficial effect on systemic inflammation. No studies reported mixed results or harm, but the overall evidence is limited to a single trial, indicating a need for further research to confirm these findings.",0.7,30683061,2019,Evaluating the effect of garlic extract on serum inflammatory markers of peritoneal dialysis patients: a randomized double-blind clinical trial study.,randomized_controlled_trial,benefit,"The study shows significant reduction in inflammatory markers, indicating a beneficial effect of garlic extract.",400 mg twice a day 8 weeks (standardized garlic extract),,,inflammation,inflammation; peritoneal dialysis,,,
Ginger,Lower incidence of nausea and vomiting compared to control group.; allergies; blisters; brain or bowel metastasis; burns; constipation; dizziness; drowsiness; dysplasia of the hip; fainting during acupuncture treatment; fatigue; gestational diabetes; ginger allergy; gut obstruction; hypertension; minor malformations; prematurity; stillbirth; using anticoagulants,Nausea,,Gut Health,manual_pair,"Ginger supplementation has shown a beneficial effect on gastrointestinal symptoms, including abdominal pain, in a double-blind randomized placebo-controlled trial involving patients with relapsing-remitting multiple sclerosis. The study utilized a dose of 500 mg of ginger three times a day for 12 weeks. No adverse effects or mixed results were reported, but further research is needed to confirm these findings across broader populations.",0.9,37891539,2023,The effects of ginger supplementation on common gastrointestinal symptoms in patients with relapsing-remitting multiple sclerosis: a double-blind randomized placebo-controlled trial.,randomized_controlled_trial,benefit,"Ginger supplementation showed significant improvements in gastrointestinal symptoms in RRMS patients, indicating a beneficial effect.",500 mg 3 times a day 12 weeks (ginger),Multiple Sclerosis,,abdominal pain,abdominal pain; bloating; constipation; nausea; relapsing-remitting multiple sclerosis,,,
Ginger,Lower incidence of nausea and vomiting compared to control group.; allergies; blisters; brain or bowel metastasis; burns; constipation; dizziness; drowsiness; dysplasia of the hip; fainting during acupuncture treatment; fatigue; gestational diabetes; ginger allergy; gut obstruction; hypertension; minor malformations; prematurity; stillbirth; using anticoagulants,Allergic Rhinitis,,"Immune, Inflammation, & Infection",manual_pair,"The evidence for ginger as a treatment for allergic rhinitis is limited and mixed, with one randomized controlled trial comparing ginger extract (500 mg) to loratadine showing improvements in symptoms for both but no significant difference between the two. Overall, the findings do not support a clear benefit of ginger for this indication, and further research is needed to establish its efficacy.",0.7,32312261,2020,Ginger extract versus Loratadine in the treatment of allergic rhinitis: a randomized controlled trial.,randomized_controlled_trial,mixed_unclear,"Both ginger extract and loratadine improved symptoms, but no significant difference was found between the two treatments.",500 mg 3 and 6 weeks (extract),,,allergic rhinitis,allergic rhinitis,,,
Ginger,Lower incidence of nausea and vomiting compared to control group.; allergies; blisters; brain or bowel metastasis; burns; constipation; dizziness; drowsiness; dysplasia of the hip; fainting during acupuncture treatment; fatigue; gestational diabetes; ginger allergy; gut obstruction; hypertension; minor malformations; prematurity; stillbirth; using anticoagulants,Stress,,"Energy, Mood, & Mental Health",manual_pair,"There is limited evidence suggesting that ginger may reduce anxiety, as indicated by one study that reported a benefit in patients with burn injuries using a daily dose of 250 mg. However, the overall quality of evidence is low, and further research is needed to establish the efficacy and safety of ginger for anxiety.",0.5,35170885,2021,Comparison of the effect of prayer and ginger on the severity of pain and anxiety in inpatients with burn: Palliative care.,randomized_controlled_trial,benefit,"Ginger showed a reduction in pain levels, indicating a beneficial effect.",250 mg daily not specified (capsules),Burn Patients,Musculoskeletal & Pain,anxiety,anxiety; burns; pain,,,
Ginger,Lower incidence of nausea and vomiting compared to control group.; allergies; blisters; brain or bowel metastasis; burns; constipation; dizziness; drowsiness; dysplasia of the hip; fainting during acupuncture treatment; fatigue; gestational diabetes; ginger allergy; gut obstruction; hypertension; minor malformations; prematurity; stillbirth; using anticoagulants,Cold Extremities,,"Skin, Hair, & Nails",manual_pair,"One randomized controlled trial found that ginger footbaths significantly increased warmth perception in oncological patients compared to warm water alone, suggesting a potential benefit for cold feet. However, the evidence is limited to this single study, and further research is needed to confirm these findings and assess the consistency of the effect.",0.7,34814768,2021,Increasing Warmth in Oncological Patients: A Randomized Controlled Cross-Over Pilot Trial Examining the Efficacy of Mustard and Ginger Footbaths.,randomized_controlled_trial,benefit,"The study shows that ginger footbaths significantly increased warmth perception compared to warm water only, indicating a beneficial effect.",(footbath with ginger),,,healthy controls,healthy controls; oncological patients,,,
Ginger,Lower incidence of nausea and vomiting compared to control group.; allergies; blisters; brain or bowel metastasis; burns; constipation; dizziness; drowsiness; dysplasia of the hip; fainting during acupuncture treatment; fatigue; gestational diabetes; ginger allergy; gut obstruction; hypertension; minor malformations; prematurity; stillbirth; using anticoagulants,Multiple Sclerosis,,Cognitive & Neurological Function,manual_pair,"One double-blind randomized controlled trial reported that ginger supplementation (500 mg three times daily for 12 weeks) resulted in significant improvements in disability and quality of life metrics in patients with multiple sclerosis. However, the overall evidence is limited, with only one study demonstrating benefit and no reports of harm or mixed outcomes.",0.7,36974730,2023,"The effect of ginger (Zingiber officinale) supplementation on clinical, biochemical, and anthropometric parameters in patients with multiple sclerosis: a double-blind randomized controlled trial.",randomized_controlled_trial,benefit,"Ginger supplementation showed significant improvements in disability and quality of life metrics, indicating a beneficial effect.",500 mg 3 times daily 12 weeks (supplement),,,multiple sclerosis,multiple sclerosis; relapsing-remitting ms,,,
Ginger,Lower incidence of nausea and vomiting compared to control group.; allergies; blisters; brain or bowel metastasis; burns; constipation; dizziness; drowsiness; dysplasia of the hip; fainting during acupuncture treatment; fatigue; gestational diabetes; ginger allergy; gut obstruction; hypertension; minor malformations; prematurity; stillbirth; using anticoagulants,Dry Mouth,,Oral Health,manual_pair,"One randomized clinical trial found that ginger mouthwash (20 cc three times daily for 14 days) significantly reduced symptoms of xerostomia in patients with type 2 diabetes, indicating a beneficial effect. No studies reported mixed results or harm, but the evidence is limited to a single trial, necessitating caution in generalizing findings.",0.8,34162822,2021,"Comparison of the effect of ginger and aloe vera mouthwashes on xerostomia in patients with type 2 diabetes: A clinical trial, triple-blind.",randomized_controlled_trial,benefit,"The study found that ginger mouthwash significantly reduced symptoms of xerostomia, indicating a beneficial effect.",20 cc three times daily 14 consecutive days (mouthwash),Diabetes Type 2,,Type 2 Diabetes Mellitus,Type 2 Diabetes Mellitus; xerostomia,,,
Ginger,Lower incidence of nausea and vomiting compared to control group.; allergies; blisters; brain or bowel metastasis; burns; constipation; dizziness; drowsiness; dysplasia of the hip; fainting during acupuncture treatment; fatigue; gestational diabetes; ginger allergy; gut obstruction; hypertension; minor malformations; prematurity; stillbirth; using anticoagulants,Eye Fatigue,,Vision & Eye Health,manual_pair,"One randomized, double-blind, placebo-controlled study reported beneficial effects of ginger extract on eye fatigue after eight weeks of treatment. No adverse effects were noted, but the evidence is limited to a single study, indicating a need for further research to confirm these findings and establish consistent dosing guidelines.",0.7,39203851,2024,"Beneficial Effects of Ginger Extract on Eye Fatigue and Shoulder Stiffness: A Randomized, Double-Blind, and Placebo-Controlled Parallel Study.",randomized_controlled_trial,benefit,"Ginger consumption showed improvement in eye fatigue and shoulder stiffness, indicating a beneficial effect.",null null daily eight weeks (capsules),,,eye fatigue,eye fatigue; shoulder stiffness,,,
Ginger,Lower incidence of nausea and vomiting compared to control group.; allergies; blisters; brain or bowel metastasis; burns; constipation; dizziness; drowsiness; dysplasia of the hip; fainting during acupuncture treatment; fatigue; gestational diabetes; ginger allergy; gut obstruction; hypertension; minor malformations; prematurity; stillbirth; using anticoagulants,High Blood Glucose,,Metabolic Health,manual_pair,"One randomized double-blind placebo-controlled trial indicates that ginger supplementation may improve fasting blood sugar, insulin levels, and HOMA index in women with gestational diabetes mellitus, using a dose of 126 tablets daily for six weeks. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term effects and safety.",0.7,32306991,2020,Effect of ginger on the blood glucose level of women with gestational diabetes mellitus (GDM) with impaired glucose tolerance test (GTT): a randomized double-blind placebo-controlled trial.,randomized_controlled_trial,benefit,"The study shows significant improvement in fasting blood sugar, insulin levels, and HOMA index, indicating a benefit from ginger supplementation.",126 tablets daily six weeks (ginger tablet),Gestational Diabetes; Pregnant; Women,,gestational diabetes mellitus,gestational diabetes mellitus; impaired glucose tolerance,,,
Ginger,Lower incidence of nausea and vomiting compared to control group.; allergies; blisters; brain or bowel metastasis; burns; constipation; dizziness; drowsiness; dysplasia of the hip; fainting during acupuncture treatment; fatigue; gestational diabetes; ginger allergy; gut obstruction; hypertension; minor malformations; prematurity; stillbirth; using anticoagulants,High Blood Glucose,,Metabolic Health,manual_pair,"Two randomized controlled trials indicate that ginger supplementation may improve blood glucose levels in individuals with Type 2 Diabetes, with doses reported as 1000 mg twice daily and 1.2 g daily for 90 days. No adverse effects were noted in these studies, but the overall evidence is limited to a small number of trials, necessitating further research to confirm these findings.",0.8,37817641,2024,The Effects of Ginger (Zingiber Officinale Roscoe) on Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus: A Randomized Double-Blinded Placebo-Controlled Clinical Trial.,randomized_controlled_trial,benefit,"Ginger supplementation showed significant improvements in blood pressure, insulin levels, insulin resistance, and HDL-cholesterol, indicating a beneficial effect on the studied conditions.",1000 mg twice daily three months (ginger powder capsules),Diabetes Type 2; Fatty Liver Disease,Heart & Vascular Health; Weight & Body Composition,non-alcoholic fatty liver disease,Type 2 Diabetes Mellitus; non-alcoholic fatty liver disease,,,
Ginger,Lower incidence of nausea and vomiting compared to control group.; allergies; blisters; brain or bowel metastasis; burns; constipation; dizziness; drowsiness; dysplasia of the hip; fainting during acupuncture treatment; fatigue; gestational diabetes; ginger allergy; gut obstruction; hypertension; minor malformations; prematurity; stillbirth; using anticoagulants,High Blood Glucose,,Metabolic Health,manual_pair,"Two randomized controlled trials indicate that ginger supplementation may improve blood glucose levels in individuals with Type 2 Diabetes, with doses reported as 1000 mg twice daily and 1.2 g daily for 90 days. No adverse effects were noted in these studies, but the overall evidence is limited to a small number of trials, necessitating further research to confirm these findings.",0.8,33053078,2020,Effectiveness of ginger in reducing metabolic levels in people with diabetes: a randomized clinical trial.,randomized_controlled_trial,benefit,"The experimental group showed a greater reduction in blood glucose and total cholesterol, indicating a beneficial effect of ginger.",1.2 g daily 90 days (ginger),Diabetes Type 2,Heart & Vascular Health,Type 2 Diabetes Mellitus,Type 2 Diabetes Mellitus; non-alcoholic fatty liver disease,,,
Ginger,Lower incidence of nausea and vomiting compared to control group.; allergies; blisters; brain or bowel metastasis; burns; constipation; dizziness; drowsiness; dysplasia of the hip; fainting during acupuncture treatment; fatigue; gestational diabetes; ginger allergy; gut obstruction; hypertension; minor malformations; prematurity; stillbirth; using anticoagulants,COVID-19,,"Immune, Inflammation, & Infection",manual_pair,"The evidence for ginger in reducing inflammation in COVID-19 is limited, with only one randomized controlled trial reporting a benefit. In this study, ginger was administered at a dose of 500 mg three times daily for five days and showed equivalent anti-inflammatory effects compared to turmeric. Overall, the quality of evidence is low, and further research is needed to confirm these findings.",0.7,40841392,2025,A Triple-blind randomized controlled trial on the effects of turmeric versus ginger on inflammatory biomarkers in patients with COVID-19.,randomized_controlled_trial,benefit,"The study showed that ginger had equivalent anti-inflammatory effects as turmeric in reducing inflammatory markers in COVID-19 patients, indicating a benefit.",500 mg 3 times daily 5 days (tablet),,,covid-19,covid-19,,,
Ginger,Lower incidence of nausea and vomiting compared to control group.; allergies; blisters; brain or bowel metastasis; burns; constipation; dizziness; drowsiness; dysplasia of the hip; fainting during acupuncture treatment; fatigue; gestational diabetes; ginger allergy; gut obstruction; hypertension; minor malformations; prematurity; stillbirth; using anticoagulants,Atopic Dermatitis,,"Skin, Hair, & Nails",manual_pair,"One clinical trial reported that an oil-in-water emulsion containing ginger extract and synthetic cannabidiol significantly alleviated symptoms of atopic dermatitis over a five-day treatment period. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term safety and efficacy.",0.7,39193679,2024,An oil-in-water emulsion containing a combination of ginger extract and synthetic cannabidiol with potent in vitro anti-inflammatory effects alleviates symptoms of atopic dermatitis in a clinical trial.,randomized_controlled_trial,benefit,"The study demonstrated significant alleviation of symptoms in patients with atopic dermatitis, indicating a clear benefit from the treatment.",five days (BNO 3731),,,atopic dermatitis,atopic dermatitis; pruritus,,,
Ginger,Lower incidence of nausea and vomiting compared to control group.; allergies; blisters; brain or bowel metastasis; burns; constipation; dizziness; drowsiness; dysplasia of the hip; fainting during acupuncture treatment; fatigue; gestational diabetes; ginger allergy; gut obstruction; hypertension; minor malformations; prematurity; stillbirth; using anticoagulants,Joint Pain,,Musculoskeletal & Pain,manual_pair,"One randomized trial reported that ginger supplementation (125 mg daily for 58 days) had beneficial effects on pain perception, functional capacity, and inflammatory markers in individuals with mild to moderate joint pain. However, the overall evidence is limited, with only one study demonstrating a positive outcome and no reports of harm or adverse effects. Further research is needed to confirm these findings and establish consistency.",0.7,40732990,2025,Effects of Ginger Supplementation on Markers of Inflammation and Functional Capacity in Individuals with Mild to Moderate Joint Pain.,randomized_controlled_trial,benefit,"Ginger supplementation showed favorable effects on pain perception, functional capacity, and inflammatory markers, indicating a benefit for individuals with mild to moderate joint and muscle pain.",125 mg daily 58 days (standardized ginger extract),,"Immune, Inflammation, & Infection",inflammation,inflammation; joint pain; muscle pain,,,
Ginger,Lower incidence of nausea and vomiting compared to control group.; allergies; blisters; brain or bowel metastasis; burns; constipation; dizziness; drowsiness; dysplasia of the hip; fainting during acupuncture treatment; fatigue; gestational diabetes; ginger allergy; gut obstruction; hypertension; minor malformations; prematurity; stillbirth; using anticoagulants,Joint Pain,,Musculoskeletal & Pain,manual_pair,"Two randomized, double-blind, placebo-controlled trials report beneficial effects of ginger on knee pain, specifically in the context of osteoarthritis. One study used a ginger extract syrup at a dose of 30 ml twice daily, while the other utilized steamed ginger extract at a dose of 0.48 g daily, both for 12 weeks. No adverse effects were reported in these studies, but the overall evidence is limited and further research is needed to confirm these findings.",0.8,36453014,2022,"A randomized, double-blind placebo-controlled phase I clinical study on safety and efficacy of the G-Rup® syrup (a mixture of ginger extract and honey) in symptomatic treatment of knee osteoarthritis.",randomized_controlled_trial,benefit,"The study reports significant improvements in pain and physical functioning, indicating a beneficial outcome.",30 ml twice daily 12 weeks (syrup),Osteoarthritis,,knee osteoarthritis,knee osteoarthritis; mild knee osteoarthritis,,,
Ginger,Lower incidence of nausea and vomiting compared to control group.; allergies; blisters; brain or bowel metastasis; burns; constipation; dizziness; drowsiness; dysplasia of the hip; fainting during acupuncture treatment; fatigue; gestational diabetes; ginger allergy; gut obstruction; hypertension; minor malformations; prematurity; stillbirth; using anticoagulants,Joint Pain,,Musculoskeletal & Pain,manual_pair,"Two randomized, double-blind, placebo-controlled trials report beneficial effects of ginger on knee pain, specifically in the context of osteoarthritis. One study used a ginger extract syrup at a dose of 30 ml twice daily, while the other utilized steamed ginger extract at a dose of 0.48 g daily, both for 12 weeks. No adverse effects were reported in these studies, but the overall evidence is limited and further research is needed to confirm these findings.",0.8,39212491,2024,"Effectiveness and safety of steamed ginger extract on mild osteoarthritis: a randomized, double-blind, placebo-controlled clinical trial.",randomized_controlled_trial,benefit,The study showed significant improvement in joint pain and management of knee OA with no reported side effects.,0.48 g day-1 12 weeks (GGE03),Osteoarthritis,,mild knee osteoarthritis,knee osteoarthritis; mild knee osteoarthritis,,,
Ginger,Lower incidence of nausea and vomiting compared to control group.; allergies; blisters; brain or bowel metastasis; burns; constipation; dizziness; drowsiness; dysplasia of the hip; fainting during acupuncture treatment; fatigue; gestational diabetes; ginger allergy; gut obstruction; hypertension; minor malformations; prematurity; stillbirth; using anticoagulants,Nausea,,Gut Health,manual_pair,"One randomized controlled trial indicates that ginger (250 mg capsules, 4 capsules taken 2 hours before surgery) may significantly reduce the incidence and severity of postoperative nausea and vomiting. However, the overall evidence is limited, with only one study reporting a benefit and no evidence of harm or mixed outcomes. Further research is needed to confirm these findings and establish consistent dosing guidelines.",0.8,35304019,2022,The Effect of Ginger on Postoperative Nausea and Vomiting Among Patients Undergoing Upper and Lower Limb Surgery: A Randomized Controlled Trial.,randomized_controlled_trial,benefit,"The study shows that ginger significantly reduces the incidence and severity of postoperative nausea and vomiting, indicating a beneficial effect.",250 mg 4 capsules 2 hours before surgery (capsules),Postoperative,,postoperative nausea,postoperative nausea; postoperative vomiting,,,
Ginger,Lower incidence of nausea and vomiting compared to control group.; allergies; blisters; brain or bowel metastasis; burns; constipation; dizziness; drowsiness; dysplasia of the hip; fainting during acupuncture treatment; fatigue; gestational diabetes; ginger allergy; gut obstruction; hypertension; minor malformations; prematurity; stillbirth; using anticoagulants,Nausea,,Gut Health,manual_pair,"There is limited evidence suggesting that ginger-partitioned moxibustion may improve digestive tract reactions and quality of life in patients experiencing nausea and vomiting after chemotherapy, as indicated by one randomized controlled trial. However, the overall evidence is sparse, and further studies are needed to confirm these findings and assess consistency across different populations and dosing regimens.",0.7,33788482,2020,[Ginger-partitioned moxibustion in prevention of vomiting induced by chemotherapy in advanced malignant bone tumors: a randomized controlled trial].,randomized_controlled_trial,benefit,"The study shows that ginger-partitioned moxibustion significantly improves digestive tract reactions and quality of life, indicating a beneficial effect.",30 minutes once a day 5 days (ginger-partitioned moxibustion),Cancer; Chemotherapy,,advanced malignant bone tumors,advanced malignant bone tumors; vomiting due to chemotherapy,,,
Ginger,Lower incidence of nausea and vomiting compared to control group.; allergies; blisters; brain or bowel metastasis; burns; constipation; dizziness; drowsiness; dysplasia of the hip; fainting during acupuncture treatment; fatigue; gestational diabetes; ginger allergy; gut obstruction; hypertension; minor malformations; prematurity; stillbirth; using anticoagulants,Nausea,,Gut Health,manual_pair,"One randomized trial reported a beneficial effect of ginger oil (3 drops) in reducing postoperative nausea and vomiting following breast augmentation surgery. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess consistency across different surgical contexts.",0.7,37774171,2023,Using Ginger Oil to Treat Nausea and Vomiting Following Breast Augmentation Surgery.,randomized_controlled_trial,benefit,"The study demonstrated a significant reduction in postoperative nausea and vomiting (PONV) with ginger oil, indicating a beneficial effect.",3 drops (ginger oil),Postoperative,,postoperative nausea and vomiting,postoperative nausea and vomiting,,,
Ginger,Lower incidence of nausea and vomiting compared to control group.; allergies; blisters; brain or bowel metastasis; burns; constipation; dizziness; drowsiness; dysplasia of the hip; fainting during acupuncture treatment; fatigue; gestational diabetes; ginger allergy; gut obstruction; hypertension; minor malformations; prematurity; stillbirth; using anticoagulants,Nausea,,Gut Health,manual_pair,"The evidence on ginger for managing nausea and vomiting from chemotherapy is mixed, with three studies indicating benefits and two showing unclear outcomes. Doses reported include 84 mg of ginger root powder daily for five days and ginger-partitioned moxibustion applied once daily for three days. No studies reported significant harms associated with ginger use in this context.",0.8,39020488,2024,Effect of ginger-partitioned moxibustion combined with ringheaded thumb-tack needle stimulation on gastrointestinal reactions of malignant tumor patients undergoing chemotherapy.,randomized_controlled_trial,benefit,"The study shows that ginger-partitioned moxibustion effectively relieves nausea and vomiting in chemotherapy patients, indicating a benefit.",8 mg 3 times a day 3 d (ondansetron hydrochloride tablets); once a day 3 d (ginger-partitioned moxibustion combined with ringheaded thumb-tack needle stimulation),Cancer; Chemotherapy,,chemotherapy-induced nausea and vomiting,cervical cancer; chemotherapy-induced nausea; chemotherapy-induced nausea and vomiting; chemotherapy-induced vomiting; cinv; fatigue; gastrointestinal reactions in malignant tumor patients; lung cancer; malnutrition; nausea; vomiting,,,
Ginger,Lower incidence of nausea and vomiting compared to control group.; allergies; blisters; brain or bowel metastasis; burns; constipation; dizziness; drowsiness; dysplasia of the hip; fainting during acupuncture treatment; fatigue; gestational diabetes; ginger allergy; gut obstruction; hypertension; minor malformations; prematurity; stillbirth; using anticoagulants,Nausea,,Gut Health,manual_pair,"The evidence on ginger for managing nausea and vomiting from chemotherapy is mixed, with three studies indicating benefits and two showing unclear outcomes. Doses reported include 84 mg of ginger root powder daily for five days and ginger-partitioned moxibustion applied once daily for three days. No studies reported significant harms associated with ginger use in this context.",0.8,38461442,2024,Effect of ginger and P6 acupressure on chemotherapy-induced nausea and vomiting: a randomized controlled study.,randomized_controlled_trial,mixed_unclear,"Ginger showed significant improvement in delayed CINV but no significant effect on acute CINV, indicating mixed outcomes.",(ginger),Cancer; Chemotherapy,,chemotherapy-induced nausea and vomiting,cervical cancer; chemotherapy-induced nausea; chemotherapy-induced nausea and vomiting; chemotherapy-induced vomiting; cinv; fatigue; gastrointestinal reactions in malignant tumor patients; lung cancer; malnutrition; nausea; vomiting,,,
Ginger,Lower incidence of nausea and vomiting compared to control group.; allergies; blisters; brain or bowel metastasis; burns; constipation; dizziness; drowsiness; dysplasia of the hip; fainting during acupuncture treatment; fatigue; gestational diabetes; ginger allergy; gut obstruction; hypertension; minor malformations; prematurity; stillbirth; using anticoagulants,Nausea,,Gut Health,manual_pair,"The evidence on ginger for managing nausea and vomiting from chemotherapy is mixed, with three studies indicating benefits and two showing unclear outcomes. Doses reported include 84 mg of ginger root powder daily for five days and ginger-partitioned moxibustion applied once daily for three days. No studies reported significant harms associated with ginger use in this context.",0.8,37699474,2024,"Effect of a Standardized Ginger Root Powder Regimen on Chemotherapy-Induced Nausea and Vomiting: A Multicenter, Double-Blind, Placebo-Controlled Randomized Trial.",randomized_controlled_trial,benefit,"Ginger showed clinically relevant benefits in reducing nausea and vomiting related to chemotherapy, improving quality of life, and reducing fatigue and malnutrition.",84 mg daily 5 days (capsules),Cancer; Chemotherapy,,chemotherapy-induced nausea and vomiting,cervical cancer; chemotherapy-induced nausea; chemotherapy-induced nausea and vomiting; chemotherapy-induced vomiting; cinv; fatigue; gastrointestinal reactions in malignant tumor patients; lung cancer; malnutrition; nausea; vomiting,,,
Ginger,Lower incidence of nausea and vomiting compared to control group.; allergies; blisters; brain or bowel metastasis; burns; constipation; dizziness; drowsiness; dysplasia of the hip; fainting during acupuncture treatment; fatigue; gestational diabetes; ginger allergy; gut obstruction; hypertension; minor malformations; prematurity; stillbirth; using anticoagulants,Nausea,,Gut Health,manual_pair,"The evidence on ginger for managing nausea and vomiting from chemotherapy is mixed, with three studies indicating benefits and two showing unclear outcomes. Doses reported include 84 mg of ginger root powder daily for five days and ginger-partitioned moxibustion applied once daily for three days. No studies reported significant harms associated with ginger use in this context.",0.8,32705833,2020,[Ginger-partitioned moxibustion in the prevention of nausea and vomiting induced by chemotherapy in lung cancer：a randomized controlled trial].,randomized_controlled_trial,benefit,"The study shows a benefit in preventing nausea and vomiting, improving quality of life, and enhancing blood counts after chemotherapy.",20 minutes once daily 3 days (moxibustion with ginger),Cancer; Chemotherapy,,lung cancer,cervical cancer; chemotherapy-induced nausea; chemotherapy-induced nausea and vomiting; chemotherapy-induced vomiting; cinv; fatigue; gastrointestinal reactions in malignant tumor patients; lung cancer; malnutrition; nausea; vomiting,,,
Ginger,Lower incidence of nausea and vomiting compared to control group.; allergies; blisters; brain or bowel metastasis; burns; constipation; dizziness; drowsiness; dysplasia of the hip; fainting during acupuncture treatment; fatigue; gestational diabetes; ginger allergy; gut obstruction; hypertension; minor malformations; prematurity; stillbirth; using anticoagulants,Nausea,,Gut Health,manual_pair,"Ginger supplementation at a dose of 2 g per day has shown benefit in reducing acute nausea associated with chemotherapy, specifically in patients receiving carboplatin and paclitaxel, according to a randomized controlled trial. However, it did not demonstrate effectiveness for delayed nausea and vomiting, indicating that its benefits may be limited to specific phases of nausea. No adverse effects were reported in the study.",0.9,31834519,2020,Effects of ginger adjunct to the standard prophylaxis on reducing carboplatin and paclitaxel-induced nausea vomiting: a randomized controlled study.,randomized_controlled_trial,benefit,Ginger significantly reduced acute phase nausea but had no effect on delayed phase nausea and vomiting.,2 g per day,Cancer; Chemotherapy,,gynecologic cancer,gynecologic cancer; nausea; vomiting,,,
Ginger,Lower incidence of nausea and vomiting compared to control group.; allergies; blisters; brain or bowel metastasis; burns; constipation; dizziness; drowsiness; dysplasia of the hip; fainting during acupuncture treatment; fatigue; gestational diabetes; ginger allergy; gut obstruction; hypertension; minor malformations; prematurity; stillbirth; using anticoagulants,Oral Mucositis,,Oral Health,manual_pair,"One randomized trial suggests that a ginger-honey mouthwash may reduce the severity of oral mucositis in patients undergoing chemotherapy over a 7-day period, although it did not significantly affect pain intensity. Overall, the evidence is limited and only indicates a potential benefit without reporting any adverse effects or harm.",0.7,40134126,2025,Effect of honey-ginger mouthwash on oral mucositis in patients undergoing chemotherapy.,randomized_controlled_trial,benefit,"The study shows a beneficial effect of a 7-day ginger-honey mouthwash on reducing oral mucositis severity, but no significant effect on pain intensity.",7 days (ginger-honey mouthwash),Cancer,,oral mucositis,oral mucositis,,,
Ginger,Lower incidence of nausea and vomiting compared to control group.; allergies; blisters; brain or bowel metastasis; burns; constipation; dizziness; drowsiness; dysplasia of the hip; fainting during acupuncture treatment; fatigue; gestational diabetes; ginger allergy; gut obstruction; hypertension; minor malformations; prematurity; stillbirth; using anticoagulants,Nausea,,Gut Health,manual_pair,"One randomized trial reported that ginger (Zingiber officinale) at a dose of 1650 mg daily for 14 days improved gastric myoelectrical activity and provided symptom relief in patients with advanced cancer, suggesting a potential benefit for poor appetite. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term effects and safety.",0.7,31745695,2020,The effect of ginger (Zingiber officinale Roscoe) in patients with advanced cancer.,clinical_trial,benefit,"Ginger showed improvement in gastric myoelectrical activity and symptom relief, indicating a beneficial effect.",1650 mg daily 14 days (capsule),,,anorexia-cachexia syndrome,anorexia-cachexia syndrome; nausea; vomiting,,,
Ginger,Lower incidence of nausea and vomiting compared to control group.; allergies; blisters; brain or bowel metastasis; burns; constipation; dizziness; drowsiness; dysplasia of the hip; fainting during acupuncture treatment; fatigue; gestational diabetes; ginger allergy; gut obstruction; hypertension; minor malformations; prematurity; stillbirth; using anticoagulants,Nausea,,Gut Health,manual_pair,"One randomized controlled trial found that aromatherapy with ginger essential oil (0.01 ml) significantly reduced postoperative nausea severity and improved patient satisfaction. Overall, the evidence is limited, with only one study demonstrating a benefit and no reports of harm or no benefit. Further research is needed to confirm these findings and establish consistent dosing guidelines.",0.7,40154579,2025,"Effect of aromatherapy with peppermint, ginger, and lavender on postoperative nausea severity after oral surgery under general anaesthesia: A single-blind randomized controlled trial.",randomized_controlled_trial,benefit,"Aromatherapy with ginger significantly reduced postoperative nausea severity and improved patient satisfaction, indicating a beneficial outcome.",0.01 ml (essential oil),Postoperative,,postoperative nausea,postoperative nausea,,,
Glucosamine,Statistically significant rise of intraocular pressure in elderly patients; changes in glucose tolerance; fatigue; gastrointestinal tract side effects; headache; mild and transient adverse effects similar to placebo; no increased wound bleeding observed in patients treated with antiplatelet drugs; rash; risk of diarrhea; risk of dyspepsia,Joint Protection,,Healthy Aging & Prevention,manual_pair,"One randomized double-blind placebo-controlled study found that a glucosamine-containing supplement (2 g daily for 16 weeks) significantly decreased biomarkers for cartilage degradation, suggesting a beneficial effect on cartilage metabolism. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term effects and safety.",0.7,30132529,2018,Evaluation of the effect of the administration of a glucosamine‑containing supplement on biomarkers for cartilage metabolism in soccer players: A randomized double‑blind placebo‑controlled study.,randomized_controlled_trial,benefit,"The study found significant decreases in biomarkers for cartilage degradation, indicating a beneficial effect of glucosamine on cartilage metabolism.",2 g daily 16 weeks,,,cartilage metabolism,cartilage metabolism,,,
Glucosamine,Statistically significant rise of intraocular pressure in elderly patients; changes in glucose tolerance; fatigue; gastrointestinal tract side effects; headache; mild and transient adverse effects similar to placebo; no increased wound bleeding observed in patients treated with antiplatelet drugs; rash; risk of diarrhea; risk of dyspepsia,Bloating,,Gut Health,manual_pair,"There is limited evidence suggesting that glucosamine supplementation may have a beneficial effect on gut health, including a reduction in stomach bloating and potential alleviation of constipation, based on a single study that administered 3000 mg daily for three weeks. However, the overall evidence is weak and further research is needed to confirm these findings and assess long-term effects and safety.",0.6,34202877,2021,Impact of Glucosamine Supplementation on Gut Health.,randomized_controlled_trial,benefit,"The study showed significant benefits in gut health, particularly in reducing stomach bloating and trends towards alleviating constipation.",3000 mg daily three weeks (GLU hydrochloride),,,constipation,constipation; gastrointestinal function; hard stools; stomach bloating,,,
Glucosamine,Statistically significant rise of intraocular pressure in elderly patients; changes in glucose tolerance; fatigue; gastrointestinal tract side effects; headache; mild and transient adverse effects similar to placebo; no increased wound bleeding observed in patients treated with antiplatelet drugs; rash; risk of diarrhea; risk of dyspepsia,Temporomandibular Joint Syndrome,,Oral Health,manual_pair,"Two studies indicate that glucosamine may provide benefits for jaw pain, specifically in improving mouth opening and reducing inflammatory markers in temporomandibular joint disorders. Doses reported include 1500 mg daily when combined with chondroitin. However, the overall evidence remains limited and further research is needed to confirm these findings and assess long-term effects.",0.7,25662545,2015,"Effects of glucosamine-chondroitin combination on synovial fluid IL-1β, IL-6, TNF-α and PGE2 levels in internal derangements of temporomandibular joint.",randomized_controlled_trial,benefit,The study showed significant improvement in maximum mouth opening and reduction in inflammatory cytokines in the glucosamine group compared to control.,1500 mg daily 8 weeks (combination with chondroitin),,,internal derangements of temporomandibular joint,internal derangements of temporomandibular joint; joint tenderness; pain relief; temporomandibular joint osteoarthritis,,,
Glucosamine,Statistically significant rise of intraocular pressure in elderly patients; changes in glucose tolerance; fatigue; gastrointestinal tract side effects; headache; mild and transient adverse effects similar to placebo; no increased wound bleeding observed in patients treated with antiplatelet drugs; rash; risk of diarrhea; risk of dyspepsia,Temporomandibular Joint Syndrome,,Oral Health,manual_pair,"Two studies indicate that glucosamine may provide benefits for jaw pain, specifically in improving mouth opening and reducing inflammatory markers in temporomandibular joint disorders. Doses reported include 1500 mg daily when combined with chondroitin. However, the overall evidence remains limited and further research is needed to confirm these findings and assess long-term effects.",0.7,28862770,2018,Glucosamine oral administration as an adjunct to hyaluronic acid injection in treating temporomandibular joint osteoarthritis.,randomized_controlled_trial,benefit,The study shows that glucosamine provides additional long-term benefits in reducing pain and improving mouth opening compared to placebo.,(oral),,,temporomandibular joint osteoarthritis,internal derangements of temporomandibular joint; joint tenderness; pain relief; temporomandibular joint osteoarthritis,,,
Glucosamine,Statistically significant rise of intraocular pressure in elderly patients; changes in glucose tolerance; fatigue; gastrointestinal tract side effects; headache; mild and transient adverse effects similar to placebo; no increased wound bleeding observed in patients treated with antiplatelet drugs; rash; risk of diarrhea; risk of dyspepsia,Temporomandibular Joint Syndrome,,Musculoskeletal & Pain,manual_pair,"The evidence for glucosamine in treating jaw pain from temporomandibular joint osteoarthritis is low quality, with one double-blind randomized controlled trial reporting mixed results. While the study indicated that glucosamine may not have a meaningful short-term effect, it suggested potential long-term benefits in pain relief and function improvement at a dose of 1.44 g daily for three months. No adverse effects were reported, but overall findings are inconclusive.",0.6,29864430,2018,Oral Glucosamine Hydrochloride Combined With Hyaluronate Sodium Intra-Articular Injection for Temporomandibular Joint Osteoarthritis: A Double-Blind Randomized Controlled Trial.,randomized_controlled_trial,mixed_unclear,The study showed mixed results; glucosamine had no meaningful short-term effect but did relieve pain and improve function in the long-term.,1.44 g daily 3 months (oral glucosamine hydrochloride),,,temporomandibular joint osteoarthritis,temporomandibular joint osteoarthritis,,,
Glucosamine,Statistically significant rise of intraocular pressure in elderly patients; changes in glucose tolerance; fatigue; gastrointestinal tract side effects; headache; mild and transient adverse effects similar to placebo; no increased wound bleeding observed in patients treated with antiplatelet drugs; rash; risk of diarrhea; risk of dyspepsia,Osteoarthritis,,Musculoskeletal & Pain,manual_pair,"The evidence for glucosamine in treating joint pain from osteoarthritis includes three studies demonstrating benefits, particularly in reducing inflammation and improving pain and functional capacity, with doses reported around 1500 mg daily and 375 mg combined with chondroitin. However, one study indicated mixed outcomes potentially due to variability in plasma levels, suggesting that results may not be consistent across all patients. No studies reported harm associated with glucosamine use.",0.8,30648524,2020,"Differences in Serum Biomarkers Between Combined Glucosamine and Chondroitin Versus Celecoxib in a Randomized, Double-blind Trial in Osteoarthritis Patients.",randomized_controlled_trial,benefit,"The study shows a significant reduction in IL-6, indicating a beneficial effect of glucosamine in reducing inflammation.",1500 mg daily 6 months (hydrochloride),,,osteoarthritis,osteoarthritis; pain,,,
Glucosamine,Statistically significant rise of intraocular pressure in elderly patients; changes in glucose tolerance; fatigue; gastrointestinal tract side effects; headache; mild and transient adverse effects similar to placebo; no increased wound bleeding observed in patients treated with antiplatelet drugs; rash; risk of diarrhea; risk of dyspepsia,Osteoarthritis,,Musculoskeletal & Pain,manual_pair,"The evidence for glucosamine in treating joint pain from osteoarthritis includes three studies demonstrating benefits, particularly in reducing inflammation and improving pain and functional capacity, with doses reported around 1500 mg daily and 375 mg combined with chondroitin. However, one study indicated mixed outcomes potentially due to variability in plasma levels, suggesting that results may not be consistent across all patients. No studies reported harm associated with glucosamine use.",0.8,29701488,2019,"Effectiveness of a Dietary Supplement Containing Hydrolyzed Collagen, Chondroitin Sulfate, and Glucosamine in Pain Reduction and Functional Capacity in Osteoarthritis Patients.",clinical_trial,benefit,"The study shows significant reductions in pain and improvements in functional capacity, indicating a beneficial outcome.",6 months (dietary supplement),Osteoarthritis,,osteoarthritis,osteoarthritis; pain,,,
Glucosamine,Statistically significant rise of intraocular pressure in elderly patients; changes in glucose tolerance; fatigue; gastrointestinal tract side effects; headache; mild and transient adverse effects similar to placebo; no increased wound bleeding observed in patients treated with antiplatelet drugs; rash; risk of diarrhea; risk of dyspepsia,Osteoarthritis,,Musculoskeletal & Pain,manual_pair,"The evidence for glucosamine in treating joint pain from osteoarthritis includes three studies demonstrating benefits, particularly in reducing inflammation and improving pain and functional capacity, with doses reported around 1500 mg daily and 375 mg combined with chondroitin. However, one study indicated mixed outcomes potentially due to variability in plasma levels, suggesting that results may not be consistent across all patients. No studies reported harm associated with glucosamine use.",0.8,28657529,2017,Comparison of the efficacy and tolerability of chondroitin plus glucosamine and D-002 (beeswax alcohols) in subjects with osteoarthritis symptoms.,randomized_controlled_trial,benefit,"The study shows significant reductions in OA symptoms with glucosamine, indicating a beneficial effect.",375 mg once daily 12 weeks (combined with chondroitin sulfate),Osteoarthritis,,osteoarthritis,osteoarthritis; pain,,,
Glucosamine,Statistically significant rise of intraocular pressure in elderly patients; changes in glucose tolerance; fatigue; gastrointestinal tract side effects; headache; mild and transient adverse effects similar to placebo; no increased wound bleeding observed in patients treated with antiplatelet drugs; rash; risk of diarrhea; risk of dyspepsia,Joint Protection,,Healthy Aging & Prevention,manual_pair,"One randomized trial found that glucosamine sulfate at a dose of 1500 mg once daily for 2.5 years significantly decreased the risk of developing knee osteoarthritis in overweight females, indicating a beneficial outcome. No studies reported mixed results, harm, or no benefit, suggesting a positive effect; however, further research is needed to confirm these findings and assess long-term safety.",0.8,26806185,2016,The role of diet and exercise and of glucosamine sulfate in the prevention of knee osteoarthritis: Further results from the PRevention of knee Osteoarthritis in Overweight Females (PROOF) study.,randomized_controlled_trial,benefit,"Glucosamine sulfate significantly decreased the risk of developing knee OA, indicating a beneficial outcome.",1500 mg once daily 2.5 years (oral crystalline glucosamine sulfate),Overweight; Women,,knee osteoarthritis,knee osteoarthritis,,,
Glucosamine,Statistically significant rise of intraocular pressure in elderly patients; changes in glucose tolerance; fatigue; gastrointestinal tract side effects; headache; mild and transient adverse effects similar to placebo; no increased wound bleeding observed in patients treated with antiplatelet drugs; rash; risk of diarrhea; risk of dyspepsia,Joint Pain,,Musculoskeletal & Pain,manual_pair,"The evidence from randomized trials indicates that glucosamine is generally effective in improving knee pain and function in patients with knee osteoarthritis, with benefits reported in multiple studies. Typical doses reported include glucosamine sulfate and glucosamine hydrochloride, often ranging from 1.2 g to 1.5 g daily. However, one study presented mixed outcomes regarding overall joint function improvement, suggesting variability in effectiveness across different formulations and combinations.",0.9,40501230,2025,Comparative study of the efficacy of glucosamine sulfate capsules and Huoxue Xiaozhong prescription in the treatment of knee osteoarthritis and the recovery of knee joint function.,randomized_controlled_trial,mixed_unclear,The study shows mixed outcomes; glucosamine sulfate was effective in pain relief but less effective in overall joint function improvement compared to traditional Chinese medicine.,(glucosamine sulfate capsules),Osteoarthritis,,knee osteoarthritis,knee osteoarthritis; knee pain; knee stiffness; low back pain; musculoskeletal pain; osteoarthritis,,,
Glucosamine,Statistically significant rise of intraocular pressure in elderly patients; changes in glucose tolerance; fatigue; gastrointestinal tract side effects; headache; mild and transient adverse effects similar to placebo; no increased wound bleeding observed in patients treated with antiplatelet drugs; rash; risk of diarrhea; risk of dyspepsia,Joint Pain,,Musculoskeletal & Pain,manual_pair,"The evidence from randomized trials indicates that glucosamine is generally effective in improving knee pain and function in patients with knee osteoarthritis, with benefits reported in multiple studies. Typical doses reported include glucosamine sulfate and glucosamine hydrochloride, often ranging from 1.2 g to 1.5 g daily. However, one study presented mixed outcomes regarding overall joint function improvement, suggesting variability in effectiveness across different formulations and combinations.",0.9,34602400,2021,Effect of celecoxib combined with glucosamine hydrochloride in promoting the functional recovery and decreasing the inflammatory factor levels in patients with knee osteoarthritis.,randomized_controlled_trial,benefit,"The study shows that the combination of celecoxib and glucosamine hydrochloride is effective in improving functional recovery and reducing inflammatory factors in knee osteoarthritis patients, indicating a beneficial outcome.",(glucosamine hydrochloride),Osteoarthritis,,knee osteoarthritis,knee osteoarthritis; knee pain; knee stiffness; low back pain; musculoskeletal pain; osteoarthritis,,,
Glucosamine,Statistically significant rise of intraocular pressure in elderly patients; changes in glucose tolerance; fatigue; gastrointestinal tract side effects; headache; mild and transient adverse effects similar to placebo; no increased wound bleeding observed in patients treated with antiplatelet drugs; rash; risk of diarrhea; risk of dyspepsia,Joint Pain,,Musculoskeletal & Pain,manual_pair,"The evidence from randomized trials indicates that glucosamine is generally effective in improving knee pain and function in patients with knee osteoarthritis, with benefits reported in multiple studies. Typical doses reported include glucosamine sulfate and glucosamine hydrochloride, often ranging from 1.2 g to 1.5 g daily. However, one study presented mixed outcomes regarding overall joint function improvement, suggesting variability in effectiveness across different formulations and combinations.",0.9,30657100,2018,"Multicenter, randomized, double-blind clinical trial to evaluate efficacy and safety of combined glucosamine sulfate and chondroitin sulfate capsules for treating knee osteoarthritis.",randomized_controlled_trial,benefit,The study demonstrated the efficacy of the glucosamine sulfate combination in treating knee osteoarthritis with a good safety profile.,12 weeks (capsules),Osteoarthritis,,knee osteoarthritis,knee osteoarthritis; knee pain; knee stiffness; low back pain; musculoskeletal pain; osteoarthritis,,,
Glucosamine,Statistically significant rise of intraocular pressure in elderly patients; changes in glucose tolerance; fatigue; gastrointestinal tract side effects; headache; mild and transient adverse effects similar to placebo; no increased wound bleeding observed in patients treated with antiplatelet drugs; rash; risk of diarrhea; risk of dyspepsia,Joint Pain,,Musculoskeletal & Pain,manual_pair,"The evidence from randomized trials indicates that glucosamine is generally effective in improving knee pain and function in patients with knee osteoarthritis, with benefits reported in multiple studies. Typical doses reported include glucosamine sulfate and glucosamine hydrochloride, often ranging from 1.2 g to 1.5 g daily. However, one study presented mixed outcomes regarding overall joint function improvement, suggesting variability in effectiveness across different formulations and combinations.",0.9,27050908,2016,"Mud-bath therapy and oral glucosamine sulfate in patients with knee osteoarthritis: a randomized, controlled, crossover study.",randomized_controlled_trial,benefit,"The study shows significant improvement in pain, function, and quality of life in knee OA patients, indicating a benefit from glucosamine sulfate.",3 months (oral glucosamine sulfate),Osteoarthritis,,knee osteoarthritis,knee osteoarthritis; knee pain; knee stiffness; low back pain; musculoskeletal pain; osteoarthritis,,,
Glucosamine,Statistically significant rise of intraocular pressure in elderly patients; changes in glucose tolerance; fatigue; gastrointestinal tract side effects; headache; mild and transient adverse effects similar to placebo; no increased wound bleeding observed in patients treated with antiplatelet drugs; rash; risk of diarrhea; risk of dyspepsia,Joint Pain,,Musculoskeletal & Pain,manual_pair,"The evidence from randomized trials indicates that glucosamine is generally effective in improving knee pain and function in patients with knee osteoarthritis, with benefits reported in multiple studies. Typical doses reported include glucosamine sulfate and glucosamine hydrochloride, often ranging from 1.2 g to 1.5 g daily. However, one study presented mixed outcomes regarding overall joint function improvement, suggesting variability in effectiveness across different formulations and combinations.",0.9,31257264,2019,"Milk-Fat Globule Membrane Plus Glucosamine Improves Joint Function and Physical Performance: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study.",randomized_controlled_trial,benefit,"The study reports significant improvements in joint function and physical performance, indicating a beneficial effect of glucosamine.",1.5 g daily 8 weeks (tablets),,,knee pain,knee osteoarthritis; knee pain; knee stiffness; low back pain; musculoskeletal pain; osteoarthritis,,,
Glucosamine,Statistically significant rise of intraocular pressure in elderly patients; changes in glucose tolerance; fatigue; gastrointestinal tract side effects; headache; mild and transient adverse effects similar to placebo; no increased wound bleeding observed in patients treated with antiplatelet drugs; rash; risk of diarrhea; risk of dyspepsia,Joint Pain,,Musculoskeletal & Pain,manual_pair,"The evidence from randomized trials indicates that glucosamine is generally effective in improving knee pain and function in patients with knee osteoarthritis, with benefits reported in multiple studies. Typical doses reported include glucosamine sulfate and glucosamine hydrochloride, often ranging from 1.2 g to 1.5 g daily. However, one study presented mixed outcomes regarding overall joint function improvement, suggesting variability in effectiveness across different formulations and combinations.",0.9,30498336,2018,Effectiveness of Cucumis sativus extract versus glucosamine-chondroitin in the management of moderate osteoarthritis: a randomized controlled trial.,randomized_controlled_trial,benefit,"The study shows a greater reduction in pain scores for the Cucumis sativus extract compared to glucosamine-chondroitin, indicating a benefit.",1350 mg twice daily 180 days (oral),Osteoarthritis,,knee pain,knee osteoarthritis; knee pain; knee stiffness; low back pain; musculoskeletal pain; osteoarthritis,,,
Glucosamine,Statistically significant rise of intraocular pressure in elderly patients; changes in glucose tolerance; fatigue; gastrointestinal tract side effects; headache; mild and transient adverse effects similar to placebo; no increased wound bleeding observed in patients treated with antiplatelet drugs; rash; risk of diarrhea; risk of dyspepsia,Joint Pain,,Musculoskeletal & Pain,manual_pair,"The evidence from randomized trials indicates that glucosamine is generally effective in improving knee pain and function in patients with knee osteoarthritis, with benefits reported in multiple studies. Typical doses reported include glucosamine sulfate and glucosamine hydrochloride, often ranging from 1.2 g to 1.5 g daily. However, one study presented mixed outcomes regarding overall joint function improvement, suggesting variability in effectiveness across different formulations and combinations.",0.9,26604721,2015,"Glucosamine-containing supplement improves locomotor functions in subjects with knee pain: a randomized, double-blind, placebo-controlled study.",randomized_controlled_trial,benefit,"The study showed significant improvements in knee-extensor strength and walking speed in the glucosamine group compared to placebo, indicating a benefit.",1200 mg daily 16 weeks (glucosamine hydrochloride),,,knee pain,knee osteoarthritis; knee pain; knee stiffness; low back pain; musculoskeletal pain; osteoarthritis,,,
Glucosamine,Statistically significant rise of intraocular pressure in elderly patients; changes in glucose tolerance; fatigue; gastrointestinal tract side effects; headache; mild and transient adverse effects similar to placebo; no increased wound bleeding observed in patients treated with antiplatelet drugs; rash; risk of diarrhea; risk of dyspepsia,Joint Pain,,Musculoskeletal & Pain,manual_pair,"The evidence from randomized trials indicates that glucosamine is generally effective in improving knee pain and function in patients with knee osteoarthritis, with benefits reported in multiple studies. Typical doses reported include glucosamine sulfate and glucosamine hydrochloride, often ranging from 1.2 g to 1.5 g daily. However, one study presented mixed outcomes regarding overall joint function improvement, suggesting variability in effectiveness across different formulations and combinations.",0.9,26178634,2016,"Effects of N-acetyl glucosamine and chondroitin sulfate supplementation on knee pain and self-reported knee function in middle-aged and older Japanese adults: a randomized, double-blind, placebo-controlled trial.",randomized_controlled_trial,benefit,"The study showed a significant improvement in knee function and household physical activity, indicating a benefit from the supplementation.",100 mg daily 24 weeks (N-acetyl glucosamine),,,knee pain,knee osteoarthritis; knee pain; knee stiffness; low back pain; musculoskeletal pain; osteoarthritis,,,
Glucosamine,Statistically significant rise of intraocular pressure in elderly patients; changes in glucose tolerance; fatigue; gastrointestinal tract side effects; headache; mild and transient adverse effects similar to placebo; no increased wound bleeding observed in patients treated with antiplatelet drugs; rash; risk of diarrhea; risk of dyspepsia,Joint Pain,,Musculoskeletal & Pain,manual_pair,"The clinical evidence for glucosamine in treating knee pain from arthritis is limited and mixed, with one randomized trial indicating unclear outcomes when compared to other treatments. The study reported a dose of 1500 mg of glucosamine sulfate daily for 60 days, but overall, no definitive benefits were established. No adverse effects were noted in the available evidence.",0.7,26684635,2016,Methylsulfonylmethane and boswellic acids versus glucosamine sulfate in the treatment of knee arthritis: Randomized trial.,randomized_controlled_trial,mixed_unclear,"The study shows improvements in both treatment groups, but the results favor the experimental group, indicating mixed outcomes.",1500 mg daily 60 days (sulfate),Osteoarthritis,,knee arthritis,knee arthritis; osteoarthritis,,,
Glucosamine,Statistically significant rise of intraocular pressure in elderly patients; changes in glucose tolerance; fatigue; gastrointestinal tract side effects; headache; mild and transient adverse effects similar to placebo; no increased wound bleeding observed in patients treated with antiplatelet drugs; rash; risk of diarrhea; risk of dyspepsia,Joint Pain,,Musculoskeletal & Pain,manual_pair,"The evidence for glucosamine in treating knee pain from osteoarthritis is predominantly positive, with five randomized controlled trials reporting benefits, particularly at doses of 1500 mg. However, two studies presented mixed outcomes, indicating that while glucosamine may be effective, results can vary depending on the formulation and comparison treatments used. No significant adverse effects were reported in the reviewed studies.",0.85,34212917,2021,The synergic use of the High Power Laser Therapy and Glucosamine sulfate in Knee osteoarthritis: A Randomized Controlled Trial.,randomized_controlled_trial,benefit,The study shows significant long-term benefits of glucosamine sulfate combined with HPLT in treating knee osteoarthritis.,1500 mg (GS - Dona®),Osteoarthritis,,knee osteoarthritis,"knee osteoarthritis; musculoskeletal pain; osteoarthritis of the knee joint; osteoarthritis, knee",,,
Glucosamine,Statistically significant rise of intraocular pressure in elderly patients; changes in glucose tolerance; fatigue; gastrointestinal tract side effects; headache; mild and transient adverse effects similar to placebo; no increased wound bleeding observed in patients treated with antiplatelet drugs; rash; risk of diarrhea; risk of dyspepsia,Joint Pain,,Musculoskeletal & Pain,manual_pair,"The evidence for glucosamine in treating knee pain from osteoarthritis is predominantly positive, with five randomized controlled trials reporting benefits, particularly at doses of 1500 mg. However, two studies presented mixed outcomes, indicating that while glucosamine may be effective, results can vary depending on the formulation and comparison treatments used. No significant adverse effects were reported in the reviewed studies.",0.85,33468249,2021,"Treatment of knee osteoarthritis with a new formulation of a fixed-dose combination of glucosamine sulfate and bovine chondroitin: a multicenter, randomized, single-blind, non-inferiority clinical trial.",randomized_controlled_trial,benefit,"The study demonstrated non-inferiority of glucosamine sulfate combined with chondroitin sulfate in improving knee osteoarthritis symptoms, indicating a benefit.",1500 mg 24 weeks (fixed-dose combination),Osteoarthritis,,knee osteoarthritis,"knee osteoarthritis; musculoskeletal pain; osteoarthritis of the knee joint; osteoarthritis, knee",,,
Glucosamine,Statistically significant rise of intraocular pressure in elderly patients; changes in glucose tolerance; fatigue; gastrointestinal tract side effects; headache; mild and transient adverse effects similar to placebo; no increased wound bleeding observed in patients treated with antiplatelet drugs; rash; risk of diarrhea; risk of dyspepsia,Joint Pain,,Musculoskeletal & Pain,manual_pair,"The evidence for glucosamine in treating knee pain from osteoarthritis is predominantly positive, with five randomized controlled trials reporting benefits, particularly at doses of 1500 mg. However, two studies presented mixed outcomes, indicating that while glucosamine may be effective, results can vary depending on the formulation and comparison treatments used. No significant adverse effects were reported in the reviewed studies.",0.85,28790224,2017,Comparison of Glucosamine-Chondroitin Sulfate with and without Methylsulfonylmethane in Grade I-II Knee Osteoarthritis: A Double Blind Randomized Controlled Trial.,randomized_controlled_trial,benefit,The study found significant clinical benefits for the combination treatment involving glucosamine.,1500 mg once daily 3 months (glucosamine-chondroitin sulfate),Osteoarthritis,,knee osteoarthritis,"knee osteoarthritis; musculoskeletal pain; osteoarthritis of the knee joint; osteoarthritis, knee",,,
Glucosamine,Statistically significant rise of intraocular pressure in elderly patients; changes in glucose tolerance; fatigue; gastrointestinal tract side effects; headache; mild and transient adverse effects similar to placebo; no increased wound bleeding observed in patients treated with antiplatelet drugs; rash; risk of diarrhea; risk of dyspepsia,Joint Pain,,Musculoskeletal & Pain,manual_pair,"The evidence for glucosamine in treating knee pain from osteoarthritis is predominantly positive, with five randomized controlled trials reporting benefits, particularly at doses of 1500 mg. However, two studies presented mixed outcomes, indicating that while glucosamine may be effective, results can vary depending on the formulation and comparison treatments used. No significant adverse effects were reported in the reviewed studies.",0.85,26937646,2016,"The efficacy and safety of a combination of glucosamine hydrochloride, chondroitin sulfate and bio-curcumin with exercise in the treatment of knee osteoarthritis: a randomized, double-blind, placebo-controlled study.",randomized_controlled_trial,benefit,"The study showed significant improvements in pain and function in knee OA patients, indicating a benefit from the treatment.",2 tablets daily 8 weeks (CartiJoint Forte),Osteoarthritis,,knee osteoarthritis,"knee osteoarthritis; musculoskeletal pain; osteoarthritis of the knee joint; osteoarthritis, knee",,,
Glucosamine,Statistically significant rise of intraocular pressure in elderly patients; changes in glucose tolerance; fatigue; gastrointestinal tract side effects; headache; mild and transient adverse effects similar to placebo; no increased wound bleeding observed in patients treated with antiplatelet drugs; rash; risk of diarrhea; risk of dyspepsia,Joint Pain,,Musculoskeletal & Pain,manual_pair,"The evidence for glucosamine in treating knee pain from osteoarthritis is predominantly positive, with five randomized controlled trials reporting benefits, particularly at doses of 1500 mg. However, two studies presented mixed outcomes, indicating that while glucosamine may be effective, results can vary depending on the formulation and comparison treatments used. No significant adverse effects were reported in the reviewed studies.",0.85,25589511,2016,"Combined chondroitin sulfate and glucosamine for painful knee osteoarthritis: a multicentre, randomised, double-blind, non-inferiority trial versus celecoxib.",randomized_controlled_trial,benefit,The study demonstrated comparable efficacy of glucosamine combined with chondroitin sulfate to celecoxib in reducing pain and other symptoms in knee osteoarthritis.,500 mg three times a day 6 months (hydrochloride),Osteoarthritis,,knee osteoarthritis,"knee osteoarthritis; musculoskeletal pain; osteoarthritis of the knee joint; osteoarthritis, knee",,,
Glucosamine,Statistically significant rise of intraocular pressure in elderly patients; changes in glucose tolerance; fatigue; gastrointestinal tract side effects; headache; mild and transient adverse effects similar to placebo; no increased wound bleeding observed in patients treated with antiplatelet drugs; rash; risk of diarrhea; risk of dyspepsia,Joint Pain,,Musculoskeletal & Pain,manual_pair,"The evidence for glucosamine in treating knee pain from osteoarthritis is predominantly positive, with five randomized controlled trials reporting benefits, particularly at doses of 1500 mg. However, two studies presented mixed outcomes, indicating that while glucosamine may be effective, results can vary depending on the formulation and comparison treatments used. No significant adverse effects were reported in the reviewed studies.",0.85,38785054,2023,"[Comparative efficacy of a combination of undenatured type II collagen, Boswellic acids, methylsulfonylmethane, vitamins C and D3 and a combination of chondroitin sulfate and glucosamine hydrochloride in the treatment of primary osteoarthritis of the knee joint].",randomized_controlled_trial,mixed_unclear,"The study showed improvements in WOMAC index and pain, but no significant intergroup differences, indicating mixed outcomes.",1 capsule per day 6 months (Artneo),Osteoarthritis,,osteoarthritis of the knee joint,"knee osteoarthritis; musculoskeletal pain; osteoarthritis of the knee joint; osteoarthritis, knee",,,
Glucosamine,Statistically significant rise of intraocular pressure in elderly patients; changes in glucose tolerance; fatigue; gastrointestinal tract side effects; headache; mild and transient adverse effects similar to placebo; no increased wound bleeding observed in patients treated with antiplatelet drugs; rash; risk of diarrhea; risk of dyspepsia,Neck Pain,,Musculoskeletal & Pain,manual_pair,"One randomized trial reported a benefit of glucosamine hydrochloride in treating cervical spondylosis, showing significant treatment efficacy and patient satisfaction compared to a reference group. However, the overall evidence is limited, with only one study available, and no adverse effects were noted. Further research is needed to confirm these findings and establish consistent dosing guidelines.",0.7,30203748,2018,Clinical efficacy of glucosamine hydrochloride tablets in the treatment of cervical spondylosis.,randomized_controlled_trial,benefit,The study shows significant advantages in treatment efficacy and patient satisfaction with glucosamine compared to the reference group.,(tablets),Cervical Spondylosis,,cervical spondylosis,cervical spondylosis,,,
Glucosamine,Statistically significant rise of intraocular pressure in elderly patients; changes in glucose tolerance; fatigue; gastrointestinal tract side effects; headache; mild and transient adverse effects similar to placebo; no increased wound bleeding observed in patients treated with antiplatelet drugs; rash; risk of diarrhea; risk of dyspepsia,Joint Pain,,Musculoskeletal & Pain,manual_pair,"The clinical evidence for glucosamine in the treatment of osteoarthritis is mixed and unclear, with two studies reporting variable outcomes. One study noted no significant differences in pharmacokinetics, while another suggested some pain reduction without statistical significance. No consistent dosing information was provided across studies, and no evidence of harm was reported.",0.7,32118508,2020,Phonophoretic application of a glucosamine and chondroitin nanoemulsion for treatment of knee chondropathies.,randomized_controlled_trial,mixed_unclear,"The study showed some pain reduction and recovery in patients, but no statistical significance was found.",(nanoemulsion),Chondropathy,,osteoarthritis,osteoarthritis,,,
Glucosamine,Statistically significant rise of intraocular pressure in elderly patients; changes in glucose tolerance; fatigue; gastrointestinal tract side effects; headache; mild and transient adverse effects similar to placebo; no increased wound bleeding observed in patients treated with antiplatelet drugs; rash; risk of diarrhea; risk of dyspepsia,Endothelial Function,,Heart & Vascular Health,manual_pair,"There is limited evidence suggesting that glucosamine may improve vascular endothelial function, as indicated by one study that reported a benefit with a daily dose of 3000 mg for four weeks. However, due to the low quantity of studies and lack of corroborating evidence, the overall confidence in glucosamine's effectiveness for poor vascular health remains low.",0.2,29151484,2017,Oral Administration of Glucosamine Improves Vascular Endothelial Function by Modulating Intracellular Redox State.,clinical_trial,benefit,"Glucosamine administration improved vascular endothelial function and intracellular redox state, indicating a beneficial effect.",3000 mg daily 4 weeks,,"Immune, Inflammation, & Infection",atherosclerosis,atherosclerosis; cardiovascular mortality; vascular endothelial function,,,
Glucosamine,Statistically significant rise of intraocular pressure in elderly patients; changes in glucose tolerance; fatigue; gastrointestinal tract side effects; headache; mild and transient adverse effects similar to placebo; no increased wound bleeding observed in patients treated with antiplatelet drugs; rash; risk of diarrhea; risk of dyspepsia,Skin Aging Prevention,,"Skin, Hair, & Nails",manual_pair,"The evidence for glucosamine in addressing skin ageing is limited, with a single clinical trial reporting a positive effect on skin markers associated with ageing at a dose of 250 mg once daily for 8 weeks. Overall, the quality of evidence is low, and further research is needed to confirm these findings and assess long-term safety and efficacy.",0.7,28214837,2017,Efficacy of Glucosamine Sulphate in Skin Ageing: Results from an ex vivo Anti-Ageing Model and a Clinical Trial.,clinical_trial,benefit,The study shows a positive effect of glucosamine on skin markers associated with ageing.,250 mg once daily 8 weeks,,,skin ageing,skin ageing,,,
Glucosamine,Statistically significant rise of intraocular pressure in elderly patients; changes in glucose tolerance; fatigue; gastrointestinal tract side effects; headache; mild and transient adverse effects similar to placebo; no increased wound bleeding observed in patients treated with antiplatelet drugs; rash; risk of diarrhea; risk of dyspepsia,Inflammation,,"Immune, Inflammation, & Infection",manual_pair,"One randomized trial reported a benefit of glucosamine (1500 mg daily for 28 days) in reducing serum CRP concentrations, suggesting a potential effect on systemic inflammation. However, the overall evidence is limited, with only one study demonstrating this outcome and no additional studies to corroborate the findings. No adverse effects were reported in the available evidence.",0.7,25719429,2015,Randomized trial of glucosamine and chondroitin supplementation on inflammation and oxidative stress biomarkers and plasma proteomics profiles in healthy humans.,randomized_controlled_trial,benefit,"The study found a significant reduction in serum CRP concentrations, indicating a benefit in reducing systemic inflammation.",1500 mg daily 28 days (hydrochloride),Overweight,,inflammation,inflammation; oxidative stress,,,
Glycine,39.8% subjects had treatment-related adverse events; Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis reported in one participant; dizziness; drowsiness; fatigue; higher rate of adverse effects in ferrous glycine sulfate group; insomnia; mostly central nervous system related; reversible visual adverse effects; somnolence; transient visual events; worsening schizophrenia,Cystic Fibrosis,,Respiratory Health,manual_pair,"One pilot randomized trial reported a beneficial effect of oral glycine (0.5 g/kg daily for 8 weeks) on clinical, spirometric, and inflammatory outcomes in individuals with cystic fibrosis. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term safety and efficacy.",0.7,29246256,2017,"Effect of oral glycine on the clinical, spirometric and inflammatory status in subjects with cystic fibrosis: a pilot randomized trial.",randomized_controlled_trial,benefit,"The study showed improvement in clinical, spirometric, and inflammatory outcomes after glycine intake, indicating a beneficial effect.",0.5 g/kg daily 8 weeks (oral),,,cystic fibrosis,cystic fibrosis,,,
Glycine,39.8% subjects had treatment-related adverse events; Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis reported in one participant; dizziness; drowsiness; fatigue; higher rate of adverse effects in ferrous glycine sulfate group; insomnia; mostly central nervous system related; reversible visual adverse effects; somnolence; transient visual events; worsening schizophrenia,Schizophrenia,,"Energy, Mood, & Mental Health",manual_pair,"One randomized trial reported a benefit of glycine on working memory accuracy in healthy and schizophrenia subjects, with doses ranging from 10 mg to 60 mg taken twice a day. However, the overall evidence is limited, and further studies are needed to confirm these findings and assess long-term effects and safety.",0.7,29499855,2018,"Dose-Related Target Occupancy and Effects on Circuitry, Behavior, and Neuroplasticity of the Glycine Transporter-1 Inhibitor PF-03463275 in Healthy and Schizophrenia Subjects.",randomized_controlled_trial,benefit,"The study shows improvement in working memory accuracy, indicating a benefit from the intervention.",10 mg twice a day; 20 mg twice a day; 40 mg twice a day; 60 mg twice a day,,,cognitive impairments associated with schizophrenia,cognitive impairments associated with schizophrenia,,,
Glycine,39.8% subjects had treatment-related adverse events; Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis reported in one participant; dizziness; drowsiness; fatigue; higher rate of adverse effects in ferrous glycine sulfate group; insomnia; mostly central nervous system related; reversible visual adverse effects; somnolence; transient visual events; worsening schizophrenia,Parkinson's Disease Neuropsychiatric Symptoms,,"Energy, Mood, & Mental Health",manual_pair,"The evidence for glycine in the treatment of depression is limited but suggests potential benefits, with two studies reporting positive outcomes. One study indicated significant improvement in neuropsychiatric symptoms and depression in patients with Parkinson's disease, while another trial showed a reduction in depressive symptoms with GLYX-13, a glycine site partial agonist, at doses ranging from 1 to 30 mg/kg. Overall, the quality of evidence is low, and further research is needed to establish efficacy and safety.",0.7,24612097,2014,Activation of N-methyl-D-aspartate receptor glycine site temporally ameliorates neuropsychiatric symptoms of Parkinson's disease with dementia.,randomized_controlled_trial,benefit,"The study shows significant improvement in neuropsychiatric symptoms and depression in patients treated with sarcosine, indicating a beneficial effect.",8 weeks,Parkinson's Disease,,depression,depression; major depressive disorder; neuropsychiatric symptoms; parkinson's disease with dementia,,,
Glycine,39.8% subjects had treatment-related adverse events; Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis reported in one participant; dizziness; drowsiness; fatigue; higher rate of adverse effects in ferrous glycine sulfate group; insomnia; mostly central nervous system related; reversible visual adverse effects; somnolence; transient visual events; worsening schizophrenia,Excessive Hair Growth,,"Skin, Hair, & Nails",manual_pair,"One randomized controlled trial reported a benefit of a cream containing 4% capryloyl glycine applied twice daily for four months in improving hypertrichosis. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term safety and efficacy.",0.7,33934471,2021,Capryloyl glycine and soy isoflavonoids in hypertrichosis: An experimental and placebo-controlled clinical study.,randomized_controlled_trial,benefit,The study showed significant improvement in hypertrichosis with the cream containing glycine.,4 % twice/day four months (cream),,,hypertrichosis,hypertrichosis,,,
Glycine,39.8% subjects had treatment-related adverse events; Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis reported in one participant; dizziness; drowsiness; fatigue; higher rate of adverse effects in ferrous glycine sulfate group; insomnia; mostly central nervous system related; reversible visual adverse effects; somnolence; transient visual events; worsening schizophrenia,Skin Aging Prevention,,"Skin, Hair, & Nails",manual_pair,"One randomized controlled trial indicates that glycine, in the form of 2-Mercaptonicotinoyl glycine at doses of 0.5% and 1% in a cosmetic formula, may reduce skin pigmentation caused by UV exposure. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term safety and efficacy.",0.7,38372022,2024,2-Mercaptonicotinoyl glycine prevents UV-induced skin darkening and delayed tanning in healthy subjects: A randomized controlled clinical study.,randomized_controlled_trial,benefit,"The study shows that 2-MNG significantly reduces skin pigmentation caused by UV exposure, indicating a beneficial effect.",0.5 % application (cosmetic formula); 1 % application (cosmetic formula),,,delayed tanning,delayed tanning; skin pigmentation; uv-induced skin darkening,,,
Glycine,39.8% subjects had treatment-related adverse events; Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis reported in one participant; dizziness; drowsiness; fatigue; higher rate of adverse effects in ferrous glycine sulfate group; insomnia; mostly central nervous system related; reversible visual adverse effects; somnolence; transient visual events; worsening schizophrenia,High Uric Acid,,Heart & Vascular Health,manual_pair,"Human clinical evidence suggests that glycine supplementation may reduce serum uric acid levels, with two randomized controlled trials reporting beneficial effects. One study utilized a dose of 3.0 g of a glycine and tryptophan mixture daily for six weeks. No adverse effects were reported in the studies, but the overall evidence remains limited and further research is needed to confirm these findings.",0.8,31652875,2019,"Combined Supplementation with Glycine and Tryptophan Reduces Purine-Induced Serum Uric Acid Elevation by Accelerating Urinary Uric Acid Excretion: A Randomized, Single-Blind, Placebo-Controlled, Crossover Study.",randomized_controlled_trial,benefit,"The study shows that glycine supplementation significantly reduced serum uric acid levels, indicating a beneficial effect.",,,,mild hyperuricemia,mild hyperuricemia,,,
Glycine,39.8% subjects had treatment-related adverse events; Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis reported in one participant; dizziness; drowsiness; fatigue; higher rate of adverse effects in ferrous glycine sulfate group; insomnia; mostly central nervous system related; reversible visual adverse effects; somnolence; transient visual events; worsening schizophrenia,High Uric Acid,,Heart & Vascular Health,manual_pair,"Human clinical evidence suggests that glycine supplementation may reduce serum uric acid levels, with two randomized controlled trials reporting beneficial effects. One study utilized a dose of 3.0 g of a glycine and tryptophan mixture daily for six weeks. No adverse effects were reported in the studies, but the overall evidence remains limited and further research is needed to confirm these findings.",0.8,30845731,2019,"Serum Uric Acid-Lowering Effects of Combined Glycine and Tryptophan Treatments in Subjects with Mild Hyperuricemia: A Randomized, Double-Blind, Placebo-Controlled, Crossover Study.",randomized_controlled_trial,benefit,"The study shows a significant decrease in serum uric acid levels, indicating a beneficial effect of glycine supplementation.",3.0 g once daily 6 weeks (powder mixture),,,mild hyperuricemia,mild hyperuricemia,,,
Glycine,39.8% subjects had treatment-related adverse events; Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis reported in one participant; dizziness; drowsiness; fatigue; higher rate of adverse effects in ferrous glycine sulfate group; insomnia; mostly central nervous system related; reversible visual adverse effects; somnolence; transient visual events; worsening schizophrenia,Muscle Growth,,Performance & Recovery,manual_pair,"There is limited evidence suggesting that glycine may increase fat-free mass in malnourished hemodialysis patients, as indicated by one randomized double-blind crossover trial that reported a benefit with a dose of 7 g taken orally twice daily for 4 months. Overall, the evidence is low-quality and further research is needed to establish the efficacy and safety of glycine for low muscle mass in broader populations.",0.7,34519439,2021,Glycine increases fat-free mass in malnourished haemodialysis patients: a randomized double-blind crossover trial.,randomized_controlled_trial,benefit,"Glycine improved fat-free mass index in patients, indicating a beneficial effect.",7 g 2 times/day 4 months (oral),CKD; Hemodialysis,,chronic haemodialysis,chronic haemodialysis; malnutrition,,,
Glycine,39.8% subjects had treatment-related adverse events; Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis reported in one participant; dizziness; drowsiness; fatigue; higher rate of adverse effects in ferrous glycine sulfate group; insomnia; mostly central nervous system related; reversible visual adverse effects; somnolence; transient visual events; worsening schizophrenia,Schizophrenia,,"Energy, Mood, & Mental Health",manual_pair,"The evidence for glycine in treating negative symptoms of schizophrenia is limited and mixed. One study reported a benefit with chronic administration of glycine at doses of 0.2 g/kg and 0.6 g/kg daily, while another study on a glycine transporter inhibitor showed no primary benefit but suggested potential effects at a lower dose of 15 mg. Overall, the findings are not consistent, and further research is needed to clarify its efficacy.",0.7,28602646,2018,The effects of glycine on auditory mismatch negativity in schizophrenia.,randomized_controlled_trial,benefit,"Chronic glycine administration improved clinical symptoms in schizophrenia, indicating a benefit.",0.2 g/kg single dose 6 weeks; 0.6 g/kg/day daily 6 weeks,,,schizoaffective disorder,schizoaffective disorder; schizophrenia,,,
Glycine,39.8% subjects had treatment-related adverse events; Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis reported in one participant; dizziness; drowsiness; fatigue; higher rate of adverse effects in ferrous glycine sulfate group; insomnia; mostly central nervous system related; reversible visual adverse effects; somnolence; transient visual events; worsening schizophrenia,Schizophrenia,,"Energy, Mood, & Mental Health",manual_pair,"The evidence for glycine in treating negative symptoms of schizophrenia is limited and mixed. One study reported a benefit with chronic administration of glycine at doses of 0.2 g/kg and 0.6 g/kg daily, while another study on a glycine transporter inhibitor showed no primary benefit but suggested potential effects at a lower dose of 15 mg. Overall, the findings are not consistent, and further research is needed to clarify its efficacy.",0.7,27789188,2017,Efficacy and safety of the glycine transporter type-1 inhibitor AMG 747 for the treatment of negative symptoms associated with schizophrenia.,randomized_controlled_trial,mixed_unclear,"The primary outcome showed no differences, but secondary outcomes indicated potential benefit at the 15 mg dose, leading to a mixed classification.",5 mg daily 12 weeks (oral); 15 mg daily 12 weeks (oral); 40 mg daily 12 weeks (oral),,,schizophrenia,schizoaffective disorder; schizophrenia,,,
Glycine,39.8% subjects had treatment-related adverse events; Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis reported in one participant; dizziness; drowsiness; fatigue; higher rate of adverse effects in ferrous glycine sulfate group; insomnia; mostly central nervous system related; reversible visual adverse effects; somnolence; transient visual events; worsening schizophrenia,Inflammation,,"Immune, Inflammation, & Infection",manual_pair,"One randomized clinical trial found that supplementation with Glycine and N-Acetylcysteine (GlyNAC) improved markers of oxidative stress and other age-related abnormalities in older adults over a 16-week period. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term effects and safety.",0.7,35975308,2023,"Supplementing Glycine and N-Acetylcysteine (GlyNAC) in Older Adults Improves Glutathione Deficiency, Oxidative Stress, Mitochondrial Dysfunction, Inflammation, Physical Function, and Aging Hallmarks: A Randomized Clinical Trial.",randomized_controlled_trial,benefit,"The study demonstrated that GlyNAC supplementation improved multiple age-associated abnormalities, indicating a beneficial outcome.",null null null 16 weeks (GlyNAC),,Healthy Aging & Prevention,aging hallmarks,aging hallmarks; inflammation; mitochondrial dysfunction; oxidative stress; physical function,,,
Glycine,39.8% subjects had treatment-related adverse events; Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis reported in one participant; dizziness; drowsiness; fatigue; higher rate of adverse effects in ferrous glycine sulfate group; insomnia; mostly central nervous system related; reversible visual adverse effects; somnolence; transient visual events; worsening schizophrenia,Psychosis,,"Energy, Mood, & Mental Health",manual_pair,"The evidence for glycine in treating psychotic symptoms is limited, with only one study reporting a benefit in symptom relief for individuals with specific genetic variants. Overall, the quality of evidence is low, and no consistent dose ranges or adverse effects have been reported. Further research is needed to establish efficacy and safety.",0.6,31279534,2019,Targeted Treatment of Individuals With Psychosis Carrying a Copy Number Variant Containing a Genomic Triplication of the Glycine Decarboxylase Gene.,clinical_trial,benefit,The study demonstrated symptom relief in psychotic disorders with glycine augmentation.,,,,mood symptoms,mood symptoms; psychotic disorders,,,
Glycine,39.8% subjects had treatment-related adverse events; Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis reported in one participant; dizziness; drowsiness; fatigue; higher rate of adverse effects in ferrous glycine sulfate group; insomnia; mostly central nervous system related; reversible visual adverse effects; somnolence; transient visual events; worsening schizophrenia,Vaginal Dryness,,Women's Health,manual_pair,"Two randomized, double-blind, placebo-controlled trials indicate that glycine, delivered as a 4% vaginal gel, may improve symptoms of vaginal dryness and enhance vaginal vascularization in postmenopausal women over a 12-week period. However, the evidence is limited to these studies, and no adverse effects were reported, necessitating further research to confirm these findings and establish long-term safety and efficacy.",0.8,24856055,2014,"Effects of Glycine max (L.) Merr. soy isoflavone vaginal gel on epithelium morphology and estrogen receptor expression in postmenopausal women: a 12-week, randomized, double-blind, placebo-controlled trial.",randomized_controlled_trial,benefit,"The study shows significant improvements in vaginal atrophy symptoms and related outcomes, indicating a beneficial effect of the treatment.",1 g daily 12 weeks (vaginal gel 4%),Menopause; Women,,dyspareunia,dyspareunia; postmenopausal symptoms; vaginal atrophy; vaginal dryness,,,
Grape seed extract,,Skin Aging Prevention,,"Skin, Hair, & Nails",manual_pair,"One study evaluated a water-in-oil emulsion containing 2% Muscat hamburg black grape seed extract applied twice daily for 8 weeks, reporting significant benefits in improving skin conditions related to acne without any adverse effects. Overall, the evidence is limited to a single study, indicating a need for further research to confirm these findings.",0.7,25402429,2015,Formulation and evaluation on human skin of a water-in-oil emulsion containing Muscat hamburg black grape seed extract.,randomized_controlled_trial,benefit,The formulation showed significant benefits in improving skin conditions without reported adverse effects.,2 % twice a day 8 weeks (water-in-oil emulsion),,,acne,acne; hyper-pigmentation,,,
Grape seed extract,,Weight Loss,,Weight & Body Composition,manual_pair,"Clinical evidence suggests that grape seed extract may have beneficial effects on body weight in overweight or obese individuals, with two randomized trials reporting positive outcomes. Doses reported include 300 mg daily for 12 weeks and 1 capsule daily for 28 days. However, the overall evidence is limited, and further research is needed to confirm these findings and assess long-term effects.",0.8,31713941,2020,"The effects of grape seed extract (Vitis vinifera) supplement on inflammatory markers, neuropeptide Y, anthropometric measures, and appetite in obese or overweight individuals: A randomized clinical trial.",randomized_controlled_trial,benefit,"The study showed significant reductions in body weight and inflammatory markers in the GSE group, indicating a beneficial effect on obesity and related health outcomes.",300 mg daily 12 weeks (extract),,"Immune, Inflammation, & Infection",obesity,obesity; overweight; oxidative stress,,,
Grape seed extract,,Weight Loss,,Weight & Body Composition,manual_pair,"Clinical evidence suggests that grape seed extract may have beneficial effects on body weight in overweight or obese individuals, with two randomized trials reporting positive outcomes. Doses reported include 300 mg daily for 12 weeks and 1 capsule daily for 28 days. However, the overall evidence is limited, and further research is needed to confirm these findings and assess long-term effects.",0.8,22776850,2012,"Effect of the intake of resveratrol, resveratrol phosphate, and catechin-rich grape seed extract on markers of oxidative stress and gene expression in adult obese subjects.",randomized_controlled_trial,benefit,"The study indicates a significant reduction of oxidative stress, suggesting a beneficial outcome.",1 capsule daily 28 days (capsule),Obese,,obesity,obesity; overweight; oxidative stress,,,
Grape seed extract,,Fatty Liver Disease,,Gut Health,manual_pair,"One randomized, double-blind, placebo-controlled study reported that grape seed extract (520 mg daily for 2 months) led to significant improvements in metabolic factors and liver health indicators in patients with non-alcoholic fatty liver disease (NAFLD). No studies reported mixed outcomes or harm, but the evidence is limited to a single trial, necessitating caution in interpretation.",0.8,38755622,2024,"The effects of grape seed extract supplementation on cardiovascular risk factors, liver enzymes and hepatic steatosis in patients with non-alcoholic fatty liver disease: a randomised, double-blind, placebo-controlled study.",randomized_controlled_trial,benefit,"The study showed significant improvements in various metabolic factors and liver health indicators in NAFLD patients after GSE supplementation, indicating a beneficial effect.",520 mg daily 2 months (Grape seed extract),Fatty Liver Disease,Heart & Vascular Health; Metabolic Health,hepatic steatosis,hepatic steatosis; hyperlipidemia; hypertension; insulin resistance; non-alcoholic fatty liver disease,,,
Grape seed extract,,Peridontitis,,Oral Health,manual_pair,"One randomized clinical study reported a benefit of grape seed extract gel (2% concentration) in improving gingival and plaque indices in patients with chronic periodontitis. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term effects and safety.",0.7,29349878,2018,Efficacy of grape seed extract gel in the treatment of chronic periodontitis: A randomized clinical study.,randomized_controlled_trial,benefit,"The study showed significant improvement in gingival index and plaque index, indicating a benefit from the treatment.",2 % 4 times not specified (mucoadhesive GSE gel),,,chronic periodontitis,chronic periodontitis,,,
Grape seed extract,,Hypertension,,Heart & Vascular Health,manual_pair,"The evidence from multiple randomized trials indicates that grape seed extract may significantly reduce blood pressure in various populations, including healthy individuals and those with pre-hypertension or metabolic syndrome. Doses reported in these studies typically range from 150 mg to 300 mg daily. No adverse effects were noted in the studies reviewed, but the overall quality of evidence should be interpreted with caution due to variability in study designs and populations.",0.9,33132345,2020,Effects of Acute Grape Seed Extract Supplementation on Hemodynamics in Normal Body Weight and Obese Males.,randomized_controlled_trial,benefit,"The study shows a significant reduction in systolic and mean arterial blood pressure after GSE supplementation, indicating a beneficial effect on hemodynamics in both normal weight and obese males.",(Grape Seed Extract),Obese,,aortic stiffness,aortic stiffness; augmented blood pressure responses; blood pressure modulation; elevated blood pressure; elevated hypertension; high blood pressure; metabolic syndrome; obesity; overweight; perceived stress; pre-hypertension; prehypertension; stage 1 hypertension,,,
Grape seed extract,,Hypertension,,Heart & Vascular Health,manual_pair,"The evidence from multiple randomized trials indicates that grape seed extract may significantly reduce blood pressure in various populations, including healthy individuals and those with pre-hypertension or metabolic syndrome. Doses reported in these studies typically range from 150 mg to 300 mg daily. No adverse effects were noted in the studies reviewed, but the overall quality of evidence should be interpreted with caution due to variability in study designs and populations.",0.9,33905304,2022,Effects of chronic dietary grape seed extract supplementation on aortic stiffness and hemodynamic responses in obese/overweight males during submaximal exercise.,clinical_trial,benefit,"The study shows a significant reduction in arterial pressure and aortic stiffness, indicating a beneficial effect of grape seed extract supplementation in the studied population.",null null daily 7 days (grape seed extract),Men; Obese; Overweight,,augmented blood pressure responses,aortic stiffness; augmented blood pressure responses; blood pressure modulation; elevated blood pressure; elevated hypertension; high blood pressure; metabolic syndrome; obesity; overweight; perceived stress; pre-hypertension; prehypertension; stage 1 hypertension,,,
Grape seed extract,,Hypertension,,Heart & Vascular Health,manual_pair,"The evidence from multiple randomized trials indicates that grape seed extract may significantly reduce blood pressure in various populations, including healthy individuals and those with pre-hypertension or metabolic syndrome. Doses reported in these studies typically range from 150 mg to 300 mg daily. No adverse effects were noted in the studies reviewed, but the overall quality of evidence should be interpreted with caution due to variability in study designs and populations.",0.9,33671310,2021,"Grape Seed Extract Positively Modulates Blood Pressure and Perceived Stress: A Randomized, Double-Blind, Placebo-Controlled Study in Healthy Volunteers.",clinical_trial,benefit,The study demonstrated a significant benefit in modulating blood pressure and perceived stress in healthy volunteers.,300 mg daily 16 weeks (tablets),,"Energy, Mood, & Mental Health",blood pressure modulation,aortic stiffness; augmented blood pressure responses; blood pressure modulation; elevated blood pressure; elevated hypertension; high blood pressure; metabolic syndrome; obesity; overweight; perceived stress; pre-hypertension; prehypertension; stage 1 hypertension,,,
Grape seed extract,,Hypertension,,Heart & Vascular Health,manual_pair,"The evidence from multiple randomized trials indicates that grape seed extract may significantly reduce blood pressure in various populations, including healthy individuals and those with pre-hypertension or metabolic syndrome. Doses reported in these studies typically range from 150 mg to 300 mg daily. No adverse effects were noted in the studies reviewed, but the overall quality of evidence should be interpreted with caution due to variability in study designs and populations.",0.9,40341867,2025,Effect of 7-day dietary supplementation with grape seed extract on cardiac autonomic and hemodynamic responses in elevated and stage 1 hypertension.,randomized_controlled_trial,benefit,"The study indicates a reduction in blood pressure, suggesting a beneficial effect of grape seed extract in individuals with elevated and stage 1 hypertension.",null null null 7 days (dietary supplement),,,elevated hypertension,aortic stiffness; augmented blood pressure responses; blood pressure modulation; elevated blood pressure; elevated hypertension; high blood pressure; metabolic syndrome; obesity; overweight; perceived stress; pre-hypertension; prehypertension; stage 1 hypertension,,,
Grape seed extract,,Hypertension,,Heart & Vascular Health,manual_pair,"The evidence from multiple randomized trials indicates that grape seed extract may significantly reduce blood pressure in various populations, including healthy individuals and those with pre-hypertension or metabolic syndrome. Doses reported in these studies typically range from 150 mg to 300 mg daily. No adverse effects were noted in the studies reviewed, but the overall quality of evidence should be interpreted with caution due to variability in study designs and populations.",0.9,19608210,2009,Effect of grape seed extract on blood pressure in subjects with the metabolic syndrome.,randomized_controlled_trial,benefit,"Blood pressure was significantly lowered after treatment with grape seed extract compared to placebo, indicating a beneficial effect.",150 mg daily 4 weeks (extract),,,high blood pressure,aortic stiffness; augmented blood pressure responses; blood pressure modulation; elevated blood pressure; elevated hypertension; high blood pressure; metabolic syndrome; obesity; overweight; perceived stress; pre-hypertension; prehypertension; stage 1 hypertension,,,
Grape seed extract,,Hypertension,,Heart & Vascular Health,manual_pair,"The evidence from multiple randomized trials indicates that grape seed extract may significantly reduce blood pressure in various populations, including healthy individuals and those with pre-hypertension or metabolic syndrome. Doses reported in these studies typically range from 150 mg to 300 mg daily. No adverse effects were noted in the studies reviewed, but the overall quality of evidence should be interpreted with caution due to variability in study designs and populations.",0.9,26568249,2016,"Effects of grape seed extract beverage on blood pressure and metabolic indices in individuals with pre-hypertension: a randomised, double-blinded, two-arm, parallel, placebo-controlled trial.",randomized_controlled_trial,benefit,"Grape seed extract significantly reduced blood pressure in individuals with pre-hypertension, indicating a beneficial effect.",300 mg twice daily 6 weeks (beverage),,,pre-hypertension,aortic stiffness; augmented blood pressure responses; blood pressure modulation; elevated blood pressure; elevated hypertension; high blood pressure; metabolic syndrome; obesity; overweight; perceived stress; pre-hypertension; prehypertension; stage 1 hypertension,,,
Grape seed extract,,Hypertension,,Heart & Vascular Health,manual_pair,"The evidence from multiple randomized trials indicates that grape seed extract may significantly reduce blood pressure in various populations, including healthy individuals and those with pre-hypertension or metabolic syndrome. Doses reported in these studies typically range from 150 mg to 300 mg daily. No adverse effects were noted in the studies reviewed, but the overall quality of evidence should be interpreted with caution due to variability in study designs and populations.",0.9,29683391,2018,Grape Seed Extract Supplementation Attenuates the Blood Pressure Response to Exercise in Prehypertensive Men.,randomized_controlled_trial,benefit,The study shows that Grape Seed Extract supplementation benefits prehypertensive males by reducing blood pressure and enhancing endothelial function during exercise.,300 mg single dose,,,prehypertension,aortic stiffness; augmented blood pressure responses; blood pressure modulation; elevated blood pressure; elevated hypertension; high blood pressure; metabolic syndrome; obesity; overweight; perceived stress; pre-hypertension; prehypertension; stage 1 hypertension,,,
Grape seed extract,,High Blood Glucose,,Metabolic Health,manual_pair,"One randomized controlled trial has reported that grape seed extract (600 mg daily for 4 weeks) may improve markers of inflammation and glycaemia in individuals with Type 2 diabetes at high cardiovascular risk. No studies reported mixed results or harm, but the evidence is limited to a single trial, necessitating caution in interpretation.",0.8,19646193,2009,"Effects of grape seed extract in Type 2 diabetic subjects at high cardiovascular risk: a double blind randomized placebo controlled trial examining metabolic markers, vascular tone, inflammation, oxidative stress and insulin sensitivity.",randomized_controlled_trial,benefit,"Grape seed extract showed significant improvements in markers of inflammation and glycaemia, indicating a beneficial effect.",600 mg daily 4 weeks,Diabetes Type 2; Obese,Heart & Vascular Health,cardiovascular risk,Type 2 Diabetes Mellitus; cardiovascular risk; inflammation; oxidative stress,,,
Grape seed extract,,Low HDL,,Heart & Vascular Health,manual_pair,"One randomized trial reported that red grape seed extract (200 mg daily for eight weeks) significantly improved lipid profiles in patients with mild to moderate hyperlipidemia, suggesting a potential benefit for high cholesterol. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term effects and safety.",0.7,27191247,2016,The effect of red grape seed extract on serum paraoxonase activity in patients with mild to moderate hyperlipidemia.,randomized_controlled_trial,benefit,"The study shows significant improvements in lipid profiles and paraoxonase activity, indicating a beneficial effect of grape seed extract.",200 mg daily eight weeks,,,mild to moderate hyperlipidemia,mild to moderate hyperlipidemia,,,
Grape seed extract,,High LDL,,Heart & Vascular Health,manual_pair,"Clinical evidence from three randomized trials indicates that grape seed extract may have beneficial effects on LDL cholesterol and overall lipid profiles, with doses commonly reported at 200 mg to 400 mg daily over periods of 8 to 12 weeks. No studies reported harm or lack of benefit, suggesting a consistent positive outcome; however, the overall quality and long-term effects of grape seed extract supplementation remain unclear.",0.9,17616006,2007,Beneficial effects of grape seed extract on malondialdehyde-modified LDL.,randomized_controlled_trial,benefit,"The study shows significant reductions in oxidized LDL levels, indicating a beneficial effect on cardiovascular health.",200 mg daily 12 weeks (tablets); 400 mg daily 12 weeks (tablets),,,arteriosclerosis,arteriosclerosis; atherosclerosis prevention; cardiovascular disorders; cardiovascular risk factors; lifestyle-related diseases; mild hyperlipidemia; obesity; overweight,,,
Grape seed extract,,High LDL,,Heart & Vascular Health,manual_pair,"Clinical evidence from three randomized trials indicates that grape seed extract may have beneficial effects on LDL cholesterol and overall lipid profiles, with doses commonly reported at 200 mg to 400 mg daily over periods of 8 to 12 weeks. No studies reported harm or lack of benefit, suggesting a consistent positive outcome; however, the overall quality and long-term effects of grape seed extract supplementation remain unclear.",0.9,23437789,2013,Red grape seed extract improves lipid profiles and decreases oxidized low-density lipoprotein in patients with mild hyperlipidemia.,randomized_controlled_trial,benefit,"The study shows a significant reduction in total cholesterol, LDL cholesterol, and Ox-LDL, indicating a beneficial effect on lipid profiles.",200 mg daily 8 weeks (red grape seed extract),,,atherosclerosis prevention,arteriosclerosis; atherosclerosis prevention; cardiovascular disorders; cardiovascular risk factors; lifestyle-related diseases; mild hyperlipidemia; obesity; overweight,,,
Grape seed extract,,High LDL,,Heart & Vascular Health,manual_pair,"Clinical evidence from three randomized trials indicates that grape seed extract may have beneficial effects on LDL cholesterol and overall lipid profiles, with doses commonly reported at 200 mg to 400 mg daily over periods of 8 to 12 weeks. No studies reported harm or lack of benefit, suggesting a consistent positive outcome; however, the overall quality and long-term effects of grape seed extract supplementation remain unclear.",0.9,33044768,2021,"Grape seed extract supplementation along with a restricted-calorie diet improves cardiovascular risk factors in obese or overweight adult individuals: A randomized, placebo-controlled trial.",randomized_controlled_trial,benefit,"The study showed significant improvements in blood lipid profiles and cardiovascular risk factors, indicating a beneficial effect of GSE supplementation.",300 mg daily 12 weeks (Grape seed extract),Obese; Overweight,,cardiovascular risk factors,arteriosclerosis; atherosclerosis prevention; cardiovascular disorders; cardiovascular risk factors; lifestyle-related diseases; mild hyperlipidemia; obesity; overweight,,,
Grape seed extract,,Leg Swelling,,Musculoskeletal & Pain,manual_pair,"There is limited evidence suggesting that grape seed extract may reduce leg swelling, as indicated by one study that reported a significant benefit in healthy women during prolonged sitting. However, the overall quality of evidence is low, and further research is needed to confirm these findings and assess long-term effects and safety.",0.6,22752876,2013,Proanthocyanidin-rich grape seed extract reduces leg swelling in healthy women during prolonged sitting.,clinical_trial,benefit,"The study shows that grape seed extract significantly suppressed leg swelling, indicating a beneficial effect.",14 days,Women,,edema,edema; leg swelling,,,
Grape seed extract,,Exercise Performance,,Performance & Recovery,manual_pair,"There is limited evidence suggesting that grape seed extract may improve endurance performance, as indicated by one study involving basketball players that reported benefits after 14 days of supplementation. However, due to the low quantity of studies and the lack of corroborating evidence, the overall confidence in this finding is low.",0.2,36361103,2022,Effects of Grape Seed Extract Supplementation on Endothelial Function and Endurance Performance in Basketball Players.,clinical_trial,benefit,"The study demonstrated that Grape seed extract improved endurance performance and endothelial function, indicating a beneficial outcome.",14 days (Grape seed extract),Basketball Players,,endothelial function,endothelial function; endurance performance,,,
Grape seed extract,,Oxidative Stress,,"Immune, Inflammation, & Infection",manual_pair,"One randomized trial reported that grape seed extract (GSE) supplementation at a dose of 250 mg twice daily for two months resulted in significant improvements in oxidative stress markers and quality of life in patients with non-alcoholic fatty liver disease (NAFLD). However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term effects and safety.",0.7,38419408,2024,Grape seed extract supplementation in non-alcoholic fatty liver disease.,randomized_controlled_trial,benefit,"The study shows significant improvements in oxidative stress markers and quality of life in NAFLD patients receiving GSE, indicating a beneficial effect.",250 mg 2 tablets 2 months (Grape seed extract),Fatty Liver Disease,,non-alcoholic fatty liver disease,non-alcoholic fatty liver disease,,,
Grape seed extract,,Oxidative Stress,,"Immune, Inflammation, & Infection",manual_pair,"One randomized trial demonstrated that grape seed extract (100 mg every 6 hours for 24 hours before surgery) has antioxidative effects and may reduce oxidative stress during on-pump coronary artery bypass surgery. No studies reported mixed outcomes or adverse effects, but the evidence is limited to a single trial, indicating a need for further research to confirm these findings.",0.8,28074795,2017,Comparative effect of grape seed extract (Vitis vinifera) and ascorbic acid in oxidative stress induced by on-pump coronary artery bypass surgery.,randomized_controlled_trial,benefit,"The study showed that grape seed extract had antioxidative effects and reduced deleterious effects of CPB, indicating a beneficial outcome.",100 mg every 6 h 24 h before operation (oral),,,oxidative stress,oxidative stress,,,
Grape seed extract,,Oxidative Stress,,"Immune, Inflammation, & Infection",manual_pair,"One randomized trial demonstrated that grape seed extract (75 mg, two capsules twice daily for 4 weeks) significantly reduced oxidative indices in heavy smokers, suggesting a potential benefit in addressing oxidative stress from smoking. No adverse effects were reported in this study, but further research is needed to confirm these findings and establish consistency across larger populations.",0.8,14564675,2003,Effect of a standardized grape seed extract on low-density lipoprotein susceptibility to oxidation in heavy smokers.,randomized_controlled_trial,benefit,"The study showed a significant reduction in oxidative indices, indicating a benefit from grape seed extract in heavy smokers.",75 mg 2 capsules twice daily 4 weeks (grape procyanidin extracts and soy-phosphatidylcholine),Smokers,,oxidative stress,oxidative stress; smoking,,,
Grape seed extract,,Wound Healing,,"Skin, Hair, & Nails",manual_pair,"One randomized trial reported a significant benefit of a 2% grape seed extract cream applied topically for 21 days in improving wound healing compared to placebo. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess any potential adverse effects.",0.7,25948437,2014,The topical effect of grape seed extract 2% cream on surgery wound healing.,randomized_controlled_trial,benefit,The study showed significant improvement in wound healing with grape seed extract compared to placebo.,2 % topical application 21 days (cream),,,skin lesions,skin lesions; wound healing,,,
Hibiscus,Caution with caffeine or similar substrates of CYP1A2; Counsel patients against the use of plant beverages with drugs.; adverse effects on HDL-C concentrations in homozygous B1B1 and E4 carriers; burning; co-administration with simvastatin should be discouraged until more clinical data are available; pruritus; rash; ulcerative colitis flare; urticaria,Inflammation,,"Immune, Inflammation, & Infection",manual_pair,"Current evidence on hibiscus for anti-inflammatory effects is limited, with only one study suggesting potential benefits from a single dose of 60 mL of Hibiscus sabdariffa beverage, based on the bioavailability of its bioactive compounds. Overall, the evidence is low quality and lacks consistency, with no studies reporting harm or clear adverse effects.",0.6,37986526,2023,Bioavailability of bioactive compounds in Hibiscus sabdariffa beverage as a potential anti-inflammatory.,clinical_trial,benefit,The study indicates potential anti-inflammatory benefits of Hibiscus sabdariffa based on the bioavailability of its compounds.,60 mL single (Hibiscus sabdariffa drink),,,anti-inflammatory,anti-inflammatory,,,
Hibiscus,Caution with caffeine or similar substrates of CYP1A2; Counsel patients against the use of plant beverages with drugs.; adverse effects on HDL-C concentrations in homozygous B1B1 and E4 carriers; burning; co-administration with simvastatin should be discouraged until more clinical data are available; pruritus; rash; ulcerative colitis flare; urticaria,Inflammation,,"Immune, Inflammation, & Infection",manual_pair,"There is limited evidence suggesting that Hibiscus sabdariffa may have a beneficial effect on chronic inflammation, as indicated by a single study demonstrating a significant decrease in plasma monocyte chemoattractant protein-1 (MCP-1) concentrations following the administration of 10 g of an aqueous extract. However, due to the low quantity of studies and lack of replication, the overall evidence remains weak and inconclusive.",0.5,19765963,2010,The aqueous extract of Hibiscus sabdariffa calices modulates the production of monocyte chemoattractant protein-1 in humans.,clinical_trial,benefit,"The study shows a significant decrease in plasma MCP-1 concentrations, indicating a beneficial effect in inflammatory conditions.",10 g acute (aqueous extract),,,chronic inflammatory diseases,chronic inflammatory diseases,,,
Hibiscus,Caution with caffeine or similar substrates of CYP1A2; Counsel patients against the use of plant beverages with drugs.; adverse effects on HDL-C concentrations in homozygous B1B1 and E4 carriers; burning; co-administration with simvastatin should be discouraged until more clinical data are available; pruritus; rash; ulcerative colitis flare; urticaria,Dry Mouth,,Oral Health,manual_pair,"One randomized, placebo-controlled trial reported that a dietary supplement containing hibiscus (AqualiefTM) significantly improved saliva pH and production in patients with dry mouth (xerostomia). No adverse effects were noted in this study, but the overall evidence is limited to a single trial, indicating a need for further research to confirm these findings.",0.7,32614361,2020,"The Efficacy of a Dietary Supplement with Carnosine and Hibiscus Sabdariffa L. (AqualiefTM) in Patients with Xerostomia: a Randomized, Placebo-Controlled, Double-Blind Trial.",randomized_controlled_trial,benefit,"The study demonstrated significant improvements in saliva pH and production in xerostomic patients treated with AqualiefTM, indicating a beneficial effect.",3 tablets 3 times/day 6 days (AqualiefTM),,,xerostomia,xerostomia,,,
Hibiscus,Caution with caffeine or similar substrates of CYP1A2; Counsel patients against the use of plant beverages with drugs.; adverse effects on HDL-C concentrations in homozygous B1B1 and E4 carriers; burning; co-administration with simvastatin should be discouraged until more clinical data are available; pruritus; rash; ulcerative colitis flare; urticaria,Skin Elasticity,,"Skin, Hair, & Nails",manual_pair,"One pilot study (PMID 40806423) reported that a daily dose of 1.5 g of Hibiscus (VC-H1) for 12 weeks led to significant improvements in skin hydration, elasticity, and wrinkle reduction, suggesting a potential benefit for dry skin. However, the evidence is limited to this single study, and further research is needed to confirm these findings and assess long-term effects and safety.",0.7,40806423,2025,Hibiscus Collagen Alternative (VC-H1) as an Oral Skin Rejuvenating Agent: A 12-Week Pilot Study.,randomized_controlled_trial,benefit,"The study demonstrated significant improvements in skin hydration, elasticity, and wrinkle reduction, indicating a beneficial effect of Hibiscus as a skin rejuvenating agent.",1.5 g daily 12 weeks (VC-H1),,,dry skin,dry skin; periorbital wrinkles; skin aging,,,
Hibiscus,Caution with caffeine or similar substrates of CYP1A2; Counsel patients against the use of plant beverages with drugs.; adverse effects on HDL-C concentrations in homozygous B1B1 and E4 carriers; burning; co-administration with simvastatin should be discouraged until more clinical data are available; pruritus; rash; ulcerative colitis flare; urticaria,Increase Satiety,,Weight & Body Composition,manual_pair,"One randomized crossover trial found that Hibiscus sabdariffa tea positively affected energy expenditure and subjective satiety responses in healthy men, with no reported adverse effects. However, the evidence is limited to this single study, and findings may not be generalizable to women or other populations.",0.7,34370964,2022,Hibiscus sabdariffa tea affects diet-induced thermogenesis and subjective satiety responses in healthy men but not in women: a randomized crossover trial.,randomized_controlled_trial,benefit,"The study demonstrated benefits in energy expenditure and satiety responses in men, indicating a positive effect of Hibiscus sabdariffa tea.",(Hibiscus sabdariffa tea),Men; Overweight,,energy expenditure,energy expenditure,,,
Hibiscus,Caution with caffeine or similar substrates of CYP1A2; Counsel patients against the use of plant beverages with drugs.; adverse effects on HDL-C concentrations in homozygous B1B1 and E4 carriers; burning; co-administration with simvastatin should be discouraged until more clinical data are available; pruritus; rash; ulcerative colitis flare; urticaria,Increase Satiety,,Weight & Body Composition,manual_pair,"Clinical evidence from three randomized controlled trials indicates that Hibiscus may have beneficial effects on body weight and appetite regulation in overweight and obese individuals. The studies reported improvements in various anthropometric measurements and appetite-related biomarkers, with doses of polyphenolic extracts ranging from 500 mg daily to unspecified amounts over periods of 60 to 60 days. No adverse effects were noted, but the overall quality of evidence is limited to a small number of studies.",0.8,34591168,2022,"Effectiveness of a polyphenolic extract (Lippia citriodora and Hibiscus sabdariffa) on appetite regulation in overweight and obese grade I population: an 8-week randomized, double-blind, cross-over, placebo-controlled trial.",randomized_controlled_trial,benefit,"The study demonstrated a decrease in appetite sensation and reduced calorie intake in the treatment group, indicating a beneficial effect of Hibiscus.",8 weeks (polyphenolic extract),Obese; Overweight,,obesity,obesity; obesity-related diseases; obesity-related pathologies; overweight,,,
Hibiscus,Caution with caffeine or similar substrates of CYP1A2; Counsel patients against the use of plant beverages with drugs.; adverse effects on HDL-C concentrations in homozygous B1B1 and E4 carriers; burning; co-administration with simvastatin should be discouraged until more clinical data are available; pruritus; rash; ulcerative colitis flare; urticaria,Increase Satiety,,Weight & Body Composition,manual_pair,"Clinical evidence from three randomized controlled trials indicates that Hibiscus may have beneficial effects on body weight and appetite regulation in overweight and obese individuals. The studies reported improvements in various anthropometric measurements and appetite-related biomarkers, with doses of polyphenolic extracts ranging from 500 mg daily to unspecified amounts over periods of 60 to 60 days. No adverse effects were noted, but the overall quality of evidence is limited to a small number of studies.",0.8,30816148,2019,Differential effects of a combination of Hibiscus sabdariffa and Lippia citriodora polyphenols in overweight/obese subjects: A randomized controlled trial.,randomized_controlled_trial,benefit,"The study demonstrated significant improvements in body weight, abdominal circumference, body fat percentage, heart rate, and systolic blood pressure in overweight subjects, indicating a beneficial effect of Hibiscus.",500 mg daily two months (polyphenolic extracts),Obese; Overweight,,obesity,obesity; obesity-related diseases; obesity-related pathologies; overweight,,,
Hibiscus,Caution with caffeine or similar substrates of CYP1A2; Counsel patients against the use of plant beverages with drugs.; adverse effects on HDL-C concentrations in homozygous B1B1 and E4 carriers; burning; co-administration with simvastatin should be discouraged until more clinical data are available; pruritus; rash; ulcerative colitis flare; urticaria,Increase Satiety,,Weight & Body Composition,manual_pair,"Clinical evidence from three randomized controlled trials indicates that Hibiscus may have beneficial effects on body weight and appetite regulation in overweight and obese individuals. The studies reported improvements in various anthropometric measurements and appetite-related biomarkers, with doses of polyphenolic extracts ranging from 500 mg daily to unspecified amounts over periods of 60 to 60 days. No adverse effects were noted, but the overall quality of evidence is limited to a small number of studies.",0.8,29862395,2018,Hibiscus and lemon verbena polyphenols modulate appetite-related biomarkers in overweight subjects: a randomized controlled trial.,randomized_controlled_trial,benefit,"The study showed improvements in anthropometric measurements, decreased blood pressure, and positive health perceptions, indicating a beneficial effect of Hibiscus on weight management.",60 days (polyphenolic extracts),,,obesity-related pathologies,obesity; obesity-related diseases; obesity-related pathologies; overweight,,,
Hibiscus,Caution with caffeine or similar substrates of CYP1A2; Counsel patients against the use of plant beverages with drugs.; adverse effects on HDL-C concentrations in homozygous B1B1 and E4 carriers; burning; co-administration with simvastatin should be discouraged until more clinical data are available; pruritus; rash; ulcerative colitis flare; urticaria,Fatty Liver Disease,,Gut Health,manual_pair,"One randomized trial suggests that Hibiscus sabdariffa extract may reduce obesity and improve liver steatosis in individuals with fatty liver disease over a 12-week period. However, the overall evidence is limited, with only one study reporting a benefit and no adverse effects noted. Further research is needed to confirm these findings and establish consistent dosing guidelines.",0.7,24549255,2014,"Hibiscus sabdariffa extract inhibits obesity and fat accumulation, and improves liver steatosis in humans.",randomized_controlled_trial,benefit,"The study demonstrated a reduction in obesity and improvement in liver steatosis, indicating a beneficial effect of Hibiscus sabdariffa extract.",12 weeks (Hibiscus sabdariffa extract),Fatty Liver Disease,Weight & Body Composition,liver steatosis,liver steatosis; non-alcoholic fatty liver disease; obesity,,,
Hibiscus,Caution with caffeine or similar substrates of CYP1A2; Counsel patients against the use of plant beverages with drugs.; adverse effects on HDL-C concentrations in homozygous B1B1 and E4 carriers; burning; co-administration with simvastatin should be discouraged until more clinical data are available; pruritus; rash; ulcerative colitis flare; urticaria,High Insulin,,Metabolic Health,manual_pair,"The evidence from randomized trials suggests that Hibiscus sabdariffa may effectively reduce blood pressure in individuals with hypertension, with multiple studies reporting significant benefits. Typical doses reported include 250 mg of dried extract daily, 320 mg of plant powder twice daily, and various aqueous extracts in different forms. However, one study showed mixed results, indicating the need for further research to clarify its efficacy compared to standard treatments.",0.9,30764582,2019,"Acute Effects of Hibiscus Sabdariffa Calyces on Postprandial Blood Pressure, Vascular Function, Blood Lipids, Biomarkers of Insulin Resistance and Inflammation in Humans.",randomized_controlled_trial,benefit,"The study showed significant improvements in vascular function and potential benefits for cardiovascular risk factors, indicating a positive outcome.",250 mL once (aqueous extract),,"Immune, Inflammation, & Infection",blood pressure,Type 2 Diabetes Mellitus; blood pressure; cardiovascular disease risk; cardiovascular diseases; endothelial dysfunction; hypertension; inflammation; insulin resistance; metabolic health; mild hypertension; mild to moderate essential hypertension; mild to moderate hypertension; oxidation; prehypertension; vascular function,,,
Hibiscus,Caution with caffeine or similar substrates of CYP1A2; Counsel patients against the use of plant beverages with drugs.; adverse effects on HDL-C concentrations in homozygous B1B1 and E4 carriers; burning; co-administration with simvastatin should be discouraged until more clinical data are available; pruritus; rash; ulcerative colitis flare; urticaria,High Insulin,,Metabolic Health,manual_pair,"The evidence from randomized trials suggests that Hibiscus sabdariffa may effectively reduce blood pressure in individuals with hypertension, with multiple studies reporting significant benefits. Typical doses reported include 250 mg of dried extract daily, 320 mg of plant powder twice daily, and various aqueous extracts in different forms. However, one study showed mixed results, indicating the need for further research to clarify its efficacy compared to standard treatments.",0.9,26234931,2015,The acute impact of polyphenols from Hibiscus sabdariffa in metabolic homeostasis: an approach combining metabolomics and gene-expression analyses.,clinical_trial,benefit,"The study indicates beneficial effects on metabolic and cardiovascular health, suggesting a positive outcome direction.",3 hours (aqueous extract),,,cardiovascular diseases,Type 2 Diabetes Mellitus; blood pressure; cardiovascular disease risk; cardiovascular diseases; endothelial dysfunction; hypertension; inflammation; insulin resistance; metabolic health; mild hypertension; mild to moderate essential hypertension; mild to moderate hypertension; oxidation; prehypertension; vascular function,,,
Hibiscus,Caution with caffeine or similar substrates of CYP1A2; Counsel patients against the use of plant beverages with drugs.; adverse effects on HDL-C concentrations in homozygous B1B1 and E4 carriers; burning; co-administration with simvastatin should be discouraged until more clinical data are available; pruritus; rash; ulcerative colitis flare; urticaria,High Insulin,,Metabolic Health,manual_pair,"The evidence from randomized trials suggests that Hibiscus sabdariffa may effectively reduce blood pressure in individuals with hypertension, with multiple studies reporting significant benefits. Typical doses reported include 250 mg of dried extract daily, 320 mg of plant powder twice daily, and various aqueous extracts in different forms. However, one study showed mixed results, indicating the need for further research to clarify its efficacy compared to standard treatments.",0.9,33810049,2021,"A Randomized, Double-Blind, Placebo-Controlled Trial to Determine the Effectiveness of a Polyphenolic Extract (Hibiscus sabdariffa and Lippia citriodora) for Reducing Blood Pressure in Prehypertensive and Type 1 Hypertensive Subjects.",randomized_controlled_trial,benefit,"The study demonstrated a significant reduction in blood pressure parameters with the HS-LC extract, indicating a beneficial effect.",84 days (HS-LC extract),,,hypertension,Type 2 Diabetes Mellitus; blood pressure; cardiovascular disease risk; cardiovascular diseases; endothelial dysfunction; hypertension; inflammation; insulin resistance; metabolic health; mild hypertension; mild to moderate essential hypertension; mild to moderate hypertension; oxidation; prehypertension; vascular function,,,
Hibiscus,Caution with caffeine or similar substrates of CYP1A2; Counsel patients against the use of plant beverages with drugs.; adverse effects on HDL-C concentrations in homozygous B1B1 and E4 carriers; burning; co-administration with simvastatin should be discouraged until more clinical data are available; pruritus; rash; ulcerative colitis flare; urticaria,High Insulin,,Metabolic Health,manual_pair,"The evidence from randomized trials suggests that Hibiscus sabdariffa may effectively reduce blood pressure in individuals with hypertension, with multiple studies reporting significant benefits. Typical doses reported include 250 mg of dried extract daily, 320 mg of plant powder twice daily, and various aqueous extracts in different forms. However, one study showed mixed results, indicating the need for further research to clarify its efficacy compared to standard treatments.",0.9,29311704,2017,Clinical efficacy of African traditional medicines in hypertension: A randomized controlled trial with Combretum micranthum and Hibiscus sabdariffa.,randomized_controlled_trial,benefit,"The study demonstrated a significant decrease in blood pressure with Hibiscus sabdariffa, indicating a beneficial effect in treating hypertension.",320 mg 2/day 4 weeks (capsules of plant powder),,,hypertension,Type 2 Diabetes Mellitus; blood pressure; cardiovascular disease risk; cardiovascular diseases; endothelial dysfunction; hypertension; inflammation; insulin resistance; metabolic health; mild hypertension; mild to moderate essential hypertension; mild to moderate hypertension; oxidation; prehypertension; vascular function,,,
Hibiscus,Caution with caffeine or similar substrates of CYP1A2; Counsel patients against the use of plant beverages with drugs.; adverse effects on HDL-C concentrations in homozygous B1B1 and E4 carriers; burning; co-administration with simvastatin should be discouraged until more clinical data are available; pruritus; rash; ulcerative colitis flare; urticaria,High Insulin,,Metabolic Health,manual_pair,"The evidence from randomized trials suggests that Hibiscus sabdariffa may effectively reduce blood pressure in individuals with hypertension, with multiple studies reporting significant benefits. Typical doses reported include 250 mg of dried extract daily, 320 mg of plant powder twice daily, and various aqueous extracts in different forms. However, one study showed mixed results, indicating the need for further research to clarify its efficacy compared to standard treatments.",0.9,18685605,2009,The effects of sour tea (Hibiscus sabdariffa) on hypertension in patients with type II diabetes.,randomized_controlled_trial,benefit,"The study shows a significant reduction in systolic blood pressure in the Hibiscus group, indicating a beneficial effect.",2 times a day 1 month (infusion),Diabetes Type 2,,hypertension,Type 2 Diabetes Mellitus; blood pressure; cardiovascular disease risk; cardiovascular diseases; endothelial dysfunction; hypertension; inflammation; insulin resistance; metabolic health; mild hypertension; mild to moderate essential hypertension; mild to moderate hypertension; oxidation; prehypertension; vascular function,,,
Hibiscus,Caution with caffeine or similar substrates of CYP1A2; Counsel patients against the use of plant beverages with drugs.; adverse effects on HDL-C concentrations in homozygous B1B1 and E4 carriers; burning; co-administration with simvastatin should be discouraged until more clinical data are available; pruritus; rash; ulcerative colitis flare; urticaria,High Insulin,,Metabolic Health,manual_pair,"The evidence from randomized trials suggests that Hibiscus sabdariffa may effectively reduce blood pressure in individuals with hypertension, with multiple studies reporting significant benefits. Typical doses reported include 250 mg of dried extract daily, 320 mg of plant powder twice daily, and various aqueous extracts in different forms. However, one study showed mixed results, indicating the need for further research to clarify its efficacy compared to standard treatments.",0.9,17315307,2007,"Clinical effects produced by a standardized herbal medicinal product of Hibiscus sabdariffa on patients with hypertension. A randomized, double-blind, lisinopril-controlled clinical trial.",randomized_controlled_trial,benefit,"The study shows significant reductions in blood pressure and good tolerability, indicating a beneficial effect of Hibiscus on hypertension.",250 mg daily 4 weeks (dried extract of H. sabdariffa calyxes),,,hypertension,Type 2 Diabetes Mellitus; blood pressure; cardiovascular disease risk; cardiovascular diseases; endothelial dysfunction; hypertension; inflammation; insulin resistance; metabolic health; mild hypertension; mild to moderate essential hypertension; mild to moderate hypertension; oxidation; prehypertension; vascular function,,,
Hibiscus,Caution with caffeine or similar substrates of CYP1A2; Counsel patients against the use of plant beverages with drugs.; adverse effects on HDL-C concentrations in homozygous B1B1 and E4 carriers; burning; co-administration with simvastatin should be discouraged until more clinical data are available; pruritus; rash; ulcerative colitis flare; urticaria,High Insulin,,Metabolic Health,manual_pair,"The evidence from randomized trials suggests that Hibiscus sabdariffa may effectively reduce blood pressure in individuals with hypertension, with multiple studies reporting significant benefits. Typical doses reported include 250 mg of dried extract daily, 320 mg of plant powder twice daily, and various aqueous extracts in different forms. However, one study showed mixed results, indicating the need for further research to clarify its efficacy compared to standard treatments.",0.9,15330492,2004,Effectiveness and tolerability of a standardized extract from Hibiscus sabdariffa in patients with mild to moderate hypertension: a controlled and randomized clinical trial.,randomized_controlled_trial,mixed_unclear,"The study showed a reduction in blood pressure with Hibiscus, but no significant differences compared to captopril, indicating mixed outcomes.",10 g daily 4 weeks (infusion),,,hypertension,Type 2 Diabetes Mellitus; blood pressure; cardiovascular disease risk; cardiovascular diseases; endothelial dysfunction; hypertension; inflammation; insulin resistance; metabolic health; mild hypertension; mild to moderate essential hypertension; mild to moderate hypertension; oxidation; prehypertension; vascular function,,,
Hibiscus,Caution with caffeine or similar substrates of CYP1A2; Counsel patients against the use of plant beverages with drugs.; adverse effects on HDL-C concentrations in homozygous B1B1 and E4 carriers; burning; co-administration with simvastatin should be discouraged until more clinical data are available; pruritus; rash; ulcerative colitis flare; urticaria,High Insulin,,Metabolic Health,manual_pair,"The evidence from randomized trials suggests that Hibiscus sabdariffa may effectively reduce blood pressure in individuals with hypertension, with multiple studies reporting significant benefits. Typical doses reported include 250 mg of dried extract daily, 320 mg of plant powder twice daily, and various aqueous extracts in different forms. However, one study showed mixed results, indicating the need for further research to clarify its efficacy compared to standard treatments.",0.9,20018807,2010,Hibiscus sabdariffa L. tea (tisane) lowers blood pressure in prehypertensive and mildly hypertensive adults.,randomized_controlled_trial,benefit,"The study found that hibiscus tea significantly lowered systolic blood pressure, indicating a beneficial effect.",720 mL 3 times per day 6 weeks (brewed hibiscus tea),,,mild hypertension,Type 2 Diabetes Mellitus; blood pressure; cardiovascular disease risk; cardiovascular diseases; endothelial dysfunction; hypertension; inflammation; insulin resistance; metabolic health; mild hypertension; mild to moderate essential hypertension; mild to moderate hypertension; oxidation; prehypertension; vascular function,,,
Hibiscus,Caution with caffeine or similar substrates of CYP1A2; Counsel patients against the use of plant beverages with drugs.; adverse effects on HDL-C concentrations in homozygous B1B1 and E4 carriers; burning; co-administration with simvastatin should be discouraged until more clinical data are available; pruritus; rash; ulcerative colitis flare; urticaria,High Insulin,,Metabolic Health,manual_pair,"The evidence from randomized trials suggests that Hibiscus sabdariffa may effectively reduce blood pressure in individuals with hypertension, with multiple studies reporting significant benefits. Typical doses reported include 250 mg of dried extract daily, 320 mg of plant powder twice daily, and various aqueous extracts in different forms. However, one study showed mixed results, indicating the need for further research to clarify its efficacy compared to standard treatments.",0.9,26600645,2015,Effects of aqueous extract of Hibiscus sabdariffa on the renin-angiotensin-aldosterone system of Nigerians with mild to moderate essential hypertension: A comparative study with lisinopril.,randomized_controlled_trial,benefit,"The study showed that Hibiscus extract significantly reduced plasma aldosterone levels comparable to lisinopril, indicating a beneficial effect on hypertension.",150 mg/kg daily 4 weeks (aqueous extract),,,mild to moderate essential hypertension,Type 2 Diabetes Mellitus; blood pressure; cardiovascular disease risk; cardiovascular diseases; endothelial dysfunction; hypertension; inflammation; insulin resistance; metabolic health; mild hypertension; mild to moderate essential hypertension; mild to moderate hypertension; oxidation; prehypertension; vascular function,,,
Hibiscus,Caution with caffeine or similar substrates of CYP1A2; Counsel patients against the use of plant beverages with drugs.; adverse effects on HDL-C concentrations in homozygous B1B1 and E4 carriers; burning; co-administration with simvastatin should be discouraged until more clinical data are available; pruritus; rash; ulcerative colitis flare; urticaria,High Insulin,,Metabolic Health,manual_pair,"The evidence from randomized trials suggests that Hibiscus sabdariffa may effectively reduce blood pressure in individuals with hypertension, with multiple studies reporting significant benefits. Typical doses reported include 250 mg of dried extract daily, 320 mg of plant powder twice daily, and various aqueous extracts in different forms. However, one study showed mixed results, indicating the need for further research to clarify its efficacy compared to standard treatments.",0.9,26289514,2015,Effect of Hibiscus sabdariffaon blood pressure and electrolyte profile of mild to moderate hypertensive Nigerians: A comparative study with hydrochlorothiazide.,randomized_controlled_trial,benefit,"The study demonstrated that Hibiscus sabdariffa significantly reduced blood pressure and did not cause electrolyte imbalance, indicating a beneficial effect compared to hydrochlorothiazide.",4 weeks (Hibiscus sabdariffa),,,mild to moderate hypertension,Type 2 Diabetes Mellitus; blood pressure; cardiovascular disease risk; cardiovascular diseases; endothelial dysfunction; hypertension; inflammation; insulin resistance; metabolic health; mild hypertension; mild to moderate essential hypertension; mild to moderate hypertension; oxidation; prehypertension; vascular function,,,
Hibiscus,Caution with caffeine or similar substrates of CYP1A2; Counsel patients against the use of plant beverages with drugs.; adverse effects on HDL-C concentrations in homozygous B1B1 and E4 carriers; burning; co-administration with simvastatin should be discouraged until more clinical data are available; pruritus; rash; ulcerative colitis flare; urticaria,Low HDL,,Heart & Vascular Health,manual_pair,"Human clinical evidence suggests that Hibiscus sabdariffa may improve lipid profiles in patients with metabolic syndrome and type II diabetes, with studies reporting benefits at doses of 100 mg daily and sour tea consumption twice daily for one month. However, the evidence is limited to two studies, both showing positive outcomes without reported harms or adverse effects, indicating a need for further research to confirm these findings.",0.8,19962289,2010,Effects of Hibiscus sabdariffa extract powder and preventive treatment (diet) on the lipid profiles of patients with metabolic syndrome (MeSy).,randomized_controlled_trial,benefit,The study reports significant improvements in lipid profiles and glucose levels in patients with metabolic syndrome treated with Hibiscus extract.,100 mg daily one month (capsules),,Metabolic Health,dyslipidemia,Type 2 Diabetes Mellitus; dyslipidemia; metabolic disorders; metabolic syndrome,,,
Hibiscus,Caution with caffeine or similar substrates of CYP1A2; Counsel patients against the use of plant beverages with drugs.; adverse effects on HDL-C concentrations in homozygous B1B1 and E4 carriers; burning; co-administration with simvastatin should be discouraged until more clinical data are available; pruritus; rash; ulcerative colitis flare; urticaria,Low HDL,,Heart & Vascular Health,manual_pair,"Human clinical evidence suggests that Hibiscus sabdariffa may improve lipid profiles in patients with metabolic syndrome and type II diabetes, with studies reporting benefits at doses of 100 mg daily and sour tea consumption twice daily for one month. However, the evidence is limited to two studies, both showing positive outcomes without reported harms or adverse effects, indicating a need for further research to confirm these findings.",0.8,19678781,2009,Effects of sour tea (Hibiscus sabdariffa) on lipid profile and lipoproteins in patients with type II diabetes.,randomized_controlled_trial,benefit,"The study shows significant improvements in lipid profiles in patients consuming sour tea, indicating a benefit.",2 times a day 1 month (sour tea),,,metabolic disorders,Type 2 Diabetes Mellitus; dyslipidemia; metabolic disorders; metabolic syndrome,,,
Hibiscus,Caution with caffeine or similar substrates of CYP1A2; Counsel patients against the use of plant beverages with drugs.; adverse effects on HDL-C concentrations in homozygous B1B1 and E4 carriers; burning; co-administration with simvastatin should be discouraged until more clinical data are available; pruritus; rash; ulcerative colitis flare; urticaria,High Triglycerides,,Heart & Vascular Health,manual_pair,"Clinical evidence from two randomized trials indicates that Hibiscus sabdariffa may significantly reduce triglyceride levels in patients, with doses reported as 10 mg and 20 mg of extract over 12 weeks, and 500 mg of calyx powder once daily for 4 weeks. No studies reported harm or lack of benefit, suggesting a consistent positive effect; however, further research is needed to confirm these findings and assess long-term safety.",0.9,22185846,2011,[Therapeutic use Hibiscus sabadariffa extract in the treatment of hypercholesterolemia. A randomized clinical trial].,randomized_controlled_trial,benefit,"The study shows that Hibiscus extract significantly reduces triglycerides, indicating a beneficial effect on hypercholesterolemia.",10 mg 12 weeks (extract); 20 mg 12 weeks (extract),,,hypercholesterolemia,hypercholesterolemia; metabolic syndrome,,,
Hibiscus,Caution with caffeine or similar substrates of CYP1A2; Counsel patients against the use of plant beverages with drugs.; adverse effects on HDL-C concentrations in homozygous B1B1 and E4 carriers; burning; co-administration with simvastatin should be discouraged until more clinical data are available; pruritus; rash; ulcerative colitis flare; urticaria,High Triglycerides,,Heart & Vascular Health,manual_pair,"Clinical evidence from two randomized trials indicates that Hibiscus sabdariffa may significantly reduce triglyceride levels in patients, with doses reported as 10 mg and 20 mg of extract over 12 weeks, and 500 mg of calyx powder once daily for 4 weeks. No studies reported harm or lack of benefit, suggesting a consistent positive effect; however, further research is needed to confirm these findings and assess long-term safety.",0.9,26982618,2016,"Evaluation of the effects of roselle (Hibiscus sabdariffa L.) on oxidative stress and serum levels of lipids, insulin and hs-CRP in adult patients with metabolic syndrome: a double-blind placebo-controlled clinical trial.",randomized_controlled_trial,benefit,"The study showed significant reductions in serum triglycerides and systolic blood pressure, indicating a beneficial effect of Hibiscus in patients with metabolic syndrome.",500 mg once daily 4 weeks (calyx powder),,,metabolic syndrome,hypercholesterolemia; metabolic syndrome,,,
Hibiscus,Caution with caffeine or similar substrates of CYP1A2; Counsel patients against the use of plant beverages with drugs.; adverse effects on HDL-C concentrations in homozygous B1B1 and E4 carriers; burning; co-administration with simvastatin should be discouraged until more clinical data are available; pruritus; rash; ulcerative colitis flare; urticaria,Exercise Induced Inflammation,,"Immune, Inflammation, & Infection",manual_pair,"Current evidence from two randomized trials suggests that Hibiscus sabdariffa may have beneficial effects on oxidative stress, with one study reporting positive outcomes at a dose of 450 mg daily for six weeks. However, the overall quality of the evidence is limited, and further research is needed to confirm these findings and establish optimal dosing. No adverse effects were reported in the studies reviewed.",0.7,27736246,2017,The Effect of Green Tea and Sour Tea (Hibiscus sabdariffa L.) Supplementation on Oxidative Stress and Muscle Damage in Athletes.,randomized_controlled_trial,benefit,"The study showed beneficial effects of Hibiscus on oxidative stress but no significant effects on muscle damage, leading to a classification of 'benefit' for oxidative stress.",450 mg daily 6 weeks (sour tea extract),Athletes,,muscle damage,muscle damage; oxidative stress; systemic antioxidant potential,,,
Hibiscus,Caution with caffeine or similar substrates of CYP1A2; Counsel patients against the use of plant beverages with drugs.; adverse effects on HDL-C concentrations in homozygous B1B1 and E4 carriers; burning; co-administration with simvastatin should be discouraged until more clinical data are available; pruritus; rash; ulcerative colitis flare; urticaria,Exercise Induced Inflammation,,"Immune, Inflammation, & Infection",manual_pair,"Current evidence from two randomized trials suggests that Hibiscus sabdariffa may have beneficial effects on oxidative stress, with one study reporting positive outcomes at a dose of 450 mg daily for six weeks. However, the overall quality of the evidence is limited, and further research is needed to confirm these findings and establish optimal dosing. No adverse effects were reported in the studies reviewed.",0.7,22331521,2012,Consumption of Hibiscus sabdariffa L. aqueous extract and its impact on systemic antioxidant potential in healthy subjects.,randomized_controlled_trial,benefit,"The study shows that Hibiscus extract enhances antioxidant potential and reduces oxidative stress, indicating a beneficial outcome.",(aqueous extract),,,oxidative stress,muscle damage; oxidative stress; systemic antioxidant potential,,,
Hibiscus,Caution with caffeine or similar substrates of CYP1A2; Counsel patients against the use of plant beverages with drugs.; adverse effects on HDL-C concentrations in homozygous B1B1 and E4 carriers; burning; co-administration with simvastatin should be discouraged until more clinical data are available; pruritus; rash; ulcerative colitis flare; urticaria,UTI,,Kidney & Bladder Health,manual_pair,"Human clinical evidence suggests that Hibiscus extract may be beneficial in preventing symptomatic episodes of recurrent uncomplicated urinary tract infections, with two studies reporting positive outcomes related to symptom relief and quality of life. The typical dose reported was 1 tablet of a combination supplement taken twice daily for 7 days. However, the overall evidence is limited and further research is needed to confirm these findings and assess long-term safety and efficacy.",0.7,30362679,2018,"Hibiscus extract, vegetable proteases and Commiphora myrrha are useful to prevent symptomatic UTI episode in patients affected by recurrent uncomplicated urinary tract infections.",clinical_trial,benefit,"The study demonstrated a significant reduction in symptomatic UTI episodes and improvement in quality of life, indicating a beneficial effect of the supplement.","1 tablet twice daily 7 days, then 10 days (combination of Hibiscus extract, vegetable proteases and Commiphora myrrha extract)",,,recurrent urinary tract infections,recurrent urinary tract infections; symptomatic uti; uncomplicated urinary tract infections,,,
Hibiscus,Caution with caffeine or similar substrates of CYP1A2; Counsel patients against the use of plant beverages with drugs.; adverse effects on HDL-C concentrations in homozygous B1B1 and E4 carriers; burning; co-administration with simvastatin should be discouraged until more clinical data are available; pruritus; rash; ulcerative colitis flare; urticaria,UTI,,Kidney & Bladder Health,manual_pair,"Human clinical evidence suggests that Hibiscus extract may be beneficial in preventing symptomatic episodes of recurrent uncomplicated urinary tract infections, with two studies reporting positive outcomes related to symptom relief and quality of life. The typical dose reported was 1 tablet of a combination supplement taken twice daily for 7 days. However, the overall evidence is limited and further research is needed to confirm these findings and assess long-term safety and efficacy.",0.7,29974725,2018,L-Methionine associated with Hibiscus sabdariffa and Boswellia serrata extracts are not inferior to antibiotic treatment for symptoms relief in patients affected by recurrent uncomplicated urinary tract infections: Focus on antibiotic-sparing approach.,randomized_controlled_trial,benefit,"The study demonstrated that the phytotherapic combination improved quality of life and reduced symptoms compared to antibiotics, indicating a benefit.",1 tablet twice daily 7 days (phytotherapic combination),,,recurrent urinary tract infections,recurrent urinary tract infections; symptomatic uti; uncomplicated urinary tract infections,,,
Hibiscus,Caution with caffeine or similar substrates of CYP1A2; Counsel patients against the use of plant beverages with drugs.; adverse effects on HDL-C concentrations in homozygous B1B1 and E4 carriers; burning; co-administration with simvastatin should be discouraged until more clinical data are available; pruritus; rash; ulcerative colitis flare; urticaria,Venous Leg Ulcers,,"Skin, Hair, & Nails",manual_pair,"There is low-quality evidence suggesting that a 4% hibiscus rosa-sinensis leaf extract ointment, applied twice daily for 12 weeks, may aid in the closure of venous leg ulcers when used alongside compression stockings. However, this finding is based on a single pilot study, and further research is needed to confirm these results and assess long-term safety and efficacy.",0.6,31298659,2019,Efficacy and Safety of 4% Hibiscus rosa-sinensis Leaf Extract Ointment as an Adjunct Treatment to Compression Stockings on the Closure of Venous Leg Ulcers: A Pilot Study.,clinical_trial,benefit,"The study demonstrated that the hibiscus ointment, when used with compression stockings, significantly contributed to the closure of venous leg ulcers, indicating a beneficial outcome.",4 % twice daily 12 weeks (leaf extract ointment),,,venous leg ulcers,venous leg ulcers,,,
Inositol,Less effective with familial diabetes; excluded those with diabetes mellitus or receiving fertility treatment; higher rate of deaths in the inositol group; hypercalcemia; increased mortality trend in inositol group; mild gastrointestinal adverse events compared to metformin; nausea in pregnancy,Cognitive Performance,,Cognitive & Neurological Function,manual_pair,"Two randomized trials have reported beneficial effects of inositol, specifically in the form of inositol-stabilized arginine silicate, on cognitive outcomes in healthy adults following single doses of 1.5 g and 1.6 g. However, the evidence is limited to acute effects and does not provide information on long-term use or potential adverse effects.",0.8,34959823,2021,Acute Inositol-Stabilized Arginine Silicate Improves Cognitive Outcomes in Healthy Adults.,randomized_controlled_trial,benefit,"The study demonstrated significant improvements in cognitive outcomes, indicating a beneficial effect of the supplement.",1.5 g single dose acute (Inositol-stabilized arginine silicate),,,cognitive function,cognitive function; executive function; memory; processing speed; reaction time; working memory,,,
Inositol,Less effective with familial diabetes; excluded those with diabetes mellitus or receiving fertility treatment; higher rate of deaths in the inositol group; hypercalcemia; increased mortality trend in inositol group; mild gastrointestinal adverse events compared to metformin; nausea in pregnancy,Cognitive Performance,,Cognitive & Neurological Function,manual_pair,"Two randomized trials have reported beneficial effects of inositol, specifically in the form of inositol-stabilized arginine silicate, on cognitive outcomes in healthy adults following single doses of 1.5 g and 1.6 g. However, the evidence is limited to acute effects and does not provide information on long-term use or potential adverse effects.",0.8,34836014,2021,Effects of Inositol-Enhanced Bonded Arginine Silicate Ingestion on Cognitive and Executive Function in Gamers.,randomized_controlled_trial,benefit,"The study shows significant improvements in cognitive tasks after ingestion of ASI + I, indicating a benefit.",1600 mg single dose (Inositol-enhanced bonded arginine silicate),,,cognitive function,cognitive function; executive function; memory; processing speed; reaction time; working memory,,,
Inositol,Less effective with familial diabetes; excluded those with diabetes mellitus or receiving fertility treatment; higher rate of deaths in the inositol group; hypercalcemia; increased mortality trend in inositol group; mild gastrointestinal adverse events compared to metformin; nausea in pregnancy,Infertiliy,,Women's Health,manual_pair,"The evidence regarding the use of inositol for difficulty conceiving is low and mixed. A randomized trial indicated that while myo-inositol may improve time-to-conception in overweight women, it may have the opposite effect in women with obesity, suggesting variability in response and the need for further research. No consistent dose ranges were reported, and no adverse effects were noted in the studies reviewed.",0.6,36754158,2023,"Time-to-conception and clinical pregnancy rate with a myo-inositol, probiotics, and micronutrient supplement: secondary outcomes of the NiPPeR randomized trial.",randomized_controlled_trial,mixed_unclear,"The intervention showed mixed results; it improved time-to-conception in overweight women but lengthened it in women with obesity, indicating a need for further studies.","(myo-inositol, probiotics, and micronutrients)",Women,,clinical pregnancy rates,clinical pregnancy rates; time-to-natural-conception,,,
Inositol,Less effective with familial diabetes; excluded those with diabetes mellitus or receiving fertility treatment; higher rate of deaths in the inositol group; hypercalcemia; increased mortality trend in inositol group; mild gastrointestinal adverse events compared to metformin; nausea in pregnancy,Elevated Liver Enzymes,,Gut Health,manual_pair,"One randomized controlled trial reported that myo-inositol supplementation for 8 weeks improved metabolic parameters and liver function in obese patients with non-alcoholic fatty liver disease (NAFLD), indicating a potential benefit. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term effects and safety.",0.7,36963888,2023,"Clinical effectiveness of α-lipoic acid, myo-inositol and propolis supplementation on metabolic profiles and liver function in obese patients with NAFLD: A randomized controlled clinical trial.",randomized_controlled_trial,benefit,"The study shows improvements in metabolic parameters and liver function, indicating a benefit from myo-inositol supplementation.",8 weeks,Fatty Liver Disease,Heart & Vascular Health,non-alcoholic fatty liver disease,non-alcoholic fatty liver disease; obesity,,,
Inositol,Less effective with familial diabetes; excluded those with diabetes mellitus or receiving fertility treatment; higher rate of deaths in the inositol group; hypercalcemia; increased mortality trend in inositol group; mild gastrointestinal adverse events compared to metformin; nausea in pregnancy,Gestational Diabetes Prevention,,Women's Health,manual_pair,"One randomized, double-blind, controlled trial found that myo-inositol supplementation at a dose of 2000 mg daily for 10 weeks significantly reduced the incidence of gestational diabetes in overweight pregnant women. No studies reported mixed outcomes or harm, suggesting a potential benefit, though further research may be needed to confirm these findings and assess long-term effects.",0.8,35686634,2023,"The effect of myo-inositol supplementation on the prevention of gestational diabetes in overweight pregnant women: a randomized, double-blind, controlled trial.",randomized_controlled_trial,benefit,"The study shows a significant reduction in the incidence of gestational diabetes in the myo-inositol group, indicating a beneficial effect.",2000 mg daily 10 weeks (supplement with folic acid),Overweight; Pregnant; Women,,gestational diabetes,gestational diabetes; overweight in pregnancy,,,
Inositol,Less effective with familial diabetes; excluded those with diabetes mellitus or receiving fertility treatment; higher rate of deaths in the inositol group; hypercalcemia; increased mortality trend in inositol group; mild gastrointestinal adverse events compared to metformin; nausea in pregnancy,High Insulin,,Metabolic Health,manual_pair,"One randomized trial reported a beneficial effect of inositol, specifically in combination with other supplements, on health parameters in patients with metabolic syndrome, which may include those with high blood sugar. The study used a daily dose of 4 g for four months. Overall, the evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term safety and efficacy.",0.7,38257142,2024,"Effectiveness of a Food Supplement Based on Glucomannan, D-Chiro-Inositol, Cinnamomum zeylanicum Blume and Inulin in Patients with Metabolic Syndrome.",randomized_controlled_trial,benefit,"The study demonstrated significant improvements in various health parameters, indicating a beneficial effect of the supplement.",4 g daily four months (oral),,Heart & Vascular Health; Weight & Body Composition,insulin resistance,Type 2 Diabetes Mellitus; insulin resistance; metabolic syndrome,,,
Inositol,Less effective with familial diabetes; excluded those with diabetes mellitus or receiving fertility treatment; higher rate of deaths in the inositol group; hypercalcemia; increased mortality trend in inositol group; mild gastrointestinal adverse events compared to metformin; nausea in pregnancy,Gestational Diabetes Prevention,,Women's Health,manual_pair,"One randomized controlled trial indicates that myo-inositol supplementation (4000 mg daily) may reduce the incidence of gestational diabetes mellitus (GDM) and improve insulin sensitivity in pregnant women. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term safety and efficacy.",0.8,39141124,2024,"Effect of dietary myo-inositol supplementation on the insulin resistance and the prevention of gestational diabetes mellitus: an open-label, randomized controlled trial.",randomized_controlled_trial,benefit,"The study shows that MI supplementation significantly reduces the incidence of GDM and improves insulin sensitivity, indicating a beneficial effect.",4000 mg daily until 26-28 weeks of gestation (myo-inositol),Pregnant; Women,,gestational diabetes mellitus,gestational diabetes mellitus; insulin resistance,,,
Inositol,Less effective with familial diabetes; excluded those with diabetes mellitus or receiving fertility treatment; higher rate of deaths in the inositol group; hypercalcemia; increased mortality trend in inositol group; mild gastrointestinal adverse events compared to metformin; nausea in pregnancy,Gestational Diabetes Prevention,,Women's Health,manual_pair,"One randomized, placebo-controlled trial indicates that myo-inositol supplementation (2 g twice daily until delivery) may reduce insulin resistance in pregnant women, suggesting a potential benefit for managing high blood sugar during pregnancy. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term safety and efficacy.",0.7,35277398,2022,"Myo-inositol nutritional supplement for prevention of gestational diabetes (EMmY): a randomised, placebo-controlled, double-blind pilot trial with nested qualitative study.",randomized_controlled_trial,benefit,"The study shows a signal for efficacy in reducing insulin resistance with myo-inositol, indicating a potential benefit.",2 g twice daily until delivery (powder),Pregnant; Women,,gestational diabetes,gestational diabetes; insulin resistance,,,
Inositol,Less effective with familial diabetes; excluded those with diabetes mellitus or receiving fertility treatment; higher rate of deaths in the inositol group; hypercalcemia; increased mortality trend in inositol group; mild gastrointestinal adverse events compared to metformin; nausea in pregnancy,High Insulin,,Metabolic Health,manual_pair,"The evidence for myo-inositol in improving fertility outcomes, particularly in women with polycystic ovary syndrome (PCOS), is generally positive, with four studies reporting benefits and one showing mixed results. Typical doses reported include 2 g to 4 g daily, often combined with folic acid. However, the mixed findings in one study suggest that further research is needed to clarify its efficacy across different populations and treatment contexts.",0.8,33928619,2021,A multicenter clinical study with myo-inositol and alpha-lactalbumin in Mexican and Italian PCOS patients.,clinical_trial,benefit,"The study showed improvement in metabolic parameters in PCOS patients, indicating a benefit from the treatment.",2 g twice a day 6 months (oral); 50 mg twice a day 6 months (oral); 200 µg twice a day 6 months (oral),PCOS; Women,,infertility,"infertility; infertility, female; insulin resistance; polycystic ovary syndrome",,,
Inositol,Less effective with familial diabetes; excluded those with diabetes mellitus or receiving fertility treatment; higher rate of deaths in the inositol group; hypercalcemia; increased mortality trend in inositol group; mild gastrointestinal adverse events compared to metformin; nausea in pregnancy,High Insulin,,Metabolic Health,manual_pair,"The evidence for myo-inositol in improving fertility outcomes, particularly in women with polycystic ovary syndrome (PCOS), is generally positive, with four studies reporting benefits and one showing mixed results. Typical doses reported include 2 g to 4 g daily, often combined with folic acid. However, the mixed findings in one study suggest that further research is needed to clarify its efficacy across different populations and treatment contexts.",0.8,40019528,2025,The ameliorative effect of myo-inositol on apoptosis-related genes expression in cumulus cells of women with polycystic ovary syndrome undergoing ICSI and its relationship with the quality of oocyte and embryo.,randomized_controlled_trial,benefit,"The study shows that myo-inositol improves the expression of apoptosis-related genes in women with PCOS, indicating a beneficial effect on health outcomes related to fertility.",2000 mg twice a day 6 weeks (Myo-inositol + folic acid),PCOS; Women,,"infertility, female","infertility; infertility, female; insulin resistance; polycystic ovary syndrome",,,
Inositol,Less effective with familial diabetes; excluded those with diabetes mellitus or receiving fertility treatment; higher rate of deaths in the inositol group; hypercalcemia; increased mortality trend in inositol group; mild gastrointestinal adverse events compared to metformin; nausea in pregnancy,High Insulin,,Metabolic Health,manual_pair,"The evidence for myo-inositol in improving fertility outcomes, particularly in women with polycystic ovary syndrome (PCOS), is generally positive, with four studies reporting benefits and one showing mixed results. Typical doses reported include 2 g to 4 g daily, often combined with folic acid. However, the mixed findings in one study suggest that further research is needed to clarify its efficacy across different populations and treatment contexts.",0.8,39718613,2025,Improvement in biochemical manifestations of the serum and follicular fluid and ICSI outcomes in PCOS patients with myo-inositol administration: prospective randomized research.,randomized_controlled_trial,benefit,"The study shows significant improvements in hormonal profiles and oocyte/embryo quality in women with PCOS, indicating a beneficial effect of myo-inositol.",2000 mg twice a day 6 weeks (myo-inositol + folic acid),PCOS; Women,,"infertility, female","infertility; infertility, female; insulin resistance; polycystic ovary syndrome",,,
Inositol,Less effective with familial diabetes; excluded those with diabetes mellitus or receiving fertility treatment; higher rate of deaths in the inositol group; hypercalcemia; increased mortality trend in inositol group; mild gastrointestinal adverse events compared to metformin; nausea in pregnancy,High Insulin,,Metabolic Health,manual_pair,"The evidence for myo-inositol in improving fertility outcomes, particularly in women with polycystic ovary syndrome (PCOS), is generally positive, with four studies reporting benefits and one showing mixed results. Typical doses reported include 2 g to 4 g daily, often combined with folic acid. However, the mixed findings in one study suggest that further research is needed to clarify its efficacy across different populations and treatment contexts.",0.8,33892722,2021,The effect of Myo-inositol on fertility rates in poor ovarian responder in women undergoing assisted reproductive technique: a randomized clinical trial.,randomized_controlled_trial,mixed_unclear,"The intervention group showed improvements in several ART outcomes, but these were not statistically significant compared to the control group, leading to a classification of mixed outcomes.",4 g daily before enrollment (Inofolic (Myo-inositol + folic acid)),Poor Ovarian Response; Women,,"infertility, female","infertility; infertility, female; insulin resistance; polycystic ovary syndrome",,,
Inositol,Less effective with familial diabetes; excluded those with diabetes mellitus or receiving fertility treatment; higher rate of deaths in the inositol group; hypercalcemia; increased mortality trend in inositol group; mild gastrointestinal adverse events compared to metformin; nausea in pregnancy,High Insulin,,Metabolic Health,manual_pair,"The evidence for myo-inositol in improving fertility outcomes, particularly in women with polycystic ovary syndrome (PCOS), is generally positive, with four studies reporting benefits and one showing mixed results. Typical doses reported include 2 g to 4 g daily, often combined with folic acid. However, the mixed findings in one study suggest that further research is needed to clarify its efficacy across different populations and treatment contexts.",0.8,32018040,2020,Effect of myo-inositol supplementation on ICSI outcomes among poor ovarian responder patients: A randomized controlled trial.,randomized_controlled_trial,benefit,"The study found significant improvements in fertilization rate and embryo quality, indicating a benefit from myo-inositol supplementation.",4 g daily one month before starting ICSI cycle until ovulation trigger (myo-inositol),Poor Ovarian Response; Women,,"infertility, female","infertility; infertility, female; insulin resistance; polycystic ovary syndrome",,,
Inositol,Less effective with familial diabetes; excluded those with diabetes mellitus or receiving fertility treatment; higher rate of deaths in the inositol group; hypercalcemia; increased mortality trend in inositol group; mild gastrointestinal adverse events compared to metformin; nausea in pregnancy,High Blood Glucose,,Metabolic Health,manual_pair,"One randomized controlled trial demonstrated that myo-inositol, in combination with acarbose and metformin, significantly improved metabolic and endocrinologic parameters in women with polycystic ovary syndrome, suggesting a potential benefit for insulin resistance. The doses used in the study included 1000 mg of myo-inositol taken twice daily for six months. No adverse effects were reported, but further research is needed to confirm these findings and assess long-term safety and efficacy.",0.9,38972164,2024,Effectiveness of dual combination therapy of acarbose plus metformin and acarbose plus myo-inositol in ameliorating the metabolic and endocrinologic complications of polycystic ovary syndrome - A randomized controlled trial.,randomized_controlled_trial,benefit,"The study shows significant improvements in metabolic and endocrinologic parameters in PCOS women, indicating a benefit from the combination therapies tested.",500 mg TID 6 months (metformin); 25 mg TID 4 weeks (acarbose); 50 mg TID 20 weeks (acarbose); 1000 mg BD 6 months (myo-inositol),PCOS,,polycystic ovary syndrome,polycystic ovary syndrome,,,
Inositol,Less effective with familial diabetes; excluded those with diabetes mellitus or receiving fertility treatment; higher rate of deaths in the inositol group; hypercalcemia; increased mortality trend in inositol group; mild gastrointestinal adverse events compared to metformin; nausea in pregnancy,Dysmenorrhea,,Women's Health,manual_pair,"The evidence from three randomized trials indicates that inositol, particularly in the form of a myo-inositol and D-chiro-inositol combination, may improve menstrual cycle regulation and ovulation in women with polycystic ovary syndrome (PCOS). Doses reported include 550 mg twice daily, 150 mg twice daily, and 2 g twice daily, with beneficial outcomes consistently observed across studies. No adverse effects were noted in the reviewed studies, but further research may be needed to confirm long-term safety and efficacy.",1.0,34624138,2022,Efficacy of myo-inositol and d-chiro-inositol combination on menstrual cycle regulation and improving insulin resistance in young women with polycystic ovary syndrome: A randomized open-label study.,randomized_controlled_trial,benefit,"The study shows significant improvement in menstrual cycle regulation and insulin resistance, indicating a beneficial effect of the supplement.",550 mg twice a day 6 months; 150 mg twice a day 6 months,PCOS; Women,Metabolic Health,insulin resistance,insulin resistance; menstrual cycle regulation; ovulation restoration; polycystic ovary syndrome; polycystic ovary syndrome (pcos),,,
Inositol,Less effective with familial diabetes; excluded those with diabetes mellitus or receiving fertility treatment; higher rate of deaths in the inositol group; hypercalcemia; increased mortality trend in inositol group; mild gastrointestinal adverse events compared to metformin; nausea in pregnancy,Dysmenorrhea,,Women's Health,manual_pair,"The evidence from three randomized trials indicates that inositol, particularly in the form of a myo-inositol and D-chiro-inositol combination, may improve menstrual cycle regulation and ovulation in women with polycystic ovary syndrome (PCOS). Doses reported include 550 mg twice daily, 150 mg twice daily, and 2 g twice daily, with beneficial outcomes consistently observed across studies. No adverse effects were noted in the reviewed studies, but further research may be needed to confirm long-term safety and efficacy.",1.0,31298405,2019,The 40:1 myo-inositol/D-chiro-inositol plasma ratio is able to restore ovulation in PCOS patients: comparison with other ratios.,randomized_controlled_trial,benefit,"The study found that the 40:1 MI/DCI ratio effectively restored ovulation in PCOS patients, indicating a beneficial outcome.",2 g twice a day 3 months (oral),PCOS; Women,,ovulation restoration,insulin resistance; menstrual cycle regulation; ovulation restoration; polycystic ovary syndrome; polycystic ovary syndrome (pcos),,,
Inositol,Less effective with familial diabetes; excluded those with diabetes mellitus or receiving fertility treatment; higher rate of deaths in the inositol group; hypercalcemia; increased mortality trend in inositol group; mild gastrointestinal adverse events compared to metformin; nausea in pregnancy,Dysmenorrhea,,Women's Health,manual_pair,"The evidence from three randomized trials indicates that inositol, particularly in the form of a myo-inositol and D-chiro-inositol combination, may improve menstrual cycle regulation and ovulation in women with polycystic ovary syndrome (PCOS). Doses reported include 550 mg twice daily, 150 mg twice daily, and 2 g twice daily, with beneficial outcomes consistently observed across studies. No adverse effects were noted in the reviewed studies, but further research may be needed to confirm long-term safety and efficacy.",1.0,39847053,2025,"Comparative efficacy of combined myo-inositol and D-chiro inositol versus metformin across PCOS Phenotypes: enhancing ovarian function, ovulation, and stress response in a prospective clinical trial.",randomized_controlled_trial,benefit,"The study shows significant improvements in various health parameters for PCOS, indicating a benefit from the treatments.",40:1 12 weeks (Myo-inositol and D-chiro-inositol),PCOS; Women,Metabolic Health; Weight & Body Composition,polycystic ovary syndrome (pcos),insulin resistance; menstrual cycle regulation; ovulation restoration; polycystic ovary syndrome; polycystic ovary syndrome (pcos),,,
Inositol,Less effective with familial diabetes; excluded those with diabetes mellitus or receiving fertility treatment; higher rate of deaths in the inositol group; hypercalcemia; increased mortality trend in inositol group; mild gastrointestinal adverse events compared to metformin; nausea in pregnancy,Improve Bone Density,,Musculoskeletal & Pain,manual_pair,"The evidence regarding inositol for low bone density is limited and mixed, primarily derived from one randomized trial (PMID 33835939) that reported no clear benefit on bone mineral density despite administering doses of 300 mg and 600 mg of Myo-inositol Hexaphosphate via intravenous infusion three times weekly for 52 weeks. Overall, the findings do not support a definitive effect of inositol on improving bone density in the studied population.",0.8,33835939,2021,"Effects of Myo-inositol Hexaphosphate (SNF472) on Bone Mineral Density in Patients Receiving Hemodialysis: An Analysis of the Randomized, Placebo-Controlled CaLIPSO Study.",randomized_controlled_trial,mixed_unclear,"Bone mineral density decreased in all groups, with no clear benefit from SNF472, indicating mixed outcomes.",300 mg three times weekly 52 weeks (intravenous infusion); 600 mg three times weekly 52 weeks (intravenous infusion),CKD; Hemodialysis,,bone mineral density reduction,bone mineral density reduction; coronary artery calcification,,,
Inositol,Less effective with familial diabetes; excluded those with diabetes mellitus or receiving fertility treatment; higher rate of deaths in the inositol group; hypercalcemia; increased mortality trend in inositol group; mild gastrointestinal adverse events compared to metformin; nausea in pregnancy,Infertility,,Women's Health,manual_pair,"One randomized controlled trial found that high doses of d-chiro-inositol (300 mg and 27.6 mg daily) improved oocyte quality in women with polycystic ovary syndrome undergoing ICSI. There is currently no evidence of harm or no benefit associated with inositol for this indication, but the overall evidence is limited to a single study, necessitating caution in interpretation.",0.8,31657275,2020,High dose of d-chiro-inositol improves oocyte quality in women with polycystic ovary syndrome undergoing ICSI: a randomized controlled trial.,randomized_controlled_trial,benefit,"The study found that high doses of DCI positively influenced oocyte quality, indicating a benefit.",300 mg daily 12 weeks (Myo-DCI combination); 27.6 mg daily 12 weeks (Myo-DCI combination),PCOS; Women,,"infertility, female","infertility, female; polycystic ovary syndrome",,,
Inositol,Less effective with familial diabetes; excluded those with diabetes mellitus or receiving fertility treatment; higher rate of deaths in the inositol group; hypercalcemia; increased mortality trend in inositol group; mild gastrointestinal adverse events compared to metformin; nausea in pregnancy,Sleep Quality,,Sleep,manual_pair,"There is limited evidence suggesting that myo-inositol supplementation may improve sleep quality, as indicated by one randomized, double-blind, placebo-controlled study involving pregnant women who received 2000 mg daily for 10 weeks. No adverse effects were reported in this study, but further research is needed to confirm these findings and assess the effects in broader populations.",0.7,32933356,2022,"The impact of myo-inositol supplementation on sleep quality in pregnant women: a randomized, double-blind, placebo-controlled study.",randomized_controlled_trial,benefit,"The study found significant improvements in sleep quality metrics, indicating a beneficial effect of myo-inositol supplementation.",2000 mg daily 10 weeks (powder),Pregnant; Women,,pregnancy,pregnancy; sleep quality,,,
Iodine,CMR is not available or feasible or is contraindicated; adverse skin reactions in 1% of control group patients; bitter taste; elevated rates of complications; goiter may lead to poor efficacy; heartburn; higher prevalence of ophthalmopathies in fetal GD group; male gender may lead to poor efficacy; more severe thyrotoxicosis may lead to poor efficacy; mortality of 33%; mucosal irritation reported in 29% of CHX group; pharyngeal discomfort; prolonged skin contact with wet iodine solution; risk of bucking and aspiration; risk of irritation from free iodine release; sore throat; younger age may lead to poor efficacy,Peridontitis,,Oral Health,manual_pair,"Two randomized controlled trials indicate that 1% povidone-iodine may be beneficial in improving clinical indicators of gum disease, specifically periodontitis, when used as a mouthwash or for subgingival irrigation. There are no reports of harm or no benefit in the studies reviewed, suggesting a positive effect; however, the evidence is limited to these two studies and further research may be needed to confirm these findings.",0.8,40523816,2025,"[Efficacy of 1% povidone-iodine mouthwash combined with scaling and root planing in the treatment of periodontitis: a randomized, controlled trial].",randomized_controlled_trial,benefit,"The study demonstrated significant improvements in clinical indicators and patient-reported outcomes, indicating a beneficial effect of the treatment.",1 % once daily 1 week (mouthwash),,,periodontitis,periodontitis,,,
Iodine,CMR is not available or feasible or is contraindicated; adverse skin reactions in 1% of control group patients; bitter taste; elevated rates of complications; goiter may lead to poor efficacy; heartburn; higher prevalence of ophthalmopathies in fetal GD group; male gender may lead to poor efficacy; more severe thyrotoxicosis may lead to poor efficacy; mortality of 33%; mucosal irritation reported in 29% of CHX group; pharyngeal discomfort; prolonged skin contact with wet iodine solution; risk of bucking and aspiration; risk of irritation from free iodine release; sore throat; younger age may lead to poor efficacy,Peridontitis,,Oral Health,manual_pair,"Two randomized controlled trials indicate that 1% povidone-iodine may be beneficial in improving clinical indicators of gum disease, specifically periodontitis, when used as a mouthwash or for subgingival irrigation. There are no reports of harm or no benefit in the studies reviewed, suggesting a positive effect; however, the evidence is limited to these two studies and further research may be needed to confirm these findings.",0.8,38764161,2025,Subgingival 0.75% boric acid vs 1% povidone-iodine adjunctive to subgingival instrumentation in stage II and III periodontitis-A double-blind randomized clinical trial.,randomized_controlled_trial,benefit,The study shows that subgingival irrigation with 1% povidone-iodine is beneficial in reducing periodontal parameters in patients with periodontitis.,1 % single application 12 months (povidone-iodine),,,periodontitis,periodontitis,,,
Iron,"Fewer gastrointestinal side effects, including constipation and nausea.; Gastrointestinal side effects observed more in the first group; Hypophosphatemia occurred asymptomatically in three patients in the FCM group.; adverse drug reactions in 6.9% of patients; black stools; constipation; diarrhea; higher risk of hypersensitivity reactions with FCM compared to IS; increase in migraines (potentially related to study intervention); iron deficiency in diabetics; metallic taste more frequent with daily dosing; nausea; nausea reported by a small minority; non-significant increased risk of hypophosphatemia; occult gastrointestinal bleeding; one death (deemed unrelated); treatment-emergent adverse events in 23.8% of patients; vomiting",Cardiac Risk,,Heart & Vascular Health,manual_pair,"One randomized trial indicated that higher-dose intravenous iron therapy (264 mg monthly) significantly reduced recurrent heart failure events and cardiovascular mortality in patients receiving maintenance dialysis. However, the evidence is limited to this single study, and further research is needed to confirm these findings and assess long-term safety and efficacy.",0.7,40393927,2025,Recurrent event analyses in patients receiving maintenance dialysis and the effect of higher- versus lower-dose chronic intravenous iron therapy: A report focusing on heart failure events from the PIVOTAL trial.,randomized_controlled_trial,benefit,"The proactive high-dose regimen significantly reduced recurrent events related to heart failure and cardiovascular mortality, indicating a benefit.",264 mg monthly 2.1 years (intravenous iron sucrose); 145 mg monthly 2.1 years (intravenous iron sucrose),CKD; Hemodialysis,,cardiovascular disease,cardiovascular disease; end-stage kidney disease; heart failure,,,
Iron,"Fewer gastrointestinal side effects, including constipation and nausea.; Gastrointestinal side effects observed more in the first group; Hypophosphatemia occurred asymptomatically in three patients in the FCM group.; adverse drug reactions in 6.9% of patients; black stools; constipation; diarrhea; higher risk of hypersensitivity reactions with FCM compared to IS; increase in migraines (potentially related to study intervention); iron deficiency in diabetics; metallic taste more frequent with daily dosing; nausea; nausea reported by a small minority; non-significant increased risk of hypophosphatemia; occult gastrointestinal bleeding; one death (deemed unrelated); treatment-emergent adverse events in 23.8% of patients; vomiting",Exercise Recovery,,Performance & Recovery,manual_pair,"The evidence on iron supplementation for low exercise performance is mixed. One randomized controlled trial found that intravenous iron therapy improved exercise economy and fatigue scores in iron-deficient females, while another study indicated that oral iron supplementation did not influence exercise performance despite aiding hematological recovery. Overall, the findings suggest potential benefits in specific populations but lack consistency across studies.",0.8,40032294,2025,"Effect of intravenous iron therapy on exercise performance, fatigue scores and mood states in iron-deficient recreationally active females of reproductive age: a double-blind, randomised control trial (IRONWOMAN Trial).",randomized_controlled_trial,benefit,"Intravenous iron therapy improved exercise economy and fatigue scores, indicating a beneficial effect.",4 weeks (intravenous),Women,,exercise performance,exercise performance; fatigue; hematological recovery; iron deficiency,,,
Iron,"Fewer gastrointestinal side effects, including constipation and nausea.; Gastrointestinal side effects observed more in the first group; Hypophosphatemia occurred asymptomatically in three patients in the FCM group.; adverse drug reactions in 6.9% of patients; black stools; constipation; diarrhea; higher risk of hypersensitivity reactions with FCM compared to IS; increase in migraines (potentially related to study intervention); iron deficiency in diabetics; metallic taste more frequent with daily dosing; nausea; nausea reported by a small minority; non-significant increased risk of hypophosphatemia; occult gastrointestinal bleeding; one death (deemed unrelated); treatment-emergent adverse events in 23.8% of patients; vomiting",Exercise Recovery,,Performance & Recovery,manual_pair,"The evidence on iron supplementation for low exercise performance is mixed. One randomized controlled trial found that intravenous iron therapy improved exercise economy and fatigue scores in iron-deficient females, while another study indicated that oral iron supplementation did not influence exercise performance despite aiding hematological recovery. Overall, the findings suggest potential benefits in specific populations but lack consistency across studies.",0.8,40030077,2025,Iron Supplementation After Blood Donation Expedites Hematological Recovery but Does Not Influence Exercise Performance.,randomized_controlled_trial,mixed_unclear,"Iron supplementation improved hematological recovery but did not affect exercise performance, indicating mixed outcomes.",60 mg daily 5 weeks (oral),,,exercise performance,exercise performance; fatigue; hematological recovery; iron deficiency,,,
L-Arginine,12% mortality during follow-up or treatment; L-arginine should be used with caution in subjects over 60 years old; Moderate adverse events reported; anorexia; dysgeusia; elevated creatine kinase levels; gastritis more common in combination group; glucose tolerance issues; hyperammonemia; liver function test abnormalities; patients with cancer; patients with higher levels of CRP; vasculitis; when used in enteral formula,Acne,,"Skin, Hair, & Nails",manual_pair,"One randomized trial indicates that a cleanser containing L-arginine may significantly improve inflammatory acne and pore size in male Thai subjects when used twice daily for four weeks. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term effects and safety.",0.7,31347768,2020,A cleanser formulated with Tris (hydroxymethyl) aminomethane and l-arginine significantly improves facial acne in male Thai subjects.,randomized_controlled_trial,benefit,"The study shows significant improvement in inflammatory acne and pore size with the Tris/Arg cleanser, indicating a beneficial outcome.",twice a day 4 weeks (Tris/Arg cleanser),,,acne vulgaris,acne vulgaris,,,
L-Arginine,12% mortality during follow-up or treatment; L-arginine should be used with caution in subjects over 60 years old; Moderate adverse events reported; anorexia; dysgeusia; elevated creatine kinase levels; gastritis more common in combination group; glucose tolerance issues; hyperammonemia; liver function test abnormalities; patients with cancer; patients with higher levels of CRP; vasculitis; when used in enteral formula,Anal Fissures,,Gut Health,manual_pair,"One randomized clinical trial reported that L-Arginine (3000 mg three times a day for one month) may improve symptoms and quality of life in patients with chronic anal fissures by reducing internal anal sphincter pressure. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term safety and efficacy.",0.7,36449096,2023,L-Arginine is a feasible supplement to heal chronic anal fissure via reducing internal anal sphincter pressure: a randomized clinical trial study.,randomized_controlled_trial,benefit,The study showed significant improvements in symptoms and quality of life in the L-arginine group compared to placebo.,3000 mg three times a day 1 month (capsule),,,chronic anal fissure,chronic anal fissure,,,
L-Arginine,12% mortality during follow-up or treatment; L-arginine should be used with caution in subjects over 60 years old; Moderate adverse events reported; anorexia; dysgeusia; elevated creatine kinase levels; gastritis more common in combination group; glucose tolerance issues; hyperammonemia; liver function test abnormalities; patients with cancer; patients with higher levels of CRP; vasculitis; when used in enteral formula,Improve Sexual Function,,Women's Health,manual_pair,"The evidence for L-Arginine in treating depression is low quality, with a single randomized controlled trial reporting mixed results. In this study, L-Arginine (1 gram twice daily for four weeks) showed some improvement in sexual function and mood, but these changes were not statistically significant compared to placebo. No studies reported clear benefits or harms associated with L-Arginine for this indication.",0.8,38745327,2024,Effect of l-arginine compared to placebo on sexual function in women with major depressive disorder: a randomized controlled trial.,randomized_controlled_trial,mixed_unclear,"While L-arginine showed some improvement in sexual function and mood, the changes were not statistically significant compared to the placebo group, leading to a classification of mixed_unclear.",1 gram twice daily four weeks,Depression,,major depressive disorder,major depressive disorder; sexual dysfunction,,,
L-Arginine,12% mortality during follow-up or treatment; L-arginine should be used with caution in subjects over 60 years old; Moderate adverse events reported; anorexia; dysgeusia; elevated creatine kinase levels; gastritis more common in combination group; glucose tolerance issues; hyperammonemia; liver function test abnormalities; patients with cancer; patients with higher levels of CRP; vasculitis; when used in enteral formula,COVID-19,,"Immune, Inflammation, & Infection",manual_pair,"One randomized clinical trial suggests that L-Arginine may have beneficial effects in patients hospitalized for COVID-19, specifically reducing the need for respiratory support and shortening hospital stays. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess safety and efficacy across diverse populations.",0.7,36804278,2023,Beneficial effects of L-Arginine in patients hospitalized for COVID-19: New insights from a randomized clinical trial.,randomized_controlled_trial,benefit,"The study shows that L-Arginine significantly reduces respiratory support needs and hospital stay duration, indicating a beneficial effect.",(oral),,,covid-19,covid-19,,,
L-Arginine,12% mortality during follow-up or treatment; L-arginine should be used with caution in subjects over 60 years old; Moderate adverse events reported; anorexia; dysgeusia; elevated creatine kinase levels; gastritis more common in combination group; glucose tolerance issues; hyperammonemia; liver function test abnormalities; patients with cancer; patients with higher levels of CRP; vasculitis; when used in enteral formula,Erectile Dysfunction,,Men's Health,manual_pair,"The clinical evidence for L-Arginine in the treatment of erectile dysfunction is positive, with five randomized controlled trials reporting significant improvements in erectile function across various doses, typically ranging from 2,500 mg to 6 g daily. No studies reported harm or lack of benefit, suggesting a consistent beneficial effect; however, the long-term safety and efficacy of high-dose supplementation remain to be fully established.",0.9,31326304,2019,"Daily Oral l-Arginine Plus Tadalafil in Diabetic Patients with Erectile Dysfunction: A Double-Blinded, Randomized, Controlled Clinical Trial.",randomized_controlled_trial,benefit,"The study shows significant improvement in erectile function and testosterone levels, indicating a beneficial effect of L-Arginine in the treatment of erectile dysfunction in diabetic patients.",(oral),,,diabetes complications,diabetes complications; erectile dysfunction; vasculogenic erectile dysfunction,,,
L-Arginine,12% mortality during follow-up or treatment; L-arginine should be used with caution in subjects over 60 years old; Moderate adverse events reported; anorexia; dysgeusia; elevated creatine kinase levels; gastritis more common in combination group; glucose tolerance issues; hyperammonemia; liver function test abnormalities; patients with cancer; patients with higher levels of CRP; vasculitis; when used in enteral formula,Erectile Dysfunction,,Men's Health,manual_pair,"The clinical evidence for L-Arginine in the treatment of erectile dysfunction is positive, with five randomized controlled trials reporting significant improvements in erectile function across various doses, typically ranging from 2,500 mg to 6 g daily. No studies reported harm or lack of benefit, suggesting a consistent beneficial effect; however, the long-term safety and efficacy of high-dose supplementation remain to be fully established.",0.9,34983126,2022,"Adjuvant daily therapy with L-arginine 2,500 mg and tadalafil 5 mg increases efficacy and duration of benefits of low-intensity extracorporeal shock wave therapy for erectile dysfunction: A prospective, randomized, single-blinded study with 1-year follow-up.",randomized_controlled_trial,benefit,"The study reports significant improvements in erectile function scores with the combination therapy, indicating a beneficial outcome.",2500 mg daily (oral),,,erectile dysfunction,diabetes complications; erectile dysfunction; vasculogenic erectile dysfunction,,,
L-Arginine,12% mortality during follow-up or treatment; L-arginine should be used with caution in subjects over 60 years old; Moderate adverse events reported; anorexia; dysgeusia; elevated creatine kinase levels; gastritis more common in combination group; glucose tolerance issues; hyperammonemia; liver function test abnormalities; patients with cancer; patients with higher levels of CRP; vasculitis; when used in enteral formula,Erectile Dysfunction,,Men's Health,manual_pair,"The clinical evidence for L-Arginine in the treatment of erectile dysfunction is positive, with five randomized controlled trials reporting significant improvements in erectile function across various doses, typically ranging from 2,500 mg to 6 g daily. No studies reported harm or lack of benefit, suggesting a consistent beneficial effect; however, the long-term safety and efficacy of high-dose supplementation remain to be fully established.",0.9,32441833,2020,"Comparison of the clinical efficacy of daily use of L-arginine, tadalafil and combined L-arginine with tadalafil in the treatment of elderly patients with erectile dysfunction.",randomized_controlled_trial,benefit,The study shows significant improvement in erectile dysfunction outcomes with L-Arginine treatment.,5 g daily 6 weeks (oral),,,erectile dysfunction,diabetes complications; erectile dysfunction; vasculogenic erectile dysfunction,,,
L-Arginine,12% mortality during follow-up or treatment; L-arginine should be used with caution in subjects over 60 years old; Moderate adverse events reported; anorexia; dysgeusia; elevated creatine kinase levels; gastritis more common in combination group; glucose tolerance issues; hyperammonemia; liver function test abnormalities; patients with cancer; patients with higher levels of CRP; vasculitis; when used in enteral formula,Erectile Dysfunction,,Men's Health,manual_pair,"The clinical evidence for L-Arginine in the treatment of erectile dysfunction is positive, with five randomized controlled trials reporting significant improvements in erectile function across various doses, typically ranging from 2,500 mg to 6 g daily. No studies reported harm or lack of benefit, suggesting a consistent beneficial effect; however, the long-term safety and efficacy of high-dose supplementation remain to be fully established.",0.9,31267684,2020,Efficacy and tolerability of sildenafil/l-arginine combination relative to sildenafil alone in patients with organic erectile dysfunction.,randomized_controlled_trial,benefit,The combination of L-Arginine with sildenafil showed improved efficacy in treating erectile dysfunction compared to sildenafil alone.,3 g daily 8 weeks (oral),,,erectile dysfunction,diabetes complications; erectile dysfunction; vasculogenic erectile dysfunction,,,
L-Arginine,12% mortality during follow-up or treatment; L-arginine should be used with caution in subjects over 60 years old; Moderate adverse events reported; anorexia; dysgeusia; elevated creatine kinase levels; gastritis more common in combination group; glucose tolerance issues; hyperammonemia; liver function test abnormalities; patients with cancer; patients with higher levels of CRP; vasculitis; when used in enteral formula,Erectile Dysfunction,,Men's Health,manual_pair,"The clinical evidence for L-Arginine in the treatment of erectile dysfunction is positive, with five randomized controlled trials reporting significant improvements in erectile function across various doses, typically ranging from 2,500 mg to 6 g daily. No studies reported harm or lack of benefit, suggesting a consistent beneficial effect; however, the long-term safety and efficacy of high-dose supplementation remain to be fully established.",0.9,34973154,2022,"Long-term high-dose L-arginine supplementation in patients with vasculogenic erectile dysfunction: a multicentre, double-blind, randomized, placebo-controlled clinical trial.",randomized_controlled_trial,benefit,"The study shows significant improvement in erectile function, indicating a beneficial effect of L-Arginine supplementation.",6 g daily 3 months (oral),,,vasculogenic erectile dysfunction,diabetes complications; erectile dysfunction; vasculogenic erectile dysfunction,,,
L-Arginine,12% mortality during follow-up or treatment; L-arginine should be used with caution in subjects over 60 years old; Moderate adverse events reported; anorexia; dysgeusia; elevated creatine kinase levels; gastritis more common in combination group; glucose tolerance issues; hyperammonemia; liver function test abnormalities; patients with cancer; patients with higher levels of CRP; vasculitis; when used in enteral formula,Increase Satiety,,Weight & Body Composition,manual_pair,"One randomized trial suggests that L-Arginine may enhance satiation and reduce calorie intake in moderately overweight male subjects at a dose of 3.2 g. However, the overall evidence is limited, with only one study reporting a benefit and no evidence of harm or no benefit. Further research is needed to confirm these findings and assess long-term effects.",0.7,31535460,2019,Wheat Protein Hydrolysate Fortified With l-Arginine Enhances Satiation Induced by the Capsaicinoid Nonivamide in Moderately Overweight Male Subjects.,randomized_controlled_trial,benefit,"The study shows a significant reduction in calorie intake and enhanced satiation, indicating a beneficial effect of L-Arginine.",3.2 g,,,overweight,overweight; satiation,,,
L-Arginine,12% mortality during follow-up or treatment; L-arginine should be used with caution in subjects over 60 years old; Moderate adverse events reported; anorexia; dysgeusia; elevated creatine kinase levels; gastritis more common in combination group; glucose tolerance issues; hyperammonemia; liver function test abnormalities; patients with cancer; patients with higher levels of CRP; vasculitis; when used in enteral formula,Heart Failure,,Heart & Vascular Health,manual_pair,"One randomized trial reported that L-Arginine supplementation (3 grams daily for 10 weeks) resulted in significant improvements in cardiac function and quality of life in patients with heart failure. However, the overall evidence is limited, with only one study demonstrating a benefit and no reports of harm or mixed outcomes. Further research is needed to confirm these findings and assess long-term effects.",0.7,33610421,2021,Effect of l-arginine on cardiac reverse remodeling and quality of life in patients with heart failure.,randomized_controlled_trial,benefit,"The study showed significant improvements in cardiac function and quality of life, indicating a beneficial effect of L-Arginine supplementation.",3 grams daily 10 weeks,,,heart failure,heart failure; ischemic heart disease,,,
L-Arginine,12% mortality during follow-up or treatment; L-arginine should be used with caution in subjects over 60 years old; Moderate adverse events reported; anorexia; dysgeusia; elevated creatine kinase levels; gastritis more common in combination group; glucose tolerance issues; hyperammonemia; liver function test abnormalities; patients with cancer; patients with higher levels of CRP; vasculitis; when used in enteral formula,Hypertension,,Heart & Vascular Health,manual_pair,"L-arginine supplementation appears to have a beneficial effect on blood pressure, as evidenced by two randomized trials showing significant reductions in blood pressure levels. Doses reported include 8 grams as a single dose and 9 grams daily for two weeks. However, the overall evidence is limited to a small number of studies, and further research is needed to confirm these findings and assess long-term effects.",0.8,34004448,2021,"L-arginine supplementation to mitigate cardiovascular effects of walking outside in the context of traffic-related air pollution in participants with elevated blood pressure: A randomized, double-blind, placebo-controlled trial.",randomized_controlled_trial,benefit,"The study shows significant reductions in blood pressure levels, indicating a beneficial effect of L-arginine supplementation.",9 g daily 2 weeks (oral),,,elevated blood pressure,elevated blood pressure; hypertension; post-exercise hypotension,,,
L-Arginine,12% mortality during follow-up or treatment; L-arginine should be used with caution in subjects over 60 years old; Moderate adverse events reported; anorexia; dysgeusia; elevated creatine kinase levels; gastritis more common in combination group; glucose tolerance issues; hyperammonemia; liver function test abnormalities; patients with cancer; patients with higher levels of CRP; vasculitis; when used in enteral formula,Hypertension,,Heart & Vascular Health,manual_pair,"L-arginine supplementation appears to have a beneficial effect on blood pressure, as evidenced by two randomized trials showing significant reductions in blood pressure levels. Doses reported include 8 grams as a single dose and 9 grams daily for two weeks. However, the overall evidence is limited to a small number of studies, and further research is needed to confirm these findings and assess long-term effects.",0.8,35903950,2023,A Single Dosage of l-Arginine Oral Supplementation Induced Post-Aerobic Exercise Hypotension in Hypertensive Patients.,randomized_controlled_trial,benefit,"The study showed significant post-exercise hypotension in hypertensive patients after l-arginine supplementation, indicating a beneficial effect on blood pressure management.",8 grams single dose (oral),,,hypertension,elevated blood pressure; hypertension; post-exercise hypotension,,,
L-Arginine,12% mortality during follow-up or treatment; L-arginine should be used with caution in subjects over 60 years old; Moderate adverse events reported; anorexia; dysgeusia; elevated creatine kinase levels; gastritis more common in combination group; glucose tolerance issues; hyperammonemia; liver function test abnormalities; patients with cancer; patients with higher levels of CRP; vasculitis; when used in enteral formula,High Blood Glucose,,Metabolic Health,manual_pair,"One study suggests that L-Arginine supplementation, when incorporated into wheat biscuits, may lower postprandial glucose levels and improve satiety in healthy subjects. However, the evidence is limited, with only one trial reporting a benefit and no studies indicating harm or mixed outcomes. Further research is needed to confirm these findings and establish consistent dosing.",0.7,36297065,2022,Postprandial Glucose and Gastrointestinal Hormone Responses of Healthy Subjects to Wheat Biscuits Enriched with L-Arginine or Branched-Chain Amino Acids of Plant Origin.,randomized_controlled_trial,benefit,"The study shows that L-Arginine supplementation in wheat biscuits leads to lower postprandial glucose levels and improved satiety, indicating a beneficial effect on metabolic responses.",(wheat biscuits enriched with L-Arginine),,,gastrointestinal hormone responses,gastrointestinal hormone responses; postprandial glucose response; satiety effects,,,
L-Arginine,12% mortality during follow-up or treatment; L-arginine should be used with caution in subjects over 60 years old; Moderate adverse events reported; anorexia; dysgeusia; elevated creatine kinase levels; gastritis more common in combination group; glucose tolerance issues; hyperammonemia; liver function test abnormalities; patients with cancer; patients with higher levels of CRP; vasculitis; when used in enteral formula,High Blood Glucose,,Metabolic Health,manual_pair,"The evidence for L-Arginine in managing high blood sugar in Type 2 Diabetes is low and mixed. A randomized double-blinded crossover study reported improved glucose tolerance in Europid participants but not in South Asians, suggesting variability in response. No consistent beneficial effects were observed across studies, and no adverse effects were reported.",0.6,30377712,2019,"Effect of L-arginine on energy metabolism, skeletal muscle and brown adipose tissue in South Asian and Europid prediabetic men: a randomised double-blinded crossover study.",randomized_controlled_trial,mixed_unclear,"L-Arginine improved glucose tolerance in Europids but not in South Asians, indicating mixed outcomes.",9 g daily 6 weeks (oral),Men; Prediabetes,,prediabetes,Type 2 Diabetes Mellitus; prediabetes,,,
L-Arginine,12% mortality during follow-up or treatment; L-arginine should be used with caution in subjects over 60 years old; Moderate adverse events reported; anorexia; dysgeusia; elevated creatine kinase levels; gastritis more common in combination group; glucose tolerance issues; hyperammonemia; liver function test abnormalities; patients with cancer; patients with higher levels of CRP; vasculitis; when used in enteral formula,Oxidative Stress,,"Immune, Inflammation, & Infection",manual_pair,"Current evidence on L-Arginine supplementation for inflammation is limited and primarily based on a single study that reported a significant reduction in interleukin-6 levels following six weeks of supplementation in trained males. Overall, the evidence is low-quality, with no consistent findings across multiple studies, and no reported adverse effects. Further research is needed to establish the efficacy and safety of L-Arginine for this indication.",0.6,36571754,2022,High intensity interval training and L-Arginine supplementation decrease interleukin-6 levels in adult trained males.,randomized_controlled_trial,benefit,"The study shows a significant reduction in IL-6 levels, indicating a benefit from L-Arginine supplementation.",six weeks (supplement),,,inflammation,inflammation,,,
L-Arginine,12% mortality during follow-up or treatment; L-arginine should be used with caution in subjects over 60 years old; Moderate adverse events reported; anorexia; dysgeusia; elevated creatine kinase levels; gastritis more common in combination group; glucose tolerance issues; hyperammonemia; liver function test abnormalities; patients with cancer; patients with higher levels of CRP; vasculitis; when used in enteral formula,Long COVID,,"Immune, Inflammation, & Infection",manual_pair,"One randomized clinical trial reported a beneficial effect of L-Arginine supplementation, in combination with Vitamin C, on serum L-arginine concentrations and markers of nitric oxide bioavailability in adults with long COVID. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess the long-term effects and safety of L-Arginine in this population.",0.7,36982151,2023,Effects of l-Arginine Plus Vitamin C Supplementation on l-Arginine Metabolism in Adults with Long COVID: Secondary Analysis of a Randomized Clinical Trial.,randomized_controlled_trial,benefit,"The study shows significant increases in serum l-arginine concentrations and markers of NO bioavailability after supplementation, indicating a beneficial effect.",null null null 28 days (L-Arginine plus Vitamin C),,,long covid,long covid,,,
L-Arginine,12% mortality during follow-up or treatment; L-arginine should be used with caution in subjects over 60 years old; Moderate adverse events reported; anorexia; dysgeusia; elevated creatine kinase levels; gastritis more common in combination group; glucose tolerance issues; hyperammonemia; liver function test abnormalities; patients with cancer; patients with higher levels of CRP; vasculitis; when used in enteral formula,Aerobic Capacity,,Performance & Recovery,manual_pair,"The evidence from five randomized trials indicates that L-Arginine supplementation may improve exercise performance across various metrics, including endurance and power output. Commonly reported doses range from 1.2 g to 10 g daily, with benefits observed in different athletic populations. No studies reported harm or lack of benefit, but the overall quality and consistency of the evidence warrant cautious interpretation.",0.9,39714103,2025,"Investigation of the effect of nitrate and L-arginine intake on aerobic, anaerobic performance, balance, agility, and recovery in elite taekwondo athletes.",randomized_controlled_trial,benefit,"The study demonstrated significant improvements in various performance metrics with L-Arginine supplementation, indicating a beneficial effect.",6 g single dose three hours before exercise (powder),Athletes; Taekwondo,,aerobic performance,aerobic performance; agility; anaerobic performance; balance; cardiopulmonary exercise responses; exercise performance; exercise tolerance; jump performance; muscle damage; overweight; physical fitness; recovery; sports performance,,,
L-Arginine,12% mortality during follow-up or treatment; L-arginine should be used with caution in subjects over 60 years old; Moderate adverse events reported; anorexia; dysgeusia; elevated creatine kinase levels; gastritis more common in combination group; glucose tolerance issues; hyperammonemia; liver function test abnormalities; patients with cancer; patients with higher levels of CRP; vasculitis; when used in enteral formula,Aerobic Capacity,,Performance & Recovery,manual_pair,"The evidence from five randomized trials indicates that L-Arginine supplementation may improve exercise performance across various metrics, including endurance and power output. Commonly reported doses range from 1.2 g to 10 g daily, with benefits observed in different athletic populations. No studies reported harm or lack of benefit, but the overall quality and consistency of the evidence warrant cautious interpretation.",0.9,33260139,2021,L-Arginine Improves Endurance to High-Intensity Interval Exercises in Overweight Men.,randomized_controlled_trial,benefit,"L-Arginine supplementation significantly decreased cardiorespiratory responses during high-intensity interval exercise, indicating a benefit in exercise tolerance for overweight individuals.",6 g,Men; Overweight,,cardiopulmonary exercise responses,aerobic performance; agility; anaerobic performance; balance; cardiopulmonary exercise responses; exercise performance; exercise tolerance; jump performance; muscle damage; overweight; physical fitness; recovery; sports performance,,,
L-Arginine,12% mortality during follow-up or treatment; L-arginine should be used with caution in subjects over 60 years old; Moderate adverse events reported; anorexia; dysgeusia; elevated creatine kinase levels; gastritis more common in combination group; glucose tolerance issues; hyperammonemia; liver function test abnormalities; patients with cancer; patients with higher levels of CRP; vasculitis; when used in enteral formula,Aerobic Capacity,,Performance & Recovery,manual_pair,"The evidence from five randomized trials indicates that L-Arginine supplementation may improve exercise performance across various metrics, including endurance and power output. Commonly reported doses range from 1.2 g to 10 g daily, with benefits observed in different athletic populations. No studies reported harm or lack of benefit, but the overall quality and consistency of the evidence warrant cautious interpretation.",0.9,33815657,2021,Effects of Chronic Supplementation of L-Arginine on Physical Fitness in Water Polo Players.,randomized_controlled_trial,benefit,"L-Arginine improved oxidative metabolism as indicated by a lower lactate-to-speed ratio, suggesting a benefit in exercise performance.",5 grams daily 4 weeks,Water Polo Players,,exercise performance,aerobic performance; agility; anaerobic performance; balance; cardiopulmonary exercise responses; exercise performance; exercise tolerance; jump performance; muscle damage; overweight; physical fitness; recovery; sports performance,,,
L-Arginine,12% mortality during follow-up or treatment; L-arginine should be used with caution in subjects over 60 years old; Moderate adverse events reported; anorexia; dysgeusia; elevated creatine kinase levels; gastritis more common in combination group; glucose tolerance issues; hyperammonemia; liver function test abnormalities; patients with cancer; patients with higher levels of CRP; vasculitis; when used in enteral formula,Aerobic Capacity,,Performance & Recovery,manual_pair,"The evidence from five randomized trials indicates that L-Arginine supplementation may improve exercise performance across various metrics, including endurance and power output. Commonly reported doses range from 1.2 g to 10 g daily, with benefits observed in different athletic populations. No studies reported harm or lack of benefit, but the overall quality and consistency of the evidence warrant cautious interpretation.",0.9,30847640,2019,A combination of oral L-citrulline and L-arginine improved 10-min full-power cycling test performance in male collegiate soccer players: a randomized crossover trial.,randomized_controlled_trial,benefit,"The study shows a significant improvement in cycling performance and subjective perception of exertion, indicating a benefit from L-Arginine supplementation.",1.2 g daily 6 days (oral),Cycling,,exercise tolerance,aerobic performance; agility; anaerobic performance; balance; cardiopulmonary exercise responses; exercise performance; exercise tolerance; jump performance; muscle damage; overweight; physical fitness; recovery; sports performance,,,
L-Arginine,12% mortality during follow-up or treatment; L-arginine should be used with caution in subjects over 60 years old; Moderate adverse events reported; anorexia; dysgeusia; elevated creatine kinase levels; gastritis more common in combination group; glucose tolerance issues; hyperammonemia; liver function test abnormalities; patients with cancer; patients with higher levels of CRP; vasculitis; when used in enteral formula,Aerobic Capacity,,Performance & Recovery,manual_pair,"The evidence from five randomized trials indicates that L-Arginine supplementation may improve exercise performance across various metrics, including endurance and power output. Commonly reported doses range from 1.2 g to 10 g daily, with benefits observed in different athletic populations. No studies reported harm or lack of benefit, but the overall quality and consistency of the evidence warrant cautious interpretation.",0.9,33805883,2021,Effects of Co-Ingestion of β-Hydroxy-β-Methylbutyrate and L-Arginine α-Ketoglutarate on Jump Performance in Young Track and Field Athletes.,randomized_controlled_trial,benefit,"The study shows that L-Arginine α-ketoglutarate helps prevent a decline in jump performance, indicating a benefit.",10 g daily 12 days (L-Arginine α-ketoglutarate),Athletes; Track & Field,,jump performance,aerobic performance; agility; anaerobic performance; balance; cardiopulmonary exercise responses; exercise performance; exercise tolerance; jump performance; muscle damage; overweight; physical fitness; recovery; sports performance,,,
L-Arginine,12% mortality during follow-up or treatment; L-arginine should be used with caution in subjects over 60 years old; Moderate adverse events reported; anorexia; dysgeusia; elevated creatine kinase levels; gastritis more common in combination group; glucose tolerance issues; hyperammonemia; liver function test abnormalities; patients with cancer; patients with higher levels of CRP; vasculitis; when used in enteral formula,Strength,,Performance & Recovery,manual_pair,"One non-randomized clinical trial reported a benefit of L-arginine (500 mg single oral dose) on quadriceps strength, particularly in smokers. However, the evidence is limited due to the lack of randomized trials and the small number of studies, indicating a need for further research to confirm these findings.",0.5,40104233,2024,THE EFFECT OF A SINGLE ORAL DOSE OF L-ARGININE ON QUADRICEPS STRENGTH IN SMOKERS AND NON-SMOKERS: A NON-RANDOMIZED CLINICAL TRIAL.,clinical_trial,benefit,"The study showed an increase in quadriceps strength after L-arginine administration, indicating a benefit, particularly in smokers.",500 mg single dose (oral),,,chronic obstructive pulmonary disease (copd),chronic obstructive pulmonary disease (copd); quadriceps strength; smoking,,,
L-Arginine,12% mortality during follow-up or treatment; L-arginine should be used with caution in subjects over 60 years old; Moderate adverse events reported; anorexia; dysgeusia; elevated creatine kinase levels; gastritis more common in combination group; glucose tolerance issues; hyperammonemia; liver function test abnormalities; patients with cancer; patients with higher levels of CRP; vasculitis; when used in enteral formula,Oral Mucositis,,Oral Health,manual_pair,"L-arginine has shown a benefit in reducing the severity of radiation-induced oral mucositis, as evidenced by a single randomized trial that reported significant improvements in mucositis severity, pain, and weight loss prevention with a dose of 5 g once daily for 7 weeks. However, the overall evidence is limited, with only one study available, and further research is needed to confirm these findings and assess long-term safety and efficacy.",0.7,40603739,2025,L-arginine vs. L-glutamine oral suspensions for radiation-induced oral mucositis: a triple-blind randomized trial.,randomized_controlled_trial,benefit,"L-arginine showed significant benefits in reducing mucositis severity, pain, and preventing weight loss compared to maltodextrin, indicating a positive outcome.",5 g once daily 7 weeks (oral suspension),Cancer,,head and neck cancer,head and neck cancer; radiation-induced oral mucositis,,,
L-Arginine,12% mortality during follow-up or treatment; L-arginine should be used with caution in subjects over 60 years old; Moderate adverse events reported; anorexia; dysgeusia; elevated creatine kinase levels; gastritis more common in combination group; glucose tolerance issues; hyperammonemia; liver function test abnormalities; patients with cancer; patients with higher levels of CRP; vasculitis; when used in enteral formula,Long COVID,,"Immune, Inflammation, & Infection",manual_pair,"There is limited evidence suggesting that L-Arginine may improve persistent fatigue, as indicated by one single-blind randomized controlled trial that reported benefits in physical performance and fatigue with a dosage of 1.66 g taken orally twice daily for 28 days. However, the overall evidence is sparse, and further research is needed to confirm these findings and assess long-term effects and safety.",0.7,36501014,2022,"Effects of l-Arginine Plus Vitamin C Supplementation on Physical Performance, Endothelial Function, and Persistent Fatigue in Adults with Long COVID: A Single-Blind Randomized Controlled Trial.",randomized_controlled_trial,benefit,"The study shows significant improvements in physical performance and fatigue, indicating a beneficial effect of L-Arginine supplementation.",1.66 g twice-daily 28 days (oral),COVID,,endothelial dysfunction,endothelial dysfunction; long covid; persistent fatigue,,,
L-Arginine,12% mortality during follow-up or treatment; L-arginine should be used with caution in subjects over 60 years old; Moderate adverse events reported; anorexia; dysgeusia; elevated creatine kinase levels; gastritis more common in combination group; glucose tolerance issues; hyperammonemia; liver function test abnormalities; patients with cancer; patients with higher levels of CRP; vasculitis; when used in enteral formula,COPD,,Respiratory Health,manual_pair,"One randomized, placebo-controlled trial found that L-arginine supplementation (1.66 g orally twice daily for 4 weeks) significantly improved dyspnea and activities of daily living in patients with COPD. Overall, the evidence suggests a potential benefit for shortness of breath, but further studies are needed to confirm these findings and assess long-term effects and safety.",0.8,40316462,2025,"Impact of L-arginine and liposomal vitamin C supplementation on quality of life and daily life activities in patients with COPD: a randomized, multicenter, single blind, placebo-controlled trial (ILDA study).",randomized_controlled_trial,benefit,"The study demonstrated significant improvements in dyspnea and ADL in COPD patients receiving L-arginine compared to placebo, indicating a beneficial effect.",1.66 g twice daily 4 weeks (oral),,,chronic obstructive pulmonary disease (copd),chronic obstructive pulmonary disease (copd); dyspnea; limitations in activities of daily living (adl),,,
L-Arginine,12% mortality during follow-up or treatment; L-arginine should be used with caution in subjects over 60 years old; Moderate adverse events reported; anorexia; dysgeusia; elevated creatine kinase levels; gastritis more common in combination group; glucose tolerance issues; hyperammonemia; liver function test abnormalities; patients with cancer; patients with higher levels of CRP; vasculitis; when used in enteral formula,Kidney Stones,,Kidney & Bladder Health,manual_pair,"One randomized controlled trial reported that L-arginine (1000 mg once daily for 4 weeks) significantly increased stone expulsion rates and reduced expulsion time in patients with lower ureteral stones compared to control and tamsulosin. Overall, the evidence is limited to a single study demonstrating a benefit, with no reported harms or mixed findings. Further research is needed to confirm these results and assess long-term safety.",0.7,40498114,2025,L-arginine role for stone lower ureter: A randomized controlled trial.,randomized_controlled_trial,benefit,"L-arginine significantly increased stone expulsion rates and reduced expulsion time compared to control and tamsulosin, indicating a beneficial effect.",1000 mg once daily 4 weeks,,,ureteral stones,ureteral stones,,,
L-Carnitine,L-Carnitine may hinder control of HBV; adverse events were mild and in a very limited number of patients; flu-like symptoms; gastric intolerance; immunosuppressive properties; limited efficacy in ADHD; limited efficacy in ALS; limited efficacy in Down syndrome; limited efficacy in ataxia; limited efficacy in chronic fatigue syndrome; limited efficacy in depression; limited efficacy in sciatica; nausea,Migraine Headache,,Musculoskeletal & Pain,manual_pair,"There is limited evidence suggesting that L-Carnitine may have a beneficial effect on anxiety, as indicated by one randomized, triple-blind, placebo-controlled trial that reported improvements in mental health and quality of life in women with migraine. The study used a dose of 500 mg of L-Carnitine daily for 12 weeks. However, the overall evidence is sparse, and further research is needed to confirm these findings and assess the consistency of effects across different populations.",0.7,40082970,2025,"The effects of concurrent alpha-linolenic acid, L-carnitine supplementation on clinical symptoms, mental health, and quality of life in women with migraine: a randomized, triple-blind, placebo-controlled trial.",randomized_controlled_trial,benefit,"The study shows significant improvements in migraine symptoms, mental health, and quality of life, indicating a beneficial effect of the supplementation.",1000 mg daily 12 weeks (alpha-linolenic acid); 500 mg daily 12 weeks (L-carnitine),,,anxiety,anxiety; depression; migraine,,,
L-Carnitine,L-Carnitine may hinder control of HBV; adverse events were mild and in a very limited number of patients; flu-like symptoms; gastric intolerance; immunosuppressive properties; limited efficacy in ADHD; limited efficacy in ALS; limited efficacy in Down syndrome; limited efficacy in ataxia; limited efficacy in chronic fatigue syndrome; limited efficacy in depression; limited efficacy in sciatica; nausea,Sciatic Pain,,Musculoskeletal & Pain,manual_pair,"There is limited evidence suggesting that L-Carnitine may provide benefits for back pain, as indicated by one randomized clinical trial that reported significant improvements in pain and quality of life with a daily dose of 1000 mg for 30 days. However, the overall evidence is sparse, and further studies are needed to confirm these findings and assess long-term effects and safety.",0.7,38138300,2023,"Combined Rehabilitation with Alpha Lipoic Acid, Acetyl-L-Carnitine, Resveratrol, and Cholecalciferolin Discogenic Sciatica in Young People: A Randomized Clinical Trial.",randomized_controlled_trial,benefit,"The study shows significant improvements in pain and quality of life, indicating a beneficial effect of the treatment.",1000 mg daily 30 days (oral),,,back pain,back pain; sciatica,,,
L-Carnitine,L-Carnitine may hinder control of HBV; adverse events were mild and in a very limited number of patients; flu-like symptoms; gastric intolerance; immunosuppressive properties; limited efficacy in ADHD; limited efficacy in ALS; limited efficacy in Down syndrome; limited efficacy in ataxia; limited efficacy in chronic fatigue syndrome; limited efficacy in depression; limited efficacy in sciatica; nausea,Inflammation,,"Immune, Inflammation, & Infection",manual_pair,"One randomized controlled trial reported that L-Carnitine (500 mg twice daily for 8 weeks) in combination with a synbiotic supplement led to significant improvements in biomarkers of metabolic-endotoxemia, inflammation, and oxidative stress in obese patients. Overall, the evidence suggests a potential benefit for chronic inflammation, but further studies are needed to confirm these findings and assess long-term effects.",0.8,36752775,2023,"L-Carnitine and synbiotic co-supplementation: beneficial effects on metabolic-endotoxemia, meta-inflammation, and oxidative-stress biomarkers in obese patients: a double blind, randomized, controlled clinical trial.",randomized_controlled_trial,benefit,"The study showed significant improvements in inflammatory and oxidative stress biomarkers with co-supplementation, indicating a beneficial effect.",500 mg 2 times a day 8 weeks (L-carnitine-tartrate),Obese; Women,,inflammation,inflammation; metabolic-endotoxemia; obesity; oxidative stress,,,
L-Carnitine,L-Carnitine may hinder control of HBV; adverse events were mild and in a very limited number of patients; flu-like symptoms; gastric intolerance; immunosuppressive properties; limited efficacy in ADHD; limited efficacy in ALS; limited efficacy in Down syndrome; limited efficacy in ataxia; limited efficacy in chronic fatigue syndrome; limited efficacy in depression; limited efficacy in sciatica; nausea,Fibromyalgia,,Musculoskeletal & Pain,manual_pair,"One randomized controlled trial reported that acetyl-L-carnitine (ALC) at a dose of 500 mg twice daily for 12 weeks resulted in significant improvements in pain and quality of life measures in patients with fibromyalgia. However, the overall evidence is limited, with only one study demonstrating a benefit and no reports of harm or mixed outcomes.",0.7,37378482,2023,Palmitoylethanolamide and acetyl-L-carnitine act synergistically with duloxetine and pregabalin in fibromyalgia: results of a randomised controlled study.,randomized_controlled_trial,benefit,"The study showed significant improvements in pain and quality of life measures in the group receiving ALC, indicating a beneficial effect.",500 mg b.i.d 12 weeks,,,fibromyalgia,fibromyalgia,,,
L-Carnitine,L-Carnitine may hinder control of HBV; adverse events were mild and in a very limited number of patients; flu-like symptoms; gastric intolerance; immunosuppressive properties; limited efficacy in ADHD; limited efficacy in ALS; limited efficacy in Down syndrome; limited efficacy in ataxia; limited efficacy in chronic fatigue syndrome; limited efficacy in depression; limited efficacy in sciatica; nausea,Improve Memory,,Cognitive & Neurological Function,manual_pair,"One randomized clinical trial reported that Acetyl-L-carnitine (1.5 g orally twice daily for 3 months) resulted in significant improvements in cognitive function and physical performance among older adults, suggesting a potential benefit for cognitive impairment. However, the overall evidence is limited, with only one study demonstrating a positive outcome and no reports of harm or mixed results.",0.7,36043711,2022,Acetyl-L-carnitine Slows the Progression from Prefrailty to Frailty in Older Subjects: A Randomized Interventional Clinical Trial.,randomized_controlled_trial,benefit,"The study shows significant improvements in cognitive function and physical performance in the treated group, indicating a beneficial effect of ALCAR.",1.5 g bis in die 3 months (oral),,,cognitive decline,cognitive decline; frailty; memory improvement; prefrailty,,,
L-Carnitine,L-Carnitine may hinder control of HBV; adverse events were mild and in a very limited number of patients; flu-like symptoms; gastric intolerance; immunosuppressive properties; limited efficacy in ADHD; limited efficacy in ALS; limited efficacy in Down syndrome; limited efficacy in ataxia; limited efficacy in chronic fatigue syndrome; limited efficacy in depression; limited efficacy in sciatica; nausea,COVID-19,,"Immune, Inflammation, & Infection",manual_pair,"One pilot study reported a benefit of L-Carnitine supplementation (3000 mg daily for five days) in patients with mild-to-moderate COVID-19, showing improved clinical parameters and survival. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess safety and efficacy in larger populations.",0.7,35997951,2022,Effects of L-carnitine supplementation in patients with mild-to-moderate COVID-19 disease: a pilot study.,randomized_controlled_trial,benefit,"The study showed improved clinical parameters and survival in the intervention group, indicating a benefit from L-Carnitine supplementation.",3000 mg daily five days (oral),,,covid-19,covid-19,,,
L-Carnitine,L-Carnitine may hinder control of HBV; adverse events were mild and in a very limited number of patients; flu-like symptoms; gastric intolerance; immunosuppressive properties; limited efficacy in ADHD; limited efficacy in ALS; limited efficacy in Down syndrome; limited efficacy in ataxia; limited efficacy in chronic fatigue syndrome; limited efficacy in depression; limited efficacy in sciatica; nausea,Weight Loss,,Weight & Body Composition,manual_pair,"One randomized controlled trial reported beneficial effects of L-Carnitine supplementation (500 mg twice daily for 8 weeks) on anthropometric measures and some cardiometabolic traits in women with obesity. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term safety and efficacy.",0.7,37929031,2023,Ameliorating effects of L-carnitine and synbiotic co-supplementation on anthropometric measures and cardiometabolic traits in women with obesity: a randomized controlled clinical trial.,randomized_controlled_trial,benefit,"The study shows significant improvements in anthropometric and some cardiometabolic parameters, indicating a beneficial effect of L-Carnitine supplementation.",500 mg 2 times a day 8 weeks (L-carnitine tartrate),Obese; Women,Metabolic Health,cardiometabolic traits,cardiometabolic traits; obesity,,,
L-Carnitine,L-Carnitine may hinder control of HBV; adverse events were mild and in a very limited number of patients; flu-like symptoms; gastric intolerance; immunosuppressive properties; limited efficacy in ADHD; limited efficacy in ALS; limited efficacy in Down syndrome; limited efficacy in ataxia; limited efficacy in chronic fatigue syndrome; limited efficacy in depression; limited efficacy in sciatica; nausea,Carpal Tunnel Syndrome,,Musculoskeletal & Pain,manual_pair,"One randomized controlled trial reported a benefit of acetyl-L-carnitine in improving symptoms and pain in patients with carpal tunnel syndrome, using a dose of 600 mg twice daily for 60 days. Overall, the evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term safety and efficacy.",0.7,37366197,2023,"Clinical usefulness of nutraceutics with acetyl-L-carnitine, α-lipoic acid, phosphatidylserine, curcumin, C, E and B-group vitamins in patients awaiting for carpal tunnel release during COVID-19 pandemic: a randomized controlled open label prospective study.",randomized_controlled_trial,benefit,The study showed significant improvement in symptoms and pain with the administration of the dietary integrator containing acetyl-L-carnitine.,600 mg twice a day 60 days (dietary integrator),,,carpal tunnel syndrome,carpal tunnel syndrome,,,
L-Carnitine,L-Carnitine may hinder control of HBV; adverse events were mild and in a very limited number of patients; flu-like symptoms; gastric intolerance; immunosuppressive properties; limited efficacy in ADHD; limited efficacy in ALS; limited efficacy in Down syndrome; limited efficacy in ataxia; limited efficacy in chronic fatigue syndrome; limited efficacy in depression; limited efficacy in sciatica; nausea,High Insulin,,Metabolic Health,manual_pair,"L-Carnitine supplementation has shown a beneficial effect on insulin resistance in a randomized trial involving overweight/obese women with polycystic ovary syndrome, with a dose of 1000 mg daily for 12 weeks. However, the overall evidence is limited to a single study, and further research is needed to confirm these findings in broader populations with Type 2 Diabetes.",0.7,34727201,2022,"The effect of L-carnitine supplementation on insulin resistance, sex hormone-binding globulin and lipid profile in overweight/obese women with polycystic ovary syndrome: a randomized clinical trial.",randomized_controlled_trial,benefit,"L-Carnitine supplementation showed significant improvement in insulin resistance, indicating a beneficial effect.",1000 mg daily 12 weeks,Obese; Overweight; PCOS; Women,,dyslipidemia,dyslipidemia; insulin resistance; polycystic ovary syndrome,,,
L-Carnitine,L-Carnitine may hinder control of HBV; adverse events were mild and in a very limited number of patients; flu-like symptoms; gastric intolerance; immunosuppressive properties; limited efficacy in ADHD; limited efficacy in ALS; limited efficacy in Down syndrome; limited efficacy in ataxia; limited efficacy in chronic fatigue syndrome; limited efficacy in depression; limited efficacy in sciatica; nausea,Graves' Disease,,Metabolic Health,manual_pair,"One randomized trial reported benefits of L-Carnitine supplementation in patients with Graves' Disease, including earlier TRAb negativity and higher rates of spontaneous remission. However, the evidence is limited to a single study, and no adverse effects were reported. Further research is needed to confirm these findings and establish consistent dosing guidelines.",0.7,40871722,2025,Adding L-Carnitine and Selenium to Methimazole in Graves' Disease: A Prospective Randomized Trial on Thyroid Markers and Quality of Life.,randomized_controlled_trial,benefit,"The study showed clinical benefits of L-Carnitine supplementation in Graves' Disease, including earlier TRAb negativity and higher rates of spontaneous remission, indicating a positive outcome.",up to 24 months (combined LCT and Se supplement),,,graves' disease,graves' disease,,,
L-Carnitine,L-Carnitine may hinder control of HBV; adverse events were mild and in a very limited number of patients; flu-like symptoms; gastric intolerance; immunosuppressive properties; limited efficacy in ADHD; limited efficacy in ALS; limited efficacy in Down syndrome; limited efficacy in ataxia; limited efficacy in chronic fatigue syndrome; limited efficacy in depression; limited efficacy in sciatica; nausea,High Insulin,,Metabolic Health,manual_pair,"One randomized clinical trial indicates that acetyl-L-carnitine (1500 mg twice daily for 12 weeks) may improve metabolic and endocrine parameters in women with PCOS, suggesting a potential benefit for insulin resistance. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term effects and safety.",0.8,34047916,2021,Acetyl-L-Carnitine Ameliorates Metabolic and Endocrine Alterations in Women with PCOS: A Double-Blind Randomized Clinical Trial.,randomized_controlled_trial,benefit,The study shows significant improvements in metabolic and endocrine parameters in the acetyl-L-carnitine group compared to the control group.,1500 mg twice daily 12 weeks (acetyl-L-carnitine),PCOS; Women,Women's Health,insulin resistance,insulin resistance; menstrual irregularities; polycystic ovary syndrome,,,
L-Carnitine,L-Carnitine may hinder control of HBV; adverse events were mild and in a very limited number of patients; flu-like symptoms; gastric intolerance; immunosuppressive properties; limited efficacy in ADHD; limited efficacy in ALS; limited efficacy in Down syndrome; limited efficacy in ataxia; limited efficacy in chronic fatigue syndrome; limited efficacy in depression; limited efficacy in sciatica; nausea,Muscle Growth,,Performance & Recovery,manual_pair,"One randomized trial reported a benefit of L-Carnitine tartrate (500 mg) in increasing muscle protein synthesis when combined with creatine, suggesting a potential positive effect on low muscle mass. However, the overall evidence is limited, with only one study demonstrating this outcome and no adverse effects reported. Further research is needed to confirm these findings and establish consistency.",0.7,34836240,2021,Effects of Low Doses of L-Carnitine Tartrate and Lipid Multi-Particulate Formulated Creatine Monohydrate on Muscle Protein Synthesis in Myoblasts and Bioavailability in Humans and Rodents.,randomized_controlled_trial,benefit,"The study shows a significant increase in muscle protein synthesis with the combination of L-Carnitine and creatine, indicating a beneficial outcome.",500 mg (L-carnitine tartrate),,,muscle protein synthesis,muscle protein synthesis,,,
L-Carnitine,L-Carnitine may hinder control of HBV; adverse events were mild and in a very limited number of patients; flu-like symptoms; gastric intolerance; immunosuppressive properties; limited efficacy in ADHD; limited efficacy in ALS; limited efficacy in Down syndrome; limited efficacy in ataxia; limited efficacy in chronic fatigue syndrome; limited efficacy in depression; limited efficacy in sciatica; nausea,Infertility,,Men's Health,manual_pair,"One randomized trial indicates that L-Carnitine, when combined with a compound amino acid capsule, may improve sperm motility in men with asthenospermia after 12 weeks of treatment. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term safety and efficacy.",0.7,38597704,2023,[Compound Amino Acid Capsule (8-11) combined with L-carnitine for the treatment of asthenospermia].,randomized_controlled_trial,benefit,"The study shows significant improvement in sperm motility and other parameters, indicating a beneficial effect of L-Carnitine in treating asthenospermia.",12 weeks (oral liquid),,,asthenospermia,asthenospermia,,,
L-Carnitine,L-Carnitine may hinder control of HBV; adverse events were mild and in a very limited number of patients; flu-like symptoms; gastric intolerance; immunosuppressive properties; limited efficacy in ADHD; limited efficacy in ALS; limited efficacy in Down syndrome; limited efficacy in ataxia; limited efficacy in chronic fatigue syndrome; limited efficacy in depression; limited efficacy in sciatica; nausea,BPH,,Kidney & Bladder Health,manual_pair,"The evidence regarding L-Carnitine for lower urinary tract symptoms is limited and mixed, with one randomized controlled trial indicating improvements in prostate volume and erectile function but no significant changes in International Prostate Symptom Score (IPSS), quality of life, or prostate-specific antigen (PSA) levels. Overall, the findings do not support a clear benefit for this indication, and the quality of evidence is low.",0.8,38105612,2024,"Effects of L-Carnitine and Coenzyme Q10 Supplementation on Lower Urinary Tract Symptoms in Men with Benign Prostatic Hyperplasia: A Randomized, Controlled, Clinical Trial.",randomized_controlled_trial,mixed_unclear,"The study showed significant improvements in prostate volume and erectile function, but no significant changes in IPSS, QoL, and PSA levels, indicating mixed outcomes.",8 weeks,,,benign prostatic hyperplasia,benign prostatic hyperplasia; lower urinary tract symptoms,,,
L-Carnitine,L-Carnitine may hinder control of HBV; adverse events were mild and in a very limited number of patients; flu-like symptoms; gastric intolerance; immunosuppressive properties; limited efficacy in ADHD; limited efficacy in ALS; limited efficacy in Down syndrome; limited efficacy in ataxia; limited efficacy in chronic fatigue syndrome; limited efficacy in depression; limited efficacy in sciatica; nausea,Infertility,,Men's Health,manual_pair,"One randomized controlled trial reported that L-Carnitine (15 g orally twice a day for three months) significantly improved sperm motility, morphology, and concentration in men with idiopathic infertility, suggesting a potential benefit for male fertility parameters. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term effects and safety.",0.7,35856361,2022,Comparison of L-Carnitine vs. Coq10 and Vitamin E for idiopathic male infertility: a randomized controlled trial.,randomized_controlled_trial,benefit,"L-Carnitine significantly improved sperm motility, morphology, and concentration, indicating a beneficial effect on male fertility parameters.",15 g twice a day three months (oral complex nutrient treatment),,,asthenozoospermia,asthenozoospermia; idiopathic male infertility; teratozoospermia,,,
L-Carnitine,L-Carnitine may hinder control of HBV; adverse events were mild and in a very limited number of patients; flu-like symptoms; gastric intolerance; immunosuppressive properties; limited efficacy in ADHD; limited efficacy in ALS; limited efficacy in Down syndrome; limited efficacy in ataxia; limited efficacy in chronic fatigue syndrome; limited efficacy in depression; limited efficacy in sciatica; nausea,Muscle Growth,,Musculoskeletal & Pain,manual_pair,"There is limited evidence from a single randomized double-blind placebo-controlled study indicating that L-Carnitine may have beneficial effects on muscle metabolism in patients experiencing muscle wasting due to glucocorticoid treatment, with a dosage of 2 g per day for 8 weeks. No adverse effects were reported, but the overall evidence is insufficient to draw definitive conclusions due to the lack of multiple studies and mixed findings in broader contexts.",0.7,37078370,2023,l-carnitine downregulate the muscle wasting effect of glucocorticoids in pemphigus patient: A randomized double-blind placebo-controlled study.,randomized_controlled_trial,benefit,"L-Carnitine supplementation led to beneficial changes in muscle metabolism markers, indicating a positive outcome.",2 g per day 8 weeks,Pemphigus Vulgaris,,muscle metabolism,muscle metabolism; muscle wasting; pemphigus vulgaris,,,
L-Carnitine,L-Carnitine may hinder control of HBV; adverse events were mild and in a very limited number of patients; flu-like symptoms; gastric intolerance; immunosuppressive properties; limited efficacy in ADHD; limited efficacy in ALS; limited efficacy in Down syndrome; limited efficacy in ataxia; limited efficacy in chronic fatigue syndrome; limited efficacy in depression; limited efficacy in sciatica; nausea,Stroke Recovery,,Cognitive & Neurological Function,manual_pair,"One pilot clinical trial (PMID 35936217) suggests that Acetyl-L-Carnitine at a dose of 1000 mg orally three times per day for three consecutive days may improve neurological outcomes after acute ischemic stroke, as indicated by significant improvements in NIHSS and mRS scores compared to placebo. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term effects and safety.",0.7,35936217,2022,Clinical Evidence of Acetyl-L-Carnitine Efficacy in the Treatment of Acute Ischemic Stroke: A Pilot Clinical Trial.,randomized_controlled_trial,benefit,"The study showed significant improvements in NIHSS and mRS scores in the ALC group compared to placebo, indicating a beneficial effect.",1000 mg three times per day three consecutive days (oral),,,acute ischemic stroke,acute ischemic stroke,,,
L-Carnitine,L-Carnitine may hinder control of HBV; adverse events were mild and in a very limited number of patients; flu-like symptoms; gastric intolerance; immunosuppressive properties; limited efficacy in ADHD; limited efficacy in ALS; limited efficacy in Down syndrome; limited efficacy in ataxia; limited efficacy in chronic fatigue syndrome; limited efficacy in depression; limited efficacy in sciatica; nausea,Fatty Liver Disease,,Gut Health,manual_pair,"There is limited evidence from a single double-blinded randomized controlled trial suggesting that L-Carnitine may provide a benefit in reducing liver enzyme levels (AST and ALT) in patients with non-alcoholic fatty liver disease (NAFLD) when administered at a dose of 2 grams for 16 weeks. However, the overall evidence is weak due to the small number of studies, and further research is needed to confirm these findings and assess long-term safety and efficacy.",0.7,36314323,2022,Hepatoprotective effect of combination of L-carnitine and magnesium-hydroxide in nonalcoholic fatty liver disease patients: a double-blinded randomized controlled pilot study.,randomized_controlled_trial,benefit,"The treatment group showed a decrease in AST and ALT levels, indicating a potential benefit for NAFLD.",2 grams 16 weeks (CIRRHOS product),Fatty Liver Disease,,non-alcoholic fatty liver disease,non-alcoholic fatty liver disease,,,
L-Carnitine,L-Carnitine may hinder control of HBV; adverse events were mild and in a very limited number of patients; flu-like symptoms; gastric intolerance; immunosuppressive properties; limited efficacy in ADHD; limited efficacy in ALS; limited efficacy in Down syndrome; limited efficacy in ataxia; limited efficacy in chronic fatigue syndrome; limited efficacy in depression; limited efficacy in sciatica; nausea,Exercise Recovery,,Performance & Recovery,manual_pair,"One randomized, double-blind, placebo-controlled trial found that L-Carnitine Tartrate supplementation for 5 weeks improved exercise recovery and reduced fatigue in both men and women. No adverse effects were reported, but the evidence is limited to a single study, indicating a need for further research to confirm these findings and establish consistency across different populations and doses.",0.7,34684429,2021,"L-Carnitine Tartrate Supplementation for 5 Weeks Improves Exercise Recovery in Men and Women: A Randomized, Double-Blind, Placebo-Controlled Trial.",randomized_controlled_trial,benefit,"The study found significant improvements in recovery and fatigue, indicating a beneficial effect of L-carnitine tartrate supplementation.",daily 5 weeks (L-carnitine tartrate),,,exercise recovery,exercise recovery; fatigue,,,
L-Citrulline,lowered diastolic blood pressure in men,Gut Injury During Exercise,,Performance & Recovery,manual_pair,"One randomized trial indicates that L-Citrulline supplementation (10 g orally) may improve splanchnic perfusion and reduce gastrointestinal injury during exercise, suggesting a potential benefit. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess any long-term effects or adverse events.",0.7,24621960,2014,L-citrulline improves splanchnic perfusion and reduces gut injury during exercise.,randomized_controlled_trial,benefit,"L-Citrulline supplementation improved splanchnic perfusion and reduced intestinal injury, indicating a beneficial effect.",10 g single dose (oral),,,gastrointestinal symptoms,gastrointestinal symptoms; intestinal injury; splanchnic hypoperfusion,,,
L-Citrulline,lowered diastolic blood pressure in men,Cardiac Function,,Heart & Vascular Health,manual_pair,"One randomized trial reported that oral L-Citrulline supplementation (3 g per day for 4 months) resulted in significant improvements in left ventricular ejection fraction and functional class in patients with systolic heart failure. However, the overall evidence is limited, with only one study demonstrating a benefit and no reports of harm or mixed outcomes.",0.7,23224924,2012,Improvement of ventricular function in systolic heart failure patients with oral L-citrulline supplementation.,randomized_controlled_trial,benefit,L-citrulline supplementation led to significant improvements in left ventricular ejection fraction and functional class.,3 g day 4 months (oral),Heart Failure,,systolic heart failure,systolic heart failure,,,
L-Citrulline,lowered diastolic blood pressure in men,Arterial Stiffness,,Heart & Vascular Health,manual_pair,"One randomized trial has demonstrated that L-Citrulline supplementation (5.6 g daily for 7 days) significantly reduces arterial stiffness in middle-aged men, indicating a potential benefit. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term effects and safety.",0.8,21067832,2012,Short-term effects of L-citrulline supplementation on arterial stiffness in middle-aged men.,randomized_controlled_trial,benefit,"The study found a significant reduction in arterial stiffness with L-Citrulline supplementation, indicating a beneficial effect.",5.6 g daily 7 days,Men,,arterial stiffness,arterial stiffness,,,
L-Citrulline,lowered diastolic blood pressure in men,Hypertension,,Heart & Vascular Health,manual_pair,"The evidence from randomized trials indicates that L-Citrulline supplementation is associated with beneficial effects on blood pressure, with 12 studies reporting positive outcomes and one showing mixed results. Typical doses reported range from 6 g to 10 g daily, particularly in populations such as older adults and hypertensive postmenopausal women. However, the evidence is not without limitations, as one study indicated potential variability in effects based on sex, suggesting that further research is needed to clarify these findings.",0.9,34990772,2022,L-Citrulline supplementation attenuates aortic pulse pressure and wave reflection responses to cold stress in older adults.,randomized_controlled_trial,benefit,"The study demonstrated significant attenuation of aortic hemodynamic responses to cold stress with L-Citrulline supplementation, indicating a beneficial effect.",6 g daily 14 days,Older Adults,,aortic pulse pressure,aortic pulse pressure; aortic systolic blood pressure; arterial stiffness; blood pressure; blood pressure response; blood pressure responses; cardiovascular diseases; cardiovascular events; cardiovascular health; cardiovascular risk; cold stress; endothelial dysfunction; exercise performance; heart failure with preserved ejection fraction; hypertension; leg muscle function; muscle mass; muscle oxygenation; muscle strength; oxygen uptake kinetics; postmenopausal women; prehypertension; pressure wave responses; wave reflection,,,
L-Citrulline,lowered diastolic blood pressure in men,Hypertension,,Heart & Vascular Health,manual_pair,"The evidence from randomized trials indicates that L-Citrulline supplementation is associated with beneficial effects on blood pressure, with 12 studies reporting positive outcomes and one showing mixed results. Typical doses reported range from 6 g to 10 g daily, particularly in populations such as older adults and hypertensive postmenopausal women. However, the evidence is not without limitations, as one study indicated potential variability in effects based on sex, suggesting that further research is needed to clarify these findings.",0.9,37664994,2024,L-Citrulline supplementation attenuates aortic pressure and pressure waves during metaboreflex activation in postmenopausal women.,randomized_controlled_trial,benefit,"The study demonstrated that L-Citrulline supplementation significantly reduced aortic pressure and pressure wave responses, indicating a beneficial effect in the studied population.",10 g daily 4 weeks,Menopause; Women,,aortic systolic blood pressure,aortic pulse pressure; aortic systolic blood pressure; arterial stiffness; blood pressure; blood pressure response; blood pressure responses; cardiovascular diseases; cardiovascular events; cardiovascular health; cardiovascular risk; cold stress; endothelial dysfunction; exercise performance; heart failure with preserved ejection fraction; hypertension; leg muscle function; muscle mass; muscle oxygenation; muscle strength; oxygen uptake kinetics; postmenopausal women; prehypertension; pressure wave responses; wave reflection,,,
L-Citrulline,lowered diastolic blood pressure in men,Hypertension,,Heart & Vascular Health,manual_pair,"The evidence from randomized trials indicates that L-Citrulline supplementation is associated with beneficial effects on blood pressure, with 12 studies reporting positive outcomes and one showing mixed results. Typical doses reported range from 6 g to 10 g daily, particularly in populations such as older adults and hypertensive postmenopausal women. However, the evidence is not without limitations, as one study indicated potential variability in effects based on sex, suggesting that further research is needed to clarify these findings.",0.9,27160957,2016,"l-Citrulline supplementation attenuates blood pressure, wave reflection and arterial stiffness responses to metaboreflex and cold stress in overweight men.",randomized_controlled_trial,benefit,L-Citrulline showed beneficial effects by attenuating increases in blood pressure and arterial stiffness during stress tests.,6 g daily 14 days,Men; Overweight,,arterial stiffness,aortic pulse pressure; aortic systolic blood pressure; arterial stiffness; blood pressure; blood pressure response; blood pressure responses; cardiovascular diseases; cardiovascular events; cardiovascular health; cardiovascular risk; cold stress; endothelial dysfunction; exercise performance; heart failure with preserved ejection fraction; hypertension; leg muscle function; muscle mass; muscle oxygenation; muscle strength; oxygen uptake kinetics; postmenopausal women; prehypertension; pressure wave responses; wave reflection,,,
L-Citrulline,lowered diastolic blood pressure in men,Hypertension,,Heart & Vascular Health,manual_pair,"The evidence from randomized trials indicates that L-Citrulline supplementation is associated with beneficial effects on blood pressure, with 12 studies reporting positive outcomes and one showing mixed results. Typical doses reported range from 6 g to 10 g daily, particularly in populations such as older adults and hypertensive postmenopausal women. However, the evidence is not without limitations, as one study indicated potential variability in effects based on sex, suggesting that further research is needed to clarify these findings.",0.9,25636814,2015,Impact of L-citrulline supplementation and whole-body vibration training on arterial stiffness and leg muscle function in obese postmenopausal women with high blood pressure.,randomized_controlled_trial,benefit,"The study shows that L-Citrulline supplementation combined with WBVT improves arterial stiffness and leg muscle function, indicating a beneficial outcome.",8 weeks,Menopause; Obese; Women,,arterial stiffness,aortic pulse pressure; aortic systolic blood pressure; arterial stiffness; blood pressure; blood pressure response; blood pressure responses; cardiovascular diseases; cardiovascular events; cardiovascular health; cardiovascular risk; cold stress; endothelial dysfunction; exercise performance; heart failure with preserved ejection fraction; hypertension; leg muscle function; muscle mass; muscle oxygenation; muscle strength; oxygen uptake kinetics; postmenopausal women; prehypertension; pressure wave responses; wave reflection,,,
L-Citrulline,lowered diastolic blood pressure in men,Hypertension,,Heart & Vascular Health,manual_pair,"The evidence from randomized trials indicates that L-Citrulline supplementation is associated with beneficial effects on blood pressure, with 12 studies reporting positive outcomes and one showing mixed results. Typical doses reported range from 6 g to 10 g daily, particularly in populations such as older adults and hypertensive postmenopausal women. However, the evidence is not without limitations, as one study indicated potential variability in effects based on sex, suggesting that further research is needed to clarify these findings.",0.9,26023227,2015,l-Citrulline supplementation improves O2 uptake kinetics and high-intensity exercise performance in humans.,randomized_controlled_trial,benefit,"The study shows that L-Citrulline supplementation improves exercise performance and blood pressure, indicating a beneficial outcome.",6 g daily 7 days (oral),,,blood pressure,aortic pulse pressure; aortic systolic blood pressure; arterial stiffness; blood pressure; blood pressure response; blood pressure responses; cardiovascular diseases; cardiovascular events; cardiovascular health; cardiovascular risk; cold stress; endothelial dysfunction; exercise performance; heart failure with preserved ejection fraction; hypertension; leg muscle function; muscle mass; muscle oxygenation; muscle strength; oxygen uptake kinetics; postmenopausal women; prehypertension; pressure wave responses; wave reflection,,,
L-Citrulline,lowered diastolic blood pressure in men,Hypertension,,Heart & Vascular Health,manual_pair,"The evidence from randomized trials indicates that L-Citrulline supplementation is associated with beneficial effects on blood pressure, with 12 studies reporting positive outcomes and one showing mixed results. Typical doses reported range from 6 g to 10 g daily, particularly in populations such as older adults and hypertensive postmenopausal women. However, the evidence is not without limitations, as one study indicated potential variability in effects based on sex, suggesting that further research is needed to clarify these findings.",0.9,19851298,2010,Oral L-citrulline supplementation attenuates blood pressure response to cold pressor test in young men.,randomized_controlled_trial,benefit,"The study shows that L-citrulline supplementation significantly decreases blood pressure responses during the cold pressor test, indicating a beneficial effect on cardiovascular health.",6 g daily 4 weeks (oral),Men,,blood pressure response,aortic pulse pressure; aortic systolic blood pressure; arterial stiffness; blood pressure; blood pressure response; blood pressure responses; cardiovascular diseases; cardiovascular events; cardiovascular health; cardiovascular risk; cold stress; endothelial dysfunction; exercise performance; heart failure with preserved ejection fraction; hypertension; leg muscle function; muscle mass; muscle oxygenation; muscle strength; oxygen uptake kinetics; postmenopausal women; prehypertension; pressure wave responses; wave reflection,,,
L-Citrulline,lowered diastolic blood pressure in men,Hypertension,,Heart & Vascular Health,manual_pair,"The evidence from randomized trials indicates that L-Citrulline supplementation is associated with beneficial effects on blood pressure, with 12 studies reporting positive outcomes and one showing mixed results. Typical doses reported range from 6 g to 10 g daily, particularly in populations such as older adults and hypertensive postmenopausal women. However, the evidence is not without limitations, as one study indicated potential variability in effects based on sex, suggesting that further research is needed to clarify these findings.",0.9,23467207,2013,The effects of short term L-citrulline supplementation on wave reflection responses to cold exposure with concurrent isometric exercise.,randomized_controlled_trial,benefit,"L-Citrulline significantly decreased blood pressure and augmentation index, indicating a beneficial effect on cardiovascular responses to cold exposure.",100 mg/kg 14 days,,,blood pressure responses,aortic pulse pressure; aortic systolic blood pressure; arterial stiffness; blood pressure; blood pressure response; blood pressure responses; cardiovascular diseases; cardiovascular events; cardiovascular health; cardiovascular risk; cold stress; endothelial dysfunction; exercise performance; heart failure with preserved ejection fraction; hypertension; leg muscle function; muscle mass; muscle oxygenation; muscle strength; oxygen uptake kinetics; postmenopausal women; prehypertension; pressure wave responses; wave reflection,,,
L-Citrulline,lowered diastolic blood pressure in men,Hypertension,,Heart & Vascular Health,manual_pair,"The evidence from randomized trials indicates that L-Citrulline supplementation is associated with beneficial effects on blood pressure, with 12 studies reporting positive outcomes and one showing mixed results. Typical doses reported range from 6 g to 10 g daily, particularly in populations such as older adults and hypertensive postmenopausal women. However, the evidence is not without limitations, as one study indicated potential variability in effects based on sex, suggesting that further research is needed to clarify these findings.",0.9,26863234,2016,Combined whole-body vibration training and l-citrulline supplementation improves pressure wave reflection in obese postmenopausal women.,randomized_controlled_trial,benefit,"The study shows that L-Citrulline supplementation, particularly in combination with WBVT, leads to improvements in blood pressure and vascular health, indicating a beneficial outcome.",8 weeks,Menopause; Obese; Women,,cardiovascular diseases,aortic pulse pressure; aortic systolic blood pressure; arterial stiffness; blood pressure; blood pressure response; blood pressure responses; cardiovascular diseases; cardiovascular events; cardiovascular health; cardiovascular risk; cold stress; endothelial dysfunction; exercise performance; heart failure with preserved ejection fraction; hypertension; leg muscle function; muscle mass; muscle oxygenation; muscle strength; oxygen uptake kinetics; postmenopausal women; prehypertension; pressure wave responses; wave reflection,,,
L-Citrulline,lowered diastolic blood pressure in men,Hypertension,,Heart & Vascular Health,manual_pair,"The evidence from randomized trials indicates that L-Citrulline supplementation is associated with beneficial effects on blood pressure, with 12 studies reporting positive outcomes and one showing mixed results. Typical doses reported range from 6 g to 10 g daily, particularly in populations such as older adults and hypertensive postmenopausal women. However, the evidence is not without limitations, as one study indicated potential variability in effects based on sex, suggesting that further research is needed to clarify these findings.",0.9,38931289,2024,L-Citrulline Supplementation Improves Arterial Blood Flow and Muscle Oxygenation during Handgrip Exercise in Hypertensive Postmenopausal Women.,randomized_controlled_trial,benefit,"The study demonstrated significant improvements in arterial blood flow and muscle oxygenation with L-Citrulline supplementation in hypertensive postmenopausal women, indicating a beneficial effect.",10 g daily 4 weeks,Menopause; Women,,endothelial dysfunction,aortic pulse pressure; aortic systolic blood pressure; arterial stiffness; blood pressure; blood pressure response; blood pressure responses; cardiovascular diseases; cardiovascular events; cardiovascular health; cardiovascular risk; cold stress; endothelial dysfunction; exercise performance; heart failure with preserved ejection fraction; hypertension; leg muscle function; muscle mass; muscle oxygenation; muscle strength; oxygen uptake kinetics; postmenopausal women; prehypertension; pressure wave responses; wave reflection,,,
L-Citrulline,lowered diastolic blood pressure in men,Hypertension,,Heart & Vascular Health,manual_pair,"The evidence from randomized trials indicates that L-Citrulline supplementation is associated with beneficial effects on blood pressure, with 12 studies reporting positive outcomes and one showing mixed results. Typical doses reported range from 6 g to 10 g daily, particularly in populations such as older adults and hypertensive postmenopausal women. However, the evidence is not without limitations, as one study indicated potential variability in effects based on sex, suggesting that further research is needed to clarify these findings.",0.9,36615732,2022,"Combined L-Citrulline Supplementation and Slow Velocity Low-Intensity Resistance Training Improves Leg Endothelial Function, Lean Mass, and Strength in Hypertensive Postmenopausal Women.",randomized_controlled_trial,benefit,"The study demonstrated significant improvements in leg endothelial function, lean mass, and strength with L-Citrulline supplementation, indicating a beneficial outcome.",10 g daily 4 weeks,Menopause; Women,,endothelial dysfunction,aortic pulse pressure; aortic systolic blood pressure; arterial stiffness; blood pressure; blood pressure response; blood pressure responses; cardiovascular diseases; cardiovascular events; cardiovascular health; cardiovascular risk; cold stress; endothelial dysfunction; exercise performance; heart failure with preserved ejection fraction; hypertension; leg muscle function; muscle mass; muscle oxygenation; muscle strength; oxygen uptake kinetics; postmenopausal women; prehypertension; pressure wave responses; wave reflection,,,
L-Citrulline,lowered diastolic blood pressure in men,Hypertension,,Heart & Vascular Health,manual_pair,"The evidence from randomized trials indicates that L-Citrulline supplementation is associated with beneficial effects on blood pressure, with 12 studies reporting positive outcomes and one showing mixed results. Typical doses reported range from 6 g to 10 g daily, particularly in populations such as older adults and hypertensive postmenopausal women. However, the evidence is not without limitations, as one study indicated potential variability in effects based on sex, suggesting that further research is needed to clarify these findings.",0.9,36297080,2022,Effects of L-Citrulline Supplementation on Endothelial Function and Blood Pressure in Hypertensive Postmenopausal Women.,randomized_controlled_trial,benefit,"The study demonstrated that L-Citrulline supplementation improved endothelial function and reduced blood pressure in hypertensive postmenopausal women, indicating a beneficial effect.",10 g daily 4 weeks,Menopause; Women,,endothelial dysfunction,aortic pulse pressure; aortic systolic blood pressure; arterial stiffness; blood pressure; blood pressure response; blood pressure responses; cardiovascular diseases; cardiovascular events; cardiovascular health; cardiovascular risk; cold stress; endothelial dysfunction; exercise performance; heart failure with preserved ejection fraction; hypertension; leg muscle function; muscle mass; muscle oxygenation; muscle strength; oxygen uptake kinetics; postmenopausal women; prehypertension; pressure wave responses; wave reflection,,,
L-Citrulline,lowered diastolic blood pressure in men,Hypertension,,Heart & Vascular Health,manual_pair,"The evidence from randomized trials indicates that L-Citrulline supplementation is associated with beneficial effects on blood pressure, with 12 studies reporting positive outcomes and one showing mixed results. Typical doses reported range from 6 g to 10 g daily, particularly in populations such as older adults and hypertensive postmenopausal women. However, the evidence is not without limitations, as one study indicated potential variability in effects based on sex, suggesting that further research is needed to clarify these findings.",0.9,21154265,2010,Effect of L-arginine or L-citrulline oral supplementation on blood pressure and right ventricular function in heart failure patients with preserved ejection fraction.,randomized_controlled_trial,benefit,"The study shows that L-Citrulline improved right ventricular function and decreased pulmonary artery pressure, indicating a beneficial effect.",3 g daily two months (citrulline malate),Heart Failure,,heart failure with preserved ejection fraction,aortic pulse pressure; aortic systolic blood pressure; arterial stiffness; blood pressure; blood pressure response; blood pressure responses; cardiovascular diseases; cardiovascular events; cardiovascular health; cardiovascular risk; cold stress; endothelial dysfunction; exercise performance; heart failure with preserved ejection fraction; hypertension; leg muscle function; muscle mass; muscle oxygenation; muscle strength; oxygen uptake kinetics; postmenopausal women; prehypertension; pressure wave responses; wave reflection,,,
L-Citrulline,lowered diastolic blood pressure in men,Hypertension,,Heart & Vascular Health,manual_pair,"The evidence from randomized trials indicates that L-Citrulline supplementation is associated with beneficial effects on blood pressure, with 12 studies reporting positive outcomes and one showing mixed results. Typical doses reported range from 6 g to 10 g daily, particularly in populations such as older adults and hypertensive postmenopausal women. However, the evidence is not without limitations, as one study indicated potential variability in effects based on sex, suggesting that further research is needed to clarify these findings.",0.9,33513929,2021,Sex May Modulate the Effects of Combined Polyphenol Extract and L-citrulline Supplementation on Ambulatory Blood Pressure in Adults with Prehypertension: A Randomized Controlled Trial.,randomized_controlled_trial,mixed_unclear,"The study showed no overall benefit on blood pressure for the supplement, but indicated a potential benefit in women, leading to a mixed outcome classification.",2 g daily 6 weeks,,,prehypertension,aortic pulse pressure; aortic systolic blood pressure; arterial stiffness; blood pressure; blood pressure response; blood pressure responses; cardiovascular diseases; cardiovascular events; cardiovascular health; cardiovascular risk; cold stress; endothelial dysfunction; exercise performance; heart failure with preserved ejection fraction; hypertension; leg muscle function; muscle mass; muscle oxygenation; muscle strength; oxygen uptake kinetics; postmenopausal women; prehypertension; pressure wave responses; wave reflection,,,
L-Citrulline,lowered diastolic blood pressure in men,High Blood Glucose,,Metabolic Health,manual_pair,"One double-blind randomized placebo-controlled trial reported that L-Citrulline supplementation (3 g per day for 8 weeks) led to significant improvements in glucose homeostasis and inflammatory markers in overweight and obese patients with type 2 diabetes. Overall, the evidence suggests a potential benefit, but further studies are needed to confirm these findings and assess long-term effects and safety.",0.8,33876875,2021,"The impact of L-citrulline supplementation on glucose homeostasis, lipid profile, and some inflammatory factors in overweight and obese patients with type 2 diabetes: A double-blind randomized placebo-controlled trial.",randomized_controlled_trial,benefit,"L-Citrulline supplementation showed significant improvements in glucose homeostasis and inflammatory markers, indicating a beneficial effect in the studied population.",3 g day 8 weeks,Diabetes Type 2; Obese; Overweight,"Heart & Vascular Health; Immune, Inflammation, & Infection",obesity,Type 2 Diabetes Mellitus; obesity; overweight,,,
L-Citrulline,lowered diastolic blood pressure in men,Muscle Endurance,,Performance & Recovery,manual_pair,"The clinical evidence for L-Citrulline in improving low exercise performance is strong, with 13 studies reporting beneficial outcomes across various exercise modalities and populations. Typical doses reported range from 2 g to 8 g daily, with no studies indicating harm or no benefit. However, the evidence is primarily focused on specific populations, such as trained athletes, and may not be generalizable to all individuals.",0.9,37125500,2023,The effects of L-Citrulline and Glutathione on Endurance performance in young adult trained males.,randomized_controlled_trial,benefit,"The study demonstrated a significant enhancement in blood flow and plasma concentrations of L-citrulline and L-arginine, indicating a benefit in endurance performance.",2 g daily 8 days (capsules),,,aerobic exercise performance,aerobic exercise performance; amino acid metabolism; athletic performance; basketball; blood biomarkers; cycling performance; endurance performance; exercise performance; exercise tolerance; fatigue; hormonal adaptations; leg muscle soreness; muscle fatigue; muscle function; muscle soreness; muscular endurance; muscular strength; nitric oxide synthesis; oxidative stress response; physical performance; rating of perceived exertion; resistance training performance; sports performance; vasodilation,,,
L-Citrulline,lowered diastolic blood pressure in men,Muscle Endurance,,Performance & Recovery,manual_pair,"The clinical evidence for L-Citrulline in improving low exercise performance is strong, with 13 studies reporting beneficial outcomes across various exercise modalities and populations. Typical doses reported range from 2 g to 8 g daily, with no studies indicating harm or no benefit. However, the evidence is primarily focused on specific populations, such as trained athletes, and may not be generalizable to all individuals.",0.9,20499249,2010,L-citrulline-malate influence over branched chain amino acid utilization during exercise.,randomized_controlled_trial,benefit,"The study shows that L-citrulline-malate supplementation enhances amino acid utilization and increases certain metabolites, indicating a beneficial effect on exercise performance.",6 g once 2 hours prior to exercise (L-citrulline-malate),,,amino acid metabolism,aerobic exercise performance; amino acid metabolism; athletic performance; basketball; blood biomarkers; cycling performance; endurance performance; exercise performance; exercise tolerance; fatigue; hormonal adaptations; leg muscle soreness; muscle fatigue; muscle function; muscle soreness; muscular endurance; muscular strength; nitric oxide synthesis; oxidative stress response; physical performance; rating of perceived exertion; resistance training performance; sports performance; vasodilation,,,
L-Citrulline,lowered diastolic blood pressure in men,Muscle Endurance,,Performance & Recovery,manual_pair,"The clinical evidence for L-Citrulline in improving low exercise performance is strong, with 13 studies reporting beneficial outcomes across various exercise modalities and populations. Typical doses reported range from 2 g to 8 g daily, with no studies indicating harm or no benefit. However, the evidence is primarily focused on specific populations, such as trained athletes, and may not be generalizable to all individuals.",0.9,40218864,2025,The Antioxidant Power of Bergamot Polyphenolic Fraction Gold Potentiates the Effects of L-Citrulline in Athlete Performance and Vasodilation in a Pilot Study.,randomized_controlled_trial,benefit,"The study demonstrated significant benefits in athletic performance and vasodilation with L-Citrulline supplementation, particularly in combination with BPFG, with no harmful effects reported.",1000 mg daily 3 months (L-Citrulline); 2000 mg daily 3 months (L-Citrulline); 500 mg daily 3 months (BPFG); 1000 mg daily 3 months (BPFG),,,athletic performance,aerobic exercise performance; amino acid metabolism; athletic performance; basketball; blood biomarkers; cycling performance; endurance performance; exercise performance; exercise tolerance; fatigue; hormonal adaptations; leg muscle soreness; muscle fatigue; muscle function; muscle soreness; muscular endurance; muscular strength; nitric oxide synthesis; oxidative stress response; physical performance; rating of perceived exertion; resistance training performance; sports performance; vasodilation,,,
L-Citrulline,lowered diastolic blood pressure in men,Muscle Endurance,,Performance & Recovery,manual_pair,"The clinical evidence for L-Citrulline in improving low exercise performance is strong, with 13 studies reporting beneficial outcomes across various exercise modalities and populations. Typical doses reported range from 2 g to 8 g daily, with no studies indicating harm or no benefit. However, the evidence is primarily focused on specific populations, such as trained athletes, and may not be generalizable to all individuals.",0.9,40010353,2025,"Effects of Combined Versus Single Supplementation of Creatine, Beta-Alanine, and L-Citrulline During Short Sprint Interval Training on Basketball Players' Performance: A Double-Blind Randomized Placebo-Controlled Trial.",randomized_controlled_trial,benefit,"The study demonstrated significant improvements in physical and physiological performance with L-Citrulline supplementation, indicating a beneficial effect.",6 g daily 28 days,Basketball Players,,athletic performance,aerobic exercise performance; amino acid metabolism; athletic performance; basketball; blood biomarkers; cycling performance; endurance performance; exercise performance; exercise tolerance; fatigue; hormonal adaptations; leg muscle soreness; muscle fatigue; muscle function; muscle soreness; muscular endurance; muscular strength; nitric oxide synthesis; oxidative stress response; physical performance; rating of perceived exertion; resistance training performance; sports performance; vasodilation,,,
L-Citrulline,lowered diastolic blood pressure in men,Muscle Endurance,,Performance & Recovery,manual_pair,"The clinical evidence for L-Citrulline in improving low exercise performance is strong, with 13 studies reporting beneficial outcomes across various exercise modalities and populations. Typical doses reported range from 2 g to 8 g daily, with no studies indicating harm or no benefit. However, the evidence is primarily focused on specific populations, such as trained athletes, and may not be generalizable to all individuals.",0.9,37229544,2023,"Effects of branched chain amino acids, l-citrulline, and alpha-glycerylphosphorylcholine supplementation on exercise performance in trained cyclists: a randomized crossover trial.",randomized_controlled_trial,benefit,"The study demonstrated significant improvements in peak power and time to fatigue, indicating a benefit from L-Citrulline supplementation.",6 g daily 7 days (combined with BCAAs and A-GPC),Cycling,,athletic performance,aerobic exercise performance; amino acid metabolism; athletic performance; basketball; blood biomarkers; cycling performance; endurance performance; exercise performance; exercise tolerance; fatigue; hormonal adaptations; leg muscle soreness; muscle fatigue; muscle function; muscle soreness; muscular endurance; muscular strength; nitric oxide synthesis; oxidative stress response; physical performance; rating of perceived exertion; resistance training performance; sports performance; vasodilation,,,
L-Citrulline,lowered diastolic blood pressure in men,Muscle Endurance,,Performance & Recovery,manual_pair,"The clinical evidence for L-Citrulline in improving low exercise performance is strong, with 13 studies reporting beneficial outcomes across various exercise modalities and populations. Typical doses reported range from 2 g to 8 g daily, with no studies indicating harm or no benefit. However, the evidence is primarily focused on specific populations, such as trained athletes, and may not be generalizable to all individuals.",0.9,31860534,2020,One Week of L-Citrulline Supplementation Improves Performance in Trained Cyclists.,randomized_controlled_trial,benefit,"The study shows a modest improvement in endurance cycling performance, indicating a benefit from L-Citrulline supplementation.",6 g daily 7 days (pure L-Citrulline),Cycling,,athletic performance,aerobic exercise performance; amino acid metabolism; athletic performance; basketball; blood biomarkers; cycling performance; endurance performance; exercise performance; exercise tolerance; fatigue; hormonal adaptations; leg muscle soreness; muscle fatigue; muscle function; muscle soreness; muscular endurance; muscular strength; nitric oxide synthesis; oxidative stress response; physical performance; rating of perceived exertion; resistance training performance; sports performance; vasodilation,,,
L-Citrulline,lowered diastolic blood pressure in men,Muscle Endurance,,Performance & Recovery,manual_pair,"The clinical evidence for L-Citrulline in improving low exercise performance is strong, with 13 studies reporting beneficial outcomes across various exercise modalities and populations. Typical doses reported range from 2 g to 8 g daily, with no studies indicating harm or no benefit. However, the evidence is primarily focused on specific populations, such as trained athletes, and may not be generalizable to all individuals.",0.9,40470618,2025,"Changes in resistance training performance, rating of perceived exertion, and blood biomarkers after six weeks of supplementation with L-citrulline vs. L-citrulline DL-malate in resistance-trained men: a double-blind placebo-controlled trial.",randomized_controlled_trial,benefit,The study shows a significant benefit in upper body muscular endurance and post-exercise NOX response with L-Citrulline supplementation compared to placebo.,8 g daily 6 weeks (L-Citrulline); 12 g daily 6 weeks (L-Citrulline DL-malate); (Placebo),Men,,blood biomarkers,aerobic exercise performance; amino acid metabolism; athletic performance; basketball; blood biomarkers; cycling performance; endurance performance; exercise performance; exercise tolerance; fatigue; hormonal adaptations; leg muscle soreness; muscle fatigue; muscle function; muscle soreness; muscular endurance; muscular strength; nitric oxide synthesis; oxidative stress response; physical performance; rating of perceived exertion; resistance training performance; sports performance; vasodilation,,,
L-Citrulline,lowered diastolic blood pressure in men,Muscle Endurance,,Performance & Recovery,manual_pair,"The clinical evidence for L-Citrulline in improving low exercise performance is strong, with 13 studies reporting beneficial outcomes across various exercise modalities and populations. Typical doses reported range from 2 g to 8 g daily, with no studies indicating harm or no benefit. However, the evidence is primarily focused on specific populations, such as trained athletes, and may not be generalizable to all individuals.",0.9,26900386,2016,Oral L-citrulline supplementation enhances cycling time trial performance in healthy trained men: Double-blind randomized placebo-controlled 2-way crossover study.,randomized_controlled_trial,benefit,"L-Citrulline supplementation significantly improved cycling performance and reduced muscle fatigue, indicating a beneficial outcome.",2.4 g daily 7 days (oral),Cycling,,cycling performance,aerobic exercise performance; amino acid metabolism; athletic performance; basketball; blood biomarkers; cycling performance; endurance performance; exercise performance; exercise tolerance; fatigue; hormonal adaptations; leg muscle soreness; muscle fatigue; muscle function; muscle soreness; muscular endurance; muscular strength; nitric oxide synthesis; oxidative stress response; physical performance; rating of perceived exertion; resistance training performance; sports performance; vasodilation,,,
L-Citrulline,lowered diastolic blood pressure in men,Muscle Endurance,,Performance & Recovery,manual_pair,"The clinical evidence for L-Citrulline in improving low exercise performance is strong, with 13 studies reporting beneficial outcomes across various exercise modalities and populations. Typical doses reported range from 2 g to 8 g daily, with no studies indicating harm or no benefit. However, the evidence is primarily focused on specific populations, such as trained athletes, and may not be generalizable to all individuals.",0.9,28513179,2017,Consumption of Watermelon Juice Enriched in l-Citrulline and Pomegranate Ellagitannins Enhanced Metabolism during Physical Exercise.,randomized_controlled_trial,benefit,"The study shows a significant maintenance of force and decrease in muscle soreness, indicating a beneficial effect of L-Citrulline.",(watermelon juice enriched with l-Citrulline),,,exercise performance,aerobic exercise performance; amino acid metabolism; athletic performance; basketball; blood biomarkers; cycling performance; endurance performance; exercise performance; exercise tolerance; fatigue; hormonal adaptations; leg muscle soreness; muscle fatigue; muscle function; muscle soreness; muscular endurance; muscular strength; nitric oxide synthesis; oxidative stress response; physical performance; rating of perceived exertion; resistance training performance; sports performance; vasodilation,,,
L-Citrulline,lowered diastolic blood pressure in men,Muscle Endurance,,Performance & Recovery,manual_pair,"The clinical evidence for L-Citrulline in improving low exercise performance is strong, with 13 studies reporting beneficial outcomes across various exercise modalities and populations. Typical doses reported range from 2 g to 8 g daily, with no studies indicating harm or no benefit. However, the evidence is primarily focused on specific populations, such as trained athletes, and may not be generalizable to all individuals.",0.9,26097441,2015,Combined L-citrulline and glutathione supplementation increases the concentration of markers indicative of nitric oxide synthesis.,randomized_controlled_trial,benefit,"The study shows significant increases in markers of nitric oxide synthesis with L-Citrulline supplementation, indicating a beneficial effect.",2 g daily 7 days (oral),,,exercise performance,aerobic exercise performance; amino acid metabolism; athletic performance; basketball; blood biomarkers; cycling performance; endurance performance; exercise performance; exercise tolerance; fatigue; hormonal adaptations; leg muscle soreness; muscle fatigue; muscle function; muscle soreness; muscular endurance; muscular strength; nitric oxide synthesis; oxidative stress response; physical performance; rating of perceived exertion; resistance training performance; sports performance; vasodilation,,,
L-Citrulline,lowered diastolic blood pressure in men,Muscle Endurance,,Performance & Recovery,manual_pair,"The clinical evidence for L-Citrulline in improving low exercise performance is strong, with 13 studies reporting beneficial outcomes across various exercise modalities and populations. Typical doses reported range from 2 g to 8 g daily, with no studies indicating harm or no benefit. However, the evidence is primarily focused on specific populations, such as trained athletes, and may not be generalizable to all individuals.",0.9,19585317,2009,Effects of L-citrulline oral supplementation on polymorphonuclear neutrophils oxidative burst and nitric oxide production after exercise.,randomized_controlled_trial,benefit,"The study shows that L-citrulline supplementation improves nitric oxide production and oxidative burst in neutrophils after exercise, indicating a beneficial effect on exercise performance and recovery.",6 g single dose (L-citrulline-malate),Cycling,,exercise performance,aerobic exercise performance; amino acid metabolism; athletic performance; basketball; blood biomarkers; cycling performance; endurance performance; exercise performance; exercise tolerance; fatigue; hormonal adaptations; leg muscle soreness; muscle fatigue; muscle function; muscle soreness; muscular endurance; muscular strength; nitric oxide synthesis; oxidative stress response; physical performance; rating of perceived exertion; resistance training performance; sports performance; vasodilation,,,
L-Citrulline,lowered diastolic blood pressure in men,Muscle Endurance,,Performance & Recovery,manual_pair,"The clinical evidence for L-Citrulline in improving low exercise performance is strong, with 13 studies reporting beneficial outcomes across various exercise modalities and populations. Typical doses reported range from 2 g to 8 g daily, with no studies indicating harm or no benefit. However, the evidence is primarily focused on specific populations, such as trained athletes, and may not be generalizable to all individuals.",0.9,30847640,2019,A combination of oral L-citrulline and L-arginine improved 10-min full-power cycling test performance in male collegiate soccer players: a randomized crossover trial.,randomized_controlled_trial,benefit,"The study shows a significant improvement in cycling performance and subjective perception of exertion, indicating a benefit from L-Citrulline.",1.2 g daily 6 days (oral),Cycling; Soccer Players,,exercise tolerance,aerobic exercise performance; amino acid metabolism; athletic performance; basketball; blood biomarkers; cycling performance; endurance performance; exercise performance; exercise tolerance; fatigue; hormonal adaptations; leg muscle soreness; muscle fatigue; muscle function; muscle soreness; muscular endurance; muscular strength; nitric oxide synthesis; oxidative stress response; physical performance; rating of perceived exertion; resistance training performance; sports performance; vasodilation,,,
L-Citrulline,lowered diastolic blood pressure in men,Muscle Endurance,,Performance & Recovery,manual_pair,"The clinical evidence for L-Citrulline in improving low exercise performance is strong, with 13 studies reporting beneficial outcomes across various exercise modalities and populations. Typical doses reported range from 2 g to 8 g daily, with no studies indicating harm or no benefit. However, the evidence is primarily focused on specific populations, such as trained athletes, and may not be generalizable to all individuals.",0.9,40469872,2025,Combined Vs. Single Supplementation of L-Citrulline and Sodium Bicarbonate During Sprint Interval Training in Basketball Players: Effects on Physical Performance and Hormonal Adaptations.,randomized_controlled_trial,benefit,"The study shows significant improvements in physical performance with L-Citrulline supplementation compared to placebo, indicating a benefit.",6 g daily 28 days (capsule),Basketball Players,,hormonal adaptations,aerobic exercise performance; amino acid metabolism; athletic performance; basketball; blood biomarkers; cycling performance; endurance performance; exercise performance; exercise tolerance; fatigue; hormonal adaptations; leg muscle soreness; muscle fatigue; muscle function; muscle soreness; muscular endurance; muscular strength; nitric oxide synthesis; oxidative stress response; physical performance; rating of perceived exertion; resistance training performance; sports performance; vasodilation,,,
L-Citrulline,lowered diastolic blood pressure in men,Muscle Growth,,Performance & Recovery,manual_pair,"One randomized trial indicates that L-Citrulline supplementation, in conjunction with resistance training, may increase lean muscle mass without adverse effects on blood clinical safety markers. However, the evidence is limited to a single study, and further research is needed to confirm these findings and establish consistent dosing guidelines.",0.7,29945625,2018,Eight weeks of resistance training in conjunction with glutathione and L-Citrulline supplementation increases lean mass and has no adverse effects on blood clinical safety markers in resistance-trained males.,randomized_controlled_trial,benefit,The study shows a benefit in lean mass increase associated with L-Citrulline supplementation during resistance training.,daily 8 weeks (capsules),,,increased lean mass,increased lean mass; muscle strength,,,
L-Citrulline,lowered diastolic blood pressure in men,Erectile Dysfunction,,Men's Health,manual_pair,"There is limited evidence suggesting that L-Citrulline may improve erection hardness in men with mild erectile dysfunction, based on one study that reported a significant benefit with a daily dose of 1.5 g for one month. However, due to the low number of studies and lack of replication, the overall evidence remains weak and further research is needed to confirm these findings.",0.6,21195829,2011,Oral L-citrulline supplementation improves erection hardness in men with mild erectile dysfunction.,clinical_trial,benefit,"The study showed a significant improvement in erection hardness scores with L-citrulline supplementation compared to placebo, indicating a benefit.",1.5 g daily 1 month (oral),,,mild erectile dysfunction,mild erectile dysfunction,,,
L-Citrulline,lowered diastolic blood pressure in men,Aerobic Capacity,,Performance & Recovery,manual_pair,"The evidence regarding L-Citrulline supplementation for muscle oxygenation is mixed and unclear, with one study indicating improved oxygen uptake kinetics in young men at a dose of 6 g daily for 7 days, but no significant effects observed in older adults or women. Overall, the findings do not support a consistent benefit across different populations.",0.7,29394491,2018,Impact of l-citrulline supplementation on oxygen uptake kinetics during walking.,randomized_controlled_trial,mixed_unclear,L-Citrulline improved oxygen uptake kinetics in young men but had no significant effect in older adults or women.,6 g daily 7 days,,,muscle oxygenation,muscle oxygenation,,,
L-Citrulline,lowered diastolic blood pressure in men,Becker Muscular Dystrophy,,Musculoskeletal & Pain,manual_pair,"The evidence for L-Citrulline in addressing muscle weakness is mixed. One study reported a benefit in improving walking speed among older adults with sarcopenia, while another study indicated unclear effects when combined with metformin in Becker muscular dystrophy patients. Typical doses reported include 5 g three times per day, but the overall quality of evidence is low and further research is needed to clarify its efficacy.",0.6,30003335,2018,Effects of single and combined metformin and L-citrulline supplementation on L-arginine-related pathways in Becker muscular dystrophy patients: possible biochemical and clinical implications.,clinical_trial,mixed_unclear,"The study shows mixed results regarding the biochemical effects of L-Citrulline and metformin, with some benefits but also indications that their combination may negate individual effects.",5 g 3 times per day,,,becker muscular dystrophy,becker muscular dystrophy; sarcopenia,,,
L-Citrulline,lowered diastolic blood pressure in men,Becker Muscular Dystrophy,,Musculoskeletal & Pain,manual_pair,"The evidence for L-Citrulline in addressing muscle weakness is mixed. One study reported a benefit in improving walking speed among older adults with sarcopenia, while another study indicated unclear effects when combined with metformin in Becker muscular dystrophy patients. Typical doses reported include 5 g three times per day, but the overall quality of evidence is low and further research is needed to clarify its efficacy.",0.6,34579009,2021,L-Citrulline Supplementation and Exercise in the Management of Sarcopenia.,randomized_controlled_trial,benefit,"The study showed significant improvement in walking speed for the citrulline group, indicating a benefit in managing sarcopenia.",six weeks (supplemented),Older Adults,,sarcopenia,becker muscular dystrophy; sarcopenia,,,
L-Citrulline,lowered diastolic blood pressure in men,Asthma,,Respiratory Health,manual_pair,"One randomized trial indicates that L-Citrulline at a dose of 15 g daily for 2 weeks may improve asthma control and FeNO levels in obese asthmatics. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term effects and safety.",0.7,31714895,2019,L-Citrulline increases nitric oxide and improves control in obese asthmatics.,randomized_controlled_trial,benefit,"L-Citrulline treatment improved asthma control and FeNO levels, indicating a beneficial effect.",15 g daily 2 weeks,Asthma,,asthma,asthma; obesity,,,
L-Citrulline,lowered diastolic blood pressure in men,Endothelial Function,,Heart & Vascular Health,manual_pair,"One randomized clinical trial reported that L-Citrulline significantly improved endothelial function in patients with coronary artery disease, as measured by the flow-mediated dilation (FMD) to nitroglycerin-mediated dilation (NMD) ratio. However, the evidence is limited to a single study, and no adverse effects were reported. Further research is needed to confirm these findings and establish consistent dosing guidelines.",0.7,27648629,2017,"The Assessment of short-term effect of L-Citrulline on endothelial function via FMD to NMD ratio in known CAD patients: A randomized, cross-over clinical trial (Clinical trial number: NCT02638727).",randomized_controlled_trial,benefit,L-Citrulline significantly improved endothelial function as measured by FMD to NMD ratio and FMD value.,null null daily 15 days (null),CAD,,coronary artery disease,coronary artery disease,,,
L-Citrulline,lowered diastolic blood pressure in men,Exercise Performance,,Performance & Recovery,manual_pair,"There is low-quality evidence suggesting that L-Citrulline may improve exercise capacity, as indicated by a single randomized trial showing significant improvements in walking distance and quality of life in patients with idiopathic pulmonary arterial hypertension. The study utilized a dose of 1 g of L-Citrulline malate three times daily for two weeks. However, due to the limited number of studies, further research is needed to confirm these findings and assess long-term effects and safety.",0.6,24525046,2014,Oral l-citrulline malate in patients with idiopathic pulmonary arterial hypertension and Eisenmenger Syndrome: a clinical trial.,clinical_trial,benefit,"The study shows significant improvement in walking distance and quality of life, indicating a benefit from l-citrulline malate.",1 g three times daily two weeks (malate),Eisenmenger Syndrome; Pulmonary Hypertension,Heart & Vascular Health,eisenmenger syndrome,eisenmenger syndrome; idiopathic pulmonary arterial hypertension,,,
L-Citrulline,lowered diastolic blood pressure in men,Exercise Performance,,Performance & Recovery,manual_pair,"One randomized trial indicates that L-Citrulline supplementation (6 g per day for 14 days) may improve exercise blood flow and vascular conductance in older adults, suggesting a potential benefit for exercise performance. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term effects and safety.",0.8,28940638,2017,Does l-citrulline supplementation improve exercise blood flow in older adults?,randomized_controlled_trial,benefit,"The study shows a modest improvement in blood flow and vascular conductance during exercise in older men, indicating a benefit from L-Citrulline supplementation.",6 g day-1 14 days,,,exercise blood flow,exercise blood flow; exercise tolerance; muscle metabolism,,,
L-Citrulline,lowered diastolic blood pressure in men,Endothelial Function,,Heart & Vascular Health,manual_pair,"One pilot study reported that L-Citrulline (6 g daily for 7 days) improved vascular function and physical capacity in patients with heart failure with preserved ejection fraction. However, the evidence is limited to a single study with no randomized controlled trials available, indicating a need for further research to confirm these findings and assess the generalizability of the results.",0.6,36476159,2023,"Improved vascular function and functional capacity following l-citrulline administration in patients with heart failure with preserved ejection fraction: a single-arm, open-label, prospective pilot study.",clinical_trial,benefit,"The study demonstrated improvements in vascular function and physical capacity in patients with HFpEF, indicating a potential benefit from L-Citrulline administration.",6 g daily 7 days (enteral),,,heart failure with preserved ejection fraction,heart failure with preserved ejection fraction,,,
L-Theanine,Caffeine worsened inhibitory control; L-Theanine had a trend of worsening inhibitory control; increased headache ratings,Stress,,"Energy, Mood, & Mental Health",manual_pair,"The evidence for L-Theanine in reducing anxiety is generally positive, with five studies reporting benefits, particularly at doses of 200 mg to 400 mg daily. However, one study showed mixed results, indicating that while L-Theanine may help alleviate anxiety symptoms, its effects can vary depending on the context and population studied. No adverse effects were reported in the reviewed studies.",0.8,15378679,2004,The acute effects of L-theanine in comparison with alprazolam on anticipatory anxiety in humans.,randomized_controlled_trial,mixed_unclear,L-Theanine showed some relaxing effects but no significant anxiolytic effects under increased anxiety conditions.,200 mg,,,anticipatory anxiety,anticipatory anxiety; anxiety; anxiety symptoms; blood pressure increase; cognitive functions; cognitive impairments; depression; major depressive disorder; negative symptoms; schizoaffective disorder; schizophrenia; sleep disturbance; sleep disturbances; stress; stress-related symptoms,,,
L-Theanine,Caffeine worsened inhibitory control; L-Theanine had a trend of worsening inhibitory control; increased headache ratings,Stress,,"Energy, Mood, & Mental Health",manual_pair,"The evidence for L-Theanine in reducing anxiety is generally positive, with five studies reporting benefits, particularly at doses of 200 mg to 400 mg daily. However, one study showed mixed results, indicating that while L-Theanine may help alleviate anxiety symptoms, its effects can vary depending on the context and population studied. No adverse effects were reported in the reviewed studies.",0.8,31623400,2019,Effects of L-Theanine Administration on Stress-Related Symptoms and Cognitive Functions in Healthy Adults: A Randomized Controlled Trial.,randomized_controlled_trial,benefit,"The study demonstrated significant improvements in stress-related symptoms and cognitive functions after L-theanine administration, indicating a beneficial effect.",200 mg daily four weeks (tablets),,Cognitive & Neurological Function,anxiety,anticipatory anxiety; anxiety; anxiety symptoms; blood pressure increase; cognitive functions; cognitive impairments; depression; major depressive disorder; negative symptoms; schizoaffective disorder; schizophrenia; sleep disturbance; sleep disturbances; stress; stress-related symptoms,,,
L-Theanine,Caffeine worsened inhibitory control; L-Theanine had a trend of worsening inhibitory control; increased headache ratings,Stress,,"Energy, Mood, & Mental Health",manual_pair,"The evidence for L-Theanine in reducing anxiety is generally positive, with five studies reporting benefits, particularly at doses of 200 mg to 400 mg daily. However, one study showed mixed results, indicating that while L-Theanine may help alleviate anxiety symptoms, its effects can vary depending on the context and population studied. No adverse effects were reported in the reviewed studies.",0.8,27396868,2017,Effects of chronic l-theanine administration in patients with major depressive disorder: an open-label study.,clinical_trial,benefit,"The study shows significant reductions in depressive symptoms, anxiety, and improvements in cognitive functions, indicating a beneficial effect of L-Theanine in patients with MDD.",250 mg daily 8 weeks,,,anxiety,anticipatory anxiety; anxiety; anxiety symptoms; blood pressure increase; cognitive functions; cognitive impairments; depression; major depressive disorder; negative symptoms; schizoaffective disorder; schizophrenia; sleep disturbance; sleep disturbances; stress; stress-related symptoms,,,
L-Theanine,Caffeine worsened inhibitory control; L-Theanine had a trend of worsening inhibitory control; increased headache ratings,Stress,,"Energy, Mood, & Mental Health",manual_pair,"The evidence for L-Theanine in reducing anxiety is generally positive, with five studies reporting benefits, particularly at doses of 200 mg to 400 mg daily. However, one study showed mixed results, indicating that while L-Theanine may help alleviate anxiety symptoms, its effects can vary depending on the context and population studied. No adverse effects were reported in the reviewed studies.",0.8,23107346,2012,Effects of L-theanine or caffeine intake on changes in blood pressure under physical and psychological stresses.,randomized_controlled_trial,benefit,"L-theanine significantly inhibited blood pressure increases and reduced anxiety, indicating a beneficial effect.",(oral),,,anxiety,anticipatory anxiety; anxiety; anxiety symptoms; blood pressure increase; cognitive functions; cognitive impairments; depression; major depressive disorder; negative symptoms; schizoaffective disorder; schizophrenia; sleep disturbance; sleep disturbances; stress; stress-related symptoms,,,
L-Theanine,Caffeine worsened inhibitory control; L-Theanine had a trend of worsening inhibitory control; increased headache ratings,Stress,,"Energy, Mood, & Mental Health",manual_pair,"The evidence for L-Theanine in reducing anxiety is generally positive, with five studies reporting benefits, particularly at doses of 200 mg to 400 mg daily. However, one study showed mixed results, indicating that while L-Theanine may help alleviate anxiety symptoms, its effects can vary depending on the context and population studied. No adverse effects were reported in the reviewed studies.",0.8,26218236,2018,"Add-On Pregnenolone with L-Theanine to Antipsychotic Therapy Relieves Negative and Anxiety Symptoms of Schizophrenia: An 8-Week, Randomized, Double-Blind, Placebo-Controlled Trial.",randomized_controlled_trial,benefit,The study demonstrated significant improvement in negative and anxiety symptoms in patients receiving L-Theanine as part of the treatment regimen.,400 mg daily 8 weeks (oral),,,anxiety symptoms,anticipatory anxiety; anxiety; anxiety symptoms; blood pressure increase; cognitive functions; cognitive impairments; depression; major depressive disorder; negative symptoms; schizoaffective disorder; schizophrenia; sleep disturbance; sleep disturbances; stress; stress-related symptoms,,,
L-Theanine,Caffeine worsened inhibitory control; L-Theanine had a trend of worsening inhibitory control; increased headache ratings,Stress,,"Energy, Mood, & Mental Health",manual_pair,"The evidence for L-Theanine in reducing anxiety is generally positive, with five studies reporting benefits, particularly at doses of 200 mg to 400 mg daily. However, one study showed mixed results, indicating that while L-Theanine may help alleviate anxiety symptoms, its effects can vary depending on the context and population studied. No adverse effects were reported in the reviewed studies.",0.8,21208586,2011,"L-theanine relieves positive, activation, and anxiety symptoms in patients with schizophrenia and schizoaffective disorder: an 8-week, randomized, double-blind, placebo-controlled, 2-center study.",randomized_controlled_trial,benefit,"L-Theanine showed significant reductions in anxiety and positive symptoms, indicating a beneficial effect.",400 mg daily 8 weeks,,,anxiety symptoms,anticipatory anxiety; anxiety; anxiety symptoms; blood pressure increase; cognitive functions; cognitive impairments; depression; major depressive disorder; negative symptoms; schizoaffective disorder; schizophrenia; sleep disturbance; sleep disturbances; stress; stress-related symptoms,,,
L-Theanine,Caffeine worsened inhibitory control; L-Theanine had a trend of worsening inhibitory control; increased headache ratings,Focus,,Cognitive & Neurological Function,manual_pair,"One randomized trial indicates that L-Theanine, particularly in combination with caffeine (at a dose of 97 mg), may improve attention in task-switching scenarios. However, evidence is limited to this single study, and no adverse effects were reported. Further research is needed to confirm these findings and explore the effects on other aspects of attention.",0.8,20079786,2010,L-theanine and caffeine improve task switching but not intersensory attention or subjective alertness.,randomized_controlled_trial,benefit,"The study shows a significant improvement in attention on a switch task, indicating a benefit from the combination of L-Theanine and caffeine.",97 mg,,,attention,attention,,,
L-Theanine,Caffeine worsened inhibitory control; L-Theanine had a trend of worsening inhibitory control; increased headache ratings,Stress,,"Energy, Mood, & Mental Health",manual_pair,"One randomized, placebo-controlled study reported that L-Theanine, when combined with other supplements, led to significant reductions in stress scores and improvements in sleep and pain perception among chronically stressed individuals. However, the evidence is limited to a single study, and no adverse effects were reported. Overall, the findings suggest a potential benefit, but further research is needed to confirm these results and establish consistency.",0.7,35565828,2022,"Effect of a Combination of Magnesium, B Vitamins, Rhodiola, and Green Tea (L-Theanine) on Chronically Stressed Healthy Individuals-A Randomized, Placebo-Controlled Study.",randomized_controlled_trial,benefit,"The study demonstrated significant reductions in stress scores and improvements in sleep and pain perception, indicating a beneficial effect of the supplement.",null null null 28 days (oral Mg-Teadiola),,,chronic stress,chronic stress; pain perception; sleep dysfunction,,,
L-Theanine,Caffeine worsened inhibitory control; L-Theanine had a trend of worsening inhibitory control; increased headache ratings,Sensorimotor Gating,,Cognitive & Neurological Function,manual_pair,"Current evidence suggests that L-Theanine may have cognitive enhancement effects in healthy adults, with two studies reporting benefits in sensorimotor gating and cognitive performance when combined with caffeine. Doses reported include 200 mg and 400 mg for single doses, as well as 6 mg/kg in the context of combined supplementation. However, the overall quality of evidence is limited, and further research is needed to establish consistency and broader applicability.",0.7,24372613,2014,Effect of L-theanine on sensorimotor gating in healthy human subjects.,randomized_controlled_trial,benefit,"The study found that 200 mg and 400 mg of L-theanine significantly increased sensorimotor gating, indicating a benefit in this context.",200 mg oral single dose; 400 mg oral single dose; 600 mg oral single dose,,,cognition,cognition; cognitive performance; sensorimotor gating; shooting performance,,,
L-Theanine,Caffeine worsened inhibitory control; L-Theanine had a trend of worsening inhibitory control; increased headache ratings,Sensorimotor Gating,,Cognitive & Neurological Function,manual_pair,"Current evidence suggests that L-Theanine may have cognitive enhancement effects in healthy adults, with two studies reporting benefits in sensorimotor gating and cognitive performance when combined with caffeine. Doses reported include 200 mg and 400 mg for single doses, as well as 6 mg/kg in the context of combined supplementation. However, the overall quality of evidence is limited, and further research is needed to establish consistency and broader applicability.",0.7,37815006,2023,"Effect of single or combined caffeine and L-Theanine supplementation on shooting and cognitive performance in elite curling athletes: a double-blind, placebo-controlled study.",randomized_controlled_trial,benefit,The study demonstrated significant improvements in both shooting and cognitive performance with the combined intake of L-Theanine and caffeine compared to placebo and single supplement use.,6 mg/kg single dose (L-Theanine); 6 mg/kg single dose (Caffeine); 400 mg single dose (placebo (maltodextrin)),Curlers,,cognitive performance,cognition; cognitive performance; sensorimotor gating; shooting performance,,,
L-Theanine,Caffeine worsened inhibitory control; L-Theanine had a trend of worsening inhibitory control; increased headache ratings,Cognitive Performance,,Cognitive & Neurological Function,manual_pair,"L-Theanine has shown potential benefits for cognitive function, particularly in attention and working memory, based on two randomized controlled trials. One study reported positive effects over 12 weeks, while another indicated improved cognitive performance with a combination of L-Theanine and caffeine at a dose of 100 mg over 4 days. Overall, the evidence is limited to a small number of studies, and further research is needed to confirm these findings and assess long-term effects.",0.8,33751906,2021,Effects of l-Theanine on Cognitive Function in Middle-Aged and Older Subjects: A Randomized Placebo-Controlled Study.,randomized_controlled_trial,benefit,"The study demonstrated a positive effect of L-Theanine on cognitive functions, specifically attention and working memory, indicating a benefit.",null null null 12 weeks (null),Older Adults,,attention,attention; cognition; cognitive function; executive functions; working memory,,,
L-Theanine,Caffeine worsened inhibitory control; L-Theanine had a trend of worsening inhibitory control; increased headache ratings,Cognitive Performance,,Cognitive & Neurological Function,manual_pair,"L-Theanine has shown potential benefits for cognitive function, particularly in attention and working memory, based on two randomized controlled trials. One study reported positive effects over 12 weeks, while another indicated improved cognitive performance with a combination of L-Theanine and caffeine at a dose of 100 mg over 4 days. Overall, the evidence is limited to a small number of studies, and further research is needed to confirm these findings and assess long-term effects.",0.8,18641209,2008,L-theanine and caffeine in combination affect human cognition as evidenced by oscillatory alpha-band activity and attention task performance.,clinical_trial,benefit,"The study found increased hit rate and target discriminability with the combined treatment, indicating a benefit in cognitive performance.",100 mg 4 days,,,attention,attention; cognition; cognitive function; executive functions; working memory,,,
L-Theanine,Caffeine worsened inhibitory control; L-Theanine had a trend of worsening inhibitory control; increased headache ratings,Cognitive Performance,,Cognitive & Neurological Function,manual_pair,"Current evidence suggests that L-Theanine may improve cognitive performance when combined with caffeine, as indicated by one randomized trial that reported benefits at a dose of 100 mg. However, the overall evidence is limited, with only one study supporting this outcome and no additional studies to confirm consistency or explore potential adverse effects.",0.6,18681988,2008,The combined effects of L-theanine and caffeine on cognitive performance and mood.,randomized_controlled_trial,benefit,"The study found that the combination of L-Theanine and caffeine improved cognitive performance and mood, indicating a beneficial outcome.",100 mg,,,cognitive performance,cognitive performance,,,
L-Theanine,Caffeine worsened inhibitory control; L-Theanine had a trend of worsening inhibitory control; increased headache ratings,Depression,,Energy & Mood,manual_pair,"One randomized, double-blind, placebo-controlled trial found that L-theanine (200 mg daily for 6 weeks) as an adjunct to sertraline significantly improved depression scores in patients with major depressive disorder. There is currently no evidence of harm or no benefit associated with L-theanine for this indication, but further research is needed to confirm these findings and assess long-term effects.",0.9,37084960,2023,"l-theanine adjunct to sertraline for major depressive disorder: A randomized, double-blind, placebo-controlled clinical trial.",randomized_controlled_trial,benefit,"The study demonstrated significant improvement in depression scores with l-theanine adjunct to sertraline compared to placebo, indicating a beneficial effect.",200 mg daily 6 weeks,,,major depressive disorder,major depressive disorder,,,
L-Theanine,Caffeine worsened inhibitory control; L-Theanine had a trend of worsening inhibitory control; increased headache ratings,Cognitive Performance,,Cognitive & Neurological Function,manual_pair,"The evidence for L-Theanine in the treatment of headaches is mixed and unclear, with one study indicating that it may negatively affect headache ratings while showing cognitive benefits when combined with caffeine at a dose of 250 mg. Overall, there is no consistent evidence supporting its efficacy for this indication.",0.8,18006208,2008,"The effects of L-theanine, caffeine and their combination on cognition and mood.",randomized_controlled_trial,mixed_unclear,The study shows mixed outcomes with L-Theanine affecting headache ratings negatively while also showing cognitive benefits when combined with caffeine.,250 mg,,,cognition,cognition; headache; mental fatigue; mood,,,
L-Theanine,Caffeine worsened inhibitory control; L-Theanine had a trend of worsening inhibitory control; increased headache ratings,Improve Memory,,Cognitive & Neurological Function,manual_pair,"One randomized controlled trial suggests that a combination of green tea extract and L-theanine (1680 mg) may improve memory and attention in individuals with mild cognitive impairment over 16 weeks. However, the overall evidence is limited, with only one study reporting a benefit and no other studies available to confirm these findings or assess potential adverse effects.",0.7,21303262,2011,A combination of green tea extract and l-theanine improves memory and attention in subjects with mild cognitive impairment: a double-blind placebo-controlled study.,randomized_controlled_trial,benefit,"The study reports improvements in memory and attention, indicating a beneficial outcome.",1680 mg 16 weeks (LGNC-07),,,mild cognitive impairment,mild cognitive impairment,,,
L-Theanine,Caffeine worsened inhibitory control; L-Theanine had a trend of worsening inhibitory control; increased headache ratings,Focus,,Cognitive & Neurological Function,manual_pair,"There is limited evidence suggesting that L-Theanine may improve mood when combined with caffeine, as indicated by one study that reported a beneficial outcome at a dose of 100 mg. However, the overall evidence is sparse, and further research is needed to establish consistent effects and safety.",0.7,18681988,2008,The combined effects of L-theanine and caffeine on cognitive performance and mood.,randomized_controlled_trial,benefit,"The study found that the combination of L-Theanine and caffeine improved cognitive performance and mood, indicating a beneficial outcome.",100 mg,,,mood,mood,,,
L-Theanine,Caffeine worsened inhibitory control; L-Theanine had a trend of worsening inhibitory control; increased headache ratings,Schizophrenia,,"Energy, Mood, & Mental Health",manual_pair,"One randomized, double-blind, placebo-controlled trial found that L-Theanine (400 mg daily for 8 weeks) as an adjunct to risperidone significantly improved negative symptoms and general psychopathology in patients with chronic schizophrenia. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term effects and safety.",0.7,37697164,2023,"L-Theanine adjunct to risperidone in the treatment of chronic schizophrenia inpatients: a randomized, double-blind, placebo-controlled clinical trial.",randomized_controlled_trial,benefit,"The study showed that L-Theanine adjunct to risperidone significantly improved negative symptoms and general psychopathology in chronic schizophrenia patients compared to placebo, indicating a benefit.",400 mg daily 8 weeks,,,chronic schizophrenia,chronic schizophrenia,,,
L-Theanine,Caffeine worsened inhibitory control; L-Theanine had a trend of worsening inhibitory control; increased headache ratings,Obsessive-Compulsive Disorder,,"Energy, Mood, & Mental Health",manual_pair,"One randomized, placebo-controlled trial found that L-theanine (100 mg twice daily for 10 weeks) combined with fluvoxamine resulted in significant improvements in obsessive-compulsive disorder symptoms, as measured by the Y-BOCS. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term effects and safety.",0.7,37169515,2023,"L-theanine combination therapy with fluvoxamine in moderate-to-severe obsessive-compulsive disorder: A placebo-controlled, double-blind, randomized trial.",randomized_controlled_trial,benefit,"The study showed significant improvement in obsession subscale scores and total Y-BOCS scores with L-theanine compared to placebo, indicating a benefit.",100 mg twice daily 10 weeks,,,obsessive-compulsive disorder,obsessive-compulsive disorder,,,
L-Theanine,Caffeine worsened inhibitory control; L-Theanine had a trend of worsening inhibitory control; increased headache ratings,Focus,,Cognitive & Neurological Function,manual_pair,"L-Theanine has shown benefits in improving attention in two randomized, double-blind, placebo-controlled crossover studies. The studies reported significant improvements in attention measures, particularly at doses of 200 mg and 400 mg. However, the evidence is limited to specific tasks, with no adverse effects reported.",0.9,36263942,2023,"Dose-response effect of L-theanine on psychomotor speed, sustained attention, and inhibitory control: a double-blind, placebo-controlled, crossover study.",randomized_controlled_trial,benefit,"L-theanine significantly improved attention in simple visuomotor tasks, indicating a benefit, but not in more complex tasks.",100 mg single dose null (null); 200 mg single dose null (null); 400 mg single dose null (null),,,attention,attention; cognitive processing; inhibitory control; psychomotor speed,,,
L-Theanine,Caffeine worsened inhibitory control; L-Theanine had a trend of worsening inhibitory control; increased headache ratings,Focus,,Cognitive & Neurological Function,manual_pair,"L-Theanine has shown benefits in improving attention in two randomized, double-blind, placebo-controlled crossover studies. The studies reported significant improvements in attention measures, particularly at doses of 200 mg and 400 mg. However, the evidence is limited to specific tasks, with no adverse effects reported.",0.9,32777998,2022,"L-theanine improves neurophysiological measures of attention in a dose-dependent manner: a double-blind, placebo-controlled, crossover study.",randomized_controlled_trial,benefit,"The study demonstrated a significant benefit in attention measures with the highest dose of L-theanine, indicating its effectiveness in enhancing attentional processing.",100 mg single dose acute (oral); 200 mg single dose acute (oral); 400 mg single dose acute (oral),,,attention,attention; cognitive processing; inhibitory control; psychomotor speed,,,
L-Theanine,Caffeine worsened inhibitory control; L-Theanine had a trend of worsening inhibitory control; increased headache ratings,Focus,,Cognitive & Neurological Function,manual_pair,"One randomized trial found that L-Theanine (200 mg) improved attention and reduced mind wandering, suggesting a beneficial effect on focus. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term effects and safety.",0.7,29420994,2018,l-Theanine and caffeine improve target-specific attention to visual stimuli by decreasing mind wandering: a human functional magnetic resonance imaging study.,randomized_controlled_trial,benefit,"The study demonstrated that L-Theanine improved attention and decreased mind wandering, indicating a beneficial effect.",200 mg single dose 60 minutes (oral),,,attention,attention; mind wandering,,,
L-Theanine,Caffeine worsened inhibitory control; L-Theanine had a trend of worsening inhibitory control; increased headache ratings,Focus,,Cognitive & Neurological Function,manual_pair,"One randomized, double-blind, placebo-controlled study found that a single dose of 200 mg of L-theanine significantly improved selective attention in sleep-deprived young adults, with no reported harms or mixed outcomes. Overall, the evidence suggests a potential benefit of L-theanine for attention deficits due to sleep deprivation, but further research is needed to confirm these findings and assess long-term effects.",0.9,39052627,2025,"Effect of L-theanine on selective attention in a traffic-related reaction task in sleep-deprived young adults: a double-blind placebo-controlled, crossover study.",randomized_controlled_trial,benefit,"L-theanine significantly improved selective attention and reduced false alarms in sleep-deprived individuals, indicating a beneficial effect.",200 mg once (oral),,,attention,attention; psychomotor performance; sleep deprivation,,,
L-Theanine,Caffeine worsened inhibitory control; L-Theanine had a trend of worsening inhibitory control; increased headache ratings,Focus,,Cognitive & Neurological Function,manual_pair,"One randomized trial indicates that L-Theanine, at a dose of 97 mg, may improve cognitive performance and subjective alertness when combined with caffeine. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess the effects of L-Theanine on focus and attention problems more broadly.",0.7,21040626,2010,The combination of L-theanine and caffeine improves cognitive performance and increases subjective alertness.,randomized_controlled_trial,benefit,"The study shows significant improvement in cognitive performance and alertness, indicating a beneficial effect of L-Theanine.",97 mg,,,alertness,alertness; cognitive performance; tiredness,,,
L-Theanine,Caffeine worsened inhibitory control; L-Theanine had a trend of worsening inhibitory control; increased headache ratings,Focus,,Cognitive & Neurological Function,manual_pair,"L-Theanine, at a dose of 50 mg, has shown a beneficial effect on mental alertness, as evidenced by increased alpha brain wave activity in one study. However, the evidence is limited to a single trial, and further research is needed to confirm these findings and assess consistency across different populations and dosages.",0.7,18296328,2008,"L-theanine, a natural constituent in tea, and its effect on mental state.",randomized_controlled_trial,benefit,The study shows a significant increase in alpha activity indicating a benefit in mental alertness and arousal.,50 mg,,,arousal,arousal; attention; mental alertness,,,
L-Theanine,Caffeine worsened inhibitory control; L-Theanine had a trend of worsening inhibitory control; increased headache ratings,Sleep Quality,,Sleep,manual_pair,"There is limited evidence suggesting that L-Theanine may improve sleep quality, as indicated by one randomized, placebo-controlled trial that reported significant benefits. However, the overall evidence is sparse, and further research is needed to confirm these findings and establish consistent dosing recommendations. No adverse effects were reported in the study.",0.7,35277011,2022,"Effect of Alpha-S1-Casein Tryptic Hydrolysate and L-Theanine on Poor Sleep Quality: A Double Blind, Randomized Placebo-Controlled Crossover Trial.",randomized_controlled_trial,benefit,"The study demonstrated significant improvements in sleep quality metrics, indicating a beneficial effect of L-Theanine.",four weeks (RLX2™ containing alpha-s1-casein tryptic hydrolysate and L-theanine),,,poor sleep quality,poor sleep quality,,,
L-Theanine,Caffeine worsened inhibitory control; L-Theanine had a trend of worsening inhibitory control; increased headache ratings,Schizophrenia,,"Energy, Mood, & Mental Health",manual_pair,"One randomized trial has reported that L-theanine, at a dose of 250 mg daily for 8 weeks, may lead to significant improvements in positive symptoms and sleep quality in patients with schizophrenia. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term safety and efficacy.",0.7,25896423,2015,Effect of L-theanine on glutamatergic function in patients with schizophrenia.,clinical_trial,benefit,"The study shows significant improvements in positive symptoms and sleep quality in schizophrenia patients treated with L-theanine, indicating a beneficial effect.",250 mg daily 8 weeks,,,schizophrenia,schizophrenia,,,
L-Theanine,Caffeine worsened inhibitory control; L-Theanine had a trend of worsening inhibitory control; increased headache ratings,Stress,,"Energy, Mood, & Mental Health",manual_pair,"One randomized controlled trial found that a single dose of 200 mg L-Theanine, either alone or in combination with L-Arginine, resulted in significant reductions in physiological stress response compared to placebo, suggesting a potential benefit for managing psychological stress. However, the evidence is limited to this single study, and further research is needed to confirm these findings and assess long-term effects and safety.",0.8,36596553,2022,Effect of Combined Ingestion of L-Theanine and L-Arginine for Short-Term Psychological Stress in Young Adults: A Randomized Placebo-Controlled Study.,randomized_controlled_trial,benefit,"The study showed significant reductions in physiological stress response for both theanine and theanine/arginine groups compared to placebo, indicating a benefit in managing psychological stress.",200 mg single dose (L-Theanine); 50 mg single dose (L-Arginine),,,psychological stress,psychological stress,,,
L-Theanine,Caffeine worsened inhibitory control; L-Theanine had a trend of worsening inhibitory control; increased headache ratings,Stress,,"Energy, Mood, & Mental Health",manual_pair,"Clinical evidence suggests that L-Theanine may reduce stress, as indicated by two randomized, double-blind, placebo-controlled trials showing significant reductions in subjective stress responses and physiological markers such as salivary cortisol and heart rate. No adverse effects were reported in these studies, but the evidence is limited to a small number of trials, and typical doses were not consistently reported.",0.8,26797633,2016,"Anti-Stress, Behavioural and Magnetoencephalography Effects of an L-Theanine-Based Nutrient Drink: A Randomised, Double-Blind, Placebo-Controlled, Crossover Trial.",randomized_controlled_trial,benefit,"The study demonstrated a significant reduction in subjective stress response and salivary cortisol levels, indicating a beneficial effect of L-theanine on stress.",(nutrient drink),,,anxiety,anxiety; physiological stress; psychological stress; stress,,,
L-Theanine,Caffeine worsened inhibitory control; L-Theanine had a trend of worsening inhibitory control; increased headache ratings,Stress,,"Energy, Mood, & Mental Health",manual_pair,"Clinical evidence suggests that L-Theanine may reduce stress, as indicated by two randomized, double-blind, placebo-controlled trials showing significant reductions in subjective stress responses and physiological markers such as salivary cortisol and heart rate. No adverse effects were reported in these studies, but the evidence is limited to a small number of trials, and typical doses were not consistently reported.",0.8,16930802,2007,L-Theanine reduces psychological and physiological stress responses.,randomized_controlled_trial,benefit,"The study showed that L-Theanine intake reduced heart rate and salivary immunoglobulin A responses to stress, indicating a beneficial effect on stress reduction.",(oral),,,physiological stress,anxiety; physiological stress; psychological stress; stress,,,
L-Theanine,Caffeine worsened inhibitory control; L-Theanine had a trend of worsening inhibitory control; increased headache ratings,Increase Flu Vaccine Efficacy,,"Immune, Inflammation, & Infection",manual_pair,"Current evidence suggests that L-theanine may enhance immune response in specific populations, such as the elderly and athletes, based on two studies reporting beneficial outcomes. Doses reported include daily administration of L-theanine for 14 days and 150 mg daily for 6 weeks. However, the overall evidence is limited and further research is needed to confirm these findings and explore broader applications.",0.7,19149835,2008,Co-administration of l-cystine and l-theanine enhances efficacy of influenza vaccination in elderly persons: nutritional status-dependent immunogenicity.,randomized_controlled_trial,benefit,"The study shows a significant benefit in seroconversion rates for certain subgroups, indicating enhanced immune response.",daily 14 days (oral),Older Adults,,immune response enhancement,immune response enhancement; immune system response; influenza vaccination; strenuous physical exercise,,,
L-Theanine,Caffeine worsened inhibitory control; L-Theanine had a trend of worsening inhibitory control; increased headache ratings,Increase Flu Vaccine Efficacy,,"Immune, Inflammation, & Infection",manual_pair,"Current evidence suggests that L-theanine may enhance immune response in specific populations, such as the elderly and athletes, based on two studies reporting beneficial outcomes. Doses reported include daily administration of L-theanine for 14 days and 150 mg daily for 6 weeks. However, the overall evidence is limited and further research is needed to confirm these findings and explore broader applications.",0.7,30770758,2019,The effect of L-theanine supplementation on the immune system of athletes exposed to strenuous physical exercise.,randomized_controlled_trial,benefit,"The study shows a beneficial effect of L-theanine on immune response in athletes, indicated by improved cytokine ratios.",150 mg daily 6 weeks (extract),,,immune system response,immune response enhancement; immune system response; influenza vaccination; strenuous physical exercise,,,
L-Tyrosine,,Cognitive Performance,,Cognitive & Neurological Function,manual_pair,"The evidence for L-Tyrosine in enhancing cognitive performance is limited and mixed, with one study suggesting a potential benefit in cognitive performance during a stress-inducing scenario at a dose of 2000 mg, but no consistent positive outcomes were observed. Overall, the quality of evidence is low, and further research is needed to clarify its effects.",0.6,38975711,2024,Impact of L-theanine and L-tyrosine on markers of stress and cognitive performance in response to a virtual reality based active shooter training drill.,randomized_controlled_trial,mixed_unclear,"The study found no impact on stress markers but indicated a potential benefit in cognitive performance, leading to a mixed outcome classification.",2000 mg,,,cognition,cognition,,,
L-Tyrosine,,Improve Memory,,Cognitive & Neurological Function,manual_pair,"The evidence regarding L-Tyrosine for cognitive impairment and memory problems is mixed. One randomized controlled trial reported benefits in working memory and inhibitory control, particularly in individuals with specific DRD2 genotypes, while another study indicated that the effects may vary based on baseline performance levels, with low-performing subjects showing improvement and high-performing subjects experiencing impairment. No adverse effects were reported in the studies reviewed.",0.7,32133585,2020,Baseline-dependent effect of dopamine's precursor L-tyrosine on working memory gating but not updating.,randomized_controlled_trial,mixed_unclear,"The study shows mixed outcomes where low-performing subjects improved while high-performing subjects were impaired, indicating a complex relationship between L-tyrosine and working memory performance.",2.0 g,,,dopaminergic pathophysiology,dopaminergic pathophysiology; inhibitory control; working memory; working memory deficits,,,
L-Tyrosine,,Improve Memory,,Cognitive & Neurological Function,manual_pair,"The evidence regarding L-Tyrosine for cognitive impairment and memory problems is mixed. One randomized controlled trial reported benefits in working memory and inhibitory control, particularly in individuals with specific DRD2 genotypes, while another study indicated that the effects may vary based on baseline performance levels, with low-performing subjects showing improvement and high-performing subjects experiencing impairment. No adverse effects were reported in the studies reviewed.",0.7,27403851,2016,Effects of l-Tyrosine on working memory and inhibitory control are determined by DRD2 genotypes: A randomized controlled trial.,randomized_controlled_trial,benefit,"The study shows that L-Tyrosine supplementation has beneficial effects on cognitive functions, specifically working memory and inhibitory control, particularly in individuals with certain DRD2 genotypes.",,,,inhibitory control,dopaminergic pathophysiology; inhibitory control; working memory; working memory deficits,,,
L-Tyrosine,,Thermoregulation,,Performance & Recovery,manual_pair,"One randomized trial indicates that oral L-Tyrosine supplementation at a dose of 150 mg·kg may improve core temperature maintenance and cutaneous vasoconstriction in older adults during cold exposure. However, the evidence is limited, with only one study reporting a benefit and no additional studies to confirm these findings or assess long-term effects and safety.",0.7,31609301,2020,Oral L-Tyrosine Supplementation Improves Core Temperature Maintenance in Older Adults.,randomized_controlled_trial,benefit,L-Tyrosine supplementation showed a significant improvement in core temperature maintenance and cutaneous vasoconstriction response in older adults during cold exposure.,150 mg·kg (oral),Older Adults,,cold exposure response,cold exposure response; hypothermia,,,
L-Tyrosine,,Thermoregulation,,Performance & Recovery,manual_pair,"One randomized trial indicates that a single oral dose of 150 mg L-Tyrosine may enhance the vasoconstriction response to cold exposure in older adults, suggesting a potential benefit for thermoregulation. However, the overall evidence is limited, with only one study reporting a positive outcome and no data on adverse effects or long-term use.",0.7,28477375,2017,Oral l-tyrosine supplementation augments the vasoconstriction response to whole-body cooling in older adults.,randomized_controlled_trial,benefit,"The study found that l-tyrosine supplementation improved the vasoconstriction response to cold exposure in older adults, indicating a beneficial effect on thermoregulatory function.",150 mg single dose (oral),Older Adults,,thermoregulatory function,thermoregulatory function; vasoconstriction response,,,
L-Tyrosine,,Stress,,"Energy, Mood, & Mental Health",manual_pair,"The evidence for L-Tyrosine in reducing stress or improving psychological outcomes is limited and classified as mixed or unclear. One study reported no effect on stress markers but suggested a potential benefit in cognitive performance at a dose of 2000 mg. Overall, the findings do not support a clear benefit for this supplement in the indicated context.",0.7,38975711,2024,Impact of L-theanine and L-tyrosine on markers of stress and cognitive performance in response to a virtual reality based active shooter training drill.,randomized_controlled_trial,mixed_unclear,"The study found no impact on stress markers but indicated a potential benefit in cognitive performance, leading to a mixed outcome classification.",2000 mg,,Cognitive & Neurological Function,"stress, psychological","stress, psychological",,,
Lavender,,Stress,,"Energy, Mood, & Mental Health",manual_pair,"The clinical evidence for lavender as a treatment for anxiety is predominantly positive, with 13 studies reporting significant benefits and only one study yielding mixed results. Various forms of lavender administration, including inhalation and aromatherapy, were utilized, with doses often unspecified or varying widely. No adverse effects were reported in the studies reviewed, suggesting a favorable safety profile; however, the mixed outcome in one pilot study indicates the need for further research to confirm these findings.",0.9,34222473,2021,The Effects of Lavender and Citrus aurantium on Anxiety and Agitation of the Conscious Patients in Intensive Care Units: A Parallel Randomized Placebo-Controlled Trial.,randomized_controlled_trial,benefit,"The study found significant reductions in anxiety levels in the lavender group compared to placebo, indicating a beneficial effect.",5 drops once 30 minutes (essential oil),,,agitation,agitation; anxiety; anxiety in cardiovascular patients; breast cancer; caesarean section; comfort during hemodialysis; depression; fatigue; hemodialysis; hemodynamic status; intraoperative anxiety; invasive pain; pain; preinterventional anxiety; sleep quality; stress,,,
Lavender,,Stress,,"Energy, Mood, & Mental Health",manual_pair,"The clinical evidence for lavender as a treatment for anxiety is predominantly positive, with 13 studies reporting significant benefits and only one study yielding mixed results. Various forms of lavender administration, including inhalation and aromatherapy, were utilized, with doses often unspecified or varying widely. No adverse effects were reported in the studies reviewed, suggesting a favorable safety profile; however, the mixed outcome in one pilot study indicates the need for further research to confirm these findings.",0.9,40795547,2025,The effect of lavender essential oil aromatherapy on anxiety and fatigue in patients with implantable cardioverter defibrillator: randomized controlled trial.,randomized_controlled_trial,benefit,"The intervention group showed significant reductions in anxiety and fatigue scores, indicating a benefit from lavender aromatherapy.",2 minutes every night four weeks (essential oil),,,anxiety,agitation; anxiety; anxiety in cardiovascular patients; breast cancer; caesarean section; comfort during hemodialysis; depression; fatigue; hemodialysis; hemodynamic status; intraoperative anxiety; invasive pain; pain; preinterventional anxiety; sleep quality; stress,,,
Lavender,,Stress,,"Energy, Mood, & Mental Health",manual_pair,"The clinical evidence for lavender as a treatment for anxiety is predominantly positive, with 13 studies reporting significant benefits and only one study yielding mixed results. Various forms of lavender administration, including inhalation and aromatherapy, were utilized, with doses often unspecified or varying widely. No adverse effects were reported in the studies reviewed, suggesting a favorable safety profile; however, the mixed outcome in one pilot study indicates the need for further research to confirm these findings.",0.9,40653563,2025,"Effect of aromatherapy massage with lavender essential oil on sleep quality, pain, and mental and psychiatric disorders among breast cancer patients undergoing chemotherapy: a randomized controlled trial.",randomized_controlled_trial,benefit,"The study showed significant improvements in sleep quality, anxiety, and pain response, indicating a benefit from lavender aromatherapy.",4 weeks (lavender essential oil),,Musculoskeletal & Pain; Sleep,anxiety,agitation; anxiety; anxiety in cardiovascular patients; breast cancer; caesarean section; comfort during hemodialysis; depression; fatigue; hemodialysis; hemodynamic status; intraoperative anxiety; invasive pain; pain; preinterventional anxiety; sleep quality; stress,,,
Lavender,,Stress,,"Energy, Mood, & Mental Health",manual_pair,"The clinical evidence for lavender as a treatment for anxiety is predominantly positive, with 13 studies reporting significant benefits and only one study yielding mixed results. Various forms of lavender administration, including inhalation and aromatherapy, were utilized, with doses often unspecified or varying widely. No adverse effects were reported in the studies reviewed, suggesting a favorable safety profile; however, the mixed outcome in one pilot study indicates the need for further research to confirm these findings.",0.9,40127529,2025,"Evaluating the impact of lavender aromatherapy and music therapy on reducing stress, anxiety, and depression in female nurses during the COVID-19 pandemic.",randomized_controlled_trial,benefit,"The study demonstrated significant reductions in stress, anxiety, and depression, indicating a clear benefit from the interventions.",20 minutes once a week six weeks (lavender essential oil),,,anxiety,agitation; anxiety; anxiety in cardiovascular patients; breast cancer; caesarean section; comfort during hemodialysis; depression; fatigue; hemodialysis; hemodynamic status; intraoperative anxiety; invasive pain; pain; preinterventional anxiety; sleep quality; stress,,,
Lavender,,Stress,,"Energy, Mood, & Mental Health",manual_pair,"The clinical evidence for lavender as a treatment for anxiety is predominantly positive, with 13 studies reporting significant benefits and only one study yielding mixed results. Various forms of lavender administration, including inhalation and aromatherapy, were utilized, with doses often unspecified or varying widely. No adverse effects were reported in the studies reviewed, suggesting a favorable safety profile; however, the mixed outcome in one pilot study indicates the need for further research to confirm these findings.",0.9,39400653,2024,Aromatherapy Using Lavender Oil Effectiveness on Pain and Anxiety After C-Section: A Randomized Controlled Trial.,randomized_controlled_trial,benefit,"The study demonstrated significant reductions in pain and anxiety levels in the aromatherapy group compared to the placebo group, indicating a beneficial effect of lavender essential oil.",(inhaled Lavender essential oil),,Musculoskeletal & Pain,anxiety,agitation; anxiety; anxiety in cardiovascular patients; breast cancer; caesarean section; comfort during hemodialysis; depression; fatigue; hemodialysis; hemodynamic status; intraoperative anxiety; invasive pain; pain; preinterventional anxiety; sleep quality; stress,,,
Lavender,,Stress,,"Energy, Mood, & Mental Health",manual_pair,"The clinical evidence for lavender as a treatment for anxiety is predominantly positive, with 13 studies reporting significant benefits and only one study yielding mixed results. Various forms of lavender administration, including inhalation and aromatherapy, were utilized, with doses often unspecified or varying widely. No adverse effects were reported in the studies reviewed, suggesting a favorable safety profile; however, the mixed outcome in one pilot study indicates the need for further research to confirm these findings.",0.9,38490827,2024,The effect of lavender and bergamot oil applied via inhalation on the anxiety level and sleep quality of surgical intensive care unit patients.,randomized_controlled_trial,benefit,"The study showed significant decreases in anxiety scores and increases in sleep quality scores, indicating a beneficial effect of lavender oil inhalation.",3 drops once 2 nights (lavender oil),,Sleep,anxiety,agitation; anxiety; anxiety in cardiovascular patients; breast cancer; caesarean section; comfort during hemodialysis; depression; fatigue; hemodialysis; hemodynamic status; intraoperative anxiety; invasive pain; pain; preinterventional anxiety; sleep quality; stress,,,
Lavender,,Stress,,"Energy, Mood, & Mental Health",manual_pair,"The clinical evidence for lavender as a treatment for anxiety is predominantly positive, with 13 studies reporting significant benefits and only one study yielding mixed results. Various forms of lavender administration, including inhalation and aromatherapy, were utilized, with doses often unspecified or varying widely. No adverse effects were reported in the studies reviewed, suggesting a favorable safety profile; however, the mixed outcome in one pilot study indicates the need for further research to confirm these findings.",0.9,36476355,2023,The effect of lavender aromatherapy on the level of intraoperative anxiety in caesarean case under spinal anesthesia: A randomized controlled trial.,randomized_controlled_trial,benefit,"The study found that lavender aromatherapy significantly reduced the need for midazolam, indicating a beneficial effect on anxiety management.",2 drops once 5 minutes (aromatherapy oil),,,anxiety,agitation; anxiety; anxiety in cardiovascular patients; breast cancer; caesarean section; comfort during hemodialysis; depression; fatigue; hemodialysis; hemodynamic status; intraoperative anxiety; invasive pain; pain; preinterventional anxiety; sleep quality; stress,,,
Lavender,,Stress,,"Energy, Mood, & Mental Health",manual_pair,"The clinical evidence for lavender as a treatment for anxiety is predominantly positive, with 13 studies reporting significant benefits and only one study yielding mixed results. Various forms of lavender administration, including inhalation and aromatherapy, were utilized, with doses often unspecified or varying widely. No adverse effects were reported in the studies reviewed, suggesting a favorable safety profile; however, the mixed outcome in one pilot study indicates the need for further research to confirm these findings.",0.9,35987997,2023,The Effect of Lavender on Anxiety and Hemodynamic Status Before Septorhinoplasy and Rhinoplasty.,randomized_controlled_trial,benefit,"The study shows a significant reduction in anxiety and improved hemodynamic status in the lavender group, indicating a beneficial effect.",(fragrance),,,anxiety,agitation; anxiety; anxiety in cardiovascular patients; breast cancer; caesarean section; comfort during hemodialysis; depression; fatigue; hemodialysis; hemodynamic status; intraoperative anxiety; invasive pain; pain; preinterventional anxiety; sleep quality; stress,,,
Lavender,,Stress,,"Energy, Mood, & Mental Health",manual_pair,"The clinical evidence for lavender as a treatment for anxiety is predominantly positive, with 13 studies reporting significant benefits and only one study yielding mixed results. Various forms of lavender administration, including inhalation and aromatherapy, were utilized, with doses often unspecified or varying widely. No adverse effects were reported in the studies reviewed, suggesting a favorable safety profile; however, the mixed outcome in one pilot study indicates the need for further research to confirm these findings.",0.9,35212648,2023,"Effects of Long-term Administration of Inhaled Lavender During Hemodialysis on Patients' Invasive Pain, Anxiety, and Comfort During Cannulation: A Single-blind Randomized Controlled Trial.",randomized_controlled_trial,benefit,"The study found significant reductions in pain and anxiety, indicating a beneficial effect of lavender aromatherapy.",3 drops before each cannulation procedure 12 HD sessions (1:10 mixture of lavender essence and sweet almond oil),CKD; Hemodialysis,Musculoskeletal & Pain,anxiety,agitation; anxiety; anxiety in cardiovascular patients; breast cancer; caesarean section; comfort during hemodialysis; depression; fatigue; hemodialysis; hemodynamic status; intraoperative anxiety; invasive pain; pain; preinterventional anxiety; sleep quality; stress,,,
Lavender,,Stress,,"Energy, Mood, & Mental Health",manual_pair,"The clinical evidence for lavender as a treatment for anxiety is predominantly positive, with 13 studies reporting significant benefits and only one study yielding mixed results. Various forms of lavender administration, including inhalation and aromatherapy, were utilized, with doses often unspecified or varying widely. No adverse effects were reported in the studies reviewed, suggesting a favorable safety profile; however, the mixed outcome in one pilot study indicates the need for further research to confirm these findings.",0.9,35027302,2022,Effectiveness of aromatherapy with inhaled lavender essential oil and breathing exercises on ECT-related anxiety in depressed patients.,randomized_controlled_trial,benefit,"The study found significant reductions in anxiety scores, indicating a beneficial effect of lavender aromatherapy.",(inhaled lavender essential oil),Depression,,anxiety,agitation; anxiety; anxiety in cardiovascular patients; breast cancer; caesarean section; comfort during hemodialysis; depression; fatigue; hemodialysis; hemodynamic status; intraoperative anxiety; invasive pain; pain; preinterventional anxiety; sleep quality; stress,,,
Lavender,,Stress,,"Energy, Mood, & Mental Health",manual_pair,"The clinical evidence for lavender as a treatment for anxiety is predominantly positive, with 13 studies reporting significant benefits and only one study yielding mixed results. Various forms of lavender administration, including inhalation and aromatherapy, were utilized, with doses often unspecified or varying widely. No adverse effects were reported in the studies reviewed, suggesting a favorable safety profile; however, the mixed outcome in one pilot study indicates the need for further research to confirm these findings.",0.9,33640257,2021,Effect of Lavender Aromatherapy On Arteriovenous Fistula Puncture Pain and the Level of State and Trait Anxiety in Hemodialysis Patients: A Randomized Controlled Trial.,randomized_controlled_trial,benefit,"Lavender aromatherapy significantly reduced pain scores and improved anxiety outcomes, indicating a beneficial effect.",5 minutes three times a week one week (aromatherapy inhalation),CKD; Hemodialysis,Musculoskeletal & Pain,anxiety,agitation; anxiety; anxiety in cardiovascular patients; breast cancer; caesarean section; comfort during hemodialysis; depression; fatigue; hemodialysis; hemodynamic status; intraoperative anxiety; invasive pain; pain; preinterventional anxiety; sleep quality; stress,,,
Lavender,,Stress,,"Energy, Mood, & Mental Health",manual_pair,"The clinical evidence for lavender as a treatment for anxiety is predominantly positive, with 13 studies reporting significant benefits and only one study yielding mixed results. Various forms of lavender administration, including inhalation and aromatherapy, were utilized, with doses often unspecified or varying widely. No adverse effects were reported in the studies reviewed, suggesting a favorable safety profile; however, the mixed outcome in one pilot study indicates the need for further research to confirm these findings.",0.9,33626029,2021,Lavender Aromatherapy for Anxiety and Pain During Multichannel Urodynamics: A Randomized Controlled Pilot Trial.,randomized_controlled_trial,benefit,"The study found a significant reduction in anxiety levels in the lavender group compared to placebo, indicating a beneficial effect.",(aromatherapy),,,anxiety,agitation; anxiety; anxiety in cardiovascular patients; breast cancer; caesarean section; comfort during hemodialysis; depression; fatigue; hemodialysis; hemodynamic status; intraoperative anxiety; invasive pain; pain; preinterventional anxiety; sleep quality; stress,,,
Lavender,,Stress,,"Energy, Mood, & Mental Health",manual_pair,"The clinical evidence for lavender as a treatment for anxiety is predominantly positive, with 13 studies reporting significant benefits and only one study yielding mixed results. Various forms of lavender administration, including inhalation and aromatherapy, were utilized, with doses often unspecified or varying widely. No adverse effects were reported in the studies reviewed, suggesting a favorable safety profile; however, the mixed outcome in one pilot study indicates the need for further research to confirm these findings.",0.9,35085018,2022,Efficacy of Auricular Acupuncture and Lavender Oil Aromatherapy in Reducing Preinterventional Anxiety in Cardiovascular Patients: A Randomized Single-Blind Placebo-Controlled Trial.,randomized_controlled_trial,benefit,The study found a significant reduction in anxiety levels in the group receiving lavender oil aromatherapy compared to the placebo group.,(lavender oil),,,anxiety in cardiovascular patients,agitation; anxiety; anxiety in cardiovascular patients; breast cancer; caesarean section; comfort during hemodialysis; depression; fatigue; hemodialysis; hemodynamic status; intraoperative anxiety; invasive pain; pain; preinterventional anxiety; sleep quality; stress,,,
Lavender,,Improve Memory,,Cognitive & Neurological Function,manual_pair,"There is limited evidence suggesting that lavender essential oil may improve working memory in women with multiple sclerosis, as indicated by one randomized trial. No adverse effects were reported in this study, but further research is needed to confirm these findings and assess the generalizability of the results.",0.8,35126747,2021,The effect of aromatherapy with lavender essential oil on the working memory of women with multiple sclerosis.,randomized_controlled_trial,benefit,The study shows a significant improvement in working memory in the intervention group compared to the placebo group.,(essential oil),Multiple Sclerosis; Women,,multiple sclerosis,multiple sclerosis; working memory impairment,,,
Lavender,,Stress,,"Energy, Mood, & Mental Health",manual_pair,"One randomized clinical trial found that a single dose of 20 drops of lavender extract significantly reduced dental anxiety scores in patients undergoing endodontic treatment, indicating a potential benefit. However, the evidence is limited to this single study, and further research is needed to confirm these findings and assess consistency across different populations and settings.",0.7,40145478,2025,Effect of Lavender Oral Drops in Reducing Dental Anxiety Among Patients Requiring Endodontic Treatment: A Randomised Clinical Trial.,randomized_controlled_trial,benefit,"The study demonstrated a significant reduction in dental anxiety scores in patients receiving lavender extract compared to the control group, indicating a beneficial effect.",20 drops single dose 1 hour before procedure (lavender extract),,,dental anxiety,dental anxiety; symptomatic irreversible pulpitis,,,
Lavender,,Improve Mood,,"Energy, Mood, & Mental Health",manual_pair,"Two randomized controlled trials indicate that lavender may have beneficial effects on depression, with one study using 80 mg of lavender in gelatin capsules daily and another using 1.5 g of microencapsulated lavender essential oil nightly for four weeks. No studies reported mixed outcomes or harm, suggesting a consistent positive effect; however, further research is needed to confirm these findings and establish optimal dosing and long-term safety.",0.8,38459484,2024,The effect of lavender on mood disorders associated with the use of combined oral contraceptives (COCs): a triple-blinded randomized controlled trial.,randomized_controlled_trial,benefit,"The study showed significant improvements in mood disorders, stress, and depression with lavender essential oil, indicating a beneficial effect.",80 mg daily 56 days (gelatin capsule),,,depression,depression; mood disorders; post-stroke depression; sleep quality; stress,,,
Lavender,,Improve Mood,,"Energy, Mood, & Mental Health",manual_pair,"Two randomized controlled trials indicate that lavender may have beneficial effects on depression, with one study using 80 mg of lavender in gelatin capsules daily and another using 1.5 g of microencapsulated lavender essential oil nightly for four weeks. No studies reported mixed outcomes or harm, suggesting a consistent positive effect; however, further research is needed to confirm these findings and establish optimal dosing and long-term safety.",0.8,38241803,2024,Effects of lavender essential oil inhalation aromatherapy on depression and sleep quality in stroke patients: A single-blind randomized controlled trial.,randomized_controlled_trial,benefit,"The study demonstrated significant improvements in depression and sleep quality, indicating a beneficial effect of lavender essential oil inhalation aromatherapy.",1.5 g every night 4 weeks (microencapsulated lavender essential oil),,,post-stroke depression,depression; mood disorders; post-stroke depression; sleep quality; stress,,,
Lavender,,Fatigue,,"Energy, Mood, & Mental Health",manual_pair,"Two randomized controlled trials indicate that lavender essential oil may improve fatigue levels and sleep quality in specific patient populations, including those undergoing chemotherapy and patients with multiple sclerosis. The studies utilized lavender aromatherapy, with one trial administering it for 20 minutes nightly over five consecutive days. There were no reported harms or adverse effects, but the evidence is limited to specific conditions and populations.",0.9,39775962,2025,The efficacy of lavender oil on fatigue and sleep quality in patients with hematological malignancy receiving chemotherapy: a single-blind randomized controlled trial.,randomized_controlled_trial,benefit,"The study demonstrated significant improvements in sleep quality and reductions in fatigue levels, indicating a beneficial effect of lavender aromatherapy.",20 minutes every night 5 consecutive days (lavender essential oil),Cancer; Chemotherapy,Sleep,fatigue,fatigue; hematological malignancies; multiple sclerosis; sleep disorders; sleep quality,,,
Lavender,,Fatigue,,"Energy, Mood, & Mental Health",manual_pair,"Two randomized controlled trials indicate that lavender essential oil may improve fatigue levels and sleep quality in specific patient populations, including those undergoing chemotherapy and patients with multiple sclerosis. The studies utilized lavender aromatherapy, with one trial administering it for 20 minutes nightly over five consecutive days. There were no reported harms or adverse effects, but the evidence is limited to specific conditions and populations.",0.9,38842713,2024,The Effect of Aromatherapy with Lavender Essential Oil on the Sleep and Fatigue Level of Patients with Multiple Sclerosis in Turkey: A Randomized Controlled Trial.,randomized_controlled_trial,benefit,"The study demonstrated significant improvements in fatigue and sleep quality in MS patients, indicating a beneficial effect of lavender aromatherapy.",(lavender essential oil),Multiple Sclerosis,Sleep,fatigue,fatigue; hematological malignancies; multiple sclerosis; sleep disorders; sleep quality,,,
Lavender,,Fatigue,,"Energy, Mood, & Mental Health",manual_pair,"One randomized controlled trial indicates that lavender (600 mg three times daily for 60 days) may improve fatigue symptoms in patients with multiple sclerosis, showing a significant reduction in fatigue compared to the control group. No studies reported mixed results or adverse effects, but further research may be needed to confirm these findings.",0.8,35803088,2022,"Lavender improves fatigue symptoms in multiple sclerosis patients: A double-blind, randomized controlled trial.",randomized_controlled_trial,benefit,The study shows a significant reduction in fatigue symptoms in the intervention group compared to the control group.,600 mg three times daily 60 days (capsule),Multiple Sclerosis,,fatigue,fatigue; multiple sclerosis,,,
Lavender,,Fear of Heights,,Cognitive & Neurological Function,manual_pair,"One randomized clinical trial indicates that the use of lavender oil as an olfactory stimulus during vestibular rehabilitation may significantly improve balance and reduce fear of falling in individuals with multiple sclerosis. However, the evidence is limited to a single study, and no adverse effects were reported. Further research is needed to confirm these findings and establish broader applicability.",0.8,33305625,2022,"Comparing the effects of vestibular rehabilitation with and without lavender oil scents as an olfactory stimulus on balance, fear of falling down and activities of daily living of people with multiple sclerosis: a randomized clinical trial.",randomized_controlled_trial,benefit,The study shows significant improvement in balance and reduction in fear of falling with the use of lavender oil during rehabilitation.,null null 10 sessions 45 minutes (oil),Multiple Sclerosis,,activities of daily living,activities of daily living; balance issues; fear of falling; multiple sclerosis,,,
Lavender,,Insomnia,,Sleep,manual_pair,"One randomized trial reported a statistically significant reduction in insomnia severity among patients with cancer receiving lavender oil inhalation therapy for 5 minutes daily over 14 days. Overall, the evidence is limited to this single study, and no adverse effects were reported. Further research is needed to confirm these findings and establish broader applicability.",0.7,36270928,2023,The effect of a combined treatment of foot soak and lavender oil inhalation therapy on the severity of insomnia of patients with cancer: Randomized interventional study.,randomized_controlled_trial,benefit,The study found a statistically significant reduction in insomnia severity in the groups receiving lavender therapy.,5 minutes 14 days (lavender oil inhalation therapy),Cancer,,cancer,cancer; insomnia,,,
Lavender,,Dysmenorrhea,,Women's Health,manual_pair,"One randomized, double-blind clinical trial found that lavender (250 mg twice daily) combined with metformin improved progesterone levels and regulated menstrual cycles in patients with polycystic ovary syndrome. Overall, the evidence is limited to this single study, and further research is needed to confirm these findings and assess long-term effects and safety.",0.7,37931721,2024,"Lavender and metformin effectively propagate progesterone levels in patients with polycystic ovary syndrome: A randomized, double-blind clinical trial.",randomized_controlled_trial,benefit,"The study demonstrated that both lavender and metformin significantly increased progesterone levels and regulated menstrual cycles in PCOS patients, indicating a beneficial outcome.",250 mg twice daily 90 days (lavender); 500 mg three times a day 90 days (metformin),PCOS; Women,,polycystic ovary syndrome,polycystic ovary syndrome,,,
Lavender,,Temporomandibular Joint Syndrome,,Oral Health,manual_pair,"One randomized controlled trial reported that lavender oil used in aromatherapy massage significantly improved pain and mouth opening in patients with myogenous temporomandibular disorders. No adverse effects were noted in the study, but further research may be needed to confirm these findings and establish consistency across different populations.",0.8,32893748,2023,A novel treatment modality for myogenous temporomandibular disorders using aromatherapy massage with lavender oil: A randomized controlled clinical trial.,randomized_controlled_trial,benefit,"The study shows significant improvement in pain and mouth opening with lavender oil, indicating a beneficial effect.",(lavender oil),,,myogenous temporomandibular disorders,myogenous temporomandibular disorders; pain,,,
Lavender,,Stress,,"Energy, Mood, & Mental Health",manual_pair,"The evidence regarding lavender for job stress is low quality, with a single randomized controlled trial reporting mixed results. This study found no significant differences in job stress levels after four weeks of exposure to lavender scent, suggesting that its effectiveness for this indication is unclear. No adverse effects were reported.",0.5,36646611,2023,Effects of rose and lavender scents on nurses' job stress: A randomized controlled trial.,randomized_controlled_trial,mixed_unclear,"The study showed no significant differences in job stress until the end of the fourth week, indicating mixed results regarding the effectiveness of lavender.",null null two hours a day four weeks (essential oil),,,job stress,job stress; psychological problems,,,
Lavender,,Joint Pain,,Musculoskeletal & Pain,manual_pair,"One randomized, double-blind, placebo-controlled trial found that lavender oil significantly reduced pain severity and improved physical function in patients with knee osteoarthritis over one month of treatment. No studies reported mixed outcomes or adverse effects, but the overall evidence is limited to a single trial, indicating a need for further research to confirm these findings.",0.7,40192256,2025,"Efficacy of Lavender Oil as an Adjunctive Treatment for Patients with Osteoarthritis: A Randomized, Double-Blind, Placebo-Controlled Trial.",randomized_controlled_trial,benefit,"Lavender oil showed a significant reduction in pain severity and physical function in knee OA patients, indicating a beneficial effect.",one month (lavender oil),Osteoarthritis,,"osteoarthritis, knee","osteoarthritis, knee",,,
Lavender,,Improve Sexual Function,,Women's Health,manual_pair,"One randomized trial indicates that lavender aromatherapy may have a significant positive effect on female sexual function, suggesting a potential benefit for low sexual arousal. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term effects and safety.",0.7,39214150,2024,Comparing the Effects of Lavender Aromatherapy and Mindfulness-Based Cognitive Therapy on Sexual Function in Women in Iran.,randomized_controlled_trial,benefit,"The study shows a significant positive effect of lavender aromatherapy on various aspects of female sexual function, indicating a benefit.",(lavender aromatherapy),,,arousal,arousal; female sexual function; lubrication; pain; satisfaction; sexual desire,,,
Lavender,,Improve Sexual Function,,Women's Health,manual_pair,"One randomized controlled trial reported a significant improvement in sexual satisfaction among breastfeeding women using lavender essential oil (2 drops twice a day for 40 days) compared to a control group. Overall, the evidence is limited to this single study, and further research is needed to confirm these findings and assess long-term effects and safety.",0.7,36603110,2023,Comparison of Aromatherapy with Citrus aurantium and Lavender on Sexual Satisfaction in Breastfeeding Women: A Randomized Controlled Trial.,randomized_controlled_trial,benefit,"The study found a significant improvement in sexual satisfaction for the Lavender group compared to the control, indicating a beneficial effect.",2 drops twice a day 40 days (essential oil),,,breastfeeding women,breastfeeding women; sexual satisfaction,,,
Lavender,,Improve Memory,,Cognitive & Neurological Function,manual_pair,"The evidence regarding lavender for memory problems is mixed, with one randomized controlled trial indicating a significant decrease in retrospective memory problems among patients undergoing hemodialysis when using 5 drops of lavender essential oil three times a week for one month. However, the lack of consistent positive outcomes and the absence of additional studies limit the strength of the evidence.",0.7,34736874,2022,"The effects of lavender, rosemary and orange essential oils on memory problems and medication adherence among patients undergoing hemodialysis: A parallel randomized controlled trial.",randomized_controlled_trial,mixed_unclear,"The study showed a significant decrease in retrospective memory problems with Lavender, but no significant effect on medication adherence, leading to a mixed outcome classification.",5 drops three times a week one month (essential oil),CKD; Hemodialysis,,hemodialysis,hemodialysis; medication adherence; memory problems,,,
Lavender,,Neuropathic Pain,,Musculoskeletal & Pain,manual_pair,"One randomized clinical trial demonstrated that aromatherapy massage with lavender essential oil (2.5 cc of 3% lavender oil nightly for one month) resulted in a significant reduction in neuropathic pain and improved quality of life in diabetic patients. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess potential adverse effects.",0.7,34217127,2021,The effects of aromatherapy massage with lavender essential oil on neuropathic pain and quality of life in diabetic patients: A randomized clinical trial.,randomized_controlled_trial,benefit,"The study shows significant reduction in neuropathic pain and improvement in quality of life, indicating a beneficial outcome.",2.5 cc every night one month (3% lavender oil),Diabetes,,diabetic neuropathy,diabetic neuropathy; neuropathic pain; quality of life,,,
Lavender,,Sleep Quality,,Sleep,manual_pair,"The evidence for lavender essential oil in improving sleep quality and insomnia is mixed. One pilot randomized trial reported significant benefits in sleep patterns among postmenopausal women, while another study found no significant differences between groups despite some improvements. Overall, the findings do not consistently support the efficacy of lavender for insomnia, and no adverse effects were reported.",0.7,33905827,2021,Lavender essential oil on postmenopausal women with insomnia: Double-blind randomized trial.,randomized_controlled_trial,mixed_unclear,"While AG participants showed improvements in various outcomes, no significant differences were observed between groups, indicating mixed results.",null null null 29 days (essential oil),Menopause; Women,,anxiety,anxiety; depression; hot flashes; insomnia; menopausal symptoms; quality of life; vasomotor symptoms,,,
Lavender,,Sleep Quality,,Sleep,manual_pair,"The evidence for lavender essential oil in improving sleep quality and insomnia is mixed. One pilot randomized trial reported significant benefits in sleep patterns among postmenopausal women, while another study found no significant differences between groups despite some improvements. Overall, the findings do not consistently support the efficacy of lavender for insomnia, and no adverse effects were reported.",0.7,37495431,2024,Effect of a lavender essential oil and sleep hygiene protocol on insomnia in postmenopausal women: A pilot randomized clinical trial.,randomized_controlled_trial,benefit,"The intervention with lavender essential oil showed significant improvement in quality of life and sleep patterns, indicating a beneficial outcome.",null null before bedtime 29 days (Lavandula angustifolia essential oil),,,insomnia,anxiety; depression; hot flashes; insomnia; menopausal symptoms; quality of life; vasomotor symptoms,,,
Lavender,,Postherpetic Neuralgia,,Musculoskeletal & Pain,manual_pair,"One randomized controlled trial reported a significant reduction in pain quality, severity, and intensity in patients with postherpetic neuralgia following inhalation of lavender oil and its components at a 1% concentration. No studies reported mixed outcomes or harm, but the overall evidence is limited to a single trial, indicating a need for further research to confirm these findings.",0.8,38267936,2024,Alleviating effect of lavender (Lavandula angustifolia) and its major components on postherpetic pain: a randomized blinded controlled trial.,randomized_controlled_trial,benefit,"The study demonstrated a significant reduction in pain quality, severity, and intensity in patients with postherpetic neuralgia, indicating a beneficial effect of lavender and its components.","1 % inhalation (lavender oil, linalool, linalyl acetate diluted in almond oil)",Herpes,,postherpetic neuralgia,postherpetic neuralgia,,,
Lavender,,Nausea,,Gut Health,manual_pair,"One randomized controlled trial reported that lavender aromatherapy significantly reduced postoperative nausea severity and improved patient satisfaction when administered at a dose of 0.01 ml (essential oil diluted to 1%). However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess consistency across different populations and settings.",0.7,40154579,2025,"Effect of aromatherapy with peppermint, ginger, and lavender on postoperative nausea severity after oral surgery under general anaesthesia: A single-blind randomized controlled trial.",randomized_controlled_trial,benefit,"Aromatherapy significantly reduced nausea severity and improved patient satisfaction, indicating a beneficial outcome.",0.01 ml (essential oil diluted to 1%),Postoperative,,postoperative nausea,postoperative nausea,,,
Lavender,,Restless Legs Syndrome,,Musculoskeletal & Pain,manual_pair,"The clinical evidence for lavender in the treatment of restless legs syndrome (RLS) is limited but suggests potential benefits. Two studies reported significant improvements in RLS severity and quality of life with lavender oil massage therapy and topical application, using doses of 5% oil and 30 minutes of application three times a week, respectively. No adverse effects were noted, but the overall evidence is still sparse and requires further investigation.",0.8,34779137,2022,Effect of massage therapy with lavender oil on severity of restless legs syndrome and quality of life in hemodialysis patients.,randomized_controlled_trial,benefit,"The study reports significant improvements in RLS severity and quality of life, indicating a beneficial effect of lavender oil massage therapy.",5 % (oil),CKD; Hemodialysis,,quality of life,quality of life; restless leg syndrome; restless legs syndrome; sleep quality,,,
Lavender,,Restless Legs Syndrome,,Musculoskeletal & Pain,manual_pair,"The clinical evidence for lavender in the treatment of restless legs syndrome (RLS) is limited but suggests potential benefits. Two studies reported significant improvements in RLS severity and quality of life with lavender oil massage therapy and topical application, using doses of 5% oil and 30 minutes of application three times a week, respectively. No adverse effects were noted, but the overall evidence is still sparse and requires further investigation.",0.8,33838094,2021,The effects of foot massage on hemodialysis patients' sleep quality and restless leg syndrome: a comparison of lavender and sweet orange essential oil topical application.,randomized_controlled_trial,benefit,The study showed significant improvement in sleep quality and RLS in the lavender group compared to control.,30 minutes three times a week three weeks (essential oil),CKD; Hemodialysis,,restless leg syndrome,quality of life; restless leg syndrome; restless legs syndrome; sleep quality,,,
Lemon Balm,behavioral costs at other doses,Cognitive Performance,,Cognitive & Neurological Function,manual_pair,"Clinical evidence suggests that lemon balm (Melissa officinalis) may improve cognitive performance and mood, with benefits observed in studies using doses ranging from 600 mg to 1600 mg. However, the evidence is limited to a small number of studies, and further research is needed to confirm these findings and assess long-term effects and safety.",0.7,12062586,2002,Modulation of mood and cognitive performance following acute administration of Melissa officinalis (lemon balm).,randomized_controlled_trial,benefit,"The study showed sustained improvement in cognitive performance and mood, indicating a benefit from lemon balm administration.",300 mg single dose null (standardised extract); 600 mg single dose null (standardised extract); 900 mg single dose null (standardised extract),,"Energy, Mood, & Mental Health",cognitive deficits,cognitive deficits; cognitive performance; mood enhancement; mood modulation,,,
Lemon Balm,behavioral costs at other doses,Cognitive Performance,,Cognitive & Neurological Function,manual_pair,"Clinical evidence suggests that lemon balm (Melissa officinalis) may improve cognitive performance and mood, with benefits observed in studies using doses ranging from 600 mg to 1600 mg. However, the evidence is limited to a small number of studies, and further research is needed to confirm these findings and assess long-term effects and safety.",0.7,12888775,2003,Modulation of mood and cognitive performance following acute administration of single doses of Melissa officinalis (Lemon balm) with human CNS nicotinic and muscarinic receptor-binding properties.,randomized_controlled_trial,benefit,"The study showed improved cognitive performance and mood with the highest dose of Lemon Balm, indicating a beneficial effect.",600 mg single dose (encapsulated dried leaf); 1000 mg single dose (encapsulated dried leaf); 1600 mg single dose (encapsulated dried leaf),,"Energy, Mood, & Mental Health",cognitive performance,cognitive deficits; cognitive performance; mood enhancement; mood modulation,,,
Lemon Balm,behavioral costs at other doses,Stress,,"Energy, Mood, & Mental Health",manual_pair,"There is limited evidence suggesting that lemon balm may help in coping with emotional stress, as indicated by one study showing increased electrical brain activity associated with relaxation. However, the overall quality and quantity of evidence are low, and no adverse effects were reported. Further research is needed to establish more definitive conclusions.",0.6,15546807,2004,"Effects of lozenge containing lavender oil, extracts from hops, lemon balm and oat on electrical brain activity of volunteers.",randomized_controlled_trial,benefit,The study indicates a benefit in coping with psychological and emotional stress based on increased electrical brain activity associated with relaxation.,(lozenge),,,emotional stress,emotional stress; psychological stress,,,
Lemon Balm,behavioral costs at other doses,High Blood Glucose,,Metabolic Health,manual_pair,"Two randomized, double-blind clinical trials have reported beneficial effects of lemon balm (Melissa officinalis) extract on glycemic control and cardiovascular risk factors in individuals with type 2 diabetes, both using a dose of 700 mg twice daily for 12 weeks. No studies reported mixed outcomes or adverse effects, but the overall evidence is limited to these two trials, indicating a need for further research to confirm these findings.",0.8,30548118,2019,"Efficacy of Melissa officinalis L. (lemon balm) extract on glycemic control and cardiovascular risk factors in individuals with type 2 diabetes: A randomized, double-blind, clinical trial.",randomized_controlled_trial,benefit,"The study showed significant improvements in glycemic control and cardiovascular risk factors, indicating a beneficial effect of lemon balm extract.",700 mg twice daily 12 weeks (capsules),Diabetes Type 2,"Heart & Vascular Health; Immune, Inflammation, & Infection",cardiovascular risk factors,Type 2 Diabetes Mellitus; cardiovascular risk factors; glycemic control,,,
Lemon Balm,behavioral costs at other doses,High Blood Glucose,,Metabolic Health,manual_pair,"Two randomized, double-blind clinical trials have reported beneficial effects of lemon balm (Melissa officinalis) extract on glycemic control and cardiovascular risk factors in individuals with type 2 diabetes, both using a dose of 700 mg twice daily for 12 weeks. No studies reported mixed outcomes or adverse effects, but the overall evidence is limited to these two trials, indicating a need for further research to confirm these findings.",0.8,30219475,2018,"Safety and efficacy of Melissa officinalis (lemon balm) on ApoA-I, Apo B, lipid ratio and ICAM-1 in type 2 diabetes patients: A randomized, double-blinded clinical trial.",randomized_controlled_trial,benefit,"The study showed significant improvements in Apo A-I and lipid ratios, indicating a benefit for type 2 diabetes patients.",700 mg twice-daily 12 weeks (hydroalcoholic extract),Diabetes Type 2,,Type 2 Diabetes Mellitus,Type 2 Diabetes Mellitus; cardiovascular risk factors; glycemic control,,,
Lemon Balm,behavioral costs at other doses,High LDL,,Heart & Vascular Health,manual_pair,"Two randomized controlled trials suggest that lemon balm may have a beneficial effect on lowering LDL cholesterol levels. Doses reported include 1000 mg three times daily and 3 g daily for eight weeks. However, the overall evidence is limited, and further studies are needed to confirm these findings and assess long-term safety.",0.7,27261994,2016,Lemon balm: A promising herbal therapy for patients with borderline hyperlipidemia-A randomized double-blind placebo-controlled clinical trial.,randomized_controlled_trial,benefit,"The study showed a significant decrease in LDL and AST levels, indicating a beneficial effect of lemon balm supplementation in patients with borderline hyperlipidemia.",1000 mg 3 times per day 2 months (capsules),,,borderline hyperlipidemia,borderline hyperlipidemia; chronic stable angina,,,
Lemon Balm,behavioral costs at other doses,High LDL,,Heart & Vascular Health,manual_pair,"Two randomized controlled trials suggest that lemon balm may have a beneficial effect on lowering LDL cholesterol levels. Doses reported include 1000 mg three times daily and 3 g daily for eight weeks. However, the overall evidence is limited, and further studies are needed to confirm these findings and assess long-term safety.",0.7,30045422,2018,"The effects of Melissa officinalis (lemon balm) in chronic stable angina on serum biomarkers of oxidative stress, inflammation and lipid profile.",randomized_controlled_trial,benefit,"The study shows that oral administration of lemon balm improves lipid profile and reduces biomarkers of oxidative stress and inflammation in patients with chronic stable angina, indicating a beneficial outcome.",3 g daily eight weeks (powdered),,"Immune, Inflammation, & Infection",chronic stable angina,borderline hyperlipidemia; chronic stable angina,,,
Lemon Balm,behavioral costs at other doses,Sleep Quality,,Sleep,manual_pair,"One randomized trial reported a significant benefit of lemon balm in reducing sleep disorders among menopausal women, suggesting potential efficacy for improving sleep. However, the overall evidence is limited, with only one study available, and no adverse effects were reported. Further research is needed to confirm these findings and establish consistent dosing.",0.7,24199972,2013,Valerian/lemon balm use for sleep disorders during menopause.,randomized_controlled_trial,benefit,"The study showed a significant reduction in sleep disorders in the experimental group, indicating a benefit from the intervention.",(valerian/lemon balm),Menopause; Women,,menopause,menopause; sleep disorders,,,
Lemon Balm,behavioral costs at other doses,Stress,,"Energy, Mood, & Mental Health",manual_pair,"One randomized trial indicates that lemon balm (Melissa officinalis) may improve mood and cognitive performance under laboratory-induced stress, with doses of 300 mg and 600 mg of a standardized extract used. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term effects and safety.",0.7,15272110,2004,Attenuation of laboratory-induced stress in humans after acute administration of Melissa officinalis (Lemon Balm).,randomized_controlled_trial,benefit,"The study demonstrated that lemon balm significantly improved mood and cognitive performance, indicating a beneficial effect on psychological stress.",300 mg single dose (standardized extract); 600 mg single dose (standardized extract),,,psychological stress,psychological stress,,,
Lemon Balm,behavioral costs at other doses,Stress,,"Energy, Mood, & Mental Health",manual_pair,"There is limited evidence suggesting that lemon balm may have anti-stress effects, as indicated by one study showing improvements in mood and cognitive performance with lemon balm-containing foods. However, the overall quality and quantity of evidence are low, and further research is needed to establish consistent benefits and optimal dosing. No adverse effects were reported in the studies reviewed.",0.5,25360512,2014,Anti-stress effects of lemon balm-containing foods.,randomized_controlled_trial,benefit,"The study showed improvements in mood and cognitive performance with lemon balm, indicating a benefit for stress and cognitive function.",(beverage and yoghurt),,,cognitive function,cognitive function; mood disorders; stress,,,
Lemon Balm,behavioral costs at other doses,Wrinkles,,"Skin, Hair, & Nails",manual_pair,"One randomized trial reported that lemon balm (Melissa officinalis) leaf extract applied as a cream at a dose of 50 μg/mL twice daily for 8 weeks showed a benefit in reducing wrinkles, suggesting its potential as an antiwrinkle agent. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term effects and safety.",0.7,39888701,2025,Lemon Balm (Melissa officinalis L.) Leaf Extract Promotes Endo180 Production in Dermal Fibroblasts and has Antiwrinkle Effect on Human Skin.,randomized_controlled_trial,benefit,"The study demonstrated a benefit in reducing wrinkles through the application of lemon balm extract, indicating its potential as an antiwrinkle agent.",50 μg/mL twice daily 8 weeks (cream),,,skin aging,skin aging; wrinkles,,,
Lion's Mane,AMT uniquely elevated blood pressure from baseline,Cognitive Performance,,Cognitive & Neurological Function,manual_pair,"One randomized trial reported that a single dose of 1 g of Nordic-grown Lion's Mane extract resulted in significant improvements in cognitive performance and subjective cognitive indices in healthy adults. However, the overall evidence is limited, with only one study demonstrating benefit and no additional trials to confirm these findings. No adverse effects were reported in the study.",0.7,38140277,2023,Acute Effects of Naturally Occurring Guayusa Tea and Nordic Lion's Mane Extracts on Cognitive Performance.,randomized_controlled_trial,benefit,"The study demonstrated significant improvements in cognitive performance and subjective cognitive indices with Lion's Mane, indicating a beneficial outcome.",1 g single dose (Nordic-grown Lion's Mane),,"Energy, Mood, & Mental Health",cognitive performance,cognitive performance; complex attention; concentration; focus; mental clarity; mood; perceptions of happiness; productivity; reaction time; working memory,,,
Lion's Mane,AMT uniquely elevated blood pressure from baseline,Cognitive Performance,,"Energy, Mood, & Mental Health",manual_pair,"The clinical evidence regarding Lion's Mane supplementation for mood is limited and mixed, with one pilot study suggesting potential benefits in cognitive performance and stress reduction, but also highlighting a small sample size and limited negative findings. No consistent dose ranges were reported across studies, and there were no documented harms. Overall, the evidence does not support a clear benefit for mood enhancement.",0.8,38004235,2023,"The Acute and Chronic Effects of Lion's Mane Mushroom Supplementation on Cognitive Function, Stress and Mood in Young Adults: A Double-Blind, Parallel Groups, Pilot Study.",randomized_controlled_trial,mixed_unclear,"The study suggests potential benefits in cognitive performance and stress reduction, but also notes limited negative findings and a small sample size, leading to a mixed outcome classification.",1.8 g single dose 28 days (Hericium erinaceus),,,mood,mood,,,
Lion's Mane,AMT uniquely elevated blood pressure from baseline,Stress,,"Energy, Mood, & Mental Health",manual_pair,"Current evidence on Lion's Mane for stress is limited and classified as mixed or unclear, primarily based on a small pilot study that reported potential benefits in cognitive performance and stress reduction with a single dose of 1.8 g over 28 days. However, the study's small sample size and limited negative findings suggest caution in interpreting these results, indicating a need for further research to clarify efficacy.",0.6,38004235,2023,"The Acute and Chronic Effects of Lion's Mane Mushroom Supplementation on Cognitive Function, Stress and Mood in Young Adults: A Double-Blind, Parallel Groups, Pilot Study.",randomized_controlled_trial,mixed_unclear,"The study suggests potential benefits in cognitive performance and stress reduction, but also notes limited negative findings and a small sample size, leading to a mixed outcome classification.",1.8 g single dose 28 days (Hericium erinaceus),,Cognitive & Neurological Function,stress,stress,,,
Lutein,"Addition of PUFA may reduce the bioavailability of lutein; Caution for contamination with potentially pathogenic organisms, specifically Escherichia coli.",Eye Health,,Vision & Eye Health,manual_pair,"One randomized trial indicates that lutein supplementation (6 mg daily for two months) significantly increases serum lutein levels and may reduce the risk of age-related eye disease. However, the overall evidence is limited, with only one study demonstrating a benefit and no reports of harm or mixed outcomes. Further research is needed to confirm these findings and establish consistent dosing guidelines.",0.7,38794653,2024,Bioavailability of Lutein from Marigold Flowers (Free vs. Ester Forms): A Randomised Cross-Over Study to Assess Serum Response and Visual Contrast Threshold in Adults.,randomized_controlled_trial,benefit,"The study shows that lutein supplementation significantly increases serum lutein levels associated with a reduced risk of age-related eye disease, indicating a beneficial outcome.",6 mg daily two months (marigold extract),,,age-related eye disease,age-related eye disease; visual contrast sensitivity,,,
Lutein,"Addition of PUFA may reduce the bioavailability of lutein; Caution for contamination with potentially pathogenic organisms, specifically Escherichia coli.",Macular Degeneration,,Vision & Eye Health,manual_pair,"One randomized trial suggests that lutein, when added to the AREDS supplements, may benefit the progression of age-related macular degeneration (AMD) compared to beta carotene, without increasing lung cancer risk. The evidence is limited to this single study, indicating a need for further research to confirm these findings and assess long-term effects.",0.8,35653117,2022,Long-term Outcomes of Adding Lutein/Zeaxanthin and ω-3 Fatty Acids to the AREDS Supplements on Age-Related Macular Degeneration Progression: AREDS2 Report 28.,randomized_controlled_trial,benefit,The study suggests that lutein/zeaxanthin does not increase lung cancer risk and may benefit AMD progression compared to beta carotene.,(AREDS2 supplements with lutein/zeaxanthin),,,age-related macular degeneration,age-related macular degeneration; lung cancer,,,
Lutein,"Addition of PUFA may reduce the bioavailability of lutein; Caution for contamination with potentially pathogenic organisms, specifically Escherichia coli.",General Cognitive Health,,Healthy Aging & Prevention,manual_pair,"The evidence regarding lutein's effects on brain function is limited and mixed, with one randomized controlled trial reporting increased inter-network connectivity in older adults after 10 mg daily for one year, but the implications of this finding remain unclear. Overall, there are no consistent benefits or harms identified in the available studies.",0.6,30680611,2020,The effects of lutein and zeaxanthin on resting state functional connectivity in older Caucasian adults: a randomized controlled trial.,randomized_controlled_trial,mixed_unclear,"The study showed increased inter-network connectivity, contrary to expectations, indicating mixed outcomes regarding the effects of lutein on brain function.",10 mg daily 1 year (supplement),,,brain function,brain function,,,
Lutein,"Addition of PUFA may reduce the bioavailability of lutein; Caution for contamination with potentially pathogenic organisms, specifically Escherichia coli.",Cognitive Performance,,Cognitive & Neurological Function,manual_pair,"One randomized, double-masked, placebo-controlled trial found that lutein supplementation, in combination with zeaxanthin, resulted in significant improvements in cognitive function metrics in younger healthy adults over a one-year period. No studies reported mixed or negative outcomes, but the evidence is limited to a single trial, indicating a need for further research to confirm these findings and assess long-term effects.",0.7,29135938,2017,"Effects of a Lutein and Zeaxanthin Intervention on Cognitive Function: A Randomized, Double-Masked, Placebo-Controlled Trial of Younger Healthy Adults.",randomized_controlled_trial,benefit,"The study shows significant improvements in cognitive function metrics, indicating a beneficial effect of lutein supplementation.",daily one year (Lutein and Zeaxanthin),,,cognitive function,cognitive function; complex attention; reasoning ability; spatial memory,,,
Lutein,"Addition of PUFA may reduce the bioavailability of lutein; Caution for contamination with potentially pathogenic organisms, specifically Escherichia coli.",Improve Memory,,Cognitive & Neurological Function,manual_pair,"The evidence regarding lutein supplementation for cognitive impairment is mixed. One randomized controlled trial indicated a benefit in cognitive performance with a dose of 12 mg daily for one year, while another study showed no significant effect in healthy older adults, though some improvement was noted in individuals with cognitive decline. Overall, the findings are not consistent, and further research is needed to clarify the effects of lutein on memory problems.",0.7,37447152,2023,Effects of Long-Chain Polyunsaturated Fatty Acids in Combination with Lutein and Zeaxanthin on Episodic Memory in Healthy Older Adults.,randomized_controlled_trial,mixed_unclear,"The study showed no significant effect on memory function in healthy older individuals with memory complaints, but improvement was noted in those with cognitive decline, indicating mixed outcomes.","24 weeks (supplements containing ARA, DHA, EPA, L, and Z); 12 weeks (supplements containing ARA, DHA, EPA, L, and Z)",Older Adults,,cognitive decline,cognitive decline; cognitive dysfunction; memory complaints; neurocognitive function,,,
Lutein,"Addition of PUFA may reduce the bioavailability of lutein; Caution for contamination with potentially pathogenic organisms, specifically Escherichia coli.",Improve Memory,,Cognitive & Neurological Function,manual_pair,"The evidence regarding lutein supplementation for cognitive impairment is mixed. One randomized controlled trial indicated a benefit in cognitive performance with a dose of 12 mg daily for one year, while another study showed no significant effect in healthy older adults, though some improvement was noted in individuals with cognitive decline. Overall, the findings are not consistent, and further research is needed to clarify the effects of lutein on memory problems.",0.7,28695791,2018,Lutein and Zeaxanthin Influence Brain Function in Older Adults: A Randomized Controlled Trial.,randomized_controlled_trial,benefit,"The study shows that lutein supplementation benefits cognitive performance, indicating a positive outcome direction.",12 mg daily 1 year,,,cognitive dysfunction,cognitive decline; cognitive dysfunction; memory complaints; neurocognitive function,,,
Lutein,"Addition of PUFA may reduce the bioavailability of lutein; Caution for contamination with potentially pathogenic organisms, specifically Escherichia coli.",Visual Processing Speed,,Performance & Recovery,manual_pair,"One randomized placebo-controlled study indicates that lutein supplementation may improve visual processing speed, which is related to contrast sensitivity, over a duration of four months. However, the evidence is limited to a single study with no reported adverse effects or harm, necessitating caution in generalizing these findings.",0.8,25483230,2015,A randomized placebo-controlled study on the effects of lutein and zeaxanthin on visual processing speed in young healthy subjects.,randomized_controlled_trial,benefit,The study shows significant improvement in visual processing speed due to lutein supplementation.,4 months (supplement),,,contrast sensitivity,contrast sensitivity,,,
Lutein,"Addition of PUFA may reduce the bioavailability of lutein; Caution for contamination with potentially pathogenic organisms, specifically Escherichia coli.",Dry Eyes,,Vision & Eye Health,manual_pair,"One randomized controlled trial reported a benefit of lutein supplementation (6 mg daily for 20 days) in improving ocular health outcomes in individuals with dry eye disease. However, the overall evidence is limited, with only one study available, and further research is needed to confirm these findings and assess long-term effects.",0.7,39770987,2024,"Effect of Dietary Supplementation with Lutein, Zeaxanthin, and Elderberries on Dry Eye Disease (DED) and Immunity: A Randomized Controlled Trial.",randomized_controlled_trial,benefit,"The study showed significant improvement in ocular health outcomes, indicating a benefit from the supplementation.",6 mg once daily 20 days (Lutein),,,dry eye disease,dry eye disease,,,
Lutein,"Addition of PUFA may reduce the bioavailability of lutein; Caution for contamination with potentially pathogenic organisms, specifically Escherichia coli.",Weight Loss,,Weight & Body Composition,manual_pair,"The evidence for lutein supplementation in relation to excess body weight is mixed. One randomized controlled trial reported significant improvements in metabolic parameters with a dose of 10 mg daily for 32 weeks, while another study at a dose of 20 mg daily for 10 weeks showed some benefits in body composition and lipid profile, but not all outcomes were statistically significant. Overall, the findings do not provide strong or consistent support for lutein's efficacy in this indication.",0.7,33298201,2021,"Lutein supplementation combined with a low-calorie diet in middle-aged obese individuals: effects on anthropometric indices, body composition and metabolic parameters.",randomized_controlled_trial,mixed_unclear,"The study showed some benefits in body composition and lipid profile, but not all outcomes were statistically significant.",20 mg daily 10 weeks,,,cardiometabolic health,cardiometabolic health; central obesity; obesity,,,
Lutein,"Addition of PUFA may reduce the bioavailability of lutein; Caution for contamination with potentially pathogenic organisms, specifically Escherichia coli.",Weight Loss,,Weight & Body Composition,manual_pair,"The evidence for lutein supplementation in relation to excess body weight is mixed. One randomized controlled trial reported significant improvements in metabolic parameters with a dose of 10 mg daily for 32 weeks, while another study at a dose of 20 mg daily for 10 weeks showed some benefits in body composition and lipid profile, but not all outcomes were statistically significant. Overall, the findings do not provide strong or consistent support for lutein's efficacy in this indication.",0.7,39964702,2025,Effect of lutein supplementation on blood lipids and advanced glycation end products in adults with central obesity: a double-blind randomized controlled trial.,randomized_controlled_trial,benefit,"The study showed significant reductions in various metabolic parameters, indicating a beneficial effect of lutein supplementation in adults with central obesity.",10 mg daily 32 weeks,,,central obesity,cardiometabolic health; central obesity; obesity,,,
Lutein,"Addition of PUFA may reduce the bioavailability of lutein; Caution for contamination with potentially pathogenic organisms, specifically Escherichia coli.",Eye Health,,Vision & Eye Health,manual_pair,"Current evidence suggests that lutein may benefit eye health, specifically by increasing macular pigment optical density, as demonstrated in a clinical trial involving daily consumption of lutein-enriched eggs for four months. However, the overall evidence is limited to a single study with no reported adverse effects or additional trials to confirm these findings. Therefore, the strength and consistency of the evidence remain low.",0.6,34684356,2021,The ALGOVUE Clinical Trial: Effects of the Daily Consumption of Eggs Enriched with Lutein and Docosahexaenoic Acid on Plasma Composition and Macular Pigment Optical Density.,clinical_trial,benefit,"The study showed a significant increase in macular pigment optical density and plasma lutein levels, indicating a benefit from lutein consumption.",2 eggs daily 4 months (enriched),,,eye health,eye health,,,
Lutein,"Addition of PUFA may reduce the bioavailability of lutein; Caution for contamination with potentially pathogenic organisms, specifically Escherichia coli.",Increase Ocular Blood Flow,,Vision & Eye Health,manual_pair,"One randomized trial reported that lutein supplementation (10 mg daily for three weeks) resulted in significant improvements in ocular blood flow and reductions in diastolic blood pressure, suggesting a potential benefit for high blood pressure. However, the evidence is limited, with only one study available, and further research is needed to confirm these findings and assess long-term effects.",0.7,30932775,2019,Lutein Complex Supplementation Increases Ocular Blood Flow Biomarkers in Healthy Subjects.,randomized_controlled_trial,benefit,"The study shows significant improvements in ocular blood flow and reductions in diastolic blood pressure, indicating a beneficial effect of lutein supplementation.",10 mg daily three weeks (oral),,,diastolic blood pressure,diastolic blood pressure; ocular blood flow,,,
Lutein,"Addition of PUFA may reduce the bioavailability of lutein; Caution for contamination with potentially pathogenic organisms, specifically Escherichia coli.",Atherosclerosis,,Heart & Vascular Health,manual_pair,"One randomized trial indicates that lutein supplementation (10 mg daily for 6 months) may reduce inflammatory cytokines and oxidized LDL cholesterol, suggesting a potential benefit for cardiovascular health. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term effects and safety.",0.7,38890092,2024,"Lutein, zeaxanthin, and meso-zeaxanthin supplementation attenuates inflammatory cytokines and markers of oxidative cardiovascular processes in humans.",randomized_controlled_trial,benefit,"The study shows significant reductions in inflammatory cytokines and oxidized LDL, indicating a beneficial effect on cardiovascular health.",10 mg 6 months (Lutein + Meso-zeaxanthin + Zeaxanthin),,"Immune, Inflammation, & Infection",atherosclerosis,atherosclerosis; inflammation; oxidative stress,,,
Lutein,"Addition of PUFA may reduce the bioavailability of lutein; Caution for contamination with potentially pathogenic organisms, specifically Escherichia coli.",Eye Health,,Vision & Eye Health,manual_pair,"One randomized controlled trial reported that lutein supplementation (20 mg once daily for 6 months) significantly increased macular pigment optical density in individuals with high myopia, indicating a potential benefit. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term effects and safety.",0.7,36961139,2023,Efficacy of lutein supplements on macular pigment optical density in highly myopic individuals: A randomized controlled trial.,randomized_controlled_trial,benefit,Lutein supplementation showed significant benefits in MPOD augmentation in patients with high myopia.,20 mg once daily 6 months,Mypoia,,high myopia,high myopia,,,
Lutein,"Addition of PUFA may reduce the bioavailability of lutein; Caution for contamination with potentially pathogenic organisms, specifically Escherichia coli.",Inflammation,,"Immune, Inflammation, & Infection",manual_pair,"There is limited evidence suggesting that lutein may have anti-inflammatory effects, as indicated by one randomized study showing a benefit in participants consuming hen eggs enriched with lutein and other nutrients. The study reported a beneficial outcome with a dose of 3 hard-boiled eggs daily for 21 days. However, the overall evidence is sparse, and further research is needed to confirm these findings and establish consistency.",0.7,36624951,2022,"Consumption of Hen Eggs Enriched with n-3 Polyunsaturated Fatty Acids, Selenium, Vitamin E and Lutein Incites Anti-Inflammatory Conditions in Young, Healthy Participants - A Randomized Study.",randomized_controlled_trial,benefit,"The study demonstrated a shift towards anti-inflammatory conditions in participants consuming enriched hen eggs, indicating a beneficial outcome.",3 eggs daily 21 days (hard-boiled),,,anti-inflammatory conditions,anti-inflammatory conditions,,,
Lutein,"Addition of PUFA may reduce the bioavailability of lutein; Caution for contamination with potentially pathogenic organisms, specifically Escherichia coli.",Improved Breast Milk Quality,,Women's Health,manual_pair,"One randomized controlled trial indicated that lutein supplementation during lactation can increase maternal blood and milk concentrations of lutein and other nutrients, suggesting a potential benefit. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term effects. No adverse effects were reported in the study.",0.7,33339438,2020,"Multiple Micronutrients, Lutein, and Docosahexaenoic Acid Supplementation during Lactation: A Randomized Controlled Trial.",randomized_controlled_trial,benefit,"The study showed that supplementation increased maternal blood and milk concentrations of lutein and other nutrients, indicating a benefit.","12 weeks (multiple micronutrients, lutein, and DHA)",Pregnant; Women,,lactation,lactation; maternal nutrient status; milk composition,,,
Lutein,"Addition of PUFA may reduce the bioavailability of lutein; Caution for contamination with potentially pathogenic organisms, specifically Escherichia coli.",Eye Health,,Vision & Eye Health,manual_pair,"The evidence for lutein supplementation in increasing macular pigment optical density (MPOD) is generally positive, with four studies reporting benefits and one showing mixed results. Typical doses reported range from 1.8 mg (dietary) to 20 mg (supplement) daily. No studies reported harm, but the mixed findings in one study suggest that further research is needed to clarify the effects of dietary sources of lutein.",0.85,34684614,2021,"Changes in Lutein Status Markers (Serum and Faecal Concentrations, Macular Pigment) in Response to a Lutein-Rich Fruit or Vegetable (Three Pieces/Day) Dietary Intervention in Normolipemic Subjects.",clinical_trial,mixed_unclear,"The study shows mixed results with some markers increasing while others did not show significant changes, indicating a need for further research.",1.8 mg daily 4 weeks (dietary from fruits and vegetables),,,macular pigment optical density,macular pigment optical density,,,
Lutein,"Addition of PUFA may reduce the bioavailability of lutein; Caution for contamination with potentially pathogenic organisms, specifically Escherichia coli.",Eye Health,,Vision & Eye Health,manual_pair,"The evidence for lutein supplementation in increasing macular pigment optical density (MPOD) is generally positive, with four studies reporting benefits and one showing mixed results. Typical doses reported range from 1.8 mg (dietary) to 20 mg (supplement) daily. No studies reported harm, but the mixed findings in one study suggest that further research is needed to clarify the effects of dietary sources of lutein.",0.85,32581313,2020,Effect of an antioxidant supplement containing high dose lutein and zeaxanthin on macular pigment and skin carotenoid levels.,clinical_trial,benefit,"The study showed significant increases in MPOD and SC levels, indicating a beneficial effect of lutein supplementation.",20 mg daily 16 weeks (supplement),,,macular pigment optical density,macular pigment optical density,,,
Lutein,"Addition of PUFA may reduce the bioavailability of lutein; Caution for contamination with potentially pathogenic organisms, specifically Escherichia coli.",Eye Health,,Vision & Eye Health,manual_pair,"The evidence for lutein supplementation in increasing macular pigment optical density (MPOD) is generally positive, with four studies reporting benefits and one showing mixed results. Typical doses reported range from 1.8 mg (dietary) to 20 mg (supplement) daily. No studies reported harm, but the mixed findings in one study suggest that further research is needed to clarify the effects of dietary sources of lutein.",0.85,30044439,2018,Effect of Long-Term Xanthophyll and Anthocyanin Supplementation on Lutein and Zeaxanthin Serum Concentrations and Macular Pigment Optical Density in Postmenopausal Women.,randomized_controlled_trial,benefit,"The study shows an increase in serum lutein concentrations, indicating a benefit from supplementation.",6 mg daily 8 months (xanthophylls),Menopause; Women,,macular pigment optical density,macular pigment optical density,,,
Lutein,"Addition of PUFA may reduce the bioavailability of lutein; Caution for contamination with potentially pathogenic organisms, specifically Escherichia coli.",Eye Health,,Vision & Eye Health,manual_pair,"The evidence for lutein supplementation in increasing macular pigment optical density (MPOD) is generally positive, with four studies reporting benefits and one showing mixed results. Typical doses reported range from 1.8 mg (dietary) to 20 mg (supplement) daily. No studies reported harm, but the mixed findings in one study suggest that further research is needed to clarify the effects of dietary sources of lutein.",0.85,27273910,2016,Comparison of macular pigment and serum lutein concentration changes between free lutein and lutein esters supplements in Japanese subjects.,randomized_controlled_trial,benefit,"Both forms of lutein showed significant increases in serum lutein concentration and MPOD levels, indicating a beneficial effect.",10 mg daily 3 months (free lutein); 20 mg daily 3 months (lutein esters),,,macular pigment optical density,macular pigment optical density,,,
Lutein,"Addition of PUFA may reduce the bioavailability of lutein; Caution for contamination with potentially pathogenic organisms, specifically Escherichia coli.",Focus,,Cognitive & Neurological Function,manual_pair,"The evidence for lutein supplementation in multiple sclerosis is limited and mixed. A single randomized, placebo-controlled study reported improved carotenoid status but no significant effect on cognitive function, suggesting unclear benefits. The typical dose reported was 20 mg daily for 4 months.",0.7,37364683,2023,"Randomized, Placebo-Controlled, Single-Blind Study of Lutein Supplementation on Carotenoid Status and Cognition in Persons with Multiple Sclerosis.",randomized_controlled_trial,mixed_unclear,"Lutein supplementation improved carotenoid status but had no significant effect on cognitive function, indicating mixed outcomes.",20 mg daily 4 months (supplement),Multiple Sclerosis,,multiple sclerosis,multiple sclerosis,,,
Lutein,"Addition of PUFA may reduce the bioavailability of lutein; Caution for contamination with potentially pathogenic organisms, specifically Escherichia coli.",Eye Health,,Vision & Eye Health,manual_pair,"Two randomized controlled trials indicate that lutein supplementation may enhance contrast sensitivity, with doses of 10 mg for 6 months and 12 mg daily for 16 weeks showing significant benefits. No studies reported mixed outcomes or harm, suggesting a consistent positive effect on this indication; however, further research may be needed to confirm these findings across diverse populations.",0.9,32998324,2020,Clinical Effects of Dietary Supplementation of Lutein with High Bio-Accessibility on Macular Pigment Optical Density and Contrast Sensitivity: A Randomized Double-Blind Placebo-Controlled Parallel-Group Comparison Trial.,randomized_controlled_trial,benefit,"The study showed significant improvements in visual function metrics, indicating a beneficial effect of lutein supplementation.",12 mg daily 16 weeks (crystalline),,,contrast sensitivity,age-related maculopathy; contrast sensitivity; glare sensitivity; macular pigment optical density,,,
Lutein,"Addition of PUFA may reduce the bioavailability of lutein; Caution for contamination with potentially pathogenic organisms, specifically Escherichia coli.",Eye Health,,Vision & Eye Health,manual_pair,"Current evidence from two randomized trials suggests that lutein supplementation may benefit eye health by improving macular pigment optical density and enhancing the bioavailability of lutein and zeaxanthin. However, the studies do not consistently report specific dose ranges, and further research is needed to confirm these findings and assess long-term effects. No adverse effects were noted in the studies reviewed.",0.8,32544914,2021,Feasibility Study of a Docosahexaenoic Acid-Optimized Nutraceutical Formulation on the Macular Levels of Lutein in a Healthy Mediterranean Population.,randomized_controlled_trial,benefit,"Lutein supplementation significantly improved macular pigment optical density, indicating a benefit for eye health.",daily 1 3 months (lutein and antioxidant vitamins),,,age-related macular degeneration,age-related macular degeneration; eye diseases; eye health,,,
Lutein,"Addition of PUFA may reduce the bioavailability of lutein; Caution for contamination with potentially pathogenic organisms, specifically Escherichia coli.",Hand-Eye Coordination,,Performance & Recovery,manual_pair,"One randomized, double-blind, placebo-controlled trial reported a significant improvement in eye-hand coordination with lutein supplementation at a dose of 10 mg once daily for eight weeks. However, the overall evidence is limited, with only one study demonstrating a benefit and no reports of harm or no benefit. Further research is needed to confirm these findings and establish consistency.",0.7,36986186,2023,"Effects of Astaxanthin, Lutein, and Zeaxanthin on Eye-Hand Coordination and Smooth-Pursuit Eye Movement after Visual Display Terminal Operation in Healthy Subjects: A Randomized, Double-Blind Placebo-Controlled Intergroup Trial.",randomized_controlled_trial,benefit,"The study showed significant improvement in eye-hand coordination, indicating a benefit from the supplementation.",10 mg once daily eight weeks (soft capsules),,,eye-hand coordination impairment,eye-hand coordination impairment; smooth-pursuit eye movement impairment,,,
Lutein,"Addition of PUFA may reduce the bioavailability of lutein; Caution for contamination with potentially pathogenic organisms, specifically Escherichia coli.",Eye Health,,Vision & Eye Health,manual_pair,"One randomized controlled trial demonstrated that lutein supplementation (10 mg daily for 1 year) resulted in significant improvements in visual performance metrics, suggesting a potential benefit for poor visual performance. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term effects and safety.",0.7,25468896,2014,"A double-blind, placebo-controlled study on the effects of lutein and zeaxanthin on photostress recovery, glare disability, and chromatic contrast.",randomized_controlled_trial,benefit,"The study shows significant improvements in visual performance metrics, indicating a benefit from lutein supplementation.",10 mg daily 1 year,,,chromatic contrast,chromatic contrast; glare disability; photostress recovery,,,
Lutein,"Addition of PUFA may reduce the bioavailability of lutein; Caution for contamination with potentially pathogenic organisms, specifically Escherichia coli.",Skin Aging Prevention,,"Skin, Hair, & Nails",manual_pair,"One randomized trial reported a benefit of lutein supplementation (20 mg daily for 16 weeks) in increasing skin carotenoid levels. However, the overall evidence is limited, with only one study available, indicating low confidence in the findings. No adverse effects were reported in the study.",0.4,32581313,2020,Effect of an antioxidant supplement containing high dose lutein and zeaxanthin on macular pigment and skin carotenoid levels.,clinical_trial,benefit,"The study showed significant increases in MPOD and SC levels, indicating a beneficial effect of lutein supplementation.",20 mg daily 16 weeks (supplement),,,skin carotenoid levels,skin carotenoid levels,,,
Lutein,"Addition of PUFA may reduce the bioavailability of lutein; Caution for contamination with potentially pathogenic organisms, specifically Escherichia coli.",Skin Aging Prevention,,"Skin, Hair, & Nails",manual_pair,"One randomized, double-blind, placebo-controlled crossover study found that oral supplementation with lutein for 12 weeks may provide protective effects against UV-induced gene expression changes in human skin, suggesting a potential benefit for skin health related to sun exposure. However, the evidence is limited to a single study, and further research is needed to confirm these findings and establish consistent dosing recommendations.",0.7,27662341,2017,"Molecular evidence that oral supplementation with lycopene or lutein protects human skin against ultraviolet radiation: results from a double-blinded, placebo-controlled, crossover study.",randomized_controlled_trial,benefit,"Lutein showed protective effects against UV-induced gene expression changes, indicating a benefit for skin health.",12 weeks (oral supplementation),,,photoageing,photoageing; photodermatoses; skin protection against ultraviolet radiation,,,
Lutein,"Addition of PUFA may reduce the bioavailability of lutein; Caution for contamination with potentially pathogenic organisms, specifically Escherichia coli.",Macular Degeneration,,Vision & Eye Health,manual_pair,"Current evidence from a randomized trial indicates that lutein supplementation (10 mg) may slow the progression of geographic atrophy in age-related macular degeneration, showing a beneficial effect. However, the overall evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term safety and efficacy.",0.7,39025435,2025,Oral Antioxidant and Lutein/Zeaxanthin Supplements Slow Geographic Atrophy Progression to the Fovea in Age-Related Macular Degeneration.,randomized_controlled_trial,benefit,"The study shows that oral micronutrient supplementation, including lutein, slows the progression of geographic atrophy in age-related macular degeneration, indicating a benefit.",10 mg (lutein/zeaxanthin),,,age-related macular degeneration,age-related macular degeneration; geographic atrophy,,,
Lutein,"Addition of PUFA may reduce the bioavailability of lutein; Caution for contamination with potentially pathogenic organisms, specifically Escherichia coli.",Macular Degeneration,,Vision & Eye Health,manual_pair,"Current evidence regarding lutein supplementation for vision problems due to age-related macular degeneration is limited and mixed. One study reported an increase in plasma lutein concentrations but did not confirm a significant increase in macular pigment optical density (MPOD), suggesting unclear benefits. The typical dose reported was 20 mg for 6 months, but overall, the evidence quality is low and does not support definitive conclusions.",0.7,32249850,2020,Effects of Lutein Supplementation in Japanese Patients with Unilateral Age-Related Macular Degeneration: The Sakai Lutein Study.,randomized_controlled_trial,mixed_unclear,The study shows a significant increase in plasma lutein concentrations but a significant increase in MPOD was not fully confirmed.,20 mg 6 months (beeswax or glycerol fatty acid esters),,,unilateral age-related macular degeneration,unilateral age-related macular degeneration,,,
Lutein,"Addition of PUFA may reduce the bioavailability of lutein; Caution for contamination with potentially pathogenic organisms, specifically Escherichia coli.",Improve Visual Acuity,,Vision & Eye Health,manual_pair,"One randomized trial reported slight improvements in visual acuity and contrast sensitivity with lutein supplementation (10 mg daily for 36 weeks) in individuals with nonproliferative diabetic retinopathy, suggesting a potential benefit. However, the overall evidence is limited, with only one study available and no reports of harm or mixed outcomes.",0.7,28429904,2017,Effect of lutein supplementation on visual function in nonproliferative diabetic retinopathy.,randomized_controlled_trial,benefit,"The study found slight improvements in visual acuity and contrast sensitivity, indicating a potential benefit from lutein supplementation.",10 mg daily 36 weeks,Diabetes; Diabetic Retinopathy,,nonproliferative diabetic retinopathy,nonproliferative diabetic retinopathy,,,
Lutein,"Addition of PUFA may reduce the bioavailability of lutein; Caution for contamination with potentially pathogenic organisms, specifically Escherichia coli.",Improve Memory,,Cognitive & Neurological Function,manual_pair,"One randomized, double-masked, placebo-controlled trial reported a benefit of lutein supplementation (12 mg daily for 12 months) in improving brain activation related to visual processing in older adults. However, the overall evidence is limited, with only one study supporting this indication and no adverse effects reported. Further research is needed to confirm these findings and assess long-term effects.",0.7,30950580,2019,"Dietary Carotenoids Lutein and Zeaxanthin Change Brain Activation in Older Adult Participants: A Randomized, Double-Masked, Placebo-Controlled Trial.",randomized_controlled_trial,benefit,"The study shows significant improvement in signal power related to visual processing after lutein supplementation, indicating a benefit.",12 mg daily 12 months,Older Adults,,visual memory,visual memory; visual processing speeds,,,
Maca,diastolic blood pressure increase with high doses of maca; moderate AST level increase,Stress,,"Energy, Mood, & Mental Health",manual_pair,"One randomized trial found that daily consumption of 3.5 g of powdered Maca for six weeks resulted in a significant reduction in psychological symptoms and sexual dysfunction in postmenopausal women, suggesting a potential benefit for anxiety. However, the evidence is limited to this single study, and further research is needed to confirm these findings and assess the effects in broader populations.",0.7,18784609,2008,Beneficial effects of Lepidium meyenii (Maca) on psychological symptoms and measures of sexual dysfunction in postmenopausal women are not related to estrogen or androgen content.,randomized_controlled_trial,benefit,"The study showed a significant reduction in psychological symptoms and sexual dysfunction in postmenopausal women after Maca consumption, indicating a beneficial effect.",3.5 g daily 6 weeks (powdered),Menopause; Women,Women's Health,anxiety,anxiety; depression; sexual dysfunction,,,
Maca,diastolic blood pressure increase with high doses of maca; moderate AST level increase,Depression,,"Energy, Mood, & Mental Health",manual_pair,"One pilot study reported that Maca (3.3 g daily for 6 weeks) resulted in significant reductions in depression among postmenopausal women, indicating a potential benefit. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess consistency across different populations.",0.7,24931003,2015,"Maca reduces blood pressure and depression, in a pilot study in postmenopausal women.",randomized_controlled_trial,benefit,"Maca treatment resulted in significant decreases in diastolic blood pressure and depression, indicating a beneficial effect.",3.3 g daily 6 weeks (Maca),Menopause; Women,Heart & Vascular Health,depression,depression; high blood pressure,,,
Maca,diastolic blood pressure increase with high doses of maca; moderate AST level increase,Infertility,,Men's Health,manual_pair,"One randomized trial reported a significant improvement in sperm concentration with maca supplementation at a dose of 2 g daily for 12 weeks. However, the overall evidence is limited, with only one study demonstrating a benefit and no reports of adverse effects or mixed outcomes. Further research is needed to confirm these findings and establish consistency.",0.7,32654242,2020,Does Lepidium meyenii (Maca) improve seminal quality?,randomized_controlled_trial,benefit,"The study showed a significant improvement in sperm concentration, indicating a benefit from maca supplementation.",2 g daily 12 weeks,,,mild asthenozoospermia,mild asthenozoospermia; mild oligozoospermia,,,
Maca,diastolic blood pressure increase with high doses of maca; moderate AST level increase,Atherosclerosis,,Heart & Vascular Health,manual_pair,"The evidence for maca in the context of metabolic syndrome is limited and mixed, with one study reporting no adverse effects but noting increases in AST and blood pressure, suggesting potential concerns. The typical dose reported was 0.6 g daily for 90 days. Overall, the findings do not support a clear benefit for this indication.",0.7,18054420,2008,Maca (Lepidium meyenii) and yacon (Smallanthus sonchifolius) in combination with silymarin as food supplements: in vivo safety assessment.,randomized_controlled_trial,mixed_unclear,"The study found no adverse effects overall, but noted specific increases in AST and blood pressure with maca, indicating mixed outcomes.",0.6 g daily 90 days (powder),,Gut Health,metabolic syndrome,metabolic syndrome,,,
Maca,diastolic blood pressure increase with high doses of maca; moderate AST level increase,Erectile Dysfunction,,Men's Health,manual_pair,"One randomized, double-blind clinical trial reported that Maca (2400 mg dry extract for 12 weeks) significantly improved erectile dysfunction and subjective well-being in patients compared to placebo. However, the overall evidence is limited, with only one study demonstrating benefit and no reports of harm or mixed outcomes.",0.7,19260845,2009,"Subjective effects of Lepidium meyenii (Maca) extract on well-being and sexual performances in patients with mild erectile dysfunction: a randomised, double-blind clinical trial.",randomized_controlled_trial,benefit,The study showed a significant improvement in erectile dysfunction and subjective well-being in patients taking Maca compared to placebo.,2400 mg 12 weeks (dry extract),,,mild erectile dysfunction,mild erectile dysfunction,,,
Maca,diastolic blood pressure increase with high doses of maca; moderate AST level increase,Improve Sexual Function,,Women's Health,manual_pair,"One randomized pilot study reported a significant improvement in sexual dysfunction associated with SSRIs following treatment with maca root at a higher dose of 3.0 g daily. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term safety and efficacy.",0.7,18801111,2008,"A double-blind, randomized, pilot dose-finding study of maca root (L. meyenii) for the management of SSRI-induced sexual dysfunction.",randomized_controlled_trial,benefit,"The study found significant improvement in sexual dysfunction for the higher dose of maca, indicating a beneficial effect.",1.5 g daily (root); 3.0 g daily (root),,,ssri-induced sexual dysfunction,ssri-induced sexual dysfunction,,,
Magnesium,Hypotension measured in some participants; decreased mitochondrial respiration; dizziness; flushing; higher incidence of adverse events and diarrhoea in naldemedine group; higher incidence of maternal side effects; higher incidence of neonatal respiratory distress syndrome; increased intestinal motility; may be associated with tachycardia; modest ergolytic effects on exercise performance; more adverse drug reactions associated with magnesium sulfate; nausea; palpitations; sensations of gastric heaviness; significant decrease in hemodynamic parameters with DEX; tachycardia,Kidney Stones,,Kidney & Bladder Health,manual_pair,"Two randomized controlled trials suggest that magnesium supplementation may benefit individuals with calcium oxalate kidney stones by reducing crystalluria and improving urinary parameters. Doses reported include 80 mg daily for 20 days and supplementation taken with meals over 7 days; however, the overall quality of evidence is limited and further studies are needed to confirm these findings. No adverse effects were reported in the studies reviewed.",0.7,39206631,2024,"Oral supplementation with probiotics, potassium citrate, and magnesium in reducing crystalluria in stone formers: A phase II study.",clinical_trial,benefit,"The study shows a reduction in crystalluria, indicating a benefit from magnesium supplementation.",80 mg daily 20 days (oral supplementation),,,calcium oxalate kidney stones,calcium oxalate kidney stones; calcium oxalate stone formation; crystalluria; hyperoxaluria; nephrolithiasis,,,
Magnesium,Hypotension measured in some participants; decreased mitochondrial respiration; dizziness; flushing; higher incidence of adverse events and diarrhoea in naldemedine group; higher incidence of maternal side effects; higher incidence of neonatal respiratory distress syndrome; increased intestinal motility; may be associated with tachycardia; modest ergolytic effects on exercise performance; more adverse drug reactions associated with magnesium sulfate; nausea; palpitations; sensations of gastric heaviness; significant decrease in hemodynamic parameters with DEX; tachycardia,Kidney Stones,,Kidney & Bladder Health,manual_pair,"Two randomized controlled trials suggest that magnesium supplementation may benefit individuals with calcium oxalate kidney stones by reducing crystalluria and improving urinary parameters. Doses reported include 80 mg daily for 20 days and supplementation taken with meals over 7 days; however, the overall quality of evidence is limited and further studies are needed to confirm these findings. No adverse effects were reported in the studies reviewed.",0.7,39913253,2025,Timing of magnesium supplementation in patients with nephrolithiasis: A randomized controlled trial.,randomized_controlled_trial,benefit,"The study found that magnesium supplementation taken with meals led to a more substantial improvement in urinary parameters, indicating a benefit for preventing recurrent calcium oxalate nephrolithiasis.",7 days,,,calcium oxalate stone formation,calcium oxalate kidney stones; calcium oxalate stone formation; crystalluria; hyperoxaluria; nephrolithiasis,,,
Magnesium,Hypotension measured in some participants; decreased mitochondrial respiration; dizziness; flushing; higher incidence of adverse events and diarrhoea in naldemedine group; higher incidence of maternal side effects; higher incidence of neonatal respiratory distress syndrome; increased intestinal motility; may be associated with tachycardia; modest ergolytic effects on exercise performance; more adverse drug reactions associated with magnesium sulfate; nausea; palpitations; sensations of gastric heaviness; significant decrease in hemodynamic parameters with DEX; tachycardia,Depression,,"Energy, Mood, & Mental Health",manual_pair,"Two randomized controlled trials suggest that magnesium supplementation may benefit individuals with depression, showing significant reductions in depressive symptoms. One study used magnesium orotate for 8 weeks, while another utilized 1300 mg of magnesium chloride daily for four months. However, the overall evidence remains limited, and further research is needed to confirm these findings and assess long-term effects.",0.7,39242786,2024,Probiotics and magnesium orotate for the treatment of major depressive disorder: a randomised double blind controlled trial.,randomized_controlled_trial,benefit,"The study found a significant reduction in depressive symptoms in the intervention group compared to placebo, indicating a benefit.",daily 8 weeks (oral),,,anxiety,anxiety; long-covid; major depressive disorder; mild to moderate depression; stress,,,
Magnesium,Hypotension measured in some participants; decreased mitochondrial respiration; dizziness; flushing; higher incidence of adverse events and diarrhoea in naldemedine group; higher incidence of maternal side effects; higher incidence of neonatal respiratory distress syndrome; increased intestinal motility; may be associated with tachycardia; modest ergolytic effects on exercise performance; more adverse drug reactions associated with magnesium sulfate; nausea; palpitations; sensations of gastric heaviness; significant decrease in hemodynamic parameters with DEX; tachycardia,Depression,,"Energy, Mood, & Mental Health",manual_pair,"Two randomized controlled trials suggest that magnesium supplementation may benefit individuals with depression, showing significant reductions in depressive symptoms. One study used magnesium orotate for 8 weeks, while another utilized 1300 mg of magnesium chloride daily for four months. However, the overall evidence remains limited, and further research is needed to confirm these findings and assess long-term effects.",0.7,39846976,2024,"Combined oral supplementation with magnesium plus vitamin D alleviates mild to moderate depressive symptoms related to long-COVID: an open-label randomized, controlled clinical trial.",randomized_controlled_trial,benefit,"The study shows significant improvement in depressive symptoms with magnesium supplementation, indicating a beneficial outcome.",1300 mg daily four months (magnesium chloride),Long COVID,,long-covid,anxiety; long-covid; major depressive disorder; mild to moderate depression; stress,,,
Magnesium,Hypotension measured in some participants; decreased mitochondrial respiration; dizziness; flushing; higher incidence of adverse events and diarrhoea in naldemedine group; higher incidence of maternal side effects; higher incidence of neonatal respiratory distress syndrome; increased intestinal motility; may be associated with tachycardia; modest ergolytic effects on exercise performance; more adverse drug reactions associated with magnesium sulfate; nausea; palpitations; sensations of gastric heaviness; significant decrease in hemodynamic parameters with DEX; tachycardia,Fatigue,,"Energy, Mood, & Mental Health",manual_pair,"The evidence regarding magnesium supplementation for fatigue is limited and mixed. One randomized trial reported a non-significant reduction in fatigue among participants receiving magnesium compared to a significant improvement in the placebo group, indicating unclear efficacy. No consistent dose ranges were reported, and no adverse effects were noted in the studies reviewed.",0.6,40151031,2025,"Effects of Coenzyme Q10, Tryptophan, and Magnesium Supplementation on Fatigue in Patients with Fibromyalgia - A Randomized Trial.",randomized_controlled_trial,mixed_unclear,"Fatigue improved significantly in the placebo group, while the dietary supplement group showed a non-significant reduction in fatigue, indicating mixed outcomes.",3 months (dietary supplement),Fibromyalgia,Sleep,fatigue,fatigue,,,
Magnesium,Hypotension measured in some participants; decreased mitochondrial respiration; dizziness; flushing; higher incidence of adverse events and diarrhoea in naldemedine group; higher incidence of maternal side effects; higher incidence of neonatal respiratory distress syndrome; increased intestinal motility; may be associated with tachycardia; modest ergolytic effects on exercise performance; more adverse drug reactions associated with magnesium sulfate; nausea; palpitations; sensations of gastric heaviness; significant decrease in hemodynamic parameters with DEX; tachycardia,Pain,,Musculoskeletal & Pain,manual_pair,"Current evidence regarding magnesium supplementation for fibromyalgia is limited and mixed. One randomized trial reported a non-significant reduction in fatigue among those receiving magnesium compared to a significant improvement in the placebo group, indicating unclear benefits. No consistent dose range was reported, and there were no noted harms associated with magnesium supplementation in the studies reviewed.",0.5,40151031,2025,"Effects of Coenzyme Q10, Tryptophan, and Magnesium Supplementation on Fatigue in Patients with Fibromyalgia - A Randomized Trial.",randomized_controlled_trial,mixed_unclear,"Fatigue improved significantly in the placebo group, while the dietary supplement group showed a non-significant reduction in fatigue, indicating mixed outcomes.",3 months (dietary supplement),Fibromyalgia,,fibromyalgia,fibromyalgia,,,
Magnesium,Hypotension measured in some participants; decreased mitochondrial respiration; dizziness; flushing; higher incidence of adverse events and diarrhoea in naldemedine group; higher incidence of maternal side effects; higher incidence of neonatal respiratory distress syndrome; increased intestinal motility; may be associated with tachycardia; modest ergolytic effects on exercise performance; more adverse drug reactions associated with magnesium sulfate; nausea; palpitations; sensations of gastric heaviness; significant decrease in hemodynamic parameters with DEX; tachycardia,Hypertension,,Heart & Vascular Health,manual_pair,"Current evidence suggests that magnesium supplementation may have a beneficial effect on high blood pressure, with two randomized trials reporting positive outcomes. One study utilized a daily oral dose of 400 mg for 12 weeks, while another employed a magnesium sulfate spray. However, the overall quality and consistency of the evidence are limited, and no adverse effects were reported in the studies reviewed.",0.7,39380547,2024,Positive effects of magnesium supplementation in metabolic syndrome.,randomized_controlled_trial,benefit,"Magnesium supplementation led to significant decreases in blood pressure and interleukin-6 levels, indicating a beneficial effect on health outcomes.",400 mg daily 12 weeks (oral),,,cardiovascular disease,cardiovascular disease; hemodynamic changes; intubation complications; metabolic syndrome,,,
Magnesium,Hypotension measured in some participants; decreased mitochondrial respiration; dizziness; flushing; higher incidence of adverse events and diarrhoea in naldemedine group; higher incidence of maternal side effects; higher incidence of neonatal respiratory distress syndrome; increased intestinal motility; may be associated with tachycardia; modest ergolytic effects on exercise performance; more adverse drug reactions associated with magnesium sulfate; nausea; palpitations; sensations of gastric heaviness; significant decrease in hemodynamic parameters with DEX; tachycardia,High Insulin,,Metabolic Health,manual_pair,"Two randomized trials indicate that magnesium supplementation may improve metabolic parameters and insulin sensitivity in individuals with high blood sugar (Type 2 Diabetes). Doses reported include 80 mg daily for 4 weeks and daily doses of deep seawater mineral extracts for 12 weeks. No adverse effects were noted in the studies, but further research is needed to confirm these findings and establish optimal dosing.",0.9,39947040,2025,Effects of deep ocean-derived magnesium-enhanced water on metabolic diseases with microbiome changes.,randomized_controlled_trial,benefit,"The study shows improvements in various metabolic parameters, indicating a beneficial effect of magnesium intake.",80 mg daily 4 weeks (water),Diabetes Type 2,"Energy, Mood, & Mental Health; Weight & Body Composition",diabetes,diabetes; hyperlipidemia; hypertension; impaired glucose tolerance; insulin resistance; pre-diabetes,,,
Magnesium,Hypotension measured in some participants; decreased mitochondrial respiration; dizziness; flushing; higher incidence of adverse events and diarrhoea in naldemedine group; higher incidence of maternal side effects; higher incidence of neonatal respiratory distress syndrome; increased intestinal motility; may be associated with tachycardia; modest ergolytic effects on exercise performance; more adverse drug reactions associated with magnesium sulfate; nausea; palpitations; sensations of gastric heaviness; significant decrease in hemodynamic parameters with DEX; tachycardia,High Insulin,,Metabolic Health,manual_pair,"Two randomized trials indicate that magnesium supplementation may improve metabolic parameters and insulin sensitivity in individuals with high blood sugar (Type 2 Diabetes). Doses reported include 80 mg daily for 4 weeks and daily doses of deep seawater mineral extracts for 12 weeks. No adverse effects were noted in the studies, but further research is needed to confirm these findings and establish optimal dosing.",0.9,39202546,2024,Magnesium from Deep Seawater as a Potentially Effective Natural Product against Insulin Resistance: A Randomized Trial.,randomized_controlled_trial,benefit,"The study shows improvements in insulin sensitivity indicators, indicating a beneficial effect of magnesium supplementation.",daily 12 weeks (deep seawater mineral extracts),Prediabetes,,impaired glucose tolerance,diabetes; hyperlipidemia; hypertension; impaired glucose tolerance; insulin resistance; pre-diabetes,,,
Magnesium,Hypotension measured in some participants; decreased mitochondrial respiration; dizziness; flushing; higher incidence of adverse events and diarrhoea in naldemedine group; higher incidence of maternal side effects; higher incidence of neonatal respiratory distress syndrome; increased intestinal motility; may be associated with tachycardia; modest ergolytic effects on exercise performance; more adverse drug reactions associated with magnesium sulfate; nausea; palpitations; sensations of gastric heaviness; significant decrease in hemodynamic parameters with DEX; tachycardia,High Total Cholesterol,,Heart & Vascular Health,manual_pair,"One randomized controlled trial reported a beneficial effect of magnesium supplementation on lowering LDL cholesterol levels in patients with type 2 diabetes over a 60-day period. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term effects and safety.",0.7,39410716,2024,Comparative Efficacy of Magnesium and Potassium Towards Cholesterol and Quality of Life in Patients With Type 2 Diabetes Mellitus: A Randomised Single-Blinded Controlled Clinical Trial.,randomized_controlled_trial,benefit,"The study shows a decrease in cholesterol levels and improvement in quality of life, indicating a beneficial effect of magnesium supplementation.",60 days (supplement),Diabetes Type 2,,hyperlipidaemia,Type 2 Diabetes Mellitus; hyperlipidaemia,,,
Magnesium,Hypotension measured in some participants; decreased mitochondrial respiration; dizziness; flushing; higher incidence of adverse events and diarrhoea in naldemedine group; higher incidence of maternal side effects; higher incidence of neonatal respiratory distress syndrome; increased intestinal motility; may be associated with tachycardia; modest ergolytic effects on exercise performance; more adverse drug reactions associated with magnesium sulfate; nausea; palpitations; sensations of gastric heaviness; significant decrease in hemodynamic parameters with DEX; tachycardia,Insomnia,,Sleep,manual_pair,"One randomized trial reported that magnesium supplementation significantly improved insomnia severity and sleep hormone levels in patients with diabetes mellitus over a two-month period. However, the overall evidence is limited, with only one study available, and no adverse effects were reported. Further research is needed to confirm these findings and establish consistent dosing guidelines.",0.5,39534260,2024,Effects of magnesium and potassium supplementation on insomnia and sleep hormones in patients with diabetes mellitus.,randomized_controlled_trial,benefit,The study showed significant improvement in insomnia severity and sleep hormone levels with magnesium supplementation.,2 months (tablets),,,diabetes mellitus,diabetes mellitus; insomnia,,,
Magnesium,Hypotension measured in some participants; decreased mitochondrial respiration; dizziness; flushing; higher incidence of adverse events and diarrhoea in naldemedine group; higher incidence of maternal side effects; higher incidence of neonatal respiratory distress syndrome; increased intestinal motility; may be associated with tachycardia; modest ergolytic effects on exercise performance; more adverse drug reactions associated with magnesium sulfate; nausea; palpitations; sensations of gastric heaviness; significant decrease in hemodynamic parameters with DEX; tachycardia,Exercise Performance,,Performance & Recovery,manual_pair,"Current evidence regarding magnesium supplementation for low exercise performance indicates potential harm, as a randomized crossover trial reported a decrease in exercise performance metrics with a dose of 300 mg (magnesium chloride) twice daily for 9 days. No studies have demonstrated a benefit or mixed outcomes in this context, suggesting a lack of supportive evidence for this indication.",1.0,40077784,2025,Short-Term Magnesium Supplementation Has Modest Detrimental Effects on Cycle Ergometer Exercise Performance and Skeletal Muscle Mitochondria and Negligible Effects on the Gut Microbiota: A Randomized Crossover Clinical Trial.,randomized_controlled_trial,harm,"The outcomes indicated a decrease in exercise performance metrics, suggesting harm from magnesium supplementation in this context.",300 mg twice per day 9 days (magnesium chloride),,,exercise performance,exercise performance; skeletal muscle function,,,
Manganese,ADRs/AEs were dose-related and predominantly of mild intensity.; Excessive Mn can lead to Parkinson-like symptoms; Mild adverse events occurred in 6 patients (30%) after contrast agent administration.; Mn toxicity in PN patients; Risk of manganese toxicity leading to neurological problems; dysarthria; fine tremors; higher manganese levels associated with increased odds for maternal complications; higher rates of gastrointestinal adverse events compared to gadobenate dimeglumine; hypomagnesemia; hypomimia; increased creatinine; mild to moderate adverse events; minor gastrointestinal adverse events; rigidity; side effects leading to participant dropouts; transiently elevated transaminases,Chronic Kidney Disease,,Kidney & Bladder Health,manual_pair,"Evidence for manganese, specifically in the form of Avasopasem manganese (GC4419), suggests a potential benefit in preventing kidney function decline associated with cisplatin-induced chronic kidney disease, based on a randomized phase 2b clinical trial that reported positive outcomes at a dose of 90 mg. However, the overall evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term safety and efficacy.",0.7,36640725,2023,Avasopasem manganese (GC4419) protects against cisplatin-induced chronic kidney disease: An exploratory analysis of renal metrics from a randomized phase 2b clinical trial in head and neck cancer patients.,randomized_controlled_trial,benefit,"The study shows that 90 mg AVA treatment prevented significant kidney function decline, indicating a benefit in mitigating cisplatin-induced chronic kidney disease.",90 mg,Cancer; Chemotherapy,,acute kidney disease,acute kidney disease; chronic kidney disease,,,
Manganese,ADRs/AEs were dose-related and predominantly of mild intensity.; Excessive Mn can lead to Parkinson-like symptoms; Mild adverse events occurred in 6 patients (30%) after contrast agent administration.; Mn toxicity in PN patients; Risk of manganese toxicity leading to neurological problems; dysarthria; fine tremors; higher manganese levels associated with increased odds for maternal complications; higher rates of gastrointestinal adverse events compared to gadobenate dimeglumine; hypomagnesemia; hypomimia; increased creatinine; mild to moderate adverse events; minor gastrointestinal adverse events; rigidity; side effects leading to participant dropouts; transiently elevated transaminases,Chronic Low Back Pain,,Musculoskeletal & Pain,manual_pair,"There is limited evidence suggesting that manganese, as part of a combination treatment including collagen peptides, vitamin C, and sodium hyaluronate, may improve pain and quality of life in individuals with chronic low back pain. The evidence is derived from a single study that reported a benefit, and further research is needed to confirm these findings and assess the efficacy of manganese alone. No adverse effects were reported in the study.",0.6,33568038,2022,"Collagen Peptides, in Association with Vitamin C, Sodium Hyaluronate, Manganese and Copper, as Part of the Rehabilitation Project in the Treatment of Chronic Low Back Pain.",randomized_controlled_trial,benefit,The study shows significant improvement in pain and quality of life with the combination treatment including manganese.,daily 3 weeks (food supplements),,,chronic low back pain,chronic low back pain,,,
Manganese,ADRs/AEs were dose-related and predominantly of mild intensity.; Excessive Mn can lead to Parkinson-like symptoms; Mild adverse events occurred in 6 patients (30%) after contrast agent administration.; Mn toxicity in PN patients; Risk of manganese toxicity leading to neurological problems; dysarthria; fine tremors; higher manganese levels associated with increased odds for maternal complications; higher rates of gastrointestinal adverse events compared to gadobenate dimeglumine; hypomagnesemia; hypomimia; increased creatinine; mild to moderate adverse events; minor gastrointestinal adverse events; rigidity; side effects leading to participant dropouts; transiently elevated transaminases,High LDL,,Heart & Vascular Health,manual_pair,"There is limited evidence suggesting that manganese may improve lipid parameters in pregnant women, as indicated by one study that reported benefits after 60 days of supplementation. However, the overall quality of evidence is low, and further research is needed to establish consistent effects and safety profiles for manganese in the context of high cholesterol.",0.5,24488919,2014,"Myo-inositol, D-chiro-inositol, folic acid and manganese in second trimester of pregnancy: a preliminary investigation.",randomized_controlled_trial,benefit,"The study showed significant improvements in glycemic and lipidic parameters, indicating a benefit from the supplement.",60 days (MDFM),Pregnant; Women,Metabolic Health,blood pressure,blood pressure; cholesterol levels; glucose parameters; glycemic parameters,,,
Melatonin,Caution should be taken by consumers using over-the-counter melatonin lotions because the undisclosed dosage can be high and well absorbed by the skin.; associated with neonatal hypoglycemia; fatigue; focal spongiotic dermatitis; headache; minimal and mild adverse reactions; nausea; potential for respiratory suppression; serious adverse events unrelated to melatonin; unpredictable effects leading to agitation,Stress,,"Energy, Mood, & Mental Health",manual_pair,"Melatonin has shown a beneficial effect on anxiety in a randomized, triple-blind, placebo-controlled trial involving breast cancer patients, where a daily dose of 20 mg was used. However, the evidence is limited to a single study with no reported adverse effects or mixed outcomes, indicating a need for further research to confirm these findings.",0.7,40888191,2025,"Efficacy of Melatonin in Alleviating Radiotherapy-Induced Fatigue, Anxiety, and Depression in Breast Cancer Patients: A Randomized, Triple-Blind, Placebo-Controlled Trial.",randomized_controlled_trial,benefit,"Melatonin significantly reduced fatigue, anxiety, and depression scores compared to placebo, indicating a beneficial effect.",20 mg daily until treatment completion (oral),Cancer,,anxiety,anxiety; breast cancer; depression; radiotherapy-induced fatigue,,,
Melatonin,Caution should be taken by consumers using over-the-counter melatonin lotions because the undisclosed dosage can be high and well absorbed by the skin.; associated with neonatal hypoglycemia; fatigue; focal spongiotic dermatitis; headache; minimal and mild adverse reactions; nausea; potential for respiratory suppression; serious adverse events unrelated to melatonin; unpredictable effects leading to agitation,Improve Bone Density,,Musculoskeletal & Pain,manual_pair,"The evidence for melatonin in the treatment of back pain is limited and mixed. One study reported an improvement in back pain with a daily dose of 20 mg over 12 months, but this was not significantly different from placebo, indicating uncertainty in its efficacy. Overall, there are no consistent findings supporting the use of melatonin for back pain.",0.7,40329508,2025,Melatonin Supplementation Alleviates Bone Mineral Density Decline and Circulating Oxidative Stress in Iron-Overloaded Thalassemia Patients.,randomized_controlled_trial,mixed_unclear,"Melatonin showed a significant improvement in back pain and BMD from baseline, but not significantly different from placebo at 12 months, indicating mixed outcomes.",20 mg daily 12 months,Thalassemia,Pain,back pain,back pain; iron overload; low bone mineral density; thalassemia,,,
Melatonin,Caution should be taken by consumers using over-the-counter melatonin lotions because the undisclosed dosage can be high and well absorbed by the skin.; associated with neonatal hypoglycemia; fatigue; focal spongiotic dermatitis; headache; minimal and mild adverse reactions; nausea; potential for respiratory suppression; serious adverse events unrelated to melatonin; unpredictable effects leading to agitation,Pelvic Pain,,Women's Health,manual_pair,"One randomized controlled trial found that melatonin (5 mg daily for 2 months) significantly improved sleep quality and reduced chronic pelvic pain in infertile women with endometriosis. There is currently no evidence of harm or no benefit, but the overall evidence is limited to a single study, indicating a need for further research to confirm these findings.",0.7,40238733,2025,Melatonin and sleep parameters in infertile women with endometriosis: first results from the triple-blind randomized controlled trial of administration of melatonin in chronic pelvic pain and sleep disturbance.,randomized_controlled_trial,benefit,"Melatonin significantly improved sleep quality and reduced chronic pelvic pain, indicating a benefit in the studied population.",5 mg daily 2 months,Endometriosis,,chronic pelvic pain,chronic pelvic pain; endometriosis; sleep disturbances,,,
Melatonin,Caution should be taken by consumers using over-the-counter melatonin lotions because the undisclosed dosage can be high and well absorbed by the skin.; associated with neonatal hypoglycemia; fatigue; focal spongiotic dermatitis; headache; minimal and mild adverse reactions; nausea; potential for respiratory suppression; serious adverse events unrelated to melatonin; unpredictable effects leading to agitation,Delirium Prevention,,Cognitive & Neurological Function,manual_pair,"The evidence for melatonin in the prevention of delirium is limited and mixed, based on a single multicenter, randomized, placebo-controlled feasibility trial that reported feasibility for protocol adherence but faced challenges with low consent rates and modest eligibility. Doses evaluated included 0.5 mg and 2 mg nightly. Overall, no clear benefit has been established, and further research is needed to clarify its efficacy in this indication.",0.7,39800236,2025,"Low-Dose Melatonin for Prevention of Delirium in Critically Ill Patients: A Multicenter, Randomized, Placebo-Controlled Feasibility Trial.",randomized_controlled_trial,mixed_unclear,The study showed feasibility for protocol adherence but had low consent rates and modest eligibility due to the presence of delirium in many screened patients.,0.5 mg nightly; 2 mg nightly,Critically Ill Patients,,critical illness,critical illness; delirium,,,
Melatonin,Caution should be taken by consumers using over-the-counter melatonin lotions because the undisclosed dosage can be high and well absorbed by the skin.; associated with neonatal hypoglycemia; fatigue; focal spongiotic dermatitis; headache; minimal and mild adverse reactions; nausea; potential for respiratory suppression; serious adverse events unrelated to melatonin; unpredictable effects leading to agitation,Stress,,"Energy, Mood, & Mental Health",manual_pair,"One randomized controlled trial found that melatonin (6 mg oral) significantly improved physiological parameters and reduced postoperative cortisol levels in patients with dental anxiety undergoing third molar extraction, indicating a potential benefit. However, the overall evidence is limited to this single study, and further research is needed to confirm these findings and assess long-term effects and safety.",0.7,40263045,2025,Comparison of melatonin and music therapy as a preoperative anxiolytic for patients undergoing impacted mandibular third molar extraction: a double-blind randomised controlled trial.,randomized_controlled_trial,benefit,"The study showed significant improvement in physiological parameters and a decrease in postoperative cortisol levels in the melatonin group, indicating a benefit in managing dental anxiety.",6 mg (oral),,,dental anxiety,dental anxiety,,,
Melatonin,Caution should be taken by consumers using over-the-counter melatonin lotions because the undisclosed dosage can be high and well absorbed by the skin.; associated with neonatal hypoglycemia; fatigue; focal spongiotic dermatitis; headache; minimal and mild adverse reactions; nausea; potential for respiratory suppression; serious adverse events unrelated to melatonin; unpredictable effects leading to agitation,Depression,,"Energy, Mood, & Mental Health",manual_pair,"Current evidence on melatonin for depression is limited, with only one randomized clinical trial indicating a benefit in psychosexual wellbeing when combined with Sildenafil in women with polycystic ovarian syndrome. The study did not specifically address depression as a primary outcome, and further research is needed to clarify its effects in this indication. No adverse effects were reported in the available study.",0.5,40105433,2025,Improved psychosexual wellbeing with administration of combined Sildenafil plus Melatonin compared than either drug alone in management of women with polycystic ovarian syndrome: a 3-month randomized clinical study.,randomized_controlled_trial,benefit,"The study shows significant improvements in various health outcomes for women with PCOS, indicating a beneficial effect of the treatment.",3 months,PCOS,Women's Health,depression,depression; health-related quality of life; polycystic ovarian syndrome; sexual function,,,
Melatonin,Caution should be taken by consumers using over-the-counter melatonin lotions because the undisclosed dosage can be high and well absorbed by the skin.; associated with neonatal hypoglycemia; fatigue; focal spongiotic dermatitis; headache; minimal and mild adverse reactions; nausea; potential for respiratory suppression; serious adverse events unrelated to melatonin; unpredictable effects leading to agitation,Infertility,,Women's Health,manual_pair,"One randomized controlled trial indicates that melatonin (3 mg daily) may improve oocyte quantity, fertilization rates, and embryo quality in women with diminished ovarian reserve. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term safety and efficacy.",0.7,39780224,2025,The effects of melatonin on follicular oxidative stress and art outcomes in women with diminished ovarian reserve: a randomized controlled trial.,randomized_controlled_trial,benefit,"Melatonin administration improved oocyte quantity, fertilization rates, and embryo quality, indicating a beneficial effect on reproductive outcomes.",3 mg daily from the fifth day of menstrual cycle until oocyte retrieval,Poor Ovarian Reserve; Women,,assisted reproductive technology outcomes,assisted reproductive technology outcomes; diminished ovarian reserve; infertility,,,
Melatonin,Caution should be taken by consumers using over-the-counter melatonin lotions because the undisclosed dosage can be high and well absorbed by the skin.; associated with neonatal hypoglycemia; fatigue; focal spongiotic dermatitis; headache; minimal and mild adverse reactions; nausea; potential for respiratory suppression; serious adverse events unrelated to melatonin; unpredictable effects leading to agitation,Migraine Headache,,Musculoskeletal & Pain,manual_pair,"One randomized clinical trial reported that melatonin (3 mg once daily for two months) significantly reduced the frequency and duration of migraine attacks compared to placebo, suggesting a potential benefit for this indication. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term safety and efficacy.",0.7,38751874,2024,"The Effect of Melatonin on Reducing the Frequency and Severity of Migraine Attacks: A Double-Blind, Randomized Clinical Trial.",randomized_controlled_trial,benefit,"Melatonin significantly reduced the frequency and duration of migraine attacks compared to placebo, indicating a beneficial effect.",3 mg once daily two months,,,episodic migraine,episodic migraine,,,
Melatonin,Caution should be taken by consumers using over-the-counter melatonin lotions because the undisclosed dosage can be high and well absorbed by the skin.; associated with neonatal hypoglycemia; fatigue; focal spongiotic dermatitis; headache; minimal and mild adverse reactions; nausea; potential for respiratory suppression; serious adverse events unrelated to melatonin; unpredictable effects leading to agitation,Peridontitis,,Oral Health,manual_pair,"One randomized controlled trial evaluated the use of a 1% melatonin gel as a local drug delivery system for treating periodontitis, reporting significant improvements in clinical parameters and microbial reduction. Overall, the evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term effects and safety.",0.8,39948592,2025,Evaluation of melatonin gel as local drug delivery system for the treatment of periodontitis: a split-mouth randomized controlled trial.,randomized_controlled_trial,benefit,"The study showed significant improvements in clinical parameters and microbial reduction, indicating a beneficial effect of melatonin gel in treating periodontitis.",1 % single application 3 months (gel),,,periodontitis,periodontitis,,,
Melatonin,Caution should be taken by consumers using over-the-counter melatonin lotions because the undisclosed dosage can be high and well absorbed by the skin.; associated with neonatal hypoglycemia; fatigue; focal spongiotic dermatitis; headache; minimal and mild adverse reactions; nausea; potential for respiratory suppression; serious adverse events unrelated to melatonin; unpredictable effects leading to agitation,Increase Flu Vaccine Efficacy,,"Immune, Inflammation, & Infection",manual_pair,"Current evidence on melatonin's effect on influenza vaccine response is limited and mixed, with one randomized trial reporting increased cellular responses but no significant differences in overall vaccine response metrics. The study utilized a dose of 5 mg daily for 14 days. Overall, the findings do not support a clear benefit of melatonin for this indication.",0.7,39539030,2024,A randomized clinical trial of the impact of melatonin on influenza vaccine: Outcomes from the melatonin and vaccine response immunity and chronobiology study (MAVRICS).,randomized_controlled_trial,mixed_unclear,"While melatonin increased certain cellular responses, overall vaccine response metrics did not show significant differences, indicating mixed outcomes.",5 mg daily 14 days,,,influenza vaccine response,influenza vaccine response,,,
Melatonin,Caution should be taken by consumers using over-the-counter melatonin lotions because the undisclosed dosage can be high and well absorbed by the skin.; associated with neonatal hypoglycemia; fatigue; focal spongiotic dermatitis; headache; minimal and mild adverse reactions; nausea; potential for respiratory suppression; serious adverse events unrelated to melatonin; unpredictable effects leading to agitation,Strength,,Musculoskeletal & Pain,manual_pair,"One randomized controlled trial found that melatonin supplementation (3 mg per night for 12 weeks) significantly improved muscle strength, manual dexterity, and postural balance in patients with multiple sclerosis, indicating a potential benefit for muscle weakness. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term effects and safety.",0.8,39849681,2025,"Effects of Melatonin Supplementation on Muscle Strength, Manual Dexterity, and Postural Balance in Patients Living with Multiple sclerosis - A Randomized Controlled Trial.",randomized_controlled_trial,benefit,"The study shows significant improvements in muscle strength, manual dexterity, postural balance, mood, and cognition, indicating a beneficial effect of melatonin supplementation.",3 mg per night 12 weeks,Multiple Sclerosis,"Cognitive & Neurological; Energy, Mood, & Mental Health",multiple sclerosis,multiple sclerosis,,,
Melatonin,Caution should be taken by consumers using over-the-counter melatonin lotions because the undisclosed dosage can be high and well absorbed by the skin.; associated with neonatal hypoglycemia; fatigue; focal spongiotic dermatitis; headache; minimal and mild adverse reactions; nausea; potential for respiratory suppression; serious adverse events unrelated to melatonin; unpredictable effects leading to agitation,Oxidative Stress,,"Immune, Inflammation, & Infection",manual_pair,"One randomized placebo-controlled trial suggests that melatonin supplementation may improve oxidative DNA damage repair capacity among night shift workers after 4 weeks of treatment. However, the result was borderline significant, indicating that the evidence is limited and further research is needed to confirm these findings. No adverse effects were reported in the study.",0.7,39993913,2025,Melatonin supplementation and oxidative DNA damage repair capacity among night shift workers: a randomised placebo-controlled trial.,randomized_controlled_trial,benefit,"The study suggests a benefit in oxidative DNA damage repair capacity among night shift workers with melatonin supplementation, despite a borderline significant result.",4 weeks (supplement),Night Shift Workers,,night shift work,night shift work,,,
Melatonin,Caution should be taken by consumers using over-the-counter melatonin lotions because the undisclosed dosage can be high and well absorbed by the skin.; associated with neonatal hypoglycemia; fatigue; focal spongiotic dermatitis; headache; minimal and mild adverse reactions; nausea; potential for respiratory suppression; serious adverse events unrelated to melatonin; unpredictable effects leading to agitation,Gait Problems,,Cognitive & Neurological Function,manual_pair,"One randomized controlled trial reported that 3 mg of melatonin taken nightly for 12 weeks improved dynamic postural stability and walking performance in individuals with multiple sclerosis. No studies indicated harm or mixed results, suggesting a potential benefit; however, the evidence is limited to a single trial, and further research is needed to confirm these findings.",0.7,39122092,2025,12-week melatonin supplementation improved dynamic postural stability and walking performance in persons living with multiple sclerosis: A randomized controlled trial.,randomized_controlled_trial,benefit,"The study shows significant improvements in postural stability, walking performance, fatigue, and sleep quality, indicating a beneficial effect of melatonin supplementation.",3 mg night 12 weeks,Multiple Sclerosis,,dynamic postural imbalance,dynamic postural imbalance; fatigue; gait disorders; multiple sclerosis; neuropathic pain; sleep quality,,,
Melatonin,Caution should be taken by consumers using over-the-counter melatonin lotions because the undisclosed dosage can be high and well absorbed by the skin.; associated with neonatal hypoglycemia; fatigue; focal spongiotic dermatitis; headache; minimal and mild adverse reactions; nausea; potential for respiratory suppression; serious adverse events unrelated to melatonin; unpredictable effects leading to agitation,Insomnia,,Sleep,manual_pair,"The evidence from randomized trials suggests that melatonin is associated with improvements in sleep quality and insomnia severity, with benefits reported across multiple studies using doses ranging from 1.9 mg to 5 mg. However, one study reported mixed results regarding sleep quality, indicating some variability in outcomes. Overall, the findings support the potential efficacy of melatonin for insomnia, but further research may be needed to clarify its effects in certain populations.",0.85,39304187,2024,"Temazepam or Melatonin Versus Placebo for the Treatment of Insomnia in Advanced Cancer: A Three-Arm, Double-Blind, Phase III, Multicenter, Randomized Clinical Trial.",randomized_controlled_trial,benefit,Melatonin showed a clinically significant improvement in insomnia severity compared to placebo.,(prolonged release),,,advanced cancer,advanced cancer; cardiac autonomic dysfunction; early awakening; insomnia; multiple sclerosis; oxidative stress; parkinson's disease; poor sleep quality; rotator cuff repair; short sleep duration; sleep disorders; sleep disturbance; sleep disturbances; sleep onset latency; sleep quality,,,
Melatonin,Caution should be taken by consumers using over-the-counter melatonin lotions because the undisclosed dosage can be high and well absorbed by the skin.; associated with neonatal hypoglycemia; fatigue; focal spongiotic dermatitis; headache; minimal and mild adverse reactions; nausea; potential for respiratory suppression; serious adverse events unrelated to melatonin; unpredictable effects leading to agitation,Insomnia,,Sleep,manual_pair,"The evidence from randomized trials suggests that melatonin is associated with improvements in sleep quality and insomnia severity, with benefits reported across multiple studies using doses ranging from 1.9 mg to 5 mg. However, one study reported mixed results regarding sleep quality, indicating some variability in outcomes. Overall, the findings support the potential efficacy of melatonin for insomnia, but further research may be needed to clarify its effects in certain populations.",0.85,39630381,2024,12-week melatonin intake attenuates cardiac autonomic dysfunction and oxidative stress in multiple sclerosis patients: a randomized controlled trial.,randomized_controlled_trial,benefit,"The study shows significant improvements in heart rate variability, oxidative stress markers, and sleep quality, indicating a beneficial effect of melatonin.",3 mg night 12 weeks,,,cardiac autonomic dysfunction,advanced cancer; cardiac autonomic dysfunction; early awakening; insomnia; multiple sclerosis; oxidative stress; parkinson's disease; poor sleep quality; rotator cuff repair; short sleep duration; sleep disorders; sleep disturbance; sleep disturbances; sleep onset latency; sleep quality,,,
Melatonin,Caution should be taken by consumers using over-the-counter melatonin lotions because the undisclosed dosage can be high and well absorbed by the skin.; associated with neonatal hypoglycemia; fatigue; focal spongiotic dermatitis; headache; minimal and mild adverse reactions; nausea; potential for respiratory suppression; serious adverse events unrelated to melatonin; unpredictable effects leading to agitation,Insomnia,,Sleep,manual_pair,"The evidence from randomized trials suggests that melatonin is associated with improvements in sleep quality and insomnia severity, with benefits reported across multiple studies using doses ranging from 1.9 mg to 5 mg. However, one study reported mixed results regarding sleep quality, indicating some variability in outcomes. Overall, the findings support the potential efficacy of melatonin for insomnia, but further research may be needed to clarify its effects in certain populations.",0.85,39437460,2024,Melatonin on sleep in Parkinson's disease: A randomized double blind placebo controlled trial.,randomized_controlled_trial,benefit,"The study shows significant improvements in sleep quality and non-motor symptoms, indicating a benefit from melatonin treatment.",3 mg 8 weeks,Parkinson's Disease,,parkinson's disease,advanced cancer; cardiac autonomic dysfunction; early awakening; insomnia; multiple sclerosis; oxidative stress; parkinson's disease; poor sleep quality; rotator cuff repair; short sleep duration; sleep disorders; sleep disturbance; sleep disturbances; sleep onset latency; sleep quality,,,
Melatonin,Caution should be taken by consumers using over-the-counter melatonin lotions because the undisclosed dosage can be high and well absorbed by the skin.; associated with neonatal hypoglycemia; fatigue; focal spongiotic dermatitis; headache; minimal and mild adverse reactions; nausea; potential for respiratory suppression; serious adverse events unrelated to melatonin; unpredictable effects leading to agitation,Insomnia,,Sleep,manual_pair,"The evidence from randomized trials suggests that melatonin is associated with improvements in sleep quality and insomnia severity, with benefits reported across multiple studies using doses ranging from 1.9 mg to 5 mg. However, one study reported mixed results regarding sleep quality, indicating some variability in outcomes. Overall, the findings support the potential efficacy of melatonin for insomnia, but further research may be needed to clarify its effects in certain populations.",0.85,38745424,2024,"The effects of melatonin and magnesium in a novel supplement delivery system on sleep scores, body composition and metabolism in otherwise healthy individuals with sleep disturbances.",randomized_controlled_trial,mixed_unclear,"The study showed improvements in sleep quality but final PSQI scores indicated poor sleep quality on average, leading to a mixed outcome classification.",1.9 mg before sleep 4 weeks (coffee pods),,,poor sleep quality,advanced cancer; cardiac autonomic dysfunction; early awakening; insomnia; multiple sclerosis; oxidative stress; parkinson's disease; poor sleep quality; rotator cuff repair; short sleep duration; sleep disorders; sleep disturbance; sleep disturbances; sleep onset latency; sleep quality,,,
Melatonin,Caution should be taken by consumers using over-the-counter melatonin lotions because the undisclosed dosage can be high and well absorbed by the skin.; associated with neonatal hypoglycemia; fatigue; focal spongiotic dermatitis; headache; minimal and mild adverse reactions; nausea; potential for respiratory suppression; serious adverse events unrelated to melatonin; unpredictable effects leading to agitation,Insomnia,,Sleep,manual_pair,"The evidence from randomized trials suggests that melatonin is associated with improvements in sleep quality and insomnia severity, with benefits reported across multiple studies using doses ranging from 1.9 mg to 5 mg. However, one study reported mixed results regarding sleep quality, indicating some variability in outcomes. Overall, the findings support the potential efficacy of melatonin for insomnia, but further research may be needed to clarify its effects in certain populations.",0.85,39279257,2024,Effects of Melatonin on Sleep Quality and Patient-Reported Outcomes After Arthroscopic Rotator Cuff Surgery: A Prospective Randomized Controlled Trial.,randomized_controlled_trial,benefit,"Melatonin improved sleep quality and functional outcomes post-surgery, indicating a beneficial effect.",5 mg 1 hour before bedtime 6 weeks (oral),Postoperative,,rotator cuff repair,advanced cancer; cardiac autonomic dysfunction; early awakening; insomnia; multiple sclerosis; oxidative stress; parkinson's disease; poor sleep quality; rotator cuff repair; short sleep duration; sleep disorders; sleep disturbance; sleep disturbances; sleep onset latency; sleep quality,,,
Melatonin,Caution should be taken by consumers using over-the-counter melatonin lotions because the undisclosed dosage can be high and well absorbed by the skin.; associated with neonatal hypoglycemia; fatigue; focal spongiotic dermatitis; headache; minimal and mild adverse reactions; nausea; potential for respiratory suppression; serious adverse events unrelated to melatonin; unpredictable effects leading to agitation,Insomnia,,Sleep,manual_pair,"The evidence from randomized trials suggests that melatonin is associated with improvements in sleep quality and insomnia severity, with benefits reported across multiple studies using doses ranging from 1.9 mg to 5 mg. However, one study reported mixed results regarding sleep quality, indicating some variability in outcomes. Overall, the findings support the potential efficacy of melatonin for insomnia, but further research may be needed to clarify its effects in certain populations.",0.85,38764237,2024,Exogenous melatonin's effect on salivary cortisol and amylase: A randomized controlled trial.,randomized_controlled_trial,benefit,"Melatonin was found to improve sleep onset latency and total sleep time, indicating a beneficial effect on sleep quality.",2 mg single dose (prolonged-release tablet),,,sleep onset latency,advanced cancer; cardiac autonomic dysfunction; early awakening; insomnia; multiple sclerosis; oxidative stress; parkinson's disease; poor sleep quality; rotator cuff repair; short sleep duration; sleep disorders; sleep disturbance; sleep disturbances; sleep onset latency; sleep quality,,,
N-Acetylcysteine (NAC),Five cerebral bleeds occurred during the treatment period; Infusion-related reactions were common; Itching; Patients who received a COVID-19 vaccine were excluded; Pregnant patients were excluded; Rashes; gastrointestinal adverse events; gastrointestinal adverse events reported more in NAC group; increased intraoperative cryoprecipitate requirements; increased red blood cell requirements; infections; mild gastrointestinal adverse events; mild to moderate discomfort; more cases of heartburn compared with placebo,Systemic Lupus Erythematosus,,Cognitive & Neurological Function,manual_pair,"One randomized double-blind clinical trial reported that N-Acetylcysteine (NAC) at a dose of 1800 mg three times per day for three months significantly decreased disease activity scores in patients with active systemic lupus erythematosus, indicating a potential benefit. However, the overall evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term safety and efficacy.",0.7,36810107,2023,Effects of N-acetylcysteine on systemic lupus erythematosus disease activity and its associated complications: a randomized double-blind clinical trial study.,randomized_controlled_trial,benefit,"The study shows a significant decrease in disease activity scores, indicating a beneficial effect of NAC.",1800 mg 3 times per day 3 months,,,systemic lupus erythematosus,systemic lupus erythematosus,,,
N-Acetylcysteine (NAC),Five cerebral bleeds occurred during the treatment period; Infusion-related reactions were common; Itching; Patients who received a COVID-19 vaccine were excluded; Pregnant patients were excluded; Rashes; gastrointestinal adverse events; gastrointestinal adverse events reported more in NAC group; increased intraoperative cryoprecipitate requirements; increased red blood cell requirements; infections; mild gastrointestinal adverse events; mild to moderate discomfort; more cases of heartburn compared with placebo,Stroke Recovery,,Cognitive & Neurological Function,manual_pair,"One randomized controlled trial (PMID 38212360) suggests that N-Acetylcysteine (NAC) may improve early neurological outcomes in patients with acute ischemic stroke when used as an adjunct to standard treatment. However, the evidence is limited to a single study, and no significant differences in safety profiles were reported. Further research is needed to confirm these findings and establish consistent dosing regimens.",0.7,38212360,2024,Safety and efficacy of N-acetylcysteine (NAC) as an adjunct to standard treatment in patients with acute ischemic stroke: a randomized controlled pilot trial (NACTLYS).,randomized_controlled_trial,benefit,"The study showed a slightly improved early neurological outcome with NAC, indicating a potential benefit despite no significant differences in safety profiles.",(intravenous),,,acute ischemic stroke,acute ischemic stroke,,,
N-Acetylcysteine (NAC),Five cerebral bleeds occurred during the treatment period; Infusion-related reactions were common; Itching; Patients who received a COVID-19 vaccine were excluded; Pregnant patients were excluded; Rashes; gastrointestinal adverse events; gastrointestinal adverse events reported more in NAC group; increased intraoperative cryoprecipitate requirements; increased red blood cell requirements; infections; mild gastrointestinal adverse events; mild to moderate discomfort; more cases of heartburn compared with placebo,Stress,,"Energy, Mood, & Mental Health",manual_pair,"One randomized trial found that N-Acetylcysteine (NAC) at a dose of 600 mg twice daily for 8 weeks significantly reduced anxiety symptoms in patients with multiple sclerosis. There is currently no evidence of harm or no benefit associated with NAC for anxiety, but the overall evidence is limited to a single study, indicating a need for further research to confirm these findings.",0.7,37386885,2023,"Effects of N-acetylcysteine on oxidative stress biomarkers, depression, and anxiety symptoms in patients with multiple sclerosis.",randomized_controlled_trial,benefit,"NAC significantly decreased anxiety symptoms and oxidative stress biomarkers, indicating a beneficial effect.",600 mg twice daily 8 weeks (oral),Multiple Sclerosis,"Immune, Inflammation, & Infection",anxiety,anxiety; depression; multiple sclerosis,,,
N-Acetylcysteine (NAC),Five cerebral bleeds occurred during the treatment period; Infusion-related reactions were common; Itching; Patients who received a COVID-19 vaccine were excluded; Pregnant patients were excluded; Rashes; gastrointestinal adverse events; gastrointestinal adverse events reported more in NAC group; increased intraoperative cryoprecipitate requirements; increased red blood cell requirements; infections; mild gastrointestinal adverse events; mild to moderate discomfort; more cases of heartburn compared with placebo,COPD,,Respiratory Health,manual_pair,"One randomized trial indicates that N-Acetylcysteine (NAC) supplementation may improve nutritional and antioxidant status in male patients with chronic obstructive pulmonary disease (COPD) over a six-month period. However, the overall evidence is limited, with only one study demonstrating a benefit and no reports of harm or no benefit. Further research is needed to confirm these findings and assess long-term effects.",0.7,27117852,2016,Efficacy of Ascorbic Acid (Vitamin C) and/N-Acetylcysteine (NAC) Supplementation on Nutritional and Antioxidant Status of Male Chronic Obstructive Pulmonary Disease (COPD) Patients.,randomized_controlled_trial,benefit,"The study shows significant improvements in nutritional and antioxidant status, indicating a benefit from NAC supplementation.",six months,Men,,chronic obstructive pulmonary disease (copd),chronic obstructive pulmonary disease (copd),,,
N-Acetylcysteine (NAC),Five cerebral bleeds occurred during the treatment period; Infusion-related reactions were common; Itching; Patients who received a COVID-19 vaccine were excluded; Pregnant patients were excluded; Rashes; gastrointestinal adverse events; gastrointestinal adverse events reported more in NAC group; increased intraoperative cryoprecipitate requirements; increased red blood cell requirements; infections; mild gastrointestinal adverse events; mild to moderate discomfort; more cases of heartburn compared with placebo,Amyloid Angiopathy,,Heart & Vascular Health,manual_pair,"The evidence for N-Acetylcysteine (NAC) in cognitive impairment or memory problems is limited, with only one nonrandomized clinical trial reporting a potential benefit at a dose of 2400 mg daily for 9 months. No randomized trials were identified, and the overall quality of evidence is low, with no reported harms or clear consensus on efficacy.",0.5,40163249,2025,N-Acetylcysteine for Hereditary Cystatin C Amyloid Angiopathy: A Nonrandomized Clinical Trial.,clinical_trial,benefit,"NAC was safe and well tolerated, with significant reductions in disease-associated biomarkers, indicating a potential benefit.",2400 mg daily 9 months,,,hereditary cystatin c amyloid angiopathy,hereditary cystatin c amyloid angiopathy,,,
N-Acetylcysteine (NAC),Five cerebral bleeds occurred during the treatment period; Infusion-related reactions were common; Itching; Patients who received a COVID-19 vaccine were excluded; Pregnant patients were excluded; Rashes; gastrointestinal adverse events; gastrointestinal adverse events reported more in NAC group; increased intraoperative cryoprecipitate requirements; increased red blood cell requirements; infections; mild gastrointestinal adverse events; mild to moderate discomfort; more cases of heartburn compared with placebo,Infertility,,Women's Health,manual_pair,"N-Acetylcysteine (NAC) supplementation at a dose of 1.8 g daily has shown beneficial effects on ovulation induction efficacy and endocrine-metabolic parameters in women with polycystic ovary syndrome (PCOS), based on one randomized trial. No studies reported mixed outcomes or adverse effects, but the overall evidence is limited to a single study, necessitating caution in interpretation.",0.8,39415242,2024,N-acetylcysteine supplementation improves endocrine-metabolism profiles and ovulation induction efficacy in polycystic ovary syndrome.,randomized_controlled_trial,benefit,"NAC supplementation showed significant improvements in ovulation induction efficacy and endocrine-metabolic parameters in women with PCOS, indicating a beneficial effect.",1.8 g daily (oral),PCOS; Women,"Immune, Inflammation, & Infection; Metabolic Health",ovulation induction,ovulation induction; polycystic ovary syndrome,,,
N-Acetylcysteine (NAC),Five cerebral bleeds occurred during the treatment period; Infusion-related reactions were common; Itching; Patients who received a COVID-19 vaccine were excluded; Pregnant patients were excluded; Rashes; gastrointestinal adverse events; gastrointestinal adverse events reported more in NAC group; increased intraoperative cryoprecipitate requirements; increased red blood cell requirements; infections; mild gastrointestinal adverse events; mild to moderate discomfort; more cases of heartburn compared with placebo,HIV,,"Immune, Inflammation, & Infection",manual_pair,"There is limited evidence suggesting that N-Acetylcysteine (NAC) may improve antioxidant levels, specifically plasma glutathione (GSH) in HIV+ patients, based on one study that administered 1 g daily for 7 days. However, the overall evidence is low, and further research is needed to establish consistent benefits and safety across broader populations.",0.7,29392418,2018,Comparative effects of acute-methionine loading on the plasma sulfur-amino acids in NAC-supplemented HIV+ patients and healthy controls.,clinical_trial,benefit,"NAC supplementation improved plasma GSH and other amino acid levels in HIV+ patients, indicating a beneficial effect.",1 g daily 7 days (dietary supplement),,,hiv infections,hiv infections,,,
N-Acetylcysteine (NAC),Five cerebral bleeds occurred during the treatment period; Infusion-related reactions were common; Itching; Patients who received a COVID-19 vaccine were excluded; Pregnant patients were excluded; Rashes; gastrointestinal adverse events; gastrointestinal adverse events reported more in NAC group; increased intraoperative cryoprecipitate requirements; increased red blood cell requirements; infections; mild gastrointestinal adverse events; mild to moderate discomfort; more cases of heartburn compared with placebo,Schizophrenia,,"Energy, Mood, & Mental Health",manual_pair,"One randomized controlled trial has reported a benefit of N-Acetylcysteine (NAC) at a dose of 2 g daily for improving negative symptoms in patients with clozapine-resistant schizophrenia. However, the overall evidence is limited, with only one study available, and no adverse effects were reported. Further research is needed to confirm these findings and establish the efficacy of NAC for this indication.",0.7,27629871,2016,N-acetylcysteine (NAC) in schizophrenia resistant to clozapine: a double blind randomised placebo controlled trial targeting negative symptoms.,randomized_controlled_trial,benefit,"The study aims to improve negative symptoms in clozapine-resistant schizophrenia, indicating a potential benefit from NAC.",2 g daily,,,clozapine-resistant schizophrenia,clozapine-resistant schizophrenia; schizophrenia,,,
N-Acetylcysteine (NAC),Five cerebral bleeds occurred during the treatment period; Infusion-related reactions were common; Itching; Patients who received a COVID-19 vaccine were excluded; Pregnant patients were excluded; Rashes; gastrointestinal adverse events; gastrointestinal adverse events reported more in NAC group; increased intraoperative cryoprecipitate requirements; increased red blood cell requirements; infections; mild gastrointestinal adverse events; mild to moderate discomfort; more cases of heartburn compared with placebo,Addiction,,"Energy, Mood, & Mental Health",manual_pair,"One randomized clinical trial suggests that N-Acetylcysteine (NAC) may have a beneficial effect on neuroplasticity and treatment response in individuals with nicotine addiction when combined with motivational enhancement therapy. However, the evidence is limited to a single study, and further research is needed to confirm these findings and establish consistent dosing and safety profiles.",0.7,40352229,2025,Efficacy of N-acetylcysteine and motivational enhancement therapy for nicotine addiction: A randomized clinical trial.,randomized_controlled_trial,benefit,"The study demonstrated that NAC combined with MET showed a higher Glx/creatine ratio in the medial prefrontal cortex and a higher NAA/creatine ratio in the bilateral cerebellum, indicating a beneficial effect on neuroplasticity and treatment response for nicotine addiction.",,,,nicotine addiction,nicotine addiction; tobacco use disorder,,,
N-Acetylcysteine (NAC),Five cerebral bleeds occurred during the treatment period; Infusion-related reactions were common; Itching; Patients who received a COVID-19 vaccine were excluded; Pregnant patients were excluded; Rashes; gastrointestinal adverse events; gastrointestinal adverse events reported more in NAC group; increased intraoperative cryoprecipitate requirements; increased red blood cell requirements; infections; mild gastrointestinal adverse events; mild to moderate discomfort; more cases of heartburn compared with placebo,Obsessive-Compulsive Disorder,,"Energy, Mood, & Mental Health",manual_pair,"The evidence for N-Acetylcysteine (NAC) in the treatment of obsessive-compulsive disorder is mixed and unclear. One randomized, placebo-controlled trial reported no significant benefit on the primary outcome, although a reduction in compulsions was observed at a dose of 3 g per day over 16 weeks. Overall, there is insufficient evidence to support its efficacy for this indication.",0.8,26374743,2015,"N-Acetyl Cysteine (NAC) in the Treatment of Obsessive-Compulsive Disorder: A 16-Week, Double-Blind, Randomised, Placebo-Controlled Study.",randomized_controlled_trial,mixed_unclear,"The primary outcome showed no significant benefit, but a significant reduction in compulsions was noted, indicating mixed results.",3 g day 16 weeks,,,obsessive-compulsive disorder,obsessive-compulsive disorder,,,
N-Acetylcysteine (NAC),Five cerebral bleeds occurred during the treatment period; Infusion-related reactions were common; Itching; Patients who received a COVID-19 vaccine were excluded; Pregnant patients were excluded; Rashes; gastrointestinal adverse events; gastrointestinal adverse events reported more in NAC group; increased intraoperative cryoprecipitate requirements; increased red blood cell requirements; infections; mild gastrointestinal adverse events; mild to moderate discomfort; more cases of heartburn compared with placebo,High Blood Glucose,,Metabolic Health,manual_pair,"One randomized trial has shown that N-Acetylcysteine (NAC) at a dose of 600 mg three times a day for 24 weeks may improve metabolic and endocrine characteristics in women with polycystic ovary syndrome, specifically enhancing lipid profile and fasting blood sugar compared to metformin. Overall, the evidence is limited to a single study with no reported adverse effects or mixed outcomes, indicating a need for further research to confirm these findings.",0.8,26654154,2016,A comparison between the effects of metformin and N-acetyl cysteine (NAC) on some metabolic and endocrine characteristics of women with polycystic ovary syndrome.,randomized_controlled_trial,benefit,"NAC showed improvements in lipid profile and fasting blood sugar compared to metformin, indicating a beneficial effect.",600 mg three times a day 24 weeks (oral),PCOS; Women,,polycystic ovary syndrome,polycystic ovary syndrome,,,
N-Acetylcysteine (NAC),Five cerebral bleeds occurred during the treatment period; Infusion-related reactions were common; Itching; Patients who received a COVID-19 vaccine were excluded; Pregnant patients were excluded; Rashes; gastrointestinal adverse events; gastrointestinal adverse events reported more in NAC group; increased intraoperative cryoprecipitate requirements; increased red blood cell requirements; infections; mild gastrointestinal adverse events; mild to moderate discomfort; more cases of heartburn compared with placebo,Schizophrenia,,"Energy, Mood, & Mental Health",manual_pair,"One randomized clinical trial indicates that adjunctive N-Acetylcysteine (NAC) at a dose of 1200 mg daily for 12 weeks may lead to significant improvements in symptoms of chronic schizophrenia and cognitive functions. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term safety and efficacy.",0.7,29126981,2018,"Therapeutic effect of adjunctive N-acetyl cysteine (NAC) on symptoms of chronic schizophrenia: A double-blind, randomized clinical trial.",randomized_controlled_trial,benefit,The study reports significant improvements in schizophrenia symptoms and cognitive functions with NAC treatment.,1200 mg daily 12 weeks (oral),,,chronic schizophrenia,chronic schizophrenia,,,
N-Acetylcysteine (NAC),Five cerebral bleeds occurred during the treatment period; Infusion-related reactions were common; Itching; Patients who received a COVID-19 vaccine were excluded; Pregnant patients were excluded; Rashes; gastrointestinal adverse events; gastrointestinal adverse events reported more in NAC group; increased intraoperative cryoprecipitate requirements; increased red blood cell requirements; infections; mild gastrointestinal adverse events; mild to moderate discomfort; more cases of heartburn compared with placebo,COVID-19,,"Immune, Inflammation, & Infection",manual_pair,"N-Acetylcysteine (NAC) has shown beneficial effects in two randomized clinical trials for severe COVID-19 symptoms, including reductions in hospitalization rates and improvements in clinical outcomes for critically ill patients. However, the evidence is limited to a small number of studies, and typical dosing regimens were not consistently reported. No adverse effects were noted in the studies reviewed.",0.8,38215974,2024,Evaluation of the efficacy of N-acetylcysteine and bromhexine compared with standard care in preventing hospitalization of outpatients with COVID-19: a double blind randomized clinical trial.,randomized_controlled_trial,benefit,"The study shows that NAC effectively reduces hospitalization rates and mortality in COVID-19 patients, indicating a beneficial outcome.",,,,covid-19,covid-19; critical illness,,,
N-Acetylcysteine (NAC),Five cerebral bleeds occurred during the treatment period; Infusion-related reactions were common; Itching; Patients who received a COVID-19 vaccine were excluded; Pregnant patients were excluded; Rashes; gastrointestinal adverse events; gastrointestinal adverse events reported more in NAC group; increased intraoperative cryoprecipitate requirements; increased red blood cell requirements; infections; mild gastrointestinal adverse events; mild to moderate discomfort; more cases of heartburn compared with placebo,COVID-19,,"Immune, Inflammation, & Infection",manual_pair,"N-Acetylcysteine (NAC) has shown beneficial effects in two randomized clinical trials for severe COVID-19 symptoms, including reductions in hospitalization rates and improvements in clinical outcomes for critically ill patients. However, the evidence is limited to a small number of studies, and typical dosing regimens were not consistently reported. No adverse effects were noted in the studies reviewed.",0.8,37405379,2023,Response to Intravenous N-Acetylcysteine Supplementation in Critically Ill Patients with COVID-19.,randomized_controlled_trial,benefit,NAC improved clinical and biochemical outcomes in critically ill COVID-19 patients.,loading dose and maintenance dose continuous infusion from admission until the third day of ICU stay,,,covid-19,covid-19; critical illness,,,
N-Acetylcysteine (NAC),Five cerebral bleeds occurred during the treatment period; Infusion-related reactions were common; Itching; Patients who received a COVID-19 vaccine were excluded; Pregnant patients were excluded; Rashes; gastrointestinal adverse events; gastrointestinal adverse events reported more in NAC group; increased intraoperative cryoprecipitate requirements; increased red blood cell requirements; infections; mild gastrointestinal adverse events; mild to moderate discomfort; more cases of heartburn compared with placebo,Immune Preservation,,Healthy Aging & Prevention,manual_pair,"One randomized clinical trial indicates that N-Acetylcysteine (NAC) at a dose of 600 mg daily, when co-administered with vitamin D, may enhance immune response in older adults with vitamin D deficiency. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term effects and safety.",0.7,40421021,2025,Co-administration of vitamin D and N-acetylcysteine to modulate immunosenescence in older adults with vitamin D deficiency: a randomized clinical trial.,randomized_controlled_trial,benefit,"The study shows that co-administration of NAC with vitamin D enhances the beneficial effects on immunosenescence, indicating a positive outcome.",600 mg daily 8 weeks (NAC); 1000 IU daily 8 weeks (vitamin D); 5000 IU daily 8 weeks (vitamin D),Older Adults,,immunosenescence,immunosenescence; vitamin d deficiency,,,
Nicotinamide mononucleotide,lower scores in SPPB; slower 5CST in mild cognitive impairment,Healthy Aging,,Healthy Aging & Prevention,manual_pair,"Current evidence on nicotinamide mononucleotide (NMN) for aging-related disorders is limited, with only one study reporting a potential benefit in healthy Japanese men after single doses of 100 mg, 250 mg, and 500 mg. The study indicated that NMN was safe and did not cause significant adverse effects; however, the overall evidence quality is low and further research is needed to confirm these findings.",0.7,31685720,2020,Effect of oral administration of nicotinamide mononucleotide on clinical parameters and nicotinamide metabolite levels in healthy Japanese men.,clinical_trial,benefit,"The study found that NMN administration was safe and did not cause significant adverse effects, indicating a potential benefit for mitigating aging-related disorders.",100 mg single 5 hours (oral); 250 mg single 5 hours (oral); 500 mg single 5 hours (oral),,,aging-related disorders,aging-related disorders,,,
Nicotinamide mononucleotide,lower scores in SPPB; slower 5CST in mild cognitive impairment,High Insulin,,Metabolic Health,manual_pair,"One randomized trial indicates that nicotinamide mononucleotide (NMN) supplementation for 10 weeks improves muscle insulin sensitivity in prediabetic women, suggesting a potential benefit for high blood sugar management. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term effects and safety.",0.7,33888596,2021,Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women.,randomized_controlled_trial,benefit,"The study shows that NMN supplementation improves muscle insulin sensitivity and related metabolic functions in prediabetic women, indicating a beneficial outcome.",10 weeks (Nicotinamide mononucleotide),Prediabetes; Women,,insulin resistance,insulin resistance; obesity; overweight; prediabetes,,,
Nicotinamide mononucleotide,lower scores in SPPB; slower 5CST in mild cognitive impairment,Aerobic Capacity,,Performance & Recovery,manual_pair,"Nicotinamide mononucleotide (NMN) supplementation appears to have a beneficial effect on low exercise performance, with three randomized trials reporting improvements in aerobic capacity and physical performance at doses ranging from 250 mg to 1200 mg daily. However, the evidence is limited to a small number of studies, and further research is needed to confirm these findings and assess long-term safety and efficacy.",0.8,34238308,2021,"Nicotinamide mononucleotide supplementation enhances aerobic capacity in amateur runners: a randomized, double-blind study.",randomized_controlled_trial,benefit,"The study shows a benefit in aerobic capacity with NMN supplementation during exercise training, indicating improved oxygen utilization in skeletal muscle.",300 mg daily 6 weeks (Nicotinamide mononucleotide); 600 mg daily 6 weeks (Nicotinamide mononucleotide); 1200 mg daily 6 weeks (Nicotinamide mononucleotide),,,aerobic capacity,aerobic capacity; cardiovascular fitness; decreased physical performance; deteriorating sleep quality; fatigue; healthy middle-aged adults,,,
Nicotinamide mononucleotide,lower scores in SPPB; slower 5CST in mild cognitive impairment,Aerobic Capacity,,Performance & Recovery,manual_pair,"Nicotinamide mononucleotide (NMN) supplementation appears to have a beneficial effect on low exercise performance, with three randomized trials reporting improvements in aerobic capacity and physical performance at doses ranging from 250 mg to 1200 mg daily. However, the evidence is limited to a small number of studies, and further research is needed to confirm these findings and assess long-term safety and efficacy.",0.8,35215405,2022,"Effect of 12-Week Intake of Nicotinamide Mononucleotide on Sleep Quality, Fatigue, and Physical Performance in Older Japanese Adults: A Randomized, Double-Blind Placebo-Controlled Study.",randomized_controlled_trial,benefit,"The study showed significant improvements in sleep quality, fatigue, and physical performance, indicating a beneficial effect of NMN.",250 mg once a day 12 weeks,Older Adults,,decreased physical performance,aerobic capacity; cardiovascular fitness; decreased physical performance; deteriorating sleep quality; fatigue; healthy middle-aged adults,,,
Nicotinamide mononucleotide,lower scores in SPPB; slower 5CST in mild cognitive impairment,Aerobic Capacity,,Performance & Recovery,manual_pair,"Nicotinamide mononucleotide (NMN) supplementation appears to have a beneficial effect on low exercise performance, with three randomized trials reporting improvements in aerobic capacity and physical performance at doses ranging from 250 mg to 1200 mg daily. However, the evidence is limited to a small number of studies, and further research is needed to confirm these findings and assess long-term safety and efficacy.",0.8,36482258,2023,"The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial.",randomized_controlled_trial,benefit,"The study demonstrated significant increases in blood NAD concentrations and improvements in physical performance, indicating a beneficial effect of NMN supplementation in healthy middle-aged adults.",300 mg once daily 60 days (oral); 600 mg once daily 60 days (oral); 900 mg once daily 60 days (oral),,,healthy middle-aged adults,aerobic capacity; cardiovascular fitness; decreased physical performance; deteriorating sleep quality; fatigue; healthy middle-aged adults,,,
Nicotinamide mononucleotide,lower scores in SPPB; slower 5CST in mild cognitive impairment,Sleep Quality,,Sleep,manual_pair,"One double-blind randomized placebo-controlled study found that a daily dose of 250 mg of nicotinamide mononucleotide for 12 weeks improved sleep quality in older adults, alongside increases in blood NAD levels and maintenance of walking speed. No adverse effects were reported, but the evidence is limited to a single study, indicating a need for further research to confirm these findings.",0.7,38789831,2024,"Ingestion of β-nicotinamide mononucleotide increased blood NAD levels, maintained walking speed, and improved sleep quality in older adults in a double-blind randomized, placebo-controlled study.",randomized_controlled_trial,benefit,"The study showed significant benefits in blood NAD levels, walking speed, and sleep quality with no adverse effects reported.",250 mg daily 12 weeks (Nicotinamide mononucleotide),Older Adults,Performance & Recovery,improved sleep quality,improved sleep quality; increased blood nad levels; maintained walking speed,,,
Nicotinamide Riboside,minor gastrointestinal side effects,COPD,,Respiratory Health,manual_pair,"One randomized, placebo-controlled trial reported a significant reduction in IL-8 levels, suggesting a beneficial effect of nicotinamide riboside on airway inflammation in COPD patients. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term effects and safety.",0.7,39548320,2024,"Effect of nicotinamide riboside on airway inflammation in COPD: a randomized, placebo-controlled trial.",randomized_controlled_trial,benefit,"The study showed a significant reduction in IL-8 levels, indicating a beneficial effect of Nicotinamide Riboside on airway inflammation in COPD patients.",null null null 6 weeks (Nicotinamide Riboside),,,chronic obstructive pulmonary disease (copd),chronic obstructive pulmonary disease (copd),,,
Nicotinamide Riboside,minor gastrointestinal side effects,Cognitive Performance,,Cognitive & Neurological Function,manual_pair,"Current evidence on nicotinamide riboside for cognitive impairment is limited, with only one pilot study suggesting a potential benefit in cognitive function among older adults with peripheral artery disease after 4 weeks of supplementation. However, the overall quality of evidence is low, and further research is needed to confirm these findings and assess long-term effects and safety.",0.6,40479886,2025,Effects of NAD+ supplementation with oral nicotinamide riboside on vascular health and cognitive function in older adults with peripheral artery disease: Results from a pilot 4-week open-label clinical trial.,clinical_trial,benefit,"The study indicates a positive trend in vascular and cognitive outcomes, suggesting benefit from NR supplementation.",4 weeks (oral),Older Adults,"Heart & Vascular Health; Immune, Inflammation, & Infection",cognitive impairment,cognitive impairment; peripheral artery disease; vascular health decline,,,
Nicotinamide Riboside,minor gastrointestinal side effects,Healthy Aging,,Healthy Aging & Prevention,manual_pair,"The evidence for nicotinamide riboside in heart failure is limited and primarily derived from a single open-label, non-randomized study that reported an increase in NAD+ levels, suggesting potential benefits. However, the lack of randomized controlled trials and the low-quality design of the available study indicate that the evidence is weak and inconclusive. No adverse effects were reported in the study, but further research is needed to establish efficacy and safety in this indication.",0.3,29211728,2017,"An open-label, non-randomized study of the pharmacokinetics of the nutritional supplement nicotinamide riboside (NR) and its effects on blood NAD+ levels in healthy volunteers.",clinical_trial,benefit,"The study indicates a benefit as NR significantly increased NAD+ levels in healthy volunteers, suggesting potential therapeutic effects for mitochondrial dysfunction.",250 mg twice daily 2 days (oral); 1000 mg twice daily 2 days (oral),,,heart failure,heart failure,,,
Nicotinamide Riboside,minor gastrointestinal side effects,Hypertension,,Heart & Vascular Health,manual_pair,"One randomized trial suggests that chronic supplementation with nicotinamide riboside for 6 weeks may improve cardiovascular functions, including blood pressure and arterial stiffness, in healthy middle-aged and older adults. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term effects and safety.",0.7,29599478,2018,Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults.,randomized_controlled_trial,benefit,"The study indicates a benefit in terms of improving cardiovascular functions, specifically blood pressure and arterial stiffness, in healthy middle-aged and older adults.",6 weeks (Nicotinamide Riboside),Older Adults,Healthy Aging & Prevention,arterial stiffness,arterial stiffness; blood pressure; cardiovascular function,,,
Nicotinamide Riboside,minor gastrointestinal side effects,Inflammation,,"Immune, Inflammation, & Infection",manual_pair,"One randomized trial indicates that nicotinamide riboside (1 g orally per day for 21 days) may reduce inflammatory cytokines and improve the NAD+ metabolome in aged individuals, suggesting a potential anti-inflammatory effect. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term safety and efficacy.",0.7,31412242,2019,Nicotinamide Riboside Augments the Aged Human Skeletal Muscle NAD+ Metabolome and Induces Transcriptomic and Anti-inflammatory Signatures.,randomized_controlled_trial,benefit,The study shows that NR supplementation benefits aged individuals by improving the NAD+ metabolome and reducing inflammatory cytokines.,1 g per day 21 days (oral),,,inflammation,inflammation; metabolic dysfunction,,,
Nicotinamide Riboside,minor gastrointestinal side effects,Elevated Liver Enzymes,,Gut Health,manual_pair,"One randomized controlled trial suggests that Nicotinamide Riboside, in combination with Pterostilbene, may reduce markers of hepatic inflammation in non-alcoholic fatty liver disease (NAFLD) when administered at a daily dose for six months. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term effects and safety.",0.7,36082508,2023,"Nicotinamide riboside and pterostilbene reduces markers of hepatic inflammation in NAFLD: A double-blind, placebo-controlled clinical trial.",randomized_controlled_trial,benefit,"The study shows a significant decrease in liver enzymes and toxic lipid levels, indicating a benefit in reducing hepatic inflammation in NAFLD.",1 dose daily 6 months (Nicotinamide Riboside and Pterostilbene),Fatty Liver Disease,,non-alcoholic fatty liver disease,non-alcoholic fatty liver disease,,,
Nicotinamide Riboside,minor gastrointestinal side effects,Neurodegenerative Disease Prevention,,Healthy Aging & Prevention,manual_pair,"One randomized trial indicates that oral nicotinamide riboside (500 mg twice daily for 6 weeks) may benefit neurodegenerative pathology by increasing NAD+ levels and reducing specific biomarkers in plasma extracellular vesicles. However, the overall evidence is limited, with only one study showing a benefit and no reports of harm or no benefit. Further research is needed to confirm these findings and assess long-term effects.",0.7,36515353,2023,Oral nicotinamide riboside raises NAD+ and lowers biomarkers of neurodegenerative pathology in plasma extracellular vesicles enriched for neuronal origin.,randomized_controlled_trial,benefit,The study shows that oral nicotinamide riboside supplementation benefits neurodegenerative pathology by increasing NAD+ levels and decreasing specific biomarkers.,500 mg 2x /day 6 weeks (oral),,,neurodegenerative diseases,neurodegenerative diseases,,,
Nicotinamide Riboside,minor gastrointestinal side effects,Neuroprotection,,Cognitive & Neurological Function,manual_pair,"The evidence for nicotinamide riboside in Parkinson's disease is limited to one randomized phase I trial, which reported mild clinical improvement with a daily dose of 1000 mg over 30 days. No studies have shown harm or no benefit, but the overall evidence is still considered low-quality and requires further investigation to confirm these findings.",0.7,35235774,2022,The NADPARK study: A randomized phase I trial of nicotinamide riboside supplementation in Parkinson's disease.,randomized_controlled_trial,benefit,"The study showed mild clinical improvement in patients with Parkinson's disease, indicating a benefit from nicotinamide riboside supplementation.",1000 mg daily 30 days (oral),Parkinson's Disease,,parkinson's disease,parkinson's disease,,,
Nicotinamide Riboside,minor gastrointestinal side effects,Parkinson's Disease,,Cognitive & Neurological Function,manual_pair,"One randomized trial reported a beneficial outcome of nicotinamide riboside at a dose of 1500 mg twice daily for four weeks in improving Parkinson's disease symptoms, with no severe adverse events noted. However, the evidence is limited to a single study, and further research is needed to confirm these findings and establish long-term safety and efficacy.",0.7,38016950,2023,"NR-SAFE: a randomized, double-blind safety trial of high dose nicotinamide riboside in Parkinson's disease.",randomized_controlled_trial,benefit,"The study demonstrated clinical improvement in Parkinson's disease symptoms with no severe adverse events, indicating a beneficial outcome.",1500 mg twice daily four weeks,,,parkinson's disease,parkinson's disease,,,
Nicotinamide Riboside,minor gastrointestinal side effects,Peripheral Artery Disease,,Heart & Vascular Health,manual_pair,"Nicotinamide riboside has shown a beneficial effect on walking distance in patients with peripheral artery disease, as evidenced by a single randomized clinical trial. However, the overall evidence is limited to this one study, and further research is needed to confirm these findings and assess long-term safety and efficacy.",0.7,38871717,2024,Nicotinamide riboside for peripheral artery disease: the NICE randomized clinical trial.,randomized_controlled_trial,benefit,"The study demonstrated a significant improvement in walking distance for patients with PAD, indicating a beneficial effect of nicotinamide riboside.",null null null 6 months (oral),,,peripheral arterial disease,peripheral arterial disease,,,
Nicotinamide Riboside,minor gastrointestinal side effects,Healthy Aging,,Healthy Aging & Prevention,manual_pair,"Nicotinamide Riboside supplementation has shown a beneficial effect in a double-blind randomized crossover placebo-controlled trial involving patients with Werner Syndrome, with a dose of 1000 mg once daily for 26 weeks. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term safety and efficacy.",0.7,40459998,2025,Nicotinamide Riboside Supplementation Benefits in Patients With Werner Syndrome: A Double-Blind Randomized Crossover Placebo-Controlled Trial.,randomized_controlled_trial,benefit,"The study demonstrated significant improvements in various health outcomes related to Werner Syndrome, indicating a beneficial effect of Nicotinamide Riboside supplementation.",1000 mg once daily 26 weeks (capsules),Werner Syndrome,,atherosclerosis,atherosclerosis; kidney dysfunction; skin ulcers; werner syndrome,,,
Panax ginseng,"Monitor patients taking CYP3A substrates with narrow therapeutic ranges closely.; abolished the increase in muscle mass; change in urine appearance; concomitant ingestion with prescription medications should be discouraged; gastric discomfort; gastrointestinal disorders; headache; hot flashes; insomnia; mild adverse events such as dyspepsia, hot flash, insomnia, and constipation; palpitation; possible drug interactions with warfarin, phenelzine, and alcohol; sleep disorders",Acne,,"Skin, Hair, & Nails",manual_pair,"There is low-quality evidence suggesting that a hydrophobic fraction of red ginseng (Panax ginseng) may improve acne symptoms, based on a single study that reported a benefit with a topical application at a dose of 3 mg/g for four weeks. No adverse effects were noted, but further research is needed to confirm these findings and establish consistency across studies.",0.7,30506753,2019,Anti-acne properties of hydrophobic fraction of red ginseng (Panax ginseng C.A. Meyer) and its active components.,clinical_trial,benefit,"The study demonstrated that red ginseng extract effectively improved acne symptoms, indicating a beneficial outcome.",3 mg/g 4 weeks (cream),,,acne vulgaris,acne vulgaris,,,
Panax ginseng,"Monitor patients taking CYP3A substrates with narrow therapeutic ranges closely.; abolished the increase in muscle mass; change in urine appearance; concomitant ingestion with prescription medications should be discouraged; gastric discomfort; gastrointestinal disorders; headache; hot flashes; insomnia; mild adverse events such as dyspepsia, hot flash, insomnia, and constipation; palpitation; possible drug interactions with warfarin, phenelzine, and alcohol; sleep disorders",ADHD,,"Energy, Mood, & Mental Health",manual_pair,"Current evidence on Panax ginseng for ADHD symptoms is limited, with only one study suggesting a slight improvement in symptoms. The overall quality of evidence is low, and no consistent dose ranges or adverse effects have been reported. Further research is needed to establish efficacy and safety.",0.7,22435351,2009,Panax ginseng may improve some symptoms of attention-deficit hyperactivity disorder.,clinical_trial,benefit,"The study indicates a slight improvement in ADHD symptoms, suggesting a benefit from Panax ginseng.",,,,attention-deficit hyperactivity disorder,attention-deficit hyperactivity disorder,,,
Panax ginseng,"Monitor patients taking CYP3A substrates with narrow therapeutic ranges closely.; abolished the increase in muscle mass; change in urine appearance; concomitant ingestion with prescription medications should be discouraged; gastric discomfort; gastrointestinal disorders; headache; hot flashes; insomnia; mild adverse events such as dyspepsia, hot flash, insomnia, and constipation; palpitation; possible drug interactions with warfarin, phenelzine, and alcohol; sleep disorders",Inflammation,,"Immune, Inflammation, & Infection",manual_pair,"One randomized, placebo-controlled trial demonstrated that Panax ginseng (1 g daily for 4 weeks) significantly reduced serum reactive oxygen species (ROS) and malondialdehyde (MDA) levels, suggesting a beneficial antioxidant effect. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term safety and efficacy.",0.7,21699953,2011,"Antioxidant effects of Panax ginseng C.A. Meyer in healthy subjects: a randomized, placebo-controlled clinical trial.",randomized_controlled_trial,benefit,"The study shows significant decreases in serum ROS and MDA levels, indicating a beneficial antioxidant effect of Panax ginseng.",1 g daily 4 weeks (extract),,,antioxidant effects,antioxidant effects,,,
Panax ginseng,"Monitor patients taking CYP3A substrates with narrow therapeutic ranges closely.; abolished the increase in muscle mass; change in urine appearance; concomitant ingestion with prescription medications should be discouraged; gastric discomfort; gastrointestinal disorders; headache; hot flashes; insomnia; mild adverse events such as dyspepsia, hot flash, insomnia, and constipation; palpitation; possible drug interactions with warfarin, phenelzine, and alcohol; sleep disorders",Arterial Stiffness,,Heart & Vascular Health,manual_pair,"The evidence for Panax ginseng in reducing arterial stiffness is limited, with only one study reporting a benefit from a single dose of 3 g of Korean red ginseng. No adverse effects were noted, but the overall quality and quantity of evidence are low, necessitating caution in interpretation.",0.6,20134405,2010,Effects of Korean red ginseng (Panax ginseng C.A. Mayer) and its isolated ginsenosides and polysaccharides on arterial stiffness in healthy individuals.,randomized_controlled_trial,benefit,"The study shows that KRG significantly lowered arterial stiffness, indicating a potential benefit for cardiovascular health.",3 g single dose (KRG root),,,arterial stiffness,arterial stiffness,,,
Panax ginseng,"Monitor patients taking CYP3A substrates with narrow therapeutic ranges closely.; abolished the increase in muscle mass; change in urine appearance; concomitant ingestion with prescription medications should be discouraged; gastric discomfort; gastrointestinal disorders; headache; hot flashes; insomnia; mild adverse events such as dyspepsia, hot flash, insomnia, and constipation; palpitation; possible drug interactions with warfarin, phenelzine, and alcohol; sleep disorders",Hypertension,,Heart & Vascular Health,manual_pair,"The evidence regarding Panax ginseng for blood pressure is limited and mixed. One study reported a decrease in diastolic blood pressure and an increase in QTc interval with a daily dose of 200 mg of extract for 28 days, but these effects were not deemed clinically significant. Overall, there is no consistent evidence supporting a beneficial effect on blood pressure.",0.7,11978148,2002,Electrocardiographic and hemodynamic effects of Panax ginseng.,randomized_controlled_trial,mixed_unclear,"The study found an increase in QTc interval and a decrease in diastolic blood pressure, but the effects were not considered clinically significant.",200 mg daily 28 days (extract),,,blood pressure,blood pressure,,,
Panax ginseng,"Monitor patients taking CYP3A substrates with narrow therapeutic ranges closely.; abolished the increase in muscle mass; change in urine appearance; concomitant ingestion with prescription medications should be discouraged; gastric discomfort; gastrointestinal disorders; headache; hot flashes; insomnia; mild adverse events such as dyspepsia, hot flash, insomnia, and constipation; palpitation; possible drug interactions with warfarin, phenelzine, and alcohol; sleep disorders",Cognitive Performance,,Cognitive & Neurological Function,manual_pair,"The evidence for Panax ginseng in enhancing brain functioning is low, with only one study reporting mixed outcomes. This study indicated potential cognitive improvements and changes in brain activation, but did not show significant differences compared to placebo. No consistent dose ranges were reported, and no adverse effects were noted in the available evidence.",0.7,30080229,2018,"A Combination of Essential Fatty Acids, Panax Ginseng Extract, and Green Tea Catechins Modifies Brain fMRI Signals in Healthy Older Adults.",randomized_controlled_trial,mixed_unclear,"The study suggests cognitive improvements and brain activation changes, but lacks significant differences compared to placebo, leading to a mixed outcome classification.",daily one month (emulsified liquid combination),,,brain functioning,brain functioning,,,
Panax ginseng,"Monitor patients taking CYP3A substrates with narrow therapeutic ranges closely.; abolished the increase in muscle mass; change in urine appearance; concomitant ingestion with prescription medications should be discouraged; gastric discomfort; gastrointestinal disorders; headache; hot flashes; insomnia; mild adverse events such as dyspepsia, hot flash, insomnia, and constipation; palpitation; possible drug interactions with warfarin, phenelzine, and alcohol; sleep disorders",COPD,,Respiratory Health,manual_pair,"The evidence for Panax ginseng in improving breathing difficulties due to COPD is currently low. One randomized controlled trial is underway, which aims to evaluate quality of life and other outcomes with a dose of 100 mg twice daily for 24 weeks, but results are not yet available. No studies have reported a clear benefit or harm associated with this supplement for this indication.",0.7,21718484,2011,Panax ginseng C.A Meyer root extract for moderate chronic obstructive pulmonary disease (COPD): study protocol for a randomised controlled trial.,randomized_controlled_trial,mixed_unclear,"The study aims to assess quality of life improvements and other outcomes, but results are not yet available.",100 mg twice daily 24 weeks (capsule),,,chronic obstructive pulmonary disease,chronic obstructive pulmonary disease; copd,,,
Panax ginseng,"Monitor patients taking CYP3A substrates with narrow therapeutic ranges closely.; abolished the increase in muscle mass; change in urine appearance; concomitant ingestion with prescription medications should be discouraged; gastric discomfort; gastrointestinal disorders; headache; hot flashes; insomnia; mild adverse events such as dyspepsia, hot flash, insomnia, and constipation; palpitation; possible drug interactions with warfarin, phenelzine, and alcohol; sleep disorders",Calmness,,"Energy, Mood, & Mental Health",manual_pair,"One randomized trial reported that Panax ginseng (G115) at doses of 200 mg and 400 mg daily for 7 days improved aspects of working memory and subjective ratings of calmness in healthy young adults. Overall, the evidence suggests a potential benefit for calmness, but further studies are needed to confirm these findings and assess long-term effects and safety.",0.8,20737519,2010,Panax ginseng (G115) improves aspects of working memory performance and subjective ratings of calmness in healthy young adults.,randomized_controlled_trial,benefit,"The study found dose-related benefits in mood and cognitive performance, indicating a positive outcome direction.",200 mg daily 7 days; 400 mg daily 7 days,,,calmness,calmness,,,
Panax ginseng,"Monitor patients taking CYP3A substrates with narrow therapeutic ranges closely.; abolished the increase in muscle mass; change in urine appearance; concomitant ingestion with prescription medications should be discouraged; gastric discomfort; gastrointestinal disorders; headache; hot flashes; insomnia; mild adverse events such as dyspepsia, hot flash, insomnia, and constipation; palpitation; possible drug interactions with warfarin, phenelzine, and alcohol; sleep disorders",Fatigue,,"Energy, Mood, & Mental Health",manual_pair,"The evidence for Panax ginseng in treating chronic fatigue is low quality, with only one randomized trial reporting mixed results. In this study, a 2 g daily dose showed some improvements in mental fatigue scores, but the overall fatigue score did not reach statistical significance compared to placebo. No adverse effects were noted, but the lack of consistent benefit limits the strength of the findings.",0.7,23613825,2013,"Antifatigue effects of Panax ginseng C.A. Meyer: a randomised, double-blind, placebo-controlled trial.",randomized_controlled_trial,mixed_unclear,"While there were improvements in mental NRS and VAS scores with 2 g of Panax ginseng, the overall total NRS score did not show statistically significant improvement compared to placebo.",1 g day(-1) 4 weeks (20% ethanol extract); 2 g day(-1) 4 weeks (20% ethanol extract),,"Immune, Inflammation, & Infection",idiopathic chronic fatigue,idiopathic chronic fatigue,,,
Panax ginseng,"Monitor patients taking CYP3A substrates with narrow therapeutic ranges closely.; abolished the increase in muscle mass; change in urine appearance; concomitant ingestion with prescription medications should be discouraged; gastric discomfort; gastrointestinal disorders; headache; hot flashes; insomnia; mild adverse events such as dyspepsia, hot flash, insomnia, and constipation; palpitation; possible drug interactions with warfarin, phenelzine, and alcohol; sleep disorders",Fibromyalgia Pain,,Musculoskeletal & Pain,manual_pair,"The evidence for Panax ginseng in the treatment of chronic pain is low quality, with only one randomized trial reporting mixed outcomes. In this study, a daily dose of 100 mg of ginseng extract for 12 weeks showed some benefits in pain reduction and quality of life, but no significant differences were observed between the treatment and placebo groups. Overall, the findings do not support a clear benefit for chronic pain management.",0.8,23567596,2013,"Effects of Panax ginseng extract in patients with fibromyalgia: a 12-week, randomized, double-blind, placebo-controlled trial.",randomized_controlled_trial,mixed_unclear,"The study showed benefits in pain reduction and quality of life, but no significant differences between groups, indicating mixed outcomes.",100 mg daily 12 weeks (extract),Fibromyalgia,,fibromyalgia,fibromyalgia,,,
Panax ginseng,"Monitor patients taking CYP3A substrates with narrow therapeutic ranges closely.; abolished the increase in muscle mass; change in urine appearance; concomitant ingestion with prescription medications should be discouraged; gastric discomfort; gastrointestinal disorders; headache; hot flashes; insomnia; mild adverse events such as dyspepsia, hot flash, insomnia, and constipation; palpitation; possible drug interactions with warfarin, phenelzine, and alcohol; sleep disorders",Cognitive Performance,,Cognitive & Neurological Function,manual_pair,"One randomized trial indicates a dose-dependent improvement in cognitive performance with Panax ginseng in healthy adults, with doses of 640 mg and 960 mg showing benefits. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term effects and safety.",0.7,12404705,2002,"Acute, dose-dependent cognitive effects of Ginkgo biloba, Panax ginseng and their combination in healthy young volunteers: differential interactions with cognitive demand.",randomized_controlled_trial,benefit,"The study shows a dose-dependent improvement in cognitive performance, indicating a benefit from Panax ginseng.",320 mg single dose (Ginkgo-Ginseng combination); 640 mg single dose (Ginseng); 960 mg single dose (Ginseng),,,cognition,cognition; cognitive performance,,,
Panax ginseng,"Monitor patients taking CYP3A substrates with narrow therapeutic ranges closely.; abolished the increase in muscle mass; change in urine appearance; concomitant ingestion with prescription medications should be discouraged; gastric discomfort; gastrointestinal disorders; headache; hot flashes; insomnia; mild adverse events such as dyspepsia, hot flash, insomnia, and constipation; palpitation; possible drug interactions with warfarin, phenelzine, and alcohol; sleep disorders",Cognitive Performance,,Cognitive & Neurological Function,manual_pair,"Human clinical evidence suggests that Panax ginseng may enhance cognitive performance in individuals with cognitive impairment, with three studies reporting benefits. Doses reported include 4.5 g daily for 12 weeks and single doses of 200 mg. No adverse effects or harms were noted in the studies; however, the overall quality and consistency of the evidence warrant cautious interpretation.",0.8,18580589,2008,Panax ginseng enhances cognitive performance in Alzheimer disease.,randomized_controlled_trial,benefit,"The study shows significant improvements in cognitive performance after treatment with Panax ginseng, indicating a benefit.",4.5 g daily 12 weeks (powder),Alzheimer's Disease,,alzheimer disease,alzheimer disease; cerebroelectrical activity; cognitive performance; mood enhancement,,,
Panax ginseng,"Monitor patients taking CYP3A substrates with narrow therapeutic ranges closely.; abolished the increase in muscle mass; change in urine appearance; concomitant ingestion with prescription medications should be discouraged; gastric discomfort; gastrointestinal disorders; headache; hot flashes; insomnia; mild adverse events such as dyspepsia, hot flash, insomnia, and constipation; palpitation; possible drug interactions with warfarin, phenelzine, and alcohol; sleep disorders",Cognitive Performance,,Cognitive & Neurological Function,manual_pair,"Human clinical evidence suggests that Panax ginseng may enhance cognitive performance in individuals with cognitive impairment, with three studies reporting benefits. Doses reported include 4.5 g daily for 12 weeks and single doses of 200 mg. No adverse effects or harms were noted in the studies; however, the overall quality and consistency of the evidence warrant cautious interpretation.",0.8,12895688,2003,Electroencephalograph effects of single doses of Ginkgo biloba and Panax ginseng in healthy young volunteers.,clinical_trial,benefit,"The study shows that Panax ginseng significantly modulates cerebroelectrical activity, indicating a benefit in cognitive performance.",200 mg single dose (G115),,,cerebroelectrical activity,alzheimer disease; cerebroelectrical activity; cognitive performance; mood enhancement,,,
Panax ginseng,"Monitor patients taking CYP3A substrates with narrow therapeutic ranges closely.; abolished the increase in muscle mass; change in urine appearance; concomitant ingestion with prescription medications should be discouraged; gastric discomfort; gastrointestinal disorders; headache; hot flashes; insomnia; mild adverse events such as dyspepsia, hot flash, insomnia, and constipation; palpitation; possible drug interactions with warfarin, phenelzine, and alcohol; sleep disorders",Cognitive Performance,,Cognitive & Neurological Function,manual_pair,"Human clinical evidence suggests that Panax ginseng may enhance cognitive performance in individuals with cognitive impairment, with three studies reporting benefits. Doses reported include 4.5 g daily for 12 weeks and single doses of 200 mg. No adverse effects or harms were noted in the studies; however, the overall quality and consistency of the evidence warrant cautious interpretation.",0.8,15582012,2004,Improved cognitive performance in human volunteers following administration of guarana (Paullinia cupana) extract: comparison and interaction with Panax ginseng.,clinical_trial,benefit,"The study shows improved cognitive performance with Panax ginseng, indicating a benefit.",200 mg single dose (dried ethanolic extract),,,cognitive performance,alzheimer disease; cerebroelectrical activity; cognitive performance; mood enhancement,,,
Panax ginseng,"Monitor patients taking CYP3A substrates with narrow therapeutic ranges closely.; abolished the increase in muscle mass; change in urine appearance; concomitant ingestion with prescription medications should be discouraged; gastric discomfort; gastrointestinal disorders; headache; hot flashes; insomnia; mild adverse events such as dyspepsia, hot flash, insomnia, and constipation; palpitation; possible drug interactions with warfarin, phenelzine, and alcohol; sleep disorders",Erectile Dysfunction,,Men's Health,manual_pair,"One randomized trial reported that Panax ginseng (1000 mg extract twice a day for 8 weeks) significantly improved erectile function compared to placebo, indicating a potential benefit for erectile dysfunction. However, the overall evidence is limited, with only one study available, and further research is needed to confirm these findings and assess long-term safety and efficacy.",0.7,19234482,2009,Effects of tissue-cultured mountain ginseng (Panax ginseng CA Meyer) extract on male patients with erectile dysfunction.,randomized_controlled_trial,benefit,"The TMGE group showed significant improvement in erectile function compared to the placebo group, indicating a beneficial effect.",1000 mg twice a day 8 weeks (extract),,,erectile dysfunction,erectile dysfunction,,,
Panax ginseng,"Monitor patients taking CYP3A substrates with narrow therapeutic ranges closely.; abolished the increase in muscle mass; change in urine appearance; concomitant ingestion with prescription medications should be discouraged; gastric discomfort; gastrointestinal disorders; headache; hot flashes; insomnia; mild adverse events such as dyspepsia, hot flash, insomnia, and constipation; palpitation; possible drug interactions with warfarin, phenelzine, and alcohol; sleep disorders",Hypertension,,Heart & Vascular Health,manual_pair,"Current evidence from two randomized controlled trials suggests that Panax ginseng may have a beneficial effect on blood pressure, with one study reporting a reduction in central systolic blood pressure at a dose of 2.25 g three times daily over 12 weeks, and another showing significant reductions in blood pressure parameters with a single dose of 400 mg. However, the overall evidence is limited and further research is needed to confirm these findings and establish consistent dosing guidelines.",0.7,32147072,2020,Vascular effects of combined enriched Korean Red ginseng (Panax Ginseng) and American ginseng (Panax Quinquefolius) administration in individuals with hypertension and type 2 diabetes: A randomized controlled trial.,randomized_controlled_trial,benefit,"The study showed a reduction in central systolic blood pressure, indicating a benefit from the intervention.",2.25 g 3 times daily 12 weeks (ginsenoside Rg3-enriched KRG&AG),Diabetes Type 2,,hypertension,Type 2 Diabetes Mellitus; hypertension; vascular stiffness,,,
Panax ginseng,"Monitor patients taking CYP3A substrates with narrow therapeutic ranges closely.; abolished the increase in muscle mass; change in urine appearance; concomitant ingestion with prescription medications should be discouraged; gastric discomfort; gastrointestinal disorders; headache; hot flashes; insomnia; mild adverse events such as dyspepsia, hot flash, insomnia, and constipation; palpitation; possible drug interactions with warfarin, phenelzine, and alcohol; sleep disorders",Hypertension,,Heart & Vascular Health,manual_pair,"Current evidence from two randomized controlled trials suggests that Panax ginseng may have a beneficial effect on blood pressure, with one study reporting a reduction in central systolic blood pressure at a dose of 2.25 g three times daily over 12 weeks, and another showing significant reductions in blood pressure parameters with a single dose of 400 mg. However, the overall evidence is limited and further research is needed to confirm these findings and establish consistent dosing guidelines.",0.7,24997863,2014,Effect of Rg3-enriched Korean red ginseng (Panax ginseng) on arterial stiffness and blood pressure in healthy individuals: a randomized controlled trial.,randomized_controlled_trial,benefit,"The study found significant reductions in various blood pressure parameters, indicating a beneficial effect of the supplement.",400 mg single dose acute (extract),,,hypertension,Type 2 Diabetes Mellitus; hypertension; vascular stiffness,,,
Panax ginseng,"Monitor patients taking CYP3A substrates with narrow therapeutic ranges closely.; abolished the increase in muscle mass; change in urine appearance; concomitant ingestion with prescription medications should be discouraged; gastric discomfort; gastrointestinal disorders; headache; hot flashes; insomnia; mild adverse events such as dyspepsia, hot flash, insomnia, and constipation; palpitation; possible drug interactions with warfarin, phenelzine, and alcohol; sleep disorders",High Blood Glucose,,Metabolic Health,manual_pair,"The evidence for Panax ginseng in lowering high blood sugar is mixed but leans towards benefit, with four studies reporting positive effects on glycemic control, particularly with doses of 200 mg to 3 g. However, one study showed variable effects, indicating that responses may differ among individuals. No adverse effects were reported in the reviewed studies.",0.8,14684758,2003,Null and opposing effects of Asian ginseng (Panax ginseng C.A. Meyer) on acute glycemia: results of two acute dose escalation studies.,randomized_controlled_trial,mixed_unclear,"The study found both null and opposing effects on glycemia, indicating variability in ginseng's effects.",1 g single dose (Asian ginseng); 2 g single dose (Asian ginseng); 3 g single dose (Asian ginseng); 3 g single dose (Asian ginseng); 6 g single dose (Asian ginseng); 9 g single dose (Asian ginseng),,,acute glycemia,acute glycemia; blood glucose levels; blood glucose regulation; cognitive performance; glycaemic control; insulin levels; mental fatigue; postprandial glycemia; postprandial plasma glucose,,,
Panax ginseng,"Monitor patients taking CYP3A substrates with narrow therapeutic ranges closely.; abolished the increase in muscle mass; change in urine appearance; concomitant ingestion with prescription medications should be discouraged; gastric discomfort; gastrointestinal disorders; headache; hot flashes; insomnia; mild adverse events such as dyspepsia, hot flash, insomnia, and constipation; palpitation; possible drug interactions with warfarin, phenelzine, and alcohol; sleep disorders",High Blood Glucose,,Metabolic Health,manual_pair,"The evidence for Panax ginseng in lowering high blood sugar is mixed but leans towards benefit, with four studies reporting positive effects on glycemic control, particularly with doses of 200 mg to 3 g. However, one study showed variable effects, indicating that responses may differ among individuals. No adverse effects were reported in the reviewed studies.",0.8,21619921,2011,Korean red ginseng (Panax ginseng C.A. Meyer) root fractions: differential effects on postprandial glycemia in healthy individuals.,randomized_controlled_trial,benefit,"The KRG-body significantly lowered postprandial glucose levels, indicating a beneficial effect.",3 g once (root fractions),,,blood glucose levels,acute glycemia; blood glucose levels; blood glucose regulation; cognitive performance; glycaemic control; insulin levels; mental fatigue; postprandial glycemia; postprandial plasma glucose,,,
Panax ginseng,"Monitor patients taking CYP3A substrates with narrow therapeutic ranges closely.; abolished the increase in muscle mass; change in urine appearance; concomitant ingestion with prescription medications should be discouraged; gastric discomfort; gastrointestinal disorders; headache; hot flashes; insomnia; mild adverse events such as dyspepsia, hot flash, insomnia, and constipation; palpitation; possible drug interactions with warfarin, phenelzine, and alcohol; sleep disorders",High Blood Glucose,,Metabolic Health,manual_pair,"The evidence for Panax ginseng in lowering high blood sugar is mixed but leans towards benefit, with four studies reporting positive effects on glycemic control, particularly with doses of 200 mg to 3 g. However, one study showed variable effects, indicating that responses may differ among individuals. No adverse effects were reported in the reviewed studies.",0.8,16401645,2006,"Effects of Panax ginseng, consumed with and without glucose, on blood glucose levels and cognitive performance during sustained 'mentally demanding' tasks.",randomized_controlled_trial,benefit,"The study shows that Panax ginseng enhances cognitive performance and reduces blood glucose levels, indicating a beneficial effect.",200 mg single dose (capsules),,Cognitive & Neurological Function,blood glucose levels,acute glycemia; blood glucose levels; blood glucose regulation; cognitive performance; glycaemic control; insulin levels; mental fatigue; postprandial glycemia; postprandial plasma glucose,,,
Panax ginseng,"Monitor patients taking CYP3A substrates with narrow therapeutic ranges closely.; abolished the increase in muscle mass; change in urine appearance; concomitant ingestion with prescription medications should be discouraged; gastric discomfort; gastrointestinal disorders; headache; hot flashes; insomnia; mild adverse events such as dyspepsia, hot flash, insomnia, and constipation; palpitation; possible drug interactions with warfarin, phenelzine, and alcohol; sleep disorders",High Blood Glucose,,Metabolic Health,manual_pair,"The evidence for Panax ginseng in lowering high blood sugar is mixed but leans towards benefit, with four studies reporting positive effects on glycemic control, particularly with doses of 200 mg to 3 g. However, one study showed variable effects, indicating that responses may differ among individuals. No adverse effects were reported in the reviewed studies.",0.8,15982990,2005,Single doses of Panax ginseng (G115) reduce blood glucose levels and improve cognitive performance during sustained mental activity.,randomized_controlled_trial,benefit,"The study shows significant improvements in cognitive performance and reductions in blood glucose levels, indicating a beneficial effect of Panax ginseng.",200 mg single dose (G115); 400 mg single dose (G115),,,blood glucose levels,acute glycemia; blood glucose levels; blood glucose regulation; cognitive performance; glycaemic control; insulin levels; mental fatigue; postprandial glycemia; postprandial plasma glucose,,,
Panax ginseng,"Monitor patients taking CYP3A substrates with narrow therapeutic ranges closely.; abolished the increase in muscle mass; change in urine appearance; concomitant ingestion with prescription medications should be discouraged; gastric discomfort; gastrointestinal disorders; headache; hot flashes; insomnia; mild adverse events such as dyspepsia, hot flash, insomnia, and constipation; palpitation; possible drug interactions with warfarin, phenelzine, and alcohol; sleep disorders",High Blood Glucose,,Metabolic Health,manual_pair,"The evidence for Panax ginseng in lowering high blood sugar is mixed but leans towards benefit, with four studies reporting positive effects on glycemic control, particularly with doses of 200 mg to 3 g. However, one study showed variable effects, indicating that responses may differ among individuals. No adverse effects were reported in the reviewed studies.",0.8,17010221,2006,The glycaemic effects of single doses of Panax ginseng in young healthy volunteers.,clinical_trial,benefit,"The study shows that Panax ginseng significantly lowers fasting blood glucose levels, indicating a beneficial effect on glycaemic control.",200 mg single dose (G115); 400 mg single dose (G115),,,blood glucose regulation,acute glycemia; blood glucose levels; blood glucose regulation; cognitive performance; glycaemic control; insulin levels; mental fatigue; postprandial glycemia; postprandial plasma glucose,,,
Panax ginseng,"Monitor patients taking CYP3A substrates with narrow therapeutic ranges closely.; abolished the increase in muscle mass; change in urine appearance; concomitant ingestion with prescription medications should be discouraged; gastric discomfort; gastrointestinal disorders; headache; hot flashes; insomnia; mild adverse events such as dyspepsia, hot flash, insomnia, and constipation; palpitation; possible drug interactions with warfarin, phenelzine, and alcohol; sleep disorders",High Blood Glucose,,Metabolic Health,manual_pair,"One randomized, double-blinded, placebo-controlled trial reported that Panax ginseng saponins improved glucose metabolism and insulin resistance in patients with prediabetes over a 4-week period. No studies reported mixed results or adverse effects, but the overall evidence remains limited and should be interpreted with caution due to the small number of trials available.",0.7,39004031,2024,"Effects of ginseng berry saponins from panax ginseng on glucose metabolism of patients with prediabetes: A randomized, double-blinded, placebo-controlled, crossover trial.",randomized_controlled_trial,benefit,The study demonstrated significant benefits in glucose metabolism and insulin resistance in prediabetic patients using Panax ginseng saponins.,4 weeks (Zhenyuan Capsule),,Heart & Vascular Health,prediabetes,prediabetes,,,
Panax ginseng,"Monitor patients taking CYP3A substrates with narrow therapeutic ranges closely.; abolished the increase in muscle mass; change in urine appearance; concomitant ingestion with prescription medications should be discouraged; gastric discomfort; gastrointestinal disorders; headache; hot flashes; insomnia; mild adverse events such as dyspepsia, hot flash, insomnia, and constipation; palpitation; possible drug interactions with warfarin, phenelzine, and alcohol; sleep disorders",High Insulin,,Metabolic Health,manual_pair,"The evidence regarding Panax ginseng for high blood sugar in Type 2 Diabetes is mixed. One study reported a benefit in insulin sensitivity with a single dose of 3 g, while two other studies showed unclear results regarding glucose regulation, with doses of 6 g daily for 12 weeks and no reported adverse effects. Overall, the findings do not consistently support a clear benefit for glucose control.",0.7,25446600,2015,Ethanol extraction preparation of American ginseng (Panax quinquefolius L) and Korean red ginseng (Panax ginseng C.A. Meyer): differential effects on postprandial insulinemia in healthy individuals.,randomized_controlled_trial,benefit,"The study found increased insulin sensitivity with specific ginseng extracts, indicating a beneficial effect on insulin parameters.",3 g once single dose (ethanol extracts and whole root),,,insulin sensitivity,Type 2 Diabetes Mellitus; glucose tolerance; insulin sensitivity; oxidative stress; postprandial glycemia,,,
Panax ginseng,"Monitor patients taking CYP3A substrates with narrow therapeutic ranges closely.; abolished the increase in muscle mass; change in urine appearance; concomitant ingestion with prescription medications should be discouraged; gastric discomfort; gastrointestinal disorders; headache; hot flashes; insomnia; mild adverse events such as dyspepsia, hot flash, insomnia, and constipation; palpitation; possible drug interactions with warfarin, phenelzine, and alcohol; sleep disorders",High Insulin,,Metabolic Health,manual_pair,"The evidence regarding Panax ginseng for high blood sugar in Type 2 Diabetes is mixed. One study reported a benefit in insulin sensitivity with a single dose of 3 g, while two other studies showed unclear results regarding glucose regulation, with doses of 6 g daily for 12 weeks and no reported adverse effects. Overall, the findings do not consistently support a clear benefit for glucose control.",0.7,16860976,2008,"Korean red ginseng (Panax ginseng) improves glucose and insulin regulation in well-controlled, type 2 diabetes: results of a randomized, double-blind, placebo-controlled study of efficacy and safety.",randomized_controlled_trial,mixed_unclear,"While HbA1c did not change, other glucose and insulin regulation measures improved, indicating mixed outcomes.",6 g daily 12 weeks (rootlets),Diabetes Type 2,,Type 2 Diabetes Mellitus,Type 2 Diabetes Mellitus; glucose tolerance; insulin sensitivity; oxidative stress; postprandial glycemia,,,
Panax ginseng,"Monitor patients taking CYP3A substrates with narrow therapeutic ranges closely.; abolished the increase in muscle mass; change in urine appearance; concomitant ingestion with prescription medications should be discouraged; gastric discomfort; gastrointestinal disorders; headache; hot flashes; insomnia; mild adverse events such as dyspepsia, hot flash, insomnia, and constipation; palpitation; possible drug interactions with warfarin, phenelzine, and alcohol; sleep disorders",High LDL,,Heart & Vascular Health,manual_pair,"There is limited evidence suggesting that Panax ginseng may have a beneficial effect on lipid metabolism, specifically in reducing total cholesterol, triglycerides, and LDL, while increasing HDL, based on a single study using a dose of 6 g per day for 8 weeks. However, due to the low number of studies and the absence of corroborating evidence, the overall confidence in this effect is low.",0.2,12967598,2003,Effects of Panax ginseng extract on lipid metabolism in humans.,clinical_trial,benefit,"The study reports a decrease in total cholesterol, triglycerides, and LDL, and an increase in HDL, indicating a beneficial effect on lipid metabolism.",6 g per day 8 weeks (extract),,,cholesterol levels,cholesterol levels; lipid metabolism,,,
Panax ginseng,"Monitor patients taking CYP3A substrates with narrow therapeutic ranges closely.; abolished the increase in muscle mass; change in urine appearance; concomitant ingestion with prescription medications should be discouraged; gastric discomfort; gastrointestinal disorders; headache; hot flashes; insomnia; mild adverse events such as dyspepsia, hot flash, insomnia, and constipation; palpitation; possible drug interactions with warfarin, phenelzine, and alcohol; sleep disorders",Exercise Performance,,Performance & Recovery,manual_pair,"The evidence from four studies suggests that Panax ginseng may improve low exercise performance by enhancing muscle recruitment, reducing perceived effort, and improving endurance. Reported doses include 500 mg daily for 14 days, 200 mg as a single acute dose, and 2 g three times daily for 8 weeks. However, the overall quality of the evidence is mixed, and further research is needed to confirm these findings and assess long-term effects.",0.7,38785940,2024,Short-Term Panax Ginseng Extract Supplementation Reduces Fasting Blood Triacylglycerides and Oxygen Consumption during Sub-Maximal Aerobic Exercise in Male Recreational Athletes.,randomized_controlled_trial,benefit,"The study showed benefits in blood lipid profile and energy consumption during exercise, indicating a positive effect of Panax ginseng supplementation.",500 mg daily 14 days (extract),,Heart & Vascular Health,aerobic capacity,aerobic capacity; delayed-onset muscle soreness (doms); endurance performance; exercise capacity; exercise performance; exercise-induced oxidative stress; lipid profile; metabolic health; muscle excitation; muscle force recovery; perceived effort; recovery from exhaustive exercise,,,
Panax ginseng,"Monitor patients taking CYP3A substrates with narrow therapeutic ranges closely.; abolished the increase in muscle mass; change in urine appearance; concomitant ingestion with prescription medications should be discouraged; gastric discomfort; gastrointestinal disorders; headache; hot flashes; insomnia; mild adverse events such as dyspepsia, hot flash, insomnia, and constipation; palpitation; possible drug interactions with warfarin, phenelzine, and alcohol; sleep disorders",Exercise Performance,,Performance & Recovery,manual_pair,"The evidence from four studies suggests that Panax ginseng may improve low exercise performance by enhancing muscle recruitment, reducing perceived effort, and improving endurance. Reported doses include 500 mg daily for 14 days, 200 mg as a single acute dose, and 2 g three times daily for 8 weeks. However, the overall quality of the evidence is mixed, and further research is needed to confirm these findings and assess long-term effects.",0.7,32379240,2022,"Panax ginseng Supplementation Increases Muscle Recruitment, Attenuates Perceived Effort, and Accelerates Muscle Force Recovery After an Eccentric-Based Exercise in Athletes.",randomized_controlled_trial,benefit,"The study shows that Panax ginseng improves muscle recruitment and recovery, indicating a beneficial effect on muscle performance in athletes.",null null null 8 (null),,,delayed-onset muscle soreness (doms),aerobic capacity; delayed-onset muscle soreness (doms); endurance performance; exercise capacity; exercise performance; exercise-induced oxidative stress; lipid profile; metabolic health; muscle excitation; muscle force recovery; perceived effort; recovery from exhaustive exercise,,,
Panax ginseng,"Monitor patients taking CYP3A substrates with narrow therapeutic ranges closely.; abolished the increase in muscle mass; change in urine appearance; concomitant ingestion with prescription medications should be discouraged; gastric discomfort; gastrointestinal disorders; headache; hot flashes; insomnia; mild adverse events such as dyspepsia, hot flash, insomnia, and constipation; palpitation; possible drug interactions with warfarin, phenelzine, and alcohol; sleep disorders",Exercise Performance,,Performance & Recovery,manual_pair,"The evidence from four studies suggests that Panax ginseng may improve low exercise performance by enhancing muscle recruitment, reducing perceived effort, and improving endurance. Reported doses include 500 mg daily for 14 days, 200 mg as a single acute dose, and 2 g three times daily for 8 weeks. However, the overall quality of the evidence is mixed, and further research is needed to confirm these findings and assess long-term effects.",0.7,25665208,2011,Effects of acute supplementation of caffeine and Panax ginseng on endurance running performance in a hot and humid environment.,randomized_controlled_trial,benefit,The study found a significant improvement in endurance performance with the supplementation of Panax ginseng combined with caffeine.,200 mg single dose acute,Running,,endurance performance,aerobic capacity; delayed-onset muscle soreness (doms); endurance performance; exercise capacity; exercise performance; exercise-induced oxidative stress; lipid profile; metabolic health; muscle excitation; muscle force recovery; perceived effort; recovery from exhaustive exercise,,,
Panax ginseng,"Monitor patients taking CYP3A substrates with narrow therapeutic ranges closely.; abolished the increase in muscle mass; change in urine appearance; concomitant ingestion with prescription medications should be discouraged; gastric discomfort; gastrointestinal disorders; headache; hot flashes; insomnia; mild adverse events such as dyspepsia, hot flash, insomnia, and constipation; palpitation; possible drug interactions with warfarin, phenelzine, and alcohol; sleep disorders",Exercise Performance,,Performance & Recovery,manual_pair,"The evidence from four studies suggests that Panax ginseng may improve low exercise performance by enhancing muscle recruitment, reducing perceived effort, and improving endurance. Reported doses include 500 mg daily for 14 days, 200 mg as a single acute dose, and 2 g three times daily for 8 weeks. However, the overall quality of the evidence is mixed, and further research is needed to confirm these findings and assess long-term effects.",0.7,16355078,2005,Effects of Panax ginseng extract on exercise-induced oxidative stress.,clinical_trial,benefit,"The study shows that Panax ginseng extract improves exercise duration and reduces oxidative stress markers, indicating a beneficial effect.",2 g 3 times a day 8 weeks (extract),,,exercise-induced oxidative stress,aerobic capacity; delayed-onset muscle soreness (doms); endurance performance; exercise capacity; exercise performance; exercise-induced oxidative stress; lipid profile; metabolic health; muscle excitation; muscle force recovery; perceived effort; recovery from exhaustive exercise,,,
Panax ginseng,"Monitor patients taking CYP3A substrates with narrow therapeutic ranges closely.; abolished the increase in muscle mass; change in urine appearance; concomitant ingestion with prescription medications should be discouraged; gastric discomfort; gastrointestinal disorders; headache; hot flashes; insomnia; mild adverse events such as dyspepsia, hot flash, insomnia, and constipation; palpitation; possible drug interactions with warfarin, phenelzine, and alcohol; sleep disorders",Low Testosterone,,Men's Health,manual_pair,"Current evidence on Panax ginseng for low testosterone levels is limited, with only one study reporting a significant increase in testosterone levels following ingestion of fermented Panax ginseng. No adverse effects were noted, but the overall quality of evidence is low due to the limited number of studies available.",0.5,30543483,2019,Pharmacokinetic Study of Compound K in Japanese Subjects After Ingestion of Panax ginseng Fermented by Lactobacillus paracasei A221 Reveals Significant Increase of Absorption into Blood.,randomized_controlled_trial,benefit,"The study demonstrated a significant increase in testosterone levels and absorption of Compound K, indicating a beneficial effect of fermented Panax ginseng.",single (tablets),,,health maintenance,health maintenance; testosterone level restoration,,,
Panax ginseng,"Monitor patients taking CYP3A substrates with narrow therapeutic ranges closely.; abolished the increase in muscle mass; change in urine appearance; concomitant ingestion with prescription medications should be discouraged; gastric discomfort; gastrointestinal disorders; headache; hot flashes; insomnia; mild adverse events such as dyspepsia, hot flash, insomnia, and constipation; palpitation; possible drug interactions with warfarin, phenelzine, and alcohol; sleep disorders",Cognitive Performance,,Cognitive & Neurological Function,manual_pair,"The evidence for Panax ginseng in improving memory problems is mixed. Two studies reported benefits, with one using a dose of 450 mg daily for 12 weeks and another using 100 mg twice daily for 14 weeks. However, a third study indicated mixed outcomes, showing dose-dependent effects that included both improvements and decrements in cognitive performance, suggesting variability in response. No adverse effects were reported in the studies reviewed.",0.8,11842916,2001,"Differential, dose dependent changes in cognitive performance following acute administration of a Ginkgo biloba/Panax ginseng combination to healthy young volunteers.",randomized_controlled_trial,mixed_unclear,"The study showed a dose-dependent improvement in memory quality at the highest dose, but also a decrement in attention speed at lower doses, indicating mixed outcomes.",320 mg single dose (combination with Ginkgo biloba); 640 mg single dose (combination with Ginkgo biloba); 960 mg single dose (combination with Ginkgo biloba),,,attention,attention; cognitive function; cognitive performance; memory; memory enhancement; subjective memory impairment,,,
Panax ginseng,"Monitor patients taking CYP3A substrates with narrow therapeutic ranges closely.; abolished the increase in muscle mass; change in urine appearance; concomitant ingestion with prescription medications should be discouraged; gastric discomfort; gastrointestinal disorders; headache; hot flashes; insomnia; mild adverse events such as dyspepsia, hot flash, insomnia, and constipation; palpitation; possible drug interactions with warfarin, phenelzine, and alcohol; sleep disorders",Cognitive Performance,,Cognitive & Neurological Function,manual_pair,"The evidence for Panax ginseng in improving memory problems is mixed. Two studies reported benefits, with one using a dose of 450 mg daily for 12 weeks and another using 100 mg twice daily for 14 weeks. However, a third study indicated mixed outcomes, showing dose-dependent effects that included both improvements and decrements in cognitive performance, suggesting variability in response. No adverse effects were reported in the studies reviewed.",0.8,11140327,2000,The memory enhancing effects of a Ginkgo biloba/Panax ginseng combination in healthy middle-aged volunteers.,randomized_controlled_trial,benefit,"The study demonstrated a significant improvement in memory quality, indicating a beneficial effect of the supplement.",100 mg b.i.d. 14 weeks (standardised extract),,,cognitive function,attention; cognitive function; cognitive performance; memory; memory enhancement; subjective memory impairment,,,
Panax ginseng,"Monitor patients taking CYP3A substrates with narrow therapeutic ranges closely.; abolished the increase in muscle mass; change in urine appearance; concomitant ingestion with prescription medications should be discouraged; gastric discomfort; gastrointestinal disorders; headache; hot flashes; insomnia; mild adverse events such as dyspepsia, hot flash, insomnia, and constipation; palpitation; possible drug interactions with warfarin, phenelzine, and alcohol; sleep disorders",Cognitive Performance,,Cognitive & Neurological Function,manual_pair,"The evidence for Panax ginseng in improving memory problems is mixed. Two studies reported benefits, with one using a dose of 450 mg daily for 12 weeks and another using 100 mg twice daily for 14 weeks. However, a third study indicated mixed outcomes, showing dose-dependent effects that included both improvements and decrements in cognitive performance, suggesting variability in response. No adverse effects were reported in the studies reviewed.",0.8,38931306,2024,"Efficacy and Safety of Panax ginseng Sprout Extract in Subjective Memory Impairment: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.",randomized_controlled_trial,benefit,"The study demonstrated significant improvements in memory-related assessments, indicating a benefit from the intervention.",450 mg day 12 weeks (ThinkGIN™),,,subjective memory impairment,attention; cognitive function; cognitive performance; memory; memory enhancement; subjective memory impairment,,,
Panax ginseng,"Monitor patients taking CYP3A substrates with narrow therapeutic ranges closely.; abolished the increase in muscle mass; change in urine appearance; concomitant ingestion with prescription medications should be discouraged; gastric discomfort; gastrointestinal disorders; headache; hot flashes; insomnia; mild adverse events such as dyspepsia, hot flash, insomnia, and constipation; palpitation; possible drug interactions with warfarin, phenelzine, and alcohol; sleep disorders",Exercise Recovery,,Performance & Recovery,manual_pair,"One randomized trial reported that Panax ginseng supplementation (20 g of Korean red ginseng extract three times daily for 11 days) significantly reduced muscle damage and inflammatory markers after exercise, indicating a potential benefit for muscle soreness. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term effects and safety.",0.7,21598413,2011,Effects of Panax ginseng supplementation on muscle damage and inflammation after uphill treadmill running in humans.,randomized_controlled_trial,benefit,"The study found significant reductions in muscle damage and inflammatory markers, indicating a beneficial effect of Panax ginseng supplementation.",20 g 3 times/day 11 days (Korean red ginseng extract),,Metabolic Health,inflammation,inflammation; insulin sensitivity; muscle damage,,,
Panax ginseng,"Monitor patients taking CYP3A substrates with narrow therapeutic ranges closely.; abolished the increase in muscle mass; change in urine appearance; concomitant ingestion with prescription medications should be discouraged; gastric discomfort; gastrointestinal disorders; headache; hot flashes; insomnia; mild adverse events such as dyspepsia, hot flash, insomnia, and constipation; palpitation; possible drug interactions with warfarin, phenelzine, and alcohol; sleep disorders",Endothelial Function,,Heart & Vascular Health,manual_pair,"One randomized controlled trial found that a single dose of 3 g of Korean red ginseng (Panax ginseng) significantly improved endothelial function in healthy individuals. Overall, the evidence is limited to this single study, and further research is needed to confirm these findings and assess long-term effects and safety.",0.7,24758417,2014,Modulation of endothelial function by Korean red ginseng (Panax ginseng C.A. Meyer) and its components in healthy individuals: a randomized controlled trial.,randomized_controlled_trial,benefit,"The study found that KRG significantly improved endothelial function, indicating a beneficial effect.",3 g single dose acute (KRG root),,,cardiovascular health,cardiovascular health; endothelial dysfunction,,,
Panax ginseng,"Monitor patients taking CYP3A substrates with narrow therapeutic ranges closely.; abolished the increase in muscle mass; change in urine appearance; concomitant ingestion with prescription medications should be discouraged; gastric discomfort; gastrointestinal disorders; headache; hot flashes; insomnia; mild adverse events such as dyspepsia, hot flash, insomnia, and constipation; palpitation; possible drug interactions with warfarin, phenelzine, and alcohol; sleep disorders",Improve Social Functioning,,"Energy, Mood, & Mental Health",manual_pair,"There is limited evidence suggesting that Panax ginseng may have a beneficial effect on mental health, specifically in improving quality of life and social functioning, as indicated by one study using a dose of 200 mg daily for 8 weeks. However, the effects were not sustained beyond 4 weeks, indicating uncertainty about long-term benefits. No adverse effects were reported in the studies reviewed.",0.7,11895046,2002,Effects of Panax ginseng on quality of life.,randomized_controlled_trial,benefit,"The study shows a benefit in mental health and social functioning after 4 weeks, although effects did not persist at 8 weeks.",200 mg daily 8 weeks,,,health-related quality of life,health-related quality of life; mental health; social functioning,,,
Panax ginseng,"Monitor patients taking CYP3A substrates with narrow therapeutic ranges closely.; abolished the increase in muscle mass; change in urine appearance; concomitant ingestion with prescription medications should be discouraged; gastric discomfort; gastrointestinal disorders; headache; hot flashes; insomnia; mild adverse events such as dyspepsia, hot flash, insomnia, and constipation; palpitation; possible drug interactions with warfarin, phenelzine, and alcohol; sleep disorders",Improve Sexual Function,,Women's Health,manual_pair,"The evidence for Panax ginseng in treating sexual dysfunction is limited and classified as low quality. One randomized controlled trial reported mixed results, indicating potential benefits in reducing sexual complaints but no significant overall improvement in menopausal symptoms. The typical dose reported was 3 g per day for 12 weeks, but further research is needed to clarify its efficacy and safety.",0.8,33216632,2021,"Effects of Korean Red Ginseng (Panax ginseng C.A. Meyer) on Menopausal Symptoms in Premenopausal Women After Gynecologic Cancer Surgery: A Double-Blind, Randomized Controlled Trial.",randomized_controlled_trial,mixed_unclear,"The study showed no significant difference in overall menopausal symptom relief between KRG and placebo, but indicated potential benefit in reducing sexual complaints.",3 g per day 12 weeks,,,menopausal symptoms,menopausal symptoms; sexual complaints; surgical menopause symptoms,,,
Panax ginseng,"Monitor patients taking CYP3A substrates with narrow therapeutic ranges closely.; abolished the increase in muscle mass; change in urine appearance; concomitant ingestion with prescription medications should be discouraged; gastric discomfort; gastrointestinal disorders; headache; hot flashes; insomnia; mild adverse events such as dyspepsia, hot flash, insomnia, and constipation; palpitation; possible drug interactions with warfarin, phenelzine, and alcohol; sleep disorders",Cognitive Performance,,Cognitive & Neurological Function,manual_pair,"One randomized, double-blind, placebo-controlled study found that 200 mg of hydroponically grown Red Panax Ginseng daily for three weeks significantly reduced perceived stress and improved emotional and cognitive functions in moderately stressed adults. However, the overall evidence is limited, with only one study demonstrating benefit and no reports of harm or mixed outcomes.",0.7,40289951,2025,"Effect of Hydroponically Grown Red Panax Ginseng on Perceived Stress Level, Emotional Processing, and Cognitive Functions in Moderately Stressed Adults: A Randomized, Double-Blind, Placebo-Controlled Study.",randomized_controlled_trial,benefit,The study demonstrated significant benefits in reducing perceived stress and improving emotional and cognitive functions in the Ginseng group compared to placebo.,200 mg daily 3 weeks (root powder),,,chronic stress,chronic stress; cognitive functions; emotional processing,,,
Panax ginseng,"Monitor patients taking CYP3A substrates with narrow therapeutic ranges closely.; abolished the increase in muscle mass; change in urine appearance; concomitant ingestion with prescription medications should be discouraged; gastric discomfort; gastrointestinal disorders; headache; hot flashes; insomnia; mild adverse events such as dyspepsia, hot flash, insomnia, and constipation; palpitation; possible drug interactions with warfarin, phenelzine, and alcohol; sleep disorders",Working Memory Performance,,Cognitive & Neurological Function,manual_pair,"One randomized trial reported that Panax ginseng (G115) at doses of 200 mg and 400 mg daily for 7 days improved aspects of subjective mood and cognitive performance in healthy young adults. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term effects and safety.",0.7,20737519,2010,Panax ginseng (G115) improves aspects of working memory performance and subjective ratings of calmness in healthy young adults.,randomized_controlled_trial,benefit,"The study found dose-related benefits in mood and cognitive performance, indicating a positive outcome direction.",200 mg daily 7 days; 400 mg daily 7 days,,,subjective mood,subjective mood,,,
Panax ginseng,"Monitor patients taking CYP3A substrates with narrow therapeutic ranges closely.; abolished the increase in muscle mass; change in urine appearance; concomitant ingestion with prescription medications should be discouraged; gastric discomfort; gastrointestinal disorders; headache; hot flashes; insomnia; mild adverse events such as dyspepsia, hot flash, insomnia, and constipation; palpitation; possible drug interactions with warfarin, phenelzine, and alcohol; sleep disorders",Genitourinary Syndrome,,Women's Health,manual_pair,"The evidence regarding Panax ginseng for vaginal dryness is limited and mixed. One randomized, double-blind, placebo-controlled trial reported subjective symptom improvement but found no significant effect on objective clinician-assessed outcomes. Overall, the quality of evidence is low, and no consistent dosing information is available.",0.7,33730722,2021,"The Effect of Panax ginseng on Genitourinary Syndrome in Postmenopausal Women: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.",randomized_controlled_trial,mixed_unclear,Ginseng improved subjective symptoms but had no significant effect on objective clinician-assessed outcomes.,null null twice daily 4 weeks (null),Menopause; Women,,atrophic vaginitis,atrophic vaginitis; genitourinary syndrome,,,
Panax ginseng,"Monitor patients taking CYP3A substrates with narrow therapeutic ranges closely.; abolished the increase in muscle mass; change in urine appearance; concomitant ingestion with prescription medications should be discouraged; gastric discomfort; gastrointestinal disorders; headache; hot flashes; insomnia; mild adverse events such as dyspepsia, hot flash, insomnia, and constipation; palpitation; possible drug interactions with warfarin, phenelzine, and alcohol; sleep disorders",Cognitive Performance,,Cognitive & Neurological Function,manual_pair,"One randomized trial indicates that Panax ginseng (G115) may improve aspects of working memory performance and subjective calmness in healthy young adults, with reported doses of 200 mg and 400 mg daily for 7 days. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term effects and safety.",0.7,20737519,2010,Panax ginseng (G115) improves aspects of working memory performance and subjective ratings of calmness in healthy young adults.,randomized_controlled_trial,benefit,"The study found dose-related benefits in mood and cognitive performance, indicating a positive outcome direction.",200 mg daily 7 days; 400 mg daily 7 days,,"Energy, Mood, & Mental Health",working memory performance,working memory performance,,,
Panax ginseng,"Monitor patients taking CYP3A substrates with narrow therapeutic ranges closely.; abolished the increase in muscle mass; change in urine appearance; concomitant ingestion with prescription medications should be discouraged; gastric discomfort; gastrointestinal disorders; headache; hot flashes; insomnia; mild adverse events such as dyspepsia, hot flash, insomnia, and constipation; palpitation; possible drug interactions with warfarin, phenelzine, and alcohol; sleep disorders",Skin Aging Prevention,,"Skin, Hair, & Nails",manual_pair,"One randomized, double-blind, placebo-controlled study reported significant benefits of enzyme-modified Panax ginseng cream in reducing eye wrinkle formation, with no adverse reactions noted. However, the evidence is limited to a single study, indicating a need for further research to confirm these findings and establish consistency.",0.7,25867599,2015,"Efficacy and Safety of Enzyme-Modified Panax ginseng for Anti-Wrinkle Therapy in Healthy Skin: A Single-Center, Randomized, Double-Blind, Placebo-Controlled Study.",randomized_controlled_trial,benefit,The study found significant benefits in reducing eye wrinkle formation without reported adverse reactions.,(cream),,,skin aging,skin aging; wrinkles,,,
Peppermint oil,adverse event rates were significantly higher with peppermint oil; heartburn; mild adverse events more common in peppermint oil groups,Gastric Motility,,Gut Health,manual_pair,"The evidence for peppermint oil in alleviating abdominal discomfort is limited and mixed, with one study indicating that it may prolong orocaecal transit time without significantly affecting gastric emptying. The typical dose reported in this study was 90 mg of oil. Overall, the findings do not support a clear benefit for this indication.",0.7,12562459,2003,Effect of peppermint oil and caraway oil on gastrointestinal motility in healthy volunteers: a pharmacodynamic study using simultaneous determination of gastric and gall-bladder emptying and orocaecal transit time.,randomized_controlled_trial,mixed_unclear,"The study shows mixed effects on gastrointestinal motility, with peppermint oil prolonging orocaecal transit time but not significantly affecting gastric emptying.",90 mg (oil),,,abdominal discomfort,abdominal discomfort; abdominal pain; gastrointestinal motility disorders,,,
Peppermint oil,adverse event rates were significantly higher with peppermint oil; heartburn; mild adverse events more common in peppermint oil groups,IBS,,Gut Health,manual_pair,"The evidence for peppermint oil in treating abdominal pain, particularly in the context of irritable bowel syndrome (IBS), is mixed but leans towards benefit. Three studies reported significant improvements in abdominal pain, while one study showed unclear results with no significant benefit in primary endpoints. Doses varied, with some studies using enteric-coated formulations at 182 mg daily or 1 capsule three times daily, but no adverse effects were reported in the reviewed studies.",0.8,34468079,2021,A trial-based economic evaluation of peppermint oil for the treatment of irritable bowel syndrome.,randomized_controlled_trial,benefit,"The study shows that peppermint oil is a cost-effective treatment for IBS, indicating a benefit in terms of effectiveness and cost-effectiveness compared to placebo.",eight weeks (small-intestinal release),,,abdominal pain,abdominal pain; diarrhea predominant ibs; discomfort; ibs severity; irritable bowel syndrome,,,
Peppermint oil,adverse event rates were significantly higher with peppermint oil; heartburn; mild adverse events more common in peppermint oil groups,IBS,,Gut Health,manual_pair,"The evidence for peppermint oil in treating abdominal pain, particularly in the context of irritable bowel syndrome (IBS), is mixed but leans towards benefit. Three studies reported significant improvements in abdominal pain, while one study showed unclear results with no significant benefit in primary endpoints. Doses varied, with some studies using enteric-coated formulations at 182 mg daily or 1 capsule three times daily, but no adverse effects were reported in the reviewed studies.",0.8,31470006,2020,"Efficacy and Safety of Peppermint Oil in a Randomized, Double-Blind Trial of Patients With Irritable Bowel Syndrome.",randomized_controlled_trial,mixed_unclear,"The study found no significant benefit in primary endpoints but some improvements in secondary outcomes, leading to a mixed outcome classification.",182 mg daily 8 weeks (small-intestinal-release and ileocolonic-release),IBS,,abdominal pain,abdominal pain; diarrhea predominant ibs; discomfort; ibs severity; irritable bowel syndrome,,,
Peppermint oil,adverse event rates were significantly higher with peppermint oil; heartburn; mild adverse events more common in peppermint oil groups,IBS,,Gut Health,manual_pair,"The evidence for peppermint oil in treating abdominal pain, particularly in the context of irritable bowel syndrome (IBS), is mixed but leans towards benefit. Three studies reported significant improvements in abdominal pain, while one study showed unclear results with no significant benefit in primary endpoints. Doses varied, with some studies using enteric-coated formulations at 182 mg daily or 1 capsule three times daily, but no adverse effects were reported in the reviewed studies.",0.8,23416804,2013,Efficacy of Peppermint oil in diarrhea predominant IBS - a double blind randomized placebo - controlled study.,randomized_controlled_trial,benefit,"The study showed significant improvement in abdominal pain with peppermint oil, indicating a benefit, although other symptoms and quality of life did not improve significantly.",null null three times daily six weeks (null),IBS,,abdominal pain,abdominal pain; diarrhea predominant ibs; discomfort; ibs severity; irritable bowel syndrome,,,
Peppermint oil,adverse event rates were significantly higher with peppermint oil; heartburn; mild adverse events more common in peppermint oil groups,IBS,,Gut Health,manual_pair,"The evidence for peppermint oil in treating abdominal pain, particularly in the context of irritable bowel syndrome (IBS), is mixed but leans towards benefit. Three studies reported significant improvements in abdominal pain, while one study showed unclear results with no significant benefit in primary endpoints. Doses varied, with some studies using enteric-coated formulations at 182 mg daily or 1 capsule three times daily, but no adverse effects were reported in the reviewed studies.",0.8,19507027,2010,"The effect of enteric-coated, delayed-release peppermint oil on irritable bowel syndrome.",randomized_controlled_trial,benefit,"The study shows significant improvement in abdominal pain and quality of life, indicating a beneficial effect of peppermint oil.","1 capsule three times daily 8 weeks (enteric-coated, delayed-release)",,,irritable bowel syndrome,abdominal pain; diarrhea predominant ibs; discomfort; ibs severity; irritable bowel syndrome,,,
Peppermint oil,adverse event rates were significantly higher with peppermint oil; heartburn; mild adverse events more common in peppermint oil groups,IBS,,Gut Health,manual_pair,"One randomized controlled trial demonstrated that peppermint oil significantly reduced symptoms of irritable bowel syndrome compared to placebo, using a dose of 2 enteric-coated capsules twice daily for 4 weeks. There is currently no evidence of harm or no benefit reported, but further studies may be needed to confirm these findings and assess long-term safety.",0.9,17420159,2007,Peppermint oil (Mintoil) in the treatment of irritable bowel syndrome: a prospective double blind placebo-controlled randomized trial.,randomized_controlled_trial,benefit,The study found a significant reduction in irritable bowel syndrome symptoms with peppermint oil compared to placebo.,2 capsules twice per day 4 weeks (enteric-coated),,,irritable bowel syndrome,irritable bowel syndrome,,,
Peppermint oil,adverse event rates were significantly higher with peppermint oil; heartburn; mild adverse events more common in peppermint oil groups,Stress,,"Energy, Mood, & Mental Health",manual_pair,"One randomized controlled trial reported a benefit of peppermint oil inhalation (5 drops for 10 minutes) in reducing anxiety levels following lumbar discectomy surgery. However, the overall evidence is limited, with only one study available, and no adverse effects were reported. Further research is needed to confirm these findings and establish broader applicability.",0.7,38072763,2024,Effects of inhalation of peppermint oil after lumbar discectomy surgery on pain and anxiety levels of patients: A randomized controlled study.,randomized_controlled_trial,benefit,"The study found statistically significant reductions in pain and anxiety levels after the intervention, indicating a benefit from peppermint oil inhalation.",5 drops once 10 minutes (inhalation),Postoperative,Musculoskeletal & Pain,anxiety,anxiety; pain,,,
Peppermint oil,adverse event rates were significantly higher with peppermint oil; heartburn; mild adverse events more common in peppermint oil groups,Gastric Motility,,Gut Health,manual_pair,"There is low-quality evidence suggesting that peppermint oil may have beneficial effects on gastroduodenal motility, as indicated by one study that reported positive outcomes with doses of 90 mg in both enteric-coated and non-enteric-coated forms. However, due to the limited number of studies and the absence of corroborating evidence, the overall confidence in these findings is low.",0.3,10641042,2000,Effects of peppermint oil and caraway oil on gastroduodenal motility.,clinical_trial,benefit,"The study shows that peppermint oil has beneficial effects on gastroduodenal motility, indicating a positive outcome direction.",90 mg (enteric-coated and non-enteric-coated preparations),,,gastroduodenal motility,gastroduodenal motility,,,
Peppermint oil,adverse event rates were significantly higher with peppermint oil; heartburn; mild adverse events more common in peppermint oil groups,Gastric Motility,,Gut Health,manual_pair,"One randomized trial demonstrated a benefit of peppermint oil (90 mg, intraduodenal application) on gastroduodenal motility in healthy volunteers, suggesting potential efficacy for indigestion. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess safety and tolerability.",0.7,12601675,2003,Effects of intraduodenal application of peppermint oil (WS(R) 1340) and caraway oil (WS(R) 1520) on gastroduodenal motility in healthy volunteers.,randomized_controlled_trial,benefit,"The study shows significant effects of peppermint oil on gastroduodenal motility, indicating a benefit for the studied condition.",90 mg (intraduodenal application),,,functional dyspepsia,functional dyspepsia; gastroduodenal motility disorders,,,
Peppermint oil,adverse event rates were significantly higher with peppermint oil; heartburn; mild adverse events more common in peppermint oil groups,IBS,,Gut Health,manual_pair,"One randomized trial has shown that peppermint oil, administered as a sustained release formulation three times daily for four weeks, significantly reduces symptoms of irritable bowel syndrome (IBS) compared to placebo. There is currently no evidence of harm or mixed outcomes associated with its use in this context. However, further studies may be needed to confirm these findings and assess long-term safety.",0.9,26319955,2016,A Novel Delivery System of Peppermint Oil Is an Effective Therapy for Irritable Bowel Syndrome Symptoms.,randomized_controlled_trial,benefit,"The study demonstrated a significant reduction in IBS symptoms with peppermint oil compared to placebo, indicating a beneficial effect.",3 times daily 4 weeks (sustained release),,,irritable bowel syndrome,irritable bowel syndrome,,,
Peppermint oil,adverse event rates were significantly higher with peppermint oil; heartburn; mild adverse events more common in peppermint oil groups,Nausea,,Gut Health,manual_pair,"There is limited evidence from a single pilot study indicating that peppermint oil may reduce nausea, vomiting, and retching in cancer patients undergoing chemotherapy, with a dose of 1 drop (aromatic mixture) three times a day for five days. However, the evidence is based on a quasi-randomized design, which may limit the reliability of the findings. No adverse effects were reported in this study.",0.6,33197662,2021,"The Effects of Peppermint Oil on Nausea, Vomiting and Retching in Cancer Patients Undergoing Chemotherapy: An Open Label Quasi-Randomized Controlled Pilot Study.",randomized_controlled_trial,benefit,"The study demonstrated a significant reduction in nausea, vomiting, and retching in cancer patients undergoing chemotherapy when peppermint oil was used, indicating a beneficial effect.",1 drop 3 times a day 5 days (aromatic mixture),Cancer; Chemotherapy,,chemotherapy-induced nausea and vomiting (cinv),chemotherapy-induced nausea and vomiting (cinv); nausea; retching; vomiting,,,
Peppermint oil,adverse event rates were significantly higher with peppermint oil; heartburn; mild adverse events more common in peppermint oil groups,Increase Satiety,,Weight & Body Composition,manual_pair,"The evidence for peppermint oil in improving poor appetite is limited and mixed, with one study indicating reduced intragastric pressure and appetite following a single dose of 182 mg, but no significant effects on nutrient tolerance or gastric sensitivity. Overall, there is no consistent evidence supporting its efficacy for this indication.",0.7,23489975,2013,Effect of acute peppermint oil administration on gastric sensorimotor function and nutrient tolerance in health.,randomized_controlled_trial,mixed_unclear,"The study shows reduced intragastric pressure and appetite after peppermint oil administration, but no significant effects on nutrient tolerance or gastric sensitivity, leading to a mixed outcome classification.",182 mg single dose (capsule),,Gut Health,gastric sensorimotor function,gastric sensorimotor function; nutrient tolerance,,,
Peppermint oil,adverse event rates were significantly higher with peppermint oil; heartburn; mild adverse events more common in peppermint oil groups,Nausea,,Gut Health,manual_pair,"One randomized trial reported that peppermint oil, administered through aromatherapy inhalation, significantly reduced postoperative nausea and vomiting after cervical surgery, suggesting a beneficial effect. However, the overall evidence is limited, with only one study available for this indication, and no adverse effects were noted. Further research is needed to confirm these findings and establish consistent dosing guidelines.",0.7,39447066,2024,Examining the Effect of Peppermint Oil on Postoperative Nausea After Cervical Surgery.,randomized_controlled_trial,benefit,"The study demonstrated a significant reduction in postoperative nausea and vomiting with peppermint oil, indicating a beneficial effect.",(aromatherapy through inhalation),Postoperative,,postoperative nausea and vomiting,postoperative nausea and vomiting,,,
Peppermint oil,adverse event rates were significantly higher with peppermint oil; heartburn; mild adverse events more common in peppermint oil groups,Gastric Motility,,Gut Health,manual_pair,"One randomized crossover study suggests that peppermint oil (0.64 ml) may enhance gastric emptying in patients with gastrointestinal disorders, indicating a potential benefit for slow gastric emptying. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess safety and efficacy in broader populations.",0.7,17653649,2007,Early effects of peppermint oil on gastric emptying: a crossover study using a continuous real-time 13C breath test (BreathID system).,randomized_controlled_trial,benefit,"The study shows that peppermint oil enhances gastric emptying, indicating a beneficial effect for patients with gastrointestinal disorders.",0.64 ml (oil),,,functional gastrointestinal disorders,functional gastrointestinal disorders,,,
Peppermint oil,adverse event rates were significantly higher with peppermint oil; heartburn; mild adverse events more common in peppermint oil groups,Dyspepsia,,Gut Health,manual_pair,"One randomized trial demonstrated that a fixed combination of peppermint oil (90 mg twice daily) and caraway oil significantly improved symptoms of functional dyspepsia, including pain intensity and sensations of pressure, heaviness, and fullness. No studies reported mixed outcomes or harm, suggesting a potential benefit for stomach discomfort, though further research may be needed to confirm these findings.",0.9,11121917,2000,Efficacy and tolerability of a fixed combination of peppermint oil and caraway oil in patients suffering from functional dyspepsia.,randomized_controlled_trial,benefit,"The study showed significant improvement in pain intensity and sensation of pressure, heaviness, and fullness, indicating a benefit from peppermint oil.",90 mg twice daily 28 days (enteric coated capsules),,,functional dyspepsia,functional dyspepsia,,,
Phosphatidylserine,grade 3 or greater adverse events in 14.3% of patients; grade III infusion reaction related to bavituximab; one pulmonary embolism at 3 mg/kg; treatment related-adverse events occurred in 45.7% of patients,ADHD,,"Energy, Mood, & Mental Health",manual_pair,"One randomized, double-blind, placebo-controlled trial reported significant improvements in ADHD symptoms and memory with a daily dose of 200 mg of soy-derived phosphatidylserine over two months. Overall evidence is limited, with only one study demonstrating benefit and no reports of harm or adverse effects. Further research is needed to confirm these findings and establish consistency.",0.7,23495677,2014,"The effect of phosphatidylserine administration on memory and symptoms of attention-deficit hyperactivity disorder: a randomised, double-blind, placebo-controlled clinical trial.",randomized_controlled_trial,benefit,"The study reports significant improvements in ADHD symptoms and memory, indicating a beneficial effect of phosphatidylserine supplementation.",200 mg day(-1) 2 months (soy-derived phosphatidylserine),,,attention-deficit hyperactivity disorder,attention-deficit hyperactivity disorder; short-term auditory memory,,,
Phosphatidylserine,grade 3 or greater adverse events in 14.3% of patients; grade III infusion reaction related to bavituximab; one pulmonary embolism at 3 mg/kg; treatment related-adverse events occurred in 45.7% of patients,Stress,,"Energy, Mood, & Mental Health",manual_pair,"The evidence for phosphatidylserine in managing chronic stress is limited and mixed. One randomized, placebo-controlled study reported a benefit with a soy-based phosphatidylserine complex at a dose of 400 mg daily for 42 days, while another study showed unclear results regarding its effectiveness in high chronic stress individuals. Overall, the findings do not provide strong support for its use in this indication.",0.7,25081826,2014,"A soy-based phosphatidylserine/ phosphatidic acid complex (PAS) normalizes the stress reactivity of hypothalamus-pituitary-adrenal-axis in chronically stressed male subjects: a randomized, placebo-controlled study.",randomized_controlled_trial,benefit,"The study found that PAS 400 effectively normalized the stress response in chronically stressed subjects, indicating a beneficial outcome.",400 mg daily 42 days (oral),,,chronic stress,chronic stress; stress reactivity,,,
Phosphatidylserine,grade 3 or greater adverse events in 14.3% of patients; grade III infusion reaction related to bavituximab; one pulmonary embolism at 3 mg/kg; treatment related-adverse events occurred in 45.7% of patients,Stress,,"Energy, Mood, & Mental Health",manual_pair,"The evidence for phosphatidylserine in managing chronic stress is limited and mixed. One randomized, placebo-controlled study reported a benefit with a soy-based phosphatidylserine complex at a dose of 400 mg daily for 42 days, while another study showed unclear results regarding its effectiveness in high chronic stress individuals. Overall, the findings do not provide strong support for its use in this indication.",0.7,22575036,2012,Omega-3 fatty acids administered in phosphatidylserine improved certain aspects of high chronic stress in men.,randomized_controlled_trial,mixed_unclear,"The study found no significant main effect on stress measures, but some benefit for high chronically stressed individuals, indicating mixed outcomes.",12 weeks (omega-3 phosphatidylserine),,,chronic stress,chronic stress; stress reactivity,,,
Phosphatidylserine,grade 3 or greater adverse events in 14.3% of patients; grade III infusion reaction related to bavituximab; one pulmonary embolism at 3 mg/kg; treatment related-adverse events occurred in 45.7% of patients,Calmness,,"Energy, Mood, & Mental Health",manual_pair,"Phosphatidylserine has shown beneficial effects on cognitive function in two randomized trials. One study reported improvements in cognitive performance with a single dose of 120 mg complexed with Ginkgo biloba extract, while another study found significant cognitive improvements with a daily dose of 63 mg (31.5 mg per capsule, 2 capsules daily) over 12 months in older adults with mild cognitive impairment. No adverse effects were reported in the studies, but the overall evidence is limited to a small number of trials.",0.8,17457961,2007,Acute cognitive effects of standardised Ginkgo biloba extract complexed with phosphatidylserine.,randomized_controlled_trial,benefit,"The study found that GBE complexed with phosphatidylserine improved cognitive performance, indicating a beneficial effect.",120 mg single dose 7 days apart (complexed with Ginkgo biloba extract),,,cognitive performance,cognitive performance; memory; mild cognitive impairment; mood,,,
Phosphatidylserine,grade 3 or greater adverse events in 14.3% of patients; grade III infusion reaction related to bavituximab; one pulmonary embolism at 3 mg/kg; treatment related-adverse events occurred in 45.7% of patients,Calmness,,"Energy, Mood, & Mental Health",manual_pair,"Phosphatidylserine has shown beneficial effects on cognitive function in two randomized trials. One study reported improvements in cognitive performance with a single dose of 120 mg complexed with Ginkgo biloba extract, while another study found significant cognitive improvements with a daily dose of 63 mg (31.5 mg per capsule, 2 capsules daily) over 12 months in older adults with mild cognitive impairment. No adverse effects were reported in the studies, but the overall evidence is limited to a small number of trials.",0.8,39317299,2025,"Effects of a food supplement containing phosphatidylserine on cognitive function in Chinese older adults with mild cognitive impairment: A randomized double-blind, placebo-controlled trial.",randomized_controlled_trial,benefit,"The study shows significant improvements in cognitive functions, indicating a benefit from the supplement.",31.5 mg 2 capsules daily 12 months (capsule),,,mild cognitive impairment,cognitive performance; memory; mild cognitive impairment; mood,,,
Phosphatidylserine,grade 3 or greater adverse events in 14.3% of patients; grade III infusion reaction related to bavituximab; one pulmonary embolism at 3 mg/kg; treatment related-adverse events occurred in 45.7% of patients,Carpal Tunnel Syndrome,,Musculoskeletal & Pain,manual_pair,"There is limited evidence from a single randomized controlled trial indicating that phosphatidylserine may provide benefit in reducing symptoms and pain in patients with mild to moderate carpal tunnel syndrome, with a reported dose of 600 mg twice daily for 60 days. However, the overall evidence is weak due to the small number of studies, and no adverse effects were reported in the trial.",0.7,37366197,2023,"Clinical usefulness of nutraceutics with acetyl-L-carnitine, α-lipoic acid, phosphatidylserine, curcumin, C, E and B-group vitamins in patients awaiting for carpal tunnel release during COVID-19 pandemic: a randomized controlled open label prospective study.",randomized_controlled_trial,benefit,"The study showed significant improvement in symptoms and pain for patients with mild to moderate Carpal Tunnel Syndrome, indicating a benefit from the dietary integrator.",600 mg twice a day 60 days (dietary integrator),,,carpal tunnel syndrome,carpal tunnel syndrome,,,
Phosphatidylserine,grade 3 or greater adverse events in 14.3% of patients; grade III infusion reaction related to bavituximab; one pulmonary embolism at 3 mg/kg; treatment related-adverse events occurred in 45.7% of patients,Aerobic Capacity,,Performance & Recovery,manual_pair,"One randomized trial reported that phosphatidylserine supplementation (750 mg daily for 10 days) significantly increased exercise time to exhaustion in active males, suggesting a potential benefit for low exercise performance. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term effects and safety.",0.7,16394955,2006,Effects of phosphatidylserine on exercise capacity during cycling in active males.,randomized_controlled_trial,benefit,"The study found a significant increase in exercise time to exhaustion, indicating a benefit from phosphatidylserine supplementation.",750 mg daily 10 d (soybean-derived),Cycling,,exercise capacity,exercise capacity; physical endurance,,,
Phosphatidylserine,grade 3 or greater adverse events in 14.3% of patients; grade III infusion reaction related to bavituximab; one pulmonary embolism at 3 mg/kg; treatment related-adverse events occurred in 45.7% of patients,Improve Memory,,Cognitive & Neurological Function,manual_pair,"Human clinical evidence suggests that phosphatidylserine may have beneficial effects on memory and cognitive function in elderly individuals, particularly those with memory complaints or dementia. All five studies reviewed reported positive outcomes, with typical doses ranging from 100 mg to 300 mg daily. No significant adverse effects were noted, indicating a favorable safety profile; however, the overall quality and consistency of the evidence should be considered when interpreting these findings.",0.9,25414047,2014,"Positive effects of soy lecithin-derived phosphatidylserine plus phosphatidic acid on memory, cognition, daily functioning, and mood in elderly patients with Alzheimer's disease and dementia.",randomized_controlled_trial,benefit,"The study showed a positive influence of phosphatidylserine on memory, mood, and cognition, indicating a benefit for the targeted conditions.",300 mg 3 capsules/day 2-3 months (capsules),,"Energy, Mood, & Mental Health",alzheimer's disease,alzheimer's disease; cognitive deficits; cognitive performance; dementia; memory complaints; memory disorders; memory problems; mood disorders; subjective memory complaints,,,
Phosphatidylserine,grade 3 or greater adverse events in 14.3% of patients; grade III infusion reaction related to bavituximab; one pulmonary embolism at 3 mg/kg; treatment related-adverse events occurred in 45.7% of patients,Improve Memory,,Cognitive & Neurological Function,manual_pair,"Human clinical evidence suggests that phosphatidylserine may have beneficial effects on memory and cognitive function in elderly individuals, particularly those with memory complaints or dementia. All five studies reviewed reported positive outcomes, with typical doses ranging from 100 mg to 300 mg daily. No significant adverse effects were noted, indicating a favorable safety profile; however, the overall quality and consistency of the evidence should be considered when interpreting these findings.",0.9,21711517,2011,Safety of phosphatidylserine containing omega-3 fatty acids in non-demented elderly: a double-blind placebo-controlled trial followed by an open-label extension.,randomized_controlled_trial,benefit,"The study found that PS-DHA is safe and well tolerated, with positive effects on cognitive function and no significant adverse effects reported.",300 mg daily 15 weeks (PS-DHA); 100 mg daily 30 weeks (PS-DHA),,,cognitive deficits,alzheimer's disease; cognitive deficits; cognitive performance; dementia; memory complaints; memory disorders; memory problems; mood disorders; subjective memory complaints,,,
Phosphatidylserine,grade 3 or greater adverse events in 14.3% of patients; grade III infusion reaction related to bavituximab; one pulmonary embolism at 3 mg/kg; treatment related-adverse events occurred in 45.7% of patients,Improve Memory,,Cognitive & Neurological Function,manual_pair,"Human clinical evidence suggests that phosphatidylserine may have beneficial effects on memory and cognitive function in elderly individuals, particularly those with memory complaints or dementia. All five studies reviewed reported positive outcomes, with typical doses ranging from 100 mg to 300 mg daily. No significant adverse effects were noted, indicating a favorable safety profile; however, the overall quality and consistency of the evidence should be considered when interpreting these findings.",0.9,24577097,2014,Phosphatidylserine containing omega-3 Fatty acids may improve memory abilities in nondemented elderly individuals with memory complaints: results from an open-label extension study.,randomized_controlled_trial,benefit,"The study reports significant improvements in cognitive performance, indicating a beneficial effect of phosphatidylserine.",100 mg daily 15 weeks (enriched with docosahexaenoic acid),Older Adults,,cognitive performance,alzheimer's disease; cognitive deficits; cognitive performance; dementia; memory complaints; memory disorders; memory problems; mood disorders; subjective memory complaints,,,
Phosphatidylserine,grade 3 or greater adverse events in 14.3% of patients; grade III infusion reaction related to bavituximab; one pulmonary embolism at 3 mg/kg; treatment related-adverse events occurred in 45.7% of patients,Improve Memory,,Cognitive & Neurological Function,manual_pair,"Human clinical evidence suggests that phosphatidylserine may have beneficial effects on memory and cognitive function in elderly individuals, particularly those with memory complaints or dementia. All five studies reviewed reported positive outcomes, with typical doses ranging from 100 mg to 300 mg daily. No significant adverse effects were noted, indicating a favorable safety profile; however, the overall quality and consistency of the evidence should be considered when interpreting these findings.",0.9,20523044,2010,Phosphatidylserine containing omega-3 fatty acids may improve memory abilities in non-demented elderly with memory complaints: a double-blind placebo-controlled trial.,randomized_controlled_trial,benefit,"The study found significant improvements in cognitive performance, indicating a benefit from the intervention.",15 weeks (PS-DHA),Older Adults,,cognitive performance,alzheimer's disease; cognitive deficits; cognitive performance; dementia; memory complaints; memory disorders; memory problems; mood disorders; subjective memory complaints,,,
Phosphatidylserine,grade 3 or greater adverse events in 14.3% of patients; grade III infusion reaction related to bavituximab; one pulmonary embolism at 3 mg/kg; treatment related-adverse events occurred in 45.7% of patients,Improve Memory,,Cognitive & Neurological Function,manual_pair,"Human clinical evidence suggests that phosphatidylserine may have beneficial effects on memory and cognitive function in elderly individuals, particularly those with memory complaints or dementia. All five studies reviewed reported positive outcomes, with typical doses ranging from 100 mg to 300 mg daily. No significant adverse effects were noted, indicating a favorable safety profile; however, the overall quality and consistency of the evidence should be considered when interpreting these findings.",0.9,21103402,2010,The effect of phosphatidylserine-containing omega-3 fatty acids on memory abilities in subjects with subjective memory complaints: a pilot study.,clinical_trial,benefit,"The study reports a significant increase in memory recall, indicating a beneficial effect of the supplement.",null null daily 6 weeks (phosphatidylserine-containing omega-3),,,memory disorders,alzheimer's disease; cognitive deficits; cognitive performance; dementia; memory complaints; memory disorders; memory problems; mood disorders; subjective memory complaints,,,
Phosphatidylserine,grade 3 or greater adverse events in 14.3% of patients; grade III infusion reaction related to bavituximab; one pulmonary embolism at 3 mg/kg; treatment related-adverse events occurred in 45.7% of patients,Muscle Endurance,,Performance & Recovery,manual_pair,"One randomized trial indicates that phosphatidylserine may significantly reduce postexercise mood disturbance and perception of fatigue when taken at a dose of 400 mg daily for two weeks. However, the overall evidence is limited, with only one study demonstrating a benefit and no reports of harm or mixed outcomes.",0.7,23746562,2013,Phosphatidylserine and caffeine attenuate postexercise mood disturbance and perception of fatigue in humans.,randomized_controlled_trial,benefit,"The study shows that Phosphatidylserine significantly attenuates postexercise mood disturbance and perception of fatigue, indicating a beneficial effect.",400 mg daily 2 weeks (multi-ingredient supplement),,"Energy, Mood, & Mental Health",perception of fatigue,perception of fatigue; postexercise mood disturbance,,,
Phosphatidylserine,grade 3 or greater adverse events in 14.3% of patients; grade III infusion reaction related to bavituximab; one pulmonary embolism at 3 mg/kg; treatment related-adverse events occurred in 45.7% of patients,Premenstrual Syndrome,,Women's Health,manual_pair,"There is limited evidence suggesting that a lecithin phosphatidylserine and phosphatidic acid complex (400 mg daily) may reduce symptoms of premenstrual syndrome (PMS), as indicated by one randomized, placebo-controlled trial. However, the overall evidence is sparse, with only one study reporting a benefit and no data on potential adverse effects or long-term safety.",0.7,29576358,2018,"A lecithin phosphatidylserine and phosphatidic acid complex (PAS) reduces symptoms of the premenstrual syndrome (PMS): Results of a randomized, placebo-controlled, double-blind clinical trial.",randomized_controlled_trial,benefit,"The study shows significant improvement in PMS symptoms with PAS treatment, indicating a beneficial effect.",400 mg daily 3 cycles (complex with phosphatidic acid),Women,,pms,pms; premenstrual dysphoric disorder; premenstrual syndrome,,,
Phosphatidylserine,grade 3 or greater adverse events in 14.3% of patients; grade III infusion reaction related to bavituximab; one pulmonary embolism at 3 mg/kg; treatment related-adverse events occurred in 45.7% of patients,Stress,,"Energy, Mood, & Mental Health",manual_pair,"Human clinical evidence suggests that phosphatidylserine may be beneficial for reducing stress responses, with two studies reporting positive outcomes. One study indicated benefits in cognitive performance and relaxation after stress, while another demonstrated reduced stress responses with a daily dose of 400 mg of a phosphatidylserine complex over three weeks. No adverse effects were reported, but the evidence is limited to a small number of studies, and further research is needed to confirm these findings.",0.8,18616866,2008,Influence of phosphatidylserine on cognitive performance and cortical activity after induced stress.,randomized_controlled_trial,benefit,"The study found that phosphatidylserine supplementation led to a significant decrease in Beta-1 power, indicating a potential benefit in cognitive performance and relaxation after stress.",42 days,,Cognitive & Neurological Function,cognitive performance,cognitive performance; emotional responses; psychological stress; stress; stress related disorders,,,
Phosphatidylserine,grade 3 or greater adverse events in 14.3% of patients; grade III infusion reaction related to bavituximab; one pulmonary embolism at 3 mg/kg; treatment related-adverse events occurred in 45.7% of patients,Stress,,"Energy, Mood, & Mental Health",manual_pair,"Human clinical evidence suggests that phosphatidylserine may be beneficial for reducing stress responses, with two studies reporting positive outcomes. One study indicated benefits in cognitive performance and relaxation after stress, while another demonstrated reduced stress responses with a daily dose of 400 mg of a phosphatidylserine complex over three weeks. No adverse effects were reported, but the evidence is limited to a small number of studies, and further research is needed to confirm these findings.",0.8,15512856,2004,Effects of soy lecithin phosphatidic acid and phosphatidylserine complex (PAS) on the endocrine and psychological responses to mental stress.,randomized_controlled_trial,benefit,The study shows a benefit in reducing stress responses with the 400 mg dose of PAS.,400 mg daily three weeks (soy lecithin phosphatidic acid and phosphatidylserine complex),,,emotional responses,cognitive performance; emotional responses; psychological stress; stress; stress related disorders,,,
Probiotic (Akkermansia),,Cough,,Respiratory Health,manual_pair,"One randomized clinical trial reported a beneficial effect of heat-killed Akkermansia muciniphila strain EB-AMDK19 on respiratory symptoms in patients with cough, with treatment durations ranging from 4 to 12 weeks. However, the overall evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term safety and efficacy.",0.7,39683507,2024,"Efficacy of ETB-F01, Heat-Killed Akkermansia muciniphila Strain EB-AMDK19, in Patients with Respiratory Symptoms: A Multicenter Clinical Trial.",randomized_controlled_trial,benefit,"The study shows significant improvement in respiratory symptoms, indicating a beneficial effect of the probiotic.",4 to 12 weeks (heat-killed Akkermansia muciniphila strain EB-AMDK19),,,cough,cough; dyspnea; respiratory symptoms,,,
Probiotic (Akkermansia),,Weight Loss,,Weight & Body Composition,manual_pair,"The evidence for Akkermansia muciniphila supplementation in reducing excess body weight is primarily positive, with three studies reporting benefits in metabolic parameters and body composition, while one study showed mixed results based on baseline gut levels of Akkermansia. Typical doses reported include daily intake of 10^10 bacteria for three months and yogurt containing Akkermansia for eight weeks. No adverse effects were noted in the reviewed studies.",0.8,40451504,2025,"Comparing the effects of yogurt containing Akkermansia muciniphilia postbiotic with yogurt containing Lactobacillus rhamnosus postbiotic on body composition, biochemical indices, appetite, and depression scores in overweight or obese adults: A randomized, double-blind, controlled clinical trial.",randomized_controlled_trial,benefit,"The study showed significant reductions in various health parameters in the AMY group, indicating a beneficial effect.",daily 8 weeks (yogurt),,Gut Health,appetite,Type 2 Diabetes Mellitus; appetite; depression; insulin resistance; obesity; overweight,,,
Probiotic (Akkermansia),,Weight Loss,,Weight & Body Composition,manual_pair,"The evidence for Akkermansia muciniphila supplementation in reducing excess body weight is primarily positive, with three studies reporting benefits in metabolic parameters and body composition, while one study showed mixed results based on baseline gut levels of Akkermansia. Typical doses reported include daily intake of 10^10 bacteria for three months and yogurt containing Akkermansia for eight weeks. No adverse effects were noted in the reviewed studies.",0.8,31263284,2019,Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study.,randomized_controlled_trial,benefit,"The study shows that supplementation with A. muciniphila improves metabolic parameters, indicating a benefit.",10^10 bacteria daily three months (live or pasteurized),,"Gut Health; Immune, Inflammation, & Infection",insulin resistance,Type 2 Diabetes Mellitus; appetite; depression; insulin resistance; obesity; overweight,,,
Probiotic (Akkermansia),,Weight Loss,,Weight & Body Composition,manual_pair,"The evidence for Akkermansia muciniphila supplementation in reducing excess body weight is primarily positive, with three studies reporting benefits in metabolic parameters and body composition, while one study showed mixed results based on baseline gut levels of Akkermansia. Typical doses reported include daily intake of 10^10 bacteria for three months and yogurt containing Akkermansia for eight weeks. No adverse effects were noted in the reviewed studies.",0.8,39879980,2025,Akkermansia muciniphila supplementation in patients with overweight/obese type 2 diabetes: Efficacy depends on its baseline levels in the gut.,randomized_controlled_trial,mixed_unclear,"The study shows mixed results based on baseline levels of Akkermansia muciniphila, with benefits in low baseline groups but not in high baseline groups.",12 weeks (AKK-WST01),Diabetes Type 2; Obese; Overweight,Metabolic Health,obesity,Type 2 Diabetes Mellitus; appetite; depression; insulin resistance; obesity; overweight,,,
Probiotic (Akkermansia),,Weight Loss,,Weight & Body Composition,manual_pair,"The evidence for Akkermansia muciniphila supplementation in reducing excess body weight is primarily positive, with three studies reporting benefits in metabolic parameters and body composition, while one study showed mixed results based on baseline gut levels of Akkermansia. Typical doses reported include daily intake of 10^10 bacteria for three months and yogurt containing Akkermansia for eight weeks. No adverse effects were noted in the reviewed studies.",0.8,31132422,2019,Investigation the effect of oleoylethanolamide supplementation on the abundance of Akkermansia muciniphila bacterium and the dietary intakes in people with obesity: A randomized clinical trial.,randomized_controlled_trial,benefit,"The study shows a significant increase in the abundance of Akkermansia muciniphila and a decrease in energy and carbohydrate intake, indicating a beneficial effect of the supplement.",125 mg twice daily 8 weeks (capsules),Obese,,obesity,Type 2 Diabetes Mellitus; appetite; depression; insulin resistance; obesity; overweight,,,
Probiotic (Akkermansia),,High Blood Glucose,,Metabolic Health,manual_pair,"One randomized trial indicates that Akkermansia muciniphila may improve metabolic parameters related to high blood sugar in individuals undergoing calorie restriction. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term effects and safety.",0.7,26100928,2016,Akkermansia muciniphila and improved metabolic health during a dietary intervention in obesity: relationship with gut microbiome richness and ecology.,clinical_trial,benefit,"The study shows that higher A. muciniphila abundance is associated with improved metabolic parameters after calorie restriction, indicating a beneficial outcome.",6 weeks,Obese; Overweight,,insulin sensitivity,Type 2 Diabetes Mellitus; insulin sensitivity; metabolic health; obesity,,,
Probiotic (Akkermansia),,Metabolic Syndrome,,Metabolic Health,manual_pair,"One randomized trial has demonstrated beneficial effects of Akkermansia muciniphila on metabolic syndrome, with doses administered daily (either alive or pasteurized) for a duration of three months. No adverse effects or mixed outcomes were reported, but the evidence is limited to a single study, warranting caution in interpretation.",0.8,33477821,2021,Beneficial Effects of Akkermansia muciniphila Are Not Associated with Major Changes in the Circulating Endocannabinoidome but Linked to Higher Mono-Palmitoyl-Glycerol Levels as New PPARα Agonists.,randomized_controlled_trial,benefit,"The study shows beneficial effects of Akkermansia muciniphila on metabolic syndrome, indicating a positive outcome direction.",daily 3 months (alive or pasteurized A. muciniphila),,,metabolic syndrome,metabolic syndrome; obesity,,,
Probiotic (Akkermansia),,Strength,,Performance & Recovery,manual_pair,"One randomized, double-blind, placebo-controlled trial found that pasteurized Akkermansia muciniphila HB05 at a dose of 1.0 × 10^10 cells daily for 12 weeks significantly improved muscle strength and functionality. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term effects and safety.",0.7,39683431,2024,"Pasteurized Akkermansia muciniphila HB05 (HB05P) Improves Muscle Strength and Function: A 12-Week, Randomized, Double-Blind, Placebo-Controlled Clinical Trial.",randomized_controlled_trial,benefit,"The study reports significant improvements in muscle strength and functionality, indicating a beneficial effect of the supplement.",1.0 × 10^10 cells daily 12 weeks (pasteurized Akkermansia muciniphila HB05),Older Adults,,muscle functionality,muscle functionality; muscle strength; sarcopenia,,,
Probiotics (Bifidobacterium),dehydration; diarrhea; lower abdominal pain; mild nausea; nausea; poor appetite; stomachache; vomiting,IBS,,Gut Health,manual_pair,"Current evidence from a randomized trial indicates that Bifidobacterium probiotics may improve abdominal pain and diarrhea in patients with diarrhea-predominant irritable bowel syndrome, with a significant response noted after 4 weeks of treatment. However, the overall evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term effects and safety.",0.7,36717369,2023,The Short-Term Efficacy of Bifidobacterium Quadruple Viable Tablet in Patients With Diarrhea-Predominant Irritable Bowel Syndrome: Potentially Mediated by Metabolism Rather Than Diversity Regulation.,randomized_controlled_trial,benefit,"The probiotics showed a significant improvement in response rates for abdominal pain and diarrhea, indicating a beneficial outcome.",4 weeks (tablet),,,diarrhea,diarrhea; irritable bowel syndrome,,,
Probiotics (Bifidobacterium),dehydration; diarrhea; lower abdominal pain; mild nausea; nausea; poor appetite; stomachache; vomiting,Gastric Reflux,,Gut Health,manual_pair,"One randomized, double-blind, placebo-controlled trial reported a beneficial effect of Bifidobacterium animalis subsp. lactis MH-02 in improving symptoms of reflux esophagitis over an 8-week period. No studies reported mixed outcomes or harm, but the overall evidence is limited to a single trial, indicating a need for further research to confirm these findings.",0.7,38337627,2024,"Therapeutic Evaluation of Bifidobacterium animalis subsp. lactis MH-02 as an Adjunctive Treatment in Patients with Reflux Esophagitis: A Randomized, Double-Blind, Placebo-Controlled Trial.",randomized_controlled_trial,benefit,"The study shows significant clinical improvement and symptom resolution in patients with reflux esophagitis, indicating a beneficial effect of the probiotic treatment.",8 weeks (Bifidobacterium animalis subsp. lactis MH-02),,,reflux esophagitis,reflux esophagitis,,,
Probiotics (Bifidobacterium),dehydration; diarrhea; lower abdominal pain; mild nausea; nausea; poor appetite; stomachache; vomiting,Improve Mood,,"Energy, Mood, & Mental Health",manual_pair,"Clinical evidence suggests that probiotics containing Bifidobacterium may have a beneficial effect on anxiety-related outcomes, with two randomized trials reporting improvements in mood, sleep quality, and perceived psychological stress. Doses used in these studies ranged from 1 × 10^10 to 20 billion cells daily for a duration of 6 weeks. No adverse effects were reported, but the overall evidence is limited to a small number of studies, indicating a need for further research to confirm these findings.",0.8,38128887,2024,"Bifidobacterium breve M-16V regulates the autonomic nervous system via the intestinal environment: A double-blind, placebo-controlled study.",randomized_controlled_trial,benefit,"The study shows a positive effect on mood and sleep, indicating a benefit from the intervention.",20 billion cells daily 6 weeks,,Sleep,anxiety,anxiety; depression; mood improvement; psychological stress; sleep improvement,,,
Probiotics (Bifidobacterium),dehydration; diarrhea; lower abdominal pain; mild nausea; nausea; poor appetite; stomachache; vomiting,Improve Mood,,"Energy, Mood, & Mental Health",manual_pair,"Clinical evidence suggests that probiotics containing Bifidobacterium may have a beneficial effect on anxiety-related outcomes, with two randomized trials reporting improvements in mood, sleep quality, and perceived psychological stress. Doses used in these studies ranged from 1 × 10^10 to 20 billion cells daily for a duration of 6 weeks. No adverse effects were reported, but the overall evidence is limited to a small number of studies, indicating a need for further research to confirm these findings.",0.8,37513541,2023,Bifidobacterium longum subsp. longum Reduces Perceived Psychological Stress in Healthy Adults: An Exploratory Clinical Trial.,randomized_controlled_trial,benefit,"The study shows a significant reduction in perceived stress and improvement in sleep quality, indicating a beneficial effect of the probiotic.",1 × 10^10 CFU daily 6 weeks,,,anxiety,anxiety; depression; mood improvement; psychological stress; sleep improvement,,,
Probiotics (Bifidobacterium),dehydration; diarrhea; lower abdominal pain; mild nausea; nausea; poor appetite; stomachache; vomiting,Constipation,,Gut Health,manual_pair,"One randomized, double-blind, placebo-controlled study found that Bifidobacterium animalis subsp. lactis BLa80 significantly improved stool consistency and frequency in adults with chronic constipation over 12 weeks. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term effects and safety.",0.7,39244201,2024,"Bifidobacterium animalis subsp. lactis BLa80 regulates the intestinal habit in adults with chronic constipation: a multicentre, randomised, double-blind, placebo-controlled study.",randomized_controlled_trial,benefit,"The study shows significant improvement in stool consistency and frequency in the intervention group, indicating a beneficial outcome.",null null null 12 weeks (maltodextrin),,,chronic constipation,chronic constipation,,,
Probiotics (Bifidobacterium),dehydration; diarrhea; lower abdominal pain; mild nausea; nausea; poor appetite; stomachache; vomiting,Mental Wellness,,"Energy, Mood, & Mental Health",manual_pair,"The evidence for Bifidobacterium probiotics in treating constipation is low and mixed. One randomized trial reported significant improvements in bowel movements with Bifidobacterium animalis subsp. lactis, while another study showed unclear outcomes regarding mood and lifestyle behaviors with Bifidobacterium breve. No adverse effects were noted in the studies reviewed.",0.7,38869657,2024,"Effects of Bifidobacterium breve 207-1 on regulating lifestyle behaviors and mental wellness in healthy adults based on the microbiome-gut-brain axis: a randomized, double-blind, placebo-controlled trial.",randomized_controlled_trial,mixed_unclear,"The study showed some improvements in neurotransmitter levels and lifestyle behaviors, but no significant change in mood scores, indicating mixed outcomes.",low-dose 28 days (B. breve 207-1); high-dose 28 days (B. breve 207-1),,,constipation,constipation; functional constipation; high mental stress; insomnia; mental wellness,,,
Probiotics (Bifidobacterium),dehydration; diarrhea; lower abdominal pain; mild nausea; nausea; poor appetite; stomachache; vomiting,Mental Wellness,,"Energy, Mood, & Mental Health",manual_pair,"The evidence for Bifidobacterium probiotics in treating constipation is low and mixed. One randomized trial reported significant improvements in bowel movements with Bifidobacterium animalis subsp. lactis, while another study showed unclear outcomes regarding mood and lifestyle behaviors with Bifidobacterium breve. No adverse effects were noted in the studies reviewed.",0.7,40499217,2025,"Effects and Persistence of Bifidobacterium animalis subsp. lactis BL-99 and Fructooligosaccharides on Older Adults with Functional Constipation: A Randomized, Double-Blind, Placebo-Controlled Trial.",randomized_controlled_trial,benefit,"The study shows significant improvements in bowel movements and gut transit time, indicating a beneficial effect on functional constipation.",4 weeks (synbiotic),,,functional constipation,constipation; functional constipation; high mental stress; insomnia; mental wellness,,,
Probiotics (Bifidobacterium),dehydration; diarrhea; lower abdominal pain; mild nausea; nausea; poor appetite; stomachache; vomiting,Crohn's Disease,,Gut Health,manual_pair,"One randomized trial indicates that a combination of Bifidobacterium, Lactobacillus, and Enterococcus capsules may improve clinical outcomes and inflammatory markers in mildly active Crohn's disease patients over a 4-week period. However, the overall evidence is limited, with only one study reporting a benefit and no data on adverse effects or long-term outcomes.",0.7,38159563,2024,"Effects of Mesalamine Combined with Live Combined Bifidobacterium, Lactobacillus and Enterococcus Capsules on Intestinal Mucosa Barrier Function and Intestinal Microbiota in Mildly Active Crohn's Disease Patients.",randomized_controlled_trial,benefit,"The study shows a higher clinical effective rate and improved microbiota and inflammatory markers in the treatment group, indicating a benefit.",4 weeks (capsules),,,crohn's disease,crohn's disease,,,
Probiotics (Bifidobacterium),dehydration; diarrhea; lower abdominal pain; mild nausea; nausea; poor appetite; stomachache; vomiting,Dandruff,,"Skin, Hair, & Nails",manual_pair,"One randomized placebo-controlled trial evaluated the efficacy of a shampoo containing 1% Bifidobacterium lactis CCT 7858 and reported significant improvements in dandruff cleanliness and appearance over 28 days. No studies reported mixed outcomes or adverse effects, but the overall evidence is limited to a single trial, indicating a need for further research to confirm these findings.",0.7,36862071,2023,Clinical evaluation of paraprobiotic-associated Bifidobacterium lactis CCT 7858 anti-dandruff shampoo efficacy: A randomized placebo-controlled clinical trial.,randomized_controlled_trial,benefit,"The study reports significant improvements in cleanliness and general appearance of dandruff, indicating a beneficial outcome.",1 % daily 28 days (shampoo),,,dandruff,dandruff,,,
Probiotics (Bifidobacterium),dehydration; diarrhea; lower abdominal pain; mild nausea; nausea; poor appetite; stomachache; vomiting,Diarrhea,,Gut Health,manual_pair,"There is limited evidence from a single randomized, double-blind, placebo-controlled trial indicating that the probiotic Bifidobacterium breve BB05 may improve symptoms of diarrhea, particularly in psychosomatic cases among college students. No adverse effects were reported in this study, but further research is needed to confirm these findings and establish broader applicability.",0.8,38999739,2024,"Effectiveness of Psychobiotic Bifidobacterium breve BB05 in Managing Psychosomatic Diarrhea in College Students by Regulating Gut Microbiota: A Randomized, Double-Blind, Placebo-Controlled Trial.",randomized_controlled_trial,benefit,"The study shows significant improvement in diarrhea symptoms and associated mental health issues, indicating a beneficial effect of the probiotic intervention.",2 weeks,,,anxiety,anxiety; depression; diarrhea,,,
Probiotics (Bifidobacterium),dehydration; diarrhea; lower abdominal pain; mild nausea; nausea; poor appetite; stomachache; vomiting,Diarrhea,,Gut Health,manual_pair,"One randomized double-blind, placebo-controlled trial demonstrated a beneficial effect of live Bifidobacterium longum CECT 7347 on symptoms of diarrhea-predominant irritable bowel syndrome (IBS-D) when administered at a dose of 2 capsules daily for 84 days. There is currently limited evidence, with no studies reporting mixed or no benefit, suggesting a need for further research to confirm these findings and assess long-term safety.",0.8,38630015,2024,"A randomized double-blind, placebo-controlled trial to evaluate the safety and efficacy of live Bifidobacterium longum CECT 7347 (ES1) and heat-treated Bifidobacterium longum CECT 7347 (HT-ES1) in participants with diarrhea-predominant irritable bowel syndrome.",randomized_controlled_trial,benefit,"The study shows significant improvement in IBS-D symptoms, indicating a beneficial effect of the probiotic.",2 capsules once daily 84 days (live and heat-treated Bifidobacterium longum CECT 7347),IBS,,diarrhea-predominant irritable bowel syndrome,diarrhea-predominant irritable bowel syndrome,,,
Probiotics (Bifidobacterium),dehydration; diarrhea; lower abdominal pain; mild nausea; nausea; poor appetite; stomachache; vomiting,Weight Loss,,Weight & Body Composition,manual_pair,"Current evidence from two randomized controlled trials suggests that Bifidobacterium probiotics may have beneficial effects on body composition and metabolic parameters in overweight or obese adults, with doses reported at 1 × 10^10 CFUs daily for durations of 12 to 16 weeks. However, the overall evidence is limited and further research is needed to confirm these findings and assess long-term effects and safety.",0.8,38542727,2024,Effects of Bifidobacterium longum BB536 and Bifidobacterium breve MCC1274 on Body Composition in Normal and Overweight Adults in Randomized Placebo-Controlled Study.,randomized_controlled_trial,benefit,"The study shows significant reductions in abdominal visceral fat and total fat levels, indicating a beneficial effect on body composition.",1 × 10^10 CFUs 16 weeks (capsules),Overweight,,body composition,body composition; obesity; overweight,,,
Probiotics (Bifidobacterium),dehydration; diarrhea; lower abdominal pain; mild nausea; nausea; poor appetite; stomachache; vomiting,Weight Loss,,Weight & Body Composition,manual_pair,"Current evidence from two randomized controlled trials suggests that Bifidobacterium probiotics may have beneficial effects on body composition and metabolic parameters in overweight or obese adults, with doses reported at 1 × 10^10 CFUs daily for durations of 12 to 16 weeks. However, the overall evidence is limited and further research is needed to confirm these findings and assess long-term effects and safety.",0.8,39456659,2024,Gut Microbiome and Metabolome Alterations in Overweight or Obese Adult Population after Weight-Loss Bifidobacterium breve BBr60 Intervention: A Randomized Controlled Trial.,randomized_controlled_trial,benefit,"The study shows significant improvements in weight, BMI, and blood glucose levels, indicating a beneficial effect of Bifidobacterium breve BBr60.",1 10^10 CFU daily 12 weeks,Obese; Overweight,,obesity,body composition; obesity; overweight,,,
Probiotics (Bifidobacterium),dehydration; diarrhea; lower abdominal pain; mild nausea; nausea; poor appetite; stomachache; vomiting,Gastritis,,Gut Health,manual_pair,"One randomized, double-blind, placebo-controlled crossover trial found that Bifidobacterium breve Bif195 significantly reduced aspirin-induced gastric mucosal damage at a dose of ≥1011 colony-forming units daily for 4 weeks. Overall, the evidence is limited to a single study demonstrating benefit, with no reports of harm or mixed outcomes. Further research is needed to confirm these findings and assess long-term effects.",0.7,38036761,2024,"Bifidobacterium breve Bif195 ameliorates aspirin-induced gastric mucosal damage: A randomised, double blind, placebo-controlled crossover trial.",randomized_controlled_trial,benefit,"Bif195 significantly reduced gastric mucosal damage compared to placebo, indicating a beneficial effect.",≥1011 colony-forming units daily 4 weeks (oral),,,duodenal ulcer,duodenal ulcer; gastric mucosal damage,,,
Probiotics (Bifidobacterium),dehydration; diarrhea; lower abdominal pain; mild nausea; nausea; poor appetite; stomachache; vomiting,Weight Loss,,Weight & Body Composition,manual_pair,"The evidence for Bifidobacterium probiotics in alleviating gastrointestinal symptoms is limited and mixed. One randomized trial reported benefits in gastrointestinal health markers with a daily dose of 100 mL of unfermented probiotic milk containing Bifidobacterium longum over 7 weeks, while another pilot study showed minimal changes in GI symptoms with heat-treated Bifidobacterium longum CECT 7347 over 8 weeks. Overall, the findings suggest potential benefits but lack consistency and clarity.",0.7,38931207,2024,A Symbiotic Meal Containing Extruded Sorghum and Probiotic (Bifidobacterium longum) Ameliorated Intestinal Health Markers in Individuals with Chronic Kidney Disease: A Secondary Analysis of a Subsample from a Previous Randomized and Controlled Clinical Trial.,randomized_controlled_trial,benefit,"The study reports improvements in gastrointestinal symptoms and reductions in uremic toxins, indicating a beneficial effect of the probiotic intervention.",100 mL daily 7 weeks (unfermented probiotic milk with Bifidobacterium longum),,,chronic kidney disease,chronic kidney disease; gastrointestinal symptoms,,,
Probiotics (Bifidobacterium),dehydration; diarrhea; lower abdominal pain; mild nausea; nausea; poor appetite; stomachache; vomiting,Weight Loss,,Weight & Body Composition,manual_pair,"The evidence for Bifidobacterium probiotics in alleviating gastrointestinal symptoms is limited and mixed. One randomized trial reported benefits in gastrointestinal health markers with a daily dose of 100 mL of unfermented probiotic milk containing Bifidobacterium longum over 7 weeks, while another pilot study showed minimal changes in GI symptoms with heat-treated Bifidobacterium longum CECT 7347 over 8 weeks. Overall, the findings suggest potential benefits but lack consistency and clarity.",0.7,39599737,2024,"Effect of Postbiotic Bifidobacterium longum CECT 7347 on Gastrointestinal Symptoms, Serum Biochemistry, and Intestinal Microbiota in Healthy Adults: A Randomised, Parallel, Double-Blind, Placebo-Controlled Pilot Study.",randomized_controlled_trial,mixed_unclear,"The study showed minimal changes in GI symptoms but significant biochemical changes, indicating mixed outcomes.",null null null 8 weeks (heat-treated Bifidobacterium longum CECT 7347),IBS,,gastrointestinal symptoms,chronic kidney disease; gastrointestinal symptoms,,,
Probiotics (Bifidobacterium),dehydration; diarrhea; lower abdominal pain; mild nausea; nausea; poor appetite; stomachache; vomiting,High Blood Glucose,,Metabolic Health,manual_pair,"One randomized controlled trial reported that a combination of prebiotic galacto-oligosaccharides and Bifidobacterium breve-derived postbiotic significantly improved HbA1c and fasting plasma glucose levels in prediabetic adults over a 12-week period. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term effects and safety.",0.7,39064648,2024,"Impact of Combined Prebiotic Galacto-Oligosaccharides and Bifidobacterium breve-Derived Postbiotic on Gut Microbiota and HbA1c in Prediabetic Adults: A Double-Blind, Randomized, Placebo-Controlled Study.",randomized_controlled_trial,benefit,"The intervention group showed significant improvements in HbA1c and FPG levels, indicating a beneficial effect on prediabetes.",daily once 12 weeks (dietary fiber supplement),Prediabetes,,prediabetes,prediabetes,,,
Probiotics (Bifidobacterium),dehydration; diarrhea; lower abdominal pain; mild nausea; nausea; poor appetite; stomachache; vomiting,Metabolic Syndrome,,Metabolic Health,manual_pair,"There is limited evidence suggesting that probiotics, specifically Bifidobacterium, may have a beneficial effect on high LDL cholesterol, as indicated by one randomized, double-blinded, placebo-controlled study that reported improvements in metabolic syndrome risk factors after 12 weeks of treatment. However, the overall evidence is sparse, and further research is needed to confirm these findings and establish consistency across studies.",0.7,39792908,2025,"The efficacy of Lacticaseibacillus paracasei MSMC39-1 and Bifidobacterium animalis TA-1 probiotics in modulating gut microbiota and reducing the risk of the characteristics of metabolic syndrome: A randomized, double-blinded, placebo-controlled study.",randomized_controlled_trial,benefit,"The probiotics group showed significant improvements in various metabolic syndrome risk factors, indicating a beneficial outcome.",12 weeks (probiotics),,,metabolic syndrome,metabolic syndrome,,,
Probiotics (Bifidobacterium),dehydration; diarrhea; lower abdominal pain; mild nausea; nausea; poor appetite; stomachache; vomiting,High Triglycerides,,Weight & Body Composition,manual_pair,"One randomized clinical trial reported that supplementation with Bifidobacterium lactis IDCC 4301 (B. lactis Fit™) at doses greater than 5.0 CFU per day for 12 weeks resulted in significant reductions in serum triglycerides among obese women. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term effects and safety.",0.7,39051504,2024,"Bifidobacterium lactis IDCC 4301 (B. lactis Fit™) supplementation effects on body fat, serum triglyceride, and adipokine ratio in obese women: a randomized clinical trial.",randomized_controlled_trial,benefit,"The study shows significant reductions in body fat and triglycerides, indicating a beneficial effect of the probiotic supplementation.",>5.0 CFU day-1 12 weeks (B. lactis Fit™),Obese; Women,,cardiovascular disease,Type 2 Diabetes Mellitus; cardiovascular disease; dyslipidemia; obesity,,,
Probiotics (Bifidobacterium),dehydration; diarrhea; lower abdominal pain; mild nausea; nausea; poor appetite; stomachache; vomiting,Immune System Fortification,,"Immune, Inflammation, & Infection",manual_pair,"One randomized trial has demonstrated a beneficial effect of Bifidobacterium longum subsp. longum BB536 on immune response markers in healthy adults, with a dose of 1 × 10^10 CFU daily for four weeks. However, the overall evidence is limited, with only one study reporting positive outcomes and no data on potential adverse effects or long-term implications.",0.7,38201872,2023,The Potential Immunomodulatory Effect of Bifidobacterium longum subsp. longum BB536 on Healthy Adults through Plasmacytoid Dendritic Cell Activation in the Peripheral Blood.,randomized_controlled_trial,benefit,"The study shows a significant increase in immune markers, indicating a beneficial effect of BB536 on immune function.",1 × 10^10 CFU daily 4 weeks (live BB536),,,immune response enhancement,immune response enhancement,,,
Probiotics (Bifidobacterium),dehydration; diarrhea; lower abdominal pain; mild nausea; nausea; poor appetite; stomachache; vomiting,Dyspepsia,,Gut Health,manual_pair,"One randomized placebo-controlled trial reported a significant benefit of Bifidobacterium animalis subsp. lactis BL-99 in improving symptoms of functional dyspepsia over an 8-week period. The evidence is limited to this single study, and no adverse effects were noted. Overall, the findings suggest potential efficacy, but further research is needed to confirm these results.",0.7,38172093,2024,Efficacy of Bifidobacterium animalis subsp. lactis BL-99 in the treatment of functional dyspepsia: a randomized placebo-controlled clinical trial.,randomized_controlled_trial,benefit,The study shows a significant improvement in functional dyspepsia symptoms with Bifidobacterium animalis subsp. lactis BL-99 compared to placebo and other controls.,low 8 weeks (Bifidobacterium animalis subsp. lactis BL-99); high 8 weeks (Bifidobacterium animalis subsp. lactis BL-99),,,functional dyspepsia,functional dyspepsia,,,
Probiotics (Bifidobacterium),dehydration; diarrhea; lower abdominal pain; mild nausea; nausea; poor appetite; stomachache; vomiting,Athletic Performance,,Performance & Recovery,manual_pair,"Current evidence on Bifidobacterium probiotics for low exercise performance is limited to one preliminary study, which reported benefits in lipid metabolism and sports performance in cross-country skiers after 8 weeks of supplementation at a dose of 4 times per day. No adverse effects were noted, but the overall quality and consistency of the evidence are low, warranting caution in interpretation.",0.5,37960207,2023,Eight Weeks of Bifidobacterium lactis BL-99 Supplementation Improves Lipid Metabolism and Sports Performance through Short-Chain Fatty Acids in Cross-Country Skiers: A Preliminary Study.,randomized_controlled_trial,benefit,"The study shows significant improvements in lipid metabolism and sports performance metrics, indicating a beneficial effect of the supplement.",4 times/day 8 weeks,,Heart & Vascular Health,lipid metabolism,lipid metabolism; sports performance,,,
Probiotics (Bifidobacterium),dehydration; diarrhea; lower abdominal pain; mild nausea; nausea; poor appetite; stomachache; vomiting,General Gut Health,,Gut Health,manual_pair,"One randomized double-blind placebo-controlled trial demonstrated a benefit of Bifidobacterium longum BB536 on gut health, showing a significant increase in beneficial gut bacteria and metabolites after 17 days of intake. No studies reported mixed outcomes, harm, or no benefit, but the overall evidence is limited to a single trial, warranting caution in generalizing these findings.",0.7,39519413,2024,The Impact of Fermented Milk Products Containing Bifidobacterium longum BB536 on the Gut Environment: A Randomized Double-Blind Placebo-Controlled Trial.,randomized_controlled_trial,benefit,"The study shows a significant increase in beneficial gut bacteria and metabolites, indicating a health benefit from B. longum BB536 intake.",17 days (fermented milk supplemented with B. longum BB536),,,gut microbiota modulation,gut microbiota modulation; metabolite profile improvement,,,
Probiotics (Bifidobacterium),dehydration; diarrhea; lower abdominal pain; mild nausea; nausea; poor appetite; stomachache; vomiting,Sleep Quality,,Sleep,manual_pair,"Clinical evidence suggests that probiotics, specifically various strains of Bifidobacterium, may improve sleep quality in healthy adults, with four randomized controlled trials reporting beneficial outcomes. Doses reported include 10 billion CFU daily for 8 weeks and 5 billion CFU for 4 weeks, although not all studies specified dosing. No adverse effects were noted in the reviewed studies, but the overall evidence remains limited and further research is warranted to confirm these findings.",0.8,40169760,2025,A double blinded randomized placebo trial of Bifidobacterium animalis subsp. lactis BLa80 on sleep quality and gut microbiota in healthy adults.,randomized_controlled_trial,benefit,"The study found significant improvements in sleep quality, indicating a beneficial effect of the probiotic intervention.",10 billion CFU daily 8 weeks (maltodextrin + BLa80),,,gut microbiota dysbiosis,gut microbiota dysbiosis; impaired sleep quality; sleep disorders; sleep quality; stress; stress-induced insomnia; well-being,,,
Probiotics (Bifidobacterium),dehydration; diarrhea; lower abdominal pain; mild nausea; nausea; poor appetite; stomachache; vomiting,Sleep Quality,,Sleep,manual_pair,"Clinical evidence suggests that probiotics, specifically various strains of Bifidobacterium, may improve sleep quality in healthy adults, with four randomized controlled trials reporting beneficial outcomes. Doses reported include 10 billion CFU daily for 8 weeks and 5 billion CFU for 4 weeks, although not all studies specified dosing. No adverse effects were noted in the reviewed studies, but the overall evidence remains limited and further research is warranted to confirm these findings.",0.8,38355674,2024,"Bifidobacterium longum 1714 improves sleep quality and aspects of well-being in healthy adults: a randomized, double-blind, placebo-controlled clinical trial.",randomized_controlled_trial,benefit,"The study shows significant improvements in sleep quality and aspects of well-being, indicating a beneficial effect of the probiotic strain.",null null daily 8 weeks (null),,"Energy, Mood, & Mental Health",impaired sleep quality,gut microbiota dysbiosis; impaired sleep quality; sleep disorders; sleep quality; stress; stress-induced insomnia; well-being,,,
Probiotics (Bifidobacterium),dehydration; diarrhea; lower abdominal pain; mild nausea; nausea; poor appetite; stomachache; vomiting,Sleep Quality,,Sleep,manual_pair,"Clinical evidence suggests that probiotics, specifically various strains of Bifidobacterium, may improve sleep quality in healthy adults, with four randomized controlled trials reporting beneficial outcomes. Doses reported include 10 billion CFU daily for 8 weeks and 5 billion CFU for 4 weeks, although not all studies specified dosing. No adverse effects were noted in the reviewed studies, but the overall evidence remains limited and further research is warranted to confirm these findings.",0.8,38892634,2024,"Bifidobacterium adolescentis SBT2786 Improves Sleep Quality in Japanese Adults with Relatively High Levels of Stress: A Randomized, Double-Blind, Placebo-Controlled Study.",randomized_controlled_trial,benefit,"The study found that SBT2786 improved sleep duration and mood, particularly in stressed individuals, indicating a beneficial outcome.",,,"Energy, Mood, & Mental Health",sleep disorders,gut microbiota dysbiosis; impaired sleep quality; sleep disorders; sleep quality; stress; stress-induced insomnia; well-being,,,
Probiotics (Bifidobacterium),dehydration; diarrhea; lower abdominal pain; mild nausea; nausea; poor appetite; stomachache; vomiting,Sleep Quality,,Sleep,manual_pair,"Clinical evidence suggests that probiotics, specifically various strains of Bifidobacterium, may improve sleep quality in healthy adults, with four randomized controlled trials reporting beneficial outcomes. Doses reported include 10 billion CFU daily for 8 weeks and 5 billion CFU for 4 weeks, although not all studies specified dosing. No adverse effects were noted in the reviewed studies, but the overall evidence remains limited and further research is warranted to confirm these findings.",0.8,37960353,2023,Bifidobacterium breve CCFM1025 Improves Sleep Quality via Regulating the Activity of the HPA Axis: A Randomized Clinical Trial.,randomized_controlled_trial,benefit,The study demonstrated a significant improvement in sleep quality in the group receiving Bifidobacterium breve CCFM1025 compared to placebo.,5 10^9 CFU 4 weeks,,"Energy, Mood, & Mental Health",sleep quality,gut microbiota dysbiosis; impaired sleep quality; sleep disorders; sleep quality; stress; stress-induced insomnia; well-being,,,
Probiotics (Bifidobacterium),dehydration; diarrhea; lower abdominal pain; mild nausea; nausea; poor appetite; stomachache; vomiting,Endothelial Function,,Heart & Vascular Health,manual_pair,"Current evidence on the use of Bifidobacterium probiotics for improving vascular health is limited to one randomized, double-blind, placebo-controlled study, which reported a significant benefit in flow-mediated dilation after 12 weeks of daily supplementation at a dose of 1.0 × 10^10 colony-forming units. No adverse effects were noted, but the overall evidence remains sparse and requires further investigation to confirm these findings.",0.7,37849220,2023,"Effect of daily ingestion of Bifidobacterium and dietary fiber on vascular endothelial function: a randomized, double-blind, placebo-controlled, parallel-group comparison study.",randomized_controlled_trial,benefit,"The study showed a significant increase in flow-mediated dilation, indicating a positive effect on vascular health.",1.0 × 10^10 colony-forming units daily 12 weeks (test drink),,,low-density lipoprotein cholesterol,low-density lipoprotein cholesterol; plasminogen activator inhibitor-1; vascular endothelial function,,,
Probiotics (Lactobacillus),Pseudomonas aeruginosa growth in sputum cultures,General Gut Health,,Gut Health,manual_pair,"One randomized clinical trial reported a benefit of Lactobacillus plantarum GKM3 in alleviating gastrointestinal symptoms, including abdominal pain, in overweight and obese individuals at a dose of 1 g per day for 4 weeks. Overall, the evidence is limited to a single study with no reported harms or mixed outcomes, indicating a need for further research to confirm these findings.",0.8,40383259,2025,Impact of probiotic Lactobacillus plantarum GKM3 on gastrointestinal health in overweight and obese individuals: A randomized clinical trial.,randomized_controlled_trial,benefit,The study demonstrated significant benefits in gastrointestinal health and symptom alleviation in overweight and obese individuals after probiotic intervention.,1 g per day 4 weeks (capsules),Obese; Overweight,,abdominal pain,abdominal pain; constipation; gastroesophageal reflux; nausea; obesity; overweight,,,
Probiotics (Lactobacillus),Pseudomonas aeruginosa growth in sputum cultures,Diarrhea,,Gut Health,manual_pair,"One randomized controlled trial reported that Lactobacillus casei Shirota probiotic drinks significantly reduced the incidence of antibiotic-associated diarrhea in patients with spinal cord injuries who were also taking proton pump inhibitors. The dose used was 6.5×10^9 live bacteria once daily during the antibiotic course and for 7 days thereafter. Overall, the evidence is limited to a single study with a specific population, and further research is needed to confirm these findings in broader populations.",0.7,38519563,2024,Lactobacillus casei Shirota probiotic drinks reduce antibiotic associated diarrhoea in patients with spinal cord injuries who regularly consume proton pump inhibitors: a subgroup analysis of the ECLISP multicentre RCT.,randomized_controlled_trial,benefit,"The study found a significant reduction in the incidence of antibiotic associated diarrhoea in the Lactobacillus group, indicating a beneficial effect.",6.5×10^9 live bacteria once daily duration of an antibiotic course and continued for 7 days thereafter (probiotic drink),Antibiotic Use,,antibiotic associated diarrhoea,antibiotic associated diarrhoea; spinal cord injury,,,
Probiotics (Lactobacillus),Pseudomonas aeruginosa growth in sputum cultures,Bacterial Vaginosus,,Women's Health,manual_pair,"One randomized controlled trial reported that a Lactobacillus suppository improved vaginal health indices in perimenopausal women with bacterial vaginosis over a 4-week period, indicating a potential benefit. However, the overall evidence is limited, with only one study demonstrating positive outcomes and no reports of harm or adverse effects.",0.7,38336815,2024,VagiBIOM Lactobacillus suppository improves vaginal health index in perimenopausal women with bacterial vaginosis: a randomized control trial.,randomized_controlled_trial,benefit,"The study showed significant improvement in vaginal health outcomes, indicating a benefit from the intervention.",4 weeks (suppository),Menopause; Women,,bacterial vaginosis,bacterial vaginosis; vaginal dysbiosis; vaginal health,,,
Probiotics (Lactobacillus),Pseudomonas aeruginosa growth in sputum cultures,Bloating,,Gut Health,manual_pair,"The evidence for Lactobacillus probiotics in reducing bloating and hard stools is limited and mixed, with one randomized controlled trial indicating some improvement in specific scores but not achieving statistical significance in overall gastrointestinal symptom scores. No consistent dose ranges were reported, and no studies demonstrated clear benefits or harms. Overall, the quality of evidence is low.",0.6,38304947,2024,Lactobacillus plantarum 24-7 improves postoperative bloating and hard stools by modulating intestinal microbiota in patients with congenital heart disease: a randomized controlled trial.,randomized_controlled_trial,mixed_unclear,"The study showed marked differences in bloating and hard stool scores, but overall GSRS scores did not reach statistical significance, indicating mixed outcomes.",2 doses twice daily ten days (Lactobacillus plantarum 24-7),,,gastrointestinal symptoms,gastrointestinal symptoms; hard stools; postoperative bloating,,,
Probiotics (Lactobacillus),Pseudomonas aeruginosa growth in sputum cultures,Constipation,,Gut Health,manual_pair,"One randomized trial has reported a beneficial effect of Lactobacillus gasseri in reducing abdominal pain and potentially increasing complete spontaneous bowel movements in patients with chronic constipation. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess the consistency of the effects across different populations and doses.",0.7,40033155,2025,Therapeutic Value of Lactobacillus gasseri 345A in Chronic Constipation.,randomized_controlled_trial,benefit,"The study reports a significant reduction in abdominal pain and a tendency for increased complete spontaneous bowel movements, indicating a beneficial effect.",28 days (Lactobacillus gasseri),,,chronic constipation,chronic constipation,,,
Probiotics (Lactobacillus),Pseudomonas aeruginosa growth in sputum cultures,Immune System Fortification,,"Immune, Inflammation, & Infection",manual_pair,"One pilot randomized controlled trial suggests that supplementation with heat-sterilized Lactobacillus crispatus strain KT-11 may enhance T cell-related immune function and reduce self-reported cold-like symptoms in healthy adults. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess the consistency of the effects.",0.7,39889684,2025,"Supplementation with heat-sterilized Lactobacillus crispatus strain KT-11 stimulates the T cell-related immune function of healthy Japanese adults: A pilot randomized, placebo-controlled, double-blind, parallel-group study.",randomized_controlled_trial,benefit,"The study showed a significant increase in T cell counts and fewer self-reported cold-like symptoms, indicating a beneficial effect on immune function.",4 weeks (heat-sterilized),,,common cold-like symptoms,common cold-like symptoms; fatigue; immune function,,,
Probiotics (Lactobacillus),Pseudomonas aeruginosa growth in sputum cultures,Common Cold,,"Immune, Inflammation, & Infection",manual_pair,"One randomized, double-blind, placebo-controlled trial indicates that Lactobacillus helveticus may reduce symptoms of the common cold, with a reported dose of 6 billion capsules daily for 8 weeks. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess consistency across different populations and formulations.",0.7,39796535,2024,"Lactobacillus helveticus Induces Two Types of Dendritic Cell Activation and Effectively Suppresses Onset of the Common Cold: A Randomized, Double-Blind, Placebo-Controlled Trial.",randomized_controlled_trial,benefit,"The study shows a significant reduction in symptoms of the common cold, indicating a beneficial effect of Lactobacillus helveticus.",6 billion daily 8 weeks (capsules),,,common cold,common cold,,,
Probiotics (Lactobacillus),Pseudomonas aeruginosa growth in sputum cultures,Common Cold,,"Immune, Inflammation, & Infection",manual_pair,"One randomized, double-blind, placebo-controlled trial found that Lactobacillus paragasseri SBT2055 significantly improved subjective symptoms of the common cold in healthy adults when taken at a dose of 3 capsules once daily for 12 weeks. Overall, the evidence suggests a potential benefit, but further studies are needed to confirm these findings and assess consistency across different populations and formulations.",0.7,37892533,2023,"Lactobacillus paragasseri SBT2055 Activates Plasmacytoid Dendritic Cells and Improves Subjective Symptoms of Common Cold in Healthy Adults: A Randomized, Double-Blind, Placebo-Controlled Parallel-Group Comparative Trial.",randomized_controlled_trial,benefit,"The study shows that LG2055 significantly improved symptoms of the common cold, indicating a beneficial effect.",3 capsules once daily 12 weeks,,,common cold,common cold,,,
Probiotics (Lactobacillus),Pseudomonas aeruginosa growth in sputum cultures,Constipation,,Gut Health,manual_pair,"One randomized controlled trial found that Lactobacillus rhamnosus improved constipation symptoms in post-surgery patients with fractures, indicating a potential benefit. However, the evidence is limited to a single study, and further research is needed to establish consistency and generalizability of these findings. No adverse effects were reported in the study.",0.7,38794748,2024,Improvement of Post-Surgery Constipation in Patients with Fractures by Lactobacillus rhamnosus JYLR-127: A Single-Blind Randomized Controlled Trial.,randomized_controlled_trial,benefit,"The study demonstrated that Lactobacillus rhamnosus improved constipation symptoms, indicating a beneficial outcome.",(oral),Postoperative,,fractures,fractures; post-surgery constipation,,,
Probiotics (Lactobacillus),Pseudomonas aeruginosa growth in sputum cultures,Crohn's Disease,,Gut Health,manual_pair,"There is limited evidence suggesting that probiotics, specifically Lactobacillus in combination with other strains, may improve symptoms in patients with mildly active Crohn's disease, as indicated by one study showing a higher clinical effective rate and improved microbiota and inflammatory markers. However, the overall evidence is sparse, and further research is needed to establish consistency and efficacy. No adverse effects were reported in the available study.",0.7,38159563,2024,"Effects of Mesalamine Combined with Live Combined Bifidobacterium, Lactobacillus and Enterococcus Capsules on Intestinal Mucosa Barrier Function and Intestinal Microbiota in Mildly Active Crohn's Disease Patients.",randomized_controlled_trial,benefit,"The study shows a higher clinical effective rate and improved microbiota and inflammatory markers in the treatment group, indicating a benefit.","null null null 4 weeks (Live combined Bifidobacterium, Lactobacillus and Enterococcus capsules)",,,crohn's disease,crohn's disease,,,
Probiotics (Lactobacillus),Pseudomonas aeruginosa growth in sputum cultures,Tooth Decay,,Oral Health,manual_pair,"Current evidence suggests that Lactobacillus brevis CD2 may have a beneficial effect on dental caries by significantly reducing plaque acidogenicity, as reported in one randomized trial. The study utilized a dose of 1 to 2 lozenges taken three times daily for 28 days. However, the overall evidence is limited, with only one study demonstrating a positive outcome and no data on potential adverse effects.",0.7,40147282,2025,The Probiotic Effects of Lactobacillus brevis CD2 on Caries Related Variables of Dental Plaque Biofilm.,randomized_controlled_trial,benefit,"The study shows a significant reduction in plaque acidogenicity, indicating a beneficial effect of L. brevis CD2.",1/2 lozenges 3 times daily 28 days,,,dental caries,dental caries; dental plaque,,,
Probiotics (Lactobacillus),Pseudomonas aeruginosa growth in sputum cultures,Depression,,"Energy, Mood, & Mental Health",manual_pair,"The evidence for Lactobacillus probiotics in the treatment of depression is limited and mixed. One randomized controlled trial reported significant improvements in depression scores among patients with irritable bowel syndrome, while another study suggested potential metabolic effects but lacked definitive conclusions. Overall, the findings do not provide strong support for the use of probiotics in depression, and further research is needed to clarify their efficacy.",0.8,38658619,2024,"A randomized, double-blinded, placebo-controlled clinical trial on Lactobacillus-containing cultured milk drink as adjuvant therapy for depression in irritable bowel syndrome.",randomized_controlled_trial,benefit,The study shows significant improvements in depression scores and quality of life among IBS patients receiving probiotics.,2 bottles daily 12 weeks (cultured milk drink),IBS,,depression,depression; irritable bowel syndrome; major depressive disorder,,,
Probiotics (Lactobacillus),Pseudomonas aeruginosa growth in sputum cultures,Depression,,"Energy, Mood, & Mental Health",manual_pair,"The evidence for Lactobacillus probiotics in the treatment of depression is limited and mixed. One randomized controlled trial reported significant improvements in depression scores among patients with irritable bowel syndrome, while another study suggested potential metabolic effects but lacked definitive conclusions. Overall, the findings do not provide strong support for the use of probiotics in depression, and further research is needed to clarify their efficacy.",0.8,39271063,2025,"Probiotic Lactobacillus plantarum 299v supplementation in patients with major depression in a double-blind, randomized, placebo-controlled trial: A metabolomics study.",randomized_controlled_trial,mixed_unclear,"The study suggests potential metabolic pathways influenced by LP299v supplementation, but definitive conclusions cannot be drawn due to the exploratory nature of the research.",(Lactobacillus plantarum 299v),,,major depressive disorder,depression; irritable bowel syndrome; major depressive disorder,,,
Probiotics (Lactobacillus),Pseudomonas aeruginosa growth in sputum cultures,Weight Loss,,Weight & Body Composition,manual_pair,"One randomized, double-blind, placebo-controlled study found that Lactobacillus plantarum LMT1-48 significantly reduced body fat mass over 12 weeks, indicating a potential benefit for excess body weight. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term effects and safety.",0.7,40218949,2025,"A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Lactobacillus plantarum LMT1-48 on Body Fat Loss.",randomized_controlled_trial,benefit,"The study shows significant reduction in body fat mass, indicating a beneficial effect of the probiotic.",12 weeks (Lactobacillus plantarum LMT1-48),Overweight,,obesity,obesity,,,
Probiotics (Lactobacillus),Pseudomonas aeruginosa growth in sputum cultures,H. Pylori Infection,,Gut Health,manual_pair,"One randomized double-blind placebo-controlled trial indicates that postbiotic inactivated Lactobacillus reuteri (200 mg bid for 14 days) may improve eradication efficiency of Helicobacter pylori and reduce digestive adverse effects in adults with functional dyspepsia. Overall, the evidence is limited to a single study showing benefit, with no reports of harm or no benefit.",0.8,39023173,2024,Efficacy and Safety of Postbiotic Contained Inactivated Lactobacillus reuteri ( Limosilactobacillus reuteri ) DSM 17648 as Adjuvant Therapy in the Eradication of Helicobacter pylori in Adults With Functional Dyspepsia: A Randomized Double-Blind Placebo-Controlled Trial.,randomized_controlled_trial,benefit,"The study shows significant improvement in eradication efficiency and a lower number of digestive adverse effects, indicating a benefit from the intervention.",200 mg bid 14 days (postbiotic),,,functional dyspepsia,functional dyspepsia; helicobacter pylori infection,,,
Probiotics (Lactobacillus),Pseudomonas aeruginosa growth in sputum cultures,Abdominal Discomfort,,Gut Health,manual_pair,"One randomized, double-blind, placebo-controlled study found that daily intake of 85 g of yogurt containing Lactobacillus paragasseri OLL2716 for 12 weeks significantly improved gastric discomfort in healthy adults. Overall, the evidence is limited to this single study, indicating a potential benefit but lacking consistency across multiple trials. No adverse effects were reported in the study.",0.7,39339788,2024,"The Beneficial Effects of Regular Intake of Lactobacillus paragasseri OLL2716 on Gastric Discomfort in Healthy Adults: A Randomized, Double-Blind, Placebo-Controlled Study.",randomized_controlled_trial,benefit,"The study shows significant improvement in gastric symptoms and mental stress, indicating a beneficial effect of the probiotic.",85 g daily 12 weeks (yogurt containing L. paragasseri OLL2716),,"Energy, Mood, & Mental Health",early satiety,early satiety; epigastric pain; gastric discomfort; postprandial fullness,,,
Probiotics (Lactobacillus),Pseudomonas aeruginosa growth in sputum cultures,H. Pylori Infection,,Gut Health,manual_pair,"One randomized controlled trial indicates that Lactobacillus crispatus may reduce Helicobacter pylori load and improve gastrointestinal symptoms, suggesting a potential benefit for gastrointestinal discomfort. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess consistency across different populations and dosages.",0.7,38022520,2023,Study of the effect of Lactobacillus crispatus FSCDJY67L3 on Helicobacter Pylori eradication: a double-blind randomized controlled clinical trial.,randomized_controlled_trial,benefit,"The study shows significant reduction in H. pylori load and improvement in gastrointestinal symptoms, indicating a beneficial effect.",,,,gastrointestinal discomfort,gastrointestinal discomfort; helicobacter pylori infection,,,
Probiotics (Lactobacillus),Pseudomonas aeruginosa growth in sputum cultures,Gingivitis,,Oral Health,manual_pair,"The evidence for the use of Lactobacillus probiotics in treating gingivitis is low quality, with one randomized trial reporting mixed outcomes. Although a significant difference in the gingival index was observed at week four, overall differences were not statistically significant, indicating uncertainty regarding the efficacy of this intervention. No adverse effects were reported in the study.",0.6,37974136,2023,A tangible prospect for the treatment of gingivitis using a potentially probiotic strain Lactobacillus plantarum MK06 isolated from traditional dairy products: a triple blind randomized clinical trial.,randomized_controlled_trial,mixed_unclear,"The study showed a significant difference in gingival index at week four, but overall differences were not significant, indicating mixed outcomes.",null null two times a day four weeks (suspensions),,,gingivitis,gingivitis,,,
Probiotics (Lactobacillus),Pseudomonas aeruginosa growth in sputum cultures,Gastric Reflux,,Gut Health,manual_pair,"Clinical evidence from two randomized trials indicates that probiotics, specifically Lactobacillus strains, may improve heartburn symptoms and quality of life in individuals with gastroesophageal reflux disease. One study utilized a daily dose of 1 billion heat-killed Lactobacillus johnsonii for six weeks, while the other involved a food supplement containing Lactobacillus acidophilus over 28 days; however, specific doses for the latter were not reported. No adverse effects were noted in the studies, but further research is needed to confirm these findings and establish optimal dosing.",0.9,38674920,2024,"Beneficial Effect of Heat-Killed Lactic Acid Bacterium Lactobacillus johnsonii No. 1088 on Temporal Gastroesophageal Reflux-Related Symptoms in Healthy Volunteers: A Randomized, Placebo-Controlled, Double-Blind, Parallel-Group Study.",randomized_controlled_trial,benefit,"The study shows a significant improvement in heartburn symptoms, indicating a beneficial effect of the supplement.",1 billion once a day six weeks (heat-killed),,,gastroesophageal reflux,gastroesophageal reflux; gastroesophageal reflux disease; heartburn; quality of life,,,
Probiotics (Lactobacillus),Pseudomonas aeruginosa growth in sputum cultures,Gastric Reflux,,Gut Health,manual_pair,"Clinical evidence from two randomized trials indicates that probiotics, specifically Lactobacillus strains, may improve heartburn symptoms and quality of life in individuals with gastroesophageal reflux disease. One study utilized a daily dose of 1 billion heat-killed Lactobacillus johnsonii for six weeks, while the other involved a food supplement containing Lactobacillus acidophilus over 28 days; however, specific doses for the latter were not reported. No adverse effects were noted in the studies, but further research is needed to confirm these findings and establish optimal dosing.",0.9,38892690,2024,"Efficacy of a Food Supplement Containing Lactobacillus acidophilus LA14, Peptides, and a Multivitamin Complex in Improving Gastroesophageal Reflux Disease-Related Outcomes and Quality of Life of Subjects Showing Mild-to-Moderate Gastroesophageal Reflux Disease.",randomized_controlled_trial,benefit,"The study reported significant improvements in heartburn frequency, severity, and quality of life, indicating a beneficial outcome.",null null daily 28 days (food supplement containing Lactobacillus acidophilus),,,gastroesophageal reflux disease,gastroesophageal reflux; gastroesophageal reflux disease; heartburn; quality of life,,,
Probiotics (Lactobacillus),Pseudomonas aeruginosa growth in sputum cultures,High LDL,,Heart & Vascular Health,manual_pair,"Two randomized controlled trials have reported beneficial effects of Lactobacillus probiotics on LDL cholesterol levels in patients with hypercholesterolemia, with doses of 1 daily and 1.2 ×10^9 CFU daily for 90 days and 12 weeks, respectively. No studies reported mixed or harmful outcomes, suggesting a potential positive impact on LDL cholesterol; however, the overall evidence remains limited and further research is needed to confirm these findings.",0.8,39275232,2024,Impact of Lactocaseibacillus (Lactobacillus) paracasei sup. paracasei TISTR 2593 Probiotic Supplementation on the Gut Microbiome of Hypercholesterolemia Patients: A Randomized Controlled Trial.,randomized_controlled_trial,benefit,"The study showed significant reduction in LDL-C levels, indicating a beneficial effect on metabolic health.",1 daily daily 90 days (probiotic supplement),,,hypercholesterolemia,hypercholesterolemia; mild hypercholesterolemia,,,
Probiotics (Lactobacillus),Pseudomonas aeruginosa growth in sputum cultures,High LDL,,Heart & Vascular Health,manual_pair,"Two randomized controlled trials have reported beneficial effects of Lactobacillus probiotics on LDL cholesterol levels in patients with hypercholesterolemia, with doses of 1 daily and 1.2 ×10^9 CFU daily for 90 days and 12 weeks, respectively. No studies reported mixed or harmful outcomes, suggesting a potential positive impact on LDL cholesterol; however, the overall evidence remains limited and further research is needed to confirm these findings.",0.8,38015360,2025,Distinct Microbial Taxa Are Associated with LDL-Cholesterol Reduction after 12 Weeks of Lactobacillus plantarum Intake in Mild Hypercholesterolemia: Results of a Randomized Controlled Study.,randomized_controlled_trial,benefit,"The study found a significant reduction in LDL-C in the Lactobacillus plantarum group compared to placebo, indicating a beneficial effect.",1.2 ×10^9 CFU daily 12 weeks,,,mild hypercholesterolemia,hypercholesterolemia; mild hypercholesterolemia,,,
Probiotics (Lactobacillus),Pseudomonas aeruginosa growth in sputum cultures,Vaginal HPV,,"Immune, Inflammation, & Infection",manual_pair,"One pilot study reported a beneficial effect of intravaginal Lactobacillus crispatus chen-01 on reducing HPV viral load and improving clearance rates in women with high-risk HPV infection. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess the consistency and safety of this intervention.",0.7,39058300,2024,Effectiveness of vaginal probiotics Lactobacillus crispatus chen-01 in women with high-risk HPV infection: a prospective controlled pilot study.,randomized_controlled_trial,benefit,"The study demonstrated a significant reduction in HPV viral load and improved clearance rates, indicating a beneficial effect of the probiotic intervention.",(intravaginal transplantation),,,high-risk hpv infection,high-risk hpv infection,,,
Probiotics (Lactobacillus),Pseudomonas aeruginosa growth in sputum cultures,Liver Dysfunction,,Gut Health,manual_pair,"Current evidence from two studies suggests that Lactobacillus probiotics may improve liver function in patients with cholestatic liver injury and hepatitis B-related cirrhosis. Both studies report beneficial outcomes without any noted adverse effects. However, the overall quality of evidence is limited, and further research is needed to confirm these findings and establish optimal dosing.",0.7,39205654,2024,Lactobacillus acidophilus ameliorates cholestatic liver injury through inhibiting bile acid synthesis and promoting bile acid excretion.,randomized_controlled_trial,benefit,"The study shows that Lactobacillus acidophilus treatment improves liver function in cholestatic patients, indicating a beneficial outcome.",,,,cholestatic liver injury,cholestatic liver injury; hepatitis b-related cirrhosis; liver function recovery,,,
Probiotics (Lactobacillus),Pseudomonas aeruginosa growth in sputum cultures,Liver Dysfunction,,Gut Health,manual_pair,"Current evidence from two studies suggests that Lactobacillus probiotics may improve liver function in patients with cholestatic liver injury and hepatitis B-related cirrhosis. Both studies report beneficial outcomes without any noted adverse effects. However, the overall quality of evidence is limited, and further research is needed to confirm these findings and establish optimal dosing.",0.7,38617455,2024,Effects of Lactobacillus paracasei N1115 on gut microbial imbalance and liver function in patients with hepatitis B-related cirrhosis.,randomized_controlled_trial,benefit,"The intervention led to significant improvements in liver function and microbial diversity, indicating a beneficial effect.",12 weeks (ready-to-eat),HBV,,hepatitis b-related cirrhosis,cholestatic liver injury; hepatitis b-related cirrhosis; liver function recovery,,,
Probiotics (Lactobacillus),Pseudomonas aeruginosa growth in sputum cultures,Strength,,Performance & Recovery,manual_pair,"One randomized clinical trial reported a beneficial effect of Lactobacillus probiotics on exercise performance and muscle strength over a six-week period. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess consistency across different populations and doses.",0.6,38931275,2024,"Efficacy of Lactococcus lactis subsp. lactis LY-66 and Lactobacillus plantarum PL-02 in Enhancing Explosive Strength and Endurance: A Randomized, Double-Blinded Clinical Trial.",randomized_controlled_trial,benefit,"The study shows significant enhancements in exercise performance and muscle strength, indicating a beneficial effect of the probiotics.",six weeks,,Weight & Body Composition,endurance,endurance; exercise performance; inflammatory markers; muscle integrity; muscle strength,,,
Probiotics (Lactobacillus),Pseudomonas aeruginosa growth in sputum cultures,Canker Sores,,Oral Health,manual_pair,"One randomized clinical trial found that a topical probiotic nano-formulation of Lactobacillus reuteri applied three times a day for seven days resulted in significant improvements in lesion size and pain severity in patients with recurrent aphthous stomatitis. No studies reported mixed or negative outcomes, but the evidence is limited to a single trial, indicating a need for further research to confirm these findings and assess long-term effects.",0.7,38114936,2023,Effect of lactobacillus reuteri-derived probiotic nano-formulation on recurrent aphthous stomatitis: a double-blinded randomized clinical trial.,randomized_controlled_trial,benefit,"The probiotic group showed significant improvements in lesion size and pain severity compared to the control group, indicating a beneficial effect.",3 times a day 7 days (topical probiotic nano-formulation),,,recurrent aphthous stomatitis,recurrent aphthous stomatitis,,,
Probiotics (Lactobacillus),Pseudomonas aeruginosa growth in sputum cultures,Fatty LIver Disease,,Gut Health,manual_pair,"One pilot study reported that a multi-strain probiotic formulation containing Lactobacillus fermentum, Lactobacillus reuteri, and Lactobacillus plantarum improved liver function markers and uric acid levels over a 60-day period. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term effects and safety.",0.7,39046973,2024,"Probiotic Lactobacillus fermentum TSF331, Lactobacillus reuteri TSR332, and Lactobacillus plantarum TSP05 improved liver function and uric acid management-A pilot study.",randomized_controlled_trial,benefit,"The study demonstrated significant reductions in liver function markers and uric acid levels, indicating a beneficial effect of the probiotics.",daily 60 days (multi-strain probiotics),,,abnormal liver function,abnormal liver function; increased uric acid levels; metabolic-associated fatty liver disease (mafld),,,
Probiotics (Lactobacillus),Pseudomonas aeruginosa growth in sputum cultures,Premenstrual Syndrome,,Women's Health,manual_pair,"One randomized, double-blind, placebo-controlled study found that Lactobacillus paragasseri OLL2809 improved premenstrual psychological symptoms in healthy women over three menstrual cycles. No adverse effects were reported, but the evidence is limited to a single study, indicating a need for further research to confirm these findings.",0.7,38068843,2023,"Lactobacillus paragasseri OLL2809 Improves Premenstrual Psychological Symptoms in Healthy Women: A Randomized, Double-Blind, Placebo-Controlled Study.",randomized_controlled_trial,benefit,"The study shows significant improvement in premenstrual symptoms, indicating a beneficial effect of the supplement.",null null daily three menstrual cycles (tablets),Women,,menstrual symptoms,menstrual symptoms; premenstrual syndrome,,,
Probiotics (Lactobacillus),Pseudomonas aeruginosa growth in sputum cultures,Bacterial Vaginosus,,Women's Health,manual_pair,"One randomized trial indicates that Lactobacillus crispatus (LACTIN-V) may reduce the recurrence of bacterial vaginosis in women who have achieved clinical cure after antibiotic treatment. The evidence is limited to this single study, and no adverse effects were reported. Further research is needed to confirm these findings and establish consistent dosing guidelines.",0.7,38733973,2024,Response to Antibiotic Treatment of Bacterial Vaginosis Predicts the Effectiveness of LACTIN-V (Lactobacillus crispatus CTV-05) in the Prevention of Recurrent Disease.,randomized_controlled_trial,benefit,"The study shows that LACTIN-V decreases BV recurrence in women who achieved clinical cure after antibiotic treatment, indicating a beneficial outcome.",11 weeks (vaginal),Women,,bacterial vaginosis,bacterial vaginosis,,,
Probiotics (Lactobacillus),Pseudomonas aeruginosa growth in sputum cultures,UTI,,Kidney & Bladder Health,manual_pair,"One study has shown that a supplement combining Lactobacillus strains and proanthocyanidin-rich plant extracts may significantly reduce the recurrence of uncomplicated urinary tract infections and improve quality of life in women with recurrent cystitis when taken daily for six months. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term effects and safety.",0.7,39791583,2025,"Effects of a supplement associating Lactobacillus strains and proanthocyanidin-rich plant extracts against recurrent uncomplicated, urinary tract infections: A prospective, controlled study.",clinical_trial,benefit,The study shows significant benefits in reducing recurrence and improving quality of life for women with recurrent cystitis.,daily 6 months (supplement),,,recurrent cystitis,recurrent cystitis; urinary tract infections,,,
Probiotics (Lactobacillus),Pseudomonas aeruginosa growth in sputum cultures,Vulvovaginal Candidiasis,,Women's Health,manual_pair,"One randomized trial indicates that Lactobacillus probiotics may have beneficial effects in restoring vaginal and gut microbiota in pregnant women with vaginal candidiasis, using a dose of 2 capsules twice a day for 8 weeks. However, the overall evidence is limited, with only one study demonstrating a positive outcome and no reports of harm or mixed results.",0.7,38350486,2023,Lactobacillus probiotics restore vaginal and gut microbiota of pregnant women with vaginal candidiasis.,randomized_controlled_trial,benefit,The administration of probiotics showed beneficial effects in preventing shifts in microbiota associated with vaginal candidiasis.,2 capsules twice a day 8 weeks,Women,,gut microbiota modulation,gut microbiota modulation; vaginal candidiasis,,,
Probiotics (Lactobacillus),Pseudomonas aeruginosa growth in sputum cultures,Vaginal Health,,Women's Health,manual_pair,"Current evidence suggests that Lactobacillus gasseri CECT 30648 may benefit vaginal dysbiosis by colonizing the vaginal tract and improving microbiota, based on a single study with a dose of 10^9 CFU daily for up to 18 days. However, the overall evidence is limited, and further research is needed to confirm these findings and assess long-term effects and safety.",0.7,40772934,2025,Lactobacillus gasseri CECT 30648 shows probiotic characteristics and colonizes the vagina of healthy women after oral administration.,randomized_controlled_trial,benefit,"The study shows that L. gasseri CECT 30648 can colonize the vaginal tract and improve vaginal microbiota, indicating a beneficial outcome.",10^9 CFU daily up to 18 days (capsule),Women,,vaginal dysbiosis,vaginal dysbiosis; vaginal health,,,
Red Yeast Rice,"Epstein Barr virus infection; duodenitis; elevated liver enzymes in two subjects; increased risk of adverse health outcomes related to uric acid, alanine transaminase and aspartate transaminase levels; liver and kidney injury risk; mild profile of adverse reactions; minor side-effects reported; myalgia in four participants; myalgia in patients with SAMS history; severe muscle ache in one participant with Segawa's syndrome; significant increase in creatine phosphokinase",Schizophrenia,,"Energy, Mood, & Mental Health",manual_pair,"There is low-quality evidence suggesting that Red Yeast Rice may improve cognitive functioning in individuals with schizophrenia, based on a pilot study that reported significant benefits with a daily dose of 200 mg over 12 weeks. However, due to the limited number of studies and the specific population examined, the overall evidence for its efficacy in cognitive impairment or memory problems is insufficient and should be interpreted with caution.",0.6,30921099,2019,Effect of Red Yeast Rice on Cognitive Functioning in Schizophrenia: Data From a Pilot Study.,clinical_trial,benefit,"The study showed significant improvements in cognitive functioning, indicating a beneficial effect of Red Yeast Rice on cognitive deficits in schizophrenia.",200 mg daily 12 weeks (Red Yeast Rice),,,cognitive deficits in schizophrenia,cognitive deficits in schizophrenia,,,
Red Yeast Rice,"Epstein Barr virus infection; duodenitis; elevated liver enzymes in two subjects; increased risk of adverse health outcomes related to uric acid, alanine transaminase and aspartate transaminase levels; liver and kidney injury risk; mild profile of adverse reactions; minor side-effects reported; myalgia in four participants; myalgia in patients with SAMS history; severe muscle ache in one participant with Segawa's syndrome; significant increase in creatine phosphokinase",High LDL,,Heart & Vascular Health,manual_pair,"Red yeast rice has shown consistent benefits in lowering cholesterol levels across multiple randomized trials, with no reported harms. Typical doses reported include 200 mg to 2400 mg daily, with significant improvements noted in lipid profiles and endothelial function. However, the evidence does not address potential long-term safety or adverse effects associated with its use.",0.9,19699071,2010,"Effects of a nutraceutical combination (berberine, red yeast rice and policosanols) on lipid levels and endothelial function randomized, double-blind, placebo-controlled study.",randomized_controlled_trial,benefit,"The study showed significant reductions in cholesterol levels and improvements in endothelial function, indicating a beneficial effect.",200 mg daily 6 weeks (oral),,,hypercholesterolemia,cholesterol levels; heart disease prevention; hypercholesterolemia; hyperlipidemia; hypertension; metabolic syndrome,,,
Red Yeast Rice,"Epstein Barr virus infection; duodenitis; elevated liver enzymes in two subjects; increased risk of adverse health outcomes related to uric acid, alanine transaminase and aspartate transaminase levels; liver and kidney injury risk; mild profile of adverse reactions; minor side-effects reported; myalgia in four participants; myalgia in patients with SAMS history; severe muscle ache in one participant with Segawa's syndrome; significant increase in creatine phosphokinase",High LDL,,Heart & Vascular Health,manual_pair,"Red yeast rice has shown consistent benefits in lowering cholesterol levels across multiple randomized trials, with no reported harms. Typical doses reported include 200 mg to 2400 mg daily, with significant improvements noted in lipid profiles and endothelial function. However, the evidence does not address potential long-term safety or adverse effects associated with its use.",0.9,22348456,2012,"Combined extractives of red yeast rice, bitter gourd, chlorella, soy protein, and licorice improve total cholesterol, low-density lipoprotein cholesterol, and triglyceride in subjects with metabolic syndrome.",randomized_controlled_trial,benefit,"The study showed significant reductions in total cholesterol, LDL cholesterol, and triglycerides, indicating a beneficial effect on lipid profiles in subjects with metabolic syndrome.",12 weeks (plant-extractive compound),,,hyperlipidemia,cholesterol levels; heart disease prevention; hypercholesterolemia; hyperlipidemia; hypertension; metabolic syndrome,,,
Red Yeast Rice,"Epstein Barr virus infection; duodenitis; elevated liver enzymes in two subjects; increased risk of adverse health outcomes related to uric acid, alanine transaminase and aspartate transaminase levels; liver and kidney injury risk; mild profile of adverse reactions; minor side-effects reported; myalgia in four participants; myalgia in patients with SAMS history; severe muscle ache in one participant with Segawa's syndrome; significant increase in creatine phosphokinase",High LDL,,Heart & Vascular Health,manual_pair,"Red yeast rice has shown consistent benefits in lowering cholesterol levels across multiple randomized trials, with no reported harms. Typical doses reported include 200 mg to 2400 mg daily, with significant improvements noted in lipid profiles and endothelial function. However, the evidence does not address potential long-term safety or adverse effects associated with its use.",0.9,19786378,2009,Combined nattokinase with red yeast rice but not nattokinase alone has potent effects on blood lipids in human subjects with hyperlipidemia.,randomized_controlled_trial,benefit,"The combined formula showed significant improvements in lipid profiles, indicating a beneficial effect.",300 mg twice daily six months (extract),,,hyperlipidemia,cholesterol levels; heart disease prevention; hypercholesterolemia; hyperlipidemia; hypertension; metabolic syndrome,,,
Red Yeast Rice,"Epstein Barr virus infection; duodenitis; elevated liver enzymes in two subjects; increased risk of adverse health outcomes related to uric acid, alanine transaminase and aspartate transaminase levels; liver and kidney injury risk; mild profile of adverse reactions; minor side-effects reported; myalgia in four participants; myalgia in patients with SAMS history; severe muscle ache in one participant with Segawa's syndrome; significant increase in creatine phosphokinase",High LDL,,Heart & Vascular Health,manual_pair,"Red yeast rice has been shown to significantly reduce LDL cholesterol levels in multiple randomized controlled trials, with beneficial outcomes reported across various doses, typically ranging from 10 mg to 2400 mg daily. While the evidence is predominantly positive, one study indicated mixed outcomes regarding tolerability compared to pravastatin, suggesting the need for caution in specific populations. Overall, the evidence supports its use for managing high LDL cholesterol, but further research may be warranted to fully understand its safety profile.",0.9,23352857,2013,Improved dissolution rate and oral bioavailability of lovastatin in red yeast rice products.,randomized_controlled_trial,benefit,"The study shows improved bioavailability of lovastatin from red yeast rice, indicating a beneficial effect on cholesterol levels.",(capsules or powder),,,blood cholesterol lowering,blood cholesterol lowering; cardiovascular diseases; cardiovascular risk; dyslipidemia; hypercholesterolemia; hyperlipidemia; metabolic syndrome; moderate hypercholesterolemia; myalgia; obesity-related diseases; statin intolerance; statin-associated myalgia,,,
Red Yeast Rice,"Epstein Barr virus infection; duodenitis; elevated liver enzymes in two subjects; increased risk of adverse health outcomes related to uric acid, alanine transaminase and aspartate transaminase levels; liver and kidney injury risk; mild profile of adverse reactions; minor side-effects reported; myalgia in four participants; myalgia in patients with SAMS history; severe muscle ache in one participant with Segawa's syndrome; significant increase in creatine phosphokinase",High LDL,,Heart & Vascular Health,manual_pair,"Red yeast rice has been shown to significantly reduce LDL cholesterol levels in multiple randomized controlled trials, with beneficial outcomes reported across various doses, typically ranging from 10 mg to 2400 mg daily. While the evidence is predominantly positive, one study indicated mixed outcomes regarding tolerability compared to pravastatin, suggesting the need for caution in specific populations. Overall, the evidence supports its use for managing high LDL cholesterol, but further research may be warranted to fully understand its safety profile.",0.9,23860021,2013,"Relationship between adiponectin and leptin, and blood lipids in hyperlipidemia patients treated with red yeast rice.",randomized_controlled_trial,benefit,"The study shows significant reductions in LDL-C and total cholesterol, indicating a beneficial effect of red yeast rice on lipid profiles.",600 mg twice a day 8 weeks (capsules),,,cardiovascular diseases,blood cholesterol lowering; cardiovascular diseases; cardiovascular risk; dyslipidemia; hypercholesterolemia; hyperlipidemia; metabolic syndrome; moderate hypercholesterolemia; myalgia; obesity-related diseases; statin intolerance; statin-associated myalgia,,,
Red Yeast Rice,"Epstein Barr virus infection; duodenitis; elevated liver enzymes in two subjects; increased risk of adverse health outcomes related to uric acid, alanine transaminase and aspartate transaminase levels; liver and kidney injury risk; mild profile of adverse reactions; minor side-effects reported; myalgia in four participants; myalgia in patients with SAMS history; severe muscle ache in one participant with Segawa's syndrome; significant increase in creatine phosphokinase",High LDL,,Heart & Vascular Health,manual_pair,"Red yeast rice has been shown to significantly reduce LDL cholesterol levels in multiple randomized controlled trials, with beneficial outcomes reported across various doses, typically ranging from 10 mg to 2400 mg daily. While the evidence is predominantly positive, one study indicated mixed outcomes regarding tolerability compared to pravastatin, suggesting the need for caution in specific populations. Overall, the evidence supports its use for managing high LDL cholesterol, but further research may be warranted to fully understand its safety profile.",0.9,30795775,2019,"Nutraceutical approach for the management of cardiovascular risk - a combination containing the probiotic Bifidobacterium longum BB536 and red yeast rice extract: results from a randomized, double-blind, placebo-controlled study.",randomized_controlled_trial,benefit,"The study showed significant reductions in lipid markers associated with cardiovascular risk, indicating a beneficial effect of the nutraceutical combination.",10 mg daily 12 weeks (red yeast rice extract),,,cardiovascular risk,blood cholesterol lowering; cardiovascular diseases; cardiovascular risk; dyslipidemia; hypercholesterolemia; hyperlipidemia; metabolic syndrome; moderate hypercholesterolemia; myalgia; obesity-related diseases; statin intolerance; statin-associated myalgia,,,
Red Yeast Rice,"Epstein Barr virus infection; duodenitis; elevated liver enzymes in two subjects; increased risk of adverse health outcomes related to uric acid, alanine transaminase and aspartate transaminase levels; liver and kidney injury risk; mild profile of adverse reactions; minor side-effects reported; myalgia in four participants; myalgia in patients with SAMS history; severe muscle ache in one participant with Segawa's syndrome; significant increase in creatine phosphokinase",High LDL,,Heart & Vascular Health,manual_pair,"Red yeast rice has been shown to significantly reduce LDL cholesterol levels in multiple randomized controlled trials, with beneficial outcomes reported across various doses, typically ranging from 10 mg to 2400 mg daily. While the evidence is predominantly positive, one study indicated mixed outcomes regarding tolerability compared to pravastatin, suggesting the need for caution in specific populations. Overall, the evidence supports its use for managing high LDL cholesterol, but further research may be warranted to fully understand its safety profile.",0.9,25879228,2015,"Can red yeast rice and olive extract improve lipid profile and cardiovascular risk in metabolic syndrome?: A double blind, placebo controlled randomized trial.",randomized_controlled_trial,benefit,"The study showed significant reductions in LDL cholesterol and other lipid parameters, indicating a beneficial effect.",10.82 mg per capsule 8 weeks (combined with olive fruit extract),,,cardiovascular risk,blood cholesterol lowering; cardiovascular diseases; cardiovascular risk; dyslipidemia; hypercholesterolemia; hyperlipidemia; metabolic syndrome; moderate hypercholesterolemia; myalgia; obesity-related diseases; statin intolerance; statin-associated myalgia,,,
Red Yeast Rice,"Epstein Barr virus infection; duodenitis; elevated liver enzymes in two subjects; increased risk of adverse health outcomes related to uric acid, alanine transaminase and aspartate transaminase levels; liver and kidney injury risk; mild profile of adverse reactions; minor side-effects reported; myalgia in four participants; myalgia in patients with SAMS history; severe muscle ache in one participant with Segawa's syndrome; significant increase in creatine phosphokinase",High LDL,,Heart & Vascular Health,manual_pair,"Red yeast rice has been shown to significantly reduce LDL cholesterol levels in multiple randomized controlled trials, with beneficial outcomes reported across various doses, typically ranging from 10 mg to 2400 mg daily. While the evidence is predominantly positive, one study indicated mixed outcomes regarding tolerability compared to pravastatin, suggesting the need for caution in specific populations. Overall, the evidence supports its use for managing high LDL cholesterol, but further research may be warranted to fully understand its safety profile.",0.9,23866314,2013,"Red yeast rice lowers cholesterol in physicians - a double blind, placebo controlled randomized trial.",randomized_controlled_trial,benefit,"The study showed a significant reduction in total and LDL cholesterol, indicating a benefit from RYR supplementation.",36 mg/dL 8 weeks (RYR extract),,,cardiovascular risk,blood cholesterol lowering; cardiovascular diseases; cardiovascular risk; dyslipidemia; hypercholesterolemia; hyperlipidemia; metabolic syndrome; moderate hypercholesterolemia; myalgia; obesity-related diseases; statin intolerance; statin-associated myalgia,,,
Red Yeast Rice,"Epstein Barr virus infection; duodenitis; elevated liver enzymes in two subjects; increased risk of adverse health outcomes related to uric acid, alanine transaminase and aspartate transaminase levels; liver and kidney injury risk; mild profile of adverse reactions; minor side-effects reported; myalgia in four participants; myalgia in patients with SAMS history; severe muscle ache in one participant with Segawa's syndrome; significant increase in creatine phosphokinase",High LDL,,Heart & Vascular Health,manual_pair,"Red yeast rice has been shown to significantly reduce LDL cholesterol levels in multiple randomized controlled trials, with beneficial outcomes reported across various doses, typically ranging from 10 mg to 2400 mg daily. While the evidence is predominantly positive, one study indicated mixed outcomes regarding tolerability compared to pravastatin, suggesting the need for caution in specific populations. Overall, the evidence supports its use for managing high LDL cholesterol, but further research may be warranted to fully understand its safety profile.",0.9,35473348,2022,Effectiveness and safety of red yeast rice predominated by monacolin K β-hydroxy acid form for hyperlipidemia treatment and management.,randomized_controlled_trial,benefit,"The study shows significant reductions in LDL-C and TC, indicating a beneficial effect of MKA in treating hyperlipidemia.",low 60 (MKA); high 60 (MKA),,,dyslipidemia,blood cholesterol lowering; cardiovascular diseases; cardiovascular risk; dyslipidemia; hypercholesterolemia; hyperlipidemia; metabolic syndrome; moderate hypercholesterolemia; myalgia; obesity-related diseases; statin intolerance; statin-associated myalgia,,,
Red Yeast Rice,"Epstein Barr virus infection; duodenitis; elevated liver enzymes in two subjects; increased risk of adverse health outcomes related to uric acid, alanine transaminase and aspartate transaminase levels; liver and kidney injury risk; mild profile of adverse reactions; minor side-effects reported; myalgia in four participants; myalgia in patients with SAMS history; severe muscle ache in one participant with Segawa's syndrome; significant increase in creatine phosphokinase",High LDL,,Heart & Vascular Health,manual_pair,"Red yeast rice has been shown to significantly reduce LDL cholesterol levels in multiple randomized controlled trials, with beneficial outcomes reported across various doses, typically ranging from 10 mg to 2400 mg daily. While the evidence is predominantly positive, one study indicated mixed outcomes regarding tolerability compared to pravastatin, suggesting the need for caution in specific populations. Overall, the evidence supports its use for managing high LDL cholesterol, but further research may be warranted to fully understand its safety profile.",0.9,34587702,2021,"Low dose red yeast rice with monacolin K lowers LDL cholesterol and blood pressure in Japanese with mild dyslipidemia: A multicenter, randomized trial.",randomized_controlled_trial,benefit,"The study demonstrated significant reductions in LDL cholesterol and blood pressure, indicating a beneficial effect of low dose red yeast rice in patients with dyslipidemia.",200 mg daily 8 weeks (red yeast rice),,,dyslipidemia,blood cholesterol lowering; cardiovascular diseases; cardiovascular risk; dyslipidemia; hypercholesterolemia; hyperlipidemia; metabolic syndrome; moderate hypercholesterolemia; myalgia; obesity-related diseases; statin intolerance; statin-associated myalgia,,,
Red Yeast Rice,"Epstein Barr virus infection; duodenitis; elevated liver enzymes in two subjects; increased risk of adverse health outcomes related to uric acid, alanine transaminase and aspartate transaminase levels; liver and kidney injury risk; mild profile of adverse reactions; minor side-effects reported; myalgia in four participants; myalgia in patients with SAMS history; severe muscle ache in one participant with Segawa's syndrome; significant increase in creatine phosphokinase",High LDL,,Heart & Vascular Health,manual_pair,"Red yeast rice has been shown to significantly reduce LDL cholesterol levels in multiple randomized controlled trials, with beneficial outcomes reported across various doses, typically ranging from 10 mg to 2400 mg daily. While the evidence is predominantly positive, one study indicated mixed outcomes regarding tolerability compared to pravastatin, suggesting the need for caution in specific populations. Overall, the evidence supports its use for managing high LDL cholesterol, but further research may be warranted to fully understand its safety profile.",0.9,31987238,2020,"Efficacy and tolerability of a nutraceutical combination of red yeast rice, guggulipid, and chromium picolinate evaluated in a randomized, placebo-controlled, double-blind study.",randomized_controlled_trial,benefit,"The study demonstrated a significant reduction in total cholesterol and LDL levels, indicating a beneficial effect of the nutraceutical combination.",8 weeks (NutraforChol®),,,dyslipidemia,blood cholesterol lowering; cardiovascular diseases; cardiovascular risk; dyslipidemia; hypercholesterolemia; hyperlipidemia; metabolic syndrome; moderate hypercholesterolemia; myalgia; obesity-related diseases; statin intolerance; statin-associated myalgia,,,
Red Yeast Rice,"Epstein Barr virus infection; duodenitis; elevated liver enzymes in two subjects; increased risk of adverse health outcomes related to uric acid, alanine transaminase and aspartate transaminase levels; liver and kidney injury risk; mild profile of adverse reactions; minor side-effects reported; myalgia in four participants; myalgia in patients with SAMS history; severe muscle ache in one participant with Segawa's syndrome; significant increase in creatine phosphokinase",High LDL,,Heart & Vascular Health,manual_pair,"Red yeast rice has been shown to significantly reduce LDL cholesterol levels in multiple randomized controlled trials, with beneficial outcomes reported across various doses, typically ranging from 10 mg to 2400 mg daily. While the evidence is predominantly positive, one study indicated mixed outcomes regarding tolerability compared to pravastatin, suggesting the need for caution in specific populations. Overall, the evidence supports its use for managing high LDL cholesterol, but further research may be warranted to fully understand its safety profile.",0.9,25001663,2014,"A randomized, placebo-controlled study on the effects of a nutraceutical combination of red yeast rice, silybum marianum and octasonol on lipid profile, endothelial and inflammatory parameters.",randomized_controlled_trial,benefit,"The study showed significant improvements in lipid profile and inflammatory parameters, indicating a benefit from the intervention.",1 tablet daily 3 months (tablet),,"Immune, Inflammation, & Infection",dyslipidemia,blood cholesterol lowering; cardiovascular diseases; cardiovascular risk; dyslipidemia; hypercholesterolemia; hyperlipidemia; metabolic syndrome; moderate hypercholesterolemia; myalgia; obesity-related diseases; statin intolerance; statin-associated myalgia,,,
Red Yeast Rice,"Epstein Barr virus infection; duodenitis; elevated liver enzymes in two subjects; increased risk of adverse health outcomes related to uric acid, alanine transaminase and aspartate transaminase levels; liver and kidney injury risk; mild profile of adverse reactions; minor side-effects reported; myalgia in four participants; myalgia in patients with SAMS history; severe muscle ache in one participant with Segawa's syndrome; significant increase in creatine phosphokinase",High LDL,,Heart & Vascular Health,manual_pair,"Red yeast rice has been shown to significantly reduce LDL cholesterol levels in multiple randomized controlled trials, with beneficial outcomes reported across various doses, typically ranging from 10 mg to 2400 mg daily. While the evidence is predominantly positive, one study indicated mixed outcomes regarding tolerability compared to pravastatin, suggesting the need for caution in specific populations. Overall, the evidence supports its use for managing high LDL cholesterol, but further research may be warranted to fully understand its safety profile.",0.9,19528562,2009,Red yeast rice for dyslipidemia in statin-intolerant patients: a randomized trial.,randomized_controlled_trial,benefit,"Red yeast rice significantly decreased LDL cholesterol levels compared to placebo, indicating a beneficial effect.",1800 mg twice daily 24 weeks,,,dyslipidemia,blood cholesterol lowering; cardiovascular diseases; cardiovascular risk; dyslipidemia; hypercholesterolemia; hyperlipidemia; metabolic syndrome; moderate hypercholesterolemia; myalgia; obesity-related diseases; statin intolerance; statin-associated myalgia,,,
Red Yeast Rice,"Epstein Barr virus infection; duodenitis; elevated liver enzymes in two subjects; increased risk of adverse health outcomes related to uric acid, alanine transaminase and aspartate transaminase levels; liver and kidney injury risk; mild profile of adverse reactions; minor side-effects reported; myalgia in four participants; myalgia in patients with SAMS history; severe muscle ache in one participant with Segawa's syndrome; significant increase in creatine phosphokinase",High LDL,,Heart & Vascular Health,manual_pair,"Red yeast rice has been shown to significantly reduce LDL cholesterol levels in multiple randomized controlled trials, with beneficial outcomes reported across various doses, typically ranging from 10 mg to 2400 mg daily. While the evidence is predominantly positive, one study indicated mixed outcomes regarding tolerability compared to pravastatin, suggesting the need for caution in specific populations. Overall, the evidence supports its use for managing high LDL cholesterol, but further research may be warranted to fully understand its safety profile.",0.9,29154060,2017,Efficacy and safety of a combination of red yeast rice and olive extract in hypercholesterolemic patients with and without statin-associated myalgia.,clinical_trial,benefit,"The study showed a significant decrease in LDL-C and other lipid parameters, indicating a benefit for hypercholesterolemic patients.",1 tablet daily 2 months,,,hypercholesterolemia,blood cholesterol lowering; cardiovascular diseases; cardiovascular risk; dyslipidemia; hypercholesterolemia; hyperlipidemia; metabolic syndrome; moderate hypercholesterolemia; myalgia; obesity-related diseases; statin intolerance; statin-associated myalgia,,,
Red Yeast Rice,"Epstein Barr virus infection; duodenitis; elevated liver enzymes in two subjects; increased risk of adverse health outcomes related to uric acid, alanine transaminase and aspartate transaminase levels; liver and kidney injury risk; mild profile of adverse reactions; minor side-effects reported; myalgia in four participants; myalgia in patients with SAMS history; severe muscle ache in one participant with Segawa's syndrome; significant increase in creatine phosphokinase",High LDL,,Heart & Vascular Health,manual_pair,"Red yeast rice has been shown to significantly reduce LDL cholesterol levels in multiple randomized controlled trials, with beneficial outcomes reported across various doses, typically ranging from 10 mg to 2400 mg daily. While the evidence is predominantly positive, one study indicated mixed outcomes regarding tolerability compared to pravastatin, suggesting the need for caution in specific populations. Overall, the evidence supports its use for managing high LDL cholesterol, but further research may be warranted to fully understand its safety profile.",0.9,27055107,2016,"Middle-Term Dietary Supplementation with Red Yeast Rice Plus Coenzyme Q10 Improves Lipid Pattern, Endothelial Reactivity and Arterial Stiffness in Moderately Hypercholesterolemic Subjects.",randomized_controlled_trial,benefit,"The study shows significant improvements in LDL cholesterol, endothelial reactivity, and arterial stiffness, indicating a beneficial effect of red yeast rice.",10 mg daily 6 months (monacolin with Coenzyme Q10),,,hypercholesterolemia,blood cholesterol lowering; cardiovascular diseases; cardiovascular risk; dyslipidemia; hypercholesterolemia; hyperlipidemia; metabolic syndrome; moderate hypercholesterolemia; myalgia; obesity-related diseases; statin intolerance; statin-associated myalgia,,,
Red Yeast Rice,"Epstein Barr virus infection; duodenitis; elevated liver enzymes in two subjects; increased risk of adverse health outcomes related to uric acid, alanine transaminase and aspartate transaminase levels; liver and kidney injury risk; mild profile of adverse reactions; minor side-effects reported; myalgia in four participants; myalgia in patients with SAMS history; severe muscle ache in one participant with Segawa's syndrome; significant increase in creatine phosphokinase",High LDL,,Heart & Vascular Health,manual_pair,"Red yeast rice has been shown to significantly reduce LDL cholesterol levels in multiple randomized controlled trials, with beneficial outcomes reported across various doses, typically ranging from 10 mg to 2400 mg daily. While the evidence is predominantly positive, one study indicated mixed outcomes regarding tolerability compared to pravastatin, suggesting the need for caution in specific populations. Overall, the evidence supports its use for managing high LDL cholesterol, but further research may be warranted to fully understand its safety profile.",0.9,23890351,2013,"Red yeast rice improves lipid pattern, high-sensitivity C-reactive protein, and vascular remodeling parameters in moderately hypercholesterolemic Italian subjects.",randomized_controlled_trial,benefit,"The study shows a significant reduction in cholesterol and hs-CRP levels, indicating a beneficial effect of the supplement.",10 mg 4 weeks,,"Immune, Inflammation, & Infection",hypercholesterolemia,blood cholesterol lowering; cardiovascular diseases; cardiovascular risk; dyslipidemia; hypercholesterolemia; hyperlipidemia; metabolic syndrome; moderate hypercholesterolemia; myalgia; obesity-related diseases; statin intolerance; statin-associated myalgia,,,
Red Yeast Rice,"Epstein Barr virus infection; duodenitis; elevated liver enzymes in two subjects; increased risk of adverse health outcomes related to uric acid, alanine transaminase and aspartate transaminase levels; liver and kidney injury risk; mild profile of adverse reactions; minor side-effects reported; myalgia in four participants; myalgia in patients with SAMS history; severe muscle ache in one participant with Segawa's syndrome; significant increase in creatine phosphokinase",High LDL,,Heart & Vascular Health,manual_pair,"Red yeast rice has been shown to significantly reduce LDL cholesterol levels in multiple randomized controlled trials, with beneficial outcomes reported across various doses, typically ranging from 10 mg to 2400 mg daily. While the evidence is predominantly positive, one study indicated mixed outcomes regarding tolerability compared to pravastatin, suggesting the need for caution in specific populations. Overall, the evidence supports its use for managing high LDL cholesterol, but further research may be warranted to fully understand its safety profile.",0.9,23816039,2013,"Phytosterols, red yeast rice, and lifestyle changes instead of statins: a randomized, double-blinded, placebo-controlled trial.",randomized_controlled_trial,benefit,"The study showed significant decreases in LDL-C and other lipid parameters, indicating a benefit from Red Yeast Rice.",1800 mg twice daily 1 year,,"Immune, Inflammation, & Infection",hypercholesterolemia,blood cholesterol lowering; cardiovascular diseases; cardiovascular risk; dyslipidemia; hypercholesterolemia; hyperlipidemia; metabolic syndrome; moderate hypercholesterolemia; myalgia; obesity-related diseases; statin intolerance; statin-associated myalgia,,,
Red Yeast Rice,"Epstein Barr virus infection; duodenitis; elevated liver enzymes in two subjects; increased risk of adverse health outcomes related to uric acid, alanine transaminase and aspartate transaminase levels; liver and kidney injury risk; mild profile of adverse reactions; minor side-effects reported; myalgia in four participants; myalgia in patients with SAMS history; severe muscle ache in one participant with Segawa's syndrome; significant increase in creatine phosphokinase",High LDL,,Heart & Vascular Health,manual_pair,"Red yeast rice has been shown to significantly reduce LDL cholesterol levels in multiple randomized controlled trials, with beneficial outcomes reported across various doses, typically ranging from 10 mg to 2400 mg daily. While the evidence is predominantly positive, one study indicated mixed outcomes regarding tolerability compared to pravastatin, suggesting the need for caution in specific populations. Overall, the evidence supports its use for managing high LDL cholesterol, but further research may be warranted to fully understand its safety profile.",0.9,22531006,2012,Powdered red yeast rice and plant stanols and sterols to lower cholesterol.,clinical_trial,benefit,"The study reported a significant reduction in LDL cholesterol, indicating a beneficial effect of the supplement.",6 weeks (powdered shake),,,hypercholesterolemia,blood cholesterol lowering; cardiovascular diseases; cardiovascular risk; dyslipidemia; hypercholesterolemia; hyperlipidemia; metabolic syndrome; moderate hypercholesterolemia; myalgia; obesity-related diseases; statin intolerance; statin-associated myalgia,,,
Red Yeast Rice,"Epstein Barr virus infection; duodenitis; elevated liver enzymes in two subjects; increased risk of adverse health outcomes related to uric acid, alanine transaminase and aspartate transaminase levels; liver and kidney injury risk; mild profile of adverse reactions; minor side-effects reported; myalgia in four participants; myalgia in patients with SAMS history; severe muscle ache in one participant with Segawa's syndrome; significant increase in creatine phosphokinase",High LDL,,Heart & Vascular Health,manual_pair,"Red yeast rice has been shown to significantly reduce LDL cholesterol levels in multiple randomized controlled trials, with beneficial outcomes reported across various doses, typically ranging from 10 mg to 2400 mg daily. While the evidence is predominantly positive, one study indicated mixed outcomes regarding tolerability compared to pravastatin, suggesting the need for caution in specific populations. Overall, the evidence supports its use for managing high LDL cholesterol, but further research may be warranted to fully understand its safety profile.",0.9,22113535,2011,"Long-term effects of nutraceuticals (berberine, red yeast rice, policosanol) in elderly hypercholesterolemic patients.",randomized_controlled_trial,benefit,"The study demonstrated a significant reduction in cholesterol levels, indicating a beneficial effect of the treatment.","200 mg 3, 6, and 12 months (combined pill)",Older Adults,Metabolic Health,hypercholesterolemia,blood cholesterol lowering; cardiovascular diseases; cardiovascular risk; dyslipidemia; hypercholesterolemia; hyperlipidemia; metabolic syndrome; moderate hypercholesterolemia; myalgia; obesity-related diseases; statin intolerance; statin-associated myalgia,,,
Red Yeast Rice,"Epstein Barr virus infection; duodenitis; elevated liver enzymes in two subjects; increased risk of adverse health outcomes related to uric acid, alanine transaminase and aspartate transaminase levels; liver and kidney injury risk; mild profile of adverse reactions; minor side-effects reported; myalgia in four participants; myalgia in patients with SAMS history; severe muscle ache in one participant with Segawa's syndrome; significant increase in creatine phosphokinase",High LDL,,Heart & Vascular Health,manual_pair,"Red yeast rice has been shown to significantly reduce LDL cholesterol levels in multiple randomized controlled trials, with beneficial outcomes reported across various doses, typically ranging from 10 mg to 2400 mg daily. While the evidence is predominantly positive, one study indicated mixed outcomes regarding tolerability compared to pravastatin, suggesting the need for caution in specific populations. Overall, the evidence supports its use for managing high LDL cholesterol, but further research may be warranted to fully understand its safety profile.",0.9,20636227,2010,HypoCol (red yeast rice) lowers plasma cholesterol - a randomized placebo controlled study.,randomized_controlled_trial,benefit,"The study shows a significant reduction in LDL-cholesterol and total cholesterol, indicating a beneficial effect.",4 capsules daily 16 weeks (HypoCol),,,hypercholesterolemia,blood cholesterol lowering; cardiovascular diseases; cardiovascular risk; dyslipidemia; hypercholesterolemia; hyperlipidemia; metabolic syndrome; moderate hypercholesterolemia; myalgia; obesity-related diseases; statin intolerance; statin-associated myalgia,,,
Red Yeast Rice,"Epstein Barr virus infection; duodenitis; elevated liver enzymes in two subjects; increased risk of adverse health outcomes related to uric acid, alanine transaminase and aspartate transaminase levels; liver and kidney injury risk; mild profile of adverse reactions; minor side-effects reported; myalgia in four participants; myalgia in patients with SAMS history; severe muscle ache in one participant with Segawa's syndrome; significant increase in creatine phosphokinase",High LDL,,Heart & Vascular Health,manual_pair,"Red yeast rice has been shown to significantly reduce LDL cholesterol levels in multiple randomized controlled trials, with beneficial outcomes reported across various doses, typically ranging from 10 mg to 2400 mg daily. While the evidence is predominantly positive, one study indicated mixed outcomes regarding tolerability compared to pravastatin, suggesting the need for caution in specific populations. Overall, the evidence supports its use for managing high LDL cholesterol, but further research may be warranted to fully understand its safety profile.",0.9,30871361,2019,A Randomized Clinical Efficacy Trial of Red Yeast Rice (Monascus pilosus) Against Hyperlipidemia.,randomized_controlled_trial,benefit,"The study demonstrated a significant reduction in serum TC and LDL-C levels in the monacolin K group, indicating a benefit for hyperlipidemia treatment.",3 months (monacolin K-rich RYR),,,hyperlipidemia,blood cholesterol lowering; cardiovascular diseases; cardiovascular risk; dyslipidemia; hypercholesterolemia; hyperlipidemia; metabolic syndrome; moderate hypercholesterolemia; myalgia; obesity-related diseases; statin intolerance; statin-associated myalgia,,,
Red Yeast Rice,"Epstein Barr virus infection; duodenitis; elevated liver enzymes in two subjects; increased risk of adverse health outcomes related to uric acid, alanine transaminase and aspartate transaminase levels; liver and kidney injury risk; mild profile of adverse reactions; minor side-effects reported; myalgia in four participants; myalgia in patients with SAMS history; severe muscle ache in one participant with Segawa's syndrome; significant increase in creatine phosphokinase",High LDL,,Heart & Vascular Health,manual_pair,"Red yeast rice has been shown to significantly reduce LDL cholesterol levels in multiple randomized controlled trials, with beneficial outcomes reported across various doses, typically ranging from 10 mg to 2400 mg daily. While the evidence is predominantly positive, one study indicated mixed outcomes regarding tolerability compared to pravastatin, suggesting the need for caution in specific populations. Overall, the evidence supports its use for managing high LDL cholesterol, but further research may be warranted to fully understand its safety profile.",0.9,27143594,2016,"ESSENS dyslipidemia: A placebo-controlled, randomized study of a nutritional supplement containing red yeast rice in subjects with newly diagnosed dyslipidemia.",randomized_controlled_trial,benefit,"The study shows a significant reduction in LDL-C and non-HDL-C levels, indicating a benefit from the intervention.","1 capsule twice daily 12 weeks (proprietary bioactive phytonutrient formulation containing red yeast rice, grape-seed, niacinamide, and folic acid)",,,hyperlipidemia,blood cholesterol lowering; cardiovascular diseases; cardiovascular risk; dyslipidemia; hypercholesterolemia; hyperlipidemia; metabolic syndrome; moderate hypercholesterolemia; myalgia; obesity-related diseases; statin intolerance; statin-associated myalgia,,,
Red Yeast Rice,"Epstein Barr virus infection; duodenitis; elevated liver enzymes in two subjects; increased risk of adverse health outcomes related to uric acid, alanine transaminase and aspartate transaminase levels; liver and kidney injury risk; mild profile of adverse reactions; minor side-effects reported; myalgia in four participants; myalgia in patients with SAMS history; severe muscle ache in one participant with Segawa's syndrome; significant increase in creatine phosphokinase",High LDL,,Heart & Vascular Health,manual_pair,"Red yeast rice has been shown to significantly reduce LDL cholesterol levels in multiple randomized controlled trials, with beneficial outcomes reported across various doses, typically ranging from 10 mg to 2400 mg daily. While the evidence is predominantly positive, one study indicated mixed outcomes regarding tolerability compared to pravastatin, suggesting the need for caution in specific populations. Overall, the evidence supports its use for managing high LDL cholesterol, but further research may be warranted to fully understand its safety profile.",0.9,20102918,2010,"Tolerability of red yeast rice (2,400 mg twice daily) versus pravastatin (20 mg twice daily) in patients with previous statin intolerance.",randomized_controlled_trial,mixed_unclear,"The study shows no significant difference in pain severity or muscle strength between red yeast rice and pravastatin, indicating mixed outcomes regarding tolerability.",2400 mg twice daily 12 weeks,,,hyperlipidemia,blood cholesterol lowering; cardiovascular diseases; cardiovascular risk; dyslipidemia; hypercholesterolemia; hyperlipidemia; metabolic syndrome; moderate hypercholesterolemia; myalgia; obesity-related diseases; statin intolerance; statin-associated myalgia,,,
Red Yeast Rice,"Epstein Barr virus infection; duodenitis; elevated liver enzymes in two subjects; increased risk of adverse health outcomes related to uric acid, alanine transaminase and aspartate transaminase levels; liver and kidney injury risk; mild profile of adverse reactions; minor side-effects reported; myalgia in four participants; myalgia in patients with SAMS history; severe muscle ache in one participant with Segawa's syndrome; significant increase in creatine phosphokinase",High LDL,,Heart & Vascular Health,manual_pair,"Red yeast rice has been shown to significantly reduce LDL cholesterol levels in multiple randomized controlled trials, with beneficial outcomes reported across various doses, typically ranging from 10 mg to 2400 mg daily. While the evidence is predominantly positive, one study indicated mixed outcomes regarding tolerability compared to pravastatin, suggesting the need for caution in specific populations. Overall, the evidence supports its use for managing high LDL cholesterol, but further research may be warranted to fully understand its safety profile.",0.9,28673363,2017,"A red yeast rice-olive extract supplement reduces biomarkers of oxidative stress, OxLDL and Lp-PLA2, in subjects with metabolic syndrome: a randomised, double-blind, placebo-controlled trial.",randomized_controlled_trial,benefit,"The study showed a significant reduction in Lp-PLA2, indicating a potential benefit for cardiovascular health in patients with metabolic syndrome.",10.82 mg 8 weeks (capsule),,,metabolic syndrome,blood cholesterol lowering; cardiovascular diseases; cardiovascular risk; dyslipidemia; hypercholesterolemia; hyperlipidemia; metabolic syndrome; moderate hypercholesterolemia; myalgia; obesity-related diseases; statin intolerance; statin-associated myalgia,,,
Red Yeast Rice,"Epstein Barr virus infection; duodenitis; elevated liver enzymes in two subjects; increased risk of adverse health outcomes related to uric acid, alanine transaminase and aspartate transaminase levels; liver and kidney injury risk; mild profile of adverse reactions; minor side-effects reported; myalgia in four participants; myalgia in patients with SAMS history; severe muscle ache in one participant with Segawa's syndrome; significant increase in creatine phosphokinase",High LDL,,Heart & Vascular Health,manual_pair,"Red yeast rice has shown a beneficial effect on non-HDL cholesterol levels in a randomized, double-blind, placebo-controlled study, where it was part of a formulation that also included berberine, chitosan, and coenzyme Q. The study reported a significant decrease in non-HDL cholesterol among dyslipidemic individuals, although the specific contribution of red yeast rice alone is not isolated in the findings. No adverse effects were noted in the reported evidence, but further studies are needed to confirm these results and assess long-term safety.",0.8,28704936,2017,"Effects of a New Nutraceutical Formulation (Berberine, Red Yeast Rice and Chitosan) on Non-HDL Cholesterol Levels in Individuals with Dyslipidemia: Results from a Randomized, Double Blind, Placebo-Controlled Study.",randomized_controlled_trial,benefit,"The intervention significantly decreased non-HDL cholesterol and other lipid parameters, indicating a benefit for dyslipidemic individuals.",200 mg once daily 12 weeks (berberine); 3 mg once daily 12 weeks (monacolin K); 10 mg once daily 12 weeks (chitosan); 10 mg once daily 12 weeks (coenzyme Q),,,dyslipidemia,dyslipidemia,,,
Red Yeast Rice,"Epstein Barr virus infection; duodenitis; elevated liver enzymes in two subjects; increased risk of adverse health outcomes related to uric acid, alanine transaminase and aspartate transaminase levels; liver and kidney injury risk; mild profile of adverse reactions; minor side-effects reported; myalgia in four participants; myalgia in patients with SAMS history; severe muscle ache in one participant with Segawa's syndrome; significant increase in creatine phosphokinase",Musculoskeletal Pain,,Musculoskeletal & Pain,manual_pair,"One randomized pilot trial found that red yeast rice resulted in less muscle fatigue compared to simvastatin in dyslipidemic patients over a 4-week period, suggesting a potential benefit for managing muscle-related side effects. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term safety and efficacy.",0.7,28521773,2017,Red yeast rice induces less muscle fatigue symptom than simvastatin in dyslipidemic patients: a single center randomized pilot trial.,randomized_controlled_trial,benefit,"Red yeast rice showed less muscle fatigue compared to simvastatin, indicating a benefit in managing muscle-related side effects in dyslipidemic patients.",4 weeks,Statin Use,,dyslipidemia,dyslipidemia; muscle fatigue,,,
Resveratrol,"ALT increased in older adults following resveratrol supplementation.; High-dose supplementation (>1,000 mg/day) appeared to increase alkaline phosphatase concentration.; adverse outcomes on implantation; subsequent pregnancy; the fetus",Ulcerative Colitis,,Gut Health,manual_pair,"One randomized clinical trial reported that resveratrol (500 mg daily for 8 weeks) was effective in reducing disease activity and improving quality of life in patients with mild-to-moderate active ulcerative colitis. However, the overall evidence is limited, with only one study demonstrating a benefit and no reports of harm or mixed outcomes. Further research is needed to confirm these findings and assess long-term effects.",0.7,38794742,2024,"Effects of Mediterranean Diet, Curcumin, and Resveratrol on Mild-to-Moderate Active Ulcerative Colitis: A Multicenter Randomized Clinical Trial.",randomized_controlled_trial,benefit,"The study showed that the interventions were effective in reducing disease activity and improving quality of life in patients with ulcerative colitis, indicating a benefit.",500 mg daily 8 weeks (supplement),,,ulcerative colitis,ulcerative colitis,,,
Resveratrol,"ALT increased in older adults following resveratrol supplementation.; High-dose supplementation (>1,000 mg/day) appeared to increase alkaline phosphatase concentration.; adverse outcomes on implantation; subsequent pregnancy; the fetus",Sciatic Pain,,Musculoskeletal & Pain,manual_pair,"There is limited evidence suggesting that resveratrol may provide benefits for back pain, as indicated by one randomized clinical trial that reported statistically significant improvements in pain and quality of life with a daily dose of 50 mg over 30 days. However, the overall evidence is sparse, and further studies are needed to confirm these findings and assess long-term effects and safety.",0.7,38138300,2023,"Combined Rehabilitation with Alpha Lipoic Acid, Acetyl-L-Carnitine, Resveratrol, and Cholecalciferolin Discogenic Sciatica in Young People: A Randomized Clinical Trial.",randomized_controlled_trial,benefit,"The study shows statistically significant improvements in pain and quality of life, indicating a benefit from the treatment including Resveratrol.",50 mg daily 30 days,,,back pain,back pain; sciatica,,,
Resveratrol,"ALT increased in older adults following resveratrol supplementation.; High-dose supplementation (>1,000 mg/day) appeared to increase alkaline phosphatase concentration.; adverse outcomes on implantation; subsequent pregnancy; the fetus",Endothelial Function,,Heart & Vascular Health,manual_pair,"Current evidence on resveratrol for cardiometabolic diseases is limited but suggests a potential benefit in vascular function, as indicated by a randomized clinical trial showing increased circulating SIRT1 and reduced sympathetic activity after 30 days of supplementation. No adverse effects or harm were reported, but the overall evidence remains sparse and requires further investigation to establish consistency and efficacy.",0.7,37447275,2023,Sirtuin 1 and Vascular Function in Healthy Women and Men: A Randomized Clinical Trial Comparing the Effects of Energy Restriction and Resveratrol.,randomized_controlled_trial,benefit,"The study shows that resveratrol increased circulating SIRT1 and reduced sympathetic activity, indicating a beneficial effect on vascular function.",30 days (supplement),,,cardiometabolic diseases,cardiometabolic diseases,,,
Resveratrol,"ALT increased in older adults following resveratrol supplementation.; High-dose supplementation (>1,000 mg/day) appeared to increase alkaline phosphatase concentration.; adverse outcomes on implantation; subsequent pregnancy; the fetus",Alzheimer's Disease,,Cognitive & Neurological Function,manual_pair,"One randomized trial indicates that resveratrol may reduce cerebrospinal fluid markers of neurodegeneration and neuroinflammation in individuals with Alzheimer's disease, suggesting a potential benefit for cognitive impairment. However, the evidence is limited to this single study, and further research is needed to confirm these findings and assess long-term effects and safety.",0.7,40507855,2025,Resveratrol Attenuates CSF Markers of Neurodegeneration and Neuroinflammation in Individuals with Alzheimer's Disease.,randomized_controlled_trial,benefit,"The study shows that resveratrol reduced markers of neurodegeneration and inflammation in Alzheimer's disease, indicating a beneficial effect.",52 weeks (resveratrol),,,alzheimer's disease,alzheimer's disease,,,
Resveratrol,"ALT increased in older adults following resveratrol supplementation.; High-dose supplementation (>1,000 mg/day) appeared to increase alkaline phosphatase concentration.; adverse outcomes on implantation; subsequent pregnancy; the fetus",COVID-19,,"Immune, Inflammation, & Infection",manual_pair,"Two randomized, double-blind, placebo-controlled trials suggest potential benefits of resveratrol in COVID-19 patients, including reductions in inflammatory markers and lower rates of hospitalization and emergency room visits. The doses reported include 750 mg daily for 10 days in one study. However, the overall evidence remains limited and further research is needed to confirm these findings and assess long-term effects.",0.8,40301181,2025,"Effects of resveratrol on inflammatory cytokines in COVID-19 patients: a randomized, double-blinded, placebo-controlled clinical trial.",randomized_controlled_trial,benefit,"The study showed significant reductions in inflammatory markers and blood glucose levels, indicating a beneficial effect of resveratrol in COVID-19 patients.",750 mg daily 10 days (oral),,,covid-19,covid-19,,,
Resveratrol,"ALT increased in older adults following resveratrol supplementation.; High-dose supplementation (>1,000 mg/day) appeared to increase alkaline phosphatase concentration.; adverse outcomes on implantation; subsequent pregnancy; the fetus",COVID-19,,"Immune, Inflammation, & Infection",manual_pair,"Two randomized, double-blind, placebo-controlled trials suggest potential benefits of resveratrol in COVID-19 patients, including reductions in inflammatory markers and lower rates of hospitalization and emergency room visits. The doses reported include 750 mg daily for 10 days in one study. However, the overall evidence remains limited and further research is needed to confirm these findings and assess long-term effects.",0.8,35768453,2022,Randomized double-blind placebo-controlled proof-of-concept trial of resveratrol for outpatient treatment of mild coronavirus disease (COVID-19).,randomized_controlled_trial,benefit,"The study showed a lower incidence of hospitalization and ER visits in the resveratrol group compared to placebo, indicating a potential benefit.",,,,covid-19,covid-19,,,
Resveratrol,"ALT increased in older adults following resveratrol supplementation.; High-dose supplementation (>1,000 mg/day) appeared to increase alkaline phosphatase concentration.; adverse outcomes on implantation; subsequent pregnancy; the fetus",Tooth Decay,,Oral Health,manual_pair,"One study indicates that resveratrol may reduce biofilm metabolic activity and mutans streptococci, suggesting a potential benefit for dental caries at a dose of 100 mg/L over 7 weeks. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term effects and safety.",0.7,39557280,2025,Resveratrol alters oral biofilm in vitro and in vivo.,randomized_controlled_trial,benefit,"Resveratrol significantly reduced biofilm metabolic activity and mutans streptococci, indicating a beneficial effect on dental caries.",100 mg/L 7 weeks (Resveratrol),,,dental caries,dental caries,,,
Resveratrol,"ALT increased in older adults following resveratrol supplementation.; High-dose supplementation (>1,000 mg/day) appeared to increase alkaline phosphatase concentration.; adverse outcomes on implantation; subsequent pregnancy; the fetus",High Uric Acid,,Heart & Vascular Health,manual_pair,"The evidence for resveratrol in improving dyslipidemia is low and mixed, with a single randomized trial indicating that while resveratrol did not significantly alter lipid profiles, it did reduce uric acid levels. Doses in this study ranged from 100 mg to 600 mg daily over 8 weeks. Overall, the findings do not support a clear benefit for dyslipidemia management.",0.8,36771199,2023,A Randomized Trial on Resveratrol Supplement Affecting Lipid Profile and Other Metabolic Markers in Subjects with Dyslipidemia.,randomized_controlled_trial,mixed_unclear,"Resveratrol did not significantly change the lipid profile but decreased uric acid levels, indicating mixed outcomes.",100 mg daily 8 weeks (supplement); 300 mg daily 8 weeks (supplement); 600 mg daily 8 weeks (supplement),,,dyslipidemia,dyslipidemia,,,
Resveratrol,"ALT increased in older adults following resveratrol supplementation.; High-dose supplementation (>1,000 mg/day) appeared to increase alkaline phosphatase concentration.; adverse outcomes on implantation; subsequent pregnancy; the fetus",High Blood Glucose,,Metabolic Health,manual_pair,"Clinical evidence suggests that resveratrol may have beneficial effects on metabolic parameters related to excess body weight, as indicated by two randomized trials. Doses reported include 500 mg daily for 60 days and 2000 mg daily (1000 mg twice daily) for 12 weeks. However, the overall evidence is limited to a small number of studies, and further research is needed to confirm these findings and assess long-term safety.",0.7,38896121,2024,[Effects of zinc and resveratrol as modulators of leptin response in adults with obesity].,randomized_controlled_trial,benefit,"The study indicates a benefit in modulating leptin and glucose signaling in obese individuals, suggesting positive health outcomes.",50 mg 60 days (Zinc); 500 mg 60 days (Resveratrol); 50 mg 60 days (Zinc and Resveratrol),,Heart & Vascular Health,obesity,obesity; polycystic ovary syndrome; stress response,,,
Resveratrol,"ALT increased in older adults following resveratrol supplementation.; High-dose supplementation (>1,000 mg/day) appeared to increase alkaline phosphatase concentration.; adverse outcomes on implantation; subsequent pregnancy; the fetus",High Blood Glucose,,Metabolic Health,manual_pair,"Clinical evidence suggests that resveratrol may have beneficial effects on metabolic parameters related to excess body weight, as indicated by two randomized trials. Doses reported include 500 mg daily for 60 days and 2000 mg daily (1000 mg twice daily) for 12 weeks. However, the overall evidence is limited to a small number of studies, and further research is needed to confirm these findings and assess long-term safety.",0.7,36169918,2023,"Treatment with combined resveratrol and myoinositol ameliorates endocrine, metabolic alterations and perceived stress response in women with PCOS: a double-blind randomized clinical trial.",randomized_controlled_trial,benefit,"The study shows significant improvements in endocrine and metabolic parameters, indicating a beneficial effect of resveratrol in PCOS management.",1000 mg twice daily 12 weeks,,,obesity,obesity; polycystic ovary syndrome; stress response,,,
Resveratrol,"ALT increased in older adults following resveratrol supplementation.; High-dose supplementation (>1,000 mg/day) appeared to increase alkaline phosphatase concentration.; adverse outcomes on implantation; subsequent pregnancy; the fetus",Inflammation,,"Immune, Inflammation, & Infection",manual_pair,"There is limited evidence from a single double-blind, randomized placebo-controlled trial indicating that resveratrol supplementation (500 mg daily for 8 weeks) may reduce fatigue in patients with relapsing-remitting multiple sclerosis through anti-inflammatory effects. Overall, the evidence is not robust, and further studies are needed to confirm these findings and assess long-term safety and efficacy.",0.7,39565038,2025,"Effects of resveratrol supplementation on inflammatory markers, fatigue scale, fasting blood sugar and lipid profile in relapsing-remitting multiple sclerosis patients: a double-blind, randomized placebo-controlled trial.",randomized_controlled_trial,benefit,"Resveratrol supplementation showed significant anti-inflammatory effects, particularly in reducing TNF-α and MDA levels, indicating a benefit for MS patients.",500 mg daily 8 weeks (capsules),Multiple Sclerosis,,fatigue,"fatigue; multiple sclerosis, relapsing-remitting",,,
Resveratrol,"ALT increased in older adults following resveratrol supplementation.; High-dose supplementation (>1,000 mg/day) appeared to increase alkaline phosphatase concentration.; adverse outcomes on implantation; subsequent pregnancy; the fetus",Peridontitis,,Oral Health,manual_pair,"The evidence for resveratrol in the treatment of gum disease is mixed. Two studies indicate a benefit, showing improvements in inflammatory markers and clinical outcomes, while one study presents unclear results regarding its effectiveness on various clinical parameters. Doses reported include 125 mg, 250 mg, and 500 mg daily, but further research is needed to clarify its overall efficacy and consistency in this indication.",0.8,35758374,2022,Resveratrol decreases local inflammatory markers and systemic endotoxin in patients with aggressive periodontitis.,randomized_controlled_trial,benefit,"The study shows that Resveratrol improves symptoms of periodontitis and decreases inflammatory markers, indicating a beneficial effect.",500 mg daily 8 weeks (oral); 250 mg daily 8 weeks (oral); 125 mg daily 8 weeks (oral),,,aggressive periodontitis,aggressive periodontitis; chronic periodontitis; periodontitis,,,
Resveratrol,"ALT increased in older adults following resveratrol supplementation.; High-dose supplementation (>1,000 mg/day) appeared to increase alkaline phosphatase concentration.; adverse outcomes on implantation; subsequent pregnancy; the fetus",Peridontitis,,Oral Health,manual_pair,"The evidence for resveratrol in the treatment of gum disease is mixed. Two studies indicate a benefit, showing improvements in inflammatory markers and clinical outcomes, while one study presents unclear results regarding its effectiveness on various clinical parameters. Doses reported include 125 mg, 250 mg, and 500 mg daily, but further research is needed to clarify its overall efficacy and consistency in this indication.",0.8,36973728,2023,Impact of resveratrol supplementation on clinical parameters and inflammatory markers in patients with chronic periodontitis: a randomized clinical trail.,randomized_controlled_trial,mixed_unclear,"Resveratrol showed a significant effect on plaque index but no significant differences in other clinical parameters or inflammatory markers, indicating mixed outcomes.",four weeks (supplements),,,chronic periodontitis,aggressive periodontitis; chronic periodontitis; periodontitis,,,
Resveratrol,"ALT increased in older adults following resveratrol supplementation.; High-dose supplementation (>1,000 mg/day) appeared to increase alkaline phosphatase concentration.; adverse outcomes on implantation; subsequent pregnancy; the fetus",Peridontitis,,Oral Health,manual_pair,"The evidence for resveratrol in the treatment of gum disease is mixed. Two studies indicate a benefit, showing improvements in inflammatory markers and clinical outcomes, while one study presents unclear results regarding its effectiveness on various clinical parameters. Doses reported include 125 mg, 250 mg, and 500 mg daily, but further research is needed to clarify its overall efficacy and consistency in this indication.",0.8,40884630,2025,Impact of systemic resveratrol on non-surgical periodontal treatment of smokers: A 12-month randomized clinical trial.,randomized_controlled_trial,benefit,"The study shows that systemic administration of resveratrol improves clinical outcomes in smokers with periodontitis, indicating a beneficial effect.",500 mg daily 180 days,Smokers,,periodontitis,aggressive periodontitis; chronic periodontitis; periodontitis,,,
Resveratrol,"ALT increased in older adults following resveratrol supplementation.; High-dose supplementation (>1,000 mg/day) appeared to increase alkaline phosphatase concentration.; adverse outcomes on implantation; subsequent pregnancy; the fetus",Cardiac Function,,Heart & Vascular Health,manual_pair,"One randomized controlled trial indicates that resveratrol supplementation (400 mg daily for 6 months) may benefit cardiac remodeling and diastolic function in hypertensive patients. However, the overall evidence is limited, with only one study reporting a positive outcome and no data on adverse effects or consistency across multiple studies.",0.7,36854725,2023,Effects of resveratrol supplementation on cardiac remodeling in hypertensive patients: a randomized controlled clinical trial.,randomized_controlled_trial,benefit,"The study shows that resveratrol supplementation can alleviate left atrial remodeling and improve left ventricular diastolic function, indicating a beneficial effect.",400 mg daily 6 months,,,cardiac remodeling,cardiac remodeling; hypertension; hypertensive heart disease,,,
Resveratrol,"ALT increased in older adults following resveratrol supplementation.; High-dose supplementation (>1,000 mg/day) appeared to increase alkaline phosphatase concentration.; adverse outcomes on implantation; subsequent pregnancy; the fetus",Oxidative Stress,,"Immune, Inflammation, & Infection",manual_pair,"Two randomized clinical trials indicate that resveratrol may have beneficial effects on oxidative stress markers and antioxidant capacity in individuals with Type 2 diabetes, with one study reporting positive outcomes at doses of 500 mg to 1000 mg daily over six months. However, the evidence is limited and does not establish a clear consensus on its efficacy for managing high blood sugar specifically, as no studies directly assessed blood glucose levels. No adverse effects were reported in the studies reviewed.",0.7,39519608,2024,The Administration of Resveratrol and Vitamin C Reduces Oxidative Stress in Postmenopausal Women-A Pilot Randomized Clinical Trial.,randomized_controlled_trial,benefit,"The study shows a significant decrease in oxidative stress markers and an increase in total antioxidant capacity, indicating a beneficial effect of resveratrol and vitamin C in postmenopausal women.",(resveratrol); (vitamin C),Menopause; Women,,insulin resistance,Type 2 Diabetes Mellitus; insulin resistance; oxidative stress; postmenopause,,,
Resveratrol,"ALT increased in older adults following resveratrol supplementation.; High-dose supplementation (>1,000 mg/day) appeared to increase alkaline phosphatase concentration.; adverse outcomes on implantation; subsequent pregnancy; the fetus",Oxidative Stress,,"Immune, Inflammation, & Infection",manual_pair,"Two randomized clinical trials indicate that resveratrol may have beneficial effects on oxidative stress markers and antioxidant capacity in individuals with Type 2 diabetes, with one study reporting positive outcomes at doses of 500 mg to 1000 mg daily over six months. However, the evidence is limited and does not establish a clear consensus on its efficacy for managing high blood sugar specifically, as no studies directly assessed blood glucose levels. No adverse effects were reported in the studies reviewed.",0.7,37108584,2023,Effect of Resveratrol on Markers of Oxidative Stress and Sirtuin 1 in Elderly Adults with Type 2 Diabetes.,randomized_controlled_trial,benefit,"The study shows a significant increase in antioxidant capacity and sirtuin 1 levels with 1000 mg/day of Resveratrol, indicating a beneficial effect.",1000 mg daily six months; 500 mg daily six months,Diabetes Type 2; Older Adults,,oxidative stress,Type 2 Diabetes Mellitus; insulin resistance; oxidative stress; postmenopause,,,
Resveratrol,"ALT increased in older adults following resveratrol supplementation.; High-dose supplementation (>1,000 mg/day) appeared to increase alkaline phosphatase concentration.; adverse outcomes on implantation; subsequent pregnancy; the fetus",Infertility,,Women's Health,manual_pair,"One randomized, triple-blind, placebo-controlled trial found that resveratrol (800 mg daily for 60 days) improved oxidative stress markers and reproductive outcomes in women with polycystic ovary syndrome (PCOS). No studies reported mixed or harmful effects, but further research is needed to confirm these findings and assess long-term safety.",0.9,38987824,2024,"Resveratrol ameliorates mitochondrial biogenesis and reproductive outcomes in women with polycystic ovary syndrome undergoing assisted reproduction: a randomized, triple-blind, placebo-controlled clinical trial.",randomized_controlled_trial,benefit,"Resveratrol showed significant improvements in oxidative stress markers and reproductive outcomes in women with PCOS, indicating a beneficial effect.",800 mg daily 60 days,PCOS; Women,"Immune, Inflammation, & Infection",polycystic ovary syndrome,polycystic ovary syndrome,,,
Resveratrol,"ALT increased in older adults following resveratrol supplementation.; High-dose supplementation (>1,000 mg/day) appeared to increase alkaline phosphatase concentration.; adverse outcomes on implantation; subsequent pregnancy; the fetus",Improve Bone Density,,Musculoskeletal & Pain,manual_pair,"One randomized clinical trial has reported a beneficial effect of resveratrol on bone turnover biomarkers and bone mineral density (BMD) in postmenopausal women, with a dose of 25 mg used over 12 months. However, the overall evidence is limited, with only one study available, and no adverse effects were reported. Further research is needed to confirm these findings and establish the efficacy of resveratrol for low bone density.",0.7,37569440,2023,Equol and Resveratrol Improve Bone Turnover Biomarkers in Postmenopausal Women: A Clinical Trial.,randomized_controlled_trial,benefit,"The study shows significant improvements in bone turnover biomarkers and BMD, indicating a beneficial effect of resveratrol.",25 mg 12 months (fermented soy),Menopause; Women,,bone turnover biomarkers,bone turnover biomarkers; postmenopausal osteoporosis,,,
Resveratrol,"ALT increased in older adults following resveratrol supplementation.; High-dose supplementation (>1,000 mg/day) appeared to increase alkaline phosphatase concentration.; adverse outcomes on implantation; subsequent pregnancy; the fetus",Vascular Health,,Heart & Vascular Health,manual_pair,"The evidence for resveratrol in the treatment of Marfan syndrome is limited and of low quality, with only one study reporting mixed outcomes. This single-arm open-label trial suggested a potential trend towards stabilization of aortic growth over one year, but the results are not definitive. No consistent dose ranges were reported, and there were no noted adverse effects.",0.5,39317438,2024,Effects of resveratrol on aortic growth in patients with Marfan syndrome: a single-arm open-label multicentre trial.,clinical_trial,mixed_unclear,"The study suggests a trend towards stabilization of aortic growth rate, but the results are not definitive, indicating a mixed outcome direction.",1 year (resveratrol),Marfan Syndrome,,marfan syndrome,marfan syndrome,,,
Resveratrol,"ALT increased in older adults following resveratrol supplementation.; High-dose supplementation (>1,000 mg/day) appeared to increase alkaline phosphatase concentration.; adverse outcomes on implantation; subsequent pregnancy; the fetus",Metabolic Syndrome,,Metabolic Health,manual_pair,"Two randomized controlled trials have reported beneficial effects of resveratrol supplementation (150 mg twice daily for 24 weeks) on metabolic syndrome, specifically in improving miRNA expression and cardiometabolic risk factors. There is no evidence of harm or no benefit, but the overall evidence is limited to these studies, and further research is needed to confirm these findings and assess long-term effects.",0.8,37086927,2023,Role of δ-tocotrienol and resveratrol supplementation in the regulation of micro RNAs in patients with metabolic syndrome: A randomized controlled trial.,randomized_controlled_trial,benefit,"The study shows significant improvements in miRNA expression related to metabolic syndrome, indicating a beneficial effect of resveratrol supplementation.",150 mg twice daily 24 weeks (capsules),,,metabolic syndrome,metabolic syndrome,,,
Resveratrol,"ALT increased in older adults following resveratrol supplementation.; High-dose supplementation (>1,000 mg/day) appeared to increase alkaline phosphatase concentration.; adverse outcomes on implantation; subsequent pregnancy; the fetus",Metabolic Syndrome,,Metabolic Health,manual_pair,"Two randomized controlled trials have reported beneficial effects of resveratrol supplementation (150 mg twice daily for 24 weeks) on metabolic syndrome, specifically in improving miRNA expression and cardiometabolic risk factors. There is no evidence of harm or no benefit, but the overall evidence is limited to these studies, and further research is needed to confirm these findings and assess long-term effects.",0.8,36125447,2023,δ-Tocotrienol in Combination with Resveratrol Improves the Cardiometabolic Risk Factors and Biomarkers in Patients with Metabolic Syndrome: A Randomized Controlled Trial.,randomized_controlled_trial,benefit,"The study showed significant improvements in cardiometabolic risk factors and biomarkers, indicating a beneficial effect of the supplement.",150 mg twice daily 24 weeks (capsule),,,metabolic syndrome,metabolic syndrome,,,
Resveratrol,"ALT increased in older adults following resveratrol supplementation.; High-dose supplementation (>1,000 mg/day) appeared to increase alkaline phosphatase concentration.; adverse outcomes on implantation; subsequent pregnancy; the fetus",Endothelial Function,,Heart & Vascular Health,manual_pair,"One randomized controlled trial reported that resveratrol supplementation at a dose of 400 mg daily for 6 weeks improved endothelial function in patients with chronic kidney disease and diabetes, suggesting a potential benefit for cardiovascular health. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term effects and safety.",0.7,37843843,2024,Effect of Resveratrol on Endothelial Function in Patients with CKD and Diabetes: A Randomized Controlled Trial.,randomized_controlled_trial,benefit,"Resveratrol supplementation improved endothelial function, indicating a beneficial effect on cardiovascular health in the studied population.",400 mg daily 6 weeks,CKD; Diabetes,,cardiovascular disease,cardiovascular disease; chronic kidney disease; diabetes,,,
Resveratrol,"ALT increased in older adults following resveratrol supplementation.; High-dose supplementation (>1,000 mg/day) appeared to increase alkaline phosphatase concentration.; adverse outcomes on implantation; subsequent pregnancy; the fetus",General Oral Health,,Oral Health,manual_pair,"There is limited evidence suggesting that resveratrol may improve oral health, as indicated by a single study showing an increase in plasma resveratrol levels and beneficial proteins in the acquired enamel pellicle following the use of a 15 mg orodispersible tablet. However, the overall evidence is sparse, and further research is needed to establish consistent benefits and safety.",0.7,38367826,2024,Increase in plasma resveratrol levels and in acid-resistant proteins in the acquired enamel pellicle after use of resveratrol-containing orodispersible tablets.,randomized_controlled_trial,benefit,"The study shows that trans-resveratrol increases bioavailability and expression of beneficial proteins, indicating a positive health outcome.",15 mg once (orodispersible tablet),,,general health,general health; oral health,,,
Resveratrol,"ALT increased in older adults following resveratrol supplementation.; High-dose supplementation (>1,000 mg/day) appeared to increase alkaline phosphatase concentration.; adverse outcomes on implantation; subsequent pregnancy; the fetus",Rosacea,,"Skin, Hair, & Nails",manual_pair,"The evidence for resveratrol in the treatment of rosacea is limited, with only one study reporting a benefit when used in conjunction with other treatments over a three-month period. The findings suggest a potential positive effect, but the overall quality and quantity of evidence are low, and further research is needed to confirm these results.",0.6,35765796,2022,"Integrative skincare trial of intense pulsed light followed by the phyto-corrective mask, phyto-corrective gel, and resveratrol BE for decreasing post-procedure downtime and improving procedure outcomes in patients with rosacea.",clinical_trial,benefit,"The study shows that the addition of resveratrol improves treatment outcomes for rosacea, indicating a beneficial effect.",nightly 3 months (serum),,,rosacea,rosacea,,,
Rhodiola Rosea,decreases bench press repetition volume; dizziness; dry mouth; few mild adverse events reported; may affect drugs with a narrow therapeutic index like phenytoin and warfarin; more subjects on sertraline reported adverse events (63.2%) than R. rosea (30.0%) or placebo (16.7%),Stress,,"Energy, Mood, & Mental Health",manual_pair,"Clinical evidence from two randomized trials indicates that Rhodiola rosea may have beneficial effects on anxiety symptoms. One study reported significant reductions in anxiety and mood symptoms with a dose of 200 mg twice daily, while another study found improvements in generalized anxiety disorder symptoms with a daily dose of 340 mg. No adverse effects were reported, but further research is needed to confirm these findings and establish optimal dosing.",0.9,26502953,2015,"The Effects of Rhodiola rosea L. Extract on Anxiety, Stress, Cognition and Other Mood Symptoms.",randomized_controlled_trial,benefit,"The study showed significant reductions in anxiety, stress, and mood symptoms, indicating a beneficial effect of Rhodiola rosea extract.",200 mg 2 times a day 14 days (Vitano®),,,anger,anger; anxiety; confusion; depression; generalized anxiety disorder; stress,,,
Rhodiola Rosea,decreases bench press repetition volume; dizziness; dry mouth; few mild adverse events reported; may affect drugs with a narrow therapeutic index like phenytoin and warfarin; more subjects on sertraline reported adverse events (63.2%) than R. rosea (30.0%) or placebo (16.7%),Stress,,"Energy, Mood, & Mental Health",manual_pair,"Clinical evidence from two randomized trials indicates that Rhodiola rosea may have beneficial effects on anxiety symptoms. One study reported significant reductions in anxiety and mood symptoms with a dose of 200 mg twice daily, while another study found improvements in generalized anxiety disorder symptoms with a daily dose of 340 mg. No adverse effects were reported, but further research is needed to confirm these findings and establish optimal dosing.",0.9,18307390,2008,A pilot study of Rhodiola rosea (Rhodax) for generalized anxiety disorder (GAD).,clinical_trial,benefit,"Significant improvement in GAD symptoms was observed, indicating a benefit from the treatment with R. rosea.",340 mg daily 10 weeks (extract),,,generalized anxiety disorder,anger; anxiety; confusion; depression; generalized anxiety disorder; stress,,,
Rhodiola Rosea,decreases bench press repetition volume; dizziness; dry mouth; few mild adverse events reported; may affect drugs with a narrow therapeutic index like phenytoin and warfarin; more subjects on sertraline reported adverse events (63.2%) than R. rosea (30.0%) or placebo (16.7%),Fatigue,,"Energy, Mood, & Mental Health",manual_pair,"The evidence for Rhodiola Rosea in treating chronic fatigue is limited, with only one open-label clinical trial reporting a statistically significant improvement in fatigue symptoms at a dose of 200 mg twice daily for 8 weeks. Overall, the quality of evidence is low, and no adverse effects were reported in the study. Further research is needed to confirm these findings and establish the efficacy of this supplement.",0.6,28219059,2017,Rhodiola rosea in Subjects with Prolonged or Chronic Fatigue Symptoms: Results of an Open-Label Clinical Trial.,clinical_trial,benefit,"The study showed statistically significant improvement in fatigue symptoms, indicating a benefit from the treatment.",200 mg 2 times daily 8 weeks (dry ethanolic extract),,,chronic fatigue symptoms,chronic fatigue symptoms; prolonged fatigue,,,
Rhodiola Rosea,decreases bench press repetition volume; dizziness; dry mouth; few mild adverse events reported; may affect drugs with a narrow therapeutic index like phenytoin and warfarin; more subjects on sertraline reported adverse events (63.2%) than R. rosea (30.0%) or placebo (16.7%),Cognitive Performance,,Cognitive & Neurological Function,manual_pair,"There is low-quality evidence suggesting that Rhodiola Rosea may improve cognitive function in adults with physical and cognitive deficiencies, based on one study that reported significant benefits with doses of 1 to 2 capsules daily over 12 weeks. However, the overall evidence is limited, and further research is needed to confirm these findings and assess long-term safety and efficacy.",0.6,17901042,2007,Efficacy and tolerability of a Rhodiola rosea extract in adults with physical and cognitive deficiencies.,clinical_trial,benefit,"The study showed significant improvements in physical and cognitive deficiencies, indicating a benefit from the treatment.",2 capsules once daily 12 weeks (oral); 1 capsule twice daily 12 weeks (oral),,,cognitive deficiencies,cognitive deficiencies; concentration deficiencies; daytime sleepiness; decreased libido; decreased memory; decreased motivation; exhaustion; forgetfulness; irritability; physical deficiencies; sleep disturbances; susceptibility to stress,,,
Rhodiola Rosea,decreases bench press repetition volume; dizziness; dry mouth; few mild adverse events reported; may affect drugs with a narrow therapeutic index like phenytoin and warfarin; more subjects on sertraline reported adverse events (63.2%) than R. rosea (30.0%) or placebo (16.7%),Depression,,"Energy, Mood, & Mental Health",manual_pair,"The evidence for Rhodiola rosea in treating depression is mixed. Two studies reported benefits in mild to moderate depression, with one study indicating less effectiveness compared to sertraline but fewer adverse events. Doses reported include 340 mg and 680 mg taken twice daily for 6 weeks, and a standardized extract used for 12 weeks; however, the overall effectiveness compared to standard treatments remains unclear.",0.7,25837277,2015,Rhodiola rosea versus sertraline for major depressive disorder: A randomized placebo-controlled trial.,randomized_controlled_trial,mixed_unclear,"R. rosea showed less antidepressant effect compared to sertraline but resulted in fewer adverse events, indicating a mixed outcome.",standardized 12 weeks (extract),,,major depressive disorder,major depressive disorder; mild to moderate depression,,,
Rhodiola Rosea,decreases bench press repetition volume; dizziness; dry mouth; few mild adverse events reported; may affect drugs with a narrow therapeutic index like phenytoin and warfarin; more subjects on sertraline reported adverse events (63.2%) than R. rosea (30.0%) or placebo (16.7%),Depression,,"Energy, Mood, & Mental Health",manual_pair,"The evidence for Rhodiola rosea in treating depression is mixed. Two studies reported benefits in mild to moderate depression, with one study indicating less effectiveness compared to sertraline but fewer adverse events. Doses reported include 340 mg and 680 mg taken twice daily for 6 weeks, and a standardized extract used for 12 weeks; however, the overall effectiveness compared to standard treatments remains unclear.",0.7,24722617,2014,"Rhodiola rosea (SHR-5), Part 2: A standardized extract of Rhodiola rosea is shown to be effective in the treatment of mild to moderate depression.",randomized_controlled_trial,benefit,"The study indicates effectiveness in treating mild to moderate depression, thus classified as a benefit.",,,,mild to moderate depression,major depressive disorder; mild to moderate depression,,,
Rhodiola Rosea,decreases bench press repetition volume; dizziness; dry mouth; few mild adverse events reported; may affect drugs with a narrow therapeutic index like phenytoin and warfarin; more subjects on sertraline reported adverse events (63.2%) than R. rosea (30.0%) or placebo (16.7%),Depression,,"Energy, Mood, & Mental Health",manual_pair,"The evidence for Rhodiola rosea in treating depression is mixed. Two studies reported benefits in mild to moderate depression, with one study indicating less effectiveness compared to sertraline but fewer adverse events. Doses reported include 340 mg and 680 mg taken twice daily for 6 weeks, and a standardized extract used for 12 weeks; however, the overall effectiveness compared to standard treatments remains unclear.",0.7,17990195,2007,Clinical trial of Rhodiola rosea L. extract SHR-5 in the treatment of mild to moderate depression.,randomized_controlled_trial,benefit,"The study showed significant improvement in depressive symptoms with no serious side effects, indicating a benefit from the treatment.",340 mg twice daily 6 weeks (tablets); 680 mg twice daily 6 weeks (tablets),,,mild to moderate depression,major depressive disorder; mild to moderate depression,,,
Rhodiola Rosea,decreases bench press repetition volume; dizziness; dry mouth; few mild adverse events reported; may affect drugs with a narrow therapeutic index like phenytoin and warfarin; more subjects on sertraline reported adverse events (63.2%) than R. rosea (30.0%) or placebo (16.7%),Exercise Induced Inflammation,,Performance & Recovery,manual_pair,"The evidence regarding Rhodiola Rosea for exercise performance is limited and mixed, with one study indicating increased antioxidant levels but no effect on oxidative damage. The typical dose reported was 100 mg of extract twice daily for four weeks. Overall, the findings do not support a clear benefit for exercise performance.",0.7,19478343,2009,The influence of supplementation with Rhodiola rosea L. extract on selected redox parameters in professional rowers.,randomized_controlled_trial,mixed_unclear,"The study showed increased antioxidant levels but no effect on oxidative damage, indicating mixed outcomes.",100 mg twice daily 4 wk (extract),Rowers,,exercise performance,exercise performance,,,
Rhodiola Rosea,decreases bench press repetition volume; dizziness; dry mouth; few mild adverse events reported; may affect drugs with a narrow therapeutic index like phenytoin and warfarin; more subjects on sertraline reported adverse events (63.2%) than R. rosea (30.0%) or placebo (16.7%),Strength,,Performance & Recovery,manual_pair,"The evidence regarding Rhodiola Rosea for explosive resistance training performance is limited and mixed. One study reported that a daily dose of 1500 mg of Golden Root Extract may enhance explosive performance but also impair endurance, indicating potential trade-offs. Overall, there are no consistent benefits reported, and further research is needed to clarify its effects.",0.7,34209617,2021,Effects of Short-Term Golden Root Extract (Rhodiola rosea) Supplementation on Resistance Exercise Performance.,randomized_controlled_trial,mixed_unclear,"The study shows that GRE enhances explosive performance but impairs endurance, leading to a mixed outcome classification.",1500 mg daily 3 days (Golden Root Extract),,,explosive resistance training performance,explosive resistance training performance,,,
Rhodiola Rosea,decreases bench press repetition volume; dizziness; dry mouth; few mild adverse events reported; may affect drugs with a narrow therapeutic index like phenytoin and warfarin; more subjects on sertraline reported adverse events (63.2%) than R. rosea (30.0%) or placebo (16.7%),Fatigue,,"Energy, Mood, & Mental Health",manual_pair,"The evidence for Rhodiola Rosea in reducing fatigue is mixed, with four studies reporting benefits and one study indicating harm. Doses reported include 576 mg daily for 28 days and 364 mg daily for 42 days, among others. Caution is warranted due to the adverse effects noted in one trial, which found that Rhodiola worsened fatigue compared to placebo.",0.7,19016404,2009,"A randomised, double-blind, placebo-controlled, parallel-group study of the standardised extract shr-5 of the roots of Rhodiola rosea in the treatment of subjects with stress-related fatigue.",randomized_controlled_trial,benefit,"The study showed significant improvements in fatigue and mental performance, indicating a benefit from the treatment.",576 mg 4 tablets daily 28 days (extract),,Cognitive & Neurological Function,burnout syndrome,burnout syndrome; depression; fatigue; fatigue recovery; lower limb explosive power; stress; stress-related fatigue,,,
Rhodiola Rosea,decreases bench press repetition volume; dizziness; dry mouth; few mild adverse events reported; may affect drugs with a narrow therapeutic index like phenytoin and warfarin; more subjects on sertraline reported adverse events (63.2%) than R. rosea (30.0%) or placebo (16.7%),Fatigue,,"Energy, Mood, & Mental Health",manual_pair,"The evidence for Rhodiola Rosea in reducing fatigue is mixed, with four studies reporting benefits and one study indicating harm. Doses reported include 576 mg daily for 28 days and 364 mg daily for 42 days, among others. Caution is warranted due to the adverse effects noted in one trial, which found that Rhodiola worsened fatigue compared to placebo.",0.7,25268730,2014,Rhodiola rosea for mental and physical fatigue in nursing students: a randomized controlled trial.,randomized_controlled_trial,harm,"The study found that Rhodiola rosea worsened fatigue compared to placebo, indicating harm.",364 mg daily 42 days,,,fatigue,burnout syndrome; depression; fatigue; fatigue recovery; lower limb explosive power; stress; stress-related fatigue,,,
Rhodiola Rosea,decreases bench press repetition volume; dizziness; dry mouth; few mild adverse events reported; may affect drugs with a narrow therapeutic index like phenytoin and warfarin; more subjects on sertraline reported adverse events (63.2%) than R. rosea (30.0%) or placebo (16.7%),Fatigue,,"Energy, Mood, & Mental Health",manual_pair,"The evidence for Rhodiola Rosea in reducing fatigue is mixed, with four studies reporting benefits and one study indicating harm. Doses reported include 576 mg daily for 28 days and 364 mg daily for 42 days, among others. Caution is warranted due to the adverse effects noted in one trial, which found that Rhodiola worsened fatigue compared to placebo.",0.7,11081987,2000,Rhodiola rosea in stress induced fatigue--a double blind cross-over study of a standardized extract SHR-5 with a repeated low-dose regimen on the mental performance of healthy physicians during night duty.,randomized_controlled_trial,benefit,"The study showed a statistically significant improvement in mental performance, indicating a benefit from Rhodiola Rosea in reducing fatigue.",1 tablet daily two weeks (standardized extract SHR/5),,,fatigue,burnout syndrome; depression; fatigue; fatigue recovery; lower limb explosive power; stress; stress-related fatigue,,,
Rhodiola Rosea,decreases bench press repetition volume; dizziness; dry mouth; few mild adverse events reported; may affect drugs with a narrow therapeutic index like phenytoin and warfarin; more subjects on sertraline reported adverse events (63.2%) than R. rosea (30.0%) or placebo (16.7%),Fatigue,,"Energy, Mood, & Mental Health",manual_pair,"The evidence for Rhodiola Rosea in reducing fatigue is mixed, with four studies reporting benefits and one study indicating harm. Doses reported include 576 mg daily for 28 days and 364 mg daily for 42 days, among others. Caution is warranted due to the adverse effects noted in one trial, which found that Rhodiola worsened fatigue compared to placebo.",0.7,40005009,2025,Effects of the Combined Supplementation of Caffeine and Rhodiola Rosea with Resistance Training on Lower Limb Explosive Power in Male Volleyball Players.,randomized_controlled_trial,benefit,"The study demonstrated significant improvements in performance metrics and fatigue recovery, indicating a beneficial outcome from the supplementation.",four weeks,,Performance & Recovery,fatigue recovery,burnout syndrome; depression; fatigue; fatigue recovery; lower limb explosive power; stress; stress-related fatigue,,,
Rhodiola Rosea,decreases bench press repetition volume; dizziness; dry mouth; few mild adverse events reported; may affect drugs with a narrow therapeutic index like phenytoin and warfarin; more subjects on sertraline reported adverse events (63.2%) than R. rosea (30.0%) or placebo (16.7%),Fatigue,,"Energy, Mood, & Mental Health",manual_pair,"The evidence for Rhodiola Rosea in reducing fatigue is mixed, with four studies reporting benefits and one study indicating harm. Doses reported include 576 mg daily for 28 days and 364 mg daily for 42 days, among others. Caution is warranted due to the adverse effects noted in one trial, which found that Rhodiola worsened fatigue compared to placebo.",0.7,24503750,2014,"Rhodiola rosea (SHR-5), Part I: a proprietary root extract of Rhodiola rosea is found to be effective in the treatment of stress-related fatigue.",randomized_controlled_trial,benefit,"The study indicates a benefit in treating stress-related fatigue, as stated in the title.",,,,stress-related fatigue,burnout syndrome; depression; fatigue; fatigue recovery; lower limb explosive power; stress; stress-related fatigue,,,
Rhodiola Rosea,decreases bench press repetition volume; dizziness; dry mouth; few mild adverse events reported; may affect drugs with a narrow therapeutic index like phenytoin and warfarin; more subjects on sertraline reported adverse events (63.2%) than R. rosea (30.0%) or placebo (16.7%),Anaerobic Capacity,,Performance & Recovery,manual_pair,"The evidence for Rhodiola Rosea in improving low exercise performance is primarily positive, with three studies reporting benefits in anaerobic and endurance performance at doses ranging from 200 mg to 1500 mg. However, one study presented mixed results, indicating that while some performance measures may improve, others remain unchanged. Overall, the findings suggest potential benefits, but the evidence is not entirely consistent.",0.7,30371146,2019,Effects of short-term Rhodiola Rosea (Golden Root Extract) supplementation on anaerobic exercise performance.,randomized_controlled_trial,benefit,"The study demonstrated that GRE supplementation improved various measures of anaerobic performance, indicating a beneficial effect.",1500 mg daily 3 days (Golden Root Extract),,,anaerobic exercise performance,anaerobic exercise performance; attention; cognitive function; endurance exercise capacity; endurance exercise performance; exercise performance; fatigue; fatty acid utilization; mood; muscle damage; muscle strength; perceived exertion; physical capacity; reaction time; speed of limb movement,,,
Rhodiola Rosea,decreases bench press repetition volume; dizziness; dry mouth; few mild adverse events reported; may affect drugs with a narrow therapeutic index like phenytoin and warfarin; more subjects on sertraline reported adverse events (63.2%) than R. rosea (30.0%) or placebo (16.7%),Anaerobic Capacity,,Performance & Recovery,manual_pair,"The evidence for Rhodiola Rosea in improving low exercise performance is primarily positive, with three studies reporting benefits in anaerobic and endurance performance at doses ranging from 200 mg to 1500 mg. However, one study presented mixed results, indicating that while some performance measures may improve, others remain unchanged. Overall, the findings suggest potential benefits, but the evidence is not entirely consistent.",0.7,15256690,2004,Acute Rhodiola rosea intake can improve endurance exercise performance.,randomized_controlled_trial,benefit,"The study demonstrated a significant improvement in endurance exercise capacity and related parameters with acute Rhodiola rosea intake, indicating a beneficial effect.",200 mg once acute (Rhodiola rosea extract),,,attention,anaerobic exercise performance; attention; cognitive function; endurance exercise capacity; endurance exercise performance; exercise performance; fatigue; fatty acid utilization; mood; muscle damage; muscle strength; perceived exertion; physical capacity; reaction time; speed of limb movement,,,
Rhodiola Rosea,decreases bench press repetition volume; dizziness; dry mouth; few mild adverse events reported; may affect drugs with a narrow therapeutic index like phenytoin and warfarin; more subjects on sertraline reported adverse events (63.2%) than R. rosea (30.0%) or placebo (16.7%),Anaerobic Capacity,,Performance & Recovery,manual_pair,"The evidence for Rhodiola Rosea in improving low exercise performance is primarily positive, with three studies reporting benefits in anaerobic and endurance performance at doses ranging from 200 mg to 1500 mg. However, one study presented mixed results, indicating that while some performance measures may improve, others remain unchanged. Overall, the findings suggest potential benefits, but the evidence is not entirely consistent.",0.7,23443221,2013,The effects of an acute dose of Rhodiola rosea on endurance exercise performance.,randomized_controlled_trial,benefit,"The study shows that Rhodiola rosea ingestion improves endurance performance and reduces perceived exertion, indicating a beneficial effect on exercise outcomes.",3 mg·kg(-1) single dose (oral),,,cognitive function,anaerobic exercise performance; attention; cognitive function; endurance exercise capacity; endurance exercise performance; exercise performance; fatigue; fatty acid utilization; mood; muscle damage; muscle strength; perceived exertion; physical capacity; reaction time; speed of limb movement,,,
Rhodiola Rosea,decreases bench press repetition volume; dizziness; dry mouth; few mild adverse events reported; may affect drugs with a narrow therapeutic index like phenytoin and warfarin; more subjects on sertraline reported adverse events (63.2%) than R. rosea (30.0%) or placebo (16.7%),Anaerobic Capacity,,Performance & Recovery,manual_pair,"The evidence for Rhodiola Rosea in improving low exercise performance is primarily positive, with three studies reporting benefits in anaerobic and endurance performance at doses ranging from 200 mg to 1500 mg. However, one study presented mixed results, indicating that while some performance measures may improve, others remain unchanged. Overall, the findings suggest potential benefits, but the evidence is not entirely consistent.",0.7,20308973,2010,Effects of chronic Rhodiola Rosea supplementation on sport performance and antioxidant capacity in trained male: preliminary results.,randomized_controlled_trial,mixed_unclear,"The study showed mixed results; while some performance parameters were unaffected, there were significant reductions in lactate and muscle damage indicators, indicating potential benefits in specific areas.",4 weeks daily,,,exercise performance,anaerobic exercise performance; attention; cognitive function; endurance exercise capacity; endurance exercise performance; exercise performance; fatigue; fatty acid utilization; mood; muscle damage; muscle strength; perceived exertion; physical capacity; reaction time; speed of limb movement,,,
Rhodiola Rosea,decreases bench press repetition volume; dizziness; dry mouth; few mild adverse events reported; may affect drugs with a narrow therapeutic index like phenytoin and warfarin; more subjects on sertraline reported adverse events (63.2%) than R. rosea (30.0%) or placebo (16.7%),Mental Fatigue,,"Energy, Mood, & Mental Health",manual_pair,"Clinical evidence from three randomized trials indicates that Rhodiola Rosea may have beneficial effects on mental fatigue, with significant improvements reported in physical fitness and mental work capacity. The studies utilized doses of standardized SHR-5 extract, with varying amounts of 2 to 3 capsules or low repeated doses over several days. No adverse effects were reported, but the overall evidence is limited to a small number of studies and should be interpreted cautiously.",0.8,10839209,2000,"A double-blind, placebo-controlled pilot study of the stimulating and adaptogenic effect of Rhodiola rosea SHR-5 extract on the fatigue of students caused by stress during an examination period with a repeated low-dose regimen.",randomized_controlled_trial,benefit,"The study showed significant improvements in physical fitness and mental fatigue, indicating a benefit from the supplement.",low repeated dose 20 days (extract SHR-5),,Performance & Recovery,fatigue,fatigue; mental fatigue; strength performance; stress,,,
Rhodiola Rosea,decreases bench press repetition volume; dizziness; dry mouth; few mild adverse events reported; may affect drugs with a narrow therapeutic index like phenytoin and warfarin; more subjects on sertraline reported adverse events (63.2%) than R. rosea (30.0%) or placebo (16.7%),Mental Fatigue,,"Energy, Mood, & Mental Health",manual_pair,"Clinical evidence from three randomized trials indicates that Rhodiola Rosea may have beneficial effects on mental fatigue, with significant improvements reported in physical fitness and mental work capacity. The studies utilized doses of standardized SHR-5 extract, with varying amounts of 2 to 3 capsules or low repeated doses over several days. No adverse effects were reported, but the overall evidence is limited to a small number of studies and should be interpreted cautiously.",0.8,40289957,2025,"The Impact of Rhodiola Rosea Extract on Strength Performance in Alternative Bench-Press and Bench-Pull Exercises Under Resting and Mental Fatigue Conditions: A Randomized, Triple-Blinded, Placebo-Controlled, Crossover Trial.",randomized_controlled_trial,benefit,"The study shows that Rhodiola Rosea supplementation has beneficial effects on strength performance, particularly under control conditions, with no reported adverse effects.",4 days (extract),,Performance & Recovery,mental fatigue,fatigue; mental fatigue; strength performance; stress,,,
Rhodiola Rosea,decreases bench press repetition volume; dizziness; dry mouth; few mild adverse events reported; may affect drugs with a narrow therapeutic index like phenytoin and warfarin; more subjects on sertraline reported adverse events (63.2%) than R. rosea (30.0%) or placebo (16.7%),Mental Fatigue,,"Energy, Mood, & Mental Health",manual_pair,"Clinical evidence from three randomized trials indicates that Rhodiola Rosea may have beneficial effects on mental fatigue, with significant improvements reported in physical fitness and mental work capacity. The studies utilized doses of standardized SHR-5 extract, with varying amounts of 2 to 3 capsules or low repeated doses over several days. No adverse effects were reported, but the overall evidence is limited to a small number of studies and should be interpreted cautiously.",0.8,12725561,2003,A randomized trial of two different doses of a SHR-5 Rhodiola rosea extract versus placebo and control of capacity for mental work.,randomized_controlled_trial,benefit,"The study showed a statistically significant antifatigue effect, indicating a benefit from the supplement.",2 capsules (standardized SHR-5 extract); 3 capsules (standardized SHR-5 extract),,,mental fatigue,fatigue; mental fatigue; strength performance; stress,,,
Rhodiola Rosea,decreases bench press repetition volume; dizziness; dry mouth; few mild adverse events reported; may affect drugs with a narrow therapeutic index like phenytoin and warfarin; more subjects on sertraline reported adverse events (63.2%) than R. rosea (30.0%) or placebo (16.7%),Oxidative Stress,,"Immune, Inflammation, & Infection",manual_pair,"The evidence for Rhodiola Rosea in reducing oxidative stress is low and mixed. One study reported increased antioxidant levels but no significant effect on oxidative damage, suggesting unclear outcomes. The typical dose reported was 100 mg of extract twice daily for four weeks.",0.7,19478343,2009,The influence of supplementation with Rhodiola rosea L. extract on selected redox parameters in professional rowers.,randomized_controlled_trial,mixed_unclear,"The study showed increased antioxidant levels but no effect on oxidative damage, indicating mixed outcomes.",100 mg twice daily 4 wk (extract),Rowers,,oxidative stress,oxidative stress,,,
Rhodiola Rosea,decreases bench press repetition volume; dizziness; dry mouth; few mild adverse events reported; may affect drugs with a narrow therapeutic index like phenytoin and warfarin; more subjects on sertraline reported adverse events (63.2%) than R. rosea (30.0%) or placebo (16.7%),Stress,,"Energy, Mood, & Mental Health",manual_pair,"There is limited evidence suggesting that Rhodiola Rosea may improve life-stress symptoms, as indicated by one open-label study that reported benefits with a dose of 200 mg twice daily for 4 weeks. However, the overall quality of evidence is low, and further randomized controlled trials are needed to confirm these findings and assess safety and efficacy more robustly.",0.6,22228617,2012,Therapeutic effects and safety of Rhodiola rosea extract WS® 1375 in subjects with life-stress symptoms--results of an open-label study.,clinical_trial,benefit,"The study reported clinically relevant improvements in life-stress symptoms, indicating a beneficial outcome.",200 mg twice daily 4 weeks (extract WS® 1375),,,life-stress symptoms,life-stress symptoms,,,
Saffron,12.0% discontinued treatment owing to TEAEs; TRAEs led to discontinuation in 23.0% of patients; Treatment-related adverse events occurred in 98.4% of patients; grade ≥ 3 treatment-related adverse events in 50.0% of patients on combination therapy; grade ≥ 3 treatment-related adverse events in 51.9% of patients on monotherapy; increased creatinine levels; minimal adverse effects reported; ≥Grade 3 TRAEs in 51.6%; ≥grade 3 TEAEs in 52.0%,Stress,,"Energy, Mood, & Mental Health",manual_pair,"Human clinical evidence suggests that saffron may have beneficial effects on anxiety, with two randomized trials reporting improvements in anxiety levels and mood regulation. Doses varied, with one study using 2 tablets daily for 12 weeks and another involving a combination of saffron and scutellaria extracts over six weeks. No adverse effects were reported, but the overall evidence remains limited and further research is needed to confirm these findings.",0.8,40226680,2024,Effectiveness of a Saffron and Withania Supplement on Mood in Women With Mild-to-Moderate Anxiety During the COVID-19 Lockdown.,clinical_trial,benefit,"The study showed a statistically significant improvement in anxiety levels and health-related quality of life, indicating a benefit from the supplement.",2 tablets daily 12 weeks (Safromotive),,,anxiety,anxiety; mild-to-moderate depressive symptoms; sleep quality,,,
Saffron,12.0% discontinued treatment owing to TEAEs; TRAEs led to discontinuation in 23.0% of patients; Treatment-related adverse events occurred in 98.4% of patients; grade ≥ 3 treatment-related adverse events in 50.0% of patients on combination therapy; grade ≥ 3 treatment-related adverse events in 51.9% of patients on monotherapy; increased creatinine levels; minimal adverse effects reported; ≥Grade 3 TRAEs in 51.6%; ≥grade 3 TEAEs in 52.0%,Stress,,"Energy, Mood, & Mental Health",manual_pair,"Human clinical evidence suggests that saffron may have beneficial effects on anxiety, with two randomized trials reporting improvements in anxiety levels and mood regulation. Doses varied, with one study using 2 tablets daily for 12 weeks and another involving a combination of saffron and scutellaria extracts over six weeks. No adverse effects were reported, but the overall evidence remains limited and further research is needed to confirm these findings.",0.8,40077679,2025,"The Effects of Combined Scutellaria and Saffron Supplementation on Mood Regulation in Participants with Mild-to-Moderate Depressive Symptoms: A Randomized, Double-Blind, Placebo-Controlled Study.",randomized_controlled_trial,benefit,"The study demonstrated beneficial effects of saffron and scutellaria on mood regulation, with improvements in depressive and anxious symptoms, indicating a positive outcome direction.","six weeks (scutellaria extract, saffron extract, combination of scutellaria and saffron extracts, placebo)",,Sleep,anxiety,anxiety; mild-to-moderate depressive symptoms; sleep quality,,,
Saffron,12.0% discontinued treatment owing to TEAEs; TRAEs led to discontinuation in 23.0% of patients; Treatment-related adverse events occurred in 98.4% of patients; grade ≥ 3 treatment-related adverse events in 50.0% of patients on combination therapy; grade ≥ 3 treatment-related adverse events in 51.9% of patients on monotherapy; increased creatinine levels; minimal adverse effects reported; ≥Grade 3 TRAEs in 51.6%; ≥grade 3 TEAEs in 52.0%,Exercise Induced Inflammation,,Performance & Recovery,manual_pair,"One randomized double-blind clinical trial found that saffron supplementation (100 mg daily for 12 weeks) significantly improved inflammatory markers in obese men with type 2 diabetes mellitus, suggesting a potential benefit for chronic inflammation. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term effects and safety.",0.8,35001410,2022,"The effects of saffron (Crocus sativus L.) in conjunction with concurrent training on body composition, glycaemic status, and inflammatory markers in obese men with type 2 diabetes mellitus: A randomized double-blind clinical trial.",randomized_controlled_trial,benefit,"The study shows significant improvements in inflammatory markers and metabolic profiles, indicating a benefit from saffron supplementation.",100 mg daily 12 weeks (pill),Diabetes Type 2; Obese,,inflammation,Type 2 Diabetes Mellitus; inflammation; obesity,,,
Saffron,12.0% discontinued treatment owing to TEAEs; TRAEs led to discontinuation in 23.0% of patients; Treatment-related adverse events occurred in 98.4% of patients; grade ≥ 3 treatment-related adverse events in 50.0% of patients on combination therapy; grade ≥ 3 treatment-related adverse events in 51.9% of patients on monotherapy; increased creatinine levels; minimal adverse effects reported; ≥Grade 3 TRAEs in 51.6%; ≥grade 3 TEAEs in 52.0%,Inflammation,,Heart & Vascular Health,manual_pair,"The evidence regarding saffron for coronary artery disease is mixed. One randomized trial reported beneficial effects on gene expression and serum levels related to CAD with a dose of 30 mg daily for eight weeks, while another study using 10 mg daily of crocetin showed improvements in some markers but no significant differences in primary outcomes. Overall, the findings are not consistent, and further research is needed to clarify the effects.",0.7,40400479,2025,The effect of crocetin (a saffron carotenoid) supplementation on antioxidant and inflammatory indexes and serum leptin concentration in patients with coronary artery disease.,randomized_controlled_trial,mixed_unclear,"Crocetin supplementation showed significant improvements in some markers but no significant differences in primary outcomes, indicating mixed results.",10 mg daily eight weeks (tablet),Coronary Artery Disease,"Immune, Inflammation, & Infection",coronary artery disease,coronary artery disease,,,
Saffron,12.0% discontinued treatment owing to TEAEs; TRAEs led to discontinuation in 23.0% of patients; Treatment-related adverse events occurred in 98.4% of patients; grade ≥ 3 treatment-related adverse events in 50.0% of patients on combination therapy; grade ≥ 3 treatment-related adverse events in 51.9% of patients on monotherapy; increased creatinine levels; minimal adverse effects reported; ≥Grade 3 TRAEs in 51.6%; ≥grade 3 TEAEs in 52.0%,Inflammation,,Heart & Vascular Health,manual_pair,"The evidence regarding saffron for coronary artery disease is mixed. One randomized trial reported beneficial effects on gene expression and serum levels related to CAD with a dose of 30 mg daily for eight weeks, while another study using 10 mg daily of crocetin showed improvements in some markers but no significant differences in primary outcomes. Overall, the findings are not consistent, and further research is needed to clarify the effects.",0.7,31797473,2020,"Effects of crocin and saffron aqueous extract on gene expression of SIRT1, AMPK, LOX1, NF-κB, and MCP-1 in patients with coronary artery disease: A randomized placebo-controlled clinical trial.",randomized_controlled_trial,benefit,The study shows significant beneficial effects on gene expression and serum levels related to CAD.,30 mg daily 8 weeks (aqueous extract),Coronary Artery Disease,,coronary artery disease,coronary artery disease,,,
Saffron,12.0% discontinued treatment owing to TEAEs; TRAEs led to discontinuation in 23.0% of patients; Treatment-related adverse events occurred in 98.4% of patients; grade ≥ 3 treatment-related adverse events in 50.0% of patients on combination therapy; grade ≥ 3 treatment-related adverse events in 51.9% of patients on monotherapy; increased creatinine levels; minimal adverse effects reported; ≥Grade 3 TRAEs in 51.6%; ≥grade 3 TEAEs in 52.0%,Depression,,"Energy, Mood, & Mental Health",manual_pair,"The evidence from randomized controlled trials suggests that saffron may have a beneficial effect on depression, with seven studies reporting positive outcomes and one showing mixed results. Typical doses reported range from 1 mg to 150 mg daily, with treatment durations varying from 4 to 12 weeks. No significant adverse effects were noted in the studies reviewed, but the mixed findings in one trial indicate that further research is needed to clarify saffron's efficacy compared to standard treatments.",0.85,39754520,2025,Therapeutic Potential of Saffron Extract in Mild Depression: A Study of Its Role on Anhedonia in Rats and Humans.,randomized_controlled_trial,benefit,"The study shows a global improvement in depressive symptoms and a significant reduction in anhedonia, indicating a beneficial effect of saffron in treating mild depression and associated anhedonia.",8 weeks (saffron extract),,,anhedonia,Type 2 Diabetes Mellitus; anhedonia; bipolar depression; depression; depression symptoms; depressive symptoms; happiness; happiness levels; major depressive disorder; mild depression; mild to moderate depression; multiple sclerosis; quality of life; sleep disturbances; sleep quality; unipolar depression,,,
Saffron,12.0% discontinued treatment owing to TEAEs; TRAEs led to discontinuation in 23.0% of patients; Treatment-related adverse events occurred in 98.4% of patients; grade ≥ 3 treatment-related adverse events in 50.0% of patients on combination therapy; grade ≥ 3 treatment-related adverse events in 51.9% of patients on monotherapy; increased creatinine levels; minimal adverse effects reported; ≥Grade 3 TRAEs in 51.6%; ≥grade 3 TEAEs in 52.0%,Depression,,"Energy, Mood, & Mental Health",manual_pair,"The evidence from randomized controlled trials suggests that saffron may have a beneficial effect on depression, with seven studies reporting positive outcomes and one showing mixed results. Typical doses reported range from 1 mg to 150 mg daily, with treatment durations varying from 4 to 12 weeks. No significant adverse effects were noted in the studies reviewed, but the mixed findings in one trial indicate that further research is needed to clarify saffron's efficacy compared to standard treatments.",0.85,37801956,2023,The effect of saffron and corrective exercises on depression and quality of life in women with multiple sclerosis: A randomized controlled clinical trial.,randomized_controlled_trial,benefit,The study shows significant benefits in reducing depression and enhancing quality of life in MS patients using saffron and corrective exercises.,12 weeks (saffron),Multiple Sclerosis; Women,,depression,Type 2 Diabetes Mellitus; anhedonia; bipolar depression; depression; depression symptoms; depressive symptoms; happiness; happiness levels; major depressive disorder; mild depression; mild to moderate depression; multiple sclerosis; quality of life; sleep disturbances; sleep quality; unipolar depression,,,
Saffron,12.0% discontinued treatment owing to TEAEs; TRAEs led to discontinuation in 23.0% of patients; Treatment-related adverse events occurred in 98.4% of patients; grade ≥ 3 treatment-related adverse events in 50.0% of patients on combination therapy; grade ≥ 3 treatment-related adverse events in 51.9% of patients on monotherapy; increased creatinine levels; minimal adverse effects reported; ≥Grade 3 TRAEs in 51.6%; ≥grade 3 TEAEs in 52.0%,Depression,,"Energy, Mood, & Mental Health",manual_pair,"The evidence from randomized controlled trials suggests that saffron may have a beneficial effect on depression, with seven studies reporting positive outcomes and one showing mixed results. Typical doses reported range from 1 mg to 150 mg daily, with treatment durations varying from 4 to 12 weeks. No significant adverse effects were noted in the studies reviewed, but the mixed findings in one trial indicate that further research is needed to clarify saffron's efficacy compared to standard treatments.",0.85,37264347,2023,The effect of Crocus sativus L. (saffron) herbal tea on happiness in postmenopausal women: a randomized controlled trial.,randomized_controlled_trial,benefit,"The study showed a significant increase in happiness scores in the intervention group, indicating a beneficial effect of saffron tea on mental health.",30 mg once daily not specified (dried stigmas of saffron boiled in water),,,depression,Type 2 Diabetes Mellitus; anhedonia; bipolar depression; depression; depression symptoms; depressive symptoms; happiness; happiness levels; major depressive disorder; mild depression; mild to moderate depression; multiple sclerosis; quality of life; sleep disturbances; sleep quality; unipolar depression,,,
Saffron,12.0% discontinued treatment owing to TEAEs; TRAEs led to discontinuation in 23.0% of patients; Treatment-related adverse events occurred in 98.4% of patients; grade ≥ 3 treatment-related adverse events in 50.0% of patients on combination therapy; grade ≥ 3 treatment-related adverse events in 51.9% of patients on monotherapy; increased creatinine levels; minimal adverse effects reported; ≥Grade 3 TRAEs in 51.6%; ≥grade 3 TEAEs in 52.0%,Depression,,"Energy, Mood, & Mental Health",manual_pair,"The evidence from randomized controlled trials suggests that saffron may have a beneficial effect on depression, with seven studies reporting positive outcomes and one showing mixed results. Typical doses reported range from 1 mg to 150 mg daily, with treatment durations varying from 4 to 12 weeks. No significant adverse effects were noted in the studies reviewed, but the mixed findings in one trial indicate that further research is needed to clarify saffron's efficacy compared to standard treatments.",0.85,33960081,2021,"Saffron improves life and sleep quality, glycaemic status, lipid profile and liver function in diabetic patients: A double-blind, placebo-controlled, randomised clinical trial.",randomized_controlled_trial,benefit,"Saffron supplementation led to significant improvements in glycaemic status, lipid profile, liver function, sleep quality, and overall quality of life, indicating a beneficial outcome.",100 mg daily 8 weeks,Diabetes Type 2,,depression,Type 2 Diabetes Mellitus; anhedonia; bipolar depression; depression; depression symptoms; depressive symptoms; happiness; happiness levels; major depressive disorder; mild depression; mild to moderate depression; multiple sclerosis; quality of life; sleep disturbances; sleep quality; unipolar depression,,,
Saffron,12.0% discontinued treatment owing to TEAEs; TRAEs led to discontinuation in 23.0% of patients; Treatment-related adverse events occurred in 98.4% of patients; grade ≥ 3 treatment-related adverse events in 50.0% of patients on combination therapy; grade ≥ 3 treatment-related adverse events in 51.9% of patients on monotherapy; increased creatinine levels; minimal adverse effects reported; ≥Grade 3 TRAEs in 51.6%; ≥grade 3 TEAEs in 52.0%,Depression,,"Energy, Mood, & Mental Health",manual_pair,"The evidence from randomized controlled trials suggests that saffron may have a beneficial effect on depression, with seven studies reporting positive outcomes and one showing mixed results. Typical doses reported range from 1 mg to 150 mg daily, with treatment durations varying from 4 to 12 weeks. No significant adverse effects were noted in the studies reviewed, but the mixed findings in one trial indicate that further research is needed to clarify saffron's efficacy compared to standard treatments.",0.85,33556410,2021,Impact of saffron (Crocus Sativus Linn) supplementation and resistance training on markers implicated in depression and happiness levels in untrained young males.,randomized_controlled_trial,benefit,The study shows significant improvements in markers related to depression and happiness levels with saffron supplementation.,150 mg after each RT session and on non-training days 6 weeks (pill),,,depression,Type 2 Diabetes Mellitus; anhedonia; bipolar depression; depression; depression symptoms; depressive symptoms; happiness; happiness levels; major depressive disorder; mild depression; mild to moderate depression; multiple sclerosis; quality of life; sleep disturbances; sleep quality; unipolar depression,,,
Saffron,12.0% discontinued treatment owing to TEAEs; TRAEs led to discontinuation in 23.0% of patients; Treatment-related adverse events occurred in 98.4% of patients; grade ≥ 3 treatment-related adverse events in 50.0% of patients on combination therapy; grade ≥ 3 treatment-related adverse events in 51.9% of patients on monotherapy; increased creatinine levels; minimal adverse effects reported; ≥Grade 3 TRAEs in 51.6%; ≥grade 3 TEAEs in 52.0%,Depression,,"Energy, Mood, & Mental Health",manual_pair,"The evidence from randomized controlled trials suggests that saffron may have a beneficial effect on depression, with seven studies reporting positive outcomes and one showing mixed results. Typical doses reported range from 1 mg to 150 mg daily, with treatment durations varying from 4 to 12 weeks. No significant adverse effects were noted in the studies reviewed, but the mixed findings in one trial indicate that further research is needed to clarify saffron's efficacy compared to standard treatments.",0.85,31669837,2019,"Crocus Sativus L. (saffron) versus sertraline on symptoms of depression among older people with major depressive disorders-a double-blind, randomized intervention study.",randomized_controlled_trial,mixed_unclear,"Both saffron and sertraline showed potential to decrease depression symptoms, but no clear advantage was found for either treatment.",60 mg daily 6 weeks,Older Adults,,depression symptoms,Type 2 Diabetes Mellitus; anhedonia; bipolar depression; depression; depression symptoms; depressive symptoms; happiness; happiness levels; major depressive disorder; mild depression; mild to moderate depression; multiple sclerosis; quality of life; sleep disturbances; sleep quality; unipolar depression,,,
Saffron,12.0% discontinued treatment owing to TEAEs; TRAEs led to discontinuation in 23.0% of patients; Treatment-related adverse events occurred in 98.4% of patients; grade ≥ 3 treatment-related adverse events in 50.0% of patients on combination therapy; grade ≥ 3 treatment-related adverse events in 51.9% of patients on monotherapy; increased creatinine levels; minimal adverse effects reported; ≥Grade 3 TRAEs in 51.6%; ≥grade 3 TEAEs in 52.0%,Depression,,"Energy, Mood, & Mental Health",manual_pair,"The evidence from randomized controlled trials suggests that saffron may have a beneficial effect on depression, with seven studies reporting positive outcomes and one showing mixed results. Typical doses reported range from 1 mg to 150 mg daily, with treatment durations varying from 4 to 12 weeks. No significant adverse effects were noted in the studies reviewed, but the mixed findings in one trial indicate that further research is needed to clarify saffron's efficacy compared to standard treatments.",0.85,40414301,2025,"An Examination into the Effects of a Saffron Extract (Affron) on Mood and General Wellbeing in Adults Experiencing Low Mood: A Randomized, Double-Blind, Placebo-Controlled Trial.",randomized_controlled_trial,benefit,"The study showed significant improvements in depressive symptoms with saffron supplementation, indicating a beneficial effect.",28 mg daily 12 weeks (saffron extract),,Sleep,depressive symptoms,Type 2 Diabetes Mellitus; anhedonia; bipolar depression; depression; depression symptoms; depressive symptoms; happiness; happiness levels; major depressive disorder; mild depression; mild to moderate depression; multiple sclerosis; quality of life; sleep disturbances; sleep quality; unipolar depression,,,
Saffron,12.0% discontinued treatment owing to TEAEs; TRAEs led to discontinuation in 23.0% of patients; Treatment-related adverse events occurred in 98.4% of patients; grade ≥ 3 treatment-related adverse events in 50.0% of patients on combination therapy; grade ≥ 3 treatment-related adverse events in 51.9% of patients on monotherapy; increased creatinine levels; minimal adverse effects reported; ≥Grade 3 TRAEs in 51.6%; ≥grade 3 TEAEs in 52.0%,Depression,,"Energy, Mood, & Mental Health",manual_pair,"The evidence from randomized controlled trials suggests that saffron may have a beneficial effect on depression, with seven studies reporting positive outcomes and one showing mixed results. Typical doses reported range from 1 mg to 150 mg daily, with treatment durations varying from 4 to 12 weeks. No significant adverse effects were noted in the studies reviewed, but the mixed findings in one trial indicate that further research is needed to clarify saffron's efficacy compared to standard treatments.",0.85,37427624,2023,Co-administration of saffron and chamomile: to determine the efficacy as an adjuvant therapy for mild to moderate depression in human subjects. A pilot randomized clinical trial.,randomized_controlled_trial,benefit,"The study showed significant improvement in depression severity and metabolic alterations in the intervention group, indicating a benefit from the combined use of saffron and chamomile.",1 mg twice a day 1 month (herbal tea sachets),,Heart & Vascular Health,mild to moderate depression,Type 2 Diabetes Mellitus; anhedonia; bipolar depression; depression; depression symptoms; depressive symptoms; happiness; happiness levels; major depressive disorder; mild depression; mild to moderate depression; multiple sclerosis; quality of life; sleep disturbances; sleep quality; unipolar depression,,,
Saffron,12.0% discontinued treatment owing to TEAEs; TRAEs led to discontinuation in 23.0% of patients; Treatment-related adverse events occurred in 98.4% of patients; grade ≥ 3 treatment-related adverse events in 50.0% of patients on combination therapy; grade ≥ 3 treatment-related adverse events in 51.9% of patients on monotherapy; increased creatinine levels; minimal adverse effects reported; ≥Grade 3 TRAEs in 51.6%; ≥grade 3 TEAEs in 52.0%,Fatigue,,"Energy, Mood, & Mental Health",manual_pair,"One randomized trial reported a significant reduction in fatigue severity in patients with multiple sclerosis following the consumption of saffron syrup at a dose of 7.5 cc every 8 hours for two months. Overall, the evidence is limited to a single study, indicating a need for further research to confirm these findings and assess the generalizability to other populations. No adverse effects were reported in the study.",0.7,32716906,2020,The effect of novel simple saffron syrup on fatigue reduction in patients with multiple sclerosis.,clinical_trial,benefit,The study shows a significant reduction in fatigue severity after saffron syrup consumption.,7.5 cc every 8 hours two months (syrup),Multiple Sclerosis,,fatigue,fatigue; multiple sclerosis,,,
Saffron,12.0% discontinued treatment owing to TEAEs; TRAEs led to discontinuation in 23.0% of patients; Treatment-related adverse events occurred in 98.4% of patients; grade ≥ 3 treatment-related adverse events in 50.0% of patients on combination therapy; grade ≥ 3 treatment-related adverse events in 51.9% of patients on monotherapy; increased creatinine levels; minimal adverse effects reported; ≥Grade 3 TRAEs in 51.6%; ≥grade 3 TEAEs in 52.0%,HIgh Total Cholesterol,,Heart & Vascular Health,manual_pair,"Two randomized controlled trials have reported benefits of saffron (200 mg daily for 12 weeks) in reducing blood pressure and improving inflammatory markers in elderly hypertensive men. There are no reports of harm or mixed outcomes, suggesting a consistent positive effect; however, further research is needed to confirm these findings across diverse populations.",0.9,35235859,2022,Improvement of inflammatory status following saffron (Crocus sativus L.) and resistance training in elderly hypertensive men: A randomized controlled trial.,randomized_controlled_trial,benefit,"The study shows significant reductions in inflammatory markers and cardiovascular risk factors, indicating a benefit from saffron supplementation.",200 mg daily 12 weeks (tablet),Men; Older Adults,"Immune, Inflammation, & Infection",cardiovascular disease risk factors,cardiovascular disease risk factors; hypertension; inflammation,,,
Saffron,12.0% discontinued treatment owing to TEAEs; TRAEs led to discontinuation in 23.0% of patients; Treatment-related adverse events occurred in 98.4% of patients; grade ≥ 3 treatment-related adverse events in 50.0% of patients on combination therapy; grade ≥ 3 treatment-related adverse events in 51.9% of patients on monotherapy; increased creatinine levels; minimal adverse effects reported; ≥Grade 3 TRAEs in 51.6%; ≥grade 3 TEAEs in 52.0%,HIgh Total Cholesterol,,Heart & Vascular Health,manual_pair,"Two randomized controlled trials have reported benefits of saffron (200 mg daily for 12 weeks) in reducing blood pressure and improving inflammatory markers in elderly hypertensive men. There are no reports of harm or mixed outcomes, suggesting a consistent positive effect; however, further research is needed to confirm these findings across diverse populations.",0.9,33496985,2021,Saffron (Crocus sativus L.) in combination with resistance training reduced blood pressure in the elderly hypertensive men: A randomized controlled trial.,randomized_controlled_trial,benefit,"The study shows a significant reduction in blood pressure with saffron supplementation, indicating a beneficial effect.",200 mg daily 12 weeks (tablet),Older Adults,,hypertension,cardiovascular disease risk factors; hypertension; inflammation,,,
Saffron,12.0% discontinued treatment owing to TEAEs; TRAEs led to discontinuation in 23.0% of patients; Treatment-related adverse events occurred in 98.4% of patients; grade ≥ 3 treatment-related adverse events in 50.0% of patients on combination therapy; grade ≥ 3 treatment-related adverse events in 51.9% of patients on monotherapy; increased creatinine levels; minimal adverse effects reported; ≥Grade 3 TRAEs in 51.6%; ≥grade 3 TEAEs in 52.0%,High Blood Glucose,,Metabolic Health,manual_pair,"One randomized controlled trial reported that saffron supplementation (15 mg daily for 8 weeks) improved glycemic indices in overweight/obese prediabetic individuals, suggesting a potential benefit. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term effects and safety.",0.7,31677703,2019,"Effect of saffron (Crocus sativus L.) on lipid profile, glycemic indices and antioxidant status among overweight/obese prediabetic individuals: A double-blinded, randomized controlled trial.",randomized_controlled_trial,benefit,"Saffron supplementation showed improvements in glycemic and antioxidant indices, indicating a benefit for prediabetic individuals.",15 mg daily 8 weeks (pills),Obese; Overweight; Prediabetes,"Immune, Inflammation, & Infection",obesity,obesity; overweight; prediabetes,,,
Saffron,12.0% discontinued treatment owing to TEAEs; TRAEs led to discontinuation in 23.0% of patients; Treatment-related adverse events occurred in 98.4% of patients; grade ≥ 3 treatment-related adverse events in 50.0% of patients on combination therapy; grade ≥ 3 treatment-related adverse events in 51.9% of patients on monotherapy; increased creatinine levels; minimal adverse effects reported; ≥Grade 3 TRAEs in 51.6%; ≥grade 3 TEAEs in 52.0%,High Blood Glucose,,Metabolic Health,manual_pair,"Saffron supplementation appears to have beneficial effects on glycemic control in patients with type 2 diabetes, as evidenced by two randomized controlled trials. Doses of 100 mg and 200 mg daily for 8 to 12 weeks were associated with significant reductions in fasting blood glucose and improvements in diabetes-related markers. However, further research is needed to confirm these findings and assess long-term safety and efficacy.",0.9,32408117,2020,"Effects of saffron supplementation on glycemia and inflammation in patients with type 2 diabetes mellitus: A randomized double-blind, placebo-controlled clinical trial study.",randomized_controlled_trial,benefit,"Saffron supplementation significantly decreased fasting blood glucose and inflammatory markers, indicating a beneficial effect on T2DM patients.",100 mg daily 8 weeks (powder capsules),Diabetes Type 2,"Immune, Inflammation, & Infection",hyperglycemia,Type 2 Diabetes Mellitus; hyperglycemia; inflammation; insulin resistance,,,
Saffron,12.0% discontinued treatment owing to TEAEs; TRAEs led to discontinuation in 23.0% of patients; Treatment-related adverse events occurred in 98.4% of patients; grade ≥ 3 treatment-related adverse events in 50.0% of patients on combination therapy; grade ≥ 3 treatment-related adverse events in 51.9% of patients on monotherapy; increased creatinine levels; minimal adverse effects reported; ≥Grade 3 TRAEs in 51.6%; ≥grade 3 TEAEs in 52.0%,High Blood Glucose,,Metabolic Health,manual_pair,"Saffron supplementation appears to have beneficial effects on glycemic control in patients with type 2 diabetes, as evidenced by two randomized controlled trials. Doses of 100 mg and 200 mg daily for 8 to 12 weeks were associated with significant reductions in fasting blood glucose and improvements in diabetes-related markers. However, further research is needed to confirm these findings and assess long-term safety and efficacy.",0.9,38874882,2024,The effect of 12 weeks of aerobic exercise training with or without saffron supplementation on diabetes-specific markers and inflammation in women with type 2 diabetes: A randomized double-blind placebo-controlled trial.,randomized_controlled_trial,benefit,"The study shows significant improvements in diabetes-related markers, indicating a beneficial effect of saffron supplementation combined with exercise.",200 mg daily 12 weeks (saffron powder),Diabetes Type 2; Women,"Immune, Inflammation, & Infection",inflammation,Type 2 Diabetes Mellitus; hyperglycemia; inflammation; insulin resistance,,,
Saffron,12.0% discontinued treatment owing to TEAEs; TRAEs led to discontinuation in 23.0% of patients; Treatment-related adverse events occurred in 98.4% of patients; grade ≥ 3 treatment-related adverse events in 50.0% of patients on combination therapy; grade ≥ 3 treatment-related adverse events in 51.9% of patients on monotherapy; increased creatinine levels; minimal adverse effects reported; ≥Grade 3 TRAEs in 51.6%; ≥grade 3 TEAEs in 52.0%,High LDL,,Heart & Vascular Health,manual_pair,"One randomized clinical trial reported a significant reduction in serum lipid levels among dyslipidemia patients using saffron petal hydroalcoholic extract, suggesting a potential benefit for high LDL cholesterol. However, the evidence is limited to a single study, and further research is needed to confirm these findings and establish consistent dosing guidelines. No adverse effects were reported in the study.",0.7,37202063,2023,The anti-dyslipidemia property of saffron petal hydroalcoholicextract in cardiovascular patients: A double-blinded randomized clinical trial.,randomized_controlled_trial,benefit,"The study demonstrated a significant reduction in serum lipid levels in dyslipidemia patients, indicating a beneficial effect of saffron.",(saffron petal pills),,,cardiovascular diseases,cardiovascular diseases; dyslipidemia,,,
Saffron,12.0% discontinued treatment owing to TEAEs; TRAEs led to discontinuation in 23.0% of patients; Treatment-related adverse events occurred in 98.4% of patients; grade ≥ 3 treatment-related adverse events in 50.0% of patients on combination therapy; grade ≥ 3 treatment-related adverse events in 51.9% of patients on monotherapy; increased creatinine levels; minimal adverse effects reported; ≥Grade 3 TRAEs in 51.6%; ≥grade 3 TEAEs in 52.0%,Rheumatoid Arthritis,,Musculoskeletal & Pain,manual_pair,"One randomized, double-blind, placebo-controlled trial reported that saffron supplementation (100 mg daily for 12 weeks) significantly improved clinical outcomes in patients with active rheumatoid arthritis. However, the overall evidence is limited, with only one study demonstrating benefit and no reports of harm or mixed results. Further research is needed to confirm these findings and establish consistency.",0.7,32048365,2020,"The effect of saffron supplement on clinical outcomes and metabolic profiles in patients with active rheumatoid arthritis: A randomized, double-blind, placebo-controlled clinical trial.",randomized_controlled_trial,benefit,"Saffron supplementation significantly improved various clinical outcomes in rheumatoid arthritis patients, indicating a beneficial effect.",100 mg daily 12 weeks (supplement),,,rheumatoid arthritis,rheumatoid arthritis,,,
Saffron,12.0% discontinued treatment owing to TEAEs; TRAEs led to discontinuation in 23.0% of patients; Treatment-related adverse events occurred in 98.4% of patients; grade ≥ 3 treatment-related adverse events in 50.0% of patients on combination therapy; grade ≥ 3 treatment-related adverse events in 51.9% of patients on monotherapy; increased creatinine levels; minimal adverse effects reported; ≥Grade 3 TRAEs in 51.6%; ≥grade 3 TEAEs in 52.0%,Cardiac Recovery,,Performance & Recovery,manual_pair,"Current evidence on saffron for enhancing exercise enjoyment is mixed, with one randomized, double-blind, placebo-controlled study reporting benefits in males but not in females when using a daily dose of 28 mg of a standardized saffron extract (affron®) over six weeks. No consistent positive effects were observed across the population studied, indicating uncertainty regarding its efficacy for this indication.",0.8,35813851,2022,"An examination into the mental and physical effects of a saffron extract (affron®) in recreationally-active adults: A randomized, double-blind, placebo-controlled study.",randomized_controlled_trial,mixed_unclear,"The study found benefits in males but not in females, indicating mixed outcomes overall.",28 mg daily 6 weeks (standardized saffron extract (affron®)),Men,,anxiety,anxiety; exercise enjoyment; heart rate variability; low mood,,,
Saffron,12.0% discontinued treatment owing to TEAEs; TRAEs led to discontinuation in 23.0% of patients; Treatment-related adverse events occurred in 98.4% of patients; grade ≥ 3 treatment-related adverse events in 50.0% of patients on combination therapy; grade ≥ 3 treatment-related adverse events in 51.9% of patients on monotherapy; increased creatinine levels; minimal adverse effects reported; ≥Grade 3 TRAEs in 51.6%; ≥grade 3 TEAEs in 52.0%,Multiple Sclerosis,,Cognitive & Neurological Function,manual_pair,"One randomized, triple-blind placebo-controlled trial has reported a beneficial effect of saffron on serum levels of MMP-9 and TIMP-1 in patients with multiple sclerosis, suggesting potential therapeutic effects. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term safety and efficacy.",0.7,32615663,2020,"A Randomized, Triple-blind Placebo-controlled Trial to Determine the Effect of Saffron on the Serum Levels of MMP-9 and TIMP-1 in Patients with Multiple Sclerosis.",randomized_controlled_trial,benefit,"The study shows significant reduction in MMP-9 and increase in TIMP-1 levels, indicating a beneficial effect of Saffron in MS patients.",12 months (pill),,,multiple sclerosis,multiple sclerosis,,,
Saffron,12.0% discontinued treatment owing to TEAEs; TRAEs led to discontinuation in 23.0% of patients; Treatment-related adverse events occurred in 98.4% of patients; grade ≥ 3 treatment-related adverse events in 50.0% of patients on combination therapy; grade ≥ 3 treatment-related adverse events in 51.9% of patients on monotherapy; increased creatinine levels; minimal adverse effects reported; ≥Grade 3 TRAEs in 51.6%; ≥grade 3 TEAEs in 52.0%,Inflammation,,"Immune, Inflammation, & Infection",manual_pair,"There is limited evidence from one double-blind randomized clinical trial indicating that saffron supplementation (100 mg daily for 12 weeks) may benefit patients with non-alcoholic fatty liver disease by reducing inflammatory and oxidative markers. However, due to the small number of studies and the lack of consistency in findings, the overall evidence remains low-quality and mixed.",0.5,32798261,2020,"The effect of saffron supplementation on some inflammatory and oxidative markers, leptin, adiponectin, and body composition in patients with nonalcoholic fatty liver disease: A double-blind randomized clinical trial.",randomized_controlled_trial,benefit,"The study showed significant decreases in inflammatory and oxidative markers, indicating a beneficial effect of saffron supplementation.",100 mg daily 12 weeks (tablet),Fatty Liver Disease,,non-alcoholic fatty liver disease,non-alcoholic fatty liver disease,,,
Saffron,12.0% discontinued treatment owing to TEAEs; TRAEs led to discontinuation in 23.0% of patients; Treatment-related adverse events occurred in 98.4% of patients; grade ≥ 3 treatment-related adverse events in 50.0% of patients on combination therapy; grade ≥ 3 treatment-related adverse events in 51.9% of patients on monotherapy; increased creatinine levels; minimal adverse effects reported; ≥Grade 3 TRAEs in 51.6%; ≥grade 3 TEAEs in 52.0%,Sleep Quality,,Sleep,manual_pair,"The evidence from five randomized controlled trials indicates that saffron supplementation is associated with significant improvements in sleep quality among individuals with poor sleep or insomnia. Typical doses reported range from 14 mg to 30 mg of saffron extract per day, with no reported adverse effects or harm. However, the studies vary in formulation and population, which may limit the generalizability of the findings.",0.9,33925432,2021,Effects of Saffron Extract on Sleep Quality: A Randomized Double-Blind Controlled Clinical Trial.,randomized_controlled_trial,benefit,"The study shows that saffron extract significantly improves sleep quality and duration, indicating a beneficial effect.",15.5 mg per day 6 weeks (saffron extract),,,anxiety,anxiety; insomnia; primary chronic insomnia; sleep complaints; sleep difficulties; sleep disorder; sleep disturbances; sleep quality; unsatisfactory sleep,,,
Saffron,12.0% discontinued treatment owing to TEAEs; TRAEs led to discontinuation in 23.0% of patients; Treatment-related adverse events occurred in 98.4% of patients; grade ≥ 3 treatment-related adverse events in 50.0% of patients on combination therapy; grade ≥ 3 treatment-related adverse events in 51.9% of patients on monotherapy; increased creatinine levels; minimal adverse effects reported; ≥Grade 3 TRAEs in 51.6%; ≥grade 3 TEAEs in 52.0%,Sleep Quality,,Sleep,manual_pair,"The evidence from five randomized controlled trials indicates that saffron supplementation is associated with significant improvements in sleep quality among individuals with poor sleep or insomnia. Typical doses reported range from 14 mg to 30 mg of saffron extract per day, with no reported adverse effects or harm. However, the studies vary in formulation and population, which may limit the generalizability of the findings.",0.9,34438361,2021,"An investigation into an evening intake of a saffron extract (affron®) on sleep quality, cortisol, and melatonin concentrations in adults with poor sleep: a randomised, double-blind, placebo-controlled, multi-dose study.",randomized_controlled_trial,benefit,"Saffron supplementation showed improvements in sleep quality and mood ratings, indicating a beneficial effect.",14 mg 1 hour before bed 28 days (saffron extract); 28 mg 1 hour before bed 28 days (saffron extract),,"Energy, Mood, & Mental Health",insomnia,anxiety; insomnia; primary chronic insomnia; sleep complaints; sleep difficulties; sleep disorder; sleep disturbances; sleep quality; unsatisfactory sleep,,,
Saffron,12.0% discontinued treatment owing to TEAEs; TRAEs led to discontinuation in 23.0% of patients; Treatment-related adverse events occurred in 98.4% of patients; grade ≥ 3 treatment-related adverse events in 50.0% of patients on combination therapy; grade ≥ 3 treatment-related adverse events in 51.9% of patients on monotherapy; increased creatinine levels; minimal adverse effects reported; ≥Grade 3 TRAEs in 51.6%; ≥grade 3 TEAEs in 52.0%,Sleep Quality,,Sleep,manual_pair,"The evidence from five randomized controlled trials indicates that saffron supplementation is associated with significant improvements in sleep quality among individuals with poor sleep or insomnia. Typical doses reported range from 14 mg to 30 mg of saffron extract per day, with no reported adverse effects or harm. However, the studies vary in formulation and population, which may limit the generalizability of the findings.",0.9,32056539,2020,"Effects of saffron on sleep quality in healthy adults with self-reported poor sleep: a randomized, double-blind, placebo-controlled trial.",randomized_controlled_trial,benefit,"Saffron was associated with significant improvements in sleep quality measures compared to placebo, indicating a beneficial effect.",14 mg twice daily 28 days (extract),,,insomnia,anxiety; insomnia; primary chronic insomnia; sleep complaints; sleep difficulties; sleep disorder; sleep disturbances; sleep quality; unsatisfactory sleep,,,
Saffron,12.0% discontinued treatment owing to TEAEs; TRAEs led to discontinuation in 23.0% of patients; Treatment-related adverse events occurred in 98.4% of patients; grade ≥ 3 treatment-related adverse events in 50.0% of patients on combination therapy; grade ≥ 3 treatment-related adverse events in 51.9% of patients on monotherapy; increased creatinine levels; minimal adverse effects reported; ≥Grade 3 TRAEs in 51.6%; ≥grade 3 TEAEs in 52.0%,Sleep Quality,,Sleep,manual_pair,"The evidence from five randomized controlled trials indicates that saffron supplementation is associated with significant improvements in sleep quality among individuals with poor sleep or insomnia. Typical doses reported range from 14 mg to 30 mg of saffron extract per day, with no reported adverse effects or harm. However, the studies vary in formulation and population, which may limit the generalizability of the findings.",0.9,32736046,2020,"Evaluation of sedative effects of an intranasal dosage form containing saffron, lettuce seeds and sweet violet in primary chronic insomnia: A randomized, double-dummy, double-blind placebo controlled clinical trial.",randomized_controlled_trial,benefit,"The study showed significant improvement in insomnia severity and quality of sleep, indicating a beneficial effect of the saffron-containing formulation.",2 drops twice daily 8 weeks (intranasal herbal oil),,,primary chronic insomnia,anxiety; insomnia; primary chronic insomnia; sleep complaints; sleep difficulties; sleep disorder; sleep disturbances; sleep quality; unsatisfactory sleep,,,
Saffron,12.0% discontinued treatment owing to TEAEs; TRAEs led to discontinuation in 23.0% of patients; Treatment-related adverse events occurred in 98.4% of patients; grade ≥ 3 treatment-related adverse events in 50.0% of patients on combination therapy; grade ≥ 3 treatment-related adverse events in 51.9% of patients on monotherapy; increased creatinine levels; minimal adverse effects reported; ≥Grade 3 TRAEs in 51.6%; ≥grade 3 TEAEs in 52.0%,Sleep Quality,,Sleep,manual_pair,"The evidence from five randomized controlled trials indicates that saffron supplementation is associated with significant improvements in sleep quality among individuals with poor sleep or insomnia. Typical doses reported range from 14 mg to 30 mg of saffron extract per day, with no reported adverse effects or harm. However, the studies vary in formulation and population, which may limit the generalizability of the findings.",0.9,40762630,2025,"A standardised saffron extract improves subjective and objective sleep quality in healthy older adults with sleep complaints: results from the gut-sleep-brain axis randomised, double-blind, placebo-controlled pilot study.",randomized_controlled_trial,benefit,"The study demonstrated significant improvements in both subjective and objective measures of sleep quality, indicating a clear benefit from saffron supplementation.",30 mg day-1 4 weeks,,,sleep complaints,anxiety; insomnia; primary chronic insomnia; sleep complaints; sleep difficulties; sleep disorder; sleep disturbances; sleep quality; unsatisfactory sleep,,,
Saffron,12.0% discontinued treatment owing to TEAEs; TRAEs led to discontinuation in 23.0% of patients; Treatment-related adverse events occurred in 98.4% of patients; grade ≥ 3 treatment-related adverse events in 50.0% of patients on combination therapy; grade ≥ 3 treatment-related adverse events in 51.9% of patients on monotherapy; increased creatinine levels; minimal adverse effects reported; ≥Grade 3 TRAEs in 51.6%; ≥grade 3 TEAEs in 52.0%,Improve Sexual Function,,Women's Health,manual_pair,"There is limited evidence suggesting that saffron may improve sexual function in women with sexual dysfunction when combined with vitamin E, as indicated by one randomized controlled trial that reported significant benefits. The study used a dose of 15 mg of saffron daily for 8 weeks. However, further research is needed to confirm these findings and assess the consistency of results across different populations.",0.7,38408971,2024,Effect of vitamin E with and without saffron on the sexual function in women of reproductive age with sexual dysfunction: a randomized controlled trial.,randomized_controlled_trial,benefit,"The study shows a significant improvement in sexual function and reduction in depression, anxiety, and stress in the experimental group, indicating a benefit from saffron combined with vitamin E.",15 mg once daily 8 weeks (capsule),,,sexual dysfunction,sexual dysfunction,,,
Saffron,12.0% discontinued treatment owing to TEAEs; TRAEs led to discontinuation in 23.0% of patients; Treatment-related adverse events occurred in 98.4% of patients; grade ≥ 3 treatment-related adverse events in 50.0% of patients on combination therapy; grade ≥ 3 treatment-related adverse events in 51.9% of patients on monotherapy; increased creatinine levels; minimal adverse effects reported; ≥Grade 3 TRAEs in 51.6%; ≥grade 3 TEAEs in 52.0%,Stress,,"Energy, Mood, & Mental Health",manual_pair,"One randomized, double-blind, placebo-controlled crossover study found that a single dose of 30 mg of saffron extract (Safr'InsideTM) and 0.06 mg of synthetic safranal significantly reduced stress and anxiety in healthy young men. No studies reported mixed or negative outcomes, indicating a potential benefit for stress reduction; however, further research is needed to confirm these findings and assess long-term effects and safety.",0.8,37447245,2023,"Acute Effect of a Saffron Extract (Safr'InsideTM) and Its Main Volatile Compound on the Stress Response in Healthy Young Men: A Randomized, Double Blind, Placebo-Controlled, Crossover Study.",randomized_controlled_trial,benefit,"The study shows a significant reduction in stress and anxiety after saffron extract and safranal administration, indicating a beneficial effect on psychological stress response.",30 mg single dose (saffron extract (Safr'InsideTM)); 0.06 mg single dose (synthetic safranal),,,acute stress,acute stress; anxiety,,,
Saffron,12.0% discontinued treatment owing to TEAEs; TRAEs led to discontinuation in 23.0% of patients; Treatment-related adverse events occurred in 98.4% of patients; grade ≥ 3 treatment-related adverse events in 50.0% of patients on combination therapy; grade ≥ 3 treatment-related adverse events in 51.9% of patients on monotherapy; increased creatinine levels; minimal adverse effects reported; ≥Grade 3 TRAEs in 51.6%; ≥grade 3 TEAEs in 52.0%,Stroke Recovery,,Cognitive & Neurological Function,manual_pair,"One randomized clinical trial reported that saffron (Crocus sativus L.) at a dose of 400 mg twice daily for 4 days resulted in significant improvements in oxidative stress markers and stroke severity in ischemic stroke patients. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term effects and safety.",0.7,33151132,2022,Evaluation of modulatory effects of saffron (Crocus sativus L.) aqueous extract on oxidative stress in ischemic stroke patients: a randomized clinical trial.,randomized_controlled_trial,benefit,"The study shows significant improvements in oxidative stress markers and stroke severity in the saffron group, indicating a beneficial effect.",400 mg twice per day 4 days (capsule),,"Immune, Inflammation, & Infection",ischemic stroke,ischemic stroke,,,
Saffron,12.0% discontinued treatment owing to TEAEs; TRAEs led to discontinuation in 23.0% of patients; Treatment-related adverse events occurred in 98.4% of patients; grade ≥ 3 treatment-related adverse events in 50.0% of patients on combination therapy; grade ≥ 3 treatment-related adverse events in 51.9% of patients on monotherapy; increased creatinine levels; minimal adverse effects reported; ≥Grade 3 TRAEs in 51.6%; ≥grade 3 TEAEs in 52.0%,Ulcerative Colitis,,Gut Health,manual_pair,"One randomized, double-blind, placebo-controlled study reported that saffron supplementation (100 mg daily for 8 weeks) led to significant improvements in antioxidant status and disease severity in patients with ulcerative colitis, suggesting a potential benefit. However, the overall evidence is limited, with only one study available, and further research is needed to confirm these findings and assess long-term effects and safety.",0.7,33015869,2021,"Effects of saffron supplementation on oxidative/antioxidant status and severity of disease in ulcerative colitis patients: A randomized, double-blind, placebo-controlled study.",randomized_controlled_trial,benefit,"The study shows significant improvements in antioxidant status and disease severity, indicating a beneficial effect of saffron supplementation.",100 mg daily 8 weeks (saffron),,,ulcerative colitis,ulcerative colitis,,,
Selenium,Minor adverse effects were observed.; application site pain; can be toxic at high doses; eye pain; higher risk for squamous cell carcinoma; not recommended for patients with PCOS to use selenium as a regular trace element supplement; potentially increased melanoma risk; risk of selenosis due to overdosing; superficial punctate keratitis; unnecessary supplementation costs,Ulcerative Colitis,,Gut Health,manual_pair,"One randomized, double-blind, placebo-controlled trial found that selenium supplementation (200 mcg daily for 10 weeks) resulted in significant improvements in disease activity and quality of life in patients with mild-to-moderate ulcerative colitis. However, the overall evidence is limited, with only one study reporting a benefit and no data on potential adverse effects or long-term outcomes.",0.7,37525068,2023,"The effect of selenium supplementation on disease activity and immune-inflammatory biomarkers in patients with mild-to-moderate ulcerative colitis: a randomized, double-blind, placebo-controlled clinical trial.",randomized_controlled_trial,benefit,"The study shows significant improvement in disease activity and quality of life in the selenium group, indicating a beneficial effect.",200 mcg daily 10 weeks (oral selenomethionine capsule),,,ulcerative colitis,ulcerative colitis,,,
Selenium,Minor adverse effects were observed.; application site pain; can be toxic at high doses; eye pain; higher risk for squamous cell carcinoma; not recommended for patients with PCOS to use selenium as a regular trace element supplement; potentially increased melanoma risk; risk of selenosis due to overdosing; superficial punctate keratitis; unnecessary supplementation costs,Healthy Aging,,Healthy Aging & Prevention,manual_pair,"One randomized clinical trial indicates that selenium supplementation (200 µg daily for 48 months) may have an anti-ageing effect by influencing age-related biomarkers in elderly individuals with low selenium levels. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term safety.",0.7,37443807,2023,Effects of an Intervention with Selenium and Coenzyme Q10 on Five Selected Age-Related Biomarkers in Elderly Swedes Low in Selenium: Results That Point to an Anti-Ageing Effect-A Sub-Analysis of a Previous Prospective Double-Blind Placebo-Controlled Randomised Clinical Trial.,randomized_controlled_trial,benefit,"The study shows that selenium supplementation influenced biomarkers in a way that suggests an anti-ageing effect, indicating a benefit.",200 µg daily 48 months,Older Adults,,ageing,ageing,,,
Selenium,Minor adverse effects were observed.; application site pain; can be toxic at high doses; eye pain; higher risk for squamous cell carcinoma; not recommended for patients with PCOS to use selenium as a regular trace element supplement; potentially increased melanoma risk; risk of selenosis due to overdosing; superficial punctate keratitis; unnecessary supplementation costs,Healthy Aging,,Healthy Aging & Prevention,manual_pair,"Two randomized clinical trials indicate a benefit of selenium supplementation (200 µg daily) for cardiovascular disease, showing improvements in health outcomes and biomarkers associated with aging and inflammation. However, the evidence is limited to these studies, and no adverse effects were reported. Further research is needed to confirm these findings and explore long-term safety.",0.8,38960007,2024,"Selenoprotein P increases upon selenium and coenzyme Q10 supplementation and is associated with telomere length, quality of life and reduced inflammation and mortality.",randomized_controlled_trial,benefit,"The study shows that selenium supplementation leads to increased SELENOP levels and is associated with improved health outcomes, indicating a benefit.",200 μg daily 4 years (selenium yeast),,,cardiovascular disease,cardiovascular disease; inflammation; mortality; quality of life; telomere length,,,
Selenium,Minor adverse effects were observed.; application site pain; can be toxic at high doses; eye pain; higher risk for squamous cell carcinoma; not recommended for patients with PCOS to use selenium as a regular trace element supplement; potentially increased melanoma risk; risk of selenosis due to overdosing; superficial punctate keratitis; unnecessary supplementation costs,Cognitive Performance,,Cognitive & Neurological Function,manual_pair,"One randomized controlled trial reported a benefit of selenium, specifically in the form of crocin-selenium nanoparticles, on cognitive function and oxidative stress markers in multiple sclerosis patients, using a dose of 55 mcg for 12 weeks. However, the overall evidence is limited, with only one study demonstrating positive outcomes and no reports of harm or mixed results.",0.7,37917350,2024,The effect of crocin-selenium nanoparticles on the cognition and oxidative stress markers of multiple sclerosis patients: a randomized triple-blinded placebo-controlled clinical trial.,randomized_controlled_trial,benefit,"The study showed significant improvements in cognitive function and oxidative stress markers, indicating a benefit from the intervention.",55 mcg 12 weeks (capsules),Multiple Sclerosis,"Immune, Inflammation, & Infection",cognitive impairment,cognitive impairment; multiple sclerosis,,,
Selenium,Minor adverse effects were observed.; application site pain; can be toxic at high doses; eye pain; higher risk for squamous cell carcinoma; not recommended for patients with PCOS to use selenium as a regular trace element supplement; potentially increased melanoma risk; risk of selenosis due to overdosing; superficial punctate keratitis; unnecessary supplementation costs,Depression,,"Energy, Mood, & Mental Health",manual_pair,"Current clinical evidence regarding selenium supplementation for depression is limited and mixed. One randomized controlled trial reported unclear outcomes, with no significant differences in gene expression despite a reduction in the nano-selenium group at a dose of 55 µg daily for 12 weeks. Overall, the evidence does not support a clear benefit for selenium in treating depression.",0.8,40796838,2025,"Impact of Nano-Selenium supplementation on the JAK/STAT signaling pathway in major depressive disorder: a Triple-Blind, randomized controlled trial.",randomized_controlled_trial,mixed_unclear,"The study showed a greater reduction in gene expression in the nano-selenium group, but the differences were not statistically significant, indicating mixed outcomes.",55 µg daily 12 weeks (nano-selenium),,,major depressive disorder,major depressive disorder,,,
Selenium,Minor adverse effects were observed.; application site pain; can be toxic at high doses; eye pain; higher risk for squamous cell carcinoma; not recommended for patients with PCOS to use selenium as a regular trace element supplement; potentially increased melanoma risk; risk of selenosis due to overdosing; superficial punctate keratitis; unnecessary supplementation costs,Dry Eyes,,Vision & Eye Health,manual_pair,"Current evidence from two randomized trials suggests that selenium sulfide, delivered as a topical ointment at doses of 0.5% and 1.0%, may improve symptoms and signs of dry eye syndrome related to meibomian gland dysfunction. Both studies reported beneficial outcomes without any noted adverse effects, although the overall quality of evidence remains limited due to the exploratory nature of the studies and the small sample sizes.",0.7,39894407,2025,The effect of a biweekly novel selenium sulfide-containing topical treatment in symptomatic contact lens wearers: An exploratory study.,randomized_controlled_trial,benefit,"The study shows significant improvement in symptoms and signs of meibomian gland dysfunction and dry eye syndrome with the selenium sulfide treatment, indicating a beneficial outcome.",1 % twice-weekly 4 months (topical ointment),,,dry eye syndrome,dry eye syndrome; meibomian gland dysfunction,,,
Selenium,Minor adverse effects were observed.; application site pain; can be toxic at high doses; eye pain; higher risk for squamous cell carcinoma; not recommended for patients with PCOS to use selenium as a regular trace element supplement; potentially increased melanoma risk; risk of selenosis due to overdosing; superficial punctate keratitis; unnecessary supplementation costs,Dry Eyes,,Vision & Eye Health,manual_pair,"Current evidence from two randomized trials suggests that selenium sulfide, delivered as a topical ointment at doses of 0.5% and 1.0%, may improve symptoms and signs of dry eye syndrome related to meibomian gland dysfunction. Both studies reported beneficial outcomes without any noted adverse effects, although the overall quality of evidence remains limited due to the exploratory nature of the studies and the small sample sizes.",0.7,39613259,2025,"Efficacy and safety of AZR-MD-001 selenium sulfide ophthalmic ointment in adults with meibomian gland dysfunction over six months of treatment: A Phase 2, vehicle-controlled, randomized extension trial.",randomized_controlled_trial,benefit,"The study showed statistically significant improvements in clinical signs and symptoms of meibomian gland dysfunction, indicating a benefit from the treatment.",0.5 % twice weekly 6 months (ophthalmic ointment); 1.0 % twice weekly 6 months (ophthalmic ointment),,,meibomian gland dysfunction,dry eye syndrome; meibomian gland dysfunction,,,
Selenium,Minor adverse effects were observed.; application site pain; can be toxic at high doses; eye pain; higher risk for squamous cell carcinoma; not recommended for patients with PCOS to use selenium as a regular trace element supplement; potentially increased melanoma risk; risk of selenosis due to overdosing; superficial punctate keratitis; unnecessary supplementation costs,Cardiac Recovery,,Performance & Recovery,manual_pair,"One randomized, double-blind, placebo-controlled trial reported a benefit of selenium supplementation (200 mcg daily for 8 weeks) in increasing resting metabolic rate and physical performance in overweight and obese individuals. However, the overall evidence is limited, with only one study available, and further research is needed to confirm these findings and assess long-term effects and safety.",0.7,37513551,2023,"The Effects of Zinc and Selenium Co-Supplementation on Resting Metabolic Rate, Thyroid Function, Physical Fitness, and Functional Capacity in Overweight and Obese People under a Hypocaloric Diet: A Randomized, Double-Blind, and Placebo-Controlled Trial.",randomized_controlled_trial,benefit,"The study showed an increase in resting metabolic rate and timed up-and-go performance, indicating a benefit from selenium supplementation.",200 mcg daily 8 weeks (L-selenomethionine),Obese; Overweight,,obesity,obesity; overweight,,,
Selenium,Minor adverse effects were observed.; application site pain; can be toxic at high doses; eye pain; higher risk for squamous cell carcinoma; not recommended for patients with PCOS to use selenium as a regular trace element supplement; potentially increased melanoma risk; risk of selenosis due to overdosing; superficial punctate keratitis; unnecessary supplementation costs,Graves' Orbitopathy,,Vision & Eye Health,manual_pair,"One randomized controlled trial reported a benefit of selenium supplementation (200 micrograms daily for 6 months) in patients with inactive moderate to severe Graves' orbitopathy, showing significant improvement in palpebral aperture. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term effects and safety.",0.7,38374579,2024,Selenium supplementation in inactive moderate to severe Graves' orbitopathy patients: a randomized controlled trial.,randomized_controlled_trial,benefit,"The selenium group showed a significant improvement in palpebral aperture, indicating a benefit from supplementation.",200 micrograms daily 6 months,,,graves' orbitopathy,graves' orbitopathy,,,
Selenium,Minor adverse effects were observed.; application site pain; can be toxic at high doses; eye pain; higher risk for squamous cell carcinoma; not recommended for patients with PCOS to use selenium as a regular trace element supplement; potentially increased melanoma risk; risk of selenosis due to overdosing; superficial punctate keratitis; unnecessary supplementation costs,Graves' Orbitopathy,,Vision & Eye Health,manual_pair,"The evidence regarding selenium for eye symptoms from Graves' disease is mixed, with one study indicating short-term benefits in symptoms and quality of life but no significant long-term effects. The study utilized selenium yeast orally for 6 months, but overall findings do not support a clear benefit. No adverse effects were reported in the available evidence.",0.7,38200401,2024,Selenium in the treatment of mild-to-moderate Graves' orbitopathy: a 5-year prospective controlled cohort study.,randomized_controlled_trial,mixed_unclear,"Selenium showed short-term benefits in symptoms and quality of life, but no significant long-term differences were observed.",null null oral 6 months (selenium yeast),,,graves' orbitopathy,graves' orbitopathy,,,
Selenium,Minor adverse effects were observed.; application site pain; can be toxic at high doses; eye pain; higher risk for squamous cell carcinoma; not recommended for patients with PCOS to use selenium as a regular trace element supplement; potentially increased melanoma risk; risk of selenosis due to overdosing; superficial punctate keratitis; unnecessary supplementation costs,Hair Loss,,"Skin, Hair, & Nails",manual_pair,"One randomized controlled trial reported a significant benefit of an oral supplement containing selenium among other ingredients for hair loss in subjects with androgenetic alopecia and telogen effluvium over a 12-week period. No adverse effects were noted, but the evidence is limited to a single study, indicating a need for further research to confirm these findings.",0.7,37357646,2023,"Efficacy and tolerability of an oral supplement containing amino acids, iron, selenium, and marine hydrolyzed collagen in subjects with hair loss (androgenetic alopecia, AGA or FAGA or telogen effluvium). A prospective, randomized, 3-month, controlled, assessor-blinded study.",randomized_controlled_trial,benefit,The study showed significant improvement in hair loss outcomes with the supplement compared to drug treatment alone.,1 tablet day 12 weeks (tablet),Alopecia,,androgenetic alopecia,androgenetic alopecia; telogen effluvium,,,
Selenium,Minor adverse effects were observed.; application site pain; can be toxic at high doses; eye pain; higher risk for squamous cell carcinoma; not recommended for patients with PCOS to use selenium as a regular trace element supplement; potentially increased melanoma risk; risk of selenosis due to overdosing; superficial punctate keratitis; unnecessary supplementation costs,High Blood Glucose,,Women's Health,manual_pair,"One randomized controlled trial reported that selenium supplementation (200 µg daily for 4 weeks) may benefit blood glucose levels in pregnant women with gestational diabetes mellitus (GDM) compared to diet alone. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term effects and safety.",0.7,38720217,2024,Selenium Supplementation and Gestational Diabetes: A Randomised Controlled Trial.,randomized_controlled_trial,benefit,Selenium supplementation showed a beneficial impact on blood glucose levels in pregnant women with GDM compared to diet alone.,200 µg daily 4 weeks,Gestational Diabetes; Pregnant; Women,Metabolic Health,gestational diabetes mellitus,gestational diabetes mellitus,,,
Selenium,Minor adverse effects were observed.; application site pain; can be toxic at high doses; eye pain; higher risk for squamous cell carcinoma; not recommended for patients with PCOS to use selenium as a regular trace element supplement; potentially increased melanoma risk; risk of selenosis due to overdosing; superficial punctate keratitis; unnecessary supplementation costs,Cardiac Risk,,Heart & Vascular Health,manual_pair,"One randomized trial indicates that selenium supplementation (200 μg daily for 48 months) may improve systemic redox status and is associated with reduced cardiovascular mortality in an elderly population. No studies reported mixed results or harm, but further research is needed to confirm these findings and establish long-term safety and efficacy.",0.8,37179031,2023,Selenium and coenzyme Q10 improve the systemic redox status while reducing cardiovascular mortality in elderly population-based individuals.,randomized_controlled_trial,benefit,"The study shows that selenium supplementation improved serum R-SH levels and was associated with reduced cardiovascular mortality, indicating a beneficial outcome.",200 μg daily 48 months (yeast),Older Adults,"Immune, Inflammation, & Infection",cardiovascular mortality,cardiovascular mortality; oxidative stress,,,
Selenium,Minor adverse effects were observed.; application site pain; can be toxic at high doses; eye pain; higher risk for squamous cell carcinoma; not recommended for patients with PCOS to use selenium as a regular trace element supplement; potentially increased melanoma risk; risk of selenosis due to overdosing; superficial punctate keratitis; unnecessary supplementation costs,Graves' Disease,,Metabolic Health,manual_pair,"One randomized trial suggests that adding selenium to methimazole may provide clinical benefits in patients with Graves' disease, including improved thyroid markers and reduced medication requirements. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term safety and efficacy.",0.7,40871722,2025,Adding L-Carnitine and Selenium to Methimazole in Graves' Disease: A Prospective Randomized Trial on Thyroid Markers and Quality of Life.,randomized_controlled_trial,benefit,"The study shows clinical benefits of adding L-Carnitine and Selenium to Methimazole in Graves' Disease, including improved TRAb negativity and lower MMI requirements.",up to 24 months (combined L-Carnitine and Selenium supplement),Diabetes Type 2; Women,,graves' disease,graves' disease,,,
Selenium,Minor adverse effects were observed.; application site pain; can be toxic at high doses; eye pain; higher risk for squamous cell carcinoma; not recommended for patients with PCOS to use selenium as a regular trace element supplement; potentially increased melanoma risk; risk of selenosis due to overdosing; superficial punctate keratitis; unnecessary supplementation costs,Rheumatoid Arthritis,,Musculoskeletal & Pain,manual_pair,"One randomized trial reported a significant reduction in joint pain and clinical symptoms in patients with rheumatoid arthritis after 12 weeks of oral selenium supplementation at a dose of 200 μg twice daily, compared to placebo. However, the overall evidence is limited, with only one study available, and further research is needed to confirm these findings and assess long-term effects.",0.7,37306592,2023,Investigation of the Effect of Oral Selenium on the Reduction of Clinical Symptoms and Joint Pain in Patients With Rheumatoid Arthritis in the Iranian Population.,randomized_controlled_trial,benefit,The study shows a significant reduction in clinical symptoms and joint pain in the selenium group compared to placebo.,200 μg twice a day 12 weeks (oral),,,joint pain,joint pain; rheumatoid arthritis,,,
Selenium,Minor adverse effects were observed.; application site pain; can be toxic at high doses; eye pain; higher risk for squamous cell carcinoma; not recommended for patients with PCOS to use selenium as a regular trace element supplement; potentially increased melanoma risk; risk of selenosis due to overdosing; superficial punctate keratitis; unnecessary supplementation costs,Rheumatoid Arthritis,,Musculoskeletal & Pain,manual_pair,"The evidence regarding selenium supplementation for rheumatoid arthritis is mixed and unclear, based on one randomized clinical trial that reported some improvements in biomarkers without statistically significant between-group differences. The study utilized a dose of 200 μg daily for 12 weeks. Overall, there is insufficient evidence to draw definitive conclusions about the efficacy of selenium for this indication.",0.7,37477848,2024,"Effects of Selenium Supplementation on the Indices of Disease Activity, Inflammation and Oxidative Stress in Patients with Rheumatoid Arthritis: a Randomized Clinical Trial.",randomized_controlled_trial,mixed_unclear,"The selenium group showed some clinically relevant improvements in biomarkers, but between-group comparisons were not statistically significant.",200 μg daily 12 weeks,,,rheumatoid arthritis,rheumatoid arthritis,,,
Selenium,Minor adverse effects were observed.; application site pain; can be toxic at high doses; eye pain; higher risk for squamous cell carcinoma; not recommended for patients with PCOS to use selenium as a regular trace element supplement; potentially increased melanoma risk; risk of selenosis due to overdosing; superficial punctate keratitis; unnecessary supplementation costs,Seborrheic Dermatitis,,"Skin, Hair, & Nails",manual_pair,"One randomized trial demonstrated a beneficial effect of a 1% selenium disulfide shampoo used once weekly for 8 weeks in reducing relapse rates and improving pruritus in patients with moderate-to-severe scalp seborrheic dermatitis. No studies reported mixed results or harm, but the evidence is limited to a single study, indicating a need for further research to confirm these findings.",0.8,37098774,2023,Maintenance effect of a once-weekly regimen of a Selenium Disulfide-based shampoo in moderate-to-severe scalp seborrheic dermatitis after initial treatment with topical corticosteroid/salicylic acid.,randomized_controlled_trial,benefit,"The study shows a significant reduction in relapse rates and improvement in pruritus, indicating a beneficial effect of the Selenium disulfide shampoo.",1 % once weekly 8 weeks (shampoo),,,scalp dermatitis,scalp dermatitis; seborrheic dermatitis,,,
Taurine,asthenia/lassitude/increased fatigability; detrimental effects on sprint performance; detrimental to muscle power in noncaffeine consumers; excludes preexisting hypertriglyceridemia; fatigue; gastrointestinal discomfort; higher blood lactate concentration post-ramp; known hypersensitivity to taurine; pregnancy or breast-feeding,Academic Performance,,Cognitive & Neurological Function,manual_pair,"One pilot study suggests that taurine supplementation (3 g per day for 2 weeks) may have a positive effect on academic-related characteristics in Korean college entrance examinees. However, the evidence is limited to a single study with no additional research to confirm these findings, indicating a need for further investigation before drawing definitive conclusions.",0.6,35882814,2022,Effects of Dietary Taurine-Containing Jelly Supplementation on Academic-Related Characteristics and Academic Achievement in Korean College Entrance Examinees: A Pilot Study.,randomized_controlled_trial,benefit,"The study suggests a positive effect of taurine supplementation on academic-related characteristics, indicating a benefit.",3 g 1 packet per day 2 weeks (jelly),,,academic achievement,academic achievement,,,
Taurine,asthenia/lassitude/increased fatigability; detrimental effects on sprint performance; detrimental to muscle power in noncaffeine consumers; excludes preexisting hypertriglyceridemia; fatigue; gastrointestinal discomfort; higher blood lactate concentration post-ramp; known hypersensitivity to taurine; pregnancy or breast-feeding,Chronic Kidney Disease,,Kidney & Bladder Health,manual_pair,"One randomized study suggests that taurine supplementation (500 mg twice daily for 6 months) may have a beneficial effect on estimated glomerular filtration rate (eGFR) in patients with non-diabetic chronic kidney disease (CKD). However, the overall evidence is limited, with only one study reporting a positive outcome and no data on potential adverse effects or long-term safety. Further research is needed to confirm these findings and assess the consistency of the effects.",0.7,35598122,2022,"Comparative Study to Evaluate the Effect of Low-Protein Diet Supplementation with Taurine and N-Acetylcysteine, N-Acetylcysteine and Pyridoxamine Dihydrochloride in Preventing the Progression of Chronic Renal Failure in Patients with Non-Diabetic Kidney Disease.",randomized_controlled_trial,benefit,The study shows a positive effect of Taurine on eGFR in patients with non-diabetic CKD.,500 mg twice a day 6 months (supplement),,,chronic kidney disease,chronic kidney disease; chronic renal failure,,,
Taurine,asthenia/lassitude/increased fatigability; detrimental effects on sprint performance; detrimental to muscle power in noncaffeine consumers; excludes preexisting hypertriglyceridemia; fatigue; gastrointestinal discomfort; higher blood lactate concentration post-ramp; known hypersensitivity to taurine; pregnancy or breast-feeding,Cognitive Performance,,Cognitive & Neurological Function,manual_pair,"The evidence from four randomized studies suggests that taurine supplementation may improve cognitive function and memory in various populations, including the elderly and those with dementia. Doses reported include 1.5 g once daily and 3 g once daily, with additional studies using taurine in combination with caffeine. No adverse effects were noted in the studies, but further research is needed to confirm these findings and establish long-term safety and efficacy.",0.9,39948152,2025,Effects of taurine combined with caffeine on repetitive sprint exercise performance and cognition in a hypoxic environment.,randomized_controlled_trial,benefit,"The study showed that taurine combined with caffeine improved time to exhaustion and cognitive performance, indicating a benefit for exercise performance in hypoxic conditions.",50 mg/kg (taurine); 5 mg/kg (caffeine); 50 mg/kg (taurine + caffeine); 5 mg/kg (placebo),Sprinting,Performance & Recovery,cognition,cognition; cognitive function; cognitive impairment; dementia; inflammation; neurodegeneration; repetitive sprint exercise performance,,,
Taurine,asthenia/lassitude/increased fatigability; detrimental effects on sprint performance; detrimental to muscle power in noncaffeine consumers; excludes preexisting hypertriglyceridemia; fatigue; gastrointestinal discomfort; higher blood lactate concentration post-ramp; known hypersensitivity to taurine; pregnancy or breast-feeding,Cognitive Performance,,Cognitive & Neurological Function,manual_pair,"The evidence from four randomized studies suggests that taurine supplementation may improve cognitive function and memory in various populations, including the elderly and those with dementia. Doses reported include 1.5 g once daily and 3 g once daily, with additional studies using taurine in combination with caffeine. No adverse effects were noted in the studies, but further research is needed to confirm these findings and establish long-term safety and efficacy.",0.9,31468412,2019,The Development of Taurine Supplementary Menus for the Prevention of Dementia and Their Positive Effect on the Cognitive Function in the Elderly with Dementia.,clinical_trial,benefit,"The study shows a significant improvement in cognitive function scores after taurine supplementation, indicating a beneficial effect.",4 weeks (tea and scorched glutinous rice water supplemented with taurine),Dementia; Older Adults; Women,,cognitive function,cognition; cognitive function; cognitive impairment; dementia; inflammation; neurodegeneration; repetitive sprint exercise performance,,,
Taurine,asthenia/lassitude/increased fatigability; detrimental effects on sprint performance; detrimental to muscle power in noncaffeine consumers; excludes preexisting hypertriglyceridemia; fatigue; gastrointestinal discomfort; higher blood lactate concentration post-ramp; known hypersensitivity to taurine; pregnancy or breast-feeding,Cognitive Performance,,Cognitive & Neurological Function,manual_pair,"The evidence from four randomized studies suggests that taurine supplementation may improve cognitive function and memory in various populations, including the elderly and those with dementia. Doses reported include 1.5 g once daily and 3 g once daily, with additional studies using taurine in combination with caffeine. No adverse effects were noted in the studies, but further research is needed to confirm these findings and establish long-term safety and efficacy.",0.9,29474803,2018,"Exercise and taurine in inflammation, cognition, and peripheral markers of blood-brain barrier integrity in older women.",randomized_controlled_trial,benefit,"Taurine supplementation showed a decrease in inflammation markers and improvement in cognitive outcomes, indicating a benefit.",1.5 g once a day 14 weeks,,"Immune, Inflammation, & Infection",cognitive impairment,cognition; cognitive function; cognitive impairment; dementia; inflammation; neurodegeneration; repetitive sprint exercise performance,,,
Taurine,asthenia/lassitude/increased fatigability; detrimental effects on sprint performance; detrimental to muscle power in noncaffeine consumers; excludes preexisting hypertriglyceridemia; fatigue; gastrointestinal discomfort; higher blood lactate concentration post-ramp; known hypersensitivity to taurine; pregnancy or breast-feeding,Cognitive Performance,,Cognitive & Neurological Function,manual_pair,"The evidence from four randomized studies suggests that taurine supplementation may improve cognitive function and memory in various populations, including the elderly and those with dementia. Doses reported include 1.5 g once daily and 3 g once daily, with additional studies using taurine in combination with caffeine. No adverse effects were noted in the studies, but further research is needed to confirm these findings and establish long-term safety and efficacy.",0.9,31468402,2019,Effects of Dietary Taurine Supplementation on Blood and Urine Taurine Concentrations in the Elderly Women with Dementia.,randomized_controlled_trial,benefit,"The study shows significant increases in taurine concentrations and positive changes in language and executive performance, indicating a beneficial effect.",3 g once daily 4 weeks (scorched rice water containing taurine),,,dementia,cognition; cognitive function; cognitive impairment; dementia; inflammation; neurodegeneration; repetitive sprint exercise performance,,,
Taurine,asthenia/lassitude/increased fatigability; detrimental effects on sprint performance; detrimental to muscle power in noncaffeine consumers; excludes preexisting hypertriglyceridemia; fatigue; gastrointestinal discomfort; higher blood lactate concentration post-ramp; known hypersensitivity to taurine; pregnancy or breast-feeding,Dry Eyes,,Vision & Eye Health,manual_pair,"One randomized trial reported a beneficial effect of taurine (0.5% in an ophthalmic solution) on ocular surface parameters in glaucoma patients with dry eyes, showing significant improvement over 90 days of use. However, the overall evidence is limited to this single study, and further research is needed to confirm these findings and assess long-term safety and efficacy.",0.7,29687335,2018,"Prospective, Randomized, Single Masked, Parallel Study Exploring the Effects of a Preservative-Free Ophthalmic Solution Containing Hyaluronic Acid 0.4% and Taurine 0.5% on the Ocular Surface of Glaucoma Patients Under Multiple Long-Term Topical Hypotensive Therapy.",randomized_controlled_trial,benefit,"The study showed significant improvement in ocular surface parameters with the use of taurine, indicating a beneficial effect.",0.5 percent QID 90 days (ophthalmic solution),Glaucoma,,dry eye syndromes,dry eye syndromes; glaucoma,,,
Taurine,asthenia/lassitude/increased fatigability; detrimental effects on sprint performance; detrimental to muscle power in noncaffeine consumers; excludes preexisting hypertriglyceridemia; fatigue; gastrointestinal discomfort; higher blood lactate concentration post-ramp; known hypersensitivity to taurine; pregnancy or breast-feeding,High LDL,,Heart & Vascular Health,manual_pair,"Three randomized clinical trials indicate that taurine supplementation (typically 3 g daily) may have beneficial effects on body composition and metabolic markers in obese women, particularly when combined with exercise. The evidence is consistent in showing improvements in lipid metabolism and energy metabolism without reported adverse effects. However, further research is needed to confirm these findings and assess long-term safety and efficacy.",0.9,32696178,2020,Effect of weight-loss diet combined with taurine supplementation on body composition and some biochemical markers in obese women: a randomized clinical trial.,randomized_controlled_trial,benefit,The study found significant improvements in lipid profile and metabolic risk factors with taurine supplementation.,3 g daily 8 weeks (capsule),,"Immune, Inflammation, & Infection",insulin resistance,insulin resistance; lipid profile improvement; obesity,,,
Taurine,asthenia/lassitude/increased fatigability; detrimental effects on sprint performance; detrimental to muscle power in noncaffeine consumers; excludes preexisting hypertriglyceridemia; fatigue; gastrointestinal discomfort; higher blood lactate concentration post-ramp; known hypersensitivity to taurine; pregnancy or breast-feeding,High LDL,,Heart & Vascular Health,manual_pair,"Three randomized clinical trials indicate that taurine supplementation (typically 3 g daily) may have beneficial effects on body composition and metabolic markers in obese women, particularly when combined with exercise. The evidence is consistent in showing improvements in lipid metabolism and energy metabolism without reported adverse effects. However, further research is needed to confirm these findings and assess long-term safety and efficacy.",0.9,33051044,2021,Taurine supplementation associated with exercise increases mitochondrial activity and fatty acid oxidation gene expression in the subcutaneous white adipose tissue of obese women.,randomized_controlled_trial,benefit,The study shows taurine supplementation improves lipid metabolism and gene expression related to mitochondrial activity in obese women.,3 g daily 8 weeks,Obese; Women,,obesity,insulin resistance; lipid profile improvement; obesity,,,
Taurine,asthenia/lassitude/increased fatigability; detrimental effects on sprint performance; detrimental to muscle power in noncaffeine consumers; excludes preexisting hypertriglyceridemia; fatigue; gastrointestinal discomfort; higher blood lactate concentration post-ramp; known hypersensitivity to taurine; pregnancy or breast-feeding,High LDL,,Heart & Vascular Health,manual_pair,"Three randomized clinical trials indicate that taurine supplementation (typically 3 g daily) may have beneficial effects on body composition and metabolic markers in obese women, particularly when combined with exercise. The evidence is consistent in showing improvements in lipid metabolism and energy metabolism without reported adverse effects. However, further research is needed to confirm these findings and assess long-term safety and efficacy.",0.9,31226435,2019,Taurine supplementation increases irisin levels after high intensity physical training in obese women.,randomized_controlled_trial,benefit,"The study shows that taurine supplementation combined with exercise increases irisin levels, indicating a beneficial effect on energy metabolism in obese women.",3 g 3 times/week 8 weeks (supplement),Obese; Women,,obesity,insulin resistance; lipid profile improvement; obesity,,,
Taurine,asthenia/lassitude/increased fatigability; detrimental effects on sprint performance; detrimental to muscle power in noncaffeine consumers; excludes preexisting hypertriglyceridemia; fatigue; gastrointestinal discomfort; higher blood lactate concentration post-ramp; known hypersensitivity to taurine; pregnancy or breast-feeding,Muscle Endurance,,Performance & Recovery,manual_pair,"The evidence regarding taurine supplementation for exercise performance is mixed, with one study indicating that while taurine may improve certain aspects of performance, it also negatively affected sprint performance. The study utilized a dose of 50 mg/kg body mass. Overall, the findings do not support a clear benefit for taurine in enhancing exercise performance.",0.8,29549523,2018,The effects of taurine on repeat sprint cycling after low or high cadence exhaustive exercise in females.,randomized_controlled_trial,mixed_unclear,"Taurine improved some aspects of performance but had negative effects on sprint performance, indicating mixed outcomes.",50 mg/kg body mass,Cycling,,exercise performance,exercise performance,,,
Taurine,asthenia/lassitude/increased fatigability; detrimental effects on sprint performance; detrimental to muscle power in noncaffeine consumers; excludes preexisting hypertriglyceridemia; fatigue; gastrointestinal discomfort; higher blood lactate concentration post-ramp; known hypersensitivity to taurine; pregnancy or breast-feeding,Muscle Endurance,,Performance & Recovery,manual_pair,"Current evidence regarding taurine supplementation for exercise recovery is limited and mixed. One study indicated a significant enhancement in time to exhaustion when combined with creatine, but did not show improvements in repeated sprint performance. Overall, the findings do not support a clear benefit for taurine in this context, and further research is needed to clarify its effects.",0.7,39972259,2025,Effect of Taurine Combined With Creatine on Repeated Sprinting Ability After Exhaustive Exercise Under Hot and Humid Conditions.,randomized_controlled_trial,mixed_unclear,"The study showed a significant enhancement in time to exhaustion (TTE) with taurine and creatine supplementation, but no significant improvement in repeated sprint performance, indicating mixed outcomes.",,Sprinting,,exercise recovery,exercise recovery,,,
Taurine,asthenia/lassitude/increased fatigability; detrimental effects on sprint performance; detrimental to muscle power in noncaffeine consumers; excludes preexisting hypertriglyceridemia; fatigue; gastrointestinal discomfort; higher blood lactate concentration post-ramp; known hypersensitivity to taurine; pregnancy or breast-feeding,Thermoregulation,,Performance & Recovery,manual_pair,"One randomized trial reported that 50 mg of oral taurine daily for one week improved thermoregulation and sweating responses during low-intensity exercise in hot conditions, suggesting a potential benefit for heat stress. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term effects and safety.",0.7,38582816,2024,The effect of 8-day oral taurine supplementation on thermoregulation during low-intensity exercise at fixed heat production in hot conditions of incremental humidity.,randomized_controlled_trial,benefit,"Taurine supplementation showed significant improvements in thermoregulation and sweating responses, indicating a beneficial effect on human health outcomes related to heat stress.",50 mg daily 1 week (oral),,,heat stress,heat stress; sweating responses; thermoregulation,,,
Taurine,asthenia/lassitude/increased fatigability; detrimental effects on sprint performance; detrimental to muscle power in noncaffeine consumers; excludes preexisting hypertriglyceridemia; fatigue; gastrointestinal discomfort; higher blood lactate concentration post-ramp; known hypersensitivity to taurine; pregnancy or breast-feeding,Arterial Stiffness,,Heart & Vascular Health,manual_pair,"One randomized trial indicates that taurine supplementation (2.0 g three times per day for 14 days) may significantly attenuate exercise-induced increases in arterial stiffness and oxidative stress, suggesting a potential benefit for high arterial stiffness. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term effects and safety.",0.8,27163699,2016,Taurine supplementation attenuates delayed increase in exercise-induced arterial stiffness.,randomized_controlled_trial,benefit,"The study shows that taurine supplementation significantly attenuates the increase in arterial stiffness and oxidative stress after exercise, indicating a beneficial effect.",2.0 g 3 times per day 14 days,,,arterial stiffness,arterial stiffness; oxidative stress,,,
Taurine,asthenia/lassitude/increased fatigability; detrimental effects on sprint performance; detrimental to muscle power in noncaffeine consumers; excludes preexisting hypertriglyceridemia; fatigue; gastrointestinal discomfort; higher blood lactate concentration post-ramp; known hypersensitivity to taurine; pregnancy or breast-feeding,Hypertension,,Heart & Vascular Health,manual_pair,"One randomized, double-blind, placebo-controlled study found that taurine supplementation (1.6 g per day for 12 weeks) significantly lowered blood pressure and improved vascular function in individuals with prehypertension. However, the overall evidence is limited, with only one study demonstrating a benefit and no reports of harm or mixed outcomes.",0.8,26781281,2016,"Taurine Supplementation Lowers Blood Pressure and Improves Vascular Function in Prehypertension: Randomized, Double-Blind, Placebo-Controlled Study.",randomized_controlled_trial,benefit,"Taurine supplementation significantly lowered blood pressure and improved vascular function, indicating a beneficial effect.",1.6 g per day 12 weeks,,,prehypertension,prehypertension,,,
Taurine,asthenia/lassitude/increased fatigability; detrimental effects on sprint performance; detrimental to muscle power in noncaffeine consumers; excludes preexisting hypertriglyceridemia; fatigue; gastrointestinal discomfort; higher blood lactate concentration post-ramp; known hypersensitivity to taurine; pregnancy or breast-feeding,High Blood Glucose,,Metabolic Health,manual_pair,"Taurine supplementation appears to have beneficial effects on glycemic control and metabolic profiles in individuals with Type 2 Diabetes, as evidenced by three randomized, double-blind, placebo-controlled trials. Doses of 3000 mg daily for 8 weeks were consistently reported in two of the studies, while another study combined taurine with TRX training, also showing positive outcomes. No adverse effects were noted in the reviewed studies, but further research may be needed to confirm these findings and explore long-term effects.",0.9,34836211,2021,"The Effects of TRX Suspension Training Combined with Taurine Supplementation on Body Composition, Glycemic and Lipid Markers in Women with Type 2 Diabetes.",randomized_controlled_trial,benefit,The study shows that TRX training combined with taurine supplementation leads to significant improvements in various health markers in women with Type 2 Diabetes.,8 weeks (supplement),Diabetes Type 2; Women,Heart & Vascular Health; Weight & Body Composition,Type 2 Diabetes Mellitus,Type 2 Diabetes Mellitus,,,
Taurine,asthenia/lassitude/increased fatigability; detrimental effects on sprint performance; detrimental to muscle power in noncaffeine consumers; excludes preexisting hypertriglyceridemia; fatigue; gastrointestinal discomfort; higher blood lactate concentration post-ramp; known hypersensitivity to taurine; pregnancy or breast-feeding,High Blood Glucose,,Metabolic Health,manual_pair,"Taurine supplementation appears to have beneficial effects on glycemic control and metabolic profiles in individuals with Type 2 Diabetes, as evidenced by three randomized, double-blind, placebo-controlled trials. Doses of 3000 mg daily for 8 weeks were consistently reported in two of the studies, while another study combined taurine with TRX training, also showing positive outcomes. No adverse effects were noted in the reviewed studies, but further research may be needed to confirm these findings and explore long-term effects.",0.9,32861603,2021,"The Effects of Taurine Supplementation on Metabolic Profiles, Pentosidine, Soluble Receptor of Advanced Glycation End Products and Methylglyoxal in Adults With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Trial.",randomized_controlled_trial,benefit,"The study shows significant improvements in metabolic profiles and diabetes-related biomarkers, indicating a beneficial effect of taurine supplementation.",3000 mg daily 8 weeks,,Heart & Vascular Health,Type 2 Diabetes Mellitus,Type 2 Diabetes Mellitus,,,
Taurine,asthenia/lassitude/increased fatigability; detrimental effects on sprint performance; detrimental to muscle power in noncaffeine consumers; excludes preexisting hypertriglyceridemia; fatigue; gastrointestinal discomfort; higher blood lactate concentration post-ramp; known hypersensitivity to taurine; pregnancy or breast-feeding,High Blood Glucose,,Metabolic Health,manual_pair,"Taurine supplementation appears to have beneficial effects on glycemic control and metabolic profiles in individuals with Type 2 Diabetes, as evidenced by three randomized, double-blind, placebo-controlled trials. Doses of 3000 mg daily for 8 weeks were consistently reported in two of the studies, while another study combined taurine with TRX training, also showing positive outcomes. No adverse effects were noted in the reviewed studies, but further research may be needed to confirm these findings and explore long-term effects.",0.9,32472292,2020,"The effects of taurine supplementation on glycemic control and serum lipid profile in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial.",randomized_controlled_trial,benefit,"The study shows significant improvements in glycemic indexes and lipid profiles, indicating a beneficial effect of taurine supplementation.",3000 mg daily 8 weeks,,Heart & Vascular Health,Type 2 Diabetes Mellitus,Type 2 Diabetes Mellitus,,,
Taurine,asthenia/lassitude/increased fatigability; detrimental effects on sprint performance; detrimental to muscle power in noncaffeine consumers; excludes preexisting hypertriglyceridemia; fatigue; gastrointestinal discomfort; higher blood lactate concentration post-ramp; known hypersensitivity to taurine; pregnancy or breast-feeding,Oxidative Stress,,"Immune, Inflammation, & Infection",manual_pair,"One randomized trial indicates that taurine supplementation (500 mg orally three times a day for two weeks) may have anti-inflammatory effects in individuals with heart failure, showing significant improvements in inflammatory and atherogenic indices. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term effects and safety.",0.8,28580833,2017,Taurine supplementation has anti-atherogenic and anti-inflammatory effects before and after incremental exercise in heart failure.,randomized_controlled_trial,benefit,"The study shows significant improvements in inflammatory and atherogenic indices with taurine supplementation, indicating a beneficial effect.",500 mg 3 times a day 2 weeks (oral taurine),Heart Failure,Heart & Vascular Health,heart failure,heart failure,,,
Taurine,asthenia/lassitude/increased fatigability; detrimental effects on sprint performance; detrimental to muscle power in noncaffeine consumers; excludes preexisting hypertriglyceridemia; fatigue; gastrointestinal discomfort; higher blood lactate concentration post-ramp; known hypersensitivity to taurine; pregnancy or breast-feeding,Power,,Performance & Recovery,manual_pair,"The evidence suggests that taurine supplementation may improve exercise performance, with seven studies reporting benefits across various athletic contexts and doses typically ranging from 2 g to 6 g. However, one study showed mixed results, indicating that the effects may vary based on individual factors such as caffeine consumption. No adverse effects were reported in the reviewed studies.",0.8,37024995,2024,The effects of taurine ingestion on anaerobic and physiological performance in female rugby players.,randomized_controlled_trial,benefit,"Moderate and high doses of taurine improved power output, indicating a beneficial effect on performance.",2 g single dose 1 hour before test (oral); 4 g single dose 1 hour before test (oral); 6 g single dose 1 hour before test (oral),Rugby Players; Women,,anaerobic performance,anaerobic performance; athletic performance; cognitive performance; endurance cycling performance; endurance exercise performance; exercise performance; lipid metabolism; lower limb neuromuscular fatigue; maximal voluntary muscle contraction; muscle power; muscle strength; physiological performance; thermoregulation,,,
Taurine,asthenia/lassitude/increased fatigability; detrimental effects on sprint performance; detrimental to muscle power in noncaffeine consumers; excludes preexisting hypertriglyceridemia; fatigue; gastrointestinal discomfort; higher blood lactate concentration post-ramp; known hypersensitivity to taurine; pregnancy or breast-feeding,Power,,Performance & Recovery,manual_pair,"The evidence suggests that taurine supplementation may improve exercise performance, with seven studies reporting benefits across various athletic contexts and doses typically ranging from 2 g to 6 g. However, one study showed mixed results, indicating that the effects may vary based on individual factors such as caffeine consumption. No adverse effects were reported in the reviewed studies.",0.8,36297081,2022,"Does Single or Combined Caffeine and Taurine Supplementation Improve Athletic and Cognitive Performance without Affecting Fatigue Level in Elite Boxers? A Double-Blind, Placebo-Controlled Study.",randomized_controlled_trial,benefit,The study shows that taurine supplementation improves athletic and cognitive performance in elite boxers.,3 g single dose,Boxers; Men,,athletic performance,anaerobic performance; athletic performance; cognitive performance; endurance cycling performance; endurance exercise performance; exercise performance; lipid metabolism; lower limb neuromuscular fatigue; maximal voluntary muscle contraction; muscle power; muscle strength; physiological performance; thermoregulation,,,
Taurine,asthenia/lassitude/increased fatigability; detrimental effects on sprint performance; detrimental to muscle power in noncaffeine consumers; excludes preexisting hypertriglyceridemia; fatigue; gastrointestinal discomfort; higher blood lactate concentration post-ramp; known hypersensitivity to taurine; pregnancy or breast-feeding,Power,,Performance & Recovery,manual_pair,"The evidence suggests that taurine supplementation may improve exercise performance, with seven studies reporting benefits across various athletic contexts and doses typically ranging from 2 g to 6 g. However, one study showed mixed results, indicating that the effects may vary based on individual factors such as caffeine consumption. No adverse effects were reported in the reviewed studies.",0.8,28338362,2017,"The Effects of Caffeine, Taurine, or Caffeine-Taurine Coingestion on Repeat-Sprint Cycling Performance and Physiological Responses.",randomized_controlled_trial,benefit,"Taurine showed improvements in performance metrics compared to placebo and other conditions, indicating a beneficial effect.",50 mg/kg single dose null (gelatin capsule),Cycling; Sprinting,,athletic performance,anaerobic performance; athletic performance; cognitive performance; endurance cycling performance; endurance exercise performance; exercise performance; lipid metabolism; lower limb neuromuscular fatigue; maximal voluntary muscle contraction; muscle power; muscle strength; physiological performance; thermoregulation,,,
Taurine,asthenia/lassitude/increased fatigability; detrimental effects on sprint performance; detrimental to muscle power in noncaffeine consumers; excludes preexisting hypertriglyceridemia; fatigue; gastrointestinal discomfort; higher blood lactate concentration post-ramp; known hypersensitivity to taurine; pregnancy or breast-feeding,Power,,Performance & Recovery,manual_pair,"The evidence suggests that taurine supplementation may improve exercise performance, with seven studies reporting benefits across various athletic contexts and doses typically ranging from 2 g to 6 g. However, one study showed mixed results, indicating that the effects may vary based on individual factors such as caffeine consumption. No adverse effects were reported in the reviewed studies.",0.8,38406865,2024,Effects of Caffeine-Taurine Co-Ingestion on Endurance Cycling Performance in High Temperature and Humidity Environments.,randomized_controlled_trial,benefit,"The study shows that TAU and CAF improve endurance performance in high temperature and humidity, indicating a benefit for exercise performance.",,Cycling,,endurance cycling performance,anaerobic performance; athletic performance; cognitive performance; endurance cycling performance; endurance exercise performance; exercise performance; lipid metabolism; lower limb neuromuscular fatigue; maximal voluntary muscle contraction; muscle power; muscle strength; physiological performance; thermoregulation,,,
Taurine,asthenia/lassitude/increased fatigability; detrimental effects on sprint performance; detrimental to muscle power in noncaffeine consumers; excludes preexisting hypertriglyceridemia; fatigue; gastrointestinal discomfort; higher blood lactate concentration post-ramp; known hypersensitivity to taurine; pregnancy or breast-feeding,Power,,Performance & Recovery,manual_pair,"The evidence suggests that taurine supplementation may improve exercise performance, with seven studies reporting benefits across various athletic contexts and doses typically ranging from 2 g to 6 g. However, one study showed mixed results, indicating that the effects may vary based on individual factors such as caffeine consumption. No adverse effects were reported in the reviewed studies.",0.8,30776254,2019,Acute taurine supplementation enhances thermoregulation and endurance cycling performance in the heat.,randomized_controlled_trial,benefit,"Taurine supplementation showed significant improvements in cycling time to exhaustion and thermoregulation, indicating a beneficial effect.",50 mg single dose 2 hours prior (oral),Cycling,,endurance cycling performance,anaerobic performance; athletic performance; cognitive performance; endurance cycling performance; endurance exercise performance; exercise performance; lipid metabolism; lower limb neuromuscular fatigue; maximal voluntary muscle contraction; muscle power; muscle strength; physiological performance; thermoregulation,,,
Taurine,asthenia/lassitude/increased fatigability; detrimental effects on sprint performance; detrimental to muscle power in noncaffeine consumers; excludes preexisting hypertriglyceridemia; fatigue; gastrointestinal discomfort; higher blood lactate concentration post-ramp; known hypersensitivity to taurine; pregnancy or breast-feeding,Power,,Performance & Recovery,manual_pair,"The evidence suggests that taurine supplementation may improve exercise performance, with seven studies reporting benefits across various athletic contexts and doses typically ranging from 2 g to 6 g. However, one study showed mixed results, indicating that the effects may vary based on individual factors such as caffeine consumption. No adverse effects were reported in the reviewed studies.",0.8,35213817,2022,"Acute Ketone Salts-Caffeine-Taurine-Leucine Supplementation but not Ketone Salts-Taurine-Leucine, Improves Endurance Cycling Performance.",clinical_trial,benefit,"The study shows that taurine, as part of a multi-ingredient supplement, contributes to improved endurance performance.",2.7 g,Cycling,,endurance exercise performance,anaerobic performance; athletic performance; cognitive performance; endurance cycling performance; endurance exercise performance; exercise performance; lipid metabolism; lower limb neuromuscular fatigue; maximal voluntary muscle contraction; muscle power; muscle strength; physiological performance; thermoregulation,,,
Taurine,asthenia/lassitude/increased fatigability; detrimental effects on sprint performance; detrimental to muscle power in noncaffeine consumers; excludes preexisting hypertriglyceridemia; fatigue; gastrointestinal discomfort; higher blood lactate concentration post-ramp; known hypersensitivity to taurine; pregnancy or breast-feeding,Power,,Performance & Recovery,manual_pair,"The evidence suggests that taurine supplementation may improve exercise performance, with seven studies reporting benefits across various athletic contexts and doses typically ranging from 2 g to 6 g. However, one study showed mixed results, indicating that the effects may vary based on individual factors such as caffeine consumption. No adverse effects were reported in the reviewed studies.",0.8,32466231,2020,Taurine Supplementation Increases Post-Exercise Lipid Oxidation at Moderate Intensity in Fasted Healthy Males.,randomized_controlled_trial,benefit,"Taurine supplementation significantly increased lipid oxidation post-exercise, indicating a beneficial effect on lipid metabolism.",3 g single dose 90 minutes before exercise (supplement); 6 g single dose 90 minutes before exercise (supplement),Men,,exercise performance,anaerobic performance; athletic performance; cognitive performance; endurance cycling performance; endurance exercise performance; exercise performance; lipid metabolism; lower limb neuromuscular fatigue; maximal voluntary muscle contraction; muscle power; muscle strength; physiological performance; thermoregulation,,,
Taurine,asthenia/lassitude/increased fatigability; detrimental effects on sprint performance; detrimental to muscle power in noncaffeine consumers; excludes preexisting hypertriglyceridemia; fatigue; gastrointestinal discomfort; higher blood lactate concentration post-ramp; known hypersensitivity to taurine; pregnancy or breast-feeding,Power,,Performance & Recovery,manual_pair,"The evidence suggests that taurine supplementation may improve exercise performance, with seven studies reporting benefits across various athletic contexts and doses typically ranging from 2 g to 6 g. However, one study showed mixed results, indicating that the effects may vary based on individual factors such as caffeine consumption. No adverse effects were reported in the reviewed studies.",0.8,28945675,2018,The Effect of Acute Taurine Ingestion on Human Maximal Voluntary Muscle Contraction.,randomized_controlled_trial,mixed_unclear,Taurine ingestion had mixed effects on muscle performance depending on caffeine consumption status.,40 mg single dose,,,maximal voluntary muscle contraction,anaerobic performance; athletic performance; cognitive performance; endurance cycling performance; endurance exercise performance; exercise performance; lipid metabolism; lower limb neuromuscular fatigue; maximal voluntary muscle contraction; muscle power; muscle strength; physiological performance; thermoregulation,,,
Taurine,asthenia/lassitude/increased fatigability; detrimental effects on sprint performance; detrimental to muscle power in noncaffeine consumers; excludes preexisting hypertriglyceridemia; fatigue; gastrointestinal discomfort; higher blood lactate concentration post-ramp; known hypersensitivity to taurine; pregnancy or breast-feeding,Muscle Cramps,,Musculoskeletal & Pain,manual_pair,"Current evidence from two randomized trials suggests that taurine supplementation may reduce muscle cramps, particularly in patients with chronic liver disease. Doses reported include 2 g daily and 3 g daily (1 g thrice a day) over a 4-week period. However, the overall quality of evidence is limited, and further studies are needed to confirm these findings and assess long-term safety.",0.7,30136291,2018,Randomised clinical trial: oral taurine supplementation versus placebo reduces muscle cramps in patients with chronic liver disease.,randomized_controlled_trial,benefit,"The study shows a significant reduction in muscle cramps with taurine supplementation, indicating a beneficial effect.",2 g daily 4 weeks (oral),Chronic Liver Disease,,chronic liver disease,chronic liver disease; liver cirrhosis; muscle cramps,,,
Taurine,asthenia/lassitude/increased fatigability; detrimental effects on sprint performance; detrimental to muscle power in noncaffeine consumers; excludes preexisting hypertriglyceridemia; fatigue; gastrointestinal discomfort; higher blood lactate concentration post-ramp; known hypersensitivity to taurine; pregnancy or breast-feeding,Muscle Cramps,,Musculoskeletal & Pain,manual_pair,"Current evidence from two randomized trials suggests that taurine supplementation may reduce muscle cramps, particularly in patients with chronic liver disease. Doses reported include 2 g daily and 3 g daily (1 g thrice a day) over a 4-week period. However, the overall quality of evidence is limited, and further studies are needed to confirm these findings and assess long-term safety.",0.7,33381931,2021,Effectiveness of 4-Week Oral Taurine Treatment for Muscle Cramps in Patients with Liver Cirrhosis: A Single-Arm Pilot Study.,clinical_trial,benefit,"The study reports improvements in muscle cramps with taurine treatment, indicating a beneficial outcome.",1 g thrice a day 4 weeks (oral solution),Cirrhosis,,liver cirrhosis,chronic liver disease; liver cirrhosis; muscle cramps,,,
Taurine,asthenia/lassitude/increased fatigability; detrimental effects on sprint performance; detrimental to muscle power in noncaffeine consumers; excludes preexisting hypertriglyceridemia; fatigue; gastrointestinal discomfort; higher blood lactate concentration post-ramp; known hypersensitivity to taurine; pregnancy or breast-feeding,Exercise Recovery,,Performance & Recovery,manual_pair,"One randomized trial indicates that taurine supplementation may reduce delayed onset muscle soreness following eccentric exercise in young men. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess the consistency of the effects across different populations and doses.",0.7,25833543,2015,Taurine supplementation reduces eccentric exercise-induced delayed onset muscle soreness in young men.,randomized_controlled_trial,benefit,The outcome is classified as 'benefit' as the study reports a reduction in muscle soreness due to Taurine supplementation.,,Men,,delayed onset muscle soreness,delayed onset muscle soreness; myalgia,,,
Taurine,asthenia/lassitude/increased fatigability; detrimental effects on sprint performance; detrimental to muscle power in noncaffeine consumers; excludes preexisting hypertriglyceridemia; fatigue; gastrointestinal discomfort; higher blood lactate concentration post-ramp; known hypersensitivity to taurine; pregnancy or breast-feeding,Inflammation,,"Immune, Inflammation, & Infection",manual_pair,"One randomized trial reported that taurine supplementation (3 g daily for 8 weeks) improved inflammatory markers and subcutaneous white adipose tissue plasticity in obese women, suggesting a potential benefit for obesity-related inflammation. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term effects and safety.",0.7,34255136,2021,Taurine supplementation in conjunction with exercise modulated cytokines and improved subcutaneous white adipose tissue plasticity in obese women.,randomized_controlled_trial,benefit,"The study showed that taurine supplementation improved inflammatory markers and scWAT plasticity, indicating a benefit for obesity-related inflammation.",3 g daily 8 weeks,Obese; Women,,inflammation,inflammation; obesity,,,
Taurine,asthenia/lassitude/increased fatigability; detrimental effects on sprint performance; detrimental to muscle power in noncaffeine consumers; excludes preexisting hypertriglyceridemia; fatigue; gastrointestinal discomfort; higher blood lactate concentration post-ramp; known hypersensitivity to taurine; pregnancy or breast-feeding,Oxidative Stress,,"Immune, Inflammation, & Infection",manual_pair,"One randomized controlled trial found that taurine supplementation (1.5 g daily for 16 weeks) may help prevent the decrease of the antioxidant enzyme superoxide dismutase (SOD) in women aged 55 to 70, suggesting a potential benefit in reducing oxidative stress. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term effects and safety.",0.8,35700594,2022,Taurine as a possible antiaging therapy: A controlled clinical trial on taurine antioxidant activity in women ages 55 to 70.,randomized_controlled_trial,benefit,"Taurine supplementation showed a benefit in preventing the decrease of the antioxidant enzyme SOD, indicating a positive effect on oxidative stress.",1.5 g daily 16 weeks (supplement),Older Adults; Women,Healthy Aging & Prevention,aging,aging; oxidative stress,,,
Taurine,asthenia/lassitude/increased fatigability; detrimental effects on sprint performance; detrimental to muscle power in noncaffeine consumers; excludes preexisting hypertriglyceridemia; fatigue; gastrointestinal discomfort; higher blood lactate concentration post-ramp; known hypersensitivity to taurine; pregnancy or breast-feeding,Inflammation,,Heart & Vascular Health,manual_pair,"One randomized trial suggests that taurine supplementation (3 g per day for 2 weeks) may enhance endothelial progenitor cell function and reduce oxidative stress, indicating a potential benefit for cardiovascular health. However, the overall evidence is limited, with only one study reporting a positive outcome and no data on long-term effects or adverse events.",0.7,27412799,2016,Taurine and magnesium supplementation enhances the function of endothelial progenitor cells through antioxidation in healthy men and spontaneously hypertensive rats.,randomized_controlled_trial,benefit,"The study shows taurine supplementation significantly increased EPC colony numbers and decreased oxidative stress markers, indicating a beneficial effect on cardiovascular health.",3 g per day 2 weeks,,"Immune, Inflammation, & Infection",cardiovascular diseases,cardiovascular diseases,,,
Taurine,asthenia/lassitude/increased fatigability; detrimental effects on sprint performance; detrimental to muscle power in noncaffeine consumers; excludes preexisting hypertriglyceridemia; fatigue; gastrointestinal discomfort; higher blood lactate concentration post-ramp; known hypersensitivity to taurine; pregnancy or breast-feeding,Aerobic Capacity,,Performance & Recovery,manual_pair,"One randomized trial indicates that taurine supplementation (500 mg three times per day for two weeks) may improve functional capacity in individuals with heart failure, suggesting a potential benefit for exercise capacity. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term effects and safety.",0.8,28118062,2017,"Taurine Supplementation Improves Functional Capacity, Myocardial Oxygen Consumption, and Electrical Activity in Heart Failure.",randomized_controlled_trial,benefit,"The study shows significant improvements in cardiac function and physical capacity, indicating a beneficial effect of taurine supplementation.",500 mg three times per day two weeks,Heart Failure,Cardiac Function,heart failure,heart failure,,,
Taurine,asthenia/lassitude/increased fatigability; detrimental effects on sprint performance; detrimental to muscle power in noncaffeine consumers; excludes preexisting hypertriglyceridemia; fatigue; gastrointestinal discomfort; higher blood lactate concentration post-ramp; known hypersensitivity to taurine; pregnancy or breast-feeding,Cardiac Function,,Heart & Vascular Health,manual_pair,"One randomized trial has reported a statistically significant improvement in heart rate variability with taurine supplementation in post-infarction patients with type 2 diabetes mellitus over a 12-week period. No adverse effects were noted in the study, but further research is needed to confirm these findings and assess long-term safety and efficacy.",0.8,31666833,2019,Normalization of heart rate variability with taurine and meldonium complex in post-infarction patients with type 2 diabetes mellitus.,randomized_controlled_trial,benefit,"The study shows a statistically significant improvement in heart rate variability, indicating a benefit from taurine treatment.",12 weeks,Diabetes Type 2,,post-infarction syndrome,Type 2 Diabetes Mellitus; post-infarction syndrome,,,
Taurine,asthenia/lassitude/increased fatigability; detrimental effects on sprint performance; detrimental to muscle power in noncaffeine consumers; excludes preexisting hypertriglyceridemia; fatigue; gastrointestinal discomfort; higher blood lactate concentration post-ramp; known hypersensitivity to taurine; pregnancy or breast-feeding,Endothelial Function,,Heart & Vascular Health,manual_pair,"One randomized trial reported that taurine supplementation at a dose of 6 g daily for 2 weeks significantly improved vascular endothelial function at rest, indicating a potential benefit for poor vascular function. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term effects and safety.",0.7,31468418,2019,Effects of Taurine Supplementation on Vascular Endothelial Function at Rest and After Resistance Exercise.,randomized_controlled_trial,benefit,"Taurine supplementation significantly increased vascular endothelial function at rest, indicating a benefit.",6 g daily 2 weeks (supplement),,,arterial stiffness,arterial stiffness; vascular endothelial function,,,
Taurine,asthenia/lassitude/increased fatigability; detrimental effects on sprint performance; detrimental to muscle power in noncaffeine consumers; excludes preexisting hypertriglyceridemia; fatigue; gastrointestinal discomfort; higher blood lactate concentration post-ramp; known hypersensitivity to taurine; pregnancy or breast-feeding,Psychosis,,"Energy, Mood, & Mental Health",manual_pair,"One randomized, placebo-controlled trial found that taurine (4 g once daily for 12 weeks) improved symptomatology in individuals with first-episode psychosis, suggesting a potential benefit for psychotic symptoms. However, the evidence is limited to a single study, and no effects on cognition were observed. There are no reported harms or adverse effects associated with taurine in this context.",0.7,27835719,2016,"Adjunctive Taurine in First-Episode Psychosis: A Phase 2, Double-Blind, Randomized, Placebo-Controlled Study.",randomized_controlled_trial,benefit,"Taurine improved symptomatology but did not improve cognition, indicating a beneficial effect on psychopathology.",4 g once-daily 12 weeks,,,first-episode psychosis,first-episode psychosis,,,
Taurine,asthenia/lassitude/increased fatigability; detrimental effects on sprint performance; detrimental to muscle power in noncaffeine consumers; excludes preexisting hypertriglyceridemia; fatigue; gastrointestinal discomfort; higher blood lactate concentration post-ramp; known hypersensitivity to taurine; pregnancy or breast-feeding,Muscle Endurance,,Performance & Recovery,manual_pair,"Current evidence on taurine supplementation for improving repeated sprinting ability is limited and mixed. One study indicated that while taurine combined with creatine improved time to exhaustion, it did not significantly enhance repeated sprint performance. Overall, the findings do not support a clear benefit for taurine in this context.",0.7,39972259,2025,Effect of Taurine Combined With Creatine on Repeated Sprinting Ability After Exhaustive Exercise Under Hot and Humid Conditions.,randomized_controlled_trial,mixed_unclear,"The study showed a significant enhancement in time to exhaustion (TTE) with taurine and creatine supplementation, but no significant improvement in repeated sprint performance, indicating mixed outcomes.",,Sprinting,,repeated sprinting ability,repeated sprinting ability,,,
Taurine,asthenia/lassitude/increased fatigability; detrimental effects on sprint performance; detrimental to muscle power in noncaffeine consumers; excludes preexisting hypertriglyceridemia; fatigue; gastrointestinal discomfort; higher blood lactate concentration post-ramp; known hypersensitivity to taurine; pregnancy or breast-feeding,Tics,,"Energy, Mood, & Mental Health",manual_pair,"One randomized trial has reported a significant improvement in tic severity with taurine as an add-on treatment in children over a 12-week period. No adverse effects were noted, but the evidence is limited to a single study, indicating a need for further research to confirm these findings and establish consistency.",0.7,31618495,2020,Safety and efficacy of taurine as an add-on treatment for tics in youngsters.,randomized_controlled_trial,benefit,The study shows significant improvement in tic severity with taurine compared to placebo.,12 weeks (oral),,,tic disorders,tic disorders; tics,,,
Tongkat Ali,,Erectile Dysfunction,,Men's Health,manual_pair,"One randomized, double-blind, placebo-controlled trial reported a benefit of Tongkat Ali (200 mg daily for 6 months) in improving erectile function and testosterone levels in aging males with androgen deficiency. However, the overall evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term safety and efficacy.",0.7,33541567,2021,"A 6-month, double-blind, placebo-controlled, randomized trial to evaluate the effect of Eurycoma longifolia (Tongkat Ali) and concurrent training on erectile function and testosterone levels in androgen deficiency of aging males (ADAM).",randomized_controlled_trial,benefit,"The study demonstrated significant improvements in erectile function and testosterone levels, indicating a beneficial effect of the supplement in the studied population.",200 mg 6 months (Eurycoma longifolia),,,androgen deficiency of aging males (adam),androgen deficiency of aging males (adam); erectile dysfunction,,,
Undenatured type II collagen,,Joint Flexibility,,Musculoskeletal & Pain,manual_pair,"One randomized, double-blind, placebo-controlled study reported a statistically significant improvement in knee joint flexibility among subjects with activity-related joint discomfort after 24 weeks of daily supplementation with 40 mg of undenatured type II collagen. No studies reported mixed outcomes or adverse effects, but overall evidence remains limited and should be interpreted with caution due to the single positive finding.",0.8,35377244,2022,"UC-II Undenatured Type II Collagen for Knee Joint Flexibility: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Study.",randomized_controlled_trial,benefit,"The study demonstrated a statistically significant improvement in knee joint flexibility in subjects with activity-related joint discomfort, indicating a benefit from the supplement.",40 mg daily 24 weeks (undenatured collagen),,,activity-related joint discomfort,activity-related joint discomfort,,,
Undenatured type II collagen,,Joint Pain,,Musculoskeletal & Pain,manual_pair,"One randomized trial reported a beneficial effect of undenatured type II collagen (10 mg daily for 42 days) on joint pain and function in individuals with arthritis. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term safety and efficacy.",0.7,12837047,2002,Effects of orally administered undenatured type II collagen against arthritic inflammatory diseases: a mechanistic exploration.,clinical_trial,benefit,"The study demonstrated significant pain reduction and improvement in joint function, indicating a beneficial effect of the supplement in treating arthritis.",10 mg daily 42 days (glycosylated undenatured type II collagen),Osteoarthritis,,osteoarthritis,osteoarthritis; rheumatoid arthritis,,,
Undenatured type II collagen,,Joint Pain,,Musculoskeletal & Pain,manual_pair,"Human clinical evidence suggests that undenatured type II collagen may provide benefits for knee pain, particularly in the context of osteoarthritis, with two randomized, double-blind, placebo-controlled trials reporting positive outcomes related to pain reduction and joint function. Doses reported include 3.2 mg daily and one capsule daily for 180 days, but the overall evidence remains limited and further studies are needed to confirm these findings and assess long-term safety. No adverse effects were reported in the studies reviewed.",0.8,35512781,2023,"Efficacy and Safety of Dietary Undenatured Type II Collagen on Joint and Motor Function in Healthy Volunteers: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study.",randomized_controlled_trial,benefit,"The study demonstrated significant improvements in joint flexibility, mobility, and pain reduction, indicating a beneficial effect of the supplement.",3.2 mg daily 12 weeks (NEXT-II®),Osteoarthritis,,knee discomfort,knee discomfort; knee osteoarthritis; lower back discomfort; osteoarthritis,,,
Undenatured type II collagen,,Joint Pain,,Musculoskeletal & Pain,manual_pair,"Human clinical evidence suggests that undenatured type II collagen may provide benefits for knee pain, particularly in the context of osteoarthritis, with two randomized, double-blind, placebo-controlled trials reporting positive outcomes related to pain reduction and joint function. Doses reported include 3.2 mg daily and one capsule daily for 180 days, but the overall evidence remains limited and further studies are needed to confirm these findings and assess long-term safety. No adverse effects were reported in the studies reviewed.",0.8,38829812,2024,"[Efficacy and safety of undenatured type II collagen in patients with knee osteoarthritis: a multicenter, prospective, double-blind, placebo-controlled, randomized trial].",randomized_controlled_trial,benefit,"The study demonstrated a positive effect of the supplement on knee osteoarthritis, showing benefits in pain reduction, stiffness, and quality of life.",1 capsule once daily 180 days (Artneo complex containing undenatured chicken collagen type II),Osteoarthritis,,knee osteoarthritis,knee discomfort; knee osteoarthritis; lower back discomfort; osteoarthritis,Tier 1,0.77,"Multicenter, double-blind, placebo-controlled RCT (n=212) in knee osteoarthritis showed significant reductions in pain (WOMAC/KOOS/VAS) and improved function/QoL over 180 days. Joint pain was a primary clinical outcome. Attribution specifically to undenatured type II collagen is somewhat tempered because the tested product was a combination formula containing UC-II."
Undenatured type II collagen,,Joint Pain,,Musculoskeletal & Pain,manual_pair,"Clinical evidence from four randomized, double-blind, placebo-controlled trials indicates that undenatured type II collagen may improve symptoms of knee osteoarthritis, with doses ranging from 40 mg daily to 1 capsule per day for durations of 90 to 180 days. All studies reported benefits without significant adverse effects; however, the overall quality of the evidence is considered tier 3, suggesting further research may be needed to confirm these findings.",0.8,26822714,2016,"Efficacy and tolerability of an undenatured type II collagen supplement in modulating knee osteoarthritis symptoms: a multicenter randomized, double-blind, placebo-controlled study.",randomized_controlled_trial,benefit,"The study demonstrated significant improvements in knee OA symptoms with UC-II compared to placebo and GC, indicating a beneficial effect.",40 mg daily 180 days (undenatured type II collagen),Osteoarthritis,,knee osteoarthritis,knee osteoarthritis; osteoarthritis of the knee; primary osteoarthritis of the knee joint; stage iii knee osteoarthritis,Tier 1,0.86,"Multicenter, randomized, double-blind, placebo-controlled RCT (n=191) in knee osteoarthritis with 180-day follow-up. Primary outcome (WOMAC total and pain subscale) directly reflects joint pain and showed significant benefit vs placebo (and vs glucosamine/chondroitin). Adequate size, rigorous methods, and clinically meaningful endpoints support strong human evidence."
Undenatured type II collagen,,Joint Pain,,Musculoskeletal & Pain,manual_pair,"Clinical evidence from four randomized, double-blind, placebo-controlled trials indicates that undenatured type II collagen may improve symptoms of knee osteoarthritis, with doses ranging from 40 mg daily to 1 capsule per day for durations of 90 to 180 days. All studies reported benefits without significant adverse effects; however, the overall quality of the evidence is considered tier 3, suggesting further research may be needed to confirm these findings.",0.8,19847319,2009,Safety and efficacy of undenatured type II collagen in the treatment of osteoarthritis of the knee: a clinical trial.,randomized_controlled_trial,benefit,"The study demonstrated significant efficacy of UC-II in reducing symptoms of osteoarthritis compared to glucosamine and chondroitin, indicating a clear benefit.",90 days (undenatured type II collagen),Osteoarthritis,,osteoarthritis of the knee,knee osteoarthritis; osteoarthritis of the knee; primary osteoarthritis of the knee joint; stage iii knee osteoarthritis,Tier 2,0.66,"Single human randomized controlled trial in osteoarthritis patients with clinically relevant primary outcomes (WOMAC, VAS, Lequesne) showed benefit of undenatured type II collagen over glucosamine/chondroitin over 90 days. However, the study appears small, with limited duration and unclear blinding/placebo control, so evidence is moderate rather than strong."
Undenatured type II collagen,,Joint Pain,,Musculoskeletal & Pain,manual_pair,"Clinical evidence from four randomized, double-blind, placebo-controlled trials indicates that undenatured type II collagen may improve symptoms of knee osteoarthritis, with doses ranging from 40 mg daily to 1 capsule per day for durations of 90 to 180 days. All studies reported benefits without significant adverse effects; however, the overall quality of the evidence is considered tier 3, suggesting further research may be needed to confirm these findings.",0.8,38785054,2023,"[Comparative efficacy of a combination of undenatured type II collagen, Boswellic acids, methylsulfonylmethane, vitamins C and D3 and a combination of chondroitin sulfate and glucosamine hydrochloride in the treatment of primary osteoarthritis of the knee joint].",randomized_controlled_trial,benefit,"The study showed improvement in pain and quality of life with no significant adverse reactions, indicating a benefit from the supplement.",1 capsule per day 6 months,Osteoarthritis,,primary osteoarthritis of the knee joint,knee osteoarthritis; osteoarthritis of the knee; primary osteoarthritis of the knee joint; stage iii knee osteoarthritis,Tier 5,0.74,"This RCT evaluated a multi-ingredient product (undenatured type II collagen plus Boswellic acids, MSM, vitamins C and D3) versus glucosamine/chondroitin in knee osteoarthritis. Although pain and quality-of-life benefits were observed, the study does not test undenatured type II collagen as a standalone supplement, so effects cannot be attributed specifically to it. Therefore, it does not constitute direct evidence for undenatured type II collagen alone for joint pain."
Undenatured type II collagen,,Joint Pain,,Musculoskeletal & Pain,manual_pair,"Clinical evidence from four randomized, double-blind, placebo-controlled trials indicates that undenatured type II collagen may improve symptoms of knee osteoarthritis, with doses ranging from 40 mg daily to 1 capsule per day for durations of 90 to 180 days. All studies reported benefits without significant adverse effects; however, the overall quality of the evidence is considered tier 3, suggesting further research may be needed to confirm these findings.",0.8,40237733,2025,"[Experience with the use of undenatured type II collagen in patients with stage III knee osteoarthritis: a multicenter, prospective, double-blind, placebo-controlled, randomized trial].",randomized_controlled_trial,benefit,"The study demonstrated significant superiority of the supplement over placebo in improving clinical manifestations of osteoarthritis, indicating a clear benefit.",1 capsule once a day 180 days (Artneo),Osteoarthritis,,stage iii knee osteoarthritis,knee osteoarthritis; osteoarthritis of the knee; primary osteoarthritis of the knee joint; stage iii knee osteoarthritis,Tier 2,0.64,"Multicenter, double-blind, placebo-controlled RCT with clinically relevant primary outcomes (pain VAS, WOMAC, KOOS) showed significant benefit. However, the analyzed cohort for stage III knee OA was small (n=50; 28 vs 22), and the indication here is broader 'joint pain,' limiting generalizability. Strong methods but modest sample size and single study keep it below Tier 1."
Vitamin A,Excessive Vitamin A supplementation may increase the incidence of ARTI in well-nourished children.; High dietary intake of total vitamin A increases hip fracture risk; Two infants developed definite necrotizing enterocolitis in the vitamin A group.; asymptomatic grade 3 hyperbilirubinemia in 1 recipient; gastrointestinal side effects; increased risk of vomiting within the first 48 hours of VAS; mucocutaneous symptoms; slightly increased bulging fontanelle of neonates and infants; temporary increase in liver enzymes; vitamin E supplementation should be avoided,COVID-19,,"Immune, Inflammation, & Infection",manual_pair,"Current evidence on vitamin A supplementation for COVID-19 symptoms is limited, with one study reporting significant improvements in clinical symptoms when administered at a dose of 25,000 IU daily for 10 days compared to standard treatment. Overall, the evidence is low-quality and further research is needed to confirm these findings and assess safety and efficacy.",0.6,36205206,2022,Evaluation and comparison of vitamin A supplementation with standard therapies in the treatment of patients with COVID-19.,randomized_controlled_trial,benefit,Vitamin A supplementation showed significant improvements in clinical symptoms compared to standard treatment.,25000 IU daily 10 days (oral),,,covid-19,covid-19,,,
Vitamin B1 (Thiamine),higher mortality in lactate > 5 mmol/L group; hyperglycemia; hypernatremia; mild and transient adverse events recorded; mild side effects detected; new hospital-acquired infection; poor food intake; potential harm in unplanned subgroup analysis; pregnancy; psychiatric illness; vomiting,Muscloskeletal Pain,,Musculoskeletal & Pain,manual_pair,"One randomized controlled trial reported a benefit of a fixed-dose combination of dexketoprofen and 100 mg of vitamin B1 (thiamine) administered every 8 hours for 7 days in reducing pain intensity in patients with post-traumatic cervical sprains. No studies reported mixed outcomes or harm, but the overall evidence is limited to a single trial, indicating a need for further research to confirm these findings.",0.7,38842764,2024,"A Randomized Control Trial of Dexketoprofen/Vitamin B (Thiamine, Pyridoxine and Cyanocobalamin) Fixed-Dose Combination in Post-Traumatic Grade I-II Cervical Sprains.",randomized_controlled_trial,benefit,The study demonstrated a statistically significant reduction in pain intensity and a better safety profile with the fixed-dose combination compared to monotherapy.,100 mg every 8 hours 7 days (fixed-dose combination with dexketoprofen),Cervical Sprain,,acute pain,acute pain; grade i-ii cervical sprains,Tier 4,0.66,"Although this was a well-designed randomized, double-blind trial with a clinically relevant primary outcome (pain reduction), the intervention combined dexketoprofen with thiamine, pyridoxine, and cyanocobalamin and compared it to dexketoprofen alone. The benefit cannot be attributed to thiamine specifically, making the evidence indirect for vitamin B1 alone in musculoskeletal pain."
Vitamin B1 (Thiamine),higher mortality in lactate > 5 mmol/L group; hyperglycemia; hypernatremia; mild and transient adverse events recorded; mild side effects detected; new hospital-acquired infection; poor food intake; potential harm in unplanned subgroup analysis; pregnancy; psychiatric illness; vomiting,Fatigue,,"Energy, Mood, & Mental Health",manual_pair,"Two randomized clinical trials have reported a beneficial effect of high-dose oral thiamine (600-1800 mg daily) on chronic fatigue in patients with quiescent inflammatory bowel disease, with improvements in clinical fatigue scores noted. There are no reports of harm or no benefit in the studies reviewed, but the evidence is limited to a specific patient population and further research is needed to confirm these findings in broader contexts.",0.8,37880581,2023,"B-vitamins, related vitamers, and metabolites in patients with quiescent inflammatory bowel disease and chronic fatigue treated with high dose oral thiamine.",randomized_controlled_trial,benefit,"The study reports improvement in clinical fatigue scores, indicating a beneficial effect of thiamine.",high dose 4 weeks (oral),IBS,,chronic fatigue,chronic fatigue; inflammatory bowel disease,Tier 2,0.6,"Randomized clinical trial in quiescent IBD patients with chronic fatigue reported improvement in clinical fatigue after 4 weeks of high-dose oral thiamine. Fatigue appears to be a primary clinical outcome. However, details on sample size and blinding are unclear, and the study population is a specific subgroup, suggesting a likely smaller trial with limited generalizability."
Vitamin B1 (Thiamine),higher mortality in lactate > 5 mmol/L group; hyperglycemia; hypernatremia; mild and transient adverse events recorded; mild side effects detected; new hospital-acquired infection; poor food intake; potential harm in unplanned subgroup analysis; pregnancy; psychiatric illness; vomiting,Fatigue,,"Energy, Mood, & Mental Health",manual_pair,"Two randomized clinical trials have reported a beneficial effect of high-dose oral thiamine (600-1800 mg daily) on chronic fatigue in patients with quiescent inflammatory bowel disease, with improvements in clinical fatigue scores noted. There are no reports of harm or no benefit in the studies reviewed, but the evidence is limited to a specific patient population and further research is needed to confirm these findings in broader contexts.",0.8,33210299,2021,Randomised clinical trial: high-dose oral thiamine versus placebo for chronic fatigue in patients with quiescent inflammatory bowel disease.,randomized_controlled_trial,benefit,"The study showed a significant beneficial effect of high-dose thiamine on chronic fatigue, indicating a positive outcome.",600-1800 mg daily 4 weeks (oral),IBD,,chronic fatigue,chronic fatigue; inflammatory bowel disease,Tier 2,0.67,"Randomized, double-blind, placebo-controlled crossover RCT with fatigue as the primary outcome showed significant benefit of high-dose thiamine in quiescent IBD patients. However, the sample size is small (n=40), duration short (4 weeks per period), and the population is disease-specific (IBD), limiting generalizability to broader fatigue. Methods are strong but size/scope keep it from Tier 1."
Vitamin B1 (Thiamine),higher mortality in lactate > 5 mmol/L group; hyperglycemia; hypernatremia; mild and transient adverse events recorded; mild side effects detected; new hospital-acquired infection; poor food intake; potential harm in unplanned subgroup analysis; pregnancy; psychiatric illness; vomiting,Dry Eyes,,Vision & Eye Health,manual_pair,"One study suggests that oral Vitamin B1 may improve symptoms and corneal nerve parameters in individuals with dry eye disease, indicating a potential benefit. However, the evidence is limited to a single study, and further research is needed to confirm these findings and establish consistent dosing and safety profiles.",0.7,36145126,2022,The Utility of Oral Vitamin B1 and Mecobalamin to Improve Corneal Nerves in Dry Eye Disease: An In Vivo Confocal Microscopy Study.,randomized_controlled_trial,benefit,"The study shows significant improvements in various symptoms and corneal nerve parameters, indicating a beneficial effect of Vitamin B1.",(oral),,,dry eye disease,dry eye disease,Tier 2,0.63,"Double-blind randomized controlled trial with a large sample showed clinically relevant improvements (OSDI, symptoms, corneal staining) in dry eye disease. However, Vitamin B1 was administered in combination with mecobalamin, so the effect cannot be attributed to thiamine alone; dose details are also not specified here. Strong design but indirect for B1 specifically, warranting a downgrade from Tier 1."
Vitamin B1 (Thiamine),higher mortality in lactate > 5 mmol/L group; hyperglycemia; hypernatremia; mild and transient adverse events recorded; mild side effects detected; new hospital-acquired infection; poor food intake; potential harm in unplanned subgroup analysis; pregnancy; psychiatric illness; vomiting,Vaginal Bleeding,,Women's Health,manual_pair,"One randomized controlled trial reported a beneficial effect of vitamin B1 (thiamine) at a dose of 100 mg daily for three months in reducing menstrual bleeding and spotting in women using an intrauterine device. However, the overall evidence is limited, with only one study available, and further research is needed to confirm these findings and assess long-term safety and efficacy.",0.7,24738933,2014,The effect of vitamin B1 on bleeding and spotting in women using an intrauterine device: a double-blind randomised controlled trial.,randomized_controlled_trial,benefit,"The intervention group showed significant reduction in menstrual bleeding and spotting, indicating a beneficial effect of vitamin B1.",100 mg daily three months,IUD Use; Women,,excessive menstrual bleeding,excessive menstrual bleeding; spotting,,,
Vitamin B1 (Thiamine),higher mortality in lactate > 5 mmol/L group; hyperglycemia; hypernatremia; mild and transient adverse events recorded; mild side effects detected; new hospital-acquired infection; poor food intake; potential harm in unplanned subgroup analysis; pregnancy; psychiatric illness; vomiting,Oxidative Stress,,"Immune, Inflammation, & Infection",manual_pair,"There is limited evidence suggesting that vitamin B1 (thiamine) may have a beneficial effect on inflammatory markers when used in combination with vitamin C in a perioperative setting, as demonstrated in one randomized controlled trial. The study reported a dose of 100 mg administered at four time points over 24 hours postoperatively. Overall, the evidence is sparse and further research is needed to confirm these findings and assess the consistency of effects across different populations and contexts.",0.7,40290059,2025,Effect of Combined Vitamin C and Thiamine Therapy on Myocardial and Inflammatory Markers in Cardiac Surgery: A Randomized Controlled Clinical Trial.,randomized_controlled_trial,benefit,"The study shows that combined therapy significantly reduced markers of myocardial injury and inflammatory responses, indicating a beneficial effect.",100 mg at four perioperative time points 24 hours postoperatively,,,inflammation,inflammation; myocardial injury; postoperative complications,,,
Vitamin B1 (Thiamine),higher mortality in lactate > 5 mmol/L group; hyperglycemia; hypernatremia; mild and transient adverse events recorded; mild side effects detected; new hospital-acquired infection; poor food intake; potential harm in unplanned subgroup analysis; pregnancy; psychiatric illness; vomiting,Dysmenorrhea,,Women's Health,manual_pair,"One randomized trial reported that Vitamin B1 (thiamine) at a dose of 100 mg daily for two months significantly reduced the severity and duration of dysmenorrhea in high school students. However, the overall evidence is limited, with only one study available, and further research is needed to confirm these findings and assess long-term safety and efficacy.",0.7,25363189,2014,The effects of fish oil capsules and vitamin B1 tablets on duration and severity of dysmenorrhea in students of high school in Urmia-Iran.,randomized_controlled_trial,benefit,"The study shows significant reduction in pain severity and duration with Vitamin B1, indicating a beneficial effect.",100 mg daily 2 months (tablets),Women,,dysmenorrhea,dysmenorrhea,Tier 1,0.73,"Double-blind, randomized, placebo-controlled trial with four arms (n≈60 per arm) in women with primary dysmenorrhea showed significant reductions in pain severity and duration with vitamin B1 (100 mg/day for 2 months) versus placebo. Outcomes were clinically relevant and primary. While methods look solid and sample size is adequate, confidence is tempered slightly by reliance on a single study and limited methodological detail in the abstract."
Vitamin B1 (Thiamine),higher mortality in lactate > 5 mmol/L group; hyperglycemia; hypernatremia; mild and transient adverse events recorded; mild side effects detected; new hospital-acquired infection; poor food intake; potential harm in unplanned subgroup analysis; pregnancy; psychiatric illness; vomiting,Sciatic Pain,,Musculoskeletal & Pain,manual_pair,"The evidence for Vitamin B1 (Thiamine) in managing pain is limited and of low quality. One study reported mixed results, indicating functional improvement but no statistically significant reduction in pain. There are no consistent dose ranges or reported adverse effects in the available literature.",0.5,39683579,2024,Evaluation of the Efficacy of the Addition of a Combination of Pyrimidine Nucleotides and Vitamin B1 and B12 to Standard Treatment in the Management of Painful Radiculopathy and in the Quality of Life of Patients.,randomized_controlled_trial,mixed_unclear,"The study showed mixed results; while there was functional improvement, pain reduction was not statistically significant.",,,,pain,pain,Tier 4,0.42,"Single RCT in painful radiculopathy tested a combination (pyrimidine nucleotides + vitamins B1 and B12) added to standard care, not thiamine alone. Results were mixed: functional improvement but no statistically significant pain reduction. Because the intervention is multi-ingredient and effects cannot be attributed specifically to thiamine, the evidence for thiamine for sciatic pain is indirect and low in strength."
Vitamin B1 (Thiamine),higher mortality in lactate > 5 mmol/L group; hyperglycemia; hypernatremia; mild and transient adverse events recorded; mild side effects detected; new hospital-acquired infection; poor food intake; potential harm in unplanned subgroup analysis; pregnancy; psychiatric illness; vomiting,Improve Bone Density,,Musculoskeletal & Pain,manual_pair,"The evidence for vitamin B1 (thiamine) supplementation in improving bone health is limited, with only one exploratory pilot study reporting a benefit through a significant reduction in a bone resorption marker at a dose of 28 mg daily for one month. Overall, the evidence is low quality and further research is needed to establish any definitive effects on bone health.",0.7,40371216,2025,Effect of vitamin B1 supplementation on bone turnover markers in adults: an exploratory single-arm pilot study.,clinical_trial,benefit,"The study showed a significant reduction in a bone resorption marker, indicating a potential benefit for bone health.",28.0 mg daily 1 month,Older Adults,,bone health,bone health; bone turnover markers,Tier 3,0.64,"Single-arm, pre–post pilot study in older adults with 1-month thiamine supplementation measured surrogate bone turnover markers (TRACP 5b decreased) without a control group and without direct bone density (BMD) outcomes. Exploratory design and short duration provide weak/preliminary human evidence relevant to bone health but not direct proof of improved bone density."
Vitamin B1 (Thiamine),higher mortality in lactate > 5 mmol/L group; hyperglycemia; hypernatremia; mild and transient adverse events recorded; mild side effects detected; new hospital-acquired infection; poor food intake; potential harm in unplanned subgroup analysis; pregnancy; psychiatric illness; vomiting,Premenstrual Syndrome,,Women's Health,manual_pair,"One randomized trial suggests that Vitamin B1 (Thiamine) may significantly reduce mental and physical symptoms of premenstrual syndrome (PMS), indicating a potential benefit. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess the consistency of the results. No adverse effects were reported in the study.",0.7,25363099,2014,The effects of vitamin B1 on ameliorating the premenstrual syndrome symptoms.,randomized_controlled_trial,benefit,"Vitamin B1 significantly reduced mental and physical symptoms of PMS, indicating a beneficial effect.",,Women,,premenstrual syndrome,premenstrual syndrome,Tier 1,0.72,"Double-blind, placebo-controlled RCT in women with PMS (n≈80) with PMS symptom severity as the primary outcome showed significant benefit from thiamine. Methods are appropriate and outcomes are directly relevant to the indication, though the single-center student population and modest sample size slightly limit generalizability."
Vitamin B1 (Thiamine),higher mortality in lactate > 5 mmol/L group; hyperglycemia; hypernatremia; mild and transient adverse events recorded; mild side effects detected; new hospital-acquired infection; poor food intake; potential harm in unplanned subgroup analysis; pregnancy; psychiatric illness; vomiting,Stress,,"Energy, Mood, & Mental Health",manual_pair,"The evidence for Vitamin B1 (Thiamine) supplementation in reducing stress is limited and mixed. One randomized, double-blind, placebo-controlled trial reported some benefits in stress reduction and sleep quality at a dose of 100 mg for 4 weeks, but no significant effect on anxiety was observed. Overall, the findings do not support a clear benefit for this indication.",0.7,40507089,2025,"Impact of Vitamin B1 and Vitamin B2 Supplementation on Anxiety, Stress, and Sleep Quality: A Randomized, Double-Blind, Placebo-Controlled Trial.",randomized_controlled_trial,mixed_unclear,"Vitamin B1 supplementation showed benefits in reducing stress and improving sleep quality, but no significant effect on anxiety.",100 mg 4 weeks,,Sleep,anxiety,anxiety; sleep quality; stress,Tier 2,0.6,"Randomized, double-blind, placebo-controlled human trial with reported benefit on stress for thiamine, but stress appears likely a secondary outcome (study categorized under sleep), sample size not provided, short duration (4 weeks), and mixed overall results (no anxiety effect). This supports moderate human evidence rather than strong."
Vitamin B12 (Cobalamin),,Postherpetic Neuralgia,,Musculoskeletal & Pain,manual_pair,"One randomized controlled trial reported significant analgesic effects and improvements in activities of daily living and quality of life with vitamin B12 (cobalamin) injections for chronic pain from postherpetic neuralgia over an 8-week period. However, the overall evidence is limited, with only one study demonstrating benefit and no reports of harm or mixed outcomes.",0.8,24196971,2014,Transcutaneous electrical nerve stimulation in combination with cobalamin injection for postherpetic neuralgia: a single-center randomized controlled trial.,randomized_controlled_trial,benefit,The study shows significant analgesic effects and improvements in activities of daily living and quality of life with the use of cobalamin injections.,8 wks (injection),Herpes,,postherpetic neuralgia,postherpetic neuralgia,Tier 2,0.63,"Single-center randomized controlled trial (n=90) in postherpetic neuralgia showed clinically meaningful pain, ADL, and QoL improvements with local cobalamin injections (with TENS) versus comparator arms. However, it used combination therapy (all groups received TENS), likely limited/unclear blinding, and short duration, so evidence is moderate rather than strong."
Vitamin B12 (Cobalamin),,Alzheimer's Disease,,Cognitive & Neurological Function,manual_pair,"The evidence from four randomized trials indicates that Vitamin B12 supplementation may improve cognitive function in individuals with cognitive impairment or dementia. Doses varied, including daily oral doses of 50 μg and intramuscular injections of hydroxocobalamin and other forms, but no adverse effects were reported. Overall, the findings suggest a beneficial effect, though the quality and consistency of the evidence warrant cautious interpretation.",0.8,34101780,2021,"Effects of Folic Acid and Vitamin B12 Supplementation on Cognitive Impairment and Inflammation in Patients with Alzheimer's Disease: A Randomized, Single-Blinded, Placebo-Controlled Trial.",randomized_controlled_trial,benefit,The study found beneficial effects on cognitive performance in Alzheimer's patients receiving Vitamin B12 supplementation.,50 μg daily 6 months,,,alzheimer's disease,alzheimer's disease; cerebral function abnormalities; cognitive dysfunction; cognitive impairment; dementia,Tier 4,0.44,"Although this is a randomized, single-blind, placebo-controlled trial with clinically relevant cognitive outcomes in Alzheimer’s patients, the intervention was a combination of folic acid plus vitamin B12. The co-supplementation prevents attributing benefits specifically to vitamin B12, making the evidence indirect for B12 alone despite positive results."
Vitamin B12 (Cobalamin),,Alzheimer's Disease,,Cognitive & Neurological Function,manual_pair,"The evidence from four randomized trials indicates that Vitamin B12 supplementation may improve cognitive function in individuals with cognitive impairment or dementia. Doses varied, including daily oral doses of 50 μg and intramuscular injections of hydroxocobalamin and other forms, but no adverse effects were reported. Overall, the findings suggest a beneficial effect, though the quality and consistency of the evidence warrant cautious interpretation.",0.8,11723153,2001,"Cobalamin supplementation improves cognitive and cerebral function in older, cobalamin-deficient persons.",clinical_trial,benefit,"The study shows improvements in cognitive and cerebral function after supplementation, indicating a beneficial effect.",5 months intramuscular injections 1 month placebo followed by 5 months treatment (hydroxocobalamin),Cobalamin Deficiency; Older Adults,,cerebral function abnormalities,alzheimer's disease; cerebral function abnormalities; cognitive dysfunction; cognitive impairment; dementia,Tier 5,0.86,"The trial tested hydroxocobalamin in cobalamin-deficient, cognitively normal older adults and assessed cognitive tests and qEEG, not Alzheimer’s disease patients or AD-related outcomes (diagnosis, progression, or AD-specific scales). Thus it does not directly evaluate vitamin B12 for Alzheimer’s disease treatment or prevention. Findings are indirect and cannot be extrapolated to AD."
Vitamin B12 (Cobalamin),,Alzheimer's Disease,,Cognitive & Neurological Function,manual_pair,"The evidence from four randomized trials indicates that Vitamin B12 supplementation may improve cognitive function in individuals with cognitive impairment or dementia. Doses varied, including daily oral doses of 50 μg and intramuscular injections of hydroxocobalamin and other forms, but no adverse effects were reported. Overall, the findings suggest a beneficial effect, though the quality and consistency of the evidence warrant cautious interpretation.",0.8,11424170,2001,Improvement of cognitive functions after cobalamin/folate supplementation in elderly patients with dementia and elevated plasma homocysteine.,clinical_trial,benefit,"Patients with mild-moderate dementia showed improvement in cognitive function after supplementation, indicating a beneficial outcome.",,,,cognitive dysfunction,alzheimer's disease; cerebral function abnormalities; cognitive dysfunction; cognitive impairment; dementia,Tier 3,0.38,"Small, uncontrolled pre–post clinical study (n≈33) using combined cobalamin/folate supplementation with cognitive test outcomes. No randomization or control group; effects reported only in a subgroup (mild–moderate dementia with elevated homocysteine). Population was ‘dementia’ rather than specifically Alzheimer’s disease, and the combination therapy limits attribution to B12 alone. Thus, preliminary human evidence with indirect relevance to AD."
Vitamin B12 (Cobalamin),,Alzheimer's Disease,,Cognitive & Neurological Function,manual_pair,"The evidence from four randomized trials indicates that Vitamin B12 supplementation may improve cognitive function in individuals with cognitive impairment or dementia. Doses varied, including daily oral doses of 50 μg and intramuscular injections of hydroxocobalamin and other forms, but no adverse effects were reported. Overall, the findings suggest a beneficial effect, though the quality and consistency of the evidence warrant cautious interpretation.",0.8,37334792,2023,Vitamin B12 supplementation improves cognitive function in middle aged and elderly patients with cognitive impairment.,randomized_controlled_trial,benefit,"The study shows significant improvement in cognitive function with Vitamin B12 supplementation, indicating a beneficial outcome.",500 mg daily seven days (intramuscular),Older Adults,,cognitive dysfunction,alzheimer's disease; cerebral function abnormalities; cognitive dysfunction; cognitive impairment; dementia,Tier 4,0.72,"The study is a randomized controlled trial but enrolled participants with general cognitive impairment rather than specifically diagnosed Alzheimer’s disease. Outcomes were global cognitive tests (MMSE, MoCA) showing improvement, which is clinically relevant but indirect for Alzheimer’s as the indication. Thus, it provides very low/indirect human evidence for Vitamin B12 in Alzheimer’s disease."
Vitamin B12 (Cobalamin),,Postherpetic Itching,,"Skin, Hair, & Nails",manual_pair,"One randomized controlled trial (PMID 23887347) reported that locally injected vitamin B12 (cobalamin) provided significant pain relief for herpetic itching over a 4-week period. No studies reported mixed outcomes or harm, but the evidence is limited to a single trial, indicating a need for further research to confirm these findings.",0.7,23887347,2014,"Thiamine, cobalamin, locally injected alone or combination for herpetic itching: a single-center randomized controlled trial.",randomized_controlled_trial,benefit,"Cobalamin showed significant pain relief, indicating a beneficial outcome for the treatment of herpetic itching.",4 weeks (locally injected),Herpes,,herpetic itching,herpetic itching; pain,Tier 2,0.63,"Single-center randomized controlled trial (~20 per arm) tested locally injected cobalamin in patients with herpetic itching and measured pruritus as a primary clinical outcome. While the RCT design provides moderate-quality human evidence, cobalamin alone did not significantly reduce itch (benefit was on pain), and sample size/blinding details limit robustness. Relevant to the indication but does not show efficacy for itching."
Vitamin B12 (Cobalamin),,High Homocysteine,,Heart & Vascular Health,manual_pair,"Evidence from three randomized controlled trials indicates that vitamin B12 supplementation is associated with a reduction in plasma homocysteine levels. Doses reported include 1.8 μg daily and 1 mg intravenously every 7 or 14 days. Overall, the findings suggest a beneficial effect of vitamin B12 on high homocysteine levels, although the studies vary in population and dosing regimens.",0.9,36889645,2023,Daily Folic Acid and/or Vitamin B12 Supplementation Between 6 and 30 Months of Age and Cardiometabolic Risk Markers After 6-7 Years: A Follow-Up of a Randomized Controlled Trial.,randomized_controlled_trial,benefit,"The study shows a decrease in plasma tHcy concentrations, indicating a beneficial effect of vitamin B12 supplementation.",1.8 μg daily 6 months (supplement with folic acid),,,cardiometabolic risk markers,cardiometabolic risk markers; elevated plasma homocysteine; elevated thcy concentrations; end-stage renal disease; homocysteine reduction; older adults,Tier 2,0.53,"Large, double-blind randomized factorial trial with homocysteine as a measured outcome shows benefit, but the significant reduction in tHcy was observed with combined vitamin B12 plus folic acid rather than clearly with B12 alone. The intervention occurred in early childhood with outcomes measured 6 years later, which limits direct applicability to treating high homocysteine and to B12 monotherapy."
Vitamin B12 (Cobalamin),,High Homocysteine,,Heart & Vascular Health,manual_pair,"Evidence from three randomized controlled trials indicates that vitamin B12 supplementation is associated with a reduction in plasma homocysteine levels. Doses reported include 1.8 μg daily and 1 mg intravenously every 7 or 14 days. Overall, the findings suggest a beneficial effect of vitamin B12 on high homocysteine levels, although the studies vary in population and dosing regimens.",0.9,15931623,2005,Cobalamin dose regimen for maximum homocysteine reduction in end-stage renal disease.,randomized_controlled_trial,benefit,"The study shows that intravenous cyanocobalamin significantly reduces plasma homocysteine levels, indicating a beneficial effect in patients with end-stage renal disease.",1 mg every 14 or 7 days 8 weeks (intravenous cyanocobalamin),CKD,,elevated plasma homocysteine,cardiometabolic risk markers; elevated plasma homocysteine; elevated thcy concentrations; end-stage renal disease; homocysteine reduction; older adults,Tier 2,0.64,"Randomized controlled trial in hemodialysis patients showed that more frequent intravenous cyanocobalamin (every 7–14 days) significantly reduced plasma homocysteine versus monthly dosing. The outcome (tHcy) directly matches the indication (high homocysteine) and is objective. However, the study appears relatively small, likely unblinded, limited to CKD/ESRD patients, and compares dosing regimens rather than supplement vs placebo/no treatment, which constrains generalizability."
Vitamin B12 (Cobalamin),,High Homocysteine,,Heart & Vascular Health,manual_pair,"Evidence from three randomized controlled trials indicates that vitamin B12 supplementation is associated with a reduction in plasma homocysteine levels. Doses reported include 1.8 μg daily and 1 mg intravenously every 7 or 14 days. Overall, the findings suggest a beneficial effect of vitamin B12 on high homocysteine levels, although the studies vary in population and dosing regimens.",0.9,15271145,2004,"Cobalamin reduces homocysteine in older adults on folic acid-fortified diet: a pilot, double-blind, randomized, placebo-controlled trial.",randomized_controlled_trial,benefit,"The study shows a benefit in reducing homocysteine levels, which is clinically relevant for older adults.",,Older Adults,,homocysteine reduction,cardiometabolic risk markers; elevated plasma homocysteine; elevated thcy concentrations; end-stage renal disease; homocysteine reduction; older adults,Tier 2,0.68,"Double-blind, randomized, placebo-controlled trial in older adults showing B12 lowers homocysteine, which is the primary outcome for the indication. However, it is a pilot (small) study, limiting strength despite good methodology."
Vitamin B12 (Cobalamin),,Migraine Headache,,Musculoskeletal & Pain,manual_pair,"One randomized, placebo-controlled trial reported a significant reduction in migraine symptoms with the combination of vitamin B12 and magnesium over a 2-month supplementation period. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess the consistency of the results. No adverse effects were reported in the study.",0.7,35112219,2022,"Artificial intelligence analysis to explore synchronize exercise, cobalamin, and magnesium as new actors to therapeutic of migraine symptoms: a randomized, placebo-controlled trial.",randomized_controlled_trial,benefit,"The study shows a significant reduction in migraine symptoms with the combination of vitamin B12 and magnesium, indicating a beneficial outcome.",2 months (supplementation),,,migraine disorders,migraine disorders,Tier 4,0.42,"Although this was a randomized, placebo-controlled trial with clinical migraine outcomes (frequency, intensity, duration, MIDAS), the supplementation arm used a combination of vitamin B12 plus magnesium and the main significant improvements occurred only in the HIIT + supplementation group. The study does not demonstrate a clear benefit for supplementation alone, nor isolate the effect of vitamin B12 independent of magnesium and exercise. Small sample size (~60) and short duration (2 months) further limit conclusions for B12 specifically."
Vitamin B12 (Cobalamin),,Stroke Recovery,,Cognitive & Neurological Function,manual_pair,"One randomized clinical trial reported a benefit of vitamin B12 (cobalamin) in improving neurological function and daily living ability in patients with acute ischemic stroke, using a dose of 1 mL injected once daily for two weeks. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term effects and safety.",0.7,29071932,2016,[Randomized Clinical Trial for Treatment of Patients with Acute Ischemic Cerebral Stroke by Acupoint Injection of Cobalamin or Gangliosides].,randomized_controlled_trial,benefit,The study shows significant improvement in neurological function and daily living ability in stroke patients treated with Cobalamin.,1 mL once daily two weeks (injection),,,acute ischemic stroke,acute ischemic stroke,Tier 2,0.58,"Randomized controlled trial in acute ischemic stroke with clinically relevant outcomes (neurological function and ADLs) showing benefit from cobalamin injections. However, sample size is small (~30 per arm), blinding and allocation concealment are unclear, outcomes include subjective 'effective rate,' and the acupoint injection method may introduce placebo or procedural effects and limits generalizability to standard B12 use. Thus, moderate but not strong human evidence."
Vitamin B12 (Cobalamin),,Fatty Liver Disease,,Gut Health,manual_pair,"The evidence regarding vitamin B12 supplementation for non-alcoholic fatty liver disease is limited and mixed, with one randomized controlled trial reporting a significant decrease in homocysteine but unclear effects on other metabolic parameters. The study utilized a dose of 1000 µg once daily for 12 weeks. Overall, the quality of evidence is low, and no clear benefits have been established.",0.8,35982162,2022,The effects of vitamin B12 supplementation on metabolic profile of patients with non-alcoholic fatty liver disease: a randomized controlled trial.,randomized_controlled_trial,mixed_unclear,Vitamin B12 supplementation showed a significant decrease in homocysteine but mixed results for other metabolic parameters compared to placebo.,1000 µg once daily 12 weeks (oral tablet),,,non-alcoholic fatty liver disease,non-alcoholic fatty liver disease,Tier 2,0.58,"Double-blind randomized controlled trial in NAFLD patients (n=40) directly measured liver-related outcomes (steatosis grade, liver enzymes) but found no significant between-group improvements versus placebo; only homocysteine decreased significantly. Study quality is moderate (RCT, blinded) but small sample and short duration with mixed/negative clinical results for the indication."
Vitamin B12 (Cobalamin),,Endothelial Function,,Heart & Vascular Health,manual_pair,"One randomized trial indicates that vitamin B12 (cobalamin) supplementation at a dose of 400 micrograms daily for six months may improve coronary endothelial function in patients with coronary artery disease. However, the overall evidence is limited, with only one study showing a benefit and no reports of harm or mixed outcomes.",0.7,12204509,2002,Coronary endothelial function in hyperhomocysteinemia: improvement after treatment with folic acid and cobalamin in patients with coronary artery disease.,randomized_controlled_trial,benefit,"The study shows a significant improvement in coronary endothelial function after treatment with cobalamin, indicating a beneficial outcome.",400 microg daily six months,,,coronary artery disease,coronary artery disease; hyperhomocysteinemia,Tier 3,0.42,"Randomized, placebo-controlled trial in hyperhomocysteinemic CAD patients showed improved coronary endothelial function after six months, but the intervention combined folic acid (5 mg) with cobalamin (400 mcg), so the effect cannot be attributed to B12 alone. The primary outcome was a surrogate physiological measure (acetylcholine-stimulated coronary blood flow) and the sample size was very small (n=15), making the evidence preliminary despite the RCT design."
Vitamin B2 (Riboflavin),Four patients discontinued due to adverse events related with deferiprone.; One mild fever documented in the <5 day storage group.; delayed epithelial healing with dendrites; desquamation; greater in-treatment pain and burning sensation; hyperpigmentation; lower riboflavin status in smokers and COPD patients; more prominent post-treatment erythema; recurrent epithelial defects; sterile infiltrates; transient recurrent corneal erosions,Neuropathic Pain,,Musculoskeletal & Pain,manual_pair,"One randomized, double-blind, placebo-controlled trial reported a significant reduction in symptoms of diabetic neuropathy with a treatment regimen that included riboflavin, administered intravenously for 10 days followed by oral dosing for 75 days. Overall, the evidence is limited to this single study, and further research is needed to confirm these findings and assess long-term safety and efficacy.",0.7,35680173,2022,"Efficacy and safety of the combined metabolic medication, containing inosine, nicotinamide, riboflavin and succinic acid, for the treatment of diabetic neuropathy: a multicenter randomized, double-blind, placebo-controlled parallel group clinical trial (CYLINDER).",randomized_controlled_trial,benefit,"The study shows a significant reduction in diabetic neuropathy symptoms, indicating a beneficial effect of the treatment including riboflavin.","10 days intravenous, 75 days oral",Diabetes,,diabetic neuropathy,Type 2 Diabetes Mellitus; diabetic neuropathy,Tier 4,0.42,"Although this is a well-designed, double-blind, placebo-controlled RCT in patients with diabetic neuropathy showing symptomatic benefit, the intervention was a multi-ingredient combination (inosine, nicotinamide, riboflavin, succinic acid). Because riboflavin was not isolated and its specific dose/effect cannot be disentangled, the evidence for riboflavin alone in neuropathic pain is indirect."
Vitamin B2 (Riboflavin),Four patients discontinued due to adverse events related with deferiprone.; One mild fever documented in the <5 day storage group.; delayed epithelial healing with dendrites; desquamation; greater in-treatment pain and burning sensation; hyperpigmentation; lower riboflavin status in smokers and COPD patients; more prominent post-treatment erythema; recurrent epithelial defects; sterile infiltrates; transient recurrent corneal erosions,Hypertension,,Heart & Vascular Health,manual_pair,"Vitamin B2 (riboflavin) supplementation at a dose of 1.6 mg daily for 16 weeks has shown beneficial effects on blood pressure in individuals with the MTHFR 677TT genotype, as evidenced by three randomized trials reporting significant reductions in both systolic and diastolic blood pressure. However, the evidence is specific to this genetic subgroup, and no adverse effects were reported in the studies reviewed.",0.9,23608654,2013,Blood pressure in treated hypertensive individuals with the MTHFR 677TT genotype is responsive to intervention with riboflavin: findings of a targeted randomized trial.,randomized_controlled_trial,benefit,"Riboflavin supplementation significantly lowered systolic blood pressure in the targeted population, indicating a beneficial effect.",1.6 mg daily 16 weeks,,,hypertension,hypertension,Tier 2,0.68,"Randomized, placebo-controlled human trial with systolic blood pressure as a primary clinical outcome showed a significant reduction with riboflavin in hypertensive individuals carrying the MTHFR 677TT genotype. Sample size was modest (~91), diastolic BP was not significantly affected, and findings are genotype-specific, limiting generalizability. Thus, moderate-quality human evidence."
Vitamin B2 (Riboflavin),Four patients discontinued due to adverse events related with deferiprone.; One mild fever documented in the <5 day storage group.; delayed epithelial healing with dendrites; desquamation; greater in-treatment pain and burning sensation; hyperpigmentation; lower riboflavin status in smokers and COPD patients; more prominent post-treatment erythema; recurrent epithelial defects; sterile infiltrates; transient recurrent corneal erosions,Hypertension,,Heart & Vascular Health,manual_pair,"Vitamin B2 (riboflavin) supplementation at a dose of 1.6 mg daily for 16 weeks has shown beneficial effects on blood pressure in individuals with the MTHFR 677TT genotype, as evidenced by three randomized trials reporting significant reductions in both systolic and diastolic blood pressure. However, the evidence is specific to this genetic subgroup, and no adverse effects were reported in the studies reviewed.",0.9,22277556,2012,Riboflavin offers a targeted strategy for managing hypertension in patients with the MTHFR 677TT genotype: a 4-y follow-up.,randomized_controlled_trial,benefit,"Riboflavin supplementation resulted in a significant decrease in both systolic and diastolic blood pressure, indicating a beneficial effect.",1.6 mg daily 16 weeks,,,hypertension,hypertension,Tier 2,0.64,"Placebo-controlled randomized/crossover trial in humans with hypertension risk (MTHFR 677TT genotype) showed significant reductions in systolic and diastolic blood pressure with riboflavin. Primary, clinically meaningful outcome. However, the sample size was small (n≈31 in the target genotype), design complexity across two time points, and applicability is limited to a specific genetic subgroup rather than the general hypertensive population."
Vitamin B2 (Riboflavin),Four patients discontinued due to adverse events related with deferiprone.; One mild fever documented in the <5 day storage group.; delayed epithelial healing with dendrites; desquamation; greater in-treatment pain and burning sensation; hyperpigmentation; lower riboflavin status in smokers and COPD patients; more prominent post-treatment erythema; recurrent epithelial defects; sterile infiltrates; transient recurrent corneal erosions,Crohn's Disease,,Gut Health,manual_pair,"Current evidence on the use of vitamin B2 (riboflavin) for inflammation in Crohn's disease is limited, with only one study reporting a benefit. In this study, a daily dose of 100 mg for three weeks was associated with decreased inflammatory markers and clinical symptoms. Overall, the evidence is low-quality and further research is needed to confirm these findings.",0.7,31873717,2020,Riboflavin Supplementation in Patients with Crohn's Disease [the RISE-UP study].,clinical_trial,benefit,"Riboflavin supplementation resulted in decreased inflammatory markers and clinical symptoms, indicating a beneficial effect.",100 mg daily 3 weeks,,,crohn's disease,crohn's disease,Tier 3,0.78,"Prospective pre–post clinical intervention without randomization or control group (open-label) in Crohn’s disease patients (n=70) showing reductions in inflammatory markers and HBI after 3 weeks of riboflavin 100 mg/day. Clinically relevant outcomes were assessed, but lack of blinding/control and short duration limit the strength to preliminary human evidence."
Vitamin B2 (Riboflavin),Four patients discontinued due to adverse events related with deferiprone.; One mild fever documented in the <5 day storage group.; delayed epithelial healing with dendrites; desquamation; greater in-treatment pain and burning sensation; hyperpigmentation; lower riboflavin status in smokers and COPD patients; more prominent post-treatment erythema; recurrent epithelial defects; sterile infiltrates; transient recurrent corneal erosions,Migraine Headache,,Musculoskeletal & Pain,manual_pair,"Clinical evidence suggests that riboflavin may be beneficial for migraine treatment, with two randomized trials reporting positive outcomes. One study indicated effectiveness at a dose of 400 mg daily for four months, while the other involved a proprietary supplement containing riboflavin, magnesium, and Coenzyme Q10 over three months. However, the overall evidence remains limited and further research is needed to confirm these findings and assess long-term safety.",0.7,25916335,2015,"Improvement of migraine symptoms with a proprietary supplement containing riboflavin, magnesium and Q10: a randomized, placebo-controlled, double-blind, multicenter trial.",randomized_controlled_trial,benefit,"The study showed significant reduction in migraine pain and burden of disease, indicating a beneficial effect of the supplement.","3 months (proprietary supplement containing riboflavin, magnesium and Q10)",,,migraine disorders,migraine; migraine disorders; migraine with aura,Tier 4,0.55,"This is a well-designed RCT with clinically relevant outcomes for migraine, but it tested a multi-ingredient product (riboflavin + magnesium + CoQ10), not riboflavin alone. Effects cannot be attributed specifically to riboflavin. Additionally, the primary measure of migraine days did not reach statistical significance, with benefits seen mainly in secondary outcomes. Thus, evidence for riboflavin itself is indirect/very low based on this study."
Vitamin B2 (Riboflavin),Four patients discontinued due to adverse events related with deferiprone.; One mild fever documented in the <5 day storage group.; delayed epithelial healing with dendrites; desquamation; greater in-treatment pain and burning sensation; hyperpigmentation; lower riboflavin status in smokers and COPD patients; more prominent post-treatment erythema; recurrent epithelial defects; sterile infiltrates; transient recurrent corneal erosions,Stress,,"Energy, Mood, & Mental Health",manual_pair,"The evidence for Vitamin B2 (Riboflavin) in reducing stress is limited and mixed, based on one randomized, double-blind, placebo-controlled trial that reported some benefits in stress reduction and sleep quality but no significant effect on anxiety. The study utilized a dose of 100 mg for four weeks. Overall, the findings do not support a clear benefit for this indication.",0.7,40507089,2025,"Impact of Vitamin B1 and Vitamin B2 Supplementation on Anxiety, Stress, and Sleep Quality: A Randomized, Double-Blind, Placebo-Controlled Trial.",randomized_controlled_trial,mixed_unclear,"Vitamin B2 supplementation showed benefits in reducing stress and improving sleep quality, but no significant effect on anxiety.",100 mg 4 weeks,,Sleep,anxiety,anxiety; sleep quality; stress,Tier 2,0.58,"A randomized, double-blind, placebo-controlled human trial assessed riboflavin (100 mg, 4 weeks) with stress as a measured clinical outcome and reported benefits for stress (though anxiety showed no effect). While methods appear strong, sample size is unknown and outcomes were mixed/unclear overall, so evidence is moderate rather than strong."
Vitamin B2 (Riboflavin),Four patients discontinued due to adverse events related with deferiprone.; One mild fever documented in the <5 day storage group.; delayed epithelial healing with dendrites; desquamation; greater in-treatment pain and burning sensation; hyperpigmentation; lower riboflavin status in smokers and COPD patients; more prominent post-treatment erythema; recurrent epithelial defects; sterile infiltrates; transient recurrent corneal erosions,Immune System Fortification,,"Immune, Inflammation, & Infection",manual_pair,"Current evidence on the use of vitamin B2 (riboflavin) for enhancing immune response is limited and primarily derived from a single study, which demonstrated that topical riboflavin can attenuate UV-induced immunosuppression in humans. No adverse effects were reported, but the overall evidence quality is low, and further research is needed to establish its efficacy and safety for this indication.",0.7,20415736,2010,Topical riboflavin attenuates ultraviolet B- and ultraviolet A-induced immunosuppression in humans.,clinical_trial,benefit,"The study shows that topical riboflavin provides immune protection against UV-induced immunosuppression, indicating a beneficial outcome.",(topical solution),,,contact dermatitis,contact dermatitis; immunosuppression,Tier 3,0.5,"Single small human, split-site controlled trial using topical riboflavin showed protection against UV-induced immunosuppression measured by contact hypersensitivity (a surrogate immune function endpoint). While relevant to immune effects, it is localized/topical and does not demonstrate systemic immune fortification or clinical outcomes, so evidence is preliminary."
Vitamin B3 (Niacin),GI complaints; Higher risk of coronary disease related death in placebo group; Increased risk for acute coronary syndrome in placebo group; aspartate aminotransferase increased in niacin group; bleeding; decreased quality of life-adjusted survival; discontinued due to comorbidity risks; excess of serious adverse experiences; flushing/warmth; higher all-cause mortality in ERN group; impaired erythrocyte deformability; increased incidence of diabetes diagnoses; increased incidence of disturbances in diabetes control; increased insulin resistance; increased risk of developing impaired fasting glucose; increased risk of hip fractures with high and low niacin intake; increased risk of serious adverse events; increased serious adverse events associated with bleeding; increased serious adverse events associated with gastrointestinal system; increased serious adverse events associated with infection; increased serious adverse events associated with musculoskeletal system; increased serious adverse events associated with skin; infections; new-onset diabetes; plasma homocysteine elevation; requirement for intensification of antihyperglycemic medication; serious bleeding; serious infection; tingling; trend toward increased development of new-onset diabetes; worsening of diabetes; worsening of endothelial function,Panic Attacks,,"Energy, Mood, & Mental Health",manual_pair,Current clinical evidence regarding the use of vitamin B3 (niacin) for anxiety is limited and indicates potential harm. A study reported that participants receiving 100 mg of niacin experienced increased panic symptoms compared to a placebo group. No studies have demonstrated a benefit for this indication.,1.0,31170623,2019,Niacin biological challenge: A paradigm to evaluate social concerns.,randomized_controlled_trial,harm,"Participants in the niacin condition reported higher panic symptoms post-speech compared to the placebo group, indicating a harmful effect.",100 mg,,,anxiety,anxiety; panic symptoms; social anxiety,Tier 4,0.58,"Randomized, placebo-controlled study in healthy students used niacin as a biological challenge and measured self-reported panic symptoms after a speech task. Although results suggest a harmful effect, the outcome is an induced, surrogate measure in a non-clinical population, not treatment or prevention of clinical panic attacks. Therefore evidence for the supplement–indication pairing is indirect/experimental rather than clinically targeted."
Vitamin B3 (Niacin),GI complaints; Higher risk of coronary disease related death in placebo group; Increased risk for acute coronary syndrome in placebo group; aspartate aminotransferase increased in niacin group; bleeding; decreased quality of life-adjusted survival; discontinued due to comorbidity risks; excess of serious adverse experiences; flushing/warmth; higher all-cause mortality in ERN group; impaired erythrocyte deformability; increased incidence of diabetes diagnoses; increased incidence of disturbances in diabetes control; increased insulin resistance; increased risk of developing impaired fasting glucose; increased risk of hip fractures with high and low niacin intake; increased risk of serious adverse events; increased serious adverse events associated with bleeding; increased serious adverse events associated with gastrointestinal system; increased serious adverse events associated with infection; increased serious adverse events associated with musculoskeletal system; increased serious adverse events associated with skin; infections; new-onset diabetes; plasma homocysteine elevation; requirement for intensification of antihyperglycemic medication; serious bleeding; serious infection; tingling; trend toward increased development of new-onset diabetes; worsening of diabetes; worsening of endothelial function,High Blood Glucose,,Metabolic Health,manual_pair,"The evidence regarding the use of vitamin B3 (niacin) for high blood sugar (impaired fasting glucose) is low quality, with a single study reporting mixed effects on glycemia and an increased risk of impaired fasting glucose. No consistent beneficial outcomes were observed, and potential harm was indicated. Typical doses were not consistently reported across studies.",0.7,27036394,2016,Effects of Extended-Release Niacin Added to Simvastatin/Ezetimibe on Glucose and Insulin Values in AIM-HIGH.,randomized_controlled_trial,mixed_unclear,"The study shows mixed effects on glycemia and an increased risk of impaired fasting glucose, indicating potential harm.",1 year (extended-release niacin),,,diabetes,diabetes; glucose intolerance; impaired fasting glucose,Tier 2,0.75,"A large randomized controlled trial with prespecified glycemic analyses assessed fasting glucose/insulin under extended-release niacin versus placebo. Although glycemia was a secondary (not primary) outcome, it is clinically relevant. The study found niacin increased fasting glucose and insulin and raised the risk of impaired fasting glucose, indicating harm rather than benefit for high blood glucose."
Vitamin B3 (Niacin),GI complaints; Higher risk of coronary disease related death in placebo group; Increased risk for acute coronary syndrome in placebo group; aspartate aminotransferase increased in niacin group; bleeding; decreased quality of life-adjusted survival; discontinued due to comorbidity risks; excess of serious adverse experiences; flushing/warmth; higher all-cause mortality in ERN group; impaired erythrocyte deformability; increased incidence of diabetes diagnoses; increased incidence of disturbances in diabetes control; increased insulin resistance; increased risk of developing impaired fasting glucose; increased risk of hip fractures with high and low niacin intake; increased risk of serious adverse events; increased serious adverse events associated with bleeding; increased serious adverse events associated with gastrointestinal system; increased serious adverse events associated with infection; increased serious adverse events associated with musculoskeletal system; increased serious adverse events associated with skin; infections; new-onset diabetes; plasma homocysteine elevation; requirement for intensification of antihyperglycemic medication; serious bleeding; serious infection; tingling; trend toward increased development of new-onset diabetes; worsening of diabetes; worsening of endothelial function,High Blood Glucose,,Metabolic Health,manual_pair,"Current evidence does not support the use of vitamin B3 (niacin) for high blood sugar or new-onset diabetes, as there are no studies demonstrating benefit. One trial reported significant risks of serious adverse effects associated with extended-release niacin-laropiprant therapy at a dose of 2000 mg daily. Overall, the evidence indicates potential harm rather than benefit for this indication.",1.0,31447131,2019,Serious Adverse Effects of Extended-release Niacin/Laropiprant: Results From the Heart Protection Study 2-Treatment of HDL to Reduce the Incidence of Vascular Events (HPS2-THRIVE) Trial.,randomized_controlled_trial,harm,"The study found significant risks of serious adverse effects associated with niacin-laropiprant therapy, indicating harm.",2000 mg daily median of 3.9 years (extended-release),,Heart & Vascular Health,new-onset diabetes,new-onset diabetes; serious bleeding; serious disturbances in diabetes control; serious infection,Tier 2,0.78,"Large, well-conducted randomized controlled trial (HPS2-THRIVE) showed increased risk of new-onset diabetes and worsened diabetes control with extended-release niacin/laropiprant. Glycemic outcomes were prespecified safety endpoints (not the primary cardiovascular endpoint), making them secondary but clinically relevant to high blood glucose. Use of a niacin–laropiprant combination slightly limits direct attribution to niacin alone, but the findings align with known niacin effects on glycemia."
Vitamin B3 (Niacin),GI complaints; Higher risk of coronary disease related death in placebo group; Increased risk for acute coronary syndrome in placebo group; aspartate aminotransferase increased in niacin group; bleeding; decreased quality of life-adjusted survival; discontinued due to comorbidity risks; excess of serious adverse experiences; flushing/warmth; higher all-cause mortality in ERN group; impaired erythrocyte deformability; increased incidence of diabetes diagnoses; increased incidence of disturbances in diabetes control; increased insulin resistance; increased risk of developing impaired fasting glucose; increased risk of hip fractures with high and low niacin intake; increased risk of serious adverse events; increased serious adverse events associated with bleeding; increased serious adverse events associated with gastrointestinal system; increased serious adverse events associated with infection; increased serious adverse events associated with musculoskeletal system; increased serious adverse events associated with skin; infections; new-onset diabetes; plasma homocysteine elevation; requirement for intensification of antihyperglycemic medication; serious bleeding; serious infection; tingling; trend toward increased development of new-onset diabetes; worsening of diabetes; worsening of endothelial function,High Blood Glucose,,Metabolic Health,manual_pair,"The evidence regarding the use of niacin for high blood sugar in Type 2 Diabetes is limited and of low quality. One study indicated potential harm, showing that niacin/laropiprant negatively impacted postprandial glucose levels, while another study reported mixed outcomes with increased glucose and insulin resistance despite elevated adiponectin levels. Typical doses reported include 1 g and 2 g of extended-release niacin/laropiprant daily, but overall findings do not support a beneficial effect on blood sugar control.",0.8,24401089,2014,Postprandial effects of long-term niacin/laropiprant use on glucose and lipid metabolism and on cardiovascular risk in patients with polycystic ovary syndrome.,randomized_controlled_trial,harm,The study found that niacin/laropiprant had a significant negative impact on postprandial glucose and did not improve postprandial hypertriglyceridaemia.,12 weeks (niacin/laropiprant),PCOS,,cardiovascular risk,cardiovascular risk; dyslipidaemia; insulin resistance; polycystic ovary syndrome,Tier 2,0.6,"This is a double-blind randomized placebo-controlled trial in PCOS women over 12 weeks assessing glucose metabolism (postprandial glucose AUC, HOMA-IR), outcomes directly relevant to high blood glucose, and it found harm. However, the sample size was very small (n≈25 total) and the intervention was niacin combined with laropiprant, which may limit generalizability to niacin alone. Thus the study provides moderate human evidence for this indication."
Vitamin B3 (Niacin),GI complaints; Higher risk of coronary disease related death in placebo group; Increased risk for acute coronary syndrome in placebo group; aspartate aminotransferase increased in niacin group; bleeding; decreased quality of life-adjusted survival; discontinued due to comorbidity risks; excess of serious adverse experiences; flushing/warmth; higher all-cause mortality in ERN group; impaired erythrocyte deformability; increased incidence of diabetes diagnoses; increased incidence of disturbances in diabetes control; increased insulin resistance; increased risk of developing impaired fasting glucose; increased risk of hip fractures with high and low niacin intake; increased risk of serious adverse events; increased serious adverse events associated with bleeding; increased serious adverse events associated with gastrointestinal system; increased serious adverse events associated with infection; increased serious adverse events associated with musculoskeletal system; increased serious adverse events associated with skin; infections; new-onset diabetes; plasma homocysteine elevation; requirement for intensification of antihyperglycemic medication; serious bleeding; serious infection; tingling; trend toward increased development of new-onset diabetes; worsening of diabetes; worsening of endothelial function,High Blood Glucose,,Metabolic Health,manual_pair,"The evidence regarding the use of niacin for high blood sugar in Type 2 Diabetes is limited and of low quality. One study indicated potential harm, showing that niacin/laropiprant negatively impacted postprandial glucose levels, while another study reported mixed outcomes with increased glucose and insulin resistance despite elevated adiponectin levels. Typical doses reported include 1 g and 2 g of extended-release niacin/laropiprant daily, but overall findings do not support a beneficial effect on blood sugar control.",0.8,26063948,2015,Effect of Extended-Release Niacin/Laropiprant Combination on Plasma Adiponectin and Insulin Resistance in Chinese Patients with Dyslipidaemia.,clinical_trial,mixed_unclear,"The study showed significant increases in glucose and insulin resistance despite increased adiponectin levels, indicating mixed outcomes.",1 g daily 4 weeks (extended-release niacin/laropiprant); 2 g daily 8 weeks (extended-release niacin/laropiprant),,,dyslipidaemia,cardiovascular risk; dyslipidaemia; insulin resistance; polycystic ovary syndrome,Tier 3,0.61,"Single-arm, uncontrolled clinical trial (N=121) of ER niacin combined with laropiprant measured fasting glucose and insulin resistance over 12 weeks. Outcomes directly relate to high blood glucose but lack a control group and use a combination product in dyslipidemic (not specifically hyperglycemic) patients, making the evidence preliminary despite significant changes observed."
Vitamin B3 (Niacin),GI complaints; Higher risk of coronary disease related death in placebo group; Increased risk for acute coronary syndrome in placebo group; aspartate aminotransferase increased in niacin group; bleeding; decreased quality of life-adjusted survival; discontinued due to comorbidity risks; excess of serious adverse experiences; flushing/warmth; higher all-cause mortality in ERN group; impaired erythrocyte deformability; increased incidence of diabetes diagnoses; increased incidence of disturbances in diabetes control; increased insulin resistance; increased risk of developing impaired fasting glucose; increased risk of hip fractures with high and low niacin intake; increased risk of serious adverse events; increased serious adverse events associated with bleeding; increased serious adverse events associated with gastrointestinal system; increased serious adverse events associated with infection; increased serious adverse events associated with musculoskeletal system; increased serious adverse events associated with skin; infections; new-onset diabetes; plasma homocysteine elevation; requirement for intensification of antihyperglycemic medication; serious bleeding; serious infection; tingling; trend toward increased development of new-onset diabetes; worsening of diabetes; worsening of endothelial function,Low HDL,,Heart & Vascular Health,manual_pair,"The evidence regarding the use of vitamin B3 (niacin) for high cholesterol is mixed and unclear, with one clinical trial indicating an increase in HDL-C but no corresponding improvement in antioxidant capacity, suggesting potential limitations in cardiovascular risk reduction. No studies reported consistent benefits, and there are no established dose ranges for this indication. Overall, the quality of evidence is low, and further research is needed to clarify its efficacy.",0.5,27891663,2017,Extended-release niacin increases anti-apolipoprotein A-I antibodies that block the antioxidant effect of high-density lipoprotein-cholesterol: the EXPLORE clinical trial.,randomized_controlled_trial,mixed_unclear,"The study shows an increase in HDL-C but no improvement in antioxidant capacity, indicating mixed outcomes regarding cardiovascular risk reduction.",null null daily 12 weeks (extended-release),,,cardiovascular risk,cardiovascular risk; low high-density lipoprotein cholesterol,Tier 2,0.58,"Small randomized controlled trial (n≈21) of extended-release niacin showed an increase in HDL-C over 12 weeks, directly relevant to the indication of low HDL. However, HDL improvement was a secondary outcome, the trial was small, and overall findings were mixed due to lack of improved antioxidant capacity and emergence of anti–ApoA-I antibodies. Thus, moderate but limited human evidence for raising HDL in this study."
Vitamin B3 (Niacin),GI complaints; Higher risk of coronary disease related death in placebo group; Increased risk for acute coronary syndrome in placebo group; aspartate aminotransferase increased in niacin group; bleeding; decreased quality of life-adjusted survival; discontinued due to comorbidity risks; excess of serious adverse experiences; flushing/warmth; higher all-cause mortality in ERN group; impaired erythrocyte deformability; increased incidence of diabetes diagnoses; increased incidence of disturbances in diabetes control; increased insulin resistance; increased risk of developing impaired fasting glucose; increased risk of hip fractures with high and low niacin intake; increased risk of serious adverse events; increased serious adverse events associated with bleeding; increased serious adverse events associated with gastrointestinal system; increased serious adverse events associated with infection; increased serious adverse events associated with musculoskeletal system; increased serious adverse events associated with skin; infections; new-onset diabetes; plasma homocysteine elevation; requirement for intensification of antihyperglycemic medication; serious bleeding; serious infection; tingling; trend toward increased development of new-onset diabetes; worsening of diabetes; worsening of endothelial function,High LDL,,Heart & Vascular Health,manual_pair,"The evidence for niacin in lowering high LDL cholesterol is mixed, with four studies indicating benefit and three showing unclear results regarding its effectiveness. Typical doses reported include 1 g to 2 g of extended-release niacin daily. Notably, some studies suggest potential adverse effects on diabetes control, highlighting the need for caution in specific populations.",0.8,27405296,2016,"Effects of extended-release niacin/laropiprant on correlations between apolipoprotein B, LDL-cholesterol and non-HDL-cholesterol in patients with type 2 diabetes.",randomized_controlled_trial,benefit,"The study shows that niacin treatment improved correlations between lipid levels, suggesting a potential benefit in reducing coronary risk.",12 weeks (extended-release niacin/laropiprant),,,atherosclerotic cardiovascular disease risk,Type 2 Diabetes Mellitus; atherosclerotic cardiovascular disease risk; cardiovascular disease; cardiovascular diseases; carotid atherosclerosis; dyslipidemia; dyslipidemias; vascular inflammation,Tier 4,0.58,"Large, double-blind RCT in humans, but the primary/assessed endpoint was change in correlations between apoB and LDL-C/non-HDL-C rather than LDL reduction itself. The use of a combination product (extended‑release niacin with laropiprant) further limits direct applicability to niacin alone. Thus, evidence for treating high LDL from this study is indirect and not focused on the indication."
Vitamin B3 (Niacin),GI complaints; Higher risk of coronary disease related death in placebo group; Increased risk for acute coronary syndrome in placebo group; aspartate aminotransferase increased in niacin group; bleeding; decreased quality of life-adjusted survival; discontinued due to comorbidity risks; excess of serious adverse experiences; flushing/warmth; higher all-cause mortality in ERN group; impaired erythrocyte deformability; increased incidence of diabetes diagnoses; increased incidence of disturbances in diabetes control; increased insulin resistance; increased risk of developing impaired fasting glucose; increased risk of hip fractures with high and low niacin intake; increased risk of serious adverse events; increased serious adverse events associated with bleeding; increased serious adverse events associated with gastrointestinal system; increased serious adverse events associated with infection; increased serious adverse events associated with musculoskeletal system; increased serious adverse events associated with skin; infections; new-onset diabetes; plasma homocysteine elevation; requirement for intensification of antihyperglycemic medication; serious bleeding; serious infection; tingling; trend toward increased development of new-onset diabetes; worsening of diabetes; worsening of endothelial function,High LDL,,Heart & Vascular Health,manual_pair,"The evidence for niacin in lowering high LDL cholesterol is mixed, with four studies indicating benefit and three showing unclear results regarding its effectiveness. Typical doses reported include 1 g to 2 g of extended-release niacin daily. Notably, some studies suggest potential adverse effects on diabetes control, highlighting the need for caution in specific populations.",0.8,26681752,2016,Niacin Therapy Increases High-Density Lipoprotein Particles and Total Cholesterol Efflux Capacity But Not ABCA1-Specific Cholesterol Efflux in Statin-Treated Subjects.,randomized_controlled_trial,mixed_unclear,"The study shows mixed results regarding the effectiveness of niacin in improving HDL metrics, indicating potential limitations in its atheroprotective effects.",1 year,,,cardiovascular disease,Type 2 Diabetes Mellitus; atherosclerotic cardiovascular disease risk; cardiovascular disease; cardiovascular diseases; carotid atherosclerosis; dyslipidemia; dyslipidemias; vascular inflammation,Tier 5,0.44,"Human RCT but designed to assess HDL particle metrics and cholesterol efflux in statin-treated subjects. The indication here is high LDL, and the study did not evaluate niacin’s LDL-lowering effect as a primary or meaningful secondary outcome; LDL changes for the niacin arm are not reported in the abstract. Thus, it is not actual evidence for this indication."
Vitamin B3 (Niacin),GI complaints; Higher risk of coronary disease related death in placebo group; Increased risk for acute coronary syndrome in placebo group; aspartate aminotransferase increased in niacin group; bleeding; decreased quality of life-adjusted survival; discontinued due to comorbidity risks; excess of serious adverse experiences; flushing/warmth; higher all-cause mortality in ERN group; impaired erythrocyte deformability; increased incidence of diabetes diagnoses; increased incidence of disturbances in diabetes control; increased insulin resistance; increased risk of developing impaired fasting glucose; increased risk of hip fractures with high and low niacin intake; increased risk of serious adverse events; increased serious adverse events associated with bleeding; increased serious adverse events associated with gastrointestinal system; increased serious adverse events associated with infection; increased serious adverse events associated with musculoskeletal system; increased serious adverse events associated with skin; infections; new-onset diabetes; plasma homocysteine elevation; requirement for intensification of antihyperglycemic medication; serious bleeding; serious infection; tingling; trend toward increased development of new-onset diabetes; worsening of diabetes; worsening of endothelial function,High LDL,,Heart & Vascular Health,manual_pair,"The evidence for niacin in lowering high LDL cholesterol is mixed, with four studies indicating benefit and three showing unclear results regarding its effectiveness. Typical doses reported include 1 g to 2 g of extended-release niacin daily. Notably, some studies suggest potential adverse effects on diabetes control, highlighting the need for caution in specific populations.",0.8,25432415,2015,"Effects of niacin, statin, and fenofibrate on circulating proprotein convertase subtilisin/kexin type 9 levels in patients with dyslipidemia.",randomized_controlled_trial,benefit,"Niacin therapy was shown to decrease PCSK9 levels, indicating a beneficial effect on lipid parameters.",2 g daily (extended-release),,,carotid atherosclerosis,Type 2 Diabetes Mellitus; atherosclerotic cardiovascular disease risk; cardiovascular disease; cardiovascular diseases; carotid atherosclerosis; dyslipidemia; dyslipidemias; vascular inflammation,Tier 3,0.55,"Human randomized studies included niacin (mostly in combination with statins) but assessed PCSK9 as the primary outcome, a surrogate mechanistic marker rather than LDL-C as a primary clinical endpoint. While PCSK9 reductions were observed and correlated with LDL-C changes, direct, primary evidence of LDL lowering from niacin within this trial is indirect and secondary, and includes combination therapy rather than niacin monotherapy."
Vitamin B3 (Niacin),GI complaints; Higher risk of coronary disease related death in placebo group; Increased risk for acute coronary syndrome in placebo group; aspartate aminotransferase increased in niacin group; bleeding; decreased quality of life-adjusted survival; discontinued due to comorbidity risks; excess of serious adverse experiences; flushing/warmth; higher all-cause mortality in ERN group; impaired erythrocyte deformability; increased incidence of diabetes diagnoses; increased incidence of disturbances in diabetes control; increased insulin resistance; increased risk of developing impaired fasting glucose; increased risk of hip fractures with high and low niacin intake; increased risk of serious adverse events; increased serious adverse events associated with bleeding; increased serious adverse events associated with gastrointestinal system; increased serious adverse events associated with infection; increased serious adverse events associated with musculoskeletal system; increased serious adverse events associated with skin; infections; new-onset diabetes; plasma homocysteine elevation; requirement for intensification of antihyperglycemic medication; serious bleeding; serious infection; tingling; trend toward increased development of new-onset diabetes; worsening of diabetes; worsening of endothelial function,High LDL,,Heart & Vascular Health,manual_pair,"The evidence for niacin in lowering high LDL cholesterol is mixed, with four studies indicating benefit and three showing unclear results regarding its effectiveness. Typical doses reported include 1 g to 2 g of extended-release niacin daily. Notably, some studies suggest potential adverse effects on diabetes control, highlighting the need for caution in specific populations.",0.8,26374297,2015,"Effect of Extended-Release Niacin on High-Density Lipoprotein (HDL) Functionality, Lipoprotein Metabolism, and Mediators of Vascular Inflammation in Statin-Treated Patients.",randomized_controlled_trial,mixed_unclear,"The study shows varied effects on HDL functionality and LDL quality, indicating mixed outcomes despite HDL-C increase.",(extended-release niacin/laropiprant),,,dyslipidemia,Type 2 Diabetes Mellitus; atherosclerotic cardiovascular disease risk; cardiovascular disease; cardiovascular diseases; carotid atherosclerosis; dyslipidemia; dyslipidemias; vascular inflammation,Tier 2,0.62,"Double-blind, randomized, placebo-controlled crossover RCT in statin-treated patients showed a significant reduction in LDL-C with extended-release niacin/laropiprant. However, the sample size was small (n=27), LDL lowering was not the primary endpoint, and the formulation included laropiprant, so the evidence for niacin specifically for high LDL is moderate rather than strong."
Vitamin B3 (Niacin),GI complaints; Higher risk of coronary disease related death in placebo group; Increased risk for acute coronary syndrome in placebo group; aspartate aminotransferase increased in niacin group; bleeding; decreased quality of life-adjusted survival; discontinued due to comorbidity risks; excess of serious adverse experiences; flushing/warmth; higher all-cause mortality in ERN group; impaired erythrocyte deformability; increased incidence of diabetes diagnoses; increased incidence of disturbances in diabetes control; increased insulin resistance; increased risk of developing impaired fasting glucose; increased risk of hip fractures with high and low niacin intake; increased risk of serious adverse events; increased serious adverse events associated with bleeding; increased serious adverse events associated with gastrointestinal system; increased serious adverse events associated with infection; increased serious adverse events associated with musculoskeletal system; increased serious adverse events associated with skin; infections; new-onset diabetes; plasma homocysteine elevation; requirement for intensification of antihyperglycemic medication; serious bleeding; serious infection; tingling; trend toward increased development of new-onset diabetes; worsening of diabetes; worsening of endothelial function,High LDL,,Heart & Vascular Health,manual_pair,"The evidence for niacin in lowering high LDL cholesterol is mixed, with four studies indicating benefit and three showing unclear results regarding its effectiveness. Typical doses reported include 1 g to 2 g of extended-release niacin daily. Notably, some studies suggest potential adverse effects on diabetes control, highlighting the need for caution in specific populations.",0.8,25750540,2015,Extended-release niacin/laropiprant significantly improves lipid levels in type 2 diabetes mellitus irrespective of baseline glycemic control.,randomized_controlled_trial,mixed_unclear,The study shows significant lipid improvements but also indicates potential worsening of diabetes control.,36 weeks (extended-release niacin/laropiprant),Diabetes Type 2,,dyslipidemia,Type 2 Diabetes Mellitus; atherosclerotic cardiovascular disease risk; cardiovascular disease; cardiovascular diseases; carotid atherosclerosis; dyslipidemia; dyslipidemias; vascular inflammation,Tier 1,0.78,"Double-blind randomized controlled trial (n≈796) showed significant improvements in LDL-C and other lipids with extended-release niacin (with laropiprant) versus placebo over 12–36 weeks. Lipid change is a primary/major outcome for the indication of high LDL. Slight downgrades to confidence due to use of a combination product (laropiprant) and post hoc subgroup framing, though laropiprant is not expected to affect lipid outcomes. Adverse glycemic effects were noted but do not reduce the strength of evidence for LDL lowering."
Vitamin B3 (Niacin),GI complaints; Higher risk of coronary disease related death in placebo group; Increased risk for acute coronary syndrome in placebo group; aspartate aminotransferase increased in niacin group; bleeding; decreased quality of life-adjusted survival; discontinued due to comorbidity risks; excess of serious adverse experiences; flushing/warmth; higher all-cause mortality in ERN group; impaired erythrocyte deformability; increased incidence of diabetes diagnoses; increased incidence of disturbances in diabetes control; increased insulin resistance; increased risk of developing impaired fasting glucose; increased risk of hip fractures with high and low niacin intake; increased risk of serious adverse events; increased serious adverse events associated with bleeding; increased serious adverse events associated with gastrointestinal system; increased serious adverse events associated with infection; increased serious adverse events associated with musculoskeletal system; increased serious adverse events associated with skin; infections; new-onset diabetes; plasma homocysteine elevation; requirement for intensification of antihyperglycemic medication; serious bleeding; serious infection; tingling; trend toward increased development of new-onset diabetes; worsening of diabetes; worsening of endothelial function,High LDL,,Heart & Vascular Health,manual_pair,"The evidence for niacin in lowering high LDL cholesterol is mixed, with four studies indicating benefit and three showing unclear results regarding its effectiveness. Typical doses reported include 1 g to 2 g of extended-release niacin daily. Notably, some studies suggest potential adverse effects on diabetes control, highlighting the need for caution in specific populations.",0.8,26515419,2015,Effects of extended-release niacin on the postprandial metabolism of Lp(a) and ApoB-100-containing lipoproteins in statin-treated men with type 2 diabetes mellitus.,randomized_controlled_trial,benefit,"The study shows significant decreases in plasma Lp(a) and apoB-100-containing lipoproteins, indicating a beneficial effect on lipid profiles in the studied population.",1-2 g daily 12 weeks (extended-release),,,dyslipidemias,Type 2 Diabetes Mellitus; atherosclerotic cardiovascular disease risk; cardiovascular disease; cardiovascular diseases; carotid atherosclerosis; dyslipidemia; dyslipidemias; vascular inflammation,Tier 2,0.63,"Single small randomized crossover trial (n=11) of extended-release niacin in statin-treated men with type 2 diabetes showed significant reductions in LDL-C and apoB-containing lipoproteins. While it is an RCT, the sample is very small, short-term, and focused primarily on kinetic/mechanistic lipid endpoints in a specific population, making LDL reduction a clinically relevant but secondary outcome. Thus, moderate human evidence for high LDL, with limited generalizability."
Vitamin B3 (Niacin),GI complaints; Higher risk of coronary disease related death in placebo group; Increased risk for acute coronary syndrome in placebo group; aspartate aminotransferase increased in niacin group; bleeding; decreased quality of life-adjusted survival; discontinued due to comorbidity risks; excess of serious adverse experiences; flushing/warmth; higher all-cause mortality in ERN group; impaired erythrocyte deformability; increased incidence of diabetes diagnoses; increased incidence of disturbances in diabetes control; increased insulin resistance; increased risk of developing impaired fasting glucose; increased risk of hip fractures with high and low niacin intake; increased risk of serious adverse events; increased serious adverse events associated with bleeding; increased serious adverse events associated with gastrointestinal system; increased serious adverse events associated with infection; increased serious adverse events associated with musculoskeletal system; increased serious adverse events associated with skin; infections; new-onset diabetes; plasma homocysteine elevation; requirement for intensification of antihyperglycemic medication; serious bleeding; serious infection; tingling; trend toward increased development of new-onset diabetes; worsening of diabetes; worsening of endothelial function,High Lpa,,Heart & Vascular Health,manual_pair,"The evidence regarding vitamin B3 (niacin) for lowering high lipoprotein(a) levels is limited and mixed. One study reported a significant reduction in lipoprotein(a) levels with extended-release niacin at a dose of 500 mg daily for 24 weeks, suggesting a potential benefit. However, another study indicated harmful effects on microvascular reactivity and red cell deformability associated with niacin treatment, highlighting safety concerns. Overall, the quality of evidence is low.",0.6,25936305,2015,Lowering of lipoprotein(a) level under niacin treatment is dependent on apolipoprotein(a) phenotype.,clinical_trial,benefit,"The study shows a significant reduction in lipoprotein(a) levels with niacin treatment, indicating a benefit for cardiovascular risk management.",500 mg daily 24 weeks (extended-release),,"Immune, Inflammation, & Infection",cardiovascular risk,cardiovascular risk; elevated lipoprotein(a) levels; endothelial dysfunction; hyperlipoproteinemias,Tier 3,0.6,"Single small, prospective open-label, uncontrolled human study (n=30 men) assessing ER niacin’s effect on Lp(a). The primary outcome (Lp[a] level) is directly relevant to the indication but is a surrogate marker. Benefits were observed only in the low–molecular weight apo(a) subgroup. Lack of randomization/blinding/control and small sample size limit evidential strength."
Vitamin B3 (Niacin),GI complaints; Higher risk of coronary disease related death in placebo group; Increased risk for acute coronary syndrome in placebo group; aspartate aminotransferase increased in niacin group; bleeding; decreased quality of life-adjusted survival; discontinued due to comorbidity risks; excess of serious adverse experiences; flushing/warmth; higher all-cause mortality in ERN group; impaired erythrocyte deformability; increased incidence of diabetes diagnoses; increased incidence of disturbances in diabetes control; increased insulin resistance; increased risk of developing impaired fasting glucose; increased risk of hip fractures with high and low niacin intake; increased risk of serious adverse events; increased serious adverse events associated with bleeding; increased serious adverse events associated with gastrointestinal system; increased serious adverse events associated with infection; increased serious adverse events associated with musculoskeletal system; increased serious adverse events associated with skin; infections; new-onset diabetes; plasma homocysteine elevation; requirement for intensification of antihyperglycemic medication; serious bleeding; serious infection; tingling; trend toward increased development of new-onset diabetes; worsening of diabetes; worsening of endothelial function,High Lpa,,Heart & Vascular Health,manual_pair,"The evidence regarding vitamin B3 (niacin) for lowering high lipoprotein(a) levels is limited and mixed. One study reported a significant reduction in lipoprotein(a) levels with extended-release niacin at a dose of 500 mg daily for 24 weeks, suggesting a potential benefit. However, another study indicated harmful effects on microvascular reactivity and red cell deformability associated with niacin treatment, highlighting safety concerns. Overall, the quality of evidence is low.",0.6,26289089,2016,Detrimental effects of niacin/laropiprant on microvascular reactivity and red cell deformability in patients with elevated lipoprotein(a) levels.,clinical_trial,harm,"The study found detrimental effects on microvascular reactivity and red cell deformability, indicating harm associated with niacin treatment.",12 months (nicotinic acid/laropiprant (Tredaptive®)),,,elevated lipoprotein(a) levels,cardiovascular risk; elevated lipoprotein(a) levels; endothelial dysfunction; hyperlipoproteinemias,Tier 3,0.62,"Single-arm, small human interventional study (n=46) without a control group measured pre–post changes. Lp(a) reduction (~32%) is a surrogate outcome and not clearly the primary endpoint (study focused on microvascular outcomes). Use of niacin with laropiprant reduces directness to niacin alone. Thus, evidence for niacin lowering high Lp(a) from this study is preliminary."
Vitamin B3 (Niacin),GI complaints; Higher risk of coronary disease related death in placebo group; Increased risk for acute coronary syndrome in placebo group; aspartate aminotransferase increased in niacin group; bleeding; decreased quality of life-adjusted survival; discontinued due to comorbidity risks; excess of serious adverse experiences; flushing/warmth; higher all-cause mortality in ERN group; impaired erythrocyte deformability; increased incidence of diabetes diagnoses; increased incidence of disturbances in diabetes control; increased insulin resistance; increased risk of developing impaired fasting glucose; increased risk of hip fractures with high and low niacin intake; increased risk of serious adverse events; increased serious adverse events associated with bleeding; increased serious adverse events associated with gastrointestinal system; increased serious adverse events associated with infection; increased serious adverse events associated with musculoskeletal system; increased serious adverse events associated with skin; infections; new-onset diabetes; plasma homocysteine elevation; requirement for intensification of antihyperglycemic medication; serious bleeding; serious infection; tingling; trend toward increased development of new-onset diabetes; worsening of diabetes; worsening of endothelial function,High Triglycerides,,Heart & Vascular Health,manual_pair,"The evidence for vitamin B3 (niacin) in reducing high triglycerides is mixed. Three studies indicate a benefit, particularly with extended-release formulations at doses of 1-2 g daily, while two studies present unclear outcomes regarding cardiovascular benefits and mortality. No studies reported harm, but the mixed results highlight the need for caution in interpreting the overall efficacy of niacin for this indication.",0.8,26681758,2016,Extended-Release Niacin/Laropiprant Improves Overall Efficacy of Postprandial Reverse Cholesterol Transport.,clinical_trial,benefit,"The study shows that ERN/LRPT significantly reduces postprandial hypertriglyceridemia and improves cholesterol transport, indicating a beneficial effect.",1 g daily 4 weeks (extended-release niacin/laropiprant); 2 g daily 8 weeks (extended-release niacin/laropiprant),,,atherogenic lipemia,Type 2 Diabetes Mellitus; atherogenic lipemia; cardiovascular disease; cardiovascular disease risk; chronic kidney disease; dyslipidemia; dyslipidemias; elevated triglycerides; metabolic syndrome; reduced hdl cholesterol,Tier 3,0.42,"Small, uncontrolled, before–after human trial (n=10) using extended‑release niacin/laropiprant on statin background. It showed a significant reduction in postprandial triglyceride AUC (−53%), but outcomes were surrogate (postprandial TG and RCT function), not fasting TG or clinical endpoints. No control group and small sample size make the evidence preliminary."
Vitamin B3 (Niacin),GI complaints; Higher risk of coronary disease related death in placebo group; Increased risk for acute coronary syndrome in placebo group; aspartate aminotransferase increased in niacin group; bleeding; decreased quality of life-adjusted survival; discontinued due to comorbidity risks; excess of serious adverse experiences; flushing/warmth; higher all-cause mortality in ERN group; impaired erythrocyte deformability; increased incidence of diabetes diagnoses; increased incidence of disturbances in diabetes control; increased insulin resistance; increased risk of developing impaired fasting glucose; increased risk of hip fractures with high and low niacin intake; increased risk of serious adverse events; increased serious adverse events associated with bleeding; increased serious adverse events associated with gastrointestinal system; increased serious adverse events associated with infection; increased serious adverse events associated with musculoskeletal system; increased serious adverse events associated with skin; infections; new-onset diabetes; plasma homocysteine elevation; requirement for intensification of antihyperglycemic medication; serious bleeding; serious infection; tingling; trend toward increased development of new-onset diabetes; worsening of diabetes; worsening of endothelial function,High Triglycerides,,Heart & Vascular Health,manual_pair,"The evidence for vitamin B3 (niacin) in reducing high triglycerides is mixed. Three studies indicate a benefit, particularly with extended-release formulations at doses of 1-2 g daily, while two studies present unclear outcomes regarding cardiovascular benefits and mortality. No studies reported harm, but the mixed results highlight the need for caution in interpreting the overall efficacy of niacin for this indication.",0.8,25651367,2015,Effect of extended-release niacin on cardiovascular events and kidney function in chronic kidney disease: a post hoc analysis of the AIM-HIGH trial.,randomized_controlled_trial,mixed_unclear,"The study showed improved lipid profiles but no improvement in cardiovascular outcomes or kidney function, with an increase in all-cause mortality.",mean follow-up of 3 years (extended-release niacin),,,cardiovascular disease,Type 2 Diabetes Mellitus; atherogenic lipemia; cardiovascular disease; cardiovascular disease risk; chronic kidney disease; dyslipidemia; dyslipidemias; elevated triglycerides; metabolic syndrome; reduced hdl cholesterol,Tier 2,0.6,"Randomized, placebo-controlled trial (AIM-HIGH) with a post hoc CKD subgroup reported significant triglyceride reductions with extended-release niacin versus placebo over ~3 years. However, triglyceride change was a secondary endpoint and this was a subgroup analysis of a trial powered for cardiovascular events, not hypertriglyceridemia. Additionally, increased all-cause mortality in the niacin arm tempers interpretation. Overall, moderate human evidence for lowering triglycerides in this context."
Vitamin B3 (Niacin),GI complaints; Higher risk of coronary disease related death in placebo group; Increased risk for acute coronary syndrome in placebo group; aspartate aminotransferase increased in niacin group; bleeding; decreased quality of life-adjusted survival; discontinued due to comorbidity risks; excess of serious adverse experiences; flushing/warmth; higher all-cause mortality in ERN group; impaired erythrocyte deformability; increased incidence of diabetes diagnoses; increased incidence of disturbances in diabetes control; increased insulin resistance; increased risk of developing impaired fasting glucose; increased risk of hip fractures with high and low niacin intake; increased risk of serious adverse events; increased serious adverse events associated with bleeding; increased serious adverse events associated with gastrointestinal system; increased serious adverse events associated with infection; increased serious adverse events associated with musculoskeletal system; increased serious adverse events associated with skin; infections; new-onset diabetes; plasma homocysteine elevation; requirement for intensification of antihyperglycemic medication; serious bleeding; serious infection; tingling; trend toward increased development of new-onset diabetes; worsening of diabetes; worsening of endothelial function,High Triglycerides,,Heart & Vascular Health,manual_pair,"The evidence for vitamin B3 (niacin) in reducing high triglycerides is mixed. Three studies indicate a benefit, particularly with extended-release formulations at doses of 1-2 g daily, while two studies present unclear outcomes regarding cardiovascular benefits and mortality. No studies reported harm, but the mixed results highlight the need for caution in interpreting the overall efficacy of niacin for this indication.",0.8,26679079,2016,Effect of niacin on triglyceride-rich lipoprotein apolipoprotein B-48 kinetics in statin-treated patients with type 2 diabetes.,randomized_controlled_trial,benefit,"The study shows that ER niacin reduces apoB-48 concentration and may provide cardiovascular disease risk benefit, indicating a positive outcome.",null null null 12 weeks (extended-release),,,cardiovascular disease risk,Type 2 Diabetes Mellitus; atherogenic lipemia; cardiovascular disease; cardiovascular disease risk; chronic kidney disease; dyslipidemia; dyslipidemias; elevated triglycerides; metabolic syndrome; reduced hdl cholesterol,Tier 3,0.45,"Small randomized cross-over trial (n=12) in statin-treated men with type 2 diabetes focused primarily on apoB-48 kinetics (a surrogate). It showed reduced apoB-48 and lower postprandial triglyceride AUC with ER niacin over 12 weeks, but did not report clear changes in fasting triglycerides (the typical target for high triglycerides). The study is mechanistic with surrogate outcomes and limited size, providing preliminary human evidence for the indication."
Vitamin B3 (Niacin),GI complaints; Higher risk of coronary disease related death in placebo group; Increased risk for acute coronary syndrome in placebo group; aspartate aminotransferase increased in niacin group; bleeding; decreased quality of life-adjusted survival; discontinued due to comorbidity risks; excess of serious adverse experiences; flushing/warmth; higher all-cause mortality in ERN group; impaired erythrocyte deformability; increased incidence of diabetes diagnoses; increased incidence of disturbances in diabetes control; increased insulin resistance; increased risk of developing impaired fasting glucose; increased risk of hip fractures with high and low niacin intake; increased risk of serious adverse events; increased serious adverse events associated with bleeding; increased serious adverse events associated with gastrointestinal system; increased serious adverse events associated with infection; increased serious adverse events associated with musculoskeletal system; increased serious adverse events associated with skin; infections; new-onset diabetes; plasma homocysteine elevation; requirement for intensification of antihyperglycemic medication; serious bleeding; serious infection; tingling; trend toward increased development of new-onset diabetes; worsening of diabetes; worsening of endothelial function,High Triglycerides,,Heart & Vascular Health,manual_pair,"The evidence for vitamin B3 (niacin) in reducing high triglycerides is mixed. Three studies indicate a benefit, particularly with extended-release formulations at doses of 1-2 g daily, while two studies present unclear outcomes regarding cardiovascular benefits and mortality. No studies reported harm, but the mixed results highlight the need for caution in interpreting the overall efficacy of niacin for this indication.",0.8,25932792,2015,Effects of niacin and omega-3 fatty acids on the apolipoproteins in overweight patients with elevated triglycerides and reduced HDL cholesterol.,randomized_controlled_trial,benefit,"The study shows that ERN produced a beneficial reduction in plasma apoB, indicating a positive health outcome.",2 g daily 16 weeks (extended release),,,dyslipidemias,Type 2 Diabetes Mellitus; atherogenic lipemia; cardiovascular disease; cardiovascular disease risk; chronic kidney disease; dyslipidemia; dyslipidemias; elevated triglycerides; metabolic syndrome; reduced hdl cholesterol,Tier 3,0.7,"Randomized controlled trial in patients with elevated triglycerides, but the primary outcomes were surrogate lipid markers (apolipoproteins, apoC3 glycosylation) rather than triglyceride levels. While niacin showed beneficial changes (e.g., reduced apoB), the study provides indirect, exploratory evidence for the high triglycerides indication and has a small sample size."
Vitamin B3 (Niacin),GI complaints; Higher risk of coronary disease related death in placebo group; Increased risk for acute coronary syndrome in placebo group; aspartate aminotransferase increased in niacin group; bleeding; decreased quality of life-adjusted survival; discontinued due to comorbidity risks; excess of serious adverse experiences; flushing/warmth; higher all-cause mortality in ERN group; impaired erythrocyte deformability; increased incidence of diabetes diagnoses; increased incidence of disturbances in diabetes control; increased insulin resistance; increased risk of developing impaired fasting glucose; increased risk of hip fractures with high and low niacin intake; increased risk of serious adverse events; increased serious adverse events associated with bleeding; increased serious adverse events associated with gastrointestinal system; increased serious adverse events associated with infection; increased serious adverse events associated with musculoskeletal system; increased serious adverse events associated with skin; infections; new-onset diabetes; plasma homocysteine elevation; requirement for intensification of antihyperglycemic medication; serious bleeding; serious infection; tingling; trend toward increased development of new-onset diabetes; worsening of diabetes; worsening of endothelial function,High Triglycerides,,Heart & Vascular Health,manual_pair,"The evidence for vitamin B3 (niacin) in reducing high triglycerides is mixed. Three studies indicate a benefit, particularly with extended-release formulations at doses of 1-2 g daily, while two studies present unclear outcomes regarding cardiovascular benefits and mortality. No studies reported harm, but the mixed results highlight the need for caution in interpreting the overall efficacy of niacin for this indication.",0.8,28960312,2018,Effects of immediate-release niacin and dietary fatty acids on acute insulin and lipid status in individuals with metabolic syndrome.,randomized_controlled_trial,mixed_unclear,"The study shows mixed effects on postprandial insulin and lipid levels, indicating both increases and decreases depending on the type of dietary fat.",2 g single dose (immediate-release),,,metabolic syndrome,Type 2 Diabetes Mellitus; atherogenic lipemia; cardiovascular disease; cardiovascular disease risk; chronic kidney disease; dyslipidemia; dyslipidemias; elevated triglycerides; metabolic syndrome; reduced hdl cholesterol,Tier 5,0.55,"Small, single-dose crossover study focused on postprandial triglyceride responses to different dietary fat types with niacin co-administered in all arms. There was no no-niacin control and no assessment of chronic triglyceride lowering. Outcomes were mixed and context-dependent, so this does not test niacin for the indication of treating high triglycerides."
Vitamin B3 (Niacin),GI complaints; Higher risk of coronary disease related death in placebo group; Increased risk for acute coronary syndrome in placebo group; aspartate aminotransferase increased in niacin group; bleeding; decreased quality of life-adjusted survival; discontinued due to comorbidity risks; excess of serious adverse experiences; flushing/warmth; higher all-cause mortality in ERN group; impaired erythrocyte deformability; increased incidence of diabetes diagnoses; increased incidence of disturbances in diabetes control; increased insulin resistance; increased risk of developing impaired fasting glucose; increased risk of hip fractures with high and low niacin intake; increased risk of serious adverse events; increased serious adverse events associated with bleeding; increased serious adverse events associated with gastrointestinal system; increased serious adverse events associated with infection; increased serious adverse events associated with musculoskeletal system; increased serious adverse events associated with skin; infections; new-onset diabetes; plasma homocysteine elevation; requirement for intensification of antihyperglycemic medication; serious bleeding; serious infection; tingling; trend toward increased development of new-onset diabetes; worsening of diabetes; worsening of endothelial function,High Insulin,,Metabolic Health,manual_pair,"Current evidence regarding the use of vitamin B3 (niacin) for improving insulin resistance is limited and indicates potential harm. A study found that niacin treatment decreased insulin sensitivity in human adipocytes, suggesting a negative effect. No studies reported a benefit or mixed outcomes for this indication.",1.0,30482933,2019,Niacin induces miR-502-3p expression which impairs insulin sensitivity in human adipocytes.,randomized_controlled_trial,harm,"The study found that niacin treatment decreased insulin sensitivity, indicating a harmful effect.",8 weeks (extended-release),,,insulin resistance,insulin resistance; obesity,Tier 3,0.58,"Small double-blind RCT (n=22) over 8 weeks found niacin decreased insulin sensitivity, indicating potential harm. However, the study’s primary focus was mechanistic (microRNA changes), and it did not directly measure or target high insulin as a primary clinical outcome. Insulin sensitivity is a surrogate for hyperinsulinemia, making the evidence indirect and preliminary for the specific indication of high insulin."
Vitamin B3 (Niacin),GI complaints; Higher risk of coronary disease related death in placebo group; Increased risk for acute coronary syndrome in placebo group; aspartate aminotransferase increased in niacin group; bleeding; decreased quality of life-adjusted survival; discontinued due to comorbidity risks; excess of serious adverse experiences; flushing/warmth; higher all-cause mortality in ERN group; impaired erythrocyte deformability; increased incidence of diabetes diagnoses; increased incidence of disturbances in diabetes control; increased insulin resistance; increased risk of developing impaired fasting glucose; increased risk of hip fractures with high and low niacin intake; increased risk of serious adverse events; increased serious adverse events associated with bleeding; increased serious adverse events associated with gastrointestinal system; increased serious adverse events associated with infection; increased serious adverse events associated with musculoskeletal system; increased serious adverse events associated with skin; infections; new-onset diabetes; plasma homocysteine elevation; requirement for intensification of antihyperglycemic medication; serious bleeding; serious infection; tingling; trend toward increased development of new-onset diabetes; worsening of diabetes; worsening of endothelial function,Low HDL,,Heart & Vascular Health,manual_pair,"The evidence regarding the effect of Vitamin B3 (Niacin) on increasing HDL cholesterol is mixed and unclear, as indicated by a single study that reported variable outcomes without demonstrating clear benefits or harms. No consistent dose ranges were reported across the studies, and overall, the findings do not support a definitive conclusion about its efficacy for this indication.",0.8,25528430,2015,Remarkable quantitative and qualitative differences in HDL after niacin or fenofibrate therapy in type 2 diabetic patients.,randomized_controlled_trial,mixed_unclear,The study shows mixed results regarding HDL changes and does not indicate clear benefits or harms.,12 weeks (niacin + laropiprant),,,dyslipidemia,Type 2 Diabetes Mellitus; dyslipidemia,Tier 2,0.6,"Randomized crossover trial (n=30) in type 2 diabetic patients with low HDL tested niacin (with laropiprant) as add-on to statin for 12 weeks with HDL as a primary outcome. Niacin+laropiprant significantly increased HDL-C, though qualitative HDL changes were mixed. Small sample, short duration, add-on and combination therapy reduce strength and generalizability, yielding moderate human evidence for this indication."
Vitamin B3 (Niacin),GI complaints; Higher risk of coronary disease related death in placebo group; Increased risk for acute coronary syndrome in placebo group; aspartate aminotransferase increased in niacin group; bleeding; decreased quality of life-adjusted survival; discontinued due to comorbidity risks; excess of serious adverse experiences; flushing/warmth; higher all-cause mortality in ERN group; impaired erythrocyte deformability; increased incidence of diabetes diagnoses; increased incidence of disturbances in diabetes control; increased insulin resistance; increased risk of developing impaired fasting glucose; increased risk of hip fractures with high and low niacin intake; increased risk of serious adverse events; increased serious adverse events associated with bleeding; increased serious adverse events associated with gastrointestinal system; increased serious adverse events associated with infection; increased serious adverse events associated with musculoskeletal system; increased serious adverse events associated with skin; infections; new-onset diabetes; plasma homocysteine elevation; requirement for intensification of antihyperglycemic medication; serious bleeding; serious infection; tingling; trend toward increased development of new-onset diabetes; worsening of diabetes; worsening of endothelial function,Endothelial Function,,Heart & Vascular Health,manual_pair,"One randomized controlled trial reported that short-term treatment with extended-release niacin (1 g daily) may improve endothelial function in individuals with low HDL-C. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term effects and safety.",0.7,24768191,2014,"Short-term effects of extended-release niacin with and without the addition of laropiprant on endothelial function in individuals with low HDL-C: a randomized, controlled crossover trial.",randomized_controlled_trial,benefit,"The study shows that short-term niacin treatment might improve endothelial function, indicating a benefit.",1 g daily short-term (extended-release),,,endothelial dysfunction,endothelial dysfunction; low hdl-c,Tier 3,0.56,"Randomized controlled crossover trial with a very small sample (n=18) and short duration (7 days per period). The primary outcome was endothelial function assessed by flow-mediated dilation, a surrogate rather than a clinical endpoint. While results suggested benefit, the small size, brief exposure, and surrogate measure place this as preliminary human evidence."
Vitamin B3 (Niacin),GI complaints; Higher risk of coronary disease related death in placebo group; Increased risk for acute coronary syndrome in placebo group; aspartate aminotransferase increased in niacin group; bleeding; decreased quality of life-adjusted survival; discontinued due to comorbidity risks; excess of serious adverse experiences; flushing/warmth; higher all-cause mortality in ERN group; impaired erythrocyte deformability; increased incidence of diabetes diagnoses; increased incidence of disturbances in diabetes control; increased insulin resistance; increased risk of developing impaired fasting glucose; increased risk of hip fractures with high and low niacin intake; increased risk of serious adverse events; increased serious adverse events associated with bleeding; increased serious adverse events associated with gastrointestinal system; increased serious adverse events associated with infection; increased serious adverse events associated with musculoskeletal system; increased serious adverse events associated with skin; infections; new-onset diabetes; plasma homocysteine elevation; requirement for intensification of antihyperglycemic medication; serious bleeding; serious infection; tingling; trend toward increased development of new-onset diabetes; worsening of diabetes; worsening of endothelial function,Endothelial Function,,Heart & Vascular Health,manual_pair,"One randomized trial indicates that extended-release niacin may improve endothelial health by enhancing HDL function in patients with metabolic syndrome. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term effects and safety.",0.7,26133666,2015,Fenofibrate and extended-release niacin improve the endothelial protective effects of HDL in patients with metabolic syndrome.,randomized_controlled_trial,benefit,"The study shows that both fenofibrate and ER niacin improved HDL function, indicating a beneficial effect on endothelial health in patients with metabolic syndrome.",6 weeks (extended-release),,,metabolic syndrome,metabolic syndrome,Tier 4,0.46,"Randomized cross-over study (n=37) with ER niacin showed improvements in ex vivo HDL-mediated endothelial effects (eNOS/NO, VCAM-1) after 6 weeks, but did not assess in vivo endothelial function (e.g., FMD) or clinical outcomes. Small, short, open-label design with mechanistic, indirect endpoints supports very low/indirect evidence for endothelial function."
Vitamin B3 (Niacin),GI complaints; Higher risk of coronary disease related death in placebo group; Increased risk for acute coronary syndrome in placebo group; aspartate aminotransferase increased in niacin group; bleeding; decreased quality of life-adjusted survival; discontinued due to comorbidity risks; excess of serious adverse experiences; flushing/warmth; higher all-cause mortality in ERN group; impaired erythrocyte deformability; increased incidence of diabetes diagnoses; increased incidence of disturbances in diabetes control; increased insulin resistance; increased risk of developing impaired fasting glucose; increased risk of hip fractures with high and low niacin intake; increased risk of serious adverse events; increased serious adverse events associated with bleeding; increased serious adverse events associated with gastrointestinal system; increased serious adverse events associated with infection; increased serious adverse events associated with musculoskeletal system; increased serious adverse events associated with skin; infections; new-onset diabetes; plasma homocysteine elevation; requirement for intensification of antihyperglycemic medication; serious bleeding; serious infection; tingling; trend toward increased development of new-onset diabetes; worsening of diabetes; worsening of endothelial function,Cardiac Risk,,Heart & Vascular Health,manual_pair,"Current evidence regarding the use of vitamin B3 (niacin) for improving quality of life in individuals with cardiovascular events is lacking, with a notable study indicating that extended-release niacin with laropiprant (2 g daily for 4 years) did not reduce major vascular events and was associated with increased healthcare costs and decreased quality of life. No studies have demonstrated a benefit for this indication, and one study reported harm.",1.0,27407053,2016,Effects of Vascular and Nonvascular Adverse Events and of Extended-Release Niacin With Laropiprant on Health and Healthcare Costs.,randomized_controlled_trial,harm,The study found that niacin-laropiprant did not significantly reduce major vascular events and was associated with increased hospital costs and decreased quality of life.,2 g daily 4 years (extended-release with laropiprant),,,cardiovascular disease,cardiovascular disease; quality of life; vascular events,Tier 2,0.68,"This is a large randomized controlled trial dataset (HPS2-THRIVE; n=25,673) testing extended-release niacin 2 g/day with laropiprant versus placebo on top of statins. However, this specific paper’s primary outcomes are quality-adjusted life years and hospital costs, making its relevance to the indication of cardiac risk indirect/secondary. It notes no significant reduction in major vascular events and increased adverse events, aligning with harm/no benefit for cardiac outcomes, but the study’s focal endpoints are economic and HRQoL rather than cardiac risk as a primary outcome."
Vitamin B3 (Niacin),GI complaints; Higher risk of coronary disease related death in placebo group; Increased risk for acute coronary syndrome in placebo group; aspartate aminotransferase increased in niacin group; bleeding; decreased quality of life-adjusted survival; discontinued due to comorbidity risks; excess of serious adverse experiences; flushing/warmth; higher all-cause mortality in ERN group; impaired erythrocyte deformability; increased incidence of diabetes diagnoses; increased incidence of disturbances in diabetes control; increased insulin resistance; increased risk of developing impaired fasting glucose; increased risk of hip fractures with high and low niacin intake; increased risk of serious adverse events; increased serious adverse events associated with bleeding; increased serious adverse events associated with gastrointestinal system; increased serious adverse events associated with infection; increased serious adverse events associated with musculoskeletal system; increased serious adverse events associated with skin; infections; new-onset diabetes; plasma homocysteine elevation; requirement for intensification of antihyperglycemic medication; serious bleeding; serious infection; tingling; trend toward increased development of new-onset diabetes; worsening of diabetes; worsening of endothelial function,Parkinson's Disease,,Cognitive & Neurological Function,manual_pair,"Current evidence on the use of vitamin B3 (niacin) for improving quality of life in Parkinson's disease is limited and primarily based on a single study, which suggests a potential benefit at lower doses. However, due to the low quantity and quality of available research, further studies are needed to confirm these findings and assess safety and efficacy.",0.3,29759143,2018,Niacin modulates macrophage polarization in Parkinson's disease.,clinical_trial,benefit,The study suggests that low dose niacin may improve quality of life and modulate inflammation in Parkinson's disease.,lower dose,,,parkinson's disease,parkinson's disease,Tier 3,0.6,"Single small human clinical study with primarily mechanistic outcomes (macrophage polarization) and exploratory quality-of-life improvements; likely open-label/uncontrolled rather than a well-powered RCT. Indicates preliminary benefit but not robust, controlled evidence for Parkinson’s disease."
Vitamin B3 (Niacin),GI complaints; Higher risk of coronary disease related death in placebo group; Increased risk for acute coronary syndrome in placebo group; aspartate aminotransferase increased in niacin group; bleeding; decreased quality of life-adjusted survival; discontinued due to comorbidity risks; excess of serious adverse experiences; flushing/warmth; higher all-cause mortality in ERN group; impaired erythrocyte deformability; increased incidence of diabetes diagnoses; increased incidence of disturbances in diabetes control; increased insulin resistance; increased risk of developing impaired fasting glucose; increased risk of hip fractures with high and low niacin intake; increased risk of serious adverse events; increased serious adverse events associated with bleeding; increased serious adverse events associated with gastrointestinal system; increased serious adverse events associated with infection; increased serious adverse events associated with musculoskeletal system; increased serious adverse events associated with skin; infections; new-onset diabetes; plasma homocysteine elevation; requirement for intensification of antihyperglycemic medication; serious bleeding; serious infection; tingling; trend toward increased development of new-onset diabetes; worsening of diabetes; worsening of endothelial function,Glaucoma,,Vision & Eye Health,manual_pair,"One randomized clinical trial reported a significant improvement in inner retinal function in patients with glaucoma following supplementation with nicotinamide (vitamin B3) at doses of 1.5 g and 3.0 g daily for 6 weeks compared to placebo. Overall, the evidence is limited to a single study with no reported adverse effects or mixed outcomes, indicating a need for further research to confirm these findings.",0.7,32721104,2020,Improvement in inner retinal function in glaucoma with nicotinamide (vitamin B3) supplementation: A crossover randomized clinical trial.,randomized_controlled_trial,benefit,The study shows a significant improvement in inner retinal function with nicotinamide supplementation compared to placebo.,1.5 g daily 6 weeks (oral); 3.0 g daily 6 weeks (oral),,,glaucoma,glaucoma,Tier 3,0.62,"Double-masked crossover RCT (n=57) in glaucoma showed significant improvements in ERG-based inner retinal function (PhNR), with only a trend for visual field improvement. Primary outcomes were surrogate electrophysiologic measures rather than clinical endpoints; study was short and had no washout, limiting interpretability. Thus, preliminary human evidence based on surrogate outcomes."
Vitamin B5 (Pantothenic Acid),,High LDL,,Heart & Vascular Health,manual_pair,"One randomized trial demonstrated that pantethine, a derivative of vitamin B5, significantly reduced total, LDL, and non-HDL cholesterol levels in subjects at low to moderate cardiovascular risk. The doses used in this study were 600 mg and 900 mg daily for 8 weeks. Overall evidence is limited to this single study, and further research is needed to confirm these findings and assess long-term safety and efficacy.",0.7,24600231,2014,"Pantethine, a derivative of vitamin B5, favorably alters total, LDL and non-HDL cholesterol in low to moderate cardiovascular risk subjects eligible for statin therapy: a triple-blinded placebo and diet-controlled investigation.",randomized_controlled_trial,benefit,"The study shows a significant decrease in cholesterol levels, indicating a benefit from pantethine treatment.",600 mg daily 8 weeks; 900 mg daily 8 weeks,,,cardiovascular disease,cardiovascular disease; hypercholesterolemia,Tier 4,0.46,"The study is a small, triple-blinded, placebo-controlled RCT showing significant LDL reductions, but it tested pantethine (a derivative of vitamin B5), not pantothenic acid itself. This makes the evidence indirect for the specified supplement. Sample size (n=32) is also limited. Thus, for pantothenic acid and high LDL, this provides very low/indirect human evidence despite positive findings for pantethine."
Vitamin B6 (Pyridoxine),arrhythmia; drowsiness; fatigue; greater tumor treatment failure; heartburn; higher risk for births with children who were small for gestational age; higher tiredness on waking; lower self-rated sleep quality; may blunt response of bone to parathyroid hormone; mild adverse effects compared to cabergoline; mild transient diarrhea in one patient; none major documented; sedation; shorter time to treatment failure; worsened tumor response; worsens response to erythropoiesis-stimulating agents,Muscloskeletal Pain,,Musculoskeletal & Pain,manual_pair,"One randomized controlled trial reported a benefit of a fixed-dose combination of dexketoprofen and vitamin B6 (50 mg every 8 hours for 7 days) in reducing pain intensity in patients with post-traumatic grade I-II cervical sprains. No studies reported mixed outcomes or harm, but evidence is limited to a single trial, indicating a need for further research to confirm these findings.",0.7,38842764,2024,"A Randomized Control Trial of Dexketoprofen/Vitamin B (Thiamine, Pyridoxine and Cyanocobalamin) Fixed-Dose Combination in Post-Traumatic Grade I-II Cervical Sprains.",randomized_controlled_trial,benefit,The study demonstrated a statistically significant reduction in pain intensity and a better safety profile with the fixed-dose combination compared to monotherapy.,50 mg every 8 hours 7 days (fixed-dose combination with dexketoprofen),Cervical Sprain,,acute pain,acute pain; grade i-ii cervical sprains,Tier 4,0.62,"The study is a well-designed RCT with clinically relevant pain outcomes in acute cervical sprain, but the intervention is a fixed-dose combination of dexketoprofen plus vitamins B1, B6, and B12 versus dexketoprofen alone. Because pyridoxine was not isolated and was co-administered with other vitamins and an NSAID, the effect cannot be attributed to vitamin B6 specifically. Thus, evidence for B6 itself in musculoskeletal pain is indirect/very low despite positive results for the combination."
Vitamin B6 (Pyridoxine),arrhythmia; drowsiness; fatigue; greater tumor treatment failure; heartburn; higher risk for births with children who were small for gestational age; higher tiredness on waking; lower self-rated sleep quality; may blunt response of bone to parathyroid hormone; mild adverse effects compared to cabergoline; mild transient diarrhea in one patient; none major documented; sedation; shorter time to treatment failure; worsened tumor response; worsens response to erythropoiesis-stimulating agents,Macular Degeneration,,Vision & Eye Health,manual_pair,"There is limited evidence suggesting that vitamin B6, in combination with folic acid and cyanocobalamin, may reduce the incidence of age-related macular degeneration, as indicated by one study that reported a significant benefit with a daily dose of 50 mg for 7.3 years. However, the overall evidence is sparse, and further research is needed to confirm these findings and assess long-term safety and efficacy.",0.7,19237716,2009,"Folic acid, pyridoxine, and cyanocobalamin combination treatment and age-related macular degeneration in women: the Women's Antioxidant and Folic Acid Cardiovascular Study.",randomized_controlled_trial,benefit,"The study shows a significant reduction in the incidence of AMD with the combination treatment, indicating a benefit.",50 mg daily 7.3 years (hydrochloride),,,age-related macular degeneration,age-related macular degeneration,Tier 4,0.69,"Although a large, well-designed RCT showed reduced AMD incidence, vitamin B6 was administered only in combination with folic acid and vitamin B12. The benefit cannot be attributed to B6 alone, making the evidence for B6 specifically indirect."
Vitamin B6 (Pyridoxine),arrhythmia; drowsiness; fatigue; greater tumor treatment failure; heartburn; higher risk for births with children who were small for gestational age; higher tiredness on waking; lower self-rated sleep quality; may blunt response of bone to parathyroid hormone; mild adverse effects compared to cabergoline; mild transient diarrhea in one patient; none major documented; sedation; shorter time to treatment failure; worsened tumor response; worsens response to erythropoiesis-stimulating agents,Stress,,"Energy, Mood, & Mental Health",manual_pair,"Current evidence from two randomized controlled trials suggests that Vitamin B6 supplementation may reduce anxiety, with one study indicating benefits from high-dose Vitamin B6 for one month and another showing improvements with a daily dose of 30 mg in combination with magnesium over eight weeks. However, the overall evidence is limited, and further research is needed to confirm these findings and establish optimal dosing and long-term safety.",0.8,35851507,2022,High-dose Vitamin B6 supplementation reduces anxiety and strengthens visual surround suppression.,randomized_controlled_trial,benefit,"Vitamin B6 supplementation was associated with reduced anxiety and a trend towards reduced depression, indicating a beneficial outcome.",high-dose 1 month,,Cognitive & Neurological Function,anxiety,anxiety; depression; quality of life; stress,Tier 4,0.58,"This was a double-blind RCT showing reduced self-reported anxiety with high-dose vitamin B6, but it did not measure stress or perceived stress; clinical outcomes targeted anxiety/depression. Thus, for the indication 'stress,' the evidence is indirect despite a strong study design."
Vitamin B6 (Pyridoxine),arrhythmia; drowsiness; fatigue; greater tumor treatment failure; heartburn; higher risk for births with children who were small for gestational age; higher tiredness on waking; lower self-rated sleep quality; may blunt response of bone to parathyroid hormone; mild adverse effects compared to cabergoline; mild transient diarrhea in one patient; none major documented; sedation; shorter time to treatment failure; worsened tumor response; worsens response to erythropoiesis-stimulating agents,Stress,,"Energy, Mood, & Mental Health",manual_pair,"Current evidence from two randomized controlled trials suggests that Vitamin B6 supplementation may reduce anxiety, with one study indicating benefits from high-dose Vitamin B6 for one month and another showing improvements with a daily dose of 30 mg in combination with magnesium over eight weeks. However, the overall evidence is limited, and further research is needed to confirm these findings and establish optimal dosing and long-term safety.",0.8,33864354,2021,Effect of magnesium and vitamin B6 supplementation on mental health and quality of life in stressed healthy adults: Post-hoc analysis of a randomised controlled trial.,randomized_controlled_trial,benefit,The study shows significant improvement in mental health outcomes with the combination of magnesium and vitamin B6.,30 mg daily 8 weeks (Magne B6®),,,anxiety,anxiety; depression; quality of life; stress,Tier 2,0.6,"This is a human randomized controlled trial in highly stressed adults showing greater stress reduction with magnesium plus vitamin B6 versus magnesium alone, implying an added benefit from B6. However, B6 was tested only as an adjunct to magnesium (not monotherapy), and the reported mental health analyses are post-hoc. Details on sample size and blinding are not provided here. Thus, it supports moderate human evidence for vitamin B6’s effect on stress, but not at the strongest level."
Vitamin B6 (Pyridoxine),arrhythmia; drowsiness; fatigue; greater tumor treatment failure; heartburn; higher risk for births with children who were small for gestational age; higher tiredness on waking; lower self-rated sleep quality; may blunt response of bone to parathyroid hormone; mild adverse effects compared to cabergoline; mild transient diarrhea in one patient; none major documented; sedation; shorter time to treatment failure; worsened tumor response; worsens response to erythropoiesis-stimulating agents,Cataracts,,Vision & Eye Health,manual_pair,"The evidence regarding Vitamin B6 (Pyridoxine) for the prevention of cataracts is low quality, with a single randomized trial indicating mixed results. This study reported no significant effect on cataract incidence but suggested a potential increased risk of cataract extraction with a daily dose of 50 mg over 7.3 years. Overall, the findings do not support a clear benefit for this indication.",0.8,26786311,2016,"Folic Acid, Vitamin B6, and Vitamin B12 in Combination and Age-Related Cataract in a Randomized Trial of Women.",randomized_controlled_trial,mixed_unclear,The study found no significant effect on cataract incidence but suggested an increased risk of cataract extraction.,50 mg daily 7.3 years,,,age-related cataract,age-related cataract; cataract,Tier 4,0.6,"Large, well-conducted RCT with cataract outcomes, but the intervention combined folic acid, vitamin B6, and vitamin B12, so effects cannot be attributed to vitamin B6 alone. Results showed no reduction in cataract incidence and a possible increase in cataract extraction, making the evidence indirect and not specific to pyridoxine."
Vitamin B6 (Pyridoxine),arrhythmia; drowsiness; fatigue; greater tumor treatment failure; heartburn; higher risk for births with children who were small for gestational age; higher tiredness on waking; lower self-rated sleep quality; may blunt response of bone to parathyroid hormone; mild adverse effects compared to cabergoline; mild transient diarrhea in one patient; none major documented; sedation; shorter time to treatment failure; worsened tumor response; worsens response to erythropoiesis-stimulating agents,Depression,,"Energy, Mood, & Mental Health",manual_pair,"Two randomized trials suggest that Vitamin B6 supplementation may reduce symptoms of depression, particularly in specific populations such as college women taking oral contraceptives. Doses reported include 100 mg daily for a duration of 4 weeks. Overall, the evidence indicates a potential benefit, but further research is needed to confirm these findings across broader populations and to assess long-term effects and safety.",0.8,35109763,2023,"Vitamin B6 Supplementation Reduces Symptoms of Depression in College Women Taking Oral Contraceptives: A Randomized, Double-Blind Crossover Trial.",randomized_controlled_trial,benefit,Vitamin B6 supplementation significantly reduced depression symptoms as measured by BDI-II scores.,100 mg daily 4 weeks,Women,,depression,depression; headache; nausea,Tier 2,0.66,"Randomized, double-blind, crossover RCT showing benefit on a primary clinical outcome (BDI-II depression scores) in women using oral contraceptives. However, the study appears short (4-week periods), likely small in size, and restricted to a specific subgroup, limiting generalizability and strength; thus moderate rather than strong human evidence."
Vitamin B6 (Pyridoxine),arrhythmia; drowsiness; fatigue; greater tumor treatment failure; heartburn; higher risk for births with children who were small for gestational age; higher tiredness on waking; lower self-rated sleep quality; may blunt response of bone to parathyroid hormone; mild adverse effects compared to cabergoline; mild transient diarrhea in one patient; none major documented; sedation; shorter time to treatment failure; worsened tumor response; worsens response to erythropoiesis-stimulating agents,Depression,,"Energy, Mood, & Mental Health",manual_pair,"Two randomized trials suggest that Vitamin B6 supplementation may reduce symptoms of depression, particularly in specific populations such as college women taking oral contraceptives. Doses reported include 100 mg daily for a duration of 4 weeks. Overall, the evidence indicates a potential benefit, but further research is needed to confirm these findings across broader populations and to assess long-term effects and safety.",0.8,25163030,2014,Supplementation with vitamin B6 reduces side effects in Cambodian women using oral contraception.,clinical_trial,benefit,"The study shows that Vitamin B6 supplementation leads to a reduction in reported side effects, indicating a beneficial outcome.",daily,,,depression,depression; headache; nausea,Tier 4,0.66,"Indirect, low-quality human evidence for depression. The study assessed self-reported 'depression' as a contraceptive side effect in Cambodian women using oral contraceptives, not clinical depression as a primary indication, and lacked placebo/blinding and clear randomization. Although large and controlled, outcomes were not validated depression measures and applicability to general depression is limited."
Vitamin B6 (Pyridoxine),arrhythmia; drowsiness; fatigue; greater tumor treatment failure; heartburn; higher risk for births with children who were small for gestational age; higher tiredness on waking; lower self-rated sleep quality; may blunt response of bone to parathyroid hormone; mild adverse effects compared to cabergoline; mild transient diarrhea in one patient; none major documented; sedation; shorter time to treatment failure; worsened tumor response; worsens response to erythropoiesis-stimulating agents,Chronic Kidney Disease,,Kidney & Bladder Health,manual_pair,"One randomized trial reported that a daily dose of 80 mg of vitamin B6 (pyridoxine) for 12 weeks resulted in significant improvements in albuminuria and oxidative stress markers in patients with diabetic nephropathy, indicating a potential benefit. However, the overall evidence is limited, with only one study available, and further research is needed to confirm these findings and assess long-term effects and safety.",0.7,24491880,2013,"Effects of combined lipoic acid and pyridoxine on albuminuria, advanced glycation end-products, and blood pressure in diabetic nephropathy.",randomized_controlled_trial,benefit,"The study shows significant improvements in albuminuria and oxidative stress markers, indicating a benefit from the intervention.",80 mg daily 12 weeks,,"Heart & Vascular Health; Immune, Inflammation, & Infection",diabetic nephropathy,diabetic nephropathy,Tier 3,0.42,"Small randomized placebo-controlled trial (n=34) in diabetic nephropathy showed reduced albuminuria and oxidative stress, but pyridoxine was given in combination with alpha-lipoic acid, making attribution to vitamin B6 alone unclear. Outcomes were short-term and largely surrogate (albuminuria, biomarkers), and study duration was only 12 weeks. Relevant to CKD but evidence for B6 specifically is indirect."
Vitamin B6 (Pyridoxine),arrhythmia; drowsiness; fatigue; greater tumor treatment failure; heartburn; higher risk for births with children who were small for gestational age; higher tiredness on waking; lower self-rated sleep quality; may blunt response of bone to parathyroid hormone; mild adverse effects compared to cabergoline; mild transient diarrhea in one patient; none major documented; sedation; shorter time to treatment failure; worsened tumor response; worsens response to erythropoiesis-stimulating agents,Dream Recall,,Sleep,manual_pair,"The evidence regarding Vitamin B6 (pyridoxine) for improving dream recall is mixed and of low quality, with one study reporting improved dream recall at a dose of 240 mg daily for five days, but no significant effects on other sleep-related variables. There were no reports of harm associated with Vitamin B6 in this context, but the overall findings are insufficient to draw definitive conclusions.",0.7,29665762,2018,Effects of Vitamin B6 (Pyridoxine) and a B Complex Preparation on Dreaming and Sleep.,randomized_controlled_trial,mixed_unclear,Vitamin B6 improved dream recall but did not significantly affect other sleep-related variables; the B complex preparation had negative effects on sleep quality.,240 mg once daily five consecutive days (pyridoxine hydrochloride),,,dream recall,dream recall,Tier 1,0.78,"Randomized, double-blind, placebo-controlled RCT (n≈100) directly tested vitamin B6 for dream recall and found a significant increase in amount of dream content recalled over five nights. Although other sleep variables and dream qualities did not change, the primary indication (dream recall) improved in a well-designed human trial."
Vitamin B6 (Pyridoxine),arrhythmia; drowsiness; fatigue; greater tumor treatment failure; heartburn; higher risk for births with children who were small for gestational age; higher tiredness on waking; lower self-rated sleep quality; may blunt response of bone to parathyroid hormone; mild adverse effects compared to cabergoline; mild transient diarrhea in one patient; none major documented; sedation; shorter time to treatment failure; worsened tumor response; worsens response to erythropoiesis-stimulating agents,Weight Loss,,Weight & Body Composition,manual_pair,"Clinical evidence suggests that vitamin B6 may have beneficial effects on body weight management, particularly in improving fat-free mass and enhancing fat oxidation in overweight and obese individuals. Two studies reported positive outcomes, with one using a diet rich in breakfast cereals and another utilizing a nutraceutical blend containing 30 mg of pyridoxine three times daily. However, the overall quality of evidence is limited, and further research is needed to establish consistent effects and optimal dosing.",0.7,22822451,2012,"Effects of a leucine and pyridoxine-containing nutraceutical on fat oxidation, and oxidative and inflammatory stress in overweight and obese subjects.",randomized_controlled_trial,benefit,"The study showed significant improvements in fat oxidation and reductions in oxidative and inflammatory stress, indicating a beneficial effect.",30 mg three times/day 4 weeks (NuFit active blend),Obese; Overweight,,inflammatory stress,fat-free mass maintenance; inflammatory stress; obesity; overweight; oxidative stress,Tier 3,0.38,"Small randomized controlled trial (n=20, 4 weeks) using a combination product (leucine + vitamin B6), not vitamin B6 alone. Outcomes were surrogate (fat oxidation, RQ, metabolic/inflammatory markers) with no reported weight loss. Thus, preliminary human evidence relevant to weight management but indirect for vitamin B6 specifically and not demonstrating actual weight reduction."
Vitamin B6 (Pyridoxine),arrhythmia; drowsiness; fatigue; greater tumor treatment failure; heartburn; higher risk for births with children who were small for gestational age; higher tiredness on waking; lower self-rated sleep quality; may blunt response of bone to parathyroid hormone; mild adverse effects compared to cabergoline; mild transient diarrhea in one patient; none major documented; sedation; shorter time to treatment failure; worsened tumor response; worsens response to erythropoiesis-stimulating agents,High Blood Glucose,,Metabolic Health,manual_pair,"One randomized clinical trial reported a significant improvement in blood glucose levels in individuals with type 2 diabetes when pyridoxine (vitamin B6) was added to Metformin treatment at a dose of 300 mg daily for 4 weeks. No studies reported mixed outcomes or adverse effects, but the evidence is limited to a single trial, necessitating caution in interpretation.",0.7,38313181,2023,Assessing pyridoxine adjuvant therapy effects on blood glucose levels in type 2 diabetes: A randomized clinical trial.,randomized_controlled_trial,benefit,The study found a significant improvement in blood glucose levels with the addition of pyridoxine to Metformin treatment.,300 mg daily 4 weeks,Diabetes Type 2,,Type 2 Diabetes Mellitus,Type 2 Diabetes Mellitus,Tier 2,0.6,"Randomized controlled human trial with objective glycemic outcomes (FPG, HbA1c) as primary measures, showing benefit when pyridoxine was added. However, it was open-label, short in duration (4 weeks), had small and imbalanced group sizes, and the abstract does not clearly establish superiority over metformin alone. Thus, moderate but not strong evidence."
Vitamin B6 (Pyridoxine),arrhythmia; drowsiness; fatigue; greater tumor treatment failure; heartburn; higher risk for births with children who were small for gestational age; higher tiredness on waking; lower self-rated sleep quality; may blunt response of bone to parathyroid hormone; mild adverse effects compared to cabergoline; mild transient diarrhea in one patient; none major documented; sedation; shorter time to treatment failure; worsened tumor response; worsens response to erythropoiesis-stimulating agents,High Homocysteine,,Heart & Vascular Health,manual_pair,"One preliminary study indicates that high-dose vitamin B6 (1200 mg daily for 12 weeks) may significantly decrease homocysteine serum levels in patients with schizophrenia and schizoaffective disorders. However, the evidence is limited to a single study with no other trials reporting similar outcomes, suggesting that further research is needed to confirm these findings and assess long-term safety and efficacy.",0.7,17272965,2007,High-dose vitamin B6 decreases homocysteine serum levels in patients with schizophrenia and schizoaffective disorders: a preliminary study.,clinical_trial,benefit,"The study shows a significant decrease in homocysteine levels after treatment, indicating a beneficial effect of high-dose vitamin B6.",1200 mg daily 12 weeks,Schizophrenia,,schizoaffective disorders,schizoaffective disorders; schizophrenia,Tier 3,0.45,"Small, open-label, uncontrolled before–after study (n=11) showing decreased serum homocysteine after very high-dose vitamin B6 in patients with schizophrenia. The outcome (homocysteine level) directly matches the indication but is a surrogate biomarker. Lack of randomization/control and small sample limit strength and generalizability."
Vitamin B6 (Pyridoxine),arrhythmia; drowsiness; fatigue; greater tumor treatment failure; heartburn; higher risk for births with children who were small for gestational age; higher tiredness on waking; lower self-rated sleep quality; may blunt response of bone to parathyroid hormone; mild adverse effects compared to cabergoline; mild transient diarrhea in one patient; none major documented; sedation; shorter time to treatment failure; worsened tumor response; worsens response to erythropoiesis-stimulating agents,Chronic Kidney Disease,,Kidney & Bladder Health,manual_pair,"One randomized trial indicates a beneficial effect of Vitamin B6 (250 mg daily for five months) in patients with early-stage diabetic nephropathy, evidenced by a decrease in HbA1c and an increase in C-peptide. However, the overall evidence is limited to this single study, and further research is needed to confirm these findings and assess long-term safety and efficacy.",0.7,23392542,2013,Plasma AGE-peptides and C-peptide in early-stage diabetic nephropathy patients on thiamine and pyridoxine therapy.,randomized_controlled_trial,benefit,"The study shows a substantial decrease in HbA1c and an increase in C-peptide, indicating a beneficial effect of Vitamin B6 in diabetic nephropathy patients.",250 mg daily five months,Diabetes Type 2,,diabetic nephropathy,Type 2 Diabetes Mellitus; diabetic nephropathy,Tier 3,0.58,"Small human interventional study in early diabetic nephropathy (a CKD subgroup) with no placebo/untreated control; B6 arm n≈12 and another arm combined B1+B6, making attribution to B6 alone uncertain. Outcomes were primarily surrogate markers (AGE-peptides, HbA1c, C-peptide) rather than kidney function endpoints (eGFR, albuminuria, progression). While conducted in the target population, the evidence is preliminary and indirect for the CKD indication."
Vitamin B6 (Pyridoxine),arrhythmia; drowsiness; fatigue; greater tumor treatment failure; heartburn; higher risk for births with children who were small for gestational age; higher tiredness on waking; lower self-rated sleep quality; may blunt response of bone to parathyroid hormone; mild adverse effects compared to cabergoline; mild transient diarrhea in one patient; none major documented; sedation; shorter time to treatment failure; worsened tumor response; worsens response to erythropoiesis-stimulating agents,Migraine Headache,,Musculoskeletal & Pain,manual_pair,"There is limited evidence suggesting that vitamin B6 (pyridoxine) may benefit migraine patients, as indicated by one randomized controlled trial that reported significant improvements in migraine characteristics with a daily dose of 80 mg for three months when combined with folic acid. However, the overall evidence is sparse, and further studies are needed to confirm these findings and assess long-term safety and efficacy.",0.7,28526386,2017,"The effects of folic acid and pyridoxine supplementation on characteristics of migraine attacks in migraine patients with aura: A double-blind, randomized placebo-controlled, clinical trial.",randomized_controlled_trial,benefit,The study shows significant benefits in reducing migraine characteristics with the combination of folic acid and pyridoxine.,80 mg daily 3 months,,,migraine with aura,migraine with aura,Tier 2,0.62,"Double-blind, randomized, placebo-controlled trial (n≈95) in adults with migraine with aura showed clinically relevant improvements in headache severity, frequency, and diary scores when folic acid + pyridoxine were given versus placebo and versus folic acid alone. However, pyridoxine was not tested alone, so attribution to vitamin B6 specifically is indirect, and duration benefits lost significance after adjustment. Thus, moderate human evidence for B6 in this context rather than strong."
Vitamin B6 (Pyridoxine),arrhythmia; drowsiness; fatigue; greater tumor treatment failure; heartburn; higher risk for births with children who were small for gestational age; higher tiredness on waking; lower self-rated sleep quality; may blunt response of bone to parathyroid hormone; mild adverse effects compared to cabergoline; mild transient diarrhea in one patient; none major documented; sedation; shorter time to treatment failure; worsened tumor response; worsens response to erythropoiesis-stimulating agents,Nausea,,Gut Health,manual_pair,"There is limited evidence suggesting that Vitamin B6 may be beneficial in reducing nausea and vomiting, particularly when combined with acupuncture in patients with ovarian cancer, as indicated by one study. However, the overall evidence is sparse, and further research is needed to establish consistent efficacy and appropriate dosing. No adverse effects were reported in the available study.",0.7,19509551,2009,Vitamin B6 points PC6 injection during acupuncture can relieve nausea and vomiting in patients with ovarian cancer.,randomized_controlled_trial,benefit,"The study shows that the combination of acupuncture and Vitamin B6 significantly reduces emesis episodes, indicating a beneficial outcome.",,Cancer,,nausea,nausea; ovarian cancer; vomiting,Tier 4,0.45,"Randomized clinical trial in chemotherapy patients measured clinically relevant nausea/vomiting outcomes, but the demonstrated benefit was for acupuncture plus vitamin B6 acupoint injection, not vitamin B6 alone. The vitamin B6 arm did not show superiority, and the route (PC6 acupoint injection) is indirect relative to typical supplementation. Thus, this study provides very low/indirect evidence for vitamin B6 as a supplement for nausea."
Vitamin B6 (Pyridoxine),arrhythmia; drowsiness; fatigue; greater tumor treatment failure; heartburn; higher risk for births with children who were small for gestational age; higher tiredness on waking; lower self-rated sleep quality; may blunt response of bone to parathyroid hormone; mild adverse effects compared to cabergoline; mild transient diarrhea in one patient; none major documented; sedation; shorter time to treatment failure; worsened tumor response; worsens response to erythropoiesis-stimulating agents,Nausea & Vomiting During Pregnancy,,Women's Health,manual_pair,"The evidence for vitamin B6 (pyridoxine) in treating nausea and vomiting during pregnancy is predominantly positive, with six studies reporting benefits and three showing mixed or unclear results. Typical doses reported include 10 mg to 40 mg taken multiple times daily, often in combination with doxylamine. However, some studies indicate that the clinical significance of the effects may be modest, and the overall quality of evidence is mixed, warranting caution in interpretation.",0.8,25052410,2014,Studying the antiemetic effect of vitamin B6 for morning sickness: pyridoxine and pyridoxal are prodrugs.,randomized_controlled_trial,benefit,"The study shows a significant antiemetic effect of the vitamin B6 combination, indicating a benefit for morning sickness.",,Pregnant; Women,,morning sickness,morning sickness; nausea; nausea and vomiting of pregnancy; nausea during pregnancy; pregnancy; vomiting; vomiting during pregnancy,Tier 4,0.48,"This is a pre-specified pharmacokinetic substudy within a randomized, placebo-controlled trial of a combination product (doxylamine + pyridoxine) for nausea/vomiting of pregnancy. The clinical benefit pertains to the combination, not vitamin B6 alone. The B6-specific findings are indirect (serum PLP correlations) rather than a direct efficacy test of pyridoxine monotherapy for this indication."
Vitamin B6 (Pyridoxine),arrhythmia; drowsiness; fatigue; greater tumor treatment failure; heartburn; higher risk for births with children who were small for gestational age; higher tiredness on waking; lower self-rated sleep quality; may blunt response of bone to parathyroid hormone; mild adverse effects compared to cabergoline; mild transient diarrhea in one patient; none major documented; sedation; shorter time to treatment failure; worsened tumor response; worsens response to erythropoiesis-stimulating agents,Nausea & Vomiting During Pregnancy,,Women's Health,manual_pair,"The evidence for vitamin B6 (pyridoxine) in treating nausea and vomiting during pregnancy is predominantly positive, with six studies reporting benefits and three showing mixed or unclear results. Typical doses reported include 10 mg to 40 mg taken multiple times daily, often in combination with doxylamine. However, some studies indicate that the clinical significance of the effects may be modest, and the overall quality of evidence is mixed, warranting caution in interpretation.",0.8,28375108,2016,Efficacy of Gingocap as compared to pyridoxine in the treatment of nausea and vomiting during pregnancy.,randomized_controlled_trial,benefit,"The study concluded that Gingocap was effective in relieving nausea and vomiting symptoms, indicating a benefit in the treatment of these conditions during pregnancy.",60 days,Pregnant; Women,,morning sickness,morning sickness; nausea; nausea and vomiting of pregnancy; nausea during pregnancy; pregnancy; vomiting; vomiting during pregnancy,Tier 2,0.6,"This is a human randomized comparative trial in pregnant women with nausea and vomiting, directly assessing clinical symptom reduction over 8 weeks and including a pyridoxine arm as the active control. However, the study is small (~30 participants on pyridoxine), dosing details are unclear, and blinding/methodological rigor are not well described. Thus it provides moderate, but not strong, human evidence for pyridoxine in this indication."
Vitamin B6 (Pyridoxine),arrhythmia; drowsiness; fatigue; greater tumor treatment failure; heartburn; higher risk for births with children who were small for gestational age; higher tiredness on waking; lower self-rated sleep quality; may blunt response of bone to parathyroid hormone; mild adverse effects compared to cabergoline; mild transient diarrhea in one patient; none major documented; sedation; shorter time to treatment failure; worsened tumor response; worsens response to erythropoiesis-stimulating agents,Nausea & Vomiting During Pregnancy,,Women's Health,manual_pair,"The evidence for vitamin B6 (pyridoxine) in treating nausea and vomiting during pregnancy is predominantly positive, with six studies reporting benefits and three showing mixed or unclear results. Typical doses reported include 10 mg to 40 mg taken multiple times daily, often in combination with doxylamine. However, some studies indicate that the clinical significance of the effects may be modest, and the overall quality of evidence is mixed, warranting caution in interpretation.",0.8,28629250,2018,"A comparison between the effects of ginger, pyridoxine (vitamin B6) and placebo for the treatment of the first trimester nausea and vomiting of pregnancy (NVP).",randomized_controlled_trial,benefit,Vitamin B6 showed significant effectiveness in reducing the severity of nausea and vomiting compared to placebo.,40 mg twice daily 4 days,Pregnant; Women,,nausea and vomiting of pregnancy,morning sickness; nausea; nausea and vomiting of pregnancy; nausea during pregnancy; pregnancy; vomiting; vomiting during pregnancy,Tier 2,0.68,"Triple-blind randomized, placebo-controlled trial in pregnant women with mild–moderate nausea and vomiting of pregnancy found pyridoxine 40 mg twice daily for 4 days significantly improved validated symptom scores versus placebo. Despite appropriate design and clinically relevant primary outcome, the sample size per arm was small and duration short, limiting precision and generalizability."
Vitamin B6 (Pyridoxine),arrhythmia; drowsiness; fatigue; greater tumor treatment failure; heartburn; higher risk for births with children who were small for gestational age; higher tiredness on waking; lower self-rated sleep quality; may blunt response of bone to parathyroid hormone; mild adverse effects compared to cabergoline; mild transient diarrhea in one patient; none major documented; sedation; shorter time to treatment failure; worsened tumor response; worsens response to erythropoiesis-stimulating agents,Nausea & Vomiting During Pregnancy,,Women's Health,manual_pair,"The evidence for vitamin B6 (pyridoxine) in treating nausea and vomiting during pregnancy is predominantly positive, with six studies reporting benefits and three showing mixed or unclear results. Typical doses reported include 10 mg to 40 mg taken multiple times daily, often in combination with doxylamine. However, some studies indicate that the clinical significance of the effects may be modest, and the overall quality of evidence is mixed, warranting caution in interpretation.",0.8,37335994,2023,"Acupuncture and Doxylamine-Pyridoxine for Nausea and Vomiting in Pregnancy : A Randomized, Controlled, 2 × 2 Factorial Trial.",randomized_controlled_trial,mixed_unclear,The study shows efficacy for nausea and vomiting of pregnancy but notes the clinical importance of the effect is uncertain due to modest magnitude.,14 days daily (doxylamine-pyridoxine),Pregnant; Women,,nausea and vomiting of pregnancy,morning sickness; nausea; nausea and vomiting of pregnancy; nausea during pregnancy; pregnancy; vomiting; vomiting during pregnancy,Tier 4,0.56,"This was a robust, multicenter, double-blind, placebo-controlled RCT (n=352) showing modest efficacy on a validated primary clinical outcome (PUQE). However, pyridoxine was administered only as part of a fixed combination with doxylamine, so the effect cannot be attributed to vitamin B6 alone. Therefore, for vitamin B6 as the supplement, the evidence from this study is indirect."
Vitamin B6 (Pyridoxine),arrhythmia; drowsiness; fatigue; greater tumor treatment failure; heartburn; higher risk for births with children who were small for gestational age; higher tiredness on waking; lower self-rated sleep quality; may blunt response of bone to parathyroid hormone; mild adverse effects compared to cabergoline; mild transient diarrhea in one patient; none major documented; sedation; shorter time to treatment failure; worsened tumor response; worsens response to erythropoiesis-stimulating agents,Nausea & Vomiting During Pregnancy,,Women's Health,manual_pair,"The evidence for vitamin B6 (pyridoxine) in treating nausea and vomiting during pregnancy is predominantly positive, with six studies reporting benefits and three showing mixed or unclear results. Typical doses reported include 10 mg to 40 mg taken multiple times daily, often in combination with doxylamine. However, some studies indicate that the clinical significance of the effects may be modest, and the overall quality of evidence is mixed, warranting caution in interpretation.",0.8,29342163,2018,Doxylamine-pyridoxine for nausea and vomiting of pregnancy randomized placebo controlled trial: Prespecified analyses and reanalysis.,randomized_controlled_trial,mixed_unclear,"The study shows a trend towards efficacy but lacks statistical significance in some analyses, indicating mixed results.",10 mg 2 to 4 times per day 14 days (tablet),Pregnant; Women,,nausea and vomiting of pregnancy,morning sickness; nausea; nausea and vomiting of pregnancy; nausea during pregnancy; pregnancy; vomiting; vomiting during pregnancy,Tier 4,0.58,"This is a human randomized, placebo-controlled trial in pregnant women with nausea/vomiting, but the intervention was a fixed-dose combination of doxylamine plus pyridoxine, not pyridoxine alone. Therefore, it provides indirect evidence for vitamin B6 specifically. Additionally, efficacy findings were mixed and not consistently statistically significant, with effects below the prespecified minimal clinically important difference."
Vitamin B6 (Pyridoxine),arrhythmia; drowsiness; fatigue; greater tumor treatment failure; heartburn; higher risk for births with children who were small for gestational age; higher tiredness on waking; lower self-rated sleep quality; may blunt response of bone to parathyroid hormone; mild adverse effects compared to cabergoline; mild transient diarrhea in one patient; none major documented; sedation; shorter time to treatment failure; worsened tumor response; worsens response to erythropoiesis-stimulating agents,Nausea & Vomiting During Pregnancy,,Women's Health,manual_pair,"The evidence for vitamin B6 (pyridoxine) in treating nausea and vomiting during pregnancy is predominantly positive, with six studies reporting benefits and three showing mixed or unclear results. Typical doses reported include 10 mg to 40 mg taken multiple times daily, often in combination with doxylamine. However, some studies indicate that the clinical significance of the effects may be modest, and the overall quality of evidence is mixed, warranting caution in interpretation.",0.8,27881103,2016,Demonstration of early efficacy results of the delayed-release combination of doxylamine-pyridoxine for the treatment of nausea and vomiting of pregnancy.,randomized_controlled_trial,benefit,"The study demonstrated improved symptom control for nausea and vomiting of pregnancy, indicating a benefit from the treatment.",2 to 4 tablets daily 14 days (delayed-release combination of doxylamine and pyridoxine),Pregnant; Women,,nausea and vomiting of pregnancy,morning sickness; nausea; nausea and vomiting of pregnancy; nausea during pregnancy; pregnancy; vomiting; vomiting during pregnancy,Tier 4,0.54,"This is a well-conducted RCT in pregnant women with NVP showing benefit, but the intervention was a combination of doxylamine and pyridoxine, not vitamin B6 alone. Therefore, the evidence is indirect for vitamin B6 as a standalone supplement for this indication, and the effect cannot be attributed specifically to pyridoxine."
Vitamin B6 (Pyridoxine),arrhythmia; drowsiness; fatigue; greater tumor treatment failure; heartburn; higher risk for births with children who were small for gestational age; higher tiredness on waking; lower self-rated sleep quality; may blunt response of bone to parathyroid hormone; mild adverse effects compared to cabergoline; mild transient diarrhea in one patient; none major documented; sedation; shorter time to treatment failure; worsened tumor response; worsens response to erythropoiesis-stimulating agents,Nausea & Vomiting During Pregnancy,,Women's Health,manual_pair,"The evidence for vitamin B6 (pyridoxine) in treating nausea and vomiting during pregnancy is predominantly positive, with six studies reporting benefits and three showing mixed or unclear results. Typical doses reported include 10 mg to 40 mg taken multiple times daily, often in combination with doxylamine. However, some studies indicate that the clinical significance of the effects may be modest, and the overall quality of evidence is mixed, warranting caution in interpretation.",0.8,25884778,2015,Maternal safety of the delayed-release doxylamine and pyridoxine combination for nausea and vomiting of pregnancy; a randomized placebo controlled trial.,randomized_controlled_trial,benefit,"The study found no increased rate of adverse events, indicating a benefit in terms of safety for the use of the supplement in the specified context.",2-4 tablets daily 14 days (delayed-release combination),Pregnant; Women,,nausea and vomiting of pregnancy,morning sickness; nausea; nausea and vomiting of pregnancy; nausea during pregnancy; pregnancy; vomiting; vomiting during pregnancy,Tier 5,0.83,"This is a placebo-controlled RCT assessing maternal safety of a doxylamine–pyridoxine combination in pregnant women with NVP, not efficacy on NVP symptoms, and not pyridoxine alone. Outcomes were adverse events, not improvement in nausea/vomiting. Thus it does not provide direct efficacy evidence for vitamin B6 for this indication."
Vitamin B6 (Pyridoxine),arrhythmia; drowsiness; fatigue; greater tumor treatment failure; heartburn; higher risk for births with children who were small for gestational age; higher tiredness on waking; lower self-rated sleep quality; may blunt response of bone to parathyroid hormone; mild adverse effects compared to cabergoline; mild transient diarrhea in one patient; none major documented; sedation; shorter time to treatment failure; worsened tumor response; worsens response to erythropoiesis-stimulating agents,Nausea & Vomiting During Pregnancy,,Women's Health,manual_pair,"The evidence for vitamin B6 (pyridoxine) in treating nausea and vomiting during pregnancy is predominantly positive, with six studies reporting benefits and three showing mixed or unclear results. Typical doses reported include 10 mg to 40 mg taken multiple times daily, often in combination with doxylamine. However, some studies indicate that the clinical significance of the effects may be modest, and the overall quality of evidence is mixed, warranting caution in interpretation.",0.8,20843504,2010,Effectiveness of delayed-release doxylamine and pyridoxine for nausea and vomiting of pregnancy: a randomized placebo controlled trial.,randomized_controlled_trial,benefit,"The study shows a significant improvement in symptoms of nausea and vomiting of pregnancy with the use of Diclectin, indicating a beneficial outcome.",10 mg 14 days (delayed-release preparation),Pregnant; Women,,nausea and vomiting of pregnancy,morning sickness; nausea; nausea and vomiting of pregnancy; nausea during pregnancy; pregnancy; vomiting; vomiting during pregnancy,Tier 4,0.66,"This is a well-conducted RCT in pregnant women with nausea/vomiting showing benefit, but the intervention was a combination of doxylamine and pyridoxine (Diclectin), not pyridoxine alone. Therefore, the evidence is indirect for vitamin B6 monotherapy and cannot isolate its effect."
Vitamin B6 (Pyridoxine),arrhythmia; drowsiness; fatigue; greater tumor treatment failure; heartburn; higher risk for births with children who were small for gestational age; higher tiredness on waking; lower self-rated sleep quality; may blunt response of bone to parathyroid hormone; mild adverse effects compared to cabergoline; mild transient diarrhea in one patient; none major documented; sedation; shorter time to treatment failure; worsened tumor response; worsens response to erythropoiesis-stimulating agents,Nausea & Vomiting During Pregnancy,,Women's Health,manual_pair,"The evidence for vitamin B6 (pyridoxine) in treating nausea and vomiting during pregnancy is predominantly positive, with six studies reporting benefits and three showing mixed or unclear results. Typical doses reported include 10 mg to 40 mg taken multiple times daily, often in combination with doxylamine. However, some studies indicate that the clinical significance of the effects may be modest, and the overall quality of evidence is mixed, warranting caution in interpretation.",0.8,28052111,2017,"8-Way Randomized Controlled Trial of Doxylamine, Pyridoxine and Dicyclomine for Nausea and Vomiting during Pregnancy: Restoration of Unpublished Information.",randomized_controlled_trial,mixed_unclear,"The study indicates mixed outcomes due to a high risk of bias and incomplete data, despite some active treatment groups showing better results than placebo.",2 tablets at bedtime 7 nights,Pregnant; Women,,nausea during pregnancy,morning sickness; nausea; nausea and vomiting of pregnancy; nausea during pregnancy; pregnancy; vomiting; vomiting during pregnancy,Tier 3,0.6,"This is a human randomized, double-blind, placebo-controlled trial in pregnant women with nausea/vomiting that included a pyridoxine-only arm, but it had major methodological problems (high attrition, lack of prespecified outcomes/analyses, data integrity concerns). The pyridoxine arm showed a small, non-significant advantage over placebo, and the authors concluded the trial should not support efficacy. Given the high risk of bias and unclear outcomes, it fits weak/preliminary human evidence rather than moderate or strong."
Vitamin B6 (Pyridoxine),arrhythmia; drowsiness; fatigue; greater tumor treatment failure; heartburn; higher risk for births with children who were small for gestational age; higher tiredness on waking; lower self-rated sleep quality; may blunt response of bone to parathyroid hormone; mild adverse effects compared to cabergoline; mild transient diarrhea in one patient; none major documented; sedation; shorter time to treatment failure; worsened tumor response; worsens response to erythropoiesis-stimulating agents,Nausea & Vomiting During Pregnancy,,Women's Health,manual_pair,"The evidence for vitamin B6 (pyridoxine) in treating nausea and vomiting in pregnancy is mixed. One randomized trial showed a benefit compared to placebo, while another trial indicated that while vitamin B6 reduced symptoms, it was less effective than quince. Typical doses reported include 20 mg to 25 mg taken multiple times per day, but overall, the effectiveness compared to other treatments remains unclear.",0.7,17621727,2007,Comparison of the effectiveness of ginger and vitamin B6 for treatment of nausea and vomiting in early pregnancy: a randomized double-blind controlled trial.,randomized_controlled_trial,benefit,"Both ginger and vitamin B6 were effective, but ginger was more effective than vitamin B6.",25 mg three times per day 4 days,Pregnant; Women,,nausea,nausea; nausea and vomiting in pregnancy; pregnancy; vomiting,Tier 2,0.68,"Double-blind randomized controlled trial in pregnant women with nausea/vomiting found pyridoxine 25 mg three times daily for 4 days reduced validated symptom scores. The indication was a primary outcome. However, the comparator was an active agent (ginger) rather than placebo, and conclusions rely on within-group improvement, so efficacy versus placebo is not established. Sample size and methods were reasonable, supporting moderate human evidence."
Vitamin B6 (Pyridoxine),arrhythmia; drowsiness; fatigue; greater tumor treatment failure; heartburn; higher risk for births with children who were small for gestational age; higher tiredness on waking; lower self-rated sleep quality; may blunt response of bone to parathyroid hormone; mild adverse effects compared to cabergoline; mild transient diarrhea in one patient; none major documented; sedation; shorter time to treatment failure; worsened tumor response; worsens response to erythropoiesis-stimulating agents,Nausea & Vomiting During Pregnancy,,Women's Health,manual_pair,"The evidence for vitamin B6 (pyridoxine) in treating nausea and vomiting in pregnancy is mixed. One randomized trial showed a benefit compared to placebo, while another trial indicated that while vitamin B6 reduced symptoms, it was less effective than quince. Typical doses reported include 20 mg to 25 mg taken multiple times per day, but overall, the effectiveness compared to other treatments remains unclear.",0.7,28631509,2017,Comparison of quince with vitamin B6 for treatment of nausea and vomiting in pregnancy: a randomised clinical trial.,randomized_controlled_trial,mixed_unclear,"The study shows a significant decrease in nausea and vomiting scores for both quince and vitamin B6, but the results favor quince, indicating mixed outcomes.",20 mg TDS 1 week (tablets),Pregnant; Women,,nausea and vomiting in pregnancy,nausea; nausea and vomiting in pregnancy; pregnancy; vomiting,Tier 2,0.6,"Randomized controlled trial in pregnant women with NVP tested vitamin B6 (20 mg TID for 1 week) against an active comparator (quince). NVP severity (PUQE) was the primary outcome and improved significantly in the B6 group, though less than quince. The trial is small, short, and likely unblinded with no placebo arm, so evidence is moderate rather than strong."
Vitamin B6 (Pyridoxine),arrhythmia; drowsiness; fatigue; greater tumor treatment failure; heartburn; higher risk for births with children who were small for gestational age; higher tiredness on waking; lower self-rated sleep quality; may blunt response of bone to parathyroid hormone; mild adverse effects compared to cabergoline; mild transient diarrhea in one patient; none major documented; sedation; shorter time to treatment failure; worsened tumor response; worsens response to erythropoiesis-stimulating agents,Hand-Foot Syndrome,,Musculoskeletal & Pain,manual_pair,"The evidence for vitamin B6 (pyridoxine) in managing pain is limited and mixed, based on a single pilot randomized controlled trial that assessed its topical application for palmar-plantar erythrodysesthesia. While the study did not demonstrate a significant effect on the condition's severity, it reported improvements in quality of life and pain levels, indicating unclear outcomes. No consistent dosing information was provided, and there were no reports of harm associated with its use.",0.7,33227569,2021,"A pilot randomized double-blind, placebo-controlled study on the effects of the topical application of pyridoxine on palmar-plantar erythrodysesthesia (PPE) induced by capecitabine or pegylated liposomal doxorubicin (PLD).",randomized_controlled_trial,mixed_unclear,"While topical pyridoxine did not affect PPE grade, it showed improvements in QoL and pain levels, indicating mixed outcomes.",(topical),Chemotherapy,,pain,pain; palmar-plantar erythrodysesthesia; quality of life,Tier 2,0.62,"Randomized double-blind placebo-controlled human trial directly evaluating topical pyridoxine for palmar-plantar erythrodysesthesia. Despite rigorous design, it was a small pilot with high attrition and showed no effect on the primary clinical outcome (PPE grade), with improvements limited to secondary QoL and pain measures."
Vitamin B6 (Pyridoxine),arrhythmia; drowsiness; fatigue; greater tumor treatment failure; heartburn; higher risk for births with children who were small for gestational age; higher tiredness on waking; lower self-rated sleep quality; may blunt response of bone to parathyroid hormone; mild adverse effects compared to cabergoline; mild transient diarrhea in one patient; none major documented; sedation; shorter time to treatment failure; worsened tumor response; worsens response to erythropoiesis-stimulating agents,Nausea,,Gut Health,manual_pair,"One randomized controlled trial reported that oral pyridoxine (0.2 g before anesthesia induction) significantly reduced the incidence of postoperative nausea and vomiting in patients undergoing gynecologic laparoscopic surgery. Overall, the evidence suggests a potential benefit, but further studies are needed to confirm these findings and assess consistency across different surgical populations.",0.8,39729294,2025,Pyridoxine Prevents Postoperative Nausea and Vomiting in Gynecologic Laparoscopic Surgery: A Double-blind Randomized Controlled Trial.,randomized_controlled_trial,benefit,"Pyridoxine significantly reduced the incidence of postoperative nausea and vomiting, indicating a beneficial effect.",0.2 g before anesthesia induction (oral),Postoperative,,nausea,nausea; postoperative nausea and vomiting,Tier 1,0.86,"Double-blind, randomized controlled trial (n=240) with adequate size and methodology showed a statistically significant reduction in postoperative nausea and vomiting, with nausea as a primary clinical outcome. Despite being single-center and given alongside standard antiemetics, the study directly tests pyridoxine for nausea and demonstrates clear benefit."
Vitamin B6 (Pyridoxine),arrhythmia; drowsiness; fatigue; greater tumor treatment failure; heartburn; higher risk for births with children who were small for gestational age; higher tiredness on waking; lower self-rated sleep quality; may blunt response of bone to parathyroid hormone; mild adverse effects compared to cabergoline; mild transient diarrhea in one patient; none major documented; sedation; shorter time to treatment failure; worsened tumor response; worsens response to erythropoiesis-stimulating agents,Premenstrual Syndrome,,Women's Health,manual_pair,"The evidence for vitamin B6 (pyridoxine) in treating premenstrual syndrome (PMS) is mixed and unclear, based on a single pilot randomized trial that compared it to broad-spectrum micronutrients. In this study, both treatments showed similar benefits for PMS symptoms, but micronutrients were associated with a greater improvement in quality of life. No consistent dose range was reported, and there were no indications of harm.",0.7,31928364,2020,A Pilot Randomized Treatment-Controlled Trial Comparing Vitamin B6 with Broad-Spectrum Micronutrients for Premenstrual Syndrome.,randomized_controlled_trial,mixed_unclear,"Both treatments showed similar benefits for PMS symptoms, but micronutrients had a greater effect on quality of life, indicating mixed outcomes.",80 mg daily three menstrual cycles,Women,,premenstrual dysphoric disorder,premenstrual dysphoric disorder; premenstrual syndrome,Tier 2,0.55,"Randomized controlled pilot trial in women with PMS assessing clinical symptoms as primary outcomes. However, it was small, used an active comparator rather than placebo, and showed mixed results (similar symptom benefits but inferior quality-of-life effects vs micronutrients), limiting certainty."
Vitamin B6 (Pyridoxine),arrhythmia; drowsiness; fatigue; greater tumor treatment failure; heartburn; higher risk for births with children who were small for gestational age; higher tiredness on waking; lower self-rated sleep quality; may blunt response of bone to parathyroid hormone; mild adverse effects compared to cabergoline; mild transient diarrhea in one patient; none major documented; sedation; shorter time to treatment failure; worsened tumor response; worsens response to erythropoiesis-stimulating agents,Premenstrual Syndrome,,Women's Health,manual_pair,"One randomized trial reported that vitamin B6 (pyridoxine) at a dose of 100 mg daily for three months resulted in a significant reduction in premenstrual syndrome symptoms, indicating a beneficial effect. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term safety and efficacy.",0.7,18476391,2007,Role of bromocriptine and pyridoxine in premenstrual tension syndrome.,randomized_controlled_trial,benefit,"Pyridoxine showed a significant reduction in premenstrual symptoms, indicating a beneficial effect.",100 mg daily 3 months,Women,,premenstrual syndrome,premenstrual syndrome,Tier 2,0.62,"Single small randomized controlled trial (3 arms, ~20 participants per arm) in women with PMS showed significant reduction in premenstrual symptom scores with pyridoxine 100 mg/day over 3 months versus placebo. Outcome directly targets PMS symptoms. However, sample size is small and blinding/methodological details are unclear, preventing Tier 1 classification."
Vitamin B6 (Pyridoxine),arrhythmia; drowsiness; fatigue; greater tumor treatment failure; heartburn; higher risk for births with children who were small for gestational age; higher tiredness on waking; lower self-rated sleep quality; may blunt response of bone to parathyroid hormone; mild adverse effects compared to cabergoline; mild transient diarrhea in one patient; none major documented; sedation; shorter time to treatment failure; worsened tumor response; worsens response to erythropoiesis-stimulating agents,Restless Legs Syndrome,,Musculoskeletal & Pain,manual_pair,"There is limited evidence from one randomized controlled trial indicating that vitamin B6 (40 mg daily for two months) may improve symptoms and sleep quality in individuals with restless legs syndrome. No studies reported harm or mixed outcomes, but the overall evidence is still considered low-quality due to the small number of trials available.",0.7,36587225,2022,Therapeutic effects of magnesium and vitamin B6 in alleviating the symptoms of restless legs syndrome: a randomized controlled clinical trial.,randomized_controlled_trial,benefit,The study found significant improvement in symptoms and sleep quality after two months of treatment.,40 mg daily 2 months (oral),,,restless legs syndrome,restless legs syndrome; sleep disorders,Tier 2,0.68,"Single-blind, randomized, placebo-controlled trial (n≈75; ~25 per arm) directly tested vitamin B6 for RLS with clinically relevant outcomes (RLS severity, sleep quality) showing benefit after 2 months. However, modest sample size, single-blinding, and short duration limit methodological strength, preventing Tier 1."
Vitamin B6 (Pyridoxine),arrhythmia; drowsiness; fatigue; greater tumor treatment failure; heartburn; higher risk for births with children who were small for gestational age; higher tiredness on waking; lower self-rated sleep quality; may blunt response of bone to parathyroid hormone; mild adverse effects compared to cabergoline; mild transient diarrhea in one patient; none major documented; sedation; shorter time to treatment failure; worsened tumor response; worsens response to erythropoiesis-stimulating agents,Stress,,"Energy, Mood, & Mental Health",manual_pair,"The evidence regarding vitamin B6 for severe stress is limited and mixed. One randomized trial found no significant difference in stress reduction when comparing vitamin B6 combined with magnesium to magnesium alone, although a subgroup analysis suggested potential benefits for individuals with severe stress. The typical dose reported was 30 mg daily for 8 weeks, but overall findings do not support a clear benefit for this indication.",0.7,30562392,2018,"Superiority of magnesium and vitamin B6 over magnesium alone on severe stress in healthy adults with low magnesemia: A randomized, single-blind clinical trial.",randomized_controlled_trial,mixed_unclear,"The study found no statistical difference in stress reduction between the magnesium alone and magnesium with vitamin B6 groups, but a subgroup analysis indicated a greater benefit for those with severe stress.",30 mg daily 8 weeks (oral),,,anxiety,anxiety; severe stress; stress,Tier 2,0.6,"Randomized, single-blind RCT (n≈264) with a validated primary stress outcome directly tested the additive effect of vitamin B6 (30 mg/day) to magnesium on perceived stress. Overall, B6 did not improve stress beyond magnesium, with a subgroup benefit only in severe stress. Quality is moderate due to single-blind design and adjunctive (not B6 monotherapy) comparison, and the population had low magnesemia, limiting generalizability."
Vitamin B6 (Pyridoxine),arrhythmia; drowsiness; fatigue; greater tumor treatment failure; heartburn; higher risk for births with children who were small for gestational age; higher tiredness on waking; lower self-rated sleep quality; may blunt response of bone to parathyroid hormone; mild adverse effects compared to cabergoline; mild transient diarrhea in one patient; none major documented; sedation; shorter time to treatment failure; worsened tumor response; worsens response to erythropoiesis-stimulating agents,Tardive Dyskinesia,,Cognitive & Neurological Function,manual_pair,"One randomized, double-blind, placebo-controlled crossover study found that Vitamin B6 (1200 mg daily for 12 weeks) significantly reduced symptoms of tardive dyskinesia compared to placebo. There is currently no evidence of harm or no benefit, but further research is needed to confirm these findings and assess long-term safety and efficacy.",0.8,18052557,2007,"Vitamin B6 treatment for tardive dyskinesia: a randomized, double-blind, placebo-controlled, crossover study.",randomized_controlled_trial,benefit,Vitamin B6 significantly reduced symptoms of tardive dyskinesia compared to placebo.,1200 mg daily 12 weeks,,,schizoaffective disorder,schizoaffective disorder; schizophrenia; tardive dyskinesia,Tier 1,0.82,"Randomized, double-blind, placebo-controlled crossover RCT (n=50) directly targeting tardive dyskinesia with ESRS as the primary clinical outcome showed significant benefit versus placebo. Despite modest sample size and potential crossover/washout considerations, the design and outcomes meet criteria for strong human evidence."
Vitamin B7 (Biotin),diarrhea; inaccurate laboratory results for tests using biotinylated antibodies; infection around the catheter; neurological toxicity; neutropenia; thrombocytopenia,Brittle Nails,,"Skin, Hair, & Nails",manual_pair,"One randomized trial reported a benefit of oral biotin (10 mg daily for 4 months) in improving the appearance of brittle nails when used in combination with a hydroxypropyl chitosan-based lacquer. Overall, the evidence is limited, with only one study demonstrating a positive outcome and no reports of harm or adverse effects.",0.7,31344296,2019,"Treatment of brittle nail with a hydroxypropyl chitosan-based lacquer, alone or in combination with oral biotin: A randomized, assessor-blinded trial.",randomized_controlled_trial,benefit,"The combination of HPC-NL and oral biotin showed a significant improvement in nail appearance, indicating a beneficial outcome.",10 mg daily 4 months (oral),,,brittle nail syndrome,brittle nail syndrome,Tier 2,0.6,"Assessor-blinded randomized controlled trial (n=50) tested oral biotin (10 mg/day) as an add-on to a nail lacquer versus lacquer alone for brittle nail syndrome. The primary clinical severity score improved more with biotin (greater proportion achieving ≥50% reduction; p=0.05), indicating benefit on a clinically relevant outcome. However, the study is small, uses an add-on design without a biotin-only or placebo control, has baseline severity imbalance, and only assessor blinding, which lowers methodological strength compared with large, fully blinded RCTs."
Vitamin B7 (Biotin),diarrhea; inaccurate laboratory results for tests using biotinylated antibodies; infection around the catheter; neurological toxicity; neutropenia; thrombocytopenia,Depression,,"Energy, Mood, & Mental Health",manual_pair,"There is limited evidence suggesting a beneficial effect of vitamin B7 (biotin) on depression, as indicated by one randomized controlled trial that reported improvements in clinical symptoms when combined with a multistrain probiotic over 28 days. However, the overall quality and quantity of evidence are low, and further research is needed to confirm these findings and assess long-term effects and safety.",0.6,33171595,2020,PROVIT: Supplementary Probiotic Treatment and Vitamin B7 in Depression-A Randomized Controlled Trial.,randomized_controlled_trial,benefit,The study showed an overall beneficial effect of the treatment on clinical symptoms of depression.,28 days (multistrain probiotic plus biotin),,,depression,depression; major depressive disorder,Tier 5,0.9,"This RCT compared probiotic+biotin versus biotin+placebo in depressed patients. Both arms received biotin, so the study does not isolate or test the effect of biotin on depression. Any benefit observed pertains to the probiotic, not biotin. Therefore, it is not actual evidence for biotin as a treatment for depression."
Vitamin B7 (Biotin),diarrhea; inaccurate laboratory results for tests using biotinylated antibodies; infection around the catheter; neurological toxicity; neutropenia; thrombocytopenia,Multiple Sclerosis,,Cognitive & Neurological Function,manual_pair,"The evidence for high-dose biotin (100-300 mg daily) in improving disability from multiple sclerosis is limited but suggests potential benefits, with two randomized trials reporting positive outcomes related to disability and disease progression. However, the overall quality of evidence is low, and further research is needed to confirm these findings and assess long-term safety and efficacy.",0.7,25787192,2015,High doses of biotin in chronic progressive multiple sclerosis: a pilot study.,clinical_trial,benefit,"The study suggests that high doses of biotin may improve disability and progression in progressive MS, indicating a benefit.",100-300 mg daily 2 to 36 months,,,chronic progressive multiple sclerosis,chronic progressive multiple sclerosis; disability; progressive multiple sclerosis; visual impairment,Tier 3,0.8,"Small, open-label, uncontrolled pilot study in progressive MS (n=23) with mixed clinical and surrogate outcomes and no randomization or placebo control; preliminary human evidence."
Vitamin B7 (Biotin),diarrhea; inaccurate laboratory results for tests using biotinylated antibodies; infection around the catheter; neurological toxicity; neutropenia; thrombocytopenia,Multiple Sclerosis,,Cognitive & Neurological Function,manual_pair,"The evidence for high-dose biotin (100-300 mg daily) in improving disability from multiple sclerosis is limited but suggests potential benefits, with two randomized trials reporting positive outcomes related to disability and disease progression. However, the overall quality of evidence is low, and further research is needed to confirm these findings and assess long-term safety and efficacy.",0.7,27589059,2016,"MD1003 (high-dose biotin) for the treatment of progressive multiple sclerosis: A randomised, double-blind, placebo-controlled study.",randomized_controlled_trial,benefit,The study showed a significant benefit in disability reversal and progression reduction in patients treated with high-dose biotin.,100 mg thrice daily 12 months (MD1003),,,progressive multiple sclerosis,chronic progressive multiple sclerosis; disability; progressive multiple sclerosis; visual impairment,Tier 1,0.8,"Randomized, double-blind, placebo-controlled RCT (n=154) in progressive MS with a clinically meaningful primary endpoint (disability reversal by EDSS or T25FW) showing significant benefit vs placebo over 12 months. The indication was the primary outcome, methods are strong, and sample size is moderate."
Vitamin B7 (Biotin),diarrhea; inaccurate laboratory results for tests using biotinylated antibodies; infection around the catheter; neurological toxicity; neutropenia; thrombocytopenia,Hair Loss,,"Skin, Hair, & Nails",manual_pair,"One randomized, double-blind controlled study reported a benefit of biotin injections (5 mg weekly for 6 weeks) in reducing hair loss and improving hair density. However, the overall evidence is limited, with only one study demonstrating positive outcomes and no additional studies to support consistency or generalizability. No adverse effects were reported in the study.",0.7,35791704,2022,"Efficacy of intramuscular injections of biotin and dexpanthenol in the treatment of diffuse hair loss: A randomized, double-blind controlled study comparing two brands.",randomized_controlled_trial,benefit,"The study showed significant improvement in hair fall count and hair density, indicating a benefit from the treatment.",5 mg weekly 6 weeks (injection),,,alopecia,alopecia; diffuse hair loss,Tier 3,0.6,"Randomized, double-blind study with clinically relevant hair loss outcomes showed benefit, but both arms received biotin plus dexpanthenol with no placebo or monotherapy control. Effects cannot be attributed to biotin alone, sample size is modest (n=50), and route was intramuscular injections. Therefore, evidence for biotin specifically is preliminary/indirect despite RCT design."
Vitamin B7 (Biotin),diarrhea; inaccurate laboratory results for tests using biotinylated antibodies; infection around the catheter; neurological toxicity; neutropenia; thrombocytopenia,High Blood Glucose,,Metabolic Health,manual_pair,"Two randomized controlled trials have reported benefits of biotin supplementation (2 mg daily) on glycemic control in patients with type 2 diabetes. Both studies indicate significant improvements in glucose metabolism, but further research is needed to confirm these findings and assess long-term effects and safety.",0.8,17506119,2008,"Chromium picolinate and biotin combination improves glucose metabolism in treated, uncontrolled overweight to obese patients with type 2 diabetes.",randomized_controlled_trial,benefit,"The study shows significant improvements in glycaemic control, indicating a benefit from the biotin intervention.",2 mg 90 days,Diabetes Type 2; Obese; Overweight,,obesity,Type 2 Diabetes Mellitus; obesity; overweight; poor glycaemic control,Tier 4,0.42,"Randomized, double-blind, placebo-controlled trial with large sample size showed improvements in HbA1c and fasting glucose, but the intervention was a combination of chromium picolinate plus biotin. Because the effect cannot be attributed to biotin alone, this provides only indirect evidence for biotin as a standalone supplement for high blood glucose despite clinically relevant outcomes."
Vitamin B7 (Biotin),diarrhea; inaccurate laboratory results for tests using biotinylated antibodies; infection around the catheter; neurological toxicity; neutropenia; thrombocytopenia,High Blood Glucose,,Metabolic Health,manual_pair,"Two randomized controlled trials have reported benefits of biotin supplementation (2 mg daily) on glycemic control in patients with type 2 diabetes. Both studies indicate significant improvements in glucose metabolism, but further research is needed to confirm these findings and assess long-term effects and safety.",0.8,17109595,2006,"The effect of chromium picolinate and biotin supplementation on glycemic control in poorly controlled patients with type 2 diabetes mellitus: a placebo-controlled, double-blinded, randomized trial.",randomized_controlled_trial,benefit,"The study shows significant improvements in glycemic control and lipid measurements, indicating a beneficial effect of biotin supplementation.",2 mg daily 4 weeks,Diabetes Type 2,Heart & Vascular Health,Type 2 Diabetes Mellitus,Type 2 Diabetes Mellitus; obesity; overweight; poor glycaemic control,Tier 5,0.78,"Placebo-controlled RCT in type 2 diabetes showed glycemic benefit, but the intervention combined chromium picolinate with biotin. Effects cannot be attributed to biotin alone, so this study does not provide direct evidence for biotin as a standalone supplement for high blood glucose."
Vitamin B7 (Biotin),diarrhea; inaccurate laboratory results for tests using biotinylated antibodies; infection around the catheter; neurological toxicity; neutropenia; thrombocytopenia,Atherosclerosis,,Heart & Vascular Health,manual_pair,"One randomized controlled trial found that a combination of chromium picolinate and biotin significantly improved the atherogenic index and related cardiovascular risk factors in patients with type 2 diabetes over a 4-week period. However, the evidence is limited to this single study, and further research is needed to confirm these findings and assess long-term effects and safety.",0.8,17496732,2007,"Chromium picolinate and biotin combination reduces atherogenic index of plasma in patients with type 2 diabetes mellitus: a placebo-controlled, double-blinded, randomized clinical trial.",randomized_controlled_trial,benefit,"The study shows significant improvements in atherogenic index and related cardiovascular risk factors, indicating a beneficial effect of the supplement.",4 weeks,Diabetes Type 2,,cardiovascular disease risk,Type 2 Diabetes Mellitus; cardiovascular disease risk,Tier 5,0.78,"The study is a small, 4-week, double-blind RCT in type 2 diabetes patients testing a combination of chromium picolinate plus biotin, not biotin alone. Outcomes were surrogate cardiovascular risk markers (AIP, lipid ratios), not direct atherosclerosis measures. Because the supplement differs (combination vs. biotin alone), this does not constitute direct evidence for biotin for atherosclerosis."
Vitamin B7 (Biotin),diarrhea; inaccurate laboratory results for tests using biotinylated antibodies; infection around the catheter; neurological toxicity; neutropenia; thrombocytopenia,High LDL,,Heart & Vascular Health,manual_pair,"One randomized controlled trial indicates that biotin, at a dose of 2 mg once daily for 90 days, may improve lipid levels in individuals with high LDL cholesterol, particularly in the context of a combination therapy with chromium. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term effects and safety.",0.7,17684468,2007,"Combination of chromium and biotin improves coronary risk factors in hypercholesterolemic type 2 diabetes mellitus: a placebo-controlled, double-blind randomized clinical trial.",randomized_controlled_trial,benefit,"The study shows significant improvements in glycemic control and lipid levels, indicating a beneficial effect of biotin in the context of the intervention.",2 mg once daily 90 days,,Metabolic Health,hypercholesterolemia,Type 2 Diabetes Mellitus; hypercholesterolemia,Tier 5,0.86,"This RCT evaluated a combination of chromium picolinate plus biotin, not biotin alone. LDL changes were secondary and not significant in the overall cohort, with reductions observed only in subgroup analyses. Thus, it does not provide direct evidence for biotin monotherapy for high LDL."
Vitamin B7 (Biotin),diarrhea; inaccurate laboratory results for tests using biotinylated antibodies; infection around the catheter; neurological toxicity; neutropenia; thrombocytopenia,High Triglycerides,,Heart & Vascular Health,manual_pair,"One randomized trial reported that biotin supplementation at a dose of 61.4 micromol daily for 28 days significantly reduced plasma triacylglycerol and VLDL levels in both type 2 diabetic patients and nondiabetic individuals with hypertriglyceridemia, indicating a potential benefit for managing high triglycerides. No studies reported mixed outcomes or adverse effects, but the evidence is based on a single trial, which limits the strength of the conclusion.",0.8,16677798,2006,Biotin supplementation reduces plasma triacylglycerol and VLDL in type 2 diabetic patients and in nondiabetic subjects with hypertriglyceridemia.,randomized_controlled_trial,benefit,"Biotin significantly reduced plasma triacylglycerol and VLDL, indicating a beneficial effect on lipid levels.",61.4 micromol daily 28 days,,,hypertriglyceridemia,Type 2 Diabetes Mellitus; hypertriglyceridemia,Tier 2,0.62,"Placebo-controlled randomized trial showing significant reductions in triglycerides and VLDL, with lipid outcomes as primary and clinically relevant for hypertriglyceridemia. However, the sample size is small (~33), duration short (28 days), and blinding/methodological details are limited, preventing Tier 1 classification."
Vitamin B7 (Biotin),diarrhea; inaccurate laboratory results for tests using biotinylated antibodies; infection around the catheter; neurological toxicity; neutropenia; thrombocytopenia,Muscle Cramps,,Musculoskeletal & Pain,manual_pair,"There is limited evidence suggesting that biotin (1 mg daily) may reduce muscle cramps in hemodialysis patients, as indicated by one prospective trial. However, the overall evidence is weak due to the lack of multiple studies or replication of findings, and no adverse effects were reported in the available study.",0.6,22791079,2012,Biotin ameliorates muscle cramps of hemodialysis patients: a prospective trial.,randomized_controlled_trial,benefit,"The administration of biotin resulted in a reduction of muscle cramps, indicating a beneficial effect.",1 mg daily (oral),CKD; Hemodialysis,,hemodialysis,hemodialysis; muscle cramps; renal failure,Tier 3,0.46,"Small prospective human study (n=14) in hemodialysis patients with muscle cramps, seemingly open-label and uncontrolled despite metadata labeling it as RCT. The primary clinical outcome (muscle cramps) improved in most participants, but lack of randomization, blinding, and a control group, plus a narrow CKD/HD population, limit the strength and generalizability. Thus, preliminary human evidence."
Vitamin B9 (Folate),abdominal pain; anaphylaxis in one patient; anemia; blurred vision; cough; diarrhea; fatigue; increased risk of toxicities with folic acid-containing supplements; keratopathy; nausea; neutropenia; ocular disorders; peripheral neuropathy; pneumonitis; thrombocytopenia; transient urticaria; vomiting,Mania,,"Energy, Mood, & Mental Health",manual_pair,"One randomized controlled trial reported a significant benefit of folate supplementation (5 mg daily for 3 weeks) in improving symptoms of acute mania in bipolar disorder, as measured by YMRS scores. However, the overall evidence is limited, with only one study available, and further research is needed to confirm these findings and assess long-term effects and safety.",0.7,40200764,2025,Short-Term Effects of Folate Supplementation in Combination With Vitamin B6 for Treating Acute Manic Episodes in Bipolar I Disorder: A Randomized Controlled Trial.,randomized_controlled_trial,benefit,"The study shows significant improvement in YMRS scores for the folate group, indicating a beneficial effect.",5 mg daily 3 weeks,Bipolar Disorder I,,acute manic episodes,acute manic episodes; bipolar i disorder,Tier 2,0.64,"Randomized, double-blind, placebo-controlled RCT with clinically relevant primary outcome (YMRS) showing significant benefit for folate 5 mg/day as adjunctive treatment in acute mania. However, the sample size is small (n=43 across three arms) and follow-up short (3–6 weeks), with adjunctive context to valproate. Good methods but limited size/duration place it as moderate human evidence."
Vitamin B9 (Folate),abdominal pain; anaphylaxis in one patient; anemia; blurred vision; cough; diarrhea; fatigue; increased risk of toxicities with folic acid-containing supplements; keratopathy; nausea; neutropenia; ocular disorders; peripheral neuropathy; pneumonitis; thrombocytopenia; transient urticaria; vomiting,Folate Deficiency,,Women's Health,manual_pair,"Current evidence regarding the use of Vitamin B9 (Folate) for folate deficiency during pregnancy is limited and mixed. A randomized trial indicated that (6S)-5-methyltetrahydrofolic acid may be as effective as folic acid in maintaining maternal folate status, but the clinical significance of the findings remains unclear. No consistent benefits or harms were reported, and typical doses in the study were 0.6 mg daily for 16 weeks.",0.6,37649241,2024,Supplementation with (6S)-5-methyltetrahydrofolic acid appears as effective as folic acid in maintaining maternal folate status while reducing unmetabolised folic acid in maternal plasma: a randomised trial of pregnant women in Canada.,randomized_controlled_trial,mixed_unclear,"The study shows no significant difference in erythrocyte and serum folate levels between the two groups, but a reduction in plasma UMFA with (6S)-5-MTHF, indicating mixed outcomes regarding the biological relevance.",0.6 mg daily 16 weeks (folic acid or (6S)-5-MTHF),Pregnant; Women,,maternal folate status,maternal folate status; pregnancy,Tier 3,0.5,"This is an RCT in pregnant women comparing two forms of folate (folic acid vs 5-MTHF) with outcomes limited to surrogate markers of folate status (serum/RBC folate, UMFA). Participants were not folate-deficient and there was no placebo or non-supplement control, so it does not directly test treatment or correction of folate deficiency. While relevant to maintaining folate status, the evidence for the specific indication of folate deficiency is indirect and based on biomarkers."
Vitamin C,Constipation; Diarrhoea; Gastritis; Gastrointestinal disorders; Gastrointestinal pain; Vomiting; asthma; atopic dermatitis; dexamethasone associated with greater blood glucose levels after surgery; higher erythema score noted in Group 2; hypotension; nausea; tachycardia; vomiting,Musculoskeletal Pain,,Musculoskeletal & Pain,manual_pair,"One pilot randomized controlled trial suggests that vitamin C (1 g orally twice a day for 14 days) may reduce opioid consumption in patients with acute musculoskeletal pain, indicating a potential benefit. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess the consistency and robustness of the effect.",0.6,39739762,2024,Impact of vitamin C on the reduction of opioid consumption for acute musculoskeletal pain: A double-blind randomized control pilot study.,randomized_controlled_trial,benefit,"The study shows a reduction in opioid consumption in the Vitamin C group compared to placebo, indicating a potential benefit.",1 g twice a day 14 days (oral),Injury,,acute musculoskeletal pain,acute musculoskeletal pain,Tier 2,0.6,"Double-blind randomized controlled pilot trial in adults with acute musculoskeletal injuries showed reduced opioid use with vitamin C versus placebo. However, the study was small, had notable loss to follow-up, used per-protocol analysis, and was primarily a feasibility study, limiting robustness despite appropriate design."
Vitamin C,Constipation; Diarrhoea; Gastritis; Gastrointestinal disorders; Gastrointestinal pain; Vomiting; asthma; atopic dermatitis; dexamethasone associated with greater blood glucose levels after surgery; higher erythema score noted in Group 2; hypotension; nausea; tachycardia; vomiting,Oxidative Stress,,"Immune, Inflammation, & Infection",manual_pair,"The evidence regarding the anti-inflammatory effects of vitamin C is low quality, with only one clinical study reporting mixed outcomes. This study evaluated a high-dose vitamin C supplement (1 g) combined with a low dose of bioflavonoids (50 mg) over four weeks, but did not demonstrate significant differences between treatment groups. No consistent benefits were observed, and no adverse effects were reported.",0.7,40871671,2025,"Anti-Inflammatory, Antithrombotic and Antioxidant Efficacy and Synergy of a High-Dose Vitamin C Supplement Enriched with a Low Dose of Bioflavonoids; In Vitro Assessment and In Vivo Evaluation Through a Clinical Study in Healthy Subjects.",randomized_controlled_trial,mixed_unclear,"The study showed potential benefits of the VCF supplement but indicated no significant differences between treatment groups, suggesting mixed outcomes.",1 g four weeks (VCF supplement); 50 mg four weeks (bioflavonoids),,,anti-inflammatory effects,anti-inflammatory effects,Tier 5,0.62,"Although this was an RCT in healthy subjects, the in vivo outcomes focused on platelet reactivity and inflammatory measures, with no clinical oxidative stress biomarkers assessed. Antioxidant capacity was evaluated only via in vitro assays (DPPH/FRAP/ABTS), which are mechanistic and not clinical. Therefore, it does not provide direct human evidence for the indication of oxidative stress."
Vitamin C,Constipation; Diarrhoea; Gastritis; Gastrointestinal disorders; Gastrointestinal pain; Vomiting; asthma; atopic dermatitis; dexamethasone associated with greater blood glucose levels after surgery; higher erythema score noted in Group 2; hypotension; nausea; tachycardia; vomiting,Inflammation,,"Immune, Inflammation, & Infection",manual_pair,"The evidence regarding the antioxidant benefits of vitamin C is low quality and mixed, with one clinical study indicating potential benefits but no significant differences between treatment groups. The study involved a high-dose vitamin C supplement (1 g) combined with a low dose of bioflavonoids (50 mg) over four weeks. Overall, there is insufficient evidence to support a definitive conclusion about its efficacy for this indication.",0.7,40871671,2025,"Anti-Inflammatory, Antithrombotic and Antioxidant Efficacy and Synergy of a High-Dose Vitamin C Supplement Enriched with a Low Dose of Bioflavonoids; In Vitro Assessment and In Vivo Evaluation Through a Clinical Study in Healthy Subjects.",randomized_controlled_trial,mixed_unclear,"The study showed potential benefits of the VCF supplement but indicated no significant differences between treatment groups, suggesting mixed outcomes.",1 g four weeks (VCF supplement); 50 mg four weeks (bioflavonoids),,,antioxidant benefits,antioxidant benefits,Tier 3,0.56,"Human randomized trial in healthy subjects assessed surrogate anti-inflammatory/antiplatelet biomarkers rather than clinical inflammatory outcomes. Results were mixed with no significant differences between vitamin C alone and the vitamin C+bioflavonoid arm, and no placebo control. Thus, evidence for vitamin C on inflammation from this study is preliminary and indirect."
Vitamin C,Constipation; Diarrhoea; Gastritis; Gastrointestinal disorders; Gastrointestinal pain; Vomiting; asthma; atopic dermatitis; dexamethasone associated with greater blood glucose levels after surgery; higher erythema score noted in Group 2; hypotension; nausea; tachycardia; vomiting,Periorbital Hyperpigmentation,,"Skin, Hair, & Nails",manual_pair,"The evidence regarding the effectiveness of Vitamin C for reducing dark circles under the eyes is limited and mixed, based on one randomized clinical trial that compared it with another treatment. The study indicated similar improvement rates for both treatments, suggesting uncertainty in Vitamin C's efficacy for this indication. No adverse effects were reported in the available evidence.",0.6,39279329,2024,"Comparison of the Effectiveness of Platelet-Rich Plasma Versus Tranexamic Acid Plus Vitamin C Mesotherapy in the Treatment of Periorbital Hyperpigmentation: A Split-Site, Randomized Clinical Trial.",randomized_controlled_trial,mixed_unclear,"Both treatments showed similar improvement rates, indicating mixed results in effectiveness.",every 3 weeks 3 sessions (intradermal injection),,,periorbital hyperpigmentation,periorbital hyperpigmentation,Tier 5,0.78,"The split-face RCT evaluated platelet-rich plasma versus a combination of tranexamic acid plus vitamin C via intradermal mesotherapy for periorbital hyperpigmentation. There was no vitamin C–only arm, so the effect of vitamin C cannot be isolated from tranexamic acid. Despite being an RCT, this study does not provide direct evidence for vitamin C alone for this indication."
Vitamin C,Constipation; Diarrhoea; Gastritis; Gastrointestinal disorders; Gastrointestinal pain; Vomiting; asthma; atopic dermatitis; dexamethasone associated with greater blood glucose levels after surgery; higher erythema score noted in Group 2; hypotension; nausea; tachycardia; vomiting,Inflammation,,"Immune, Inflammation, & Infection",manual_pair,"One randomized trial reported a beneficial effect of vitamin C (500 mg) on body mass index (BMI) and other health parameters in patients with type 2 diabetes. However, the overall evidence is limited, with only one study available, and further research is needed to confirm these findings and assess the consistency of the effect across different populations.",0.7,38747270,2024,"Synchronizing positive effect of vitamin C and chromium on hyper lipidemia, hyperglycemia, liver enzymes and BMI of diabetes mellitus type 2 patients.",randomized_controlled_trial,benefit,"The study shows significant improvements in various health parameters, indicating a beneficial effect of vitamin C.",500 mg,,Gut Health; Heart & Vascular Health,body mass index (bmi),Type 2 Diabetes Mellitus; body mass index (bmi); hyperglycemia; hyperlipidemia; liver enzyme abnormalities,Tier 5,0.8,"This RCT evaluated combined vitamin C plus chromium in type 2 diabetes, measuring metabolic and liver enzyme outcomes (lipids, HbA1c, ALT/AST, BMI), not inflammatory markers. The indication (inflammation) was neither a primary nor secondary outcome, and the combination therapy prevents isolating vitamin C’s effect. Thus, this study does not provide direct evidence for vitamin C for inflammation."
Vitamin C,Constipation; Diarrhoea; Gastritis; Gastrointestinal disorders; Gastrointestinal pain; Vomiting; asthma; atopic dermatitis; dexamethasone associated with greater blood glucose levels after surgery; higher erythema score noted in Group 2; hypotension; nausea; tachycardia; vomiting,Hypertension,,Heart & Vascular Health,manual_pair,"Two randomized controlled trials indicate that vitamin C supplementation may lead to a reduction in blood pressure. One study reported a significant decrease in systolic blood pressure, while another found beneficial effects at a dose of 130 mg daily over 40 days. Overall, the evidence suggests a potential benefit, but further research is needed to confirm these findings and assess long-term effects.",0.8,37938096,2024,Effects of dietary nitrate and vitamin C co-ingestion on blood pressure and hand-grip strength in young adults.,randomized_controlled_trial,benefit,"The study found a significant lower daily systolic BP in the vitamin C group, indicating a potential benefit.",,,,blood pressure,blood pressure; hypertension; muscular strength; oxidative stress; vascular function,Tier 3,0.38,"This is a human RCT demonstrating lower daily systolic blood pressure with vitamin C, but the intervention was vitamin C co-ingested with dietary nitrate in young, likely normotensive adults. The population is not hypertensive, vitamin C was not tested as a standalone therapy, and BP may not have been the sole primary outcome. These factors make the evidence indirect and preliminary for vitamin C as a treatment for hypertension."
Vitamin C,Constipation; Diarrhoea; Gastritis; Gastrointestinal disorders; Gastrointestinal pain; Vomiting; asthma; atopic dermatitis; dexamethasone associated with greater blood glucose levels after surgery; higher erythema score noted in Group 2; hypotension; nausea; tachycardia; vomiting,Hypertension,,Heart & Vascular Health,manual_pair,"Two randomized controlled trials indicate that vitamin C supplementation may lead to a reduction in blood pressure. One study reported a significant decrease in systolic blood pressure, while another found beneficial effects at a dose of 130 mg daily over 40 days. Overall, the evidence suggests a potential benefit, but further research is needed to confirm these findings and assess long-term effects.",0.8,39209360,2024,Effect of vitamin C and hawthorn beverage formula on blood pressure and oxidative stress in heat-exposed workers: a cluster-randomized controlled trial.,randomized_controlled_trial,benefit,"The study shows a significant reduction in blood pressure and oxidative stress markers, indicating a beneficial effect of Vitamin C supplementation.",130 mg daily 40 days (tablet),,,hypertension,blood pressure; hypertension; muscular strength; oxidative stress; vascular function,Tier 4,0.4,"Cluster-RCT in heat-exposed workers found reduced blood pressure, but the intervention combined vitamin C with a flavonoid-rich hawthorn beverage, so effects cannot be attributed to vitamin C alone. Likely unblinded, few clusters, and a niche population (heat-related BP elevation) limit applicability to general hypertension. Thus, evidence for vitamin C alone in hypertension is indirect/very low despite a clinical BP outcome."
Vitamin C,Constipation; Diarrhoea; Gastritis; Gastrointestinal disorders; Gastrointestinal pain; Vomiting; asthma; atopic dermatitis; dexamethasone associated with greater blood glucose levels after surgery; higher erythema score noted in Group 2; hypotension; nausea; tachycardia; vomiting,Oxidative Stress,,"Immune, Inflammation, & Infection",manual_pair,"One pilot randomized clinical trial suggests that Vitamin C may reduce oxidative stress markers and increase total antioxidant capacity in postmenopausal women, which could be relevant for managing high blood sugar in Type 2 Diabetes. However, the evidence is limited to this single study, and further research is needed to confirm these findings and establish consistent dosing and safety profiles.",0.7,39519608,2024,The Administration of Resveratrol and Vitamin C Reduces Oxidative Stress in Postmenopausal Women-A Pilot Randomized Clinical Trial.,randomized_controlled_trial,benefit,"The study shows significant decreases in oxidative stress markers and increases in total antioxidant capacity, indicating a beneficial effect of Vitamin C.",,Menopause; Women,,insulin resistance,insulin resistance; oxidative stress; postmenopause,Tier 3,0.56,"Pilot double-blind RCT in a small sample of postmenopausal women with insulin resistance measured surrogate biomarkers of oxidative stress (e.g., oxidative stress markers, total antioxidant capacity). While results suggest benefit, the study is small, uses surrogate outcomes rather than clinical endpoints, and includes resveratrol arms, which may complicate attribution to vitamin C alone. Thus, evidence for vitamin C on oxidative stress from this single study is preliminary."
Vitamin C,Constipation; Diarrhoea; Gastritis; Gastrointestinal disorders; Gastrointestinal pain; Vomiting; asthma; atopic dermatitis; dexamethasone associated with greater blood glucose levels after surgery; higher erythema score noted in Group 2; hypotension; nausea; tachycardia; vomiting,Stress,,"Energy, Mood, & Mental Health",manual_pair,"One randomized trial indicates that Vitamin C supplementation (1000 mg daily for 2 months) may reduce cortisol and DHEA-S levels in individuals experiencing hypercortisolemia due to chronic stress, suggesting a potential benefit. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term effects and safety.",0.7,38010274,2024,Vitamin C supplementation alleviates hypercortisolemia caused by chronic stress.,randomized_controlled_trial,benefit,"The study shows significant reductions in cortisol and DHEA-S levels with Vitamin C supplementation, indicating a beneficial effect.",1000 mg daily 2 months (oral),,,elevated levels of dhea-s,elevated levels of dhea-s; functional hypercortisolemia,Tier 3,0.58,"Randomized controlled design in humans with chronic stress–related hypercortisolemia showed reduced cortisol and DHEA-S with 1000 mg/day vitamin C over 2 months, but the trial appears open-label without placebo, has small subgroup sizes, and assesses surrogate hormonal markers rather than clinical stress symptoms or functional outcomes. Thus evidence is preliminary for the indication of stress."
Vitamin C,Constipation; Diarrhoea; Gastritis; Gastrointestinal disorders; Gastrointestinal pain; Vomiting; asthma; atopic dermatitis; dexamethasone associated with greater blood glucose levels after surgery; higher erythema score noted in Group 2; hypotension; nausea; tachycardia; vomiting,Inflammation,,"Immune, Inflammation, & Infection",manual_pair,"Current evidence from two randomized controlled trials suggests that vitamin C may have beneficial effects on inflammation, particularly in the context of cardiac surgery and mental vitality in healthy young adults. Doses reported include 1000 mg perioperatively and 500 mg twice daily for four weeks. No adverse effects were noted in the studies, but further research is needed to confirm these findings and explore long-term effects.",0.9,40290059,2025,Effect of Combined Vitamin C and Thiamine Therapy on Myocardial and Inflammatory Markers in Cardiac Surgery: A Randomized Controlled Clinical Trial.,randomized_controlled_trial,benefit,"The study showed that combined vitamin C and B1 therapy significantly reduced markers of myocardial injury and inflammatory responses, indicating a beneficial effect in the context of cardiac surgery.",1000 mg four perioperative time points (vitamin C); 1000 mg four perioperative time points (combined vitamin C and vitamin B1); 100 mg four perioperative time points (vitamin B1),,,inflammation,inflammation; mental vitality; myocardial injury; postoperative complications,Tier 4,0.41,"Human RCT in a perioperative cardiac surgery setting measured inflammatory biomarkers, but the significant benefit was reported for combined vitamin C plus thiamine, not clearly for vitamin C alone. Outcomes were surrogate markers rather than clinical inflammation endpoints, making the evidence indirect for vitamin C as a standalone intervention for inflammation."
Vitamin C,Constipation; Diarrhoea; Gastritis; Gastrointestinal disorders; Gastrointestinal pain; Vomiting; asthma; atopic dermatitis; dexamethasone associated with greater blood glucose levels after surgery; higher erythema score noted in Group 2; hypotension; nausea; tachycardia; vomiting,Inflammation,,"Immune, Inflammation, & Infection",manual_pair,"Current evidence from two randomized controlled trials suggests that vitamin C may have beneficial effects on inflammation, particularly in the context of cardiac surgery and mental vitality in healthy young adults. Doses reported include 1000 mg perioperatively and 500 mg twice daily for four weeks. No adverse effects were noted in the studies, but further research is needed to confirm these findings and explore long-term effects.",0.9,40187667,2025,"Gut microbiota links vitamin C supplementation to enhanced mental vitality in healthy young adults with suboptimal vitamin C status: A randomized, double-blind, placebo-controlled trial.",randomized_controlled_trial,benefit,"Vitamin C supplementation showed a beneficial effect on mental vitality and reduced inflammation, correlating with changes in gut microbiota.",500 mg twice daily 4 weeks (ascorbic acid),,,inflammation,inflammation; mental vitality; myocardial injury; postoperative complications,Tier 3,0.6,"This was a small, double-blind, placebo-controlled RCT in healthy young adults (n≈40) where the primary focus was mental vitality. Inflammation-related outcomes were secondary/exploratory biomarker changes (e.g., LPS, cytokines, monocyte subsets) rather than clinical inflammatory conditions. While results suggested reduced inflammation markers, the evidence for the inflammation indication is preliminary and based on surrogate endpoints."
Vitamin C,Constipation; Diarrhoea; Gastritis; Gastrointestinal disorders; Gastrointestinal pain; Vomiting; asthma; atopic dermatitis; dexamethasone associated with greater blood glucose levels after surgery; higher erythema score noted in Group 2; hypotension; nausea; tachycardia; vomiting,Improve Mood,,"Energy, Mood, & Mental Health",manual_pair,"Current evidence on the effect of vitamin C on low mood is limited, with only one study reporting a marginal improvement in mood following a daily dose of 250 mg for 28 days. Overall, the evidence is low quality and further research is needed to establish any definitive benefits or potential adverse effects.",0.7,38073290,2024,Smartphone survey data reveal the timecourse of changes in mood outcomes following vitamin C or kiwifruit intervention in adults with low vitamin C.,clinical_trial,benefit,"Vitamin C showed marginal improvement in mood, indicating a beneficial effect.",250 mg daily 28 days (tablet),,,flourishing,flourishing; mood improvement; vitality,Tier 2,0.6,"Placebo-controlled human RCT in adults with low vitamin C assessed mood via intensive smartphone surveys and found a marginal beneficial effect with 250 mg/day for 28 days. Although randomized and controlled, the mood outcomes appear to be secondary/exploratory (secondary data analysis) and the reported benefit was modest, with limited detail on sample size and primary endpoints, lowering confidence from Tier 1."
Vitamin C,Constipation; Diarrhoea; Gastritis; Gastrointestinal disorders; Gastrointestinal pain; Vomiting; asthma; atopic dermatitis; dexamethasone associated with greater blood glucose levels after surgery; higher erythema score noted in Group 2; hypotension; nausea; tachycardia; vomiting,Inflammation,,"Immune, Inflammation, & Infection",manual_pair,"One randomized clinical study reported a benefit of vitamin C in improving markers of oxidative stress and inflammation in individuals recovering from COVID-19, using doses of 1000 mg as a single dose. However, the overall evidence is limited, with only one study demonstrating a positive outcome and no reports of harm or mixed results. Further research is needed to confirm these findings and establish consistent dosing guidelines.",0.7,40508019,2025,"A Plant-Based Dietary Supplement Exhibits Significant Effects on Markers of Oxidative Stress, Inflammation, and Immune Response in Subjects Recovering from Respiratory Viral Infection: A Randomized, Double-Blind Clinical Study Using Vitamin C as a Positive Control.",randomized_controlled_trial,benefit,"The study shows that PB-Blend has a significant impact on markers of oxidative stress and inflammation in individuals recovering from COVID-19, indicating a benefit in immune support.",50 mg single dose (encapsulated); 1000 mg single dose (Vitamin C),,,covid-19,covid-19; respiratory viral infection,Tier 3,0.58,"Randomized, double-blind human study with vitamin C as an active comparator arm, but small sample (~28 total), single acute dose, and outcomes limited to short-term surrogate biomarkers of oxidative stress and inflammation rather than clinical inflammatory outcomes. Provides preliminary human evidence relevant to inflammation but not strong or clinically definitive."
Vitamin C,Constipation; Diarrhoea; Gastritis; Gastrointestinal disorders; Gastrointestinal pain; Vomiting; asthma; atopic dermatitis; dexamethasone associated with greater blood glucose levels after surgery; higher erythema score noted in Group 2; hypotension; nausea; tachycardia; vomiting,COPD,,Respiratory Health,manual_pair,"One randomized, placebo-controlled trial found that supplementation with liposomal vitamin C (500 mg) and L-arginine (1.66 g) twice daily for 4 weeks resulted in significant improvements in dyspnea and daily activities in patients with COPD. Overall, the evidence is limited to this single study, and further research is needed to confirm these findings and assess long-term effects.",0.7,40316462,2025,"Impact of L-arginine and liposomal vitamin C supplementation on quality of life and daily life activities in patients with COPD: a randomized, multicenter, single blind, placebo-controlled trial (ILDA study).",randomized_controlled_trial,benefit,"The study demonstrated significant improvements in dyspnea and activities of daily living in COPD patients receiving the supplementation, indicating a beneficial outcome.",1.66 g twice daily 4 weeks (oral L-arginine plus liposomal vitamin C 500 mg),,,chronic obstructive pulmonary disease (copd),chronic obstructive pulmonary disease (copd); dyspnea; limitations in activities of daily living (adl),Tier 4,0.6,"Human RCT with clinically relevant COPD outcomes showed benefit, but the intervention combined L-arginine with liposomal vitamin C and the trial’s goal centered on L-arginine. Effects cannot be attributed to vitamin C alone, making the evidence indirect. Single-blind design and short duration (4 weeks) further limit attribution to vitamin C."
Vitamin C,Constipation; Diarrhoea; Gastritis; Gastrointestinal disorders; Gastrointestinal pain; Vomiting; asthma; atopic dermatitis; dexamethasone associated with greater blood glucose levels after surgery; higher erythema score noted in Group 2; hypotension; nausea; tachycardia; vomiting,Musculoskeletal Pain,,Musculoskeletal & Pain,manual_pair,"The evidence regarding the use of vitamin C for shoulder pain is limited and mixed. One randomized controlled trial found that while both vitamin C combined with platelet-rich plasma (PRP) and PRP alone resulted in significant pain reduction, there was no significant difference between the two treatment groups. Therefore, the overall efficacy of vitamin C in this context remains unclear.",0.7,39044241,2024,Comparative efficacy of platelet-rich plasma (PRP) injection versus PRP combined with vitamin C injection for partial-thickness rotator cuff tears: a randomized controlled trial.,randomized_controlled_trial,mixed_unclear,"Both treatment groups showed significant pain reduction, but no significant difference between the groups was found, indicating mixed outcomes.",3 months (injection),Rotator Cuff Tears,,partial-thickness rotator cuff tears,partial-thickness rotator cuff tears,Tier 1,0.73,"A randomized controlled trial (n=110) directly tested vitamin C (as an adjunct to PRP) for musculoskeletal pain in partial-thickness rotator cuff tears using clinically relevant outcomes (pain VAS, ASES, Constant) over 3 months. It found no significant added benefit from vitamin C versus PRP alone. Despite the null/mixed result, the study design and outcomes meet Tier 1 criteria; the evidence is strong but does not support efficacy."
Vitamin C,Constipation; Diarrhoea; Gastritis; Gastrointestinal disorders; Gastrointestinal pain; Vomiting; asthma; atopic dermatitis; dexamethasone associated with greater blood glucose levels after surgery; higher erythema score noted in Group 2; hypotension; nausea; tachycardia; vomiting,Skin Aging Prevention,,"Skin, Hair, & Nails",manual_pair,"One randomized, double-blind, placebo-controlled trial reported beneficial effects of vitamin C combined with hydrolyzed collagen on skin density and texture after 16 weeks of supplementation at a dose of 80 mg daily. However, the overall evidence is limited, with only one study demonstrating a positive outcome and no reports of harm or no benefit. Further research is needed to confirm these findings and establish the efficacy of vitamin C for skin aging.",0.7,38931263,2024,"The Effects of Dietary Supplementation with Collagen and Vitamin C and Their Combination with Hyaluronic Acid on Skin Density, Texture and Other Parameters: A Randomised, Double-Blind, Placebo-Controlled Trial.",randomized_controlled_trial,benefit,"The study showed beneficial effects on skin density and texture, indicating a positive outcome direction.",80 mg daily 16 weeks (hydrolysed collagen with vitamin C),,,skin aging,skin aging; wrinkles,Tier 4,0.4,"Double-blind, randomized, placebo-controlled human trial with objective skin outcomes showed benefit, but vitamin C was administered only as part of a combination (hydrolyzed collagen ± hyaluronic acid), so effects cannot be attributed to vitamin C alone. Outcomes (skin density/texture) are surrogate markers for skin aging rather than clinical endpoints. Therefore, evidence for vitamin C specifically in skin aging prevention from this study is indirect/very low."
Vitamin C,Constipation; Diarrhoea; Gastritis; Gastrointestinal disorders; Gastrointestinal pain; Vomiting; asthma; atopic dermatitis; dexamethasone associated with greater blood glucose levels after surgery; higher erythema score noted in Group 2; hypotension; nausea; tachycardia; vomiting,UTI,,Kidney & Bladder Health,manual_pair,"One randomized crossover trial reported that an oral preparation containing vitamin C, along with other components, significantly improved urinary symptoms in participants with recurrent urinary tract infections. However, the evidence is limited to this single study, and no adverse effects were noted. Further research is needed to confirm these findings and establish consistent dosing recommendations.",0.7,38721680,2024,"Oral preparation of hyaluronic acid, chondroitin sulfate, N-acetylglucosamine, and vitamin C improves sexual and urinary symptoms in participants with recurrent urinary tract infections: a randomized crossover trial.",randomized_controlled_trial,benefit,"The study shows significant improvement in sexual and urinary symptoms, indicating a beneficial effect of the intervention.",1 dose once a day 3 months (oral preparation),,,recurrent urinary tract infections,recurrent urinary tract infections; sexual dysfunction,Tier 4,0.38,"Randomized crossover pilot in rUTI participants showed symptom improvement, but the intervention was a multi-ingredient formula (hyaluronic acid, chondroitin sulfate, N-acetylglucosamine, and vitamin C) given on top of other supplements, with no arm isolating vitamin C. Outcomes were urinary/sexual symptom scales rather than UTI incidence or microbiologic cure. Thus evidence for vitamin C specifically for UTI is indirect and low-level."
Vitamin C,Constipation; Diarrhoea; Gastritis; Gastrointestinal disorders; Gastrointestinal pain; Vomiting; asthma; atopic dermatitis; dexamethasone associated with greater blood glucose levels after surgery; higher erythema score noted in Group 2; hypotension; nausea; tachycardia; vomiting,Skin Aging Prevention,,"Skin, Hair, & Nails",manual_pair,"One randomized controlled trial reported a beneficial effect of a topical antioxidant serum containing vitamin C, E, and ferulic acid on neck skin rejuvenation, showing significant improvements in skin parameters and histological outcomes. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term effects and safety.",0.7,40464749,2025,"Fractional microneedle radiofrequency with the application of vitamin C, E, and ferulic acid serum for neck skin rejuvenation: a prospective, double-blinded, split-neck, placebo-controlled trial.",randomized_controlled_trial,benefit,"The study demonstrated significant improvements in skin parameters and histological outcomes, indicating a beneficial effect of the treatment.",null null daily null (topical antioxidant serum),,,neck aging,neck aging; skin rejuvenation,Tier 4,0.44,"This is a randomized, double-blind, split-neck trial with clinical and histological improvements, but the intervention was a combined topical antioxidant serum (vitamin C, E, and ferulic acid) used adjunctively with fractional microneedle radiofrequency. The effect cannot be attributed to vitamin C alone, the route is topical (not dietary supplementation), and there was a co-intervention (FMR). Thus, evidence for vitamin C specifically for skin aging prevention is indirect despite the high-quality design."
Vitamin D,"Discontinuation of vitamin D supplementation due to colic; Mild, asymptomatic hypercalcemia noted in 7 children",Healthy Aging,,Healthy Aging & Prevention,manual_pair,"One randomized controlled trial (VITAL) reported that daily supplementation with 2000 IU of Vitamin D3 for four years significantly decreased telomere attrition, suggesting a potential benefit in relation to cell senescence. However, the evidence is limited to this single study, and further research is needed to confirm these findings and assess long-term effects.",0.7,40409468,2025,Vitamin D3 and marine ω-3 fatty acids supplementation and leukocyte telomere length: 4-year findings from the VITamin D and OmegA-3 TriaL (VITAL) randomized controlled trial.,randomized_controlled_trial,benefit,"Vitamin D3 supplementation significantly decreased telomere attrition, indicating a beneficial effect.",2000 IU daily 4 years (Vitamin D3),,,cell senescence,cell senescence,Tier 3,0.66,"This is a large, double-blind, randomized, placebo-controlled trial showing that 2000 IU/day vitamin D3 reduced leukocyte telomere attrition over 4 years. However, telomere length is a surrogate biomarker rather than a direct clinical outcome of healthy aging, so the evidence is indirect for the stated indication."
Vitamin D,"Discontinuation of vitamin D supplementation due to colic; Mild, asymptomatic hypercalcemia noted in 7 children",High Insulin,,Metabolic Health,manual_pair,"The evidence regarding vitamin D supplementation for high blood sugar in prediabetes is mixed, with one double-blind randomized controlled trial reporting unclear effects on metabolic biomarkers and abdominal obesity. The study utilized a dose of 50,000 IU every two weeks for 12 weeks. Overall, the findings do not support a clear benefit, and further research is needed to clarify the role of vitamin D in this context.",0.8,40497345,2025,"The interaction of vitamin D supplementation with Omentin-1 gene polymorphism on metabolic biomarkers, omentin-1 levels and anthropometric measures in women with prediabetes: A double-blind randomized controlled trial.",randomized_controlled_trial,mixed_unclear,"The study shows mixed results regarding the effects of vitamin D on HDL-C and abdominal obesity, with some significant findings and others not reaching significance.",50000 IU every two weeks 12 weeks,Prediabetes; Women,Weight & Body Composition,insulin resistance,insulin resistance; obesity; prediabetes,Tier 2,0.62,"Double-blind randomized controlled trial (~96 participants) in women with prediabetes measured insulin and insulin-resistance indices as part of metabolic biomarkers. While well-controlled, the study’s primary emphasis included genotype interactions and lipid/anthropometric outcomes, making high insulin a secondary/surrogate endpoint. Results on glycemic markers were mixed/unclear. Thus, moderate human evidence for this indication."
Vitamin D,"Discontinuation of vitamin D supplementation due to colic; Mild, asymptomatic hypercalcemia noted in 7 children",Oxidative Stress,,"Immune, Inflammation, & Infection",manual_pair,"The evidence for vitamin D's role in immune modulation is limited, with one study indicating a beneficial effect on immune function following a 1000 IU bolus of vitamin D3. However, due to the low quantity of studies and the lack of replication, the overall confidence in this evidence remains low.",0.3,40389645,2025,Transcriptomic profiling of immune modulation induced by vitamin D3 in the VitDPAS and VitDHiD cohort studies.,clinical_trial,benefit,"The study shows a consistent immunomodulatory response to vitamin D3, indicating a beneficial effect on immune function.",1000 IU bolus (vitamin D3),,,immune modulation,immune modulation,Tier 5,0.87,"The study investigates immune transcriptomic changes after vitamin D3 dosing and reports immunomodulatory effects. It does not assess oxidative stress outcomes (clinical or surrogate markers such as MDA, TAC, SOD/GPx) and is therefore not evidence for the oxidative stress indication."
Vitamin D,"Discontinuation of vitamin D supplementation due to colic; Mild, asymptomatic hypercalcemia noted in 7 children",Immune Preservation,,"Immune, Inflammation, & Infection",manual_pair,"One randomized clinical trial indicates that higher doses of vitamin D (1000 IU and 5000 IU daily for 8 weeks) may improve outcomes related to impaired immune response in older adults with vitamin D deficiency. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term effects and safety.",0.8,40421021,2025,Co-administration of vitamin D and N-acetylcysteine to modulate immunosenescence in older adults with vitamin D deficiency: a randomized clinical trial.,randomized_controlled_trial,benefit,The study shows that higher doses of Vitamin D significantly improve outcomes related to immunosenescence.,1000 IU daily 8 weeks; 5000 IU daily 8 weeks,Older Adults,,aging,aging; immunosenescence; vitamin d deficiency,Tier 3,0.63,"Human randomized controlled trial in older adults with vitamin D deficiency showed that vitamin D alone (especially 5000 IU/day) improved immunosenescence biomarkers in PBMCs. However, outcomes were surrogate/mechanistic (senescence markers and inflammatory factors) rather than clinical immune-preservation endpoints, and likely a modest sample size. Therefore, evidence for immune preservation is preliminary despite RCT design."
Vitamin D,"Discontinuation of vitamin D supplementation due to colic; Mild, asymptomatic hypercalcemia noted in 7 children",Inflammation,,"Immune, Inflammation, & Infection",manual_pair,"The evidence for vitamin D in modulating inflammatory processes is limited, with one study indicating a beneficial effect on immune function following a 1000 IU bolus of vitamin D3. However, due to the low quantity of studies and the lack of consistency in findings, the overall evidence remains low quality and inconclusive.",0.6,40389645,2025,Transcriptomic profiling of immune modulation induced by vitamin D3 in the VitDPAS and VitDHiD cohort studies.,clinical_trial,benefit,"The study shows a consistent immunomodulatory response to vitamin D3, indicating a beneficial effect on immune function.",1000 IU bolus (vitamin D3),,,inflammatory processes,inflammatory processes,Tier 4,0.64,"Human study in healthy volunteers assessing mechanistic, transcriptomic immune modulation after a bolus of vitamin D3. No clinical inflammatory outcomes or patient population with an inflammatory condition; endpoints are surrogate/mechanistic rather than clinically meaningful. Therefore, evidence for the indication of inflammation is indirect and very low."
Vitamin D,"Discontinuation of vitamin D supplementation due to colic; Mild, asymptomatic hypercalcemia noted in 7 children",IBS,,Gut Health,manual_pair,"One randomized, double-blind, placebo-controlled trial reported a benefit of vitamin D combined with multistrain probiotics in improving gut barrier function and microbiota composition in individuals with irritable bowel syndrome without constipation over a 12-week period. However, the overall evidence is limited, and further studies are needed to confirm these findings and assess long-term effects and safety.",0.7,40431448,2025,"Multistrain Probiotics Plus Vitamin D Improve Gut Barrier Function and Gut Microbiota Composition in Irritable Bowel Syndrome Without Constipation: Results from a Double-Blind, Randomized, Placebo-Controlled Trial.",randomized_controlled_trial,benefit,"The study shows significant improvements in gut barrier function and microbiota composition, indicating a beneficial effect of the intervention.",cholecalciferol 12 weeks (combined with multistrain probiotics),,,irritable bowel syndrome,irritable bowel syndrome,Tier 3,0.45,"Double-blind RCT in IBS patients showed benefits on surrogate endpoints (zonulin, microbiota) after 12 weeks, but the intervention combined multistrain probiotics with vitamin D, preventing attribution to vitamin D alone. Sample size appears small and clinical IBS symptom outcomes are not clearly primary or reported. Thus, evidence for vitamin D specifically in IBS is preliminary/indirect."
Vitamin D,"Discontinuation of vitamin D supplementation due to colic; Mild, asymptomatic hypercalcemia noted in 7 children",Migraine Headache,,Musculoskeletal & Pain,manual_pair,"One randomized trial reported a beneficial effect of vitamin D on migraine index in adults, using a dose of 50,000 IU every two weeks for 12 weeks. However, the overall evidence is limited, with only one study demonstrating a positive outcome and no reports of harm or mixed results.",0.7,40360751,2025,"Effects of probiotic and vitamin D co-supplementation on migraine index, quality of life, and oxidative stress in adults with migraine headache: a randomized triple-blinded clinical trial.",randomized_controlled_trial,benefit,"The study showed significant improvement in migraine index and serum levels of vitamin D, indicating a beneficial effect.",50000 IU every two weeks 12 weeks,,,migraine headache,migraine headache,Tier 4,0.55,"Although this was a well-designed triple-blinded RCT with clinically relevant outcomes (migraine index) and showed benefit, the intervention was probiotic plus vitamin D versus placebo. Because vitamin D was not tested as a standalone supplement, the effect cannot be attributed specifically to vitamin D, making the evidence indirect for this supplement-indication pair."
Vitamin D,"Discontinuation of vitamin D supplementation due to colic; Mild, asymptomatic hypercalcemia noted in 7 children",Parkinson's Disease,,Cognitive & Neurological Function,manual_pair,"One randomized trial found that vitamin D3 supplementation significantly improved motor function in Parkinson's disease patients with vitamin D deficiency over a period of three months. No adverse effects were reported, but further research is needed to confirm these findings and assess long-term effects.",0.8,40646117,2025,Impact of vitamin D3 supplementation on motor functionality and the immune response in Parkinson's disease patients with vitamin D deficiency.,randomized_controlled_trial,benefit,"Vitamin D3 supplementation significantly improved motor function and altered immune cell levels, indicating a beneficial effect.",null null null 3 months (Vitamin D3),,,parkinson's disease,parkinson's disease; vitamin d deficiency,Tier 2,0.7,"Double-blind, randomized, placebo-controlled trial in PD patients showed improvement in clinically relevant motor outcomes (UPDRS) with vitamin D3, but the sample was small (n=30, 15 per arm), duration short (3 months), and limited to vitamin D–deficient patients. Solid design but underpowered/pilot in scope."
Vitamin D,"Discontinuation of vitamin D supplementation due to colic; Mild, asymptomatic hypercalcemia noted in 7 children",Oral Precancerous Lesions,,Oral Health,manual_pair,"The evidence regarding the efficacy of vitamin D for oral pain is limited and mixed, with one randomized clinical trial suggesting that it may have comparable effects to topical corticosteroids in the management of symptomatic oral lichen planus. No studies reported clear benefits or harms associated with vitamin D for this indication. Overall, the quality of evidence is low, and further research is needed to clarify its role.",0.7,40457259,2025,Supplementary zinc and vitamin D in management of symptomatic oral lichen planus: a three-arm randomized clinical trial.,randomized_controlled_trial,mixed_unclear,"The study shows that vitamin D has a comparable effect to topical corticosteroid alone, indicating mixed outcomes regarding its efficacy.",8 weeks (systemic),,,oral lichen planus,oral lichen planus,Tier 2,0.62,"A three-arm randomized clinical trial in oral lichen planus (an oral potentially malignant disorder) assessed systemic vitamin D as an adjunct to topical corticosteroid with clinical outcomes (pain and lesion scores). While relevant and randomized, the study was small (n=42), blinding was not reported, and vitamin D performed comparably to steroid alone, indicating moderate-quality human evidence rather than strong."
Vitamin D,"Discontinuation of vitamin D supplementation due to colic; Mild, asymptomatic hypercalcemia noted in 7 children",Exercise Performance,,Performance & Recovery,manual_pair,"There is low-quality evidence suggesting that vitamin D supplementation, when combined with high-protein food and exercise, may improve physical function in elderly individuals with decreased physical capabilities, as indicated by one study. No adverse effects were reported, but the overall evidence is limited and further research is needed to confirm these findings.",0.6,40618056,2025,Effects of branched-chain amino acid- and vitamin D-containing high-protein food supplementation plus exercise on elderly people with decreased physical functions.,clinical_trial,benefit,"The study showed maintenance of soft lean mass and improvement in physical functions, indicating a benefit from the supplementation.",12 weeks (high-protein food containing BCAA and vitamin D),Older Adults,,impaired physical functions,impaired physical functions; locomotive syndrome,Tier 4,0.4,"Human controlled trial in older adults showed functional benefits and lean mass maintenance when a combined BCAA + vitamin D high‑protein supplement was added to exercise. However, vitamin D was not tested alone (combination product), likely nonrandomized and unblinded, and added benefit over exercise alone was limited/inconsistent across outcomes. Thus evidence for vitamin D specifically improving exercise performance is indirect and very low."
Vitamin E,Vitamin E supplementation may be harmful to patients with NMIBC; abdominal bloating; gastrointestinal bleeding; hemorrhagic complications; increased risk of hemorrhagic stroke; respiratory allergy,Stress,,"Energy, Mood, & Mental Health",manual_pair,"One randomized controlled trial reported a benefit of vitamin E (50 mg daily for 8 weeks) in improving sexual function and reducing anxiety among women with sexual dysfunction. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess the generalizability of the results.",0.7,38408971,2024,Effect of vitamin E with and without saffron on the sexual function in women of reproductive age with sexual dysfunction: a randomized controlled trial.,randomized_controlled_trial,benefit,"The study shows a significant improvement in sexual function and reduction in depression, anxiety, and stress, indicating a benefit from the intervention.",50 mg evening 8 weeks (capsule),Women,Women's Health,anxiety,anxiety; depression; sexual dysfunction; stress,Tier 5,0.9,"Triple-blind RCT compared saffron+vitamin E versus vitamin E alone in women; stress (DASS-21) improved more with the combination. Vitamin E was present in both arms and not tested against placebo or no treatment, so the study does not provide direct evidence for vitamin E as an intervention for stress."
Vitamin E,Vitamin E supplementation may be harmful to patients with NMIBC; abdominal bloating; gastrointestinal bleeding; hemorrhagic complications; increased risk of hemorrhagic stroke; respiratory allergy,Dry Mouth,,Oral Health,manual_pair,"One randomized trial suggests that vitamin E may have a protective effect on salivary gland function, specifically improving parotid excretion in patients with differentiated thyroid cancer treated with 131I. However, the overall evidence is limited, with only one study reporting a benefit and no consistent dose ranges or adverse effects noted. Further research is needed to establish the efficacy and safety of vitamin E for dry mouth.",0.7,35950355,2022,Effect of vitamin E and supragingival scaling on salivary gland function in patients with differentiated thyroid cancer treated with 131I.,randomized_controlled_trial,benefit,"Vitamin E showed a protective effect on parotid excretion function, indicating a benefit for salivary gland function in patients post-131I treatment.",,Cancer,,differentiated thyroid carcinoma,differentiated thyroid carcinoma,Tier 3,0.62,"Randomized controlled trial in thyroid cancer patients receiving 131I showed improved salivary gland scintigraphy parameters with vitamin E, but outcomes were surrogate imaging/function indices rather than clinical xerostomia symptoms or measured saliva flow. Sample size was modest (~30 per arm) and the context is specific (radiation-induced dysfunction), making evidence indirect for general dry mouth."
Vitamin E,Vitamin E supplementation may be harmful to patients with NMIBC; abdominal bloating; gastrointestinal bleeding; hemorrhagic complications; increased risk of hemorrhagic stroke; respiratory allergy,Fatty LIver Disease,,Gut Health,manual_pair,"Clinical evidence suggests that vitamin E may provide benefits in the treatment of fatty liver disease, particularly in conditions like metabolic-associated steatotic liver disease (MASLD) and nonalcoholic steatohepatitis (NASH), with studies reporting improvements in liver function and histology. Doses reported include 300 mg daily and 400 IU twice daily, with no adverse effects noted in the studies. However, the overall quality of evidence is mixed, and further research is needed to confirm these findings.",0.8,40564891,2025,"Therapeutic Efficacy of Silymarin, Vitamin E, and Essential Phospholipid Combination Therapy on Hepatic Steatosis, Fibrosis, and Metabolic Parameters in MASLD Patients: A Prospective Clinical Study.",clinical_trial,benefit,"The study shows a significant benefit in liver function and metabolic parameters in MASLD patients treated with the combination therapy, with no reported adverse effects.","6 months (combination therapy with silymarin, vitamin E, and essential phospholipids)",,,hepatic steatosis,hepatic steatosis; liver fibrosis; metabolic dysfunction-associated steatohepatitis (mash); metabolic dysfunction-associated steatotic liver disease (masld); nonalcoholic steatohepatitis (nash),Tier 4,0.37,"Prospective human study in MASLD showed benefit, but it tested a combination (silymarin + vitamin E + essential phospholipids) without a control group or randomization, and effects cannot be attributed to vitamin E alone. Outcomes are clinically relevant but evidence for vitamin E specifically is indirect and methodologically weak."
Vitamin E,Vitamin E supplementation may be harmful to patients with NMIBC; abdominal bloating; gastrointestinal bleeding; hemorrhagic complications; increased risk of hemorrhagic stroke; respiratory allergy,Fatty LIver Disease,,Gut Health,manual_pair,"Clinical evidence suggests that vitamin E may provide benefits in the treatment of fatty liver disease, particularly in conditions like metabolic-associated steatotic liver disease (MASLD) and nonalcoholic steatohepatitis (NASH), with studies reporting improvements in liver function and histology. Doses reported include 300 mg daily and 400 IU twice daily, with no adverse effects noted in the studies. However, the overall quality of evidence is mixed, and further research is needed to confirm these findings.",0.8,39970876,2025,"Vitamin E (300 mg) in the treatment of MASH: A multi-center, randomized, double-blind, placebo-controlled study.",randomized_controlled_trial,benefit,"The study shows significant improvement in liver histology, indicating a benefit from vitamin E treatment for MASH.",300 mg daily (oral),,,metabolic dysfunction-associated steatohepatitis (mash),hepatic steatosis; liver fibrosis; metabolic dysfunction-associated steatohepatitis (mash); metabolic dysfunction-associated steatotic liver disease (masld); nonalcoholic steatohepatitis (nash),Tier 1,0.8,"Multi-center, randomized, double-blind, placebo-controlled RCT (n=124) in biopsy-proven MASH directly tested vitamin E 300 mg/day with hepatic histologic improvement as the primary outcome. The vitamin E group showed significantly higher histologic improvement vs placebo and benefits in key histologic features. This is high-quality, directly relevant human evidence, though based on a single moderate-sized trial."
Vitamin E,Vitamin E supplementation may be harmful to patients with NMIBC; abdominal bloating; gastrointestinal bleeding; hemorrhagic complications; increased risk of hemorrhagic stroke; respiratory allergy,Fatty LIver Disease,,Gut Health,manual_pair,"Clinical evidence suggests that vitamin E may provide benefits in the treatment of fatty liver disease, particularly in conditions like metabolic-associated steatotic liver disease (MASLD) and nonalcoholic steatohepatitis (NASH), with studies reporting improvements in liver function and histology. Doses reported include 300 mg daily and 400 IU twice daily, with no adverse effects noted in the studies. However, the overall quality of evidence is mixed, and further research is needed to confirm these findings.",0.8,40383220,2025,Comparative efficacy of febuxostat and vitamin E in the management of MASLD: Insights from a randomized parallel clinical study.,randomized_controlled_trial,benefit,"The study shows improvement in steatosis in MASLD patients treated with vitamin E, indicating a beneficial effect.",400 mg twice daily 24 weeks,,,metabolic dysfunction-associated steatotic liver disease (masld),hepatic steatosis; liver fibrosis; metabolic dysfunction-associated steatohepatitis (mash); metabolic dysfunction-associated steatotic liver disease (masld); nonalcoholic steatohepatitis (nash),Tier 2,0.58,"Randomized parallel-group clinical trial with 32 participants in the vitamin E arm over 24 weeks, assessing steatosis (a primary, clinically relevant outcome for MASLD) via FibroScan/CAP. The study reports significant within-group improvement with vitamin E. However, it uses an active comparator (no placebo), likely unblinded, small sample size, and relies on surrogate outcomes (CAP) without hard clinical endpoints. These factors reduce certainty despite being an RCT."
Vitamin E,Vitamin E supplementation may be harmful to patients with NMIBC; abdominal bloating; gastrointestinal bleeding; hemorrhagic complications; increased risk of hemorrhagic stroke; respiratory allergy,Fatty LIver Disease,,Gut Health,manual_pair,"Clinical evidence suggests that vitamin E may provide benefits in the treatment of fatty liver disease, particularly in conditions like metabolic-associated steatotic liver disease (MASLD) and nonalcoholic steatohepatitis (NASH), with studies reporting improvements in liver function and histology. Doses reported include 300 mg daily and 400 IU twice daily, with no adverse effects noted in the studies. However, the overall quality of evidence is mixed, and further research is needed to confirm these findings.",0.8,40480879,2025,New Approach Combination-Dosed Therapy for Nonalcoholic Steatohepatitis Versus Vitamin E: A Randomized Controlled Trial.,randomized_controlled_trial,benefit,"The study showed a statistically significant decrease in steatosis in the vitamin E group, indicating a benefit in managing NASH.",400 IU twice daily 6 months (Vitamin E),,,nonalcoholic steatohepatitis (nash),hepatic steatosis; liver fibrosis; metabolic dysfunction-associated steatohepatitis (mash); metabolic dysfunction-associated steatotic liver disease (masld); nonalcoholic steatohepatitis (nash),Tier 2,0.64,"Double-blind randomized controlled trial (n=90; 45 on vitamin E 400 IU twice daily for 6 months) in NASH showed a statistically significant reduction in steatosis in the vitamin E group. Outcomes were major disease-relevant measures, but vitamin E served as an active comparator rather than versus placebo, improvements were modest and largely on surrogate markers, and fibrosis/other biomarkers showed limited change in the vitamin E arm. Thus, moderate human evidence from this study alone."
Vitamin E,Vitamin E supplementation may be harmful to patients with NMIBC; abdominal bloating; gastrointestinal bleeding; hemorrhagic complications; increased risk of hemorrhagic stroke; respiratory allergy,High Blood Glucose,,Metabolic Health,manual_pair,"One randomized controlled trial reported that vitamin E (200 IU twice daily for eight weeks) significantly improved fasting blood glucose levels in postmenopausal women without adverse effects. However, the overall evidence is limited, with only one study demonstrating a benefit and no other trials to corroborate these findings.",0.7,36053717,2024,"Curcumin and vitamin E improve hot flashes, lipid profile, and fasting blood glucose without any detrimental effect on the liver and renal function in postmenopausal women: A triple-blind placebo-controlled clinical trial.",randomized_controlled_trial,benefit,Vitamin E significantly decreased hot flashes and improved lipid profile and liver function without adverse effects.,200 IU twice daily eight weeks (capsules),Menopause; Women,Heart & Vascular Health; Women's Health,blood glucose,blood glucose; hot flashes; lipid profile,Tier 5,0.86,"Triple-blind RCT in postmenopausal women measured fasting blood glucose, but only curcumin reduced it; vitamin E (200 IU BID, 8 weeks) did not significantly affect fasting blood glucose. Thus, this study provides no supportive evidence for vitamin E for high blood glucose."
Vitamin E,Vitamin E supplementation may be harmful to patients with NMIBC; abdominal bloating; gastrointestinal bleeding; hemorrhagic complications; increased risk of hemorrhagic stroke; respiratory allergy,High Insulin,,Metabolic Health,manual_pair,"One randomized controlled trial indicates that co-administration of Vitamin E (400 IU daily for 12 weeks) with atorvastatin may improve insulin sensitivity and PPAR-γ expression in patients with Type 2 Diabetes. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term effects and safety.",0.7,35291435,2022,Co-Administration of Vitamin E and Atorvastatin Improves Insulin Sensitivity and Peroxisome Proliferator-Activated Receptor-γ Expression in Type 2 Diabetic Patients: A Randomized Double-Blind Clinical Trial.,randomized_controlled_trial,benefit,"The study shows significant improvement in insulin resistance and PPAR-γ expression, indicating a beneficial effect of Vitamin E in the context of atorvastatin treatment.",400 IU daily 12 weeks,,,insulin resistance,Type 2 Diabetes Mellitus; insulin resistance,Tier 2,0.6,"Double-blind randomized controlled trial showing reduced serum insulin and HOMA-IR with vitamin E vs placebo, but sample size is very small (n=30), limited to statin-treated female T2DM patients, and outcomes are short-term metabolic biomarkers. This supports moderate human evidence for lowering high insulin, but not strong due to size and population specificity."
Vitamin E,Vitamin E supplementation may be harmful to patients with NMIBC; abdominal bloating; gastrointestinal bleeding; hemorrhagic complications; increased risk of hemorrhagic stroke; respiratory allergy,High LDL,,Heart & Vascular Health,manual_pair,"One randomized controlled trial reported that Vitamin E supplementation may lower LDL cholesterol levels, indicating a potential benefit for individuals with high LDL cholesterol. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term effects and safety.",0.7,40087044,2025,Vitamin E ameliorates blood cholesterol level and alters gut microbiota composition: A randomized controlled trial.,randomized_controlled_trial,benefit,"The study demonstrated a benefit in lowering LDL-C levels, indicating a positive health outcome from Vitamin E supplementation.",(Vitamin E),,,blood cholesterol level,blood cholesterol level,Tier 2,0.64,"Human randomized controlled trial with placebo control found LDL-C reduction from vitamin E. However, the sample size per arm was modest (~30), blinding and whether LDL-C was a primary endpoint are unclear, and participants were healthy rather than hyperlipidemic, reducing direct applicability to high LDL."
Vitamin E,Vitamin E supplementation may be harmful to patients with NMIBC; abdominal bloating; gastrointestinal bleeding; hemorrhagic complications; increased risk of hemorrhagic stroke; respiratory allergy,Fatty LIver Disease,,Gut Health,manual_pair,"Current evidence from a randomized clinical trial suggests that vitamin E, when combined with ertugliflozin, may improve liver fat content and metabolic indicators in patients with non-alcoholic fatty liver disease (NAFLD) and type 2 diabetes mellitus (T2DM). However, the overall evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term safety and efficacy. No adverse effects were reported in this study.",0.7,40202706,2025,Combination therapy with vitamin E and ertugliflozin in patients with non-alcoholic fatty liver disease and type 2 diabetes mellitus: a randomized clinical trial.,randomized_controlled_trial,benefit,The combination therapy of vitamin E and ertugliflozin showed significant benefits in improving liver fat content and metabolic indicators in patients with NAFLD and T2DM.,24 weeks,Diabetes Type 2,,non-alcoholic fatty liver disease,Type 2 Diabetes Mellitus; non-alcoholic fatty liver disease,Tier 1,0.67,"This is a double-blind, randomized controlled clinical trial in humans with NAFLD (primary outcome: liver steatosis by ultrasound). It directly tested a vitamin E monotherapy arm (n≈42) alongside comparators and a combination arm over 24 weeks. While the clearest benefits were observed with vitamin E plus ertugliflozin and vitamin E alone showed limited/no effect on metabolic and fibrosis indices, the study design and relevance to the indication meet Tier 1 criteria. Confidence is tempered because the benefit signal pertains mainly to combination therapy rather than vitamin E monotherapy."
Vitamin E,Vitamin E supplementation may be harmful to patients with NMIBC; abdominal bloating; gastrointestinal bleeding; hemorrhagic complications; increased risk of hemorrhagic stroke; respiratory allergy,Oxidative Stress,,"Immune, Inflammation, & Infection",manual_pair,"One randomized study indicates that Vitamin E supplementation, through consumption of enriched hen eggs providing 3.29 mg daily for 21 days, may have a beneficial effect on inflammatory markers and oxidative stress in healthy participants. However, the evidence is limited to a single study with no reports of mixed or harmful outcomes, suggesting the need for further research to confirm these findings.",0.8,36624951,2022,"Consumption of Hen Eggs Enriched with n-3 Polyunsaturated Fatty Acids, Selenium, Vitamin E and Lutein Incites Anti-Inflammatory Conditions in Young, Healthy Participants - A Randomized Study.",randomized_controlled_trial,benefit,"The study shows a beneficial effect on inflammatory markers and oxidative stress, indicating a positive outcome from Vitamin E supplementation.",3.29 mg daily 21 days (enriched hen eggs),,,anti-inflammatory conditions,anti-inflammatory conditions; oxidative stress,Tier 3,0.46,"Small randomized trial (n=34) in healthy adults using enriched eggs containing multiple nutrients (n-3 PUFA, selenium, vitamin E, lutein). Outcomes were inflammatory/oxidative stress biomarkers (surrogate, not clinical). The multi-nutrient design prevents attribution to vitamin E alone, so evidence for vitamin E on oxidative stress is weak/preliminary."
Vitamin E,Vitamin E supplementation may be harmful to patients with NMIBC; abdominal bloating; gastrointestinal bleeding; hemorrhagic complications; increased risk of hemorrhagic stroke; respiratory allergy,Infertility,,Men's Health,manual_pair,"The evidence on vitamin E for male infertility is mixed, with two studies indicating benefits in improving sperm parameters, particularly in varicocele patients, while one study showed mixed outcomes when compared to L-carnitine. Reported doses include 100 U to 400 units daily for three months. Overall, the quality of evidence is low, and further research is needed to clarify its effectiveness.",0.7,35856361,2022,Comparison of L-Carnitine vs. Coq10 and Vitamin E for idiopathic male infertility: a randomized controlled trial.,randomized_controlled_trial,mixed_unclear,"The study shows mixed outcomes with L-carnitine being superior to the combination of CoQ10 and Vitamin E, indicating some benefit from Vitamin E but not as effective as L-carnitine.",100 mg thrice daily three months (tablet),,,asthenozoospermia,asthenozoospermia; idiopathic infertility; idiopathic male infertility; infertility; male infertility; teratozoospermia; varicocele,Tier 2,0.6,"Single-blind RCT (n=143) in men with idiopathic infertility measured primary semen parameters. The arm containing Vitamin E (100 mg TID) was combined with CoQ10, not Vitamin E alone, limiting attribution. It showed improvements in motility and morphology from baseline but was inferior to L-carnitine; no pregnancy outcomes were assessed. Thus, moderate human evidence for infertility-related surrogate outcomes, but indirect for Vitamin E specifically."
Vitamin E,Vitamin E supplementation may be harmful to patients with NMIBC; abdominal bloating; gastrointestinal bleeding; hemorrhagic complications; increased risk of hemorrhagic stroke; respiratory allergy,Infertility,,Men's Health,manual_pair,"The evidence on vitamin E for male infertility is mixed, with two studies indicating benefits in improving sperm parameters, particularly in varicocele patients, while one study showed mixed outcomes when compared to L-carnitine. Reported doses include 100 U to 400 units daily for three months. Overall, the quality of evidence is low, and further research is needed to clarify its effectiveness.",0.7,38103848,2024,Effect of Medicago sativa seed powder (Plus vitamin E vs. vitamin E alone) on semen analysis in men with idiopathic infertility: A double blind randomized clinical trial.,randomized_controlled_trial,benefit,"The study shows significant improvements in sperm parameters with the addition of M. sativa to vitamin E, indicating a beneficial effect.",100 U daily 3 months,,,idiopathic infertility,asthenozoospermia; idiopathic infertility; idiopathic male infertility; infertility; male infertility; teratozoospermia; varicocele,Tier 5,0.78,"This RCT evaluates Medicago sativa added to vitamin E versus vitamin E alone. Vitamin E is present in both arms, so the study does not test vitamin E against placebo or control for infertility. The primary outcomes are semen parameters (surrogates), and the reported benefit is attributable to the add-on M. sativa, not vitamin E. Therefore, this study does not provide direct evidence for vitamin E for infertility."
Vitamin E,Vitamin E supplementation may be harmful to patients with NMIBC; abdominal bloating; gastrointestinal bleeding; hemorrhagic complications; increased risk of hemorrhagic stroke; respiratory allergy,Infertility,,Men's Health,manual_pair,"The evidence on vitamin E for male infertility is mixed, with two studies indicating benefits in improving sperm parameters, particularly in varicocele patients, while one study showed mixed outcomes when compared to L-carnitine. Reported doses include 100 U to 400 units daily for three months. Overall, the quality of evidence is low, and further research is needed to clarify its effectiveness.",0.7,39891146,2025,The impact of vitamin E supplementation on sperm analysis in varicocelectomy patients: a triple-blind randomized controlled trial.,randomized_controlled_trial,benefit,"Vitamin E supplementation showed significant improvement in sperm parameters, indicating a benefit for male infertility related to varicocele.",400 units daily 3 months,,,infertility,asthenozoospermia; idiopathic infertility; idiopathic male infertility; infertility; male infertility; teratozoospermia; varicocele,Tier 3,0.62,"Triple-blind RCT (n=90) found vitamin E 400 IU/day for 3 months improved sperm motility vs placebo post-varicocelectomy, but outcomes were surrogate (semen parameters) rather than clinical fertility endpoints (pregnancy/live birth). Effect appears limited mainly to motility, and the population is specific to men after varicocelectomy, limiting generalizability to broader infertility."
Vitamin E,Vitamin E supplementation may be harmful to patients with NMIBC; abdominal bloating; gastrointestinal bleeding; hemorrhagic complications; increased risk of hemorrhagic stroke; respiratory allergy,Alzheimer's Disease,,Cognitive & Neurological Function,manual_pair,"One randomized trial suggests that vitamin E supplementation (15 mg daily for 12 months) may improve memory and mood in Alzheimer's patients, indicating a potential benefit for memory problems. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term effects and safety.",0.7,36093704,2022,"Supplementation With Carotenoids, Omega-3 Fatty Acids, and Vitamin E Has a Positive Effect on the Symptoms and Progression of Alzheimer's Disease.",randomized_controlled_trial,benefit,"The study reports significant improvements in memory and mood in Alzheimer's patients, indicating a beneficial effect of the supplementation.",15 mg daily 12 months (dietary supplement),,,alzheimer's disease,alzheimer's disease,Tier 4,0.38,"This is a double-blind RCT with clinical outcomes in Alzheimer’s disease, but vitamin E was administered only as part of a multi-ingredient supplement (carotenoids, omega-3s, and vitamin E), so effects cannot be attributed specifically to vitamin E. Sample size is modest (50 active, 27 placebo). Therefore, for vitamin E alone in AD, the evidence from this study is indirect/very low."
Vitamin E,Vitamin E supplementation may be harmful to patients with NMIBC; abdominal bloating; gastrointestinal bleeding; hemorrhagic complications; increased risk of hemorrhagic stroke; respiratory allergy,Sleep Quality,,Sleep,manual_pair,"One randomized controlled trial found that Vitamin E supplementation (400 units of mixed tocopherols daily for one month) significantly improved sleep quality and reduced sedative drug use in postmenopausal women with chronic insomnia disorder. However, the overall evidence is limited, with only one study reporting a benefit and no additional studies to confirm these findings or assess long-term effects and safety.",0.7,36904186,2023,"Effect of Vitamin E Supplementation on Chronic Insomnia Disorder in Postmenopausal Women: A Prospective, Double-Blinded Randomized Controlled Trial.",randomized_controlled_trial,benefit,"The study shows significant improvement in sleep quality and reduction in sedative drug use, indicating a benefit from Vitamin E supplementation.",400 units daily one month (mixed tocopherol),Menopause; Women,,chronic insomnia disorder,chronic insomnia disorder; sleep quality,Tier 1,0.84,"Double-blind, randomized, placebo-controlled trial (n=160) in postmenopausal women with chronic insomnia tested vitamin E 400 IU/day for one month. Primary outcome was sleep quality (PSQI), a validated clinical measure, with reported improvement vs placebo and reduced sedative use. Methods and sample size are adequate for strong human evidence; caveats include short duration and specific population."
Vitamin K1,excessive vitamin K in parenteral nutrition; may interfere with oral anticoagulant treatment,Acne,,"Skin, Hair, & Nails",manual_pair,"The evidence for vitamin K1 in treating acne-like skin rashes is low and mixed. A randomized trial indicated that while vitamin K1 cream did not meet the primary endpoint of reducing severe skin rash, it showed some reduction in rash severity. No consistent beneficial effects were reported across studies, and no adverse effects were noted.",0.7,29360920,2018,"EVITA-a double-blind, vehicle-controlled, randomized phase II trial of vitamin K1 cream as prophylaxis for cetuximab-induced skin toxicity.",randomized_controlled_trial,mixed_unclear,"The primary endpoint of reducing grade ≥2 skin rash was not met, but vitamin K1 cream reduced the severity of the rash, indicating mixed outcomes.",8 weeks (cream),,,acne-like skin rash,acne-like skin rash; skin toxicity,Tier 5,0.78,"This double-blind RCT evaluated topical vitamin K1 as prophylaxis for cetuximab-induced acneiform rash, not acne vulgaris. The primary endpoint was not met; only secondary measures showed reduced severity later in treatment. Because the condition studied (drug-induced acneiform rash) is distinct from acne and the outcomes are mixed, this does not constitute direct evidence for vitamin K1 in acne."
Vitamin K1,excessive vitamin K in parenteral nutrition; may interfere with oral anticoagulant treatment,Acne,,"Skin, Hair, & Nails",manual_pair,"One randomized trial indicates that Vitamin K1 cream may significantly reduce the incidence and severity of cetuximab-related acneiform skin rash in women. However, the evidence is limited to this single study, and further research is needed to confirm these findings and assess the generalizability of the results.",0.7,30307464,2018,Vitamin K1 cream significantly reduces incidence and severity of cetuximab-related acneiform skin rash in women: a post hoc analysis of the EVITA trial.,randomized_controlled_trial,benefit,"The study indicates a significant reduction in incidence and severity of a specific skin rash in women, suggesting a beneficial outcome.",(cream),,,cetuximab-related acneiform skin rash,cetuximab-related acneiform skin rash,Tier 5,0.78,"This post hoc analysis of an RCT evaluated topical vitamin K1 cream for preventing cetuximab-induced acneiform rash, which is a drug-related toxicity and not acne vulgaris. The outcome and population are indirect and do not address the specified indication of acne, so it does not constitute applicable evidence for this indication."
Vitamin K1,excessive vitamin K in parenteral nutrition; may interfere with oral anticoagulant treatment,Atherosclerosis,,Heart & Vascular Health,manual_pair,"The evidence for vitamin K1 in reducing arterial calcification in individuals with diabetes is limited, with only one randomized controlled trial reporting a benefit. In this study, a daily dose of 10 mg for three months was associated with a significant reduction in new calcifying lesions. Overall, the evidence is low-quality and further research is needed to confirm these findings.",0.7,34637494,2022,"The effect of vitamin K1 on arterial calcification activity in subjects with diabetes mellitus: a post hoc analysis of a double-blind, randomized, placebo-controlled trial.",randomized_controlled_trial,benefit,"Vitamin K1 supplementation showed a significant reduction in the development of new calcifying lesions in individuals with diabetes mellitus, indicating a beneficial effect.",10 mg daily 3 months (oral),Diabetes Type 2,,diabetes mellitus,diabetes mellitus,Tier 3,0.6,"Double-blind, placebo-controlled RCT in humans showing reduced development of new 18F-NaF PET-positive calcifying lesions with vitamin K1, but this is a post hoc analysis with a short 3-month duration and uses an imaging surrogate rather than clinical atherosclerosis outcomes. Thus, evidence is preliminary despite good trial design."
Vitamin K1,excessive vitamin K in parenteral nutrition; may interfere with oral anticoagulant treatment,Improve Bone Density,,Musculoskeletal & Pain,manual_pair,"One randomized trial indicates that Vitamin K1 supplementation (1 mg daily for 3 years) may reduce bone loss at the femoral neck in postmenopausal women aged 50 to 60. However, the overall evidence is limited, with only one study demonstrating a benefit and no reports of harm or mixed outcomes. Further research is needed to confirm these findings and assess long-term effects.",0.7,14506950,2003,Vitamin K1 supplementation retards bone loss in postmenopausal women between 50 and 60 years of age.,randomized_controlled_trial,benefit,The study shows a significant reduction in bone loss at the femoral neck with Vitamin K1 supplementation.,1 mg daily 3 years (supplement with minerals and vitamin D),Menopause; Women,,osteoporosis,osteoporosis; postmenopausal bone loss,Tier 1,0.78,"Randomized, double-blind, placebo-controlled RCT (n=181; 155 completers) over 3 years found vitamin K1 (1 mg/day) added to minerals+vitamin D significantly reduced femoral neck bone loss vs placebo and vs minerals+vitamin D. BMD by DXA was a primary outcome. Limitations: benefit was site-specific (no effect at lumbar spine) and K1 was co-administered with other nutrients, with modest effect size."
Vitamin K1,excessive vitamin K in parenteral nutrition; may interfere with oral anticoagulant treatment,Atherosclerosis,,Heart & Vascular Health,manual_pair,"One randomized controlled trial found that vitamin K1 supplementation (10 mg intravenously thrice weekly for 12 months) significantly reduced the progression of coronary artery calcifications in hemodialysis patients. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term effects and safety.",0.7,39680321,2025,Effect of vitamin K1 supplementation on coronary calcifications in hemodialysis patients: a randomized controlled trial.,randomized_controlled_trial,benefit,"Vitamin K1 supplementation significantly reduced the progression of coronary artery calcifications in hemodialysis patients, indicating a beneficial effect.",10 mg thrice weekly 12 months (intravenous),CKD; Hemodialysis,,chronic kidney disease,chronic kidney disease; coronary artery calcifications,Tier 3,0.56,"Single-center RCT (n=60) in hemodialysis patients found reduced progression of coronary artery calcification with IV vitamin K1 over 12 months. The primary outcome is a surrogate imaging marker of atherosclerosis rather than clinical events, the sample is small, and the effect was borderline (RR 0.45; 95% CI 0.18–1.15). Specialized population and IV dosing limit generalizability. Thus, preliminary human evidence."
Vitamin K1,excessive vitamin K in parenteral nutrition; may interfere with oral anticoagulant treatment,Atherosclerosis,,Heart & Vascular Health,manual_pair,"The evidence regarding vitamin K1 for coronary artery disease is limited and mixed. One study indicated a potential association between low vitamin K1 levels and coronary artery calcium progression, particularly in hypertensive individuals, but the primary analysis was not statistically significant. Overall, there is no clear benefit demonstrated in the available studies.",0.7,23719555,2013,Association between circulating vitamin K1 and coronary calcium progression in community-dwelling adults: the Multi-Ethnic Study of Atherosclerosis.,randomized_controlled_trial,mixed_unclear,"The study suggests a potential association between low vitamin K1 and CAC progression, particularly in hypertensive individuals, but the primary analysis was not statistically significant.",null null null 3 years (supplementation),,,coronary artery disease,coronary artery disease; hypertension,Tier 3,0.4,"Evidence is preliminary. The primary analysis was observational with a non-significant association between low vitamin K1 and CAC progression. The supportive RCT signal comes from a post hoc, per‑protocol subgroup (antihypertensive users) with CAC progression as a surrogate imaging endpoint rather than clinical atherosclerotic outcomes. This aligns with weak/preliminary human evidence based on exploratory, surrogate outcomes and subgroup analyses."
Vitamin K1,excessive vitamin K in parenteral nutrition; may interfere with oral anticoagulant treatment,Improve Bone Density,,Musculoskeletal & Pain,manual_pair,"One randomized controlled trial reported a beneficial effect of vitamin K1 (200 microg daily for 2 years) on bone mineral content in older women, suggesting a positive impact on bone health. However, the overall evidence is limited to this single study, and further research is needed to confirm these findings and assess long-term effects.",0.7,17243866,2007,Two-year randomized controlled trial of vitamin K1 (phylloquinone) and vitamin D3 plus calcium on the bone health of older women.,randomized_controlled_trial,benefit,"The study shows a significant increase in bone mineral content with vitamin K1 supplementation, indicating a beneficial effect on bone health.",200 microg daily 2 years,Older Adults; Women,,bone health,bone health; bone mineral density; osteoporosis prevention,Tier 2,0.56,"Double-blind RCT (n=244) with bone density as a primary outcome. However, vitamin K1 alone (200 mcg/day) did not significantly improve BMD/BMC versus placebo; the modest benefit at the ultradistal radius occurred only with co-supplementation of vitamin D3 plus calcium. Thus, while the study is high quality and directly relevant, the evidence supporting vitamin K1 monotherapy for improving bone density is limited and largely indirect."
Vitamin K1,excessive vitamin K in parenteral nutrition; may interfere with oral anticoagulant treatment,Improve Bone Density,,Musculoskeletal & Pain,manual_pair,"One randomized trial indicated that vitamin K1 (500 micrograms twice daily for 14 weeks) may favorably impact biomarkers of bone turnover in postmenopausal women, showing a significant reduction in serum osteocalcin. However, the overall evidence is limited and further studies are needed to confirm these findings and assess long-term effects.",0.7,20024591,2010,"Hop rho iso-alpha acids, berberine, vitamin D3 and vitamin K1 favorably impact biomarkers of bone turnover in postmenopausal women in a 14-week trial.",randomized_controlled_trial,benefit,"The treatment group showed a significant reduction in serum osteocalcin, indicating a benefit for bone health.",500 microg twice daily 14 weeks,Menopause; Women,,"osteoporosis, postmenopausal","osteoporosis, postmenopausal",Tier 3,0.41,"Single-blind, small pilot RCT in postmenopausal women showed reduced bone turnover marker (osteocalcin) over 14 weeks, but did not measure bone mineral density. The intervention was a multi-ingredient combination including vitamin K1, making attribution to K1 alone uncertain. Short duration and surrogate outcomes indicate preliminary human evidence."
Vitamin K1,excessive vitamin K in parenteral nutrition; may interfere with oral anticoagulant treatment,Atherosclerosis,,Heart & Vascular Health,manual_pair,"Current evidence on the effect of Vitamin K1 on vascular calcification is limited and classified as low quality. The only study available is a protocol for a trial (VitaVasK) that aims to evaluate its impact in haemodialysis patients, with no definitive outcomes reported yet. Therefore, the efficacy of Vitamin K1 for this indication remains unclear.",0.5,24285427,2014,Vitamin K1 to slow vascular calcification in haemodialysis patients (VitaVasK trial): a rationale and study protocol.,randomized_controlled_trial,mixed_unclear,"The study aims to assess the impact of Vitamin K1 on vascular calcification, but the outcomes are not yet determined as it is a protocol for a trial.",5 mg thrice weekly 18 months (oral),CKD; Hemodialysis,,coronary artery disease,coronary artery disease; haemodialysis; vascular calcification,Tier 5,0.9,"This is a study protocol with no reported outcomes, so it provides no actual evidence for Vitamin K1 treating atherosclerosis. Although it is a randomized trial design targeting vascular calcification (a surrogate marker relevant to atherosclerosis) in hemodialysis patients, without results it cannot support or refute efficacy."
Vitamin K2,"Severe bleeding complications may be lower with rivaroxaban than with VKAs.; gastrointestinal discomfort; gastrointestinal side-effects related to the unpleasant smell of the tablets; higher adverse reaction rate in vitamin K2 group; higher adverse reaction rates in the vitamin K2 group; hyper- or hypoparathyroidism; mental disorders; minor gastrointestinal cases; non-osteoporotic metabolic bone diseases; prior warfarin use; secondary osteoporosis; serious heart, liver, or kidney disease",Weight Loss,,Weight & Body Composition,manual_pair,"The evidence regarding vitamin K2 (menaquinone-7) for reducing abdominal fat mass is low quality, with a single study reporting mixed results. In a 3-year intervention, a daily dose of 180 mcg showed no overall effect on body composition despite some changes in markers, indicating unclear benefits. No studies reported harm or consistent positive outcomes.",0.8,28952607,2018,Vitamin K-induced effects on body fat and weight: results from a 3-year vitamin K2 intervention study.,randomized_controlled_trial,mixed_unclear,"The study showed mixed results; while MK-7 increased certain markers, it had no overall effect on body composition, indicating unclear benefits.",180 mcg daily 3 years (menaquinone-7 (MK-7)),,,abdominal fat mass,abdominal fat mass,Tier 1,0.72,"This is a randomized, placebo-controlled trial (n=214) over 3 years directly assessing body weight/composition outcomes relevant to weight loss. Methods and sample size are robust and the indication was a primary outcome. However, overall results were null with benefits only in a post hoc responder subgroup, so while the evidence quality is strong, efficacy remains unclear."
Vitamin K2,"Severe bleeding complications may be lower with rivaroxaban than with VKAs.; gastrointestinal discomfort; gastrointestinal side-effects related to the unpleasant smell of the tablets; higher adverse reaction rate in vitamin K2 group; higher adverse reaction rates in the vitamin K2 group; hyper- or hypoparathyroidism; mental disorders; minor gastrointestinal cases; non-osteoporotic metabolic bone diseases; prior warfarin use; secondary osteoporosis; serious heart, liver, or kidney disease",Improve Bone Density,,Musculoskeletal & Pain,manual_pair,"The evidence for vitamin K2 in preventing bone loss is mixed but leans towards benefit, with two studies demonstrating positive effects on bone mineral density, particularly at doses of 90 µg daily. However, one pilot trial yielded unclear results, indicating that further research is needed to establish consistent efficacy and optimal dosing. No adverse effects were reported in the reviewed studies.",0.8,12003435,2002,Vitamin K2 (menatetrenone) for bone loss in patients with cirrhosis of the liver.,randomized_controlled_trial,benefit,The study shows a significant benefit in bone mineral density for the vitamin K2-treated group compared to the control group.,2 years (menatetrenone),Cirrhosis,,bone loss,"bone loss; cirrhosis of the liver; osteopenia; osteoporosis, postmenopausal",Tier 2,0.64,"Randomized controlled trial in women with cirrhosis showed significant preservation of lumbar spine BMD over 2 years with vitamin K2 (menatetrenone) vs control. Bone density was a primary outcome and showed clear benefit. However, the study is small (~50 total), blinding/placebo control is unclear, and the population (cirrhosis) limits generalizability, keeping it below Tier 1."
Vitamin K2,"Severe bleeding complications may be lower with rivaroxaban than with VKAs.; gastrointestinal discomfort; gastrointestinal side-effects related to the unpleasant smell of the tablets; higher adverse reaction rate in vitamin K2 group; higher adverse reaction rates in the vitamin K2 group; hyper- or hypoparathyroidism; mental disorders; minor gastrointestinal cases; non-osteoporotic metabolic bone diseases; prior warfarin use; secondary osteoporosis; serious heart, liver, or kidney disease",Improve Bone Density,,Musculoskeletal & Pain,manual_pair,"The evidence for vitamin K2 in preventing bone loss is mixed but leans towards benefit, with two studies demonstrating positive effects on bone mineral density, particularly at doses of 90 µg daily. However, one pilot trial yielded unclear results, indicating that further research is needed to establish consistent efficacy and optimal dosing. No adverse effects were reported in the reviewed studies.",0.8,11682046,2001,Randomized pilot trial of vitamin K2 for bone loss in patients with primary biliary cirrhosis.,randomized_controlled_trial,mixed_unclear,"The outcome direction is classified as mixed_unclear due to the pilot nature of the trial, which may not provide definitive results.",,Cirrhosis,,bone loss,"bone loss; cirrhosis of the liver; osteopenia; osteoporosis, postmenopausal",Tier 2,0.46,"Randomized controlled pilot trial assessing bone density outcomes in primary biliary cirrhosis patients. The indication (bone density) is a primary/clinically relevant outcome, but the study is small/pilot with mixed/unclear results, limiting certainty."
Vitamin K2,"Severe bleeding complications may be lower with rivaroxaban than with VKAs.; gastrointestinal discomfort; gastrointestinal side-effects related to the unpleasant smell of the tablets; higher adverse reaction rate in vitamin K2 group; higher adverse reaction rates in the vitamin K2 group; hyper- or hypoparathyroidism; mental disorders; minor gastrointestinal cases; non-osteoporotic metabolic bone diseases; prior warfarin use; secondary osteoporosis; serious heart, liver, or kidney disease",Improve Bone Density,,Musculoskeletal & Pain,manual_pair,"The evidence for vitamin K2 in preventing bone loss is mixed but leans towards benefit, with two studies demonstrating positive effects on bone mineral density, particularly at doses of 90 µg daily. However, one pilot trial yielded unclear results, indicating that further research is needed to establish consistent efficacy and optimal dosing. No adverse effects were reported in the reviewed studies.",0.8,32060566,2020,Effect of Low-Dose Vitamin K2 Supplementation on Bone Mineral Density in Middle-Aged and Elderly Chinese: A Randomized Controlled Study.,randomized_controlled_trial,benefit,"The study showed a significant reduction in bone loss in postmenopausal women with 90 µg/day of VK2, indicating a benefit for this indication.",50 µg daily 1 year; 90 µg daily 1 year; 500 mg daily 1 year (calcium); 10 µg daily 1 year (vitamin D3),Menopause; Women,,"osteoporosis, postmenopausal","bone loss; cirrhosis of the liver; osteopenia; osteoporosis, postmenopausal",Tier 2,0.62,"This is a human randomized controlled trial assessing bone mineral density, a clinically relevant primary outcome for the indication. It reports benefit at 90 µg/day in postmenopausal women. However, details on sample size, blinding, and the role of co-supplementation with calcium and vitamin D are unclear, which lowers methodological certainty and generalizability."
Vitamin K2,"Severe bleeding complications may be lower with rivaroxaban than with VKAs.; gastrointestinal discomfort; gastrointestinal side-effects related to the unpleasant smell of the tablets; higher adverse reaction rate in vitamin K2 group; higher adverse reaction rates in the vitamin K2 group; hyper- or hypoparathyroidism; mental disorders; minor gastrointestinal cases; non-osteoporotic metabolic bone diseases; prior warfarin use; secondary osteoporosis; serious heart, liver, or kidney disease",Improve Bone Density,,Musculoskeletal & Pain,manual_pair,"One randomized trial indicates that Vitamin K2 (menaquinone-7) at a dose of 375 µg daily for 12 months may help preserve trabecular bone microarchitecture in postmenopausal women with osteopenia. No studies reported mixed outcomes or adverse effects, suggesting a potential benefit in this population, though further research may be needed to confirm these findings.",0.9,27625301,2016,Vitamin K2 (menaquinone-7) prevents age-related deterioration of trabecular bone microarchitecture at the tibia in postmenopausal women.,randomized_controlled_trial,benefit,The study shows that MK-7 has a beneficial effect on preserving trabecular bone structure in postmenopausal women with osteopenia.,375 µg 12 months,Menopause; Women,,age-related deterioration of trabecular bone microarchitecture,age-related deterioration of trabecular bone microarchitecture; osteopenia,Tier 4,0.62,"Double-blind, placebo-controlled RCT in postmenopausal women with osteopenia (n=148) tested MK-7 for 12 months. While it improved ucOC and preserved trabecular microarchitecture at the tibia (HRpQCT), there were no significant differences in DXA-measured bone mineral density at any site. Because the indication is to improve bone density (BMD) and this outcome did not improve, the supportive findings are indirect (imaging/surrogate), yielding very low/indirect evidence for this specific indication."
Vitamin K2,"Severe bleeding complications may be lower with rivaroxaban than with VKAs.; gastrointestinal discomfort; gastrointestinal side-effects related to the unpleasant smell of the tablets; higher adverse reaction rate in vitamin K2 group; higher adverse reaction rates in the vitamin K2 group; hyper- or hypoparathyroidism; mental disorders; minor gastrointestinal cases; non-osteoporotic metabolic bone diseases; prior warfarin use; secondary osteoporosis; serious heart, liver, or kidney disease",Improve Bone Density,,Musculoskeletal & Pain,manual_pair,"One randomized trial indicates that menatetrenone (vitamin K2) treatment may reduce bone loss in patients with anorexia nervosa compared to a control group, suggesting a beneficial effect. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term safety and efficacy.",0.8,12686368,2003,Effect of menatetrenone (vitamin K2) treatment on bone loss in patients with anorexia nervosa.,clinical_trial,benefit,"The study shows that menatetrenone treatment resulted in less bone loss compared to the control group, indicating a beneficial effect.",mean 0.9-year (menatetrenone),Anorexia Nervosa,,anorexia nervosa,anorexia nervosa; osteoporosis,Tier 3,0.58,"Small, non-randomized, open-label comparative study (10 vs 11) in anorexia nervosa patients showing reduced lumbar BMD loss with menatetrenone. Outcome is a surrogate (BMD) and design is prone to bias (self-selection, no blinding). Suggestive but preliminary; RCTs needed."
Vitamin K2,"Severe bleeding complications may be lower with rivaroxaban than with VKAs.; gastrointestinal discomfort; gastrointestinal side-effects related to the unpleasant smell of the tablets; higher adverse reaction rate in vitamin K2 group; higher adverse reaction rates in the vitamin K2 group; hyper- or hypoparathyroidism; mental disorders; minor gastrointestinal cases; non-osteoporotic metabolic bone diseases; prior warfarin use; secondary osteoporosis; serious heart, liver, or kidney disease",Improve Bone Density,,Musculoskeletal & Pain,manual_pair,"One randomized trial indicates that Vitamin K2 (15 mg per day) may inhibit glucocorticoid-induced bone loss by preventing the reduction of osteoprotegerin (OPG). No studies reported mixed or negative outcomes, suggesting a potential benefit, but further research is needed to confirm these findings and assess long-term safety and efficacy.",0.8,15616893,2005,Vitamin K2 inhibits glucocorticoid-induced bone loss partly by preventing the reduction of osteoprotegerin (OPG).,randomized_controlled_trial,benefit,Vitamin K2 showed a beneficial effect in preventing bone loss compared to glucocorticoid treatment alone.,15 mg per day,Steroid Use,,glucocorticoid-induced bone loss,glucocorticoid-induced bone loss; osteoporosis,Tier 2,0.62,"Small randomized controlled trial (n=20) in glucocorticoid-treated patients measured lumbar spine BMD and bone turnover markers; vitamin K2 prevented BMD loss versus control. Clinically relevant primary outcome but limited by small sample size and likely weak blinding, so moderate—not strong—human evidence."
Vitamin K2,"Severe bleeding complications may be lower with rivaroxaban than with VKAs.; gastrointestinal discomfort; gastrointestinal side-effects related to the unpleasant smell of the tablets; higher adverse reaction rate in vitamin K2 group; higher adverse reaction rates in the vitamin K2 group; hyper- or hypoparathyroidism; mental disorders; minor gastrointestinal cases; non-osteoporotic metabolic bone diseases; prior warfarin use; secondary osteoporosis; serious heart, liver, or kidney disease",Improve Bone Density,,Musculoskeletal & Pain,manual_pair,"One randomized trial indicates that Vitamin K2 may have beneficial effects on bone health in patients with rheumatoid arthritis over a 24-month period, particularly when used alone or in combination with bisphosphonates. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term safety and efficacy.",0.7,18260178,2008,Osteoclast inhibitory effects of vitamin K2 alone or in combination with etidronate or risedronate in patients with rheumatoid arthritis: 2-year results.,randomized_controlled_trial,benefit,"The study shows that Vitamin K2, alone or with bisphosphonates, has beneficial effects on bone health in RA patients.",24 months (oral),Osteoporosis; Rheumatoid Arthritis,,osteoporosis,osteoporosis; rheumatoid arthritis,Tier 4,0.29,"In RA patients on steroids, all arms received vitamin K2, so there was no non-K2 control. BMD benefit was seen only when K2 was combined with bisphosphonates; K2 alone did not show significant BMD improvement, and most positive findings were on surrogate markers (NTx, RANKL). This makes the evidence for K2 alone to improve bone density indirect and very low quality for this indication."
Vitamin K2,"Severe bleeding complications may be lower with rivaroxaban than with VKAs.; gastrointestinal discomfort; gastrointestinal side-effects related to the unpleasant smell of the tablets; higher adverse reaction rate in vitamin K2 group; higher adverse reaction rates in the vitamin K2 group; hyper- or hypoparathyroidism; mental disorders; minor gastrointestinal cases; non-osteoporotic metabolic bone diseases; prior warfarin use; secondary osteoporosis; serious heart, liver, or kidney disease",Improve Bone Density,,Musculoskeletal & Pain,manual_pair,"Clinical evidence suggests that vitamin K2 (MK-4) supplementation may benefit bone health in postmenopausal women, with studies indicating improvements in bone mineral content and metabolism. Doses reported include 1.5 mg daily for 12 months and 45 mg daily for 3 years, both showing positive outcomes without significant adverse effects. However, the evidence is limited to a small number of studies, and further research may be needed to confirm these findings.",0.8,17287908,2007,Vitamin K2 supplementation improves hip bone geometry and bone strength indices in postmenopausal women.,randomized_controlled_trial,benefit,"Vitamin K2 improved bone mineral content and femoral neck width, contributing to bone strength maintenance.",45 mg daily 3 years (MK-4 (menatetrenone)),Menopause; Women,,bone health,bone health; bone metabolism; bone mineral density; bone strength; osteoporosis; postmenopausal osteoporosis,Tier 1,0.87,"Large, long-duration randomized controlled trial (n=325, 3 years) in postmenopausal women directly assessed bone density (DXA-BMD) as a major outcome. Vitamin K2 (MK-4, 45 mg/day) did not improve BMD, though it increased bone mineral content and femoral neck width and maintained hip strength indices. Thus, this is strong, directly relevant human evidence for the indication, albeit showing no BMD benefit."
Vitamin K2,"Severe bleeding complications may be lower with rivaroxaban than with VKAs.; gastrointestinal discomfort; gastrointestinal side-effects related to the unpleasant smell of the tablets; higher adverse reaction rate in vitamin K2 group; higher adverse reaction rates in the vitamin K2 group; hyper- or hypoparathyroidism; mental disorders; minor gastrointestinal cases; non-osteoporotic metabolic bone diseases; prior warfarin use; secondary osteoporosis; serious heart, liver, or kidney disease",Improve Bone Density,,Musculoskeletal & Pain,manual_pair,"Clinical evidence suggests that vitamin K2 (MK-4) supplementation may benefit bone health in postmenopausal women, with studies indicating improvements in bone mineral content and metabolism. Doses reported include 1.5 mg daily for 12 months and 45 mg daily for 3 years, both showing positive outcomes without significant adverse effects. However, the evidence is limited to a small number of studies, and further research may be needed to confirm these findings.",0.8,23702931,2014,Low-dose vitamin K2 (MK-4) supplementation for 12 months improves bone metabolism and prevents forearm bone loss in postmenopausal Japanese women.,randomized_controlled_trial,benefit,The study shows that low-dose MK-4 supplementation improved bone quality and reduced specific biomarkers without significant adverse effects.,1.5 mg daily 12 months (MK-4),Menopause; Women,,bone metabolism,bone health; bone metabolism; bone mineral density; bone strength; osteoporosis; postmenopausal osteoporosis,Tier 2,0.6,"Randomized, double-blind, placebo-controlled trial (n=48) in postmenopausal women showed prevention of forearm BMD loss over 12 months and improvements in bone turnover markers with low-dose MK-4. While clinically relevant BMD was measured, the study is small and BMD appears secondary to biomarker outcomes, limiting strength despite good design."
Vitamin K2,"Severe bleeding complications may be lower with rivaroxaban than with VKAs.; gastrointestinal discomfort; gastrointestinal side-effects related to the unpleasant smell of the tablets; higher adverse reaction rate in vitamin K2 group; higher adverse reaction rates in the vitamin K2 group; hyper- or hypoparathyroidism; mental disorders; minor gastrointestinal cases; non-osteoporotic metabolic bone diseases; prior warfarin use; secondary osteoporosis; serious heart, liver, or kidney disease",Depression,,"Energy, Mood, & Mental Health",manual_pair,"There is limited evidence suggesting that vitamin K2 (90 µg daily for 8 weeks) may improve depression status in patients with polycystic ovary syndrome, as indicated by one randomized clinical trial. However, the overall evidence is sparse and further research is needed to confirm these findings and establish consistency across different populations.",0.7,35883082,2022,Effect of vitamin K2 administration on depression status in patients with polycystic ovary syndrome: a randomized clinical trial.,randomized_controlled_trial,benefit,"The study showed a significant improvement in depression status in PCOS patients after vitamin K2 administration, indicating a beneficial outcome.",90 µg daily 8 weeks (Menaquinone-7),PCOS,,depression,depression; polycystic ovary syndrome,Tier 1,0.7,"Randomized, double-blind, placebo-controlled trial (n=84) in PCOS patients found significant improvement in depression symptoms (BDI-II) after 8 weeks of vitamin K2 (MK-7, 90 µg/day), with depression as a primary clinical outcome. Methods are strong, though sample size is modest and population is a specific subgroup (PCOS), limiting generalizability beyond this group."
Vitamin K2,"Severe bleeding complications may be lower with rivaroxaban than with VKAs.; gastrointestinal discomfort; gastrointestinal side-effects related to the unpleasant smell of the tablets; higher adverse reaction rate in vitamin K2 group; higher adverse reaction rates in the vitamin K2 group; hyper- or hypoparathyroidism; mental disorders; minor gastrointestinal cases; non-osteoporotic metabolic bone diseases; prior warfarin use; secondary osteoporosis; serious heart, liver, or kidney disease",Arterial Stiffness,,Heart & Vascular Health,manual_pair,"The evidence for vitamin K2 supplementation in reducing high arterial stiffness is limited to a single clinical trial involving renal transplant recipients, which reported a significant benefit with a dose of 360 μg (menaquinone-7) daily for 8 weeks. No adverse effects were noted, but the overall evidence quality is low due to the lack of multiple studies and mixed findings in the broader literature.",0.5,28756183,2017,"Vitamin K2 supplementation and arterial stiffness among renal transplant recipients-a single-arm, single-center clinical trial.",clinical_trial,benefit,"The study showed a significant reduction in arterial stiffness and improvement in vitamin K status, indicating a beneficial effect of supplementation.",360 μg once daily 8 weeks (menaquinone-7),Kidney Transplant,,arterial stiffness,arterial stiffness; cardiovascular disease risk; subclinical vitamin k deficiency,Tier 3,0.68,"Single-arm, uncontrolled clinical trial (n=60) in renal transplant recipients showing improvement in a surrogate outcome (cfPWV) after MK-7 supplementation. Lack of randomization/control and short duration make the evidence preliminary despite a relevant primary outcome."
Vitamin K2,"Severe bleeding complications may be lower with rivaroxaban than with VKAs.; gastrointestinal discomfort; gastrointestinal side-effects related to the unpleasant smell of the tablets; higher adverse reaction rate in vitamin K2 group; higher adverse reaction rates in the vitamin K2 group; hyper- or hypoparathyroidism; mental disorders; minor gastrointestinal cases; non-osteoporotic metabolic bone diseases; prior warfarin use; secondary osteoporosis; serious heart, liver, or kidney disease",High Blood Glucose,,Metabolic Health,manual_pair,"One randomized controlled trial suggests that Vitamin K2 supplementation may improve insulin sensitivity in individuals with Type 2 Diabetes. However, the evidence is limited, with only a single study reporting a benefit and no consistent dose ranges or additional studies to confirm these findings. No adverse effects were noted in the reported study, but further research is needed to establish the efficacy and safety of Vitamin K2 for this indication.",0.5,21868771,2011,Vitamin K2 supplementation improves insulin sensitivity via osteocalcin metabolism: a placebo-controlled trial.,clinical_trial,benefit,"The study shows that Vitamin K2 supplementation improves insulin sensitivity, indicating a beneficial outcome.",,,,insulin resistance,insulin resistance,Tier 3,0.62,"Placebo-controlled human trial reports improved insulin sensitivity with vitamin K2, but the indication is high blood glucose and the study assessed a surrogate (insulin sensitivity/osteocalcin metabolism) rather than direct glycemic outcomes (e.g., fasting glucose, HbA1c). Thus evidence is preliminary/indirect for this specific indication despite RCT design."
Vitamin K2,"Severe bleeding complications may be lower with rivaroxaban than with VKAs.; gastrointestinal discomfort; gastrointestinal side-effects related to the unpleasant smell of the tablets; higher adverse reaction rate in vitamin K2 group; higher adverse reaction rates in the vitamin K2 group; hyper- or hypoparathyroidism; mental disorders; minor gastrointestinal cases; non-osteoporotic metabolic bone diseases; prior warfarin use; secondary osteoporosis; serious heart, liver, or kidney disease",Improve Bone Density,,Musculoskeletal & Pain,manual_pair,"One randomized clinical trial (PMID 23828145) suggests that vitamin K2 (45 mg daily for 2 years) may reduce fracture risk in osteoporotic patients when used concurrently with risedronate. No studies reported mixed or negative outcomes, but the evidence is limited to a single trial, necessitating caution in interpretation.",0.7,23828145,2014,Design of a randomized clinical trial of concurrent treatment with vitamin K2 and risedronate compared to risedronate alone in osteoporotic patients: Japanese Osteoporosis Intervention Trial-03 (JOINT-03).,randomized_controlled_trial,benefit,"The primary endpoint is fracture reduction, indicating a potential benefit from the treatment.",45 mg daily 2 years,Osteoporosis; Women,,osteoporosis,osteoporosis,Tier 5,0.86,"This is a trial design/protocol without reported outcomes. While bone mineral density is a prespecified secondary endpoint in an open-label RCT of vitamin K2 added to risedronate, no efficacy results are provided. Therefore, it does not constitute actual evidence for improving bone density."
Vitamin K2,"Severe bleeding complications may be lower with rivaroxaban than with VKAs.; gastrointestinal discomfort; gastrointestinal side-effects related to the unpleasant smell of the tablets; higher adverse reaction rate in vitamin K2 group; higher adverse reaction rates in the vitamin K2 group; hyper- or hypoparathyroidism; mental disorders; minor gastrointestinal cases; non-osteoporotic metabolic bone diseases; prior warfarin use; secondary osteoporosis; serious heart, liver, or kidney disease",Improve Bone Density,,Musculoskeletal & Pain,manual_pair,"Clinical evidence suggests that vitamin K2 may improve bone mineral density in individuals with low bone density, as demonstrated in two randomized trials. Doses reported include 50 mcg (menaquinone-7) and 180 mcg (menakinon-7) over one year, both showing beneficial effects. No adverse effects were noted in the studies, but further research is needed to confirm these findings and assess long-term safety.",0.9,24136015,2013,The efficacy of vitamin K2 and calcitriol combination on thalassemic osteopathy.,clinical_trial,benefit,"The study demonstrated a significant improvement in bone mineral density, indicating a beneficial effect of vitamin K2.",50 mcg 1 year (menaquinone-7),Thalassemia,,beta-thalassemia,beta-thalassemia; bone health; heart transplantation; lung transplantation; osteoporosis; thalassemic osteopathy,Tier 3,0.44,"Small prospective pilot study (n=20), likely uncontrolled and unblinded, in pediatric thalassemia patients using a combination of vitamin K2 (MK-7) and calcitriol. Outcome was bone mineral density/Z-score (surrogate but relevant). Positive results but attribution to K2 alone is confounded by concurrent vitamin D analog and the specific population limits generalizability. Fits weak/preliminary human evidence."
Vitamin K2,"Severe bleeding complications may be lower with rivaroxaban than with VKAs.; gastrointestinal discomfort; gastrointestinal side-effects related to the unpleasant smell of the tablets; higher adverse reaction rate in vitamin K2 group; higher adverse reaction rates in the vitamin K2 group; hyper- or hypoparathyroidism; mental disorders; minor gastrointestinal cases; non-osteoporotic metabolic bone diseases; prior warfarin use; secondary osteoporosis; serious heart, liver, or kidney disease",Improve Bone Density,,Musculoskeletal & Pain,manual_pair,"Clinical evidence suggests that vitamin K2 may improve bone mineral density in individuals with low bone density, as demonstrated in two randomized trials. Doses reported include 50 mcg (menaquinone-7) and 180 mcg (menakinon-7) over one year, both showing beneficial effects. No adverse effects were noted in the studies, but further research is needed to confirm these findings and assess long-term safety.",0.9,20177349,2010,Dietary vitamin K2 supplement improves bone status after lung and heart transplantation.,randomized_controlled_trial,benefit,"The study shows a favorable effect on lumbar spine bone mineral density in transplant recipients, indicating a benefit from vitamin K2 supplementation.",180 microg 1 year (menakinon-7),Heart Transplant; Lung Transplant,,bone health,beta-thalassemia; bone health; heart transplantation; lung transplantation; osteoporosis; thalassemic osteopathy,Tier 2,0.64,"Randomized, double-blind, placebo-controlled human trial with bone mineral density as a primary/major outcome directly matching the indication. Sample size is modest and results are mixed: borderline overall effect (P≈0.055) but significant after adjustment (P=0.019) and in lung recipients; not significant in heart recipients. Special transplant population and common vitamin D insufficiency limit generalizability and may confound effects, so evidence is moderate rather than strong."
Vitamin K2,"Severe bleeding complications may be lower with rivaroxaban than with VKAs.; gastrointestinal discomfort; gastrointestinal side-effects related to the unpleasant smell of the tablets; higher adverse reaction rate in vitamin K2 group; higher adverse reaction rates in the vitamin K2 group; hyper- or hypoparathyroidism; mental disorders; minor gastrointestinal cases; non-osteoporotic metabolic bone diseases; prior warfarin use; secondary osteoporosis; serious heart, liver, or kidney disease",Improve Bone Density,,Musculoskeletal & Pain,manual_pair,"One randomized trial demonstrated a benefit of vitamin K2 in improving osteocalcin carboxylation in early postmenopausal women with low bone density, using a dose of 45 mg daily for 2 years. There is currently no evidence of harm or no benefit, but the overall evidence is limited to a single study, indicating a need for further research to confirm these findings and assess long-term effects.",0.7,17012108,2006,Effect of vitamin K2 treatment on carboxylation of osteocalcin in early postmenopausal women.,randomized_controlled_trial,benefit,"The study shows a significant decrease in undercarboxylated osteocalcin levels, indicating a benefit from vitamin K2 treatment.",45 mg daily 2 years (oral),Menopause; Women,,bone turnover,bone turnover; osteopenia; osteoporosis; postmenopausal health,Tier 3,0.45,"Small human interventional study (n=34) with no placebo/control arm for vitamin K2 alone; significant effects were on a surrogate biomarker (undercarboxylated osteocalcin), not on the clinical endpoint of bone density. BMD was measured but not clearly improved with K2 alone, and any suggestion of benefit pertained to the combination with vitamin D3. Thus, evidence for improving bone density is weak and largely indirect."
Vitamin K2,"Severe bleeding complications may be lower with rivaroxaban than with VKAs.; gastrointestinal discomfort; gastrointestinal side-effects related to the unpleasant smell of the tablets; higher adverse reaction rate in vitamin K2 group; higher adverse reaction rates in the vitamin K2 group; hyper- or hypoparathyroidism; mental disorders; minor gastrointestinal cases; non-osteoporotic metabolic bone diseases; prior warfarin use; secondary osteoporosis; serious heart, liver, or kidney disease",Improve Bone Density,,Musculoskeletal & Pain,manual_pair,"Clinical evidence from three randomized trials indicates that vitamin K2 may improve bone mineral density in postmenopausal women with osteoporosis, with consistent doses of 45 mg (menatetrenone) reported in two studies. No adverse effects were noted in the reviewed studies, but the overall quality of evidence should be interpreted with caution due to the limited number of trials and potential variability in study designs.",0.8,11180916,2000,Effect of combined administration of vitamin D3 and vitamin K2 on bone mineral density of the lumbar spine in postmenopausal women with osteoporosis.,randomized_controlled_trial,benefit,"The study shows a significant increase in bone mineral density with the administration of Vitamin K2, indicating a beneficial effect.",45 mg daily 2 years (menatetrenone),Menopause; Osteoporosis; Women,,osteoporosis,osteoporosis; postmenopausal osteoporosis,Tier 2,0.7,"Randomized controlled trial in postmenopausal women with osteoporosis showed vitamin K2 (menatetrenone 45 mg/day) increased lumbar spine BMD versus calcium control over 2 years. The outcome (BMD change) directly matches the indication. However, the K2 arm was small (n=22), blinding is unclear, and the comparator was calcium rather than placebo, so methodological strength and size are not sufficient for Tier 1."
Vitamin K2,"Severe bleeding complications may be lower with rivaroxaban than with VKAs.; gastrointestinal discomfort; gastrointestinal side-effects related to the unpleasant smell of the tablets; higher adverse reaction rate in vitamin K2 group; higher adverse reaction rates in the vitamin K2 group; hyper- or hypoparathyroidism; mental disorders; minor gastrointestinal cases; non-osteoporotic metabolic bone diseases; prior warfarin use; secondary osteoporosis; serious heart, liver, or kidney disease",Improve Bone Density,,Musculoskeletal & Pain,manual_pair,"Clinical evidence from three randomized trials indicates that vitamin K2 may improve bone mineral density in postmenopausal women with osteoporosis, with consistent doses of 45 mg (menatetrenone) reported in two studies. No adverse effects were noted in the reviewed studies, but the overall quality of evidence should be interpreted with caution due to the limited number of trials and potential variability in study designs.",0.8,39197463,2025,Efficacy of Recombinant Human Parathyroid Hormone 1-34 and Vitamin K2 Combination Therapy in Postmenopausal Osteoporosis.,randomized_controlled_trial,benefit,"The study demonstrated that the combination therapy was more effective than vitamin K2 alone in improving bone mineral density and bone metabolism markers, indicating a benefit.",(vitamin K2); (rhPTH (1-34) and vitamin K2),Menopause; Osteoporosis,,postmenopausal osteoporosis,osteoporosis; postmenopausal osteoporosis,Tier 5,0.66,"This RCT compared vitamin K2 alone versus vitamin K2 plus rhPTH(1-34). It was designed to test the added benefit of rhPTH, not the efficacy of vitamin K2 versus control/placebo. Any improvement in the K2 arm is pre–post without a true control, so it does not provide direct evidence that vitamin K2 improves bone density."
Vitamin K2,"Severe bleeding complications may be lower with rivaroxaban than with VKAs.; gastrointestinal discomfort; gastrointestinal side-effects related to the unpleasant smell of the tablets; higher adverse reaction rate in vitamin K2 group; higher adverse reaction rates in the vitamin K2 group; hyper- or hypoparathyroidism; mental disorders; minor gastrointestinal cases; non-osteoporotic metabolic bone diseases; prior warfarin use; secondary osteoporosis; serious heart, liver, or kidney disease",Improve Bone Density,,Musculoskeletal & Pain,manual_pair,"Clinical evidence from three randomized trials indicates that vitamin K2 may improve bone mineral density in postmenopausal women with osteoporosis, with consistent doses of 45 mg (menatetrenone) reported in two studies. No adverse effects were noted in the reviewed studies, but the overall quality of evidence should be interpreted with caution due to the limited number of trials and potential variability in study designs.",0.8,16594930,2006,Vitamin K2 treatment for postmenopausal osteoporosis in Indonesia.,randomized_controlled_trial,benefit,"The treatment resulted in a significant increase in lumbar BMD and a decrease in undercarboxylated OC levels, indicating a beneficial effect.",45 mg daily 48 weeks (menatetrenone),Menopause; Osteoporosis,,postmenopausal osteoporosis,osteoporosis; postmenopausal osteoporosis,Tier 2,0.7,"Double-blind, randomized, placebo-controlled trial (n=63) in postmenopausal women with osteoporosis showed a significant increase in lumbar spine BMD with vitamin K2 versus control over 48 weeks. The outcome directly matches the indication. However, the sample size is modest and this is a single study, so the evidence is moderate rather than strong."
Vitamin K2,"Severe bleeding complications may be lower with rivaroxaban than with VKAs.; gastrointestinal discomfort; gastrointestinal side-effects related to the unpleasant smell of the tablets; higher adverse reaction rate in vitamin K2 group; higher adverse reaction rates in the vitamin K2 group; hyper- or hypoparathyroidism; mental disorders; minor gastrointestinal cases; non-osteoporotic metabolic bone diseases; prior warfarin use; secondary osteoporosis; serious heart, liver, or kidney disease",Aerobic Capacity,,Performance & Recovery,manual_pair,"One randomized trial reported that oral supplementation of Vitamin K2 (300 mg daily for 4 weeks followed by 150 mg daily for another 4 weeks) was associated with a significant increase in maximal cardiac output during exercise, suggesting a potential benefit for low exercise performance. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term effects and safety.",0.7,28646812,2017,Oral Consumption of Vitamin K2 for 8 Weeks Associated With Increased Maximal Cardiac Output During Exercise.,randomized_controlled_trial,benefit,"The study showed a significant increase in maximal cardiac output, indicating a benefit from Vitamin K2 supplementation.",300 mg daily 4 weeks (oral); 150 mg daily 4 weeks (oral),,,cardiovascular function,cardiovascular function; increased maximal cardiac output,Tier 3,0.56,"Single small RCT (N=26) in trained athletes found increased maximal cardiac output after 8 weeks of vitamin K2, but did not demonstrate improvements in direct measures of aerobic capacity (e.g., VO2max or performance). The outcome is a physiological surrogate rather than a primary clinical measure of aerobic capacity, making the evidence preliminary despite randomized, placebo-controlled design."
Vitamin K2,"Severe bleeding complications may be lower with rivaroxaban than with VKAs.; gastrointestinal discomfort; gastrointestinal side-effects related to the unpleasant smell of the tablets; higher adverse reaction rate in vitamin K2 group; higher adverse reaction rates in the vitamin K2 group; hyper- or hypoparathyroidism; mental disorders; minor gastrointestinal cases; non-osteoporotic metabolic bone diseases; prior warfarin use; secondary osteoporosis; serious heart, liver, or kidney disease",Muscle Cramps,,Musculoskeletal & Pain,manual_pair,"One randomized controlled trial reported that Vitamin K2 supplementation (360 µg daily for 4 weeks) significantly reduced the frequency, duration, and severity of muscle cramps in hemodialysis patients. However, the overall evidence is limited, with only one study available, indicating a need for further research to confirm these findings and assess generalizability.",0.7,35203045,2022,"Vitamin K2 as a potential therapeutic candidate for the prevention of muscle cramps in hemodialysis patients: A prospective multicenter, randomized, controlled, crossover pilot trial.",randomized_controlled_trial,benefit,"Vitamin K2 supplementation showed a significant reduction in the frequency, duration, and severity of muscle cramps in hemodialysis patients, indicating a beneficial outcome.",360 µg daily 4 weeks,CKD; Hemodialysis,,muscle cramps,muscle cramps,Tier 2,0.65,"Placebo-controlled randomized crossover trial with primary outcomes (frequency, duration, severity of cramps) showing benefit, but small pilot sample and restricted to hemodialysis patients limit strength and generalizability, preventing Tier 1."
Vitamin K2,"Severe bleeding complications may be lower with rivaroxaban than with VKAs.; gastrointestinal discomfort; gastrointestinal side-effects related to the unpleasant smell of the tablets; higher adverse reaction rate in vitamin K2 group; higher adverse reaction rates in the vitamin K2 group; hyper- or hypoparathyroidism; mental disorders; minor gastrointestinal cases; non-osteoporotic metabolic bone diseases; prior warfarin use; secondary osteoporosis; serious heart, liver, or kidney disease",Muscle Cramps,,Musculoskeletal & Pain,manual_pair,"One randomized clinical trial reported that vitamin K2 supplementation (180 μg daily for 8 weeks) significantly reduced the frequency, intensity, and duration of nocturnal leg cramps, indicating a beneficial effect. However, the overall evidence is limited to this single study, and further research is needed to confirm these findings and assess long-term safety and efficacy.",0.7,39466236,2024,Vitamin K2 in Managing Nocturnal Leg Cramps: A Randomized Clinical Trial.,randomized_controlled_trial,benefit,"The study demonstrated a significant reduction in the frequency, intensity, and duration of nocturnal leg cramps with vitamin K2 supplementation, indicating a beneficial outcome.",180 μg daily 8 weeks (capsules),,,nocturnal leg cramps,nocturnal leg cramps,Tier 1,0.82,"Multicenter, double-blind, placebo-controlled RCT (n=199) with nocturnal leg cramps as the primary outcome showed significant reductions in frequency, severity, and duration with vitamin K2 (MK-7) 180 μg daily over 8 weeks. Sample size and methods are robust, and outcomes are clinically relevant, though limited to older adults and short duration."
Vitamin K2,"Severe bleeding complications may be lower with rivaroxaban than with VKAs.; gastrointestinal discomfort; gastrointestinal side-effects related to the unpleasant smell of the tablets; higher adverse reaction rate in vitamin K2 group; higher adverse reaction rates in the vitamin K2 group; hyper- or hypoparathyroidism; mental disorders; minor gastrointestinal cases; non-osteoporotic metabolic bone diseases; prior warfarin use; secondary osteoporosis; serious heart, liver, or kidney disease",Improve Bone Density,,Musculoskeletal & Pain,manual_pair,"Current clinical evidence regarding Vitamin K2 for osteoporosis is limited and mixed, with one study showing no significant differences in key outcomes such as undercarboxylated osteocalcin levels and vertebral fracture incidence. As such, the benefits of Vitamin K2 in this context remain unclear, and no consistent dosing information is available. No adverse effects were reported in the reviewed study.",0.7,23846118,2014,Effects of risedronate alone or combined with vitamin K2 on serum undercarboxylated osteocalcin and osteocalcin levels in postmenopausal osteoporosis.,randomized_controlled_trial,mixed_unclear,"The study shows mixed results with no significant differences in ucOC levels and vertebral fracture incidence between the groups, indicating unclear benefits of Vitamin K2 in this context.",6 and 12 months,Menopause; Osteoporosis; Women,,postmenopausal osteoporosis,postmenopausal osteoporosis,Tier 5,0.78,"This RCT in postmenopausal osteoporotic women evaluated vitamin K2 added to risedronate with outcomes of ucOC/OC and vertebral fracture incidence; bone mineral density was not measured. With no BMD assessment and no significant fracture benefit, the study does not test the supplement for the specific indication of improving bone density."
Vitamin K2,"Severe bleeding complications may be lower with rivaroxaban than with VKAs.; gastrointestinal discomfort; gastrointestinal side-effects related to the unpleasant smell of the tablets; higher adverse reaction rate in vitamin K2 group; higher adverse reaction rates in the vitamin K2 group; hyper- or hypoparathyroidism; mental disorders; minor gastrointestinal cases; non-osteoporotic metabolic bone diseases; prior warfarin use; secondary osteoporosis; serious heart, liver, or kidney disease",Improve Bone Density,,Musculoskeletal & Pain,manual_pair,"Clinical evidence suggests that vitamin K2 supplementation may have beneficial effects on bone health, as indicated by improved serum osteocalcin levels in postmenopausal women and increased gamma-carboxylated osteocalcin with fermented soybean intake. Doses reported include 1.5 mg daily for MK-4 and varying amounts of natto providing up to 1765 micrograms of MK-7. However, the overall evidence is limited to a small number of studies, and further research is needed to confirm these findings and assess long-term safety.",0.8,19352059,2009,Effect of low dose vitamin K2 (MK-4) supplementation on bio-indices in postmenopausal Japanese women.,randomized_controlled_trial,benefit,"The study suggests that MK-4 supplementation may be beneficial for maintaining bone health, indicated by improved serum osteocalcin levels.",1.5 mg daily 4 weeks,Menopause; Women,,bone health,bone health; osteoporosis; postmenopausal women,Tier 3,0.47,"Randomized, double-blind, placebo-controlled RCT (n=40) in postmenopausal women, but short duration (4 weeks) and primary outcomes were surrogate biomarkers (osteocalcin carboxylation) rather than bone mineral density or fractures. Suggests effect on bone metabolism, not direct evidence for improved bone density."
Vitamin K2,"Severe bleeding complications may be lower with rivaroxaban than with VKAs.; gastrointestinal discomfort; gastrointestinal side-effects related to the unpleasant smell of the tablets; higher adverse reaction rate in vitamin K2 group; higher adverse reaction rates in the vitamin K2 group; hyper- or hypoparathyroidism; mental disorders; minor gastrointestinal cases; non-osteoporotic metabolic bone diseases; prior warfarin use; secondary osteoporosis; serious heart, liver, or kidney disease",Improve Bone Density,,Musculoskeletal & Pain,manual_pair,"Clinical evidence suggests that vitamin K2 supplementation may have beneficial effects on bone health, as indicated by improved serum osteocalcin levels in postmenopausal women and increased gamma-carboxylated osteocalcin with fermented soybean intake. Doses reported include 1.5 mg daily for MK-4 and varying amounts of natto providing up to 1765 micrograms of MK-7. However, the overall evidence is limited to a small number of studies, and further research is needed to confirm these findings and assess long-term safety.",0.8,10874601,2000,Intake of fermented soybean (natto) increases circulating vitamin K2 (menaquinone-7) and gamma-carboxylated osteocalcin concentration in normal individuals.,clinical_trial,benefit,"The study shows that intake of natto increases serum MK-7 and gamma-carboxylated osteocalcin, indicating a beneficial effect on bone health.",775 micrograms daily (fermented soybeans (natto)); 1298 micrograms daily (fermented soybeans (natto)); 1765 micrograms daily (fermented soybeans (natto)),,,bone health,bone health; osteoporosis; postmenopausal women,Tier 4,0.62,"Small, non-randomized human study and observational component assessing surrogate mechanistic markers (serum MK-7 and osteocalcin carboxylation), not bone density or fracture outcomes. Findings are indirect for the indication of improving bone density."
Vitamin K2,"Severe bleeding complications may be lower with rivaroxaban than with VKAs.; gastrointestinal discomfort; gastrointestinal side-effects related to the unpleasant smell of the tablets; higher adverse reaction rate in vitamin K2 group; higher adverse reaction rates in the vitamin K2 group; hyper- or hypoparathyroidism; mental disorders; minor gastrointestinal cases; non-osteoporotic metabolic bone diseases; prior warfarin use; secondary osteoporosis; serious heart, liver, or kidney disease",Improve Bone Density,,Musculoskeletal & Pain,manual_pair,"One randomized trial indicates that Vitamin K2 (menatetrenone) at a dose of 45 mg daily for 24 months effectively prevents fractures and maintains lumbar bone mineral density in osteoporotic patients. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term safety and efficacy.",0.8,10750566,2000,Vitamin K2 (menatetrenone) effectively prevents fractures and sustains lumbar bone mineral density in osteoporosis.,randomized_controlled_trial,benefit,"The study shows that Vitamin K2 treatment effectively prevents new fractures in osteoporotic patients, indicating a beneficial outcome.",45 mg daily 24 months (oral),Osteoporosis,,fractures,fractures; osteoporosis,Tier 2,0.65,"Single randomized controlled trial (n=241, 24 months) in osteoporotic patients found vitamin K2 (45 mg/day MK-4) significantly attenuated lumbar spine BMD loss versus control by DXA. However, the study was open-label without placebo and fracture prevention appears to have been the primary endpoint, with BMD a key secondary outcome. These methodological limitations and the fact that BMD was maintained rather than increased support moderate, not strong, evidence for improving bone density."
Vitamin K2,"Severe bleeding complications may be lower with rivaroxaban than with VKAs.; gastrointestinal discomfort; gastrointestinal side-effects related to the unpleasant smell of the tablets; higher adverse reaction rate in vitamin K2 group; higher adverse reaction rates in the vitamin K2 group; hyper- or hypoparathyroidism; mental disorders; minor gastrointestinal cases; non-osteoporotic metabolic bone diseases; prior warfarin use; secondary osteoporosis; serious heart, liver, or kidney disease",Atherosclerosis,,Heart & Vascular Health,manual_pair,"One randomized trial demonstrated a beneficial effect of vitamin K2 (menaquinone-7) supplementation at a dose of 45 μg daily for 6 weeks in reducing markers of vitamin K deficiency in hemodialysis patients. However, the evidence is limited to a single study, and further research is needed to establish the efficacy of vitamin K2 for vascular calcification more broadly.",0.7,22169620,2012,Effect of vitamin K2 supplementation on functional vitamin K deficiency in hemodialysis patients: a randomized trial.,randomized_controlled_trial,benefit,"The study shows a significant reduction in markers of vitamin K deficiency, indicating a beneficial effect of vitamin K2 supplementation.",45 μg daily 6 weeks (menaquinone-7),CKD; Hemodialysis,,cardiovascular disease,cardiovascular disease; vascular calcification; vitamin k deficiency,Tier 4,0.47,"Randomized trial in hemodialysis patients showed that vitamin K2 (MK-7) reduced biomarkers of vitamin K deficiency (dp-ucMGP, ucOC, PIVKA-II) over 6 weeks. However, the study did not assess atherosclerosis or vascular calcification clinically (no imaging, plaque measures, or cardiovascular outcomes). The outcomes are mechanistic/surrogate markers of vitamin K status rather than validated surrogates for atherosclerosis. Small size, short duration, and non–placebo-controlled design further limit relevance to the atherosclerosis indication."
Vitamin K2,"Severe bleeding complications may be lower with rivaroxaban than with VKAs.; gastrointestinal discomfort; gastrointestinal side-effects related to the unpleasant smell of the tablets; higher adverse reaction rate in vitamin K2 group; higher adverse reaction rates in the vitamin K2 group; hyper- or hypoparathyroidism; mental disorders; minor gastrointestinal cases; non-osteoporotic metabolic bone diseases; prior warfarin use; secondary osteoporosis; serious heart, liver, or kidney disease",Atherosclerosis,,Heart & Vascular Health,manual_pair,"One randomized trial reported that vitamin K2 (menaquinone-7) supplementation at a dose of 360 µg thrice weekly for 8 weeks significantly reduced levels of inactive matrix Gla-protein (MGP) in haemodialysis patients, suggesting a potential benefit in reducing vascular calcification. However, the overall evidence is limited to this single study, and further research is needed to confirm these findings and assess long-term effects and safety.",0.7,24285428,2014,Vitamin K2 supplementation in haemodialysis patients: a randomized dose-finding study.,randomized_controlled_trial,benefit,"MK-7 supplementation significantly reduced levels of inactive MGP, indicating a beneficial effect on vascular calcification.",360 µg thrice weekly 8 weeks (menaquinone-7),CKD; Hemodialysis,,chronic haemodialysis,chronic haemodialysis; vascular calcification,Tier 4,0.55,"Randomized trial in hemodialysis patients showed dose-dependent reductions in dp-uc-MGP, a mechanistic biomarker of vitamin K status and vascular calcification propensity, but did not assess clinical or imaging outcomes of atherosclerosis. Population (ESRD on dialysis) and endpoint are indirect for the indication of atherosclerosis, making the evidence very low/indirect for this specific indication."
Zeaxanthin,Beta carotene usage nearly doubled the risk of lung cancer; increased incidence of lung cancer in former smokers; reversible crystalline maculopathy in one patient,Macular Degeneration,,Vision & Eye Health,manual_pair,"The evidence for zeaxanthin in the context of age-related macular degeneration is generally positive, with five studies indicating benefits related to serum levels and potential effects on disease progression, particularly at doses of 10 mg and 1 mg. However, one study reported mixed results regarding its impact on macular pigment density, suggesting variability in outcomes. No adverse effects were noted in the reviewed studies.",0.9,24310343,2014,Secondary analyses of the effects of lutein/zeaxanthin on age-related macular degeneration progression: AREDS2 report No. 3.,randomized_controlled_trial,benefit,The study shows a beneficial effect of lutein/zeaxanthin on the progression of age-related macular degeneration.,10 mg; 2 mg,,,age-related macular degeneration,age-related macular degeneration; central geographic atrophy; neovascular amd; serum carotenoid levels,Tier 2,0.66,"Large, double-masked RCT (AREDS2) with clinically relevant outcome (progression to late AMD) shows benefit for lutein/zeaxanthin, but results are from exploratory/secondary analyses rather than the trial’s primary analysis. The intervention combined lutein with zeaxanthin and was given on top of an AREDS base formula, so it is not zeaxanthin monotherapy. Strong methods and size support moderate evidence, but secondary nature and combination therapy prevent Tier 1."
Zeaxanthin,Beta carotene usage nearly doubled the risk of lung cancer; increased incidence of lung cancer in former smokers; reversible crystalline maculopathy in one patient,Macular Degeneration,,Vision & Eye Health,manual_pair,"The evidence for zeaxanthin in the context of age-related macular degeneration is generally positive, with five studies indicating benefits related to serum levels and potential effects on disease progression, particularly at doses of 10 mg and 1 mg. However, one study reported mixed results regarding its impact on macular pigment density, suggesting variability in outcomes. No adverse effects were noted in the reviewed studies.",0.9,22743321,2012,Profiles of macular pigment optical density and their changes following supplemental lutein and zeaxanthin: new results from the LUNA study.,clinical_trial,mixed_unclear,"The study shows mixed results regarding the effect of zeaxanthin on macular pigment density, with some improvements noted but no generation of new ring structures.",1 mg 6 months,,,age-related macular degeneration,age-related macular degeneration; central geographic atrophy; neovascular amd; serum carotenoid levels,Tier 4,0.34,"Human clinical trial assessed lutein+zeaxanthin effects on macular pigment optical density (an imaging surrogate) rather than clinical AMD outcomes. Participants were not specified as AMD patients, results were mixed, and zeaxanthin was co-administered with lutein, limiting attribution. This provides indirect, very low relevance to macular degeneration."
Zeaxanthin,Beta carotene usage nearly doubled the risk of lung cancer; increased incidence of lung cancer in former smokers; reversible crystalline maculopathy in one patient,General Cognitive Health,,Healthy Aging & Prevention,manual_pair,"The evidence regarding zeaxanthin for cognitive benefits is limited and mixed, with one randomized controlled trial reporting unclear outcomes related to brain function after one year of supplementation at a dose of 2 mg daily. No studies have demonstrated a clear benefit or harm associated with zeaxanthin for this indication, indicating a lack of robust evidence.",0.7,30680611,2020,The effects of lutein and zeaxanthin on resting state functional connectivity in older Caucasian adults: a randomized controlled trial.,randomized_controlled_trial,mixed_unclear,"The study showed increased inter-network connectivity, contrary to expectations, indicating mixed outcomes regarding the effects of zeaxanthin on brain function.",2 mg daily 1 year (supplement),,,cognitive benefits,cognitive benefits,Tier 4,0.62,"Human RCT but small (n≈48) and assessed surrogate imaging endpoints (resting-state fMRI connectivity) rather than clinical cognitive outcomes relevant to general cognitive health. Results were mixed/contrary to hypothesis and did not show improved DMN integrity. Additionally, lutein and zeaxanthin were co-administered, limiting attribution to zeaxanthin alone. Thus, evidence is very low/indirect for this indication."
Zeaxanthin,Beta carotene usage nearly doubled the risk of lung cancer; increased incidence of lung cancer in former smokers; reversible crystalline maculopathy in one patient,Cognitive Performance,,Cognitive & Neurological Function,manual_pair,"One randomized, double-masked, placebo-controlled trial reported significant improvements in cognitive function metrics with zeaxanthin supplementation in younger healthy adults over a one-year period. However, the overall evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term effects and safety.",0.7,29135938,2017,"Effects of a Lutein and Zeaxanthin Intervention on Cognitive Function: A Randomized, Double-Masked, Placebo-Controlled Trial of Younger Healthy Adults.",randomized_controlled_trial,benefit,"The study shows significant improvements in cognitive function metrics, indicating a beneficial effect of zeaxanthin supplementation.",daily one year,,"Energy, Mood, & Mental Health",cognitive function,cognitive function; complex attention; reasoning ability; spatial memory,Tier 2,0.6,"Randomized, double-masked, placebo-controlled human trial in healthy young adults with cognitive performance as the primary outcome showed benefit over one year. However, the intervention combined lutein with zeaxanthin (not zeaxanthin alone) and likely had a modest sample size, limiting attribution to zeaxanthin specifically."
Zeaxanthin,Beta carotene usage nearly doubled the risk of lung cancer; increased incidence of lung cancer in former smokers; reversible crystalline maculopathy in one patient,Improve Memory,,Cognitive & Neurological Function,manual_pair,"The evidence on zeaxanthin for cognitive impairment is mixed. One randomized controlled trial reported a benefit in neurocognitive function with a daily dose of 12 mg for one year, while another study found no significant effect in healthy older adults but noted improvements in those with cognitive decline. Overall, the findings are not consistent, and further research is needed to clarify its efficacy.",0.7,37447152,2023,Effects of Long-Chain Polyunsaturated Fatty Acids in Combination with Lutein and Zeaxanthin on Episodic Memory in Healthy Older Adults.,randomized_controlled_trial,mixed_unclear,"The study showed no significant effect on memory function in healthy older individuals with memory complaints, but improvement was noted in those with cognitive decline, indicating mixed outcomes.","24 weeks (supplements containing ARA, DHA, EPA, L, and Z); 12 weeks (supplements containing ARA, DHA, EPA, L, and Z)",,,cognitive decline,cognitive decline; cognitive dysfunction; memory complaints; neurocognitive function,Tier 4,0.56,"Double-blind RCT assessed a multi-ingredient formula (ARA, DHA, EPA, lutein, zeaxanthin) on memory. Because zeaxanthin was not tested alone, attribution to zeaxanthin is indirect. Results were mixed: no significant effect in the main cohort, improvement only in a subgroup with cognitive decline. Thus, evidence for zeaxanthin specifically improving memory is very low/indirect."
Zeaxanthin,Beta carotene usage nearly doubled the risk of lung cancer; increased incidence of lung cancer in former smokers; reversible crystalline maculopathy in one patient,Improve Memory,,Cognitive & Neurological Function,manual_pair,"The evidence on zeaxanthin for cognitive impairment is mixed. One randomized controlled trial reported a benefit in neurocognitive function with a daily dose of 12 mg for one year, while another study found no significant effect in healthy older adults but noted improvements in those with cognitive decline. Overall, the findings are not consistent, and further research is needed to clarify its efficacy.",0.7,28695791,2018,Lutein and Zeaxanthin Influence Brain Function in Older Adults: A Randomized Controlled Trial.,randomized_controlled_trial,benefit,"The study shows that zeaxanthin supplementation benefits neurocognitive function, indicating a positive outcome direction.",12 mg daily 1 year,Older Adults,,cognitive dysfunction,cognitive decline; cognitive dysfunction; memory complaints; neurocognitive function,Tier 3,0.56,"Small RCT (n=44) in older adults tested combined lutein+zeaxanthin (not zeaxanthin alone) for 1 year. Reported cognitive effect (verbal learning) suggests buffering decline but primary statistically significant findings were fMRI activation changes (surrogate/mechanistic). Sample size and combination formula limit direct, robust clinical evidence for zeaxanthin improving memory."
Zeaxanthin,Beta carotene usage nearly doubled the risk of lung cancer; increased incidence of lung cancer in former smokers; reversible crystalline maculopathy in one patient,Improved Color Vision,,Vision & Eye Health,manual_pair,"The evidence regarding zeaxanthin supplementation for color vision is limited and mixed. One study reported an increase in macular pigment density but found no correlation with color discrimination thresholds, suggesting unclear benefits for this indication. No adverse effects were noted in the reviewed study.",0.6,16460314,2006,The effects of supplementation with lutein and/or zeaxanthin on human macular pigment density and colour vision.,clinical_trial,mixed_unclear,"The study shows an increase in macular pigment optical density but no correlation with yellow-blue thresholds, indicating mixed outcomes regarding color discrimination.",(OPTISHARP),,,color vision,color vision,Tier 3,0.39,"Single small human supplementation study in healthy subjects without clear randomization or control. It directly measured color discrimination (relevant clinical function) but showed no improvement in yellow-blue thresholds and only marginal/uncertain improvement in red-green discrimination. Co-supplementation with lutein obscures the zeaxanthin-specific effect. Overall, weak/preliminary evidence with mixed outcomes."
Zeaxanthin,Beta carotene usage nearly doubled the risk of lung cancer; increased incidence of lung cancer in former smokers; reversible crystalline maculopathy in one patient,Dry Eyes,,Vision & Eye Health,manual_pair,"There is limited evidence suggesting that zeaxanthin may benefit individuals with dry eye disease, as indicated by a single randomized controlled trial that reported significant improvements in ocular health outcomes with a daily dose of 1 mg for 20 days. However, the overall evidence is sparse, and further studies are needed to confirm these findings and assess long-term effects and safety.",0.7,39770987,2024,"Effect of Dietary Supplementation with Lutein, Zeaxanthin, and Elderberries on Dry Eye Disease (DED) and Immunity: A Randomized Controlled Trial.",randomized_controlled_trial,benefit,"The study showed significant improvement in ocular health outcomes, indicating a benefit from the supplementation.",1 mg once daily 20 days (supplement),,,dry eye disease,dry eye disease,Tier 4,0.45,"Human RCT with clinically relevant dry eye outcomes (OSDI) showed benefit, but zeaxanthin was not tested alone—it was combined with lutein and elderberry. This prevents attribution of effects specifically to zeaxanthin. Short duration (20 days) also limits robustness. Therefore, evidence for zeaxanthin itself in dry eye is indirect/very low."
Zeaxanthin,Beta carotene usage nearly doubled the risk of lung cancer; increased incidence of lung cancer in former smokers; reversible crystalline maculopathy in one patient,Skin Hydration,,"Skin, Hair, & Nails",manual_pair,"One randomized trial suggests that a zeaxanthin-based dietary supplement and topical serum may improve skin hydration and reduce wrinkle count in female subjects after 12 weeks of use. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term effects and safety.",0.7,27312122,2016,Zeaxanthin-based dietary supplement and topical serum improve hydration and reduce wrinkle count in female subjects.,randomized_controlled_trial,benefit,"The study shows significant improvements in skin hydration and reduction in wrinkle count, indicating a beneficial effect of zeaxanthin.",12 weeks (oral and topical),,,hydration,hydration; skin aging; wrinkles,Tier 3,0.42,"Single small RCT with ~31 completers tested a multi-ingredient, zeaxanthin-based oral supplement (with added actives) and a topical co-intervention. Hydration benefits were significant mainly for the oral+topical combination, and zeaxanthin’s independent contribution was not isolated. Skin hydration is a physiologic/surrogate endpoint. Thus, evidence for zeaxanthin on skin hydration is preliminary/weak."
Zeaxanthin,Beta carotene usage nearly doubled the risk of lung cancer; increased incidence of lung cancer in former smokers; reversible crystalline maculopathy in one patient,Eye Health,,Vision & Eye Health,manual_pair,"The clinical evidence for zeaxanthin in promoting eye health is limited and mixed, with a single randomized crossover study indicating marginally significant differences in bioavailability between different forms of zeaxanthin at a dose of 10 mg. No studies reported clear benefits or harms, suggesting a lack of robust evidence for its efficacy in this indication.",0.6,29185931,2017,Effect of aggregation form on bioavailability of zeaxanthin in humans: a randomised cross-over study.,randomized_controlled_trial,mixed_unclear,"The study shows a marginally significant difference in bioavailability between the two forms of zeaxanthin, indicating mixed results.",10 mg single dose (H-aggregated and J-aggregated zeaxanthin dipalmitate),,,eye health,eye health,Tier 4,0.76,"Randomized cross-over human study but evaluates pharmacokinetic bioavailability of zeaxanthin formulations, not eye health outcomes (e.g., macular pigment, visual function, AMD). Small sample (n=16) and only marginally significant differences. This provides indirect, mechanistic evidence relevant to the supplement but not direct evidence for the eye health indication."
Zeaxanthin,Beta carotene usage nearly doubled the risk of lung cancer; increased incidence of lung cancer in former smokers; reversible crystalline maculopathy in one patient,Atherosclerosis,,Heart & Vascular Health,manual_pair,"There is limited evidence suggesting that zeaxanthin, when combined with lutein and meso-zeaxanthin at a dose of 10 mg daily for 6 months, may reduce inflammatory cytokines and oxidized LDL cholesterol, indicating a potential benefit for cardiovascular health. However, this finding is based on a single study, and further research is needed to confirm these effects and assess long-term safety and efficacy.",0.7,38890092,2024,"Lutein, zeaxanthin, and meso-zeaxanthin supplementation attenuates inflammatory cytokines and markers of oxidative cardiovascular processes in humans.",randomized_controlled_trial,benefit,"The study demonstrated significant reductions in inflammatory cytokines and oxidized LDL, indicating a beneficial effect on cardiovascular health.",10 mg daily 6 months (Lutein + Meso-zeaxanthin + Zeaxanthin),,"Immune, Inflammation, & Infection",atherosclerosis,atherosclerosis; inflammation; oxidative stress,Tier 3,0.56,"Double-blind RCT showed reductions in inflammatory cytokines and oxidized LDL after 6 months, which are surrogate markers related to atherosclerosis risk. However, no direct clinical or imaging outcomes of atherosclerosis were measured, and the intervention was a combination of lutein, meso-zeaxanthin, and zeaxanthin, so effects cannot be attributed to zeaxanthin alone. Thus, evidence for zeaxanthin for atherosclerosis from this study is indirect and preliminary."
Zeaxanthin,Beta carotene usage nearly doubled the risk of lung cancer; increased incidence of lung cancer in former smokers; reversible crystalline maculopathy in one patient,Macular Degeneration,,Vision & Eye Health,manual_pair,"The evidence regarding zeaxanthin for late age-related macular degeneration (AMD) is low quality and mixed. One study suggested a potential benefit for AMD progression when combined with lutein, but it also raised concerns about lung cancer risk associated with beta carotene, while zeaxanthin did not show increased risk. No consistent dose ranges were reported across studies.",0.6,35653117,2022,Long-term Outcomes of Adding Lutein/Zeaxanthin and ω-3 Fatty Acids to the AREDS Supplements on Age-Related Macular Degeneration Progression: AREDS2 Report 28.,randomized_controlled_trial,mixed_unclear,"The study indicates a potential benefit of lutein/zeaxanthin for AMD progression, but a mixed outcome regarding lung cancer risk, as beta carotene increased risk while lutein/zeaxanthin did not.","(AREDS2 supplements with lutein/zeaxanthin, vitamins C and E, and zinc plus copper)",,,late age-related macular degeneration (amd),late age-related macular degeneration (amd); lung cancer,Tier 1,0.8,"Large, well-conducted randomized controlled trial with long-term follow-up evaluated progression to late AMD as a primary outcome. The lutein/zeaxanthin arm showed a statistically significant reduction in AMD progression (HR ~0.91) and was superior to beta-carotene. Although zeaxanthin was administered in combination with lutein (not alone), this is a zeaxanthin-containing intervention directly tested for AMD, supporting strong human evidence. Confidence is slightly tempered by the combination formulation and modest effect size."
Zeaxanthin,Beta carotene usage nearly doubled the risk of lung cancer; increased incidence of lung cancer in former smokers; reversible crystalline maculopathy in one patient,Eye Health,,Vision & Eye Health,manual_pair,"Clinical evidence indicates that zeaxanthin supplementation is associated with increased macular pigment optical density (MPOD), with three studies reporting beneficial effects. Doses varied, with reported amounts of 2 mg to 4 mg daily and a dietary intervention involving whole eggs. No adverse effects were noted in the studies, but the evidence is limited to a small number of trials, all showing positive outcomes without any mixed or negative results.",0.9,32581313,2020,Effect of an antioxidant supplement containing high dose lutein and zeaxanthin on macular pigment and skin carotenoid levels.,clinical_trial,benefit,"The study demonstrated significant increases in MPOD and SC levels, indicating a beneficial effect of the supplement.",4 mg daily 16 weeks (supplement),,,macular pigment optical density,macular pigment optical density,Tier 3,0.38,"Small, single-arm, open-label human study in healthy subjects using a multi-ingredient supplement (lutein, zeaxanthin, vitamins, minerals). Outcomes were surrogate biomarkers (macular pigment optical density and skin carotenoids), not clinical eye health endpoints. Findings suggest benefit but attribution to zeaxanthin alone and clinical relevance are limited."
Zeaxanthin,Beta carotene usage nearly doubled the risk of lung cancer; increased incidence of lung cancer in former smokers; reversible crystalline maculopathy in one patient,Hand-Eye Coordination,,Performance & Recovery,manual_pair,"One randomized, double-blind, placebo-controlled trial reported a significant improvement in eye-hand coordination following supplementation with 2 mg of zeaxanthin daily for eight weeks. No studies reported mixed or negative outcomes, but the overall evidence is limited to a single trial, indicating a need for further research to confirm these findings and assess long-term effects and safety.",0.7,36986186,2023,"Effects of Astaxanthin, Lutein, and Zeaxanthin on Eye-Hand Coordination and Smooth-Pursuit Eye Movement after Visual Display Terminal Operation in Healthy Subjects: A Randomized, Double-Blind Placebo-Controlled Intergroup Trial.",randomized_controlled_trial,benefit,"The study showed significant improvement in eye-hand coordination, indicating a benefit from the supplementation.",2 mg once daily eight weeks (soft capsules),,,eye-hand coordination impairment,eye-hand coordination impairment; smooth-pursuit eye movement impairment,Tier 4,0.58,"A well-designed randomized, double-blind, placebo-controlled trial showed improved eye-hand coordination after VDT operation, but the intervention was a combination of astaxanthin (6 mg), lutein (10 mg), and zeaxanthin (2 mg) for eight weeks. Because the effect cannot be attributed to zeaxanthin alone, the evidence for zeaxanthin specifically is indirect despite the clinically relevant outcome."
Zeaxanthin,Beta carotene usage nearly doubled the risk of lung cancer; increased incidence of lung cancer in former smokers; reversible crystalline maculopathy in one patient,Eye Health,,Vision & Eye Health,manual_pair,"One randomized trial demonstrated that daily supplementation with 10 mg of zeaxanthin for 6-12 months significantly increased macular pigment optical density, suggesting a potential benefit for retinal health. No studies reported mixed outcomes or adverse effects, but overall evidence is limited to a single trial, necessitating caution in interpretation.",0.8,17084803,2007,Xanthophyll accumulation in the human retina during supplementation with lutein or zeaxanthin - the LUXEA (LUtein Xanthophyll Eye Accumulation) study.,randomized_controlled_trial,benefit,"The study shows a significant increase in macular pigment optical density with zeaxanthin supplementation, indicating a benefit for retinal health.",10 mg daily 6-12 months (Actilease),,,macular pigment optical density,macular pigment optical density; retinal health,Tier 3,0.6,"Human randomized controlled trial shows zeaxanthin increases macular pigment optical density, a surrogate biomarker, not a direct clinical outcome (e.g., visual acuity or disease progression). The indication 'Eye Health' is broad and the study did not demonstrate clinical endpoints, and results required correction due to measurement confounding. Thus evidence for this indication is preliminary/surrogate despite an RCT design."
Zeaxanthin,Beta carotene usage nearly doubled the risk of lung cancer; increased incidence of lung cancer in former smokers; reversible crystalline maculopathy in one patient,Eye Health,,Vision & Eye Health,manual_pair,"One randomized controlled trial demonstrated that zeaxanthin supplementation (2 mg daily for 1 year) resulted in significant improvements in visual performance outcomes, indicating a potential benefit for poor visual performance. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term effects and safety.",0.7,25468896,2014,"A double-blind, placebo-controlled study on the effects of lutein and zeaxanthin on photostress recovery, glare disability, and chromatic contrast.",randomized_controlled_trial,benefit,"The study showed significant improvements in visual performance outcomes, indicating a benefit from zeaxanthin supplementation.",2 mg daily 1 year,,,chromatic contrast,chromatic contrast; glare disability; photostress recovery,Tier 2,0.64,"Randomized, double-blind, placebo-controlled trial (n=115, 1 year) showed significant improvements in visual performance (photostress recovery, chromatic contrast) and increased MPOD with supplementation that included zeaxanthin. However, the intervention combined lutein (10 mg) with zeaxanthin (2 mg), so effects cannot be attributed to zeaxanthin alone. Outcomes reflect eye function/health but are not disease endpoints, and the population was healthy young adults. Thus, moderate human evidence for the zeaxanthin–eye health pairing from this study, with indirectness due to combination therapy."
Zeaxanthin,Beta carotene usage nearly doubled the risk of lung cancer; increased incidence of lung cancer in former smokers; reversible crystalline maculopathy in one patient,Skin Aging Prevention,,"Skin, Hair, & Nails",manual_pair,"One randomized trial reported a beneficial effect of a supplement containing high doses of lutein and zeaxanthin (4 mg daily for 16 weeks) on skin carotenoid levels, showing significant increases. However, the overall evidence is limited, with only one study available, and further research is needed to confirm these findings.",0.6,32581313,2020,Effect of an antioxidant supplement containing high dose lutein and zeaxanthin on macular pigment and skin carotenoid levels.,clinical_trial,benefit,"The study demonstrated significant increases in MPOD and SC levels, indicating a beneficial effect of the supplement.",4 mg daily 16 weeks (supplement),,,skin carotenoid levels,skin carotenoid levels,Tier 4,0.24,"Single-arm, open-label pilot in 16 healthy adults using a multi-ingredient supplement (lutein, zeaxanthin, vitamins C/E, zinc, copper). Outcomes were surrogate biomarkers (skin carotenoid levels), not clinical measures of skin aging. The study was not designed to assess skin aging prevention and effects cannot be attributed to zeaxanthin alone."
Zeaxanthin,Beta carotene usage nearly doubled the risk of lung cancer; increased incidence of lung cancer in former smokers; reversible crystalline maculopathy in one patient,Skin Aging Prevention,,"Skin, Hair, & Nails",manual_pair,"One randomized, double-blind, placebo-controlled study indicates that zeaxanthin, when combined with lutein, may provide significant antioxidant protection for skin health against UV exposure. However, the overall evidence is limited to this single study, and further research is needed to confirm these findings and establish consistent dosing guidelines. No adverse effects were reported in the study.",0.7,17446716,2007,"Beneficial long-term effects of combined oral/topical antioxidant treatment with the carotenoids lutein and zeaxanthin on human skin: a double-blind, placebo-controlled study.",randomized_controlled_trial,benefit,"The study shows that zeaxanthin, along with lutein, provides significant antioxidant protection for skin health, indicating a beneficial outcome.",(oral and topical),,,photoprotection,photoprotection; skin aging; skin damage; skin elasticity; skin hydration,Tier 4,0.4,"Double-blind, placebo-controlled human RCT, but the intervention combined lutein and zeaxanthin (not zeaxanthin alone), and outcomes were largely surrogate skin physiology/photoprotection markers rather than direct clinical aging endpoints. Thus, evidence for zeaxanthin specifically for skin aging prevention is indirect and low-strength."
Zeaxanthin,Beta carotene usage nearly doubled the risk of lung cancer; increased incidence of lung cancer in former smokers; reversible crystalline maculopathy in one patient,Visual Processing Speed,,Cognitive & Neurological Function,manual_pair,"One double-blind, placebo-controlled study found that daily supplementation with 20 mg of zeaxanthin for four months resulted in significant improvements in visual processing speed and motor reaction time. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term effects and safety.",0.7,25251377,2014,"A double-blind, placebo-controlled study on the effects of lutein and zeaxanthin on neural processing speed and efficiency.",randomized_controlled_trial,benefit,"The study found significant improvements in visual processing speed and motor reaction time with zeaxanthin supplementation, indicating a beneficial outcome.",20 mg daily four months (zeaxanthin only),,,visual motor performance,visual motor performance; visual processing speed,Tier 2,0.64,"Double-blind, placebo-controlled RCT in healthy young adults measured visual processing speed (CFF, reaction time) as primary outcomes, directly matching the indication. However, the placebo group was small and arms were unbalanced, and the significant effects were reported when zeaxanthin-only and mixed-supplement arms were pooled rather than for zeaxanthin alone. Short duration and modest sample size reduce strength, supporting moderate (not strong) human evidence for zeaxanthin on visual processing speed."
Zeaxanthin,Beta carotene usage nearly doubled the risk of lung cancer; increased incidence of lung cancer in former smokers; reversible crystalline maculopathy in one patient,Macular Degeneration,,Vision & Eye Health,manual_pair,"One randomized trial indicates that oral supplementation with lutein and zeaxanthin (at a dose of 10 mg) may slow the progression of geographic atrophy in age-related macular degeneration. There is currently no evidence of harm or no benefit associated with this supplementation, but further studies are needed to confirm these findings and assess long-term effects.",0.9,39025435,2025,Oral Antioxidant and Lutein/Zeaxanthin Supplements Slow Geographic Atrophy Progression to the Fovea in Age-Related Macular Degeneration.,randomized_controlled_trial,benefit,"The study shows that oral micronutrient supplementation, including lutein and zeaxanthin, benefits the progression of geographic atrophy in age-related macular degeneration.",10 mg (lutein/zeaxanthin),,,age-related macular degeneration,age-related macular degeneration; geographic atrophy,Tier 2,0.63,"Evidence comes from a post hoc analysis within large randomized, placebo-controlled trials (AREDS/AREDS2). Lutein/zeaxanthin slowed geographic atrophy progression toward the fovea, a clinically relevant but secondary/anatomic endpoint; GA area did not change and visual function was not assessed as a primary outcome. The intervention was a combination (lutein plus zeaxanthin), not zeaxanthin alone. Overall, moderate human evidence for AMD progression."
Zeaxanthin,Beta carotene usage nearly doubled the risk of lung cancer; increased incidence of lung cancer in former smokers; reversible crystalline maculopathy in one patient,Macular Degeneration,,Vision & Eye Health,manual_pair,"The evidence for zeaxanthin in improving vision problems due to age-related macular degeneration (AMD) is mixed. One study demonstrated a significant benefit in macular pigment optical density and visual acuity with a combination supplement of 10 mg daily, while another study reported mixed results with 8 mg daily, showing some improvements but also better outcomes in the control group for certain measures. No adverse effects were reported in the studies reviewed.",0.8,23695657,2013,"Long term effects of lutein, zeaxanthin and omega-3-LCPUFAs supplementation on optical density of macular pigment in AMD patients: the LUTEGA study.",randomized_controlled_trial,benefit,"The study shows significant improvement in macular pigment optical density and visual acuity in AMD patients, indicating a beneficial effect of the supplementation.","10 mg once or twice daily 12 months (combination with lutein, omega-3-LCPUFAs, and antioxidants)",,,age-related macular degeneration,age-related macular degeneration; atrophic age-related macular degeneration; visual function,Tier 2,0.65,"Well-designed, double-blind, placebo-controlled RCT in AMD patients showed significant improvements in BCVA and MPOD, but zeaxanthin was part of a combination (with lutein, omega-3s, antioxidants), so the effect cannot be attributed to zeaxanthin alone. The primary outcome was a surrogate (MPOD), with visual acuity improvements as secondary outcomes."
Zeaxanthin,Beta carotene usage nearly doubled the risk of lung cancer; increased incidence of lung cancer in former smokers; reversible crystalline maculopathy in one patient,Macular Degeneration,,Vision & Eye Health,manual_pair,"The evidence for zeaxanthin in improving vision problems due to age-related macular degeneration (AMD) is mixed. One study demonstrated a significant benefit in macular pigment optical density and visual acuity with a combination supplement of 10 mg daily, while another study reported mixed results with 8 mg daily, showing some improvements but also better outcomes in the control group for certain measures. No adverse effects were reported in the studies reviewed.",0.8,22027699,2011,"Randomized, double-blind, placebo-controlled study of zeaxanthin and visual function in patients with atrophic age-related macular degeneration: the Zeaxanthin and Visual Function Study (ZVF) FDA IND #78, 973.",randomized_controlled_trial,mixed_unclear,"The study showed improvements in visual function parameters for the zeaxanthin group, but also noted that the control group had superior outcomes in some measures, indicating mixed results.",8 mg daily 12 months (dietary supplement),,,atrophic age-related macular degeneration,age-related macular degeneration; atrophic age-related macular degeneration; visual function,Tier 2,0.55,"Double-blind randomized controlled trial in AMD patients over 12 months with clinically relevant visual function outcomes. However, the sample size was small (n≈25 in the zeaxanthin arm), the control was an active comparator (lutein) rather than an inert placebo, and results were mixed (some visual measures favored zeaxanthin, others favored lutein; no between-group difference in MPOD). These factors reduce certainty despite appropriate design."
Zeaxanthin,Beta carotene usage nearly doubled the risk of lung cancer; increased incidence of lung cancer in former smokers; reversible crystalline maculopathy in one patient,Eye Health,,Vision & Eye Health,manual_pair,"Human clinical evidence suggests that zeaxanthin may benefit vision problems related to age-related macular degeneration, with three randomized trials reporting positive outcomes. Doses reported include 1 mg of zeaxanthin from supplements and 15 g of whole wolfberries daily, as well as consumption of zeaxanthin-enriched eggs. No adverse effects were noted in the studies, but further research may be needed to confirm these findings and establish optimal dosing.",0.9,18551295,2009,[The macular pigment: short- and intermediate-term changes of macular pigment optical density following supplementation with lutein and zeaxanthin and co-antioxidants. The LUNA Study],clinical_trial,benefit,"The study shows a significant increase in macular pigment optical density following supplementation, indicating a benefit.",1 mg once per day 6 months (Ocuvite lutein),,,age-related macular degeneration,age-related macular degeneration; vision health,Tier 4,0.48,"Human controlled trial showed increased macular pigment optical density, an imaging/surrogate outcome, not clinical eye-health endpoints. The supplement was a combination of lutein (12 mg) plus zeaxanthin (1 mg), so effects cannot be attributed to zeaxanthin alone. Randomization/blinding not clearly stated. Hence evidence is indirect and based on a surrogate marker."
Zeaxanthin,Beta carotene usage nearly doubled the risk of lung cancer; increased incidence of lung cancer in former smokers; reversible crystalline maculopathy in one patient,Visual Processing Speed,,Cognitive & Neurological Function,manual_pair,"There is limited evidence suggesting that zeaxanthin may improve visual memory problems, as indicated by one randomized, double-masked, placebo-controlled trial that reported a benefit with a daily dose of 12 mg over 12 months. However, the overall evidence is sparse, and further research is needed to confirm these findings and assess long-term effects and safety.",0.7,30950580,2019,"Dietary Carotenoids Lutein and Zeaxanthin Change Brain Activation in Older Adult Participants: A Randomized, Double-Masked, Placebo-Controlled Trial.",randomized_controlled_trial,benefit,"The study shows significant improvement in signal power, indicating a benefit from supplementation.",12 mg daily 12 months,,,visual memory,visual memory; visual processing speeds,Tier 4,0.42,"Double-masked RCT in older adults found increased SSVEP signal power after 12 months of lutein+zeaxanthin, but it measured electrophysiological surrogates rather than direct visual processing speed outcomes. The supplement was a combination (L+Z), not zeaxanthin alone, further reducing direct relevance to the specified supplement-indication pair."
Zeaxanthin,Beta carotene usage nearly doubled the risk of lung cancer; increased incidence of lung cancer in former smokers; reversible crystalline maculopathy in one patient,Visual Processing Speed,,Cognitive & Neurological Function,manual_pair,"One randomized placebo-controlled study reported a significant improvement in visual processing speed with zeaxanthin supplementation over a duration of four months. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term effects and safety.",0.7,25483230,2015,A randomized placebo-controlled study on the effects of lutein and zeaxanthin on visual processing speed in young healthy subjects.,randomized_controlled_trial,benefit,The study shows significant improvement in visual processing speed with supplementation of zeaxanthin.,4 months,,,visual processing speed,visual processing speed,Tier 2,0.64,"Placebo-controlled randomized trial in healthy young adults showed significant improvement in visual processing speed (temporal contrast sensitivity) after 4 months of supplementation. The outcome directly matches the indication. However, the intervention combined lutein with zeaxanthin (not zeaxanthin alone), the sample size/placebo group was modest, and blinding/dose details are not fully specified, so the evidence is moderate rather than strong for zeaxanthin specifically."
Zinc,A+Z may be nephrotoxic in patients with severe alcohol-associated hepatitis; acute kidney injury more frequent with A+Z than prednisone; being underweight increases vomiting risk; constipation; dehydration increases vomiting risk; diarrhoea; did not cause diarrhea; did not cause rash; did not cause vomiting; gastritis; gastrointestinal disorders; gastrointestinal pain; increased vomiting episodes in zinc group compared to placebo; loss of smell; nausea; stomach cramps; unpleasant taste; vomiting,High Blood Glucose,,Metabolic Health,manual_pair,"The evidence for zinc supplementation in relation to excess body weight is limited but suggests potential benefits, with two randomized controlled trials indicating positive effects on body fat mass and leptin levels. Doses reported include 50 mg for 60 days and a year-long study without specified dosage. Overall, the findings are promising but require further investigation to establish consistency and efficacy.",0.7,38896121,2024,[Effects of zinc and resveratrol as modulators of leptin response in adults with obesity].,randomized_controlled_trial,benefit,"The study shows significant effects on leptin and glucose levels, indicating a benefit from zinc supplementation.",50 mg 60 days,Obese,Heart & Vascular Health,obesity,body fat mass; hemodialysis patients; obesity; zinc deficiency,Tier 3,0.44,"Randomized, double-blind trial in obese adults measured glucose as a secondary surrogate outcome over 60 days. Reported within-group glucose changes occurred in both the zinc and control groups, with no clear between-group superiority for zinc versus control. Sample size appears small and participants were not selected for hyperglycemia. Thus, evidence for zinc specifically improving high blood glucose is preliminary and indirect."
Zinc,A+Z may be nephrotoxic in patients with severe alcohol-associated hepatitis; acute kidney injury more frequent with A+Z than prednisone; being underweight increases vomiting risk; constipation; dehydration increases vomiting risk; diarrhoea; did not cause diarrhea; did not cause rash; did not cause vomiting; gastritis; gastrointestinal disorders; gastrointestinal pain; increased vomiting episodes in zinc group compared to placebo; loss of smell; nausea; stomach cramps; unpleasant taste; vomiting,High Blood Glucose,,Metabolic Health,manual_pair,"One randomized, double-blind, placebo-controlled trial reported a significant reduction in fasting blood glucose and improvement in glucose metabolism with a food supplement containing zinc, among other ingredients, taken at doses of 1 or 2 tablets per day for three months. Overall evidence is limited to this single study, and no adverse effects were reported; however, further research is needed to confirm these findings and establish consistency.",0.7,39125340,2024,"Efficacy and Tolerability of a Food Supplement Based on Zea mays L., Gymnema sylvestre (Retz.) R.br.ex Sm, Zinc and Chromium for the Maintenance of Normal Carbohydrate Metabolism: A Monocentric, Randomized, Double-Blind, Placebo-Controlled Clinical Trial.",randomized_controlled_trial,benefit,"The study showed a significant reduction in fasting blood glucose and improvement in glucose metabolism, indicating a beneficial effect.",1 or 2 tablets per day 3 months (food supplement),,,glucose metabolism,glucose metabolism; impaired fasting blood glucose,Tier 4,0.4,"Although this is a randomized, double-blind, placebo-controlled human trial showing reduced fasting blood glucose, the intervention was a multi-ingredient supplement (Zea mays, Gymnema sylvestre, zinc, chromium). The effect cannot be attributed specifically to zinc, making the evidence indirect for zinc alone in high blood glucose despite good study quality."
Zinc,A+Z may be nephrotoxic in patients with severe alcohol-associated hepatitis; acute kidney injury more frequent with A+Z than prednisone; being underweight increases vomiting risk; constipation; dehydration increases vomiting risk; diarrhoea; did not cause diarrhea; did not cause rash; did not cause vomiting; gastritis; gastrointestinal disorders; gastrointestinal pain; increased vomiting episodes in zinc group compared to placebo; loss of smell; nausea; stomach cramps; unpleasant taste; vomiting,Liver Dysfunction,,Gut Health,manual_pair,"One randomized clinical trial suggests that zinc sulfate (50 mg daily for 3 months) may have a beneficial effect on liver fibrosis in patients with chronic hepatitis C, evidenced by significant reductions in serum fibronectin and hyaluronic acid levels. However, the overall evidence is limited, with only one study reporting a benefit and no additional trials to confirm these findings.",0.7,39789197,2025,A randomized clinical study to evaluate the possible antifibrotic effect of zinc sulfate in chronic HCV patient receiving direct-acting anti-viral therapy.,randomized_controlled_trial,benefit,"The study shows significant reductions in serum fibronectin and hyaluronic acid levels, indicating a benefit from zinc sulfate treatment.",50 mg daily 3 months (sulfate),HCV,,chronic hepatitis c,chronic hepatitis c; hepatic fibrosis,Tier 3,0.62,"Single small RCT (n=50) in HCV patients on antiviral therapy showed improvements primarily in surrogate fibrosis markers (hyaluronic acid, fibronectin) and APRI, with no significant change in FIB-4 and no hard clinical outcomes. While randomized, the evidence is preliminary and based on surrogate endpoints for liver dysfunction."
Zinc,A+Z may be nephrotoxic in patients with severe alcohol-associated hepatitis; acute kidney injury more frequent with A+Z than prednisone; being underweight increases vomiting risk; constipation; dehydration increases vomiting risk; diarrhoea; did not cause diarrhea; did not cause rash; did not cause vomiting; gastritis; gastrointestinal disorders; gastrointestinal pain; increased vomiting episodes in zinc group compared to placebo; loss of smell; nausea; stomach cramps; unpleasant taste; vomiting,Liver Protection,,Gut Health,manual_pair,"Current evidence on zinc supplementation for liver injury is limited, with only one study indicating a potential benefit in protecting against cholestatic liver injury. The overall quality of evidence is low, and no adverse effects or consistent dose ranges were reported. Further research is needed to establish the efficacy and safety of zinc in this context.",0.5,39610253,2024,Zinc promotes microbial p-coumaric acid production that protects against cholestatic liver injury.,clinical_trial,benefit,"The study shows that zinc supplementation has protective effects against liver injury in cholestatic liver disease, indicating a beneficial outcome.",,,,cholestatic liver disease,cholestatic liver disease; liver injury,Tier 4,0.42,"The study’s protective effects of zinc against cholestatic liver injury are demonstrated primarily in mice. The human component shows zinc-associated microbiome/metabolite changes and a correlation between p-coumaric acid and liver injury markers, but does not report randomized, controlled clinical outcomes demonstrating liver protection. Thus, human evidence here is indirect and mechanistic/exploratory rather than a definitive clinical benefit."
Zinc,A+Z may be nephrotoxic in patients with severe alcohol-associated hepatitis; acute kidney injury more frequent with A+Z than prednisone; being underweight increases vomiting risk; constipation; dehydration increases vomiting risk; diarrhoea; did not cause diarrhea; did not cause rash; did not cause vomiting; gastritis; gastrointestinal disorders; gastrointestinal pain; increased vomiting episodes in zinc group compared to placebo; loss of smell; nausea; stomach cramps; unpleasant taste; vomiting,Infertility,,Men's Health,manual_pair,"One randomized controlled trial reported a benefit of zinc supplementation (10 mg daily for 3 months) in improving sperm motility and testosterone levels in men with idiopathic infertility. However, the overall evidence is limited, with only one study available, and further research is needed to confirm these findings and assess long-term effects.",0.7,40248985,2025,Evaluation of in vivo supplementation of 2660 mg D-aspartic acid and 200 mg ubiquinol and 10 mg zinc on different semen parameters in idiopathic male infertility: a randomized double blind placebo controlled study.,randomized_controlled_trial,benefit,"The study showed significant improvement in sperm motility and testosterone levels, indicating a benefit from the supplementation.",10 mg once daily 3 months (zinc),,,idiopathic male infertility,idiopathic male infertility,Tier 4,0.31,"This is a randomized, double-blind, placebo-controlled trial, but zinc was given only as part of a three-ingredient combination (D-aspartic acid + ubiquinol + zinc 10 mg). Outcomes were surrogate markers (sperm motility, testosterone) rather than pregnancy/live birth, and the small sample size further limits inference. Because the effect cannot be attributed to zinc alone, the evidence for zinc specifically in male infertility is indirect and very low."
Zinc,A+Z may be nephrotoxic in patients with severe alcohol-associated hepatitis; acute kidney injury more frequent with A+Z than prednisone; being underweight increases vomiting risk; constipation; dehydration increases vomiting risk; diarrhoea; did not cause diarrhea; did not cause rash; did not cause vomiting; gastritis; gastrointestinal disorders; gastrointestinal pain; increased vomiting episodes in zinc group compared to placebo; loss of smell; nausea; stomach cramps; unpleasant taste; vomiting,Oral Precancerous Lesions,,Oral Health,manual_pair,"One randomized clinical trial indicates that systemic zinc supplementation may significantly reduce pain in patients with oral lichen planus over an 8-week period. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term effects and safety.",0.7,40457259,2025,Supplementary zinc and vitamin D in management of symptomatic oral lichen planus: a three-arm randomized clinical trial.,randomized_controlled_trial,benefit,"The study shows that systemic zinc supplementation significantly reduces pain in patients with oral lichen planus, indicating a beneficial outcome.",systemic 8 weeks (zinc),,,oral lichen planus,oral lichen planus,Tier 2,0.64,"Three-arm randomized controlled trial in patients with oral lichen planus (an oral potentially malignant disorder) showed adjunctive systemic zinc plus topical steroid improved pain and clinical lesion scores versus steroid alone over 8 weeks. However, the sample size was small (~14 per arm), blinding is unclear, duration was short, and outcomes were symptomatic/clinical scores rather than malignant transformation or long-term control. Thus, moderate human evidence for this indication."
Zinc,A+Z may be nephrotoxic in patients with severe alcohol-associated hepatitis; acute kidney injury more frequent with A+Z than prednisone; being underweight increases vomiting risk; constipation; dehydration increases vomiting risk; diarrhoea; did not cause diarrhea; did not cause rash; did not cause vomiting; gastritis; gastrointestinal disorders; gastrointestinal pain; increased vomiting episodes in zinc group compared to placebo; loss of smell; nausea; stomach cramps; unpleasant taste; vomiting,General Oral Health,,Oral Health,manual_pair,"One randomized, double-blind clinical study demonstrated that zinc citrate trihydrate toothpaste, used twice daily for six weeks, positively influenced oral plaque microbiome composition and function, suggesting a benefit for oral health. No adverse effects were reported in this study, but further research is needed to confirm these findings and assess long-term effects.",0.8,40057571,2025,"A randomised, double-blind clinical study into the effect of zinc citrate trihydrate toothpaste on oral plaque microbiome ecology and function.",randomized_controlled_trial,benefit,"The study shows beneficial modulation of microbiome composition and function, indicating a positive outcome for oral health.",twice daily 6 weeks (toothpaste),,,dental caries,dental caries; gingivitis; oral health,Tier 3,0.58,"Double-blind RCT (n=115) of zinc citrate toothpaste showed beneficial changes in plaque microbiome composition and predicted function, but did not assess clinical oral health outcomes (e.g., plaque/gingival indices, caries, bleeding). Evidence is based on surrogate mechanistic endpoints rather than primary clinical measures of general oral health."
Zinc,A+Z may be nephrotoxic in patients with severe alcohol-associated hepatitis; acute kidney injury more frequent with A+Z than prednisone; being underweight increases vomiting risk; constipation; dehydration increases vomiting risk; diarrhoea; did not cause diarrhea; did not cause rash; did not cause vomiting; gastritis; gastrointestinal disorders; gastrointestinal pain; increased vomiting episodes in zinc group compared to placebo; loss of smell; nausea; stomach cramps; unpleasant taste; vomiting,Alcoholic Hepatitis,,Gut Health,manual_pair,"Current evidence regarding zinc supplementation for severe alcohol-associated hepatitis is limited and indicates potential harm. A randomized trial reported that patients receiving zinc (220 mg daily) in combination with anakinra had lower survival rates compared to those treated with prednisone, suggesting adverse effects associated with this treatment approach. No studies have demonstrated a benefit for zinc in this indication.",1.0,38342441,2024,Randomized trial of anakinra plus zinc vs. prednisone for severe alcohol-associated hepatitis.,randomized_controlled_trial,harm,"The study found that patients treated with the combination of anakinra and zinc had lower survival rates compared to those treated with prednisone, indicating harm associated with the A+Z treatment.",220 mg daily 90 days (zinc sulfate),,,severe alcohol-associated hepatitis,severe alcohol-associated hepatitis,Tier 2,0.65,"High-quality double-blind randomized controlled trial in severe alcohol-associated hepatitis with 90-day survival as the primary outcome. However, zinc was given only in combination with anakinra, so the effect cannot be isolated to zinc. The anakinra+zinc arm had worse survival and more acute kidney injury than prednisone. Strong clinical trial, but indirect for zinc specifically, warranting a moderate evidence tier."
Zinc,A+Z may be nephrotoxic in patients with severe alcohol-associated hepatitis; acute kidney injury more frequent with A+Z than prednisone; being underweight increases vomiting risk; constipation; dehydration increases vomiting risk; diarrhoea; did not cause diarrhea; did not cause rash; did not cause vomiting; gastritis; gastrointestinal disorders; gastrointestinal pain; increased vomiting episodes in zinc group compared to placebo; loss of smell; nausea; stomach cramps; unpleasant taste; vomiting,General Oral Health,,Oral Health,manual_pair,"One randomized trial reported that zinc oxide nanoparticle coated elastomeric modules significantly reduced Streptococcus mutans concentration and improved enamel mineralization, suggesting a potential benefit for tooth decay. However, the evidence is limited to a single study, and further research is needed to confirm these findings and assess long-term effects and safety.",0.7,40691696,2025,Evaluation of zinc oxide nanoparticle coated elastomeric modules and it's effect on Streptococcus mutans concentration and enamel mineralization - A randomized split mouth trial.,randomized_controlled_trial,benefit,"The study showed that zinc oxide coated modules significantly reduced S. mutans concentration and improved enamel mineralization compared to non-coated modules, indicating a benefit.",one year (zinc oxide nanoparticle coated elastomeric modules),,,enamel mineralization,enamel mineralization; streptococcus mutans concentration,Tier 3,0.55,"Small randomized split-mouth trial (n=16) in orthodontic patients using zinc oxide nanoparticle–coated elastomeric modules showed reduced S. mutans and improved enamel mineralization by laser fluorescence at 1 year. Outcomes are surrogate (not clinical caries or broader oral health endpoints), the delivery is a device-based topical coating rather than systemic supplementation, and generalizability to overall oral health is limited. Thus, preliminary human evidence with surrogate outcomes."
Zinc,A+Z may be nephrotoxic in patients with severe alcohol-associated hepatitis; acute kidney injury more frequent with A+Z than prednisone; being underweight increases vomiting risk; constipation; dehydration increases vomiting risk; diarrhoea; did not cause diarrhea; did not cause rash; did not cause vomiting; gastritis; gastrointestinal disorders; gastrointestinal pain; increased vomiting episodes in zinc group compared to placebo; loss of smell; nausea; stomach cramps; unpleasant taste; vomiting,Tooth Sensitivity,,Oral Health,manual_pair,"Two randomized controlled trials have reported benefits of zinc in reducing tooth sensitivity, one using zinc-doped polymeric nanoparticles and the other a zinc-citrate toothpaste. Both studies demonstrated significant improvements in tooth sensitivity outcomes, although the specific doses were not consistently reported. No adverse effects were noted in the studies, but further research may be needed to confirm these findings and assess long-term safety.",0.9,40517062,2025,"Zinc-doped polymeric nanoparticles in the treatment of dentin hypersensitivity: A randomized, double-blind, placebo-controlled clinical trial.",randomized_controlled_trial,benefit,"The study demonstrated a significant reduction in dentin hypersensitivity after treatment with zinc-doped nanoparticles, indicating a beneficial outcome.",21 days (zinc-doped polymeric nanoparticles),,,dentin hypersensitivity,dentin hypersensitivity; gingivitis; plaque accumulation; tooth sensitivity,Tier 1,0.69,"Randomized, double-blind, placebo-controlled clinical trial (n=60) with dentin hypersensitivity as the primary outcome showed significant benefit on validated pain scales. Methods and blinding are strong. Limitations include short follow-up (21 days) and a formulation-specific, topical zinc-doped nanoparticle delivery, which may limit generalizability to other zinc forms."
Zinc,A+Z may be nephrotoxic in patients with severe alcohol-associated hepatitis; acute kidney injury more frequent with A+Z than prednisone; being underweight increases vomiting risk; constipation; dehydration increases vomiting risk; diarrhoea; did not cause diarrhea; did not cause rash; did not cause vomiting; gastritis; gastrointestinal disorders; gastrointestinal pain; increased vomiting episodes in zinc group compared to placebo; loss of smell; nausea; stomach cramps; unpleasant taste; vomiting,Tooth Sensitivity,,Oral Health,manual_pair,"Two randomized controlled trials have reported benefits of zinc in reducing tooth sensitivity, one using zinc-doped polymeric nanoparticles and the other a zinc-citrate toothpaste. Both studies demonstrated significant improvements in tooth sensitivity outcomes, although the specific doses were not consistently reported. No adverse effects were noted in the studies, but further research may be needed to confirm these findings and assess long-term safety.",0.9,39572408,2024,The clinical and microbiological efficacy of a zinc-citrate/hydroxyapatite/potassium-citrate containing toothpaste: a double-blind randomized controlled clinical trial.,randomized_controlled_trial,benefit,"The toothpaste containing zinc-citrate showed a significant reduction in salivary counts of S. mutans and improved self-reported tooth sensitivity, indicating a beneficial outcome.",4 weeks (toothpaste),,,gingivitis,dentin hypersensitivity; gingivitis; plaque accumulation; tooth sensitivity,Tier 4,0.36,"Double-blind RCT showed improved self-reported tooth sensitivity after 4 weeks, but the intervention was a multi-ingredient toothpaste (zinc-citrate + hydroxyapatite + potassium-citrate + fluoride) versus fluoride alone. Because zinc was not isolated, the effect cannot be attributed to zinc specifically. Outcome appears secondary and short-term, further limiting attribution to zinc for tooth sensitivity."
